PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ando, T; Charindra, D; Shrestha, M; Umehara, H; Ogawa, I; Miyauchi, M; Takata, T				Ando, T.; Charindra, D.; Shrestha, M.; Umehara, H.; Ogawa, I.; Miyauchi, M.; Takata, T.			Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer	ONCOGENE			English	Article							HIPPO PATHWAY; ONCOGENIC ACTIVITY; REGULATES YAP; SIZE-CONTROL; 1 TIMP-1; GROWTH; TEAD; PROGNOSIS; TAZ; TUMORIGENESIS	Tissue inhibitor of metalloproteinase-1 (TIMP-1), a member of the TIMP family (TIMP-1 to 4), is highly expressed in various types of cancer and forms a complex with its receptor CD63 and Integrin beta 1. However, the precise oncogenic mechanism of TIMP-1 remains unclear. Yes-associated protein (YAP) and transcriptional co-activator with PDZ binding motif (TAZ) are transcription co-activators enhancing the transcription of specific genes related to cell proliferation. But the mechanism of aberrant YAP/TAZ activation in cancer is not fully understood. Here, we showed that TIMP-1 activates YAP/TAZ as novel downstream targets to promote cell proliferation. The TIMP-1-CD63-Integrin beta 1 axis activates Src and promotes RhoA-mediated F-actin assembly, leading to LATS1/2 inactivation. This results in under-phosphorylation, protein stabilization and nuclear translocation of YAP/TAZ (YAP/TAZ activation); CTGF production; and cell proliferation. Furthermore, the TIMP-1-YAP/TAZ axis is aberrantly activated in various types of cancer cells or tissues. TIMP-1 knockdown inhibits cell proliferation through YAP/TAZ inactivation in cancer cells. This study found that TIMP-1 accelerates cell proliferation through YAP/TAZ activation in cancer, and suggests the TIMP-1-YAP/TAZ axis may be a novel potential drug target for cancer patients.	[Ando, T.; Charindra, D.; Shrestha, M.; Umehara, H.; Miyauchi, M.; Takata, T.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Ogawa, I.] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan	Hiroshima University; Hiroshima University	Takata, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Basic Life Sci,Mimami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	ttakata@hiroshima-u.ac.jp	Ando, Toshinori/AAG-4033-2021; Shrestha, Madhu/HHC-3819-2022; Ando, Toshinori/AAA-6401-2021; Miyauchi, Mutsumi/G-5268-2019	Ando, Toshinori/0000-0002-3141-8173; Ando, Toshinori/0000-0002-3141-8173; 	JSPS KAKENHI [JP25293373, JP16H05503, 17K17084]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Professor Koichiro Ozawa (Department of Pharmacotherapy, Hiroshima University) for valuable discussion and Professor Makiko Fujii (Department of Global Dental Medicine and Molecular Oncology, Hiroshima University) for providing us HA-tagged YAP-WT vector and anti-HA antibody. This work was funded, in part, by JSPS KAKENHI Grant Number JP25293373 and JP16H05503 to (TT) and 17K17084 to (TA). Hanako Umehara currently belongs to department of advanced prosthodontics, Hiroshima University.	Aaberg-Jessen C, 2009, J NEURO-ONCOL, V95, P117, DOI 10.1007/s11060-009-9910-8; Ando T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40187; Brodowska K, 2014, EXP EYE RES, V124, P67, DOI 10.1016/j.exer.2014.04.011; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; Dechaphunkul A, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/290854; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Egea V, 2012, P NATL ACAD SCI USA, V109, pE309, DOI 10.1073/pnas.1115083109; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Grunnet M, 2013, SCAND J GASTROENTERO, V48, P899, DOI 10.3109/00365521.2013.812235; Honkavuori M, 2008, ANTICANCER RES, V28, P2715; Jackson HW, 2017, NAT REV CANCER, V17, P38, DOI 10.1038/nrc.2016.115; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kozlowski M, 2013, ADV MED SCI-POLAND, V58, P227, DOI 10.2478/ams-2013-0017; Liu G, 2015, ONCOGENE, V34, P3536, DOI 10.1038/onc.2014.281; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; Liu XW, 2005, CANCER RES, V65, P898; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Ma J, 2014, INT J CLIN EXP PATHO, V7, P246; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Mi W, 2015, ONCOGENE, V34, P3095, DOI 10.1038/onc.2014.251; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Oh WK, 2011, CANCER-AM CANCER SOC, V117, P517, DOI 10.1002/cncr.25394; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Shanzer M, 2017, P NATL ACAD SCI USA, V114, P1678, DOI 10.1073/pnas.1610223114; Song GH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0427-7; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Terpos E, 2010, LEUKEMIA RES, V34, P399, DOI 10.1016/j.leukres.2009.08.035; Toricelli M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-22; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Xia YF, 2012, NAT CELL BIOL, V14, P257, DOI 10.1038/ncb2428; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoo YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14018; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2016, CURR OPIN PHARMACOL, V29, P26, DOI 10.1016/j.coph.2016.05.002; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	57	28	28	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					263	270		10.1038/onc.2017.321	http://dx.doi.org/10.1038/onc.2017.321			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28925394				2022-12-26	WOS:000422631700012
J	Comiskey, DF; Jacob, AG; Sanford, BL; Montes, M; Goodwin, AK; Steiner, H; Matsa, E; Tapia-Santos, AS; Bebee, TW; Grieves, J; La Perle, K; Boyaka, P; Chandler, DS				Comiskey, D. F., Jr.; Jacob, A. G.; Sanford, B. L.; Montes, M.; Goodwin, A. K.; Steiner, H.; Matsa, E.; Tapia-Santos, A. S.; Bebee, T. W.; Grieves, J.; La Perle, K.; Boyaka, P.; Chandler, D. S.			A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo	ONCOGENE			English	Article							SPLICED MDM2 TRANSCRIPTS; DNA-DAMAGE RESPONSE; MESSENGER-RNA STABILIZATION; P53 MUTANT MICE; GENOMIC INSTABILITY; PEDIATRIC RHABDOMYOSARCOMA; SIGNALING PATHWAY; ONCOPROTEIN MDM2; TUMOR SPECTRUM; CELL-LINES	Alternative splicing of the oncogene murine double minute 2 (MDM2) is induced in response to genotoxic stress. MDM2-ALT1, the major splice variant generated, is known to activate the p53 pathway and impede full-length MDM2's negative regulation of p53. Despite this perceptible tumor-suppressive role, MDM2-ALT1 is also associated with several cancers. Furthermore, expression of MDM2-ALT1 has been observed in aggressive metastatic disease in pediatric rhabdomyosarcoma (RMS), irrespective of histological subtype. Therefore, we generated a transgenic MDM2-ALT1 mouse model that would allow us to investigate the effects of this splice variant on the progression of tumorigenesis. Here we show that when MDM2-ALT1 is ubiquitously expressed in p53 null mice it leads to increased incidence of spindle cell sarcomas, including RMS. Our data provide evidence that constitutive MDM2-ALT1 expression is itself an oncogenic lesion that aggravates the tumorigenesis induced by p53 loss. On the contrary, when MDM2-ALT1 is expressed solely in B-cells in the presence of homozygous wild-type p53 it leads to significantly increased lymphomagenesis (56%) when compared with control mice (27%). However, this phenotype is observable only at later stages in life (>= 18 months). Moreover, flow cytometric analyses for B-cell markers revealed an MDM2-ALT1-associated decrease in the B-cell population of the spleens of these animals. Our data suggest that the B-cell loss is p53 dependent and is a response mounted to persistent MDM2-ALT1 expression in a wild-type p53 background. Overall, our findings highlight the importance of an MDM2 splice variant as a critical modifier of both p53-dependent and -independent tumorigenesis, underscoring the complexity of MDM2 posttranscriptional regulation in cancer. Furthermore, MDM2-ALT1-expressing p53 null mice represent a novel mouse model of fusion-negative RMS.	[Comiskey, D. F., Jr.; Jacob, A. G.; Montes, M.; Tapia-Santos, A. S.; Bebee, T. W.; Chandler, D. S.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Comiskey, D. F., Jr.; Jacob, A. G.; Montes, M.; Tapia-Santos, A. S.; Bebee, T. W.; Chandler, D. S.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Comiskey, D. F., Jr.; Jacob, A. G.; Sanford, B. L.; Montes, M.; Goodwin, A. K.; Matsa, E.; Tapia-Santos, A. S.; Bebee, T. W.; Chandler, D. S.] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, 700 Childrens Dr, Columbus, OH 43205 USA; [Steiner, H.; Grieves, J.; La Perle, K.; Boyaka, P.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Grieves, J.] Takeda Calif Inc, Drug Safety Res & Evaluat 10410 Sci Ctr Dr, San Diego, CA 92121 USA; [Chandler, D. S.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; University System of Ohio; Ohio State University	Chandler, DS (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, 700 Childrens Dr, Columbus, OH 43205 USA.	chandler.135@osu.edu	La Perle, Krista Marie DuBray/B-3099-2015	Boyaka, Prosper/0000-0001-6857-9088	NCI Cancer Center Support Grant [P30 CA016058]; Alex's Lemonade Stand; NIH [CA133571]; Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA133571] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alex's Lemonade Stand; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Matthew Rouhier for optimizing conditions for cell cycle analysis of B-cells; Juliann Rectenwald and The Ohio State University Comparative Pathology & Mouse Phenotyping Shared Resource, supported in part through NCI Cancer Center Support Grant P30 CA016058; and funding sources Alex's Lemonade Stand, Sarcoma Foundation of America, NIH (CA133571) awarded to DSC and Pelotonia (awarded to DFC and AGJ). We also thank Dr Andras Nagy for kindly providing the plasmid used in generating the mouse models.	Abraham J, 2014, GENE DEV, V28, P1578, DOI 10.1101/gad.238733.114; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; ALTMANNSBERGER M, 1985, AM J PATHOL, V118, P85; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartel F, 2001, ONCOL RES, V12, P451, DOI 10.3727/096504001108747459; Bartel F, 2001, INT J CANCER, V95, P168, DOI 10.1002/1097-0215(20010520)95:3<168::AID-IJC1029>3.0.CO;2-A; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Brien DO, 2012, HISTOL HISTOPATHOL, V27, P13, DOI 10.14670/HH-27.13; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Carr MI, 2016, CELL REP, V16, P2618, DOI 10.1016/j.celrep.2016.08.014; Carrillo AM, 2015, ONCOGENE, V34, P846, DOI 10.1038/onc.2014.27; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Cheng Q, 2011, MOL CELL BIOL, V31, P4951, DOI 10.1128/MCB.05553-11; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Dang JJ, 2002, CANCER RES, V62, P1222; Davis RJ, 1997, P NATL ACAD SCI USA, V94, P8047, DOI 10.1073/pnas.94.15.8047; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Ellsworth RE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-297; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Evdokiou A, 2001, INT J ONCOL, V19, P625; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fernandez K, 2010, AM J PATHOL, V176, P416, DOI 10.2353/ajpath.2010.090405; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Fridman JS, 2003, CANCER RES, V63, P5703; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Gannon HS, 2012, CANCER CELL, V21, P668, DOI 10.1016/j.ccr.2012.04.011; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gu L, 2012, ONCOGENE, V31, P1342, DOI 10.1038/onc.2011.343; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Hachitanda Y, 1998, MODERN PATHOL, V11, P1222; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Hong SK, 2006, CELL CYCLE, V5, P801, DOI 10.4161/cc.5.8.2638; Hori M, 2000, PATHOL INT, V50, P786, DOI 10.1046/j.1440-1827.2000.01119.x; Hosur V, 2012, CANCER GENET-NY, V205, P232, DOI 10.1016/j.cancergen.2012.03.005; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacob AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104444; Jacob AG, 2013, NEOPLASIA, V15, P1049, DOI 10.1593/neo.13286; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Jung CH, 2013, CANCER LETT, V335, P270, DOI 10.1016/j.canlet.2013.02.035; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Kraus A, 1999, INT J CANCER, V80, P930, DOI 10.1002/(SICI)1097-0215(19990315)80:6<930::AID-IJC20>3.3.CO;2-D; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar S, 2000, MODERN PATHOL, V13, P988, DOI 10.1038/modpathol.3880179; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lukas J, 2001, CANCER RES, V61, P3212; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Lynch CJ, 2006, ONCOGENE, V25, P3463, DOI 10.1038/sj.onc.1209387; Mai S, 1996, CHROMOSOME RES, V4, P365, DOI 10.1007/BF02257272; Matsumoto R, 1998, CANCER RES, V58, P609; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; McDonnell TJ, 1999, J PATHOL, V188, P322, DOI 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F; MINNITI CP, 1994, AM J CLIN PATHOL, V101, P198, DOI 10.1093/ajcp/101.2.198; Miron K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8094; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nanni P, 2003, CANCER RES, V63, P2728; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ognjanovic Simona, 2012, Sarcoma, V2012, P492086, DOI 10.1155/2012/492086; Okoro DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077643; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; RANGDAENG S, 1991, AM J CLIN PATHOL, V96, P32, DOI 10.1093/ajcp/96.1.32; Sanchez-Aguilera A, 2006, ONCOGENE, V25, P2565, DOI 10.1038/sj.onc.1209282; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Singh S, 2013, CELL DEATH DIFFER, V20, P558, DOI 10.1038/cdd.2012.153; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Takano Ai, 2011, Kobe J Med Sci, V56, pE220; Takano A, 2010, DEV DYNAM, V239, P1789, DOI 10.1002/dvdy.22287; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Tang YA, 2012, CLIN CANCER RES, V18, P4325, DOI 10.1158/1078-0432.CCR-11-2617; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Volk EL, 2009, MOL CANCER RES, V7, P863, DOI 10.1158/1541-7786.MCR-08-0418; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zanola A, 2012, J CELL MOL MED, V16, P1377, DOI 10.1111/j.1582-4934.2011.01518.x; Zheng TS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3996; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	101	7	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					95	106		10.1038/onc.2017.282	http://dx.doi.org/10.1038/onc.2017.282			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28892044	Green Accepted			2022-12-26	WOS:000422625000010
J	Ringel, MT; Drager, G; Bruser, T				Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			The periplasmic transaminase PtaA of Pseudomonas fluorescens converts the glutamic acid residue at the pyoverdine fluorophore to -ketoglutaric acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; iron; Pseudomonas; pyridoxal phosphate; siderophore; periplasmic tailoring; pyoverdines; transaminase	POLYACRYLAMIDE-GELS; WEB SERVER; ELECTROPHORETIC TRANSFER; ESCHERICHIA-COLI; SIDEROPHORES; PROTEIN; AERUGINOSA; BIOSYNTHESIS; SECRETION; NITROCELLULOSE	The periplasmic conversion of ferribactin to pyoverdine is essential for siderophore biogenesis in fluorescent pseudomonads, such as pathogenic Pseudomonas aeruginosa or plant growth-promoting Pseudomonas fluorescens. The non-ribosomal peptide ferribactin undergoes cyclizations and oxidations that result in the fluorophore, and a strictly conserved fluorophore-bound glutamic acid residue is converted to a range of variants, including succinamide, succinic acid, and -ketoglutaric acid residues. We recently discovered that the pyridoxal phosphate-containing enzyme PvdN is responsible for the generation of the succinamide, which can be hydrolyzed to succinic acid. Based on this, a distinct unknown enzyme was postulated to be responsible for the conversion of the glutamic acid to -ketoglutaric acid. Here we report the identification and characterization of this enzyme in P. fluorescens strain A506. In silico analyses indicated a periplasmic transaminase in fluorescent pseudomonads and other proteobacteria that we termed PtaA for periplasmic transaminase A. An in-frame-deleted ptaA mutant selectively lacked the -ketoglutaric acid form of pyoverdine, and recombinant PtaA complemented this phenotype. The ptaA/pvdN double mutant produced exclusively the glutamic acid form of pyoverdine. PtaA is homodimeric and contains a pyridoxal phosphate cofactor. Mutation of the active-site lysine abolished PtaA activity and affected folding as well as Tat-dependent transport of the enzyme. In pseudomonads, the occurrence of ptaA correlates with the occurrence of -ketoglutaric acid forms of pyoverdines. As this enzyme is not restricted to pyoverdine-producing bacteria, its catalysis of periplasmic transaminations is most likely a general tool for specific biosynthetic pathways.	[Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Schneiderberg 1 B, D-30167 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Science Foundation (Deutsche Forschungsgemeinschaft) [GRK1798, BR 2285/7-1]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (Deutsche Forschungsgemeinschaft) GRK1798 "Signaling at the Plant-Soil Interface" and Project BR 2285/7-1. The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRISKOT G, 1986, Z NATURFORSCH C, V41, P497; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Calhoun DH, 2001, GENOME BIOL, V2; Cezard C, 2015, CURR MED CHEM, V22, P165, DOI 10.2174/0929867321666141011194624; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; DEMANGE P, 1990, BIOCHEMISTRY-US, V29, P11041, DOI 10.1021/bi00502a005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Drake EJ, 2016, ACTA CRYSTALLOGR F, V72, P403, DOI 10.1107/S2053230X16006257; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GEISEN K, 1992, MONATSH CHEM, V123, P151, DOI 10.1007/BF01045308; Gulick AM, 2017, NAT PROD REP, V34, P981, DOI 10.1039/c7np00029d; GWOSE I, 1992, Z NATURFORSCH C, V47, P487; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; HOHLNEICHER U, 1992, Z NATURFORSCH B, V47, P1633, DOI 10.1515/znb-1992-1119; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KOEDAM N, 1994, BIOMETALS, V7, P287; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz C, 2000, Z NATURFORSCH C, V55, P146; Meyer JM, 2008, BIOMETALS, V21, P259, DOI 10.1007/s10534-007-9115-6; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POPPE K, 1987, TETRAHEDRON, V43, P2261, DOI 10.1016/S0040-4020(01)86810-1; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; SCHAFER H, 1991, Z NATURFORSCH C, V46, P398; Schalk IJ, 2017, J MED CHEM, V60, P4573, DOI 10.1021/acs.jmedchem.7b00554; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Schons V, 2005, BIOCHEMISTRY-US, V44, P14069, DOI 10.1021/bi051155s; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; TEINTZE M, 1981, BIOCHEMISTRY-US, V20, P6446, DOI 10.1021/bi00525a025; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wilson MJ, 2001, J BACTERIOL, V183, P2151, DOI 10.1128/JB.183.6.2151-2155.2001; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; YANG CC, 1984, BIOCHEMISTRY-US, V23, P3534, DOI 10.1021/bi00310a023; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0	58	8	8	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18660	18671		10.1074/jbc.M117.812545	http://dx.doi.org/10.1074/jbc.M117.812545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28912270	Green Published, hybrid			2022-12-26	WOS:000414958100022
J	Torres-da-Silvali, KR; Tessarin, GWL; Dias, CA; Guiati, IZ; Ervolino, E; Goncalves, A; Beneti, IM; Lovejoy, DA; Casatti, CA				Torres-da-Silvali, K. R.; Tessarin, G. W. L.; Dias, C. A.; Guiati, I. Z.; Ervolino, E.; Goncalves, A.; Beneti, I. M.; Lovejoy, D. A.; Casatti, C. A.			Teneurin-2 presence in rat and human odontoblasts	PLOS ONE			English	Article							TERMINAL-ASSOCIATED PEPTIDES; PAIR-RULE GENE; INTRACELLULAR DOMAIN; IN-SITU; EXPRESSION; DYSTROGLYCAN; PROTEINS; FAMILY; DIFFERENTIATION; ORGANIZATION	Teneurins are transmembrane proteins consisting of four paralogues (Ten-1-4), notably expressed in the central nervous system during development. All teneurins contain a bioactive peptide in their carboxyl terminal named teneurin C-terminal associated peptide (TCAP). The present study analyzed the detailed distribution of teneurin-2-like immunoreactive (Ten-2-LI) cells in developing and mature rat molar teeth, as well as in mature human dental pulps. Ten-2 and TCAP-2 genic expressions were also evaluated in rat and human dental pulps. Finally, Ten-2-LI cells were analyzed during the repair process after dentinpulp complex injury in rat lower molar teeth. For this, histological sections of rat molar teeth and human dental pulps were submitted to immunohistochemical techniques, while total RNA from developing rat teeth and mature human dental pulps were submitted to conventional RT-PCR. Ten-2-LI cells were evident in the initial bell stage of rat molar teeth development, especially in ectomesenchymal cells of the dental papilla. Ten-2-LI odontoblasts showed strong immunoreactivity in rat and human mature teeth. Ten-2 and TCAP-2 genic expressions were confirmed in rat and human dental pulps. Dentin-pulp complex injury resulted in a decrease of Ten-2-LI odontoblasts after traumatic injury. Interestingly, Ten-2-LI cells were also evident in the pulp cell-rich zone in all postoperative days. In conclusion, Ten-2-LI presence in rat and human odontoblasts was demonstrated for the first time and Ten-2/TCAP-2 genic expressions were confirmed in rat and human dental pulps. Furthermore, it was revealed that Ten-2-LI rat odontoblasts can be modulated during the regenerative process.	[Torres-da-Silvali, K. R.; Tessarin, G. W. L.; Guiati, I. Z.; Casatti, C. A.] Sao Paulo State Univ, Inst Biosci Botucatu, Botucatu, SP, Brazil; [Dias, C. A.; Guiati, I. Z.; Ervolino, E.; Goncalves, A.; Casatti, C. A.] Sao Paulo State Univ, Sch Dent Aracatuba, Basic Sci Dept, Aracatuba, SP, Brazil; [Dias, C. A.] Sao Paulo State Univ, Sch Dent Aracatuba, Restorat Dent Dept, Aracatuba, SP, Brazil; [Beneti, I. M.] Sao Paulo State Univ, Sch Dent Aracatuba, Dept Surg & Integrated Clin, Aracatuba, SP, Brazil; [Lovejoy, D. A.] Univ Toronto, Cell & Syst Biol Dept, Toronto, ON, Canada	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Toronto	Casatti, CA (corresponding author), Sao Paulo State Univ, Inst Biosci Botucatu, Botucatu, SP, Brazil.; Casatti, CA (corresponding author), Sao Paulo State Univ, Sch Dent Aracatuba, Basic Sci Dept, Aracatuba, SP, Brazil.	ccasatti@foa.uneap.br	Casatti, Cláudio/AAD-1451-2019; casatti, claudio A/C-3633-2012; Ervolino, Edilson/D-1500-2018	Casatti, Cláudio/0000-0001-5650-7343; ervolino, edilson/0000-0003-4859-0583	FAPESP (Sao Paulo State Research Foundation, SP, Brazil) [2012/03067-6]; FAPESP (KRTS) [FAPESP 2012/08833-9]; FAPESP (CAD) [FAPESP 2013/0635-06]; FAPESP (IZG) [FAPESP 2013/01288-8]	FAPESP (Sao Paulo State Research Foundation, SP, Brazil); FAPESP (KRTS); FAPESP (CAD); FAPESP (IZG)	This work was supported by FAPESP (Sao Paulo State Research Foundation, SP, Brazil) for: a) research (2012/03067-6); b) fellowship (KRTS, FAPESP 2012/08833-9; c) fellowship (CAD, FAPESP 2013/0635-06); d) fellowship (IZG, FAPESP 2013/01288-8).	Al Chawaf A, 2007, NEUROSCIENCE, V144, P1241, DOI 10.1016/j.neuroscience.2006.09.062; Al Chawaf A, 2007, PEPTIDES, V28, P1406, DOI 10.1016/j.peptides.2007.05.014; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Boucard AA, 2014, J BIOL CHEM, V289, P387, DOI 10.1074/jbc.M113.504779; Chand D, 2012, NEUROSCIENCE, V219, P255, DOI 10.1016/j.neuroscience.2012.05.069; Chand D, 2014, HISTOCHEM CELL BIOL, V141, P191, DOI 10.1007/s00418-013-1154-1; Han PP, 2015, J BONE MINER RES, V30, P1160, DOI 10.1002/jbmr.2445; Harada M, 2008, HISTOCHEM CELL BIOL, V130, P773, DOI 10.1007/s00418-008-0438-3; Ida-Yonemochi H, 2013, GENE EXPR PATTERNS, V13, P293, DOI 10.1016/j.gep.2013.05.004; Ishii K, 2015, STEM CELLS, V33, P3017, DOI 10.1002/stem.2058; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; LEVY GG, 1980, J PERIODONTOL, V51, P393, DOI 10.1902/jop.1980.51.7.393; Li ST, 2015, J CELL PHYSIOL, V230, P2164, DOI 10.1002/jcp.24945; Lossie AC, 2005, GENETICS, V169, P285, DOI 10.1534/genetics.104.034967; Lovejoy DA, 2009, ANN NY ACAD SCI, V1163, P215, DOI 10.1111/j.1749-6632.2008.03629.x; Luan XH, 2007, J HISTOCHEM CYTOCHEM, V55, P127, DOI 10.1369/jhc.6A7018.2006; Lucchini M, 2004, J DENT RES, V83, P552, DOI 10.1177/154405910408300708; Mieda M, 1999, MECH DEVELOP, V87, P223, DOI 10.1016/S0925-4773(99)00155-0; Moon CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053900; Mosca TJ, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00204, 10.3389/fncel.2015.00204]; Murakami T, 2010, J ANAT, V217, P236, DOI 10.1111/j.1469-7580.2010.01267.x; Neves VC, 2017, SCI REP; Ng T, 2012, REGUL PEPTIDES, V174, P79, DOI 10.1016/j.regpep.2011.12.003; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Otaki JM, 1999, DEV BIOL, V212, P165, DOI 10.1006/dbio.1999.9310; Qian XJ, 2004, GEN COMP ENDOCR, V137, P205, DOI 10.1016/j.ygcen.2004.02.007; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Sharpe P T, 2001, Adv Dent Res, V15, P4; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Staquet MJ, 2006, CELL TISSUE RES, V323, P457, DOI 10.1007/s00441-005-0104-1; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Trubiani G, 2007, BRAIN RES, V1176, P27, DOI 10.1016/j.brainres.2007.07.087; Trzebiatowska A, 2008, MOL BIOL CELL, V19, P3898, DOI 10.1091/mbc.E08-01-0028; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Tucker RP, 2000, MECH DEVELOP, V98, P187, DOI 10.1016/S0925-4773(00)00444-5; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Vysokov NV, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00059; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Woelfle R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00146, 10.3389/fnins.2015.00146]; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	45	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184794	10.1371/journal.pone.0184794	http://dx.doi.org/10.1371/journal.pone.0184794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926618	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600042
J	Laub, KR; Marek, M; Stanchev, LD; Herrera, SA; Kanashova, T; Bourmaud, A; Dittmar, G; Pomorski, TG				laub, Katrine Rude; Marek, Magdalena; Stanchev, Lyubomir Dimitrov; Herrera, Sara Abad; Kanashova, Tamara; Bourmaud, Adele; Dittmar, Gunnar; Pomorski, Thomas Guenther			Purification and characterisation of the yeast plasma membrane ATP binding cassette transporter Pdr11p	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; STEROL UPTAKE; NUCLEOTIDE-BINDING; ABC TRANSPORTERS; P-GLYCOPROTEIN; HYDROLYSIS; CHOLESTEROL; PROTEINS; LIPIDS; CELLS	The ATP binding cassette (ABC) transporters Pdr11p and its paralog Aus1p are expressed under anaerobic growth conditions at the plasma membrane of the yeast Saccharomyces cerevisiae and are required for sterol uptake. However, the precise mechanism by which these ABC transporters facilitate sterol movement is unknown. In this study, an overexpression and purification procedure was developed with the aim to characterise the Pdr11p transporter. Engineering of Pdr11p variants fused at the C terminus with green fluorescent protein (Pdr11p-GFP) and containing a FLAG tag at the N terminus facilitated expression analysis and one-step purification, respectively. The detergent-solubilised and purified protein displayed a stable ATPase activity with a broad pH optimum near 7.4. Mutagenesis of the conserved lysine to methionine (K788M) in the Walker A motif abolished ATP hydrolysis. Remarkably, and in contrast to Aus1p, ATPase activity of Pdr11p was insensitive to orthovanadate and not specifically stimulated by phosphatidylserine upon reconstitution into lipo-somes. Our results highlight distinct differences between Pdr11p and Aus1p and create an experimental basis for further biochemical studies of both ABC transporters to elucidate their function.	[laub, Katrine Rude; Marek, Magdalena; Stanchev, Lyubomir Dimitrov; Herrera, Sara Abad; Pomorski, Thomas Guenther] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Stanchev, Lyubomir Dimitrov; Herrera, Sara Abad; Pomorski, Thomas Guenther] Ruhr Univ Bochum, Dept Mol Biochem, Bochum, Germany; [Kanashova, Tamara; Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Mass Spectrometry Core Unit, Berlin, Germany; [Bourmaud, Adele; Dittmar, Gunnar] Luxembourg Inst Hlth, Proteome & Genome Res Lab, Strassen, Luxembourg; [Marek, Magdalena] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Copenhagen; Ruhr University Bochum; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Luxembourg Institute of Health; University of Lausanne	Pomorski, TG (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark.; Pomorski, TG (corresponding author), Ruhr Univ Bochum, Dept Mol Biochem, Bochum, Germany.	tgp@plen.ku.dk	Dittmar, Gunnar/C-6333-2019; Pomorski, Thomas Günther/G-4804-2014	Dittmar, Gunnar/0000-0003-3647-8623; Pomorski, Thomas Günther/0000-0002-4889-0829; Stanchev, Lyubomir Dimitrov/0000-0002-0338-8210; Bourmaud, Adele/0000-0002-0557-3639	Research Centre 'bioSYNergy' at University of Copenhagen - UCPH; Villium Fonden [022868]; FNR [FNR/P09/01]; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	Research Centre 'bioSYNergy' at University of Copenhagen - UCPH; Villium Fonden; FNR(Luxembourg National Research Fund); Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	This work was supported by the Research Centre 'bioSYNergy' at University of Copenhagen funded by the UCPH Excellence Program for Interdisciplinary Research and the Villium Fonden (grant 022868 to TGP). AB was supported by FNR grant FNR/P09/01. TK was funded by the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hirayama H, 2013, J LIPID RES, V54, P496, DOI 10.1194/jlr.M033209; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Ketchum CJ, 2001, J BIOL CHEM, V276, P29007, DOI 10.1074/jbc.M100810200; Kohut P, 2011, BIOCHEM BIOPH RES CO, V404, P233, DOI 10.1016/j.bbrc.2010.11.099; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Lanfermeijer FC, 1998, PROTEIN EXPRES PURIF, V12, P29, DOI 10.1006/prep.1997.0788; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Mao QC, 1999, BBA-BIOMEMBRANES, V1461, P69, DOI 10.1016/S0005-2736(99)00150-9; Marek M, 2014, FEMS YEAST RES, V14, P1223, DOI 10.1111/1567-1364.12219; Marek M, 2011, J BIOL CHEM, V286, P21835, DOI 10.1074/jbc.M111.244525; MEAD DJ, 1986, MOL GEN GENET, V205, P417, DOI 10.1007/BF00338076; Nagi M, 2013, MOL MICROBIOL, V88, P371, DOI 10.1111/mmi.12189; Nakayama H, 2007, J ANTIMICROB CHEMOTH, V60, P1264, DOI 10.1093/jac/dkm321; Neumann J, 2017, BBA-BIOMEMBRANES, V1859, P605, DOI 10.1016/j.bbamem.2016.09.023; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184236	10.1371/journal.pone.0184236	http://dx.doi.org/10.1371/journal.pone.0184236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922409	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000411059300013
J	Murray, JW; Yin, D; Wolkoff, AW				Murray, John W.; Yin, David; Wolkoff, Allan W.			Reduction of organelle motility by removal of potassium and other solutes	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; MICROTUBULES IN-VITRO; COATED PIT FORMATION; CYTOPLASMIC DYNEIN; INTRACELLULAR POTASSIUM; MITOCHONDRIAL TRANSPORT; DEPENDENT MOVEMENT; VESICLE MOTILITY; KINESIN; CELLS	There are surprisingly few studies that describe how the composition of cell culture medium may affect the trafficking of organelles. Here we utilize time lapse multi-channel fluorescent imaging to show that short term exposure of Huh-7 cells to medium lacking potassium, sodium, or chloride strongly reduces but does not eliminate the characteristic back and forth and cell-traversing movement of fluorescent EGF (FL-EGF) containing organelles. We focused on potassium because of its relatively low abundance in media and serum and its energy requiring accumulation into cells. Upon exposure to potassium free medium, organelle motility declined steadily through 90 min and then persisted at a low level. Reduced motility was confirmed in 5 independent cell lines and for organelles of the endocytic pathway (FL-EGF and Lysotracker), autophagosomes (LC3-GFP), and mitochondria (TMRE). As has been previously established, potassium free medium also inhibited endocytosis. We expected that diminished cellular metabolism would precede loss of organelle motility. However, extracellular flux analysis showed near normal mitochondrial oxygen consumption and only a small decrease in extracellular acidification, the latter suggesting decreased glycolysis or proton efflux. Other energy dependent activities such as the accumulation of Lysotracker, TMRE, DiBAC4(3), and the exclusion of propidium iodide remained intact, as did the microtubule cytoskeleton. We took advantage of cell free in vitro motility assays and found that removal of potassium or sodium from the reconstituted cytosolic medium decreased the movement of endosomes on purified microtubules. The results indicate that although changes in proton homeostasis and cell energetics under solute depletion are not fully understood, potassium as well as sodium appear to be directly required by the motile machinery of organelles for optimal trafficking.	[Murray, John W.; Yin, David; Wolkoff, Allan W.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Div Gastroenterol & Liver Dis, Bronx, NY 10467 USA; [Murray, John W.; Yin, David; Wolkoff, Allan W.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Murray, John W.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Murray, JW (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Div Gastroenterol & Liver Dis, Bronx, NY 10467 USA.; Murray, JW (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.; Murray, JW (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	john.murray@einstein.yu.edu		Murray, John/0000-0002-4347-7824	National Institutes of Health Research [P30 DK041296, R01 DK098408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK023026] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grants P30 DK041296 (Wolkoff), R01 DK098408 (Wolkoff, Allan W., Cuervo, Ana Maria), https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KH, 2006, J EXP BIOL, V209, P3101, DOI 10.1242/jeb.02357; ALTANKOV G, 1993, J CELL BIOL, V120, P1449, DOI 10.1083/jcb.120.6.1449; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bananis E, 2003, J CELL SCI, V116, P2749, DOI 10.1242/jcs.00478; BRIMIJOIN S, 1979, J PHYSIOL-LONDON, V287, P303, DOI 10.1113/jphysiol.1979.sp012660; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; COHN SA, 1989, J BIOL CHEM, V264, P4290; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; Dejonghe W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11710; EAGLE H, 1956, ARCH BIOCHEM BIOPHYS, V61, P356, DOI 10.1016/0003-9861(56)90358-7; ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Gerencser AA, 2008, BIOPHYS J, V95, P3079, DOI 10.1529/biophysj.108.135657; GIBBONS BH, 1985, J CELL BIOL, V101, P1281, DOI 10.1083/jcb.101.4.1281; GIBBONS IR, 1966, J BIOL CHEM, V241, P5590; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hong WL, 2016, BIOPHYS J, V111, P1287, DOI 10.1016/j.bpj.2016.08.006; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; LANG F, 1995, KIDNEY INT, V48, P1200, DOI 10.1038/ki.1995.403; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LEDBETTER MLS, 1977, EXP CELL RES, V105, P223, DOI 10.1016/0014-4827(77)90120-3; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Macdonald JE, 2004, J AM COLL CARDIOL, V43, P155, DOI 10.1016/j.jacc.2003.06.021; MADSHUS IH, 1987, J CELL PHYSIOL, V131, P6, DOI 10.1002/jcp.1041310103; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCDONALD TF, 1972, EXP CELL RES, V74, P201, DOI 10.1016/0014-4827(72)90498-3; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Murray John W, 2007, Methods Mol Biol, V392, P143; Murray JW, 2008, TRAFFIC, V9, P833, DOI 10.1111/j.1600-0854.2008.00725.x; Murray JW, 2005, METHOD ENZYMOL, V403, P92, DOI 10.1016/S0076-6879(05)03009-0; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nunes P, 2015, P NATL ACAD SCI USA, V112, pE3104, DOI 10.1073/pnas.1421290112; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Rapp S, 1996, J CELL SCI, V109, P837; Readnower RD, 2012, PHYSIOL GENOMICS, V44, P1208, DOI 10.1152/physiolgenomics.00129.2012; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; SAMUELSON AC, 1988, AM J PHYSIOL, V254, pC829, DOI 10.1152/ajpcell.1988.254.6.C829; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; SHIMIZU T, 1991, J CELL BIOL, V112, P1189, DOI 10.1083/jcb.112.6.1189; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; SWANSON JA, 1992, J CELL SCI, V103, P201; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Toomre D, 1999, J CELL SCI, V112, P21; VALE RD, 1989, J CELL BIOL, V108, P2327, DOI 10.1083/jcb.108.6.2327; Wang PJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1052, DOI 10.1152/ajpgi.00584.2007; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375; Xu MF, 2001, AM J PHYSIOL-HEART C, V281, pH1295, DOI 10.1152/ajpheart.2001.281.3.H1295	60	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184898	10.1371/journal.pone.0184898	http://dx.doi.org/10.1371/journal.pone.0184898			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922372	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300040
J	Taglauer, ES; Artemiuk, PA; Hanscom, SR; Lindsay, AJ; Wuebbolt, D; Breathnach, FM; Tully, EC; Khan, AR; McCaffrey, MW				Taglauer, Elizabeth S.; Artemiuk, Patrycja A.; Hanscom, Sara R.; Lindsay, Andrew J.; Wuebbolt, Danielle; Breathnach, Fionnuala M.; Tully, Elizabeth C.; Khan, Amir R.; McCaffrey, Mary W.			Rab11 family expression in the human placenta: Localization at the maternal-fetal interface	PLOS ONE			English	Article							IN-VITRO MODELS; TROPHOBLAST CELLS; PROTEINS; TRANSPORT	Rab proteins are a family of small GTPases involved in a variety of cellular processes. The Rab11 subfamily in particular directs key steps of intracellular functions involving vesicle trafficking of the endosomal recycling pathway. This Rab subfamily works through a series of effector proteins including the Rab11-FIPs (Rab11 Family-Interacting Proteins). While the Rab11 subfamily has been well characterized at the cellular level, its function within human organ systems is still being explored. In an effort to further study these proteins, we conducted a preliminary investigation of a subgroup of endosomal Rab proteins in a range of human cell lines by Western blotting. The results from this analysis indicated that Rab11a, Rab11c(Rab25) and Rab14 were expressed in a wide range of cell lines, including the human placental trophoblastic BeWo cell line. These findings encouraged us to further analyse the localization of these Rabs and their common effector protein, the Rab Coupling Protein (RCP), by immunofluorescence microscopy and to extend this work to normal human placental tissue. The placenta is a highly active exchange interface, facilitating transfer between mother and fetus during pregnancy. As Rab11 proteins are closely involved in transcytosis we hypothesized that the placenta would be an interesting human tissue model system for Rab investigation. By immunofluorescence microscopy, Rab11a, Rab11c (Rab25), Rab14 as well as their common FIP effector RCP showed prominent expression in the placental cell lines. We also identified the expression of these proteins in human placental lysates by Western blot analysis. Further, via fluorescent immunohistochemistry, we noted abundant localization of these proteins within key functional areas of primary human placental tissues, namely the outer syncytial layer of placental villous tissue and the endothelia of fetal blood vessels. Overall these findings highlight the expression of the Rab11 family within the human placenta, with novel localization at the maternal-fetal interface.	[Taglauer, Elizabeth S.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Taglauer, Elizabeth S.; Khan, Amir R.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Artemiuk, Patrycja A.; Hanscom, Sara R.; Lindsay, Andrew J.; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Sch Biochem & Cell Biol, Mol Cell Biol Lab, Cork, Ireland; [Wuebbolt, Danielle] Royal Coll Surgeons Ireland, Sch Med, Dublin, Ireland; [Breathnach, Fionnuala M.; Tully, Elizabeth C.] Royal Coll Surgeons Ireland, Dept Obstet & Gynaecol, Dublin, Ireland	Harvard University; Boston Children's Hospital; Trinity College Dublin; University College Cork; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Taglauer, ES (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.; Taglauer, ES (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	elizabeth.taglauer@childrens.harvard.edu	Lindsay, Andrew J/P-9778-2017	Lindsay, Andrew J/0000-0001-9693-7022; Khan, Amir/0000-0003-1176-6952	Irish Research Council, IRCSET [GOIPD/2014/42]; Science Foundation Ireland [12/IA/1239, 09/IN.1/B2629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER	Irish Research Council, IRCSET; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by Irish Research Council, IRCSET Post-Doctoral fellowship (http://www.research.ie) GOIPD/2014/42 to EST; Science Foundation Ireland (sfi.ie) Principal Investigator Award (12/IA/1239) to ARK and a Science Foundation Ireland (sfi.ie) Principal Investigator Award (09/IN.1/B2629) to MWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Gavin McManus for confocal microscopy imaging analysis at Trinity College Dublin. This work was funded by the following grants/fellowships: Irish Research Council, IRCSET Post-Doctoral fellowship GOIPD/2014/42 to ES Taglauer, Science Foundation Ireland Principal Investigator Award (09/IN.1/B2629) to MW McCaffrey and a Science Foundation Ireland Principal Investigator Award (12/IA/1239) to AR Khan.	Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Bode CJ, 2006, METH MOLEC MED, V122, P225; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Gonzalez IM, 2014, PLACENTA, V35, P442, DOI 10.1016/j.placenta.2014.04.015; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Gupta AK, 2004, CLIN CHEM, V50, P2187, DOI 10.1373/clinchem.2004.040196; Haugsten EM, 2014, TRAFFIC, V15, P665, DOI 10.1111/tra.12168; Heaton SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1445, DOI 10.1152/ajpcell.00286.2008; Ishikawa T, 2015, INT J MOL MED, V35, P1273, DOI 10.3892/ijmm.2015.2141; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Kelly EE, 2012, BIOCHEM SOC T, V40, P1337, DOI 10.1042/BST20120203; Li LP, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0070-8; Lindsay AJ, 2016, RAB COUPLING PROTEIN; Nguyen T, 2013, PLACENTA, V34, P765, DOI 10.1016/j.placenta.2013.06.003; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Petroff MG, 2006, METH MOLEC MED, V121, P203; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; Vidricaire G, 2005, J IMMUNOL, V175, P6517, DOI 10.4049/jimmunol.175.10.6517; Yan ZB, 2016, ARTERIOSCL THROM VAS, V36, P339, DOI 10.1161/ATVBAHA.115.306549	22	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184864	10.1371/journal.pone.0184864	http://dx.doi.org/10.1371/journal.pone.0184864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922401	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300037
J	Baer, J; Hartmann, F; Brinker, A				Baer, Jan; Hartmann, Frank; Brinker, Alexander			Invasion strategy and abiotic activity triggers for non-native gobiids of the River Rhine	PLOS ONE			English	Article							GOBY NEOGOBIUS MELANOSTOMUS; ROUND GOBY; GREAT-LAKES; FISH; DIFFERENTIATION; COMMUNITY; BELGIUM; DANUBE; GROWTH; GOBIES	The 24 hour activity patterns of three non-native gobiids (round goby Neogobius melanostomus, Western tubenose goby Proterorhinus semilunaris and bighead goby Ponticola kessleri) were assessed over 46 consecutive months between 2011 and 2014 from their occurrence in the cooling water intake of a nuclear power plant on the River Rhine, Germany. In total, 117717 gobiids were identified and classified. The occurrence of all three species varied strongly between sampling years, and species-specific activity triggers were identified. The activity of juveniles of all three gobiids species was positively temperature dependent while adult tubenose goby activity appeared to be negatively temperature dependent. Increasing fluvial discharge in the adjoining main river stimulated the activity of juvenile round goby but inhibited activity of adult tubenose goby. Except for adult bighead goby, activity was also structured by time of day, but with no uniform mean. Meteorological factors such as precipitation, air pressure and duration of sunshine hours had little or no influence on gobiid activity. On selected rare occasions, mainly at night, all three species exhibited pulsed swarming behaviour, with thousands of individuals recorded in the intake water. Round goby swarms exhibited both the highest intensity and the largest swarming individuals, suggesting a potential competitive advantage over tubenose and bighead goby. Electric fishing surveys in natural river stretches corroborated this observation. Negative effects on the native fish fauna were apparent only for the bullhead, Cottus gobio. The activity triggers identified offer a unique insight into the invasion mechanisms of these ecosystem-changing non-native gobiids.	[Baer, Jan; Brinker, Alexander] LAZBW, Fisheries Res Stn Baden Wurttemberg, Langenargen, Germany; [Hartmann, Frank] Regierungsprasidium Karlsruhe, Fisheries Adm, Karlsruhe, Germany		Baer, J (corresponding author), LAZBW, Fisheries Res Stn Baden Wurttemberg, Langenargen, Germany.	Jan.Baer@lazbw.bwl.de	Brinker, Alexander/ABF-4644-2020	Brinker, Alexander/0000-0002-2433-5652; Baer, Jan/0000-0001-8388-6684				Adamek Z, 2007, INT REV HYDROBIOL, V92, P554, DOI 10.1002/iroh.200510998; Baer J., 2014, ROTE LISTE BADEN WUR; Bjorklund M, 2010, BIOL INVASIONS, V12, P2609, DOI 10.1007/s10530-009-9669-z; Borcherding J, 2013, LIMNOLOGICA, V43, P49, DOI 10.1016/j.limno.2012.08.003; Brandner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073036; Bronnenhuber JE, 2011, MOL ECOL, V20, P1845, DOI 10.1111/j.1365-294X.2011.05030.x; Cammaerts R, 2012, AQUAT INVASIONS, V7, P251, DOI 10.3391/ai.2012.7.2.011; Chuang YL, 2009, J SEA RES, V61, P197, DOI 10.1016/j.seares.2009.01.001; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Coulter DP, 2011, J FRESHWATER ECOL, V26, P155, DOI 10.1080/02705060.2011.553987; Cullen P, 2003, ENVIRON BIOL FISH, V67, P349, DOI 10.1023/A:1025878830457; Dopazo SN, 2008, J GREAT LAKES RES, V34, P450, DOI 10.3394/0380-1330(2008)34[450:FAAEVA]2.0.CO;2; Dubs DOL, 1996, J GREAT LAKES RES, V22, P838, DOI 10.1016/S0380-1330(96)71005-5; Gertzen S, 2016, THESIS; Glarer H., LENGTH DAY TWILIGHT; GREGORY RS, 1993, CAN J FISH AQUAT SCI, V50, P241, DOI 10.1139/f93-027; Grul'a D, 2012, CENT EUR J BIOL, V7, P448, DOI 10.2478/s11535-012-0024-5; HADDERINGH R H, 1983, Hydrobiological Bulletin, V17, P129, DOI 10.1007/BF02280822; Janac M, 2013, ECOL FRESHW FISH, V22, P430, DOI 10.1111/eff.12037; Janac M, 2012, FUND APPL LIMNOL, V181, P73, DOI 10.1127/1863-9135/2012/0321; Jonsson N., 1991, NORD J FRESHW RES, V66, P20; Kennish M.J., 1992, ECOLOGY ESTUARIES AN; Kocovsky PM, 2011, BIOL INVASIONS, V13, P2775, DOI 10.1007/s10530-011-9962-5; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kovac V, 2009, J APPL ICHTHYOL, V25, P33, DOI 10.1111/j.1439-0426.2009.01189.x; Krause J, 2002, LIVING GROUPS; Maes J, 1998, ESTUAR COAST SHELF S, V47, P143, DOI 10.1006/ecss.1998.0350; Manne S, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013069; Martens Andreas, 2007, Lauterbornia, V61, P145; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Plant, 2008, EKOLOGIYA, V54, P124; REUTTER J M, 1976, Ohio Journal of Science, V76, P39; Sandstrom O., 1990, 3868 SWED ENV PROT A; Scholl F, 2012, LAUTERBORNIA, V74, P111; Schreck C.B., 1990, METHODS FISH BIOL; Smith R. J. F., 1991, CYPRINID FISHES SYST, P509; Teixeira TP, 2009, MAR ENVIRON RES, V68, P188, DOI 10.1016/j.marenvres.2009.06.004; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	38	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0183769	10.1371/journal.pone.0183769	http://dx.doi.org/10.1371/journal.pone.0183769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915248	Green Submitted, gold, Green Published			2022-12-26	WOS:000410861600005
J	Ehret, C; Aid-Launais, R; Sagardoy, T; Siadous, R; Bareille, R; Rey, S; Pechev, S; Etienne, L; Kalisky, J; de Mones, E; Letourneur, D; Vilamitjana, JA				Ehret, C.; Aid-Launais, R.; Sagardoy, T.; Siadous, R.; Bareille, R.; Rey, S.; Pechev, S.; Etienne, L.; Kalisky, J.; de Mones, E.; Letourneur, D.; Vilamitjana, J. Amedee			Strontium-doped hydroxyapatite polysaccharide materials effect on ectopic bone formation	PLOS ONE			English	Article							SUBSTITUTED HYDROXYAPATITE; NANO-HYDROXYAPATITE; CALCIUM POLYPHOSPHATE; IN-VITRO; SR; SCAFFOLD; ANGIOGENESIS; BIOMATERIALS; BIOACTIVITY; DESIGN	Previous studies performed using polysaccharide-based matrices supplemented with hydroxyapatite (HA) particles showed their ability to form in subcutaneous and intramuscular sites a mineralized and osteoid tissue. Our objectives are to optimize the HA content in the matrix and to test the combination of HA with strontium (Sr-HA) to increase the matrix bioactivity. First, non-doped Sr-HA powders were combined to the matrix at three different ratios and were implanted subcutaneously for 2 and 4 weeks. Interestingly, matrices showed radiolucent properties before implantation. Quantitative analysis of micro-CT data evidenced a significant increase of mineralized tissue formed ectopically with time of implantation and allowed us to select the best ratio of HA to polysaccharides of 30% (w/w). Then, two Sr-substitution of 8% and 50% were incorporated in the HA powders (8Sr-HA and 50Sr-HA). Both Sr-HA were chemically characterized and dispersed in matrices. In vitro studies performed with human mesenchymal stem cells (MSCs) demonstrated the absence of cytotoxicity of the Sr-doped matrices whatever the amount of incorporated Sr. They also supported osteoblastic differentiation and activated the expression of one late osteoblastic marker involved in the mineralization process i.e. osteopontin. In vivo, subcutaneous implantation of these Sr-doped matrices induced osteoid tissue and blood vessels formation.	[Ehret, C.; Sagardoy, T.; Siadous, R.; Bareille, R.; Rey, S.; Kalisky, J.; de Mones, E.; Vilamitjana, J. Amedee] Univ Bordeaux, Tissue Bioengn, INSERM, U1026, Bordeaux, France; [Aid-Launais, R.; Letourneur, D.] Univ Paris Diderot, X Bichat Hosp, LVTS, Inserm U1148, F-75018 Paris, France; [Aid-Launais, R.; Letourneur, D.] Univ Paris 13, Inst Galilee, Villetaneuse, France; [Pechev, S.; Etienne, L.] Bordeaux Univ, ICMCB, Bordeaux, France; [de Mones, E.] CHU Bordeaux, Oral & Maxillofacial Dept, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; CHU Bordeaux	Vilamitjana, JA (corresponding author), Univ Bordeaux, Tissue Bioengn, INSERM, U1026, Bordeaux, France.	joelle.amedee@inserm.fr	AMEDEE, Joelle VILAMITJANA/F-3369-2013; Letourneur, Didier/H-5268-2012	EHRET, Camille/0000-0002-8346-3822; Letourneur, Didier/0000-0003-2197-9468	Fondation pour la recherche medicale [DBS20131128435]	Fondation pour la recherche medicale(Fondation pour la Recherche Medicale)	This work was supported by Fondation pour la recherche medicale, Grant number: DBS20131128435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina V, 2013, MAT SCI ENG C-MATER, V33, P1132, DOI 10.1016/j.msec.2012.12.005; Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004; Basha RY, 2015, MAT SCI ENG C-MATER, V57, P452, DOI 10.1016/j.msec.2015.07.016; Beachler DC, 2016, J BONE JOINT SURG AM, V98, P1064, DOI 10.2106/JBJS.15.01106; Boanini E, 2011, J MATER SCI-MATER M, V22, P2079, DOI 10.1007/s10856-011-4379-3; Boissard CIR, 2009, ACTA BIOMATER, V5, P3316, DOI 10.1016/j.actbio.2009.05.001; Boyd AR, 2015, MAT SCI ENG C-MATER, V46, P290, DOI 10.1016/j.msec.2014.10.046; Boyd AR, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5377-z; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Catros S, 2010, IRBM, V31, P226, DOI 10.1016/j.irbm.2010.04.002; Chandran S, 2016, J BIOMATER APPL, V31, P499, DOI 10.1177/0885328216647197; Chen YW, 2008, J MATER SCI-MATER M, V19, P2655, DOI 10.1007/s10856-007-3350-9; Cheng H, 2016, ACTA BIOMATER, V31, P388, DOI 10.1016/j.actbio.2015.11.046; Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015; Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039; Elgali I, 2016, ACTA BIOMATER, V29, P409, DOI 10.1016/j.actbio.2015.10.005; Fernandez-Yague MA, 2015, ADV DRUG DELIVER REV, V84, P1, DOI 10.1016/j.addr.2014.09.005; Frasnelli M, 2017, MAT SCI ENG C-MATER, V71, P653, DOI 10.1016/j.msec.2016.10.047; Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; Gopi D, 2014, COLLOID SURFACE B, V114, P234, DOI 10.1016/j.colsurfb.2013.10.011; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Gu ZP, 2013, J MATER SCI-MATER M, V24, P1251, DOI 10.1007/s10856-013-4891-8; Guerrero J, 2013, ACTA BIOMATER, V9, P8200, DOI 10.1016/j.actbio.2013.05.025; Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24; Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818; Kondiah PJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21111580; Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006; Li YF, 2015, J APPL BIOMATER FUNC, V13, P28, DOI 10.5301/jabfm.5000168; Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056; Lindahl C, 2015, MAT SCI ENG C-MATER, V53, P322, DOI 10.1016/j.msec.2015.04.015; Lindahl C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045018; Luo XM, 2015, ACTA BIOMATER, V26, P331, DOI 10.1016/j.actbio.2015.07.044; Marie PJ, 2010, MOL INTERV, V10, P305, DOI 10.1124/mi.10.5.7; Munarin F, 2015, INT J BIOL MACROMOL, V72, P199, DOI 10.1016/j.ijbiomac.2014.07.050; Nardone V, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/871863; Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Robert D, 2010, BIOMATERIALS, V31, P1586, DOI 10.1016/j.biomaterials.2009.11.014; Rosa Jucely Aparecida da, 2016, Braz. Dent. J., V27, P502, DOI 10.1590/0103-6440201600693; Roy M, 2013, BIOMATER SCI, V1; Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009; Tadier S, 2012, J BIOMED MATER RES B, V100B, P378, DOI 10.1002/jbm.b.31959; Tayton E, 2014, J BIOMED MATER RES A, V102, P2613, DOI 10.1002/jbm.a.34926; Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036; Valiense H, 2016, J BIOMED MATER RES B, V104, P274, DOI 10.1002/jbm.b.33392; Vandecandelaere N, 2012, J MATER SCI-MATER M, V23, P2593, DOI 10.1007/s10856-012-4719-y; Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893; Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031	49	31	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184663	10.1371/journal.pone.0184663	http://dx.doi.org/10.1371/journal.pone.0184663			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910401	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200073
J	Lavrov, AV; Ustaeva, OA; Adilgereeva, EP; Smirnikhina, SA; Chelysheva, EY; Shukhov, OA; Shatokhin, YV; Mordanov, SV; Turkina, AG; Kutsev, SI				Lavrov, Alexander V.; Ustaeva, Oksana A.; Adilgereeva, Elmira P.; Smirnikhina, Svetlana A.; Chelysheva, Ekaterina Y.; Shukhov, Oleg A.; Shatokhin, Yuriy V.; Mordanov, Sergey V.; Turkina, Anna G.; Kutsev, Sergey I.			Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia	PLOS ONE			English	Article							GENE POLYMORPHISMS; IMATINIB TREATMENT; EXPRESSION; GSTT1; GSTM1; RISK; PHARMACOKINETICS; SUSCEPTIBILITY; TRANSPORTERS; RESISTANT	Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of BCR/ABL fusion gene in leukemic cells, which promotes uncontrolled cell proliferation. Up to 20% of CML patients show primary resistance or non-optimal response to tyrosine kinase inhibitor (TKI) therapy. We investigated the association between copy number variation (CNV) in glutathione S-transferases (GST) and cytochromes (CYP) and the response rate to TKI. We enrolled 47 patients with CML: 31 with an optimal response and 16 with failure at 6 months in accordance with European LeukemiaNet 2013 recommendations. CNV detection was performed using SALSA MLPA P128-C1 Cytochrome P450 probe mix. Patients with optimal response and with failure of TKI therapy showed different frequencies of wild type and mutated CYPs and GST (p<0.0013). Validation in the group of 15 patients proved high prognostic value (p = 0.02): positive and negative predictive value 83% and 78%; sensitivity and specificity 71% and 88%. Wild type genotypes of CYP and GST associate with a worse response to TKI treatment in CML patients. This test can be recommended for further clinical trials.	[Lavrov, Alexander V.; Adilgereeva, Elmira P.; Smirnikhina, Svetlana A.; Kutsev, Sergey I.] Res Ctr Med Genet, Fed State Budgetary Inst, Lab Mutagenesis, Moscow, Russia; [Lavrov, Alexander V.; Kutsev, Sergey I.] Russian Natl Res Med Univ, State Budgetary Educ Inst Higher Profess Educ, Dept Mol & Cellular Genet, Moscow, Russia; [Ustaeva, Oksana A.; Shatokhin, Yuriy V.; Mordanov, Sergey V.] Rostov State Med Univ, Lab Med Genet, Rostov Na Donu, Russia; [Chelysheva, Ekaterina Y.; Shukhov, Oleg A.; Turkina, Anna G.] Minist Healthcare Russian Federat, Natl Res Ctr Hematol, Fed State Funded Inst, Sci & Advisory Dept Chemotherapy Myeloproliferat, Moscow, Russia	Research Centre for Medical Genetics; Pirogov Russian National Research Medical University; Rostov State Medical University; Russian Academy of Medical Sciences; National Medical Research Center for Hematology	Lavrov, AV (corresponding author), Res Ctr Med Genet, Fed State Budgetary Inst, Lab Mutagenesis, Moscow, Russia.; Lavrov, AV (corresponding author), Russian Natl Res Med Univ, State Budgetary Educ Inst Higher Profess Educ, Dept Mol & Cellular Genet, Moscow, Russia.	alexandervlavrov@gmail.com	Kutsev, Sergey I/L-3633-2018; Turkina, Anna/GQP-6907-2022; Mordanov, Sergey/O-9226-2015; Smirnikhina, Svetlana/A-9637-2016	Kutsev, Sergey I/0000-0002-3133-8018; Adil'gereeva, El'mira/0000-0002-6440-0500; Smirnikhina, Svetlana/0000-0002-1558-3048	Russian Ministry of Education and Science [8113]	Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Ministry of Education and Science (agreement # 8113 from 28/08/2012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini S, 2013, HAEMATOLOGICA, V98, P193, DOI 10.3324/haematol.2012.066480; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Ben Hassine I, 2017, CANCER CHEMOTH PHARM, V79, P737, DOI 10.1007/s00280-017-3266-0; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Das P, 2009, LEUKEMIA LYMPHOMA, V50, P1345, DOI 10.1080/10428190903003236; Davies A, 2014, CLIN PHARMACOL THER, V96, P694, DOI 10.1038/clpt.2014.176; de Lima LT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0851-5; Dinama O, 2014, AUST NZ J PSYCHIAT, V48, P778, DOI 10.1177/0004867413520050; Frank O, 2006, LEUKEMIA, V20, P1400, DOI 10.1038/sj.leu.2404270; Gromicho M, 2013, ONCOL REP, V29, P741, DOI 10.3892/or.2012.2153; Harrach S, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.79; He HR, 2014, JPN J CLIN ONCOL, V44, P1070, DOI 10.1093/jjco/hyu121; Hoffmann VS, 2015, LEUKEMIA, V29, P1336, DOI 10.1038/leu.2015.73; Hoglund M., 2015, Annals of Hematology, V94, P241, DOI 10.1007/s00277-015-2314-2; Joseph T, 2004, PEDIATR BLOOD CANCER, V43, P560, DOI 10.1002/pbc.20074; Kassogue Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0047-z; Koh Y, 2010, CANCER GENET CYTOGEN, V203, P215, DOI 10.1016/j.cancergencyto.2010.08.022; Lavrov AV, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0308-7; Maddin N, 2016, ONCOL THER, V4, P303, DOI 10.1007/s40487-016-0035-x; Mitchell B, 2011, LEUKEMIA LYMPHOMA, V52, P4, DOI 10.3109/10428194.2010.546916; Ogu C C, 2000, Proc (Bayl Univ Med Cent), V13, P421; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; San Jose-Eneriz E, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-69; Jose-Eneriz ES, 2009, EUR J CANCER, V45, P1877, DOI 10.1016/j.ejca.2009.04.005; Seong SJ, 2013, ANN ONCOL, V24, P756, DOI 10.1093/annonc/mds532; Shukhov O, 2016, HAEMATOLOGICA, V101, P744; Shuvaev V, 2016, HAEMATOLOGICA, V101, P835; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smahelova J, 2017, ONCOL REP, V37, P547, DOI 10.3892/or.2016.5226; Smirnikhina SA, 2016, LEUKEMIA LYMPHOMA, V57, P1669, DOI 10.3109/10428194.2015.1132420; Steinberg DM, 2009, BIOSTATISTICS, V10, P94, DOI 10.1093/biostatistics/kxn018; Voso MT, 2002, BLOOD, V100, P2703, DOI 10.1182/blood.V100.8.2703; Wang YF, 2008, BRIT J CLIN PHARMACO, V65, P885, DOI 10.1111/j.1365-2125.2008.03150.x; Ye Z, 2005, EUR J CANCER, V41, P980, DOI 10.1016/j.ejca.2005.01.014; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182901	10.1371/journal.pone.0182901	http://dx.doi.org/10.1371/journal.pone.0182901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902850	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200007
J	Paluh, DJ; Bauer, AM				Paluh, Daniel J.; Bauer, Aaron M.			Comparative skull anatomy of terrestrial and crevice-dwelling Trachylepis skinks (Squamata: Scincidae) with a survey of resources in scincid cranial osteology	PLOS ONE			English	Article							HEAD SHAPE; LIZARD; PERFORMANCE; REPTILIA; KINESIS; CLASSIFICATION; CONVERGENCE; SYSTEMATICS; EVOLUTION; EUMECES	Skinks account for more than 25% of all lizard species; however, representatives of fewer than a quarter of all species have been characterized osteologically. All but a few of the available cranial descriptions concentrate solely on characters that can be seen externally on the intact skull. Mabuyid skinks of the genus Trachylepis are the dominant, fully limbed skinks in Sub-Saharan Africa, and nearly all species have the same generalized body plan. Although a few rock crevice-dwelling species possess slight body depression, extreme dorsoventral depression is observed only in Trachylepis laevis. We investigated the detailed skull anatomy of three Trachylepis skinks (T. laevis, T. sulcata, and T. gonwouoi, a recently described species allied to T. affinis) using high-resolution X-ray micro-computed tomography. Our goals were to review the scincid cranial osteology literature in a phylogenetic context, provide a detailed anatomical atlas for the mabuyid lineage, and investigate the morphological adaptations of the highly modified T. laevis. Our results demonstrate that there is significant morphological variation between these three taxa, including the loss and fusion of structures, as well as changes in the shape, scale, and relationship between individual elements. Trachylepis laevis possesses several osteological modifications that have produced a reducton in head depth that are likely functional consequences of extreme rupi-colous habits, including a flat skull roof, many strongly recumbent elements, and a depressed neurocranium. We hypothesize these modifications may correspond to descreased bite force and increased capabilities of cranial kinesis. Our study is the first element-by-element description of a skink using computed tomography technology.	[Paluh, Daniel J.; Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Paluh, Daniel J.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Paluh, Daniel J.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Villanova University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Paluh, DJ (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.; Paluh, DJ (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Paluh, DJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	dpaluh@ufl.edu; aaron.bauer@villanova.edu	Paluh, Daniel/ABB-7618-2021	Paluh, Daniel/0000-0003-3506-2669	NIH [1S100D012287]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Imaging data was acquired through the Cornell University Biotechnology Resource Center, with NIH 1S100D012287 funding for the ZEISS-Xradia Versa 520 X-ray Microscope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Imaging data was acquired through the Cornell University Biotechnology Resource Center, with NIH 1S100D012287 funding for the ZEISS-Xradia Versa 520 X-ray Microscope. We thank Jens Vindum (California Academy of Sciences), Jack W. Sites, Jr., Luke J. Welton (Brigham Young University), and Katie E. Allen (University of Kansas) for access to museum materials used in this study. We thank Dr. Hongyu Yi and one anonymous reviewer for helpful comments that improved the manuscript.	Allen KE, 2017, ZOOTAXA, V4268, P255, DOI 10.11646/zootaxa.4268.2.5; Arnold EN, 1998, EVOL BIOL, V30, P323; Baird IL, 1970, BIOL REPTILIA, V2, P263; Bell CJ, 2014, ANAT REC, V297, P344, DOI 10.1002/ar.22852; Bell CJ, 2003, ZOOL J LINN SOC-LOND, V139, P283, DOI 10.1046/j.1096-3642.2003.00077.x; Bever GS, 2005, PALAEONTOL ELECTRON, V8; Blom MPK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0181; Branch B., 1998, FIELD GUIDE SNAKES O; Camp CL, 1923, B AM MUS NAT HIST, V48, P289; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2004, ZOOL J LINN SOC-LOND, V141, P399, DOI 10.1111/j.1096-3642.2004.00128.x; Cuvier G, 1824, RECHERCHES OSSEMENTS, V5; Daza J.D., 2015, ALL ANIMALS ARE INTE, P303; Daza JD, 2008, J MORPHOL, V269, P1340, DOI 10.1002/jmor.10664; Daza JD, 2012, ACTA ZOOL-STOCKHOLM, V93, P465, DOI 10.1111/j.1463-6395.2011.00521.x; de Vree F., 1989, Progress in Zoology, V35, P115; EL-TOUB1 M. R., 1959, JOUR MORPHOL, V105, P55, DOI 10.1002/jmor.1051050104; Estes R., 1988, P119; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; FRAZZETTA TH, 1962, J MORPHOL, V111, P287, DOI 10.1002/jmor.1051110306; Gamble T, 2011, ZOOL J LINN SOC-LOND, V163, P1244, DOI 10.1111/j.1096-3642.2011.00741.x; GANS C, 1961, AM ZOOL, V1, P217; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gelnaw WB., 2011, THESIS; GREER A E, 1979, Records of the Australian Museum, V32, P321; GREER A E, 1983, Records of the Australian Museum, V35, P29; GREER A E, 1970, Bulletin of the Museum of Comparative Zoology, V140, P1; GREER A E, 1968, Breviora, V302, P1; GREER A E, 1970, Bulletin of the Museum of Comparative Zoology, V139, P151; GREER A E, 1979, Records of the Australian Museum, V32, P339; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Greer A.E. Jr., 1974, Australian J Zool, VNo. 31, P1; GREER AE, 1976, J NAT HIST, V10, P691, DOI 10.1080/00222937600770551; GREER AE, 1986, J HERPETOL, V20, P123, DOI 10.2307/1564144; GREER AE, 1977, J NAT HIST, V11, P515, DOI 10.1080/00222937700770451; Greer AE, 1967, EUMECIA BREVIORA, V276, P1; Greer AE, 1970, DASIA BREVIORA, V348, P1; GREER ALLEN E., 1967, BREVIORA, V267, P1; Hedges SB, 2014, ZOOTAXA, V3765, P317, DOI 10.11646/zootaxa.3765.4.2; Herrel A, 2000, J EXP BIOL, V203, P1415; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; HIKIDA T, 1978, Japanese Journal of Herpetology, V7, P56; Hollenshead Marci G., 2011, Records of the Western Australian Museum, V26, P138; Jerez Adriana, 2015, Acta Zool. Mex, V31, P391; Jerez Adriana, 2012, Actu Biol, V34, P207; JOLLIE M. T., 1960, ACTA ZOOL [STOCKHOLM], V41, P1; Jones MEH, 2011, PALAEONTOL ELECTRON, V14; Lambert SM, 2015, MOL PHYLOGENET EVOL, V82, P146, DOI 10.1016/j.ympev.2014.10.004; Lappin AK, 2006, BIOL J LINN SOC, V88, P215, DOI 10.1111/j.1095-8312.2006.00615.x; Linkem CW, 2016, SYST BIOL, V65, P465, DOI 10.1093/sysbio/syw001; LOURYAN S, 1989, ANN SOC ROY ZOOL BEL, V119, P47; Masterson Gavin, 2014, Suricata, V1, P267; McBrayer LD, 2004, ZOOL J LINN SOC-LOND, V140, P403, DOI 10.1111/j.1096-3642.2003.00106.x; McDOWELL SAMUEL BOOKER, 1954, BULL AMER MUS NAT HIST, V105, P1; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Metzger KA, 2005, BIOL J LINN SOC, V86, P433, DOI 10.1111/j.1095-8312.2005.00546.x; MOHAMMED M B, 1988, Qatar University Science Bulletin, V8, P117; Mohammed M.B.H., 1991, Journal of the Egyptian German Society of Zoology, V3, P25; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Olori JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032450; Pearson HS, 1921, J ANAT, V56, P20; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; Rice EL, 1920, J MORPHOL, V34, P119; RIEPPEL O, 1984, ZOOL J LINN SOC-LOND, V82, P291, DOI 10.1111/j.1096-3642.1984.tb00645.x; Rieppel O, 1980, PHYLOGENY ANGUIMORPH; SHEA G M, 1990, Memoirs of the Queensland Museum, V29, P495; Siebenrock R, 1892, ANN NATURHIST HOFMUS, V7, P163; SKINNER M M, 1973, Annale Universiteit van Stellenbosch Serie A, V48, P1; STEYN W., 1965, CIMBEBASIA, V12, P2; Tol P., 2012, SRONEPSTN09002; Travassos H, 1946, MABUYA PUNCTATA, V60, P1; Uetz P., 2020, REPTILE DATABASE; WEVER EG, 1973, J EXP ZOOL, V183, P225, DOI 10.1002/jez.1401830211; WINESKI LE, 1984, J MORPHOL, V181, P271, DOI 10.1002/jmor.1051810303	76	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184414	10.1371/journal.pone.0184414	http://dx.doi.org/10.1371/journal.pone.0184414			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902864	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200036
J	Popolin, CP; Reis, JPB; Becceneri, AB; Graminha, AE; Almeida, MAP; Correa, RS; Colina-Vegas, LA; Ellena, J; Batista, AA; Cominetti, MR				Popolin, Cecilia P.; Reis, Joao P. B.; Becceneri, Amanda B.; Graminha, Angelica E.; Almeida, Marcio A. P.; Correa, Rodrigo S.; Colina-Vegas, Legna A.; Ellena, Javier; Batista, Alzir A.; Cominetti, Marcia R.			Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells	PLOS ONE			English	Article							BOTHROPS ALTERNATUS; TUMOR-CELLS; APOPTOSIS; MIGRATION; ADHESION; INVASION; MATRIX; VENOM; PCR; DNA	Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype. The high rate of metastasis associated to the fact that these cells frequently display multidrug resistance, make the treatment of metastatic disease difficult. Development of antitumor metal-based drugs was started with the discovery of cisplatin, however, the severe side effects represent a limitation for its clinical use. Ruthenium (Ru) complexes with different ligands have been successfully studied as prospective antitumor drugs. In this work, we demonstrated the activity of a series of biphosphine bipyridine Ru complexes (1) [Ru(SO4) (dppb)(bipy)], (2) [Ru(CO3)(dppb)(bipy)], (3) [Ru(C2O4)(dppb)(bipy)] and (4) [Ru(CH3CO2) (dppb)(bipy)]PF6 [where dppb = 1,4-bis(diphenylphosphino) butane and bipy = 2,2'-bipyridine], on proliferation of TNBC (MDA-MB-231), estrogen-dependent breast tumor cells (MCF-7) and a non-tumor breast cell line (MCF-10A). Complex (4) was most effective among the complexes and was selected to be further investigated on effects on tumor cell adhesion, migration, invasion and in apoptosis. Moreover, DNA and HSA binding properties of this complex were also investigated. Results show that complex (4) was more efficient inhibiting proliferation of MDA-MB-231 cells over non-tumor cells. In addition, complex (4) was able to inhibit MDA-MB231 cells adhesion, migration and invasion and to induce apoptosis and inhibit MMP-9 secretion in TNBC cells. Complex (4) should be further investigated in vivo in order to stablish its potential to improve breast cancer treatment.	[Popolin, Cecilia P.; Becceneri, Amanda B.; Graminha, Angelica E.; Cominetti, Marcia R.] Univ Fed Sao Carlos, Dept Gerontol, Sao Carlos, SP, Brazil; [Reis, Joao P. B.; Colina-Vegas, Legna A.; Batista, Alzir A.] Univ Fed Sao Carlos, Dept Quim, Sao Carlos, SP, Brazil; [Almeida, Marcio A. P.] Univ Fed Maranhao, Dept Quim, Sao Luis, Maranhao, Brazil; [Correa, Rodrigo S.] Univ Fed Ouro Preto, Dept Quim, Ouro Preto, MG, Brazil; [Ellena, Javier] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Ciencia Interdisciplinar, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Federal do Maranhao; Universidade Federal de Ouro Preto; Universidade de Sao Paulo	Cominetti, MR (corresponding author), Univ Fed Sao Carlos, Dept Gerontol, Sao Carlos, SP, Brazil.	mcominetti@ufscar.br	Almeida, Marcio/W-2857-2019; Cominetti, Marcia Regina/B-8080-2012; Ellena, Javier/B-9104-2012; Batista, Alzir A./C-3492-2012; Graminha, Angelica Ellen/GYA-2571-2022; Correa, Rodrigo/A-8227-2013; Graminha, Angelica E/C-9325-2014; Almeida, Marcio A.P./F-8902-2012; Colina Vegas, Legna/E-9402-2017	Almeida, Marcio/0000-0003-2494-7912; Cominetti, Marcia Regina/0000-0001-6385-7392; Ellena, Javier/0000-0002-0676-3098; Correa, Rodrigo/0000-0003-2783-0816; Graminha, Angelica E/0000-0002-5665-0817; Almeida, Marcio A.P./0000-0003-2494-7912; Colina Vegas, Legna/0000-0003-3557-5544; Blanque Becceneri, Amanda/0000-0001-5223-961X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/00798-2, 2015/24940-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/00798-2 and 2015/24940-8); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson VG, 2015, CANCER-AM CANCER SOC, V121, P8, DOI 10.1002/cncr.28914; ALBERTS DS, 1980, LANCET, V2, P340; Baka E, 2008, J PHARMACEUT BIOMED, V46, P335, DOI 10.1016/j.jpba.2007.10.030; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Barbosa MIF, 2014, J INORG BIOCHEM, V136, P33, DOI 10.1016/j.jinorgbio.2014.03.009; Brabec V, 2006, DRUG RESIST UPDATE, V9, P111, DOI 10.1016/j.drup.2006.05.002; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Buss I, 2011, J INORG BIOCHEM, V105, P709, DOI 10.1016/j.jinorgbio.2011.02.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao WQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09157; Carreira M, 2012, J INORG BIOCHEM, V116, P204, DOI 10.1016/j.jinorgbio.2012.06.017; Ciarimboli G, 2014, ANTICANCER RES, V34, P547; Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4; Correa RS, 2016, J INORG BIOCHEM, V156, P153, DOI 10.1016/j.jinorgbio.2015.12.024; da Silva JA, 2012, J CHROMATOGR B, V903, P157, DOI 10.1016/j.jchromb.2012.07.013; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fuzer AM, 2013, ANTI-CANCER AGENT ME, V13, P1645, DOI 10.2174/18715206113139990314; Gehler S, 2013, CRIT REV EUKAR GENE, V23, P139, DOI 10.1615/CritRevEukarGeneExpr.2013006647; Gou Y, 2015, CURR PHARM DESIGN, V21, P1848, DOI 10.2174/1381612821666150302114739; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hartinger CG, 2006, J INORG BIOCHEM, V100, P891, DOI 10.1016/j.jinorgbio.2006.02.013; Hongthong K, 2016, CURR CANCER DRUG TAR, V16, P606, DOI 10.2174/1568009616666160203113957; Leber TM, 2000, METH MOLEC MED, V39, P509; Leijen S, 2015, INVEST NEW DRUG, V33, P201, DOI 10.1007/s10637-014-0179-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; McKeage MJ, 2000, CANCER CHEMOTH PHARM, V46, P343, DOI 10.1007/s002800000166; Nhukeaw T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-73; Norum JH, 2014, BRIT J SURG, V101, P925, DOI 10.1002/bjs.9562; Pages BJ, 2015, DALTON T, V44, P3505, DOI 10.1039/c4dt02700k; Popolin CP, 2017, MINI REV MED CHEM; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Queiroz SL, 1998, INORG CHIM ACTA, V267, P209, DOI 10.1016/S0020-1693(97)05615-6; Ratanaphan A, 2016, ANTICANCER AGENTS ME; Sava G, 2004, EUR J CANCER, V40, P1383, DOI 10.1016/j.ejca.2004.01.034; Selistre-de-Araujo HS, 2005, BRAZ J MED BIOL RES, V38, P1505, DOI 10.1590/S0100-879X2005001000007; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wu Q, 2014, METALLOMICS, V6, P2204, DOI 10.1039/c4mt00158c; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zeng ZP, 2016, INORG CHEM, V55, P5710, DOI 10.1021/acs.inorgchem.6b00824	41	37	37	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183275	10.1371/journal.pone.0183275	http://dx.doi.org/10.1371/journal.pone.0183275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898246	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500003
J	Sun, ZL; Pan, T; Hu, CC; Sun, L; Ding, HW; Wang, H; Zhang, CL; Jin, H; Chang, Q; Kan, XZ; Zhang, BW				Sun, Zhonglou; Pan, Tao; Hu, Chaochao; Sun, Lu; Ding, Hengwu; Wang, Hui; Zhang, Chenling; Jin, Hong; Chang, Qing; Kan, Xianzhao; Zhang, Baowei			Rapid and recent diversification patterns in Anseriformes birds: Inferred from molecular phylogeny and diversification analyses	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; STEAMER-DUCKS ANATIDAE; PLIOPLEISTOCENE DIVERSIFICATION; PLEISTOCENE DIVERSIFICATION; CLIMATIC OSCILLATIONS; ADAPTIVE RADIATION; AVIAN POPULATIONS; SPECIATION; EVOLUTION; EOCENE	The Anseriformes is a well-known and widely distributed bird order, with more than 150 species in the world. This paper aims to revise the classification, determine the phylogenetic relationships and diversification patterns in Anseriformes by exploring the Cyt b, ND2, COI genes and the complete mitochondrial genomes (mito-genomes). Molecular phylogeny and genetic distance analyses suggest that the Dendrocygna species should be considered as an independent family, Dendrocygnidae, rather than a member of Anatidae. Molecular time-scale analyses suggests that the ancestral diversification occurred during the Early Eocene Climatic Optimum (58 similar to 50 Ma). Furthermore, diversification analyses showed that, after a long period of constant diversification, the median initial speciation rate was accelerated three times, and finally increased to approximately 0.3 sp/My. In the present study, both molecular phylogeny and diversification analyses results support that Anseriformes birds underwent rapid and recent diversification in their evolutionary history, especially in modern ducks, which show extreme diversification during the Plio-Pleistocene (similar to 5.3 Ma). Therefore, our study support that the Plio-Pleistocene climate fluctuations are likely to have played a significant role in promoting the recent diversification for Anseriformes.	[Sun, Zhonglou; Pan, Tao; Wang, Hui; Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei, Anhui, Peoples R China; [Hu, Chaochao; Jin, Hong; Chang, Qing] Nanjing Normal Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Sun, Lu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Ding, Hengwu; Kan, Xianzhao] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Zhang, Chenling] Jiangsu Second Normal Univ, Fac Life Sci & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Jin, Hong] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England	Anhui University; Nanjing Normal University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Anhui Normal University; Jiangsu Second Normal University; University of Leicester	Wang, H; Zhang, BW (corresponding author), Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei, Anhui, Peoples R China.; Kan, XZ (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	kikihui86025@163.com; xianzhao@ahnu.edu.cn; zhangbw@ahu.edu.cn	lu, sun/K-4484-2019; Kan, Xianzhao/AAA-5050-2021	lu, sun/0000-0002-7688-6472; Kan, Xianzhao/0000-0002-9225-407X	Anhui Province Higher Education Revitalization Plan	Anhui Province Higher Education Revitalization Plan	This work was supported by the Anhui Province Higher Education Revitalization Plan, 2014 Colleges and Universities Outstanding Youth Talent Support Program.	Alstrom P, 2013, MOL PHYLOGENET EVOL, V69, P1043, DOI 10.1016/j.ympev.2013.06.005; An M, 2016, MITOCHONDRIAL DNA A, V27, P2800, DOI 10.3109/19401736.2015.1053073; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2001, PRIMER V5; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bulgarella M, 2010, J AVIAN BIOL, V41, P186, DOI 10.1111/j.1600-048X.2009.04819.x; Burland T G, 2000, Methods Mol Biol, V132, P71; CORBIN KW, 1988, CONDOR, V90, P773, DOI 10.2307/1368834; CRACRAFT J, 1981, AUK, V98, P681; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Dawson NG, 2014, J BIOGEOGR, V41, P464, DOI 10.1111/jbi.12221; de Swardt D.H., 2010, Ornithological Observations, V1, P63; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delacour Jean, 1945, WILSON BULL, V57, P3; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dickinson EC., 2003, HOWARD MOORE COMPLET; Ding L, 2016, MITOCHONDRIAL DNA A, V27, P1003, DOI 10.3109/19401736.2014.926525; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubey S, 2010, MOL PHYLOGENET EVOL, V56, P1119, DOI 10.1016/j.ympev.2010.04.028; Dubey S, 2010, J BIOGEOGR, V37, P902, DOI 10.1111/j.1365-2699.2009.02266.x; FARRELL BD, 1994, AM ZOOL, V34, P57, DOI 10.1093/icb/34.1.57; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Freethy R., 1982, BIRDS WORK GUIDE BIR; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Giorgi CD, 1989, CELL BIOCH BIOPHYS, V14, P67; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hawlitschek O, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-142; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HOWARD R, 1991, COMPLETE CHECKLIST B; Hoyo JD, 1994, HDB BIRDS WORLD; Hu CC, 2015, MITOCHONDR DNA, V26, P625, DOI 10.3109/19401736.2013.834434; Huntley JW, 2017, ZOOL SCR, V46, P523, DOI 10.1111/zsc.12240; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiang FW, 2010, MOL BIOL REP, V37, P3001, DOI 10.1007/s11033-009-9868-9; Jiang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136297; Jiang LC, 2014, GENE, V539, P21, DOI 10.1016/j.gene.2014.01.067; Johns GC, 1998, EVOLUTION, V52, P1135, DOI 10.1111/j.1558-5646.1998.tb01840.x; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Johnson NK, 2004, EVOLUTION, V58, P1122; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Kearney M, 2008, MOL ECOL, V17, P5257, DOI 10.1111/j.1365-294X.2008.03991.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koju NP, 2017, MOL PHYLOGENET EVOL, V107, P239, DOI 10.1016/j.ympev.2016.11.005; Koscinski D, 2008, MOL ECOL, V17, P2012, DOI 10.1111/j.1365-294X.2008.03733.x; Levsen ND, 2012, SYST BIOL, V61, P401, DOI 10.1093/sysbio/syr120; Li XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1234-9; Liu G, 2013, PLOS ONE, V9; Liu G., 2013, INT J ANTENN PROPAG, V2013, P5; Liu G, 2012, MOL BIOL REP, V39, P2139, DOI 10.1007/s11033-011-0961-5; LIVEZEY BC, 1991, AUK, V108, P471, DOI 10.2307/4088089; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Livezey BC, 1997, ANN CARNEGIE MUS, V66, P457; LIVEZEY BC, 1986, SYST ZOOL, V35, P458, DOI 10.2307/2413109; Livezey BC, 1996, SYST BIOL, V45, P415, DOI 10.2307/2413524; LIVEZEY BC, 1986, AUK, V103, P737, DOI 10.1093/auk/103.4.737; Livezey BC, 1998, ZOOL J LINN SOC-LOND, V124, P397, DOI 10.1111/j.1096-3642.1998.tb00584.x; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Lovette IJ, 1999, P ROY SOC B-BIOL SCI, V266, P1629, DOI 10.1098/rspb.1999.0825; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Marshall DC, 2008, MOL PHYLOGENET EVOL, V48, P1054, DOI 10.1016/j.ympev.2008.05.007; McCracken KG, 1999, SYST BIOL, V48, P683, DOI 10.1080/106351599259979; Menezes L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154626; Meng SQ, 2016, MITOCHONDRIAL DNA A, V27, P318, DOI 10.3109/19401736.2014.892096; Mindell DP, 1998, P NATL ACAD SCI USA, V95, P10693, DOI 10.1073/pnas.95.18.10693; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Nadachowska-Brzyska K, 2015, CURR BIOL, V25, P1375, DOI 10.1016/j.cub.2015.03.047; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nylander JAA., 2004, BIOINFORMATICS; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Osborn HF, 1902, AM NAT, V36, P353, DOI 10.1086/278137; Ottenburghs J, 2016, MOL PHYLOGENET EVOL, V101, P303, DOI 10.1016/j.ympev.2016.05.021; Ottenburghs J, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0153-1; Ottenburghs J, 2015, IBIS, V157, P892, DOI 10.1111/ibi.12285; [欧先交 Ou Xianjiao], 2015, [第四纪研究, Quaternary Sciences], V35, P12; Pan T, 2014, MITOCHONDR DNA, V25, P111, DOI 10.3109/19401736.2013.786709; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parker Theodore A. Iii, 1996, P113; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Ruber L, 2003, EVOLUTION, V57, P1584; Ruokonen M, 2000, J EVOLUTION BIOL, V13, P532, DOI 10.1046/j.1420-9101.2000.00184.x; Sambrook J., 2001, MOL CLONING LAB MANU; SANDERSON MJ, 1994, SCIENCE, V264, P1590, DOI 10.1126/science.264.5165.1590; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schattner P, 2007, NUCLEIC ACIDS RES, V33, P686; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shen Yong-Yi, 2010, BMC Evol Biol, V10, P132, DOI 10.1186/1471-2148-10-132; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Sibley CG, 1993, SUPPLEMENT DISTRIBUT; Sibley CG, 1990, DISTRIBUTION TAXONOM; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Sraml M, 1996, AUST J ZOOL, V44, P47, DOI 10.1071/ZO9960047; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stumpel N, 2016, MOL PHYLOGENET EVOL, V101, P336, DOI 10.1016/j.ympev.2016.04.025; Sun ZL, 2016, MITOCHONDRIAL DNA A, V27, P4320, DOI 10.3109/19401736.2015.1089482; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tripati A, 2005, SCIENCE, V308, P1894, DOI 10.1126/science.1109202; Tu JF, 2016, MITOCHONDRIAL DNA A, V27, P682, DOI 10.3109/19401736.2014.913141; Turner GF, 2001, HEREDITY, V86, P749; van Tuinen M, 2000, MOL BIOL EVOL, V17, P451, DOI 10.1093/oxfordjournals.molbev.a026324; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Wang N, 2013, PLOS ONE, V8, P394; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Westerhold T, 2009, CLIM PAST, V5, P309, DOI 10.5194/cp-5-309-2009; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Willows-Munro S, 2011, J BIOGEOGR, V38, P1976, DOI 10.1111/j.1365-2699.2011.02543.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Woodburne MO, 2009, P NATL ACAD SCI USA, V106, P13399, DOI 10.1073/pnas.0906802106; Wu Ai-Ping, 2005, Acta Zoologica Sinica, V51, P898; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan LH, 2015, MITOCHONDR DNA, V26, P297, DOI 10.3109/19401736.2013.825783; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; YE Z, 2016, SCI REP UK, V6; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Yu W, 2014, J EVOLUTION BIOL, V27, P2204, DOI 10.1111/jeb.12477; Yu WH, 2012, INT J BIOL SCI, V8, P486, DOI 10.7150/ijbs.3982; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zhou W, 2014, MITOCHONDR DNA, V27, P968; Zhou WL, 2015, MITOCHONDR DNA, V26, P265, DOI 10.3109/19401736.2013.823191	155	31	33	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184529	10.1371/journal.pone.0184529	http://dx.doi.org/10.1371/journal.pone.0184529			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892502	Green Published, gold, Green Submitted			2022-12-26	WOS:000410243200016
J	Wahedi, M; Wortham, AM; Kleven, MD; Zhao, NN; Jue, S; Enns, CA; Zhang, AS				Wahedi, Mastura; Wortham, Aaron M.; Kleven, Mark D.; Zhao, Ningning; Jue, Shall; Enns, Caroline A.; Zhang, An-Sheng			Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); iron; liver; receptor; signaling; HFE; hemojuvelin; hepcidin; matriptase-2; transferrin receptor-2	MESSENGER-RNA EXPRESSION; IRON-DEFICIENCY ANEMIA; JUVENILE HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR-2; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN-LEVELS; MICE LACKING; HEMOJUVELIN; TMPRSS6	Systemic iron homeostasis is maintained by regulation of iron absorption in the duodenum, iron recycling from erythrocytes, and iron mobilization from the liver and is controlled by the hepatic hormone hepcidin. Hepcidin expression is induced via the bone morphogenetic protein (BMP) signaling pathway that preferentially uses two type I (ALK2 and ALK3) and two type II (ActRIIA and BMPR2) BMP receptors. Hemojuvelin (HJV), HFE, and transferrin receptor-2 (TfR2) facilitate this process presumably by forming a plasma membrane complex with BMP receptors. Matriptase-2 (MT2) is a protease and key suppressor of hepatic hepcidin expression and cleaves HJV. Previous studies have therefore suggested that MT2 exerts its inhibitory effect by inactivating HJV. Here, we report that MT2 suppresses hepcidin expression independently of HJV. In Hjv(-/-) mice, increased expression of exogenous MT2 in the liver significantly reduced hepcidin expression similarly as observed in wild-type mice. Exogenous MT2 could fully correct abnormally high hepcidin expression and iron deficiency in MT2(-/-) mice. In contrast to MT2, increased Hjv expression caused no significant changes in wild-type mice, suggesting that Hjv is not a limiting factor for hepcidin expression. Further studies revealed that MT2 cleaves ALK2, ALK3, ActRIIA, Bmpr2, Hfe, and, to a lesser extent, Hjv and Tfr2. MT2-mediated Tfr2 cleavage was also observed in HepG2 cells endogenously expressing MT2 and TfR2. Moreover, iron-loaded transferrin blocked MT2-mediated Tfr2 cleavage, providing further insights into the mechanism of Tfr2's regulation by transferrin. Together, these observations indicate that MT2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.	[Wahedi, Mastura; Wortham, Aaron M.; Kleven, Mark D.; Jue, Shall; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA; [Zhao, Ningning] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	Oregon Health & Science University; University of Arizona	Zhang, AS (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu		Kleven, Mark/0000-0003-1204-6658	National Institutes of Health [R01DK102791, R01DK072166, R00DK104066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R01DK102791, R00DK104066, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK102791 (to A. S. Z.), R01DK072166 (to C. A. E.), and R00DK104066 (to N. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2011, BLOOD, V117, P4590, DOI 10.1182/blood-2010-10-315507; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gkouvatsos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085530; Gurieva I, 2017, BLOOD CELL MOL DIS, V64, P1, DOI 10.1016/j.bcmd.2017.02.007; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kent P, 2015, J MOL MED, V93, P489, DOI 10.1007/s00109-015-1253-7; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lee P, 2012, BLOOD CELL MOL DIS, V48, P173, DOI 10.1016/j.bcmd.2011.12.005; Lefebvre T, 2015, CLIN CHEM LAB MED, V53, P1557, DOI 10.1515/cclm-2014-1093; Lenoir A, 2011, BLOOD, V117, P647, DOI 10.1182/blood-2010-07-295147; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Mayeur C, 2014, BLOOD, V124, P2116, DOI 10.1182/blood-2014-04-572644; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nai A, 2010, BLOOD, V116, P851, DOI 10.1182/blood-2010-04-278655; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pagani A, 2017, BLOOD, V129, P3392, DOI 10.1182/blood-2017-03-773481; Pagani A, 2015, HAEMATOLOGICA, V100, P461, DOI 10.3324/haematol.2014.118521; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Rausa M, 2015, J CELL MOL MED, V19, P879, DOI 10.1111/jcmm.12462; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang CY, 2017, BLOOD, V130, P73, DOI 10.1182/blood-2016-12-759423; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhao NN, 2016, J BIOL CHEM, V291, P12322, DOI 10.1074/jbc.M116.721191; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	62	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18354	18371		10.1074/jbc.M117.801795	http://dx.doi.org/10.1074/jbc.M117.801795			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924039	Green Published, hybrid			2022-12-26	WOS:000414458200031
J	Wu, BX; Li, AQ; Lei, LM; Kaneko, S; Wallace, C; Li, X; Li, ZH				Wu, Bill X.; Li, Anqi; Lei, Liming; Kaneko, Satoshi; Wallace, Caroline; Li, Xue; Li, Zihai			Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) 3 and is essential for mouse palatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell signaling; development; embryo; TGF; GARP; palatogenesis	MEDIAL EDGE EPITHELIUM; CLEFT-PALATE; T-CELLS; KNOCKOUT MICE; SURFACE EXPRESSION; ACTIVE TGF-BETA-1; IN-VITRO; BETA; FUSION; FACTOR-BETA-3	Glycoprotein A repetitions predominant (GARP) (encoded by the Lrrc32 gene) plays important roles in cell-surface docking and activation of TGF. However, GARP's role in organ development in mammalian systems is unclear. To determine the function of GARP in vivo, we generated a GARP KO mouse model. Unexpectedly, the GARP KO mice died within 24 h after birth and exhibited defective palatogenesis without apparent abnormalities in other major organs. Furthermore, we observed decreased apoptosis and SMAD2 phosphorylation in the medial edge epithelial cells of the palatal shelf of GARP KO embryos at embryonic day 14.5 (E14.5), indicating a defect in the TGF signaling pathway in the GARP-null developing palates. Of note, the failure to develop the secondary palate and concurrent reduction of SMAD phosphorylation without other defects in GARP KO mice phenocopied TGF3 KO mice, although GARP has not been suggested previously to interact with TGF3. We found that GARP and TGF3 co-localize in medial edge epithelial cells at E14.5. In vitro studies confirmed that GARP and TGF3 directly interact and that GARP is indispensable for the surface expression of membrane-associated latent TGF3. Our findings indicate that GARP is essential for normal morphogenesis of the palate and demonstrate that GARP plays a crucial role in regulating TGF3 signaling during embryogenesis. In conclusion, we have uncovered a novel function of GARP in positively regulating TGF3 activation and function.	[Wu, Bill X.; Li, Anqi; Wallace, Caroline; Li, Zihai] Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Lei, Liming; Kaneko, Satoshi; Li, Xue] Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Lei, Liming; Kaneko, Satoshi; Li, Xue] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Lei, Liming; Kaneko, Satoshi; Li, Xue] Harvard Med Sch, Boston, MA 02115 USA; [Li, Zihai] Zhengzhou Univ, Sch Med, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China	Medical University of South Carolina; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Zhengzhou University	Li, ZH (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu		Wallace, Caroline/0000-0001-8960-756X	NHLBI, National Institutes of Health [R01HL136921]; National Institutes of Health [R01DK110477]; NCI, National Institutes of Health [P01CA186866 02]; NIAID, National Institutes of Health [R01AI070603]; NATIONAL CANCER INSTITUTE [P01CA186866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110477] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NHLBI, National Institutes of Health Grant R01HL136921 and National Institutes of Health Grant R01DK110477 (to X. L.) and NCI, National Institutes of Health Grant P01CA186866 02 and NIAID, National Institutes of Health Grant R01AI070603 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrio MC, 2014, CELLS TISSUES ORGANS, V199, P201, DOI 10.1159/000362227; Carrillo-Galvez AB, 2015, STEM CELLS, V33, P183, DOI 10.1002/stem.1821; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; Cox TC, 2004, CLIN GENET, V65, P163, DOI 10.1111/j.0009-9163.2004.00225.x; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; Cui XM, 2005, DEV BIOL, V278, P193, DOI 10.1016/j.ydbio.2004.10.023; Cui XM, 2003, DEV DYNAM, V227, P387, DOI 10.1002/dvdy.10326; Dedobbeleer O, 2017, J IMMUNOL, V199, P391, DOI 10.4049/jimmunol.1601882; Edwards JP, 2016, EUR J IMMUNOL, V46, P1480, DOI 10.1002/eji.201546204; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Hahn SA, 2016, ONCOTARGET, V7, P42996, DOI 10.18632/oncotarget.9598; Huang X, 2011, J DENT RES, V90, P981, DOI 10.1177/0022034511408613; Kaartinen V, 1997, DEV DYNAM, V209, P255, DOI 10.1002/(SICI)1097-0177(199707)209:3<255::AID-AJA1>3.0.CO;2-H; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li Y, 2015, J IMMUNOL, V195, P2648, DOI 10.4049/jimmunol.1500139; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Metelli A, 2016, CANCER RES, V76, P7106, DOI 10.1158/0008-5472.CAN-16-1456; Murillo J, 2009, DIFFERENTIATION, V77, P209, DOI 10.1016/j.diff.2008.10.004; Nacinovich Renata, 2014, BMC Res Notes, V7, P248, DOI 10.1186/1756-0500-7-248; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Rachidi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7911; Rachidi S, 2015, J HEPATOL, V62, P879, DOI 10.1016/j.jhep.2014.11.010; Roubin R, 1996, INT J DEV BIOL, V40, P545; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shevach EM, 2017, EXPERT OPIN THER TAR, V21, P191, DOI 10.1080/14728222.2017.1275568; Stockis J, 2017, MOL BIOSYST, V13, P1925, DOI 10.1039/c7mb00251c; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Vermeersch E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173329; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wincent J, 2010, EUR J MED GENET, V53, P50, DOI 10.1016/j.ejmg.2009.10.003; Wolfraim LA, 2002, J IMMUNOL METHODS, V266, P7, DOI 10.1016/S0022-1759(02)00090-X; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang LT, 2007, DEV BIOL, V312, P384, DOI 10.1016/j.ydbio.2007.09.034; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014	42	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18091	18097		10.1074/jbc.M117.797613	http://dx.doi.org/10.1074/jbc.M117.797613			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28912269	Green Published, hybrid			2022-12-26	WOS:000414458200009
J	Li, YQ; Zhang, LJ; Hu, YQ; Chen, M; Han, F; Qin, Y; Chen, M; Cui, XH; Duo, SG; Tang, FC; Gao, F				Li, Yaqiong; Zhang, Lianjun; Hu, Yuqiong; Chen, Min; Han, Feng; Qin, Yan; Chen, Min; Cui, Xiuhong; Duo, Shuguang; Tang, Fuchou; Gao, Fei			beta-Catenin directs the transformation of testis Sertoli cells to ovarian granulosa-like cells by inducing Foxl2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADAL DEVELOPMENT; SIGNALING PATHWAY; SEX-REVERSAL; DIFFERENTIATION; MOUSE; MICE; TRANSCRIPTION; ACTIVATION; GENE; SRY	Sertoli and granulosa cells are two major types of somatic cells in male and female gonads, respectively. Previous studies have shown that Sertoli and granulosa cells are derived from common progenitor cells and that differentiation of these two cell types is regulated by sex differentiation genes. The signaling pathway including the adhesion and transcription factor Ctnnb1 (cadherin-associated protein, beta 1, also known as beta-catenin) regulates differentiation of granulosa cells in the absence of the transcription factor Sry, and overactivation of beta-catenin in the presence of Sry leads to granulosa prior to sex determination. Surprisingly, our previous study found that beta-catenin overactivation in Sertoli cells after sex determination can also cause disruption of the testicular cord and aberrant testis development. However, the underlying molecular mechanism was unclear. In this study, we found that constitutive activation of Ctnnb1 in Sertoli cells led to ectopic expression of the granulosa cell-specific marker FOXL2in testes. Co-staining experiments revealed that FOXL2-positive cells were derived from Sertoli cells, and Sertoli cells were transformed into granulosa-like cells after Ctnnb1 overactivation. Further studies demonstrated that CTNNB1 induced Foxl2 expression by directly binding to transcription factor Tcf/Lef-binding sites in the FOXL2 promoter region. We also found that direct overexpression of Foxl2 decreased the expression of Sertoli cell-specific genes in primary Sertoli cells. Taken together, these results demonstrate that repression of beta-catenin (CTNNB1) signaling is required for lineage maintenance of Sertoli cells. Our study provides a new mechanism for Sertoli cell lineage maintenance during gonad development.	[Li, Yaqiong; Zhang, Lianjun; Chen, Min; Han, Feng; Qin, Yan; Chen, Min; Cui, Xiuhong; Duo, Shuguang; Gao, Fei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Li, Yaqiong; Zhang, Lianjun; Han, Feng; Qin, Yan; Chen, Min; Gao, Fei] Univ Chinese Acad Sci, Beijing 101408, Peoples R China; [Hu, Yuqiong; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Gao, F (corresponding author), Univ Chinese Acad Sci, Beijing 101408, Peoples R China.	gaof@ioz.ac.cn		Han, Feng/0000-0002-0274-9272	National Key R&D program of China [2016YFA0500901]; National Natural Science Funds for Distinguished Young Scholar [81525011]; National Natural Science Foundation of China [31471348, 31601193, 31671496]	National Key R&D program of China; National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D program of China Grant 2016YFA0500901, National Natural Science Funds for Distinguished Young Scholar Grant 81525011, and National Natural Science Foundation of China Grants 31471348, 31601193, and 31671496. The authors declare that they have no conflicts of interest with the contents of this article.	BAR A, 1978, J NUTR, V108, P1322, DOI 10.1093/jn/108.8.1322; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Clark PE, 2011, AM J PATHOL, V179, P3045, DOI 10.1016/j.ajpath.2011.08.006; Dang YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0991-3; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 2001, J EXP ZOOL, V290, P463, DOI 10.1002/jez.1089; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Li XX, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109405; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Pan B, 2011, MOL HUM REPROD, V17, P550, DOI 10.1093/molehr/gar017; Richards JS, 2012, ONCOGENE, V31, P1504, DOI 10.1038/onc.2011.341; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076642; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20	35	22	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17577	17586		10.1074/jbc.M117.811349	http://dx.doi.org/10.1074/jbc.M117.811349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28900034	Green Published, hybrid			2022-12-26	WOS:000414013000001
J	Kedage, V; Strittmatter, BG; Dausinas, PB; Hollenhorst, PC				Kedage, Vivekananda; Strittmatter, Brady G.; Dausinas, Paige B.; Hollenhorst, Peter C.			Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER PROGRESSION; REGULATORY NETWORK; ANDROGEN RECEPTOR; ETS; FUSION; TMPRSS2-ERG; EXPRESSION; SPECIFICITY; INHIBITION; INVASION	In similar to 50% of prostate cancers, chromosomal rearrangements cause the fusion of the promoter and 5'-UTR of the androgenregulated TMPRSS2 (transmembrane protease, serine 2) gene to the open reading frame of ERG, encoding an ETS family transcription factor. This fusion results in expression of full-length or N-terminally truncated ERG protein in prostate epithelia. ERG is not expressed in normal prostate epithelia, but when expressed, it promotes tumorigenesis via altered gene expression, stimulating epithelial-mesenchymal transition, cellular migration/invasion, and transformation. However, limited knowledge about the molecular mechanisms of ERG function in prostate cells has hampered efforts to therapeutically target ERG. ERK-mediated phosphorylation of ERG is required for ERG functions in prostate cells, but the reason for this requirement is unknown. Here, we report a mechanism whereby ERK-mediated phosphorylation of ERG at one serine residue causes a conformational change that allows ERK phosphorylation at a second serine residue, Ser-96. We found that the Ser-96 phosphorylation resulted in dissociation of EZH2 and SUZ12, components of polycomb repressive complex 2 (PRC2), transcriptional activation of ERG target genes, and increased cell migration. Conversely, loss of ERG phosphorylation at Ser-96 resulted in recruitment of EZH2 across the ERG-cistrome and a genome-wide loss of ERG-mediated transcriptional activation and cell migration. In conclusion, our findings have identified critical molecular mechanisms involving ERK-mediated ERG activation that could be exploited for therapeutic intervention in ERG-positive prostate cancers.	[Kedage, Vivekananda; Strittmatter, Brady G.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Dausinas, Paige B.; Hollenhorst, Peter C.] Indiana Univ, Dept Med Sci, Bloomington, IN 47405 USA; [Kedage, Vivekananda] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Roche Holding; Genentech	Hollenhorst, PC (corresponding author), Indiana Univ, Dept Med Sci, Bloomington, IN 47405 USA.	pchollen@indiana.edu		Strittmatter, Brady/0000-0001-6989-0038	American Cancer Society [RSG-13-215-01-DMC]; Indiana University; Indiana University Simon Cancer Center [P30CA82709]; Indiana University [T32 GM109825]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM109825] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Indiana University; Indiana University Simon Cancer Center; Indiana University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Research Scholar Award RSG-13-215-01-DMC, by the Indiana University Vice Provost for Research through the Faculty Research Support Program, and by Indiana University Simon Cancer Center P30 Support Grant P30CA82709 (to P. C. H.). This work was also supported by the Indiana University Graduate Training Program in Quantitative and Chemical Biology under Award T32 GM109825 (to B. G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blee AM, 2016, ONCOTARGET, V7, P38319, DOI 10.18632/oncotarget.9513; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Ducret C, 1999, MOL CELL BIOL, V19, P7076; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hagen RM, 2014, AM J CLIN PATHOL, V142, P533, DOI 10.1309/AJCPH88QHXARISUP; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hu Y, 2008, CLIN CANCER RES, V14, P4719, DOI 10.1158/1078-0432.CCR-08-0531; Huang Y, 2016, LEUKEMIA, V30, P1552, DOI 10.1038/leu.2016.55; Kedage V, 2016, CELL REP, V17, P1289, DOI 10.1016/j.celrep.2016.10.001; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Selvaraj N, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0089-7; Selvaraj N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-61; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	36	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17225	17235		10.1074/jbc.M117.796458	http://dx.doi.org/10.1074/jbc.M117.796458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28887309	hybrid, Green Published			2022-12-26	WOS:000414009300007
J	Afonso, AS; Garla, R; Hazin, FHV				Afonso, Andre S.; Garla, Ricardo; Hazin, Fabio H. V.			Tiger sharks can connect equatorial habitats and fisheries across the Atlantic Ocean basin	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; APEX PREDATORY SHARKS; GALEOCERDO-CUVIER; MARINE PREDATOR; AUSTRALIA; MOVEMENTS; BEHAVIOR; GEOLOCATION; ECOSYSTEMS; MIGRATION	Increasing our knowledge about the spatial ecology of apex predators and their interactions with diverse habitats and fisheries is necessary for understanding the trophic mechanisms that underlie several aspects of marine ecosystem dynamics and for guiding informed management policies. A preliminary assessment of tiger shark (Galeocerdo cuvier) population structure off the oceanic insular system of Fernando de Noronha (FEN) and the large-scale movements performed by this species in the equatorial Atlantic Ocean was conducted using longline and handline fishing gear and satellite telemetry. A total of 25 sharks measuring 175-372 cm in total length (TL) were sampled. Most sharks were likely immature females ranging between 200 and 260 cm TL, with few individuals < 200 cm TL being caught. This contrasts greatly with the tiger shark size-distribution previously reported for coastal waters off the Brazilian mainland, where most individuals measured < 200 cm TL. Also, the movements of 8 individuals measuring 202-310 cm TL were assessed with satellite transmitters for a combined total of 757 days (mean = 94.6 days.shark(-1); SD = 65.6). These sharks exhibited a considerable variability in their horizontal movements, with three sharks showing a mostly resident behavior around FEN during the extent of the respective tracks, two sharks traveling west to the South American continent, and two sharks moving mostly along the middle of the oceanic basin, one of which ending up in the northern hemisphere. Moreover, one shark traveled east to the African continent, where it was eventually caught by fishers from Ivory Coast in less than 474 days at liberty. The present results suggest that young tiger sharks measuring < 200 cm TL make little use of insular oceanic habitats from the western South Atlantic Ocean, which agrees with a previously-hypothesized ontogenetic habitat shift from coastal to oceanic habitats experienced by juveniles of this species in this region. In addition, this study adds evidence that tiger sharks are able to connect marine trophic webs from the neritic provinces of the eastern and western margins of the Atlantic Ocean across the equatorial basin and that they may experience mortality induced by remote fisheries. All this information is extremely relevant for understanding the energetic balance of marine ecosystems as much as the exposure of this species to fishing pressure in this yet poorly-known region.	[Afonso, Andre S.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Garla, Ricardo] Univ Fed Rio Grande do Norte, Dept Botanifca Ecol & Zool, Natal, RN, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal do Rio Grande do Norte	Afonso, AS (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil.	afonso.andre@gmail.com	Garla, Ricardo C/A-2990-2014	Afonso, Andre/0000-0001-9129-278X; Hazin, Fabio/0000-0003-3755-5379; Garla, Ricardo/0000-0002-0827-225X	Coordenagao de Aperfeigoamento de Pessoal do Ensino Superior [BJT-A049/2013]; State Government of Pernambuco; Fundo Nacional do Meio Ambiente [03/2006]; National Geographic Society Conservation Trust [C314-15]	Coordenagao de Aperfeigoamento de Pessoal do Ensino Superior; State Government of Pernambuco; Fundo Nacional do Meio Ambiente; National Geographic Society Conservation Trust(National Geographic Society)	This study was funded by the Coordenagao de Aperfeigoamento de Pessoal do Ensino Superior (http://www.capes.gov.br) (BJT-A049/2013 granted to ASA), the State Government of Pernambuco (http://www.sds.pe.gov.br), the Fundo Nacional do Meio Ambiente (http://www. mma.gov.br/fundo-national-do-meio-ambiente) (#03/2006 granted to RCG), and the National Geographic Society Conservation Trust (http:// www.nationalgeographic.com/explorers/grants programs/conservation-trust) (C314-15 granted to ASA). Precious collaborative field work and tracking data provided by Chris Fischer and Ocearch (www.ocearch.org) are deeply acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116720; Afonso AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102369; Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Bernard A, 2014, MOL ECOL IN PRESS; Bernard A, MOL ECOL IN PRESS; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Castro J.I., 1999, FAO FISHERIES TECHNI; Compagno LJV, 1984, FAO SPECIES CATALOGU, V4, P125; Domingo A, 2016, J FISH BIOL, V88, P1223, DOI 10.1111/jfb.12887; Driggers WB, 2008, AQUAT BIOL, V2, P161, DOI 10.3354/ab00045; Ferreira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116916; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Francis MP, 2015, MAR BIOL, V162, P2305, DOI 10.1007/s00227-015-2756-z; Gallagher AJ, 2016, SHARK RECREATIONAL F; Galuardi B, 2010, ANALYZEPSAT R PACKAG; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Hammerschlag N, 2016, BEHAV ECOL SOCIOBIOL, V70, P1777, DOI 10.1007/s00265-016-2183-2; Hammerschlag N, 2015, ECOLOGY, V96, P2117, DOI 10.1890/14-2113.1; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Holmes BJ, 2015, J FISH BIOL, V87, P422, DOI 10.1111/jfb.12732; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Jonsen ID, 2015, MAR BIOL; Ketchum JT, 2014, MAR BIOL, V161, P939, DOI 10.1007/s00227-014-2393-y; Kohler NE, 1998, MAR FISH REV, V60, P1; Lam CH, 2000, FISH RES, V91, P15; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Lea JSE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11202; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Queiroz N, 2016, P NATL ACAD SCI USA, V113, P1582, DOI 10.1073/pnas.1510090113; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Simpfendorfer CA, 2014, IUCN 2013 IUCN RED L; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; STRAMMA L, 1991, J MAR RES, V49, P281, DOI 10.1357/002224091784995864; Sulikowski JA., 2016, AQUAT BIOL, V24, P175, DOI [10.3354/ab00648, DOI 10.3354/AB00648]; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081	49	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184763	10.1371/journal.pone.0184763	http://dx.doi.org/10.1371/journal.pone.0184763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926627	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600037
J	Du, YH; Martine, JS; Mcgee, J; Yang, YC; Liu, EY; Suns, YR; Geihs, M; Kong, XJ; Zhou, EL; Li, Y; Huang, J				Du, Yonghong; Martine, Joshua S.; Mcgee, John; Yang, Yuchen; Liu, Eric Yi; Suns, Yingrui; Geihs, Matthias; Kong, Xuejun; Zhou, Eric Lingfeng; Li, Yun; Huang, Jie			A SNP panel and online tool for checking genotype concordance through comparing QR codes	PLOS ONE			English	Article							ASSOCIATION; SEQUENCE; HEALTH	In the current precision medicine era, more and more samples get genotyped and sequenced. Both researchers and commercial companies expend significant time and resources to reduce the error rate. However, it has been reported that there is a sample mix-up rate of between 0.1% and 1%, not to mention the possibly higher mix-up rate during the down-stream genetic reporting processes. Even on the low end of this estimate, this translates to a significant number of mislabeled samples, especially over the projected one billion people that will be sequenced within the next decade. Here, we first describe a method to identify a small set of Single nucleotide polymorphisms (SNPs) that can uniquely identify a personal genome, which utilizes allele frequencies of five major continental populations reported in the 1000 genomes project and the ExAC Consortium. To make this panel more informative, we added four SNPs that are commonly used to predict ABO blood type, and another two SNPs that are capable of predicting sex. We then implement a web interface (http://qrcme.tech), nicknamed QRC (for QR code based Concordance check), which is capable of extracting the relevant ID SNPs from a raw genetic data, coding its genotype as a quick response (QR) code, and comparing QR codes to report the concordance of underlying genetic datasets. The resulting 80 fingerprinting SNPs represent a significant decrease in complexity and the number of markers used for genetic data labelling and tracking. Our method and web tool is easily accessible to both researchers and the general public who consider the accuracy of complex genetic data as a prerequisite towards precision medicine.	[Du, Yonghong] Beijing Normal Univ, Sch Stat, Beijing, Peoples R China; [Martine, Joshua S.; Yang, Yuchen; Li, Yun] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA; [Mcgee, John] Univ North Carolina Chapel Hill, NC Translat & Clin Sci Inst, Chapel Hill, NC USA; [Liu, Eric Yi; Li, Yun] Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Suns, Yingrui] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Geihs, Matthias] Tech Univ Darmstadt, Dept Comp Sci, Darmstadt, Germany; [Kong, Xuejun] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhou, Eric Lingfeng; Li, Yun] Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC 27599 USA; [Huang, Jie] Boston VA Res Inst, Boston, MA 02130 USA; [Huang, Jie] Harvard Med Sch, Brigham Womens Hosp, Div Aging, Boston, MA 02115 USA	Beijing Normal University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Boston University; Technical University of Darmstadt; Harvard University; Beth Israel Deaconess Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Li, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.; Li, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC 27599 USA.; Li, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC 27599 USA.; Huang, J (corresponding author), Boston VA Res Inst, Boston, MA 02130 USA.; Huang, J (corresponding author), Harvard Med Sch, Brigham Womens Hosp, Div Aging, Boston, MA 02115 USA.	yenli@med.unc.edu; jhuang@bwh.harvard.edu	Yang, Yuchen/GZK-6062-2022	Huang, Jie/0000-0002-9036-4304	Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Robert Dawson Evans Endowment of the Department of Medicine at Boston Medical Center; NIH [R01HG006292, R01 HL129132, UL1TR001111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129132] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292] Funding Source: NIH RePORTER	Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Robert Dawson Evans Endowment of the Department of Medicine at Boston Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The research is supported by NIH grants R01HG006292, R01 HL129132, and UL1TR001111.; We thank Dr. Alkes Price at the Harvard TH Chan School of Public Health for commenting on an earlier version of this manuscript. We acknowledge the UK Biobank for making the data available. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The research is supported by NIH grants R01HG006292, R01 HL129132, and UL1TR001111.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Eisenstein M, 2015, NATURE, V527, pS2, DOI 10.1038/527S2a; Fradkin JE, 2016, DIABETES CARE, V39, P1080, DOI 10.2337/dc16-0541; Galichon P, 2012, NUCLEIC ACIDS RES, V40, P4774, DOI 10.1093/nar/gks169; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Hu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10247; Hwa HL, 2016, INT J LEGAL MED, V130, P81, DOI 10.1007/s00414-015-1250-y; Kim JJ, 2010, INT J LEGAL MED, V124, P125, DOI 10.1007/s00414-009-0389-9; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Lee HJ, 2017, INT J LEGAL MED, V131, P1203, DOI 10.1007/s00414-017-1564-z; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ling Hua, 2009, BMC Proc, V3 Suppl 7, pS57; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035146; Pakstis AJ, 2010, HUM GENET, V127, P315, DOI 10.1007/s00439-009-0771-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Storry J R, 2009, Immunohematology, V25, P48; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5	22	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0182438	10.1371/journal.pone.0182438	http://dx.doi.org/10.1371/journal.pone.0182438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926565	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600001
J	Kim, M; Ding, Y; Malcolm, P; Speeckaert, J; Siviy, CJ; Walsh, CJ; Kuindersma, S				Kim, Myunghee; Ding, Ye; Malcolm, Philippe; Speeckaert, Jozefien; Siviy, Christoper J.; Walsh, Conor J.; Kuindersma, Scott			Human-in-the-loop Bayesian optimization of wearable device parameters	PLOS ONE			English	Article							CMA EVOLUTION STRATEGY; PUSH-OFF WORK; EXOSKELETON ASSISTANCE; GLOBAL OPTIMIZATION; METABOLIC-RATE; WALKING; PROSTHESIS; REGRESSION; COST; SLOW	The increasing capabilities of exoskeletons and powered prosthetics for walking assistance have paved the way for more sophisticated and individualized control strategies. In response to this opportunity, recent work on human-in-the-loop optimization has considered the problem of automatically tuning control parameters based on realtime physiological measurements. However, the common use of metabolic cost as a performance metric creates significant experimental challenges due to its long measurement times and low signalto- noise ratio. We evaluate the use of Bayesian optimization-a family of sample-efficient, noise-tolerant, and global optimization methods-for quickly identifying near-optimal control parameters. To manage experimental complexity and provide comparisons against related work, we consider the task of minimizing metabolic cost by optimizing walking step frequencies in unaided human subjects. Compared to an existing approach based on gradient descent, Bayesian optimization identified a near-optimal step frequency with a faster time to convergence (12 minutes, p < 0.01), smaller inter-subject variability in convergence time (+/- 2 minutes, p < 0.01), and lower overall energy expenditure (p < 0.01).	[Kim, Myunghee; Ding, Ye; Malcolm, Philippe; Speeckaert, Jozefien; Siviy, Christoper J.; Walsh, Conor J.; Kuindersma, Scott] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kim, Myunghee; Ding, Ye; Malcolm, Philippe; Speeckaert, Jozefien; Siviy, Christoper J.; Walsh, Conor J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Malcolm, Philippe] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Malcolm, Philippe] Univ Nebraska, Ctr Res Human Movement Variabil, Omaha, NE 68182 USA	Harvard University; Harvard University; University of Nebraska System; University of Nebraska System	Kim, M; Walsh, CJ; Kuindersma, S (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Kim, M; Walsh, CJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	myunghee_kirn@g.harvard.edu; walsh@seas.harvard.edu; scottk@seas.harvard.edu		Siviy, Christopher/0000-0003-0789-0109; Kim, Myunghee/0000-0001-8965-6206	Defense Advanced Research Projects Agency (DARPA), Warrior Web Program [W911NF-14-C-0051]; National Science Foundation [DGE1144152]; Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH [P20GM109090]; Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA), Warrior Web Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based on the work supported by the Defense Advanced Research Projects Agency (DARPA), Warrior Web Program (contract no. W911NF-14-C-0051), and the National Science Foundation Graduate Research Fellowship Program (grant no. DGE1144152). P.M. was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090). This work was also supported in part by the Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA or the NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based on the work supported by the Defense Advanced Research Projects Agency (DARPA), Warrior Web Program (contract no. W911NF-14-C-0051), and the National Science Foundation Graduate Research Fellowship Program (grant no. DGE1144152). P.M. was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090). This work was also supported in part by the Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard.	Asbeck AT, 2015, IEEE INT CONF ROBOT, P6197, DOI 10.1109/ICRA.2015.7140069; Ascher U, 2016, VIETNAM J MATH, V44, P49, DOI 10.1007/s10013-015-0167-6; Bae J, 2015, INT C REHAB ROBOT, P131, DOI 10.1109/ICORR.2015.7281188; BERA AK, 1981, ECON LETT, V7, P313, DOI 10.1016/0165-1765(81)90035-5; Brochu E., 2008, ADV NEURAL INFORM PR, P409; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Calandra R, 2016, ANN MATH ARTIF INTEL, V76, P5, DOI 10.1007/s10472-015-9463-9; CAMUS G, 1988, EUR J APPL PHYSIOL O, V58, P197, DOI 10.1007/BF00636626; Caputo JM, 2015, IEEE INT CONF ROBOT, P6445, DOI 10.1109/ICRA.2015.7140104; Caputo JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07213; Ding Y, 2017, IEEE T NEUR SYS REH, V25, P119, DOI 10.1109/TNSRE.2016.2523250; Ding Y, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0196-8; Eric Brochu, 2010, TUTORIAL BAYESIAN OP; Felt W., 2012, INSTANTANEUOS COST M; Felt W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135342; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Galle S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0235-0; Garde A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086427; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Hansen N, 2004, LECT NOTES COMPUT SC, V3242, P282; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Huang D, 2006, J GLOBAL OPTIM, V34, P441, DOI 10.1007/s10898-005-2454-3; Jackson RW, 2017, J EXP BIOL, V220, P2082, DOI 10.1242/jeb.150011; Jones DR, 2001, J GLOBAL OPTIM, V21, P345, DOI 10.1023/A:1012771025575; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Kim M., 2015, THESIS CARNEGIE MELL; Kim M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0027-3; Koller JR, 2016, ROBOTICS: SCIENCE AND SYSTEMS XII; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Kuindersma SR, 2013, INT J ROBOT RES, V32, P806, DOI 10.1177/0278364913476124; Kushner H.J., 1964, J BASIC ENG-T ASME, V86, P97, DOI 10.1115/1.3653121; Lee J, 2017, INT C REHAB ROBOT, P498, DOI 10.1109/ICORR.2017.8009297; Lee SJ, 2016, IEEE INT CONF ROBOT, P3509, DOI 10.1109/ICRA.2016.7487531; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Lizotte DJ, 2008, PRACTICAL BAYESIAN O; Lorenz R, 2016, NEUROIMAGE, V129, P320, DOI 10.1016/j.neuroimage.2016.01.032; Lourens MS, 2000, INTENS CARE MED, V26, P1612, DOI 10.1007/s001340000632; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mockus J., 1978, GLOBAL OPTIMIZATION, V2, P2, DOI DOI 10.1007/978-94-009-0909-0_80394.90090; Mokus J., 1975, OPTIMIZATION TECHNIQ, P400, DOI [10.1007/3-540-07165-2_55, DOI 10.1007/3-540-07165-2_55]; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Ogawa Y, 2006, J CLIN ANESTH, V18, P87, DOI 10.1016/j.jclinane.2005.06.004; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Perez-Cruz F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2013.2250352; Pfeiffer KA, 2002, MED SCI SPORT EXER, V34, P2057, DOI 10.1097/00005768-200212000-00029; Quesada RE, 2016, J BIOMECH, V49, P3452, DOI 10.1016/j.jbiomech.2016.09.015; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Ratkevicius A, 2006, J SPORT SCI MED, V5, P440; Roberts JW, 2009, ADV NEURAL INFORM PR, P1361; SCHAFFER C, 1993, MACH LEARN, V10, P153, DOI 10.1023/A:1022653209073; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Seo K, 2016, IEEE INT CONF ROBOT, P4628, DOI 10.1109/ICRA.2016.7487663; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Swersky K., 2013, ADV NEURAL INFORM PR, V2, P2004, DOI DOI 10.1038/S41598-021-83582-6; Bui-Thanh T, 2012, SIAM J SCI COMPUT, V34, pA2837, DOI 10.1137/110851419; van Vaerenbergh S., 2012, IEEE INT WORKSH MACH, P1; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wehner M, 2013, IEEE INT CONF ROBOT, P3362, DOI 10.1109/ICRA.2013.6631046; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	62	32	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184054	10.1371/journal.pone.0184054	http://dx.doi.org/10.1371/journal.pone.0184054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926613	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600008
J	Ambrisko, TD; Schramel, JP; Auer, U; Moens, YPS				Ambrisko, Tamas D.; Schramel, Johannes P.; Auer, Ulrike; Moens, Yves P. S.			Impact of four different recumbencies on the distribution of ventilation in conscious or anaesthetized spontaneously breathing beagle dogs: An electrical impedance tomography study	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; COMPUTED-TOMOGRAPHY; LUNG VENTILATION; PERFUSION; CONSOLIDATION; RECRUITMENT; NEED; EIT	The aim was to examine the effects of recumbency and anaesthesia on distribution of ventilation in beagle dogs using Electrical Impedance Tomography (EIT). Nine healthy beagle dogs, aging 3.7 +/- 1.7 (mean +/- SD) years and weighing 16.3 +/- 1.6 kg, received a series of treatments in a fixed order on a single occasion. Conscious dogs were positioned in right lateral recumbency (RLR) and equipped with 32 EIT electrodes around the thorax. Following five minutes of equilibration, two minutes of EIT recordings were made in each recumbency in the following order: RLR, dorsal (DR), left (LLR) and sternal (SR). The dogs were then positioned in RLR, premedicated (medetomidine 0.01, midazolam 0.1, butorphanol 0.1 mg kg(-1) iv) and pre-oxygenated. Fifteen minutes later anaesthesia was induced with 1 mg kg(-1) propofol iv and maintained with propofol infusion (0.1 +/- 0.2 mg kg(-1) minute(-1) iv). After induction, the animals were intubated and allowed to breathe spontaneously (FIO2 = 1). Recordings of EIT were performed again in four recumbencies similarly to conscious state. Centre of ventilation (COV) and global inhomogeneity (GI) index were calculated from the functional EIT images. Repeated-measures ANOVA and Bonferroni tests were used for statistical analysis (p < 0.05). None of the variables changed in the conscious state. During anaesthesia left-toright COV increased from 46.8 +/- 2.8% in DR to 49.8 +/- 2.9% in SR indicating a right shift, and ventral-to-dorsal COV increased from 49.8 +/- 1.7% in DR to 51.8 +/- 1.1% in LLR indicating a dorsal shift in distribution of ventilation. Recumbency affected distribution of ventilation in anaesthetized but not in conscious dogs. This can be related to loss of respiratory muscle tone (e.g. diaphragm) and changes in thoracic shape. Changing position of thoraco-abdominal organs under the EIT belt should be considered as alternative explanation of these findings.	[Ambrisko, Tamas D.; Schramel, Johannes P.; Auer, Ulrike; Moens, Yves P. S.] Univ Vet Med, Dept Compan Anim & Horses, Anaesthesiol & Perioperat Intens Care Med, Vienna, Austria	University of Veterinary Medicine Vienna	Ambrisko, TD (corresponding author), Univ Vet Med, Dept Compan Anim & Horses, Anaesthesiol & Perioperat Intens Care Med, Vienna, Austria.	tambrisko@hotmail.com		Ulrike, Auer/0000-0003-0390-2678	Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany	Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany	This work was supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany (http://gkf-boon.de/index.php/startserte.html). Funding was acquired by TDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany. The authors thank Dr. Martina Mosing for providing a CT image of a beagle dog that was used to create an EIT mesh for dogs. Preliminary results were presented as an Abstract at the 12th World Congress of Veterinary Anaesthesiology, Kyoto, Japan, 1st- 4th September 2015. None of the authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper.	Adler A, 1998, J APPL PHYSIOL, V84, P726, DOI 10.1152/jappl.1998.84.2.726; Adler A, 1996, IEEE T BIO-MED ENG, V43, P414, DOI 10.1109/10.486261; Adler A, 1997, J APPL PHYSIOL, V83, P1762, DOI 10.1152/jappl.1997.83.5.1762; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Ambrisko TD, 2016, PHYSIOL MEAS, V37, P175, DOI 10.1088/0967-3334/37/2/175; BEYDON L, 1992, CHEST, V102, P1697, DOI 10.1378/chest.102.6.1697; Bloomfield FH, 1999, PEDIATR RADIOL, V29, P459, DOI 10.1007/s002470050617; Chang H, 2002, J APPL PHYSIOL, V92, P745, DOI 10.1152/japplphysiol.00377.2001; Costa ELV, 2008, CRIT CARE MED, V36, P1230, DOI 10.1097/CCM.0b013e31816a0380; Costa ELV, 2009, CURR OPIN CRIT CARE, V15, P18, DOI 10.1097/MCC.0b013e3283220e8c; De Monte V, 2013, AM J VET RES, V74, P25, DOI 10.2460/ajvr.74.1.25; Frerichs I, 2006, AM J RESP CRIT CARE, V174, P772, DOI 10.1164/rccm.200512-1942OC; Gloning S, 2017, TIERAERZTL PRAX K H, V45, P15, DOI 10.15654/TPK-150569; Gomez-Laberge C, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S13; Hoareau GL, 2011, J VET EMERG CRIT CAR, V21, P226, DOI 10.1111/j.1476-4431.2011.00635.x; Leonhardt S, 2012, INTENS CARE MED, V38, P1917, DOI 10.1007/s00134-012-2684-z; Luepschen H, 2007, PHYSIOL MEAS, V28, pS247, DOI 10.1088/0967-3334/28/7/S18; Marcucci C, 2001, J APPL PHYSIOL, V90, P421, DOI 10.1152/jappl.2001.90.2.421; Mosing M, 2016, VET ANAESTH ANALG; Newell JC, 1996, IEEE T BIO-MED ENG, V43, P133, DOI 10.1109/10.481982; Rocchi A., 2014, AVA C NOTT ASS VET A; Rooney D, 2009, PHYSIOL MEAS, V30, P1075, DOI 10.1088/0967-3334/30/10/008; Schibler A, 2009, PEDIATR PULM, V44, P851, DOI 10.1002/ppul.21000; Tusman G, 2010, BEST PRACT RES-CLIN, V24, P183, DOI 10.1016/j.bpa.2010.02.006; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405; Zhao ZQ, 2009, INTENS CARE MED, V35, P1900, DOI 10.1007/s00134-009-1589-y	27	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183340	10.1371/journal.pone.0183340	http://dx.doi.org/10.1371/journal.pone.0183340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922361	gold, Green Published, Green Submitted			2022-12-26	WOS:000411059300004
J	Cieplak, AS				Cieplak, Andrzej Stanislaw			Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; INDUCED CONFORMATIONAL-CHANGES; PARTIALLY FOLDED STRUCTURE; PAIRED HELICAL FILAMENTS; ATOMIC-FORCE MICROSCOPY; SODIUM DODECYL-SULFATE; C-TERMINAL THREONINE; HUMAN PRION PROTEIN; O HYDROGEN-BONDS; A-BETA	Proteins associated with neurodegenerative diseases are highly pleiomorphic and may adopt an all-a-helical fold in one environment, assemble into all-beta-sheet or collapse into a coil in another, and rapidly polymerize in yet another one via divergent aggregation pathways that yield broad diversity of aggregates' morphology. A thorough understanding of this behaviour may be necessary to develop a treatment for Alzheimer's and related disorders. Unfortunately, our present comprehension of folding and misfolding is limited for want of a physicochemical theory of protein secondary and tertiary structure. Here we demonstrate that electronic configuration and hyperconjugation of the peptide amide bonds ought to be taken into account to advance such a theory. To capture the effect of polarization of peptide linkages on conformational and H-bonding propensity of the polypeptide backbone, we introduce a function of shielding tensors of the C-a atoms. Carrying no information about side chain-side chain interactions, this function nonetheless identifies basic features of the secondary and tertiary structure, establishes sequence correlates of the metamorphic and pHdriven equilibria, relates binding affinities and folding rate constants to secondary structure preferences, and manifests common patterns of backbone density distribution in amyloidogenic regions of Alzheimer's amyloid beta and tau, Parkinson's a-synuclein and prions. Based on those findings, a split-intein like mechanism of molecular recognition is proposed to underlie dimerization of A beta, tau, aS and PrPC, and divergent pathways for subsequent association of dimers are outlined; a related mechanism is proposed to underlie formation of PrP Sc fibrils. The model does account for: (i) structural features of paranuclei, off-pathway oligomers, non-fibrillar aggregates and fibrils; (ii) effects of incubation conditions, point mutations, isoform lengths, small-molecule assembly modulators and chirality of solid-liquid interface on the rate and morphology of aggregation; (iii) fibril-surface catalysis of secondary nucleation; and (iv) self-propagation of infectious strains of mammalian prions.	[Cieplak, Andrzej Stanislaw] Bilkent Univ, Dept Chem, Ankara, Turkey; [Cieplak, Andrzej Stanislaw] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Cieplak, Andrzej Stanislaw] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	Ihsan Dogramaci Bilkent University; Yale University; Brandeis University	Cieplak, AS (corresponding author), Bilkent Univ, Dept Chem, Ankara, Turkey.; Cieplak, AS (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Cieplak, AS (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02254 USA.	cieplak@gmail.com	Ertan, Asli/AAE-6201-2021					Adhikary R, 2014, J AM CHEM SOC, V136, P13474, DOI 10.1021/ja503107h; Adler J, 2014, PHYS CHEM CHEM PHYS, V16, P7461, DOI 10.1039/c3cp54501f; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Albright TA, 2013, ORBITAL INTERACTIONS IN CHEMISTRY, 2ND EDITION, P1, DOI 10.1002/9781118558409; Alexander PA, 2009, P NATL ACAD SCI USA, V106, P21149, DOI 10.1073/pnas.0906408106; Anderson WJ, 2011, PROTEIN ENG DES SEL, V24, P765, DOI 10.1093/protein/gzr027; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; [Anonymous], 2001, PROTEIN SCI S1, V10, P111; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Ball KA, 2013, BIOPHYS J, V104, P2714, DOI 10.1016/j.bpj.2013.04.056; Banavar JR, 2007, ANNU REV BIOPH BIOM, V36, P261, DOI 10.1146/annurev.biophys.36.040306.132808; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Baranczak A, 2016, CURR OPIN CHEM BIOL, V32, P10, DOI 10.1016/j.cbpa.2016.01.009; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Bateman DA, 2011, BIOPHYS J, V101, P2485, DOI 10.1016/j.bpj.2011.10.009; Beerten J, 2015, BIOINFORMATICS, V31, P1698, DOI 10.1093/bioinformatics/btv027; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; BenTal N, 1997, J PHYS CHEM B, V101, P450, DOI 10.1021/jp961825r; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Berthelot K, 2011, J MOL BIOL, V412, P137, DOI 10.1016/j.jmb.2011.07.009; Berthelot K, 2009, FASEB J, V23, P2254, DOI 10.1096/fj.08-125724; Bhowmik D, 2014, PHYS CHEM CHEM PHYS, V16, P885, DOI 10.1039/c3cp54151g; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bockris J.OM., 1998, MODERN ELECTROCHEMIS, V1; Brogan APS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6058; Brogan APS, 2012, CHEM SCI, V3, P1839, DOI 10.1039/c2sc20143g; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burnouf S, 2015, ACTA NEUROPATHOL, V130, P35, DOI 10.1007/s00401-015-1419-y; Burton RE, 1996, J MOL BIOL, V263, P311, DOI 10.1006/jmbi.1996.0577; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chakrabarti P, 1997, PROTEIN SCI, V6, P851; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chemuru S, 2016, J MOL BIOL, V428, P274, DOI 10.1016/j.jmb.2015.06.008; Chemuru S, 2014, BIOPOLYMERS, V102, P206, DOI 10.1002/bip.22470; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chen YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061874; Cheng RP, 2012, AMINO ACIDS, V43, P195, DOI 10.1007/s00726-011-1064-2; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiu HP, 2006, J AM CHEM SOC, V128, P15556, DOI 10.1021/ja0640445; Chiu HP, 2009, J AM CHEM SOC, V131, P13192, DOI 10.1021/ja903631h; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Christopeit T, 2005, PROTEIN SCI, V14, P2125, DOI 10.1110/ps.051470405; CIEPLAK AS, 1985, J AM CHEM SOC, V107, P271, DOI 10.1021/ja00287a060; Cieplak AS, 2004, J ORG CHEM, V69, P3250, DOI 10.1021/jo0358372; CIEPLAK AS, 1994, STRUCT CHEM, V5, P85, DOI 10.1007/BF02265350; Cieplak AS, 1999, CHEM REV, V99, P1265, DOI 10.1021/cr980381n; CIEPLAK AS, 1981, J AM CHEM SOC, V103, P4540, DOI 10.1021/ja00405a041; Cieplak AS, 1994, STRUCTURE CORRELATIO, V1; Cieplak AS, 1999, AMIDE LINKAGE STRUCT; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Coleman BM, 2014, J VIROL, V88, P2690, DOI 10.1128/JVI.02720-13; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Conicella AE, 2014, BIOCHEMISTRY-US, V53, P3095, DOI 10.1021/bi500131a; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Cuervo A, 2014, P NATL ACAD SCI USA, V111, pE3624, DOI 10.1073/pnas.1405702111; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Daskalov A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004158; De Alba E, 1999, PROTEIN SCI, V8, P854; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; de la Paz ML, 2001, J MOL BIOL, V312, P229, DOI 10.1006/jmbi.2001.4918; Dean DN, 2016, BIOCHEMISTRY-US, V55, P2238, DOI 10.1021/acs.biochem.6b00161; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Debye P, 1923, PHYS Z, V24, P185; Deechongkit S, 2004, J AM CHEM SOC, V126, P16762, DOI 10.1021/ja045934s; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Dewar M.J.S., 1975, PMO THEORY ORGANIC C; Dimitriadis G, 2004, P NATL ACAD SCI USA, V101, P3809, DOI 10.1073/pnas.0306433101; Dodson CA, 2015, FEBS LETT, V589, P1740, DOI 10.1016/j.febslet.2015.06.002; Doi T, 2012, BIOCHEM BIOPH RES CO, V428, P458, DOI 10.1016/j.bbrc.2012.10.096; Dubnovitsky A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066101; Economou NJ, 2016, J AM CHEM SOC, V138, P1772, DOI 10.1021/jacs.5b11913; Eildal JNN, 2013, J AM CHEM SOC, V135, P12998, DOI 10.1021/ja402875h; Elgabarty H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9318; Epiotis ND, 1977, TOP CURR CHEM, P70; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Fabiola GF, 1997, ACTA CRYSTALLOGR D, V53, P316, DOI 10.1107/S0907444997000383; Faria TQ, 2015, PHYS CHEM CHEM PHYS, V17, P7255, DOI 10.1039/c4cp04549a; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Ferguson N, 2001, J MOL BIOL, V307, P393, DOI 10.1006/jmbi.2000.4492; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fischer FR, 2008, P NATL ACAD SCI USA, V105, P17290, DOI 10.1073/pnas.0806129105; Fisk JD, 2006, J AM CHEM SOC, V128, P7148, DOI 10.1021/ja060942p; Fleming I., 2011, MOL ORBITALS ORGANIC; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frisch M. J., 2016, GAUSSIAN 16 REVISION, V16; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Fufezan C, 2010, PROTEINS, V78, P2831, DOI 10.1002/prot.22800; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; Gao GB, 2015, ANGEW CHEM INT EDIT, V54, P2245, DOI 10.1002/anie.201410768; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Gendoo DMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027342; Georgieva ER, 2014, BIOPHYS J, V107, P1441, DOI 10.1016/j.bpj.2014.07.046; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Ghosh JC, 1918, J CHEM SOC, V113, P449, DOI 10.1039/ct9181300449; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Giri R, 2012, P NATL ACAD SCI USA, V109, P17772, DOI 10.1073/pnas.1201794109; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gleiter R., 2012, AROMATICITY OTHER CO, P72; Glendening ED, 1997, J AM CHEM SOC, V119, P12940, DOI 10.1021/ja970074j; Goldsteins G, 1999, P NATL ACAD SCI USA, V96, P3108, DOI 10.1073/pnas.96.6.3108; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Griffiths-Jones SR, 2000, J AM CHEM SOC, V122, P8350, DOI 10.1021/ja000787t; Groenning M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11443; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Gruning CSR, 2014, J BIOL CHEM, V289, P23209, DOI 10.1074/jbc.M114.560920; Gu L, 2014, J BIOL CHEM, V289, P27300, DOI 10.1074/jbc.M114.569004; Gu L, 2013, J BIOL CHEM, V288, P18673, DOI 10.1074/jbc.M113.457739; Gueroult M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041704; Habchi J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501244; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; HADDON RC, 1975, J AM CHEM SOC, V97, P3608, DOI 10.1021/ja00846a009; Hamill SJ, 1998, BIOCHEMISTRY-US, V37, P8071, DOI 10.1021/bi9801659; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Harder E, 2008, J PHYS CHEM B, V112, P3509, DOI 10.1021/jp709729d; Hayden EY, 2015, BIOCHEMISTRY-US, V54, P4599, DOI 10.1021/acs.biochem.5b00280; He YA, 2012, STRUCTURE, V20, P283, DOI 10.1016/j.str.2011.11.018; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Hinderaker MP, 2003, PROTEIN SCI, V12, P1188, DOI 10.1110/ps.0241903; Ho BK, 2003, PROTEIN SCI, V12, P2508, DOI 10.1110/ps.03235203; Hoffmann R, 1998, THEOCHEM-J MOL STRUC, V424, P1, DOI 10.1016/S0166-1280(97)00219-4; HOFFMANN R, 1971, ACCOUNTS CHEM RES, V4, P1, DOI 10.1021/ar50037a001; Honda RP, 2014, J BIOL CHEM, V289, P30355, DOI 10.1074/jbc.M114.559450; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Hubin E, 2015, CELL MOL LIFE SCI, V72, P4899, DOI 10.1007/s00018-015-1983-2; Gallea JI, 2014, J BIOL CHEM, V289, P26733, DOI 10.1074/jbc.M114.566695; Jarrold MF, 2007, PHYS CHEM CHEM PHYS, V9, P1659, DOI 10.1039/b612615d; Jarrold MF, 1999, ACCOUNTS CHEM RES, V32, P360, DOI 10.1021/ar960081x; Jemth P, 2005, J MOL BIOL, V350, P363, DOI 10.1016/j.jmb.2005.04.067; Jeong JS, 2013, J MOL BIOL, V425, P1765, DOI 10.1016/j.jmb.2013.02.005; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kadavath H, 2015, ANGEW CHEM INT EDIT, V54, P10347, DOI 10.1002/anie.201501714; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kamer KJ, 2013, J ORG CHEM, V78, P2099, DOI 10.1021/jo302265k; Kendall J, 1922, J AM CHEM SOC, V44, P717, DOI 10.1021/ja01425a006; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; KLOTZ IM, 1962, J AM CHEM SOC, V84, P3461, DOI 10.1021/ja00877a009; Korshavn KJ, 2016, CHEM COMMUN, V52, P882, DOI 10.1039/c5cc08634e; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kretner B, 2016, EMBO MOL MED, V8, P458, DOI 10.15252/emmm.201505952; Krishna N, 2011, INT J BIOL MACROMOL, V49, P218, DOI 10.1016/j.ijbiomac.2011.04.017; Kubelka J, 2003, J MOL BIOL, V329, P625, DOI 10.1016/S0022-2836(03)00519-9; Kukic P, 2013, J AM CHEM SOC, V135, P16968, DOI 10.1021/ja406995j; Kuloglu ES, 2001, BIOCHEMISTRY-US, V40, P12486, DOI 10.1021/bi011106p; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111492; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kung VM, 2015, ANGEW CHEM INT EDIT, V54, P14336, DOI 10.1002/anie.201506448; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Lambermon MHL, 2005, J NEUROCHEM, V95, P1667, DOI 10.1111/j.1471-4159.2005.03497.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lan MY, 2014, J CLIN NEUROSCI, V21, P513, DOI 10.1016/j.jocn.2013.03.038; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Larda ST, 2013, J AM CHEM SOC, V135, P10533, DOI 10.1021/ja404584s; Lario PI, 2003, J AM CHEM SOC, V125, P12787, DOI 10.1021/ja0289954; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lawrence JR, 2002, BIOPHYS CHEM, V101, P375, DOI 10.1016/S0301-4622(02)00173-4; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Leka O, 2014, FEBS J, V281, P2115, DOI 10.1111/febs.12783; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; Lim KH, 2016, BIOCHEMISTRY-US, V55, P5272, DOI 10.1021/acs.biochem.6b00649; Lim KH, 2016, BIOCHEMISTRY-US, V55, P1941, DOI 10.1021/acs.biochem.6b00164; Lipfert J, 2014, ANNU REV BIOCHEM, V83, P813, DOI 10.1146/annurev-biochem-060409-092720; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Luo JH, 2014, BIOCHEMISTRY-US, V53, P6302, DOI 10.1021/bi5003579; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Lv ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02880; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Ma K, 1999, J AM CHEM SOC, V121, P8698, DOI 10.1021/ja990864o; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Mc Donald JM, 2015, ALZHEIMERS DEMENT, V11, P1286, DOI 10.1016/j.jalz.2015.01.005; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Messa M, 2014, J BIOL CHEM, V289, P24143, DOI 10.1074/jbc.M114.576256; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Mikhalyov I, 2010, BIOPHYS J, V99, P1510, DOI 10.1016/j.bpj.2010.06.043; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; MilnerWhite EJ, 1997, PROTEIN SCI, V6, P2477; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Mo YR, 2007, ACCOUNTS CHEM RES, V40, P113, DOI 10.1021/ar068073w; Moriarty GM, 2013, FEBS LETT, V587, P1128, DOI 10.1016/j.febslet.2013.02.049; Muller-Schiffmann A, 2016, BRAIN, V139, P509, DOI 10.1093/brain/awv355; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Myers JK, 2001, NAT STRUCT BIOL, V8, P552, DOI 10.1038/88626; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Natesh R, 2003, ACTA CRYSTALLOGR D, V59, P105, DOI 10.1107/S0907444902020164; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nystrom S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10101; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; Pace CN, 2014, FEBS LETT, V588, P2177, DOI 10.1016/j.febslet.2014.05.006; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PADMANABHAN S, 1991, J MOL BIOL, V219, P135, DOI 10.1016/0022-2836(91)90553-I; Padmanabhan S, 1996, J MOL BIOL, V257, P726, DOI 10.1006/jmbi.1996.0197; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; PAULING L, 1953, PROC R SOC SER B-BIO, V141, P21, DOI 10.1098/rspb.1953.0012; Penel S, 2003, PROTEIN ENG, V16, P957, DOI 10.1093/protein/gzg147; Pires RH, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2587; Pires RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044992; Pross A, 1981, PROGR PHYS ORGANIC C, V13; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qing GY, 2014, J AM CHEM SOC, V136, P10736, DOI 10.1021/ja5049626; Rajan R, 1997, BIOPOLYMERS, V42, P125, DOI 10.1002/(SICI)1097-0282(199708)42:2<125::AID-BIP1>3.0.CO;2-P; Ramachandran G, 2014, BIOCHEMISTRY-US, V53, P6550, DOI 10.1021/bi500528x; Ramachandran G, 2013, BIOCHEMISTRY-US, V52, P4107, DOI 10.1021/bi400209z; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roche J, 2016, BIOCHEMISTRY-US, V55, P762, DOI 10.1021/acs.biochem.5b01259; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Ryan TM, 2015, J NEUROSCI, V35, P2871, DOI 10.1523/JNEUROSCI.2912-14.2015; Ryan TM, 2012, J BIOL CHEM, V287, P16947, DOI 10.1074/jbc.M111.321778; Sabareesan AT, 2016, J MOL BIOL, V428, P3935, DOI 10.1016/j.jmb.2016.08.015; Sabareesan AT, 2016, BIOPHYS J, V110, P1766, DOI 10.1016/j.bpj.2016.03.017; Sabate R, 2009, FEBS J, V276, P5053, DOI 10.1111/j.1742-4658.2009.07202.x; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; SALEMME FR, 1983, PROG BIOPHYS MOL BIO, V42, P95, DOI 10.1016/0079-6107(83)90005-6; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Sebollela A, 2014, ACS CHEM NEUROSCI, V5, P1238, DOI 10.1021/cn500156r; Serag AA, 2001, BIOCHEMISTRY-US, V40, P9089, DOI 10.1021/bi010655s; Shabestari MH, 2016, J BIOL PHYS, V42, P299, DOI 10.1007/s10867-016-9408-5; Shah NH, 2013, J AM CHEM SOC, V135, P18673, DOI 10.1021/ja4104364; Shamovsky IL, 2000, J PHYS CHEM B, V104, P11296, DOI 10.1021/jp002590t; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Shelimov KB, 1997, J AM CHEM SOC, V119, P2987, DOI 10.1021/ja962914k; Shepherd TR, 2011, BIOCHEMISTRY-US, V50, P1296, DOI 10.1021/bi1013613; SHERIDAN RP, 1979, BIOPOLYMERS, V18, P2451, DOI 10.1002/bip.1979.360181006; Shivu B, 2013, BIOCHEMISTRY-US, V52, P5176, DOI 10.1021/bi400625v; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; Singh J, 2016, BIOCHEMISTRY-US, V55, P459, DOI 10.1021/acs.biochem.5b01266; Singh J, 2015, ANGEW CHEM INT EDIT, V54, P7529, DOI 10.1002/anie.201501011; Singh J, 2013, J MOL BIOL, V425, P3510, DOI 10.1016/j.jmb.2013.06.009; Sippl MJ, 2009, CURR OPIN STRUC BIOL, V19, P312, DOI 10.1016/j.sbi.2009.03.010; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Spitzer J, 2009, MICROBIOL MOL BIOL R, V73, P371, DOI 10.1128/MMBR.00010-09; Spivey AC, INTRO STEREOELECTRON; Sridhar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107647; Stanger HE, 2001, P NATL ACAD SCI USA, V98, P12015, DOI 10.1073/pnas.211536998; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Susa AC, 2014, J AM CHEM SOC, V136, P12912, DOI 10.1021/ja504031d; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Terry C, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160035; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Tiiman A, AIP ADV; Tosatto L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16696; Trevitt CR, 2014, J BIOL CHEM, V289, P25497, DOI 10.1074/jbc.M114.566588; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Ueno H, 2014, BIOCHEMISTRY-US, V53, P7523, DOI 10.1021/bi501239q; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Vignaud H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080262; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Vitalis A, 2010, J MOL BIOL, V403, P148, DOI 10.1016/j.jmb.2010.08.003; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walti MA, 2015, CHEMBIOCHEM, V16, P659, DOI 10.1002/cbic.201402595; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wan W, 2014, P NATL ACAD SCI USA, V111, P5201, DOI 10.1073/pnas.1322933111; Wan W, 2013, J BIOL CHEM, V288, P29604, DOI 10.1074/jbc.M113.505511; Wan W, 2012, BIOPHYS J, V102, P2339, DOI [10.1016/j.bpj.2012.04.011, 10.1016/j.bpj.2012.04.01]; Wang CC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00048; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang Y, 2013, P NATL ACAD SCI USA, V110, pE3743, DOI 10.1073/pnas.1308381110; Wasmer C, 2008, ANGEW CHEM INT EDIT, V47, P5839, DOI 10.1002/anie.200704896; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wathen B, 2011, CHEMBIOCHEM, V12, P1674, DOI 10.1002/cbic.201100156; Weinhold F, 2006, VALENCY BONDING NATU; WIBERG KB, 1995, J AM CHEM SOC, V117, P4261, DOI 10.1021/ja00120a006; Wiberg KB, 2003, AMIDE LINKAGE STRUCT; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Williams AD, 2005, P NATL ACAD SCI USA, V102, P7115, DOI 10.1073/pnas.0408582102; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Wolff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127865; Wu JIC, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2228-2; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yagi-Utsumi M, 2011, INT J ALZHEIMERS DIS, V11; Yagi-Utsumi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146405; Yagi-Utsumi M, 2015, BIOL PHARM BULL, V38, P1668, DOI 10.1248/bpb.b15-00466; Yi XY, 2015, BIOCHEMISTRY-US, V54, P6323, DOI 10.1021/acs.biochem.5b00719; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang HM, 2010, LANGMUIR, V26, P7343, DOI 10.1021/la904237d; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhang YJ, 2012, J BIOL CHEM, V287, P748, DOI 10.1074/jbc.M111.281295; Zhang-Haagen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150267; Zheng XY, 2015, ACS CHEM NEUROSCI, V6, P1732, DOI 10.1021/acschemneuro.5b00171; Zheng XY, 2012, J BIOL CHEM, V287, P6084, DOI 10.1074/jbc.C111.328575; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100; Zhu YJ, 2004, CHEM PHYS, V307, P99, DOI 10.1016/j.chemphys.2004.05.008; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200; Zou K, 2013, AM J PATHOL, V182, P2322, DOI 10.1016/j.ajpath.2013.01.053	363	11	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0180905	10.1371/journal.pone.0180905	http://dx.doi.org/10.1371/journal.pone.0180905			71	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922400	Green Submitted, Green Published, gold			2022-12-26	WOS:000411059300001
J	Sasaki, F; Koga, T; Saeki, K; Okuno, T; Kazuno, S; Fujimura, T; Ohkawa, Y; Yokomizo, T				Sasaki, Fumiyuki; Koga, Tomoaki; Saeki, Kazuko; Okuno, Toshiaki; Kazuno, Saiko; Fujimura, Tsutomu; Ohkawa, Yasuyuki; Yokomizo, Takehiko			Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B-4 receptor 1	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; T-CELL RECRUITMENT; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; AIRWAY HYPERRESPONSIVENESS; MAINTENANCE THERAPY; LIPID MEDIATORS; IN-VIVO; BLT1; MICE	Leukotriene B-4 (LTB4) receptor 1 (BLT1) is a G protein-coupled receptor expressed in various leukocyte subsets; however, the precise expression of mouse BLT1 (mBLT1) has not been reported because a mBLT1 monoclonal antibody (mAb) has not been available. In this study, we present the successful establishment of a hybridoma cell line (clone 7A8) that produces a high-affinity mAb for mBLT1 by direct immunization of BLT1-deficient mice with mBLT1-overexpressing cells. The specificity of clone 7A8 was confirmed using mBLT1-overexpressing cells and mouse peripheral blood leukocytes that endogenously express BLT1. Clone 7A8 did not cross-react with human BLT1 or other G protein-coupled receptors, including human chemokine (C-X-C motif) receptor 4. The 7A8 mAb binds to the second extracellular loop of mBLT1 and did not affect LTB4 binding or intracellular calcium mobilization by LTB4. The 7A8 mAb positively stained Gr-1-positive granulocytes, CD11b-positive granulocytes/monocytes, F4/80-positive monocytes, CCR2-high and CCR2-low monocyte subsets in the peripheral blood and a CD4-positive T cell subset, Th1 cells differentiated in vitro from naive CD4-positive T cells. This mAb was able to detect Gr-1-positive granulocytes and monocytes in the spleens of naive mice by immunohistochemistry. Finally, intraperitoneal administration of 7A8 mAb depleted granulocytes and monocytes in the peripheral blood. We have therefore succeeded in generating a high-affinity anti-mBLT1 mAb that is useful for analyzing mBLT1 expression in vitro and in vivo.	[Sasaki, Fumiyuki; Koga, Tomoaki; Saeki, Kazuko; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Kazuno, Saiko] Juntendo Univ, Grad Sch Med, Lab Prote, Tokyo, Japan; [Kazuno, Saiko] Juntendo Univ, Grad Sch Med, Biomol Sci Res Support Ctr, Tokyo, Japan; [Fujimura, Tsutomu] Tohoku Med & Pharmaceut Univ, Lab Bioanalyt Chem, Sendai, Miyagi, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Koga, Tomoaki] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan	Juntendo University; Juntendo University; Juntendo University; Tohoku Medical & Pharmaceutical University; Kyushu University; Kumamoto University	Yokomizo, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan.	yokomizo-tky@umin.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021; Yokomizo, Takehiko/P-5673-2016	Ohkawa, Yasuyuki/0000-0001-6440-9954; Yokomizo, Takehiko/0000-0002-5219-1553; Fujimura, Tsutomu/0000-0003-1744-7725	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japan Society for the Promotion of Science (JSPS) [22116001, 22116002, 15H05901, 15H05904, 15H04708, 15H06604, 25860223, 15K19032, 24590386, 15K08316, 25460374]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Nakatomi Foundation; Takeda Science Foundation; Foundation for Strategic Research Projects in Private Universities of the MEXT [S1311011]; Institute for Environmental and Gender-Specific Medicine; CREST; JST [JPMJCR16G1]; JSPS [25116010, 17H03608]; Grants-in-Aid for Scientific Research [15H05897, 25116010, 17K19356] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japan Society for the Promotion of Science (JSPS); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Strategic Research Projects in Private Universities of the MEXT; Institute for Environmental and Gender-Specific Medicine; CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japan Society for the Promotion of Science (JSPS: grant numbers 22116001, 22116002, 15H05901, 15H05904, 15H04708, and 15H06604 to TY, 25860223 and 15K19032 to TK, 24590386 and 15K08316 to KS, 25460374 to TO; http://www.jsps.go.jp/english/e-grants/index.html) and by grants from the Naito Foundation (http://www.naito-f.or.jp/en/), the Ono Medical Research Foundation (https://www.ono.co. jp/jp/zaidan/), the Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/), the Mitsubishi Foundation (www.mitsubishi-zaidan.jp/en/index.html), the Nakatomi Foundation (http://www.nakatomi.or.jp/eni/), and the Takeda Science Foundation (http://www.takeda-sci.or.jp/). This study was supported in part by a Grant-in-Aid (S1311011 to TY) from the Foundation for Strategic Research Projects in Private Universities of the MEXT (http://www.mext.go.jp/en/index.htm) and by a grant from the Institute for Environmental and Gender-Specific Medicine (http://www. juntendo.ac.jp/english/department/gra/gender specific medicine/). This work was also supported by CREST (https://www.jst.go.jp/kisoken/crest/en/ index.html), JST (http://www.jst.go.jp/EN/index. html), Grant JPMJCR16G1 (to YO) (JSPS: grant numbers 25116010 and 17H03608 to YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Basu S, 2007, J BIOL CHEM, V282, P10005, DOI 10.1074/jbc.M609552200; CASTROP J, 1995, IMMUNOBIOLOGY, V193, P281, DOI 10.1016/S0171-2985(11)80556-5; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; FRASER CM, 1980, P NATL ACAD SCI-BIOL, V77, P7034, DOI 10.1073/pnas.77.12.7034; Friedrich EB, 2003, ARTERIOSCL THROM VAS, V23, P1761, DOI 10.1161/01.ATV.0000092941.77774.3C; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hagemann UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103776; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Hrabovska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012892; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Ichiki T, 2016, FASEB J, V30, P1811, DOI 10.1096/fj.201500117; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Majumdar R, 2012, FEBS LETT, V586, P810, DOI 10.1016/j.febslet.2012.01.052; Martin A, 2009, PROTEIN SCI, V18, P727, DOI 10.1002/pro.55; Matsumoto Y, 2007, THROMB RES, V119, P319, DOI 10.1016/j.thromres.2006.01.023; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175452; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohkubo H, 2013, FASEB J, V27, P3132, DOI 10.1096/fj.13-227421; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Pass J, 2003, SCAND J IMMUNOL, V58, P298, DOI 10.1046/j.1365-3083.2003.01299.x; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; Pettersson A, 2000, BIOCHEM BIOPH RES CO, V279, P520, DOI 10.1006/bbrc.2000.3989; Peyrassol X, 2016, J IMMUNOL, V196, P2893, DOI 10.4049/jimmunol.1500888; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; Sabirsh A, 2006, BIOCHEMISTRY-US, V45, P5733, DOI 10.1021/bi060076t; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; Scott MJ, 2004, CLIN DIAGN LAB IMMUN, V11, P936, DOI 10.1128/CDLI.11.5.936-941.2004; Serezani CH, 2012, J IMMUNOL, V189, P906, DOI 10.4049/jimmunol.1200257; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Shimada M, 2002, J BIOL CHEM, V277, P31774, DOI 10.1074/jbc.M204166200; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Soares EM, 2013, J IMMUNOL, V190, P1614, DOI 10.4049/jimmunol.1202932; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; Tussiwand R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00533; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078	72	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185133	10.1371/journal.pone.0185133	http://dx.doi.org/10.1371/journal.pone.0185133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922396	gold, Green Published, Green Submitted			2022-12-26	WOS:000411059300058
J	Cherkaoui-Rbati, MH; Paine, SW; Littlewood, P; Rauch, C				Cherkaoui-Rbati, Mohammed H.; Paine, Stuart W.; Littlewood, Peter; Rauch, Cyril			A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions	PLOS ONE			English	Article							CRYOPRESERVED HUMAN HEPATOCYTES; CYTOCHROME-P450 3A ACTIVITY; IN-VITRO; HEPATIC ELIMINATION; METABOLIC-CLEARANCE; DISPERSION MODEL; ORAL MIDAZOLAM; INDUCTION DATA; INHIBITION; CYP3A	All pharmaceutical companies are required to assess pharmacokinetic drug- drug interactions (DDIs) of new chemical entities (NCEs) and mathematical prediction helps to select the best NCE candidate with regard to adverse effects resulting from a DDI before any costly clinical studies. Most current models assume that the liver is a homogeneous organ where the majority of the metabolism occurs. However, the circulatory system of the liver has a complex hierarchical geometry which distributes xenobiotics throughout the organ. Nevertheless, the lobule (liver unit), located at the end of each branch, is composed of many sinusoids where the blood flow can vary and therefore creates heterogeneity (e. g. drug concentration, enzyme level). A liver model was constructed by describing the geometry of a lobule, where the blood velocity increases toward the central vein, and by modeling the exchange mechanisms between the blood and hepatocytes. Moreover, the three major DDI mechanisms of metabolic enzymes; competitive inhibition, mechanism based inhibition and induction, were accounted for with an undefined number of drugs and/or enzymes. The liver model was incorporated into a physiological- based pharmacokinetic (PBPK) model and simulations produced, that in turn were compared to ten clinical results. The liver model generated a hierarchy of 5 sinusoidal levels and estimated a blood volume of 283 mL and a cell density of 193 x 10(6) cells/g in the liver. The overall PBPK model predicted the pharmacokinetics of midazolam and the magnitude of the clinical DDI with perpetrator drug(s) including spatial and temporal enzyme levels changes. The model presented herein may reduce costs and the use of laboratory animals and give the opportunity to explore different clinical scenarios, which reduce the risk of adverse events, prior to costly human clinical studies.	[Cherkaoui-Rbati, Mohammed H.; Paine, Stuart W.; Rauch, Cyril] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Littlewood, Peter] Vertex Pharmaceut Europe Ltd, Abingdon, Oxon, England	University of Nottingham; Vertex Pharmaceuticals	Cherkaoui-Rbati, MH (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	mohammed.h.cherkaoui@gmail.com	rauch, cyril/G-5380-2011	CHERKAOUI RBATI, Mohammed, Hussain/0000-0001-9630-3863; Rauch, Cyril/0000-0001-8584-420X	Vertex Pharmaceutical	Vertex Pharmaceutical(Vertex Pharmaceuticals)	The funder, Vertex Pharmaceutical, provided support in the form of PhD sponsoring for MHCR and welcomed MHCR in their offices for 6 months to conduct his experiments, where PL was supervising him. Furthermore, PL was attending in a regular basis meetings at the University of Nottingham from the conceptualization to the validation of the PhD. Finally he was also part of the review of this manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abdel-Rahman SM, 1998, ANTIMICROB AGENTS CH, V42, P2706, DOI 10.1128/AAC.42.10.2706; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; [Anonymous], 2015, MATLAB VERS 8 6 R201; BACKMAN JT, 1994, BRIT J CLIN PHARMACO, V37, P221, DOI 10.1111/j.1365-2125.1994.tb04266.x; Bjorkman S, 2001, J PHARM SCI-US, V90, P1226, DOI 10.1002/jps.1076; BRAMMER KW, 1990, REV INFECT DIS, V12, pS318; Brown HS, 2007, DRUG METAB DISPOS, V35, P293, DOI 10.1124/dmd.106.011569; Chien JY, 2006, DRUG METAB DISPOS, V34, P1208, DOI 10.1124/dmd.105.008730; Chung E, 2006, CLIN PHARMACOL THER, V79, P350, DOI 10.1016/j.clpt.2005.11.016; Dash A, 2013, AM J PHYSIOL-CELL PH, V304, pC1053, DOI 10.1152/ajpcell.00331.2012; Einolfl HJ, 2014, CLIN PHARMACOL THER, V95, P179, DOI 10.1038/clpt.2013.170; Fahmi OA, 2008, DRUG METAB DISPOS, V36, P1971, DOI 10.1124/dmd.108.021907; Fahmi OA, 2008, DRUG METAB DISPOS, V36, P1698, DOI 10.1124/dmd.107.018663; Fahmi OA, 2009, DRUG METAB DISPOS, V37, P1658, DOI 10.1124/dmd.108.026252; FEE JPH, 1987, CLIN PHARMACOL THER, V41, P80, DOI 10.1038/clpt.1987.13; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Gertz M, 2011, DRUG METAB DISPOS, V39, P1633, DOI 10.1124/dmd.111.039248; Guest EJ, 2011, BRIT J CLIN PHARMACO, V71, P72, DOI 10.1111/j.1365-2125.2010.03799.x; Guo HF, 2013, J PHARM SCI-US, V102, P2819, DOI 10.1002/jps.23613; Gurley B, 2006, J CLIN PHARMACOL, V46, P201, DOI 10.1177/0091270005284854; Hisaka A, 2010, DRUG METAB PHARMACOK, V25, P48, DOI 10.2133/dmpk.25.48; Huang SM, 2008, J CLIN PHARMACOL, V48, P662, DOI 10.1177/0091270007312153; Ito K, 2003, DRUG METAB DISPOS, V31, P945, DOI 10.1124/dmd.31.7.945; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Lam YWF, 2003, J CLIN PHARMACOL, V43, P1274, DOI 10.1177/0091270003259216; Ma JD, 2006, J CLIN PHARMACOL, V46, P103, DOI 10.1177/0091270005283286; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; OLKKOLA KT, 1994, CLIN PHARMACOL THER, V55, P481, DOI 10.1038/clpt.1994.60; Olkkola KT, 1996, ANESTH ANALG, V82, P511, DOI 10.1097/00000539-199603000-00015; Paine SW, 2008, DRUG METAB DISPOS, V36, P1365, DOI 10.1124/dmd.107.019455; Paixao P, 2009, EUR J PHARM SCI, V36, P544, DOI 10.1016/j.ejps.2008.12.011; Palovaara S, 2000, BRIT J CLIN PHARMACO, V50, P333, DOI 10.1046/j.1365-2125.2000.00271.x; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P655, DOI 10.1007/BF01059689; Pang KS, 1977, J PHARMACOKINET BIOP, V5; Quinney SK, 2010, DRUG METAB DISPOS, V38, P241, DOI 10.1124/dmd.109.028746; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-52; Riley RJ, 2005, DRUG METAB DISPOS, V33, P1304, DOI 10.1124/dmd.105.004259; ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P261, DOI 10.1007/BF01106707; ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P227, DOI 10.1007/BF01106706; Rodvold KA, 1999, CLIN PHARMACOKINET, V37, P385, DOI 10.2165/00003088-199937050-00003; Saito H, 2000, PHARM RES-DORDR, V17, P761, DOI 10.1023/A:1007550820196; SCHENKER S, 1988, CLIN PHARMACOL THER, V44, P353, DOI 10.1038/clpt.1988.161; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x; Snyder W, 1975, REPORT TASK GROUP RE, P23; Soars MG, 2009, MOL PHARMACEUT, V6, P1662, DOI 10.1021/mp800246x; Tannenbaum C, 2014, EXPERT REV CLIN PHAR, V7, P533, DOI 10.1586/17512433.2014.910111; *US FDA, 1997, GUID IND DRUG MET DR; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; Wilson ZE, 2003, BRIT J CLIN PHARMACO, V56, P433, DOI 10.1046/j.1365-2125.2003.01881.x; Yamano K, 1999, DRUG METAB DISPOS, V27, P1225; Yang JS, 2007, CURR DRUG METAB, V8, P676, DOI 10.2174/138920007782109733; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Yeo KR, 2010, EUR J PHARM SCI, V39, P298, DOI 10.1016/j.ejps.2009.12.002; Zhang HJ, 2007, CLIN PHARMACOKINET, V46, P133, DOI 10.2165/00003088-200746020-00003; Zimmermann T, 1996, ARZNEIMITTEL-FORSCH, V46, P213	58	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183794	10.1371/journal.pone.0183794	http://dx.doi.org/10.1371/journal.pone.0183794			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910306	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200017
J	Dhillon, JKS; Riffe, C; Moore, BD; Ran, Y; Chakrabarty, P; Golde, TE; Giasson, BI				Dhillon, Jess-Karan S.; Riffe, Cara; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.			A novel panel of alpha-synuclein antibodies reveal distinctive staining profiles in synucleinopathies	PLOS ONE			English	Article							PARKINSONS-DISEASE; TRANSGENIC MODEL; LEWY BODIES; MOUSE MODEL; IMMUNOTHERAPY; PATHOLOGY; PROPAGATION; IMMUNIZATION; AGGREGATION; FIBRILS	Synucleinopathies are a spectrum of neurodegenerative diseases characterized by the intracellular deposition of the protein alpha-synuclein leading to multiple outcomes, including dementia and Parkinsonism. Recent findings support the notion that across the spectrum of synucleinopathies there exist diverse but specific biochemical modifications and/or structural conformations of alpha-synuclein, which would give rise to protein strain specific prion-like intercellular transmission, a proposed model that could explain synucleinopathies disease progression. Herein, we characterized a panel of antibodies with epitopes within both the C- and N- termini of alpha-synuclein. A comprehensive analysis of human pathological tissue and mouse models of synucleinopathy with these antibodies support the notion that alpha-synuclein exists in distinct modified forms and/or structural variants. Furthermore, these well-characterized and specific tools allow the investigation of biochemical changes associated with alpha-synuclein inclusion formation. We have identified several antibodies of interest with diverse staining and epitope properties that will prove useful in future investigations of strain specific disease progression and the development of targeted immunotherapeutic approaches to synucleinopathies.	[Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	bgiasson@ufl.edu		Moore, Brenda/0000-0002-9685-6561	National Institute of Neurological Disorders and Stroke [NS089622, T32 NS082168]; National Institute on Aging [AG047266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS082168, R01NS089622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740, P50AG047266] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS089622) (BIG) and (T32 NS082168) (JSD) and the National Institute on Aging (AG047266) (TEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Cookson MR, ANN REV BIOCH, V74, P29; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; El-Agnaf O, 2017, NEUROBIOL DIS, V104, P85, DOI 10.1016/j.nbd.2017.05.002; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; George JM, 2002, GENOME BIOL, V3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Gustafsson G, 2017, CELL MOL NEUROBIOL, V37, P121, DOI 10.1007/s10571-016-0352-5; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Lee JS, 2016, J MOV DISORD, V9, P14, DOI 10.14802/jmd.15059; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lindstrom V, 2014, NEUROBIOL DIS, V69, P134, DOI 10.1016/j.nbd.2014.05.009; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mamais A, 2013, NEUROBIOL DIS, V58, P183, DOI 10.1016/j.nbd.2013.05.017; Mandler M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0008-9; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; PAPP MI, 1992, J NEUROL SCI, V107, P172, DOI 10.1016/0022-510X(92)90286-T; Pieri L, 2016, BBA-GEN SUBJECTS, V1860, P8, DOI 10.1016/j.bbagen.2015.10.007; Rutherford NJ, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0029-4; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sanchez-Guajardo V, 2013, J NEUROPATH EXP NEUR, V72, P624, DOI 10.1097/NEN.0b013e31829768d2; Schenk DB, 2017, MOVEMENT DISORD, V32, P211, DOI 10.1002/mds.26878; Schneeberger A, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS11, DOI 10.1016/S1353-8020(11)70006-2; Schneeberger A, 2016, MOVEMENT DISORD, V31, P214, DOI 10.1002/mds.26377; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shahaduzzaman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116841; Spencer B, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0410-8; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Su JMF, 2004, BRAIN PATHOL, V14, P175, DOI 10.1111/j.1750-3639.2004.tb00050.x; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Uchihara T, 2016, ACTA NEUROPATHOL, V131, P49, DOI 10.1007/s00401-015-1485-1; Valera E, 2013, PHARMACOL THERAPEUT, V138, P311, DOI 10.1016/j.pharmthera.2013.01.013; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013	58	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184731	10.1371/journal.pone.0184731	http://dx.doi.org/10.1371/journal.pone.0184731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910367	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200087
J	Khedoe, PPSJ; de Kleijn, S; van Oeveren-Rietdijk, AM; Plomp, JJ; de Boer, HC; van Pel, M; Rensen, PCN; Berbee, JFP; Hiemstra, PS				Khedoe, P. Padmini S. J.; de Kleijn, Stan; van Oeveren-Rietdijk, Annemarie M.; Plomp, Jaap J.; de Boer, Hetty C.; van Pel, Melissa; Rensen, Patrick C. N.; Berbee, Jimmy F. P.; Hiemstra, Pieter S.			Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development	PLOS ONE			English	Article							STEM-CELLS; LUNG INJURY; TRANSPLANTATION; MODEL; SURVIVAL; DELIVERY; DISEASE; COPD; MICE	Background COPD is a pulmonary disorder often accompanied by cardiovascular disease (CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in COPD triggered by smoke and microbial exposure is suggested to link COPD and CVD. Mesenchymal stromal cells (MSC) possess anti-inflammatory capacities and MSC treatment is considered an attractive treatment option for various chronic inflammatory diseases. Therefore, we investigated the immunomodulatory properties of MSC in an acute and chronic model of lipopolysaccharide (LPS)-induced inflammation, emphysema and atherosclerosis development in APOE*3-Leiden (E3L) mice. Methods Hyperlipidemic E3L mice were intranasally instilled with 10 mu g LPS or vehicle twice in an acute 4-day study, or twice weekly during 20 weeks Western-type diet feeding in a chronic study. Mice received 0.5x10 6 MSC or vehicle intravenously twice after the first LPS instillation (acute study) or in week 14, 16, 18 and 20 (chronic study). Inflammatory parameters were measured in bronchoalveolar lavage (BAL) and lung tissue. Emphysema, pulmonary inflammation and atherosclerosis were assessed in the chronic study. Results In the acute study, intranasal LPS administration induced a marked systemic IL-6 response on day 3, which was inhibited after MSC treatment. Furthermore, MSC treatment reduced LPS-induced total cell count in BAL due to reduced neutrophil numbers. In the chronic study, LPS increased emphysema but did not aggravate atherosclerosis. Emphysema and atherosclerosis development were unaffected after MSC treatment. Conclusion These data show that MSC inhibit LPS-induced pulmonary and systemic inflammation in the acute study, whereas MSC treatment had no effect on inflammation, emphysema and atherosclerosis development in the chronic study.	[Khedoe, P. Padmini S. J.; de Kleijn, Stan; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Khedoe, P. Padmini S. J.; Rensen, Patrick C. N.; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands; [van Oeveren-Rietdijk, Annemarie M.; de Boer, Hetty C.] Leiden Univ, Med Ctr, Div Nephrol, Dept Med, Leiden, Netherlands; [van Oeveren-Rietdijk, Annemarie M.; de Boer, Hetty C.; Rensen, Patrick C. N.; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Plomp, Jaap J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van Pel, Melissa] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khedoe, PPSJ (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.; Khedoe, PPSJ (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands.	p.p.s.j.khedoe@lumc.nl	Hiemstra, Pieter S/K-8587-2018; /V-8478-2019; Rensen, Patrick C.N./D-7176-2018	Hiemstra, Pieter S/0000-0002-0238-5982; Rensen, Patrick C.N./0000-0002-8455-4988; Khedoe, Padmini/0000-0002-0798-014X	Lung Foundation Netherlands [3.2.10.048]; P.C.N.R. is an Established Investigator of the Dutch Heart Foundation [2009T038]	Lung Foundation Netherlands; P.C.N.R. is an Established Investigator of the Dutch Heart Foundation	This research was funded by a grant from the Lung Foundation Netherlands (grant 3.2.10.048). P.C.N.R. is an Established Investigator of the Dutch Heart Foundation (2009T038).	Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Antunes MA, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0118-x; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Atsma DE, 2007, CURR OPIN LIPIDOL, V18, P645, DOI 10.1097/MOL.0b013e3282f0dd1f; Barua RS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00572; Bayes HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35838; Bernardo ME, 2015, IMMUNOL LETT, V168, P215, DOI 10.1016/j.imlet.2015.06.013; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fang SM, 2013, THROMB RES, V131, pE253, DOI 10.1016/j.thromres.2013.04.002; Fibbe Willem E, 2014, Rinsho Ketsueki, V55, P2190; Frodermann V, 2015, SCI REP-UK, V5, DOI 10.1038/srep15559; Fruchter O, 2015, AM J MED SCI, V349, P338, DOI 10.1097/MAJ.0000000000000435; GOLD, 2016, GLOBAL STRATEGY DIAG; GU W, 2015, SCI REP UK, V5; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176; Havekes LM, 1997, PROSTAG LEUKOTR ESS, V57, P463, DOI 10.1016/S0952-3278(97)90429-4; Hoogduijn MJ, 2013, STEM CELLS DEV, V22, P2825, DOI 10.1089/scd.2013.0193; Huh JW, 2011, AM J PHYSIOL-LUNG C, V301, pL255, DOI 10.1152/ajplung.00253.2010; Katsha AM, 2011, MOL THER, V19, P196, DOI 10.1038/mt.2010.192; Khedoe PPSJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080196; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Li MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082743; Liao JQ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/165296; Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313; Luppi Fabrizio, 2008, Proc Am Thorac Soc, V5, P848, DOI 10.1513/pats.200809-101TH; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Ojo O, 2014, PULM PHARMACOL THER, V29, P121, DOI 10.1016/j.pupt.2014.04.004; Pera T, 2014, J PHARMACOL EXP THER, V349, P229, DOI 10.1124/jpet.113.210138; Qin ZH, 2012, J CELL MOL MED, V16, P2745, DOI 10.1111/j.1582-4934.2012.01597.x; Schepers K, 2016, ANN NY ACAD SCI, V1370, P15, DOI 10.1111/nyas.12984; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song LC, 2014, ADV CLIM CHANG RES, V5, P1, DOI 10.3724/SP.J.1248.2014.001; Stolk J, 2016, QJM-INT J MED, V109, P331, DOI 10.1093/qjmed/hcw001; Tibboel J, 2014, COPD, V11, P310, DOI 10.3109/15412555.2013.854322; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Vivodtzev I, 2014, CHEST, V145, P861, DOI 10.1378/chest.13-1809; Weiss DJ, 2014, STEM CELLS, V32, P16, DOI 10.1002/stem.1506; Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094; Xu QC, 2014, INT J CLIN EXP PATHO, V7, P1580; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66; Zhen GH, 2008, FRONT BIOSCI, V13, P3415; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888	49	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183741	10.1371/journal.pone.0183741	http://dx.doi.org/10.1371/journal.pone.0183741			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910300	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200016
J	Taib, T; Leconte, C; Van Steenwinckel, J; Cho, AH; Palmier, B; Torsello, E; Kuen, RL; Onyeomah, S; Ecomard, K; Benedetto, C; Coqueran, B; Novak, AC; Deou, E; Plotkine, M; Gressens, P; Marchand-Leroux, C; Besson, VC				Taib, Toufik; Leconte, Claire; Van Steenwinckel, Juliette; Cho, Angelo H.; Palmier, Bruno; Torsello, Egle; Kuen, Rene Lai; Onyeomah, Somfieme; Ecomard, Karine; Benedetto, Chiara; Coqueran, Berard; Novak, Anne-Catherine; Deou, Edwige; Plotkine, Michel; Gressens, Pierre; Marchand-Leroux, Catherine; Besson, Valerie C.			Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; WHITE-MATTER; AXONAL INJURY; IMPAIRMENT; DEFICITS; NEURODEGENERATION; INCREASES; PATHOLOGY; DAMAGE	Traumatic brain injury (TBI) results in white matter injury (WMI) that is associated with neurological deficits. Neuroinflammation originating from microglial activation may participate in WMI and associated disorders. To date, there is little information on the time courses of these events after mild TBI. Therefore we investigated (i) neuroinflammation, (ii) WMI and (iii) behavioral disorders between 6 hours and 3 months after mild TBI. For that purpose, we used experimental mild TBI in mice induced by a controlled cortical impact. (i) For neuroinflammation, IL-1b protein as well as microglial phenotypes, by gene expression for 12 microglial activation markers on isolated CD11b(+) cells from brains, were studied after TBI. IL-1b protein was increased at 6 hours and 1 day. TBI induced a mixed population of microglial phenotypes with both pro-inflammatory, anti-inflammatory and immunomodulatory markers from 6 hours to 3 days post-injury. At 7 days, microglial activation was completely resolved. (ii) Three myelin proteins were assessed after TBI on ipsi-and contralateral corpus callosum, as this structure is enriched in white matter. TBI led to an increase in 2', 3'-cyclic-nucleotide 3'-phosphodiesterase, a marker of immature and mature oligodendrocyte, at 2 days post-injury; a bilateral demyelination, evaluated by myelin basic protein, from 7 days to 3 months post-injury; and an increase in myelin oligodendrocyte glycoprotein at 6 hours and 3 days post-injury. Transmission electron microscopy study revealed various myelin sheath abnormalities within the corpus callosum at 3 months post-TBI. (iii) TBI led to sensorimotor deficits at 3 days post-TBI, and late cognitive flexibility disorder evidenced by the reversal learning task of the Barnes maze 3 months after injury. These data give an overall invaluable overview of time course of neuroinflammation that could be involved in demyelination and late cognitive disorder over a time-scale of 3 months in a model of mild TBI. This model could help to validate a pharmacological strategy to prevent post-traumatic WMI and behavioral disorders following mild TBI.	[Taib, Toufik; Leconte, Claire; Cho, Angelo H.; Palmier, Bruno; Torsello, Egle; Onyeomah, Somfieme; Ecomard, Karine; Benedetto, Chiara; Coqueran, Berard; Novak, Anne-Catherine; Deou, Edwige; Plotkine, Michel; Marchand-Leroux, Catherine; Besson, Valerie C.] Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Sorbonne Paris Cite, Paris, France; [Van Steenwinckel, Juliette; Gressens, Pierre] Univ Paris Diderot, PROTECT U1141, INSERM, Sorbonne Paris Cite, Paris, France; [Kuen, Rene Lai] Univ Paris 05, Sorbonne Paris Cite, Cellular & Mol Imaging Platform, Fac Pharm Paris,INSERM US25,UMS CNRS 3612,CRP2, F-CRP2 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Besson, VC (corresponding author), Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Sorbonne Paris Cite, Paris, France.	valerie.besson@parisdescartes.fr	gressens, pierre/M-7557-2017; BESSON, VALERIE/AAZ-9989-2020; MARCHAND-LEROUX, Catherine/L-7453-2017; besson, valerie C/L-7388-2017	gressens, pierre/0000-0002-0909-4221; BESSON, VALERIE/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; besson, valerie C/0000-0002-1491-2380; leconte, claire/0000-0002-8206-9938; Van Steenwinckel, Juliette/0000-0003-3463-4856	Fondation des Gueules Cassees	Fondation des Gueules Cassees	This work was supported by Fondation des Gueules Cassees (VCB; CML); 2013; 2014; 40-2015 (www.gueules-cassees.asso.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; BOISSIER JR, 1967, ARCH INT PHARMACOD T, V169, P312; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Girgis H, 2013, BRAIN RES, V1491, P78, DOI 10.1016/j.brainres.2012.10.049; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ihara M, 2010, ACTA NEUROPATHOL, V119, P579, DOI 10.1007/s00401-009-0635-8; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JIN X, 2012, PLOS ONE, V7; Johns TG, 1999, J NEUROCHEM, V72, P1, DOI 10.1046/j.1471-4159.1999.0720001.x; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Leconte C, 2009, STROKE, V40, P3349, DOI 10.1161/STROKEAHA.109.557314; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; SCOLDING NJ, 1989, IMMUNOLOGY, V67, P441; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	76	54	55	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184811	10.1371/journal.pone.0184811	http://dx.doi.org/10.1371/journal.pone.0184811			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910378	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200098
J	Mao, WB; Caballero, A; Mckay, R; Primiano, C; Sun, W				Mao, Wenbin; Caballero, Andres; Mckay, Raymond; Primiano, Charles; Sun, Wei			Fully-coupled fluid-structure interaction simulation of the aortic and mitral valves in a realistic 3D left ventricle model	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; CHORDAL FORCE DISTRIBUTION; SADDLE-SHAPED ANNULUS; VITRO DYNAMIC STRAIN; BLOOD-FLOW; COMPUTATIONAL ANALYSIS; NUMERICAL-SIMULATION; BEHAVIOR; HEART; HEMODYNAMICS	In this study, we present a fully-coupled fluid-structure interaction (FSI) framework that combines smoothed particle hydrodynamics (SPH) and nonlinear finite element (FE) method to investigate the coupled aortic and mitral valves structural response and the bulk intraventricular hemodynamics in a realistic left ventricle (LV) model during the entire cardiac cycle. The FSI model incorporates valve structures that consider native asymmetric leaflet geometries, anisotropic hyperelastic material models and human material properties. Comparison of FSI results with subject-specific echocardiography data demonstrates that the SPH-FE approach is able to quantitatively predict the opening and closing times of the valves, the mitral leaflet opening and closing angles, and the large-scale intraventricular flow phenomena with a reasonable agreement. Moreover, comparison of FSI results with a LV model without valves reveals substantial differences in the flow field. Peak systolic velocities obtained from the FSI model and the LV model without valves are 2.56 m/s and 1.16 m/s, respectively, compared to the Doppler echo data of 2.17 m/s. The proposed SPH-FE FSI framework represents a further step towards modeling patient-specific coupled LV-valve dynamics, and has the potential to improve our understanding of cardiovascular physiology and to support professionals in clinical decision-making.	[Mao, Wenbin; Caballero, Andres; Sun, Wei] Georgia Inst Technol, Tissue Mech Lab, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Mao, Wenbin; Caballero, Andres; Sun, Wei] Emory Univ, Atlanta, GA 30322 USA; [Mckay, Raymond; Primiano, Charles] Hartford Hosp, Cardiol Dept, Hartford, CT 06115 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Hartford Hospital	Sun, W (corresponding author), Georgia Inst Technol, Tissue Mech Lab, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Sun, W (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	wei.sun@bme.gatech.edu	Caballero, Andrés/AAQ-7567-2020; Mao, Wenbin/J-4546-2014	Caballero, Andrés/0000-0001-8640-9672; Mao, Wenbin/0000-0002-8582-0205	NIH [HL104080, HL127570]; American Heart Association Post-doctoral Fellowship [15P0ST25910002]; Fulbright-Colciencias fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104080, R21HL127570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Post-doctoral Fellowship(American Heart Association); Fulbright-Colciencias fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the NIH HL104080 and HL127570 grants, https://grants.nih.gov/grants/funding/r01.htm. WM is in part supported by an American Heart Association Post-doctoral Fellowship 15P0ST25910002, https://professional.heart.org/professional/ResearchPrograms/ApplicationInformation/UCM_443314_Postdoctoral-Fellowship.isp. AC is in part supported by a Fulbright-Colciencias fellowship, http://www.fulbright.edu.co/us-scholar.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini R, 2012, ANN BIOMED ENG, V40, P1455, DOI 10.1007/s10439-012-0524-5; Bavo AM, 2017, J BIOMECH, V50, P144, DOI 10.1016/j.jbiomech.2016.11.039; Caballero A., 2017, CARDIOVASCULAR ENG T, P1; Carmody CJ, 2006, J BIOMECH, V39, P158, DOI 10.1016/j.jbiomech.2004.10.038; Chandran KB., 2012, BIOFLUID MECH HUMAN; Chandran KB, 2015, ANN BIOMED ENG, V43, P1348, DOI 10.1007/s10439-014-1094-5; Charonko JJ, 2013, ANN BIOMED ENG, V41, P1049, DOI 10.1007/s10439-013-0755-0; Chnafa C, 2016, ANN BIOMED ENG, V44, P3346, DOI 10.1007/s10439-016-1614-6; Dahl SK, 2012, COMPUT METHOD BIOMEC, V15, P121, DOI 10.1080/10255842.2010.517200; Dahl SK., 2012, CARDIOVASC ENG TECHN, V3, P269, DOI [10.1007/s13239-012-0099-1, DOI 10.1007/s13239-012-0099-1, DOI 10.1007/S13239-012-0099-1]; Date K, 2014, CIRCULATION, V130; Gao H, 2017, ARXIV170401960; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; He ZM, 2005, J BIOMECH ENG-T ASME, V127, P504, DOI 10.1115/1.1894385; He ZM, 2003, J HEART VALVE DIS, V12, P488; Hermange C., 2016, P 3 INT C VIOL FLOWS; HUGHES TJR, 1981, COMPUT METHOD APPL M, V29, P329, DOI 10.1016/0045-7825(81)90049-9; Imanparast A, 2016, J BIOMECH, V49, P1482, DOI 10.1016/j.jbiomech.2016.03.021; Jimenez JH, 2005, ANN BIOMED ENG, V33, P557, DOI 10.1007/s10439-005-1512-9; Jimenez JH, 2003, ANN BIOMED ENG, V31, P1171, DOI 10.1114/1.1616929; Jimenez JH, 2007, J THORAC CARDIOV SUR, V134, P1562, DOI 10.1016/j.jtcvs.2007.08.037; Kulp S., 2013, BIOM IM ISBI 2013 IE; Le TB, 2012, EUR J MECH B-FLUID, V35, P20, DOI 10.1016/j.euromechflu.2012.01.013; Lee CH, 2015, BIOMECH MODEL MECHAN, V14, P1281, DOI 10.1007/s10237-015-0674-0; Leyh RG, 1999, CIRCULATION, V100, P2153, DOI 10.1161/01.CIR.100.21.2153; Liang L, 2017, INT J NUMERICAL METH, V33; Ma C, 2017, 6 INT C MAR STRUCT M; Mao WB, 2016, CARDIOVASC ENG TECHN, V7, P374, DOI 10.1007/s13239-016-0285-7; Marom G, 2015, ARCH COMPUT METHOD E, V22, P595, DOI 10.1007/s11831-014-9133-9; MCQUEEN DM, 1982, AM J PHYSIOL, V242, P1095; Mittal R, 2016, J COMPUT PHYS, V305, P1065, DOI 10.1016/j.jcp.2015.11.022; Monaghan JJ, 2012, ANNU REV FLUID MECH, V44, P323, DOI 10.1146/annurev-fluid-120710-101220; Moosavi MH, 2014, COMPUT METHOD BIOMEC, V17, P740, DOI 10.1080/10255842.2012.715638; Nakamura M, 2006, J BIOMECH ENG-T ASME, V128, P837, DOI 10.1115/1.2400864; Ogden R., 1972, P ROYAL SOC LOND MAT; Padala M, 2009, ANN THORAC SURG, V88, P1499, DOI 10.1016/j.athoracsur.2009.06.042; Pedrizzetti G, 2014, NAT REV CARDIOL, V11, P545, DOI 10.1038/nrcardio.2014.75; PESKIN CS, 1989, J COMPUT PHYS, V81, P372, DOI 10.1016/0021-9991(89)90213-1; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4; Pham T, 2013, J BIOMEDICAL MAT R A; Rausch MK, 2011, J BIOMECH, V44, P1149, DOI 10.1016/j.jbiomech.2011.01.020; Sacks MS, 2006, ANN THORAC SURG, V82, P1369, DOI 10.1016/j.athoracsur.2006.03.117; Sacks MS, 2002, ANN BIOMED ENG, V30, P1281, DOI 10.1114/1.1529194; Saikrishnan N, 2014, CIRCULATION, V129, P244, DOI 10.1161/CIRCULATIONAHA.113.002310; Seo JH, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4904094; Shahriari S, 2012, INT J NUMER METH BIO, V28, P1121, DOI 10.1002/cnm.2482; Shahriari S., 2011, COMPUTATIONAL MODELI; Sturla F, 2013, MED ENG PHYS, V35, P1721, DOI 10.1016/j.medengphy.2013.07.015; Su BY, 2014, COMPUT METH PROG BIO, V113, P474, DOI 10.1016/j.cmpb.2013.11.009; Sun W, 2014, ANNU REV BIOMED ENG, V16, P53, DOI 10.1146/annurev-bioeng-071813-104517; Sun W, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979872; Le TB, 2013, J COMPUT PHYS, V244, P41, DOI 10.1016/j.jcp.2012.08.036; Wang Q., 2011, CARDIOVASC ENG TECHN, V2, P324, DOI DOI 10.1007/S13239-011-0052-8; Wang Q, 2013, ANN BIOMED ENG, V41, P142, DOI 10.1007/s10439-012-0620-6; Watton PN, 2008, J FLUID STRUCT, V24, P58, DOI 10.1016/j.jfluidstructs.2007.06.004; Yamaguchi T, 2010, ANN BIOMED ENG, V38, P1225, DOI 10.1007/s10439-010-9904-x; Zamorano JL, 2010, ESC TEXTBOOK OF CARDIOVASCULAR IMAGING, P1	58	51	54	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184729	10.1371/journal.pone.0184729	http://dx.doi.org/10.1371/journal.pone.0184729			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886196	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100182
J	Nakao, S; Zandi, S; Sun, DW; Hafezi-Moghadam, A				Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali			Cathepsin B-mediated CD18 shedding regulates leukocyte recruitment from angiogenic vessels	FASEB JOURNAL			English	Article						cornea; CD31; molecular imaging; ICAM-1; IL-1 beta	IN-VIVO; INFLAMMATORY ANGIOGENESIS; RETINAL MICROCIRCULATION; CYSTEINE PROTEASES; ENDOTHELIAL INJURY; EXPRESSION; INFILTRATION; CELLS; LYMPHANGIOGENESIS; ADHESION	Cathepsin B (CtsB) contributes to atherosclerosis and cancer progression by processing the extracellular matrix and promoting angiogenesis. Although CtsB was reported to promote and reduce angiogenesis, there is no mechanistic explanation that reconciles this apparent discrepancy. CtsB cleaves CD18 from the surface of immune cells, but its contribution to angiogenesis has not been studied. We developed an in vivo technique for visualization of immune cell transmigration from corneal vessels toward implanted cytokines. Wild-type (WT) leukocytes extravasated from limbal vessels, angiogenic stalks, and growing tip vessels and migrated toward the cytokines, indicating immune competence of angiogenic vessels. Compared to WT leukocytes, CtsB(-/-) leukocytes accumulated in a higher number in angiogenic vessels, but extravasated less toward the implanted cytokine. The accumulated CtsB(-/-) leukocytes in angiogenic vessels expressed more CD18. CD18(-/-) leukocytes extravasated later than WT leukocytes. However, once extravasated, CD18(-/-) leukocytes transmigrated more rapidly than their WT counterparts. These results suggest that, although CD18 facilitates efficient extravasation, outside of the vessel CD18 interaction with the extracellular matrix, it reduced transmigration velocity. Our results reveal an unexpected role for CtsB in leukocyte extravasation and transmigration, which advances our understanding of the complex contribution of CtsB to angiogenesis.	[Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Mol Biomarkers Nanoimaging Lab, Boston, MA 02115 USA; [Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kyushu University	Hafezi-Moghadam, A (corresponding author), Harvard Med Sch, Brigham Womens Hosp, MBNI Lab, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Zandi, Souska/0000-0001-9351-4278	U.S. National Institutes of Health (NIH) Impact Award, National Institute of Diabetes and Digestive and Kidney Diseases [DK108238-01]; Juvenile Diabetes Research Fund (JDRF) Innovation award; overseas Research Fellowship Award from Bausch Lomb; Japan Eye Bank Association and Tear Film and Ocular Surface Society; Young Investigator Fellowship; Japan Society for the Promotion of Science (JSPS) KAKENHI [25713057, 17K11456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108238] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Impact Award, National Institute of Diabetes and Digestive and Kidney Diseases; Juvenile Diabetes Research Fund (JDRF) Innovation award; overseas Research Fellowship Award from Bausch Lomb; Japan Eye Bank Association and Tear Film and Ocular Surface Society; Young Investigator Fellowship; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Rebecca Garland and Aliaa Barakat (Molecular Biomarkers Nano-Imaging Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School) for preparation of the manuscript. Rebecca Garland passed away on August 11, 2017. The authors are deeply saddened by her departure and she will be much missed. This work was supported by the U.S. National Institutes of Health (NIH) Impact Award, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK108238-01 (to A.H.-M.); Juvenile Diabetes Research Fund (JDRF) Innovation award (to A.H.-M.); an overseas Research Fellowship Award from Bausch & Lomb; a Fellowship Award from the Japan Eye Bank Association and Tear Film and Ocular Surface Society; a Young Investigator Fellowship (to S.N., under the mentorship of A.H.-M.); and grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant-in-Aid for Young Scientists (A) 25713057 (to S.N.) and Grant-in-Aid for Scientific Research (C) 17K11456 (to S.N.). The authors declare no conflicts of interest.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Berquin IM, 1996, ADV EXP MED BIOL, V389, P281; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; Fukuda S, 2003, P NATL ACAD SCI USA, V100, P13152, DOI 10.1073/pnas.2336130100; Garland RC, 2011, FASEB J, V25, P1284, DOI 10.1096/fj.10-160051; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Hafezi-Moghadam A, 2004, AM J PHYSIOL-CELL PH, V286, pC876, DOI 10.1152/ajpcell.00500.2003; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Miyahara S, 2004, INVEST OPHTH VIS SCI, V45, P4197, DOI 10.1167/iovs.04-0192; Miyahara S, 2008, FASEB J, V22, P1973, DOI 10.1096/fj.07-096891; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Nakao S, 2016, METHODS MOL BIOL, V1430, P311, DOI 10.1007/978-1-4939-3628-1_21; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P4323, DOI 10.1167/iovs.11-9119; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P3296, DOI 10.1167/iovs.11-8114; Nakao S, 2012, FASEB J, V26, P808, DOI 10.1096/fj.11-183897; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Nakao S, 2011, BLOOD, V117, P1081, DOI 10.1182/blood-2010-02-267427; NISHIWAKI H, 1995, INVEST OPHTH VIS SCI, V36, P123; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; SINHA AA, 1995, ANAT REC, V241, P353, DOI 10.1002/ar.1092410309; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Strojnik T, 1999, CLIN CANCER RES, V5, P559; Sun DW, 2014, FASEB J, V28, P3942, DOI 10.1096/fj.14-251934; Sun DW, 2010, FASEB J, V24, P1532, DOI 10.1096/fj.09-148981; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Xie F, 2010, AM J PATHOL, V177, P39, DOI 10.2353/ajpath.2010.100007; Yamaguchi M, 2016, INVEST OPHTH VIS SCI, V57, P2264, DOI 10.1167/iovs.15-17411	39	10	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					143	154		10.1096/fj.201601229R	http://dx.doi.org/10.1096/fj.201601229R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904019	Green Published			2022-12-26	WOS:000419172700015
J	Birech, Z; Mwangi, PW; Bukachi, F; Mandela, KM				Birech, Zephania; Mwangi, Peter Waweru; Bukachi, Fredrick; Mandela, Keith Makori			Application of Raman spectroscopy in type 2 diabetes screening in blood using leucine and isoleucine amino-acids as biomarkers and in comparative anti-diabetic drugs efficacy studies	PLOS ONE			English	Article							CONTROLLED-TRIAL; PIOGLITAZONE; ALLOXAN; PLASMA	Diabetes is an irreversible condition characterized by elevated blood glucose levels. Currently, there are no predictive biomarkers for this disease and the existing ones such as hemoglobin A1c and fasting blood glucose are used only when diabetes symptoms are noticed. The objective of this work was first to explore the potential of leucine and isoleucine amino acids as diabetes type 2 biomarkers using their Raman spectroscopic signatures. Secondly, we wanted to explore whether Raman spectroscopy can be applied in comparative efficacy studies between commercially available anti-diabetic drug pioglitazone and the locally used anti-diabetic herbal extract Momordica spinosa (Gilg.) Chiov. Sprague Dawley (SD) rat's blood was used and were pipetted onto Raman substrates prepared from conductive silver paste smeared glass slides. Prominent Raman bands associated with glucose (926, 1302, 1125 cm(-1)), leucine (1106, 1248, 1302, 1395 cm(-1)) and isolecucine (1108, 1248, 1437 and 1585 cm(-1)) were observed. The Raman bands centered at 1125 cm(-1), 1395 cm(-1) and 1437 cm(-1) associated respectively to glucose, leucine and isoleucine were chosen as biomarker Raman peaks for diabetes type 2. These Raman bands displayed decreased intensities in blood from diabetic SD rats administered antidiabetic drugs pioglitazone and herbal extract Momordica spinosa (Gilg.) Chiov. The intensity decrease indicated reduced concentration levels of the respective biomarker molecules: glucose (1125 cm(-1)), leucine (1395 cm(-1)) and isoleucine (1437 cm(-1)) in blood. The results displayed the power and potential of Raman spectroscopy in rapid (10 seconds) diabetes and pre-diabetes screening in blood (human or rat's) with not only glucose acting as a biomarker but also leucine and isoleucine amino-acids where intensities of respectively assigned bands act as references. It also showed that using Raman spectroscopic signatures of the chosen biomarkers, the method can be an alternative for performing comparative efficacy studies between known and new anti-diabetic drugs. Reports on use of Raman spectroscopy in type 2 diabetes mellitus screening with Raman bands associated with leucine and isoleucine molecules acting as reference is rare in literature. The use of Raman spectroscopy in prediabetes screening of blood for changes in levels of leucine and isoleucine amino acids is particularly interesting as once elevated levels are noticed, necessary interventions to prevent diabetes development can be initiated.	[Birech, Zephania] Univ Nairobi, Dept Phys, POB 30197-00100, Nairobi, Kenya; [Mwangi, Peter Waweru; Bukachi, Fredrick; Mandela, Keith Makori] Univ Nairobi, Dept Med Physiol, POB 30197-00100, Nairobi, Kenya	University of Nairobi; University of Nairobi	Birech, Z (corresponding author), Univ Nairobi, Dept Phys, POB 30197-00100, Nairobi, Kenya.; Mandela, KM (corresponding author), Univ Nairobi, Dept Med Physiol, POB 30197-00100, Nairobi, Kenya.	birech@uonbi.ac.ke; keithmandela@gmail.com	Mwangi, Peter Waweru/W-2562-2019; Mandela, Keith/K-4170-2019	Mwangi, Peter Waweru/0000-0002-9019-5969; Birech, Dr. Zephania/0000-0001-7445-1603	International Science Program (ISP), Uppsala University [KE04]	International Science Program (ISP), Uppsala University	This work was supported by International Science Program (ISP), Uppsala University for Grant KE04.	Almeida FM, 2006, J RAMAN SPECTROSC, V37, P1296, DOI 10.1002/jrs.1553; Barman I, 2012, ANAL CHEM, V84, P2474, DOI 10.1021/ac203266a; Behera TK, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P217, DOI 10.1007/978-3-642-20450-0_10; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Ben O O, 2017, ANAL BIOANAL CHEM; Botta Raju, 2016, Sensing and Bio-Sensing Research, V9, P13, DOI 10.1016/j.sbsr.2016.05.001; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chen XP, 2015, J DIABETES INVEST, V6, P369, DOI 10.1111/jdi.12345; Delbanco AS, 2017, ECON BOT, P1; Dieing T, 2010, SPRINGER SER OPT SCI, V158, P61; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Firdous S, 2012, LASER PHYS, V22, P1090, DOI 10.1134/S1054660X12060023; Giesbertz P, 2016, CURR OPIN CLIN NUTR, V19, P48, DOI 10.1097/MCO.0000000000000235; Hernandez B, 2009, J PHYS CHEM B, V113, P3169, DOI 10.1021/jp809204d; Jenkins AL, 2005, SPECTROCHIM ACTA A, V61, P1585, DOI 10.1016/j.saa.2004.11.055; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lin JY, 2014, J RAMAN SPECTROSC, V45, P884, DOI 10.1002/jrs.4574; Lin JQ, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S179354581350051X; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Maynard JD, 2007, DIABETES CARE, V30, P1120, DOI 10.2337/dc06-2377; ROBITAILLE L, 1988, CAN J PHYSIOL PHARM, V66, P613, DOI 10.1139/y88-095; Shah SH, 2011, CELL METAB, V13, P491, DOI 10.1016/j.cmet.2011.04.003; Shao JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048127; Silveira L, 2017, LASER MED SCI, P1; Szkudelski T, 2001, PHYSIOL RES, V50, P537; WHO, 2015, ANALYST, V140, P2266; Wrobel M., 2016, MATER SCI ENG, V104; Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Zhao J, 2007, APPL SPECTROSC, V61, P1225, DOI 10.1366/000370207782597003; Zhou GM, 2007, ACTA CHIM SINICA, V65, P640; Zhu GY, 2011, SPECTROCHIM ACTA A, V78, P1187, DOI [10.1016/j.saa.2010.12.079, 10.1016/j.saa.2010.12.07]	32	19	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185130	10.1371/journal.pone.0185130	http://dx.doi.org/10.1371/journal.pone.0185130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926628	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600071
J	Burggren, WW; Elmonoufy, NA				Burggren, Warren W.; Elmonoufy, Nourhan A.			Critical developmental windows for morphology and hematology revealed by intermittent and continuous hypoxic incubation in embryos of quail (Coturnix coturnix)	PLOS ONE			English	Article							CHICKEN GALLUS-GALLUS; ACID-BASE-BALANCE; HIGH-ALTITUDE; HEART-RATE; OXYGEN-AFFINITY; JAPANESE-QUAIL; ORGAN GROWTH; CARDIOVASCULAR REGULATION; BLOOD-FLOW; IN-VIVO	Hypoxia during embryonic growth in embryos is frequently a powerful determinant of development, but at least in avian embryos the effects appear to show considerable intra- and inter-specific variation. We hypothesized that some of this variation may arise from different protocols that may or may not result in exposure during the embryo's critical window for hypoxic effects. To test this hypothesis, quail embryos (Coturnix coturnix) in the intact egg were exposed to hypoxia (similar to 15% O-2) during "early" (Day 0 through Day 5, abbreviated as D0-D5), "middle" (D6-D10) or "late" (D11-D15) incubation or for their entire 16-18 day incubation ("continuous hypoxia") to determine critical windows for viability and growth. Viability, body mass, beak and toe length, heart mass, and hematology (hematocrit and hemoglobin concentration) were measured on D5, D10, D15 and at hatching typically between D16 and D18 Viability rate was similar to 50-70% immediately following the exposure period in the early, middle and late hypoxic groups, but viability improved in the early and late groups once normoxia was restored. Middle hypoxia groups showed continuing low viability, suggesting a critical period from D6-D10 for embryo viability. The continuous hypoxia group experienced viability reaching <10% after D15. Hypoxia, especially during late and continuous hypoxia, also inhibited growth of body, beak and toe when measured at D15. Full recovery to normal body mass upon hatching occurred in all other groups except for continuous hypoxia. Contrary to previous avian studies, heart mass, hematocrit and hemoglobin concentration were not altered by any hypoxic incubation pattern. Although hypoxia can inhibit embryo viability and organ growth during most incubation periods, the greatest effects result from continuous or middle incubation hypoxic exposure. Hypoxic inhibition of growth can subsequently be "repaired" by catch-up growth if a final period of normoxic development is available. Collectively, these data indicate a critical developmental window for hypoxia susceptibility during the mid-embryonic period of development.	[Burggren, Warren W.; Elmonoufy, Nourhan A.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Burggren, WW (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.	burggren@unt.edu	Burggren, Warren W/A-1561-2016	Burggren, Warren W/0000-0001-8023-420X	National Science Foundation [IOS1543301]	National Science Foundation(National Science Foundation (NSF))	This study was supported by operating grant IOS1543301 from the National Science Foundation (nsf.gov) to WB.; This study was supported by operating grant IOS1543301 from the National Science Foundation (nsf.gov) to WB. We are grateful to Dr. Amelie Crespel for providing a thoughtful critique of the manuscript.	Altimiras J, 2000, J EXP ZOOL, V286, P450, DOI 10.1002/(SICI)1097-010X(20000401)286:5<450::AID-JEZ2>3.0.CO;2-Y; Andrewartha SJ, 2014, RESP PHYSIOL NEUROBI, V195, P1, DOI 10.1016/j.resp.2014.01.019; Andrewartha SJ, 2011, RESP PHYSIOL NEUROBI, V179, P142, DOI 10.1016/j.resp.2011.07.010; Andrewartha SJ, 2011, RESP PHYSIOL NEUROBI, V178, P84, DOI 10.1016/j.resp.2011.04.014; Azzam MA, 2007, RESP PHYSIOL NEUROBI, V159, P155, DOI 10.1016/j.resp.2007.06.003; BARTELS H, 1985, AVIAT SPACE ENVIR MD, V56, P976; BAUMANN R, 1983, AM J PHYSIOL, V244, pR733, DOI 10.1152/ajpregu.1983.244.5.R733; BAUMANN R, 1992, PHYSIOL REV, V72, P941, DOI 10.1152/physrev.1992.72.4.941; Baumann R., 1984, RESPIRATION METABOLI, P221; Branum SR, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12712; Brunstrom B, 2009, GEN COMP ENDOCR, V163, P97, DOI 10.1016/j.ygcen.2009.01.006; Burggren W, 2004, AM J PHYSIOL-REG I, V287, pR1399, DOI 10.1152/ajpregu.00086.2004; Burggren W, 2002, COMP BIOCHEM PHYS A, V132, P661, DOI 10.1016/S1095-6433(02)00127-7; Burggren Warren W., 1998, Biological Bulletin National Taiwan Normal University, V33, P71; Burggren WW, 2016, REV BRAS ZOOTECN, V45, P709, DOI [10.1590/S1806-92902016001100010, 10.1590/s1806-92902016001100010]; Burggren WW, 2015, PHYSIOL BIOCHEM ZOOL, V88, P91, DOI 10.1086/679906; Burggren WW, 2011, RESP PHYSIOL NEUROBI, V178, P13, DOI 10.1016/j.resp.2011.05.001; Burggren WW, 2005, J EXP BIOL, V208, P105, DOI 10.1242/jeb.01349; Burggren WW, 2000, ZOOL-ANAL COMPLEX SY, V102, P148; BURTON RR, 1969, FED PROC, V28, P1170; Buzala M, 2015, POULTRY SCI, V94, P728, DOI 10.3382/ps/pev015; CAREY C, 1982, AUK, V99, P710; Chan T, 2005, RESP PHYSIOL NEUROBI, V145, P251, DOI 10.1016/j.resp.2004.09.005; Choi YM, 2013, POULTRY SCI, V92, P1870, DOI 10.3382/ps.2012-02892; Crossley DA, 2012, POULTRY SCI, V91, P2628, DOI 10.3382/ps.2012-02344; Crossley DA, 2003, J EXP BIOL, V206, P2703, DOI 10.1242/jeb.00476; Crossley DA, 2003, AM J PHYSIOL-REG I, V284, pR219, DOI 10.1152/ajpregu.00654.2001; Crossley DAI, 2016, COMPREHENSI IN PRESS; Crossley DA, 2010, J COMP PHYSIOL B, V180, P1057, DOI 10.1007/s00360-010-0473-y; Crossley DA, 2009, J MORPHOL, V270, P1400, DOI 10.1002/jmor.10764; Dragon S, 1999, J EXP BIOL, V202, P2787; Dzialowski EM, 2002, COMP BIOCHEM PHYS A, V131, P713, DOI 10.1016/S1095-6433(02)00009-0; El-Tarabany MS, 2016, J THERM BIOL, V61, P38, DOI 10.1016/j.jtherbio.2016.08.004; Everaert N, 2008, BRIT POULTRY SCI, V49, P574, DOI 10.1080/00071660802357025; Everaert N, 2011, COMP BIOCHEM PHYS A, V158, P215, DOI 10.1016/j.cbpa.2010.10.031; Fawcett TW, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S3; Ferner K, 2009, RESP PHYSIOL NEUROBI, V165, P49, DOI 10.1016/j.resp.2008.10.004; Gu S, 2012, DEV DYNAM, V241, P534, DOI 10.1002/dvdy.23727; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Hirst Claire E, 2015, Results Probl Cell Differ, V56, P99, DOI 10.1007/978-3-662-44608-9_5; Ho DH, 2011, J EXP BIOL, V214, P619, DOI 10.1242/jeb.046714; Hoper J, 1995, INT J MICROCIRC, V15, P186, DOI 10.1159/000178974; HOWE RS, 1995, AM J PHYSIOL-HEART C, V268, pH56, DOI 10.1152/ajpheart.1995.268.1.H56; Huang SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173698; Hyankova L, 2012, BRIT POULTRY SCI, V53, P592, DOI 10.1080/00071668.2012.736610; Ide R, 2016, RESP PHYSIOL NEUROBI, V230, P29, DOI 10.1016/j.resp.2016.05.005; ISAACKS RE, 1976, POULTRY SCI, V55, P1788, DOI 10.3382/ps.0551788; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; Jonker SS, 2015, AM J PHYSIOL-REG I, V308, pR680, DOI 10.1152/ajpregu.00484.2014; Khandoker AH, 2003, COMP BIOCHEM PHYS A, V136, P289, DOI 10.1016/S1095-6433(03)00171-5; Kohl ZF, 2015, COMP BIOCHEM PHYS A, V190, P1, DOI 10.1016/j.cbpa.2015.07.023; Lewallen MA, 2015, RESP PHYSIOL NEUROBI, V219, P85, DOI 10.1016/j.resp.2015.08.004; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; Liu HB, 2009, DEV DYNAM, V238, P2760, DOI 10.1002/dvdy.22103; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; MCCUTCHEON IE, 1982, RESP PHYSIOL, V50, P153, DOI 10.1016/0034-5687(82)90014-7; METCALFE J, 1981, RESP PHYSIOL, V46, P81, DOI 10.1016/0034-5687(81)90091-8; MEUER HJ, 1992, RESP PHYSIOL, V90, P227, DOI 10.1016/0034-5687(92)90083-9; Miller SL, 2002, AM J OBSTET GYNECOL, V186, P261, DOI 10.1067/mob.2002.119629; Mortola JP, 2008, RESP PHYSIOL NEUROBI, V162, P223, DOI 10.1016/j.resp.2008.07.015; Mortola JP, 2013, RESP PHYSIOL NEUROBI, V188, P172, DOI 10.1016/j.resp.2013.05.030; Mortola JP, 2010, COMP BIOCHEM PHYS A, V155, P301, DOI 10.1016/j.cbpa.2009.11.003; Mortola JP, 2005, RESP PHYSIOL NEUROBI, V146, P97, DOI 10.1016/j.resp.2004.10.011; Mueller CA, 2016, J EXP BIOL, V219, P571, DOI 10.1242/jeb.125823; Mueller CA, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P739; Mueller CA, 2015, J COMP PHYSIOL B, V185, P315, DOI 10.1007/s00360-015-0886-8; Mueller CA, 2013, AM J PHYSIOL-REG I, V305, pR855, DOI 10.1152/ajpregu.00298.2013; Mulder ALM, 1998, J PHYSIOL-LONDON, V508, P281, DOI 10.1111/j.1469-7793.1998.281br.x; Mulder ALM, 2000, J PHYSIOL-LONDON, V527, P593, DOI 10.1111/j.1469-7793.2000.00593.x; OLANDER HJ, 1967, AVIAN DIS, V11, P609, DOI 10.2307/1588303; Osterman H, 2015, AM J PHYSIOL-REG I, V309, pR1204, DOI 10.1152/ajpregu.00499.2014; Reyna K, 2017, PLOS ONE IN PRESS; Ricklefs RE, 2006, P ROY SOC B-BIOL SCI, V273, P2077, DOI 10.1098/rspb.2006.3544; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; Sato M, 2006, COMP BIOCHEM PHYS A, V143, P382, DOI 10.1016/j.cbpa.2005.12.019; Sato Y, 2013, DEV GROWTH DIFFER, V55, P113, DOI 10.1111/dgd.12010; Sirsat SKG, 2016, J EXP BIOL, V219, P1214, DOI 10.1242/jeb.132282; SMITH AH, 1969, FED PROC, V28, P1092; Smith F, 2013, DIS MODEL MECH, V6, P915, DOI 10.1242/dmm.011064; STOCK MK, 1983, RESP PHYSIOL, V52, P1, DOI 10.1016/0034-5687(83)90132-9; Tazawa H, 2012, RESP PHYSIOL NEUROBI, V184, P86, DOI 10.1016/j.resp.2012.08.002; Tazawa H, 2011, COMP BIOCHEM PHYS A, V159, P225, DOI 10.1016/j.cbpa.2011.02.024; van Golde JMCG, 1999, J PHYSIOL-LONDON, V515, P243, DOI 10.1111/j.1469-7793.1999.243ad.x; VELARDE FL, 1991, CR ACAD SCI III-VIE, V313, P401; WEBER RE, 1993, J APPL PHYSIOL, V75, P2646, DOI 10.1152/jappl.1993.75.6.2646; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; Wilson RE, 2013, EVOLUTION, V67, P170, DOI 10.1111/j.1558-5646.2012.01740.x; WITZEL DA, 1990, POULTRY SCI, V69, P741, DOI 10.3382/ps.0690741; WOODARD AE, 1975, POULTRY SCI, V54, P1708, DOI 10.3382/ps.0541708; YERSIN AG, 1992, AVIAN DIS, V36, P189, DOI 10.2307/1591489; Yoneta H, 2007, COMP BIOCHEM PHYS A, V147, P529, DOI 10.1016/j.cbpa.2007.02.001; Yoshizaki N, 2002, POULTRY SCI, V81, P246, DOI 10.1093/ps/81.2.246; Yue XP, 1999, DEV DYNAM, V216, P28, DOI 10.1002/(SICI)1097-0177(199909)216:1<28::AID-DVDY5>3.3.CO;2-L; Yue XP, 2001, AM J PHYSIOL-HEART C, V280, pH2240, DOI 10.1152/ajpheart.2001.280.5.H2240; Zhang H, 2012, POULTRY SCI, V91, P3191, DOI 10.3382/ps.2012-02449	97	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0183649	10.1371/journal.pone.0183649	http://dx.doi.org/10.1371/journal.pone.0183649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926567	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600004
J	Perez-Lachaud, G; Lachaud, JP				Perez-Lachaud, Gabriela; Lachaud, Jean-Paul			Hidden biodiversity in entomological collections: The overlooked co-occurrence of dipteran and hymenopteran ant parasitoids in stored biological material	PLOS ONE			English	Article							MUSEUM COLLECTIONS; 1ST RECORD; FORMICIDAE; DIVERSITY; PONERINAE; SPECIMENS; UNLOCKING; ATTACKING; BEHAVIOR; WHEELER	Biological collections around the world are the repository of biodiversity on Earth; they also hold a large quantity of unsorted, unidentified, or misidentified material and can house behavioral information on species that are difficult to access or no longer available to science. Among the unsorted, alcohol-preserved material stored in the Formicidae Collection of the ` El Colegio de la Frontera Sur' Research Center (Chetumal, Mexico), we found nine colonies of the ponerine ant Neoponera villosa, that had been collected in bromeliads at Calakmul (Campeche, Mexico) in 1999. Ants and their brood were revised for the presence of any sign of parasitism. Cocoons were dissected and their content examined under a stereomicroscope. Six N. villosa prepupae had been attacked by the ectoparasitoid syrphid fly Hypselosyrphus trigonus Hull (Syrphidae: Microdontinae), to date the only known dipteran species of the Microdontinae with a parasitoid lifestyle. In addition, six male pupae from three colonies contained gregarious endoparasitoid wasps. These were specialized in parasitizing this specific host caste as no gyne or worker pupae displayed signs of having been attacked. Only immature stages (larvae and pupae) of the wasp could be obtained. Due to the long storage period, DNA amplification failed; however, based on biological and morphological data, pupae were placed in the Encyrtidae family. This is the first record of an encyrtid wasp parasitizing N. villosa, and the second example of an encyrtid as a primary parasitoid of ants. Furthermore, it is also the first record of co-occurrence of a dipteran ectoparasitoid and a hymenopteran endoparasitoid living in sympatry within the same population of host ants. Our findings highlight the importance of biological collections as reservoirs of hidden biodiversity, not only at the taxonomic level, but also at the behavioral level, revealing complex living networks. They also highlight the need for funding in order to carry out biodiversity inventories and manage existing collections.	[Perez-Lachaud, Gabriela; Lachaud, Jean-Paul] Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Lachaud, Jean-Paul] Univ Toulouse UPS, Ctr Biol Integrat, Ctr Rech Cognit Anim, Toulouse, France	El Colegio de la Frontera Sur (ECOSUR); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Lachaud, JP (corresponding author), Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.; Lachaud, JP (corresponding author), Univ Toulouse UPS, Ctr Biol Integrat, Ctr Rech Cognit Anim, Toulouse, France.	jlachaud@ecosur.mx	Lachaud, Jean-Paul/H-4266-2019; LACHAUD, Jean-Paul/ABG-3831-2021	LACHAUD, Jean-Paul/0000-0002-5082-8987; Perez-Lachaud, Gabriela/0000-0002-8924-1606	Mexican 'Comision Nacional para el Conocimiento y Uso de la Biodiversidad' [CONABIO ME006]; French program 'Evaluation orientation de la Cooperation Scientifique' [ECOS-Nord/CONACyT M12A01]	Mexican 'Comision Nacional para el Conocimiento y Uso de la Biodiversidad'; French program 'Evaluation orientation de la Cooperation Scientifique'	Funds to JPL were partly provided by the Mexican 'Comision Nacional para el Conocimiento y Uso de la Biodiversidad' (Project CONABIO ME006 "Fortalecimiento de las colecciones de ECOSUR") and by the French program 'Evaluation orientation de la Cooperation Scientifique' (project ECOS-Nord/CONACyT M12A01 "Systematique, biogeographie et organisation sociale chez les especes du complexe Pachycondyla villosa et du genre Ectatomma"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aririo AH, 2010, BIODIV INFORM, V7, P81; Aronsen GP, 2017, B PEABODY MUS NAT HI, V58, P209, DOI 10.3374/014.058.0107; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Brooks SJ, 2014, INT J BIOMETEOROL, V58, P1749, DOI 10.1007/s00484-013-0780-6; D'Elia J, 2016, CONDOR, V118, P703, DOI 10.1650/CONDOR-16-35.1; DEJEAN A, 1995, BIOTROPICA, V27, P57, DOI 10.2307/2388903; Dejean A, 1997, J NAT HIST, V31, P1313, DOI 10.1080/00222939700770741; DEJEAN A, 1990, SOCIOBIOLOGY, V17, P271; DiEuliis D, 2016, P NATL ACAD SCI USA, V113, P4, DOI 10.1073/pnas.1522680112; Donisthorpe HSJK., 1927, GUESTS BRIT ANTS THE; Feener DH, 1997, ANNU REV ENTOMOL, V42, P73, DOI 10.1146/annurev.ento.42.1.73; Fernandes Itanna Oliveira, 2014, Myrmecological News, V19, P133; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine B, 2012, CURR BIOL, V22, pR943, DOI 10.1016/j.cub.2012.10.029; Galindo-Leal C., 2003, CONT HERPETOLOGY, V1, P1, DOI DOI 10.17161/ch.vi1.11966; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Gonzalez CT, 2016, ANN ENTOMOL SOC AM, V109, P639, DOI 10.1093/aesa/saw023; GOSSWALD K., 1950, VERH DTSCH ZOOL MAIN, V1949, P256; Green SV, 1998, J INSECT CONSERV, V2, P151, DOI 10.1023/A:1009633811789; Grissell E. E., 1997, ANNOTATED KEYS GENER, V40392, P45; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harper GL, 2006, BIOL J LINN SOC, V88, P447, DOI 10.1111/j.1095-8312.2006.00632.x; Hill A, 2012, ZOOKEYS, P219, DOI 10.3897/zookeys.209.3472; Holldobler B., 1990, pi; Hull F. N., 1937, Psyche Cambridge Mass, V44, P12, DOI 10.1155/1937/46960; Johnson KG, 2011, BIOSCIENCE, V61, P147, DOI 10.1525/bio.2011.61.2.10; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Kempf WW, 1972, STUD ENTOMOL, V15, P1; Kistner D. H., 1982, Social insects. Vol. III, P1; Lachaud JP, 2015, INSECT SOC, V62, P121, DOI 10.1007/s00040-015-0390-x; Lachaud J. P., 1984, FOLIA ENTOMOL MEX, V61, P159; Lachaud J. P, 2013, FORMICIDAE DE MEXICO, P23; Lachaud Jean-Paul, 2012, Psyche (Cambridge), V2012; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Mackay W. P., 2010, SYSTEMATICS BIOL NEW; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Noyes JS., 2015, UNIVERSAL CHALCIDOID; PEREZ-BAUTISTA M, 1985, Folia Entomologica Mexicana, P119; Perez-Lachaud G, 2006, ANN ENTOMOL SOC AM, V99, P567, DOI 10.1603/0013-8746(2006)99[567:BABOKH]2.0.CO;2; Perez-Lachaud G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45530; Perez-Lachaud G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100155; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Lachaud G, 2012, FLA ENTOMOL, V95, P1066, DOI 10.1653/024.095.0436; Polus E, 2007, BIODIVERS CONSERV, V16, P3423, DOI 10.1007/s10531-006-9008-y; Pozo C., 2003, COLECCIONES BIOL COL, P47; Pyke GH, 2010, BIOL REV, V85, P247, DOI 10.1111/j.1469-185X.2009.00098.x; Rettenmeyer CW, 2011, INSECT SOC, V58, P281, DOI 10.1007/s00040-010-0128-8; RICKLEFS RE, 1980, AUK, V97, P206; Sarukhan Jose, 2001, P419; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Scheper J, 2010, P NATL ACAD SCI USA, V107, P22169; Schmidt CA, 2014, ZOOTAXA, V3817, P1, DOI 10.11646/zootaxa.3817.1.1; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Stephens CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005725; Stork NE, 2015, P NATL ACAD SCI USA, V112, P7519, DOI 10.1073/pnas.1502408112; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Valenzuela-Gonzalez Jorge, 1995, Folia Entomologica Mexicana, V91, P9; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Wild Alexander L., 2003, Boletin del Museo Nacional de Historia Natural del Paraguay, V14, P1; Witek M, 2014, INSECT SOC, V61, P307, DOI 10.1007/s00040-014-0362-6; WOJCIK DP, 1987, FLA ENTOMOL, V70, P181, DOI 10.2307/3495108	67	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184614	10.1371/journal.pone.0184614	http://dx.doi.org/10.1371/journal.pone.0184614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926617	Green Published, gold			2022-12-26	WOS:000411166600025
J	Ferraz, MSA; Melo-Silva, HLC; Kihara, AH				Ayres Ferraz, Mariana Sacrini; Cardeal Melo-Silva, Hiago Lucas; Kihara, Alexandre Hiroaki			Optimizing information processing in neuronal networks beyond critical states	PLOS ONE			English	Article							CORTICAL NETWORKS; OLFACTORY-BULB; AVALANCHES; CONNEXIN36; RETINA; MEMORY; REPLAY; TRANSMISSION; HIPPOCAMPUS; PATTERNS	Critical dynamics have been postulated as an ideal regime for neuronal networks in the brain, considering optimal dynamic range and information processing. Herein, we focused on how information entropy encoded in spatiotemporal activity patterns may vary in critical networks. We employed branching process based models to investigate how entropy can be embedded in spatiotemporal patterns. We determined that the information capacity of critical networks may vary depending on the manipulation of microscopic parameters. Specifically, the mean number of connections governed the number of spatiotemporal patterns in the networks. These findings are compatible with those of the real neuronal networks observed in specific brain circuitries, where critical behavior is necessary for the optimal dynamic range response but the uncertainty provided by high entropy as coded by spatiotemporal patterns is not required. With this, we were able to reveal that information processing can be optimized in neuronal networks beyond critical states.	[Ayres Ferraz, Mariana Sacrini; Cardeal Melo-Silva, Hiago Lucas; Kihara, Alexandre Hiroaki] Univ Fed ABC, Nucleo Cognicao & Sistemas Complexos, Ctr Matemat Computacao & Cognicao, Sao Bernardo Do Campo, SP, Brazil	Universidade Federal do ABC (UFABC)	Kihara, AH (corresponding author), Univ Fed ABC, Nucleo Cognicao & Sistemas Complexos, Ctr Matemat Computacao & Cognicao, Sao Bernardo Do Campo, SP, Brazil.	alexandrekihara@gmail.com	KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Kihara, Alexandre H/C-2458-2012	KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Kihara, Alexandre H/0000-0002-4027-7261	Sao Paulo Research Foundation (FAPESP) [2015/50122-0]; FAPESP [2014/16711-6]; CNPq [308608/2014-3]; UFABC; CNPq;  [DFG-IRTG 1740/2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UFABC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This research is supported by grant 2015/50122-0 from Sao Paulo Research Foundation (FAPESP) and DFG-IRTG 1740/2. HCM is grateful for UFABC scholarship. MAF is grateful for CNPq scholarship. AHK is grateful for grants from FAPESP (2014/16711-6) and CNPq (308608/2014-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Campos JGF, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042303; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kihara AH, 2009, J COMP NEUROL, V512, P651, DOI 10.1002/cne.21920; Kihara AH, 2006, NEUROSCI LETT, V393, P36, DOI 10.1016/j.neulet.2005.09.033; Kihara AH, 2006, J NEUROSCI RES, V83, P1331, DOI 10.1002/jnr.20815; Kinjo ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109149; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kosaka T, 2005, NEUROSCIENCE, V134, P757, DOI 10.1016/j.neuroscience.2005.04.057; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Li XM, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.023104; Luczak A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00030; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Rasmussen RG, 2017, ELIFE, V6, DOI 10.7554/eLife.21409; Scarpetta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064162; Scarpetta S, 2013, J COMPUT NEUROSCI, V34, P319, DOI 10.1007/s10827-012-0423-7; Schmeltzer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121794; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Stein PSG, 2013, ANN NY ACAD SCI, V1279, P1, DOI 10.1111/nyas.12083; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013	34	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184367	10.1371/journal.pone.0184367	http://dx.doi.org/10.1371/journal.pone.0184367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922366	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300016
J	Epstein, T; Gatenby, RA; Brown, JS				Epstein, Tamir; Gatenby, Robert A.; Brown, Joel S.			The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand	PLOS ONE			English	Article							GRADIENTS; ATP; GLYCOLYSIS	To maintain optimal fitness, a cell must balance the risk of inadequate energy reserve for response to a potentially fatal perturbation against the long-term cost of maintaining high concentrations of ATP to meet occasional spikes in demand. Here we apply a game theoretic approach to address the dynamics of energy production and expenditure in eukaryotic cells. Conventionally, glucose metabolism is viewed as a function of oxygen concentrations in which the more efficient oxidation of glucose to CO2 and H2O produces all or nearly all ATP except under hypoxic conditions when less efficient (2 ATP/glucose vs. about 36ATP/glucose) anaerobic metabolism of glucose to lactic acid provides an emergency backup. We propose an alternative in which energy production is governed by the complex temporal and spatial dynamics of intracellular ATP demand. In the short term, a cell must provide energy for constant baseline needs but also maintain capacity to rapidly respond to fluxes in demand particularly due to external perturbations on the cell membrane. Similarly, longer-term dynamics require a trade-off between the cost of maintaining high metabolic capacity to meet uncommon spikes in demand versus the risk of unsuccessfully responding to threats or opportunities. Here we develop a model and computationally explore the cell's optimal mix of glycolytic and oxidative capacity. We find the Warburg effect, high glycolytic metabolism even under normoxic conditions, is represents a metabolic strategy that allow cancer cells to optimally meet energy demands posed by stochastic or fluctuating tumor environments.	[Epstein, Tamir; Gatenby, Robert A.; Brown, Joel S.] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33607 USA; [Brown, Joel S.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Brown, Joel S.] Univ Illinois, Ctr Canc, Chicago, IL 60680 USA	H Lee Moffitt Cancer Center & Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Epstein, T (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33607 USA.	tamir.epstein@gmail.com			National Institute of Health / National Cancer Institut [U54CA143970-05]	National Institute of Health / National Cancer Institut	RAG received the financial support from the National Institute of Health / National Cancer Institute U54CA143970-05 (Physical Science Oncology Network EPSON]).	Aw TY, 2000, INT REV CYTOL, V192, P223; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Browne SE, 2013, J NEUROCHEM, V126, P301, DOI 10.1111/jnc.12321; Chronopoulos M, 2011, EUR J OPER RES, V213, P221, DOI 10.1016/j.ejor.2011.03.007; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Cochran J, 2014, NRELTP 6A20 61721, DOI 10.2172/1130630; Cohen Y, 2003, EVOL ECOL RES, V5, P819; Cohen Y., 2005, J APPL MATH, V2005, P403, DOI DOI 10.1155/JAM.2005.403; Cohen Y, 2009, EVOL ECOL RES, V11, P611; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; Gandelman M, 2013, J NEUROCHEM, V126, P382, DOI 10.1111/jnc.12286; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hippocrates Pare A, 1910, SCI PAPERS PHYSL MED; Hofmeyr JHS, 1995, J BIOENERG BIOMEMBR, V27, P479, DOI 10.1007/BF02110188; Hoppe A, 2011, BIOSYSTEMS, V105, P122, DOI 10.1016/j.biosystems.2011.05.006; Huberts NFD, 2015, DYN GAMES APPL, V5, P424, DOI 10.1007/s13235-015-0162-2; Huisman KJM, 2015, RAND J ECON, V46, P376, DOI 10.1111/1756-2171.12089; JONES DP, 1986, AM J PHYSIOL, V250, pC663, DOI 10.1152/ajpcell.1986.250.5.C663; Kirschen D., 2018, FUNDAMENTALS POWER S, V2nd ed.; Liebermeister W., 2014, ARXIV14045252; Mao LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058168; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; Stephens D., 2007, FORAGING BEHAV ECOLO; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Tilman D., 1980, AM NAT; Warburg O., 1924, BIOCH Z; Watkins S, 2011, J NEUROSCI, V31, P17250, DOI 10.1523/JNEUROSCI.3938-11.2011	36	89	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185085	10.1371/journal.pone.0185085	http://dx.doi.org/10.1371/journal.pone.0185085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922380	Green Submitted, Green Published, gold			2022-12-26	WOS:000411059300057
J	Jando, J; Camargo, SMR; Herzog, B; Verrey, F				Jando, Julia; Camargo, Simone M. R.; Herzog, Brigitte; Verrey, Francois			Expression and regulation of the neutral amino acid transporter B(0)AT1 in rat small intestine	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; BORDER MEMBRANE-VESICLES; DIETARY-REGULATION; HARTNUP DISORDER; SARS CORONAVIRUS; MOUSE; PEPTIDE; SLC6A19; PEPT-1; ACE2	Absorption of neutral amino acids across the luminal membrane of intestinal enterocytes is mediated by the broad neutral amino acid transporter B(0)AT1 (SLC6A19). Its intestinal expression depends on co-expression of the membrane-anchored peptidase angiotensin converting enzyme 2 (ACE2) and is additionally enhanced by aminopeptidase N (CD13). We investigated in this study the expression of B(0)AT1 and its auxiliary peptidases as well as its transport function along the rat small intestine. Additionally, we tested its possible short-and long-term regulation by dietary proteins and amino acids. We showed by immunofluorescence that B(0)AT1, ACE2 and CD13 co-localize on the luminal membrane of small intestinal villi and by Western blotting that their protein expression increases in distal direction. Furthermore, we observed an elevated transport activity of the neutral amino acid L-isoleucine during the nocturnal active phase compared to the inactive one. Gastric emptying was delayed by intragastric application of an amino acid cocktail but we observed no acute dietary regulation of B(0)AT1 protein expression and L-isoleucine transport. Investigation of the chronic dietary regulation of B(0)AT1, ACE2 and CD13 by different diets revealed an increased B(0)AT1 protein expression under amino acid-supplemented diet in the proximal section but not in the distal one and for ACE2 protein expression a reverse localization of the effect. Dietary regulation for CD13 protein expression was not as distinct as for the two other proteins. Ring uptake experiments showed a tendency for increased L-isoleucine uptake under amino acid-supplemented diet and in vivo L-isoleucine absorption was more efficient under high protein and amino acid-supplemented diet. Additionally, plasma levels of branched-chain amino acids were elevated under high protein and amino acid diet. Taken together, our experiments did not reveal an acute amino acid-induced regulation of B(0)AT1 but revealed a chronic dietary adaptation mainly restricted to the proximal segment of the small intestine.	[Verrey, Francois] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; Univ Zurich, NCCR Kidney CH, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Verrey, F (corresponding author), Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	francois.verrey@uzh.ch		Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	Swiss National Science Foundation [310030_166430]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grant 310030_166430 to FV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi SA, 2003, AM J PHYSIOL-GASTR L, V285, pG779, DOI 10.1152/ajpgi.00056.2003; Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Bohmer C, 2005, BIOCHEM J, V389, P745; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DEBNAM ES, 1985, DIGESTION, V31, P25, DOI 10.1159/000199173; DIAMOND JM, 1984, J PHYSIOL-LONDON, V349, P419, DOI 10.1113/jphysiol.1984.sp015165; ERICKSON RH, 1995, BIOCHEM BIOPH RES CO, V216, P249, DOI 10.1006/bbrc.1995.2617; Fairweather SJ, 2012, BIOCHEM J, V446, P135, DOI 10.1042/BJ20120307; Fatima J, 2009, J GASTROINTEST SURG, V13, P634, DOI 10.1007/s11605-008-0776-4; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1069, DOI 10.1152/ajpgi.1992.262.6.G1069; FERRARIS RP, 1988, AM J PHYSIOL, V255, pG143, DOI 10.1152/ajpgi.1988.255.2.G143; FERRARIS RP, 1989, ANNU REV PHYSIOL, V51, P125, DOI 10.1146/annurev.ph.51.030189.001013; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Jordi J, 2014, AM J PHYSL GASTROINT, V306; Jordi J, 2013, J PHYSIOL-LONDON, V591, P5611, DOI 10.1113/jphysiol.2013.258947; KARASOV WH, 1987, AM J PHYSIOL, V252, pG614, DOI 10.1152/ajpgi.1987.252.5.G614; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Ma K, 2012, PHARM RES-DORDR, V29, P535, DOI 10.1007/s11095-011-0580-9; Mentlein R, 2004, INT REV CYTOL, V235, P165, DOI 10.1016/S0074-7696(04)35004-7; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mourad FH, 2009, AM J PHYSIOL-GASTR L, V297, pG292, DOI 10.1152/ajpgi.00100.2009; Muratsubaki H, 2011, INDIAN J CLIN BIOCHE, V26, P416, DOI 10.1007/s12291-011-0125-3; PLAKIDOUDYMOCK S, 1993, BIOCHEM J, V290, P59, DOI 10.1042/bj2900059; Qandeel HG, 2009, J SURG RES, V156, P123, DOI 10.1016/j.jss.2009.03.052; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; SALLOUM RM, 1990, J SURG RES, V48, P635, DOI 10.1016/0022-4804(90)90244-V; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Sharp PA, 1996, GUT, V39, P545, DOI 10.1136/gut.39.4.545; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; SHIRAZIBEECHEY SP, 1990, GASTROENTEROLOGY, V98, P676, DOI 10.1016/0016-5085(90)90288-C; Singer D, 2012, AM J PHYSIOL-GASTR L, V303, pG686, DOI 10.1152/ajpgi.00140.2012; Terada T, 2005, BIOCHEM PHARMACOL, V70, P1756, DOI 10.1016/j.bcp.2005.09.027; Terada T, 2004, CURR DRUG METAB, V5, P85, DOI 10.2174/1389200043489153; Thamotharan M, 1999, METABOLISM, V48, P681, DOI 10.1016/S0026-0495(99)90164-6; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6	48	41	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184845	10.1371/journal.pone.0184845	http://dx.doi.org/10.1371/journal.pone.0184845			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915252	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000410861600017
J	Fehrholz, M; Seidenspinner, S; Kunzmann, S				Fehrholz, Markus; Seidenspinner, Silvia; Kunzmann, Steffen			Expression of surfactant protein B is dependent on cell density in H441 lung epithelial cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; GLUCOCORTICOID REGULATION; PRETERM INFANTS; GROWTH; RECEPTOR; TRANSCRIPTION; MODULATION; CULTURE	Background Expression of surfactant protein (SP)-B, which assures the structural stability of the pulmonary surfactant film, is influenced by various stimuli, including glucocorticoids; however, the role that cell-cell contact plays in SP-B transcription remains unknown. The aim of the current study was to investigate the impact of cell-cell contact on SP-B mRNA and mature SPB expression in the lung epithelial cell line H441. Methods Different quantities of H441 cells per growth area were either left untreated or incubated with dexamethasone. The expression of SP-B, SP-B transcription factors, and tight junction proteins were determined by qPCR and immunoblotting. The influence of cell density on SP-B mRNA stability was investigated using the transcription inhibitor actinomycin D. Results SP-B mRNA and mature SP-B expression levels were significantly elevated in untreated and dexamethasone-treated H441 cells with increasing cell density. High cell density as a sole stimulus was found to barely have an impact on SP-B transcription factor and tight junction mRNA levels, while its stimulatory ability on SP-B mRNA expression could be mimicked using SP-B-negative cells. SP-B mRNA stability was significantly increased in high-density cells, but not by dexamethasone alone. Conclusion SP-B expression in H441 cells is dependent on cell-cell contact, which increases mRNA stability and thereby potentiates the glucocorticoid-mediated induction of transcription. Loss of cell integrity might contribute to reduced SP-B secretion in damaged lung cells via downregulation of SP-B transcription. Cell density-mediated effects should thus receive greater attention in future cell culture-based research.	[Fehrholz, Markus; Seidenspinner, Silvia] Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany; [Kunzmann, Steffen] Buergerhosp Frankfurt Main, Clin Neonatol, Frankfurt, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Fehrholz, M (corresponding author), Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de			Deutsche Forschungsgemeinschaft (DE); University of Wuerzburg	Deutsche Forschungsgemeinschaft (DE)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by Deutsche Forschungsgemeinschaft (DE) and University of Wuerzburg, Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva E, 2015, CELL BIOCHEM FUNCT, V33, P386, DOI 10.1002/cbf.3125; Bachmeier BE, 2005, EXP CELL RES, V305, P83, DOI 10.1016/j.yexcr.2004.12.019; Berhane K, 2001, GENE, V268, P141, DOI 10.1016/S0378-1119(01)00417-6; Bersani I, 2012, EXPERT REV ANTI-INFE, V10, P573, DOI [10.1586/eri.12.34, 10.1586/ERI.12.34]; Boggaram V, 2003, FRONT BIOSCI-LANDMRK, V8, pD751, DOI 10.2741/1062; BROWER M, 1986, CANCER RES, V46, P798; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Fehrholz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153578; Fehrholz M, 2014, AM J PHYSIOL-LUNG C, V306, pL101, DOI 10.1152/ajplung.00257.2013; Fehrholz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051575; Foster CD, 2010, PEDIATR RES, V67, P585, DOI 10.1203/PDR.0b013e3181dbc708; Fukushima S, 2007, INT J ONCOL, V31, P1485; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; GOODMAN LV, 1989, J BIOL CHEM, V264, P5241; HAMBURGER AW, 1991, PATHOBIOLOGY, V59, P329, DOI 10.1159/000163672; Hattar K, 2001, J IMMUNOL, V166, P6287, DOI 10.4049/jimmunol.166.10.6287; Huang HW, 2008, AM J RESP CELL MOL, V38, P473, DOI 10.1165/rcmb.2007-0303OC; Jacobs AT, 2003, NITRIC OXIDE-BIOL CH, V8, P222, DOI 10.1016/S1089-8603(03)00027-2; Jobin C, 1997, INFLAMMATION, V21, P235, DOI 10.1023/A:1027326405788; Kavaliauskiene S, 2014, CELL MOL LIFE SCI, V71, P1097, DOI 10.1007/s00018-013-1441-y; Kim D. Y., 2014, SCI WORLD J, V2014, P1, DOI [DOI 10.4174/ASTR.2014.86.4.199.], 10.1155/2014/305452, DOI 10.1155/2014/305452]; Kim SW, 2015, INT J ONCOL, V46, P2067, DOI 10.3892/ijo.2015.2930; Koura AN, 1996, CANCER RES, V56, P3891; KUTOH E, 1995, EUR J BIOCHEM, V234, P557, DOI 10.1111/j.1432-1033.1995.557_b.x; Lee MW, 2013, BLOOD RES, V48, P107, DOI 10.5045/br.2013.48.2.107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; OREILLY MA, 1991, AM J PHYSIOL, V260, pL37, DOI 10.1152/ajplung.1991.260.2.L37; OSHIMA H, 1992, ENDOCRINOLOGY, V130, P2106, DOI 10.1210/en.130.4.2106; POCSIK E, 1994, J CELL BIOCHEM, V54, P453, DOI 10.1002/jcb.240540412; Ranayhossaini DJ, 2014, INT J MOL SCI, V15, P17686, DOI 10.3390/ijms151017686; Rozycki HJ, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00045; Schlingmann B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12276; Schlingmann B, 2015, SEMIN CELL DEV BIOL, V42, P47, DOI 10.1016/j.semcdb.2015.04.009; Schmitt-Ney M, 2004, EXP CELL RES, V295, P236, DOI 10.1016/j.yexcr.2003.12.022; Sporty JL, 2008, EXPERT OPIN DRUG MET, V4, P333, DOI [10.1517/17425255.4.4.333, 10.1517/17425255.4.4.333 ]; Tillis CC, 2011, AM J PHYSIOL-LUNG C, V300, pL940, DOI 10.1152/ajplung.00420.2010; VENKATESH VC, 1993, AM J RESP CELL MOL, V8, P222, DOI 10.1165/ajrcmb/8.2.222; Wang L, 2000, ENDOCRINOLOGY, V141, P2481, DOI 10.1210/en.141.7.2481; Whitsett JA, 1998, BBA-MOL BASIS DIS, V1408, P303, DOI 10.1016/S0925-4439(98)00076-3; Whitsett JA, 2015, AM J RESP CELL MOL, V53, P1, DOI 10.1165/rcmb.2015-0128PS; Wirbelauer J, 2009, J PERINATOL, V29, pS18, DOI 10.1038/jp.2009.30; ZEN K, 1994, EXP CELL RES, V215, P172, DOI 10.1006/excr.1994.1329; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184556	10.1371/journal.pone.0184556	http://dx.doi.org/10.1371/journal.pone.0184556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910374	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200062
J	Galbraith, NJ; Burton, J; Ekman, MB; Kenney, J; Walker, SP; Manek, S; Bishop, C; Carter, JV; Gardner, SA; Polk, HC				Galbraith, Norman James; Burton, James; Ekman, Mathew Brady; Kenney, Joseph; Walker, Samuel Patterson; Manek, Stephen; Bishop, Campbell; Carter, Jane Victoria; Gardner, Sarah Appel; Polk, Hiram C.			I kappa K-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response	PLOS ONE			English	Article							KAPPA-B KINASE; ENDOTOXIN TOLERANCE; GENE-EXPRESSION; SEPSIS; INHIBITION; INJURY; MICRORNA-155; DYSFUNCTION; MIR-155; PATHWAY	Excessive inflammatory responses in the surgical patient may result in cellular hypo-responsiveness, which is associated with an increased risk of secondary infection and death. microRNAs (miRNAs), such as miR-155, are powerful regulators of inflammatory signalling pathways including nuclear factor kappa B (NF kappa B). Our objective was to determine the effect of I kappa K-16, a selective blocker of inhibitor of kappa-B kinase (I kappa K), on miRNA expression and the monocyte inflammatory response. In a model of endotoxin tolerance using primary human monocytes, impaired monocytes had decreased p65 expression with suppressed TNF-alpha and IL-10 production (P < 0.05). miR-155 and miR-138 levels were significantly upregulated at 17 h in the impaired monocyte (P < 0.05). Notably, I kappa K-16 decreased miR-155 expression with a corresponding dose-dependent decrease in TNF-alpha and IL-10 production (P < 0.05), and impaired monocyte function was associated with increased miR-155 and miR-138 expression. In the context of I kappa K-16 inhibition, miR-155 mimics increased TNF-alpha production, while miR-155 antagomirs decreased both TNF-alpha and IL-10 production. These data demonstrate that I kappa K-16 treatment attenuates the monocyte inflammatory response, which may occur through a miR-155-mediated mechanism, and that I kappa K-16 is a promising approach to limit the magnitude of an excessive innate inflammatory response to LPS.	[Galbraith, Norman James; Burton, James; Ekman, Mathew Brady; Kenney, Joseph; Walker, Samuel Patterson; Manek, Stephen; Bishop, Campbell; Carter, Jane Victoria; Gardner, Sarah Appel; Polk, Hiram C.] Univ Louisville, Sch Med, Hiram C Polk Jr MD Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA	University of Louisville	Polk, HC (corresponding author), Univ Louisville, Sch Med, Hiram C Polk Jr MD Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA.	hcpolk01@louisville.edu	Carter, Jane/AAU-7945-2020	Carter, Jane/0000-0002-1203-1889; Galbraith, Norman/0000-0002-6354-6946	John W. Price and Barbara Thruston Atwood Price Trust; James and Emmeline Ferguson Research Fellowship Trust; Dizney Family Foundation; Mary K. Oxley Foundation	John W. Price and Barbara Thruston Atwood Price Trust; James and Emmeline Ferguson Research Fellowship Trust; Dizney Family Foundation; Mary K. Oxley Foundation	This publication was funded by the John W. Price and Barbara Thruston Atwood Price Trust, by the James and Emmeline Ferguson Research Fellowship Trust, by the Dizney Family Foundation, and by the Mary K. Oxley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to acknowledge the use of equipment from Jason Smith, MD PhD.; This work was funded by the John W. Price and Barbara Thruston Atwood Price Trust, by the James and Emmeline Ferguson Research Fellowship Trust, by the Dizney Family Foundation, and by the Mary K. Oxley Foundation. We would like to acknowledge the use of equipment from Jason Smith, MD, PhD.	Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; Billeter AT, 2016, ANN SURG, V263, P601, DOI 10.1097/SLA.0000000000001175; Billeter AT, 2014, FASEB J, V28, P5322, DOI 10.1096/fj.14-258335; Billeter AT, 2012, SURGERY, V151, P1, DOI 10.1016/j.surg.2011.08.006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Carter JV, 2016, ANN SURG, V264, P575, DOI 10.1097/SLA.0000000000001873; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen J, 2016, J AM SOC NEPHROLOGY; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Coldewey SM, 2013, DIS MODEL MECH, V6, P1031, DOI 10.1242/dmm.012435; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Frede S, 2009, J IMMUNOL, V182, P6470, DOI 10.4049/jimmunol.0802378; Galbraith N, 2016, SURG INFECT, V17, P563, DOI 10.1089/sur.2016.014; Galbraith N, 2016, SURG INFECT, V17, P303, DOI 10.1089/sur.2015.245; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Guo K, 2013, J MOL NEUROSCI, V51, P941, DOI 10.1007/s12031-013-9958-y; Lahiri R, 2016, ANN SURG, V263, P1028, DOI 10.1097/SLA.0000000000001248; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Li H, 2013, MEDIAT INFLAMM, V2013; Liu JQ, 2015, INT J INFECT DIS, V40, P135, DOI 10.1016/j.ijid.2015.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lv X, 2015, MOL MED REP, V12, P6013, DOI 10.3892/mmr.2015.4188; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; POLK HC, 1986, ANN SURG, V204, P282; Sen A, 2014, FEBS LETT, V588, P906, DOI 10.1016/j.febslet.2014.01.033; Shu YS, 2014, J TRAUMA ACUTE CARE, V76, P1417, DOI 10.1097/TA.0000000000000229; Sordi R, 2015, MOL MED, V21, P563, DOI 10.2119/molmed.2015.00049; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Wang H, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.80; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wu XY, 2014, J CELL BIOCHEM, V115, P1928, DOI 10.1002/jcb.24864; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhou JH, 2015, CYTOKINE, V71, P89, DOI 10.1016/j.cyto.2014.09.003; Zhou X, 2016, J DENT RES, V95, P230, DOI 10.1177/0022034515613043	43	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183987	10.1371/journal.pone.0183987	http://dx.doi.org/10.1371/journal.pone.0183987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910312	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200026
J	Hellum, M; Franco-Lie, I; Ovstebo, R; Hauge, T; Henriksson, CE				Hellum, Marit; Franco-Lie, Isabel; Ovstebo, Reidun; Hauge, Truls; Henriksson, Carola E.			The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls	PLOS ONE			English	Article							TISSUE FACTOR ACTIVITY; VENOUS THROMBOEMBOLISM; FACTOR EXPRESSION; MICROPARTICLES; BLOOD; PLASMA; INITIATION; PLATELET; COAGULATION; PREDICTION	Circulating microvesicles (MVs) are suggested to be important contributors to cancer-associated thrombosis due to the presence of surface-bound procoagulant molecules like tissue factor (TF) and phosphatidylserine (PS). Pancreatic cancer is considered to be one of the most prothrombotic malignancies. The aim of this study was to describe the impact of analytical variables on MV-associated thrombin generation in patients with pancreatic cancer and in healthy controls. MVs were isolated from citrated plasma and added to pooled normal plasma (PNP). Thrombin generation was measured by the calibrated automated thrombogram. The impact of corn trypsin inhibitor (CTI), anti-tissue factor pathway inhibitor (TFPI) antibodies and phospholipids was described. Antibodies against TF were used to assess TF-dependency, and MV-bound PS activity was measured with the Zymuphen MP-activity kit. MVs from the pancreatic cancer patients displayed higher thrombin generation and higher PS-activity than MVs from the healthy control group, while TF-dependency was observed in only 1 out of 13 patient samples. Adequate thrombin generation-curves were only achieved when CTI was omitted and anti-TFPI antibodies were added to PNP prepared in low contact-activating tubes. Addition of phospholipids reduced the significant differences between the two groups, and should be omitted. This modified thrombin generation assay could be useful for measurement of procoagulant circulating MVs, allowing the contribution from MVs affecting both the intrinsic and the extrinsic pathway to be measured.	[Hellum, Marit; Hauge, Truls; Henriksson, Carola E.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hellum, Marit; Ovstebo, Reidun; Henriksson, Carola E.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Franco-Lie, Isabel; Hauge, Truls] Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Henriksson, CE (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Henriksson, CE (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	carola.henriksson@medisin.uio.no			South-Eastern Norway Regional Health Authority through the Regional Research Network on Extracellular Vesicles (RRNEV)	South-Eastern Norway Regional Health Authority through the Regional Research Network on Extracellular Vesicles (RRNEV)	This project received funding from the South-Eastern Norway Regional Health Authority through the Regional Research Network on Extracellular Vesicles (RRNEV, http://www.extracellularvesicles.no/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2011, J THROMB HAEMOST, V9, P2251, DOI 10.1111/j.1538-7836.2011.04488.x; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Bharthuar A, 2013, THROMB RES, V132, P180, DOI 10.1016/j.thromres.2013.06.026; Bidot L, 2008, J THROMB HAEMOST, V6, P913, DOI 10.1111/j.1538-7836.2008.02963.x; Boknas N, 2014, J THROMB HAEMOST, V12, P515, DOI 10.1111/jth.12503; Brodin E, 2009, TRANSL RES, V153, P124, DOI 10.1016/j.trsl.2008.12.004; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Campello E, 2016, BIOMARK MED, V10, P743, DOI 10.2217/bmm-2015-0063; Freyssinet JM, 2010, THROMB RES, V125, pS46, DOI 10.1016/j.thromres.2010.01.036; Gheldof D, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19728; Gheldof D, 2013, BLOOD COAGUL FIBRIN, V24, P567, DOI 10.1097/MBC.0b013e328360a56e; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Han X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0054-8; Hellum M, 2014, THROMB RES, V133, P507, DOI 10.1016/j.thromres.2013.12.031; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Keuren JF, 2006, BRIT J HAEMATOL, V134, P307, DOI 10.1111/j.1365-2141.2006.06167.x; Key NS, 2010, SEMIN THROMB HEMOST, V36, P865, DOI 10.1055/s-0030-1267040; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Khorana AA, 2004, LANCET ONCOL, V5, P655, DOI 10.1016/S1470-2045(04)01606-7; Khorana AA, 2007, CLIN CANCER RES, V13, P2870, DOI 10.1158/1078-0432.CCR-06-2351; Kluft C, 2010, SEMIN THROMB HEMOST, V36, P791, DOI 10.1055/s-0030-1265296; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Mooberry MJ, 2015, CYTOMETRY J INT SO A; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nickel KF, 2015, BLOOD, V126, P1379, DOI 10.1182/blood-2015-01-622811; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Pabinger I, 2014, HEMATOL-AM SOC HEMAT, P410, DOI 10.1182/asheducation-2014.1.410; Pabinger I, 2013, BLOOD, V122, P2011, DOI 10.1182/blood-2013-04-460147; Ramstrom S, 2005, BLOOD COAGUL FIBRIN, V16, P447, DOI 10.1097/01.mbc.0000178827.52242.89; RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111; Rautou PE, 2013, EXPERT REV HEMATOL, V6, P91, DOI [10.1586/ehm.12.74, 10.1586/EHM.12.74]; Seto S, 2000, CANCER, V88, P295, DOI 10.1002/(SICI)1097-0142(20000115)88:2<295::AID-CNCR8>3.0.CO;2-U; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Tesselaar MET, 2009, J THROMB HAEMOST, V7, P1421, DOI 10.1111/j.1538-7836.2009.03504.x; Thaler J, 2012, J THROMB HAEMOST, V10, P1363, DOI 10.1111/j.1538-7836.2012.04754.x; Thaler J, 2014, TRANSL RES, V163, P145, DOI 10.1016/j.trsl.2013.06.009; Thaler J, 2013, EUR J CLIN INVEST, V43, P277, DOI 10.1111/eci.12042; Thaler J, 2011, ANN HEMATOL, V90, P447, DOI 10.1007/s00277-010-1111-1; Thomassen MCLGD, 2015, J THROMB HAEMOST, V13, P92, DOI 10.1111/jth.12766; Ueno T, 2000, BRIT J CANCER, V83, P164; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; van Doormaal FF, 2012, THROMB HAEMOSTASIS, V108, P160, DOI 10.1160/TH12-02-0099; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Yuana Y, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29260	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184579	10.1371/journal.pone.0184579	http://dx.doi.org/10.1371/journal.pone.0184579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910348	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200063
J	Hucker, SM; Ardern, Z; Goldberg, T; Schafferhans, A; Bernhofer, M; Vestergaard, G; Nelson, CW; Schloter, M; Rost, B; Scherer, S; Neuhaus, K				Huecker, Sarah M.; Ardern, Zachary; Goldberg, Tatyana; Schafferhans, Andrea; Bernhofer, Michael; Vestergaard, Gisle; Nelson, Chase W.; Schloter, Michael; Rost, Burkhard; Scherer, Siegfried; Neuhaus, Klaus			Discovery of numerous novel small genes in the intergenic regions of the Escherichia coli O157:H7 Sakai genome	PLOS ONE			English	Article							RIBOSOME PROFILING EXPERIMENTS; SMALL MEMBRANE-PROTEINS; FRAME-ENCODED PEPTIDES; OPEN READING FRAMES; TRANSCRIPTION TERMINATION; DARK-MATTER; HUMAN-CELLS; RNA-SEQ; TRANSLATION; SEQUENCE	In the past, short protein-coding genes were often disregarded by genome annotation pipelines. Transcriptome sequencing (RNAseq) signals outside of annotated genes have usually been interpreted to indicate either ncRNA or pervasive transcription. Therefore, in addition to the transcriptome, the translatome (RIBOseq) of the enteric pathogen Escherichia coli O157: H7 strain Sakai was determined at two optimal growth conditions and a severe stress condition combining low temperature and high osmotic pressure. All intergenic open reading frames potentially encoding a protein of >= 30 amino acids were investigated with regard to coverage by transcription and translation signals and their translatability expressed by the ribosomal coverage value. This led to discovery of 465 unique, putative novel genes not yet annotated in this E. coli strain, which are evenly distributed over both DNA strands of the genome. For 255 of the novel genes, annotated homologs in other bacteria were found, and a machine-learning algorithm, trained on small protein-coding E. coli genes, predicted that 89% of these translated open reading frames represent bona fide genes. The remaining 210 putative novel genes without annotated homologs were compared to the 255 novel genes with homologs and to 250 short annotated genes of this E. coli strain. All three groups turned out to be similar with respect to their translatability distribution, fractions of differentially regulated genes, secondary structure composition, and the distribution of evolutionary constraint, suggesting that both novel groups represent legitimate genes. However, the machine-learning algorithm only recognized a small fraction of the 210 genes without annotated homologs. It is possible that these genes represent a novel group of genes, which have unusual features dissimilar to the genes of the machine-learning algorithm training set.	[Huecker, Sarah M.; Ardern, Zachary; Scherer, Siegfried; Neuhaus, Klaus] Tech Univ Munich, Chair Microbial Ecol, Freising Weihenstephan, Germany; [Huecker, Sarah M.; Ardern, Zachary; Scherer, Siegfried] Tech Univ Munich, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany; [Goldberg, Tatyana; Schafferhans, Andrea; Bernhofer, Michael; Rost, Burkhard] Tech Univ Munich, Dept Informat Bioinformat, Garching, Germany; [Goldberg, Tatyana; Schafferhans, Andrea; Bernhofer, Michael; Rost, Burkhard] Tech Univ Munich, TUM IAS, Garching, Germany; [Vestergaard, Gisle; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Nelson, Chase W.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Neuhaus, Klaus] Tech Univ Munich, Core Facil Microbiome NGS, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; American Museum of Natural History (AMNH); Technical University of Munich	Neuhaus, K (corresponding author), Tech Univ Munich, Chair Microbial Ecol, Freising Weihenstephan, Germany.; Neuhaus, K (corresponding author), Tech Univ Munich, Core Facil Microbiome NGS, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany.	neuhaus@tum.de	Schloter, 1Michael/H-9151-2013; Scherer, Siegfried/I-1320-2013; Ardern, Zachary/AAV-7375-2020; Schafferhans, Andrea/C-9985-2009	Ardern, Zachary/0000-0002-9008-0897; Schafferhans, Andrea/0000-0002-5569-6186; Hucker, Sarah/0000-0002-6167-0265; Vestergaard, Gisle/0000-0003-2541-4974; Nelson, Chase/0000-0001-6287-1598; Scherer, Siegfried/0000-0002-0394-9890; Neuhaus, Klaus/0000-0002-6020-2814; Bernhofer, Michael/0000-0001-6103-3306	Deutsche Forschungsgemeinschaft DFG [SCHE316/3-2, KE740/13-2, SPP 1395]; Alexander von Humboldt foundation through the German Ministry for Research and Education (Bundesministerium fur Bildung and Forschung BMBF); Gerstner Family Foundation at the American Museum of Natural History	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Alexander von Humboldt foundation through the German Ministry for Research and Education (Bundesministerium fur Bildung and Forschung BMBF); Gerstner Family Foundation at the American Museum of Natural History	This work was supported by the Deutsche Forschungsgemeinschaft DFG (SCHE316/3-2, KE740/13-2) within SPP 1395 InKoMBio to S.M.H., Z.A., S.S., and K.N., by Alexander von Humboldt foundation through the German Ministry for Research and Education (Bundesministerium fur Bildung and Forschung BMBF) to T.G., A.B., M.B., and B.R., and by a Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History to C.W.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann F, 2015, METHODS; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baek J, 2017, G3-GENES GENOM GENET, V7, P983, DOI 10.1534/g3.116.036939; Banerjee S, 2006, J MICROBIOL, V44, P11; Baumgartner D, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0896-z; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bernhofer M, 2016, PROTEINS, V84, P1706, DOI 10.1002/prot.25155; Bitard-Feildel T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41425; Boekhorst J, 2011, MICROB BIOTECHNOL, V4, P308, DOI 10.1111/j.1751-7915.2011.00261.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Brylinski M, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-47; Byrgazov K, 2013, CURR OPIN MICROBIOL, V16, P133, DOI 10.1016/j.mib.2013.01.009; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carlevaro-Fita J, 2016, RNA, V22, P867, DOI 10.1261/rna.053561.115; Carver T, 2010, BIOINFORMATICS, V26, P676, DOI 10.1093/bioinformatics/btq010; Cassidy L, 2016, J PROTEOME RES, V15, P3773, DOI 10.1021/acs.jproteome.6b00569; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; de Castro BG, 2013, REV BRAS PARASITOL V, V22, P318, DOI 10.1590/S1984-29612013000200052; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dornenburg JE, 2010, MBIO, V1; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Gerashchenko MV, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw822; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Goldberg T, 2014, NUCLEIC ACIDS RES, V42, pW350, DOI 10.1093/nar/gku396; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hou Z, 2013, FOOD MICROBIOL, V35, P136, DOI 10.1016/j.fm.2013.03.002; Hsu PY, 2016, P NATL ACAD SCI US; Hucker SM, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw262; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Hwang JY, 2017, NUCLEIC ACIDS RES, V45, P327, DOI 10.1093/nar/gkw944; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jeong Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11605; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kans J., 2017, ENTREZ DIRECT E UTIL; Kemp G, 2014, BIOL CHEM, V395, P1365, DOI 10.1515/hsz-2014-0213; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landstorfer R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-353; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Latif H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00821-14; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lewis SB, 2015, INFECT IMMUN, V83, P942, DOI 10.1128/IAI.02928-14; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lin YF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-620; Liu XQ, 2013, P NATL ACAD SCI USA, V110, P11928, DOI 10.1073/pnas.1309739110; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Ma JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023191; Marks J, 2016, P NATL ACAD SCI USA, V113, P12150, DOI 10.1073/pnas.1613055113; Mohammad F, 2016, CELL REP, V14, P686, DOI 10.1016/j.celrep.2015.12.073; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Neme R, 2016, ELIFE, V5, DOI 10.7554/eLife.09977; Neuhaus K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3586-9; Neuhaus K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2456-1; O'Connor PBF, 2013, BIOINFORMATICS, V29, P1488, DOI 10.1093/bioinformatics/btt184; OhEigeartaigh SS, 2014, J BACTERIOL, V196, P2030, DOI 10.1128/JB.01368-13; Perdigao N, 2015, P NATL ACAD SCI USA, V112, P15898, DOI 10.1073/pnas.1508380112; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Smith JE, 2014, CELL REP, V7, P1858, DOI 10.1016/j.celrep.2014.05.023; Solovyev VV, 2011, GENOME MED, V3, DOI 10.1186/gm264; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Tatarinova TV, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-015-0104-3; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Wilson BA, 2011, GENOME BIOL EVOL, V3, P1245, DOI 10.1093/gbe/evr099; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yomtovian I, 2010, BIOINFORMATICS, V26, P996, DOI 10.1093/bioinformatics/btq093; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zur H, 2016, SCI REP, P6	98	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184119	10.1371/journal.pone.0184119	http://dx.doi.org/10.1371/journal.pone.0184119			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902868	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200026
J	Verbeurgt, C; Veithen, A; Carlot, S; Tarabichi, M; Dumont, JE; Hassid, S; Chatelain, P				Verbeurgt, Christophe; Veithen, Alex; Carlot, Sebastien; Tarabichi, Maxime; Dumont, Jacques E.; Hassid, Sergio; Chatelain, Pierre			The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds	PLOS ONE			English	Article							SOLITARY CHEMOSENSORY CELLS; PHENYLTHIOCARBAMIDE; SENSITIVITY; FAMILY	T2R38 has been shown to be a specific bacterial detector implicated in innate immune defense mechanism of human upper airway. Several clinical studies have demonstrated that this receptor is associated with the development of chronic rhinosinusitis (CRS). T2R38 was previously reported to bind to homoserine lactones (HSL), quorum sensing molecules specific of Pseudomonas Aeruginosa and other gram negative species. Nevertheless, these bacteria are not the major pathogens found in CRS. Here we report on the identification of bacterial metabolites acting as new agonists of T2R38 based on a single cell calcium imaging study. Two quorum sensing molecules (Agr D1 thiolactone from Staphylococcus Aureus and CSP-1 from Streptococcus Pneumoniae) and a list of 32 bacterial metabolites from pathogens frequently implicated in CRS were tested. First, we observed that HSL failed to activate T2R38 in our experimental system, but that the dimethylsulfoxide (DMSO), used as a solvent for these lactones may, by itself, account for the agonistic effect previously described. Secondly, we showed that both Agr D1 thiolactone and CSP-1 are inactive but that at least 7 bacterial metabolites (acetone, 2-butanone, 2-pentanone, 2-methylpropanal, dimethyl disulfide, methylmercaptan, gamma-butyrolactone) are able to specifically trigger this receptor. T2R38 is thus much more broadly tuned for bacterial compounds than previously thought.	[Verbeurgt, Christophe; Carlot, Sebastien; Hassid, Sergio] Free Univ Brussels, Erasme Univ Hosp, Dept Otorhinolaryngol, Brussels, Belgium; [Veithen, Alex; Chatelain, Pierre] ChemCom SA, Brussels, Belgium; [Tarabichi, Maxime; Dumont, Jacques E.] Free Univ Brussels, Inst Interdisciplinary Res Human & Mol Biol, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Verbeurgt, C (corresponding author), Free Univ Brussels, Erasme Univ Hosp, Dept Otorhinolaryngol, Brussels, Belgium.	christophe.verbeurgt@erasme.ulb.ac.be	Tarabichi, Maxime/ABA-9246-2020	Tarabichi, Maxime/0000-0002-1635-2348	Fonds Erasme	Fonds Erasme	Two authors (AV and PC) are employed by the commercial company Chemcom S.A., Brussels. The funder, Fonds Erasme, provided support in the form of salaries for author [CV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adappa ND, 2015, INT FORUM ALLERGY RH; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P25, DOI 10.1002/alr.21666; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Avau B, 2015, ACTA PHYSL OXF; Bandara HMHN, 2012, CRIT REV MICROBIOL, V38, P217, DOI 10.3109/1040841X.2011.652065; Barham HP, 2013, INT FORUM ALLERGY RH, V3, P450, DOI 10.1002/alr.21149; Baumler DJ, 2007, EXTREMOPHILES, V11, P841, DOI 10.1007/s00792-007-0108-8; Behrens M, 2013, CHEM SENSES, V38, P475, DOI 10.1093/chemse/bjt016; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Braun T, 2011, RHINOLOGY, V49, P507, DOI 10.4193/Rhino.11.121; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Farquhar DR, 2015, INT FORUM ALLERGY RH, V5, P111, DOI 10.1002/alr.21437; Filipiak W, 2012, MICROBIOL-SGM, V158, P3044, DOI 10.1099/mic.0.062687-0; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Hadad I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056007; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Jacob Stanley W., 2015, TRAUMA AND DIS; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; LEWIS HL, 1970, J GEN MICROBIOL, V63, P203, DOI 10.1099/00221287-63-2-203; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Preti G, 2009, J CHROMATOGR B, V877, P2011, DOI 10.1016/j.jchromb.2009.05.028; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Ueda T, 2003, J NEUROSCI, V23, P7376; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755	39	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0181302	10.1371/journal.pone.0181302	http://dx.doi.org/10.1371/journal.pone.0181302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902853	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200003
J	Zeidan, AM; Long, JB; Wang, R; Hu, X; Yu, JB; Huntington, SF; Abel, GA; Mougalian, SS; Podoltsev, NA; Gore, SD; Gross, CP; Ma, XM; Davidoff, AJ				Zeidan, Amer M.; Long, Jessica B.; Wang, Rong; Hu, Xin; Yu, James B.; Huntington, Scott F.; Abel, Gregory A.; Mougalian, Sarah S.; Podoltsev, Nikolai A.; Gore, Steven D.; Gross, Cary P.; Ma, Xiaomei; Davidoff, Amy J.			Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study	PLOS ONE			English	Article							MYELODYSPLASTIC SYNDROMES; RADIATION-THERAPY; ADJUVANT BREAST; LEUKEMIA; SURVIVAL; MODEL	Background There are inconsistent and limited data regarding the risk of myeloid neoplasms (MN) among breast cancer survivors who received radiotherapy (RT) in the absence of chemotherapy. Concern about subsequent MN might influence the decision to use adjuvant RT for women with localized disease. As patients with therapy-related MN have generally poor outcomes, the presumption of subsequent MN being therapy-related could affect treatment recommendations. Methods We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database to study older women with in-situ or stage 1-3 breast cancer diagnosed 2001-2009 who received surgery. Chemotherapy and RT were ascertained using Medicare claims, and new MN diagnoses were captured using both SEER registry and Medicare claims. We excluded women who received chemotherapy for initial treatment, and censored at receipt of subsequent chemotherapy. Competing-risk survival analysis was used to assess the association between RT and risk of subsequent MN adjusting for relevant characteristics. Results Median follow-up for 60,426 eligible patients was 68 months (interquartile range, 46 to 92 months), with 47.6% receiving RT. In total, 316 patients (0.52%) were diagnosed with MN; the cumulative incidence per 10,000 person-years was 10.6 vs 9.0 among RT-treated vs non-RT-treated women, respectively (p = .004); the increased risk of subsequent MN persisted in the adjusted analysis (hazard ratio = 1.36, 95% confidence interval: 1.03-1.80). The results were consistent in multiple sensitivity analyses. Conclusions Our data suggest that RT is associated with a significant risk of subsequent MN among older breast cancer survivors, though the absolute risk increase is very small. These findings suggest the benefits of RT outweigh the risks of development of subsequent MN.	[Zeidan, Amer M.; Huntington, Scott F.; Mougalian, Sarah S.; Podoltsev, Nikolai A.; Gore, Steven D.; Gross, Cary P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Zeidan, Amer M.; Long, Jessica B.; Wang, Rong; Hu, Xin; Yu, James B.; Huntington, Scott F.; Mougalian, Sarah S.; Gross, Cary P.; Ma, Xiaomei; Davidoff, Amy J.] Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA; [Wang, Rong; Ma, Xiaomei] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Yu, James B.] Yale Univ, Dept Therapeut Radiol, New Haven, CT USA; [Abel, Gregory A.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA; [Davidoff, Amy J.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Harvard University; Dana-Farber Cancer Institute; Yale University	Zeidan, AM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Zeidan, AM (corresponding author), Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA.	amer.zeidan@yale.edu	HU, XIN/G-7183-2018	HU, XIN/0000-0003-1097-3300; Zeidan, Amer/0000-0001-7017-8160; Yu, James/0000-0002-3119-3226	Dennis Cooper Hematology Young Investigator Award; National Cancer Institute [P30 CA016359]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	Dennis Cooper Hematology Young Investigator Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly funded by the Dennis Cooper Hematology Young Investigator Award, and a P30 CA016359 from the National Cancer Institute (https://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Bach PB, 2002, MED CARE, V40; Braithwaite D, 2016, CLIN INTERV AGING, V11, P111, DOI 10.2147/CIA.S65304; Cogle CR, 2011, BLOOD, V117, P7121, DOI 10.1182/blood-2011-02-337964; Craig BM, 2012, CANCER EPIDEM BIOMAR, V21, P474, DOI 10.1158/1055-9965.EPI-11-1087; CURTIS RE, 1992, NEW ENGL J MED, V326, P1745, DOI 10.1056/NEJM199206253262605; Davidoff AJ, 2013, J GERIATR ONCOL, V4, P157, DOI 10.1016/j.jgo.2012.12.005; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gale RP, 2014, LEUKEMIA RES, V38, P1162, DOI 10.1016/j.leukres.2014.08.002; Grantzau T, 2013, RADIOTHER ONCOL, V106, P42, DOI 10.1016/j.radonc.2013.01.002; Jagsi R, 2012, CANCER-AM CANCER SOC, V118, P333, DOI 10.1002/cncr.26295; Kaplan H, 2013, BREAST CANCER RES TR, V137, P863, DOI 10.1007/s10549-012-2386-9; Kaplan HG, 2013, BREAST CANCER RES TR, V142, P629, DOI 10.1007/s10549-013-2773-x; Kaplan HG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-260; Kaplan HG, 2004, CANCER, V101, P1529, DOI 10.1002/cncr.20475; Martin MG, 2009, BREAST CANCER RES TR, V118, P593, DOI 10.1007/s10549-009-0376-3; Nardi V, 2012, J CLIN ONCOL, V30, P2340, DOI 10.1200/JCO.2011.38.7340; Ornstein MC, 2014, AM J HEMATOL, V89, P168, DOI 10.1002/ajh.23605; Roberts KB, 2013, INT J RADIAT ONCOL, V85, P1186, DOI 10.1016/j.ijrobp.2012.10.009; Smith RE, 2003, J CLIN ONCOL, V21, P1195, DOI 10.1200/JCO.2003.03.114; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang R, 2017, PROSTATE, V77, P437, DOI 10.1002/pros.23281; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, J CLIN ONCOL, V20, P307, DOI 10.1200/JCO.20.1.307; Wolff AC, 2015, J CLIN ONCOL, V33, P340, DOI 10.1200/JCO.2013.54.6119; Yu GP, 2006, CANCER CAUSE CONTROL, V17, P411, DOI 10.1007/s10552-005-0338-y; Zeidan AM, 2013, CANCER-AM CANCER SOC, V119, P3870, DOI 10.1002/cncr.28298	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184747	10.1371/journal.pone.0184747	http://dx.doi.org/10.1371/journal.pone.0184747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902882	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200060
J	Gebreegziabher, T; Stoecker, BJ				Gebreegziabher, Tafere; Stoecker, Barbara J.			Iron deficiency was not the major cause of anemia in rural women of reproductive age in Sidama zone, southern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							BIOMARKERS REFLECTING INFLAMMATION; NUTRITIONAL DETERMINANTS; BRINDA PROJECT; BIOAVAILABILITY; PREVALENCE; ZINC; HEMOGLOBIN; PREGNANCY; CHILDREN; PHYTATE	Background Anemia, which has many etiologies, is a moderate/severe public health problem in young children and women of reproductive age in many developing countries. The aim of this study was to investigate prevalence of iron deficiency, anemia, and iron deficiency anemia using multiple biomarkers and to evaluate their association with food insecurity and food consumption patterns in non-pregnant women from a rural area of southern Ethiopia. Methods A cross-sectional study was conducted in 202 rural women of reproductive age in southern Ethiopia. Anthropometrics and socio-demographic data were collected. A venipuncture blood sample was analyzed for hemoglobin (Hb) and for biomarkers of iron status. Biomarkers were skewed and were log transformed before analysis. Mean, median, Pearson's correlations and ordinary least-squares regressions were calculated. Results Median (IQR) Hb was 138 (127, 151) g/L. Based on an altitude-adjusted (1708 m) cutoff of 125 g/L for Hb, 21.3% were anemic. Plasma ferritin was < 15 mu g/L in 18.6% of the women. Only one woman had alpha-1-acid glycoprotein (AGP) > 1.0 g/L; four women (2%) had > 5 mg/L of C-reactive protein (CRP). Of the 43 women who were anemic, 23.3% (10 women) had depleted iron stores based on plasma ferritin. Three of these had elevated soluble transferrin receptors (sTfR). Hemoglobin (Hb) concentration was negatively correlated with sTfR (r = -0.24, p = 0.001), and positively correlated with ferritin (r = 0.17, p = 0.018), plasma iron (r = 0.15, p = 0.046), transferrin saturation (TfS) (r = 0.15, p = 0.04) and body iron (r = 0.14, p = 0.05). Overall prevalence of iron deficiency anemia was only 5%. Conclusion Iron deficiency anemia was not prevalent in the study population, despite the fact that anemia would be classified as a moderate public health problem.	[Gebreegziabher, Tafere] Hawassa Univ, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia; [Gebreegziabher, Tafere] Cent Washington Univ, Dept Hlth Sci, Ellensburg, WA 98926 USA; [Stoecker, Barbara J.] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA	Hawassa University; Central Washington University; Oklahoma State University System; Oklahoma State University - Stillwater	Gebreegziabher, T (corresponding author), Hawassa Univ, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia.; Gebreegziabher, T (corresponding author), Cent Washington Univ, Dept Hlth Sci, Ellensburg, WA 98926 USA.	tafere.bl@gmail.com			Hawassa University, Hawassa Ethiopia; Oklahoma Agricultural Experiment Station [W3002]; Hawassa University	Hawassa University, Hawassa Ethiopia; Oklahoma Agricultural Experiment Station; Hawassa University	This work was supported by Hawassa University, Hawassa Ethiopia and W3002 Multistate Project - Oklahoma Agricultural Experiment Station. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the study participants for their time and willingness to take part in the study and Mr. Keneni Fufa for his contributions in sample collection. This study was supported by Hawassa University and Oklahoma Agricultural Experiment Station Multi State Project W3002.	Abebe Y, 2006, PUBLIC HEALTH NUTR, V11, P379; Abebe Y, 2007, J FOOD COMPOS ANAL, V20, P161, DOI 10.1016/j.jfca.2006.09.003; Alemayehu AA, 2011, NUTRITION, V27, P919, DOI 10.1016/j.nut.2010.10.015; Assefa Selomon, 2014, BMC Hematol, V14, P3, DOI 10.1186/2052-1839-14-3; Baye K, 2014, INT J FOOD SCI TECH, V49, P174, DOI 10.1111/ijfs.12295; Baynes RD, 1996, CLIN BIOCHEM, V29, P209, DOI 10.1016/0009-9120(96)00010-K; Bekele A, 2016, ANEMIA, V2016, DOI 10.1155/2016/1073192; Central Statistical Agency and ICF International, 2012, ADD AB ETH CALV; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; de Benoist B, 2008, WHO GLOBAL DATABASE; Deitchler M, 2011, INTRO SIMPLE MEASURE, V12; Ethiopian Public Health Institute, 2016, ETH NAT MICR SURV RE; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Gashu D, 2016, PUBLIC HEALTH NUTR, V19, P1834, DOI 10.1017/S1368980015003626; GEBREMEDHIN M, 1976, SCAND J HAEMATOL, V16, P168; Gebremedhin S, 2014, AFR J REPROD HEALTH, V18, P44; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; Haidar Jemal A, 2009, BMC Blood Disord, V9, P7, DOI 10.1186/1471-2326-9-7; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112858; Hofvander Y., 1968, ACTA MED SCAND, V494, P1; Mei ZG, 2017, AM J CLIN NUTR, V106, p383S, DOI 10.3945/ajcn.116.142307; Melaku Umeta, 2008, Ethiopian Journal of Health Development, V22, P252; Namaste SML, 2017, AM J CLIN NUTR, V106, p359S, DOI 10.3945/ajcn.116.141762; Pynaert I, 2005, EUR J CLIN NUTR, V59, P826, DOI 10.1038/sj.ejcn.1602149; Regassa N., 2011, ETHIOP J ENV STUD MA, V4; Regassa N, 2012, PUBLIC HEALTH NUTR, V15, P1276, DOI 10.1017/S1368980011003119; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; WHO, 2011, SER FERR CONC ASS IR; WHO/ UNICEF/ UNU, 1996, IND ASS DEF STRAT IT; Who/unicef/unu ed, 2001, WHONHD013 UNICEFUNU; World Health Organization, 2006, GLOB DAT BOD MASS IN; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP; Yigzaw Y, 2001, LATHYRUS LATHYRISM N, V2	39	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184742	10.1371/journal.pone.0184742	http://dx.doi.org/10.1371/journal.pone.0184742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898272	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500046
J	Kyaw, KWY; Oo, MM; Kyaw, NTT; Phyo, KH; Aung, TK; Mya, T; Aung, N; Oo, HN; Isaakidis, P				Kyaw, Khine Wut Yee; Oo, Myo Minn; Kyaw, Nang Thu Thu; Phyo, Khaing Hnin; Aung, Thet Ko; Mya, Theingi; Aung, Nilar; Oo, Htun Nyunt; Isaakidis, Petros			Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PREVENTION	Introduction Loss-to-follow-up (LTFU) throughout the Prevention of Mother-To-Child Transmission (PMTCT) cascade remains one of the major threats to the success of PMTCT programs. In this study, we aimed to determine the mother-to-child transmission rate in a programmatic setting and to determine factors associated with LTFU among enrolled mothers and unfavorable outcomes among HIV-exposed babies which includes being HIV positive, death and LTFU. Methods A retrospective cohort study reviewing routinely collected data in an Integrated HIV care program, Mandalay, Myanmar in June 2016. LTFU means mother/infant missing appointed visit for more than three months. Results Of 678 pregnant women enrolled in PMTCT program between March 2011 and June 2014, one stillbirth and 607 live births were recorded in this cohort. Of 457 HIV-exposed babies with HIV-test recorded at the end of the intervention, nine (2%) were HIV-positive. Pregnant women's and exposed-babies' LTFU rate was 7 per 1000 person-years, and 10 per 1000 person-years respectively. PMTCT option B protocol was found to be significantly associate with maternal LTFU [adjusted Hazard Ratio (aHR) 95% CI: 3.52 (1.38-8.96)] when compare to mothers receiving option B+/lifelong antiretroviral therapy (ART). Weight <2.5 Kg at enrolment, receiving mixed-feeding, vaginal delivery and option B PMTCT protocol were significantly associated with unfavorable outcomes among exposed babies [aHR(95% CI): 5.40 (1.66-17.53), 5.91(1.68-20.84), 2.27 (1.22-4.22) and 2.33 (1.16-4.69) respectively]. Conclusion Mother-to-child HIV transmission rate in this public hospital-based program was lower than the 5% national target, which indicates a successful PMTCT intervention. However, a high proportion of HIV-infected mothers and exposed babies LTFU was recorded. Lifelong ART provision to HIV-positive pregnant women was shown to reduce exposed babies' LTFU, death and transmission rate (unfavorable outcomes) in this setting. Lessons learned from this program could be used to inform policy and practice in the country, while the programmatic challenge of LTFU should be urgently addressed.	[Kyaw, Khine Wut Yee; Oo, Myo Minn; Kyaw, Nang Thu Thu] Int Union TB & Lung Dis Union, Dept Operat Res, Mandalay, Myanmar; [Phyo, Khaing Hnin; Aung, Thet Ko] Int Union TB & Lung Dis Union, HIV Unit, Mandalay, Myanmar; [Mya, Theingi] Cent Women Hosp, Dept Obstet & Gynecol, Mandalay, Myanmar; [Aung, Nilar] Cent Women Hosp, Neonatol Unit, Mandalay, Myanmar; [Oo, Htun Nyunt] Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Program, Nay Pyi Taw, Myanmar; [Isaakidis, Petros] Medecins Sans Frontieres MSF Doctors Borders, Dept Operat Res, Bombay, Maharashtra, India		Kyaw, KWY (corresponding author), Int Union TB & Lung Dis Union, Dept Operat Res, Mandalay, Myanmar.	dr.khinewutyeekyaw2015@gmail.com	Oo, Myo Minn/P-3720-2018; Kyaw, Khine Wut Yee/K-4130-2019	Oo, Myo Minn/0000-0003-4089-016X; Kyaw, Khine Wut Yee/0000-0003-0709-484X; Isaakidis, Petros/0000-0002-7881-1554	Department for International Development (DFID), UK; National AIDS program (NAP); Medical Superintendent Professor and Head of Obstetrics and Gynecology Department of Central Women Hospital; HIV unit (The Union); PLHIV network	Department for International Development (DFID), UK; National AIDS program (NAP); Medical Superintendent Professor and Head of Obstetrics and Gynecology Department of Central Women Hospital; HIV unit (The Union); PLHIV network	The training program was funded by the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support of National AIDS program (NAP), Medical Superintendent Professor and Head of Obstetrics and Gynecology Department of Central Women Hospital, HIV unit (The Union), PLHIV network and all PLHIV and exposed babies included in this study. This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Program for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres (MSF/Doctors Without Borders). The specific SORT IT program which resulted in this publication was jointly developed and implemented by: The Union South-East Asia Office, New Delhi, India; the Centre for Operational Research, The Union, Paris, France; The Union, Mandalay, Myanmar; the Operational Research Unit (LUXOR), MSF Brussels Operational Center, Luxembourg; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India; Department of Community Medicine, Government T.D Medical College, Alappuzha, India; College of Life and Environmental Sciences, Exeter University, UK; Velammal Medical College Hospital & Research Institute, Madurai, India; and Institute of Medicine, University of Chester, UK.	Altan AMD, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.72.7958; Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; Chetty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-146; Chintu N, 2013, NIH PUBLIC ACCESS, V58, P224; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Geldsetzer P, 2016, J INT AIDS SOC, P19; Giuliano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068950; Iroezi Ngozi D, 2013, Afr J Reprod Health, V17, P118; Js R, 2007, EFFICACY SAFETY CESA, P1; Kalembo FW, 2013, CHINESE MED J-PEKING, V126, P3172, DOI 10.3760/cma.j.issn.0366-6999.20123475; Kristine SF, 2016, AIDS BEHAV, P2602; Landers DV, 1999, NEW ENGL J MED, V341, P205; National AIDS Program, 2015, NAT STRAT PLAN HIV A; National AIDS Program, 2014, GLOB AIDS RESP PROGR; National AIDS Program, 2015, GLOB AIDS RESP PROGR; Nduati EW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2355-4; Noubiap JJN, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.65.2551; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Thida A, 2014, PLOS ONE, P9; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; UNAIDS, 2013, HIV AS PAS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, GAP REP 2014; UNAIDS, 2016, GAP REPRT 2016; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zhou ZQ, 2010, JAIDS-J ACQ IMM DEF, V53, pS15, DOI 10.1097/QAI.0b013e3181c7d47b	29	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184426	10.1371/journal.pone.0184426	http://dx.doi.org/10.1371/journal.pone.0184426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886165	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100118
J	Kolimi, N; Ajjugal, Y; Rathinavelan, T				Kolimi, Narendar; Ajjugal, Yogeeshwar; Rathinavelan, Thenmalarchelvi			A B-Z junction induced by an A ... A mismatch in GAC repeats in the gene for cartilage oligomeric matrix protein promotes binding with the hZ(ADAR1) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD; molecular dynamics; NMR; RNA editing; trinucleotide repeat disease; cartilage oligomeric matrix protein; human adar1 protein; pseudoachdroplasia	Z-ALPHA DOMAIN; HANDED Z-DNA; MULTIPLE EPIPHYSEAL DYSPLASIA; BASE TRIPLET NONISOMORPHISM; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; NONCODING RNAS; EDITING ENZYME; Z TRANSITION; PSEUDOACHONDROPLASIA	GAC repeat expansion from five to seven in the exonic region of the gene for cartilage oligomeric matrix protein (COMP) leads to pseudoachondroplasia, a skeletal abnormality. However, the molecular mechanism by which GAC expansions in the COMP gene lead to skeletal dysplasias is poorly understood. Here we used molecular dynamics simulations, which indicate that an A ... A mismatch in a d(GAC)(6)<bold>d</bold>(GAC)(6) duplex induces negative supercoiling, leading to a local B-to-Z DNA transition. This transition facilitates the binding of d(GAC)(7)<bold>d</bold>(GAC)(7) with the Z-binding domain of human adenosine deaminase acting on RNA 1 (ADAR1, hZ(ADAR1)), as confirmed by CD, NMR, and microscale thermophoresis studies. The CD results indicated that hZ(ADAR1) recognizes the zigzag backbone of d(GAC)(7)<bold>d</bold>(GAC)(7) at the B-Z junction and subsequently converts it into Z-DNA via the so-called passive mechanism. Molecular dynamics simulations carried out for the modeled hZ(ADAR1)-d(GAC)(6).d(GAC)(6) complex confirmed the retention of previously reported important interactions between the two molecules. These findings suggest that hZ(ADAR1) binding with the GAC hairpin stem in COMP can lead to a non-genetic, RNA editing-mediated substitution in COMP that may then play a crucial role in the development of pseudoachondroplasia.	[Kolimi, Narendar; Ajjugal, Yogeeshwar; Rathinavelan, Thenmalarchelvi] Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi 502285, Telangana State, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Rathinavelan, T (corresponding author), Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi 502285, Telangana State, India.	tr@iith.ac.in			Department of Biotechnology, Government of India IYBA [BT/06/IYBA/2012]; Department of Biotechnology, Government of India BIO-CaRE [102/IFD/SAN/1811/2013-2014]; Department of Biotechnology, Government of India RD [102/IFD/SAN/3426/2013-2014]; Indian Institute of Technology Hyderabad; Ministry of Human Resources Development, Government of India	Department of Biotechnology, Government of India IYBA; Department of Biotechnology, Government of India BIO-CaRE; Department of Biotechnology, Government of India RD; Indian Institute of Technology Hyderabad; Ministry of Human Resources Development, Government of India	This work was supported by the Department of Biotechnology, Government of India IYBA-2012 (D.O. No. BT/06/IYBA/2012), BIO-CaRE (SAN. No. 102/IFD/SAN/1811/2013-2014), and R&D (SAN. No. 102/IFD/SAN/3426/2013-2014) and the Indian Institute of Technology Hyderabad (to T. R.). The Ministry of Human Resources Development, Government of India provided fellowships to N. K. and Y. A. The authors declare that they have no conflicts of interest with the contents of this article.	Ananth P, 2013, RNA, V19, P1038, DOI 10.1261/rna.036905.112; Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Berger I, 1998, BIOCHEMISTRY-US, V37, P13313, DOI 10.1021/bi9813126; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Case DA, 2012, AMBER 12; Dans PD, 2014, NUCLEIC ACIDS RES, V42, P11304, DOI 10.1093/nar/gku809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Goldsmith G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155090; Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson GC, 2012, HUM MUTAT, V33, P144, DOI 10.1002/humu.21611; Jeong M, 2014, ARCH BIOCHEM BIOPHYS, V558, P95, DOI 10.1016/j.abb.2014.06.026; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kang YM, 2009, J AM CHEM SOC, V131, P11485, DOI 10.1021/ja902654u; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; Khan N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004162; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kim D, 2014, NUCLEIC ACIDS RES, V42, P5937, DOI 10.1093/nar/gku189; Kim D, 2009, NUCLEIC ACIDS RES, V37, P4353, DOI 10.1093/nar/gkp364; Kimura T, 2004, J ORG CHEM, V69, P1169, DOI 10.1021/jo035194q; Krepl M, 2012, J CHEM THEORY COMPUT, V8, P2506, DOI 10.1021/ct300275s; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MEIER JC, 2016, FRONT MOL NEUROSCI, V9; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Mochmann LH, 2004, NUCLEIC ACIDS RES, V32, P4469, DOI 10.1093/nar/gkh787; Moradi M, 2013, NUCLEIC ACIDS RES, V41, P33, DOI 10.1093/nar/gks1003; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; NORDHEIM A, 1982, CELL, V31, P309, DOI 10.1016/0092-8674(82)90124-6; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Patro LPP, 2017, J MOL BIOL, V429, P2438, DOI 10.1016/j.jmb.2017.06.013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; POHL FM, 1972, J MOL BIOL, V67, P375, DOI 10.1016/0022-2836(72)90457-3; Rathinavelan T, 2006, BIOPOLYMERS, V82, P443, DOI [10.1002/bip.20484, 10.1002/BIP.20484]; Rathinavelan T, 2014, J MOL BIOL, V426, P2958, DOI 10.1016/j.jmb.2014.06.009; Rathinavelan T, 2011, J BIOL CHEM, V286, P4922, DOI 10.1074/jbc.M110.159434; Schade M, 1999, P NATL ACAD SCI USA, V96, P12465, DOI 10.1073/pnas.96.22.12465; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Singh Minati, 2013, Frontiers in Genetics, V3, P326, DOI 10.3389/fgene.2012.00326; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Susic S, 1998, HUM MUTAT, pS125; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Thenmalarchelvi R, 2005, NUCLEIC ACIDS RES, V33, P43, DOI 10.1093/nar/gki143; Tufan AC, 2007, EUR J HUM GENET, V15, P1023, DOI 10.1038/sj.ejhg.5201882; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vorlickova M, 2001, EUR BIOPHYS J BIOPHY, V30, P179, DOI 10.1007/s002490000121; Vorlickova M, 1999, NUCLEIC ACIDS RES, V27, P581, DOI 10.1093/nar/27.2.581; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X; Yildirim I, 2013, J AM CHEM SOC, V135, P3528, DOI 10.1021/ja3108627	57	5	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18732	18746		10.1074/jbc.M117.796235	http://dx.doi.org/10.1074/jbc.M117.796235			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924040	hybrid, Green Published			2022-12-26	WOS:000415848000001
J	Gaspar, ML; Chang, YF; Jesch, SA; Aregullin, M; Henry, SA				Gaspar, Maria L.; Chang, Yu-Fang; Jesch, Stephen A.; Aregullin, Manuel; Henry, Susan A.			Interaction between repressor Opi1p and ER membrane protein Scs2p facilitates transit of phosphatidic acid from the ER to mitochondria and is essential for INO1 gene expression in the presence of choline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; choline; lipid droplet; phosphatidic acid; triacylglycerol; inositol	YEAST SACCHAROMYCES-CEREVISIAE; STORAGE LIPID-SYNTHESIS; ENDOPLASMIC-RETICULUM; PHOSPHOLIPID BIOSYNTHESIS; INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHATIDYLCHOLINE SYNTHESIS; CARDIOLIPIN BIOSYNTHESIS; BINDING PROTEINS; CONTACT SITES; METABOLISM	In the yeast Saccharomyces cerevisiae, the Opi1p repressor controls the expression of INO1 via the Opi1p/Ino2p-Ino4p regulatory circuit. Inositol depletion favors Opi1p interaction with both Scs2p and phosphatidic acid at the endoplasmic reticulum (ER) membrane. Inositol supplementation, however, favors the translocation of Opi1p from the ER into the nucleus, where it interacts with the Ino2p-Ino4p complex, attenuating transcription of INO1. A strain devoid of Scs2p (scs2) and a mutant, OPI1FFAT, lacking the ability to interact with Scs2p were utilized to examine the specific role(s) of the Opi1p-Scs2p interaction in the regulation of INO1 expression and overall lipid metabolism. Loss of the Opi1p-Scs2p interaction reduced INO1 expression and conferred inositol auxotrophy. Moreover, inositol depletion in strains lacking this interaction resulted in Opi1p being localized to sites of lipid droplet formation, coincident with increased synthesis of triacylglycerol. Supplementation of choline to inositol-depleted growth medium led to decreased TAG synthesis in all three strains. However, in strains lacking the Opi1p-Scs2p interaction, Opi1p remained in the nucleus, preventing expression of INO1. These data support the conclusion that a specific pool of phosphatidic acid, associated with lipid droplet formation in the perinuclear ER, is responsible for the initial rapid exit of Opi1p from the nucleus to the ER and is required for INO1 expression in the presence of choline. Moreover, the mitochondria-specific phospholipid, cardiolipin, was significantly reduced in both strains compromised for Opi1p-Scs2p interaction, indicating that this interaction is required for the transfer of phosphatidic acid from the ER to the mitochondria for cardiolipin synthesis.	[Gaspar, Maria L.; Chang, Yu-Fang; Jesch, Stephen A.; Aregullin, Manuel; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14853 USA; [Chang, Yu-Fang] Harvard Med Sch, Dept Syst Biol, Warren Alpert Bldg 412,200 Longwood Ave, Boston, MA 02115 USA	Cornell University; Harvard University; Harvard Medical School	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu			National Institutes of Health [GM-19629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019629, R37GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-19629 (to S. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008; Brachmann CB, 1998, YEAST, V14, P115; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chao JT, 2014, CELL, V158, P620, DOI 10.1016/j.cell.2014.06.033; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; CULBERTSON MR, 1975, GENETICS, V80, P23; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Di Bartolomeo F, 2017, BBA-MOL CELL BIOL L, V1862, P25, DOI 10.1016/j.bbalip.2016.09.007; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GREENBERG ML, 1982, GENETICS, V100, P19; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Han S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0075-3; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SAa H., 2005, CELL BIOL DYNAMICS Y, P105; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kannan M, 2015, TRAFFIC, V16, P123, DOI 10.1111/tra.12236; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luevano-Martinez LA, 2013, FUNGAL GENET BIOL, V60, P150, DOI 10.1016/j.fgb.2013.03.005; MANDERS EMM, 1992, J CELL SCI, V103, P857; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; TSUKAGOSHI Y, 1987, EUR J BIOCHEM, V169, P477, DOI 10.1111/j.1432-1033.1987.tb13635.x; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922; WEISS SB, 1958, J BIOL CHEM, V231, P53; Wilson JD, 2011, MOL BIOL CELL, V22, P1430, DOI 10.1091/mbc.E10-07-0559; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	72	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18713	18728		10.1074/jbc.M117.809970	http://dx.doi.org/10.1074/jbc.M117.809970			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924045	Green Published, hybrid			2022-12-26	WOS:000414958100027
J	Bessa, LM; Launay, H; Dujardin, M; Cantrelle, FX; Lippens, G; Landrieu, I; Schneider, R; Hanoulle, X				Bessa, Luiza M.; Launay, Helene; Dujardin, Marie; Cantrelle, Francois-Xavier; Lippens, Guy; Landrieu, Isabelle; Schneider, Robert; Hanoulle, Xavier			NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; nuclear magnetic resonance (NMR); protein dynamic; protein-protein interaction; RNA-protein interaction	MOLECULAR-WEIGHT PROTEINS; RELAXATION DISPERSION EXPERIMENTS; CRYSTAL-STRUCTURE; NONNUCLEOSIDE INHIBITORS; NONSTRUCTURAL PROTEIN; REPLICATION COMPARTMENT; VIRAL REPLICATION; STRUCTURAL BASIS; FUZZY COMPLEXES; METHYL-TROSY	Non-structural protein 5B (NS5B) is the RNA-dependent RNA polymerase that catalyzes replication of the hepatitis C virus (HCV) RNA genome and therefore is central for its life cycle. NS5B interacts with the intrinsically disordered domain 2 of NS5A (NS5A-D2), another essential multifunctional HCV protein that is required for RNA replication. As a result, these two proteins represent important targets for anti-HCV chemotherapies. Despite this importance and the existence of NS5B crystal structures, our understanding of the conformational and dynamic behavior of NS5B in solution and its relationship with NS5A-D2 remains incomplete. To address these points, we report the first detailed NMR spectroscopic study of HCV NS5B lacking its membrane anchor (NS5B(21)). Analysis of constructs with selective isotope labeling of the 1 methyl groups of isoleucine side chains demonstrates that, in solution, NS5B(21) is highly dynamic but predominantly adopts a closed conformation. The addition of NS5A-D2 leads to spectral changes indicative of binding to both allosteric thumb sites I and II of NS5B(21) and induces long-range perturbations that affect the RNA-binding properties of the polymerase. We compared these modifications with the short- and long-range effects triggered in NS5B(21) upon binding of filibuvir, an allosteric inhibitor. We demonstrate that filibuvir-bound NS5B(21) is strongly impaired in the binding of both NS5A-D2 and RNA. NS5A-D2 induces conformational and functional perturbations in NS5B similar to those triggered by filibuvir. Thus, our work highlights NS5A-D2 as an allosteric regulator of the HCV polymerase and provides new insight into the dynamics of NS5B in solution.	[Bessa, Luiza M.; Launay, Helene; Dujardin, Marie; Cantrelle, Francois-Xavier; Lippens, Guy; Landrieu, Isabelle; Schneider, Robert; Hanoulle, Xavier] Univ Lille, CNRS, UMR 8576, UGSF,Unite Glycobiol Struct & Fonct, Campus CNRS Haute Borne,50 Ave Halley, F-59000 Lille, France; [Launay, Helene] Univ Aix Marseille, CNRS, UMR 7258, INSERM,U1068,Inst Pauli Calmettes,CRCM, F-13273 Marseille, France; [Dujardin, Marie] Univ Lyon, CNRS, UMR 5086, MMSB, F-69367 Lyon, France; [Lippens, Guy] Univ Toulouse, INSA, CNRS, Lab Ingn Syst Biol & Procedes,INRA, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Schneider, R; Hanoulle, X (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF,Unite Glycobiol Struct & Fonct, Campus CNRS Haute Borne,50 Ave Halley, F-59000 Lille, France.	robert.schneider@univ-lille1.fr; xavier.hanoulle@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Hanoulle, Xavier/AAK-7236-2021; Landrieu, Isabelle/AAF-8495-2019; Schneider, Robert/C-1868-2013	Hanoulle, Xavier/0000-0002-3755-2680; Landrieu, Isabelle/0000-0002-4883-2637; Schneider, Robert/0000-0003-3279-5365; Lippens, Guy/0000-0002-8236-0901; cantrelle, francois-xavier/0000-0002-3413-5443; Launay, Helene/0000-0003-0639-2642; Bessa, Luiza/0000-0002-1993-3105	European Community; CNRS (IR RMN THC) [FR-3050]; University of Lille; Region Hauts-de-France (France); Pasteur Institute of Lille (IPL)	European Community(European Commission); CNRS (IR RMN THC); University of Lille; Region Hauts-de-France (France)(Region Hauts-de-France); Pasteur Institute of Lille (IPL)	The NMR facility was supported by the European Community, the CNRS (IR RMN THC, FR-3050), the University of Lille, the Region Hauts-de-France (France), and the Pasteur Institute of Lille (IPL).	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; [Anonymous], 2017, HEP C FACT SHEET; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Badillo A, 2017, BIOCHEMISTRY-US, V56, P3029, DOI 10.1021/acs.biochem.7b00212; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Boyce SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084808; Brass V, 2010, J VIROL, V84, P11580, DOI 10.1128/JVI.01519-10; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Caillet-Saguy C, 2011, J MOL BIOL, V414, P370, DOI 10.1016/j.jmb.2011.10.001; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Cho NJ, 2016, ACS CENTRAL SCI, V2, P456, DOI 10.1021/acscentsci.6b00112; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Davis BC, 2015, BIOPHYS J, V108, P1785, DOI 10.1016/j.bpj.2015.03.005; Davis BC, 2013, PROTEINS, V81, P40, DOI 10.1002/prot.24154; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Di Maio VC, 2014, ANTIMICROB AGENTS CH, V58, P2781, DOI 10.1128/AAC.02386-13; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dujardin M, 2015, J BIOL CHEM, V290, P19104, DOI 10.1074/jbc.M115.644419; Eastman KJ, 2017, MEDCHEMCOMM, V8, P796, DOI 10.1039/c6md00636a; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Eltahla AA, 2015, VIRUSES-BASEL, V7, P5206, DOI 10.3390/v7102868; Eltahla AA, 2014, ANTIMICROB AGENTS CH, V58, P7215, DOI 10.1128/AAC.03699-14; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hansen DF, 2010, J AM CHEM SOC, V132, P7589, DOI 10.1021/ja102090z; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Ishima R, 2005, J BIOMOL NMR, V32, P41, DOI 10.1007/s10858-005-3593-z; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Korzhnev DM, 2005, J AM CHEM SOC, V127, P15602, DOI 10.1021/ja054550e; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; Lam AM, 2014, ANTIMICROB AGENTS CH, V58, P6861, DOI 10.1128/AAC.03847-14; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li H, 2009, J MED CHEM, V52, P1255, DOI 10.1021/jm8014537; Li JW, 2016, J BIOL CHEM, V291, P10067, DOI 10.1074/jbc.M115.708354; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Ngure M, 2016, ACS INFECT DIS, V2, P839, DOI 10.1021/acsinfecdis.6b00143; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Ollerenshaw JE, 2003, MAGN RESON CHEM, V41, P843, DOI 10.1002/mrc.1256; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Quezada Elizabeth M, 2009, Open Biochem J, V3, P39, DOI 10.2174/1874091X00903010039; Ramiere C, 2014, J VIROL, V88, P3246, DOI 10.1128/JVI.02862-13; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Ranjith-Kumar CT, 2006, RNA, V12, P303, DOI 10.1261/rna.2163106; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rice CM, 2014, NATURE, V510, P43, DOI 10.1038/510043a; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Schlutter J, 2011, NATURE, V474, pS5, DOI 10.1038/474S5a; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Scrima N, 2012, J VIROL, V86, P7107, DOI 10.1128/JVI.00459-12; Sesmero E, 2015, VIRUSES-BASEL, V7, P3974, DOI 10.3390/v7072808; Shi ST, 2009, ANTIMICROB AGENTS CH, V53, P2544, DOI 10.1128/AAC.01599-08; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Solyom Z, 2015, BIOPHYS J, V109, P1483, DOI 10.1016/j.bpj.2015.06.040; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Troke PJF, 2012, ANTIMICROB AGENTS CH, V56, P1331, DOI 10.1128/AAC.05611-11; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Winquist J, 2013, ANTIVIR RES, V97, P356, DOI 10.1016/j.antiviral.2012.12.027; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yi GH, 2012, ANTIMICROB AGENTS CH, V56, P830, DOI 10.1128/AAC.05438-11	104	5	5	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18024	18043		10.1074/jbc.M117.813766	http://dx.doi.org/10.1074/jbc.M117.813766			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28912275	Green Published, hybrid			2022-12-26	WOS:000414458200004
J	Fortini, F; Dalla Sega, FV; Caliceti, C; Aquila, G; Pannella, M; Pannuti, A; Miele, L; Ferrari, R; Rizzo, P				Fortini, Francesca; Dalla Sega, Francesco Vieceli; Caliceti, Cristiana; Aquila, Giorgio; Pannella, Micaela; Pannuti, Antonio; Miele, Lucio; Ferrari, Roberto; Rizzo, Paola			Estrogen receptor -dependent Notch1 activation protects vascular endothelium against tumor necrosis factor (TNF)-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; endothelial dysfunction; estrogen; estrogen receptor; Notch pathway; tumor necrosis factor (TNF); Akt; ER; Notch1	NF-KAPPA-B; CARDIOVASCULAR-DISEASE; CELL APOPTOSIS; THERAPEUTIC TARGET; BREAST-CANCER; TNF-ALPHA; INFLAMMATION; PATHWAY; ATHEROSCLEROSIS; ANGIOGENESIS	Unlike age-matched men, premenopausal women benefit from cardiovascular protection. Estrogens protect against apoptosis of endothelial cells (ECs), one of the hallmarks of endothelial dysfunction leading to cardiovascular disorders, but the underlying molecular mechanisms remain poorly understood. The inflammatory cytokine TNF causes EC apoptosis while dysregulating the Notch pathway, a major contributor to EC survival. We have previously reported that 17-estradiol (E2) treatment activates Notch signaling in ECs. Here, we sought to assess whether in TNF-induced inflammation Notch is involved in E2-mediated protection of the endothelium. We treated human umbilical vein endothelial cells (HUVECs) with E2, TNF, or both and found that E2 counteracts TNF-induced apoptosis. When Notch1 was inhibited, this E2-mediated protection was not observed, whereas ectopic overexpression of Notch1 diminished TNF-induced apoptosis. Moreover, TNF reduced the levels of active Notch1 protein, which were partially restored by E2 treatment. Moreover, siRNA-mediated knockdown of estrogen receptor (ER), but not ER, abolished the effect of E2 on apoptosis. Additionally, the E2-mediated regulation of the levels of active Notch1 was abrogated after silencing ER. In summary, our results indicate that E2 requires active Notch1 through a mechanism involving ER to protect the endothelium in TNF-induced inflammation. These findings could be relevant for assessing the efficacy and applicability of menopausal hormone treatment, because they may indicate that in women with impaired Notch signaling, hormone therapy might not effectively protect the endothelium.	[Fortini, Francesca; Dalla Sega, Francesco Vieceli; Aquila, Giorgio; Ferrari, Roberto] Univ Ferrara, Dept Med Sci, I-44121 Ferrara, Italy; [Rizzo, Paola] Univ Ferrara, Dept Morphol Surg & Expt Med, Via Fossato Mortara 64-B, I-44121 Ferrara, Italy; [Caliceti, Cristiana] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy; [Caliceti, Cristiana] Univ Bologna, Interdept Ctr Ind Res Energy & Environm CIRI EA, I-40126 Bologna, Italy; [Caliceti, Cristiana] Natl Inst Biostruct & Biosyst INBB, I-00136 Rome, Italy; [Pannella, Micaela] Univ Bologna, Fdn IRET, Interdept Ctr Ind Res & Life Sci CIRI SDV, I-40064 Ozzano Dell Emilia, BO, Italy; [Pannuti, Antonio; Miele, Lucio] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA 70112 USA; [Pannuti, Antonio; Miele, Lucio] Louisiana Canc Res Consortium, New Orleans, LA 70112 USA; [Ferrari, Roberto; Rizzo, Paola] ES Hlth Sci Fdn, Maria Cecilia Hosp, GVM Care & Res, I-48033 Cotignola, Italy; [Ferrari, Roberto; Rizzo, Paola] Univ Ferrara, Lab Technol Adv Therapies LTTA, I-44121 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Bologna; University of Bologna; University of Bologna; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Maria Cecilia Hospital; University of Ferrara	Rizzo, P (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Via Fossato Mortara 64-B, I-44121 Ferrara, Italy.	rzzpla@unife.it	FERRARI, ROBERTO/ABD-5169-2020; Aquila, Giorgio/X-4412-2019; Vieceli Dalla Sega, Francesco/GQZ-1869-2022	Aquila, Giorgio/0000-0002-3936-8895; rizzo, paola/0000-0001-7174-9674; Ferrari, Roberto/0000-0003-2046-9175; Miele, Lucio/0000-0002-5853-7287	NIGMS NIH HHS [U54 GM104940] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnabas O, 2013, J GERIATR CARDIOL, V10, P377, DOI 10.3969/j.issn.1671-5411.2013.04.008; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Billon-Gales A, 2009, CIRCULATION, V120, P2567, DOI 10.1161/CIRCULATIONAHA.109.898445; Briot A, 2015, J EXP MED, V212, P2147, DOI 10.1084/jem.20150603; Caliceti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071440; Chakrabarti S, 2016, METHODS MOL BIOL, V1366, P503, DOI 10.1007/978-1-4939-3127-9_39; Dabral S, 2016, EUR RESPIR J, V48, P1137, DOI 10.1183/13993003.00773-2015; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Florian M, 2008, STEROIDS, V73, P47, DOI 10.1016/j.steroids.2007.08.010; Girdler F, 2000, BREAST, V9, P194, DOI 10.1054/brst.2000.0203; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Hatsumi T, 2006, EXP BIOL MED, V231, P311; Jensen HA, 2016, EXPERT REV CARDIOVAS, V14, P1021, DOI 10.1080/14779072.2016.1207527; Karsan A, 1998, TRENDS CARDIOVAS MED, V8, P19, DOI 10.1016/S1050-1738(97)00126-6; Kim KH, 2014, MOL CELL ENDOCRINOL, V389, P65, DOI 10.1016/j.mce.2014.02.001; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Koga M, 2004, BIOCHEM BIOPH RES CO, V324, P321, DOI 10.1016/j.bbrc.2004.09.060; Koh KK, 2003, INT J CARDIOL, V87, P1; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Lin CC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0165-8; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Nichols M, 2014, EUR HEART J, V35, P2929, DOI 10.1093/eurheartj/ehu378; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Pannella M, 2016, J CELL PHYSIOL, V231, P2700, DOI 10.1002/jcp.25373; Pedrosa AR, 2015, ARTERIOSCL THROM VAS, V35, P1134, DOI 10.1161/ATVBAHA.114.304741; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rizzo P, 2013, EUR HEART J, V34, P2504, DOI 10.1093/eurheartj/ehs141; Rostama B, 2014, VASC PHARMACOL, V63, P97, DOI 10.1016/j.vph.2014.10.003; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Sites CK, 2002, FERTIL STERIL, V77, P128, DOI 10.1016/S0015-0282(01)02934-X; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Smirnova NF, 2015, CIRC RES, V117, P770, DOI 10.1161/CIRCRESAHA.115.306416; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Sobrino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008242; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Sudoh N, 2001, CIRCULATION, V103, P724; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Villablanca AC, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-214; Villablanca AC, 2009, J CARDIOVASC TRANSL, V2, P289, DOI 10.1007/s12265-009-9103-z; Walshe TE, 2011, INVEST OPHTH VIS SCI, V52, P4472, DOI 10.1167/iovs.10-7061; Wang X.J., 2010, J INEQUAL APPL, V2010, DOI DOI 10.1155/2010/465915; Yang XP, 2011, CURR OPIN NEPHROL HY, V20, P133, DOI 10.1097/MNH.0b013e3283431921; Zhou Z, 2008, AM J PHYSIOL-RENAL, V295, pF932, DOI 10.1152/ajprenal.00066.2008	58	39	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18178	18191		10.1074/jbc.M117.790121	http://dx.doi.org/10.1074/jbc.M117.790121			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28893903	hybrid, Green Published			2022-12-26	WOS:000414458200016
J	Blumer, T; Coto-Llerena, M; Duong, FHT; Heim, MH				Blumer, Tanja; Coto-Llerena, Mairene; Duong, Francois H. T.; Heim, Markus H.			SOCS1 is an inducible negative regulator of interferon lambda (IFN-lambda)-induced gene expression in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; IFN-LAMBDA; STIMULATED GENES; HCV CLEARANCE; CYTOKINE; ALPHA; RECEPTOR; CELLS; IFN-LAMBDA-4; HEPATOCYTES	Type I (alpha and beta) and type III (lambda) IFNs are induced upon viral infection through host sensory pathways that activate IFN regulatory factors (IRFs) and nuclear factor kappa B. Secreted IFNs induce autocrine and paracrine signaling through the JAK-STAT pathway, leading to the transcriptional induction of hundreds of IFN-stimulated genes, among them sensory pathway components such as cGAS, STING, RIG-I, MDA5, and the transcription factor IRF7, which enhance the induction of IFN-alpha s and IFN-alpha s. This positive feedback loop enables a very rapid and strong host response that, at some point, has to be controlled by negative regulators to maintain tissue homeostasis. Type I IFN signaling is controlled by the inducible negative regulators suppressor of cytokine signaling 1 (SOCS1), SOCS3, and ubiquitin-specific peptidase 18 (USP18). The physiological role of these proteins in IFN-gamma signaling has not been clarified. Here we used knockout cell lines and mice to show that IFN-lambda signaling is regulated by SOCS1 but not by SOCS3 or USP18. These differences were the basis for the distinct kinetic properties of type I and III IFNs. We found that IFN-alpha signaling is transient and becomes refractory after hours, whereas IFN-lambda provides a long-lasting IFN-stimulated gene induction.	[Blumer, Tanja; Coto-Llerena, Mairene; Duong, Francois H. T.; Heim, Markus H.] Univ Basel, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland; [Blumer, Tanja; Coto-Llerena, Mairene; Duong, Francois H. T.; Heim, Markus H.] Univ Hosp Basel, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Heim, MH (corresponding author), Univ Basel, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.	markus.heim@unibas.ch	Heim, Markus/A-7526-2008	Heim, Markus/0000-0002-7523-4894; DUONG, Hong Tuan Francois/0000-0003-0928-2123	Swiss National Science Foundation [310030B_147089, 310030_166202]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 310030B_147089 and 310030_166202 (to M. H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Heim MH, 2016, J HEPATOL, V65, pS22, DOI 10.1016/j.jhep.2016.07.037; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Koutsoudakis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023587; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lauber C, 2015, GENES IMMUN, V16, P414, DOI 10.1038/gene.2015.23; Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506; Liu B.L., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1186/S40467-015-0036-6; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Wei HT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003845; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	39	35	36	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17928	17938		10.1074/jbc.M117.788877	http://dx.doi.org/10.1074/jbc.M117.788877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28900038	hybrid, Green Published			2022-12-26	WOS:000414013000028
J	Lyman, KA; Han, Y; Heuermann, RJ; Cheng, XY; Kurz, JE; Lyman, RE; Van Veldhoven, PP; Chetkovich, DM				Lyman, Kyle A.; Han, Ye; Heuermann, Robert J.; Cheng, Xiangying; Kurz, Jonathan E.; Lyman, Reagan E.; Van Veldhoven, Paul P.; Chetkovich, Dane M.			Allostery between two binding sites in the ion channel subunit TRIP8b confers binding specificity to HCN channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; PEROXISOME-TARGETING SIGNAL; CA1 PYRAMIDAL NEURONS; IMPORT RECEPTOR; MATRIX PROTEINS; TERMINAL DOMAIN; PEX5; PTS1; CAMP; LOCALIZATION	Tetratricopeptide repeat (TPR) domains are ubiquitous structural motifs that mediate protein-protein interactions. For example, the TPR domains in the peroxisomal import receptor PEX5 enable binding to a range of type 1 peroxisomal targeting signal motifs. A homolog of PEX5, tetratricopeptide repeatcontaining Rab8b-interacting protein (TRIP8b), binds to and functions as an auxiliary subunit of hyperpolarization-activated cyclic nucleotide (HCN)-gated channels. Given the similarity between TRIP8b and PEX5, this difference in function raises the question of what mechanism accounts for their binding specificity. In this report, we found that the cyclic nucleotidebinding domain and the C terminus of the HCN channel are critical for conferring specificity to TRIP8b binding. We show that TRIP8b binds the HCN cyclic nucleotide-binding domain through a 37-residue domain and the HCN C terminus through the TPR domains. Using a combination of fluorescence polarization-and co-immunoprecipitation-based assays, we establish that binding at either site increases affinity at the other. Thus, allosteric coupling of the TRIP8b TPR domains both promotes binding to HCN channels and limits binding to type 1 peroxisomal targeting signal substrates. These results raise the possibility that other TPR domains may be similarly influenced by allosteric mechanisms as a general feature of protein-protein interactions.	[Lyman, Kyle A.; Han, Ye; Heuermann, Robert J.; Cheng, Xiangying; Lyman, Reagan E.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Kurz, Jonathan E.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, Campus Gasthuisberg, B-3000 Leuven, Belgium	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; KU Leuven	Chetkovich, DM (corresponding author), 303 E Chicago Ave,Ward Bldg 10-201, Chicago, IL 60611 USA.	d-chetkovich@northwestern.edu	Chetkovich, Dane/AAV-5457-2021; , Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564; Kurz, Jonathan/0000-0002-2259-4263	NCI, National Institutes of Health [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150, UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104471, T32MH067564, R01MH106511, R21MH113262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Structural Biology facility at Northwestern University and the Northwestern University Center for Advanced Microscopy are generously supported by NCI, National Institutes of Health CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center.	Amery L, 1998, BIOCHEM J, V336, P367, DOI 10.1042/bj3360367; Amery L, 2001, BIOCHEM J, V357, P635, DOI 10.1042/0264-6021:3570635; Apanasets O, 2014, TRAFFIC, V15, P94, DOI 10.1111/tra.12129; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; DeBerg HA, 2015, STRUCTURE, V23, P734, DOI 10.1016/j.str.2015.02.007; Effelsberg D, 2016, J CELL SCI, V129, P4057; Emmanouilidis L, 2016, BBA-MOL CELL RES, V1863, P804, DOI 10.1016/j.bbamcr.2015.09.034; Fodor K, 2015, TRAFFIC, V16, P85, DOI 10.1111/tra.12238; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Fransen M, 2008, BBA-MOL CELL RES, V1783, P864, DOI 10.1016/j.bbamcr.2008.02.013; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hagen S, 2015, J BIOL CHEM, V290, P26610, DOI 10.1074/jbc.M115.657973; Han Y, 2017, MOL PSYCHIATR, V22, P458, DOI 10.1038/mp.2016.99; Han Y., 2016, JOVE-J VIS EXP; Han Y, 2015, J BIOMOL SCREEN, V20, P1124, DOI 10.1177/1087057115589590; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Harper CC, 2003, J BIOL CHEM, V278, P7897, DOI 10.1074/jbc.M206651200; Hu L, 2013, J GEN PHYSIOL, V142, P599, DOI 10.1085/jgp.201311013; Lanyon-Hogg T, 2014, FEBS LETT, V588, P2223, DOI 10.1016/j.febslet.2014.05.038; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lyman KA, 2017, EXPERT OPIN THER TAR, V21, P235, DOI 10.1080/14728222.2017.1287899; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Maynard EL, 2004, PROTEINS, V55, P856, DOI 10.1002/prot.20112; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Shin M, 2006, BRAIN RES, V1083, P14, DOI 10.1016/j.brainres.2006.01.102; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Yifrach E, 2016, J CELL SCI, V129, P4067, DOI 10.1242/jcs.195255; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	51	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17718	17730		10.1074/jbc.M117.802256	http://dx.doi.org/10.1074/jbc.M117.802256			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887304	Green Published, hybrid			2022-12-26	WOS:000414013000012
J	Petrara, MR; Cattelan, AM; Sasset, L; Freguja, R; Carmona, F; Sanavia, S; Zanchetta, M; Del Bianco, P; De Rossi, A				Petrara, Maria Raffaella; Cattelan, Anna Maria; Sasset, Lolita; Freguja, Riccardo; Carmona, Francesco; Sanavia, Silvia; Zanchetta, Marisa; Del Bianco, Paola; De Rossi, Anita			Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus	PLOS ONE			English	Article							PROTEASE INHIBITOR MONOTHERAPY; HIV-1-INFECTED CHILDREN; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; PLASMA-LEVELS; B-CELLS; INFECTION; LOAD; DNA; DARUNAVIR/RITONAVIR	Objectives Although monotherapy (mART) effectiveness in maintaining viral suppression and CD4 cell count has been extensively examined in HIV-1-infected patients, its impact on HIV-1 reservoir, immune activation, microbial translocation and co-infection with Epstein-Barr Virus (EBV) is unclear. Methods This retrospective study involved 32 patients who switched to mART; patients were studied at baseline, 48 and 96 weeks after mART initiation. Thirty-two patients who continued combined antiretroviral therapy (cART) over the same period of time were included in the study. Markers of HIV-1 reservoir (HIV-1 DNA and intracellular HIV-1 RNA) were quantified by real-time PCR. Markers of T-(CD3(+)CD8(+)CD38(+)) and B-(CD19(+)CD80/86(+) and CD19(+)CD10-CD21(low)CD27(+)) cell activation were evaluated by flow cytometry. Plasma levels of microbial translocation markers were quantified by real-time PCR (16S ribosomal DNA and mitochondrial [mt] DNA) or by ELISA (LPS and sCD14). EBV was typed and quantified by multiplex real-time PCR. Results At baseline, no differences were found between mART and cART groups. Three (10%) mART-treated patients had a virological failure vs none in the cART group. Levels of HIV-1 DNA, intracellular HIV-1 RNA and EBV-DNA remained stable in the mART group, while decreased significantly in the cART group. Percentages of T-and B-activated cells significantly increased in the mART-treated patients, while remained at low levels in the cART-treated ones (p = 0.014 and p<0.001, respectively). Notably, levels of mtDNA remained stable in the cART group, but significantly rose in the mART one (p<0.001). Conclusions Long-term mART is associated with higher levels of T-and B-cell activation and, conversely to cART, does not reduce the size of HIV-1 reservoir and EBV co-infection.	[Petrara, Maria Raffaella; Freguja, Riccardo; De Rossi, Anita] Univ Padua, Sect Oncol & Immunol, Dept Surg Oncol & Gastroenterol, AIDS Reference Ctr, Padua, Italy; [Cattelan, Anna Maria] Azienda Osped, Div Infect & Trop Dis, Padua, Italy; [Cattelan, Anna Maria] Univ Padua, Padua, Italy; [Sasset, Lolita] Azienda Osped Rovigo, Div Infect Dis, Rovigo, Italy; [Carmona, Francesco; Sanavia, Silvia; Zanchetta, Marisa; Del Bianco, Paola; De Rossi, Anita] IRCCS, IOV, Padua, Italy	University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; ULSS 5 Polesana; Ospedale di Rovigo; IRCCS Istituto Oncologico Veneto (IOV)	De Rossi, A (corresponding author), Univ Padua, Sect Oncol & Immunol, Dept Surg Oncol & Gastroenterol, AIDS Reference Ctr, Padua, Italy.; De Rossi, A (corresponding author), IRCCS, IOV, Padua, Italy.	anita.derossi@unipd.it	De Rossi, Anita/Q-4845-2019; CATTELAN, ANNA MARIA/AAL-3654-2020; Petrara, Maria Raffaella/AAB-4806-2019; De Rossi, A./L-3128-2015; Del Bianco, Paola/F-4655-2014	De Rossi, Anita/0000-0001-6435-7509; CATTELAN, ANNA MARIA/0000-0003-2869-2945; Petrara, Maria Raffaella/0000-0003-3609-6107; De Rossi, A./0000-0001-6435-7509; Del Bianco, Paola/0000-0002-6597-0265	Associazione Italiana per la Ricerca sul Cancro [IG-14258, IG-19112]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by Associazione Italiana per la Ricerca sul Cancro, grant no. IG-14258 and grant no. IG-19112.	Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Arenas-Pinto A, 2016, CLIN INFECT DIS, V63, P257, DOI 10.1093/cid/ciw279; Arribas JR, 2016, HIV MED, V17, P358, DOI 10.1111/hiv.12348; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Avettand-Fenoel V, 2010, J ANTIMICROB CHEMOTH, V65, P2212, DOI 10.1093/jac/dkq282; BENMARZOUKHIDALGO, 2015, MEDICINE, V94, DOI DOI 10.1097/MD.0000000000000781; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burighel N, 2006, HAEMATOL-HEMATOL J, V91, P244; Castagna A, 2014, AIDS, V28, P2269, DOI [10.1097/QAD.000000, 10.1097/QAD.0000000000000407]; Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002; Cossarizza A, 2011, MITOCHONDRION, V11, P750, DOI 10.1016/j.mito.2011.06.005; Costenaro P, 2014, J CLIN MICROBIOL, V52, P2665, DOI 10.1128/JCM.00961-14; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Engels EA, 2010, JAIDS-J ACQ IMM DEF, V54, P78, DOI 10.1097/01.qai.0000371677.48743.8d; Freguja R, 2011, CLIN EXP IMMUNOL, V164, P373, DOI 10.1111/j.1365-2249.2011.04383.x; Gaidano G, 1995, ADV CANCER RES, V67, P113, DOI 10.1016/S0065-230X(08)60712-5; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Lambert-Niclot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041390; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Marks MA, 2013, AIDS, V27, P469, DOI 10.1097/QAD.0b013e32835c1333; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Murray AJ, 2016, J IMMUNOL, V197, P407, DOI 10.4049/jimmunol.1600343; Ometto L, 2002, AIDS, V16, P839, DOI 10.1097/00002030-200204120-00003; Paton NI, 2015, LANCET HIV, V2, pE417, DOI 10.1016/S2352-3018(15)00176-9; Petrara MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00311; Petrara MR, 2014, J INFECT DIS, V210, P392, DOI 10.1093/infdis/jiu099; Petrara MR, 2012, J CLIN VIROL, V53, P195, DOI 10.1016/j.jcv.2011.12.013; Righetti E, 2002, AIDS, V16, P63, DOI 10.1097/00002030-200201040-00009; Torres-Cornejo A, 2014, AIDS, V28, P201, DOI 10.1097/QAD.0000000000000060; Tran TA, 2015, J ANTIMICROB CHEMOTH, V70, P2627, DOI 10.1093/jac/dkv138; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185128	10.1371/journal.pone.0185128	http://dx.doi.org/10.1371/journal.pone.0185128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926641	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600070
J	Kim, Y; Wu, AG; Jaja-Chimedza, A; Graf, BL; Waterman, C; Verzi, MP; Raskin, I				Kim, Youjin; Wu, Alex G.; Jaja-Chimedza, Asha; Graf, Brittany L.; Waterman, Carrie; Verzi, Michael P.; Raskin, Ilya			Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; MOUSE MODEL; PHENETHYL ISOTHIOCYANATE; OXIDATIVE STRESS; CLINICAL-ASPECTS; GENE-EXPRESSION; OLEIFERA LEAVES; SULFORAPHANE	Moringa (Moringa oleifera Lam.) seed extract (MSE) has anti-inflammatory and antioxidant activities. We investigated the effects of MSE enriched in moringa isothiocyanate-1 (MIC-1), its putative bioactive, on ulcerative colitis (UC) and its anti-inflammatory/antioxidant mechanism likely mediated through Nrf2-signaling pathway. Dextran sulfate sodium (DSS)-induced acute (n = 8/group; 3% DSS for 5 d) and chronic (n = 6/group; cyclic rotations of 2.5% DSS/water for 30 d) UC was induced in mice that were assigned to 4 experimental groups: healthy control (water/vehicle), disease control (DSS/vehicle), MSE treatment (DSS/MSE), or 5-aminosalicyic acid (5-ASA) treatment (positive control; DSS/5-ASA). Following UC induction, water (vehicle), 150 mg/kg MSE, or 50 mg/kg 5-ASA were orally administered for 1 or 2 wks. Disease activity index (DAI), spleen/colon sizes, and colonic histopathology were measured. From colon and/or fecal samples, pro-inflammatory biomarkers, tight-junction proteins, and Nrf2-mediated enzymes were analyzed at protein and/or gene expression levels. Compared to disease control, MSE decreased DAI scores, and showed an increase in colon lengths and decrease in colon weight/length ratios in both UC models. MSE also reduced colonic inflammation/damage and histopathological scores (modestly) in acute UC. MSE decreased colonic secretions of pro-inflammatory keratinocyte-derived cytokine (KC), tumor necrosis factor (TNF)-alpha, nitric oxide (NO), and myeloperoxidase (MPO) in acute and chronic UC; reduced fecal lipocalin-2 in acute UC; downregulated gene expression of pro-inflammatory interleukin (IL)-1, IL-6, TNF-alpha, and inducible nitric oxide synthase (iNOS) in acute UC; upregulated expression of claudin-1 and ZO-1 in acute and chronic UC; and upregulated GSTP1,an Nrf2-mediated phase II detoxifying enzyme, in chronic UC. MSE was effective in mitigating UC symptoms and reducing UC-induced colonic pathologies, likely by suppressing proinflammatory biomarkers and increasing tight-junction proteins. This effect is consistent with Nrf2-mediated anti-inflammatory/antioxidant signaling pathway documented for other isothiocyanates similar to MIC-1. Therefore, MSE, enriched with MIC-1, may be useful in prevention and treatment of UC.	[Kim, Youjin] Nutrasorb LLC, Freehold, NJ 07728 USA; [Kim, Youjin; Jaja-Chimedza, Asha; Graf, Brittany L.; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA; [Wu, Alex G.; Verzi, Michael P.] Rutgers State Univ, Dept Genet, Piscataway Township, NJ USA; [Wu, Alex G.; Verzi, Michael P.] Rutgers State Univ, Human Genet Inst New Jersey, Piscataway Township, NJ USA; [Waterman, Carrie] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Davis	Kim, Y (corresponding author), Nutrasorb LLC, Freehold, NJ 07728 USA.; Kim, Y (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.	youjin@nutrasorb.com			National Institute of Health National Center for Complementary and Integrative Health (NIH-NCCIH) [5R43AT008628-02]; NIH-NCCIH [P50 AT002776-06]; NIH Office of Dietary Supplements (NIH-ODS); Botanical Dietary Supplements Research Center (BDSRC) of Pennington Biomedical Research Center; NIH training grant [T32: 5T32AT004094]; FOGARTY INTERNATIONAL CENTER [K01TW009987] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT004094, P50AT002776, R43AT008628] Funding Source: NIH RePORTER	National Institute of Health National Center for Complementary and Integrative Health (NIH-NCCIH); NIH-NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Dietary Supplements (NIH-ODS); Botanical Dietary Supplements Research Center (BDSRC) of Pennington Biomedical Research Center; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	YK salary was paid by a SBIR grant # 5R43AT008628-02 from the National Institute of Health National Center for Complementary and Integrative Health (NIH-NCCIH), funding Nutrasorb, LLC. IR receives consulting income from Nutrasorb, LLC. IR was partially funded by a grant # 2-P50 AT002776-06 from the NIH-NCCIH and NIH Office of Dietary Supplements (NIH-ODS), funding the Botanical Dietary Supplements Research Center (BDSRC) of Pennington Biomedical Research Center, and AJ by an NIH training grant (# T32: 5T32AT004094). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bennett RN, 2003, J AGR FOOD CHEM, V51, P3546, DOI 10.1021/jf0211480; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Boyanapalli SSS, 2014, CHEM RES TOXICOL, V27, P2036, DOI 10.1021/tx500234h; Brunelli D, 2010, BIOCHEM PHARMACOL, V79, P1141, DOI 10.1016/j.bcp.2009.12.008; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cheenpracha S, 2010, BIOORGAN MED CHEM, V18, P6598, DOI 10.1016/j.bmc.2010.03.057; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Choi K, 2011, GASTROENTEROLOGY, V141, P1293, DOI 10.1053/j.gastro.2011.06.074; Edalat M, 2004, HISTOCHEM CELL BIOL, V122, P151, DOI 10.1007/s00418-004-0688-7; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fahey J. W., 2005, TREES LIFE J, V1, P1, DOI DOI 10.1201/9781420039078.CH12; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Frink M, 2007, SHOCK, V28, P576, DOI 10.1097/shk.0b013e31814b8e0d; Fuentes Francisco, 2015, Curr Pharmacol Rep, V1, P179; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Islam MS, 2008, BRIT J PHARMACOL, V154, P812, DOI 10.1038/bjp.2008.137; Jaja-Chimedza A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182658; Jones DT, 2008, AM J GASTROENTEROL, V103, P2382, DOI 10.1111/j.1572-0241.2008.01999.x; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lean QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128453; Leone A, 2015, INT J MOL SCI, V16, P12791, DOI 10.3390/ijms160612791; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Lirk Philipp, 2002, Current Drug Targets - Inflammation and Allergy, V1, P89, DOI 10.2174/1568010023344913; Lu M, 2016, MED RES REV, P1; Maillard M. H., 2010, INFLAMM BOWEL DIS, P119; Mbikay M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00024; Mikhailov TA, 2009, WORLD J GASTROENTERO, V15, P270, DOI 10.3748/wjg.15.270; Murphy CT, 2010, CLIN EXP IMMUNOL, V162, P188, DOI 10.1111/j.1365-2249.2010.04234.x; Murthy S, 2002, INFLAMM RES, V51, P522, DOI 10.1007/PL00012423; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Saxena Arpit, 2014, J Tradit Complement Med, V4, P203, DOI 10.4103/2225-4110.139111; Schulze HA, 2008, GENES IMMUN, V9, P240, DOI 10.1038/gene.2008.11; Stallhofer J, 2015, INFLAMM BOWEL DIS, V21, P2327, DOI 10.1097/MIB.0000000000000515; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Tumer TB, 2015, J AGR FOOD CHEM, V63, P1505, DOI 10.1021/jf505014n; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wagner AE, 2013, J NUTR BIOCHEM, V24, P2085, DOI 10.1016/j.jnutbio.2013.07.009; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Waterman C, 2014, PHYTOCHEMISTRY, V103, P114, DOI 10.1016/j.phytochem.2014.03.028; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	55	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184709	10.1371/journal.pone.0184709	http://dx.doi.org/10.1371/journal.pone.0184709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922365	Green Submitted, gold, Green Published			2022-12-26	WOS:000411059300023
J	Rose, J; Rillich, J; Stevenson, PA				Rose, Jacqueline; Rillich, Jan; Stevenson, Paul A.			Chronic social defeat induces long-term behavioral depression of aggressive motivation in an invertebrate model system	PLOS ONE			English	Article							GRYLLUS-BIMACULATUS ORTHOPTERA; FIELD CRICKET; AGONISTIC BEHAVIOR; EXPERIENCE; OCTOPAMINE; FIGHT; STRESS; COMPETITION; ENCOUNTERS; MODULATION	Losing a fight against a conspecific male (social defeat) induces a period of suppressed aggressiveness and general behaviour, often with symptoms common to human psychiatric disorders. Agonistic experience is also discussed as a potential cause of consistent, behavioral differences between individuals (animal "personality"). In non-mammals, however, the impact of single agonistic encounters typically last only hours, but then again studies of repeated intermittent defeat (chronic social defeat) are seldom. We report the effect of chronic social defeat in adult male crickets (Gryllus bimaculatus), for which all known behavioral effects of defeat last only 3 h. Firstly, after 48 h social isolation, crickets that experienced 5 defeats at 24 h intervals against the same, weight-matched opponent exhibited suppressed aggressiveness lasting > 24 h, which was still evident when the animals were matched against an unfamiliar opponent at the last trial. Secondly, this longer-term depression of aggression also occurred in 48 h isolated crickets that lost 6 fights at 1 h intervals against unfamiliar opponents at each trial. Thirdly, crickets isolated as larvae until adult maturity (> 16 days) were significantly more aggressive, and less variable in their aggressiveness at their very first fight than 48 h isolates, and also significantly more resilient to the effects of chronic social defeat. We conclude that losing an aggressive encounter in crickets has a residual effect, lasting at least 24 h, that accumulates when repeated defeats are experienced, and leads to a prolonged depression of aggressive motivation in subordinates. Furthermore, our data indicate that social interactions between young adults and possibly larvae can have even longer, possibly lifelong influences on subsequent behavior. Social subjugation is thus likely to be a prime determinant of inter-individual behavioral differences in crickets. Our work also opens new avenues for investigating proximate mechanisms underlying depression-like phenomena.	[Rose, Jacqueline; Rillich, Jan; Stevenson, Paul A.] Univ Leipzig, Inst Biol, Talstr, Leipzig, Germany	Leipzig University	Stevenson, PA (corresponding author), Univ Leipzig, Inst Biol, Talstr, Leipzig, Germany.	stevenson@rz.uni-leipzig.de	Stevenson, Paul A/A-2048-2010	Stevenson, Paul Anthony/0000-0002-3232-5155	Deutsche Forschungsgemeinschaft [STE 714/4-1];  [RI 2728/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was funded by the Deutsche Forschungsgemeinschaft, grant STE 714/4-1; J. Rillich is funded by grant RI 2728/2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, J EXP BIOL, V198, P1691; ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; Adamo SA, 2013, J EXP BIOL, V216, P4608, DOI 10.1242/jeb.094482; Adamo SA, 2011, HORM BEHAV, V60, P478, DOI 10.1016/j.yhbeh.2011.07.015; Adamo Shelley A., 2008, ISJ, V5, P12; Alexander R.D., 1961, BEHAVIOUR, V17, P130; BARNARD CJ, 1979, J THEOR BIOL, V81, P65, DOI 10.1016/0022-5193(79)90081-X; Breithaupt T, 2002, J EXP BIOL, V205, P1221; Briffa M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1007; Carnevali L, 2012, PHYSIOL BEHAV, V106, P142, DOI 10.1016/j.physbeh.2012.01.022; Chichinadze K, 2014, BIOL REV, V89, P1005, DOI 10.1111/brv.12091; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; Dreier S, 2007, BIOL LETTERS, V3, P459, DOI 10.1098/rsbl.2007.0224; Ghosal K, 2010, ARCH INSECT BIOCHEM, V74, P38, DOI 10.1002/arch.20360; Ghosal K, 2009, J EXP BIOL, V212, P2044, DOI 10.1242/jeb.026682; Hack MA, 1997, BEHAV ECOL, V8, P28, DOI 10.1093/beheco/8.1.28; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Hollis F, 2014, ILAR J, V55, P221, DOI 10.1093/ilar/ilu002; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Iwasaki M, 2008, COMP BIOCHEM PHYS A, V149, P306, DOI 10.1016/j.cbpa.2008.01.008; Iwasaki M, 2006, ZOOL SCI, V23, P863, DOI 10.2108/zsj.23.863; Khazraie K, 1999, BEHAV PROCESS, V44, P341, DOI 10.1016/S0376-6357(98)00058-8; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Kortet R, 2007, BIOL J LINN SOC, V91, P475, DOI 10.1111/j.1095-8312.2007.00812.x; KOYAMA S, 1993, J ETHOL, V11, P117, DOI 10.1007/BF02350045; PARMIGIANI S, 1983, BEHAV PROCESS, V8, P45, DOI 10.1016/0376-6357(83)90042-6; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Rillich J, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00050; Rillich J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00095; Rillich J, 2014, HORM BEHAV, V66, P696, DOI 10.1016/j.yhbeh.2014.09.012; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; Rose J, 2017, ANIM BEHAV, V123, P441, DOI 10.1016/j.anbehav.2016.11.021; Rudin FS, 2017, BEHAV ECOL, V28, P270, DOI 10.1093/beheco/arw151; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Sayed S, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0623-8; Sheehan MJ, 2008, CURR BIOL, V18, pR851, DOI 10.1016/j.cub.2008.07.032; Sheehan MJ, 2011, SCIENCE, V334, P1272, DOI 10.1126/science.1211334; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SIMMONS LW, 1987, J ANIM ECOL, V56, P1015, DOI 10.2307/4963; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Stevenson PA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500060; Stevenson PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074965; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Trannoy S, 2016, P NATL ACAD SCI USA, V113, P4818, DOI 10.1073/pnas.1520953113; Tregenza T, 1997, ANIM BEHAV, V54, P979, DOI 10.1006/anbe.1997.0500; Urszan TJ, 2015, ECOL EVOL, V5, pS847, DOI 10.1002/ece3.1804; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Yu WC, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00110	53	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184121	10.1371/journal.pone.0184121	http://dx.doi.org/10.1371/journal.pone.0184121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910319	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200033
J	Woitke, F; Ceanga, M; Rudolph, M; Niv, F; Witte, OW; Redecker, C; Kunze, A; Keiner, S				Woitke, Florus; Ceanga, Mihai; Rudolph, Max; Niv, Fanny; Witte, Otto W.; Redecker, Christoph; Kunze, Albrecht; Keiner, Silke			Adult hippocampal neurogenesis poststroke: More new granule cells but aberrant morphology and impaired spatial memory	PLOS ONE			English	Article							COGNITIVE DECLINE; DENTATE GYRUS; PATTERN SEPARATION; STATUS EPILEPTICUS; NEURONS; STROKE; PERSPECTIVES; CONTRIBUTES; INFARCTS	Stroke significantly stimulates neurogenesis in the adult dentate gyrus, though the functional role of this postlesional response is mostly unclear. Recent findings suggest that newborn neurons generated in the context of stroke may fail to correctly integrate into pre-existing networks. We hypothesized that increased neurogenesis in the dentate gyrus following stroke is associated with aberrant neurogenesis and impairment of hippocampus-dependent memory. To address these questions we used the middle cerebral artery occlusion model (MCAO) in mice. Animals were housed either under standard conditions or with free access to running wheels. Newborn granule cells were labelled with the thymidine analoque EdU and retroviral vectors. To assess memory performance, we employed a modified version of the Morris water maze (MWM) allowing differentiation between hippocampus dependent and independent learning strategies. Newborn neurons were morphologically analyzed using confocal microscopy and Neurolucida system at 7 weeks. We found that neurogenesis was significantly increased following MCAO. Animals with MCAO needed more time to localize the platform and employed less hippocampus-dependent search strategies in MWM versus controls. Confocal studies revealed an aberrant cell morphology with basal dendrites and an ectopic location (e. g. hilus) of new granule cells born in the ischemic brain. Running increased the number of new neurons but also enhanced aberrant neurogenesis. Running, did not improve the general performance in the MWM but slightly promoted the application of precise spatial search strategies. In conclusion, ischemic insults cause hippocampal-dependent memory deficits which are associated with aberrant neurogenesis in the dentate gyrus indicating ischemia-induced maladaptive plasticity in the hippocampus.	[Woitke, Florus; Ceanga, Mihai; Rudolph, Max; Niv, Fanny; Witte, Otto W.; Redecker, Christoph; Kunze, Albrecht; Keiner, Silke] Jena Univ Hosp, Hans Berger Dept Neurol, Klinikum 1, Jena, Germany	Friedrich Schiller University of Jena	Kunze, A (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Klinikum 1, Jena, Germany.	albrecht.kunze@med.uni-jena.de	Witte, Otto/P-4127-2018; Keiner, Silke/A-5405-2018	Witte, Otto/0000-0003-2101-4105; 	BMBF program [01GN0977]; Interdisciplinary Center for Clinical Research (IZKF) Jena	BMBF program(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research (IZKF) Jena	Financial support was received from the BMBF program "Cell-based, regenerative therapies," 01GN0977; and the Interdisciplinary Center for Clinical Research (IZKF) Jena.	Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; Blum S, 2012, NEUROLOGY, V78, P38, DOI 10.1212/WNL.0b013e31823ed0cc; Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Geibig CS, 2012, NEUROBIOL DIS, V46, P431, DOI 10.1016/j.nbd.2012.02.007; Jessberger S, 2015, COLD SPRING HARB PER; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Parent JM, 1997, J NEUROSCI, V17, P3727; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rangel LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4181; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616	27	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183463	10.1371/journal.pone.0183463	http://dx.doi.org/10.1371/journal.pone.0183463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910298	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200011
J	Yadav, DK; Arora, R; Jain, A				Yadav, Dinesh Kumar; Arora, Reena; Jain, Anand			Classification and conservation priority of five Deccani sheep ecotypes of Maharashtra, India	PLOS ONE			English	Article							ALLELE FREQUENCY DATA; SEMI ARID ZONE; GENETIC DIVERSITY; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; MORPHOLOGICAL TRAITS; MULTIVARIATE CHARACTERIZATION; FIELD CONDITIONS; BREEDS; MUNJAL	Characterization of Indian livestock breeds has mostly been limited to single breed/population focused on either physical description of traditionally recognized breeds/populations or to their genetic description. Usually, morphological and genetic characterization has taken place in isolation. A parallel morphological characterization of genetically identified breeds or genetic characterization of morphologically described breeds is mostly missing, and their conservation priorities have largely been based on solely considering degree of endangerment. This study uses parallel approach based on morphometric and genetic differentiation for classification of five sheep ecotypes of Maharashtra state, and sets their conservation priority using threat parameters, current utilities/merits and contribution to genetic diversity. A total of 1101 animals were described for 7 body measurements for morphometric characterization. From this sample set, 456 animals were genotyped for 25 microsatellite markers for genetic characterization. Conservation priorities were assessed combining genetic and non-genetic factors. All studied traits varied significantly among ecotypes (p<0.05). All morphometric traits exhibited substantial sexual dimorphism except ear length. Males were 42% heavier than females. Madgyal sheep were the largest amongst the five ecotypes. In the stepwise discriminant analysis, all measured traits were significant and were found to have potential discriminatory power. Tail length was the most discriminatory trait. The Maha-lanobis distance of the morphological traits between Kolhapuri and Madgyal was maximum (12.07) while the least differentiation was observed between Madgyal and Solapuri (1.50). Discriminant analysis showed that 68.12% sheep were classified into their source population. The Sangamneri sheep showed least assignment error (22%) whilst Solapuri exhibited maximum error level (41%). A total of 407 alleles were observed, with an average of 16.28 alleles per locus. Sufficient levels of genetic diversity were observed in all the ecotypes with observed heterozygosity values exceeding 0.47 and gene diversity values exceeding 0.76. About 6% of the total genetic variation was explained by population differences (F-ST = 0.059). Pairwise F-ST values indicated least differentiation between Solapuri and Madgyal (0.025). In terms of genetic distances, Kolhapuri and Lonand were most closely related (Ds = 0.177). The most probable structure clustering of the five studied populations was at K = 5. The study showed a fair congruence between the dendrogram constructed on the basis of Mahalanobis distances and Nei's as well as Reynolds genetic distances. The findings gave highest conservation priority to Lonand and least to Solapuri ecotype.	[Yadav, Dinesh Kumar; Arora, Reena; Jain, Anand] ICAR Natl Bur Anim Genet Resources, Karnal, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources	Yadav, DK (corresponding author), ICAR Natl Bur Anim Genet Resources, Karnal, Haryana, India.	dkyadav66@gmail.com	ARORA, REENA/AAK-6892-2021; Arora, Reena/AAR-2240-2021		Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	The authors received no specific funding for this work. The project was part of institute funding by Indian Council of Agricultural Research.	ACHARYA RM, 1982, 30 FAO AN PROD HLTH; Agaviezor BO, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-38; [Anonymous], 2012, STAT AN SYST; Arora R, 2011, ANIM GENET, V42, P242, DOI 10.1111/j.1365-2052.2010.02147.x; Arora R, 2011, LIVEST SCI, V135, P193, DOI 10.1016/j.livsci.2010.07.008; Arora R, 2009, ASIAN AUSTRAL J ANIM, V22, P1; Arora RJ, 2011, TROP ANIM HEALTH PRO, V43, P401, DOI 10.1007/s11250-010-9706-z; Baumung R, 2006, J ANIM BREED GENET, V123, P265, DOI 10.1111/j.1439-0388.2006.00583.x; Ben Sassi-Zaidy Y, 2014, SMALL RUMINANT RES, V119, P52, DOI 10.1016/j.smallrumres.2014.02.005; Bhatia S, 2005, ASIAN AUSTRAL J ANIM, V18, P1387, DOI 10.5713/ajas.2005.1387; Birteeb P T, 2012, TROP ANIM HLTH PROD, V12, P23; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradley D G, 1997, REPORT ADVISORY GROU, P1; Carneiro H, 2010, SMALL RUMINANT RES, V94, P58, DOI 10.1016/j.smallrumres.2010.07.001; Cornuet JM, 1996, GENETICS, V144, P2001; d'Arnoldi CT, 1998, GENET SEL EVOL, V30, P149, DOI 10.1051/gse:19980204; Dalvit C, 2008, SMALL RUMINANT RES, V80, P45, DOI 10.1016/j.smallrumres.2008.09.005; Derban S., 2002, WEITZPRO SOFTWARE AN; Di Stasio L, 2001, PANELS MARKERS PAREN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2007, OB PLAN ACT AN GEN R; Gaouar SBS, 2016, SMALL RUMINANT RES, V144, P23, DOI 10.1016/j.smallrumres.2016.07.021; Gaouar SBS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122667; Ghanekar V M., 1983, WOOL WOOLLENS INDIA, V20, P51; Gizaw S, 2007, ANIM GENET, V38, P621, DOI 10.1111/j.1365-2052.2007.01659.x; Gizaw S, 2008, GENET SEL EVOL, V40, P433, DOI 10.1051/gse:2008012; Gokhale S B., 2003, EVALUATION CHARACTER, P5; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gurmej Singh, 2007, Indian Journal of Animal Sciences, V77, P1158; Hedrick PW, 2013, J HERED, V104, P298, DOI 10.1093/jhered/ess139; Herrera M, 1996, SMALL RUMINANT RES, V22, P39, DOI 10.1016/0921-4488(96)00863-2; Jyotsana B, 2010, SMALL RUMINANT RES, V93, P57, DOI 10.1016/j.smallrumres.2010.03.008; LANGELLA O, 2002, POPULATIONS 1 2 28; Legaz E, 2008, SMALL RUMINANT RES, V80, P39, DOI 10.1016/j.smallrumres.2008.09.001; Legaz E, 2011, SMALL RUMINANT RES, V100, P122, DOI 10.1016/j.smallrumres.2011.06.005; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reist-Marti SB, 2003, CONSERV BIOL, V17, P1299, DOI 10.1046/j.1523-1739.2003.01587.x; REYNOLDS J, 1983, GENETICS, V105, P767; Riva J, 2004, SMALL RUMINANT RES, V55, P221, DOI 10.1016/j.smallrumres.2003.12.010; Ruane J, 2000, CONSERV BIOL, V14, P1385, DOI 10.1046/j.1523-1739.2000.99276.x; Sahana G, 2004, ANIMAL GENETIC RESOU, V34, P67; Simianer H, 2003, ECOL ECON, V45, P377, DOI 10.1016/S0921-8009(03)00092-2; Spanish Assaf, 2008, SMALL RUMINANT RES, V80, P39; Traore A, 2008, SMALL RUMINANT RES, V80, P62, DOI 10.1016/j.smallrumres.2008.09.011; Waghmode P. S., 2008, Indian Journal of Small Ruminants, V14, P127; WEITZMAN ML, 1992, Q J ECON, V107, P363, DOI 10.2307/2118476; Yadav D. K., 2014, Indian Journal of Small Ruminants, V20, P91; Yadav D K, 2015, MONOGRAPH, V91, P5; Yadav DK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-29; Yadav DK, 2014, INDIAN J ANIM SCI, V84, P527; Yadav DK, 2012, INDIAN J ANIM SCI, V82, P216; Yadav DK, 2011, INDIAN J ANIM SCI, V81, P943; Yadav DK, 2009, INDIAN J ANIM SCI, V79, P1242; Yakubu A, 2011, ITAL J ANIM SCI, V10, P83, DOI 10.4081/ijas.2011.e17; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yilmaz O, 2014, ANIM GENET, V45, P604, DOI 10.1111/age.12173	63	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184691	10.1371/journal.pone.0184691	http://dx.doi.org/10.1371/journal.pone.0184691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910329	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200079
J	Fuller, AW; Young, P; Pierce, BD; Kitson-Finuff, J; Jain, P; Schneider, K; Lazar, S; Taran, O; Palmer, AG; Lynn, DG				Fuller, Alexandra W.; Young, Phoebe; Pierce, B. Daniel; Kitson-Finuff, Jamie; Jain, Purvi; Schneider, Karl; Lazar, Stephen; Taran, Olga; Palmer, Andrew G.; Lynn, David G.			Redox-mediated quorum sensing in plants	PLOS ONE			English	Article							KIN RECOGNITION; RHIZOSPHERE MICROBIOME; MOLECULAR-OXYGEN; STRIGA-ASIATICA; CROSS-TALK; HOST; CHEMISTRY; OXIDATION; CALCIUM; CA2+	The rhizosphere, the narrow zone of soil around plant roots, is a complex network of interactions between plants, bacteria, and a variety of other organisms. The absolute dependence on host-derived signals, or xenognosins, to regulate critical developmental checkpoints for host commitment in the obligate parasitic plants provides a window into the rhizosphere's chemical dynamics. These sessile intruders use H2O2 in a process known as semagenesis to chemically modify the mature root surfaces of proximal host plants and generate p-benzoquinones (BQs). The resulting redox-active signaling network regulates the spatial and temporal commitments necessary for host attachment. Recent evidence from non-parasites, including Arabidopsis thaliana, establishes that reactive oxygen species (ROS) production regulates similar redox circuits related to root recognition, broadening xenognosins' role beyond the parasites. Here we compare responses to the xenognosin dimethoxybenzoquinone (DMBQ) between the parasitic plant Striga asiatica and the non-parasitic A. thaliana. Exposure to DMBQ simulates the proximity of a mature root surface, stimulating an increase in cytoplasmic Ca2+ concentration in both plants, but leads to remarkably different phenotypic responses in the parasite and non-parasite. In S. asiatica, DMBQ induces development of the host attachment organ, the haustorium, and decreases ROS production at the root tip, while in A. thaliana, ROS production increases and further growth of the root tip is arrested. Obstruction of Ca2+ channels and the addition of antioxidants both lead to a decrease in the DMBQ response in both parasitic and non-parasitic plants. These results are consistent with Ca2+ regulating the activity of NADPH oxidases, which in turn sustain the autocatalytic production of ROS via an external quinone/hydroquinone redox cycle. Mechanistically, this chemistry is similar to black and white photography with the emerging dynamic reaction-diffusion network laying the foundation for the precise temporal and spatial control underlying rhizosphere architecture.	[Fuller, Alexandra W.; Young, Phoebe; Pierce, B. Daniel; Taran, Olga; Lynn, David G.] Emory Univ, Dept Biol & Chem, Atlanta, GA 30322 USA; [Pierce, B. Daniel] Univ Richmond, Gottwald Sci Ctr, Richmond, VA 23173 USA; [Kitson-Finuff, Jamie; Jain, Purvi; Schneider, Karl; Lazar, Stephen; Palmer, Andrew G.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Emory University; University of Richmond; Florida Institute of Technology	Taran, O; Lynn, DG (corresponding author), Emory Univ, Dept Biol & Chem, Atlanta, GA 30322 USA.; Palmer, AG (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	otarani@emory.edu; apalmer@fit.edu; dlynn2@emory.edu		Taran, Olga/0000-0003-1994-0847; Pierce, B Daniel/0000-0002-0004-2054; Palmer, Andrew/0000-0001-6506-5292; Young, Phoebe/0000-0001-9408-912X	Emory University; Florida Institute of Technology; NIH; Emory University's Department of Neurology	Emory University; Florida Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University's Department of Neurology	We thank Emory University for undergraduate student research fellowships to AWF and PY, the Florida Institute of Technology for graduate fellowship support of SL, the NIH FIRST Fellowship to BDP, and Emory University's Department of Neurology for fellowship support to OT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bhatt MV, 2011, NEW PHYTOL, V189, P1135, DOI 10.1111/j.1469-8137.2010.03548.x; Biedrzycki ML, 2011, PLANT SIGNAL BEHAV, V6, P1515, DOI 10.4161/psb.6.10.16525; Biedrzycki ML, 2014, COMMUN INTEGR BIOL, V3, P28; Binns A. N., 1993, Advances in molecular genetics of plant-microbe interactions. Vol. 2. Proceedings of the 6th International Symposium of Molecular Plant-Microbe Interactions, Seattle, Washington, USA, July 1992., P51; CARLSON BW, 1985, J AM CHEM SOC, V107, P479, DOI 10.1021/ja00288a035; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHANG M, 1986, J AM CHEM SOC, V108, P7858, DOI 10.1021/ja00284a074; Depuydt S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00614; Dorr I, 1997, ANN BOT-LONDON, V79, P463, DOI 10.1006/anbo.1996.0385; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; El-Shemy, 2015, PLANTS FUTURE, P135; Fang F, 2015, CHEMBIOCHEM, V16, P2183, DOI 10.1002/cbic.201500334; FATE G, 1990, PLANT PHYSIOL, V93, P201, DOI 10.1104/pp.93.1.201; Fate GD, 1996, J AM CHEM SOC, V118, P11369, DOI 10.1021/ja961395i; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Golisz A, 2011, PLANTA, V233, P231, DOI 10.1007/s00425-010-1294-7; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Hood ME, 1998, PHYTOPATHOLOGY, V88, P70, DOI 10.1094/PHYTO.1998.88.1.70; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Keyes WJ, 2007, PLANT J, V51, P707, DOI 10.1111/j.1365-313X.2007.03171.x; Keyes WJ, 2001, PLANT PHYSL, V127; Kim DJ, 1998, CHEM BIOL, V5, P103, DOI 10.1016/S1074-5521(98)90144-2; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Liang LiZhi, 2016, American Journal of Plant Sciences, V7, P1275; Lohar DP, 2007, NEW PHYTOL, V173, P39, DOI 10.1111/j.1469-8137.2006.01901.x; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; LYNN DG, 1990, ANNU REV PLANT PHYS, V41, P497, DOI 10.1146/annurev.pp.41.060190.002433; Mazars C, 2010, MOL PLANT, V3, P706, DOI 10.1093/mp/ssq024; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Palmer AG, 2004, ANNU REV PHYTOPATHOL, V42, P439, DOI 10.1146/annurev.phyto.41.052002.095701; Palmer AG, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1224045; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Palmer AG, 2008, PLANT SIGNAL BEHAV, V3, P560, DOI 10.4161/psb.3.8.5703; Palmer AG, 2009, PEST MANAG SCI, V65, P512, DOI 10.1002/ps.1717; Panayotaros J-GC, 2015, J PHYS A, V48, P75102; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Roginsky V, 2000, J CHEM SOC PERK T 2, P1575, DOI 10.1039/b000538j; Roginsky VA, 1999, J CHEM SOC PERK T 2, P871, DOI 10.1039/a807650b; Roginsky VA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P200; Sella E, 2013, ORG BIOMOL CHEM, V11, P5074, DOI 10.1039/c3ob40962g; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; SMITH CE, 1990, PLANT PHYSIOL, V93, P208, DOI 10.1104/pp.93.1.208; Smith CE, 1996, P NATL ACAD SCI USA, V93, P6986, DOI 10.1073/pnas.93.14.6986; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Soumen Bhattacharjee, 2012, Journal of Botany, V2012, P985298; Stacy A, 2014, P NATL ACAD SCI USA, V111, P7819, DOI 10.1073/pnas.1400586111; Steinbock O, 1995, NAVIGATING COMPLEX L; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Tschiersch H, 2012, NEW PHYTOL, V196, P926, DOI 10.1111/j.1469-8137.2012.04295.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Yoder JI, 2001, CURR OPIN PLANT BIOL, V4, P359, DOI 10.1016/S1369-5266(00)00185-0; Zeng ZX, 1996, J AM CHEM SOC, V118, P1233, DOI 10.1021/ja950372l; Zhang DJ, 2010, ECOL RES, V25, P13, DOI 10.1007/s11284-009-0627-0; Zhou LL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/951210; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	68	10	11	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182655	10.1371/journal.pone.0182655	http://dx.doi.org/10.1371/journal.pone.0182655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902851	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200005
J	Li, Y; Khalafalla, AI; Paden, CR; Yusof, MF; Eltahir, YM; Al Hammadi, ZM; Tao, Y; Queen, K; Al Hosani, F; Gerber, SI; Hall, AJ; Al Muhairi, S; Tong, SX				Li, Yan; Khalafalla, Abdelmalik Ibrahim; Paden, Clinton R.; Yusof, Mohammed F.; Eltahir, Yassir M.; Al Hammadi, Zulaikha M.; Tao, Ying; Queen, Krista; Al Hosani, Farida; Gerber, Susan I.; Hall, Aron J.; Al Muhairi, Salama; Tong, Suxiang			Identification of diverse viruses in upper respiratory samples in dromedary camels from United Arab Emirates	PLOS ONE			English	Article							CONGO HEMORRHAGIC-FEVER; CORONAVIRUS MERS-COV; MIDDLE-EAST; SAUDI-ARABIA; MOLECULAR CHARACTERIZATION; METAGENOMIC ANALYSIS; VIROME REVEALS; VIRAL GENOMES; DNA VIRUSES; ABU-DHABI	Camels are known carriers for many viral pathogens, including Middle East respiratory syndrome coronavirus (MERS-CoV). It is likely that there are additional, as yet unidentified viruses in camels with the potential to cause disease in humans. In this study, we performed metagenomic sequencing analysis on nasopharyngeal swab samples from 108 MERS-CoV-positive dromedary camels from a live animal market in Abu Dhabi, United Arab Emirates. We obtained a total of 846.72 million high-quality reads from these nasopharyngeal swab samples, of which 2.88 million (0.34%) were related to viral sequences while 512.63 million (60.5%) and 50.87 million (6%) matched bacterial and eukaryotic sequences, respectively. Among the viral reads, sequences related to mammalian viruses from 13 genera in 10 viral families were identified, including Coronaviridae, Nairoviridae, Paramyxoviridae, Parvoviridae, Polyomaviridae, Papillomaviridae, Astroviridae, Picornaviridae, Poxviridae, and Genomoviridae. Some viral sequences belong to known camel or human viruses and others are from potentially novel camel viruses with only limited sequence similarity to virus sequences in GenBank. A total of five potentially novel virus species or strains were identified. Co-infection of at least two recently identified camel coronaviruses was detected in 92.6% of the camels in the study. This study provides a comprehensive survey of viruses in the virome of upper respiratory samples in camels that have extensive contact with the human population.	[Li, Yan; Paden, Clinton R.; Tao, Ying; Queen, Krista; Gerber, Susan I.; Hall, Aron J.; Tong, Suxiang] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA 30329 USA; [Khalafalla, Abdelmalik Ibrahim; Yusof, Mohammed F.; Eltahir, Yassir M.; Al Hammadi, Zulaikha M.; Al Muhairi, Salama] Abu Dhabi Food Control Author, Anim Wealth Sect, Abu Dhabi, U Arab Emirates; [Paden, Clinton R.; Queen, Krista] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Al Hosani, Farida] Hlth Author Abu Dhabi, Abu Dhabi, U Arab Emirates	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Tong, SX (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA 30329 USA.; Al Muhairi, S (corresponding author), Abu Dhabi Food Control Author, Anim Wealth Sect, Abu Dhabi, U Arab Emirates.	salama.almuhairi@adfca.ae; sot1@cdc.gov	Khalafalla, Abdelmalik Ibrahim/GLT-3730-2022	Khalafalla, Abdelmalik Ibrahim/0000-0001-9156-1361; Alhosani, Farida/0000-0002-4901-0280				Abou Zaid A, 2001, J EGYPT VET VET ASSU, V61, P15; AFZAL M, 1994, REV SCI TECH OIE, V13, P787, DOI 10.20506/rst.13.3.794; Al Hammadi ZM, 2015, EMERG INFECT DIS, V21, P2197, DOI 10.3201/eid2112.151132; Al Muhairi S, 2016, VIRUS GENES, V52, P848, DOI 10.1007/s11262-016-1367-1; Al-Ruwaili MA, 2012, SAUDI J BIOL SCI, V19, P35, DOI 10.1016/j.sjbs.2011.10.001; Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]; Buck CB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005574; Calvignac-Spencer S, 2016, ARCH VIROL, V161, P1739, DOI 10.1007/s00705-016-2794-y; Champour M, 2016, J ARTHROPOD-BORNE DI, V10, P168; Champour M, 2014, J VECTOR DIS, V51, P62; Corman VM, 2016, P NATL ACAD SCI USA, V113, P9864, DOI 10.1073/pnas.1604472113; Assis MRD, 2016, FOOD ENVIRON VIROL, V8, P305, DOI 10.1007/s12560-016-9254-4; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Du ZG, 2014, ARCH VIROL, V159, P1527, DOI 10.1007/s00705-013-1890-5; Fawaz M, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0113-5; Halary S, 2016, EMERG INFECT DIS, V22, P1839, DOI 10.3201/eid2210.160052; Huang CP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005883; Intisar KS, 2010, J VIROL METHODS, V163, P82, DOI 10.1016/j.jviromet.2009.08.017; Intisar KS, 2009, ACTA TROP, V111, P243, DOI 10.1016/j.actatropica.2009.05.001; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Khalafalla AI, 2017, VECTOR-BORNE ZOONOT, V17, P281, DOI 10.1089/vbz.2016.2070; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Khan AS, 1997, AM J TROP MED HYG, V57, P519, DOI 10.4269/ajtmh.1997.57.519; Krupovic M, 2016, ARCH VIROL, V161, P2633, DOI 10.1007/s00705-016-2943-3; Lager KM, 2012, J VET DIAGN INVEST, V24, P1177, DOI 10.1177/1040638712463212; Lau SKP, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.129; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-54; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li PE, 2017, NUCLEIC ACIDS RES, V45, P67, DOI 10.1093/nar/gkw1027; MAURICE PY, 1968, REV ELEV MED VET PAY, V21, P443; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Saeed IK, 2015, TROP ANIM HEALTH PRO, V47, P995, DOI 10.1007/s11250-015-0798-3; Sasaki M, 2015, J GEN VIROL, V96, P440, DOI 10.1099/vir.0.071209-0; SINGH KV, 1967, VET REC, V81, P84, DOI 10.1136/vr.81.3.84; Steel O, 2016, INFECT GENET EVOL, V43, P151, DOI 10.1016/j.meegid.2016.05.008; Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16; Tao Y, 2013, J GEN VIROL, V94, P738, DOI 10.1099/vir.0.047928-0; Telmadarraiy Z, 2010, SCAND J INFECT DIS, V42, P137, DOI 10.3109/00365540903362501; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011; Uch R, 2015, EMERG INFECT DIS, V21, P2096, DOI 10.3201/eid2111.150486; Ure AE, 2011, J GEN VIROL, V92, P1769, DOI 10.1099/vir.0.031039-0; Varsani A, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew037; Wernery U, 1999, J VET MED B, V46, P131, DOI 10.1111/j.0931-1793.1999.00250.x; Wernery U, 2014, INFECT DISORDERS CAM; Wernery U, 2008, J GEN VIROL, V89, P660, DOI 10.1099/vir.0.82215-0; WHO, 2016, MERS COV GLOB SUMM R; Woo PCY, 2006, J VIROL, V80, P7136, DOI 10.1128/JVI.00509-06; Woo PCY, 2015, J GEN VIROL, V96, P2697, DOI 10.1099/jgv.0.000233; Woo PCY, 2015, J GEN VIROL, V96, P1723, DOI 10.1099/vir.0.000131; Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020; Woo PCY, 2014, EMERG INFECT DIS, V20, P560, DOI 10.3201/eid2004.131769; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woo PC, 2017, J GEN VIROLOGY; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; YAM BAZ, 2015, RES J AGR ENV MANAGE, V4, P496; Yousif A.A., 2004, ARAB J BIOTECHNOL, V7, P8; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Yusof MF, 2015, VIRUS GENES, V50, P509, DOI 10.1007/s11262-015-1174-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang W, 2016, TRANSFUSION, V56, P2248, DOI 10.1111/trf.13692; Zhou CL, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0431-0; Zivcec M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040106	74	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184718	10.1371/journal.pone.0184718	http://dx.doi.org/10.1371/journal.pone.0184718			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902913	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200056
J	Zhang, WD; Randell, EW; Sun, G; Likhodii, S; Liu, M; Furey, A; Zhai, GJ				Zhang, Weidong; Randell, Edward W.; Sun, Guang; Likhodii, Sergei; Liu, Ming; Furey, Andrew; Zhai, Guangju			Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes	PLOS ONE			English	Article							COMPLICATION-FREE PATIENTS; SYNOVIAL-FLUID; METHYLGLYOXAL; METFORMIN; GLUCOSE; RAGE; PIOGLITAZONE; RESPONSES; PROTEOME; RECEPTOR	To test whether type 2 diabetic patients have an elevated level of advanced glycation end-products (AGEs) and responsible for altered phosphatidylcholine metabolism, which we recently found to be associated with osteoarthritis (OA) and diabetes mellitus (DM), synovial fluid (SF) and plasma samples were collected from OA patients with and without DM. Hyperglycemia-related AGEs including methylglyoxal (MG), free methylglyoxal-derived hydroimidazolone (MG-H1), and protein bound N-(Carboxymethyl) lysine (CML) and N-(Carboxyethyl) lysine (CEL) levels were measured in both SF and plasma samples using liquid chromatography coupled tandem mass spectrometry methodology. The correlation between these AGEs and phosphatidylcholine acyl-alkyl C34: 3 (PC ae C34: 3) and C36:3 (PC ae C36: 3) were examined. Eighty four patients with knee OA, including 46 with DM and 38 without DM, were included in the study. There was no significant difference in plasma levels of MG, MG-H1, CML, and CEL between OA patients with and without DM. However, the levels of MG and MG-H1, but not CML and CEL in SF were significantly higher in OA patients with DM than in those without (all p <= 0.04). This association strengthened after adjustment for age, body mass index (BMI), sex and hexose level (p<0.02). Moreover, the levels of MG-H1 in SF was negatively and significantly correlated with PC ae C34: 3 (rho = -0.34; p = 0.02) and PC ae C36: 3 (rho = -0.39; P = 0.03) after the adjustment of age, BMI, sex and hexose level. Our data indicated that the production of non-protein bound AGEs was increased within the OA-affected joint of DM patients. This is associated with changes in phosphatidylcholine metabolism and might be responsible for the observed epidemiological association between OA and DM.	[Zhang, Weidong; Liu, Ming; Zhai, Guangju] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China; [Randell, Edward W.; Likhodii, Sergei] Mem Univ Newfoundland, Fac Med, Dept Lab Med, St John, NF, Canada; [Sun, Guang] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Furey, Andrew] Mem Univ Newfoundland, Fac Med, Dept Surg, St John, NF, Canada; [Zhai, Guangju] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Memorial University Newfoundland; Jilin University; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; University of Tasmania; Menzies Institute for Medical Research	Zhai, GJ (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.; Zhai, GJ (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	guangju.zhai@med.mun.ca			Canadian Institutes of Health Research (CIHR) [RNL-132178]; Newfoundland & Labrador Research and Development Corporation; Memorial University of Newfoundland (MUN)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Newfoundland & Labrador Research and Development Corporation; Memorial University of Newfoundland (MUN)	This work was supported by the Canadian Institutes of Health Research (CIHR); Grant number:RNL-132178, GJZ (http://webapps. cihr-irsc.gc.ca/cfdd/db_search); the Newfoundland & Labrador Research and Development Corporation and Memorial University of Newfoundland (MUN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BASKARAN S, 1990, INDIAN J BIOCHEM BIO, V27, P13; Bennike T, 2014, J PROTEOME RES, V13, P4377, DOI 10.1021/pr500587x; Chen Yi, 2007, J Orthop Surg Res, V2, P14, DOI 10.1186/1749-799X-2-14; Chen YJ, 2016, J ORTHOP RES, V34, P791, DOI 10.1002/jor.23083; Di Marco Elyse, 2013, Front Endocrinol (Lausanne), V4, P68, DOI 10.3389/fendo.2013.00068; Diamanti-Kandarakis E, 2007, METABOLISM, V56, P129, DOI 10.1016/j.metabol.2006.09.006; Eymard F, 2015, OSTEOARTHR CARTILAGE, V23, P851, DOI 10.1016/j.joca.2015.01.013; Freitas C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155741; Garg S, 2013, CLIN J PAIN, V29, P717, DOI 10.1097/AJP.0b013e318272ebec; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Han YC, 2009, CLIN BIOCHEM, V42, P562, DOI 10.1016/j.clinbiochem.2008.12.016; HILLS BA, 1990, LYMPHOLOGY, V23, P39; Hirose H, 2002, METABOLISM, V51, P314, DOI 10.1053/meta.2002.30506; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Karimi J, 2011, DIABETES RES CLIN PR, V91, P61, DOI 10.1016/j.diabres.2010.09.024; Kender Z, 2014, EXP CLIN ENDOCR DIAB, V122, P316, DOI 10.1055/s-0034-1371818; Kiho T, 2005, CLIN CHIM ACTA, V358, P139, DOI 10.1016/j.cccn.2005.02.012; King KB, 2015, OSTEOARTHR CARTILAGE, V23, P841, DOI 10.1016/j.joca.2015.03.031; Kontomanolis EN, 2016, CLIN EXP OBSTET GYN, V43, P276; LAL S, 1995, ARCH BIOCHEM BIOPHYS, V318, P191, DOI 10.1006/abbi.1995.1220; Li WG, 2008, EXP BIOL MED, V233, P176, DOI 10.3181/0705-BC-131; Li Y, 2016, OSTEOARTHR CARTILAGE, V24, P307, DOI 10.1016/j.joca.2015.08.001; Lv X, 2016, CHIN J NAT MEDICINES, V14, P844, DOI 10.1016/S1875-5364(16)30101-7; Magnusson CD, 2011, CHEM PHYS LIPIDS, V164, P315, DOI 10.1016/j.chemphyslip.2011.04.010; Magnusson K, 2015, ARTHRIT CARE RES, V67, P187, DOI 10.1002/acr.22460; Miranda C, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1228-z; Oloyede A, 2004, CONNECT TISSUE RES, V45, P86, DOI 10.1080/03008200490442653; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; Rabbani N, 2014, BIOCHEM SOC T, V42, P425, DOI 10.1042/BST20140018; Rabbani N, 2014, DIABETES, V63, P50, DOI 10.2337/db13-1606; Rahbar S, 2000, CLIN CHIM ACTA, V301, P65, DOI 10.1016/S0009-8981(00)00327-2; Rahman MM, 2014, INT J RHEUMATOL, V2014, DOI 10.1155/2014/620920; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; SZWERGOLD BS, 1990, SCIENCE, V247, P451, DOI 10.1126/science.2300805; Teerlink T, 2004, CLIN CHEM, V50, P1222, DOI 10.1373/clinchem.2004.031286; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P939, DOI 10.2174/138161208784139756; Zhang WD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0937-x; Zhang WD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006286	46	28	28	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184105	10.1371/journal.pone.0184105	http://dx.doi.org/10.1371/journal.pone.0184105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898260	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000410449500013
J	Bjelland, EK; Owe, KM; Nordeng, HME; Engdahl, BL; Kristiansson, P; Vangen, S; Eberhard-Gran, M				Bjelland, Elisabeth Krefting; Owe, Katrine Mari; Nordeng, Hedvig Marie Egeland; Engdahl, Bo Lars; Kristiansson, Per; Vangen, Siri; Eberhard-Gran, Malin			Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study	PLOS ONE			English	Article							HORMONAL CONTRACEPTION; INTRAUTERINE SYSTEM; NORWEGIAN MOTHER; CHILD COHORT; WOMEN; PREVALENCE; DELIVERY; MENARCHE; HEALTH; RISK	Objective To estimate associations of progestin-only contraceptives with persistent pelvic girdle pain 18 months after delivery. Methods Prospective population based cohort study during the years 2003-2011. We included 20,493 women enrolled in the Norwegian Mother and Child Cohort Study who reported pelvic girdle pain in pregnancy week 30. Data were obtained by 3 self-administered questionnaires and the exposure was obtained by linkage to the Prescription Database of Norway. The outcome was pelvic girdle pain 18 months after delivery. Results Pelvic girdle pain 18 months after delivery was reported by 9.7% (957/9830) of women with dispense of a progestin-only contraceptive and by 10.5% (1114/10,663) of women without dispense (adjusted odds ratio 0.93; 95% CI 0.84-1.02). In sub-analyses, long duration of exposure to a progestin intrauterine device or progestin-only oral contraceptives was associated with reduced odds of persistent pelvic girdle pain (P-trend = 0.021 and P-trend = 0.005). Conversely, long duration of exposure to progestin injections and/or a progestin implant was associated with modest increased odds of persistent pelvic girdle pain (P-trend = 0.046). Early timing of progestin-only contraceptive dispense following delivery (<= 3 months) was not significantly associated with persistent pelvic girdle pain. Conclusions Our findings suggest a small beneficial effect of progestin intrauterine devices and progestin-only oral contraceptives on recovery from pelvic girdle pain. We cannot completely rule out an opposing adverse effect of exposure to progestin injections and/or progestin implants. However, the modest increased odds of persistent pelvic girdle pain among these users could be a result of unmeasured confounding.	[Bjelland, Elisabeth Krefting; Eberhard-Gran, Malin] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway; [Bjelland, Elisabeth Krefting; Engdahl, Bo Lars] Norwegian Inst Publ Hlth, Dept Hlth & Aging, Oslo, Norway; [Bjelland, Elisabeth Krefting] Akershus Univ Hosp, Dept Obstet & Gynecol, Lorenskog, Norway; [Owe, Katrine Mari; Vangen, Siri] Natl Hosp Norway, Oslo Univ Hosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway; [Owe, Katrine Mari; Nordeng, Hedvig Marie Egeland; Eberhard-Gran, Malin] Norwegian Inst Publ Hlth, Dept Child Hlth, Oslo, Norway; [Nordeng, Hedvig Marie Egeland] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway; [Kristiansson, Per] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Eberhard-Gran, Malin] Univ Oslo, Inst Clin Med, Campus Ahus, Lorenskog, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; National Hospital Norway; Norwegian Institute of Public Health (NIPH); University of Oslo; Uppsala University; University of Oslo	Bjelland, EK (corresponding author), Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway.; Bjelland, EK (corresponding author), Norwegian Inst Publ Hlth, Dept Hlth & Aging, Oslo, Norway.; Bjelland, EK (corresponding author), Akershus Univ Hosp, Dept Obstet & Gynecol, Lorenskog, Norway.	Elisabeth.Krefting.Bjelland@ahus.no	Bjelland, Elisabeth Krefting/Q-5531-2016; Engdahl, Bo/ABC-6923-2020; Owe, Katrine M/I-1909-2017	Bjelland, Elisabeth Krefting/0000-0003-3206-524X; Engdahl, Bo/0000-0002-9166-5782; 	South-Eastern Norway Regional Health Authority [2013073]; Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present study was supported by the South-Eastern Norway Regional Health Authority [grant no. 2013073]. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS [contract no. N01-ES-75558], NIH/NINDS [grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2001, ACTA OBSTET GYN SCAN, V80, P505, DOI 10.1034/j.1600-0412.2001.080006505.x; Bjelland EK, 2013, HUM REPROD, V28, P3134, DOI 10.1093/humrep/det301; Bjelland EK, 2011, BJOG-INT J OBSTET GY, V118, P1646, DOI 10.1111/j.1471-0528.2011.03099.x; Bjelland EK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.040; Bjorklund K, 2000, ACTA OBSTET GYN SCAN, V79, P979, DOI 10.3109/00016340009169246; Casper RF, 2017, FERTIL STERIL, V107, P533, DOI 10.1016/j.fertnstert.2017.01.003; d'Arcangues C, 2006, CONTRACEPTION, V73, P443, DOI 10.1016/j.contraception.2006.01.002; Fotoohi AK, 2010, J OBSTET GYNAECOL RE, V36, P1142, DOI 10.1111/j.1447-0756.2010.01291.x; Fraser IS, 2013, CONTRACEPTION, V87, P273, DOI 10.1016/j.contraception.2012.08.039; Furu K., 2008, Norsk Epidemiologi, V18, P129; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hubacher D, 2006, HUM REPROD, V21, P1467, DOI 10.1093/humrep/del029; Kirkeby MJ, 2013, J OBSTET GYNAECOL RE, V39, P1037, DOI 10.1111/jog.12008; Kovacs CS, 2015, OSTEOPOROSIS INT, V26, P2223, DOI 10.1007/s00198-015-3149-3; Kristiansson P, 1999, AM J OBSTET GYNECOL, V180, P128, DOI 10.1016/S0002-9378(99)70162-6; Kumle Merethe, 2004, BMC Pregnancy Childbirth, V4, P11, DOI 10.1186/1471-2393-4-11; Lanza LL, 2013, OBSTET GYNECOL, V121, P593, DOI 10.1097/AOG.0b013e318283d1a1; Larsen EC, 1999, ACTA OBSTET GYN SCAN, V78, P105, DOI 10.1034/j.1600-0412.1999.780206.x; Lindh I, 2013, HUM REPROD, V28, P1953, DOI 10.1093/humrep/det101; Lopez LM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006033.pub5; Lopez LM, 2015, COCHRANE DB SYST REV, V3; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Maximo MM, 2015, FERTIL STERIL, V104, P1182, DOI 10.1016/j.fertnstert.2015.07.1165; Mogren IM, 2009, OPEN EPIDEMIOL J, V2, P26; Nielsen LL, 2010, ACTA OBSTET GYN SCAN, V89, P1187, DOI 10.3109/00016349.2010.501853; Sverdrup B, 2004, ACTA OBSTET GYN SCAN, V83, P316, DOI 10.1111/j.0001-6349.2004.0089d.x; VanderWeele TJ, 2015, EXPLANATION CAUSAL I, P66; Vleeming A, 2008, EUR SPINE J, V17, P794, DOI 10.1007/s00586-008-0602-4; World Health Organization, PROG ONL CONTR US DU	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184071	10.1371/journal.pone.0184071	http://dx.doi.org/10.1371/journal.pone.0184071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892506	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000410243200009
J	Domingo, A; Jimenez, S; Abreu, M; Forselledo, R; Yates, O				Domingo, Andres; Jimenez, Sebastian; Abreu, Martin; Forselledo, Rodrigo; Yates, Oliver			Effectiveness of tori line use to reduce seabird bycatch in pelagic longline fishing	PLOS ONE			English	Article							DIVING BEHAVIOR; FISHERIES; ALBATROSSES; MITIGATION; TUNA; MORTALITY; PETRELS; DEPTHS; TRAWL	Industrial longline fisheries cause the death of large numbers of seabirds annually. Various mitigation measures have been proposed, including the use of tori lines. In this study the efficiency of a single tori line to reduce seabird bycatch was tested on pelagic longline vessels (25-37m length). Thirteen fishing trips were carried out in the area and season of the highest bycatch rates recorded in the southwest Atlantic (2009-2011). We deployed two treatments in random order: sets with a tori line and without a tori line (control treatment). The use of a tori line significantly reduced seabird bycatch rates. Forty three and seven birds were captured in the control (0.85 birds/1,000 hooks, n = 49 sets) and in the tori line treatment (0.13 birds/1,000 hooks, n = 51 sets), respectively. In 47% of the latter sets the tori line broke either because of entanglement with the longline gear or by tension. This diminished the tori line effectiveness; five of the seven captures during sets where a tori line was deployed were following ruptures. Nine additional trips were conducted with a tori line that was modified to reduce entanglements (2012-2016). Seven entanglements were recorded in 73 longline sets. The chance of a rupture on these trips was 4% (95% c. l. = 1-18%) of that during 2009-2011. This work shows that the use of a tori line reduces seabird bycatch in pelagic longline fisheries and is a practice suitable for medium size vessels (similar to 25-40m length). Because the study area has historically very high bycatch rates at global level, this tori line design is potentially useful to reduce seabird bycatch in many medium size pelagic longline vessel fishing in the southern hemisphere.	[Domingo, Andres; Jimenez, Sebastian; Forselledo, Rodrigo] Direcc Nacl Recursos Acuat, Lab Recursos Pelag, Montevideo, Uruguay; [Jimenez, Sebastian; Abreu, Martin] Ctr Invest & Conservac Marina CICMAR, Albatross Task Force, Proyecto Albatros & Petreles Uruguay, Canelones, Uruguay; [Yates, Oliver] RSPB, BirdLife Int Marine Programme, Sandy, Beds, England	BirdLife International; Royal Society for Protection of Birds	Domingo, A; Jimenez, S (corresponding author), Direcc Nacl Recursos Acuat, Lab Recursos Pelag, Montevideo, Uruguay.; Jimenez, S (corresponding author), Ctr Invest & Conservac Marina CICMAR, Albatross Task Force, Proyecto Albatros & Petreles Uruguay, Canelones, Uruguay.	adomingo@dinara.gub.uy; jimenezpsebastian@gmail.com	Fennell, Hannah/AAI-1408-2019	Jimenez, Sebastian/0000-0003-3945-4619	Royal Society for the Protection of Birds (RSPB); BirdLife International; Direccion Nacional de Recursos Acuaticos (DINARA); RSPB	Royal Society for the Protection of Birds (RSPB); BirdLife International; Direccion Nacional de Recursos Acuaticos (DINARA); RSPB	The Royal Society for the Protection of Birds (RSPB) and BirdLife International funded the Albatross Task Force-Uruguay of the Proyecto Albatros y Petreles-Uruguay (PAP-U) to conduct a large part of this work. Research trips in the RN Aldebaran were funded by Direccion Nacional de Recursos Acuaticos (DINARA). SJ was funded by the RSPB to write this paper. The publication fee for this article was provided by RSPB.	ACAP, 2016, REP SEAB BYC WORK GR; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boggs CH, 2001, SEABIRD BYCATCH TREN; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Brothers N.P., 1999, INCIDENTAL CATCH SEA; Bull LS, 2007, FISH FISH, V8, P31, DOI 10.1111/j.1467-2979.2007.00234.x; Domingo A, 2012, B MAR SCI, V88, P499, DOI 10.5343/bms.2011.1069; HUIN N, 1994, CONDOR, V96, P1111, DOI 10.2307/1369125; Jimenez S, 2015, REVISION PLANES ACCI, P11; Jimenez S, 2009, POLAR BIOL, V32, P187, DOI 10.1007/s00300-008-0519-8; Jimenez S, 2014, BIOL CONSERV, V171, P9, DOI 10.1016/j.biocon.2013.12.035; Jimenez S, 2012, AQUAT CONSERV, V22, P436, DOI 10.1002/aqc.2242; Jimenez S, 2010, AQUAT LIVING RESOUR, V23, P49, DOI 10.1051/alr/2010002; Lokkeborg S, 2011, MAR ECOL PROG SER, V435, P285, DOI 10.3354/meps09227; Melvin EF, 2014, FISH RES, V149, P5, DOI 10.1016/j.fishres.2013.07.012; Melvin EF, 2013, FISH RES, V147, P72, DOI 10.1016/j.fishres.2013.04.015; Melvin EF, 2004, CCAMLR SCI, V11, P189; Murray T.E., 1993, BIRD CONSERV INT, V3, P181, DOI DOI 10.1017/S0959270900000897; Neves T, 2008, MEDIDAS MITIGADORAS; Phillips RA, 2016, BIOL CONSERV, V201, P169, DOI 10.1016/j.biocon.2016.06.017; PRINCE PA, 1994, ANTARCT SCI, V6, P353, DOI 10.1017/S0954102094000532; Robertson G, 2013, AQUAT CONSERV, V23, P885, DOI 10.1002/aqc.2346; Rollinson DP, 2014, POLAR BIOL, V37, P1301, DOI 10.1007/s00300-014-1521-y; Ronconi RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015508; Sato N, 2014, AQUATIC CONSERVATION; Sato N, 2013, FISH RES, V140, P14, DOI 10.1016/j.fishres.2012.11.007; Sato N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037546; Stagi A, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P220; Yokota K, 2011, FISHERIES SCI, V77, P479, DOI 10.1007/s12562-011-0357-4	31	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184465	10.1371/journal.pone.0184465	http://dx.doi.org/10.1371/journal.pone.0184465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886183	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100129
J	Fujita, K; Nishimoto, S; Fujiwara, T; Sotsuka, Y; Tonooka, M; Kawai, K; Kakibuchi, M				Fujita, Kazutoshi; Nishimoto, Soh; Fujiwara, Toshihiro; Sotsuka, Yohei; Tonooka, Maki; Kawai, Kenichiro; Kakibuchi, Masao			A new rabbit model of impaired wound healing in an X-ray-irradiated field	PLOS ONE			English	Article							PLATELET-RICH PLASMA; BONE-MARROW ASPIRATE; INJURY MODEL; RADIATION; SKIN; THERAPY; REPAIR	Radiation is an important therapy for cancer with many benefits; however, its side effects, such as impaired wound healing, are a major problem. While many attempts have been made to overcome this particular disadvantage, there are few effective treatments for impaired wound healing in an X-ray-irradiated field. One reason for this deficiency is the lack of experimental models, especially animal models. We have previously reported a mouse model of impaired wound healing in which the irradiation area was restricted to the hindlimbs. In this mouse model, due to the size of the animal, a diameter of five millimeters was considered the largest wound size suitable for the model. In addition, the transplanted cells had to be harvested from other inbred animals. To investigate larger wounds and the impact of autologous specimen delivery, a rabbit model was developed. Rabbits were kept in a special apparatus to shield the body and hindlimbs while the irradiation field was exposed to radiation. Six weeks after irradiation, a 2 x 2 cm, full-thickness skin defect was made inside the irradiation field. Then, the wound area was observed over time. The wound area after irradiation was larger than that without irradiation at all time points. Both angiogenesis and collagen formation were reduced. For further study, as an example of using this model, the effect of autologous platelet-rich plasma (PRP) was observed. Autologous PRP from peripheral blood (pb-PRP) and bone marrow aspirate (bm-PRP) was processed and injected into the wounds in the irradiated field. Two weeks later, the wounds treated with bm-PRP were significantly smaller than those treated with phosphate buffer vehicle controls. In contrast, the wounds treated with pb-PRP were not significantly different from the controls. This rabbit model is useful for investigating the mechanism of impaired wound healing in an X-ray-irradiated field.	[Fujita, Kazutoshi; Nishimoto, Soh; Fujiwara, Toshihiro; Sotsuka, Yohei; Tonooka, Maki; Kawai, Kenichiro; Kakibuchi, Masao] Hyogo Coll Med, Dept Plast Surg, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine	Nishimoto, S (corresponding author), Hyogo Coll Med, Dept Plast Surg, Nishinomiya, Hyogo, Japan.	nishimot@hyo-med.ac.jp	Fujita, Kazutoshi/AAQ-4428-2020	Fujita, Kazutoshi/0000-0002-6774-7497; Nishimoto, Soh/0000-0002-0165-1273				Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; BUJKO K, 1993, SURG GYNECOL OBSTET, V176, P124; Fernberg JO, 2001, MED ONCOL, V18, P231, DOI 10.1385/mo:18:3:231; Forcheron F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031694; Hilmi AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/795458; Kim JW, 2013, J RADIAT RES, V54, P823, DOI 10.1093/jrr/rrt016; Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003; Kronowitz SJ, 2009, PLAST RECONSTR SURG, V124, P395, DOI 10.1097/PRS.0b013e3181aee987; Kunisada T, 2002, EUR J SURG ONCOL, V28, P75, DOI 10.1053/ejso.2001.1213; Lataillade JJ, 2007, REGEN MED, V2, P785, DOI 10.2217/17460751.2.5.785; Mapara Manjeet, 2012, Dent Res J (Isfahan), V9, P111, DOI 10.4103/1735-3327.92960; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Meng J, 2003, B AM MUS NAT HIST, P1; MILLER SH, 1990, CLIN PLAST SURG, V17, P503; Nishimoto S, 2007, WOUND REPAIR REGEN, V15, P156, DOI 10.1111/j.1524-475X.2006.00196.x; Nishimoto S, 2013, J PLAST SURG HAND SU, V47, P169, DOI 10.3109/2000656X.2012.752739; Nishimoto S, 2012, INDIAN J PLAST SURG, V45, P109, DOI 10.4103/0970-0358.96599; Rifkin LH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-68; Rodgers KE, 2016, INT J RADIAT BIOL, V92, P434, DOI 10.1080/09553002.2016.1186302; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Tsumano T, 2013, J PLAST SURG HAND SU, V47, P83, DOI 10.3109/2000656X.2012.731000; WANG Q, 1994, BRIT J DERMATOL, V130, P551, DOI 10.1111/j.1365-2133.1994.tb13098.x; Zheng K, 2015, MOL MED REP, V12, P7065, DOI 10.3892/mmr.2015.4270; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	24	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184534	10.1371/journal.pone.0184534	http://dx.doi.org/10.1371/journal.pone.0184534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886194	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100151
J	Walve, R; Salmela, L; Makinen, V				Walve, Riku; Salmela, Leena; Makinen, Veli			Variant genotyping with gap filling	PLOS ONE			English	Article								Although recent developments in DNA sequencing have allowed for great leaps in both the quality and quantity of genome assembly projects, de novo assemblies still lack the efficiency and accuracy required for studying genetic variation of individuals. Thus, efficient and accurate methods for calling and genotyping genetic variants are fundamental to studying the genomes of individuals. We study the problem of genotyping insertion variants. We assume that the location of the insertion is given, and the task is to find the insertion sequence. Insertions are the hardest structural variant to genotype, because the insertion sequence must be assembled from the reads, whereas genotyping other structural variants only requires transformations of the reference genome. The current methods for constructing insertion variants are mostly linked to variation calling methods and are only able to construct small insertions. A sub-problem in genome assembly, the gap filling problem, provides techniques that are readily applicable to insertion genotyping. Gap filling takes the context and length of a missing sequence in a genome assembly and attempts to assemble the intervening sequence. In this paper we show how tools and methods for gap filling can be used to assemble insertion variants by modeling the problem of insertion genotyping as filling gaps in the reference genome. We further give a general read filtering scheme to make the method scalable to large data sets. Our results show that gap filling methods are competitive against insertion genotyping tools. We further show that read filtering improves performance of insertion genotyping especially for long insertions. Our experiments show that on long insertions the new proposed method is the most accurate one, whereas on short insertions it has comparable performance as compared against existing tools.	[Walve, Riku; Salmela, Leena; Makinen, Veli] Univ Helsinki, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland	University of Helsinki	Salmela, L (corresponding author), Univ Helsinki, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland.	leena.salmela@cs.helsinki.fi		Makinen, Veli/0000-0003-4454-1493; Salmela, Leena/0000-0002-0756-543X; Walve, Riku Mikael/0000-0003-0397-003X	Academy of Finland [284598]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (http://www.aka.fi/en) [grant 284598 (Center of Excellence in Cancer Genetics Research) to VM]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Huang W, 2011, BIOINFORMATICS; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Rizk G, 2014, BIOINFORMATICS; Salmela L, 2016, LNBI, V9838; Salmela L, 2016, J COMPUT BIOL, V23, P347, DOI 10.1089/cmb.2015.0197; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Vergara IA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-255; Ye K, 2009, BIOINFORMATICS	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184608	10.1371/journal.pone.0184608	http://dx.doi.org/10.1371/journal.pone.0184608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886164	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100166
J	Jammal, J; Zaknoon, F; Mor, A				Jammal, Joanna; Zaknoon, Fadia; Mor, Amram			Eliciting improved antibacterial efficacy of host proteins in the presence of antibiotics	FASEB JOURNAL			English	Article						innate immunity; antibiotic resistance; peptidomimetics; synergism	GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; MOLECULAR-MECHANISMS; PEPTIDE ANTIBIOTICS; OUTER-MEMBRANE; RESISTANCE; INFECTIONS; RIFAMPIN; PERMEABILIZATION; SENSITIZATION	We recently reported the aptitude of a membrane-active lipopeptide (C(10)OOc(12)O) to sensitize gram-negative bacilli (GNB) to host antibacterial proteins. Here we explored the potential of harnessing such capacity in the presence of antibiotics. For this purpose, we compared Escherichia coli sensitization to antibiotics in broth and plasma; assessed inner and outer membrane damages using scanning electron microscopy, dyes, and mutant strains; and assessed the ability to affect disease course using the mouse peritonitis-sepsis model for mono-and combination therapies. We found that by altering permeability of both outer and inner membranes, subinhibitory concentrations of C(10)OOc(12)O can transiently sensitize GNB to diverse cytoplasm-targeting antibiotics in simple media. Sensitization was maintained in plasma, where C(10)OOc(12)O instigated greater bactericidal activities, including in the presence of a bacteriostatic antibiotic (erythromycin). Single-dose administrations of rifampin and C(10)OOc(12)O to E. coli-infectedmice resulted in 55% vs. 0, and 36% viability, respectively, for combined and individual treatments. Combining C(10)OOc(12)O and erythromycin has similarly improved mice protection from developing fatal sepsis. Consequently, the data confirmed that C(10)OOc(12)O renders GNB sensitive to both endogenous and exogenous antibacterials, and suggested that the tripartite concomitant presence increases therapeutic efficacy synergistically. This approach might expand the available treatment options to comprise antimicrobials with lowpermeability and/or efflux issues.	[Jammal, Joanna; Zaknoon, Fadia; Mor, Amram] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	amor@tx.technion.ac.il			Israel Science Foundation [909/12]; Russell Berrie Nanotechnology Institute (Technion-Israel Institute of Technology)	Israel Science Foundation(Israel Science Foundation); Russell Berrie Nanotechnology Institute (Technion-Israel Institute of Technology)	This work was supported, in part, by the Israel Science Foundation (Grant 909/12), and the Russell Berrie Nanotechnology Institute (Technion-Israel Institute of Technology). The authors declare no conflicts of interest.	Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; ELLARD GA, 1986, AM REV RESPIR DIS, V133, P1076; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2016, BBA-BIOMEMBRANES, V1858, P980, DOI 10.1016/j.bbamem.2015.10.018; FERNANDES PB, 1989, ANTIMICROB AGENTS CH, V33, P1531, DOI 10.1128/AAC.33.9.1531; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; HANCOCK REW, 1991, ANTIMICROB AGENTS CH, V35, P1309, DOI 10.1128/AAC.35.7.1309; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jammal J, 2017, J INFECT DIS, V215, P1599, DOI 10.1093/infdis/jix119; Jammal J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09216; Kaneti G, 2016, BBA-BIOMEMBRANES, V1858, P995, DOI 10.1016/j.bbamem.2015.10.022; Kaneti G, 2013, FASEB J, V27, P4834, DOI 10.1096/fj.13-237610; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1033, DOI 10.1016/j.drudis.2014.03.018; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; Meir O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02373-0; Mensa B, 2011, ANTIMICROB AGENTS CH, V55, P5043, DOI 10.1128/AAC.05009-11; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Schaberle TF, 2014, TRENDS MICROBIOL, V22, P165, DOI 10.1016/j.tim.2013.12.007; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Ude C, 2016, APPL MICROBIOL BIOT, V100, P4147, DOI 10.1007/s00253-016-7403-1; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vaara M, 2010, CURR OPIN MICROBIOL, V13, P574, DOI 10.1016/j.mib.2010.09.002; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111; Zabawa TP, 2016, CURR OPIN MICROBIOL, V33, P7, DOI 10.1016/j.mib.2016.05.005; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; Zhang LJ, 2000, ANTIMICROB AGENTS CH, V44, P3317, DOI 10.1128/AAC.44.12.3317-3321.2000; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	47	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					369	376		10.1096/fj.201700652R	http://dx.doi.org/10.1096/fj.201700652R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904017				2022-12-26	WOS:000419172700033
J	Zhang, XW; Rui, ML; Gan, GM; Huang, C; Yi, JK; Lv, HH; Xie, W				Zhang, Xinwang; Rui, Menglong; Gan, Guangmin; Huang, Cong; Yi, Jukang; Lv, Huihui; Xie, Wei			Neuroligin 4 regulates synaptic growth via the bone morphogenetic protein (BMP) signaling pathway at the Drosophila neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); development; Drosophila; neurodevelopment; synaptic plasticity; NMJ; Neuroligin 4	EXCITATORY SYNAPSES; INHIBITORY SYNAPSES; II RECEPTOR; HOMOLOG GBB; NEUREXIN; DIFFERENTIATION; BETA; TRANSMISSION; EXPRESSION; MUTATIONS	The neuroligin (Nlg) family of neural cell adhesion molecules is thought to be required for synapse formation and development and has been linked to the development of autism spectrum disorders in humans. In Drosophila melanogaster, mutations in the neuroligin 1-3 genes have been reported to induce synapse developmental defects at neuromuscular junctions (NMJs), but the role of neuroligin 4 (dnlg4) in synapse development has not been determined. Here, we report that the Drosophila neuroligin 4 (DNlg4) is different from DNlg1-3 in that it presynaptically regulates NMJ synapse development. Loss of dnlg4 results in reduced growth of NMJs with fewer synaptic boutons. The morphological defects caused by dnlg4 mutant are associated with a corresponding decrease in synaptic transmission efficacy. All of these defects could only be rescued when DNlg4 was expressed in the presynapse of NMJs. To understand the basis of DNlg4 function, we looked for genetic interactions and found connections with the components of the bone morphogenetic protein (BMP) signaling pathway. Immunostaining and Western blot analyses demonstrated that the regulation of NMJ growth by DNlg4 was due to the positive modulation of BMP signaling by DNlg4. Specifically, BMP type I receptor thickvein (Tkv) abundance was reduced in dnlg4 mutants, and immunoprecipitation assays showed that DNlg4 and Tkv physically interacted in vivo. Our study demonstrates that DNlg4 presynaptically regulates neuromuscular synaptic growth via the BMP signaling pathway by modulating Tkv.	[Zhang, Xinwang; Rui, Menglong; Huang, Cong; Lv, Huihui; Xie, Wei] Southeast Univ, Inst Life Sci, Collaborat Innovat Ctr Brain Sci, Nanjing 210096, Jiangsu, Peoples R China; [Rui, Menglong; Gan, Guangmin; Yi, Jukang; Lv, Huihui; Xie, Wei] Southeast Univ, Jiangsu Coinnovat Ctr Neuroregenerat, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Zhang, Xinwang] Shanxi Med Univ, Dept Biol, Basic Med Sch, Taiyuan 030001, Shanxi, Peoples R China	Southeast University - China; Southeast University - China; Shanxi Medical University	Xie, W (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	wei.xie@seu.edu.cn		Colbran, Roger/0000-0001-7401-8244; Rui, Menglong/0000-0002-1911-8397	National Natural Science Foundation of China [31171041, 31430035]; China National Basic Research Program (973 Program) [2012CB517903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31171041, 31430035 to W.X.) and the China National Basic Research Program (973 Program 2012CB517903 to W.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Baines RA, 2004, J NEUROSCI, V24, P6904, DOI 10.1523/JNEUROSCI.1978-04.2004; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Berke B, 2013, J NEUROSCI, V33, P17937, DOI 10.1523/JNEUROSCI.6075-11.2013; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dong T, 2016, P NATL ACAD SCI USA, V113, P7644, DOI 10.1073/pnas.1602152113; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Hu W, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002115; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li WH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006062; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Liu ZH, 2014, J NEUROSCI, V34, P2785, DOI 10.1523/JNEUROSCI.3547-13.2014; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Piccioli ZD, 2014, J NEUROSCI, V34, P4371, DOI 10.1523/JNEUROSCI.4943-13.2014; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Sand P, 2006, SCHIZOPHR RES, V82, P277, DOI 10.1016/j.schres.2005.11.003; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi WW, 2013, J NEUROSCI, V33, P12352, DOI 10.1523/JNEUROSCI.0386-13.2013; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tian Y, 2017, NEUROSCI BULL, V33, P737, DOI 10.1007/s12264-017-0166-6; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; Xing GL, 2014, J BIOL CHEM, V289, P31867, DOI 10.1074/jbc.M114.574897; Zhao GL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004984; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	62	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					17991	18005		10.1074/jbc.M117.810242	http://dx.doi.org/10.1074/jbc.M117.810242			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28912273	Green Published, hybrid			2022-12-26	WOS:000414458200002
J	Ren, YL; Shang, JH; Li, JL; Liu, WJ; Zhang, Z; Yuan, JP; Yang, M				Ren, Yanli; Shang, Jinhua; Li, Jinliang; Liu, Wenjuan; Zhang, Zhao; Yuan, Jupeng; Yang, Ming			The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; POOR-PROGNOSIS; IDENTIFIES CRKL; PROSTATE-CANCER; LUNG-CANCER; PROLIFERATION; REVEALS; RISK; TUMORIGENESIS; TRANSCRIPTOME	The long non-coding RNA (lncRNA) PCAT-1 resides in the chromosome 8q24 cancer-risk locus and acts as a vital oncogene during tumorigenesis and progression. However, how PCAT-1 is post-transcriptionally regulated, for example, by small ncRNAs, such as microRNAs (miRNAs) is largely unknown. Here, we report how miRNAs regulate PCAT-1 expression and also investigate the biological significance of this regulation in hepatocellular carcinoma (HCC). We found that miR-215, a P53-inducible miRNA, is a key regulator of PCAT-1 expression in HCC and identified an interaction between miR-215 and PCAT-1 in dual luciferase reporter gene assays. We also found that post-transcriptional silencing of PCAT-1 by miR-215 or PCAT-1 siRNAs significantly inhibited proliferation of HCC cells and, conversely, that inhibition of endogenous miR-215 up-regulated PCAT-1 expression and promoted cell viability. The tumor-suppressing role of miR-215 was further confirmed in an in vivo mouse HCC xenograft model. Of note, gene profiling assays suggested that the kinase CRK-like proto-oncogene, adaptor protein (CRKL), is a potential downstream target of the miR-215-PCAT-1 axis in HCC, and we demonstrated that CRKL silencing significantly suppresses cell proliferation. Taken together and considering the essential role of CRKL in cancer cells, we propose that the TP53-miR-215-PCAT-1-CRKL axis might represent an important regulatory pathway in HCC. In summary, our results highlight the involvement of several ncRNAs in HCC and thus provide critical insights into the molecular pathways operating in this malignancy.	[Ren, Yanli; Liu, Wenjuan; Yuan, Jupeng; Yang, Ming] Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Canc Res Ctr,Shandong Prov Key Lab Radiat Oncol, Jinan 250117, Shandong, Peoples R China; [Shang, Jinhua; Li, Jinliang; Zhang, Zhao] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100021, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; Beijing University of Chemical Technology	Yang, M (corresponding author), Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Canc Res Ctr,Shandong Prov Key Lab Radiat Oncol, Jinan 250117, Shandong, Peoples R China.	aaryoung@yeah.net	liu, wen/HGE-3071-2022; Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487	National Natural Science Foundation of China [31671300]; National High-Tech Research and Development Program of China [2015AA020950]; Taishan Scholars Program of Shandong Province [tsqn20161060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Taishan Scholars Program of Shandong Province	This work was supported by National Natural Science Foundation of China Grant 31671300, the National High-Tech Research and Development Program of China Grant 2015AA020950, and Taishan Scholars Program of Shandong Province (tsqn20161060). The authors declare that they have no conflicts of interest with the contents of this article.	Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chen ZH, 2016, BIOCHEM BIOPH RES CO, V479, P482, DOI 10.1016/j.bbrc.2016.09.089; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Deng YJ, 2014, CANCER LETT, V342, P27, DOI 10.1016/j.canlet.2013.08.033; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Evans JR, 2016, J CLIN INVEST, V126, P2775, DOI 10.1172/JCI84421; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ge GQ, 2016, ONCOL REP, V35, P1816, DOI 10.3892/or.2015.4482; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Goff LA, 2015, GENOME RES, V25, P1456, DOI 10.1101/gr.191122.115; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hu J, 2016, CANCER CELL, V29, P49, DOI 10.1016/j.ccell.2015.12.005; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Laursen Lucas, 2014, Nature, V516, pS2, DOI 10.1038/516S2a; Liu CH, 2013, MOL CELL PROTEOMICS, V12, P1335, DOI 10.1074/mcp.O112.020404; Liu L, 2015, TUMOR BIOL, V36, P7685, DOI 10.1007/s13277-015-3490-3; Madhavan D, 2016, CARCINOGENESIS, V37, P461, DOI 10.1093/carcin/bgw008; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Prensner JR, 2014, CANCER RES, V74, P1651, DOI 10.1158/0008-5472.CAN-13-3159; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qin HD, 2016, AM J HUM GENET, V98, P709, DOI 10.1016/j.ajhg.2016.02.021; Ren YL, 2016, ADV FUNCT MATER, V26, P7314, DOI 10.1002/adfm.201603041; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; Shi WH, 2015, TUMOR BIOL, V36, P2501, DOI 10.1007/s13277-014-2863-3; Tamura M, 2015, CANCER SCI, V106, P1033, DOI 10.1111/cas.12713; Tang L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.41; Wang XY, 2015, FEBS LETT, V589, P4079, DOI 10.1016/j.febslet.2015.11.024; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Wang YX, 2016, JPN J CLIN ONCOL, V46, P350, DOI 10.1093/jjco/hyv204; Wen JF, 2016, MOL MED REP, V13, P4481, DOI 10.3892/mmr.2016.5075; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; Worns MA, 2014, NAT REV GASTRO HEPAT, V11, P447, DOI 10.1038/nrgastro.2014.10; Yan TH, 2015, INT J CLIN EXP PATHO, V8, P4126; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yang X, 2015, CANCER LETT, V360, P119, DOI 10.1016/j.canlet.2015.02.035; Yang XY, 2016, AM J HUM GENET, V99, P275, DOI 10.1016/j.ajhg.2016.05.029; Yao J, 2017, ONCOL LETT, V14, P1097, DOI 10.3892/ol.2017.6200; Ye MX, 2015, CANCER LETT, V357, P196, DOI 10.1016/j.canlet.2014.11.028; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Yuan SX, 2016, HEPATOLOGY, V63, P499, DOI 10.1002/hep.27893	46	52	53	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17939	17949		10.1074/jbc.M116.773978	http://dx.doi.org/10.1074/jbc.M116.773978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887306	hybrid, Green Published			2022-12-26	WOS:000414013000029
J	Howard, MJ; Wilson, SH				Howard, Michael J.; Wilson, Samuel H.			Processive searching ability varies among members of the gap-filling DNA polymerase X family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACILITATED DIFFUSION; INTERSEGMENT TRANSFER; RNA-POLYMERASE; COGNATE SITES; GLYCOSYLASE; REPAIR; DAMAGE; TRANSLOCATION; MECHANISM; PROTEIN	DNA repair proteins must locate rare damaged sites within the genome. DNA polymerase beta (Pol beta), a member of the DNA polymeraseXfamily that is involved in base excision repair, uses a processive hopping search mechanism to locate substrates. This effectively enhances its search footprint on DNA, increasing the probability of locating damaged sites. Processive searching has been reported or proposed for many DNA-binding proteins, raising the question of how widespread or specific to certain enzymes the ability to perform this function is. To provide insight into this question, we compared the ability of three homologous DNA Pol X family members to perform a processive search for 1-nucleotide gaps in DNA using a previously developed biochemical assay. We found that at near-predicted physiological ionic strengths, the intramolecular searching ability of Pol beta is at least 4-fold higher than that of Pol mu and similar to 2-fold higher than that of Pol beta. Pol beta also was able to perform intersegmental transfer with the intersegmental searching ability of Pol beta being at least 6- and similar to 2-fold higher than that of Pols mu and lambda, respectively. Mutational analysis suggested that differences in the N-terminal domains of these polymerases are responsible for the varying degrees of searching competence. Of note, the differences in processive searching ability observed among the DNA Pol X family members correlated with their proposed biological functions in base excision repair and nonhomologous end joining.	[Howard, Michael J.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Howard, Michael/0000-0001-9990-930X	NIEHS, National Institutes of Health Intramural Research Program [Z01-ES050158, Z01-ES050161]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050161, Z01ES050158, Z01ES050161] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Intramural Research Program Grants Z01-ES050158 and Z01-ES050161 (to S.H.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beard WA, 1995, METHOD ENZYMOL, V262, P98; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bienstock RJ, 2014, DNA REPAIR, V22, P77, DOI 10.1016/j.dnarep.2014.07.003; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Cravens SL, 2015, NUCLEIC ACIDS RES, V43, P4087, DOI 10.1093/nar/gkv301; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Esadze A, 2014, NUCLEIC ACIDS RES, V42, P7039, DOI 10.1093/nar/gku418; FRIED MG, 1984, J MOL BIOL, V172, P263, DOI 10.1016/S0022-2836(84)80026-1; Friedman LJ, 2013, P NATL ACAD SCI USA, V110, P9740, DOI 10.1073/pnas.1300221110; Frouin I, 2005, NUCLEIC ACIDS RES, V33, P5354, DOI 10.1093/nar/gki845; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2013, J BIOL CHEM, V288, P24550, DOI 10.1074/jbc.M113.477018; Hendershot JM, 2017, J BIOL CHEM, V292, P16070, DOI 10.1074/jbc.M117.782813; Howard MJ, 2017, NUCLEIC ACIDS RES, V45, P3822, DOI 10.1093/nar/gkx047; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.0.CO;2-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Redding S, 2013, CHEM PHYS LETT, V570, P1, DOI 10.1016/j.cplett.2013.03.035; Rowland MM, 2014, NUCLEIC ACIDS RES, V42, P9295, DOI 10.1093/nar/gku621; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Schmidt H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102444; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tian L, 2009, BIOCHEMISTRY-US, V48, P264, DOI 10.1021/bi801630b; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wentzell LM, 1998, J MOL BIOL, V281, P433, DOI 10.1006/jmbi.1998.1967; Zhang YR, 2015, ACS CHEM BIOL, V10, P2606, DOI 10.1021/acschembio.5b00409	39	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17473	17481		10.1074/jbc.M117.801860	http://dx.doi.org/10.1074/jbc.M117.801860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28893909	hybrid, Green Published			2022-12-26	WOS:000414009300027
J	Medrzycki, P; Jarzyna, I; Obidzinski, A; Tokarska-Guzik, B; Sotek, Z; Pabjanek, P; Pytlarczyk, A; Sachajdakiewicz, I				Medrzycki, Piotr; Jarzyna, Ingeborga; Obidzinski, Artur; Tokarska-Guzik, Barbara; Sotek, Zofia; Pabjanek, Piotr; Pytlarczyk, Adam; Sachajdakiewicz, Izabela			Simple yet effective: Historical proximity variables improve the species distribution models for invasive giant hogweed (Heracleum mantegazzianum s. l.) in Poland	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; PROPAGULE PRESSURE; PHRAGMITES-AUSTRALIS; PLANT; CONSTRAINTS; SCALES; CONSERVATION; BIODIVERSITY; PREDICTIONS; DISPERSAL	Species distribution models are scarcely applicable to invasive species because of their breaking of the models' assumptions. So far, few mechanistic, semi-mechanistic or statistical solutions like dispersal constraints or propagule limitation have been applied. We evaluated a novel quasi-semi-mechanistic approach for regional scale models, using historical proximity variables (HPV) representing a state of the population in a given moment in the past. Our aim was to test the effects of addition of HPV sets of different minimal recentness, information capacity and the total number of variables on the quality of the species distribution model for Heracleum mantegazzianum on 116000 km(2) in Poland. As environmental predictors, we used fragments of 103 1x1 km, world-wide, free-access rasters from WorldGrids. org. Single and ensemble models were computed using BIO-MOD2 package 3.1.47 working in R environment 3.1.0. The addition of HPV improved the quality of single and ensemble models from poor to good and excellent. The quality was the highest for the variants with HPVs based on the distance from the most recent past occurrences. It was mostly affected by the algorithm type, but all HPV traits (minimal recentness, information capacity, model type or the number of the time periods) were significantly important determinants. The addition of HPVs improved the quality of current projections, raising the occurrence probability in regions where the species had occurred before. We conclude that HPV addition enables semi-realistic estimation of the rate of spread and can be applied to the short-term forecasting of invasive or declining species, which also break equal-dispersal probability assumptions.	[Medrzycki, Piotr; Pytlarczyk, Adam; Sachajdakiewicz, Izabela] Univ Ecol & Management Warsaw, Fac Ecol, Lab Appl Plant Ecol, Warsaw, Poland; [Jarzyna, Ingeborga] Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Dept Plant Ecol & Environm Protect, Warsaw, Poland; [Obidzinski, Artur] Warsaw Univ Life Sci, Fac Forestry, Dept Forest Bot, Warsaw, Poland; [Tokarska-Guzik, Barbara] Univ Silesia Katowice, Fac Biol & Environm Protect, Deptartment Bot & Nat Protect, Katowice, Poland; [Sotek, Zofia] Univ Szczecin, Dept Bot & Nat Conservat, Fac Biol, Szczecin, Poland; [Pabjanek, Piotr] Univ Warsaw, Fac Geog & Reg Studies, Dept Geoinformat Cartog & Remote Sensing, Warsaw, Poland	University of Warsaw; Warsaw University of Life Sciences; University of Silesia in Katowice; University of Szczecin; University of Warsaw	Medrzycki, P (corresponding author), Univ Ecol & Management Warsaw, Fac Ecol, Lab Appl Plant Ecol, Warsaw, Poland.	piotr.medrzycki@pser.pl	Tokarska-Guzik, Barbara/L-8891-2019	Tokarska-Guzik, Barbara/0000-0002-4058-1220; Jarzyna, Ingeborga/0000-0002-6676-8210; Medrzycki, Piotr/0000-0002-3203-1034; Sotek, Zofia/0000-0002-8303-9044	Wyzsza Szkola Ekologii i Zarzadzania [21/2013]; European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; University of Ecology and Management in Warsaw [21/2013]	Wyzsza Szkola Ekologii i Zarzadzania; European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; University of Ecology and Management in Warsaw	The first author was awarded a research grant from his university - i.e. Wyzsza Szkola Ekologii i Zarzadzania (Award Number: 21/2013; Recipient: Piotr Medrzycki, Ph.D.) - covering costs of gathering data on giant hogweed distribution in Poland in 2013. The study was partly carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Damien Georges from the BIOMOD team for his valuable help in getting our BIO-MOD2 scripts running and Matthew E. Gladden for proofreading the text. The study was partly founded by a research grant No.: 21/2013 awarded by University of Ecology and Management in Warsaw, covering costs of gathering data on giant hogweed distribution in Poland, and was partly carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013. We are also grateful to the anonymous reviewers for their very constructive comments that allowed us to improve a first ms version.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], BIOMOD2 ENSEMBLE PLA; Beauregard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092642; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bosso L, 2017, ENVIRON MANAGE, V60, P304, DOI 10.1007/s00267-017-0882-8; Caffrey JM, 1999, HYDROBIOLOGIA, V415, P223, DOI 10.1023/A:1003854221931; Clegg L, 1974, T BOT SOC EDINBURGH, V42, P223, DOI [10.1080/03746607408685282, DOI 10.1080/03746607408685282]; Collingham YC, 2000, J APPL ECOL, V37, P13, DOI 10.1046/j.1365-2664.2000.00556.x; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; Dawson FH, 1999, HYDROBIOLOGIA, V415, P193, DOI 10.1023/A:1003872325274; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Dostal P, 2013, ECOL LETT, V16, P1277, DOI 10.1111/ele.12166; Elith J., 2013, PREDICTING DISTRIBUT, V69, P77; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Fischer M.M., 2014, HDB REGIONAL SCI, P1477, DOI [10.1007/978-3-642-23430-9_72, DOI 10.1007/978-3-642-23430-9, DOI 10.1007/978-3-642-23430-9_72]; Fortin MJ, 2009, GEOGR ANAL, V41, P392, DOI 10.1111/j.1538-4632.2009.00766.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Kabuce N., ONLINE DATABASE EURO; Klingenstein F., 2007, NOBANIS INVASIVE ALI; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Laman N A, 2009, GIGANTSKIE BORSHHEVI; Leroy B, 2016, ECOGRAPHY, V39, P599, DOI 10.1111/ecog.01388; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Long AL, 2017, WETLANDS, V37, P45, DOI 10.1007/s13157-016-0838-4; Maheu-Giroux M, 2007, LANDSCAPE ECOL, V22, P285, DOI 10.1007/s10980-006-9024-z; Moenickes S, 2013, BIOL INVASIONS, V15, P61, DOI 10.1007/s10530-012-0268-z; Mokany K, 2011, DIVERS DISTRIB, V17, P374, DOI 10.1111/j.1472-4642.2010.00735.x; Mujuni N, 2014, USE SPECIES DISTRIBU; Nehrbass N, 2006, PERSPECT PLANT ECOL, V7, P253, DOI 10.1016/j.ppees.2005.11.001; Nehrbass N., 2006, USING ECOLOGICAL MOD; Nehrbass N, 2007, ECOL MODEL, V201, P377, DOI 10.1016/j.ecolmodel.2006.10.004; Nielsen C, 2008, DIVERS DISTRIB, V14, P307, DOI 10.1111/j.1472-4642.2007.00456.x; Parry Hazel R., 2013, NeoBiota, V18, P41; Pellissier L, 2013, J BIOGEOGR, V40, P1939, DOI 10.1111/jbi.12140; Phillips ND, 2017, J BIOGEOGR, P1; Pysek P, 2008, DIVERS DISTRIB, V14, P355, DOI 10.1111/j.1472-4642.2007.00431.x; Reuter HI, 2012, DIGITAL SOIL ASSESSMENTS AND BEYOND, P287; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Sachajdakiewicz I, 2014, WYTYCZNE DOTYCZQCE Z; Sachajdakiewicz I, 2014, RAPORT KORICOWY SPI; Sachajdakiewicz I., 2008, THESIS; Schmitt T, 2014, GLOBAL CHANGE BIOL, V20, P2045, DOI 10.1111/gcb.12462; Sheppard AW, 2006, WEED RES, V46, P93, DOI 10.1111/j.1365-3180.2006.00497.x; Simpson M., 2011, GEOMORPHOLOGY, V3, P5; Simpson M, 2013, ENVIRON CONSERV, V40, P167, DOI 10.1017/S037689291200032X; Sosnowskyi H., 2013, DAT HER MANT; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thiele J., 2012, CAB Reviews, V7, P1, DOI [10.1079/PAVSNNR20127017, 10.1079/PAVSNNR20127020, 10.1079/PAVSNNR20127016, 10.1079/PAVSNNR20127018, 10.1079/PAVSNNR20127019]; Thiele J, 2008, J NAT CONSERV, V16, P61, DOI 10.1016/j.jnc.2007.08.002; Thomas SM, 2013, LANDSCAPE ECOL, V28, P81, DOI 10.1007/s10980-012-9816-2; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tokarska-Guzik B., 2005, ESTABLISHMENT SPREAD; Tokarska-Guzik B., 2001, BUTION ATLAS VASCULA, P274; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wallentin G., 2013, INT J GEOINFORMATICS, V9; Warren RJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00393.1; Welk E, 2004, ECOL MODEL, V179, P551, DOI 10.1016/j.ecolmodel.2004.04.020; Zhang H, 2000, WEATHER FORECAST, V15, P80, DOI 10.1175/1520-0434(2000)015<0080:VOCPF>2.0.CO;2; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	67	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184677	10.1371/journal.pone.0184677	http://dx.doi.org/10.1371/journal.pone.0184677			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926580	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600033
J	Andrade, GM; da Silveira, JC; Perrini, C; Del Collado, M; Gebremedhn, S; Tesfaye, D; Meirelles, FV; Perecin, F				Andrade, Gabriella Mamede; da Silveira, Juliano Coelho; Perrini, Claudia; Del Collado, Maite; Gebremedhn, Samuel; Tesfaye, Dawit; Meirelles, Flavio Vieira; Perecin, Felipe			The role of the PI3K-Akt signaling pathway in the developmental competence of bovine oocytes	PLOS ONE			English	Article							IN-VITRO; PRIMORDIAL FOLLICLES; OXIDATIVE STRESS; GENE-EXPRESSION; OVARIAN-CANCER; CELLS; QUALITY; PTEN; ACTIVATION; APOPTOSIS	The ovarian follicle encloses oocytes in a microenvironment throughout their growth and acquisition of competence. Evidence suggests a dynamic interplay among follicular cells and oocytes, since they are constantly exchanging "messages". We dissected bovine ovarian follicles and recovered follicular cells (FCs-granulosa and cumulus cells) and cumulus-oocyte complexes (COCs) to investigate whether the PI3K-Akt signaling pathway impacted oocyte quality. Following follicle rupture, COCs were individually selected for in vitro cultures to track the follicular cells based on oocyte competence to reach the blastocyst stage after parthenogenetic activation. Levels of PI3K-Akt signaling pathway components in FCs correlated with oocyte competence. This pathway is upregulated in FCs from follicles with high-quality oocytes that are able to reach the blastocyst stage, as indicated by decreased levels of PTEN and increased levels of the PTEN regulators bta-miR-494 and bta-miR-20a. Using PI3K-Akt responsive genes, we showed decreased FOXO3a levels and BAX levels in lower quality groups, indicating changes in cell cycle progression, oxidative response and apoptosis. Based on these results, the measurement of levels of PI3K-Akt pathway components in FCs from ovarian follicles carrying oocytes with distinct developmental competences is a useful tool to identify putative molecular pathways involved in the acquisition of oocyte competence.	[Andrade, Gabriella Mamede; da Silveira, Juliano Coelho; Del Collado, Maite; Meirelles, Flavio Vieira; Perecin, Felipe] Univ Sao Paulo, Fac Anim Sci & Food Engn, Vet Med Dept, Pirassununga, SP, Brazil; [Perrini, Claudia] Univ Milan, Reprod Unit, Large Anim Hosp, Lodi, Italy; [Gebremedhn, Samuel; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci ITW, Bonn, Germany	Universidade de Sao Paulo; University of Milan; University of Bonn	Perecin, F (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Vet Med Dept, Pirassununga, SP, Brazil.	fperecin@usp.br	Gebremedhn, Samuel/AAQ-3139-2020; Andrade, Gabriella M/F-9881-2012; Silveira, Juliano C/B-3086-2013; Meirelles, Flavio V/B-5048-2010; del Collado, Maite/M-4870-2015; Da Silveira, Juliano/AAH-9784-2020; Perecin, Felipe/C-7268-2012; CTC USP, CEPID 13 18/J-8951-2014	Andrade, Gabriella M/0000-0002-8095-3738; Silveira, Juliano C/0000-0002-4796-6393; Meirelles, Flavio V/0000-0003-0372-4920; del Collado, Maite/0000-0002-4098-4855; Da Silveira, Juliano/0000-0002-4796-6393; Perecin, Felipe/0000-0003-2009-5863; CTC USP, CEPID 13 18/0000-0002-7123-9524; Gebremedhn, Samuel/0000-0002-9977-2347	Sao Paulo Research Foundation (FAPESP) [2014/21034-3, 2014/22887-0, 2013/08135-2, 2012/50533-2]; National Counsel of Technological and Scientific Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP grants 2014/21034-3; 2014/22887-0; 2013/08135-2 and 2012/50533-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors like to thank the staff and students at the Laboratory of Molecular Morphophysiology and Development (LMMD) for all their help with the sample collections and laboratory procedures. This work was supported by the Sao Paulo Research Foundation (FAPESP grants 2014/21034-3; 2014/22887-0; 2013/08135-2 and 2012/50533-2) and the National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Andreas E, 2016, CELL TISSUE RES, P1; Brenkman AB, 2003, TRENDS MOL MED, V9, P464, DOI 10.1016/j.molmed.2003.09.003; Combelles CMH, 2010, REPRODUCTION, V139, P871, DOI 10.1530/REP-09-0390; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Driancourt MA, 1998, REPROD NUTR DEV, V38, P345, DOI 10.1051/rnd:19980401; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Feng WG, 2007, THERIOGENOLOGY, V67, P1339, DOI 10.1016/j.theriogenology.2007.01.017; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gebremedhn S, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137539; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Krisher RL, 2013, ANNU REV ANIM BIOSCI, V1, P393, DOI 10.1146/annurev-animal-031412-103647; Lai K, 2015, J CLIN PATHOL, V68, P253, DOI 10.1136/jclinpath-2015-202885; Li HJ, 2009, ANIM REPROD SCI, V114, P89, DOI 10.1016/j.anireprosci.2008.09.018; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Lonergan P, 2003, REPROD DOMEST ANIM, V38, P259, DOI 10.1046/j.1439-0531.2003.00437.x; Luo X, 2013, CELL PROLIFERAT, V46, P436, DOI 10.1111/cpr.12038; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Makker A, 2014, J MOL ENDOCRINOL, V53, pR103, DOI 10.1530/JME-14-0220; Marx D, 1997, ANTICANCER RES, V17, P2233; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; Mermillod P, 2008, REPROD DOMEST ANIM, V43, P393, DOI 10.1111/j.1439-0531.2008.01190.x; Neri C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00015; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Sangalli JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101022; Sharma I, 2012, REPRODUCTION, V144, P373, DOI 10.1530/REP-12-0079; Sirard M. A., 2013, Oocyte physiology and development in domestic animals, P191; Sirard MA, 2003, REPRODUCTION, P117; Wang L-Q, 2014, REPROD FERTILITY DEV; Xu M, 2012, CELL MOL LIFE SCI, V69, P3601, DOI 10.1007/s00018-012-1129-8; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5	34	41	47	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185045	10.1371/journal.pone.0185045	http://dx.doi.org/10.1371/journal.pone.0185045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922408	Green Published, gold, Green Submitted			2022-12-26	WOS:000411059300054
J	De Zanet, D; Battiston, M; Lombardi, E; Specogna, R; Trevisan, F; De Marco, L; Affanni, A; Mazzucato, M				De Zanet, Denise; Battiston, Monica; Lombardi, Elisabetta; Specogna, Ruben; Trevisan, Francesco; De Marco, Luigi; Affanni, Antonio; Mazzucato, Mario			Impedance biosensor for real-time monitoring and prediction of thrombotic individual profile in flowing blood	PLOS ONE			English	Article							WHOLE-BLOOD; GROWTH	A new biosensor for the real-time analysis of thrombus formation is reported. The fast and accurate monitoring of the individual thrombotic risk represents a challenge in cardiovascular diagnostics and in treatment of hemostatic diseases. Thrombus volume, as representative index of the related thrombotic status, is usually estimated with confocal microscope at the end of each in vitro experiment, without providing a useful behavioral information of the biological sample such as platelets adhesion and aggregation in flowing blood. Our device has been developed to work either independently or integrated with the microscopy system; thus, images of the fluorescently labeled platelets are acquired in real-time during the whole blood perfusion, while the global electrical impedance of the blood sample is simultaneously monitored between a pair of specifically designed gold microelectrodes. Fusing optical and electrical data with a novel technique, the dynamic of thrombus formation events in flowing blood can be reconstructed in real-time, allowing an accurate extrapolation of the three-dimensional shape and the spatial distribution of platelet thrombi forming and growing within artificial capillaries. This biosensor is accurate and it has been used to discriminate different hemostatic conditions and to identify weakening and detaching platelet aggregates. The results obtained appear compatible with those quantified with the traditional optical method. With advantages in terms of small size, user-friendliness and promptness of response, it is a promising device for the fast and automatic individual health monitoring at the Point of Care (POC).	[De Zanet, Denise; Specogna, Ruben; Trevisan, Francesco; Affanni, Antonio] Univ Udine, Polytech Dept Engn & Architecture, Udine, Italy; [De Zanet, Denise; Battiston, Monica; Lombardi, Elisabetta; De Marco, Luigi; Mazzucato, Mario] Natl Canc Inst CRO IRCCS, Dept Translat Res, Stem Cells Unit, Aviano, Pordenone, Italy	University of Udine; IRCCS Aviano (CRO)	Mazzucato, M (corresponding author), Natl Canc Inst CRO IRCCS, Dept Translat Res, Stem Cells Unit, Aviano, Pordenone, Italy.	mmazzucato@cro.it	Specogna, Ruben/E-6574-2018; Mazzucato, Mario/ABF-5472-2020; Lombardi, Elisabetta/AAC-2396-2020; Battiston, Monica/S-8997-2019	Mazzucato, Mario/0000-0001-8319-053X; Lombardi, Elisabetta/0000-0002-3688-9281; Battiston, Monica/0000-0001-6657-4195	Italian Ministry of Health [RF-2010-2316198, RF-2010-2317993]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grant from the Italian Ministry of Health RF-2010-2316198 and RF-2010-2317993 (Dr. Luigi De Marco, Dr. Mario Mazzucato).	Affanni A, 2016, MEASUREMENT, V79, P260, DOI 10.1016/j.measurement.2015.05.045; Affanni A, 2013, IEEE T INSTRUM MEAS, V62, P2954, DOI 10.1109/TIM.2013.2266012; Affanni A, 2012, IEEE IMTC P, P1477; Affanni A, 2013, J PHYS C SERIES, V459; Affanni A., 2011, IEEE INT S MED MEAS, P80; Affanni A, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2281987; Affanni A, 2012, IEEE T BIO-MED ENG, V59, P2619, DOI 10.1109/TBME.2012.2207897; Agilent Technology, 2008, AG E4980A PREC LCR M; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Bonanno LM, 2007, BIOSENS BIOELECTRON, V23, P444, DOI 10.1016/j.bios.2007.05.008; Branchford BR, 2015, THROMB RES, V136, P13, DOI 10.1016/j.thromres.2015.05.012; Chen D, 2017, BIOSENS BIOELECTRON, V91, P465, DOI 10.1016/j.bios.2016.12.063; Claesson K, 2016, THROMB HAEMOSTASIS, V115, P1178, DOI 10.1160/TH15-10-0799; Eils R, 2003, J CELL BIOL, V161, P477, DOI 10.1083/jcb.200302097; HIRSCH FG, 1950, BLOOD, V5, P1017, DOI 10.1182/blood.V5.11.1017.1017; HUBBELL JA, 1986, REV SCI INSTRUM, V57, P892, DOI 10.1063/1.1138830; JCGM, 2008, JCGM 100 2008 EVALUA; Lei KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076243; Li M, 2012, LAB CHIP, V12, P1355, DOI 10.1039/c2lc21145a; Mazzucato M, 2004, BLOOD, V104, P3221, DOI 10.1182/blood-2004-03-1145; Mazzucato Mario, 2007, Ann Ist Super Sanita, V43, P130; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Puckett LG, 2003, BIOSENS BIOELECTRON, V18, P675, DOI 10.1016/S0956-5663(03)00033-2; Roest M, 2011, J THROMB HAEMOST, V9, P2322, DOI 10.1111/j.1538-7836.2011.04492.x; Ruggeri M., 2013, PLATELETS, P399, DOI [DOI 10.1016/B978-0-12-387837-3.00020-1, 10.1016/B978-0-12-387837-3.00020-1]; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Westein E, 2012, PLATELETS, V23, P501, DOI 10.3109/09537104.2012.709653; Zhang YS, 2016, LAB CHIP, V16, P4097, DOI 10.1039/c6lc00380j; Zhbanov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129337	31	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184941	10.1371/journal.pone.0184941	http://dx.doi.org/10.1371/journal.pone.0184941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922391	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300049
J	Pusterla, JM; Schneck, E; Funari, SS; Deme, B; Tanaka, M; Oliveira, RG				Pusterla, Julio M.; Schneck, Emanuel; Funari, Sergio S.; Deme, Bruno; Tanaka, Motomu; Oliveira, Rafael G.			Cooling induces phase separation in membranes derived from isolated CNS myelin	PLOS ONE			English	Article							X-RAY-DIFFRACTION; NERVOUS-SYSTEM MYELIN; AIR-WATER-INTERFACE; ELECTRON-MICROSCOPY; NEUTRON-SCATTERING; MONOLAYERS; VESICLES; TRANSITIONS; BEHAVIOR; NERVES	Purified myelin membranes (PMMs) are the starting material for biochemical analyses such as the isolation of detergent-insoluble glycosphingolipid-rich domains (DIGs), which are believed to be representatives of functional lipid rafts. The normal DIGs isolation protocol involves the extraction of lipids under moderate cooling. Here, we thus address the influence of cooling on the structure of PMMs and its sub-fractions. Thermodynamic and structural aspects of periodic, multilamellar PMMs are examined between 4 degrees C and 45 degrees C and in various biologically relevant aqueous solutions. The phase behavior is investigated by small-angle X-ray scattering (SAXS) and differential scanning calorimetry (DSC). Complementary neutron diffraction (ND) experiments with solid-supported myelin multilayers confirm that the phase behavior is unaffected by planar confinement. SAXS and ND consistently show that multilamellar PMMs in pure water become heterogeneous when cooled by more than 10-15 degrees C below physiological temperature, as during the DIGs isolation procedure. The heterogeneous state of PMMs is stabilized in physiological solution, where phase coexistence persists up to near the physiological temperature. This result supports the general view that membranes under physiological conditions are close to critical points for phase separation. In presence of elevated Ca2+ concentrations (> 10 mM), phase coexistence is found even far above physiological temperatures. The relative fractions of the two phases, and thus presumably also their compositions, are found to vary with temperature. Depending on the conditions, an "expanded" phase with larger lamellar period or a "compacted" phase with smaller lamellar period coexists with the native phase. Both expanded and compacted periods are also observed in DIGs under the respective conditions. The observed subtle temperature-dependence of the phase behavior of PMMs suggests that the composition of DIGs is sensitive to the details of the isolation protocol.	[Pusterla, Julio M.; Oliveira, Rafael G.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBC, Dept Quim Biol, Cordoba, Argentina; [Schneck, Emanuel] Max Planck Inst Colloids & Interfaces, Biomat Dept, Potsdam, Germany; [Funari, Sergio S.] DESY, HASYLAB, Hamburg, Germany; [Deme, Bruno] ILL Grenoble, Grenoble, France; [Tanaka, Motomu] Heidelberg Univ, Biophys Chem 2, Inst Phys Chem, Heidelberg, Germany; [Tanaka, Motomu] Heidelberg Univ, BIOQUANT, Heidelberg, Germany; [Tanaka, Motomu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan	National University of Cordoba; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Institut Laue-Langevin (ILL); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Kyoto University	Oliveira, RG (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBC, Dept Quim Biol, Cordoba, Argentina.	rafaeltum@gmail.com	Tanaka, Motomu/S-5949-2016; Demé, Bruno/AAG-1620-2021	Tanaka, Motomu/0000-0003-3663-9554; Demé, Bruno/0000-0002-9523-7662; Pusterla, Julio Martin/0000-0002-2996-5290; Schneck, Emanuel/0000-0001-9769-2194; Oliveira, Rafael Gustavo/0000-0001-5948-5338	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [11220150100621CO]; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) [2012-2583]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina); Secretaria de Ciencia y Tecnologia, University of Cordoba (SECyT-UNC); Alexander von Humboldt Foundation	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina); Secretaria de Ciencia y Tecnologia, University of Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) grant no. 11220150100621CO, Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) grant no. 2012-2583, Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina) and Secretaria de Ciencia y Tecnologia, University of Cordoba (SECyT-UNC) to RGO. RGO is career investigators of CONICET (Argentina). JMP is doctoral fellow from CONICET. RGO thanks the Alexander von Humboldt Foundation for a postdoctoral research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis DN, 2002, J NEUROSCI RES, V70, P8, DOI 10.1002/jnr.10383; CHIA LS, 1984, P NATL ACAD SCI-BIOL, V81, P1871, DOI 10.1073/pnas.81.6.1871; Denninger AR, 2015, BIOPHYS J, V109, P1387, DOI 10.1016/j.bpj.2015.08.012; Denninger AR, 2014, ACTA CRYSTALLOGR D, V70, P3198, DOI 10.1107/S1399004714023815; ELKES J, 1953, EXP CELL RES, V4, P82, DOI 10.1016/0014-4827(53)90190-6; FINEAN JB, 1988, CHEM PHYS LIPIDS, V46, P63, DOI 10.1016/0009-3084(88)90115-6; HALEY JE, 1981, CELL MOL NEUROBIOL, V1, P175, DOI 10.1007/BF00710718; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; INOUYE H, 1989, BIOPHYS J, V56, P129, DOI 10.1016/S0006-3495(89)82658-X; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; Inouye H., 2009, MOL NUCL AGGREGATION, P73; Jin AJ, 1999, BIOCHEMISTRY-US, V38, P13275, DOI 10.1021/bi9912084; JOHNSTON DS, 1988, BIOCHIM BIOPHYS ACTA, V939, P603, DOI 10.1016/0005-2736(88)90108-3; KARTHIGASAN J, 1988, J NEUROCHEM, V51, P228, DOI 10.1111/j.1471-4159.1988.tb04860.x; Keller SL, 1998, PHYS REV LETT, V81, P5019, DOI 10.1103/PhysRevLett.81.5019; KERN W, 1970, RCA REV, V31, P187; Kim T, 1999, J NEUROCYTOL, V28, P281, DOI 10.1023/A:1007001427597; Kirschner D., 1984, DIFFRACTION STUDIES, P51; KIRSCHNER DA, 1975, P NATL ACAD SCI USA, V72, P3513, DOI 10.1073/pnas.72.9.3513; KIRSCHNER DA, 1979, J CELL BIOL, V82, P140, DOI 10.1083/jcb.82.1.140; KIRSCHNER DA, 1980, J ULTRA MOL STRUCT R, V73, P211, DOI 10.1016/S0022-5320(80)90125-2; Larocca JN, 2006, CURRENT PROTOCOLS CE, P33; Luzzati V, 1999, J MOL BIOL, V286, P1389, DOI 10.1006/jmbi.1998.2587; MATEU L, 1995, J MOL BIOL, V245, P110, DOI 10.1006/jmbi.1994.0011; MELCHIOR V, 1979, BIOCHIM BIOPHYS ACTA, V554, P204, DOI 10.1016/0005-2736(79)90019-1; Min Y, 2011, BIOPHYS J, V100, P1490, DOI 10.1016/j.bpj.2011.02.009; MOSCARELLO MA, 1983, BIOCHIM BIOPHYS ACTA, V728, P201, DOI 10.1016/0005-2736(83)90472-8; Nagle JF, 2016, SOFT MATTER, V12, P1884, DOI 10.1039/c5sm02336j; Oliveira RG, 2010, BIOPHYS J, V99, P1500, DOI 10.1016/j.bpj.2010.06.053; Oliveira RG, 2002, BBA-BIOMEMBRANES, V1561, P238, DOI 10.1016/S0005-2736(02)00350-4; Oliveira RG, 1998, BBA-BIOMEMBRANES, V1370, P127, DOI 10.1016/S0005-2736(97)00254-X; Oliveira RG, 2000, NEUROCHEM RES, V25, P77, DOI 10.1023/A:1007591516539; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Petrascu AM, 1998, J MACROMOL SCI PHYS, VB37, P463, DOI 10.1080/00222349808220487; Rosetti CM, 2005, BBA-BIOMEMBRANES, V1668, P75, DOI 10.1016/j.bbamem.2004.11.009; RUIZSANZ J, 1992, EUR BIOPHYS J BIOPHY, V21, P169, DOI 10.1007/BF00196760; Sackmann E., 1995, HDB BIOL PHYS A&B, V1A, P213, DOI [10.1016/S1383-8121(06)80022-9, DOI 10.1016/S1383-8121(06)80022-9]; Schlaich A, 2015, PHYSICA A, V418, P105, DOI 10.1016/j.physa.2014.06.088; Schmitt FO, 1935, RADIOLOGY, V25, P131; Schneck E, 2011, BIOPHYS J, V100, P2151, DOI 10.1016/j.bpj.2011.03.011; Schneck E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061924; SEDZIK J, 1984, J NEUROCHEM, V43, P1415, DOI 10.1111/j.1471-4159.1984.tb05402.x; SEDZIK J, 1995, J NEUROSCI RES, V41, P145, DOI 10.1002/jnr.490410202; Taylor C.M., 2004, MYELIN BIOL DISORDER, V1; Taylor CM, 2002, J NEUROCHEM, V81, P993, DOI 10.1046/j.1471-4159.2002.00884.x; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; WORTHINGTON CR, 1976, BIOCHIM BIOPHYS ACTA, V436, P707, DOI 10.1016/0005-2736(76)90452-1; WORTHINGTON CR, 1980, ARCH BIOCHEM BIOPHYS, V201, P429, DOI 10.1016/0003-9861(80)90531-7; WORTHINGTON CR, 1981, INT J BIOL MACROMOL, V3, P159, DOI 10.1016/0141-8130(81)90057-X	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184881	10.1371/journal.pone.0184881	http://dx.doi.org/10.1371/journal.pone.0184881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915267	Green Published, Green Submitted, gold			2022-12-26	WOS:000410861600020
J	Byun, SJ; Bae, WH; Jung, SM; Lee, SW; Park, YB; Song, JJ				Byun, Se Jin; Bae, William Han; Jung, Seung Min; Lee, Sang-Won; Park, Yong-Beom; Song, Jason Jungsik			Fever as an initial manifestation of spondyloarthritis: A retrospective study	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; CLINICAL-ASPECTS; DOUBLE-BLIND; ARTHRITIS; EFFICACY	Objectives: We aimed to evaluate a wide spectrum of clinical features of adult patients with spondyloarthritis (SpA) whose initial manifestation was fever, using the Assessment of SpondyloArthritis international Society (ASAS) classification criteria. Methods: We retrospectively collected the electronic medical records of hospitalized SpA patients who initially presented to the Severance Hospital (Seoul, Korea) with fever from January 2010 to May 2016. As a control group, we also recruited one-hundred consecutive patients who were diagnosed with SpA in our outpatient clinic. Clinical features and laboratory findings were compared in two patient groups. Results: There were 26 patients who had fever as initial presentation of SpA (reactive arthritis 50%, undifferentiated SpA 26.9%, ankylosing spondylitis 15.4%, enteropathic arthritis 3.8%, psoriatic arthritis 3.8%). Peripheral SpA was more common in febrile SpA patients than in control SpA patients (65.4% vs 24.0%, p<0.001). Febrile SpA patients were less frequently HLA-B27 positive than control SpA patients (52.2% vs 77.0%, p<0.05). At baseline, systemic inflammatory markers were significantly higher in the febrile SpA patients (white blood cell count, 11.57 vs 7.81 cells/mu L, p<0.001; erythrocyte sedimentation rate, 69.2 vs 41.0 mm/h, p<0.001; C-reactive protein, 109.6 vs 15.3 mg/L, p<0.001). The proportion of patients treated with systemic steroids was significantly higher in febrile SpA patients (57.7% vs. 11.0%, p<0.001). The proportion of patients who visited rheumatology specialty was significantly lower in febrile SpA patients than in control SpA patients (7.7% vs 59.0%, p<0.001). Conclusion: Various subgroups of SpA can be presented with fever as an initial manifestation. Febrile SpA patients demonstrated higher systemic inflammation and a lower chance to visit rheumatology in early stage. When evaluating febrile patients with any clinical features of SpA, clinicians are advised to consider performing SpA-focused evaluation including HLA-B27 or a simple sacroiliac joint radiograph.	[Byun, Se Jin; Bae, William Han; Jung, Seung Min; Lee, Sang-Won; Park, Yong-Beom; Song, Jason Jungsik] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Song, Jason Jungsik] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Song, JJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.; Song, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea.	JSKSONG@yuhs.ac		Lee, Sang-Won/0000-0002-8038-3341; Jung, Seung Min/0000-0003-3465-2181; Song, Jason/0000-0003-0662-7704	Basic Science Research Program through National Research Foundation of Korea [2015R1C1A1A01053140]; Ministry of Education, Science, and Technology	Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program (2015R1C1A1A01053140) through the National Research Foundation of Korea, and funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten D, 2013, ARTHRITIS RHEUM-US, V65, P12, DOI 10.1002/art.37829; Behar VM, 2016, JOINT BONE SPINE; Carter JD, 2009, RHEUM DIS CLIN N AM, V35, P21, DOI 10.1016/j.rdc.2009.03.010; Courcoul A, 2017, JOINT BONE SPINE; Danve A, 2015, CLIN RHEUMATOL, V34, P987, DOI 10.1007/s10067-015-2958-2; del Rio-Martinez P, 2016, SEMINARS ARTHRITIS R; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Fauci AS, 2015, HARRISONS PRINCIPLES, V1; Guo RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128979; Haibel H, 2014, ANN RHEUM DIS, V73, P243, DOI 10.1136/annrheumdis-2012-203055; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Inman RD, 1999, J RHEUMATOL, V26, P1219; Maugars Y, 1996, BRIT J RHEUMATOL, V35, P767; Pato E, 2000, J RHEUMATOL, V27, P2198; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Seo MR, 2015, CLIN RHEUMATOL, V34, P1397, DOI 10.1007/s10067-014-2768-y; Stolwijk C, 2013, ANN RHEUMATIC DIS; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van der Heijde D, 2011, ANN RHEUM DIS, V70, P905, DOI 10.1136/ard.2011.151563; van Tubergen A, 2015, NAT REV RHEUMATOL, V11, P110, DOI 10.1038/nrrheum.2014.181; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298; ZELICKSON BD, 1991, ARCH DERMATOL, V127, P1339, DOI 10.1001/archderm.127.9.1339; Zochling J, 2010, BEST PRACT RES CL RH, V24, P747, DOI 10.1016/j.berh.2011.02.002	25	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184323	10.1371/journal.pone.0184323	http://dx.doi.org/10.1371/journal.pone.0184323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910361	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200041
J	Qin, J; Song, QJ; Shi, AN; Li, S; Zhang, MC; Zhang, B				Qin, Jun; Song, Qijian; Shi, Ainong; Li, Song; Zhang, Mengchen; Zhang, Bo			Genome-wide association mapping of resistance to Phytophthora sojae in a soybean [Glycine max (L.) Merr.] germplasm panel from maturity groups IV and V	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ROOT-ROT; IDENTIFICATION; TOLERANCE; SOFTWARE; QTL; YIELD	Phytophthora sojae, an oomycete pathogen of soybean, causes stem and root rot, resulting in annual economic loss up to $2 billion worldwide. Varieties with P. sojae resistance are environmental friendly to effectively reduce disease damages. In order to improve the resistance of P. sojae and broaden the genetic diversity in Southern soybean cultivars and germplasm in the U.S., we established a P. sojae resistance gene pool that has high genetic diversity, and explored genomic regions underlying the host resistance to P. sojae races 1, 3, 7, 17 and 25. A soybean germplasm panel from maturity groups (MGs) IV and V including 189 accessions originated from 10 countries were used in this study. The panel had a high genetic diversity compared to the 6,749 accessions from MGs IV and V in USDA Soybean Germplasm Collection. Based on disease evaluation dataset of these accessions inoculated with P. sojae races 1, 3, 7, 17 and 25, which are publically available, five accessions in this panel were resistant to all races. Genome-wide association analysis identified a total of 32 significant SNPs, which were clustered in resistance-associated genomic regions, among those, ss715619920 was only 3kb away from the gene Glyma. 14g087500, a subtilisin protease. Gene expression analysis showed that the gene was down-regulated more than 4 fold (log2 fold > 2.2) in response to P. sojae infection. The identified molecular markers and genomic regions that are associated with the disease resistance in this gene pool will greatly assist the U.S. Southern soybean breeders in developing elite varieties with broad genetic background and P. sojae resistance.	[Qin, Jun; Li, Song; Zhang, Bo] Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [Qin, Jun; Zhang, Mengchen] Hebei Acad Agr & Forestry Sci, Cereal & Oil Crop Inst, Minist Agr,Natl Soybean Improvement Ctr Shijiazhu, North China Key Lab Biol & Genet Improvement Soyb, Shijiazhuang, Hebei, Peoples R China; [Song, Qijian] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Shi, Ainong] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA	Virginia Polytechnic Institute & State University; Hebei Academy of Agricultural & Forestry Sciences; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville	Zhang, B (corresponding author), Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.	bozhang@vt.edu	Shi, Ainong/L-6384-2017	Shi, Ainong/0000-0002-1066-7920				Akond M, 2013, SNP BASED GENETIC LI; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CHURCHILL GA, 1994, GENETICS, V138, P963; Dorrance AE, 2000, PLANT DIS, V84, P1303, DOI 10.1094/PDIS.2000.84.12.1303; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Figueiredo A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00739; Han YP, 2008, EUPHYTICA, V162, P231, DOI 10.1007/s10681-007-9558-4; Huang JQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2434-7; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kandel H., 2010, SOYBEAN PRODUCTION F; LANDER ES, 1989, GENETICS, V121, P185; Lee S, 2014, THEOR APPL GENET, V127, P429, DOI 10.1007/s00122-013-2229-z; Lee S, 2013, CROP SCI, V53, P1022, DOI 10.2135/cropsci2012.10.0578; Lee S, 2013, THEOR APPL GENET, V126, P1121, DOI 10.1007/s00122-013-2040-x; Li LH, 2016, MOL GENET GENOMICS, V291, P1095, DOI 10.1007/s00438-015-1164-x; Lin F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-18; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Ping JQ, 2016, THEOR APPL GENET, V129, P445, DOI 10.1007/s00122-015-2638-2; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Ryley MJ, 1998, PLANT DIS, V82, P1048, DOI 10.1094/PDIS.1998.82.9.1048; Schmitthenner A.F., 1999, COMPENDIUM SOYBEAN D, V4th edn, P39; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2918-5; Shi AN, 2016, EUPHYTICA, V208, P143, DOI 10.1007/s10681-015-1610-1; Song QJ, 2015, G3-GENES GENOM GENET, V5, P1999, DOI 10.1534/g3.115.019000; Stasko AK, 2016, CROP SCI, V56, P2476, DOI 10.2135/cropsci2015.12.0749; Sun JT, 2014, J GENET, V93, P355, DOI 10.1007/s12041-014-0383-y; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tucker DM, 2010, CROP SCI, V50, P628, DOI 10.2135/cropsci2009.03.0161; Wang H., 2012, BMC GENOMICS, V13, P1; Wang HH, 2012, CROP SCI, V52, P609, DOI 10.2135/cropsci2011.06.0336; Wang HH, 2010, PLANT GENOME-US, V3, P23, DOI 10.3835/plantgenome2009.12.0029; Weng CR, 2007, EUPHYTICA, V158, P81, DOI 10.1007/s10681-007-9428-0; Wu X, 2011, PLANT BREEDING, V130, P144, DOI 10.1111/j.1439-0523.2010.01799.x; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184613	10.1371/journal.pone.0184613	http://dx.doi.org/10.1371/journal.pone.0184613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910339	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200068
J	Wu, F; Ma, JX; Meng, YQ; Zhang, DY; Muvunyi, BP; Luo, K; Di, HY; Guo, WL; Wang, YR; Feng, BC; Zhang, JY				Wu, Fan; Ma, Jinxing; Meng, Yuqin; Zhang, Daiyu; Muvunyi, Blaise Pascal; Luo, Kai; Di, Hongyan; Guo, Wenli; Wang, Yanrong; Feng, Baochang; Zhang, Jiyu			Potential DNA barcodes for Melilotus species based on five single loci and their combinations (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							GENUS; IDENTIFY; REGION; IDENTIFICATION; DIVERSITY; PRIMERS; NUCLEAR	Melilotus, an annual or biennial herb, belongs to the tribe Trifolieae (Leguminosae) and consists of 19 species. As an important green manure crop, diverse Melilotus species have different values as feed and medicine. To identify different Melilotus species, we examined the efficiency of five candidate regions as barcodes, including the internal transcribed spacer (ITS) and two chloroplast loci, rbcL and matK, and two non-coding loci, trnH-psbA and trnL-F. In total, 198 individuals from 98 accessions representing 18 Melilotus species were sequenced for these five potential barcodes. Based on inter-specific divergence, we analysed sequences and confirmed that each candidate barcode was able to identify some of the 18 species. The resolution of a single barcode and its combinations ranged from 33.33% to 88.89%. Analysis of pairwise distances showed that matK+rbcL+trnL-F+trnH-psbA+ITS (MRTPI) had the greatest value and rbcL the least. Barcode gap values and similarity value analyses confirmed these trends. The results indicated that an ITS region, successfully identifying 13 of 18 species, was the most appropriate single barcode and that the combination of all five potential barcodes identified 16 of the 18 species. We conclude that MRTPI is the most effective tool for Melilotus species identification. Taking full advantage of the barcode system, a clear taxonomic relationship can be applied to identify Melilotus species and enhance their practical production.	[Wu, Fan; Zhang, Daiyu; Muvunyi, Blaise Pascal; Luo, Kai; Di, Hongyan; Guo, Wenli; Wang, Yanrong; Zhang, Jiyu] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Ma, Jinxing; Feng, Baochang] Minist Agr, Natl Qual Control Inspect Ctr Grassland Ind Prod, Natl Anim Husb Serv, Beijing, Peoples R China; [Meng, Yuqin] China Agr Veterinarian Biol Sci & Technol Co Ltd, Lanzhou, Gansu, Peoples R China	Lanzhou University; Ministry of Agriculture & Rural Affairs	Zhang, JY (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China.; Feng, BC (corresponding author), Minist Agr, Natl Qual Control Inspect Ctr Grassland Ind Prod, Natl Anim Husb Serv, Beijing, Peoples R China.	bcfeng@163.com; zhangjy@lzu.edu.cn	Zhang, Jiyu/AAG-3452-2021	Zhang, Jiyu/0000-0002-3642-373X; , Fan/0000-0002-3230-8996	National Basic Research Program (973) of China [2014CB138704]; Special Fund for Agro-scientific Research in the Public Interest [20120304205]; National Natural Science Foundation of China [31572453]; 111 project [B12002]; State Key Laboratory of Grassland Agroecosystems [SKLGAE201702]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_17R50]	National Basic Research Program (973) of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); State Key Laboratory of Grassland Agroecosystems; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	Funded by National Basic Research Program (973) of China (2014CB138704), Special Fund for Agro-scientific Research in the Public Interest (20120304205), National Natural Science Foundation of China (31572453), the 111 project (B12002), State Key Laboratory of Grassland Agroecosystems (SKLGAE201702), and Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R50). We thank the National Plant Germplasm System (NPGS, US) and National Gene Bank of Forage Germplasm (NGBFG, China) for providing experimental materials used in our study. Yanrong Wang, Baochang Feng and Jinxing Ma secured financial support. Yanrong Wang and Jiyu Zhang decided to publish the manuscript.; This work was supported by National Basic Research Program (973) of China (2014CB138704), Special Fund for Agro-scientific Research in the Public Interest (20120304205), National Natural Science Foundation of China (31572453), the 111 project (B12002), State Key Laboratory of Grassland Agro-ecosystems (SKLGAE201702), and Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R50). Additionally, we thank the National Plant Germplasm System (NPGS, US) and National Gene Bank of Forage Germplasm (NGBFG, China) for providing experimental materials used in our study. We also thank the reviewers for reviewing our manuscript.	ABOEL-ATTA ABDEL-MONEIM IBRAHEIM, 2009, ACAD J PLANT SCI, V2, P113; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Castro C., 2015, American Journal of Plant Sciences, V6, P95, DOI 10.4236/ajps.2015.61011; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chen SL, 2015, PLOS ONE, V10, P1903; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cong JM, 2012, J ANHUI AGR SCI, V5, P155; Costion CM, 2016, DIVERSITY-BASEL, V8, DOI 10.3390/d8010005; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Di HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132596; Di HY, 2014, ACTA BOT BOREALI-OCC; Dong R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00649; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; Evans PM, 2003, AUST J EXP AGR, V43, P349, DOI 10.1071/EA02079; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fu YM, 2011, J SYST EVOL, V49, P237, DOI 10.1111/j.1759-6831.2011.00126.x; Gao T, 2013, BIOL PHARM BULL, V36, P1975, DOI 10.1248/bpb.b13-00611; Gong XY, 2016, J EXP BOT; Guo XR, 2011, BIOL PHARM BULL, V34, P1198, DOI 10.1248/bpb.34.1198; Guo X, 2011, J SYST EVOL, V49, P203, DOI 10.1111/j.1759-6831.2011.00130.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; [骆凯 Luo Kai], 2014, [草业科学, Pratacultural Science], V31, P2125; Moon BC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017064; Moussavi S., 2001, SPECIES MELILOTUS IR, V2; Musa MA, 2008, CURR MED CHEM, V15, P2664, DOI 10.2174/092986708786242877; Muscarella R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112843; Nadia Z, 2014, BIOCHEM SYST ECOL, V55, P296, DOI 10.1016/j.bse.2014.03.016; Nair RM, NZ J AGR; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; Parnmen S, 2016, J TOXICOL SCI, V41, P65, DOI 10.2131/jts.41.65; Rogers ME, 2008, PLANT SOIL, V304, P89, DOI 10.1007/s11104-007-9523-y; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Sakiroglu M, 2011, TURK J BOT, V35, P509, DOI 10.3906/bot-1002-47; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; [单志 SHAN Zhi], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P113; Shi SL, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010001; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiersema J. H., 2013, WORLD EC PLANTS STAN; Wu F, 2016, IND CROP PROD, V85, P84, DOI 10.1016/j.indcrop.2016.02.055; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang DQ, 2014, BIOCHEM SYST ECOL, V52, P14, DOI 10.1016/j.bse.2013.10.004; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	57	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0182693	10.1371/journal.pone.0182693	http://dx.doi.org/10.1371/journal.pone.0182693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910286	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200004
J	Zebende, GF; Oliveira, FM; Cruz, JAL				Zebende, Gilney Figueira; Oliveira Filho, Florencio Mendes; Leyva Cruz, Juan Alberto			Auto-correlation in the motor/imaginary human EEG signals: A vision about the F-DFA fluctuations	PLOS ONE			English	Article							MEMORY	In this paper we analyzed, by the F-DFA root mean square fluctuation (rms) function, the motor/imaginary human activity produced by a 64-channel electroencephalography (EEG). We utilized the Physionet on-line databank, a publicly available database of human EEG signals, as a standardized reference database for this study. Herein, we report the use of detrended fluctuation analysis (DFA) method for EEG analysis. We show that the complex time series of the EEG exhibits characteristic fluctuations depending on the analyzed channel in the scalp-recorded EEG. In order to demonstrate the effectiveness of the proposed technique, we analyzed four distinct channels represented here by F(3)32, F(6)37 (frontal region of the head) and P(3)49, P(6)54 (parietal region of the head). We verified that the amplitude of the F-DFA rms function is greater for the frontal channels than for the parietal. To tabulate this information in a better way, we define and calculate the difference between F-DFA (in log scale) for the channels, thus defining a new path for analysis of EEG signals. Finally, related to the studied EEG signals, we obtain the auto-correlation exponent, alpha(DFA) by DFA method, that reveals self-affinity at specific time scale. Our results shows that this strategy can be applied to study the human brain activity in EEG processing.	[Zebende, Gilney Figueira; Leyva Cruz, Juan Alberto] State Univ Feira de Santana, Dept Phys, Feira De Santana, BA, Brazil; [Oliveira Filho, Florencio Mendes] Estacio de Sa Univ, Gilberto Gil Campus, Salvador, BA, Brazil; [Oliveira Filho, Florencio Mendes] SENAI CIMATEC, Computat Modeling Program, Salvador, BA, Brazil	Universidade Estadual de Feira de Santana; Faculdade de Tecnologia Senai Cimatec	Zebende, GF (corresponding author), State Univ Feira de Santana, Dept Phys, Feira De Santana, BA, Brazil.	gfzebende@hotmail.com	Cruz, Juan Alberto Leyva/AAP-8764-2021; Zebende, Gilney Figueira/AAZ-6135-2020; Filho, Florêncio MO/P-3141-2018	Cruz, Juan Alberto Leyva/0000-0003-4019-4463; Zebende, Gilney Figueira/0000-0003-2420-9805; Oliveira Filho, Florencio Mendes/0000-0002-8675-6444	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309288/2013-4]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico) [309288/2013-4]; Brazilian agency	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 309288/2013-4, GFZ.; Gilney F. Zebende thanks the CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico) (Grant 309288/2013-4), Brazilian agency.	[Anonymous], 2004, BCI2000 GEN PURPOSE; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Galaska R, 2007, J ELECTROCARDIOL S1, V40, pS41; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Heneghan C, 2000, PHYS REV E, V62, P6103, DOI 10.1103/PhysRevE.62.6103; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Lee JM, 2002, COMPUT BIOL MED, V32, P37, DOI 10.1016/S0010-4825(01)00031-2; Lee JS, 2017, CLIN NEUROPHYSIOL, V118, P2489; Marton LF, 2014, PROC TECH, V12, P125, DOI 10.1016/j.protcy.2013.12.465; Mirzayof D, 2010, PHYSICA A, V389, P5573, DOI 10.1016/j.physa.2010.08.035; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Romine CB, 2004, NEUROPSYCHOL REV, V14, P43, DOI 10.1023/B:NERV.0000026648.94811.32; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Swartz BE, 1998, ELECTROEN CLIN NEURO, V106, P113, DOI 10.1016/S0013-4694(97)00113-2; Walleczek J., 2000, SELF ORGANIZED BIOLO; William O., 2014, HDB EEG INTERPRETATI; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Yang S., 2015, USE EEG SIGNALS BIOM; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zebende GF, 2017, MON NOT R ASTRON SOC, V464, P2638, DOI 10.1093/mnras/stw2611	24	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183121	10.1371/journal.pone.0183121	http://dx.doi.org/10.1371/journal.pone.0183121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910294	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200006
J	Kaneko, M; Takanashi, S; Thongprachum, A; Hanaoka, N; Fujimoto, T; Nagasawa, K; Kimura, H; Okitsu, S; Mizuguchi, M; Ushijima, H				Kaneko, Mei; Takanashi, Sayaka; Thongprachum, Aksara; Hanaoka, Nozomu; Fujimoto, Tsuguto; Nagasawa, Koo; Kimura, Hirokazu; Okitsu, Shoko; Mizuguchi, Masashi; Ushijima, Hiroshi			Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015	PLOS ONE			English	Article							LESS-THAN-5 YEARS; UNITED-STATES; RT-PCR; PENTAVALENT; DIARRHEA; MONOVALENT; DS-1-LIKE; COVERAGE; INFANTS; ASSAY	Two live attenuated oral rotavirus vaccines, Rotarix and RotaTeq, have been introduced as voluntary vaccination in Japan since 2011 and 2012, respectively. Effectiveness of the vaccines has been confirmed, whereas concerns such as shedding of the vaccine strains and gastroenteritis cases caused by vaccine strains are not well assessed. We aimed to identify the vaccine strains in children with acute gastroenteritis (AGE) to investigate the prevalence of AGE caused by vaccination or horizontal transmission of vaccine strains. A total of 1,824 stool samples were collected from children with AGE at six outpatient clinics in 2012-2015. Among all, 372 group A rotavirus (RVA) positive samples were screened for vaccine components by real-time RT-PCR which were designed to differentiate vaccine strains from rotavirus wild-type strains with high specificity. For samples possessing both vaccine and wildtype strains, analyses by next-generation sequencing (NGS) were conducted to characterize viruses existed in the intestine. As a result, Rotarix-derived strains were identified in 6 of 372 (1.6%) RVA positive samples whereas no RotaTeq strain was detected. Among six samples, four possessed Rotarix-derived strains while two possessed both Rotarix-derived strains and wild-type strains. In addition, other pathogens such as norovirus, enterovirus and E. coli were detected in four samples. The contribution of these vaccine strains to each patient's symptoms was unclear as all of the cases were vaccinated 2-14 days before sample collection. Proportion of average coverage for each segmented gene by NGS strongly suggested the concurrent infection of the vaccine-derived strain and the wild-type strain rather than reassortment of these two strains in one sample. This is the first study to report the prevalence of vaccine-derived strains in patients with RVA AGE in Japan as 1.6% without evidence of horizontal transmission. The results emphasized the importance of continuous monitoring on vaccine strains and their clinical impacts on children.	[Kaneko, Mei; Takanashi, Sayaka; Okitsu, Shoko; Mizuguchi, Masashi; Ushijima, Hiroshi] Univ Tokyo, Dept Dev Med Sci, Grad Sch Med, Tokyo, Japan; [Thongprachum, Aksara; Okitsu, Shoko; Ushijima, Hiroshi] Nihon Univ, Sch Med, Div Microbiol, Dept Pathol & Microbiol, Tokyo, Japan; [Hanaoka, Nozomu; Fujimoto, Tsuguto; Nagasawa, Koo; Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	University of Tokyo; Nihon University; National Institute of Infectious Diseases (NIID)	Takanashi, S (corresponding author), Univ Tokyo, Dept Dev Med Sci, Grad Sch Med, Tokyo, Japan.	sayat@m.u-tokyo.ac.jp	Nagasawa, Koo/I-3723-2019; hanaoka, nozomu/L-7717-2019; Fujimoto, Tsuguto/AAG-8675-2019	Fujimoto, Tsuguto/0000-0002-4861-4349; hanaoka, nozomu/0000-0002-1039-6278	Japan Society for the Promotion of Science (JSPS) [24390266, 16H05360]; Public Foundation of the Vaccination Research Center [2015-34]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Public Foundation of the Vaccination Research Center	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (Grant number: 24390266, 16H05360) and Public Foundation of the Vaccination Research Center (2015-34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Araki K, 2015, HUM VACC IMMUNOTHER, V12, P1; Boom JA, 2012, J INFECT DIS, V206, P1275, DOI 10.1093/infdis/jis490; Committee for Immunization and vaccines, 2015, 13 MIN HLTH LAB WELF; Donato CM, 2012, J INFECT DIS, V206, P377, DOI 10.1093/infdis/jis361; Elfving K, 2014, J CLIN MICROBIOL, V52, P916, DOI 10.1128/JCM.02697-13; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2012, MICROBIOL IMMUNOL, V56, P630, DOI 10.1111/j.1348-0421.2012.00479.x; Gautam R, 2014, HUM VACC IMMUNOTHER, V10, P767, DOI 10.4161/hv.27388; Hacimustafaoglu M, 2013, J PEDIATR INFECT, V7, P13, DOI 10.5152/ced.2013.04; Hall T., 2011, GERF B BIOSCI, V2, P60; Hashizume Masahiro, 2015, Trop Med Health, V43, P177, DOI 10.2149/tmh.2015-23; Hill HA, 2015, MMWR-MORBID MORTAL W, V64, P889, DOI 10.15585/mmwr.mm6433a1; Hsieh YC, 2014, VACCINE, V32, P1199, DOI 10.1016/j.vaccine.2013.08.041; Jothikumar N, 2009, J VIROL METHODS, V155, P126, DOI 10.1016/j.jviromet.2008.09.025; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kaplon J, 2015, PEDIATR INFECT DIS J, V34, P326, DOI 10.1097/INF.0000000000000560; Kawada J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33452; Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548; Klinkenberg D, 2015, PEDIATR INFECT DIS J, V34, P114, DOI 10.1097/INF.0000000000000507; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Loharikar A, 2016, MMWR-MORBID MORTAL W, V65, P1136, DOI 10.15585/mmwr.mm6541a3; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164; Payne DC, 2010, PEDIATRICS, V125, pE438, DOI 10.1542/peds.2009-1901; Sabbe M, 2016, EUROSURVEILLANCE, V21, P19, DOI 10.2807/1560-7917.ES.2016.21.27.30273; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Thongprachum A, 2017, J MED VIROL, V89, P818, DOI 10.1002/jmv.24711; Velazquez RF, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0771-y; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; Werther RL, 2009, J ALLERGY CLIN IMMUN, V124, P600, DOI 10.1016/j.jaci.2009.07.005; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326; Yamashita A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00032; Zeller M, 2015, GENOME BIOL EVOL, V7, P2473, DOI 10.1093/gbe/evv157	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184067	10.1371/journal.pone.0184067	http://dx.doi.org/10.1371/journal.pone.0184067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902863	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200025
J	Naidoo, K; Hassan-Moosa, R; Yende-Zuma, N; Govender, D; Padayatchi, N; Dawood, H; Adams, RN; Govender, A; Chinappa, T; Abdool-Karim, S; Abdool-Karim, Q				Naidoo, Kogieleum; Hassan-Moosa, Razia; Yende-Zuma, Nonhlanhla; Govender, Dhineshree; Padayatchi, Nesri; Dawood, Halima; Adams, Rochelle Nicola; Govender, Aveshen; Chinappa, Tilagavathy; Abdool-Karim, Salim; Abdool-Karim, Quarraisha			High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							GENDER-DIFFERENCES; RURAL DISTRICT; HIV-INFECTION; THERAPY; COHORT; HEALTH; OUTCOMES; WOMEN; RETENTION; MALAWI	In attaining UNAIDS targets of 90-90-90 to achieve epidemic control, understanding who the current utilizers of HIV treatment services are will inform efforts aimed at reaching those not being reached. A retrospective chart review of CAPRISA AIDS Treatment Program (CAT) patients between 2004 and 2013 was undertaken. Of the 4043 HIV-infected patients initiated on ART, 2586 (64.0%) were women. At ART initiation, men, compared to women, had significantly lower median CD4+ cell counts (113 vs 131 cells/mm(3), p < 0.001), lower median body mass index (BMI) (21.0 vs 24.2 kg/m(2), p< 0.001), higher mean log viral load (5.0 vs 4.9 copies/ml, p< 0.001) and were significantly older (median age: 35 vs. 32 years, p< 0.001). Men had higher mortality rates compared to women, 6.7 per 100 person-years (p-y), (95% CI: 5.8-7.8) vs. 4.4 per 100 p-y, (95% CI: 3.8-5.0); mortality rate ratio: 1.54, (95% CI: 1.27-1.87), p < 0.001. Age-standardised mortality rate was 7.9 per 100 p-y (95% CI: 4.1-11.7) for men and 5.7 per 100 p-y (95% CI: 2.7 to 8.6) for women (standardised mortality ratio: 1.38 (1.15 to 1.70)). Mean CD4+ cell count increases post-ART initiation were lower in men at all follow-up time points. Men presented later in the course of their HIV disease for ART initiation with more advanced disease and experienced a higher mortality rate compared to women.	[Naidoo, Kogieleum; Hassan-Moosa, Razia; Yende-Zuma, Nonhlanhla; Govender, Dhineshree; Padayatchi, Nesri; Dawood, Halima; Adams, Rochelle Nicola; Govender, Aveshen; Chinappa, Tilagavathy; Abdool-Karim, Salim; Abdool-Karim, Quarraisha] CAPRISA, Durban, Kwazulu Natal, South Africa; [Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Padayatchi, Nesri; Abdool-Karim, Salim] Univ KwaZulu Natal, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Doris Duke Med Res Inst, Durban, Kwazulu Natal, South Africa; [Abdool-Karim, Salim] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Naidoo, K; Hassan-Moosa, R (corresponding author), CAPRISA, Durban, Kwazulu Natal, South Africa.; Naidoo, K (corresponding author), Univ KwaZulu Natal, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Doris Duke Med Res Inst, Durban, Kwazulu Natal, South Africa.	Kogie.Naidoo@caprisa.org; Razia.Hassan-Moosa@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022; padayatchi, nesri/Q-2780-2019; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Dawood, Halima/AAO-6963-2020; Dawood, Halima/AAF-6045-2020	Abdool Karim, Quarraisha/0000-0002-0985-477X; padayatchi, nesri/0000-0003-2543-9071; Karim, Salim Abdool/0000-0002-4986-2133; Dawood, Halima/0000-0001-8180-6791; Naidoo, Kogieleum/0000-0002-8874-6661	US President's Emergency Plan for AIDS Relief (PEPFAR); Global Fund to fight AIDS, Tuberculosis and Malaria; National Institutes of Health Comprehensive International Program of Research on AIDS [UM1A1069469]; Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP) [D43 TW000231]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069469] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund to fight AIDS, Tuberculosis and Malaria; National Institutes of Health Comprehensive International Program of Research on AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to fight AIDS, Tuberculosis and Malaria and the National Institutes of Health Comprehensive International Program of Research on AIDS (UM1A1069469). K.N. and N.P. were supported by the Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP, Grant D43 TW000231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to fight AIDS, Tuberculosis and Malaria and the National Institutes of Health Comprehensive International Program of Research on AIDS (UM1AI069469). K.N. and N.P. were supported by the Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP, Grant D43 TW000231).	Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Boulle C, 2015, JAIDS-J ACQ IMM DEF, V69, P355, DOI 10.1097/QAI.0000000000000604; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cescon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083649; Cornell M, 2013, S AFR J HIV MED, V14, P12, DOI 10.7196/SAJHIVMED.894; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Giles ML, 2016, SEX HEALTH, V13, P155, DOI 10.1071/SH15124; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Ikuabe P. O., 2015, J MED, V24, P103; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn S, 2012, AIDS, V26; Lee MP, 2015, AIDS PATIENT CARE ST, V29, P229, DOI 10.1089/apc.2014.0232; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; Menzaghi B, 2014, BIOMED PHARMACOTHER, V68, P385, DOI 10.1016/j.biopha.2014.01.007; Naidoo K, 2014, JAIDS-J ACQ IMM DEF, V65, P438, DOI 10.1097/QAI.0000000000000060; Naranbhai V, 2012, LANCET, V380, P1907, DOI 10.1016/S0140-6736(12)62110-2; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Ramkissoon A, 2011, JAIDS-J ACQ IMM DEF, V58, pE138, DOI 10.1097/QAI.0b013e3182381171; Rosin C, 2015, HIV MED, V16, P319, DOI 10.1111/hiv.12203; Rudatsikira E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-176; Saunders P, 2016, HIV MED, V17, P18, DOI 10.1111/hiv.12272; STATISTICS SOUTH AFRICA, 2015, MID POP EST; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Thorsteinsson K, 2012, SCAND J INFECT DIS, V44, P766, DOI 10.3109/00365548.2012.684220; Yende-Zuma N, 2016, J ACQUIRED IMMUNE DE; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184124	10.1371/journal.pone.0184124	http://dx.doi.org/10.1371/journal.pone.0184124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902869	Green Published, gold			2022-12-26	WOS:000410669200027
J	Haaland, OA; Jugessur, A; Gjerdevik, M; Romanowska, J; Shi, M; Beaty, TH; Marazita, ML; Murray, JC; Wilcox, AJ; Lie, RT; Gjessing, HK				Haaland, Oystein A.; Jugessur, Astanand; Gjerdevik, Miriam; Romanowska, Julia; Shi, Min; Beaty, Terri H.; Marazita, Mary L.; Murray, Jeffrey C.; Wilcox, Allen J.; Lie, Rolv T.; Gjessing, Hakon K.			Genome-wide analysis of parent-of-origin interaction effects with environmental exposure (PoOxE): An application to European and Asian cleft palate trios	PLOS ONE			English	Article							POPULATION-BASED COHORT; OROFACIAL CLEFTS; ORAL CLEFTS; RISK; RECURRENCE; ASSOCIATION; LIP; PREVALENCE; EXPRESSION; RELATIVES	Cleft palate only is a common birth defect with high heritability. Only a small fraction of this heritability is explained by the genetic variants identified so far, underscoring the need to investigate other disease mechanisms, such as gene-environment (GxE) interactions and parent-of-origin (PoO) effects. Furthermore, PoO effects may vary across exposure levels (PoOxE effects). Such variation is the focus of this study. We upgraded the R-package Haplin to enable direct tests of PoOxE effects at the genome-wide level. From a previous GWAS, we had genotypes for 550 case-parent trios, of mainly European and Asian ancestry, and data on three maternal exposures (smoking, alcohol, and vitamins). Data were analyzed for Europeans and Asians separately, and also for all ethnicities combined. To account for multiple testing, a false discovery rate method was used, where q-values were generated from the p-values. In the Europeans-only analyses, interactions with maternal smoking yielded the lowest q-values. Two SNPs in the 'Interactor of little elongation complex ELL subunit 1' (ICE1) gene had a q-value of 0.14, and five of the 20 most significant SNPs were in the 'N-acetylated alpha-linked acidic dipeptidase-like 2' (NAALADL2) gene. No evidence of PoOxE effects was found in the other analyses. The connections to ICE1 and NAALADL2 are novel and warrant further investigation. More generally, the new methodology presented here is easily applicable to other traits and exposures in which a family-based study design has been implemented.	[Haaland, Oystein A.; Jugessur, Astanand; Gjerdevik, Miriam; Romanowska, Julia; Lie, Rolv T.; Gjessing, Hakon K.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Jugessur, Astanand; Gjerdevik, Miriam] NIPH, Dept Genet & Bioinformat, Oslo, Norway; [Jugessur, Astanand; Gjessing, Hakon K.] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway; [Shi, Min] NIEHS, Biostat & Computat Biol Branch, NIH, Durham, NC USA; [Beaty, Terri H.] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Durham, NC USA; [Lie, Rolv T.] Norwegian Inst Publ Hlth, Dept Hlth Registries, Oslo, Norway	University of Bergen; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH)	Haaland, OA (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	oystein.haaland@uib.no	Wilcox, Allen J/C-7723-2019; Gjerdevik, Miriam/ABE-4722-2021; Shi, Min/GXM-3977-2022	Wilcox, Allen J/0000-0002-3376-1311; Romanowska, Julia/0000-0001-6733-1953; Haaland, Oystein Ariansen/0000-0001-5288-7879	Bergen Medical Research Foundation [807191]; National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS); NIH [DE08559]; Research Council of Norway through Centres of Excellence [262700]; National Institute of Environmental Health Sciences, NIH/NIEHS; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	Bergen Medical Research Foundation; National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway through Centres of Excellence; National Institute of Environmental Health Sciences, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Bergen Medical Research Foundation, grant 807191, in part by the Intramural Program of the National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS), by NIH grant DE08559, and partly by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bergen Medical Research Foundation, grant 807191 (AJ, HKG, RTL), in part by the Intramural Program of the National Institute of Environmental Health Sciences, NIH/NIEHS (AJW), by NIH grant DE08559 (JCM), and by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700 (HKG, AJ).	Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Blanton SH, 2011, BIRTH DEFECTS RES A, V91, P50, DOI 10.1002/bdra.20740; Borg K, 2005, HUM GENET, V118, P267, DOI 10.1007/s00439-005-0021-0; Christensen K, 1996, AM J HUM GENET, V58, P182; Corcos Laurent, 2012, Drug Metabolism and Drug Interactions, V27, P63, DOI [10.1515/DMDI-2011-0037, 10.1515/dmdi-2011-0037]; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Du J, 2014, BIOTECH HISTOCHEM, V89, P14, DOI 10.3109/10520295.2013.795661; Du J, 2011, ACTA HISTOCHEM, V113, P636, DOI 10.1016/j.acthis.2010.08.001; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Grosen D, 2011, EPIDEMIOLOGY, V22, P313, DOI 10.1097/EDE.0b013e3182125f9c; Grosen D, 2010, AM J MED GENET A, V152A, P2468, DOI 10.1002/ajmg.a.33608; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Jugessur A., 2012, NORSK EPIDEMIOLOGI, V21, P251, DOI DOI 10.5324/NJE.V21I2.1503; Krey KF, 2002, EXP TOXICOL PATHOL, V54, P69, DOI 10.1078/0940-2993-00235; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; Marazita ML, 2012, ANN REV GENOMICS HUM; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mossey P., 2003, GLOBAL REGISTRY DATA; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2015, R LANG ENV STAT COMP; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Romanovska J, 2017, ANN HUM GENET; Sharp GC, 2017, CLEFT PALATE CRANIOF; Sharp GC, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0362-2; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Skare O, 2012, ANN HUM GENET, V76, P221, DOI 10.1111/j.1469-1809.2012.00707.x; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang S, 2011, HUM HERED, V71, P196, DOI 10.1159/000328006; Whitaker HC, 2014, ONCOGENE, V33, P5274, DOI 10.1038/onc.2013.464; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	37	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184358	10.1371/journal.pone.0184358	http://dx.doi.org/10.1371/journal.pone.0184358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898263	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000410449500023
J	Moreno-Fernandez, MM; Blanco, F; Matute, H				Manuela Moreno-Fernandez, Maria; Blanco, Fernando; Matute, Helena			Causal illusions in children when the outcome is frequent	PLOS ONE			English	Article							BIAS BLIND SPOT; CONTINGENCY JUDGMENTS; DEVELOPMENTAL DIFFERENCES; PERCEIVED CONTROL; BINARY VARIABLES; WORKING-MEMORY; DENSITY BIAS; INFORMATION; AGE; COVARIATION	Causal illusions occur when people perceive a causal relation between two events that are actually unrelated. One factor that has been shown to promote these mistaken beliefs is the outcome probability. Thus, people tend to overestimate the strength of a causal relation when the potential consequence (i.e. the outcome) occurs with a high probability (outcome-density bias). Given that children and adults differ in several important features involved in causal judgment, including prior knowledge and basic cognitive skills, developmental studies can be considered an outstanding approach to detect and further explore the psychological processes and mechanisms underlying this bias. However, the outcome density bias has been mainly explored in adulthood, and no previous evidence for this bias has been reported in children. Thus, the purpose of this study was to extend outcome-density bias research to childhood. In two experiments, children between 6 and 8 years old were exposed to two similar setups, both showing a non-contingent relation between the potential cause and the outcome. These two scenarios differed only in the probability of the outcome, which could either be high or low. Children judged the relation between the two events to be stronger in the high probability of the outcome setting, revealing that, like adults, they develop causal illusions when the outcome is frequent.	[Manuela Moreno-Fernandez, Maria; Blanco, Fernando; Matute, Helena] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Deusto	Moreno-Fernandez, MM (corresponding author), Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	manuela.moreno@deusto.es	Moreno-Fernandez, María Manuela/D-8654-2015; Matute, Helena/A-8256-2011; Blanco, Fernando/E-8941-2010; FERNANDEZ, MARIA MANUELA MORENO/U-3060-2019	Blanco, Fernando/0000-0003-1283-8313; FERNANDEZ, MARIA MANUELA MORENO/0000-0002-1747-4128	Agencia Estatal de Investigacion of the Spanish Government (AEI) [PSI2016-78818-R AEI/FEDER]; Fondo Europeo de Desarrollo Regional (FEDER); Basque Government [IT955-16]	Agencia Estatal de Investigacion of the Spanish Government (AEI); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Basque Government(Basque Government)	Support for this research was provided by Grant PSI2016-78818-R AEI/FEDER from Agencia Estatal de Investigacion of the Spanish Government (AEI) and Fondo Europeo de Desarrollo Regional (FEDER), as well as Grant IT955-16 from the Basque Government, both granted to Helena Matute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; ALLAN LG, 1980, CAN J PSYCHOL, V34, P1, DOI 10.1037/h0081013; Allan LG, 2005, LEARN BEHAV, V33, P250; ALLAN LG, 1980, B PSYCHONOMIC SOC, V15, P147; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; Blanco F., 2012, PLOS ONE, V7; Blanco F, 2017, CONSCIOUS COGN, V50, P56, DOI 10.1016/j.concog.2016.08.012; Blanco F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084084; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Blanco F, 2010, PSYCHON B REV, V17, P117, DOI 10.3758/PBR.17.1.117; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Chambers CT, 2002, J PEDIATR PSYCHOL, V27, P27, DOI 10.1093/jpepsy/27.1.27; CHAPMAN LJ, 1967, J ABNORM PSYCHOL, V72, P193, DOI 10.1037/h0024670; Crump MJC, 2007, Q J EXP PSYCHOL, V60, P753, DOI 10.1080/17470210701257685; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Elashi FB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141809; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gallagher MW, 2014, COGNITIVE THER RES, V38, P571, DOI 10.1007/s10608-014-9624-x; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2000, J EDUC PSYCHOL, V92, P377, DOI 10.1037//0022-0663.92.2.377; Gathercole SE, 1998, J CHILD PSYCHOL PSYC, V39, P3, DOI 10.1111/1469-7610.00301; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Gopnik A, 2015, CURR DIR PSYCHOL SCI, V24, P87, DOI 10.1177/0963721414556653; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; KAO SF, 1993, J EXP PSYCHOL LEARN, V19, P1363, DOI 10.1037/0278-7393.19.6.1363; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Larrick R.P., 2004, BLACKWELL HDB JUDGME, P316, DOI [DOI 10.1002/9780470752937.CH16, 10.1002/9780470752937.ch16]; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Lucas CG, 2014, COGNITION, V131, P284, DOI 10.1016/j.cognition.2013.12.010; Mandel DR, 2009, Q J EXP PSYCHOL, V62, P2388, DOI 10.1080/17470210902794148; MATUTE H, 1995, Q J EXP PSYCHOL-B, V48, P142; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Matute H, 2015, FRONT PSYCHOL, V6, P1; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meltzoff AN, 2012, DEV PSYCHOL, V48, P1215, DOI 10.1037/a0027440; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Moreno-Fernandez MM, 2017, OPEN SCI FRAMEWORK; Morris SC, 2000, DEV PSYCHOL, V36, P582, DOI 10.1037/0012-1649.36.5.582; Msetfi RM, 2017, ACTA PSYCHOL, V178, P1, DOI 10.1016/j.actpsy.2017.05.003; Msetfi RM, 2016, Q J EXP PSYCHOL, V69, P1073, DOI 10.1080/17470218.2016.1138134; Msetfi RM, 2005, J EXP PSYCHOL GEN, V134, P10, DOI 10.1037/0096-3445.134.1.10; Mueller SM, 2013, ACTA PSYCHOL, V144, P472, DOI 10.1016/j.actpsy.2013.08.004; Muller-Lyer FC., 1889, ARCHIV F R ANATOMIE, V2, P263; Musca SC, 2010, CONNECT SCI, V22, P177, DOI 10.1080/09540091003623797; MUTTER SA, 1994, PSYCHOL AGING, V9, P53, DOI 10.1037/0882-7974.9.1.53; Mutter SA, 1996, J GERONTOL B-PSYCHOL, V51, pP70, DOI 10.1093/geronb/51B.2.P70; Mutter SA, 2007, MEM COGNITION, V35, P875, DOI 10.3758/BF03193462; Nakabayashi K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00831; Parr WV, 1998, CAN J EXP PSYCHOL, V52, P147, DOI 10.1037/h0087288; Perales JC, 2005, J EXP PSYCHOL LEARN, V31, P1105, DOI 10.1037/0278-7393.31.5.1105; Piaget J, 1930, CHILDS CONCEPTION PH; Pronin E, 2004, PSYCHOL REV, V111, P781, DOI 10.1037/0033-295X.111.3.781; Pronin E, 2002, PERS SOC PSYCHOL B, V28, P369, DOI 10.1177/0146167202286008; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reuven-Magril O, 2008, J ABNORM PSYCHOL, V117, P334, DOI 10.1037/0021-843X.117.2.334; SANDERSON WC, 1989, ARCH GEN PSYCHIAT, V46, P157; Scopelliti I, 2015, MANAGE SCI, V61, P2468, DOI 10.1287/mnsc.2014.2096; SHANKS DR, 1987, PSYCHOL LEARN MOTIV, V21, P229; SHANKS DR, 1991, MEM COGNITION, V19, P353, DOI 10.3758/BF03197139; SHANKS DR, 1991, PSYCHOL SCI, V2, P341, DOI 10.1111/j.1467-9280.1991.tb00163.x; Vadillo MA, 2016, EXP PSYCHOL, V63, P3, DOI 10.1027/1618-3169/a000309; Vallee-Tourangeau F, 2005, Q J EXP PSYCHOL-B, V58, P177, DOI 10.1080/02724990444000104; Waismeyer A, 2015, DEVELOPMENTAL SCI, V18, P175, DOI 10.1111/desc.12208; Waldmann MR, 2001, COGNITION, V82, P27, DOI 10.1016/S0010-0277(01)00141-X; Waldmann MR, 1996, PSYCHOL LEARN MOTIV, V34, P47, DOI 10.1016/S0079-7421(08)60558-7; Wann D. L., 2013, Athletic Insight: The Online Journal of Sport Psychology, V15, punpaginated; WASSERMAN EA, 1990, J EXP PSYCHOL LEARN, V16, P509, DOI 10.1037/0278-7393.16.3.509; WASSERMAN EA, 1990, PSYCHOL LEARN MOTIV, V26, P27, DOI DOI 10.1016/S0079-7421(08)60051-1; White PA, 2009, MEM COGNITION, V37, P500, DOI 10.3758/MC.37.4.500; WONG PTP, 1982, SEX ROLES, V8, P381; Yarritu I, 2015, BRIT J PSYCHOL, V106, P597, DOI 10.1111/bjop.12119; Yarritu I, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00389; Yarritu I, 2014, EXP PSYCHOL, V61, P38, DOI 10.1027/1618-3169/a000225	83	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184707	10.1371/journal.pone.0184707	http://dx.doi.org/10.1371/journal.pone.0184707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG6AR	28898294	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500045
J	Cenik, B; Cenik, C; Snyder, MP; Brown, ES				Cenik, Basar; Cenik, Can; Snyder, Michael P.; Brown, E. Sherwood			Plasma sterols and depressive symptom severity in a population-based cohort	PLOS ONE			English	Article							16-ITEM QUICK INVENTORY; REPORT QIDS-SR; MAJOR DEPRESSION; LIPID RAFTS; CHOLESTEROL; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; OXYSTEROLS; METABOLISM	Convergent evidence strongly suggests major depressive disorder is heterogeneous in its etiology and clinical characteristics. Depression biomarkers hold potential for identifying etiological subtypes, improving diagnostic accuracy, predicting treatment response, and personalization of treatment. Human plasma contains numerous sterols that have not been systematically studied. Changes in cholesterol concentrations have been implicated in suicide and depression, suggesting plasma sterols may be depression biomarkers. Here, we investigated associations between plasma levels of 34 sterols (measured by mass spectrometry) and scores on the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16) scale in 3117 adult participants in the Dallas Heart Study, an ethnically diverse, population-based cohort. We built a random forest model using feature selection from a pool of 43 variables including demographics, general health indicators, and sterol concentrations. This model comprised 19 variables, 13 of which were sterol concentrations, and explained 15.5% of the variation in depressive symptoms. Desmosterol concentrations below the fifth percentile (1.9 ng/mL, OR 1.9, 95% CI 1.2-2.9) were significantly associated with depressive symptoms of at least moderate severity (QIDS-SR16 score >= 10.5). This is the first study reporting a novel association between plasma concentrations cholesterol precursors and depressive symptom severity.	[Cenik, Basar; Brown, E. Sherwood] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Cenik, Can; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Brown, ES (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	sherwood.brown@utsouthwestern.edu		Snyder, Michael/0000-0003-0784-7987; Cenik, Can/0000-0001-6370-0889	NATIONAL CANCER INSTITUTE [K99CA204522] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001105] Funding Source: Medline; NCI NIH HHS [K99 CA204522] Funding Source: Medline; NIMH NIH HHS [R25 MH101078] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Beasley CL, 2005, BIPOLAR DISORD, V7, P449, DOI 10.1111/j.1399-5618.2005.00239.x; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Bjorkholm C, 2016, NEUROPHARMACOLOGY, V102, P72, DOI 10.1016/j.neuropharm.2015.10.034; Boscarino JA, 2009, J PSYCHIATR RES, V43, P848, DOI 10.1016/j.jpsychires.2008.11.007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Cantarelli MD, 2014, PSYCHIAT RES, V220, P745, DOI 10.1016/j.psychres.2014.10.017; Dubrovsky BO, 2005, PROG NEURO-PSYCHOPH, V29, P169, DOI 10.1016/j.pnpbp.2004.11.001; Fiedorowicz JG, 2007, PSYCHIAT RES, V152, P11, DOI 10.1016/j.psychres.2006.09.003; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hasler G, 2010, WORLD PSYCHIATRY, V9, P155; Hastie T., 2016, R PACKAGE VERSION 1; Huang TL, 2015, ADV CLIN CHEM, V68, P177, DOI 10.1016/bs.acc.2014.11.003; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; Korade Z, 2017, SCHIZOPHR RES; Kuhn M., 2016, CARET CLASSIFICATION; Lalovic A, 2007, INT J NEUROPSYCHOPH, V10, P159, DOI 10.1017/S1461145706006663; Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431; Linsenbardt AJ, 2014, NEUROPHARMACOLOGY, V85, P232, DOI 10.1016/j.neuropharm.2014.05.027; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; MORGAN RE, 1993, LANCET, V341, P75, DOI 10.1016/0140-6736(93)92556-9; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nowaczyk MJM, 2012, AM J MED GENET C, V160C, P250, DOI 10.1002/ajmg.c.31343; Partonen T, 1999, BRIT J PSYCHIAT, V175, P259, DOI 10.1192/bjp.175.3.259; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Raeder MB, 2006, NEUROSCI LETT, V395, P185, DOI 10.1016/j.neulet.2005.10.096; Reilly TJ, 2015, J PSYCHIATR RES, V60, P132, DOI 10.1016/j.jpsychires.2014.09.008; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Singh P, 2011, BBA-BIOMEMBRANES, V1808, P2428, DOI 10.1016/j.bbamem.2011.06.022; Steegmans PHA, 2000, PSYCHOSOM MED, V62, P205, DOI 10.1097/00006842-200003000-00009; Stiles AR, 2014, P NATL ACAD SCI USA, V111, pE4006, DOI 10.1073/pnas.1413561111; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Weaver A, 2015, JAMA PSYCHIAT, V72, P576, DOI 10.1001/jamapsychiatry.2015.10; Wellington CL, 2016, CURR OPIN LIPIDOL, V27, P225, DOI 10.1097/MOL.0000000000000291; Weston S., 2015, R PACKAGE VERSION 1; Wu SQ, 2016, J PSYCHIATR NEUROSCI, V41, P56, DOI 10.1503/jpn.150079; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	46	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184382	10.1371/journal.pone.0184382	http://dx.doi.org/10.1371/journal.pone.0184382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886149	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100106
J	Estrada-Aviles, R; Rodriguez, G; Zarain-Herzberg, A				Estrada-Aviles, Rafael; Rodriguez, Gabriela; Zarain-Herzberg, Angel			The cardiac calsequestrin gene transcription is modulated at the promoter by NFAT and MEF-2 transcription factors	PLOS ONE			English	Article							SKELETAL-MUSCLE DEVELOPMENT; SARCOPLASMIC-RETICULUM; HEART-FAILURE; OVEREXPRESSING CALSEQUESTRIN; RYANODINE RECEPTOR; CALCINEURIN; EXPRESSION; CALCIUM; HYPERTROPHY; PROTEINS	Calsequestrin-2 (CASQ2) is the main Ca2+-binding protein inside the sarcoplasmic reticulum of cardiomyocytes. Previously, we demonstrated that MEF-2 and SRF binding sites within the human CASQ2 gene (hCASQ2) promoter region are functional in neonatal cardiomyocytes. In this work, we investigated if the calcineurin/NFAT pathway regulates hCASQ2 expression in neonatal cardiomyocytes. The inhibition of NFAT dephosphorylation with CsA or INCA-6, reduced both the luciferase activity of hCASQ2 promoter constructs (-3102/+176 bp and -288/+176 bp) and the CASQ2 mRNA levels in neonatal rat cardiomyocytes. Additionally, NFATc1 and NFATc3 over-expressing neonatal cardiomyocytes showed a 2-3-fold increase in luciferase activity of both hCASQ2 promoter constructs, which was prevented by CsA treatment. Site-directed mutagenesis of the -133 bp MEF-2 binding site prevented trans-activation of hCASQ2 promoter constructs induced by NFAT overexpression. Chromatin Immunoprecipitation (ChIP) assays revealed NFAT and MEF-2 enrichment within the -288 bp to +76 bp of the hCASQ2 gene promoter. Besides, a direct interaction between NFAT and MEF-2 proteins was demonstrated by protein co-immunoprecipitation experiments. Taken together, these data demonstrate that NFAT interacts with MEF-2 bound to the -133 bp binding site at the hCASQ2 gene promoter. In conclusion, in this work, we demonstrate that the Ca2+-calcineurin/NFAT pathway modulates the transcription of the hCASQ2 gene in neonatal cardiomyocytes.	[Estrada-Aviles, Rafael; Rodriguez, Gabriela; Zarain-Herzberg, Angel] Univ Nacl Autonoma Mexico, Sch Med, Dept Biochem, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Zarain-Herzberg, A (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Dept Biochem, Mexico City, DF, Mexico.	zarain@unam.mx		Zarain-Herzberg, Angel/0000-0002-1916-4780	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [164413]; CONACyT [57838]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant 164413 to A.Z.-H. and by a Scholarship CONACyT No. 57838 to R.E.-A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; ARAI M, 1991, GENE, V109, P275, DOI 10.1016/0378-1119(91)90621-H; ARAI M, 1992, AM J PHYSIOL, V262, pC614, DOI 10.1152/ajpcell.1992.262.3.C614; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2009, CLIN EXP PHARMACOL P, V36, P340, DOI 10.1111/j.1440-1681.2008.05094.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Birkeland JA, 2005, SCAND CARDIOVASC J, V39, P13, DOI 10.1080/14017430410004632; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Chopra N, 2009, J CARDIOVASC ELECTR, V20, P1179, DOI 10.1111/j.1540-8167.2009.01531.x; CLAYCOMB WC, 1981, EXP CELL RES, V131, P231, DOI 10.1016/0014-4827(81)90423-7; Doevendans PA, 1996, INT J BIOCHEM CELL B, V28, P387, DOI 10.1016/1357-2725(95)00145-X; Frank KF, 2001, BASIC RES CARDIOL, V96, P636, DOI 10.1007/s003950170016; Gyorke S, 2009, J PHYSIOL-LONDON, V587, P3091, DOI 10.1113/jphysiol.2009.172049; Haddad R, 2013, CAN J PHYSIOL PHARM, V91, P741, DOI 10.1139/cjpp-2013-0014; Hanninen SL, 2010, CARDIOVASC RES, V88, P75, DOI 10.1093/cvr/cvq180; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ihara Y, 2002, CELL CALCIUM, V32, P21, DOI 10.1016/S0143-4160(02)00096-9; Im SH, 2004, MOL CELLS, V18, P1; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Kasneci A, 2009, CARDIOVASC RES, V81, P695, DOI 10.1093/cvr/cvn357; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Korzick DH, 2003, ADV PHYSIOL EDUC, V27, P192, DOI 10.1152/advan.00028.2003; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Lee D, 2010, BMB REP, V43, P151, DOI 10.5483/BMBRep.2010.43.3.151; Lehnart SE, 1998, ANN NY ACAD SCI, V853, P220, DOI 10.1111/j.1749-6632.1998.tb08270.x; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Protasi F, 2011, J MUSCLE RES CELL M, V32, P257, DOI 10.1007/s10974-011-9277-2; Reyes-Juarez JL, 2007, J BIOL CHEM, V282, P35554, DOI 10.1074/jbc.M707788200; Rinne A, 2010, AM J PHYSIOL-HEART C, V298, pH2001, DOI 10.1152/ajpheart.01072.2009; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Rossi D, 2008, TRAFFIC, V9, P1044, DOI 10.1111/j.1600-0854.2008.00717.x; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zima AV, 2014, PFLUG ARCH EUR J PHY, V466, P1129, DOI 10.1007/s00424-014-1469-3	50	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184724	10.1371/journal.pone.0184724	http://dx.doi.org/10.1371/journal.pone.0184724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886186	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100180
J	Lietman, CD; Segedy, AK; Li, B; Fazio, S; Atkinson, JB; Linton, MF; Young, PP				Lietman, Caressa D.; Segedy, Amanda K.; Li, Bin; Fazio, Sergio; Atkinson, James B.; Linton, MacRae F.; Young, Pampee P.			Loss of SPRR3 in ApoE(-/-) mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; APOE-DEFICIENT MICE; PLAQUE RUPTURE; MATRIX METALLOPROTEINASES; SIGNAL-TRANSDUCTION; CORNIFIED ENVELOPE; CORONARY-ARTERIES; GROWTH-FACTOR; ATHEROSCLEROSIS; EXPRESSION	Vascular smooth muscle cells (VSMCs) represent important modulators of plaque stability in advanced lesions. We previously reported that loss of small proline-rich repeat protein 3 (Sprr3), leads to VSMC apoptosis in a PI3K/Akt-dependent manner and accelerates lesion progression. Here, we investigated the role of Sprr3 in modulating plaque stability in hyperlipidemic ApoE(-/-) mice. We show that loss of Sprr3 increased necrotic core size and reduced cap collagen content of atheromas in brachiocephalic arteries with evidence of plaque rupture and development of intraluminal thrombi. Moreover, Sprr3(-/-) ApoE(-/-) mice developed advanced coronary artery lesions accompanied by intraplaque hemorrhage and left ventricle microinfarcts. SPRR3 is known to reduce VSMC survival in lesions by promoting their apoptosis. In addition, we demonstrated that Sprr3(-/-) VSMCs displayed reduced expression of procollagen in a PI3K/Akt dependent manner. SPRR3 loss also increased MMP gelatinase activity in lesions, and increased MMP2 expression, migration and contraction of VSMCs independently of PI3K/Akt. Consequently, Sprr3 represents the first described VSMC modulator of each of the critical features of cap stability, including VSMC numbers, collagen type I synthesis, and protease activity through Akt dependent and independent pathways.	[Lietman, Caressa D.; Segedy, Amanda K.; Li, Bin; Atkinson, James B.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Fazio, Sergio] Oregon Hlth & Sci Univ, Ctr Prevent Cardiol, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Atkinson, James B.; Young, Pampee P.] Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Linton, MacRae F.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37235 USA; [Linton, MacRae F.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA	Vanderbilt University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.; Young, PP (corresponding author), Vet Affairs Med Ctr, Nashville, TN 37212 USA.; Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	pampee.young@vanderbilt.edu		Lietman, Caressa/0000-0003-3863-2751	Department of Veterans Affairs [BX002337]; National Institutes of Health [R21 EB019509]; National Institutes of Health, National Heart Lung and Blood Institute [057986]; National Heart Lung and Blood Institute [HL116263]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL116263] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Award from the Department of Veterans Affairs BX002337 (PPY) [https://www.va.gov/] and National Institutes of Health R21 EB019509 (PPY) [https://www.nih.gov/]. SF was supported by the National Institutes of Health, National Heart Lung and Blood Institute 057986 [https://www.nhlbi.nih.gov/]. MFL was supported by the National Heart Lung and Blood Institute HL116263 [https://www.nhlbi.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathna P, 2014, FASEB J S, V28; Babaev VR, 2014, J LIPID RES, V55, P2296, DOI 10.1194/jlr.M050633; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen CCA, 2007, FASEB J, V21, pA520; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Cullen P, 2003, ARTERIOSCLER THROMB, V23, P529; da Cunha V, 2006, J VASC SURG, V44, P364, DOI 10.1016/j.jvs.2006.04.033; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Ikedo H, 2003, INT J MOL MED, V11, P645; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P714, DOI 10.1161/01.ATV.0000261873.86623.e1; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Kenagy RD, 1997, CIRCULATION, V96, P3555; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Kobayashi E, 2000, INTERV NEURORADIOL, V6, P165, DOI 10.1177/15910199000060S125; Kusuhara M, 1998, CIRC RES, V83, P824, DOI 10.1161/01.RES.83.8.824; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Lee R, 2012, EUR HEART J, V33, P1039, DOI 10.1093/eurheartj/ehs028; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Liu Q, 2013, ONCOLOGY LETT, V7, P427; Matoba T, 2013, CURR OPIN LIPIDOL, P24; Matoba T, 2013, CURR OPIN LIPIDOL, V24, P419, DOI 10.1097/MOL.0b013e3283646e4d; Matsui T, 2005, J MOL CELL CARDIOL, V38, P63, DOI 10.1016/j.yjmcc.2004.11.005; Mughal MM, 2011, EXPERT REV CARDIOVAS, V9, P1315, DOI [10.1586/erc.11.120, 10.1586/ERC.11.120]; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Pyle AL, 2008, AM J PATHOL, V173, P1577, DOI 10.2353/ajpath.2008.080042; Pyle AL, 2010, AM J PATHOL, V177, P4, DOI 10.2353/ajpath.2010.090615; Pyle Amy L, 2010, Cardiovasc Pathol, V19, pe13, DOI 10.1016/j.carpath.2008.12.006; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Rodella LF, 2007, ACTA HISTOCHEM, V109, P45, DOI 10.1016/j.acthis.2006.08.002; Rotllan N, 2015, CIRC RES, V116, P1744, DOI 10.1161/CIRCRESAHA.116.305895; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sato K, 2012, J ATHEROSCLER THROMB, V19, P986, DOI 10.5551/jat.13391; Scherberich A, 1998, ARTERIOSCL THROM VAS, V18, P1691, DOI 10.1161/01.ATV.18.11.1691; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Segedy AK, 2014, ARTERIOSCL THROM VAS, V34, P2527, DOI 10.1161/ATVBAHA.114.303644; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1994, BASIC RES CARDIOL, V89, P17; Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77; Watanabe Noboru, 2004, Curr Atheroscler Rep, V6, P112, DOI 10.1007/s11883-004-0099-1; Yokoyama K, 2012, GRAEF ARCH CLIN EXP, V250, P15, DOI 10.1007/s00417-011-1766-x; Young PP, 2005, CIRCULATION, V111, P2382, DOI 10.1161/01.CIR.0000164235.26339.78; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184620	10.1371/journal.pone.0184620	http://dx.doi.org/10.1371/journal.pone.0184620			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886156	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100171
J	Nishimukai, A; Inoue, N; Kira, A; Takeda, M; Morimoto, K; Araki, K; Kitajima, K; Watanabe, T; Hirota, S; Katagiri, T; Nakamori, S; Akazawa, K; Miyoshi, Y				Nishimukai, Arisa; Inoue, Natsuko; Kira, Ayako; Takeda, Masashi; Morimoto, Koji; Araki, Kazuhiro; Kitajima, Kazuhiro; Watanabe, Takahiro; Hirota, Seiichi; Katagiri, Toyomasa; Nakamori, Shoji; Akazawa, Kouhei; Miyoshi, Yasuo			Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of F-18-deoxyglucose levels on positron emission tomography for breast cancers	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; F-18-FDG PET/CT; PATHOLOGICAL RESPONSE; GLUCOSE-METABOLISM; EARLY PREDICTION; PROGNOSIS; PATHWAY; KI-67	It has been well established that maximum standardized uptake value (SUVmax) for F-18-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) is clinically useful for evaluating treatment efficacy as well as predicting prognosis of breast cancer patients. Although SUVmax reflects increased glucose uptake and metabolism possibly induced by activation of growth factor signaling or TP53 dysfunction, tumor characteristics of SUVmax-high breast cancers remain to be elucidated. For the present study, we used immunohistochemical staining to investigate expressions of phospho-ribosomal protein S6 (pS6, downstream molecule of phosphatidyl inositol 3-kinase/Akt/mammalian target of the rapamycin/S6K pathway) and phosphor-p44/42 mitogen-activated protein kinase (pMAPK). Expression levels of TP53 and proliferative marker geminin as well as Ki67 were also examined by means of immunostaining in 163 invasive breast cancers. Cutoff values were set at 10% for pS6, 20% for pMAPK and TP53, and 4% for geminin. The SUVmax levels were significantly higher in the pS6-positive (p = 0.0173), TP53-positive (p = 0.0207) and geminin-high cancers (p<0.0001), but there was no significant association between pMAPK expression levels and SUVmax levels. Multivariable analysis showed that a high geminin level (odds ratio: 6.497, 95% confidence interval: 2.427-19.202, p = 0.0001) and large tumor size (6.438, 2.224-20.946, p = 0.0005) were significantly and independently associate d with SUVmax-high. Univariable but not multivariable analysis indicated that Ki67-high significantly correlated with SUVmax-high. Twenty of 23 (87.0%) breast cancers with tumor size >2cm and geminin-high showed SUVmax-high, while only 6 of 49 (12.2%) breast cancers <= 2cm in size and with low geminin levels were SUVmax-high. In conclusion, we could determine that breast cancers with a large tumor and a geminin-high rather than Ki67-high proliferative marker were significantly associated with high levels of SUVmax. These findings may signify that SUVmax reflects tumor characteristics with high proliferative activity but not activation of mTOR/S6K and MAPK pathways or increased glucose metabolism due to dysfunction of TP53.	[Nishimukai, Arisa; Inoue, Natsuko; Kira, Ayako; Araki, Kazuhiro; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo, Japan; [Takeda, Masashi] Yao Municipal Hosp, Dept Pathol, Yao, Osaka, Japan; [Morimoto, Koji] Osaka Womens Jr Coll, Dept Sci Living, Fujiidera City, Osaka, Japan; [Morimoto, Koji; Nakamori, Shoji] Natl Hosp Org, Osaka Natl Hosp, Dept Surg, Chuo Ku, Osaka, Japan; [Kitajima, Kazuhiro] Hyogo Coll Med, Dept Nucl Med, Nishinomiya, Hyogo, Japan; [Kitajima, Kazuhiro] Hyogo Coll Med, PET Ctr, Nishinomiya, Hyogo, Japan; [Watanabe, Takahiro; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo, Japan; [Katagiri, Toyomasa] Tokushima Univ, Inst Genome Res, Div Genome Med, Kuramoto Cho, Tokushima, Japan; [Akazawa, Kouhei] Niigata Univ Med & Dent Hosp, Dept Med Informat, Niigata, Japan	Hyogo College of Medicine; Osaka National Hospital; Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine; Niigata University	Miyoshi, Y (corresponding author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo, Japan.	ymiyoshi@hyo-med.ac.jp	Araki, kazuhiro/AAD-5658-2019; Miyoshi, Yasuo/AAI-6321-2020	Araki, kazuhiro/0000-0001-7623-7715; Miyoshi, Yasuo/0000-0001-8535-4008	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26461963]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 26461963) (https://www.jsps.go.jp/english/index.html).	Ahn SG, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0502-y; Avril S, 2016, J NUCL MED, V57, p34S, DOI 10.2967/jnumed.115.157875; Chang JS, 2016, CANCER RES TREAT, V48, P508, DOI 10.4143/crt.2015.172; Crippa F, 2015, EUR J NUCL MED MOL I, V42, P818, DOI 10.1007/s00259-015-2995-8; Evangelista L, 2015, EUR J NUCL MED MOL I, V42, P1648, DOI 10.1007/s00259-015-3088-4; Gao D, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160122; Garami Z, 2012, EJSO-EUR J SURG ONC, V38, P31, DOI 10.1016/j.ejso.2011.09.002; Gonzalez MA, 2004, J PATHOL, V204, P121, DOI 10.1002/path.1625; Groheux D, 2016, EUR J NUCL MED MOL I, V43, P983, DOI 10.1007/s00259-015-3295-z; Groheux D, 2015, J NUCL MED, V56, P824, DOI 10.2967/jnumed.115.154138; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Higuchi T, 2016, BREAST, V30, P5, DOI 10.1016/j.breast.2016.08.003; Kadoya T, 2013, BREAST CANCER RES TR, V141, P269, DOI 10.1007/s10549-013-2687-7; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kitajima K, 2016, JPN J RADIOL, V34, P220, DOI 10.1007/s11604-015-0515-1; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo HR, 2015, EUR RADIOL, V25, P3314, DOI 10.1007/s00330-015-3734-z; Lee HW, 2016, J NUCL MED, V57, P1183, DOI 10.2967/jnumed.115.166322; Lee JH, 2013, SEMIN NUCL MED, V43, P294, DOI 10.1053/j.semnuclmed.2013.04.001; Loddo M, 2009, BRIT J CANCER, V100, P959, DOI 10.1038/sj.bjc.6604924; Mizuno T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1097-0; Nguyen QD, 2011, TRANSL ONCOL, V4, P241, DOI 10.1593/tlo.11118; Sakamoto Goi, 2005, Breast Cancer, V12 Suppl, pS1; Schwarz JK, 2012, CLIN CANCER RES, V18, P1464, DOI 10.1158/1078-0432.CCR-11-2485; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Son SH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-585; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Stanton KJ, 2003, AM J SURG, V186, P486, DOI 10.1016/j.amjsurg.2003.07.002; Tchou J, 2010, MOL IMAGING BIOL, V12, P657, DOI 10.1007/s11307-009-0294-0; Tegnebratt T, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0034-6; Yagi T, 2016, BREAST CANCER-TOKYO, V23, P224, DOI 10.1007/s12282-014-0556-9; Yanai A, 2015, CLIN BREAST CANCER, V15, P197, DOI 10.1016/j.clbc.2014.12.002; Zhao K, 2014, ONCOL LETT, V7, P984, DOI 10.3892/ol.2014.1877	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184508	10.1371/journal.pone.0184508	http://dx.doi.org/10.1371/journal.pone.0184508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886153	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100142
J	Mizrahi, A; Barzilai, A; Gur-Wahnon, D; Ben-Dov, IZ; Glassberg, S; Meningher, T; Elharar, E; Masalha, M; Jacob-Hirsch, J; Tabibian-Keissar, H; Barshack, I; Roszik, J; Leibowitz-Amit, R; Sidi, Y; Avni, D				Mizrahi, A.; Barzilai, A.; Gur-Wahnon, D.; Ben-Dov, I. Z.; Glassberg, S.; Meningher, T.; Elharar, E.; Masalha, M.; Jacob-Hirsch, J.; Tabibian-Keissar, H.; Barshack, I.; Roszik, J.; Leibowitz-Amit, R.; Sidi, Y.; Avni, D.			Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes	ONCOGENE			English	Article							DOWN-REGULATION; POOR-PROGNOSIS; CYCLIN D1; CANCER; EXPRESSION; METASTASIS; CLUSTER; DIFFERENTIATION; METHYLATION; SYSTEM	Skin carcinogenesis is known to be a multi-step process with several stages along its malignant evolution. We hypothesized that transformation of normal epidermis to cutaneous squamous cell carcinoma (cSCC) is causally linked to alterations in microRNAs (miRNA) expression. For this end we decided to evaluate their alterations in the pathologic states ending in cSCC. Total RNA was extracted from formalin fixed paraffin embedded biopsies of five stages along the malignant evolution of keratinocytes towards cSCC: Normal epidermis, solar elastosis, actinic keratosis KIN1-2, advanced actinic keratosis KIN3 and well-differentiated cSCC. Next-generation small RNA sequencing was performed. We found that 18 miRNAs are overexpressed and 28 miRNAs are underexpressed in cSCC compared to normal epidermis. miR-424, miR-320, miR-222 and miR-15a showed the highest fold change among the overexpressed miRNAs. And miR-100, miR-101 and miR-497 showed the highest fold change among the underexpressed miRNAs. Heat map of hierarchical clustering analysis of significantly changed miRNAs and principle component analysis disclosed that the most prominent change in miRNAs expression occurred in the switch from 'early' stages; normal epidermis, solar elastosis and early actinic keratosis to the 'late' stages of epidermal carcinogenesis; late actinic keratosis and cSCC. We found several miRNAs with 'stage specific' alterations while others display a clear 'gradual', either progressive increase or decrease in expression along the malignant evolution of keratinocytes. The observed alterations focused in miRNAs involved in the regulation of AKT/mTOR or in those involved in epithelial to mesenchymal transition. We chose to concentrate on the evaluation of the molecular role of miR-497. We found that it induces reversion of epithelial to mesenchymal transition. We proved that SERPINE-1 is its biochemical target. The present study allows us to further study the pathways that are regulated by miRNAs along the malignant evolution of keratinocytes towards cSCC.	[Mizrahi, A.; Glassberg, S.; Meningher, T.; Elharar, E.; Masalha, M.; Sidi, Y.; Avni, D.] Sheba Med Ctr, Ctr Canc Res, Lab Mol Cell Biol, Tel Hashomer, Israel; [Mizrahi, A.; Glassberg, S.; Meningher, T.; Elharar, E.; Masalha, M.; Sidi, Y.; Avni, D.] Sheba Med Ctr, Dept Med C, Tel Hashomer, Israel; [Barzilai, A.] Sheba Med Ctr, Dept Dermatol, Tel Hashomer, Israel; [Barzilai, A.] Sheba Med Ctr, Inst Pathol, Tel Hashomer, Israel; [Gur-Wahnon, D.; Ben-Dov, I. Z.] Hadassah Hebrew Univ, Med Ctr, Lab Med Transcript Nephrol & Hypertens Serv, Jerusalem, Israel; [Masalha, M.; Barshack, I.; Leibowitz-Amit, R.; Sidi, Y.] Tel Aviv Univ, Sackler Sch Med, Fac Med, Tel Aviv, Israel; [Jacob-Hirsch, J.] Sheba Med Ctr, Ctr Canc Res, Tel Hashomer, Israel; [Tabibian-Keissar, H.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Tabibian-Keissar, H.; Barshack, I.] Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel; [Roszik, J.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Roszik, J.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Leibowitz-Amit, R.] Sheba Med Ctr, Inst Oncol, Tel Hashomer, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Bar Ilan University; Chaim Sheba Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center	Sidi, Y; Avni, D (corresponding author), Sheba Med Ctr, Ctr Canc Res, Lab Mol Cell Biol, IL-52621 Ramat Gan, Israel.; Sidi, Y; Avni, D (corresponding author), Sheba Med Ctr, Dept Med C, IL-52621 Ramat Gan, Israel.	yehezkel.sidi@sheba.health.gov.il; droravni@msn.com	Avni, Dror/GRE-8325-2022; Ben-Dov, Iddo/F-3282-2010	Ben-Dov, Iddo/0000-0002-9180-3604; Roszik, Jason/0000-0002-4561-6170; sidi, yechezkel/0000-0001-7781-6153; Avni, Dror/0000-0002-8738-1840	Israel Cancer Association (ICA) [20110076, 20160038]; Ministry of Health, State of Israel (Ministry of Health) [3-10132]	Israel Cancer Association (ICA); Ministry of Health, State of Israel (Ministry of Health)	This work was funded by: Israel Cancer Association (ICA)-grant number 20110076 to Avni D, and Ministry of Health, State of Israel (Ministry of Health)-grant number 3-10132 to Avni D, and Israel Cancer Association (ICA)-grant number 20160038 to Avni D.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Barrette K, 2014, BRIT J DERMATOL, V171, P1014, DOI 10.1111/bjd.12967; Barzilai A, 2007, J AM ACAD DERMATOL, V57, P669, DOI 10.1016/j.jaad.2007.04.025; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Boukamp Petra, 2005, J Dtsch Dermatol Ges, V3, P493, DOI 10.1111/j.1610-0387.2005.05037.x; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burnworth B, 2007, EUR J CELL BIOL, V86, P763, DOI 10.1016/j.ejcb.2006.11.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; Cockerell CJ, 2000, J AM ACAD DERMATOL, V42, pS11, DOI 10.1067/mjd.2000.103344; Cockerell Clay J, 2005, J Drugs Dermatol, V4, P462; Corbalan-Velez R, 2010, ACTAS DERMO-SIFILOGR, V101, P517, DOI 10.1016/j.ad.2010.01.008; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; Eshkoor SA, 2009, BIOSCI TRENDS, V3, P105; Farazi TA, 2012, METHODS, V58, P171, DOI 10.1016/j.ymeth.2012.07.020; Feng FQ, 2016, HUM PATHOL, V58, P47, DOI 10.1016/j.humpath.2016.04.022; Freytag J, 2010, J INVEST DERMATOL, V130, P2179, DOI 10.1038/jid.2010.106; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Gillespie J, 2016, J EUR ACAD DERMATOL, V30, P1043, DOI 10.1111/jdv.13098; Green J, 2006, BRIT J CANCER, V94, P1446, DOI 10.1038/sj.bjc.6603135; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Guo R, 2017, J CELL BIOCHEM, V118, P3401, DOI 10.1002/jcb.25997; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; He XX, 2015, MOL BIOSYST, V11, P532, DOI 10.1039/c4mb00563e; Hu Yang, 2014, Microrna, V3, P108; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Huang Hou-Gang, 2015, Asian Pac J Cancer Prev, V16, P4937; Huntley MA, 2013, BIOINFORMATICS, V29, P3220, DOI 10.1093/bioinformatics/btt551; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo M, 2013, SURGERY, V153, P836, DOI 10.1016/j.surg.2012.12.004; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Mathias RA, 2013, J PROTEOMICS, V78, P545, DOI 10.1016/j.jprot.2012.10.016; Menigatti M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.21; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Omori K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148969; Pang L., 2014, SCI WORLD J, V2014, P1; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Ra SH, 2011, MODERN PATHOL, V24, P963, DOI 10.1038/modpathol.2011.39; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Sand M, 2012, J DERMATOL SCI, V68, P119, DOI 10.1016/j.jdermsci.2012.09.004; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Sun D, 2014, ONCOGENE, V33, P1448, DOI 10.1038/onc.2013.77; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; TILGEN W, 1983, CANCER RES, V43, P5995; Toll A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0537-z; Toll A, 2013, J DERMATOL SCI, V72, P93, DOI 10.1016/j.jdermsci.2013.07.001; van Haaften G, 2010, GENE DEV, V24, P1, DOI 10.1101/gad.1887110; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103206; Wang N, 2014, ASIAN PAC J CANCER P, V15, P10355, DOI 10.7314/APJCP.2014.15.23.10355; Wang SH, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-172; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu ZH, 2016, TUMOR BIOL, V37, P7939, DOI 10.1007/s13277-015-4665-7; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yan H, 2014, MOL CARCINOGEN, V53, P960, DOI 10.1002/mc.22064; Yu X, 2016, J CELL MOL MED, V20, P3, DOI 10.1111/jcmm.12649; Zaravinos A., 2015, J ONCOL, V2015, DOI DOI 10.1155/2015/865816; Zehavi L, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0338-9; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhang JS, 2012, CANCER METAST REV, V31, P653, DOI 10.1007/s10555-012-9368-6; Zhang L, 2016, WORLD J PSYCHIATR, V6, P1, DOI 10.5498/wjp.v6.i1.1; Zhang N, 2016, ONCOTARGETS THER, V9, P6597, DOI 10.2147/OTT.S114609; Zhao XL, 2015, INT J CLIN EXP PATHO, V8, P758	81	34	36	0	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					218	230		10.1038/onc.2017.315	http://dx.doi.org/10.1038/onc.2017.315			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28925390				2022-12-26	WOS:000422631700008
J	Cushing, L; Winkler, A; Jelinsky, SA; Lee, K; Korver, W; Hawtin, R; Rao, VR; Fleming, M; Lin, LL				Cushing, Leah; Winkler, Aaron; Jelinsky, Scott A.; Lee, Katherine; Korver, Wouter; Hawtin, Rachael; Rao, Vikram R.; Fleming, Margaret; Lin, Lih-Ling			IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; inflammation; interferon regulatory factor; IRF5; NFB; Toll-like receptor; TLR; IRAK4; TAK1; IKK	NF-KAPPA-B; INTERFERON REGULATORY FACTOR; GENE-EXPRESSION SIGNATURE; IKK-BETA; PERIPHERAL-BLOOD; INTERLEUKIN-1; ACTIVATION; LUPUS; INDUCTION; PROTEIN	Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role in innate immune signaling by Toll-like receptors (TLRs), and loss of IRAK4 activity in mice and humans increases susceptibility to bacterial infections and causes defects in TLR and IL1 ligand sensing. However, the mechanism by which IRAK4 activity regulates the production of downstream inflammatory cytokines is unclear. Using transcriptomic and biochemical analyses of human monocytes treated with a highly potent and selective inhibitor of IRAK4, we show that IRAK4 kinase activity controls the activation of interferon regulatory factor 5 (IRF5), a transcription factor implicated in the pathogenesis of multiple autoimmune diseases. Following TLR7/8 stimulation by its agonist R848, chemical inhibition of IRAK4 abolished IRF5 translocation to the nucleus and thus prevented IRF5 binding to and activation of the promoters of inflammatory cytokines in human monocytes. We also found that IKK, an upstream IRF5 activator, is phosphorylated in response to the agonist-induced TLR signaling. Of note, IRAK4 inhibition blocked IKK phosphorylation but did not block the nuclear translocation of NFB, which was surprising, given the canonical role of IKK in phosphorylating IB to allow NFB activation. Moreover, pharmacological inhibition of either IKK or the serine/threonine protein kinase TAK1 in monocytes blocked TLR-induced cytokine production and IRF5 translocation to the nucleus, but not nuclear translocation of NFB. Taken together, our data suggest a mechanism by which IRAK4 activity regulates TAK1 and IKK activation, leading to the nuclear translocation of IRF5 and induction of inflammatory cytokines in human monocytes.	[Cushing, Leah; Winkler, Aaron; Jelinsky, Scott A.; Rao, Vikram R.; Fleming, Margaret; Lin, Lih-Ling] Pfizer Inc, Dept Inflammat & Immunol, Cambridge, MA 02139 USA; [Lee, Katherine] Pfizer Inc, Dept Med Chem, Cambridge, MA 02139 USA; [Korver, Wouter; Hawtin, Rachael] Nodality Inc, San Francisco, CA 94080 USA; [Cushing, Leah] EMD Serono Inc, 45 Middlesex Turnpike, Billerica, MA 01821 USA; [Korver, Wouter] Allakos Inc, 75 Shoreway Rd,Suite A, San Carlos, CA 94070 USA; [Hawtin, Rachael] Gilead Sci, 333 Lakeside Dr, Foster City, CA 94404 USA; [Fleming, Margaret] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Pfizer; Pfizer; Merck KGaA; EMD Serono Inc.; Gilead Sciences; Novartis	Lin, LL (corresponding author), 1 Portland St, Cambridge, MA 02139 USA.	lih-ling.lin@pfizer.com						Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cesano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056714; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Cushing L, 2014, J BIOL CHEM, V289, P10865, DOI 10.1074/jbc.M113.544809; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; Dudhgaonkar S, 2017, J IMMUNOL, V198, P1308, DOI 10.4049/jimmunol.1600583; Feng D, 2012, EUR J IMMUNOL, V42, P1477, DOI 10.1002/eji.201141642; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Hayden MS, 2014, P NATL ACAD SCI USA, V111, P17348, DOI 10.1073/pnas.1419689111; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2009, ARTHRITIS RHEUM-US, V60, P1661, DOI 10.1002/art.24552; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Marchlik E, 2010, J LEUKOCYTE BIOL, V88, P1171, DOI 10.1189/jlb.0210071; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Richez C, 2010, JOINT BONE SPINE, V77, P525, DOI 10.1016/j.jbspin.2010.08.005; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Seganish WM, 2016, EXPERT OPIN THER PAT, V26, P917, DOI 10.1080/13543776.2016.1202926; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Wright HL, 2015, RHEUMATOLOGY, V54, P188, DOI 10.1093/rheumatology/keu299; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	43	43	47	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18689	18698		10.1074/jbc.M117.796912	http://dx.doi.org/10.1074/jbc.M117.796912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924041	Green Published, hybrid			2022-12-26	WOS:000414958100025
J	Waraky, A; Lin, YB; Warsito, D; Haglund, F; Aleem, E; Larsson, O				Waraky, Ahmed; Lin, Yingbo; Warsito, Dudi; Haglund, Felix; Aleem, Eiman; Larsson, Olle			Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor (IGF); phosphorylation; post-transcriptional regulation; proliferating cell nuclear antigen (PCNA); ubiquitin	IGF-1 RECEPTOR; POLYMERASE-ETA; FACTOR-I; TYROSINE PHOSPHORYLATION; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; UBIQUITIN LIGASE; HUMAN SHPRH; POL-ETA; PCNA	We have previously shown that the insulin-like growth factor 1 receptor (IGF-1R) translocates to the cell nucleus, where it binds to enhancer-like regions and increases gene transcription. Further studies have demonstrated that nuclear IGF-1R (nIGF-1R) physically and functionally interacts with some nuclear proteins, i.e. the lymphoid enhancer-binding factor 1 (Lef1), histone H3, and Brahma-related gene-1 proteins. In this study, we identified the proliferating cell nuclear antigen (PCNA) as a nIGF-1R-binding partner. PCNA is a pivotal component of the replication fork machinery and a main regulator of the DNA damage tolerance (DDT) pathway. We found that IGF-1R interacts with and phosphorylates PCNA in human embryonic stem cells and other cell lines. In vitro MS analysis of PCNA co-incubated with the IGF-1R kinase indicated tyrosine residues 60, 133, and 250 in PCNA as IGF-1R targets, and PCNA phosphorylation was followed by mono- and polyubiquitination. Co-immunoprecipitation experiments suggested that these ubiquitination events may be mediated by DDT-dependent E2/E3 ligases (e.g. RAD18 and SHPRH/HLTF). Absence of IGF-1R or mutation of Tyr-60, Tyr-133, or Tyr-250 in PCNA abrogated its ubiquitination. Unlike in cells expressing IGF-1R, externally induced DNA damage in IGF-1R-negative cells caused G(1) cell cycle arrest and S phase fork stalling. Taken together, our results suggest a role of IGF-1R in DDT.	[Waraky, Ahmed; Lin, Yingbo; Warsito, Dudi; Haglund, Felix; Aleem, Eiman; Larsson, Olle] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, SE-17176 Stockholm, Sweden; [Aleem, Eiman] Univ Arizona, Phoenix Childrens Hosp, Inst Mol Med, Phoenix, AZ 85004 USA; [Aleem, Eiman] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85004 USA	Karolinska Institutet; Phoenix Children's Hospital; University of Arizona; University of Arizona	Larsson, O (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, SE-17176 Stockholm, Sweden.	olle.larsson@ki.se	Aleem, Eiman/AAK-3208-2021	Aleem, Eiman/0000-0002-9215-8213; Waraky, Ahmed/0000-0003-4635-021X	Swedish Cancer Foundation; Swedish Research Council; Cancer Society in Stockholm; Swedish Children Cancer Society; Stockholm County Council; Karolinska Institutet	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Swedish Children Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the Cancer Society in Stockholm, the Swedish Children Cancer Society, Stockholm County Council, and the Karolinska Institutet. The authors declare that they have no conflicts of interest with the contents of this article.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Baple EL, 2014, J CLIN INVEST, V124, P3137, DOI 10.1172/JCI74593; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Carr AM, 2011, SEMIN CELL DEV BIOL, V22, P866, DOI 10.1016/j.semcdb.2011.10.008; Castells-Roca L, 2015, CELL CYCLE, V14, P467, DOI 10.1080/15384101.2015.1006543; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chitnis MM, 2014, ONCOGENE, V33, P5262, DOI 10.1038/onc.2013.460; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; de Feraudy S, 2007, ONCOGENE, V26, P5713, DOI 10.1038/sj.onc.1210385; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; Ermolaeva MA, 2015, AGEING RES REV, V23, P3, DOI 10.1016/j.arr.2014.12.009; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Liefshitz B, 1998, MUTAT RES-DNA REPAIR, V407, P135, DOI 10.1016/S0921-8777(97)00070-0; Lin YB, 2017, J CELL PHYSIOL, V232, P2722, DOI 10.1002/jcp.25818; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Niu MZ, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-4; Olsen H, 2006, EXP CELL RES, V312, P1371, DOI 10.1016/j.yexcr.2005.12.023; Ortega J, 2015, P NATL ACAD SCI USA, V112, P5667, DOI 10.1073/pnas.1417711112; Parvaresch S, 2002, FEBS LETT, V532, P357, DOI 10.1016/S0014-5793(02)03708-0; PIETRZKOWSKI Z, 1992, MOL CELL BIOL, V12, P3883, DOI 10.1128/MCB.12.9.3883; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Pohlhaus JR, 2006, METHOD ENZYMOL, V409, P477, DOI 10.1016/S0076-6879(05)09028-2; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; PROSPERI E, 1993, EXP CELL RES, V205, P320, DOI 10.1006/excr.1993.1092; Schwab R. A., 2011, JOVE-J VIS EXP, V27; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stary A, 2002, RES MICROBIOL, V153, P441, DOI 10.1016/S0923-2508(02)01343-8; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Waraky A, 2016, BIOCHEM BIOPH RES CO, V478, P1575, DOI 10.1016/j.bbrc.2016.08.157; Waraky A, 2014, ONCOTARGET, V5, P8379, DOI 10.18632/oncotarget.2292; Warsito D, 2016, ONCOTARGET, V7, P42288, DOI 10.18632/oncotarget.9785; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang XH, 2009, CELL CYCLE, V8, P191, DOI 10.4161/cc.8.2.7357; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84	53	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18227	18239		10.1074/jbc.M117.781492	http://dx.doi.org/10.1074/jbc.M117.781492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28924044	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000414458200020
J	Meng, XN; Chen, QM; Fan, HY; Song, TF; Cui, N; Zhao, JY; Jia, SM; Meng, KX				Meng, Xiang Nan; Chen, Qiu Min; Fan, Hai Yan; Song, Tie Feng; Cui, Na; Zhao, Ju Yong; Jia, Shu Min; Meng, Ke Xin			Molecular characterization, expression analysis and heterologous expression of two translationally controlled tumor protein genes from Cucumis sativus	PLOS ONE			English	Article							TCTP; CLONING; GROWTH; ARABIDOPSIS; DROSOPHILA; STRESS; GTPASE; RICE; SALT	The translationally controlled tumor protein (TCTP) is a family of abundant and ubiquitous proteins involved in several important primary functions. Cucumbers harbor two TCTP genes, CsTCTP1 and CsTCTP2; however, their functional roles remain unclear. In this study, we isolated CsTCTP1 and CsTCTP2 (XP-004134215 and XP-004135602, respectively) promoters, full-length cDNA and genomic sequences from Cucumis sativus. Bioinformatics analysis, containing cis-acting elements, structural domains, phylogenetic tree and conserved motifs, suggested the conservation and divergence of CsTCTP1 and CsTCTP2, thus providing knowledge regarding their functions. Expression analysis indicated that CsTCTP1 and CsTCTP2 exhibited tissue-specific expression and were regulated by biotic or abiotic stresses in C. sativus. Furthermore, CsTCTP1 and CsTCTP2 were regulated by ABA and may be associated with the TOR (target of rapamycin) signaling pathway. In a prokaryotic expression analysis, CsTCTP1 and CsTCTP2 showed positive responses to salt and heat stresses and a negative response to drought and HgCl2 stresses. TCTP may exert multiple functions in various cellular processes.	[Meng, Xiang Nan] Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China; [Chen, Qiu Min; Fan, Hai Yan; Cui, Na; Jia, Shu Min] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang, Liaoning, Peoples R China; [Fan, Hai Yan] Shenyang Agr Univ, Minist Educ, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China; [Song, Tie Feng; Zhao, Ju Yong] Liaoning Acad Agr Sci, Shenyang, Liaoning, Peoples R China; [Meng, Ke Xin] Shenyang Agr Univ, Foreign Languages Dept, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University; Shenyang Agricultural University; Shenyang Agricultural University	Fan, HY (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang, Liaoning, Peoples R China.; Fan, HY (corresponding author), Shenyang Agr Univ, Minist Educ, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China.	Hyfan74@163.com			National Natural Science Foundation of China [31772314]; Natural Science Foundation of Liaoning Province of China [20170540802]; Program for Science and Technology Plan of Shenyang [171246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province); Program for Science and Technology Plan of Shenyang	This study was funded by National Natural Science Foundation of China (31772314), Natural Science Foundation of Liaoning Province of China (20170540802) and Program for Science and Technology Plan of Shenyang (171246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Chou MX, 2016, PLANT MOL BIOL, V90, P389, DOI 10.1007/s11103-015-0424-9; Deng Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00789; Fan HY, 2014, ACTA PHYSIOL PLANT, V36, P1781, DOI 10.1007/s11738-014-1552-6; Gutierrez-Galeano DF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00361; Hoepflinger MC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-135; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Le TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11501; Li Gang, 2010, Bulletin of Botanical Research, V30, P441; Liu WY, 2009, J INTEGR PLANT BIOL, V51, P825, DOI 10.1111/j.1744-7909.2009.00853.x; MAKRIDES S, 1988, NUCLEIC ACIDS RES, V16, P2349, DOI 10.1093/nar/16.5.2349; PAY A, 1992, PLANT MOL BIOL, V19, P501, DOI 10.1007/BF00023399; Reddy PS, 2012, MOL BIOL REP, V39, P7163, DOI 10.1007/s11033-012-1548-5; Santa Brigida AB, 2014, MOL BIOL REP, V41, P1787, DOI 10.1007/s11033-014-3028-6; Schmidt I, 2007, FEBS J, V274, P5416, DOI 10.1111/j.1742-4658.2007.06069.x; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Toscano-Morales R, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1071003; Toscano-Morales R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00468; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vincent D, 2007, J EXP BOT, V58, P1873, DOI 10.1093/jxb/erm012; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang FJ, 2012, J ENVIRON SCI, V24, P2149, DOI 10.1016/S1001-0742(11)61062-0; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; [郑舒扬 Zheng Shuyang], 2014, [生物技术通报, Biotechnology Bulletin], P72	33	4	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184872	10.1371/journal.pone.0184872	http://dx.doi.org/10.1371/journal.pone.0184872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926624	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600047
J	Renna, LV; Bose, F; Iachettini, S; Fossati, B; Saraceno, L; Milani, V; Colombo, R; Meola, G; Cardani, R				Renna, Laura Valentina; Bose, Francesca; Iachettini, Sara; Fossati, Barbara; Saraceno, Lorenzo; Milani, Valentina; Colombo, Roberto; Meola, Giovanni; Cardani, Rosanna			Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GLUCOSE-TRANSPORT; MICROTUBULE NETWORK; CENTRAL NUCLEATION; DIABETIC SUBJECTS; CHLORIDE CHANNEL; CTG REPEAT; PROTEIN; GLUT4; RNA	Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are autosomal dominant multisystemic disorders caused by expansion of microsatellite repeats. In both forms, the mutant transcripts accumulate in nuclear foci altering the function of alternative splicing regulators which are necessary for the physiological mRNA processing. Missplicing of insulin receptor (IR) gene (INSR) has been associated with insulin resistance, however, it cannot be excluded that post-receptor signalling abnormalities could also contribute to this feature in DM. We have analysed the insulin pathway in skeletal muscle biopsies and in myotube cultures from DM patients to assess whether downstream metabolism might be dysregulated and to better characterize the mechanism inducing insulin resistance. DM skeletal muscle exhibits alterations of basal phosphorylation levels of Akt/PKB, p70S6K, GSK3 beta and ERK1/2, suggesting that these changes might be accompanied by a lack of further insulin stimulation. Alterations of insulin pathway have been confirmed on control and DM myotubes expressing fetal INSR isoform (INSR-A). The results indicate that insulin action appears to be lower in DM than in control myotubes in terms of protein activation and glucose uptake. Our data indicate that post-receptor signalling abnormalities might contribute to DM insulin resistance regardless the alteration of INSR splicing.	[Renna, Laura Valentina; Bose, Francesca; Iachettini, Sara; Meola, Giovanni; Cardani, Rosanna] Policlin San Donato, IRCCS, Lab Muscle Histopathol & Mol Biol, San Donato Milanese, Italy; [Fossati, Barbara; Meola, Giovanni] Policlin San Donato, IRCCS, Dept Neurol, San Donato Milanese, Italy; [Saraceno, Lorenzo; Meola, Giovanni] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Milani, Valentina] Policlin San Donato, IRCCS, Sci Directorate, Milan, Italy; [Colombo, Roberto] Univ Milan, Dept Biosci, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; University of Milan; IRCCS Policlinico San Donato; University of Milan	Cardani, R (corresponding author), Policlin San Donato, IRCCS, Lab Muscle Histopathol & Mol Biol, San Donato Milanese, Italy.	rosanna.cardani@grupposandonato.it	Renna, Laura Valentina/ABH-7699-2020; IACHETTINI, SARA/AAY-6180-2021; Meola, Giovanni/K-4775-2016; cardani, rosanna/ABH-6525-2020; Milani, Valentina/AAB-5367-2019	Renna, Laura Valentina/0000-0003-1316-7478; IACHETTINI, SARA/0000-0002-9442-0326; Meola, Giovanni/0000-0001-6396-717X; cardani, rosanna/0000-0001-8858-4327; Milani, Valentina/0000-0002-2989-981X; Bose', Francesca/0000-0003-3898-1572	MDF-Myotonic Dystrophy Foundation; Wyck Foundation; FMM-Fondazione Malattie Miotoniche; Italian Ministry of Health [RF-2010-2314711]	MDF-Myotonic Dystrophy Foundation; Wyck Foundation; FMM-Fondazione Malattie Miotoniche; Italian Ministry of Health(Ministry of Health, Italy)	This work is supported by MDF-Myotonic Dystrophy Foundation and Wyck Foundation Postdoctoral Research Award to LVR, and by FMM-Fondazione Malattie Miotoniche to RC. The Italian Registry for Myotonic Dystrophy Type 1 and Type 2 is funded by the Italian Ministry of Health (RF-2010-2314711) to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2012, ARTERIOSCL THROM VAS, V32, P2068, DOI 10.1161/ATVBAHA.111.241984; ANNANE D, 1994, CIRCULATION, V90, P2629, DOI 10.1161/01.CIR.90.6.2629; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Bassez G, 2008, J NEUROPATH EXP NEUR, V67, P319, DOI 10.1097/NEN.0b013e31816b4acc; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Botta A, 2013, GENES-BASEL, V4, P275, DOI 10.3390/genes4020275; Brockhoff M, 2017, J CLIN INVEST, V127, P549, DOI 10.1172/JCI89616; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Cardani R, 2014, NEUROMUSCULAR DISORD, V24, P1042, DOI 10.1016/j.nmd.2014.06.435; Cardani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083777; Cardani R, 2009, NEUROMUSCULAR DISORD, V19, P335, DOI 10.1016/j.nmd.2009.03.002; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; FIORELLI M, 1992, NEUROLOGY, V42, P91, DOI 10.1212/WNL.42.1.91; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Furling D, 1999, ENDOCRINOLOGY, V140, P4244, DOI 10.1210/en.140.9.4244; Gao ZH, 2013, P NATL ACAD SCI USA, V110, P13570, DOI 10.1073/pnas.1308806110; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; GORDEN P, 1969, J CLIN ENDOCR METAB, V29, P684, DOI 10.1210/jcem-29-5-684; Groh WJ, 2008, NEW ENGL J MED, V358, P2688, DOI 10.1056/NEJMoa062800; Harper PS, 2001, MYOTONIC DYSTROPHY; Iachettini S, 2015, EUR J HISTOCHEM, V59, P251, DOI 10.4081/ejh.2015.2562; Jones K, 2015, P NATL ACAD SCI USA, V112, P8041, DOI 10.1073/pnas.1422273112; Jones K, 2012, J CLIN INVEST, V122, P4461, DOI 10.1172/JCI64081; KAKEHI T, 1990, J LAB CLIN MED, V115, P688; Kelley DE, 1996, J CLIN INVEST, V97, P2705, DOI 10.1172/JCI118724; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu LZ, 2013, MOL CELL ENDOCRINOL, V365, P64, DOI 10.1016/j.mce.2012.09.005; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meola G, 2000, MUSCLE NERVE, V23, P1789, DOI 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4; Meola G, 2014, BIOCH BIOPHYS ACTA; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; Moxley Richard T 3rd, 2002, Neuromuscul Disord, V12, P306, DOI 10.1016/S0960-8966(01)00284-X; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; MOXLEY RT, 1980, NEUROLOGY, V30, P1077, DOI 10.1212/WNL.30.10.1077; MOXLEY RT, 1984, ANN NEUROL, V15, P157, DOI 10.1002/ana.410150208; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Pisani V, 2008, MUSCLE NERVE, V38, P1405, DOI 10.1002/mus.21122; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Santoro M, 2013, MOL CELL BIOCHEM, V380, P259, DOI 10.1007/s11010-013-1681-z; Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; TEVAARWERK GJM, 1979, J CLIN ENDOCR METAB, V49, P216, DOI 10.1210/jcem-49-2-216; Valaperta R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/958510; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; WALSH J C, 1970, Brain Behavior and Evolution, V93, P731, DOI 10.1093/brain/93.4.731	66	23	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184987	10.1371/journal.pone.0184987	http://dx.doi.org/10.1371/journal.pone.0184987			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915272	Green Submitted, Green Published, gold			2022-12-26	WOS:000410861600024
J	Kappel, S; Mendl, MT; Barrett, DC; Murrell, JC; Whay, HR				Kappel, Sarah; Mendl, Michael T.; Barrett, David C.; Murrell, Joanna C.; Whay, Helen R.			Lateralized behaviour as indicator of affective state in dairy cows	PLOS ONE			English	Article							FALSE DISCOVERY RATE; COGNITIVE BIAS; CATTLE; RESPONSES; LAMENESS; STIMULI; EMOTION; HORSES; BRAIN; SHEEP	In humans, there is evidence that sensory processing of novel or threatening stimuli is right hemisphere dominated, especially in people experiencing negative affective states. There is also evidence for similar lateralization in a number of non-human animal species. Here we investigate whether this is also the case in domestic cattle that may experience long-term negative states due to commonly occurring conditions such as lameness. Health and welfare implications associated with pain in lame cows are a major concern in dairy farming. Behavioural tests combining animal behaviour and cognition could make a meaningful contribution to our understanding of disease-related changes in sensory processing in animals, and consequently enhance their welfare. We presented 216 lactating Holstein-Friesian cows with three different unfamiliar objects which were placed either bilaterally (e.g. two yellow party balloons, two black/white checkerboards) or hung centrally (a Kong (TM)) within a familiar area. Cows were individually exposed to the objects on three consecutive days, and their viewing preference/eye use, exploration behaviour/nostril use, and stop position during approach was assessed. Mobility (lameness) was repeatedly scored during the testing period. Overall, a bias to view the right rather than the left object was found at initial presentation of the bilateral objects. More cows also explored the right object rather than the left object with their nose. There was a trend for cows appearing hesitant in approaching the objects by stopping at a distance to them, to then explore the left object rather than the right. In contrast, cows that approached the objects directly had a greater tendency to contact the right object. No significant preference in right or left eye/nostril use was found when cows explored the centrally-located object. We found no relationship between lameness and lateralized behaviour. Nevertheless, observed trends suggesting that lateralized behaviour in response to bilaterally located unfamiliar objects may reflect an immediate affective response are discussed. Further study is needed to understand the impact of long-term affective states on hemispheric dominance and lateralized behaviour.	[Kappel, Sarah; Mendl, Michael T.; Barrett, David C.; Murrell, Joanna C.; Whay, Helen R.] Univ Bristol, Bristol Vet Sch, Langford, North Somerset, England	University of Bristol	Kappel, S (corresponding author), Univ Bristol, Bristol Vet Sch, Langford, North Somerset, England.	sk14101@bristol.ac.uk	Mendl, Michael/D-7220-2016	Mendl, Michael/0000-0002-5302-1871; Kappel, Sarah/0000-0002-8877-5462	University of Bristol [DFASGC1227]; BBSRC [BB/J004197/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J004197/1] Funding Source: researchfish	University of Bristol; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the University of Bristol (grant number DFASGC1227). The recipient for this grant was HRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RJ, ADV VERTEBRATE NEURO; Archer S, 2010, IN PRACTICE, V32, P492, DOI 10.1136/inp.c6672; Austin NP, 2007, LATERALITY, V12, P464, DOI 10.1080/13576500701495307; Barnard S, 2016, ANIM COGN, V19, P207, DOI 10.1007/s10071-015-0928-3; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y, 1999, J STAT PLAN INFER, V82, P163, DOI 10.1016/S0378-3758(99)00040-3; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Davidson R.J., 1995, CEREBRAL ASYMMETRY E, P361; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; Farmer K, 2010, ANIM COGN, V13, P229, DOI 10.1007/s10071-009-0260-x; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hemsworth PH, 1996, APPL ANIM BEHAV SCI, V50, P43, DOI 10.1016/0168-1591(96)01067-2; Larose C, 2007, LATERALITY ASYMMETRI, V11, P355; Leliveld LMC, 2013, APPL ANIM BEHAV SCI, V145, P1, DOI 10.1016/j.applanim.2013.02.002; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; McGreevy PD, 2005, APPL ANIM BEHAV SCI, V92, P337, DOI 10.1016/j.applanim.2004.11.012; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; O'Callaghan K, 2002, IN PRACTICE, V24, P212, DOI 10.1136/inpract.24.4.212; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Phillips C, 2002, CATTLE BEHAV WELFARE; Phillips CJC, 2015, J DAIRY SCI, V98, P2389, DOI 10.3168/jds.2014-8648; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Robins A, 2010, LATERALITY, V15, P514, DOI 10.1080/13576500903049324; Rogers LJ, 2010, APPL ANIM BEHAV SCI, V127, P1, DOI 10.1016/j.applanim.2010.06.008; ROGERS LJ, 1979, PHARMACOL BIOCHEM BE, V10, P679, DOI 10.1016/0091-3057(79)90320-4; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ, 2002, CAMBRIDGE; Rogers LJ, 2013, CAMBRIDGE; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Siniscalchi M, 2013, CURR BIOL, V23, P2279, DOI 10.1016/j.cub.2013.09.027; Siniscalchi M, 2011, ANIM BEHAV, V82, P399, DOI 10.1016/j.anbehav.2011.05.020; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 2017, APA HDB COMP PSYCHOL, V1, P557, DOI [10.1037/0000011-027, DOI 10.1037/0000011-027]; Versace E, 2007, BEHAV BRAIN RES, V184, P72, DOI 10.1016/j.bbr.2007.06.016; Versace E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00233; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Whay H, 2002, PRACT, P444; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6	42	13	14	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184933	10.1371/journal.pone.0184933	http://dx.doi.org/10.1371/journal.pone.0184933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910416	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200122
J	Zielinski, B; Plichta, A; Misztal, K; Spurek, P; Brzychczy-Wloch, M; Ochonska, D				Zielinski, Bartosz; Plichta, Anna; Misztal, Krzysztof; Spurek, Przemyslaw; Brzychczy-Wloch, Monika; Ochonska, Dorota			Deep learning approach to bacterial colony classification	PLOS ONE			English	Article							AUTOMATIC IDENTIFICATION	In microbiology it is diagnostically useful to recognize various genera and species of bacteria. It can be achieved using computer-aided methods, which make the recognition processes more automatic and thus significantly reduce the time necessary for the classification. Moreover, in case of diagnostic uncertainty (the misleading similarity in shape or structure of bacterial cells), such methods can minimize the risk of incorrect recognition. In this article, we apply the state of the art method for texture analysis to classify genera and species of bacteria. This method uses deep Convolutional Neural Networks to obtain image descriptors, which are then encoded and classified with Support Vector Machine or Random Forest. To evaluate this approach and to make it comparable with other approaches, we provide a new dataset of images. DIBaS dataset (Digital Image of Bacterial Species) contains 660 images with 33 different genera and species of bacteria.	[Zielinski, Bartosz; Misztal, Krzysztof; Spurek, Przemyslaw] Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland; [Plichta, Anna] Cracow Univ Technol, Dept Comp Sci, 24 Warszawska St, PL-31422 Krakow, Poland; [Brzychczy-Wloch, Monika] Jagiellonian Univ, Med Coll, Chair Microbiol, Dept Bacteriol Microbial Ecol & Parasitol, 18 Czysta St, PL-31121 Krakow, Poland; [Ochonska, Dorota] Jagiellonian Univ, Med Coll, Fac Med, Chair Microbiol,Dept Infect Epidemiol, 18 Czysta St, PL-31121 Krakow, Poland	Jagiellonian University; Cracow University of Technology; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Misztal, K (corresponding author), Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland.	krzysztof.misztal@uj.edu.pl		Misztal, Krzysztof/0000-0003-2480-3505	National Science Centre (Poland) [2015/19/D/ST6/01215, 2015/19/D/ST6/01472, 2012/07/N/ST6/02192]; PL-Grid infrastructure	National Science Centre (Poland); PL-Grid infrastructure	The work of B. Zielinski was supported by the National Science Centre (Poland) under grant agreement no 2015/19/D/ST6/01215; 2016-2019. The work of P. Spurek was supported by the National Science Centre (Poland) under grant agreement no. 2015/19/D/ST6/01472; 2016-2019. The work of K. Misztal was supported by the National Science Centre (Poland) under grant agreement no. 2012/07/N/ST6/02192; 2012-2017. This research was supported in part by PL-Grid infrastructure.; The work of B. Zielinski was supported by the National Science Centre (Poland) under grant agreement no 2015/19/D/ST6/01215; 2016-2019.; The work of P. Spurek was supported by the National Science Centre (Poland) under grant agreement no. 2015/19/D/ST6/01472; 2016-2019.; The work of K. Misztal was supported by the National Science Centre (Poland) under grant agreement no. 2012/07/N/ST6/02192; 2012-2017.; This research was supported in part by PL-Grid infrastructure.	Ahmed WM, 2013, IEEE J BIOMED HEALTH, V17, P232, DOI 10.1109/TITB.2012.2222654; Ates H, 2009, 2009 24TH INTERNATIONAL SYMPOSIUM ON COMPUTER AND INFORMATION SCIENCES, P18, DOI 10.1109/ISCIS.2009.5291926; Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246; Bosch A, 2006, LECT NOTES COMPUT SC, V3954, P517; Chatfield K, 2014, ARXIV140535312014; Cimpoi M, 2016, INT J COMPUT VISION, V118, P65, DOI 10.1007/s11263-015-0872-3; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; De Bruyne K, 2011, SYST APPL MICROBIOL, V34, P20, DOI 10.1016/j.syapm.2010.11.003; Forero MG, 2006, J MICROSC-OXFORD, V223, P120, DOI 10.1111/j.1365-2818.2006.01610.x; Hiremath P., 2009, P IEEE INT C SIGN IM, P209; Holmberg M, 1998, BIOTECHNOL TECH, V12, P319, DOI 10.1023/A:1008862617082; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu J, 2001, MICROB ECOL, V41, P173, DOI 10.1007/s002480000004; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Perner P., 2001, MED DATA ANAL, V2199, P219; Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Simonyan K, 2014, ARXIV140915562014; Snoek J., 2012, ADV NEURAL INFORM PR, V2, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Trattner S, 2004, IEEE T MED IMAGING, V23, P807, DOI 10.1109/TMI.2004.827481	24	52	55	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184554	10.1371/journal.pone.0184554	http://dx.doi.org/10.1371/journal.pone.0184554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910352	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200061
J	Boldinova, EO; Stojkovic, G; Khairullin, R; Wanrooij, S; Makarova, AV				Boldinova, Elizaveta O.; Stojkovic, Gorazd; Khairullin, Rafil; Wanrooij, Sjoerd; Makarova, Alena V.			Optimization of the expression, purification and polymerase activity reaction conditions of recombinant human PrimPol	PLOS ONE			English	Article							TRANSLESION DNA-SYNTHESIS; ESCHERICHIA-COLI; ACCESSORY SUBUNITS; LOW-FIDELITY; REPLICATION; ZETA; PROTEINS; CELLS; POL; CHAPERONES	Human PrimPol is a DNA primase/polymerase involved in DNA damage tolerance and prevents nuclear genome instability. PrimPol is also localized to the mitochondria, but its precise function in mitochondrial DNA maintenance has remained elusive. PrimPol works both as a translesion (TLS) polymerase and as the primase that restarts DNA replication after a lesion. However, the observed biochemical activities of PrimPol vary considerably between studies as a result of different reaction conditions used. To reveal the effects of reaction composition on PrimPol DNA polymerase activity, we tested the polymerase activity in the presence of various buffer agents, salt concentrations, pH values and metal cofactors. Additionally, the enzyme stability was analyzed under various conditions. We demonstrate that the reaction buffer with pH 6-6.5, low salt concentrations and 3 mM Mg2+ or 0.3-3 mM Mn2+ cofactor ions supports the highest DNA polymerase activity of human PrimPol in vitro. The DNA polymerase activity of PrimPol was found to be stable after multiple freeze-thaw cycles and prolonged protein incubation on ice. However, rapid heat-inactivation of the enzyme was observed at 37 degrees C. We also for the first time describe the purification of human PrimPol from a human cell line and compare the benefits of this approach to the expression in Escherichia coli and in Saccharomyces cerevisiae cells. Our results show that active PrimPol can be purified from E. coli and human suspension cell line in high quantities and that the activity of the purified enzyme is similar in both expression systems. Conversely, the yield of full-length protein expressed in S. cerevisiae was considerably lower and this system is therefore not recommended for expression of full-length recombinant human PrimPol.	[Boldinova, Elizaveta O.; Makarova, Alena V.] Russian Acad Sci, Inst Mol Genet, Kurchatov Sq 2, Moscow, Russia; [Boldinova, Elizaveta O.] Moscow State Univ Fine Chem Technol, Vernadsky Prospect 78, Moscow, Russia; [Stojkovic, Gorazd; Khairullin, Rafil; Wanrooij, Sjoerd] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Khairullin, Rafil] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan 18, Russia	Russian Academy of Sciences; MIREA - Russian Technological University; Umea University; Kazan Federal University	Makarova, AV (corresponding author), Russian Acad Sci, Inst Mol Genet, Kurchatov Sq 2, Moscow, Russia.; Wanrooij, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	sjoerd.wanrooij@umu.se; amakarova-img@yandex.ru	Khairullin, Rafil/H-7560-2013; Makarova, Alena Vladimirovna/I-1338-2014; Wanrooij, Sjoerd/J-1367-2019	Khairullin, Rafil/0000-0001-9879-378X; Wanrooij, Sjoerd/0000-0001-6126-4382; Boldinova, Elizaveta/0000-0002-5462-6709	RAS; D. Zimin "Dynasty" Foundation; RFBR [15-04-08398-a]; Wallenberg Foundation; Olle Engkvist Byggmastare foundation	RAS(Russian Academy of SciencesRegione Sardegna); D. Zimin "Dynasty" Foundation; RFBR(Russian Foundation for Basic Research (RFBR)); Wallenberg Foundation(European Commission); Olle Engkvist Byggmastare foundation	This work was supported by the RAS Presidium Program "Molecular and Cellular Biology. New Groups", D. Zimin "Dynasty" Foundation and partially by RFBR (15-04-08398-a) to A.M. and by the Wallenberg Foundation to S.W. G.S. was supported by Olle Engkvist Byggmastare foundation.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Brown JA, 2011, ANTIMICROB AGENTS CH, V55, P276, DOI 10.1128/AAC.01229-10; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Guilliam TA, 2015, NUCLEIC ACIDS RES, V43, P1056, DOI 10.1093/nar/gku1321; Holz Caterina, 2003, Journal of Structural and Functional Genomics, V4, P97, DOI 10.1023/A:1026226429429; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kazachenko KY, 2017, DNA REPAIR, V50, P77, DOI 10.1016/j.dnarep.2017.01.001; Keen BA, 2014, NUCLEIC ACIDS RES, V42, P12102, DOI 10.1093/nar/gku879; Keen BA, 2014, NUCLEIC ACIDS RES, V42, P5830, DOI 10.1093/nar/gku214; KLENOW H, 1969, EUR J BIOCHEM, V9, P133, DOI 10.1111/j.1432-1033.1969.tb00586.x; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Makarova AV, 2014, DNA REPAIR, V18, P63, DOI 10.1016/j.dnarep.2014.02.017; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Martinez-Jimenez MI, 2015, DNA REPAIR, V29, P127, DOI 10.1016/j.dnarep.2015.02.013; Mislak AC, 2016, ANTIMICROB AGENTS CH, V60, P561, DOI 10.1128/AAC.02270-15; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Nishimoto N, 2016, BIOL PHARM BULL, V39, P953, DOI 10.1248/bpb.b15-00900; Porowinska D, 2014, APPL BIOCHEM BIOTECH, V173, P1349, DOI 10.1007/s12010-014-0858-6; Rechkoblit O, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601317; Rudd SG, 2013, MOL CELL, V52, P554, DOI 10.1016/j.molcel.2013.10.034; Schiavone D, 2016, MOL CELL, V61, P161, DOI 10.1016/j.molcel.2015.10.038; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; Schumann W, 2004, GENET MOL BIOL, V27, P442, DOI 10.1590/S1415-47572004000300022; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; Stojkovic G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28942; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Zafar MK, 2014, BIOCHEMISTRY-US, V53, P6584, DOI 10.1021/bi501024u; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184489	10.1371/journal.pone.0184489	http://dx.doi.org/10.1371/journal.pone.0184489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902865	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200039
J	Diaz-Rizo, V; Bonilla-Lara, D; Gonzalez-Lopez, L; Sanchez-Mosco, D; Fajardo-Robledo, NS; Perez-Guerrero, EE; Rodriguez-Jimenez, NA; Saldana-Cruz, AM; Vazquez-Villegas, ML; Gomez-Banuelos, E; Vazquez-Del Mercado, M; Cardona-Munoz, EG; Cardona-Muller, D; Trujillo, X; Huerta, M; Salazar-Paramo, M; Gamez-Nava, JI				Diaz-Rizo, Valeria; Bonilla-Lara, David; Gonzalez-Lopez, Laura; Sanchez-Mosco, Dalia; Fajardo-Robledo, Nicte S.; Perez-Guerrero, Edsaul E.; Alejandra Rodriguez-Jimenez, N.; Miriam Saldana-Cruz, A.; Luisa Vazquez-Villegas, M.; Gomez-Banuelos, Eduardo; Vazquez-Del Mercado, Monica; German Cardona-Munoz, E.; Cardona-Muller, David; Trujillo, Xochitl; Huerta, Miguel; Salazar-Paramo, Mario; Gamez-Nava, Jorge I.			Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis	PLOS ONE			English	Article							ERYTHEMATOSUS RELATIONSHIP; INSULIN-RESISTANCE; IMMUNE-RESPONSE; ADIPOKINES; INFLAMMATION; DISEASE; ADIPOCYTOKINES; PLASMA; INJURY; INDEX	Introduction There are controversial results about the role of serum leptin and adiponectin levels as biomarkers of the severity of proteinuria in lupus nephritis. Objective The aim of this study was to evaluate the relationship between serum leptin and adiponectin levels with severity of proteinuria secondary to lupus nephritis (LN). Methods In a cross-sectional study, 103 women with systemic lupus erythematosus (SLE) were evaluated for kidney involvement. We compared 30 SLE patients with LN, all of them with proteinuria, versus 73 SLE patients without renal involvement (no LN). A comprehensive set of clinical and laboratory variables was assessed, including serum levels of leptin and adiponectin by ELISA. Multivariate analyses were used to adjust for potential confounders associated with proteinuria in LN. Results We found higher adiponectin levels in the LN group compared with the no LN group (20.4 +/- 10.3 vs 15.6 +/- 7.8 mu g/mL; p = 0.02), whereas no differences were observed in leptin levels (33.3 +/- 31.4 vs 22.5 +/- 25.5 ng/mL; p = 0.07). Severity of proteinuria correlated with an increase in adiponectin levels (r = 0.31; p = 0.001), but no correlation was observed with leptin. Adiponectin levels were not related to anti-dsDNA or anti-nucleosome antibodies. In the logistic regression, adiponectin levels were associated with a high risk of proteinuria in SLE (OR = 1.06; 95% CI 1.01 - 1.12; p = 0.02). Instead, leptin was not associated with LN. Conclusion These findings indicate that adiponectin levels are useful markers associated with proteinuria in LN. Further longitudinal studies are required to identify if these levels are predictive of renal relapse.	[Diaz-Rizo, Valeria; Gamez-Nava, Jorge I.] Hosp Especialidades Ctr Med La Raza, IMSS, CMNO, Unidad Invest Biomed 02, Guadalajara, Jalisco, Mexico; [Diaz-Rizo, Valeria; Sanchez-Mosco, Dalia; Trujillo, Xochitl; Huerta, Miguel] Univ Colima, Programa Posgrad Ciencias Med, Colima, Mexico; [Diaz-Rizo, Valeria; Bonilla-Lara, David; Gonzalez-Lopez, Laura; Perez-Guerrero, Edsaul E.; Alejandra Rodriguez-Jimenez, N.; Gamez-Nava, Jorge I.] Univ Guadalajara, CUCS, Programa Posgrad Farmacol, Guadalajara, Jalisco, Mexico; [Bonilla-Lara, David; Gonzalez-Lopez, Laura; Sanchez-Mosco, Dalia] IMSS, Hosp Gen Reg 110, Dept Med Interna Reumatol, Guadalajara, Jalisco, Mexico; [Fajardo-Robledo, Nicte S.] Univ Guadalajara, Ctr Univ Ciencias Exactas & Ingn, Lab Invest & Desarrollo Farmaceut, Guadalajara, Jalisco, Mexico; [Perez-Guerrero, Edsaul E.] Univ Guadalajara, Ctr Univ Ciencias Exactas & Ingn, Dept Farmacobiol, Guadalajara, Jalisco, Mexico; [Miriam Saldana-Cruz, A.] Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Biomed, Guadalajara, Jalisco, Mexico; [Luisa Vazquez-Villegas, M.] IMSS, Dept Epidemiol, Unidad Med Familiar 4 & 8, Guadalajara, Jalisco, Mexico; [Luisa Vazquez-Villegas, M.] Univ Guadalajara, Programa Posgrad Salud Publ, CUCS, Guadalajara, Jalisco, Mexico; [Gomez-Banuelos, Eduardo] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Invest Reumatol & Sistema Musculoesquelet, Guadalajara, Jalisco, Mexico; [Vazquez-Del Mercado, Monica] Hosp Civil Juan I Menchaca, Div Med Marna OPD, Serv Reumatol, Guadalajara, Jalisco, Mexico; [German Cardona-Munoz, E.; Cardona-Muller, David] Univ Guadalajara, CUCS, Dept Fisiol, Inst Terapeut Expt & Clin, Guadalajara, Jalisco, Mexico; [Salazar-Paramo, Mario] Hosp Especialidades Ctr Med La Raza, IMSS, CMNO, Div Invest Salud,Unidad Med Alta Especialidad, Guadalajara, Jalisco, Mexico	Universidad de Colima; Universidad de Guadalajara; Instituto Mexicano del Seguro Social; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara	Gamez-Nava, JI (corresponding author), Hosp Especialidades Ctr Med La Raza, IMSS, CMNO, Unidad Invest Biomed 02, Guadalajara, Jalisco, Mexico.; Gamez-Nava, JI (corresponding author), Univ Guadalajara, CUCS, Programa Posgrad Farmacol, Guadalajara, Jalisco, Mexico.	drivangamez@prodigy.net.mx	Gomez-Bañuelos, Eduardo/M-2616-2019; del Mercado, Monica Vazquez/F-5856-2017; Huerta, Miguel/AEP-0820-2022; Trujillo, Xóchitl/AHC-2100-2022; Trujillo, Xochitl/P-7020-2017	del Mercado, Monica Vazquez/0000-0002-3823-4676; Huerta, Miguel/0000-0001-8515-0777; Trujillo, Xóchitl/0000-0001-8146-5667; Diaz-Rizo, Valeria/0000-0001-9808-289X; Vazquez-Villegas, Maria Luisa/0000-0003-1399-270X; Perez-Guerrero, Edsaul Emilio/0000-0002-0007-1824; Fajardo-Robledo, Nicte/0000-0002-3471-5835; Gomez-Banuelos, Eduardo/0000-0001-9730-1851; Trujillo, Xochitl/0000-0001-7506-1674; Cardona-Muller, David/0000-0002-9470-2489; Rodriguez Jimenez, Norma Alejandra/0000-0001-7643-6298	Fondo de Investigacion en Salud (FIS) of the Institute Mexicano del Seguro Social (IMSS) [FIS/IMSS/PROT/G11/937]; IMSS; Mexican Institute for Social Security Foundation (Foundation IMSS, A.C.)	Fondo de Investigacion en Salud (FIS) of the Institute Mexicano del Seguro Social (IMSS); IMSS; Mexican Institute for Social Security Foundation (Foundation IMSS, A.C.)	This work was financially supported by a grant of the Fondo de Investigacion en Salud (FIS) of the Institute Mexicano del Seguro Social (IMSS). Grant number: FIS/IMSS/PROT/G11/937, held by the Ph.D. Jorge Ivan Gamez-Nava (JIGN), corresponding of this work. Dr. Gamez-Nava JI, was the supervisor of this work, he received the funding by the IMSS to make this possible. He also contributed in the conceptualization, the formal analysis, investigation, methodology of the manuscript, the project administration, he provided resources, he made part of the validation of the data, the software and supervision and the writing original draft preparation, review and editing the final version.; Also, we wish to thank the Mexican Institute for Social Security Foundation (Foundation IMSS, A.C.) for their support to this research.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Al M, 2009, RHEUMATOLOGY, V48, P497, DOI 10.1093/rheumatology/kep030; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; Choi HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2844; Chung CP, 2009, LUPUS, V18, P799, DOI 10.1177/0961203309103582; Cohen SS, 2011, ANN EPIDEMIOL, V21, P86, DOI 10.1016/j.annepidem.2010.10.011; De Sanctis JB, 2009, AUTOIMMUNITY, V42, P272, DOI 10.1080/08916930902828031; Salgado AD, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/849684; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fantuzzi G, 2013, CYTOKINE, V64, P1, DOI 10.1016/j.cyto.2013.06.317; Frommer KW, 2012, ANN RHEUM DIS, V71, P1724, DOI 10.1136/annrheumdis-2011-200924; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Fujita H, 2006, ENDOCR J, V53, P745, DOI 10.1507/endocrj.K06-016; Garcia-Gonzalez A, 2002, RHEUMATOL INT, V22, P138, DOI 10.1007/s00296-002-0216-9; Gladman D, 1996, J RHEUMATOL, V23, P1953; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hayakawa K, 2009, NEPHROLOGY, V14, P327, DOI 10.1111/j.1440-1797.2008.01047.x; Hutcheson J, 2015, CLIN EXP IMMUNOL, V179, P435, DOI 10.1111/cei.12473; Koo HS, 2016, LUPUS, V25, P3, DOI 10.1177/0961203315595130; Krysiak R, 2012, EUR J NUTR, V51, P513, DOI 10.1007/s00394-012-0370-0; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Landolt-Marticorena C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1120-0; Lee JH, 2001, INT J OBESITY, V25, P1471, DOI 10.1038/sj.ijo.0801736; Loghman M, 2016, INT J RHEUM DIS, V19, P678, DOI 10.1111/1756-185X.12284; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Neumann E, 2016, NAT REV RHEUMATOL, V12, P296, DOI 10.1038/nrrheum.2016.49; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Reyes-Thomas J, 2011, CLIN REV ALLERG IMMU, V40, P138, DOI 10.1007/s12016-010-8197-z; Rovin BH, 2006, CLIN IMMUNOL, V120, P99, DOI 10.1016/j.clim.2006.01.010; Rovin BH, 2005, KIDNEY INT, V68, P1825, DOI 10.1111/j.1523-1755.2005.00601.x; Sada KE, 2006, J RHEUMATOL, V33, P1545; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Scotece M, 2014, BASIC CLIN PHARMACOL, V114, P97, DOI 10.1111/bcpt.12109; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Touma Z, 2014, J RHEUMATOL, V41, P688, DOI 10.3899/jrheum.130005; Toussirot E, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/938408; Tsioufis C, 2005, AM J CARDIOL, V96, P946, DOI 10.1016/j.amjcard.2005.05.052; Vadacca M, 2009, J RHEUMATOL, V36, P295, DOI 10.3899/jrheum.080503; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	45	26	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184056	10.1371/journal.pone.0184056	http://dx.doi.org/10.1371/journal.pone.0184056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898254	gold, Green Published, Green Submitted			2022-12-26	WOS:000410449500012
J	Leftin, A; Ben-Chetrit, N; Klemm, F; Joyce, JA; Koutcher, JA				Leftin, Avigdor; Ben-Chetrit, Nir; Klemm, Florian; Joyce, Johanna A.; Koutcher, Jason A.			Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAGNETIC-SUSCEPTIBILITY; MICROENVIRONMENTAL REGULATION; BRAIN; ANGIOGENESIS; RELAXATION; FERRITIN; INFILTRATION; CHELATORS; BLOOD	Iron-deposition is a metabolic biomarker of macrophages in both normal and pathological situations, but the presence of iron in tumor and metastasis-associated macrophages is not known. Here we mapped and quantified hemosiderin-laden macrophage ( HLM) deposits in murine models of metastatic breast cancer using iron and macrophage histology, and in vivo MRI. Iron MRI detected high-iron pixel clusters in mammary tumors, lung metastasis, and brain metastasis as well as liver and spleen tissue known to contain the HLMs. Iron histology showed these regions to contain clustered macrophages identified by their common iron status and tissue-intrinsic association with other phenotypic macrophage markers. The in vivo MRI and ex vivo histological images were further processed to determine the frequencies and sizes of the iron deposits, and measure the number of HLMs in each deposit to estimate the in vivo MRI sensitivity for these cells. Hemosiderin accumulation is a macrophage biomarker and intrinsic contrast source for cellular MRI associated with the innate function of macrophages in iron metabolism systemically, and in metastatic cancer.	[Leftin, Avigdor; Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Ben-Chetrit, Nir; Klemm, Florian; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Klemm, Florian; Joyce, Johanna A.] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Klemm, Florian; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Koutcher, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA.; Koutcher, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Koutcher, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA.	koutchej@mskcc.org		Klemm, Florian/0000-0002-8944-9175	NIH [P01 CA115675, DOD PC120233, P30 CA008748]; Deutsche Forschungsgemeinschaft (DFG) [KL 2491/1-1]; Breast Cancer Research Foundation; MSKCC Evelyn H. Lauder Breast Center [NIH 1F32CA206277]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Breast Cancer Research Foundation; MSKCC Evelyn H. Lauder Breast Center	The authors acknowledge funding support from NIH grants P01 CA115675, DOD PC120233 and P30 CA008748 (Cancer Center Support Grants), Breast and Molecular Imaging Fund at MSKCC Evelyn H. Lauder Breast Center, NIH 1F32CA206277 to A.L., Deutsche Forschungsgemeinschaft (DFG) grant KL 2491/1-1 to F.K., and the Breast Cancer Research Foundation to J.A.J. and J.A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PD, 2000, BBA-MOL BASIS DIS, V1500, P186, DOI 10.1016/S0925-4439(99)00104-0; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; BRITTENHAM GM, 1982, NEW ENGL J MED, V307, P1671, DOI 10.1056/NEJM198212303072703; BROOKS RA, 1995, JMRI-J MAGN RESON IM, V5, P446, DOI 10.1002/jmri.1880050414; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; Carneiro A A, 2004, Neurol Clin Neurophysiol, V2004, P85; Daldrup-Link H, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19457; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; Navarrete MG, 2014, ANN DIAGN PATHOL, V18, P193, DOI 10.1016/j.anndiagpath.2014.01.005; Gammella E, 2014, METALLOMICS, V6, P1336, DOI 10.1039/c4mt00104d; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Garbowski MW, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-40; GILLIS P, 1987, MAGN RESON MED, V5, P323, DOI 10.1002/mrm.1910050404; GOMORI JM, 1987, J COMPUT ASSIST TOMO, V11, P684, DOI 10.1097/00004728-198707000-00025; Gwak JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125728; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kleinig TJ, 2013, J CLIN NEUROSCI, V20, P919, DOI 10.1016/j.jocn.2012.12.002; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Neuwelt A, 2015, AM J ROENTGENOL, V204, pW302, DOI 10.2214/AJR.14.12733; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; RICHTER GW, 1960, J EXP MED, V112, P551, DOI 10.1084/jem.112.4.551; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Sage D, 2012, IMAGESJ US DEV C 201; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Takada S, 2011, NEUROL MED-CHIR, V51, P275, DOI 10.2176/nmc.51.275; THULBORN KR, 1990, AM J ROENTGENOL, V154, P1053, DOI 10.2214/ajr.154.5.2108542; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Valkovic T, 2002, VIRCHOWS ARCH, V440, P583, DOI 10.1007/s004280100458; Weissleder R, 2014, NAT MATER, V13, P125, DOI [10.1038/nmat3780, 10.1038/NMAT3780]; Westra C, 2014, AM J ROENTGENOL, V202, pW183, DOI 10.2214/AJR.13.11266; Wood JC, 2015, MAGN RESON IN PRESS; Yuan ZY, 2014, ONCOTARGETS THER, V7, P1, DOI 10.2147/OTT.S61838; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; ZHOU XH, 1993, MAGNET RESON MED, V30, P92, DOI 10.1002/mrm.1910300114	50	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184765	10.1371/journal.pone.0184765	http://dx.doi.org/10.1371/journal.pone.0184765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898277	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500048
J	Ortiz, GJ; Li, Y; Post, SM; Pant, V; Xiong, S; Larsson, CA; El-Naggar, AK; Johnson, DG; Lozano, G				Ortiz, G. J.; Li, Y.; Post, S. M.; Pant, V.; Xiong, S.; Larsson, C. A.; El-Naggar, A. K.; Johnson, D. G.; Lozano, G.			Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes	ONCOGENE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; CODON 72 POLYMORPHISM; CANCER-RISK; P53 PATHWAY; PROMOTER POLYMORPHISM; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; IONIZING-RADIATION; COLORECTAL-CANCER	MDM2, an E3 ubiquitin ligase, is a potent inhibitor of the p53 tumor suppressor and is elevated in many human cancers that retain wild-type p53. MDM2 SNP309G is a functional polymorphism that results in elevated levels of MDM2 (due to enhanced SP1 binding to the MDM2 promoter) thus decreasing p53 activity. Mdm2SNP309G/G mice are more prone to spontaneous tumor formation than Mdm2SNP309T/T mice, providing direct evidence for the impact of this SNP in tumor development. We asked whether environmental factors impact SNP309G function and show that SNP309G cooperates with ionizing radiation to exacerbate tumor development. Surprisingly, ultraviolet B light or Benzo(a) pyrene exposure of skin shows that SNP309G allele actually protects against squamous cell carcinoma susceptibility. These contrasting differences led us to interrogate the mechanism by which Mdm2 SNP309 regulates tumor susceptibility in a tissue-specific manner. Although basal Mdm2 levels were significantly higher in most tissues in Mdm2SNP309G/G mice compared with Mdm2SNP309T/T mice, they were significantly lower in Mdm2SNP309G/G keratinocytes, the cell-type susceptible to squamous cell carcinoma. The assessment of potential transcriptional regulators in ENCODE ChIP-seq database identified transcriptional repressor E2F6 as a possible negative regulator of MDM2 expression. Our data show that E2F6 suppresses Mdm2 expression in cells harboring the SNP309G allele but not the SNP309T allele. Thus, Mdm2 SNP309G exhibits tissue-specific regulation and differentially impacts cancer risk.	[Ortiz, G. J.; Pant, V.; Xiong, S.; Larsson, C. A.; Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Ortiz, G. J.; Larsson, C. A.; Johnson, D. G.; Lozano, G.] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Li, Y.; Johnson, D. G.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Virginia Harris Cockrell Canc Res Ctr, Smithville, TX USA; [Post, S. M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [El-Naggar, A. K.] Univ Texas MD Anderson Canc, Dept Pathol, Div Pathol Lab Med Unit 085, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Johnson, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, 1808 Pk Rd 1C,POB 389,Unit 116, Smithville, TX 78957 USA.	djohnson@mdanderson.org; gglozano@mdanderson.org	Xiong, Shunbin/AAR-5823-2021; Ortiz, Guadalupe/P-9425-2017	Ortiz, Guadalupe/0000-0002-8728-5090; Pant, Vinod/0000-0002-3286-1804; Larsson, Connie/0000-0002-7829-0023	NIH [R01ES015587, CA47296]; Cancer Prevention Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE [R01CA047296, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Laura Pageon (MD Anderson Cancer Center) for her pathology advice, Jen Orona for assistance with mouse studies and the members of the Lozano lab for their support and technical advice. NIH Grants R01ES015587 (DGJ), CA47296 (GL) and the Cancer Prevention Institute of Texas (CPRIT) supported this study.	Alvarez S, 2006, INT J RADIAT BIOL, V82, P761, DOI 10.1080/09553000600949624; Asomaning K, 2008, CLIN CANCER RES, V14, P4010, DOI 10.1158/1078-0432.CCR-07-4187; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; Bassi DE, 2007, CURR PROTOC PHARM; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cotignola J, 2012, J INVEST DERMATOL, V132, P1471, DOI 10.1038/jid.2012.15; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eischen CM, 2014, HUM MUTAT, V35, P728, DOI 10.1002/humu.22524; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Glick A, 2007, MOL CARCINOGEN, V46, P605, DOI 10.1002/mc.20345; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Hu ZB, 2007, CANCER EPIDEM BIOMAR, V16, P2717, DOI 10.1158/1055-9965.EPI-07-0634; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Johne A, 2003, CANCER EPIDEM BIOMAR, V12, P68; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lazarus P, 1998, CARCINOGENESIS, V19, P509, DOI 10.1093/carcin/19.3.509; Li Guojun, 2006, Curr Oncol Rep, V8, P130, DOI 10.1007/s11912-006-0048-y; Liu GY, 2012, INT J UROL, V19, P914, DOI 10.1111/j.1442-2042.2012.03067.x; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lu MX, 2012, MOL CARCINOGEN, V51, pE132, DOI 10.1002/mc.21882; LUNA RMD, 1995, NATURE, V378, P203; MAUTHE RJ, 1995, CARCINOGENESIS, V16, P133, DOI 10.1093/carcin/16.1.133; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; MIYASHITA T, 1995, CELL, V80, P293; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Pant V, 2013, GENE DEV, V27, P1857, DOI 10.1101/gad.227249.113; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Qin JX, 2015, J DERMATOL SCI, V79, P171, DOI 10.1016/j.jdermsci.2015.04.008; Qin JZ, 2002, ONCOGENE, V21, P2991, DOI 10.1038/sj.onc.1205404; Ramzi NH, 2014, INDIAN J MED RES, V139, P873; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; Russell JL, 2006, ONCOGENE, V25, P867, DOI 10.1038/sj.onc.1209120; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Wasylishen AR, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026211; Wo XM, 2011, J GENET GENOMICS, V38, P341, DOI 10.1016/j.jgg.2011.07.005; Wong CF, 2004, BIOCHEM BIOPH RES CO, V324, P497, DOI 10.1016/j.bbrc.2004.09.084; Yang X, 2016, MOL CLIN ONCOL, V5, P175, DOI 10.3892/mco.2016.868; Yu HP, 2011, MOL CARCINOGEN, V50, P697, DOI 10.1002/mc.20806	53	10	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					332	340		10.1038/onc.2017.344	http://dx.doi.org/10.1038/onc.2017.344			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28925402	Green Accepted, Green Submitted			2022-12-26	WOS:000422753900006
J	Stelloo, S; Nevedomskaya, E; Kim, Y; Hoekman, L; Bleijerveld, OB; Mirza, T; Wessels, LFA; van Weerden, WM; Altelaar, AFM; Bergman, AM; Zwart, W				Stelloo, S.; Nevedomskaya, E.; Kim, Y.; Hoekman, L.; Bleijerveld, O. B.; Mirza, T.; Wessels, L. F. A.; van Weerden, W. M.; Altelaar, A. F. M.; Bergman, A. M.; Zwart, W.			Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis	ONCOGENE			English	Article							DNA-REPAIR; XENOGRAFT MODELS; RNA-BINDING; CANCER; TRANSCRIPTION; CHROMATIN; IDENTIFICATION; HOXB13; COACTIVATOR; ENHANCERS	Androgen receptor (AR) is a key player in prostate cancer development and progression. Here we applied immunoprecipitation mass spectrometry of endogenous AR in LNCaP cells to identify components of the AR transcriptional complex. In total, 66 known and novel AR interactors were identified in the presence of synthetic androgen, most of which were critical for AR-driven prostate cancer cell proliferation. A subset of AR interactors required for LNCaP proliferation were profiled using chromatin immunoprecipitation assays followed by sequencing, identifying distinct genomic subcomplexes of AR interaction partners. Interestingly, three major subgroups of genomic subcomplexes were identified, where selective gain of function for AR genomic action in tumorigenesis was found, dictated by FOXA1 and HOXB13. In summary, by combining proteomic and genomic approaches we reveal subclasses of AR transcriptional complexes, differentiating normal AR behavior from the oncogenic state. In this process, the expression of AR interactors has key roles by reprogramming the AR cistrome and interactome in a genomic location-specific manner.	[Stelloo, S.; Nevedomskaya, E.; Kim, Y.; Mirza, T.; Bergman, A. M.; Zwart, W.] Netherlands Canc Inst, Div Oncogen, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Nevedomskaya, E.; Kim, Y.; Wessels, L. F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Hoekman, L.; Bleijerveld, O. B.; Altelaar, A. F. M.] Netherlands Canc Inst, Mass Spectrometry & Prote Facil, Amsterdam, Netherlands; [Wessels, L. F. A.] Delft Univ Technol, Fac EEMCS, Delft, Netherlands; [van Weerden, W. M.] Erasmus Univ, Erasmus MC Canc Inst, Dept Urol, Med Ctr, Rotterdam, Netherlands; [Altelaar, A. F. M.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Altelaar, A. F. M.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Netherlands Prote Ctr, Utrecht, Netherlands; [Bergman, A. M.] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University; Netherlands Cancer Institute	Stelloo, S; Zwart, W (corresponding author), Netherlands Canc Inst, Div Oncogen, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	s.stelloo@nki.nl; w.zwart@nki.nl		Zwart, Wilbert/0000-0002-9823-7289; Kim, Yongsoo/0000-0002-2995-2131	Movember [NKI01]; KWF Dutch Cancer Society/Alpe d'HuZes Bas Mulder Award [NKI 2014-6711]; Netherlands Organisation for Scientific Research (NWO) [016.156.401]; NWO as part of the National Roadmap Large-scale Research Facilities of the Netherlands [184.032.201]; VIDI grant [723.012.102]	Movember; KWF Dutch Cancer Society/Alpe d'HuZes Bas Mulder Award; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO as part of the National Roadmap Large-scale Research Facilities of the Netherlands; VIDI grant	We thank the NKI Genomics Core Facility for Illumina sequencing and bioinformatic support. SS is supported by Movember (NKI01). We thank Corrina MA de Ridder for dedicated maintenance and biobanking of the PDX models. WZ is supported by a KWF Dutch Cancer Society/Alpe d'HuZes Bas Mulder Award (NKI 2014-6711) and a VIDI grant (016.156.401) from The Netherlands Organisation for Scientific Research (NWO). This work is further supported by NWO as part of the National Roadmap Large-scale Research Facilities of the Netherlands, Proteins@Work (184.032.201) to OBB and AFMA and a VIDI grant (723.012.102) to AFMA.	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Ameziane N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9829; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Asangani IA, 2016, MOL CANCER RES, V14, P324, DOI 10.1158/1541-7786.MCR-15-0472; Barfeld SJ, 2017, EBIOMEDICINE, V18, P83, DOI 10.1016/j.ebiom.2017.04.006; Beltran M, 2016, GENOME RES, V26, P896, DOI 10.1101/gr.197632.115; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bose DA, 2017, CELL, V168, P135, DOI 10.1016/j.cell.2016.12.020; Chen Z, 2015, EMBO J, V34, P502, DOI 10.15252/embj.201490306; Comuzzi Barbara, 2006, Cellscience, V3, P61; Cross DS, 2008, MED ONCOL, V25, P287, DOI 10.1007/s12032-007-9033-z; Etani T, 2015, ONCOTARGET, V6, P2865, DOI 10.18632/oncotarget.3067; Fan SL, 2006, BIOCHEM BIOPH RES CO, V341, P192, DOI 10.1016/j.bbrc.2005.12.167; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Fei T, 2017, P NATL ACAD SCI USA, V114, pE5207, DOI 10.1073/pnas.1617467114; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Goto K, 2003, J STEROID BIOCHEM, V85, P201, DOI 10.1016/S0960-0760(03)00196-1; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hendrickson DG, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0878-3; Hsiao JJ, 2016, J BIOL CHEM, V291, P18818, DOI 10.1074/jbc.M116.732313; Hsiao JJ, 2015, MOL ENDOCRINOL, V29, P1195, DOI 10.1210/me.2015-1021; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Imberg-Kazdan K, 2013, GENOME RES, V23, P581, DOI 10.1101/gr.144774.112; Jangal M, 2014, NUCLEIC ACIDS RES, V42, P11339, DOI 10.1093/nar/gku791; Jasavala R, 2007, MOL CELL PROTEOMICS, V6, P252, DOI 10.1074/mcp.M600169-MCP200; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Jin H, 2014, BIOMED RES INT, V2014, P1; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kim SD, 2010, ANAT CELL BIOL, V43, P284, DOI 10.5115/acb.2010.43.4.284; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Marshall TW, 2003, J BIOL CHEM, V278, P30605, DOI 10.1074/jbc.M304582200; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Mooslehner KA, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/381824; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Paltoglou S, 2017, CANCER RES, V77, P3417, DOI 10.1158/0008-5472.CAN-16-1616; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Schiewer MJ, 2016, TRENDS ENDOCRIN MET, V27, P216, DOI 10.1016/j.tem.2016.02.004; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Stelloo S, 2015, EMBO MOL MED, V7, P1450, DOI 10.15252/emmm.201505424; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; Van Tilborgh N, 2013, J ENDOCRINOL INVEST, V36, P699, DOI 10.3275/8927; van Weerden WM, 2009, BRIT J CANCER, V100, P13, DOI 10.1038/sj.bjc.6604822; Vander Griend DJ, 2014, INT J BIOL SCI, V10, P627, DOI 10.7150/ijbs.8756; VANSTEENBRUGGE GJ, 1984, PROSTATE, V5, P639, DOI 10.1002/pros.2990050610; vanWeerden WM, 1996, AM J PATHOL, V149, P1055; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Yang YA, 2015, GENES DIS, V2, P144, DOI 10.1016/j.gendis.2015.01.003; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779	57	55	56	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					313	322		10.1038/onc.2017.330	http://dx.doi.org/10.1038/onc.2017.330			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28925401				2022-12-26	WOS:000422753900004
J	Aoyama, K; Bhadhprasit, W; Watabe, M; Wang, F; Matsumura, N; Nakaki, T				Aoyama, Koji; Bhadhprasit, Wattanaporn; Watabe, Masahiko; Wang, Fan; Matsumura, Nobuko; Nakaki, Toshio			GTRAP3-18 regulates food intake and body weight by interacting with pro-opiomelanocortin	FASEB JOURNAL			English	Article						appetite; obesity; diabetes; hypothalamus; neuron	NERVOUS-SYSTEM CONTROL; INSULIN-RESISTANCE; ALPHA-MSH; NEUROPEPTIDE-Y; GLUTAMATE TRANSPORTER; NEURONAL GLUTATHIONE; ENERGY HOMEOSTASIS; POMC NEURONS; AMP-KINASE; MICE	Pro-opiomelanocortin (POMC)-expressing neurons provide alpha-melanocyte-stimulating hormone (alpha-MSH), which stimulates melanocortin 4 receptor to induce hypophagia by AMPK inhibition in the hypothalamus. alpha-MSH is produced by POMC cleavage in secretory granules and released. However, it is not known yet whether any posttranscriptional regulatory mechanism of POMC signaling exists upstream of the secretory granules in neurons. Here we show that glutamate transporter-associated protein 3-18 (GTRAP3-18), an anchor protein that retains interacting proteins in the endoplasmic reticulum, is a critical regulator of food intake and body weight by interacting with POMC. GTRAP3-18-deficient mice showed hypophagia, lean bodies, and lower blood glucose, insulin, and leptin levels with increased serum and brain alpha-MSH levels, leading to AMPK inhibition. Intraperitoneal glucose tolerance tests revealed significantly decreased blood glucose levels and areas under the curve in GTRAP3-18-deficient mice compared to wild-type mice. An intracerebroventricular infusion of a selective melanocortin 4 receptor antagonist to GTRAP3-18-deficient mice significantly increased their food intake and body weight. A fluorescence resonance energy transfer study showed an interaction between GTRAP3-18 and POMC in vitro. These findings suggest that activation of the melanocortin pathway by modulating GTRAP3-18/POMC interaction could be an alternative strategy for obesity and/or type 2 diabetes.	[Aoyama, Koji; Bhadhprasit, Wattanaporn; Wang, Fan; Matsumura, Nobuko; Nakaki, Toshio] Teikyo Univ, Sch Med, Dept Pharmacol, Tokyo, Japan; [Watabe, Masahiko] Teikyo Univ, Sch Med, G MEC, Tokyo, Japan	Teikyo University; Teikyo University	Nakaki, T (corresponding author), Teikyo Univ, Sch Med, Dept Pharmacol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	nakaki@med.teikyo-u.ac.jp		Aoyama, Koji/0000-0003-4752-9262	Japan Society for the Promotion of Science [JP23500454, JP24590333]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant JP23500454 (to K.A.) and Grant JP24590333 (to T.N. and K.A.). The authors declare no conflicts of interest.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anderson EJP, 2016, J MOL ENDOCRINOL, V56, pT157, DOI 10.1530/JME-16-0014; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Aoyama K, 2012, NEUROBIOL DIS, V45, P973, DOI 10.1016/j.nbd.2011.12.016; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cakir I, 2013, J BIOL CHEM, V288, P17675, DOI 10.1074/jbc.M113.475343; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chaput JP, 2009, INT J OBESITY, V33, P46, DOI 10.1038/ijo.2008.221; Chretien M, 2016, J MOL ENDOCRINOL, V56, pT49, DOI 10.1530/JME-15-0261; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; DagogoJack S, 1996, DIABETES, V45, P695, DOI 10.2337/diabetes.45.5.695; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; DEROTTE AA, 1980, BRAIN RES BULL, V5, P375, DOI 10.1016/S0361-9230(80)80007-4; Enriori PJ, 2016, MOL METAB, V5, P807, DOI 10.1016/j.molmet.2016.07.009; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ikemoto MJ, 2002, NEUROREPORT, V13, P2079, DOI 10.1097/00001756-200211150-00018; Inoue K, 2005, NEUROSCI LETT, V386, P184, DOI 10.1016/j.neulet.2005.06.013; Ioffe E, 1998, P NATL ACAD SCI USA, V95, P11852, DOI 10.1073/pnas.95.20.11852; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Maier S, 2009, J CELL MOL MED, V13, P114, DOI 10.1111/j.1582-4934.2008.00303.x; Marie LS, 2005, P NATL ACAD SCI USA, V102, P18632, DOI 10.1073/pnas.0509240102; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Mercer AJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE904, DOI 10.1152/ajpendo.00540.2013; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Mizuno TM, 2003, DIABETES, V52, P2675, DOI 10.2337/diabetes.52.11.2675; Moller CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161047; Moller CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157027; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pritchard LE, 2007, ENDOCRINOLOGY, V148, P4201, DOI 10.1210/en.2006-1686; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Ruggiero AM, 2008, J BIOL CHEM, V283, P6175, DOI 10.1074/jbc.M701008200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez VC, 2004, J CLIN INVEST, V114, P357, DOI 10.1172/jci200421620; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Crespo CS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00058; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; USATEGUI R, 1976, ENDOCRINOLOGY, V98, P189, DOI 10.1210/endo-98-1-189; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; WILSON JF, 1984, PEPTIDES, V5, P681, DOI 10.1016/0196-9781(84)90006-8; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	59	1	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					330	341		10.1096/fj.201700421R	http://dx.doi.org/10.1096/fj.201700421R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904020				2022-12-26	WOS:000419172700030
J	Liang, TT; Zhou, B; Shi, L; Wang, H; Chu, QP; Xu, FL; Li, Y; Chen, RN; Shen, CY; Schinckel, AP				Liang, Tingting; Zhou, Bo; Shi, Lei; Wang, Han; Chu, Qingpo; Xu, Feilong; Li, Yuan; Chen, Ruonan; Shen, Chunyan; Schinckel, Allan P.			lncRNA AK017368 promotes proliferation and suppresses differentiation of myoblasts in skeletal muscle development by attenuating the function of miR-30c	FASEB JOURNAL			English	Article						myogenesis; ceRNA; C2C12 cells; TNRC6A	LONG NONCODING RNA; REGENERATION; EXPRESSION; LINCRNAS; MECHANISMS; MICRORNAS; EVOLUTION; SEQUENCE; TISSUE; DOMAIN	Long noncoding RNAs (lncRNAs) have been reported to play diverse roles in biologic and pathologic processes, including myogenesis. We found that lncRNA AK017368 is highly expressed in skeletal muscle cells. Functional analyses showed that overexpression of AK017368 promoted proliferation and restrained differentiation of myoblasts; whereas inhibition of AK017368 had completely opposite effects in vitro. In mice, knockdown of AK017368 promoted muscle hypertrophy in vivo. RNA molecules of AK017368 acted mechanistically as competing endogenous RNAs to target micro-RNA (miR)-30c, which was supported by the results of bioinformatics analyses and dual-luciferase reporter assays. It has been shown that lncRNA AK017368 competes with trinucleotide repeat containing-6A (Tnrc6a) for miR-30c. Tnrc6a was previously reported to promote proliferation and inhibit differentiation of myoblast cells, whereas miR-30c targets the 39-UTR of Tnrc6a mRNA to weaken its function. Taken together, lncRNA AK017368 promotes proliferation and inhibits differentiation of myoblast cells by attenuating function ofmiR-30c.	[Liang, Tingting; Zhou, Bo; Shi, Lei; Wang, Han; Chu, Qingpo; Xu, Feilong; Li, Yuan; Chen, Ruonan; Shen, Chunyan] Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China; [Schinckel, Allan P.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Nanjing Agricultural University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China.	zhoubo@njau.edu.cn	Zhou, Bo/AFL-8720-2022	Zhou, Bo/0000-0003-2857-8536	National Natural Science Foundation of China [31672465]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31672465 (to B.Z.). The authors declare no conflicts of interest.	Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Butchart LC, 2016, DIFFERENTIATION, V92, P237, DOI 10.1016/j.diff.2016.05.003; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dey BK, 2011, MOL CELL BIOL, V31, P1329, DOI 10.1128/MCB.05013-11; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Diniz GP, 2016, COMPR PHYSIOL, V6, P1279, DOI 10.1002/cphy.c150041; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; Grote P, 2015, TRENDS GENET, V31, P329, DOI 10.1016/j.tig.2015.02.002; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guess M. G., 2014, CHARACTERIZATION MIC; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hiramuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130436; Izaurralde E, 2012, EMBO REP, V13, P662, DOI 10.1038/embor.2012.91; Jiang YQ, 2013, BBA-REV CANCER, V1835, P155, DOI 10.1016/j.bbcan.2012.12.003; Kanduri C, 2008, RNA BIOL, V5, P208, DOI 10.4161/rna.7113; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Le Guen Claire L, 2013, F1000Res, V2, P197, DOI 10.12688/f1000research.2-197.v1; Liu J., 2005, NAT CELL BIOL, V8, P100; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lu W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21620; Nishi K, 2015, NUCLEIC ACIDS RES, V43, P9856, DOI 10.1093/nar/gkv1026; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; Simionescu-Bankston A, 2016, J MOL MED, V94, P853, DOI 10.1007/s00109-016-1443-y; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang G, 2016, SCI PROGRAMMING-NETH, V2016, DOI 10.1155/2016/3676149; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Xia T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06088; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang J, 2014, BIOCHEM BIOPH RES CO, V443, P1028, DOI 10.1016/j.bbrc.2013.12.092	41	41	44	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					377	389		10.1096/fj.201700560RR	http://dx.doi.org/10.1096/fj.201700560RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904016				2022-12-26	WOS:000419172700034
J	Caraher, EJ; Kwon, S; Haider, SH; Crowley, G; Lee, A; Ebrahim, M; Zhang, LQ; Chen, LC; Gordon, T; Liu, ML; Prezant, DJ; Schmidt, AM; Nolan, A				Caraher, Erin J.; Kwon, Sophia; Haider, Syed H.; Crowley, George; Lee, Audrey; Ebrahim, Minah; Zhang, Liqun; Chen, Lung-Chi; Gordon, Terry; Liu, Mengling; Prezant, David J.; Schmidt, Ann Marie; Nolan, Anna			Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: A case-cohort study and murine model of acute particulate exposure	PLOS ONE			English	Article							YORK-CITY FIREFIGHTERS; AIR-FLOW OBSTRUCTION; SMOOTH-MUSCLE-CELLS; SOLUBLE RECEPTOR; CENTER DISASTER; INFLAMMATORY RESPONSE; LYSOPHOSPHATIDIC ACID; ANTIINFLAMMATORY ROLE; METABOLIC SYNDROME; EPITHELIAL-CELLS	World Trade Center-particulate matter(WTC-PM) exposure and metabolic-risk are associated with WTC-Lung Injury(WTC-LI). The receptor for advanced glycation end-products (RAGE) is most highly expressed in the lung, mediates metabolic risk, and single-nucleotide polymorphisms at the AGER-locus predict forced expiratory volume(FEV). Our objectives were to test the hypotheses that RAGE is a biomarker of WTC-LI in the FDNY-cohort and that loss of RAGE in a murine model would protect against acute PM-induced lung disease. We know from previous work that early intense exposure at the time of the WTC collapse was most predictive of WTC-LI therefore we utilized a murine model of intense acute PM-exposure to determine if loss of RAGE is protective and to identify signaling/cytokine intermediates. This study builds on a continuing effort to identify serum biomarkers that predict the development of WTC-LI. A case-cohort design was used to analyze a focused cohort of male never-smokers with normal pre-9/11 lung function. Odds of developing WTC-LI increased by 1.2, 1.8 and 1.0 in firefighters with soluble RAGE (sRAGE) >= 97pg/mL, CRP >= 2.4mg/L, and MMP-9 <= 397ng/mL, respectively, assessed in a multivariate logistic regression model (ROCAUC of 0.72). Wild type(WT) and RAGE-deficient(Ager(-/-)) mice were exposed to PM or PBS-control by oropharyngeal aspiration. Lung function, airway hyperreactivity, bronchoalveolar lavage, histology, transcription factors and plasma/BAL cytokines were quantified. WT-PM mice had decreased FEV and compliance, and increased airway resistance and methacholine reactivity after 24-hours. Decreased IFN-Y and increased LPA were observed in WT-PM mice; similar findings have been reported for firefighters who eventually develop WTC-LI. In the murine model, lack of RAGE was protective from loss of lung function and airway hyperreactivity and was associated with modulation of MAP kinases. We conclude that in a multivariate adjusted model increased sRAGE is associated with WTC-LI. In our murine model, absence of RAGE mitigated acute deleterious effects of PM and may be a biologically plausible mediator of PM-related lung disease.	[Caraher, Erin J.; Kwon, Sophia; Haider, Syed H.; Crowley, George; Lee, Audrey; Ebrahim, Minah; Zhang, Liqun; Nolan, Anna] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA; [Zhang, Liqun] Army Gen Hosp, PLA, Dept Resp Med, Beijing, Peoples R China; [Chen, Lung-Chi; Gordon, Terry; Liu, Mengling; Nolan, Anna] NYU, Sch Med, Dept Environm Med, New York, NY 10003 USA; [Liu, Mengling] NYU, Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA; [Prezant, David J.; Nolan, Anna] Fire Dept New York, Bur Hlth Serv, Brooklyn, NY 11201 USA; [Prezant, David J.; Nolan, Anna] Fire Dept New York, Off Med Affairs, Brooklyn, NY 11201 USA; [Prezant, David J.] Montefiore Med Ctr, Dept Med, Pulm Med Div, Bronx, NY 10467 USA; [Prezant, David J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Schmidt, Ann Marie] NYU, Sch Med, Dept Biochem, Div Endocrinol, New York, NY 10016 USA; [Schmidt, Ann Marie] NYU, Sch Med, Dept Mol Pharmacol & Pathol, Div Endocrinol, New York, NY USA	New York University; New York University; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University; New York University	Nolan, A (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA.; Nolan, A (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10003 USA.; Nolan, A (corresponding author), Fire Dept New York, Bur Hlth Serv, Brooklyn, NY 11201 USA.; Nolan, A (corresponding author), Fire Dept New York, Off Med Affairs, Brooklyn, NY 11201 USA.	anna.nolan@med.nyu.edu	Nolan, Anna/C-2796-2012	Nolan, Anna/0000-0002-0631-1171; Liu, Mengling/0000-0001-9758-8522; Chen, Lung Chi/0000-0003-1154-2107; Kwon, Sophia/0000-0003-3639-5107	National Heart Lung and Blood Institute [R01HL119326, K23HL08419]; National Institute of Occupational Safety and Health [U10-OH008243, U10-OH008242]; National Institute of Environmental Health Sciences [P30-00260, UL1RR029893]; National Institutes of Health [UL1TR001445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U01OH011300] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by National Heart Lung and Blood Institute (R01HL119326, K23HL08419), National Institute of Occupational Safety and Health (U10-OH008243, U10-OH008242), National Institute of Environmental Health Sciences (P30-00260, UL1RR029893), National Institutes of Health (UL1TR001445), and the Saperstein Scholars Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2016, CHEST, V149, P1419, DOI 10.1016/j.chest.2015.10.067; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Allen IC, SPRINGER SCI BUSINES; Antao VC, 2013, EUR RESPIR J, V41, P999, DOI 10.1183/09031936.00181112; Balmes JR, 2012, CHEST, V142, P278, DOI 10.1378/chest.12-0126; Berger KI, 2013, CHEST, V144, P249, DOI 10.1378/chest.12-1411; Berkman N, 1996, IMMUNOLOGY, V87, P599, DOI 10.1046/j.1365-2567.1996.477579.x; Beucher J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041913; Boulet Louis-Philippe, 2005, Can Respir J, V12, P371; BRUNEKREEF B, 1993, J EXPO ANAL ENV EPID, V3, P117; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Caffrey AK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004625; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Carbognin E, 2016, EMBO J, V35, P618, DOI 10.15252/embj.201592629; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; CHO S, 2013, AM J RESP CRIT CARE, V187; Cho S, 2013, CTS-CLIN TRANSL SCI, V6, P136; Collins RA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-142; Corvol H, 2012, J CYST FIBROS, V11, P63, DOI 10.1016/j.jcf.2011.09.006; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; de Castro HA, 2009, REV SAUDE PUBL, V43, P26, DOI 10.1590/S0034-89102009000100004; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Ferrier NV, 2011, AM J RESP CRIT CARE, V183; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P981, DOI 10.1289/ehp.5931; Ge X, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-110; Geyh AS, 2005, J OCCUP ENVIRON HYG, V2, P179, DOI 10.1080/15459620590923154; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; HABER PS, 1983, J APPL PHYSIOL, V54, P837, DOI 10.1152/jappl.1983.54.3.837; Hamakawa H, 2011, AM J RESP CELL MOL, V45, P517, DOI 10.1165/rcmb.2010-0473OC; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; Hartney JM, 2013, METHODS MOL BIOL, V1032, P205, DOI 10.1007/978-1-62703-496-8_16; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Holguin F, 2012, AM J RESP CRIT CARE, V185, P352, DOI 10.1164/rccm.201112-2172ED; Hoonhorst SJM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0363-2; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hunt LC, 2013, HISTOCHEM CELL BIOL, V139, P13, DOI 10.1007/s00418-012-1018-0; Jabaudon M, 2015, RESPIROLOGY, V20, P1131, DOI 10.1111/resp.12583; Jabaudon M, 2015, AM J RESP CRIT CARE, V192, P191, DOI 10.1164/rccm.201501-0020OC; John M, 1997, J IMMUNOL, V158, P1841; Katsuoka F, 1997, BIOCHEM BIOPH RES CO, V238, P512, DOI 10.1006/bbrc.1997.7263; Kazeros A, 2015, J OCCUP ENVIRON MED, V57, P610, DOI 10.1097/JOM.0000000000000458; Kazeros A, 2013, J ASTHMA, V50, P25, DOI 10.3109/02770903.2012.743149; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; Kwon S, 2013, CTS-CLIN TRANSL SCI, V6, P151; Kwon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076099; Laki J, 2006, INT IMMUNOL, V18, P1585, DOI 10.1093/intimm/dxl091; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; LUM H, 1990, J APPL PHYSIOL, V68, P2280, DOI 10.1152/jappl.1990.68.6.2280; Manichaikul A, 2017, ANN AM THORACIC SOC; Manigrasso MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22450; Matsumoto H, 2015, J TRAUMA ACUTE CARE, V78, P1086, DOI [10.1097/TA.0000000000000653, 10.1097/TA.0000000000000651]; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Metz VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041823; MIETTINEN O, 1982, SCAND J WORK ENV HEA, V8, P7; Miller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164041; Milutinovic PS, 2012, AM J PATHOL, V181, P1215, DOI 10.1016/j.ajpath.2012.06.031; Mitzner W, 2008, J APPL PHYSIOL, V105, P1980, DOI 10.1152/japplphysiol.90968.2008; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Munoz-Barrutia A, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/734734; Naveed B, 2012, AM J RESP CRIT CARE, V185; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nolan A, 2004, INFLAMMATION, V28, P271, DOI 10.1007/s10753-004-6050-3; Nolan A, 2004, SHOCK, V22, P538, DOI 10.1097/01.shk.0000143416.20649.30; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Nolan A, 2012, CHEST, V142, P412, DOI 10.1378/chest.11-1202; Novali M, 2015, RESP PHYSIOL NEUROBI, V218, P11, DOI 10.1016/j.resp.2015.07.007; OLDMIXON EH, 1994, J MICROSC-OXFORD, V175, P60, DOI 10.1111/j.1365-2818.1994.tb04788.x; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; Penyige A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-152; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Rai V, 2012, J EXP MED, V209, P2339, DOI 10.1084/jem.20120873; Ramsgaard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009604; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Rivera-Sanchez YM, 2004, J APPL PHYSIOL, V96, P2200, DOI 10.1152/japplphysiol.00960.2003; Robichaud A, 2015, AM J PHYSIOL-LUNG C, V308, pL837, DOI 10.1152/ajplung.00343.2014; Rom William N, 2010, Proc Am Thorac Soc, V7, P142, DOI 10.1513/pats.200908-092RM; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Rundle AG, 2005, CANCER EPIDEM BIOMAR, V14, P1899, DOI 10.1158/1055-9965.EPI-04-0860; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Ryu MH, 2014, AM J PHYSIOL-LUNG C, V307, pL765, DOI 10.1152/ajplung.00100.2014; Sabbagh MN, 2011, ALZ DIS ASSOC DIS, V25, P206, DOI 10.1097/WAD.0b013e318204b550; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Sambamurthy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118979; SCHENCK E, 2013, AM J RESP CRIT CARE, V187; Schenck Edward J, 2014, BMJ Open, V4, pe005575, DOI 10.1136/bmjopen-2014-005575; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; SCHWARTZ J, 1995, THORAX, V50, P531, DOI 10.1136/thx.50.5.531; Shalaby KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-82; Shvedova AA, 2014, AM J PHYSIOL-LUNG C, V306, pL170, DOI 10.1152/ajplung.00167.2013; Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636; Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003; Standiford Theodore J, 2005, Proc Am Thorac Soc, V2, P226, DOI 10.1513/pats.200501-010AC; Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Szatmari I, 2008, EMBO J, V27, P2353, DOI 10.1038/emboj.2008.160; Timonen KL, 2002, OCCUP ENVIRON MED, V59, P129, DOI 10.1136/oem.59.2.129; Toure F, 2008, BIOCHEM J, V416, P255, DOI 10.1042/BJ20080054; Tsukiji J, 2014, BIOMARKERS, V19, P159, DOI 10.3109/1354750X.2014.891047; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vela L, 2016, J BIOMOLECULAR SCREE; Wang G, 2005, METABOLISM, V54, P590, DOI 10.1016/j.metabol.2004.11.017; Wang K, 2006, J PHARMACOL EXP THER, V317, P37, DOI 10.1124/jpet.105.095125; Waseda K, 2015, AM J RESP CELL MOL, V52, P482, DOI 10.1165/rcmb.2014-0027OC; Weiden M. D., 2012, EUROPEAN RESP J, P1023; Weiden MD, 2015, SEMIN RESP CRIT CARE, V36, P323, DOI 10.1055/s-0035-1547349; Weiden MD, 2013, EUR RESPIR J, V41, P1023, DOI 10.1183/09031936.00077012; Weiden MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040016; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580; Winden DR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-108; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; YANG QH, 1991, J APPL PHYSIOL, V71, P76, DOI 10.1152/jappl.1991.71.1.76; Yonchuk JG, 2015, AM J RESP CRIT CARE, V192, P785, DOI 10.1164/rccm.201501-0137PP; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhou B, 2013, FASEB J, V27; Zhu M, 2001, J IMMUNOL, V166, P2049, DOI 10.4049/jimmunol.166.3.2049	141	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184331	10.1371/journal.pone.0184331	http://dx.doi.org/10.1371/journal.pone.0184331			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926576	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600014
J	Liu, ML; Clarke, CJ; Salama, MF; Choim, YJ; Obeid, LM; Hannun, YA				Liu, Mengling; Clarke, Christopher J.; Salama, Mohamed F.; Choim, Yeon Ja; Obeid, Lina M.; Hannun, Yusuf A.			Co-ordinated activation of classical and novel PKC isoforms is required for PMA-induced mTORC1 activation	PLOS ONE			English	Article							PROTEIN-KINASE-C; TUMOR-SUPPRESSOR COMPLEX; PROMOTING PHORBOL ESTERS; PHOSPHOLIPASE-D; RAG GTPASES; RECYCLING ENDOSOMES; SIGNALING PATHWAYS; PHOSPHATIDIC-ACID; DEPENDENT MANNER; AMINO-ACIDS	Protein kinase C (PKC) has been shown to activate the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, a central hub in the regulation of cell metabolism, growth and proliferation. However, the mechanisms by which PKCs activate mTORC1 are still ambiguous. Our previous study revealed that activation of classical PKCs (cPKC) results in the perinuclear accumulation of cPKC and phospholipase D2 (PLD2) in recycling endosomes in a PLD2-dependent manner. Here, we report that mTORC1 activation by phorbol 12,13-myristate acetate (PMA) requires both classic, cPKC, and novel PKC (nPKC) isoforms, specifically PKC., acting through distinct pathways. The translocation of mTOR to perinuclear lysosomes was detected after treatment of PKC activators, which was not colocalized with PKCa-or RAB11-positive endosomes and was not inhibited by PLD inhibitors. We found that PKC. inhibition by siRNA or bisindolylmaleimide I effectively decreased mTOR accumulation in lysosomes and its activity. Also, we identified that PKC. plays a role upstream of the v-ATPase/Ragulator/Rag pathway in response to PMA. These data provides a spatial aspect to the regulation of mTORC1 by sustained activation of PKC, requiring co-ordinated activation of two distinct elements, the perinuclear accumulation of cPKC-and PLD-containing endosomes and the nPKC-dependent translation of of mTOR in the perinuclear lysosomes. The close proximity of these two distinct compartments shown in this study suggests the possibility that transcompartment signaling may be a factor in the regulation of mTORC1 activity and also underscores the importance of PKC. as a potential therapeutic target of mTORC-related disorders.	[Liu, Mengling; Clarke, Christopher J.; Salama, Mohamed F.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Liu, Mengling; Clarke, Christopher J.; Choim, Yeon Ja; Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Univ Hosp, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.] Mansoura Univ, Fac Vet Med, Dept Biochem, Mansoura, Egypt; [Choim, Yeon Ja; Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Egyptian Knowledge Bank (EKB); Mansoura University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Stony Brook Univ Hosp, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Salama, Mohamed/S-3493-2019; Salama, Mohamed F/C-9010-2017	Salama, Mohamed/0000-0002-0002-9108; Salama, Mohamed F/0000-0002-0002-9108; Liu, Mengling/0000-0003-1309-0087	NIH [HL 43707, CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants HL 43707 and CA97132 award to Y.A.H., https://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeder SE, 2004, ONCOGENE, V23, P9062, DOI 10.1038/sj.onc.1208093; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; El Osta M, 2014, FASEB J, V28, P495, DOI 10.1096/fj.13-230557; El-Osta MA, 2011, J BIOL CHEM, V286, P19340, DOI 10.1074/jbc.M110.152330; Fan Q. W., 2009, SCI SIGNAL, V2, pra4, DOI DOI 10.1126/SCISIGNAL.2000014; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; HEMING TA, 1995, J LEUKOCYTE BIOL, V57, P600, DOI 10.1002/jlb.57.4.600; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Kikumori M, 2012, J MED CHEM, V55, P5614, DOI 10.1021/jm300566h; Kim YM, 2012, MOL CELL, V46, P833, DOI 10.1016/j.molcel.2012.04.007; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Leseux L, 2008, BLOOD, V111, P285, DOI 10.1182/blood-2007-04-085092; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080721; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; NANDA A, 1992, J BIOL CHEM, V267, P22740; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Yoshida S, 2015, J CELL BIOL, V211, P159, DOI 10.1083/jcb.201504097; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184818	10.1371/journal.pone.0184818	http://dx.doi.org/10.1371/journal.pone.0184818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926616	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600043
J	Aloy, MA; Adsuara, JE; Cerda-Duran, P; Obergaulinger, M; Esteve-Taboada, JJ; Ferrer-Blasco, T; Montes-Mico, R				Aloy, M. A.; Adsuara, J. E.; Cerda-Duran, P.; Obergaulinger, M.; Esteve-Taboada, J. J.; Ferrer-Blasco, T.; Montes-Mico, R.			Estimation of the mechanical properties of the eye through the study of its vibrational modes	PLOS ONE			English	Article							X-RAY OSCILLATIONS; BIOMECHANICAL PROPERTIES; MATHEMATICAL-MODEL; BIOMETER; VISCOELASTICITY; ACCOMMODATION; REPEATABILITY; FLUCTUATIONS; DISCOVERY; CORNEA	Measuring the eye's mechanical properties in vivo and with minimally invasive techniques can be the key for individualized solutions to a number of eye pathologies. The development of such techniques largely relies on a computational modelling of the eyeball and, it optimally requires the synergic interplay between experimentation and numerical simulation. In Astrophysics and Geophysics the remote measurement of structural properties of the systems of their realm is performed on the basis of (helio-) seismic techniques. As a biomechanical system, the eyeball possesses normal vibrational modes encompassing rich information about its structure and mechanical properties. However, the integral analysis of the eyeball vibrational modes has not been performed yet. Here we develop a new finite difference method to compute both the spheroidal and, specially, the toroidal eigenfrequencies of the human eye. Using this numerical model, we show that the vibrational eigenfrequencies of the human eye fall in the interval 100 Hz-10 MHz. We find that compressible vibrational modes may release a trace on high frequency changes of the intraocular pressure, while incompressible normal modes could be registered analyzing the scattering pattern that the motions of the vitreous humour leave on the retina. Existing contact lenses with embebed devices operating at high sampling frequency could be used to register the microfluctuations of the eyeball shape we obtain. We advance that an inverse problem to obtain the mechanical properties of a given eye (e.g., Young's modulus, Poisson ratio) measuring its normal frequencies is doable. These measurements can be done using non-invasive techniques, opening very interesting perspectives to estimate the mechanical properties of eyes in vivo. Future research might relate various ocular pathologies with anomalies in measured vibrational frequencies of the eye.	[Aloy, M. A.; Adsuara, J. E.; Cerda-Duran, P.; Obergaulinger, M.] Univ Valencia, Dept Astron & Astrophys, E-46100 Burjassot, Spain; [Esteve-Taboada, J. J.; Ferrer-Blasco, T.; Montes-Mico, R.] Univ Valencia, Dept Opt & Optometry & Vis Sci, E-46100 Burjassot, Spain	University of Valencia; University of Valencia	Aloy, MA (corresponding author), Univ Valencia, Dept Astron & Astrophys, E-46100 Burjassot, Spain.	miguel.a.aloy@uv.es	Aloy, Miguel A/K-9941-2014; Esteve, Jose/ABB-6548-2021; Aloy, Miguel-Ángel/ABC-1245-2021; Cerda-Duran, Pablo/D-7857-2015; Adsuara, Jose E./AAB-5516-2019	Aloy, Miguel A/0000-0002-5552-7681; Aloy, Miguel-Ángel/0000-0002-5552-7681; Cerda-Duran, Pablo/0000-0003-4293-340X; Adsuara, Jose E./0000-0002-3842-965X; Montes-Mico, Robert/0000-0001-6179-8261; Esteve-Taboada, Jose Juan/0000-0001-8663-6373	Spanish Government Grant Explora [SAF2013-49284-EXP]; Spanish Ministerio de Economia y Competitividad, Subsecretaria de Estado de Investigacion Desarrollo e Innovacion [SAF2013-49284-EXP]	Spanish Government Grant Explora; Spanish Ministerio de Economia y Competitividad, Subsecretaria de Estado de Investigacion Desarrollo e Innovacion	This work was supported by Spanish Ministerio de Economia y Competitividad, Subsecretaria de Estado de Investigacion Desarrollo e Innovacion (URL: http://www.idi.mineco.gob.es/portal/site/MICINN), Grant Explora Ciencia SAF2013-49284-EXP.; Authors acknowledge financial support from the Spanish Government Grant Explora (SAF2013-49284-EXP).	Adsuara JE, 2017, J COMPUT PHYS, V332, P446, DOI 10.1016/j.jcp.2016.12.020; Adsuara JE, 2016, J COMPUT PHYS, V321, P369, DOI 10.1016/j.jcp.2016.05.053; Adsuara JE, 2017, SPEEDING FEW ORDERS; AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Akca BI, 2015, BIOMED OPT EXPRESS, V6, P3313, DOI 10.1364/BOE.6.003313; Akman A, 2015, BRIT J OPHTHALMOLOGY; Bonfiglio A, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0020-8; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; Chung CW, 2016, INVEST OPHTH VIS SCI, V57, P236, DOI 10.1167/iovs.15-18053; COQUART L, 1992, J BIOMECH, V25, P1105, DOI 10.1016/0021-9290(92)90067-B; de Guillebon Z H, 1972, RETINAL TRACTION VIT, V11, P46; DEGUILLEBON H, 1972, ARCH OPHTHALMOL-CHIC, V87, P545, DOI 10.1001/archopht.1972.01000020547012; Downs JC, 2011, INVEST OPHTH VIS SCI, V52, P7365, DOI 10.1167/iovs.11-7955; Dubra A, 2004, THESIS; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055; Ferrer-Blasco T, 2017, GRAEF ARCH CLIN EXP, V255, P343, DOI 10.1007/s00417-016-3555-z; Gough D.O., 1991, SOLAR INTERIOR ATMOS, P519; Hirneiss C, 2011, ACTA OPHTHALMOL, V89, pE189, DOI 10.1111/j.1755-3768.2010.02093.x; Hugar DL, 2013, MAT SCI ENG C-MATER, V33, P1867, DOI 10.1016/j.msec.2013.02.009; Israel GL, 2005, ASTROPHYS J, V628, pL53, DOI 10.1086/432615; JONES IL, 1992, EYE, V6, P556, DOI 10.1038/eye.1992.121; Kling S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0920; Kling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104904; Koprowski R, 2015, J BIOPHOTONICS, V8, P968, DOI 10.1002/jbio.201400137; Kunert KS, 2016, J CATARACT REFR SURG, V42, P76, DOI 10.1016/j.jcrs.2015.07.039; Lam A, 2005, AM J OPHTHALMOL, V140, P329, DOI 10.1016/j.ajo.2005.02.014; Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x; Lombardo M, 2009, J CATARACT REFR SURG, V35, P1266, DOI 10.1016/j.jcrs.2009.02.029; Love AEH, 1944, TREATISE MATH THEORY, V4; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Lyubimov GA, 2007, FLUID DYNAM+, V42, P684, DOI 10.1134/S001546280705002X; Mansouri Kaweh, 2014, J Ophthalmic Vis Res, V9, P260; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; MAURICE D M, 1958, Br J Ophthalmol, V42, P321; Meskauskas J, 2011, J FLUID MECH, V685, P1, DOI 10.1017/jfm.2011.263; Morita T, 2012, ACTA OPHTHALMOL, V90, pE48, DOI 10.1111/j.1755-3768.2011.02242.x; Nenadic IZ, 2011, PHYS MED BIOL, V56, P2245, DOI 10.1088/0031-9155/56/7/021; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Oliveira C, 2006, J GLAUCOMA, V15, P190, DOI 10.1097/01.ijg.0000212220.42675.c5; Rue J, 1996, THESIS; Salimi S, 2011, J BIOMECHANICAL ENG, V133, P433; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P99, DOI 10.1007/s10237-008-0119-0; Srivannaboon S, 2015, J CATARACT REFR SURG, V41, P2224, DOI 10.1016/j.jcrs.2015.03.019; Strohmayer TE, 2005, ASTROPHYS J, V632, pL111, DOI 10.1086/497911; Tejwani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097591; Terai N, 2012, CURR EYE RES, V37, P553, DOI 10.3109/02713683.2012.669007; Tian X, 2016, FRONTIERS SYSTEMS NE, V10; Uchio E, 1999, BRIT J OPHTHALMOL, V83, P1106, DOI 10.1136/bjo.83.10.1106; VISSCHER WM, 1991, J ACOUST SOC AM, V90, P2154, DOI 10.1121/1.401643; Vorontsov SV, 2002, SCIENCE, V296, P101, DOI 10.1126/science.1069190; Walton KA, 2002, EXP EYE RES, V74, P173, DOI 10.1006/exer.2001.1136; WEINBAUM S, 1965, B MATH BIOPHYS, V27, P325, DOI 10.1007/BF02478410; Zhang XY, 2015, ULTRASOUND MED BIOL, V41, P1461, DOI 10.1016/j.ultrasmedbio.2014.12.017; ZIMMERMAN RL, 1980, BIOPHYS J, V29, P539, DOI 10.1016/S0006-3495(80)85152-6	58	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183892	10.1371/journal.pone.0183892	http://dx.doi.org/10.1371/journal.pone.0183892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922351	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300009
J	Dholakia, U; Clark-Price, SC; Keating, SCJ; Stern, AW				Dholakia, Urshulaa; Clark-Price, Stuart C.; Keating, Stephanie C. J.; Stern, Adam W.			Anesthetic effects and body weight changes associated with ketamine-xylazine-lidocaine administered to CD-1 mice	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; CONTINUOUS-RATE INFUSION; INTRAVENOUS LIDOCAINE; INTRAPERITONEAL INJECTION; POSTOPERATIVE ANALGESIA; ENDOTRACHEAL INTUBATION; SYSTEMIC LIDOCAINE; LABORATORY MICE; COUGH RESPONSE; RATS	Anesthesia for mice is commonly performed through the injection of parenteral agents via the intraperitoneal (IP) route. Variability in anesthetic sensitivities has been noted in mice resulting in inconsistencies in anesthetic depth and/or mortality. Anesthetic protocols that improve consistency and safety are needed. The objectives of this study were to assess the effects of intraperitoneal (IP) ketamine (95 mg/kg) and xylazine (7 mg/kg) alone or combined with lidocaine at 4, 8, or 16 mg/kg on time to loss (LRR) and return (RRR) of righting reflex, duration of immobilization and loss of pedal withdrawal response (PWR), body weight and histopathology in CD-1 mice. In a prospective, randomized trial, 36 male CD-1 mice, 4-6 weeks of age were randomly assigned to 5 groups: saline (SA, n = 4); ketamine-xylazine (KX, n = 8); ketamine-xylazine-lidocaine 4 mg/kg (KXL4, n = 8); ketamine-xylazine-lidocaine 8 mg/kg (KXL8, n = 8); ketamine-xylazine-lidocaine 16 mg/kg (KXL16, n = 8). Two mice in each group were euthanized at day 2 post-injection and the remaining mice were euthanized at day 11 post-injection. After IP injection, LRR and RRR, duration of immobilization and loss of PWR, body weight and histopathology were evaluated. LRR occurred sooner in mice receiving KXL16 compared with KX, with median (range) times of 78 (62-104) and 107 (91-298) seconds, respectively. Loss of PWR occurred in 1, 5, 4, 6 mice for groups KX, KXL4, KXL8, and KXL16 respectively. Median (range) duration of absent PWR was longer in mice receiving KXL16 at 13 (0-30) minutes, compared to KX at 0 (0-9) minutes. Duration of immobilization and RRR were not different between groups. Weight loss occurred 2 days following anesthesia but was not different between groups. Weight gain was significantly greater in all lidocaine groups 11 days post-injection compared to KX. No mortality or histopathologic abnormalities were observed in any group. Lidocaine administered with ketamine and xylazine shortens the onset of anesthesia in mice and improves anesthetic depth without prolonging recovery time.	[Dholakia, Urshulaa; Clark-Price, Stuart C.; Keating, Stephanie C. J.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Stern, Adam W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Clark-Price, SC (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.	sccp@illinois.edu	, Adam/AAY-4010-2021	, Adam/0000-0002-6794-6592				Adler DMT, 2017, VET J, V223, P31, DOI 10.1016/j.tvjl.2017.05.001; Alves HC, 2009, LAB ANIM-UK, V43, P27, DOI 10.1258/la.2008.007036; Antognini JF, 2005, COMPARATIVE MED, V55, P413; Arras M, 2001, COMPARATIVE MED, V51, P443; Baker NJ, 2011, J AM ASSOC LAB ANIM, V50, P916; Bellini L, 2016, JAVMA-J AM VET MED A, V248, P422, DOI 10.2460/javma.248.4.422; Bittencourt AL, 1997, EUR J PHARMACOL, V330, P109, DOI 10.1016/S0014-2999(97)00182-9; BLAHA MD, 2008, J AM ASSOC LAB ANIM, V47, P8; Brennan MP, 2009, LAB ANIMAL, V38, P87, DOI 10.1038/laban0309-87; Buitrago S, 2008, J AM ASSOC LAB ANIM, V47, P11; Burnside WM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-48; Cheung HMC, 2011, CAN J ANESTH, V58, P443, DOI 10.1007/s12630-011-9479-5; Cook VL, 2008, EQUINE VET J, V40, P353, DOI 10.2746/042516408X293574; Cook VL, 2009, AM J VET RES, V70, P1259, DOI 10.2460/ajvr.70.10.1259; De Oliveira GS, 2012, ANESTH ANALG, V115, P262, DOI 10.1213/ANE.0b013e318257a380; DEJONG RH, 1980, ANESTH ANALG, V59, P401; Enderle AK, 2008, VET ANAESTH ANALG, V35, P297, DOI 10.1111/j.1467-2995.2007.00391.x; Erickson RL, 2016, J AM ASSOC LAB ANIM, V55, P548; Euasobhon P, 2016, COCHRANE DB SYST REV, V18; Flecknell PA, 2013, VET ANAESTH ANALG, P754; Fleischmann T, 2016, LAB ANIM-UK, V50, P264, DOI 10.1177/0023677216631458; Gaertner DJ, 2008, AM COLL LAB, P239, DOI 10.1016/B978-012373898-1.50014-0; Harvey KP, 2009, AM J SURG, V198, P231, DOI 10.1016/j.amjsurg.2008.10.015; Hayes JH, 1999, LAB ANIM-UK, V33, P16, DOI 10.1258/002367799780578534; He SQ, 2010, J AM ASSOC LAB ANIM, V49, P45; Jaber SM, 2014, J AM ASSOC LAB ANIM, V53, P684; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Khan ZH, 2016, ANESTH PAIN MED, V6; KIRSCHENBAUM HL, 1982, AM J HOSP PHARM, V39, P1013, DOI 10.1093/ajhp/39.6.1013; Lauretti Gabriela Rocha, 2008, Rev. Bras. Anestesiol., V58, P280, DOI 10.1590/S0034-70942008000300011; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; LILES JH, 1992, LAB ANIM, V26, P180, DOI 10.1258/002367792780740558; McCarthy GC, 2010, DRUGS, V70, P1149, DOI 10.2165/10898560-000000000-00000; Panti A, 2016, VET ANAESTH ANALG, V43, P405, DOI 10.1111/vaa.12332; Re M, 2016, J AM ASSOC LAB ANIM, V55, P317; Rioja GE., 2015, VET ANAESTH ANALG, P332; Sakuragi T, 1996, REGION ANESTH, V21, P239; Schnellbacher RW, 2013, AM J VET RES, V74, P1377, DOI 10.2460/ajvr.74.11.1377; Serrano-Caballero JM, 2013, VET MED-CZECH, V58, P364, DOI 10.17221/6917-VETMED; Silva A, 2012, LAB ANIM-UK, V46, P85, DOI 10.1258/la.2012.011135; Struck MB, 2011, J AM ASSOC LAB ANIM, V50, P344; Svendsen O, 2007, LAB ANIM-UK, V41, P197, DOI 10.1258/002367707780378140; Thompson KR, 2016, VET ANAESTH ANALG, V43, P371, DOI 10.1111/vaa.12303; Torfs S, 2009, J VET INTERN MED, V23, P606, DOI 10.1111/j.1939-1676.2009.0311.x; Valverde A, 2004, VET ANAESTH ANALG, V31, P264, DOI 10.1111/j.1467-2995.2004.00165.x; van der Wal S, 2015, ACTA ANAESTH SCAND, V59, P47, DOI 10.1111/aas.12417; Weibel S, 2016, BRIT J ANAESTH, V116, P770, DOI 10.1093/bja/aew101; Welberg LAM, 2006, J AM ASSOC LAB ANIM, V45, P13; WHELAN G, 1992, LAB ANIM-UK, V26, P153, DOI 10.1258/002367792780740602; Wilson J, 2008, VET ANAESTH ANALG, V35, P289, DOI 10.1111/j.1467-2995.2007.00389.x	50	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184911	10.1371/journal.pone.0184911	http://dx.doi.org/10.1371/journal.pone.0184911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910423	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200118
J	Lorbeer, R; Hetterich, H; Strobl, R; Schafnitzel, A; Patscheider, H; Schindler, A; Muller-Peltzer, K; Sommer, W; Peters, A; Meisinger, C; Heier, M; Rathmann, W; Bamberg, F; Grill, E				Lorbeer, Roberto; Hetterich, Holger; Strobl, Ralf; Schafnitzel, Anina; Patscheider, Hannah; Schindler, Andreas; Mueller-Peltzer, Katharina; Sommer, Wieland; Peters, Annette; Meisinger, Christa; Heier, Margit; Rathmann, Wolfgang; Bamberg, Fabian; Grill, Eva			Lack of association of MRI determined subclinical cardiovascular disease with dizziness and vertigo in a cross-sectional population-based study	PLOS ONE			English	Article							CAROTID-ARTERY; EPIDEMIOLOGY; OCCLUSION; LESIONS; STROKE; COMMON	Objective We investigated the association between subclinical cardiovascular diseases assessed by MRI examination and symptoms of dizziness and vertigo in participants of a population-based sample. Methods Data from 400 participants (169 women) aged from 39 to 73 of a cross-sectional MRI sub-study of the "Kooperative Gesundheitsforschung in der Region Augsburg" (KORA) FF4 study from the south of Germany was used. MRI determined subclinical cardiovascular diseases include left and right ventricular structure and function as well as the presence of carotid plaque and carotid wall thickness. Cerebrum diseases include white matter lesions (WML) and cerebral microbleeds (CMB). The main outcomes of dizziness and vertigo were assessed by standardized interview. Logistic regression models were applied and adjusted odds ratios (OR) with 95% confidence intervals (CI) were provided. Results Lifetime and 12-month prevalence of dizziness and vertigo were 30% (95% CI 26% to 35%) and 21% (95% CI 17% to 26%) respectively in this sample. On multivariable analysis, cardiac and carotid measurements were not associated with dizziness and vertigo excluding orthostatic vertigo (20%, 95CI 16% to 24%). Only in male participants, there was a significant association between WML and the presence of dizziness and vertigo (OR = 2.95, 95% CI 1.08 to 8.07). There was no significant association of CMB with dizziness and vertigo. However, CMB and WML were tending to associate with a higher risk of dizziness and vertigo in the whole sample (CMB: OR = 1.48, 95% CI 0.70; 3.15; WML: OR = 1.71, 95% CI 0.80 to 3.67;), in persons with prediabetes and diabetes (WML: OR = 2.71, 95% CI 0.89 to 8.23) and in men with normal glucose metabolism (CMB: OR = 2.60, 95% CI 0.56 to 12.0; WML: OR = 3.08, 95% CI 0.58 to 16.5). Conclusions In this sample of participants without manifest cardiovascular diseases, subclinical left and right ventricular function and carotid structure were consistently not associated with dizziness and vertigo. Subclinical cerebrum measurements, however, tend to increase the risk for dizziness and vertigo, especially in men and in persons with prediabetes or diabetes.	[Lorbeer, Roberto; Hetterich, Holger; Schafnitzel, Anina; Patscheider, Hannah; Schindler, Andreas; Mueller-Peltzer, Katharina; Sommer, Wieland; Bamberg, Fabian] Univ Hosp, LMU Munich, Dept Radiol, Munich, Germany; [Strobl, Ralf; Grill, Eva] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Peters, Annette; Meisinger, Christa; Heier, Margit] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Peters, Annette] German Ctr Diabet Res DZD EV, Neuherberg, Germany; [Peters, Annette] German Ctr Cardiovasc Dis Res DZHK EV, Munich, Germany; [Meisinger, Christa] UNIKA T Augsburg, LMU Munich, Chair Epidemiol, Augsburg, Germany; [Heier, Margit] Cent Hosp Augsburg, KORA Myocardial Infarct Registry, Augsburg, Germany; [Rathmann, Wolfgang] German Diabet Ctr, Dept Biometr & Epidemiol, Dusseldorf, Germany; [Bamberg, Fabian] Eberhard Karls Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Grill, Eva] Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Grill, Eva] Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci MC Hlth, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; University of Munich; Deutsches Diabetes-Zentrum (DDZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich	Lorbeer, R (corresponding author), Univ Hosp, LMU Munich, Dept Radiol, Munich, Germany.	roberto.lorbeer@med.uni-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Peters, Annette/A-6117-2011; Grill, Eva/AAF-8104-2020	Peters, Annette/0000-0001-6645-0985; Grill, Eva/0000-0002-0273-7984	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat as part of LM Uinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft); Siemens Healthcare; German Federal Ministry of Education and Research [01E01401]	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat as part of LM Uinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Siemens Healthcare(Siemens AG); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The KORAMRI sub-study received funding by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft). The KORA-MRI sub study was supported by an unrestricted research grant from Siemens Healthcare. Research on vertigo was supported by funds from the German Federal Ministry of Education and Research under the Grant Code 01E01401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad H, 2015, J NEUROL SCI, V358, P428, DOI 10.1016/j.jns.2015.09.006; Bamberg F, 2017, DIABETES, V66, P158, DOI 10.2337/db16-0630; Barin K, 2011, OTOLARYNG CLIN N AM, V44, P437, DOI 10.1016/j.otc.2011.01.013; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Du Bois D, 1989, Nutrition, V5, P303; Fernandez L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00144; Fujishima M, 2000, INTERNAL MED, V39, P727, DOI 10.2169/internalmedicine.39.727; Gillett RC, 2011, AM FAM PHYSICIAN, V83, P879; Grover S, 2011, J NUCL CARDIOL, V18, P351, DOI 10.1007/s12350-010-9334-z; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Kerwin William, 2007, Top Magn Reson Imaging, V18, P371; Komiyama M, 2006, SURG NEUROL, V66, P513, DOI 10.1016/j.surneu.2006.02.037; Kroenke K, 2000, SOUTH MED J, V93, P160; Lai SL, 2005, J NEUROL SCI, V238, P101, DOI 10.1016/j.jns.2005.06.012; Mueller M, 2014, QUAL LIFE RES, V23, P2301, DOI 10.1007/s11136-014-0684-x; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Pollak L, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.402; Post RE, 2010, AM FAM PHYSICIAN, V82, P361; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; Stevens KN, 2008, AGE AGEING, V37, P300, DOI 10.1093/ageing/afn019; Tabara Y, 2015, STROKE, V46, P16, DOI 10.1161/STROKEAHA.114.006704; Tarnutzer AA, 2011, CAN MED ASSOC J, V183, P1025, DOI 10.1503/cmaj.100174; Tehrani ASS, 2014, NEUROLOGY, V83, P169, DOI 10.1212/WNL.0000000000000573; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184858	10.1371/journal.pone.0184858	http://dx.doi.org/10.1371/journal.pone.0184858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910373	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200109
J	Ni, X; Wang, A; Zhang, L; Shan, LY; Zhang, HC; Li, L; Si, JQ; Luo, J; Li, XZ; Ma, KT				Ni, Xin; Wang, Ai; Zhang, Liang; Shan, Li-ya; Zhang, Hai-chao; Li, Li; Si, Jun-qiang; Luo, Jian; Li, Xin-zhi; Ma, Ke-tao			Up-regulation of gap junction in peripheral blood T lymphocytes contributes to the inflammatory response in essential hypertension	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; IMMUNE-SYSTEM; CELL-ACTIVATION; SEX-DIFFERENCES; RAT MODEL; CONNEXINS; EXPRESSION; PRESSURE; CHANNELS; HEMICHANNELS	Inflammation has been shown to play an important role in the mechanisms involved in the pathogenesis of hypertension. Connexins (Cxs)-based gap junction channels (GJCs) or hemichannels (HCs) are involved in the maintenance of homeostasis in the immune system. However, the role of Cx43-based channels in T lymphocytes in mediating the immune response in essential hypertension is not fully understand. The present study was designed to investigate the role of Cxs-based channels in T-lymphocytes in the regulation of hypertension-mediated inflammation. The surface expressions of T lymphocyte subtypes, Cx40/Cx43, and inflammatory cytokines (IFN-gamma (interferon-gamma) and TNF-alpha (tumor necrosis factor alpha)) in T cells, as well as gap junction communication of peripheral blood lymphocytes from essential hypertensive patients (EHs) and normotensive healthy subjects (NTs) were detected by flow cytometry. Expression levels and phosphorylation of Cx43 protein in peripheral blood lymphocytes of EHs and NTs were analyzed by Western blot. The proliferation rate of peripheral blood mononuclear cells (PBMCs) after treatment with a Cxs inhibitor was examined by a CCK-8 assay. The levels of inflammatory cytokines were detected using ELISA. Within the CD3(+) T cell subsets, we found a significant trend toward an increase in the percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio as well as in serum levels of IFN-gamma and TNF-alpha in the peripheral blood of EHs compared with those in NTs. Moreover, the peripheral blood lymphocytes of EH patients exhibited enhanced GJCs formation, increased Cx43 protein level and Cx43 phosphorylation at Ser368, and a significant increase in Cx40/Cx43 surface expressions levels in CD4(+)or CD8(+) T lymphocytes. Cx43-based channel inhibition by a mimetic peptide greatly reduced the exchange of dye between lymphocytes, proliferation of stimulated lymphocytes and the pro-inflammatory cytokine levels of EHs and NTs. Our data suggest that Cx40/Cx43-based channels in lymphocytes may be involved in the regulation of T lymphocyte proliferation and the production of proinflammatory cytokines, which contribute to the hypertensive inflammatory response.	[Ni, Xin; Wang, Ai; Zhang, Liang; Shan, Li-ya; Zhang, Hai-chao; Li, Li; Si, Jun-qiang; Li, Xin-zhi; Ma, Ke-tao] Shihezi Univ, Med Coll, Dept Physiol, Shihezi, Xinjiang, Peoples R China; [Ni, Xin; Wang, Ai; Zhang, Liang; Shan, Li-ya; Zhang, Hai-chao; Li, Li; Si, Jun-qiang; Ma, Ke-tao] Shihezi Univ, Med Coll, Key Lab Xingjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Luo, Jian] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Li, Xin-zhi] Shihezi Univ, Med Coll, Dept Pathophysiol, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Xinjiang Medical University; Shihezi University	Li, XZ; Ma, KT (corresponding author), Shihezi Univ, Med Coll, Dept Physiol, Shihezi, Xinjiang, Peoples R China.; Ma, KT (corresponding author), Shihezi Univ, Med Coll, Key Lab Xingjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.; Luo, J (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.; Li, XZ (corresponding author), Shihezi Univ, Med Coll, Dept Pathophysiol, Shihezi, Xinjiang, Peoples R China.	docsummer@163.com; lixinzhi@shzu.edu.cn; maketao@hotmail.com			National Natural Science Foundation of China [81660271, 81460098, 81560081, 81600325]; International Cooperation Project of Shihezi University [GJHZ201603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Shihezi University	This work was supported by the grants from the National Natural Science Foundation of China (nos. 81660271 to Ke-Tao Ma, 81460098 to Xin-Zhi Li, 81560081 to Jun-Qiang Si and 81600325 to Liang Zhang); and International Cooperation Project of Shihezi University (nos. GJHZ201603 to Ke-tao Ma).	Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Bermudez-Fajardo A, 2007, J LEUKOCYTE BIOL, V82, P608, DOI 10.1189/jlb.0307134; Corvalan LA, 2007, J CELL PHYSIOL, V211, P649, DOI 10.1002/jcp.20971; Cruciani V, 2002, BIOL CELL, V94, P433, DOI 10.1016/S0248-4900(02)00014-X; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Elgueta R, 2009, J IMMUNOL, V183, P277, DOI 10.4049/jimmunol.0801854; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Gooch JL, 2014, CURR OPIN NEPHROL HY, V23, P473, DOI 10.1097/MNH.0000000000000052; Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006; Leibowitz A, 2011, CURR HYPERTENS REP, V13, P465, DOI 10.1007/s11906-011-0224-9; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mattson DL, 2006, HYPERTENSION, V48, P149, DOI 10.1161/01.HYP.0000228320.23697.29; Mendoza-Naranjo A, 2011, J IMMUNOL, V187, P3121, DOI 10.4049/jimmunol.1100378; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oviedo-Orta E, 2000, IMMUNOLOGY, V99, P578, DOI 10.1046/j.1365-2567.2000.00991.x; Oviedo-Orta E, 2002, CELL BIOL INT, V26, P253, DOI 10.1006/cbir.2001.0840; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Oviedo-Orta E, 2010, J LEUKOCYTE BIOL, V88, P79, DOI 10.1189/jlb.0909613; Pruijm M, 2013, J HUM HYPERTENS, V27, P169, DOI 10.1038/jhh.2012.12; Rajnai H, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/528098; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Rodriguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191, DOI 10.1152/ajprenal.0197.2001; Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004; Saez PJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/742734; Singh MV, 2014, IMMUNOL RES, V59, P243, DOI 10.1007/s12026-014-8548-6; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stout RF, 2015, J BIOL CHEM, V290, P23497, DOI 10.1074/jbc.M115.659979; Su V, 2014, FEBS LETT, V588, P1212, DOI 10.1016/j.febslet.2014.01.013; Tian N, 2007, AM J PHYSIOL-HEART C, V292, pH1018, DOI 10.1152/ajpheart.00487.2006; Tinsley JH, 2009, AM J HYPERTENS, V22, P1107, DOI 10.1038/ajh.2009.125; Tipton AJ, 2014, CLIN THER, V36, P1882, DOI 10.1016/j.clinthera.2014.07.011; Tittarelli A, 2014, J IMMUNOL, V192, P1313, DOI 10.4049/jimmunol.1301297; Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013; Trott DW, 2014, HYPERTENSION, V64, P1108, DOI 10.1161/HYPERTENSIONAHA.114.04147; Wallace K, 2014, HYPERTENS PREGNANCY, V33, P41, DOI 10.3109/10641955.2013.835820; Wallace K, 2011, HYPERTENSION, V57, P949, DOI 10.1161/HYPERTENSIONAHA.110.168344; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Willebrords J, 2016, CRIT REV BIOCHEM MOL, V51, P413, DOI 10.1080/10409238.2016.1204980; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441	43	18	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184773	10.1371/journal.pone.0184773	http://dx.doi.org/10.1371/journal.pone.0184773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910394	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200093
J	Lee, M; Um, H; Van Dyke, MW				Lee, Minwoo; Um, Hyejin; Van Dyke, Michael W.			Identification and characterization of preferred DNA-binding sites for the Thermus thermophilus transcriptional regulator FadR	PLOS ONE			English	Article							COMBINATORIAL METHOD REPSA; ESCHERICHIA-COLI; SEQUENCE SPECIFICITY; COMPARATIVE GENOMICS; PROTEIN COMPLEXES; GENE-EXPRESSION; HB8; METABOLISM; SELECTION; DATABASE	One of the primary transcriptional regulators of fatty acid homeostasis in many prokaryotes is the protein FadR. To better understand its biological function in the extreme thermophile Thermus thermophilus HB8, we sought to first determine its preferred DNA-binding sequences in vitro using the combinatorial selection method Restriction Endonuclease Protection, Selection, and Amplification (REPSA) and then use this information to bioinformatically identify potential regulated genes. REPSA determined a consensus FadR-binding sequence 5'-TTRNACYNRGTNYAA-3', which was further characterized using quantitative electrophoretic mobility shift assays. With this information, a search of the T. thermophilus HB8 genome found multiple operons potentially regulated by FadR. Several of these were identified as encoding proteins involved in fatty acid biosynthesis and degradation; however, others were novel and not previously identified as targets of FadR. The role of FadR in regulating these genes was validated by physical and functional methods, as well as comparative genomic approaches to further characterize regulons in related organisms. Taken together, our study demonstrates that a systematic approach involving REPSA, biophysical characterization of protein-DNA binding, and bioinformatics can be used to postulate biological roles for potential transcriptional regulators.	[Lee, Minwoo; Um, Hyejin; Van Dyke, Michael W.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University	Van Dyke, MW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	mvandyk2@kennesaw.edu	Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002	US National Institutes of Health [1R15GM104833-01]; US National Science Foundation [DBI 1624654, MCB 1714778]; Kennesaw State University Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104833] Funding Source: NIH RePORTER; Direct For Biological Sciences [1624654] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Kennesaw State University Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the US National Institutes of Health ([http://]www.nih.gov, Grant 1R15GM104833-01, MVD), the US National Science Foundation ([http://]www.nsf.gov, Grant DBI 1624654 and Grant MCB 1714778, MVD), and the Kennesaw State University Foundation ([http://] www.kennesaw.edu/foundation/, Foundation Fellow in Biochemistry, MVD). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2013, PROTEINS, V81, P1166, DOI 10.1002/prot.24266; Agari Y, 2012, J BACTERIOL, V194, P4630, DOI 10.1128/JB.00668-12; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BECK CF, 1988, MICROBIOL REV, V52, P318, DOI 10.1128/MMBR.52.3.318-326.1988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Charoensawan V, 2010, NUCLEIC ACIDS RES, V38, P7364, DOI 10.1093/nar/gkq617; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Gopal YNV, 2003, BIOCHEMISTRY-US, V42, P6891, DOI 10.1021/bi027373s; Hardenbol P, 1996, P NATL ACAD SCI USA, V93, P2811, DOI 10.1073/pnas.93.7.2811; Hardenbol P, 1997, NUCLEIC ACIDS RES, V25, P3339, DOI 10.1093/nar/25.16.3339; Hardenbol P, 1997, BIOCONJUGATE CHEM, V8, P617, DOI 10.1021/bc970066s; Iwanaga N, 2014, EXTREMOPHILES, V18, P995, DOI 10.1007/s00792-014-0669-2; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; McGuire AM, 2000, NUCLEIC ACIDS RES, V28, P4523, DOI 10.1093/nar/28.22.4523; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Perez-Rueda E, 2015, COMPUT BIOL CHEM, V58, P93, DOI 10.1016/j.compbiolchem.2015.06.002; Perez-Rueda Ernesto, 2012, Science Progress, V95, P315, DOI 10.3184/003685012X13420097673409; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Sakamoto K, 2011, J BACTERIOL, V193, P4388, DOI 10.1128/JB.05203-11; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Shen J, 2001, BIOORGAN MED CHEM, V9, P2285, DOI 10.1016/S0968-0896(01)00146-8; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Solovjev V, 2011, METAGENOMICITAPP, P61; Sunavala-Dossabhoy G, 2005, BIOCHEMISTRY-US, V44, P2510, DOI 10.1021/bi047877l; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Takano H, 2014, MICROBIOL-SGM, V160, P2650, DOI 10.1099/mic.0.082263-0; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Dyke MW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159408; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zhang YM, 2009, J LIPID RES, V50, pS115, DOI 10.1194/jlr.R800046-JLR200; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	47	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184796	10.1371/journal.pone.0184796	http://dx.doi.org/10.1371/journal.pone.0184796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902898	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200070
J	Waeber, PO; Gardner, CJ; Lourenco, WR; Wilme, L				Waeber, Patrick O.; Gardner, Charlie J.; Lourenco, Wilson R.; Wilme, Lucienne			On specimen killing in the era of conservation crisis - A quantitative case for modernizing taxonomy and biodiversity inventories	PLOS ONE			English	Article							NATIONAL-DHISTOIRE-NATURELLE; MOUSE LEMURS MICROCEBUS; OF-NATURAL-HISTORY; RODENTS MUROIDEA; MAMMALIAN FAUNA; MADAGASCAR; COLLECTIONS; DIVERSITY; BIRDS; NESOMYINAE	Background to the work For centuries taxonomy has relied on dead animal specimens, a practice that persists today despite the emergence of innovative biodiversity assessment methods. Taxonomists and conservationists are engaged in vigorous discussions over the necessity of killing animals for specimen sampling, but quantitative data on taxonomic trends and specimen sampling over time, which could inform these debates, are lacking. Methods We interrogated a long-term research database documenting 2,723 land vertebrate and 419 invertebrate taxa from Madagascar, and their associated specimens conserved in the major natural history museums. We further compared specimen collection and species description rates for the birds, mammals and scorpions over the last two centuries, to identify trends and links to taxon descriptions. Results We located 15,364 specimens documenting endemic mammals and 11,666 specimens documenting endemic birds collected between 1820 and 2010. Most specimens were collected at the time of the Mission Zoologique Franco-Anglo-Ame A ricaine (MZFAA) in the 1930s and during the last two decades, with major differences according to the groups considered. The small mammal and bat collections date primarily from recent years, and are paralleled by the description of new species. Lemur specimens were collected during the MZFAA but the descriptions of new taxa are recent, with the type series limited to non-killed specimens. Bird specimens, particularly of non-passerines, are mainly from the time of the MZFAA. The passerines have also been intensely collected during the last two decades; the new material has been used to solve the phylogeny of the groups and only two new endemic taxa of passerine birds have been described over the last two decades. Conclusions Our data show that specimen collection has been critical for advancing our understanding of the taxonomy of Madagascar's biodiversity at the onset of zoological work in Madagascar, but less so in recent decades. It is crucial to look for alternatives to avoid killing animals in the name of documenting life, and encourage all efforts to share the information attached to historical and recent collections held in natural history museums. In times of conservation crisis and the advancement in digital technologies and open source sharing, it seems obsolete to kill animals in well-known taxonomic groups for the sake of enriching natural history collections around the world.	[Waeber, Patrick O.] ETH, Dept ITES, Forest Management & Dev ForDev Grp, Univ Str 16, Zurich, Switzerland; [Gardner, Charlie J.] Univ Kent, DICE, Canterbury, Kent, England; [Lourenco, Wilson R.] UPMC, Muse Natl Hist Nat, Sorbonne Univ,MNHN,EPHE, Inst Systemat Evolut Biodiversite ISYEB,UMR7205,C, CP 53,57 Rue Cuvier, Paris, France; [Wilme, Lucienne] Missouri Bot Garden, Madagascar Res & Conservat Program, Antananarivo 101, Madagascar; [Wilme, Lucienne] World Resources Inst, Washington, DC 20006 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kent; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Missouri Botanical Gardens	Waeber, PO (corresponding author), ETH, Dept ITES, Forest Management & Dev ForDev Grp, Univ Str 16, Zurich, Switzerland.; Wilme, L (corresponding author), Missouri Bot Garden, Madagascar Res & Conservat Program, Antananarivo 101, Madagascar.; Wilme, L (corresponding author), World Resources Inst, Washington, DC 20006 USA.	patrick.waeber@usys.ethz.ch; lucienne.wilme@mobot-mg.org	Waeber, Patrick O./A-3649-2016; Wilmé, Lucienne/AAQ-6653-2020; Wilmé, Lucienne/A-3818-2016	Waeber, Patrick O./0000-0002-3229-0124; Wilmé, Lucienne/0000-0002-8344-1957; Wilmé, Lucienne/0000-0002-8344-1957; Gardner, Charlie/0000-0002-2750-3690				ANDRIANTOMPOHAV.R, 2007, SPECIAL PUBLICATIONS, V51, P1; Bartlett Edward, 1875, Proceedings of the Zoological Society, P62; BENGTSON SA, 1984, AUK, V101, P1; BENSON C W, 1970, Bulletin of the British Ornithologists' Club, V90, P168; BENSON C W, 1971, Bulletin of the British Ornithologists' Club, V91, P1; Benson CW, 1999, B BRIT ORNITHOLOGIST; Berner PO, 1997, AKONNY ALA, V20, P2; Blagoderov V, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.209.3178; Buettner-Janusch J, 1985, AM MUS NOVIT, V2834, P1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CARLETON M D, 1990, American Museum Novitates, P1; Carleton MD, 2014, P BIOL SOC WASH, V126, P414, DOI 10.2988/0006-324X-126.4.414; Carleton Michael D., 1996, Fieldiana Zoology, V85, P231; Carleton Michael D., 1994, American Museum Novitates, V3087, P1; Ceriaco LMP, 2016, ZOOTAXA, V4196, P435, DOI 10.11646/zootaxa.4196.3.9; Cianferoni F, 2016, ZOOTAXA, V4139, P128, DOI 10.11646/zootaxa.4139.1.8; Cibois A, 2010, ZOOTAXA, P65, DOI 10.11646/zootaxa.2554.1.6; Collen Ben, 2013, P71; Dekker R.W.R.J., 2003, NNM Technical Bulletin, V6, P1; DELACOUR J., 1932, OISEAU ET REV FRANC ORNITHOL, V2, P1; Filardi C. E., 2015, WHY I COLLECTED MOUS; Fontaine B, 2012, CURR BIOL, V22, pR943, DOI 10.1016/j.cub.2012.10.029; Frasier Cynthia L., 2016, Primate Conservation, V30, P59; Goodman SM, 1996, FIELDIANA ZOOLOGY, V85, P1; Goodman Steven M., 2000, Fieldiana Zoology, V97, P1; Goodman Steven M., 2009, Bonner Zoologische Beitraege, V56, P133; Gray GR, 1869, TRUSTEES BRIT MUSEUM, Vi-xx, P1; Gray GR, 1871, TRUSTEES BRIT MUSEUM, p[i, 1]; Gray GR, 1870, TRUSTEES BRIT MUSEUM, Vi-xv, P1; Gutierrez EE, 2017, SCIENCE, V355, P1275, DOI 10.1126/science.aan0926; HABERMAN Karen L., 2015, J NATURAL HIST ED EX, V9, P8; Hebert P. D., 2013, PLOS ONE, V10; Helgen KM, 2011, SCIENCE, V334, P458, DOI 10.1126/science.1214544; HELLMAYR C. E., 1928, AUK, V45, P293; Hertu O, 2001, BIODIVERSITE BIOTYPO, P361; Hotaling S, 2016, MOL ECOL, V25, P2029, DOI 10.1111/mec.13604; Ito Ryo, 2013, Madagascar Conservation & Development, V8, P45; IUCN, 2021, WIKIPEDIA; Jenkins P.D., 1987, CATALOGUE PRIMATES B; Jenkins PD, 2005, J NAT HIST, V39, P1779, DOI 10.1080/00222930400023719; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Jiguet Frederic, 2002, Bulletin of the British Ornithologists' Club, V122, P50; Kappeler P.M., 2005, Primate Report, V71, P3; Krell FT, 2014, SCIENCE, V344, P815, DOI 10.1126/science.344.6186.815; LeCroy M, 2005, B AM MUS NAT HIST, P1; LeCroy M, 2003, B AM MUS NAT HIST, P1; Lei Runhua, 2015, Primate Conservation, V29, P43; Lei Runhua, 2008, Texas Tech University Museum Special Publications, V53, P1; Lesson RP, 1831, ANN SCI NATURELLES, V22, P421; Lobl Ivan, 2016, Bulletin of Zoological Nomenclature, V73, P83; LONNBERG EINAR, 1926, AUK, V43, P434; Louis Jr E.E., 2006, SPECIAL PUBLICATIONS, V49, P1; Lourenco W. R., 2010, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V15, P173; Lourenco Wilson R., 2003, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V14, P129; Lourenco WR, 1996, MUSEUM NATL HIST NAT; Lourenco WR, 2016, COMPTES RENDUS BIOL, V339, P427; Menegaux MA, 1907, B MUSEUM HIST NATURE, V13, P104; Mercier J.-R., 2006, MADAGASCAR CONSERVAT, V1, P50, DOI [10.4314/mcd.v1i1.44122, DOI 10.4314/MCD.V1I1.44122]; MILON PH, 1951, NAT MALGACHE, V3, P167; Minteer BA, 2014, SCIENCE, V344, P260, DOI 10.1126/science.1250953; Moratelli R, 2014, ZOOLOGIA-CURITIBA, V31, P413, DOI 10.1590/S1984-46702014000500001; Ostende Hoek, 1997, NATL NATUURHIST MUS, V1, P1; Pape T, 2016, NATURE, V537, P307, DOI 10.1038/537307b; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Pucheran J., 1849, REV MAGASIN ZOOLOGIE, V12, P17; Radespiel U, 2008, AM J PRIMATOL, V70, P1033, DOI 10.1002/ajp.20592; Rand A. L., 1936, Bulletin of the American Museum of Natural History, V72, P143; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Richmond CW, 1897, P US NATL MUS, V19, P677; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Rodriguez-Estrella R, 2006, BIODIVERS CONSERV, V15, P1621, DOI 10.1007/s10531-004-4308-6; Rosauer DF, 2015, GLOBAL ECOL BIOGEOGR, V24, P168, DOI 10.1111/geb.12237; Roselaar C. S., 2003, Bulletin of the British Ornithologists' Club, V123A, P253; Garraffoni ARS, 2017, SCIENCE, V355, P805, DOI 10.1126/science.aam7686; Seregin AP, 2016, TAXON, V65, P206; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Tattersall Ian, 2013, Madagascar Conservation & Development, V8, P7; Thalmann U, 2000, INT J PRIMATOL, V21, P915, DOI 10.1023/A:1005507028567; Thiele D, 2013, MOL PHYLOGENET EVOL, V69, P593, DOI 10.1016/j.ympev.2013.07.019; Umetsu F, 2006, J MAMMAL, V87, P757, DOI 10.1644/05-MAMM-A-285R2.1; Voisin C., 1991, Oiseau et la Revue Francaise d'Ornithologie, V61, P341; Voisin C, 1999, MAMMALIA, V63, P535; Voisin C, 2008, ZOOSYSTEMA, V30, P463; Voisin Claire, 1993, Oiseau et la Revue Francaise d'Ornithologie, V63, P45; Voisin Claire, 2008, Journal of the National Museum Prague Natural History Series, V177, P1; Voisin Claire, 2001, Zoosystema, V23, P173; Waeber PO, 2015, INT FOREST REV, V17, P127, DOI 10.1505/146554815815834822; Waeber PO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161115; Wakeham-Dawson Andrew, 2002, Bulletin of Zoological Nomenclature, V59, P282; Wilme L, 1996, COLLOQ SEMI, P349; WILME L, 1994, BIOL CONSERV, V69, P15, DOI 10.1016/0006-3207(94)90324-7; Wilme Lucienne, 2012, Madagascar Conservation &  Development, V7, P30, DOI 10.4314/mcd.v7i1.6; Wilson D. E., 2005, MAMMAL SPECIES WORLD; World Wide Fund for Nature, 2016, LIV PLAN REP 2016; WOZENCRAFT WC, 1986, J MAMMAL, V67, P561, DOI 10.2307/1381288	95	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183903	10.1371/journal.pone.0183903	http://dx.doi.org/10.1371/journal.pone.0183903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902889	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000410669200023
J	Romo-Munoz, RA; Cabas-Monje, JH; Garrido-Henrriquez, HM; Gil, JM				Alejandro Romo-Munoz, Rodrigo; Hernan Cabas-Monje, Juan; Manuel Garrido-Henrriquez, Hector; Maria Gil, Jose			Heterogeneity and nonlinearity in consumers' preferences: An application to the olive oil shopping behavior in Chile	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CHOICE EXPERIMENTS; QUALITY; PURCHASE; PRICE; INFERENCE; ORIGIN; LABELS	In relatively unknown products, consumers use prices as a quality reference. Under such circumstances, the utility function can be non-negative for a specific price range and generate an inverted U-shaped function. The extra virgin olive oil market in Chile is a good example. Although domestic production and consumption have increased significantly in the last few years, consumer knowledge of this product is still limited. The objective of this study was to analyze Chilean consumer preferences and willingness to pay for extra virgin olive oil attributes. Consumers were segmented taking into account purchasing frequency. A Random Parameter Logit model was estimated for preference heterogeneity. Results indicate that the utility function is nonlinear allowing us to differentiate between two regimes. In the first regime, olive oil behaves as a conspicuous good, that is, higher utility is assigned to higher prices and consumers prefer foreign products in smaller containers. Under the second regime, Chilean olive oil in larger containers is preferred.	[Alejandro Romo-Munoz, Rodrigo; Hernan Cabas-Monje, Juan; Manuel Garrido-Henrriquez, Hector] Univ Bio Bio, Business Management Dept, Agribusiness Res Grp, Chillan, Chile; [Maria Gil, Jose] Ctr Agrofood Econ & Dev CREDA UPC IRTA, Parc Mediterrani Tecnol,Edifici ESAB, Barcelona, Spain	Universidad del Bio-Bio; IRTA	Gil, JM (corresponding author), Ctr Agrofood Econ & Dev CREDA UPC IRTA, Parc Mediterrani Tecnol,Edifici ESAB, Barcelona, Spain.	chema.gil@upc.edu	GIL, Jose M./B-2699-2012	GIL, Jose M./0000-0003-3313-9052; Romo Munoz, Rodrigo/0000-0001-6839-8834; Garrido Henriquez, Hector Manuel/0000-0002-9560-8267	University of Bio Bio	University of Bio Bio	This work was supported by the Research Council at the University of Bio Bio.	Alfnes F, 2006, AM J AGR ECON, V88, P1050, DOI 10.1111/j.1467-8276.2006.00915.x; Bernabeu R, 2009, GRASAS ACEITES, V60, P525, DOI 10.3989/gya.053409; Camarena D. M., 2004, Economia Agraria y Recursos Naturales, V4, P105; Campbell J, 2014, INT J HOSP MANAG, V42, P39, DOI 10.1016/j.ijhm.2014.05.014; Chan-Halbrendt C, 2010, INT FOOD AGRIBUS MAN, V13, P55; Chang JB, 2009, AM J AGR ECON, V91, P518, DOI 10.1111/j.1467-8276.2008.01242.x; Cicia G., 2011, International Journal on Food System Dynamics, V2, P106; Costanigro M, 2014, FOOD QUAL PREFER, V31, P81, DOI 10.1016/j.foodqual.2013.08.002; Cronley ML, 2005, J CONSUM PSYCHOL, V15, P159, DOI 10.1207/s15327663jcp1502_8; de-Magistris T, 2014, SPAN J AGRIC RES, V12, P529, DOI 10.5424/sjar/2014123-4499; Del Giudice T, 2015, AGR FOOD EC, DOI [10.1186/s40100-015-0034-5, DOI 10.1186/S40100-015-0034-5]; dell'Olio L, 2011, TRANSPORT RES C-EMER, V19, P1060, DOI 10.1016/j.trc.2011.06.004; Denver S, 2014, FOOD QUAL PREFER, V31, P129, DOI 10.1016/j.foodqual.2013.08.014; Ding M, 2005, J MARKETING RES, V42, P67, DOI 10.1509/jmkr.42.1.67.56890; Fotopoulos C, 2001, J INT FOOD AGRIBUS M, V12, P1, DOI 10.1300/J047v12n01_01; Grunert KG, 2015, FOOD QUAL PREFER, V42, P37, DOI 10.1016/j.foodqual.2015.01.001; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; INE, 2011, SANTIAGO; Jimenez-Guerrero J, INTECH, DOI DOI 10.5772/30390; Johnson R. L., 1988, ADV CONSUM RES, V15, P316; Judd VC, 2000, J FOOD PROD MARK, V6, P11, DOI 10.1300/J038v06n01_02; Kallas Z, 2012, APPETITE, V58, P285, DOI 10.1016/j.appet.2011.09.017; Kallas Z, 2011, FOOD QUAL PREFER, V22, P181, DOI 10.1016/j.foodqual.2010.09.010; Kapaj A, 2013, J FOOD AGRIC ENVIRON, V11, P76; Krystallis A., 2005, INT FOOD AGRIBUS MAN, V8, P62, DOI [10.22004/ag.econ.8161, DOI 10.22004/AG.ECON.8161]; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2013, SOC SCI MED, V76, P74, DOI 10.1016/j.socscimed.2012.10.007; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Lusk J.L., 2007, EXPT AUCTIONS METHOD; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Marian L, 2014, FOOD QUAL PREFER, V37, P52, DOI 10.1016/j.foodqual.2014.05.001; Martinez MG, 2002, AGRIBUSINESS, V18, P163, DOI DOI 10.1002/(ISSN)1520-6297; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; Menapace L, 2011, EUR REV AGRIC ECON, V38, P193, DOI 10.1093/erae/jbq051; Mtimet N, 2011, INT C AUG 30 SEP 2 2; Mtimet N, 2006, AGRIBUSINESS, V22, P343, DOI 10.1002/agr.20090; Obermiller C., 1988, ADV CONSUM RES, V15, P304; Panico T., 2014, Agricultural Economics Review, V15, P100; RAO AR, 1989, J MARKETING RES, V26, P351, DOI 10.2307/3172907; Santibanez F, 2008, ANALISIS VULNERABILI; Scarpa R., 2004, Journal of Agricultural & Food Industrial Organization, V2, P7, DOI 10.2202/1542-0485.1080; Scarpa R., 2005, Agribusiness (New York), V21, P329, DOI 10.1002/agr.20051; Scarpa R, 2011, AM J AGR ECON, V93, P809, DOI 10.1093/ajae/aaq174; Scozzafava G, 2016, APPETITE, V96, P70, DOI 10.1016/j.appet.2015.09.004; Sporleder EM, 2014, INT FOOD AGRIBUS MAN, V17, P59; Street D. J., 2007, CONSTRUCTION OPTIMAL; Sundt S, 2015, ENERG ECON, V51, P1, DOI 10.1016/j.eneco.2015.06.005; Tempesta T, 2013, FOOD QUAL PREFER, V27, P35, DOI 10.1016/j.foodqual.2012.06.005; Tempesta T., 2013, INT AGR POLICY, V2, P33; van der Lans IA, 2001, EUR REV AGRIC ECON, V28, P451, DOI 10.1093/erae/28.4.451; Van Loo EJ, 2011, FOOD QUAL PREFER, V22, P603, DOI 10.1016/j.foodqual.2011.02.003; Ward R. W., 2003, Agribusiness (New York), V19, P393, DOI 10.1002/agr.10068; Wu LH, 2015, CHINA ECON REV, V35, P121, DOI 10.1016/j.chieco.2015.07.001; Yangui A, 2016, FOOD QUAL PREFER, V51, P27, DOI 10.1016/j.foodqual.2016.02.012	54	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184585	10.1371/journal.pone.0184585	http://dx.doi.org/10.1371/journal.pone.0184585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892516	Green Submitted, Green Published, gold			2022-12-26	WOS:000410243200018
J	Buhrmann, M; Wiedemann, BM; Muller, MP; Hardick, J; Ecke, M; Rauh, D				Buehrmann, Mike; Wiedemann, Bianca M.; Mueller, Matthias P.; Hardick, Julia; Ecke, Maria; Rauh, Daniel			Structure-based design, synthesis and crystallization of 2-arylquinazolines as lipid pocket ligands of p38 alpha MAPK	PLOS ONE			English	Article							KINASE; INHIBITORS; PROTEIN; BINDING; HYDROPHOBICITY; NUCLEOTIDE; TOOL	In protein kinase research, identifying and addressing small molecule binding sites other than the highly conserved ATP-pocket are of intense interest because this line of investigation extends our understanding of kinase function beyond the catalytic phosphotransfer. Such alternative binding sites may be involved in altering the activation state through subtle conformational changes, control cellular enzyme localization, or in mediating and disrupting protein-protein interactions. Small organic molecules that target these less conserved regions might serve as tools for chemical biology research and to probe alternative strategies in targeting protein kinases in disease settings. Here, we present the structure-based design and synthesis of a focused library of 2-arylquinazoline derivatives to target the lipophilic C-terminal binding pocket in p38 alpha MAPK, for which a clear biological function has yet to be identified. The interactions of the ligands with p38 alpha MAPK was analyzed by SPR measurements and validated by protein X-ray crystallography.	[Buehrmann, Mike; Wiedemann, Bianca M.; Mueller, Matthias P.; Hardick, Julia; Ecke, Maria; Rauh, Daniel] TU Dortmund Univ, Fac Chem & Chem Biol, Dortmund, Germany	Dortmund University of Technology	Rauh, D (corresponding author), TU Dortmund Univ, Fac Chem & Chem Biol, Dortmund, Germany.	daniel.rauh@tu-dortmund.de		Muller, Matthias/0000-0002-1529-8933	German Federal Ministry for Education and Research (NGFNPlus); German Federal Ministry for Education and Research (e:Med) [BMBF 01GS08104, 01ZX1303C]; Deutsche Forschungsgemeinschaft (DFG); European Union [EFRE-800400]; German federal state North Rhine Westphalia (NRW)	German Federal Ministry for Education and Research (NGFNPlus); German Federal Ministry for Education and Research (e:Med); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); German federal state North Rhine Westphalia (NRW)	This work was co-funded by the German Federal Ministry for Education and Research (NGFNPlus and e:Med) (Grant No. BMBF 01GS08104, 01ZX1303C) and by the Deutsche Forschungsgemeinschaft (DFG). https://www.bmbf.de/en/index.html; http://mv.dtp.de/. DR thanks the German federal state North Rhine Westphalia (NRW) and the European Union (European Regional Development Fund: Investing In Your Future) (EFRE-800400).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Biffinger JC, 2004, CHEMBIOCHEM, V5, P622, DOI 10.1002/cbic.200300910; Buehrmann M, 2017, ANGEW CHEM INT EDIT, V56, P13232, DOI 10.1002/anie.201706345; Bukhtiyarova M, 2004, PROTEIN EXPRES PURIF, V37, P154, DOI 10.1016/j.pep.2004.05.017; Cheng R, 2013, SYNTHESIS-STUTTGART, V45, P8; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Comess KM, 2011, ACS CHEM BIOL, V6, P234, DOI 10.1021/cb1002619; Cox KJ, 2011, FUTURE MED CHEM, V3, P29, DOI 10.4155/FMC.10.272; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel J, 2015, J MED CHEM, V58, P6844, DOI 10.1021/acs.jmedchem.5b01082; Getlik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039713; Giet R, 2001, J CELL SCI, V114, P2095; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hour MJ, 2000, J MED CHEM, V43, P4479, DOI 10.1021/jm000151c; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; Nouira I, 2008, TETRAHEDRON LETT, V49, P7033, DOI 10.1016/j.tetlet.2008.09.135; Perry JJP, 2009, J MOL BIOL, V391, P1, DOI 10.1016/j.jmb.2009.06.005; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen ZL, 2011, TETRAHEDRON, V67, P1665, DOI 10.1016/j.tet.2010.12.067; Simard JR, 2010, J AM CHEM SOC, V132, P4152, DOI 10.1021/ja908083e; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Weisner J, 2015, ANGEW CHEM INT EDIT, V54, P10313, DOI 10.1002/anie.201502142; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zhang WX, 2005, ANAL BIOCHEM, V343, P76, DOI 10.1016/j.ab.2005.05.011	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184627	10.1371/journal.pone.0184627	http://dx.doi.org/10.1371/journal.pone.0184627			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892510	Green Published, Green Submitted, gold			2022-12-26	WOS:000410243200020
J	Gasco, S; Zaragoza, P; Garcia-Redondo, A; Calvo, AC; Osta, R				Gasco, Samanta; Zaragoza, Pilar; Garcia-Redondo, Alberto; Calvo, Ana C.; Osta, Rosario			Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR2; HEMATOPOIETIC STEM; PROTEIN ABUNDANCE; MESSENGER-RNA; EXPRESSION; DIFFERENTIATION; MACROPHAGE; SUBSETS; MCP-1; NEUROPROTECTION	Amyotrophic Lateral Sclerosis (ALS) has lately become a suitable scenario to study the interplay between the hematopoietic system and disease progression. Recent studies in C9orf72 null mice have demonstrated that C9orf72 is necessary for the normal function of myeloid cells. In this study, we aimed to analyze in depth the connection between the hematopoietic system and secondary lymphoid (spleen) and non-lymphoid (liver and skeletal muscle) organs and tissues along the disease progression in the transgenic SOD1G93A mice. Our findings suggested that the inflammatory response due to the neurodegeneration in this animal model affected all three organs and tissues, especially the liver and the skeletal muscle. However, the liver was able to compensate this inflammatory response by means of the action of non-inflammatory monocytes, while in the skeletal muscle inflammatory monocytes prompted a further inflammation process until the terminal state of the animals. Interestingly, in blood, a positive correlation was found between non-inflammatory monocytes and survival of the transgenic SOD1G93A mice, while the contrary (a negative correlation) was found in the case of inflammatory monocytes, supporting their potential role as biomarkers of disease progression and survival in this animal model. These findings could prompt future translational studies in ALS patients, promoting the identification of new reliable biomarkers of disease progression.	[Gasco, Samanta; Zaragoza, Pilar; Calvo, Ana C.; Osta, Rosario] Univ Zaragoza, Vet Fac Zaragoza, Hlth Res Inst Aragon IIS, Inst Agroalimentario Aragon,CITA,LAGENBIO, Zaragoza, Spain; [Garcia-Redondo, Alberto] October 12th Hosp, Hlth Res Inst, CIBERER U 723, Biochem Dept, Madrid, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gasco, S (corresponding author), Univ Zaragoza, Vet Fac Zaragoza, Hlth Res Inst Aragon IIS, Inst Agroalimentario Aragon,CITA,LAGENBIO, Zaragoza, Spain.	samantagasco@gmail.com	Osta, Rosario/R-5410-2019; REDONDO, ALBERTO GARCÍA/AAD-9453-2020; zaragoza, pilar/AAN-9479-2021; Calvo, Ana/L-2826-2017	Gasco, Samanta/0000-0002-3318-4286; Calvo, Ana/0000-0001-5193-7782; Osta, Rosario/0000-0001-5687-6704	FIS [PI14/00947]; Institute de Salud Carlos III; FEDER	FIS(Instituto de Salud Carlos III); Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by the Grant FIS (PI14/00947); Institute de Salud Carlos III and FEDER Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Bellavance MA, 2015, BRAIN STRUCT FUNCT, V220, P1759, DOI 10.1007/s00429-014-0759-z; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Breslin WL, 2013, J IMMUNOL METHODS, V390, P1, DOI 10.1016/j.jim.2011.03.005; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Carri MT, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00041; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Eckert C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00179; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Finkelstein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022374; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gupta PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038382; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hu ZT, 2015, J IMMUNOL, V194, P2746, DOI 10.4049/jimmunol.1401928; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jaiswal Manoj Kumar, 2014, Mol Cell Ther, V2, P26, DOI 10.1186/2052-8426-2-26; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jung HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128387; Kan X, 2015, CARDIOVASCULAR RES; King AE, 2016, EXP NEUROL, V275, P162, DOI 10.1016/j.expneurol.2015.09.019; Laferriere F, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14054; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Massberg S, 2009, ANN NY ACAD SCI, V1176, P87, DOI 10.1111/j.1749-6632.2009.04609.x; Mehra A, 2003, BIOTECHNOL BIOENG, V84, P822, DOI 10.1002/bit.10860; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Murdock BJ, 2015, NEUROBIOL DIS, V77, P1, DOI 10.1016/j.nbd.2015.02.017; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Philips T, 2015, CURRENT PROTOCOLS PH, V69; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Vaknin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026921; Van den Bosch L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/348765; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhao WH, 2013, J NEUROIMMUNE PHARM, V8, P888, DOI 10.1007/s11481-013-9489-x	58	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184626	10.1371/journal.pone.0184626	http://dx.doi.org/10.1371/journal.pone.0184626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886177	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100172
J	Jackson, RM; Griesel, BA; Gurley, JM; Szweda, LI; Olson, AL				Jackson, Robert M.; Griesel, Beth A.; Gurley, Jami M.; Szweda, Luke I.; Olson, Ann Louise			Glucose availability controls adipogenesis in mouse 3T3-L1 adipocytes via up-regulation of nicotinamide metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; glucose metabolism; glucose transporter type 4 (GLUT4); lipogenesis; NAD; adipocyte differentiation	ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; RECEPTOR LXR; GLUT4 TRANSCRIPTION; INSULIN SENSITIVITY; GENE-EXPRESSION; TRANSGENIC MICE; FAT; OBESITY; LIVER	Expansion of adipose tissue in response to a positive energy balance underlies obesity and occurs through both hypertrophy of existing cells and increased differentiation of adipocyte precursors (hyperplasia). To better understand the nutrient signals that promote adipocyte differentiation, we investigated the role of glucose availability in regulating adipocyte differentiation and maturation. 3T3-L1 preadipocytes were grown and differentiated in medium containing a standard differentiation hormone mixture and either 4 or 25 mm glucose. Adipocyte maturation at day 9 post-differentiation was determined by key adipocyte markers, including glucose transporter 4 (GLUT4) and adiponectin expression and Oil Red O staining of neutral lipids. We found that adipocyte differentiation and maturation required a pulse of 25 mm glucose only during the first 3 days of differentiation. Importantly, fatty acids were unable to substitute for the 25 mm glucose pulse during this period. The 25 mm glucose pulse increased adiponectin and GLUT4 expression and accumulation of neutral lipids via distinct mechanisms. Adiponectin expression and other early markers of differentiation required an increase in the intracellular pool of total NAD/P. In contrast, GLUT4 protein expression was only partially restored by increased NAD/P levels. Furthermore, GLUT4 mRNA expression was mediated by glucose-dependent activation of GLUT4 gene transcription through the cis-acting GLUT4-liver X receptor element (LXRE) promoter element. In summary, this study supports the conclusion that high glucose promotes adipocyte differentiation via distinct metabolic pathways and independently of fatty acids. This may partly explain the mechanism underlying adipocyte hyperplasia that occurs much later than adipocyte hypertrophy in the development of obesity.	[Jackson, Robert M.; Griesel, Beth A.; Gurley, Jami M.; Szweda, Luke I.; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 26901,Rm 853-BMSB, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Olson, Ann Louise] Oklahoma Med Res Fdn, Program Aging & Metab, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Olson, AL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, POB 26901,Rm 853-BMSB, Oklahoma City, OK 73104 USA.	ann-olson@ouhsc.edu		Gurley, Jami/0000-0002-7919-9328	Harold Hamm Diabetes Center	Harold Hamm Diabetes Center	This manuscript was supported in part by a grant from the Harold Hamm Diabetes Center. The authors declare that they have no conflicts of interest with the contents of this article.	Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Budihardjo II, 1998, CLIN CANCER RES, V4, P117; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Devalaraja-Narashimha K, 2010, J ENDOCRINOL, V205, P242, DOI 10.1677/JOE-09-0402; Erener S, 2012, MOL ENDOCRINOL, V26, P79, DOI 10.1210/me.2011-1163; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; HASSID WZ, 1957, METHOD ENZYMOL, V3, P34, DOI 10.1016/S0076-6879(57)03345-5; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Letexier D, 2003, J LIPID RES, V44, P2127, DOI 10.1194/jlr.M300235-JLR200; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Luo X, 2017, MOL CELL, V65, P260, DOI 10.1016/j.molcel.2016.11.015; MacKellar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008197; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rindler PM, 2016, AM J PHYSIOL-HEART C, V311, pH1091, DOI 10.1152/ajpheart.00066.2016; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shapiro ALB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159575; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weems JC, 2012, DIABETES, V61, P1404, DOI 10.2337/db11-0737; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001	42	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18556	18564		10.1074/jbc.M117.791970	http://dx.doi.org/10.1074/jbc.M117.791970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28916720	Green Published, hybrid			2022-12-26	WOS:000414958100014
J	Zattelman, L; Regev, R; Usaj, M; Reinke, PYA; Giese, S; Samson, AO; Taft, MH; Manstein, DJ; Henn, A				Zattelman, Lilach; Regev, Ronit; Usaj, Marko; Reinke, Patrick Y. A.; Giese, Sven; Samson, Abraham O.; Taft, Manuel H.; Manstein, Dietmar J.; Henn, Arnon			N-terminal splicing extensions of the human MYO1C gene fine-tune the kinetics of the three full-length myosin IC isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MEMBRANE TENSION; INNER-EAR; DUTY RATIO; MOTOR; NUCLEUS; BINDING; TRANSCRIPTION; SENSITIVITY; ACTIN; IDENTIFICATION	The MYO1C gene produces three alternatively spliced isoforms, differing only in their N-terminal regions (NTRs). These isoforms, which exhibit both specific and overlapping nuclear and cytoplasmic functions, have different expression levels and nuclear-cytoplasmic partitioning. To investigate the effect of NTR extensions on the enzymatic behavior of individual isoforms, we overexpressed and purified the three full-length human isoforms from suspension-adapted HEK cells. MYO1C(C) favored the actomyosin closed state (AMC), MYO1C16 populated the actomyosin open state (AMO) and AMC equally, and MYO1C(35) favored theAMOstate. Moreover, the full-length constructs isomerized before ADP release, which has not been observed previously in truncated MYO1CC constructs. Furthermore, global numerical simulation analysis predicted that MYO1C35 populated the actomyosin "ADP closed state (AMDC) 5-fold more than the actomyosin " ADP open state (AMDO) and to a greater degree than MYO1CC and MYO1C(16) (4-and 2-fold, respectively). On the basis of a homology model of the 35-amino acid NTR of MYO1C35 (NTR35) docked to the X-ray structure ofMYO1CC, we predicted thatMYO1C(35)NTRresidue Arg-21 would engage in a specific interaction with post-relay helix residue Glu-469, which affects the mechanics of the myosin power stroke. In addition, we found that adding the NTR35 peptide to MYO1C(C) yielded a protein that transiently mimics MYO1C(35) kinetic behavior. By contrast, NTR35, which harbors the R21G mutation, was unable to confer MYO1C(35)-like kinetic behavior. Thus, the NTRs affect the specific nucleotide-binding properties ofMYO1Cisoforms, adding to their kinetic diversity. We propose that this level of fine-tuning within MYO1C broadens its adaptability within cells.	[Zattelman, Lilach; Regev, Ronit; Usaj, Marko; Henn, Arnon] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Samson, Abraham O.] Bar Ilan Univ, Fac Med Galilee, IL-1311520 Safed, Israel; [Reinke, Patrick Y. A.; Giese, Sven; Taft, Manuel H.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE 4350,Carl Neuberg Str 1, D-30625 Hannover, Germany	Technion Israel Institute of Technology; Bar Ilan University; Hannover Medical School	Henn, A (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel.	arnon.henn@technion.ac.il	Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019; Henn, Arnon/O-1896-2019; Taft, Manuel/O-1396-2019; Taft, Manuel H/T-2508-2017	Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147; Henn, Arnon/0000-0001-6360-7211; Taft, Manuel/0000-0001-5853-8629; Taft, Manuel H/0000-0001-5853-8629; Zattelman, Lilach/0000-0002-2658-9031; Giese, Sven/0000-0003-0984-0543; Reinke, Patrick/0000-0002-7354-0839	Marie Curie Career Integration Grant from the Israeli Scientific Foundation [1403705/11, 296/13]; Volkswagen Stiftung, Niedersachsisches Vorab, Joint Lower Saxony-Israeli Research Projects [VWZN3012]	Marie Curie Career Integration Grant from the Israeli Scientific Foundation; Volkswagen Stiftung, Niedersachsisches Vorab, Joint Lower Saxony-Israeli Research Projects	This work was supported by Marie Curie Career Integration Grant 1403705/11 and Grant 296/13 from the Israeli Scientific Foundation (to A. H.). This work also was supported by the Volkswagen Stiftung, Niedersachsisches Vorab, Joint Lower Saxony-Israeli Research Projects (Grant VWZN3012) (to A. H., M. H. T., and D. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamek N, 2008, P NATL ACAD SCI USA, V105, P5710, DOI 10.1073/pnas.0710520105; Adamek Nancy, 2014, Exp Suppl, V105, P87, DOI 10.1007/978-3-0348-0856-9_5; ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Brandstaetter H, 2012, J CELL SCI, V125, P1991, DOI 10.1242/jcs.097212; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Desmond Molecular Dynamics System, 2017, REL 2017 1; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Greenberg MJ, 2012, P NATL ACAD SCI USA, V109, pE2433, DOI 10.1073/pnas.1207811109; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Ihnatovych I, 2012, CYTOSKELETON, V69, P555, DOI 10.1002/cm.21040; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Lewis JH, 2012, BIOPHYS J, V102, P2799, DOI 10.1016/j.bpj.2012.05.014; Lin TM, 2011, BIOCHEMISTRY-US, V50, P1831, DOI 10.1021/bi1016777; Maly IV, 2016, CYTOSKELETON, V73, P341, DOI 10.1002/cm.21310; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Obrdlik A, 2010, FASEB J, V24, P146, DOI 10.1096/fj.09-135863; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; PUTKEY JA, 1987, METHOD ENZYMOL, V139, P303; Schru┬dinger, 2017, 1 MAESTR; Schwab RS, 2013, EXP CELL RES, V319, P1111, DOI 10.1016/j.yexcr.2013.02.008; Shneyer BI, 2016, J CELL SCI, V129, P543, DOI 10.1242/jcs.175349; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Sielski NL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-8; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Venit T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30864; Venit T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061406; Zuo J, 2002, J NEUROBIOL, V53, P286, DOI 10.1002/neu.10128	53	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17804	17818		10.1074/jbc.M117.794008	http://dx.doi.org/10.1074/jbc.M117.794008			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893906	Green Published, hybrid			2022-12-26	WOS:000414013000018
J	Lin, YS; Bai, Y; Liu, P; Yang, XJ; Qin, W; Gu, JQ; Ding, DG; Tian, J; Wang, MY				Lin, Yusong; Bai, Yan; Liu, Peng; Yang, Xuejuan; Qin, Wei; Gu, Jianqin; Ding, Degang; Tian, Jie; Wang, Meiyun			Alterations in regional homogeneity of resting-state cerebral activity in patients with chronic prostatitis/chronic pelvic pain syndrome	PLOS ONE			English	Article							OPIOID RECEPTOR AVAILABILITY; ANTERIOR CINGULATE CORTEX; NATIONAL-INSTITUTES; SYMPTOM INDEX; BRAIN; HEALTH; ACTIVATION; MECHANISMS; PLACEBO; BINDING	The purpose of this study was to explore the neural mechanism in Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS) using resting-state functional magnetic resonance imaging. The functional magnetic resonance imaging was performed on 31 male CP/CPPS-patients and 31 age and education matched male healthy controls on a 3-T magnetic resonance imaging unit. A two-sample t-test was adopted to reveal the regional homogeneity between the patients and healthy controls. The mean regional homogeneity values in the alerted brain regions of patients were correlated with the clinical measurements by using Pearson's correlation analyses. The CP/CPPS-patients had significantly decreased regional homogeneity in the bilateral anterior cingulate cortices, insular cortices and right medial prefrontal cortex, while significantly increased regional homogeneity in the brainstem and right thalamus compared with the healthy controls. In the CP/CPPSpatients, the mean regional homogeneity value in the left anterior cingulate cortex, bilateral insular cortices and brainstem were respectively correlated with the National Institutes of Health Chronic Prostatitis Symptom Index total score and pain subscale. These brain regions are important in the pain modulation process. Therefore, an impaired pain modulatory system, either by decreased descending pain inhibition or enhanced pain facilitation, may explain the pain symptoms in CP/CPPS.	[Lin, Yusong] Zhengzhou Univ, Cooperat Innovat Ctr Internet Healthcare, Zhengzhou, Henan, Peoples R China; [Lin, Yusong] Zhengzhou Univ, Sch Software & Appl Technol, Zhengzhou, Henan, Peoples R China; [Bai, Yan; Wang, Meiyun] Zhengzhou Univ, Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China; [Bai, Yan; Gu, Jianqin; Ding, Degang; Wang, Meiyun] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Bai, Yan; Wang, Meiyun] Henan Key Lab Med Imaging Neurol Dis, Xinjiang, Peoples R China; [Bai, Yan; Wang, Meiyun] Henan Univ, Med Sch, Zhengzhou, Henan, Peoples R China; [Liu, Peng; Yang, Xuejuan; Qin, Wei] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Gu, Jianqin; Wang, Meiyun] Zhengzhou Univ, Peoples Hosp, Henan Prov Clin Big Data Anal & Serv Engn Res Ctr, Zhengzhou, Henan, Peoples R China; [Ding, Degang] Zhengzhou Univ, Peoples Hosp, Dept Urol, Zhengzhou, Henan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Henan University; Xidian University; Zhengzhou University; Zhengzhou University; Chinese Academy of Sciences; Institute of Automation, CAS	Wang, MY (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China.; Ding, DG; Wang, MY (corresponding author), Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China.; Wang, MY (corresponding author), Henan Key Lab Med Imaging Neurol Dis, Xinjiang, Peoples R China.; Wang, MY (corresponding author), Henan Univ, Med Sch, Zhengzhou, Henan, Peoples R China.; Wang, MY (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Prov Clin Big Data Anal & Serv Engn Res Ctr, Zhengzhou, Henan, Peoples R China.; Ding, DG (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Urol, Zhengzhou, Henan, Peoples R China.; Tian, J (corresponding author), Chinese Acad Sci, Inst Automat, Beijing, Peoples R China.	bghlh2007@126.com; jie.tian@ia.ac.cn; mywang@ha.edu.cn	Tian, Jie/H-1190-2011	Tian, Jie/0000-0003-0498-0432	National Natural Science Foundation of China [31470047, 81641168, 81271565, 81601466, 81271644, 81471811]; Henan Province Scientific and Technological Innovation Talents Project [164200510014]; Henan Province Scientific and Technological Cooperation Project [152106000014]; Key Project of Henan Medical Science and Technology Project [201501011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province Scientific and Technological Innovation Talents Project; Henan Province Scientific and Technological Cooperation Project; Key Project of Henan Medical Science and Technology Project	Research by MW was funded by the National Natural Science Foundation of China (No. 31470047, 81641168 and 81271565), Henan Province Scientific and Technological Innovation Talents Project (No. 164200510014), Henan Province Scientific and Technological Cooperation Project (No. 152106000014) and Key Project of Henan Medical Science and Technology Project (No. 201501011). Research by YB was funded by the National Natural Science Foundation of China (No. 81601466). Research by PL was funded by the National Natural Science Foundation of China (No. 81271644). Research by WQ was funded by the National Natural Science Foundation of China (No. 81471811).	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Bao CH, 2016, PAIN, V157, P1037, DOI 10.1097/j.pain.0000000000000479; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Dunckley P, 2005, NEUROSCIENCE, V133, P533, DOI 10.1016/j.neuroscience.2005.02.041; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Foerster BR, 2012, ARTHRITIS RHEUM-US, V64, P579, DOI 10.1002/art.33339; Gao JJ, 2014, J SEX MED, V11, P3093, DOI 10.1111/jsm.12696; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Jiang LL, 2016, NEUROSCIENTIST, V22, P486, DOI 10.1177/1073858415595004; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; JONES AKP, 1994, BRIT J RHEUMATOL, V33, P909; Kessler TM, 2016, EUR UROL, V69, P298, DOI 10.1016/j.eururo.2015.09.028; Kwon JK, 2013, INT NEUROUROL J, V17, P48, DOI 10.5213/inj.2013.17.2.48; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Li HJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/374828; Liu J, 2013, PAIN, V154, P110, DOI 10.1016/j.pain.2012.09.016; Lui F, 2010, PAIN, V151, P816, DOI 10.1016/j.pain.2010.09.021; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Magistro G, 2016, EUR UROL, V69, P286, DOI 10.1016/j.eururo.2015.08.061; Matthey A, 2013, PAIN PHYSICIAN, V16, pE553; Mochizuki H, 2007, NEUROIMAGE, V36, P706, DOI 10.1016/j.neuroimage.2007.04.003; Mordasini L, 2012, J UROLOGY, V188, P2233, DOI 10.1016/j.juro.2012.08.043; Nickel JC, 2008, NEW ENGL J MED, V359, P2663, DOI 10.1056/NEJMoa0803240; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Schulz E, 2015, CEREB CORTEX, V25, P4407, DOI 10.1093/cercor/bhv043; Stoeter P, 2007, NEUROIMAGE, V36, P418, DOI 10.1016/j.neuroimage.2007.01.052; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Wagenlehner FME, 2013, EUR UROL, V63, P953, DOI 10.1016/j.eururo.2012.10.042; Xia Y, 2016, EUR J NUTR; Yelle MD, 2009, J NEUROSCI, V29, P10264, DOI 10.1523/JNEUROSCI.4648-08.2009; Yen Chen-Tung, 2013, Acta Anaesthesiol Taiwan, V51, P73, DOI 10.1016/j.aat.2013.06.011; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	45	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e184896	10.1371/journal.pone.0184896	http://dx.doi.org/10.1371/journal.pone.0184896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926645	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600050
J	Qiu, CF; Lawrence, W; Gelaye, B; Stoner, L; Frederick, IO; Enquobahrie, DA; Sorensen, TK; Williams, MA				Qiu, Chunfang; Lawrence, Wayne; Gelaye, Bizu; Stoner, Lee; Frederick, Ihunnaya O.; Enquobahrie, Daniel A.; Sorensen, Tanya K.; Williams, Michelle A.			Risk of glucose intolerance and gestational diabetes mellitus in relation to maternal habitual snoring during early pregnancy	PLOS ONE			English	Article							SLEEP DISTURBANCES; WOMEN; POPULATION; HYPERTENSION; DISORDERS; DURATION; OUTCOMES; DISEASE; APNEA; MEN	Background Obstructive sleep apnea (OSA) or habitual snoring is known to be associated with impaired glucose tolerance and type 2 diabetes among both men and non-pregnant women. We examined the association of habitual snoring during early pregnancy with risk of impaired glucose tolerance (IGT) and gestational diabetes mellitus (GDM). Methods A cohort of 1,579 women was interviewed during early pregnancy. We collected information about snoring frequency during early pregnancy. Results from screening and diagnostic tests for IGT and GDM were abstracted from medical records. Multivariate logistic regression models were fitted to estimate odds ratios (OR) and 95% confidence intervals (95% CI) of IGT and GDM associated with snoring in early pregnancy. Results Overall, women who snored "most or all of the time" had a 2.1-fold increased odds of IGT (OR 2.10; 95% CI 1.31-3.35) and a 2.5-fold increased odds of GDM (OR 2.50; 95% CI 1.34-4.67) as compared with women who never snored. Compared with lean women (pre-pregnancy body mass index (BMI) < 25 kg/m(2)) who did not snore, lean snorers had a 2-fold increased odds of GDM (OR = 1.99, 95% CI: 1.07-3.68). The odds of GDM risk was particularly elevated among overweight women (BMI-25 kg/m(2)) who snored (OR = 5.01; 95% CI 2.71-9.26). However, there was no evidence of an interaction between overweight and snoring with GDM risk (p-value = 0.144). Conclusions These findings, if confirmed, may have important implications for tailoring prenatal care for overweight pregnant women, and/or those with a history of habitual snoring in early pregnancy.	[Qiu, Chunfang; Frederick, Ihunnaya O.; Sorensen, Tanya K.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA 98104 USA; [Lawrence, Wayne; Gelaye, Bizu; Williams, Michelle A.] Harvard T Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Stoner, Lee] Univ N Carolina, Dept Sport & Exercise Sci, Chapel Hill, NC USA; [Enquobahrie, Daniel A.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	Swedish Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Qiu, CF (corresponding author), Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA 98104 USA.	Qiu4free@gmail.com	Lawrence, Wayne/N-3626-2016; Stoner, Lee/C-8504-2011	Lawrence, Wayne/0000-0002-2992-5897; Stoner, Lee/0000-0002-0682-2270	National Institutes of Health [T37-MD-001449, R01HD-055566, R01HD-32562]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055566] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032562] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Our research was supported by awards from the National Institutes of Health (T37-MD-001449, R01HD-055566 and R01HD-32562). There was no additional external funding received for this study.	Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; American Diabetes Association, 2011, DIABETES CARE S1, V34, ps15; Balserak BI, 2013, SLEEP BREATH, V17, P1093, DOI 10.1007/s11325-013-0809-4; BLIWISE DL, 1991, CHEST, V99, P600, DOI 10.1378/chest.99.3.600; Carroll JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118467; Elmasry A, 2000, J INTERN MED, V248, P13, DOI 10.1046/j.1365-2796.2000.00683.x; Facco FL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.041; Ge X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148732; GISLASON T, 1993, CHEST, V103, P1147, DOI 10.1378/chest.103.4.1147; Izci-Balserak B, 2010, CURR OPIN PULM MED, V16, P574, DOI 10.1097/MCP.0b013e32833f0d55; JENNUM P, 1995, CHEST, V108, P138, DOI 10.1378/chest.108.1.138; Lindberg E, 2007, RESP MED, V101, P1283, DOI 10.1016/j.rmed.2006.10.015; Louis J, 2012, OBSTET GYNECOL, V120, P1085, DOI 10.1097/AOG.0b013e31826eb9d8; Luque-Fernandez MA, 2013, DIABETES CARE, V36, P3353, DOI 10.2337/dc13-0778; O'Brien LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.034; O'Keeffe M, 2013, INT J OBESITY, V37, P765, DOI 10.1038/ijo.2012.142; Orta OR, 2015, J AFFECT DISORDERS, V172, P390, DOI 10.1016/j.jad.2014.10.032; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Qiu CF, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-17; Reutrakul S, 2011, DIABETES CARE, V34, P2454, DOI 10.2337/dc11-0780; Sabanayagam C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/879134; Sharma SK, 2016, SLEEP BREATH, V20, P87, DOI 10.1007/s11325-015-1188-9; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Tuomilehto H, 2008, DIABETES OBES METAB, V10, P468, DOI 10.1111/j.1463-1326.2007.00729.x; Ugur MG, 2012, CLIN EXP OBSTET GYN, V39, P214; Williams CJ, 2007, DIABETES CARE, V30, P1233, DOI 10.2337/dc06-2107	26	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184966	10.1371/journal.pone.0184966	http://dx.doi.org/10.1371/journal.pone.0184966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926639	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600056
J	Wei, SQ; Perera, MLW; Sakhtemanil, R; Bhagwat, AS				Wei, Shanqiao; Perera, Madusha L. W.; Sakhtemanil, Ramin; Bhagwat, Ashok S.			A novel class of chemicals that react with abasic sites in DNA and specifically kill B cell cancers	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; BASE EXCISION-REPAIR; APURINIC/APYRIMIDINIC ENDONUCLEASE-1 INHIBITORS; ALKYLATING AGENT TEMOZOLOMIDE; SINGLE-STRANDED-DNA; GENOMIC URACIL; SOMATIC HYPERMUTATION; PROPARGYL ALCOHOL; AID EXPRESSION; BREAST-CANCER	Most B cell cancers overexpress the enzyme activation-induced deaminase at high levels and this enzyme converts cytosines in DNA to uracil. The constitutive expression of this enzyme in these cells greatly increases the uracil content of their genomes. We show here that these genomes also contain high levels of abasic sites presumably created during the repair of uracils through base-excision repair. We further show that three alkoxyamines with an alkyne functional group covalently link to abasic sites in DNA and kill immortalized cell lines created from B cell lymphomas, but not other cancers. They also do not kill normal B cells. Treatment of cancer cells with one of these chemicals causes strand breaks, and the sensitivity of the cells to this chemical depends on the ability of the cells to go through the S phase. However, other alkoxyamines that also link to abasic sites-but lack the alkyne functionality- do not kill cells from B cell lymphomas. This shows that the ability of alkoxyamines to covalently link to abasic sites is insufficient for their cytotoxicity and that the alkyne functionality may play a role in it. These chemicals violate the commonly accepted bioorthogonality of alkynes and are attractive prototypes for anti-B cell cancer agents.	[Wei, Shanqiao; Perera, Madusha L. W.; Sakhtemanil, Ramin; Bhagwat, Ashok S.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Bhagwat, Ashok S.] Wayne State Univ, Immunol & Microbiol, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Bhagwat, AS (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.; Bhagwat, AS (corresponding author), Wayne State Univ, Immunol & Microbiol, Detroit, MI 48202 USA.	axb@chem.wayne.edu	Bhagwat, Ashok/ABA-3861-2020; Bhagwat, Ashok/AAU-4186-2021	Bhagwat, Ashok/0000-0003-1188-0579; Sakhtemani, Ramin/0000-0001-5342-9415	NIH grant [R01 GM 057200]; Grants Plus award from the Wayne State University; Thomas C. Rumble University Graduate Fellowship from Wayne State University; Summer dissertation fellowship from Wayne State University	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants Plus award from the Wayne State University; Thomas C. Rumble University Graduate Fellowship from Wayne State University; Summer dissertation fellowship from Wayne State University	The work reported here was supported by NIH grant R01 GM 057200 and a Grants Plus award from the Wayne State University to A.S.B., and a Thomas C. Rumble University Graduate Fellowship and Summer dissertation fellowship from Wayne State University to S. W.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; ARCHER TE, 1985, J ENVIRON SCI HEAL B, V20, P593, DOI 10.1080/03601238509372497; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dingler FA, 2014, EUR J IMMUNOL, V44, P1925, DOI 10.1002/eji.201444482; Feng Zhiwei, 2015, Journal of Chemical Biology, V8, P79, DOI 10.1007/s12154-015-0131-7; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Futagami S, 2008, DIGESTION, V78, P93, DOI 10.1159/000167978; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Hardianti MS, 2004, LEUKEMIA, V18, P826, DOI 10.1038/sj.leu.2403323; HUANG CH, 1981, BIOCHEMISTRY-US, V20, P233, DOI 10.1021/bi00505a001; IDE H, 1993, BIOCHEMISTRY-US, V32, P8276, DOI 10.1021/bi00083a031; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Liu L, 1999, CLIN CANCER RES, V5, P2908; Lossos IS, 2004, LEUKEMIA, V18, P1775, DOI 10.1038/sj.leu.2403488; Luo MH, 2004, ANTICANCER RES, V24, P2127; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Montaldi AP, 2013, CLIN EXP MED, V13, P279, DOI 10.1007/s10238-012-0201-x; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Peters Carrie E, 2005, Methods Mol Biol, V302, P95; Pettersen HS, 2015, DNA REPAIR, V25, P60, DOI 10.1016/j.dnarep.2014.11.006; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Shalhout S, 2014, MOL CELL BIOL, V34, P4019, DOI 10.1128/MCB.00589-14; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Smit LA, 2003, CANCER RES, V63, P3894; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Srinivasan A, 2012, BIOCHEMISTRY-US, V51, P6246, DOI 10.1021/bi300490r; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Thakur SA, 2013, TOXICOLOGY, V314, P100, DOI 10.1016/j.tox.2013.09.002; TICHY M, 1985, ENVIRON HEALTH PERSP, V61, P321, DOI 10.2307/3430082; van Swieten PF, 2005, ORG BIOMOL CHEM, V3, P20, DOI 10.1039/b412558d; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; Wei SQ, 2015, DNA REPAIR, V27, P9, DOI 10.1016/j.dnarep.2014.12.006; Wille U, 2013, CHEM REV, V113, P813, DOI 10.1021/cr100359d; Yan L, 2007, CLIN CANCER RES, V13, P1532, DOI 10.1158/1078-0432.CCR-06-1595; Zou GM, 2009, J CELL PHYSIOL, V219, P209, DOI 10.1002/jcp.21666	52	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185010	10.1371/journal.pone.0185010	http://dx.doi.org/10.1371/journal.pone.0185010			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926604	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600061
J	Laskar, RA; Khan, S				Laskar, Rafiul Amin; Khan, Samiullah			Assessment on induced genetic variability and divergence in the mutagenized lentil populations of microsperma and macrosperma cultivars developed using physical and chemical mutagenesis	PLOS ONE			English	Article							MUTATION	Induced mutagenesis was employed to create genetic variation in the lentil cultivars for yield improvement. The assessments were made on genetic variability, character association, and genetic divergence among the twelve mutagenized populations and one parent population of each of the two lentil cultivars, developed by single and combination treatments with gamma rays and hydrazine hydrates. Analysis of variance revealed significant inter-population differences for the observed quantitative phenotypic traits. The sample mean of six treatment populations in each of the cultivar exhibited highly superior quantitative phenotypic traits compared to their parent cultivars. The higher values of heritability and genetic advance with a high genotypic coefficient of variation for most of the yield attributing traits confirmed the possibilities of lentil yield improvement through phenotypic selection. The number of pods and seeds per plant appeared to be priority traits in selection for higher yield due to their strong direct association with yield. The cluster analysis divided the total populations into three divergent groups in each lentil cultivar with parent genotypes in an independent group showing the high efficacy of the mutagens. Considering the highest contribution of yield trait to the genetic divergence among the clustered population, it was confirmed that the mutagenic treatments created a wide heritable variation for the trait in the mutant populations. The selection of high yielding mutants from the mutant populations of DPL 62 (100 Gy) and Pant L 406 (100Gy + 0.1% HZ) in the subsequent generation is expected to give elite lentil cultivars. Also, hybridization between members of the divergent group would produce diverse segregants for crop improvement. Apart from this, the induced mutations at loci controlling economically important traits in the selected high yielding mutants have successfully contributed in diversifying the accessible lentil genetic base and will definitely be of immense value to the future lentil breeding programmes in India.	[Laskar, Rafiul Amin; Khan, Samiullah] Aligarh Muslim Univ, Dept Bot, Mutat Breeding Lab, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Laskar, RA (corresponding author), Aligarh Muslim Univ, Dept Bot, Mutat Breeding Lab, Aligarh, Uttar Pradesh, India.	rafihkd@gmail.com	LASKAR, RAFIUL AMIN/K-5865-2014	LASKAR, RAFIUL AMIN/0000-0002-4279-3972				Afuape S. O., 2011, African Journal of Plant Science, V5, P123; Ahmad F, 2015, PLOS ONE, V10, P9; Al-Ghzawi A. L. A., 2011, Advances in Environmental Biology, V5, P3676; Ali A, 2012, ASIAN J PLANT SCI, V1, P420; Allard R.W., 1960, PRINCIPLES PLANT BRE, P92; Amin R., 2015, COGENT FOOD AGR, V1; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barulina E.I., 1930, B APPL BOT GENET PL, V40, P265, DOI DOI 10.1023/A:1018306723777; Beaumont Mark A., 1998, P315; BOROJEVIO K., 1972, Proceedings of a Latin American study group on induced mutations and plant improvement, Buenos Aires, 16-20 November 1970., P237; Cubero J. I., 1981, Lentils, P15; Dhumal KN, 2012, ADROVIC FERIZ PROF, P208; Erskine W., 2009, The lentil: botany, production and uses, P4, DOI 10.1079/9781845934873.0004; ERSKINE W, 1990, ANIM FEED SCI TECH, V28, P61, DOI 10.1016/0377-8401(90)90068-J; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; GREGORY WC, 1965, RAD BOT S, V5, P429; Ignacimuthu S., 1993, Journal of Nuclear Agriculture and Biology, V22, P133; ISTA (International Seed Testing Association), 1985, SEED SCI TECHNOL, V3, P299; Joshi Prashant, 2004, Indian Journal of Genetics & Plant Breeding, V64, P155; KAUL MLH, 1983, BIOL ZBL, V102, P559; Khan S., 1998, J IND BOT SOC, V77, P95; Laskar R. A., 2015, Journal of Agronomy, V14, P102, DOI 10.3923/ja.2015.102.111; LOESCH P. J., 1964, CROP SCI, V4, P73; Malek MA, 2014, SCI WORLD J, DOI 10.1155/2014/968796; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Muduli K. C., 2008, Journal of Crop Science and Biotechnology, V11, P63; Najeeb S., 2009, Maize Genetics Cooperation Newsletter, P46; Ogunniyan DJ, 2014, NIGERIAN J GENETICS, V28, P24; Rizwan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171846; Rohman M. M., 2004, Asian Journal of Plant Sciences, V3, P211; SAKAI KAN-ICHI, 1964, RADIAT BOT, V4, P141, DOI 10.1016/S0033-7560(64)80065-X; Sharma B., 1995, P S GEN RES ED CURR, VIII, P1210; Shin JM, 2011, AFR J AGR RES, V6, P1447; Siddiqui MA, 2009, PAK J BOT, V41, P1189; Singh R.K., 1985, BIOMETRICAL METHODS; Solanki IS, 2016, LEGUME RES, V39, P170, DOI 10.18805/lr.v39i2.9529; Swaminathan M. S., 1969, 12 P INT C GEN TOK, V3, P327; Wani M.R., 2006, THAI J AGR SCI, V39, P83; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waxman D, 2003, GENETICS, V164, P1615	40	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184598	10.1371/journal.pone.0184598	http://dx.doi.org/10.1371/journal.pone.0184598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922405	gold, Green Published, Green Submitted			2022-12-26	WOS:000411059300019
J	Baltes, A; Akpinar, F; Inankur, B; Yin, J				Baltes, Ashley; Akpinar, Fulya; Inankur, Bahar; Yin, John			Inhibition of infection spread by co-transmitted defective interfering particles	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; RIBONUCLEIC-ACID SYNTHESIS; INFLUENZA RNA; REPLICATION; GENOME; CELLS; IDENTIFICATION; SENSITIVITY; COMPETITION; GENERATION	Although virus release from host cells and tissues propels the spread of many infectious diseases, most virus particles are not infectious; many are defective, lacking essential genetic information needed for replication. When defective and viable particles enter the same cell, the defective particles can multiply while interfering with viable particle production. Defective interfering particles (DIPs) occur in nature, but their role in disease pathogenesis and spread is not known. Here, we engineered an RNA virus and its DIPs to express different fluorescent reporters, and we observed how DIPs impact viral gene expression and infection spread. Across thousands of host cells, co-infected with infectious virus and DIPs, gene expression was highly variable, but average levels of viral reporter expression fell at higher DIP doses. In cell populations spatial patterns of infection spread provided the first direct evidence for the co-transmission of DIPs with infectious virus. Patterns of spread were highly sensitive to the behavior of initial or early co-infected cells, with slower overall spread stemming from higher early DIP doses. Under such conditions striking patterns of patchy gene expression reflected localized regions of DIP or virus enrichment. From a broader perspective, these results suggest DIPs contribute to the ecological and evolutionary persistence of viruses in nature.	[Baltes, Ashley; Akpinar, Fulya; Inankur, Bahar; Yin, John] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Baltes, Ashley; Akpinar, Fulya; Inankur, Bahar; Yin, John] Univ Wisconsin, Wisconsin Inst Discovery, Syst Biol Theme, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yin, J (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.; Yin, J (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Syst Biol Theme, Madison, WI 53706 USA.	john.yin@wisc.edu		Yin, John/0000-0001-6146-0594	National Institute of Allergy and Infectious Disease; National Institutes of Health (USA) [Al091646, Al104317, T32-HG002760]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104317] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health (USA): Al091646 (J.Y.), Al104317 (J.Y.), T32-HG002760 (A.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Akpinar F, 2016, J VIROL, V90, P7552, DOI 10.1128/JVI.00807-16; Akpinar F, 2016, J VIROL, V90, P1599, DOI 10.1128/JVI.02190-15; Akpinar F, 2015, J VIROL METHODS, V218, P71, DOI 10.1016/j.jviromet.2015.02.006; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; BELLETT AJD, 1959, J GEN MICROBIOL, V21, P498, DOI 10.1099/00221287-21-3-498; Clark NR, 2011, STOCHASTIC MODEL VIR; Dimmock NJ, 2015, VIRUSES-BASEL, V7, P3768, DOI 10.3390/v7072796; DOYLE M, 1973, P NATL ACAD SCI USA, V70, P2105, DOI 10.1073/pnas.70.7.2105; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Frank SA, 2000, J THEOR BIOL, V206, P279, DOI 10.1006/jtbi.2000.2120; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GIACHETTI C, 1989, VIROLOGY, V170, P264, DOI 10.1016/0042-6822(89)90375-9; Grdzelishvili VZ, 2006, VIROLOGY, V350, P394, DOI 10.1016/j.virol.2006.02.021; Haseltine EL, 2008, B MATH BIOL, V70, P1730, DOI 10.1007/s11538-008-9316-3; Henson R., 2013, DSCATTER FLOW CYTOME; Hofacre A, 2012, VIROLOGY, V423, P89, DOI 10.1016/j.virol.2011.11.014; HOLLAND J J, 1990, P151; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; HUANG AS, 1972, J VIROL, V9, P909, DOI 10.1128/JVI.9.6.909-916.1972; Huang AS, 1977, DEFECTIVE INTERFERIN, p73 ; Iwai A, 2006, J VIRAL HEPATITIS, V13, P523, DOI 10.1111/j.1365-2893.2006.00760.x; Kim H, 2004, ANTIMICROB AGENTS CH, V48, P1017, DOI 10.1128/AAC.48.3.1017-1020.2004; Klasse PJ, 2015, PROG MOL BIOL TRANSL, V129, P285, DOI 10.1016/bs.pmbts.2014.10.012; KRAMER MJ, 1983, J INTERFERON RES, V3, P425, DOI 10.1089/jir.1983.3.425; Laske T, 2016, VIRUS RES, V213, P90, DOI 10.1016/j.virusres.2015.11.016; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; LAZZARINI RA, 1981, CELL, V26, P145, DOI 10.1016/0092-8674(81)90298-1; Li D, 2011, PLOS ONE, V6; Li T, 1997, VIROLOGY, V232, P248, DOI 10.1006/viro.1997.8571; MEIER E, 1984, J VIROL, V51, P515, DOI 10.1128/JVI.51.2.515-521.1984; Metzger VT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002015; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Noble S, 2004, VACCINE, V22, P3018, DOI 10.1016/j.vaccine.2004.02.013; Odagiri T, 1997, J VIROL, V71, P2138, DOI 10.1128/JVI.71.3.2138-2145.1997; OTSUKI K, 1979, ARCH VIROL, V60, P249, DOI 10.1007/BF01317496; PALMA EL, 1974, J INFECT DIS, V129, P402, DOI 10.1093/infdis/129.4.402; PATTNAIK AK, 1995, VIROLOGY, V206, P760, DOI 10.1016/S0042-6822(95)80005-0; Perrault J, 1981, ORIGIN REPLICATION D, P151; Pesko KN, 2012, VIROLOGY, V427, P10, DOI 10.1016/j.virol.2012.01.028; Ram PJ, IMAGE PROCESSING IMA; RAO DD, 1982, J VIROL, V41, P210, DOI 10.1128/JVI.41.1.210-221.1982; Rast LI, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004799; Saira K, 2013, J VIROL, V87, P8064, DOI 10.1128/JVI.00240-13; SEKELLICK MJ, 1980, VIROLOGY, V104, P247, DOI 10.1016/0042-6822(80)90385-2; Smith CM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080237; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; STAMPFER M, 1969, J VIROL, V4, P154, DOI 10.1128/JVI.4.2.154-161.1969; Stauffer KA, 2009, J GEN VIROL, V90, P888, DOI 10.1099/vir.0.005249-0; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Swick A, 2014, BIOTECHNOL BIOENG, V111, P1200, DOI 10.1002/bit.25170; Thompson KAS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-257; Timm A, 2012, VIROLOGY, V424, P11, DOI 10.1016/j.virol.2011.12.005; Timm C, 2014, J VIROL, V88, P2623, DOI 10.1128/JVI.02675-13; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; von Magnus P., 1947, MINERAL GEOL, V24; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Warrick JW, 2016, PLOS ONE, V11; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Yuan TTT, 1998, J VIROL, V72, P2168, DOI 10.1128/JVI.72.3.2168-2176.1998	65	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184029	10.1371/journal.pone.0184029	http://dx.doi.org/10.1371/journal.pone.0184029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915264	Green Published, gold, Green Submitted			2022-12-26	WOS:000410861600008
J	Brotons, P; Bassat, Q; Lanaspa, M; Henares, D; Perez-Arguello, A; Madrid, L; Balcells, R; Acacio, S; Andres-Franch, M; Marcos, MA; Valero-Rello, A; Munoz-Almagro, C				Brotons, Pedro; Bassat, Quique; Lanaspa, Miguel; Henares, Desiree; Perez-Arguello, Amaresh; Madrid, Lola; Balcells, Reyes; Acacio, Sozinho; Andres-Franch, Maria; Angeles Marcos, Maria; Valero-Rello, Ana; Munoz-Almagro, Carmen			Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive pneumococcal disease in children from Mozambique	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; YOUNG-CHILDREN; SPUTUM SAMPLES; COLONIZATION; DENSITY; SEROTYPES; VIRUSES; RATES; ASSAY	Background Current diagnostic methods for detection of Streptococcus pneumoniae in children with suspected invasive pneumococcal disease have limitations of accuracy, timeliness, and patient convenience. This study aimed to determine the performance of pneumococcal load quantified with a real-time polymerase-chain reaction in nasopharyngeal samples to diagnose invasive pneumococcal disease in children. Methods Matched case-control study of patients < 5 years of age with invasive pneumococcal disease admitted to the Manhica District Hospital (Mozambique) and asymptomatic controls recruited in different periods between 2006 and 2014. Cases were confirmed by a positive bacterial culture for S. pneumoniae in blood or cerebrospinal fluid. Nasopharyngeal aspirates were collected from cases and controls and pneumococcal density was quantified by lytA real-time polymerase-chain reaction. Results Thirty cases (median age 12.8 months) and sixty controls (median age 11.7 months) were enrolled and 70% of them were male. Nasopharyngeal pneumococcal carriage was high in both groups: 28/30 (93.3%) for cases vs. 53/60 (88.3%) for controls (p = 0.71). Mean nasopharyngeal pneumococcal load was identified as a marker for invasive pneumococcal disease (7.0 log(10) copies/mL in cases vs. 5.8 log10 copies/mL in controls, p<0.001) and showed good discriminatory power ( AUC-ROC: 82.1%, 95% CI 72.5%-91.8%). A colonization density of 6.5 log(10) copies/mL was determined as the optimal cut-off value to distinguish cases from controls (sensitivity 75.0%, specificity 73.6%). Conclusion Use of non-invasive nasopharyngeal aspirates coupled with rapid and accurate quantification of pneumococcal load by real-time polymerase chain reaction has the potential to become a useful surrogate marker for early diagnosis of invasive pneumococcal disease in children.	[Brotons, Pedro; Henares, Desiree; Perez-Arguello, Amaresh; Andres-Franch, Maria; Valero-Rello, Ana; Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain; [Brotons, Pedro; Andres-Franch, Maria; Valero-Rello, Ana; Munoz-Almagro, Carmen] Inst Salud Carlos III, CIBERESP, Madrid, Spain; [Bassat, Quique; Lanaspa, Miguel; Madrid, Lola; Angeles Marcos, Maria] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bassat, Quique] CISM, Maputo, Mozambique; [Bassat, Quique; Lanaspa, Miguel; Madrid, Lola; Balcells, Reyes; Acacio, Sozinho] ICREA, Pg Lluis Co 23, Barcelona, Spain; [Bassat, Quique] Univ Barcelona, Pediat Dept, Pediat Infect Dis Unit, Hosp Sant Joan de Deu, Barcelona, Spain; [Bassat, Quique] Univ Europea Madrid, Madrid, Spain; [Munoz-Almagro, Carmen] Univ Int Catalunya, Sch Med, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; ICREA; University of Barcelona; European University of Madrid; Universitat Internacional de Catalunya (UIC)	Munoz-Almagro, C (corresponding author), Univ Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain.; Munoz-Almagro, C (corresponding author), Inst Salud Carlos III, CIBERESP, Madrid, Spain.; Munoz-Almagro, C (corresponding author), Univ Int Catalunya, Sch Med, Barcelona, Spain.	cma@sjdhospitalbarcelona.org	Lanaspa, Miguel/AAO-4971-2020; Muñoz-Almagro, Carmen/N-7248-2015; Rello, Ana Valero/J-9479-2015; Bassat, Quique/P-2341-2016; Henares Bonilla, Desiree/K-2543-2017	Muñoz-Almagro, Carmen/0000-0001-5586-404X; Rello, Ana Valero/0000-0002-0126-1128; Bassat, Quique/0000-0003-0875-7596; Madrid, Lola/0000-0003-4034-6033; Henares Bonilla, Desiree/0000-0003-2631-2718; Lanaspa, Miguel/0000-0002-9310-177X	Fondo Europeo de Desarrollo Regional (FEDER); Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII), Projects of Research on Health [PI13/01729]; program Miguel Servet of the Institute de Salud Carlos III [Plan Nacional de I+D+I] [CP11/00269]; World Health Organization [WHO-C6-181-489]; Bill & Melinda Gates Foundation [OPP50092]; Spanish Agency for International Cooperation and Developement (AECID)	Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII), Projects of Research on Health; program Miguel Servet of the Institute de Salud Carlos III [Plan Nacional de I+D+I]; World Health Organization(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Cooperation and Developement (AECID)	This work was supported by Fondo Europeo de Desarrollo Regional (FEDER) and the Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII), Projects of Research on Health [FIS project number PI13/01729, Principal Investigator: Carmen Munoz-Almagro]. Quique Bassat had during the time of the study a fellowship from the program Miguel Servet of the Institute de Salud Carlos III [Plan Nacional de I+D+I 2008-2011, grant number: CP11/00269] (http://www.isciii.es/). The OVERLAP Project was supported by a grant from the World Health Organization [grant number: WHO-C6-181-489] (http://www.who.int/es/). The RAPID Project was supported by the Bill & Melinda Gates Foundation [grant number: OPP50092] (http://www.gatesfeundatien.org/es/). The Centro de Investigacao em Saude de Manhica - Fundacao Manhica (CISM - FM) receives financial support from the Spanish Agency for International Cooperation and Developement (AECID). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Albrich WC, 2014, J CLIN MICROBIOL, V52, P4224, DOI 10.1128/JCM.01553-14; Almagro C, 2014, CLIN MICROBIOL INFEC, V20, pO745; Anh DD, 2007, TOHOKU J EXP MED, V213, P167, DOI 10.1620/tjem.213.167; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; Brook I, 2010, INT J PEDIATR OTORHI, V74, P447, DOI 10.1016/j.ijporl.2010.01.006; Ciruela P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3061-6; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; Fan RR, 2016, EMERG INFECT DIS, V22, P1996, DOI 10.3201/eid2211.160902; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kuczmarski RJ., 2000, ADV DATA, P1; Lanaspa M, 2014, BIOMARK MED, V8, P1057, DOI [10.2217/BMM.14.65, 10.2217/bmm.14.65]; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Morpeth Susan C, 2014, Biomol Detect Quantif, V2, P1; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Stralin K, 2014, J CLIN MICROBIOL, V52, P83, DOI 10.1128/JCM.01742-13; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005	34	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184762	10.1371/journal.pone.0184762	http://dx.doi.org/10.1371/journal.pone.0184762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910402	Green Published, gold			2022-12-26	WOS:000410859200092
J	Jia, B; McNeil, LK; Dupont, CD; Tsioris, K; Barry, RM; Scully, IL; Ogunniyi, AO; Gonzalez, C; Pride, MW; Gierahn, TM; Liberator, PA; Jansen, KU; Love, JC				Jia, Bin; McNeil, Lisa K.; Dupont, Christopher D.; Tsioris, Konstantinos; Barry, Rachel M.; Scully, Ingrid L.; Ogunniyi, Adebola O.; Gonzalez, Christopher; Pride, Michael W.; Gierahn, Todd M.; Liberator, Paul A.; Jansen, Kathrin U.; Love, J. Christopher			Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CAPSULAR POLYSACCHARIDE; SOMATIC HYPERMUTATION; NAIVE ADULTS; VACCINATION; RESPONSES; IMMUNOGENICITY; SAFETY; OLDER; REVACCINATION	Background The efficacy of protein-conjugated pneumococcal polysaccharide vaccines has been well characterized for children. The level of protection conferred by unconjugated polysaccharide vaccines remains less clear, particularly for elderly individuals who have had prior antigenic experience through immunization with unconjugated polysaccharide vaccines or natural exposure to Streptococcus pneumoniae. Methods We compared the magnitude, diversity and genetic biases of antigen-specific memory B cells in two groups of adult cynomolgus macaques that were immunized with a 7-valent conjugated vaccine and boosted after five years with either a 13-valent pneumococcal polysaccharide conjugate vaccine (13vPnC) or a 23-valent unconjugated pneumococcal polysaccharide vaccine (23vPS) using microengraving (a single-cell analysis method) and single-cell RT-PCR. Results Seven days after boosting, the mean frequency of antigen-specific memory B cells was significantly increased in macaques vaccinated with 13vPnC compared to those receiving 23vPS. The 13vPnC-vaccinated macaques also exhibited a more even distribution of antibody specificities to four polysaccharides in the vaccine (PS4, 6B, 14, 23F) that were examined. However, single-cell analysis of the antibody variable region sequences from antigen-specific B cells elicited by unconjugated and conjugated vaccines indicated that both the germline gene segments forming the heavy chains and the average lengths of the Complementary Determining Region 3 (CDR3) were similar. Conclusions Our results confirm that distinctive differences can manifest between antigen-specific memory B cell repertoires in nonhuman primates immunized with conjugated and unconjugated pneumococcal polysaccharide vaccines. The study also supports the notion that the conjugated vaccines have a favorable profile in terms of both the frequency and breadth of the anamnestic response among antigen-specific memory B cells.	[Jia, Bin; Dupont, Christopher D.; Tsioris, Konstantinos; Barry, Rachel M.; Ogunniyi, Adebola O.; Gonzalez, Christopher; Gierahn, Todd M.; Love, J. Christopher] MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [McNeil, Lisa K.; Scully, Ingrid L.; Pride, Michael W.; Liberator, Paul A.; Jansen, Kathrin U.] Pfizer Vaccine Res & Early Dev, Pearl River, NY USA; [Love, J. Christopher] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Pfizer; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Love, JC (corresponding author), MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Love, JC (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA.	clove@mit.edu		Love, John/0000-0003-0921-3144	Pfizer; National Institute of Allergy and Infectious Disease [F32AI112359]; National Cancer Institute [P30CA140514]	Pfizer(Pfizer); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Pfizer, and in part by grants from the National Institute of Allergy and Infectious Disease (Grant F32AI112359) and the National Cancer Institute (P30CA140514). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Pfizer provided support in the form of salaries for authors LKM, ILS, MWP, PAL and KUJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Baxendale HE, 2000, EUR J IMMUNOL, V30, P1214, DOI 10.1002/(SICI)1521-4141(200004)30:4<1214::AID-IMMU1214>3.0.CO;2-D; Baxendale HE, 2010, VACCINE, V28, P4763, DOI 10.1016/j.vaccine.2010.04.103; Bradshaw EM, 2008, CLIN IMMUNOL, V129, P10, DOI 10.1016/j.clim.2008.06.009; Brezinschek HP, 1998, J IMMUNOL, V160, P4762; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Choi JH, 2010, BIOTECHNOL PROGR, V26, P888, DOI 10.1002/btpr.374; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; DAVIDSON M, 1994, ARCH INTERN MED, V154, P2209, DOI 10.1001/archinte.154.19.2209; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; Feldman C, 2014, J INFECT; Gierahn TM, 2014, J PROTEOME RES; Goldblatt D, 2000, CLIN EXP IMMUNOL, V119, P1, DOI 10.1046/j.1365-2249.2000.01109.x; Greenberg RN, 2014, VACCINE, V32, P2364, DOI 10.1016/j.vaccine.2014.02.002; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2013, VACCINE, V31, P3594, DOI 10.1016/j.vaccine.2013.04.084; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Juergens C, 2014, HUM VACCINES IMMUNOT, V10; KONRADSEN HB, 1995, CLIN INFECT DIS, V21, P616, DOI 10.1093/clinids/21.3.616; Kroger AT, GEN RECOMMENDATIONS; Kuwata T, 2011, AIDS RES HUM RETROV, V27, P487, DOI 10.1089/aid.2010.0191; Leggat DJ, 2013, VACCINE, V31, P4632, DOI 10.1016/j.vaccine.2013.07.030; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; MacIntyre CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094578; McDaniel LS, 2004, INFECT DIS CLIN PRAC, V12, P93, DOI [10.1016/S0140-6736(09)61114-4, DOI 10.1016/S0140-6736(09)61114-4]; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Melegaro A, 2006, J INFECTION, V52, P37, DOI 10.1016/j.jinf.2005.02.008; Musher DM, 2010, J INFECT DIS, V201, P516, DOI 10.1086/649839; Nuorti JP, 2010, PREV PNEUM DIS INF C; OBrien KL, 1996, PEDIATR INFECT DIS J, V15, P425, DOI 10.1097/00006454-199605000-00009; Ogunniyi AO, 2014, VACCINE, V32, P2866, DOI 10.1016/j.vaccine.2014.02.020; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Sankilampi U, 1997, J INFECT DIS, V176, P1100, DOI 10.1086/516521; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Smith K, 2013, IMMUNOBIOLOGY, V218, P745, DOI 10.1016/j.imbio.2012.08.278; Story CM, 2008, P NATL ACAD SCI USA, V105, P17902, DOI 10.1073/pnas.0805470105; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Tomczyk S, USE 13 VALENT PNEUMO; Torling J, VACCINE; Tsioris K, 2015, INTEGR BIOL-UK, V7, P1587, DOI [10.1039/c5ib00169b, 10.1039/C5IB00169B]; Wang XW, 2000, J IMMUNOL METHODS, V244, P217, DOI 10.1016/S0022-1759(00)00260-X; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu Y, 2012, ADV MATER RES-SWITZ, V528, P3, DOI 10.4028/www.scientific.net/AMR.528.3; Zhou JH, 2002, INFECT IMMUN, V70, P4083, DOI 10.1128/IAI.70.8.4083-4091.2002	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183738	10.1371/journal.pone.0183738	http://dx.doi.org/10.1371/journal.pone.0183738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910279	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200015
J	Liang, X; Liao, CY; Soupir, ML; Jarboe, LR; Thompson, ML; Dixon, PM				Liang, Xiao; Liao, Chunyu; Soupir, Michelle L.; Jarboe, Laura R.; Thompson, Michael L.; Dixon, Philip M.			Escherichia coli attachment to model particulates: The effects of bacterial cell characteristics and particulate properties	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; E. COLI; SUSPENDED PARTICLES; SURFACE-PROPERTIES; BACILLUS-SUBTILIS; SOIL PARTICLES; INTACT CORES; TRANSPORT; ADHESION; SURVIVAL	E. coli bacteria move in streams freely in a planktonic state or attached to suspended particulates. Attachment is a dynamic process, and the fraction of attached microorganisms is thought to be affected by both bacterial characteristics and particulate properties. In this study, we investigated how the properties of cell surfaces and stream particulates influence attachment. Attachment assays were conducted for 77 E. coli strains and three model particulates (ferrihydrite, Ca-montmorillonite, or corn stover) under environmentally relevant conditions. Surface area, particle size distribution, and total carbon content were determined for each type of particulate. Among the three particulates, attachment fractions to corn stover were significantly larger than the attachments to 2-line ferrihydrite (p-value = 0.0036) and Ca-montmorillonite (p-value = 0.022). Furthermore, attachment to Ca-montmorillonite and corn stover was successfully modeled by a Generalized Additive Model (GAM) using cell characteristics as predictor variables. The natural logarithm of the net charge on the bacterial surface had a significant, positive, and linear impact on the attachment of E. coli bacteria to Ca-montmorillonite (p-value = 0.013), but it did not significantly impact the attachment to corn stover (p-value = 0.36). The large diversities in cell characteristics among 77 E. coli strains, particulate properties, and attachment fractions clearly demonstrated the inadequacy of using a static parameter or linear coefficient to predict the attachment behavior of E. coli in stream water quality models.	[Liang, Xiao; Soupir, Michelle L.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Liao, Chunyu; Jarboe, Laura R.] Iowa State Univ, Dept Microbiol, Ames, IA USA; [Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA; [Thompson, Michael L.] Iowa State Univ, Dept Agron, Ames, IA USA; [Dixon, Philip M.] Iowa State Univ, Dept Stat, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University	Soupir, ML (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.	msoupir@iastate.edu	Dixon, Philip Michael/I-4843-2019	Dixon, Philip Michael/0000-0002-1778-0686; Liao, Chunyu/0000-0002-5563-3513; Soupir, Michelle/0000-0003-3449-1146	National Science Foundation [CBET-1236510]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the National Science Foundation (CBET-1236510); opinions, findings, and conclusions are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparatin of the manuscript.	Baffaut C, 2010, T ASABE, V53, P1585; Bai S, 2005, WATER RES, V39, P5232, DOI 10.1016/j.watres.2005.10.013; BITTON G, 1972, APPL MICROBIOL, V23, P870, DOI 10.1128/AEM.23.5.870-874.1972; Bolster CH, 2009, J ENVIRON QUAL, V38, P465, DOI 10.2134/jeq2008.0137; Bolster CH, 2001, J CONTAM HYDROL, V50, P287, DOI 10.1016/S0169-7722(01)00106-1; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Chapra S.C., 2008, SURFACE WATER QUALIT; Corry JEL, 2007, FOOD MICROBIOL, V24, P230, DOI 10.1016/j.fm.2006.05.003; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Dimkpa CO, 2011, J HAZARD MATER, V188, P428, DOI 10.1016/j.jhazmat.2011.01.118; Dogsa I, 2005, BIOPHYS J, V89, P2711, DOI 10.1529/biophysj.105.061648; Dong HL, 2002, ENVIRON SCI TECHNOL, V36, P891, DOI 10.1021/es010144t; Dorner SM, 2006, ENVIRON SCI TECHNOL, V40, P4746, DOI 10.1021/es060426z; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Entry JA, 2000, J ENVIRON QUAL, V29, P1206, DOI 10.2134/jeq2000.00472425002900040026x; Fein JB, 2005, GEOCHIM COSMOCHIM AC, V69, P1123, DOI 10.1016/j.gca.2004.07.033; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Foppen JW, 2010, WATER RES, V44, P1202, DOI 10.1016/j.watres.2009.08.034; Fuller ME, 2000, WATER RESOUR RES, V36, P2417, DOI 10.1029/2000WR900075; Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000; GANNON JT, 1991, APPL ENVIRON MICROB, V57, P190, DOI 10.1128/AEM.57.1.190-193.1991; Goulter RM, 2009, LETT APPL MICROBIOL, V49, P1, DOI 10.1111/j.1472-765X.2009.02591.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; HACH, TOT FEC E COL US MEM; HARTLEY MG, 1993, GUT, V34, P63, DOI 10.1136/gut.34.1.63; Hipsey MR, 2006, WATER AIR SOIL POLL, V170, P191, DOI 10.1007/s11270-006-3010-6; Im Sun-A, 2010, Immune Netw, V10, P230, DOI 10.4110/in.2010.10.6.230; Jamieson R, 2005, WATER RES, V39, P2665, DOI 10.1016/j.watres.2005.04.040; Jamieson R. C., 2002, CAN BIOSYST ENG, V44, P1; Jeng HWC, 2005, J ENVIRON SCI HEAL A, V40, P779, DOI 10.1081/ESE-200048264; Kim JW, 2010, ECOL MODEL, V221, P1592, DOI 10.1016/j.ecolmodel.2010.03.005; Kosmulski M, 2009, J COLLOID INTERF SCI, V337, P439, DOI 10.1016/j.jcis.2009.04.072; Krometis LAH, 2007, WATER RES, V41, P506, DOI 10.1016/j.watres.2006.09.029; Lenntech, IR WAT REACT MECH EN; Levy J, 2007, J CONTAM HYDROL, V89, P71, DOI 10.1016/j.jconhyd.2006.08.006; Liang X, 2014, J APPL MICROBIOL, V117, P1730, DOI 10.1111/jam.12660; Liang X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01732; Liao C, 2015, J APPL MICROBIOL, V119, P315, DOI 10.1111/jam.12860; Liao CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00708; LINDAHL M, 1981, BIOCHIM BIOPHYS ACTA, V677, P471, DOI 10.1016/0304-4165(81)90261-0; Liu Y, 2004, J BIOTECHNOL, V110, P251, DOI 10.1016/j.jbiotec.2004.02.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matthysse AG, 2008, APPL ENVIRON MICROB, V74, P2384, DOI 10.1128/AEM.01854-07; Miller CM, 2010, ADHESION SURFACE ENE; Mohapatra BR, 2008, WATER SCI TECHNOL, V58, P537, DOI 10.2166/wst.2008.424; Muirhead RW, 2006, APPL ENVIRON MICROB, V72, P3406, DOI 10.1128/AEM.72.5.3406-3411.2006; Niemela S. I., 2002, UNCERTAINTY QUANTITA; Oliver DM, 2007, WATER AIR SOIL POLL, V185, P369, DOI 10.1007/s11270-007-9451-8; Omoike A, 2004, BIOMACROMOLECULES, V5, P1219, DOI 10.1021/bm034461z; Pachepsky YA, 2008, INT AGROPHYS, V22, P61; Pachepsky YA, 2006, AGR WATER MANAGE, V86, P81, DOI 10.1016/j.agwat.2006.06.010; Pandey PK, 2012, WATER RES, V46, P115, DOI 10.1016/j.watres.2011.10.019; Parikh SJ, 2006, LANGMUIR, V22, P8492, DOI 10.1021/la061359p; Pembrey RS, 1999, APPL ENVIRON MICROB, V65, P2877; Piorkowski G, 2013, WATER RES, V47, P6701, DOI 10.1016/j.watres.2013.09.003; Rad AY, 1998, J BIOMED MATER RES, V41, P349, DOI 10.1002/(SICI)1097-4636(19980905)41:3<349::AID-JBM2>3.0.CO;2-C; Rhoton FE, 2009, J ENVIRON QUAL, V38, P1887, DOI 10.2134/jeq2008.0454; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Russo SA, 2011, J ENVIRON ENG-ASCE, V137, P697, DOI 10.1061/(ASCE)EE.1943-7870.0000363; Mendonca RCS, 2012, FOOD CONTROL, V23, P389, DOI 10.1016/j.foodcont.2011.08.004; SCHALLENBERG M, 1993, ECOLOGY, V74, P919, DOI 10.2307/1940816; SCHILLINGER JE, 1985, J WATER POLLUT CON F, V57, P384; SCHOLL M A, 1990, Journal of Contaminant Hydrology, V6, P321, DOI 10.1016/0169-7722(90)90032-C; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; SHERER BM, 1992, J ENVIRON QUAL, V21, P591, DOI 10.2134/jeq1992.00472425002100040011x; Shin HS, 2001, WATER SCI TECHNOL, V43, P193, DOI 10.2166/wst.2001.0373; Soupir ML, 2008, J AM WATER RESOUR AS, V44, P1591, DOI 10.1111/j.1752-1688.2008.00262.x; Terrio PJ, 1996, ANAL SUSPENDED SEDIM, P61801; Tessier D., 1990, Soil colloids and their associations in aggregates., P387; USEPA, 1986, AMB WAT QUAL CRIT BA; USEPA, 2014, WAT ASS TRACK ENV RE; Van der Bruggen B, 2003, ENVIRON POLLUT, V122, P435, DOI 10.1016/S0269-7491(02)00308-1; VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404; WAN JM, 1995, WATER RESOUR RES, V31, P1627, DOI 10.1029/95WR01255; Wenck, 2013, STRESS ID REP VERM R; Zhao WQ, 2014, WATER RES, V53, P35, DOI 10.1016/j.watres.2014.01.009; Zita A, 1997, APPL ENVIRON MICROB, V63, P1168, DOI 10.1128/AEM.63.3.1168-1170.1997	78	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184664	10.1371/journal.pone.0184664	http://dx.doi.org/10.1371/journal.pone.0184664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910343	Green Published, gold			2022-12-26	WOS:000410859200074
J	Liu, ZZ; Qu, HJ; Tian, ZL; Han, MJ; Fan, Y; Ge, LZ; Zang, YF; Zhang, H				Liu, Zan-Zan; Qu, Hui-Jie; Tian, Zhuo-Ling; Han, Meng-Jian; Fan, Yi; Ge, Lie-Zhong; Zang, Yu-Feng; Zhang, Hang			Reproducibility of frequency-dependent low frequency fluctuations in reaction time over time and across tasks	PLOS ONE			English	Article							INTRA-SUBJECT VARIABILITY; DEFICIT-HYPERACTIVITY-DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TEST-RETEST RELIABILITY; SUSTAINED ATTENTION; HUMAN BRAIN; RESPONSE VARIABILITY; ADHD; CHILDREN; MRI	Objective Increased levels of reaction time variability (RTV) are characteristics of sustained attention deficits. The clinical significance of RTV has been widely recognized. However, the reliability of RTV measurements has not been widely studied. The present study aimed to assess the test-retest reliability of RTV conventional measurements, e.g., the standard deviation (SD), the coefficient of variation (CV), and a new measurement called the amplitude of low frequency fluctuation (ALFF) of RT. In addition, we aimed to assess differences and similarities of these measurements between different tasks. Method Thirty-seven healthy college students participated in 2 tasks, i.e., an Eriksen flanker task (EFT) and a simple reaction task (SRT), twice over a mean interval of 56 days. Conventional measurements of RTV including RT-SD and RT-CV were assessed first. Then the RT time series were converted into frequency domains, and RT-ALFF was further calculated for the whole frequency band (0.0023-0.167 Hz) and for a few sub-frequency bands including Slow-6(< 0.01 Hz), Slow-5 (0.01-0.027 Hz), Slow-4 (0.027-0.073 Hz), and Slow-3 (0.073-0.167 Hz). The test-retest reliability of these measurements was evaluated through intra-class correlation (ICC) tests. Differences and correlations between each EFT and SRT measurement were further examined during both visits. Results 1) The RT-ALFF of the Slow-5/4/3 and conventional measurements of RT-SD and RT-CV showed moderate to high levels of test-retest reliability. EFT RT-ALFF patterns generated slightly higher ICC values than SRT values in higher frequency bands (Slow-3), but SRT RT-ALFF values showed slightly higher ICC values than EFT values in lower frequency bands (Slow-5 and Slow-4). 2) RT-ALFF magnitudes in each sub-frequency band were greater for the SRT than those for the EFT. 3) The RT-ALFF in the Slow-4 of the EFT was found to be correlated with the RT-ALFF in the Slow-5 of the SRT for both two visits, but no consistently significant correlation was found between the same frequency bands. Conclusions These findings reveal good test-retest reliability for conventional measurements and for the RT-ALFF of RTV. The RT-ALFF presented frequency-dependent similarities across tasks. All of our results reveal the presence of different frequency structures between the two tasks, and thus the frequency-dependent characteristics of different tasks deserve more attention in future studies.	[Liu, Zan-Zan; Qu, Hui-Jie; Ge, Lie-Zhong] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhuo-Ling; Fan, Yi; Zang, Yu-Feng] Hangzhou Normal Univ, Inst Psychol Sci, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhuo-Ling; Fan, Yi; Zang, Yu-Feng] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhuo-Ling; Fan, Yi; Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Han, Meng-Jian] Zhejiang Sci Tech Univ, Dept Phys, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China	Zhejiang Sci-Tech University; Hangzhou Normal University; Hangzhou Normal University; Zhejiang Sci-Tech University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zang, YF (corresponding author), Hangzhou Normal Univ, Inst Psychol Sci, Hangzhou, Zhejiang, Peoples R China.; Zang, YF (corresponding author), Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China.; Zang, YF (corresponding author), Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.; Zhang, H (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	zangyf@gmail.com; kevinhangbnu@foxmail.com	ZANG, Yu-Feng/J-1558-2012	ZANG, Yu-Feng/0000-0003-1833-8010	National Natural Science Foundation of China [81271652, 81520108016, 31471084, 81401481]; Natural Science Foundation of Zhejiang Province, China [LY16C090006]; Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province [20146030301013]; Qian Jiang Distinguished Professor	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province; Qian Jiang Distinguished Professor	This study was supported by the National Natural Science Foundation of China (81271652, 81520108016, 31471084), recipient: Yu-Feng Zang; the National Natural Science Foundation of China (81401481), recipient: Hang Zhang; the Natural Science Foundation of Zhejiang Province, China (LY16C090006), recipient: Lie-Zhong Ge; Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (20146030301013), recipient: Xin Liu and Dr. Yu-Feng Zang is partly supported through the "Qian Jiang Distinguished Professor" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jin-Xuan Cheng for her help with recruiting subjects. Dr. Yu-Feng Zang is partly supported through the "Qian Jiang Distinguished Professor" program. We wish to acknowledge the two anonymous reviewers' careful reviews and helpful suggestions.	Adamo N, 2014, EUR CHILD ADOLES PSY, V23, P69, DOI 10.1007/s00787-013-0428-4; Adamo N, 2014, J ATTEN DISORD, V18, P434, DOI 10.1177/1087054712439419; Anastasi A., 1997, PSYCHOL TESTING; Andellini M, 2015, J NEUROSCI METH, V253, P183, DOI 10.1016/j.jneumeth.2015.05.020; Bastiaansen JA, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.03.005; Bellgrove MA, 2005, NEUROPSYCHOLOGIA, V43, P1847, DOI 10.1016/j.neuropsychologia.2005.03.011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bora E, 2006, PROG NEURO-PSYCHOPH, V30, P1097, DOI 10.1016/j.pnpbp.2006.04.016; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buyck I, 2015, NEUROPSYCHOLOGY, V29, P433, DOI 10.1037/neu0000148; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Epstein JN, 2011, NEUROPSYCHOLOGY, V25, P427, DOI 10.1037/a0022155; Epstein JN, 2010, J INT NEUROPSYCH SOC, V16, P138, DOI 10.1017/S1355617709991111; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Esterman M, 2014, J NEUROSCI, V34, P1724, DOI 10.1523/JNEUROSCI.2658-13.2014; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hahn E, 2011, SCHIZOPHR RES, V133, P218, DOI 10.1016/j.schres.2011.09.026; Helps SK, 2011, NEUROPSYCHOLOGY, V25, P711, DOI 10.1037/a0024479; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Johnson KA, 2008, NEUROPSYCHOLOGIA, V46, P1532, DOI 10.1016/j.neuropsychologia.2008.01.002; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Karalunas SL, 2013, J CHILD PSYCHOL PSYC, V54, P536, DOI 10.1111/jcpp.12028; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Klotz JM, 2012, CHILD NEUROPSYCHOL, V18, P576, DOI 10.1080/09297049.2011.625356; Kuntsi J, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-40; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Rosch KS, 2013, J ABNORM CHILD PSYCH, V41, P485, DOI 10.1007/s10802-012-9690-z; Saville CWN, 2011, PERS INDIV DIFFER, V51, P148, DOI 10.1016/j.paid.2011.03.034; Scheres A, 2003, J ABNORM CHILD PSYCH, V31, P105, DOI 10.1023/A:1021729501230; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wostmann NM, 2013, BRAIN COGNITION, V81, P82, DOI 10.1016/j.bandc.2012.09.010; Yue Y, 2015, BIOMED RES INT, V2015; YUE YY, 2015, BIOMED RES INT, DOI DOI 10.1155/2015/505479; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	42	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184476	10.1371/journal.pone.0184476	http://dx.doi.org/10.1371/journal.pone.0184476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910331	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200049
J	Mo, FH; Jiang, XQ; Duan, SY; Xiao, Z; Xiao, S; Shi, W				Mo, Fuhao; Jiang, Xiaoqing; Duan, Shuyong; Xiao, Zhi; Xiao, Sen; Shi, Wei			Parametric analysis of occupant ankle and tibia injuries in frontal impact	PLOS ONE			English	Article							CRASHES	Objective Non-fatal tibia and ankle injuries without proper protection from the restraint system has gotten wide attention from researchers. This study aimed to investigate occupant tibia and ankle injuries under realistic frontal impact environment that is rarely considered in previous experimental and simulant studies. Methods An integrated occupant-vehicle model was established by coupling an isolated car cab model and a hybrid occupant model with a biofidelic pelvis-lower limb model, while its loading conditions were extracted from the realistic full-frontal impact test. A parametric study was implemented concerning instrument panel (IP) design and pedal intrusion/rotation parameters. Results The significant influences of the IP angle, pedal intrusion and pedal rotation on tibia axial force, tibia bending moment and ankle dorsiflexion angle are noted. By coupling their effects, a new evaluation index named CAIEI (Combined Ankle Injury Evaluation Index) is established to evaluate ankle injury (including tibia fractures in ankle region) risk and severity in robustness. Conclusions Overall results and analysis indicate that ankle dorsiflexion angle should be considered when judging the injury in lower limb under frontal impact. Meanwhile, the current index with coupling effects of tibia axial force, bending moment and ankle dorsiflexion angle is in a good correlation with the simulation injury outcomes.	[Mo, Fuhao; Xiao, Zhi; Shi, Wei] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha, Hunan, Peoples R China; [Jiang, Xiaoqing] CRRC Zhuzhou Inst CO LTD, Zhuzhou, Peoples R China; [Duan, Shuyong; Xiao, Sen] Hebei Univ Technol, Sch Mech Engn, Tianjin, Peoples R China	Hunan University; CRRC Corporation; Hebei University of Technology	Xiao, S (corresponding author), Hebei Univ Technol, Sch Mech Engn, Tianjin, Peoples R China.	xiaosen@hnu.edu.cn	MO, Fuhao/HCI-3604-2022		National Natural Science Foundation of China [51405150, 51475154]; Hunan Province Science and Technology Plan [2015JJ3052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Science and Technology Plan	This study was sponsored by the National Natural Science Foundation of China (Grant No. 51405150 and 51475154) and Hunan Province Science and Technology Plan (Grant No. 2015JJ3052).	Begeman P, 1997, 7 INJ PREV BIOM S DE; China Automotive Technology & Research Center, 2013, CNCAP STANDARD VERSI; Chong M, 2007, J TRAUMA, V62, P720, DOI 10.1097/01.ta.0000222577.43192.a6; Hoglund N, 2003, INT J CRASHWORTHINES, V8, P285, DOI 10.1533/ijcr.2003.0237; Jiang XQ, 2014, THESIS; Kuppa S, 2001, 17 INT TECHN C ENH S; Kuppa S., 2003, 18 INT TECHN C ENH S; Laituri Tony R, 2006, Stapp Car Crash J, V50, P97; [刘志新 Liu Zhixin], 2008, [汽车工程, Automotive Engineering], V30, P969; Morgan RM, 1991, SAE C P; Otte D., 1996, SAE C P; Otte D, 1992, SAE C P; Portier L, 1997, SAE C P; Rudd Rodney, 2004, Stapp Car Crash J, V48, P1; Rudd RW, 2009, 21 INT TECHN C ENH S; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; Sochor MR, 2003, SAE C P; Thomas P, 1995, SAE C P; Yoganandan N, 2014, TRAFFIC INJ PREV, V15, pS151, DOI 10.1080/15389588.2014.935357; Zhu HT, 2009, AUTOMOT ENG, V31, P1143	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184521	10.1371/journal.pone.0184521	http://dx.doi.org/10.1371/journal.pone.0184521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910377	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200054
J	Mao, LP; Wang, YG; Wang, DL; Han, G; Fu, SZ; Wang, JX				Mao, Liping; Wang, Yueguo; Wang, Delin; Han, Gang; Fu, Shouzhong; Wang, Jianxin			TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma	PLOS ONE			English	Article							TIE2-EXPRESSING MONOCYTES; EXPRESSION	Background & aims Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is prevalent worldwide. Despite its limitations, serum alpha-fetoprotein (AFP) remains the most widely-used bio-marker for the diagnosis of HCC. This study aimed to assess whether measurement of peripheral plasma Dickkopf-1 (DKK1) and Tie2-expressing monocytes (TEMs) could overcome the limitations of AFP and improve the diagnostic accuracy of HCC. Methods Plasma DKK1 level and the percentage of TEMs in peripheral CD14+CD16+monocytes from HCC patients (n = 82), HBV-related liver cirrhosis (LC) patients (n = 29), chronic hepatitis B (CHB) infected patients (n = 28) and healthy volunteers (n = 31) were analyzed by ELISA and flow cytometry. Receiver operating characteristic (ROC) curves were used to analyze a single biomarker, or a combination of two or three biomarkers. Univariate and multivariate analyses were performed to assess the significance of each marker in prediction of HCC and AFP-negative HCC from LC patients. Results The percentage of TEMs in peripheral CD14+CD16+monocytes and plasma level of DKK1 in HCC group were significantly higher than those in LC, CHB and healthy control groups (all P-values < 0.05). The percentage of TEMs alone was also significantly higher in AFP-negative HCC group than that in LC, CHB and healthy control groups (all P-values < 0.05). Plasma DKK1 level alone could not distinguish between AFP-negative HCC and LC patients. ROC curves showed that the optimal diagnostic cutoff value was 550.93 ng/L for DKK1 and 4.95% for TEMs. There was no significant difference in AUC of DKK1, TEMs and AFP in HCC diagnosis between the four groups (all P>0.05). A combination of DKK1, TEMs and AFP measurements increased the AUC for HCC diagnosis as compared with either marker alone (0.833; 95% CI 0.768-0.886). The AUC for TEMs was 0.692 (95% CI 0.564-0.819) in differentiating AFP-negative HCC from LC, with a sensitivity of 80.0% and a specificity of 65.52%. Only TEMs prevailed as a significant predictor for AFP-negative HCC differentiating from LC patients in univariate and multivariate analyses (P = 0.016, P = 0.023). Conclusions TEMs and DKK1 may prove to be potential complementary biomarkers for AFP in the diagnosis of HCC. TEMs rather than DKK1 could serve as a complementary biomarker for AFP in the differential diagnosis of AFP-negative HCC versus LC patients.	[Mao, Liping; Wang, Delin; Han, Gang] Nantong Univ, Affiliated Nantong Hosp 3, Dept Lab Med, Nantong, Jiangsu, Peoples R China; [Wang, Yueguo] Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Fu, Shouzhong] Nantong Univ, Affiliated Nantong Hosp 3, Dept Intervent, Nantong, Jiangsu, Peoples R China; [Wang, Jianxin] Nantong Univ, Affiliated Nantong Hosp 3, Dept Liver & Gall Surg, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Wang, YG (corresponding author), Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong, Jiangsu, Peoples R China.	yueguowang@163.com			Project of "226 Project" of Nantong City [CR201401]	Project of "226 Project" of Nantong City	This study was funded by the Project of "226 Project" of Nantong City in 2014 (CR201401).	Chaiteerakij R, 2015, CLIN GASTROENTEROL H, V13, P237, DOI 10.1016/j.cgh.2013.10.038; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; He YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143657; Jang ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151069; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Matsubara T, 2013, HEPATOLOGY, V57, P1416, DOI 10.1002/hep.25965; Ministry of Health of the People's Republic of China, 2011, J CLIN HEPATOL, V27, P1141; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qian EN, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0332-3; Schauer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044450; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Tanaka F, 2002, CANCER RES, V62, P7124; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Voorzanger-Rousselot N, 2009, BRIT J HAEMATOL, V145, P264, DOI 10.1111/j.1365-2141.2009.07587.x; Zhu WW, 2013, CLIN CANCER RES, V19, P3944, DOI 10.1158/1078-0432.CCR-12-3363	18	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183880	10.1371/journal.pone.0183880	http://dx.doi.org/10.1371/journal.pone.0183880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902891	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200022
J	Barreto-Vieira, DF; Jacome, FC; da Silva, MAN; Caldas, GC; de Filippis, AMB; de Sequeira, PC; de Souza, EM; Andrade, AA; Manso, PPD; Trindade, GF; Lima, SMB; Barth, OM				Barreto-Vieira, Debora Ferreira; Jacome, Fernanda Cunha; Nunes da Silva, Marcos Alexandre; Caldas, Gabriela Cardoso; Bispo de Filippis, Ana Maria; de Sequeira, Patricia Carvalho; de Souza, Elen Mello; Andrade, Audrien Alves; de Abreu Manso, Pedro Paulo; Trindade, Gisela Freitas; Barbosa Lima, Sheila Maria; Barth, Ortrud Monika			Structural investigation of C6/36 and Vero cell cultures infected with a Brazilian Zika virus	PLOS ONE			English	Article							DENGUE VIRUS; REPLICATION; VIROPLASM; FACTORIES	Zika virus (ZIKV) is a member of the flavivirus genus, and its genome is approximately 10.8 kilobases of positive-strand RNA enclosed in a capsid and surrounded by a membrane. Studies on the replication dynamics of ZIKV are scarce, which limits the development of antiviral agents and vaccines directed against ZIKV. In this study, Aedes albopictus mosquito lineage cells (C6/36 cells) and African green monkey kidney epithelial cells (Vero cells) were inoculated with a ZIKV sample isolated from a Brazilian patient, and the infection was characterized by immunofluorescence staining, phase contrast light microscopy, transmission electron microscopy and real-time RT-PCR. The infection was observed in both cell lineages, and ZIKV particles were observed inside lysosomes, the rough endoplasmic reticulum and viroplasm-like structures. The susceptibility of C6/36 and Vero cells to ZIKV infection was demonstrated. Moreover, this study showed that part of the replicative cycle may occur within viroplasm-like structures, which has not been previously demonstrated in other flaviviruses.	[Barreto-Vieira, Debora Ferreira; Jacome, Fernanda Cunha; Nunes da Silva, Marcos Alexandre; Caldas, Gabriela Cardoso; de Souza, Elen Mello; Andrade, Audrien Alves; Barth, Ortrud Monika] Fiocruz MS, Inst Oswaldo Cruz, Lab Morphol & Viral Morphogenesis, Ave Brasil, Rio De Janeiro, RJ, Brazil; [Bispo de Filippis, Ana Maria; de Sequeira, Patricia Carvalho] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Ave Brasil, Rio De Janeiro, RJ, Brazil; [de Abreu Manso, Pedro Paulo] Fiocruz MS, Inst Oswaldo Cruz, Lab Pathol, Ave Brasil, Rio De Janeiro, RJ, Brazil; [Trindade, Gisela Freitas; Barbosa Lima, Sheila Maria] Biomanguinhos, Lab Virol Technol, Ave Brasil, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Barreto-Vieira, DF (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Morphol & Viral Morphogenesis, Ave Brasil, Rio De Janeiro, RJ, Brazil.	barreto@ioc.fiocruz.br	de Abreu Manso, Pedro Paulo/M-7326-2018	de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Trindade, Gisela/0000-0002-1630-4143	Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj; European Union's Horizon program [734857]; Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj	Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj; European Union's Horizon program; Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj	This study was funded by Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj, and Ana Maria Bispo de Filippis is supported by the European Union's Horizon 2020 program under grant agreement No. 734857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jose Farias Filho and Arthur da Costa Rasinhas for technical assistance, to the Electron Microscopy Platform of the Biology Institute, Universidade Federal Fluminense and to the Microscopy Platform of Rudolf Barth, Instituto Oswaldo Cruz, Fiocruz. Ana Maria Bispo de Filippis is supported by the European Union's Horizon 2020 program under grant agreement No. 734857.; Financial Support: Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj.	Altman LK, 2007, NY TIMES; Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1; Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Bak A, 2013, J VIROL, V87, P12207, DOI 10.1128/JVI.01883-13; Barreto-Vieira DF, 2015, INDIAN J APPL RES, V5, P44; Barreto-Vieira DF, 2016, MEM I O CRUZ, V111, P1; Barth O. M., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P407; Barth OM, 1996, MEM I OSWALDO CRUZ, V91, P255, DOI 10.1590/S0074-02761996000200025; Barth OM, 2000, ATLAS DENGUE VIRUSES; Barth OM, 2016, MEM I OSWALDO CRUZ, V111, P411, DOI 10.1590/0074-02760150433; Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049; Calvet G, 2016, LANCET INFECT DIS; CHAN JFW, 2016, EMERG MICROBES INFEC, V5; Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014; Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332; Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES; MAJEROWICZ S, 1994, MEM I OSWALDO CRUZ, V89, P395, DOI 10.1590/S0074-02761994000300018; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Nikolay A, 2017, VACCINE; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740; Sesso A., 2007, MANUAL TECNICAS BASI, P13; Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; Szajner P, 2001, J VIROL, V75, P5752, DOI 10.1128/JVI.75.13.5752-5761.2001; Tang BL, 2016, ARCH MICROBIOL, V13; Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0; Wei T, 2006, ARCH VIROL, V151, P1701, DOI 10.1007/s00705-006-0757-4; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; World Health Organization (WHO), 2016, HIST ZIK VIR; XIONG C, 1982, EMBO J, V1, P971, DOI 10.1002/j.1460-2075.1982.tb01280.x; Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206	53	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184397	10.1371/journal.pone.0184397	http://dx.doi.org/10.1371/journal.pone.0184397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898286	gold, Green Published, Green Submitted			2022-12-26	WOS:000410449500025
J	Clark, A; Black, R; Tate, J; Roose, A; Kotloff, K; Lam, D; Blackwelder, W; Parashar, U; Lanata, C; Kang, G; Troeger, C; Platts-Mills, J; Mokdad, A; Sanderson, C; Lamberti, L; Levine, M; Santosham, M; Steele, D				Clark, Andrew; Black, Robert; Tate, Jacqueline; Roose, Anna; Kotloff, Karen; Lam, Diana; Blackwelder, William; Parashar, Umesh; Lanata, Claudio; Kang, Gagandeep; Troeger, Christopher; Platts-Mills, James; Mokdad, Ali; Sanderson, Colin; Lamberti, Laura; Levine, Myron; Santosham, Mathuram; Steele, Duncan		Global Rotavirus Surveillance	Estimating global, regional and national rotavirus deaths in children aged < 5 years: Current approaches, new analyses and proposed improvements	PLOS ONE			English	Article							ENTERIC MULTICENTER; DEVELOPING-COUNTRIES; DIARRHEAL DISEASE; YOUNG-CHILDREN; MORTALITY; BURDEN; GEMS; INFANTS	Background Rotavirus is a leading cause of diarrhoeal mortality in children but there is considerable disagreement about how many deaths occur each year. Methods and findings We compared CHERG, GBD and WHO/CDC estimates of age under 5 years (U5) rotavirus deaths at the global, regional and national level using a standard year (2013) and standard list of 186 countries. The global estimates were 157,398 (CHERG), 122,322 (GBD) and 215,757 (WHO/CDC). The three groups used different methods: (i) to select data points for rotavirus-positive proportions; (ii) to extrapolate data points to individual countries; (iii) to account for rotavirus vaccine coverage; (iv) to convert rotavirus-positive proportions to rotavirus attributable fractions; and (v) to calculate uncertainty ranges. We conducted new analyses to inform future estimates. We found that acute watery diarrhoea was associated with 87% (95% CI 83-90%) of U5 diarrhoea hospitalisations based on data from 84 hospital sites in 9 countries, and 65% (95% CI 57-74%) of U5 diarrhoea deaths based on verbal autopsy reports from 9 country sites. We reanalysed data from the Global Enteric Multicenter Study (GEMS) and found 44% (55% in Asia, and 32% in Africa) rotavirus-positivity among U5 acute watery diarrhoea hospitalisations, and 28% rotavirus-positivity among U5 acute watery diarrhoea deaths. 97% (95% CI 95-98%) of the U5 diarrhoea hospitalisations that tested positive for rotavirus were entirely attributable to rotavirus. For all clinical syndromes combined the rotavirus attributable fraction was 34% (95% CI 31-36%). This increased by a factor of 1.08 (95% CI 1.02-1.14) when the GEMS results were reanalysed using a more sensitive molecular test. Conclusions We developed consensus on seven proposals for improving the quality and transparency of future rotavirus mortality estimates.	[Clark, Andrew; Sanderson, Colin] London Sch Hyg & Trop Med, London, England; [Black, Robert; Santosham, Mathuram] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tate, Jacqueline; Parashar, Umesh] Ctr Dis Control & Prevent, Atlanta, GA USA; [Roose, Anna; Kotloff, Karen; Lam, Diana; Blackwelder, William; Levine, Myron] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Lanata, Claudio] Inst Invest Nutr, Lima, Peru; [Lanata, Claudio] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kang, Gagandeep] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Troeger, Christopher; Mokdad, Ali] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Platts-Mills, James] Univ Virginia, Charlottesville, VA USA; [Global Rotavirus Surveillance] WHO, Geneva, Switzerland; [Lamberti, Laura; Steele, Duncan] Bill & Melinda Gates Fdn, Seattle, WA USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; Christian Medical College & Hospital (CMCH) Vellore; Institute for Health Metrics & Evaluation; University of Virginia; World Health Organization; Bill & Melinda Gates Foundation	Clark, A (corresponding author), London Sch Hyg & Trop Med, London, England.	andrew.clark@lshtm.ac.uk	Mokdad, Ali H./AAD-1232-2022; Sanderson, Colin F/O-9877-2014; kotloff, karen l/E-7768-2012	Mokdad, Ali H./0000-0002-4994-3339; kotloff, karen l/0000-0003-1808-6431; Steele, Andrew Duncan/0000-0002-4946-037X; Sanderson, Colin/0000-0002-4838-6112	Bill and Melinda Gates Foundation [OPP1147721]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	n We acknowledge funding from the Bill and Melinda Gates Foundation-www.gatesfoundation.org (Investment Code OPP1147721). ADS and LML were involved in the preparation of the manuscript and decision to publish.	Agocs M.M., 2014, MMWR-MORBID MORTAL W, V25. 63, P634; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; BHANDARI N, 1992, ACTA PAEDIATR, V81, P3, DOI 10.1111/j.1651-2227.1992.tb12363.x; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; IHME, MORT EST PROC; IHME. GBD, 2013, CSV FIL IHME GBD 201; IHME. GBD, 2013, CSV FIL ROT CO UNPUB; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Rahman AE, 2014, B WORLD HEALTH ORGAN, V92, P664, DOI 10.2471/BLT.13.134809; StataCorp, 2015, STAT STAT SOFTW REL; Stevens GA, 2016, LANCET; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Vos Theo B R, AUTHORS REPLY CORRES; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1	21	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183392	10.1371/journal.pone.0183392	http://dx.doi.org/10.1371/journal.pone.0183392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892480	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000410243200004
J	Krogsgaard, LW; Vestergaard, CH; Plana-Ripoll, O; Lutzen, TH; Vestergaard, M; Fenger-Gron, M; Bech, BH; Rytter, D				Krogsgaard, Lene Wulff; Vestergaard, Claus Hostrup; Plana-Ripoll, Oleguer; Lutzen, Tina Hovgaard; Vestergaard, Mogens; Fenger-Gron, Morten; Bech, Bodil Hammer; Rytter, Dorte			Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINES; DENMARK; SYSTEM	Objective The Human Papillomavirus (HPV) vaccine has increasingly been suspected of adverse effects in Denmark since 2013. By using consultations with the general practitioner (GP) as an indicator for morbidity, this study aims to examine the association between HPV vaccination and morbidity in girls in the Danish childhood immunization program. Methods The study is a nationwide register-based cohort study. Both the HPV and the Measles, Mumps and Rubella (MMR) vaccines were offered to 12-year-old girls in Denmark in the study period (2008-2015). Therefore, both vaccines were included as exposures to allow differentiation between potential effects. This resulted in four exposure groups: HPV only vaccinated, HPV+MMR vaccinated, MMR only vaccinated, and Non-vaccinated girls. Outcomes were: daytime consultation rates and frequent GP attendance (>7 annual GP consultations). We estimated consultation rates by negative binomial regressions analysis and frequent GP attendance by logistic regression analysis. Both analyses were stratified on the years 2008-2013 versus 2014. Results The study included 214,240 girls born in 1996-2002. All vaccinated groups consulted the GP more often than the non-vaccinated group, both before and after the vaccination. After the vaccination, an increase in consultations was observed for all three vaccinated groups; most distinct for girls vaccinated in 2014. For girls vaccinated before 2014, we found a slightly higher risk of frequent GP attendance after vaccination in the HPV only group compared to the non-vaccinated group, whereas in 2014, frequent GP attendance was seen for all three vaccinated groups; most substantial for the MMR only vaccinated group. Conclusion In this study, no exclusive increase in health care utilization was detected after HPV vaccination. However, a general difference in the health care utilization pattern was found between vaccinated and non-vaccinated girls, which increased after the time of vaccination, primarily for girls vaccinated after 2013.	[Krogsgaard, Lene Wulff; Vestergaard, Claus Hostrup; Vestergaard, Mogens; Fenger-Gron, Morten; Bech, Bodil Hammer] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Krogsgaard, Lene Wulff; Lutzen, Tina Hovgaard; Bech, Bodil Hammer; Rytter, Dorte] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark; [Plana-Ripoll, Oleguer] Aarhus Univ, Aarhus BSS, Natl Ctr Register Based Res, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Krogsgaard, LW (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.; Krogsgaard, LW (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark.	l.krogsgaard@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Randrup, Tina/GWV-3271-2022; Plana-Ripoll, Oleguer/E-1448-2015	Bech, Bodil Hammer/0000-0002-0287-3687; Plana-Ripoll, Oleguer/0000-0002-6470-7465; Vestergaard, Claus Hostrup/0000-0003-2916-1548; Krogsgaard, Lene/0000-0002-3936-6240; Rytter, Dorte/0000-0003-1518-0975; Fenger-Gron, Morten/0000-0002-6354-5871; Lutzen, Tina/0000-0002-5384-2557	Program for Clinical Research Infrastructure (PROCRIN)	Program for Clinical Research Infrastructure (PROCRIN)	This work was supported by the Program for Clinical Research Infrastructure (PROCRIN), which was established by the Lundbeck Foundation and Novo Nordisk Foundation and administrated by Danish Regions. The funder had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; [Anonymous], 2015, WKLY EPIDEMIOL REC, V91, P21; Brinth L, 2015, DAN MED J, V62; Brinth LS, 2015, VACCINE, V33, P2602, DOI 10.1016/j.vaccine.2015.03.098; Christiansen T, 2002, HEALTH POLICY, V59, P107, DOI 10.1016/S0168-8510(01)00201-9; Danish Health and Medicines Authority, 2015, REP DAN HLTH MED AUT; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Geier DA, 2016, IMMUNOL RES; Hequet D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172906; Holt N, 2017, DAN MED J, V64; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Stanley M, 2012, VACCINE, V30, pF83, DOI 10.1016/j.vaccine.2012.04.106; Stanley Margaret, 2010, Infect Agent Cancer, V5, P19, DOI 10.1186/1750-9378-5-19; Statens Serum Institut, 2008, HPV VACC CHILDH VACC; Stillo M, 2015, EXPERT OPIN DRUG SAF, V14, P697, DOI 10.1517/14740338.2015.1013532; Svahn MF, 2016, SCAND J PUBLIC HEALT, V44, P551, DOI 10.1177/1403494816653669; The Danish Health Authority, 2017, DAN CHILDH VACC PROG; Vichnin M, 2015, PEDIATR INFECT DIS J, V34, P983, DOI 10.1097/INF.0000000000000793; WHO, 2016, HUMAN PAPILLOMAVIRUS, DOI 10.12968/indn.2020.2.20; WHO, 2016, GLOB ADV COMM VACC S; Willame C, 2016, HUM VACCIN IMMUNOTHE, V18	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184658	10.1371/journal.pone.0184658	http://dx.doi.org/10.1371/journal.pone.0184658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886180	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100174
J	Quinn, KM; Kan, WT; Watson, KA; Liddicoat, BJ; Swan, NG; McQuilten, H; Denton, AE; Li, J; Chen, W; Brown, LE; Jackson, DC; Reading, PC; Doherty, PC; Kedzierska, K; Kedzierski, L; Turner, SJ; La Gruta, NL				Quinn, Kylie M.; Kan, Wan-Ting; Watson, Katherine A.; Liddicoat, Brian J.; Swan, Natasha G.; McQuilten, Hayley; Denton, Alice E.; Li, Jasmine; Chen, Weisan; Brown, Lorena E.; Jackson, David C.; Reading, Patrick C.; Doherty, Peter C.; Kedzierska, Katherine; Kedzierski, Lukasz; Turner, Stephen J.; La Gruta, Nicole L.			Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+T cell response magnitude	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CD8(+) T-CELLS; INFLUENZA INFECTION; DEFICIENT MICE; ALPHA; IMMUNOPATHOLOGY; CYTOKINE; LUNG; INFLAMMATION; LYMPHOTOXIN	TNF is a pro-inflammatory cytokine produced by both lymphoid and non-lymphoid cells. As a consequence of the widespread expression of its receptors (TNFR1 and 2), TNF plays a role in many important biological processes. In the context of influenza A virus (IAV) infection, TNF has variably been implicated in mediating immunopathology as well as suppression of the immune response. Although a number of cell types are able to produce TNF, the ability of CD8(+) T cells to produce TNF following viral infection is a hallmark of their effector function. As such, the regulation and role of CD8(+) T cell-derived TNF following viral infection is of great interest. Here, we show that the biphasic production of TNF by CD8(+) T cells following in vitro stimulation corresponds to distinct patterns of epigenetic modifications. Further, we show that a global loss of TNF during IAV infection results in an augmentation of the peripheral virus-specific CD8+ T cell response. Subsequent adoptive transfer experiments demonstrated that this attenuation of the CD8(+) T cell response was largely, but not exclusively, conferred by extrinsic TNF, with intrinsically-derived TNF making only modest contributions. In conclusion, TNF exerts an immunoregulatory role on CD8(+) T cell responses following IAV infection, an effect that is largely mediated by extrinsically-derived TNF.	[Quinn, Kylie M.; Li, Jasmine; Turner, Stephen J.; La Gruta, Nicole L.] Monash Univ, Infect & Immun Program, Clayton, Vic, Australia; [Quinn, Kylie M.; Li, Jasmine; Turner, Stephen J.; La Gruta, Nicole L.] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Kan, Wan-Ting; Watson, Katherine A.; Liddicoat, Brian J.; Swan, Natasha G.; McQuilten, Hayley; Denton, Alice E.; Brown, Lorena E.; Jackson, David C.; Reading, Patrick C.; Doherty, Peter C.; Kedzierska, Katherine; Turner, Stephen J.; La Gruta, Nicole L.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Chen, Weisan] La Trobe Univ, Sch Mol Sci, T Cell Lab, Bundoora, Vic, Australia; [Doherty, Peter C.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kedzierski, Lukasz] Univ Melbourne, Fac Vet & Agr Sci, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Watson, Katherine A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Liddicoat, Brian J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Denton, Alice E.] Babraham Inst, Babraham Res Campus, Cambridge, England	Monash University; Monash University; University of Melbourne; La Trobe University; St Jude Children's Research Hospital; University of Melbourne; Walter & Eliza Hall Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	La Gruta, NL (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic, Australia.; La Gruta, NL (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia.; La Gruta, NL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia.	Nicole.la.gruta@monash.edu	Quinn, Kylie/AAJ-5066-2021; Turner, Stephen/GXM-4654-2022	Reading, Patrick/0000-0002-8860-5308; Jackson, David/0000-0001-7255-270X; Brown, Lorena/0000-0001-9342-909X; La Gruta, Nicole/0000-0001-5358-9363; Denton, Alice/0000-0002-4580-3443; Turner, Stephen/0000-0002-1002-0000; Quinn, Kylie/0000-0002-0417-3625; Kedzierska, Katherine/0000-0001-6141-335X; McQuilten, Hayley/0000-0002-7089-5300	Australian National Health and Medical Research Council (NHMRC) [APP1071916]; Sylvia and Charles Viertel Senior Medical Research Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Research Fellowship	This work was supported by Australian National Health and Medical Research Council (NHMRC) funding (APP1071916). and a Sylvia and Charles Viertel Senior Medical Research Fellowship awarded to N.L.L.G.; This work was supported by Australian National Health and Medical Research Council (NHMRC) funding (APP1071916). and a Sylvia and Charles Viertel Senior Medical Research Fellowship awarded to N.L.L.G.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; ALLAN W, 1990, J IMMUNOL, V144, P3980; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DeBerge MP, 2014, J IMMUNOL, V192, P5839, DOI 10.4049/jimmunol.1302729; Denton AE, 2011, P NATL ACAD SCI USA, V108, P15306, DOI 10.1073/pnas.1112520108; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; Grell M, 1996, J INFLAMM, V47, P8; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kuprash DV, 2002, MOL CELL BIOL, V22, P8626, DOI 10.1128/MCB.22.24.8626-8634.2002; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; MARASKOVSKY E, 1992, INT IMMUNOL, V4, P475, DOI 10.1093/intimm/4.4.475; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Morty RE, 2007, INTENS CARE MED, V33, P1229, DOI 10.1007/s00134-007-0662-7; Muller S, 2009, EUR J IMMUNOL, V39, P3171, DOI 10.1002/eji.200939554; Nolz JC, 2015, CELL MOL LIFE SCI, V72, P2461, DOI 10.1007/s00018-015-1835-0; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Richter MV, 2007, J IMMUNOL, V179, P5054, DOI 10.4049/jimmunol.179.8.5054; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SARIN A, 1995, J IMMUNOL, V155, P3716; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wortzman ME, 2013, PLOS ONE, V8; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721	36	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184732	10.1371/journal.pone.0184732	http://dx.doi.org/10.1371/journal.pone.0184732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886201	Green Published, gold			2022-12-26	WOS:000410001100184
J	Wang, F; Wang, AY; Chesnelong, C; Yang, Y; Nabbi, A; Thalappilly, S; Alekseev, V; Riabowol, K				Wang, F.; Wang, A. Y.; Chesnelong, C.; Yang, Y.; Nabbi, A.; Thalappilly, S.; Alekseev, V.; Riabowol, K.			ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways	ONCOGENE			English	Article							TUMOR-SUPPRESSOR P33(ING1); HISTONE ACETYLTRANSFERASE; NEURAL PROGENITORS; GROWTH-FACTOR; CANCER CELLS; BRAIN; DIFFERENTIATION; GLIOMA; PROLIFERATION; MUTATIONS	Stem cell-like brain tumor initiating cells (BTICs) cause recurrence of glioblastomas, with BTIC 'stemness' affected by epigenetic mechanisms. The ING family of epigenetic regulators (ING1-5) function by targeting histone acetyltransferase (HAT) or histone deacetylase complexes to the H3K4me3 mark to alter histone acetylation and subsequently, gene expression. Here we find that ectopic expression of ING5, the targeting subunit of HBO1, MOZ and MORF HAT complexes increases expression of the Oct4, Olig2 and Nestin stem cell markers, promotes self-renewal, prevents lineage differentiation and increases stem cell pools in BTIC populations. This activity requires the plant homeodomain region of ING5 that interacts specifically with the H3K4me3 mark. ING5 also enhances PI3K/AKT and MEK/ERK activity to sustain self-renewal of BTICs over serial passage of stem cell-like spheres. ING5 exerts these effects by activating transcription of calcium channel and follicle stimulating hormone pathway genes. In silico analyses of The Cancer Genome Atlas data suggest that ING5 is a positive regulator of BTIC stemness, whose expression negatively correlates with patient prognosis, especially in the Proneural and Classical subtypes, and in tumors with low SOX2 expression. These data suggest that altering histone acetylation status and signaling pathways induced by ING5 may provide useful clinical strategies to target tumor resistance and recurrence in glioblastoma.	[Wang, F.; Yang, Y.; Nabbi, A.; Thalappilly, S.; Alekseev, V.; Riabowol, K.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Wang, F.; Wang, A. Y.; Chesnelong, C.; Yang, Y.; Nabbi, A.; Thalappilly, S.; Riabowol, K.] Univ Calgary, Arnie Charbonneau Canc Inst, Cumming Sch Med, Dept Oncol, 311 HMRB,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Wang, A. Y.; Chesnelong, C.] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB, Canada; [Yang, Y.] Harbin Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Harbin, Heilongjiang, Peoples R China	University of Calgary; University of Calgary; University of Calgary; Harbin Medical University	Riabowol, K (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Riabowol, K (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Cumming Sch Med, Dept Oncol, 311 HMRB,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	karl@ucalgary.ca	Alekseev, Vladislav/G-6157-2019	Alekseev, Vladislav/0000-0001-6751-6210; Thalappilly, Subhash/0000-0003-1766-3057; Nabbi, Arash/0000-0002-3195-7361	Alberta Cancer Foundation [26512]; Canadian Institutes of Health Research [MOP-133646]	Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to Dr. Samuel Weiss's group, particularly Dr. Artee Luchman and Rozina Hassam, from the University of Calgary for providing the patient-derived BTIC lines and technical support. We thank Dr. Jennifer Cobb and Dr. Derrick Rancourt from the University of Calgary for valuable experimental insights. This work was funded by the Alberta Cancer Foundation (Project 26512) and Canadian Institutes of Health Research (MOP-133646). This work was funded by grants from the Alberta Cancer Foundation (Project 26512) and Canadian Institutes of Health Research (MOP-133646) to KR.	Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bhartiya D, 2015, REPRODUCTION, V149, pR35, DOI 10.1530/REP-14-0220; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Caren H, 2015, STEM CELL REP, V5, P829, DOI 10.1016/j.stemcr.2015.09.014; Chai SJ, 2015, ONCOTARGET, V6, P16069, DOI 10.18632/oncotarget.3866; Chang KC, 2012, BIOESSAYS, V34, P301, DOI 10.1002/bies.201100090; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Cusulin C, 2015, STEM CELL REP, V5, P1, DOI 10.1016/j.stemcr.2015.05.010; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; Ding XQ, 2017, ONCOTARGET; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eapen SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040684; FLORES JA, 1990, ENDOCRINOLOGY, V127, P3172, DOI 10.1210/endo-127-6-3172; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao XF, 2013, CANCER RES, V73, P1481, DOI 10.1158/0008-5472.CAN-12-3429; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Gou WF, 2015, ONCOTARGET, V6, P19552, DOI 10.18632/oncotarget.3735; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Heddleston JM, 2012, CELL DEATH DIFFER, V19, P428, DOI 10.1038/cdd.2011.109; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Kang SS, 2010, CANCER RES, V70, P1173, DOI 10.1158/0008-5472.CAN-09-2886; Kataoka H, 2003, CANCER RES, V63, P5785; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kim MS, 2015, FEBS LETT, V589, P941, DOI 10.1016/j.febslet.2015.02.029; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Lawn S, 2015, J BIOL CHEM, V290, P3814, DOI 10.1074/jbc.M114.599373; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Linzen U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123736; Liu L, 2015, BIOCHEM BIOPH RES CO, V461, P525, DOI 10.1016/j.bbrc.2015.04.061; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Liu NS, 2013, CANCER RES, V73, P3749, DOI 10.1158/0008-5472.CAN-12-3684; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Luberg K, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0215-x; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Merson TD, 2006, J NEUROSCI, V26, P11359, DOI 10.1523/JNEUROSCI.2247-06.2006; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; Perez-Campo FM, 2009, BLOOD, V113, P4866, DOI 10.1182/blood-2008-04-152017; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Rajarajacholan UK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001502; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Safa AR, 2015, GENES DIS, V2, P152, DOI 10.1016/j.gendis.2015.02.001; Saito M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015541; Sarkar P, 2016, J PROTEOME RES, V15, P2433, DOI 10.1021/acs.jproteome.5b01118; Schafer A, 2013, GENE DEV, V27, P261, DOI 10.1101/gad.186916.112; Scott M, 2001, J CELL SCI, V114, P3455; Sheikh BN, 2012, J CELL SCI, V125, P295, DOI 10.1242/jcs.077271; Shiseki M, 2003, CANCER RES, V63, P2373; Siegel ET, 2013, REPROD SCI, V20, P211, DOI 10.1177/1933719112461184; Signaroldi E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10753; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Singh SK, 2003, CANCER RES, V63, P5821; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Suzuki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074749; Swartling FJ, 2015, CELL TISSUE RES, V359, P225, DOI 10.1007/s00441-014-2046-y; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Thomas T, 2000, DEVELOPMENT, V127, P2537; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Velasco I, 2011, CURR TOP MED CHEM, V11, P1684, DOI 10.2174/156802611796117586; Vieyra D, 2003, CLIN CANCER RES, V9, P5952; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; Vlismas A, 2016, STEM CELLS DEV, V25, P160, DOI 10.1089/scd.2015.0284; Wang Y, 2012, CELL, V150, P816, DOI 10.1016/j.cell.2012.06.034; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yang HM, 2007, J CELL BIOCHEM, V101, P1198, DOI 10.1002/jcb.21244; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; Zhang F, 2015, ONCOTARGET, V6, P16239, DOI 10.18632/oncotarget.3842; Zhang FR, 2011, ADV DIFFER EQU-NY, DOI 10.1155/2011/213485; Zhang ZB, 2013, INT J ONCOL, V43, P1194, DOI 10.3892/ijo.2013.2054; Zhao NJ, 2010, ONCOL REP, V23, P1443, DOI 10.3892/or_00000782; Zhao S, 2017, ONCOTARGET, V8, P56558, DOI 10.18632/oncotarget.17802; Zhao S, 2016, ONCOTARGET, V7, P54596, DOI 10.18632/oncotarget.10519	94	24	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					286	301		10.1038/onc.2017.324	http://dx.doi.org/10.1038/onc.2017.324			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28925404	hybrid, Green Published			2022-12-26	WOS:000422753900002
J	Niesen, MJM; Marshall, SS; Miller, TF; Clemons, WM				Niesen, Michiel J. M.; Marshall, Stephen S.; Miller, Thomas F., III; Clemons, William M., Jr.			Improving membrane protein expression by optimizing integration efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flow cytometry; membrane protein; molecular dynamics; protein expression; protein translocation; Sec translocon; TatC; topogenesis	TOPOLOGY; SEQUENCE; OVEREXPRESSION; INSERTION; DESIGN; TRANSLOCATION; RECOGNITION; PREDICTION; STABILITY; INDICATOR	The heterologous overexpression of integral membrane proteins in Escherichia coli often yields insufficient quantities of purifiable protein for applications of interest. The current study leverages a recently demonstrated link between co-translational membrane integration efficiency and protein expression levels to predict protein sequence modifications that improve expression. Membrane integration efficiencies, obtained using a coarse-grained simulation approach, robustly predicted effects on expression of the integral membrane protein TatC for a set of 140 sequence modifications, including loop-swap chimeras and single-residue mutations distributed throughout the protein sequence. Mutations that improve simulated integration efficiency were 4-fold enriched with respect to improved experimentally observed expression levels. Furthermore, the effects of double mutations on both simulated integration efficiency and experimentally observed expression levels were cumulative and largely independent, suggesting that multiple mutations can be introduced to yield higher levels of purifiable protein. This work provides a foundation for a general method for the rational overexpression of integral membrane proteins based on computationally simulated membrane integration efficiencies.	[Niesen, Michiel J. M.; Marshall, Stephen S.; Miller, Thomas F., III; Clemons, William M., Jr.] CALTECH, Dept Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Miller, TF; Clemons, WM (corresponding author), CALTECH, Dept Chem & Chem Engn, Pasadena, CA 91125 USA.	tfm@caltech.edu; clemons@caltech.edu	Clemons, William M/D-1026-2009; Niesen, Michiel/AAF-6824-2020	Clemons, William M/0000-0002-0021-889X; 	NIGMS, National Institutes of Health [1R01GM125063]; National Institutes of Health Pioneer Award [5DP1GM105385]; Caltech's Center for Environmental Microbial Interactions; NRSA, National Institutes of Health [5T32GM07616]; Office of Naval Research [N00014-10-1-0884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125063, T32GM007616, DP1GM105385] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech's Center for Environmental Microbial Interactions; NRSA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant 1R01GM125063 (to T. F. M. and W. M. C.). Work in the Clemons laboratory was supported by National Institutes of Health Pioneer Award 5DP1GM105385 (to W. M. C.), funds from Caltech's Center for Environmental Microbial Interactions, and NRSA, National Institutes of Health, Training Grant 5T32GM07616 (to S. S. M.). Work in the Miller group is supported in part by Office of Naval Research Grant N00014-10-1-0884. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fluman N, 2017, P NATL ACAD SCI USA, V114, P7987, DOI 10.1073/pnas.1706905114; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Hanke F, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/53001; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; KREMER K, 1990, J CHEM PHYS, V92, P5057, DOI 10.1063/1.458541; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Lundstrom K, 2006, CELL MOL LIFE SCI, V63, P2597, DOI 10.1007/s00018-006-6252-y; Ma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076913; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marshall SS, 2016, CELL REP, V16, P2169, DOI 10.1016/j.celrep.2016.07.042; Niesen MJM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005427; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Saladi S. M., 2017, BIORXIV, DOI [10.1101/098673, DOI 10.1101/098673]; Saraogi I, 2014, BBA-MOL CELL RES, V1843, P1433, DOI 10.1016/j.bbamcr.2013.10.013; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; Schlinkmann KM, 2012, P NATL ACAD SCI USA, V109, P9810, DOI 10.1073/pnas.1202107109; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DJ, 2013, CURR OPIN CHEM BIOL, V17, P427, DOI 10.1016/j.cbpa.2013.04.002; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Staple DB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248301; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Tress ML, 2010, PROTEINS, V78, P1980, DOI 10.1002/prot.22714; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Woodall NB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9099; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039; Zhang B, 2012, J AM CHEM SOC, V134, P13700, DOI 10.1021/ja3034526; Zhang B, 2010, P NATL ACAD SCI USA, V107, P5399, DOI 10.1073/pnas.0914752107	55	10	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19537	19545		10.1074/jbc.M117.813469	http://dx.doi.org/10.1074/jbc.M117.813469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28918393	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000416226700031
J	Sato-Matsubara, M; Matsubara, T; Daikoku, A; Okina, Y; Longato, L; Rombouts, K; Thuy, LTT; Adachi, J; Tomonaga, T; Ikeda, K; Yoshizato, K; Pinzani, M; Kawada, N				Sato-Matsubara, Misako; Matsubara, Tsutomu; Daikoku, Atsuko; Okina, Yoshinori; Longato, Lisa; Rombouts, Krista; Le Thi Thanh Thuy; Adachi, Jun; Tomonaga, Takeshi; Ikeda, Kazuo; Yoshizato, Katsutoshi; Pinzani, Massimo; Kawada, Norifumi			Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); fibroblast growth factor (FGF); fibrosis; hepatic stellate cell (HSC); liver; cytoglobin	FAT-STORING CELLS; LIVER FIBROSIS; OXIDATIVE STRESS; RAT; FIBROGENESIS; KINASE; PHOSPHORYLATION; PROLIFERATION; TRANSCRIPTION; MECHANISMS	Cytoglobin (CYGB) belongs to the mammalian globin family and is exclusively expressed in hepatic stellate cells (HSCs) in the liver. In addition to its gas-binding ability, CYGB is relevant to hepatic inflammation, fibrosis, and cancer because of its anti-oxidative properties; however, the regulation of CYGB gene expression remains unknown. Here, we sought to identify factors that induce CYGB expression in HSCs and to clarify the molecular mechanism involved. We used the human HSC cell line HHSteC and primary human HSCs isolated from intact human liver tissues. In HHSteC cells, treatment with a culture supplement solution that included fibroblast growth factor 2 (FGF2) increased CYGB expression with concomitant and time-dependent -smooth muscle actin (SMA) down-regulation. We found that FGF2 is a key factor in inducing the alteration in both CYGB and SMA expression in HHSteCs and primary HSCs and that FGF2 triggered the rapid phosphorylation of both c-Jun N-terminal kinase (JNK) and c-JUN. Both the JNK inhibitor PS600125 and transfection of c-JUN-targeting siRNA abrogated FGF2-mediated CYGB induction, and conversely, c-JUN overexpression induced CYGB and reduced SMA expression. Chromatin immunoprecipitation analyses revealed that upon FGF2 stimulation, phospho-c-JUN bound to its consensus motif (5-TGA(C/G)TCA), located -218 to -222 bases from the transcription initiation site in the CYGB promoter. Of note, in bile duct-ligated mice, FGF2 administration ameliorated liver fibrosis and significantly reduced HSC activation. In conclusion, FGF2 triggers CYGB gene expression and deactivation of myofibroblastic human HSCs, indicating that FGF2 has therapeutic potential for managing liver fibrosis.	[Sato-Matsubara, Misako; Daikoku, Atsuko; Okina, Yoshinori; Le Thi Thanh Thuy; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; [Sato-Matsubara, Misako; Yoshizato, Katsutoshi] Osaka City Univ, Grad Sch Med, Endowed Lab Synthet Biol, Osaka 5458585, Japan; [Matsubara, Tsutomu; Ikeda, Kazuo] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 5458585, Japan; [Longato, Lisa; Rombouts, Krista; Pinzani, Massimo] UCL, Inst Liver & Digest Hlth, Regenerat Med & Fibrosis Grp, Royal Free, London NW3 2PF, England; [Adachi, Jun; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Proteome Res Ctr, Lab Proteome Res, Osaka 5670085, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; University of London; University College London; Royal Free London NHS Foundation Trust; National Institute of Health Sciences - Japan	Kawada, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan.	kawadanori@med.osaka-cu.ac.jp	kawada, norifumi/AAS-1367-2020; Adachi, Jun/H-2813-2014; Thuy, Le Thi Thanh/GLS-7476-2022; Rombouts, Krista/ABB-2602-2020; Rombouts, Krista/AAE-8179-2020	Adachi, Jun/0000-0003-1220-3246; Rombouts, Krista/0000-0001-9440-0571; Thuy, Le Thi Thanh/0000-0003-4460-735X	Japan Society for the Promotion of Science KAKENHI [15K08314]; Japan Society for the Promotion of Science [25293177, 16H05290]; Japan Agency for Medical Research and Development	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant-in-aid for Scientific Research (C) 15K08314. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Grants-in-aid for Scientific Research 25293177 and 16H05290 from Japan Society for the Promotion of Science and a Grant for Research Program on Hepatitis from the Japan Agency for Medical Research and Development. To whom correspondence should be addressed: Dept. of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, 545-8585, Japan. Tel.: 81-6-6645-3897; Fax: 81-6-6646-6072; E-mail: kawadanori@med.osaka-cu.ac.jp.	Ahmad A, 2012, SAUDI J GASTROENTERO, V18, P155, DOI 10.4103/1319-3767.96445; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Das A, 2010, AM J PHYSIOL-GASTR L, V298, pG908, DOI 10.1152/ajpgi.00510.2009; de Andrade KQ, 2015, INT J MOL SCI, V16, P30269, DOI 10.3390/ijms161226225; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; El Taghdouini A, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0031-z; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Galli A, 2000, HEPATOLOGY, V31, P101, DOI 10.1002/hep.510310117; Gandhi C. R., 2015, STELLATE CELLS HLTH; Gursel DB, 2011, NEURO-ONCOLOGY, V13, P610, DOI 10.1093/neuonc/nor035; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; He X, 2011, PROTEIN J, V30, P437, DOI 10.1007/s10930-011-9340-2; Heier CR, 2009, HUM MOL GENET, V18, P1310, DOI 10.1093/hmg/ddp030; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ismail Mona H, 2009, Saudi J Gastroenterol, V15, P72, DOI 10.4103/1319-3767.45072; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kawada N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00329; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Thuy LTT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24990; Thuy LTT, 2015, AM J PATHOL, V185, P1045, DOI 10.1016/j.ajpath.2014.12.017; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep23508; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135; Nair DG, 2014, J CELL MOL MED, V18, P444, DOI 10.1111/jcmm.12193; Nakatani K, 2002, VIRCHOWS ARCH, V441, P466, DOI 10.1007/s00428-002-0631-z; Pan RL, 2015, HEPATOLOGY, V61, P1708, DOI 10.1002/hep.27649; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Rombouts K, 2016, METHODS MOL BIOL, V1376, P203, DOI 10.1007/978-1-4939-3170-5_17; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuppan D, 2012, J HEPATOL, V56, pS66, DOI 10.1016/S0168-8278(12)60008-7; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Thuy TTV, 2017, SCI REP-UK, V7, DOI 10.1038/srep41888; Wake K, 1980, Int Rev Cytol, V66, P303; Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; Welsh JA, 2013, J PEDIATR-US, V162, P496, DOI 10.1016/j.jpeds.2012.08.043; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5	55	21	21	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18961	18972		10.1074/jbc.M117.793794	http://dx.doi.org/10.1074/jbc.M117.793794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28916723	Green Published, hybrid			2022-12-26	WOS:000415848000020
J	Dutzmann, J; Musmann, RJ; Haertle, M; Daniel, JM; Sonnenschein, K; Schafer, A; Kolkhof, P; Bauersachs, J; Sedding, DG				Dutzmann, Jochen; Musmann, Robert-Jonathan; Haertle, Marco; Daniel, Jan-Marcus; Sonnenschein, Kristina; Schaefer, Andreas; Kolkhof, Peter; Bauersachs, Johann; Sedding, Daniel G.			The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; BAY 94-8862; EPLERENONE; ALDOSTERONE; MICE; HYPERPLASIA	Background The novel nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone holds promise to be safe and efficient in the treatment of patients with heart failure and/or chronic kidney disease. However, its effects on vascular function remain elusive. Purpose The aim of this study was to determine the functional effect of selective MR antagonism by finerenone in vascular cells in vitro and the effect on vascular remodeling following acute vascular injury in vivo. Methods and results In vitro, finerenone dose-dependently reduced aldosterone-induced smooth muscle cell (SMC) proliferation, as quantified by BrdU incorporation, and prevented aldosteroneinduced endothelial cell (EC) apoptosis, as measured with a flow cytometry based caspase 3/7 activity assay. In vivo, oral application of finerenone resulted in an accelerated re-endothelialization 3 days following electric injury of the murine carotid artery. Furthermore, finerenone treatment inhibited intimal and medial cell proliferation following wire-induced injury of the murine femoral artery 10 days following injury and attenuated neointimal lesion formation 21 days following injury. Conclusion Finerenone significantly reduces apoptosis of ECs and simultaneously attenuates SMC proliferation, resulting in accelerated endothelial healing and reduced neointima formation of the injured vessels. Thus, finerenone appears to provide favorable vascular effects through restoring vascular integrity and preventing adverse vascular remodeling.	[Dutzmann, Jochen; Musmann, Robert-Jonathan; Haertle, Marco; Daniel, Jan-Marcus; Sonnenschein, Kristina; Schaefer, Andreas; Bauersachs, Johann; Sedding, Daniel G.] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Kolkhof, Peter] Bayer AG, Global Drug Discovery, Cardiol Res, Wuppertal, Germany	Hannover Medical School; Bayer AG	Sedding, DG (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.		Schäfer, Andreas/AAQ-9512-2021; Haertlé, Marco/GON-4471-2022		Bayer Pharma AG (Wuppertal, Germany); Hannover Medical School (Hochschulinterne Leistungsforderung, HiLF); German Heart Foundation (Deutsche Herzstiftung); German Research Foundation (Cluster of excellence REBIRTH)	Bayer Pharma AG (Wuppertal, Germany); Hannover Medical School (Hochschulinterne Leistungsforderung, HiLF); German Heart Foundation (Deutsche Herzstiftung); German Research Foundation (Cluster of excellence REBIRTH)	This study was supported by a fund from Bayer Pharma AG (Wuppertal, Germany) to DGS and JB. The funder provided support in the form of salaries for author PK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JD has received research support from the Hannover Medical School (Hochschulinterne Leistungsforderung, HiLF). KS has received a grant of the German Heart Foundation (Deutsche Herzstiftung). DGS and JB received research support from the German Research Foundation (Cluster of excellence REBIRTH).	Amano T, 2006, AM J CARDIOL, V97, P785, DOI 10.1016/j.amjcard.2005.10.017; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Barfacker L, 2014, J CARDIOVASC PHARM; Bauersachs J, 2015, HYPERTENSION, V65, P257, DOI 10.1161/HYPERTENSIONAHA.114.04488; Bauersachs J, 2013, EUR HEART J, V34, P2426, DOI 10.1093/eurheartj/eht235; Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; Carmeliet P, 1997, AM J PATHOL, V150, P761; Daniel JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0261-9; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Favre J, 2011, AM J PHYSIOL-HEART C, V300, pH2035, DOI 10.1152/ajpheart.00552.2010; Filippatos G, 2016, EUR HEART J, V37, P2105, DOI 10.1093/eurheartj/ehw132; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Galigniana MD, 1996, LIFE SCI, V59, P511, DOI 10.1016/0024-3205(96)00331-1; Gueret A, 2016, HYPERTENSION, V67, P717, DOI 10.1161/HYPERTENSIONAHA.115.06709; Ivanes F, 2012, EUR HEART J, V33, P191, DOI 10.1093/eurheartj/ehr176; Jia GH, 2016, CIRC RES, V118, P935, DOI 10.1161/CIRCRESAHA.115.308269; Kolkhof P, 2015, CURR OPIN NEPHROL HY, V24, P417, DOI 10.1097/MNH.0000000000000147; Kursaklioglu H, 2004, ANN ACAD MED SINGAP, V33, P769; Le HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145958; Montalescot G, 2014, EUR HEART J, V35, P2295, DOI 10.1093/eurheartj/ehu164; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; Pruthi D, 2014, ARTERIOSCL THROM VAS, V34, P355, DOI 10.1161/ATVBAHA.113.302854; Raz-Pasteur A, 2012, J CARDIOVASC PHARM, V60, P508, DOI 10.1097/FJC.0b013e31826f5535; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Sun JY, 2016, ARTERIOSCL THROM VAS, V36, P874, DOI 10.1161/ATVBAHA.115.307031; Wakabayashi K, 2006, INT J CARDIOL, V107, P260, DOI 10.1016/j.ijcard.2005.03.078; Zwadlo C, 2013, CURR OPIN PHARMACOL, V13, P280, DOI 10.1016/j.coph.2012.12.007	30	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184888	10.1371/journal.pone.0184888	http://dx.doi.org/10.1371/journal.pone.0184888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926607	Green Submitted, gold, Green Published			2022-12-26	WOS:000411166600048
J	Salabert, AS; Vaysse, L; Beaurain, M; Alonso, M; Arribarat, G; Lotterie, JA; Loubinoux, I; Tafani, M; Payoux, P				Salabert, Anne-Sophie; Vaysse, Laurence; Beaurain, Marie; Alonso, Mathieu; Arribarat, Germain; Lotterie, Jean-Albert; Loubinoux, Isabelle; Tafani, Mathieu; Payoux, Pierre			Imaging grafted cells with [F-18] FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model	PLOS ONE			English	Article							REPORTER GENE-EXPRESSION; PRECLINICAL EVALUATION; EXTENSIVE METHYLATION; TRANSGENE EXPRESSION; FOCUSED ULTRASOUND; IN-VIVO; PET; PROMOTER; THERAPY; STROKE	Introduction Cell transplantation is an innovative therapeutic approach after brain injury to compensate for tissue damage. To have real-time longitudinal monitoring of intracerebrally grafted cells, we explored the feasibility of a molecular imaging approach using thymidine kinase HSV1-TK gene encoding and [F-18]FHBG as a reporter probe to image enzyme expression. Methods A stable neuronal cell line expressing HSV1-TK was developed with an optimised mammalian expression vector to ensure long-term transgene expression. After [F-18]FHBG incubation under defined parameters, calibration ranges from 1 X 10(4) to 3 X 10(6) Neuro2A-TK cells were analysed by gamma counter or by PET-camera. In parallel, grafting with different quantities of [F-18]FHBG prelabelled Neuro2A-TK cells was carried out in a rat brain injury model induced by stereotaxic injection of malonate toxin. Image acquisition of the rats was then performed with PET/CT camera to study the [F-18]FHBG signal of transplanted cells in vivo. Results Under the optimised incubation conditions, [F-18]FHBG cell uptake rate was around 2.52%. In-vitro calibration range analysis shows a clear linear correlation between the number of cells and the signal intensity. The PET signal emitted into rat brain correlated well with the number of cells injected and the number of surviving grafted cells was recorded via the in-vitro calibration range. PET/CT acquisitions also allowed validation of the stereotaxic injection procedure. Technique sensitivity was evaluated under 5 X 104 grafted cells in vivo. No [F-18]FHBG or [F-18]metabolite release was observed showing a stable cell uptake even 2 h post -graft. Conclusion The development of this kind of approach will allow grafting to be controlled and ensure longitudinal follow-up of cell viability and biodistribution after intracerebral injection.	[Salabert, Anne-Sophie; Vaysse, Laurence; Beaurain, Marie; Arribarat, Germain; Lotterie, Jean-Albert; Loubinoux, Isabelle; Tafani, Mathieu; Payoux, Pierre] Univ Toulouse, INSERM, UPS, ToNIC,Toulouse NeuroImaging Ctr,UMR1214, Toulouse, France; [Salabert, Anne-Sophie; Alonso, Mathieu; Tafani, Mathieu] Univ Hosp, Radiopharm Unit, Toulouse, France; [Lotterie, Jean-Albert; Payoux, Pierre] Univ Hosp, Nucl Med Unit, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse	Salabert, AS (corresponding author), Univ Toulouse, INSERM, UPS, ToNIC,Toulouse NeuroImaging Ctr,UMR1214, Toulouse, France.; Salabert, AS (corresponding author), Univ Hosp, Radiopharm Unit, Toulouse, France.	anne-sophie.salabert@inserm.fr	Payoux, Pierre/AGU-9727-2022; Loubinoux, Isabelle/E-5537-2016	Payoux, Pierre/0000-0002-1374-1620; Loubinoux, Isabelle/0000-0003-4461-0890; Vaysse, Laurence/0000-0001-6371-9360; ARRIBARAT, Germain/0000-0002-8754-8110; Beaurain, Marie/0000-0002-5301-871X	French National Agency for Research [ANR-11-LABX-0018-01]	French National Agency for Research(French National Research Agency (ANR))	This work has been supported in part by a grant from the French National Agency for Research called "Investissements d'Avenir" no ANR-11-LABX-0018-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauddin MM, 2010, CURR TOP MED CHEM, V10, P1617; Alauddin MM, 2001, J NUCL MED, V42, P1682; Bazzani RP, 2016, BIOMATERIALS, V93, P20, DOI 10.1016/j.biomaterials.2016.03.029; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Buursma AR, 2006, NUCL MED COMMUN, V27, P25, DOI 10.1097/01.mnm.0000186609.12895.20; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Daadi MM, 2013, CELL TRANSPLANT, V22, P881, DOI 10.3727/096368912X656144; Eissenberg LG, 2014, FRONT PHARMACOL, P5; Eissenberg LG, 2015, MOL THER, V23, P1110, DOI 10.1038/mt.2015.48; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Johnson M, 2009, J NUCL MED, V50, P757, DOI 10.2967/jnumed.108.058438; Kanda GN, 2014, INT J PHARMACEUT, V464, P27, DOI 10.1016/j.ijpharm.2014.01.025; Likar Y, 2008, J NUCL MED, V49, P713, DOI 10.2967/jnumed.107.046425; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Loser P, 1998, J VIROL, V72, P180; Micci MA, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0129-7; Mitsui M, 2009, J GENE MED, V11, P435, DOI 10.1002/jgm.1317; Moisan A, 2014, CEREBROVASC DIS, V38, P344, DOI 10.1159/000368597; Muller U, 2013, AM J NUCL MED MOLEC, V3, P71; Ponde DE, 2004, NUCL MED BIOL, V31, P133, DOI 10.1016/S0969-8051(03)00096-9; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ray P, 2011, J BIOSCIENCES, V36, P499, DOI 10.1007/s12038-011-9079-0; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Schaller BJ, 2008, CURR MOL MED, V8, P711, DOI 10.2174/156652408786733766; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Sullivan EV, 2006, ALCOHOL CLIN EXP RES, V30, P1234, DOI 10.1111/j.1530-0277.2006.00145.x; Tensaouti F, 2008, EUR SOC MAGN RES MED, P2; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Tsuchiya R, 2002, BRAIN RES, V956, P221, DOI 10.1016/S0006-8993(02)03518-7; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; Vaysse L, 2015, BEHAV NEUROSCI; Waerzeggers Y, 2008, MOL IMAGING, V7, P77, DOI 10.2310/7290.2008.0010; Yaghoubi S, 2001, J NUCL MED, V42, P1225; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459; Yaghoubi SS, 2012, THERANOSTICS, V2, P374, DOI 10.7150/thno.3677; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006; Yang FY, 2015, ONCOTARGET, V6, P36260, DOI 10.18632/oncotarget.5389; Zhao C, 2010, OPEN NUCL MED J, V2, P171, DOI DOI 10.2174/1876388X01002010171	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184630	10.1371/journal.pone.0184630	http://dx.doi.org/10.1371/journal.pone.0184630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926581	Green Submitted, gold, Green Published			2022-12-26	WOS:000411166600027
J	Nault, R; Fader, KA; Harkema, JR; Zacharewski, T				Nault, Rance; Fader, Kelly A.; Harkema, Jack R.; Zacharewski, Tim			Loss of liver-specific and sexually dimorphic gene expression by aryl hydrocarbon receptor activation in C57BL/6 mice	PLOS ONE			English	Article							FEMALE MOUSE-LIVER; GROWTH-HORMONE; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN TCDD; HEPATIC-FIBROSIS; LIPID-METABOLISM; ZINC FINGERS; BINDING; ZHX2; 3-METHYLCHOLANTHRENE; HEPATOTOXICITY	The aryl hydrocarbon receptor (AhR) is a highly conserved transcription factor that mediates a broad spectrum of species-, strain-, sex-, age-, tissue-, and cell-specific responses elicited by structurally diverse ligands including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Dose-dependent effects on liver-specific and sexually dimorphic gene expression were examined in male and female mice gavaged with TCDD every 4 days for 28 or 92 days. RNA-seq data revealed the coordinated repression of 181 genes predominately expressed in the liver including albumin (3.7-fold), alpha-fibrinogen (14.5-fold), and beta-fibrinogen (17.4-fold) in males with corresponding AhR enrichment at 2 hr. Liver-specific genes exhibiting sexually dimorphic expression also demonstrated diminished divergence between sexes. For example, male-biased Gstp1 was repressed 3.0-fold in males and induced 4.5-fold in females, which were confirmed at the protein level. Disrupted regulation is consistent with impaired GHR-JAK2-STAT5 signaling and inhibition of female specific CUX2-mediated transcription as well as the repression of other key transcriptional regulators including Ghr, Stat5b, Bcl6, Hnf4a, Hnf6, Foxa1/2/3, and Zhx2. Attenuated liver-specific and sexually dimorphic gene expression was concurrent with the induction of fetal genes such as alpha-fetoprotein. The results suggest AhR activation causes the loss of liver-specific and sexually dimorphic gene expression producing a functionally "de-differentiated" hepatic phenotype.	[Nault, Rance; Fader, Kelly A.; Zacharewski, Tim] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Nault, Rance; Fader, Kelly A.; Zacharewski, Tim] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Harkema, Jack R.] Michigan State Univ, Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Zacharewski, T (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.; Zacharewski, T (corresponding author), Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA.	tzachare@msu.edu		Fader, Kelly/0000-0002-8797-5577; Nault, Rance/0000-0002-6822-4962	National Institute of Environmental Health Sciences Superfund Research Program [NIEHS SRP P42ES04911]; AgBioResearch at MSU; MSU Barnett Rosenberg Endowed Assistantship and Integrative Training in the Pharmacological Sciences grant [NIH 5T32GM092715]; Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award [DFS-140386]	National Institute of Environmental Health Sciences Superfund Research Program; AgBioResearch at MSU; MSU Barnett Rosenberg Endowed Assistantship and Integrative Training in the Pharmacological Sciences grant; Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Institute of Environmental Health Sciences Superfund Research Program (NIEHS SRP P42ES04911). TRZ is supported by AgBioResearch at MSU. RN was supported by the MSU Barnett Rosenberg Endowed Assistantship and Integrative Training in the Pharmacological Sciences grant (NIH 5T32GM092715). KAF is supported by the Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award (DFS-140386).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Bunger MK, 2008, TOXICOL SCI, V106, P83, DOI 10.1093/toxsci/kfn149; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Conforto TL, 2012, MOL CELL BIOL, V32, P4611, DOI 10.1128/MCB.00886-12; Creasy Kate Townsend, 2016, Gene Expression, V17, P7, DOI 10.3727/105221616X691712; Della Torre S, 2017, CELL METAB, V25, P499, DOI 10.1016/j.cmet.2017.01.006; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; EMMETT EA, 1985, ENVIRON HEALTH PERSP, V60, P185, DOI 10.2307/3429960; Fader KA, 2017, TOXICOL APPL PHARM, V321, P1, DOI 10.1016/j.taap.2017.02.006; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Fernandez-Perez Leandro, 2013, Front Endocrinol (Lausanne), V4, P66, DOI 10.3389/fendo.2013.00066; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gargalovic PS, 2010, CIRC-CARDIOVASC GENE, V3, P60, DOI 10.1161/CIRCGENETICS.109.902320; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Huang GM, 2012, MOL PHARMACOL, V81, P338, DOI 10.1124/mol.111.075952; Hurst JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44992; Jiang JY, 2017, J BIOL CHEM, V292, P6765, DOI 10.1074/jbc.M116.768275; Jin L, 2009, DEV BIOL, V336, P294, DOI 10.1016/j.ydbio.2009.09.026; Kang MJ, 2005, J PROTEOME RES, V4, P1248, DOI 10.1021/pr049756d; Kociba R J, 1979, Ann N Y Acad Sci, V320, P397, DOI 10.1111/j.1749-6632.1979.tb56620.x; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lebensztejn DM, 2016, ACTA BIOCHIM POL, V63, P459, DOI 10.18388/abp.2015_1252; Lee C, 2012, CAN J PHYSIOL PHARM, V90, P1354, DOI [10.1139/Y2012-099, 10.1139/y2012-099]; Lee J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1840-6; Morford LA, 2007, HEPATOLOGY, V46, P1541, DOI 10.1002/hep.21825; Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Nault R, 2016, TOXICOL SCI; Nault R, 2017, CHEM RES TOXICOL, V30, P1060, DOI 10.1021/acs.chemrestox.6b00430; Nault R, 2016, TOXICOL SCI, V154, P381, DOI 10.1093/toxsci/kfw175; Nault R, 2016, TOXICOL SCI, V154, P253, DOI 10.1093/toxsci/kfw163; Nault R, 2016, TOXICOL SCI, V149, P358, DOI 10.1093/toxsci/kfv245; Nault R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1527-z; NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8; Nukaya M, 2004, FEBS LETT, V558, P96, DOI 10.1016/S0014-5793(03)01528-X; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148308; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150284; Peterson ML, 2011, SEMIN CANCER BIOL, V21, P21, DOI 10.1016/j.semcancer.2011.01.001; Prokopec SD, 2015, TOXICOL APPL PHARM, V284, P188, DOI 10.1016/j.taap.2015.02.012; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timsit YE, 2000, TOXICOL APPL PHARM, V163, P105, DOI 10.1006/taap.1999.8862; Timsit YE, 2002, ENDOCRINOLOGY, V143, P3284, DOI 10.1210/en.2002-220212; VOS JG, 1974, TOXICOL APPL PHARM, V29, P229, DOI 10.1016/0041-008X(74)90060-X; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang YX, 2016, GENE DEV, V30, P1636, DOI 10.1101/gad.281972.116; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7	55	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184842	10.1371/journal.pone.0184842	http://dx.doi.org/10.1371/journal.pone.0184842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922406	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300033
J	Griffen, TC; Haley, MS; Fontanini, A; Maffei, A				Griffen, Trevor C.; Haley, Melissa S.; Fontanini, Alfredo; Maffei, Arianna			Rapid plasticity of visually evoked responses in rat monocular visual cortex	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; CORTICAL INHIBITION; SYNAPTIC RESPONSES; EXPERIENCE; NEURONS; PERIODS; ABSENCE	Sensory cortical circuits are shaped by experience during sensitive periods in development. In the primary visual cortex (V1) altered visual experience results in changes in visual responsiveness of cortical neurons. The experience-dependent refinement of the circuit in V1 is thought to rely on competitive interactions between feedforward circuits driven by the two eyes. However, recent data have provided evidence for an additional role of cortico-cortical circuits in this process. Indeed, experience-dependent changes in intracortical circuits can be induced rapidly and may result in rapid-onset functional changes. Unilateral occlusion of vision rapidly alters visual responsiveness, synaptic strength and connectivity of local circuits in the binocular region of V1 (V1b), where the inputs from the two eyes converge. In the monocular region of rodent V1 (V1m), where feedforward inputs from the ipsilateral eye are virtually absent, visual deprivation induces rapid plasticity in local circuits; however, functional changes seem to occur only after long periods of deprivation. In V1m there is currently no evidence for functional changes occurring within a time window compatible with that of local circuit plasticity. Here, we probed the visual responsiveness of neurons in rat V1m and assessed the effect of one day unilateral eye lid suture on single neuron visual responses. We report a novel form of plasticity within V1m that occurs on a timescale consistent with the earliest known changes in synaptic strength. Our data provide new insights into how sensory experience can rapidly modulate neuronal responses, even in the absence of direct competition between feedforward thalamocortical inputs.	[Griffen, Trevor C.; Haley, Melissa S.; Fontanini, Alfredo; Maffei, Arianna] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Griffen, Trevor C.; Maffei, Arianna] SUNY Eye Inst, Syracuse, NY 13202 USA; [Griffen, Trevor C.] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Fontanini, Alfredo; Maffei, Arianna] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Maffei, A (corresponding author), SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA.; Maffei, A (corresponding author), SUNY Eye Inst, Syracuse, NY 13202 USA.; Maffei, A (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	Arianna.Maffei@StonyBrook.edu		Maffei, Arianna/0000-0001-6755-8904	NIH/R01 [EY019885]; Whitehall Foundation; NIHGM MSTP Training award [T32-GM008444]	NIH/R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; NIHGM MSTP Training award	This study was supported by NIH/R01 EY019885 and the Whitehall Foundation Award to A.M and by NIHGM MSTP Training award T32-GM008444 to T.C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 1999, J NEUROSCI, V19, P4388; Caleo M, 1999, EUR J NEUROSCI, V11, P2979, DOI 10.1046/j.1460-9568.1999.00737.x; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Iurilli G, 2012, CEREB CORTEX, V22, P2171, DOI 10.1093/cercor/bhr304; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Krahe TE, 2011, J NEUROSCI, V31, P6842, DOI 10.1523/JNEUROSCI.1173-11.2011; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Ma WP, 2013, J NEUROSCI, V33, P11276, DOI 10.1523/JNEUROSCI.5598-12.2013; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Manning KA, 2009, NEUROSCIENCE, V163, P695, DOI 10.1016/j.neuroscience.2009.06.060; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Priebe NJ, 2008, J NEUROSCI, V28, P8553, DOI 10.1523/JNEUROSCI.2182-08.2008; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; Stone ME, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00003; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2015, CURR OPIN NEUROBIOL, V35, P44, DOI 10.1016/j.conb.2015.06.006; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; TYLER CW, 1977, INVEST OPHTH VIS SCI, V16, P1070; Wang L, 2013, J NEUROSCI, V33, P4181, DOI 10.1523/JNEUROSCI.4423-12.2013; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184618	10.1371/journal.pone.0184618	http://dx.doi.org/10.1371/journal.pone.0184618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910338	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200069
J	Lee, WJ; Jung, KH; Ryu, YJ; Kim, JM; Lee, ST; Chu, K; Kim, M; Lee, SK; Roh, JK				Lee, Woo-Jin; Jung, Keun-Hwa; Ryu, Young Jin; Kim, Jeong-Min; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression	PLOS ONE			English	Article							SMALL VESSEL DISEASE; AUSTRIAN STROKE PREVENTION; CHRONIC KIDNEY-DISEASE; INTERSTITIAL FLUID; ARTERIAL STIFFNESS; AMYLOID ANGIOPATHY; BRAIN; DRAINAGE; LEUKOARAIOSIS; PULSATILITY	Cerebral white matter hyperintensities (WMHs) are central MRI markers of the brain aging process, but the mechanisms for its progression remain unclear. In this study, we aimed to determine whether the baseline serum cystatin C level represented one mechanism underlying WMH progression, and whether it was associated with the long-term progression of cerebral WMH volume in MRI. 166 consecutive individuals who were >= 50 years of age and who underwent initial/follow-up MRI evaluations within an interval of 34-45 months were included. Serum cystatin C level, glomerular-filtration rate (GFR), and other laboratory parameters were measured at their initial evaluation and at the end of follow-up. Cerebrovascular risk factors, medications, and blood-pressure parameters were also reviewed. WMH progression rate was measured by subtracting WMH volume at baseline from that at the follow-up using volumetric analysis, divided by the MRI intervals. At baseline, WMH volume was 9.61 +/- 13.17 mL, mean GFR was 77.3 +/- 22.8 mL/min, and mean cystatin C level was 0.92 +/- 0.52 mg/L. After 37.9 +/- 3.4 months, the change in WMH volume was 3.64 +/- 6.85 mL, the progression rate of WMH volume was 1.18 +/- 2.28 mL/year, the mean Delta GFR was 2.4 +/- 7.9 mL/min, and the mean Delta cystatin C was 0.03 +/- 0.34 mg/L. The progression rate of WMH volume was linearly associated with cystatin C level (B coefficient = 0.856; 95% confidence interval [CI] 0.174-1.538; P = 0.014), along with the baseline WMH volume (B = 0.039; 95% CI 0.019-0.059; P<0.001), after adjusting for the conventional vascular risk factors, laboratory parameters, medication profiles, and GFR. Especially, patients with a baseline level of cystatin C >= 1.00 mg/L exhibited a much higher progression rate of WMH as compared with those with a baseline level of cystatin C <1.00 mg/L (1.60 +/- 1.91 mL/year vs. 0.82 +/- 1.63 mL/year, P = 0.010). We concluded that serum cystatin C level is independently associated with the long-term progression rate of the cerebral WMH volume. Therefore, serum cystatin C level might predict the progression of cerebral WMH.	[Lee, Woo-Jin; Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun] Seoul Natl Univ, Neurosci Res Inst SNUMRC, Coll Med, Program Neurosci, Seoul, South Korea; [Ryu, Young Jin] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jeong-Min] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea; [Roh, Jae-Kyu] Armed Forces Capital Hosp, Dept Neurol, Sungnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital	Jung, KH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.; Jung, KH (corresponding author), Seoul Natl Univ, Neurosci Res Inst SNUMRC, Coll Med, Program Neurosci, Seoul, South Korea.	jungkh@gmail.com		Kim, Jeong-Min/0000-0001-7213-5527; Jung, Keun-Hwa/0000-0003-1433-8005; Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; JW Pharmaceutical (Republic of Korea) [0620160950]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; JW Pharmaceutical (Republic of Korea)	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002) (http://english.msip.go.kr/english.main/main.do). Jung KH was supported by research grant from JW Pharmaceutical (Republic of Korea, 0620160950).	Godin O, 2011, CIRCULATION, V123, P266, DOI 10.1161/CIRCULATIONAHA.110.961052; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee W-J, 2017, RADIOLOGY; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Markus HS, 2005, STROKE, V36, P1410, DOI 10.1161/01.STR.0000169924.60783.d4; Meng D, 2016, RADIOLOGY; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Nederkoorn PJ, 2003, RADIOLOGY, V228, P677, DOI 10.1148/radiol.2283020824; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Peralta CA, 2009, AM J EPIDEMIOL; Peralta CA, 2012, AM J KIDNEY DIS, V59, P41, DOI 10.1053/j.ajkd.2011.08.015; Sachdev P, 2007, NEUROLOGY, V68, P214, DOI 10.1212/01.wnl.0000251302.55202.73; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Schmidt R, 2005, ANN NEUROL, V58, P610, DOI 10.1002/ana.20630; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Scuteri A, 2014, J ALZHEIMERS DIS, V42, pS401, DOI 10.3233/JAD-141416; Seliger SL, 2005, J AM SOC NEPHROL, V16, P3721, DOI 10.1681/ASN.2005010006; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Takahashi W, 2012, J STROKE CEREBROVASC, V21, P18, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.015; van den Heuvel DMJ, 2004, NEUROLOGY, V63, P1699, DOI 10.1212/01.WNL.0000143058.40388.44; Wada M, 2010, EUR J NEUROL, V17, P383, DOI 10.1111/j.1468-1331.2009.02809.x; Wang ZZ, 1997, APMIS, V105, P41, DOI 10.1111/j.1699-0463.1997.tb00538.x; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2015, BRAIN PATHOL, V25, P63, DOI 10.1111/bpa.12218; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Yang S, 2017, J STROKE CEREBROVASC, V26, P186, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.007	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184999	10.1371/journal.pone.0184999	http://dx.doi.org/10.1371/journal.pone.0184999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910415	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200124
J	Ong, J; Timens, W; Rajendran, V; Algra, A; Spira, A; Lenburg, ME; Campbell, JD; van den Berge, M; Postma, DS; van den Berg, A; Kluiver, J; Brandsma, CA				Ong, Jennie; Timens, Wim; Rajendran, Vijay; Algra, Arjan; Spira, Avrum; Lenburg, Marc E.; Campbell, Joshua D.; van den Berge, Maarten; Postma, Dirkje S.; van den Berg, Anke; Kluiver, Joost; Brandsma, Corry-Anke			Identification of transforming growth factorbeta-lregulated microRNAs and the microRNAtargetomes in primary lung fibroblasts	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENE-EXPRESSION; INHIBITION; TARGETS; REPAIR; AIRWAY; COPD	Background Lung fibroblasts are involved in extracellular matrix homeostasis, which is mainly regulated by transforming growth factor-beta (TGF-beta), and are therefore crucial in lung tissue repair and remodeling. Abnormal repair and remodeling has been observed in lung diseases like COPD. As miRNA levels can be influenced by TGF-beta, we hypothesized that TGF-beta influences miRNA expression in lung fibroblasts, thereby affecting their function. Materials and methods We investigated TGF-beta 1-induced miRNA expression changes in 9 control primary parenchymal lung fibroblasts using miRNA arrays. TGF-beta 1-induced miRNA expression changes were validated and replicated in an independent set of lung fibroblasts composted of 10 controls and 15 COPD patients using qRT-PCR. Ago2-immunoprecipitation followed by mRNA expression profiling was used to identify the miRNA-targetomes of unstimulated and TGF-beta 1-stimulated primary lung fibroblasts (n = 2). The genes affected by TGF-beta 1-modulated miRNAs were identified by comparing the miRNA targetomes of unstimulated and TGF-beta 1stimulated fibroblasts. Results Twenty-nine miRNAs were significantly differentially expressed after TGF-beta 1 stimulation (FDR< 0.05). The TGF-beta 1-induced miR-455-3p and miR-21-3p expression changes were validated and replicated, with in addition, lower miR-455-3p levels in COPD (p< 0.05). We identified 964 and 945 genes in the miRNA-targetomes of unstimulated and TGF-beta 1-stimulated lung fibroblasts, respectively. The TGF-beta and Wnt pathways were significantly enriched among the Ago2-IP enriched and predicted targets of miR-455-3p and miR-21-3p. The miR-455-3p target genes HN1, NGF, STRADB, DLD and ANO3 and the miR-21-3p target genes HHEX, CHORDC1 and ZBTB49 were consistently more enriched after TGF-beta 1 stimulation. Conclusion Two miRNAs, miR-455-3p and miR-21-3p, were induced by TGF-beta 1 in lung fibroblasts. The significant Ago2-IP enrichment of targets of these miRNAs related to the TGF-beta and/or Wnt pathways ( NGF, DLD, HHEX) in TGF-beta 1-stimulated fibroblasts suggest a role for these miRNAs in lung diseases by affecting lung fibroblast function.	[Ong, Jennie; Timens, Wim; Rajendran, Vijay; Algra, Arjan; van den Berg, Anke; Kluiver, Joost; Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Ong, Jennie; Timens, Wim; Rajendran, Vijay; van den Berge, Maarten; Postma, Dirkje S.; Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Spira, Avrum; Lenburg, Marc E.; Campbell, Joshua D.] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA USA; [van den Berge, Maarten; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands	University of Groningen; University of Groningen; Boston University; University of Groningen	Brandsma, CA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.; Brandsma, CA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.	c.a.brandsma@umcg.nl	Lenburg, Marc/B-8027-2008; Kluiver, Joost/G-6406-2014; van den Berg, Anke/H-1718-2011; Timens, Wim/K-5570-2013	Lenburg, Marc/0000-0002-5760-4708; Kluiver, Joost/0000-0001-7650-2937; van den Berg, Anke/0000-0002-8894-2638; Timens, Wim/0000-0002-4146-6363; van den Berge, Maarten/0000-0002-9336-7340	 [3.2.12.044]		This work was supported by Grant number: 3.2.12.044, https://www.longfonds.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091; Brandsma CA, 2013, AM J PHYSIOL-LUNG C, V305, pL582, DOI 10.1152/ajplung.00152.2013; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Cui HC, 2016, AM J RESP CELL MOL, V54, P843, DOI 10.1165/rcmb.2015-0205OC; Das S, 2014, AM J RESP CELL MOL, V50, P882, DOI 10.1165/rcmb.2013-0195OC; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fernandes Lynette B, 2007, Ther Adv Respir Dis, V1, P25, DOI 10.1177/1753465807080740; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jeon BN, 2014, NUCLEIC ACIDS RES, V42, P11447, DOI 10.1093/nar/gku857; Kluiver Joost, 2013, Methods Mol Biol, V971, P265, DOI 10.1007/978-1-62703-269-8_15; Kohyama T, 2002, J LAB CLIN MED, V140, P329, DOI 10.1067/mlc.2002.128347; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Noordhoek Jacobien A, 2005, COPD, V2, P17; Osei ET, 2015, EUR RESPIR J, V46, P807, DOI 10.1183/13993003.02139-2014; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Slezak-Prochazka I, 2016, ONCOTARGET, V7, P2391, DOI 10.18632/oncotarget.6165; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Wang MY, 2016, CLIN RESPIR J, V10, P104, DOI 10.1111/crj.12194; Wen YC, 2015, ONCOTARGET, V6, P21120, DOI 10.18632/oncotarget.4229; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200	41	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183815	10.1371/journal.pone.0183815	http://dx.doi.org/10.1371/journal.pone.0183815			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910321	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200018
J	Huang, P; Lan, M; Peng, AF; Yu, QF; Chen, WZ; Liu, ZL; Liu, JM; Huang, SH				Huang, Ping; Lan, Min; Peng, Ai-Fen; Yu, Qing-Fu; Chen, Wen-Zhao; Liu, Zhi-Li; Liu, Jia-Ming; Huang, Shan-Hu			Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer	PLOS ONE			English	Article							SKELETAL METASTASES; PROSTATE-CANCER; LUNG-CANCER; PHOSPHATASE; DIAGNOSIS; BREAST; MANAGEMENT; CARCINOMA; PROGNOSIS; EFFICACY	Early detection of bone metastases is helpful for the treatment of bladder cancer (BC). In this study, we investigated the potential risk factors for bone metastasis in newly diagnosed patients with BC. A total of 902 patients diagnosed with BC between January 2000 and August 2016 were retrospectively reviewed. Of these patient, 50 (5.5%) were identified with bone metastasis. The serum levels of alkaline phosphatase (ALP) and calcium were significantly higher in patients with bone metastases than those without bone metastases (P = 0.015 and P<0.001). And the concentration of hemoglobin (HB) was significant lower in bone metastatic patients compared with non bone metastatic patients (P = 0.009). Multivariate logistic regression analysis indicated that ALP, HB and calcium were independent risk factors for bone metastases in patients with BC. The cut off values of ALP, HB and calcium were 116 U/L, 37.5g/L and 2.54 mmol/L according to the receiver operating characteristic (ROC) curves analysis. And combined ALP, HB with calcium had the highest diagnostic accuracy for predicting bone metastases in BC patients (AUC = 0.760, P<0.001). Therefore, for newly diagnosed patients with BC, the concentrations of ALP > 116 U/L, HB < 37.5 g/Land calcium > 2.54 mmol/L were the risk factors for developing bone metastases. Combined ALP, HB with calcium was more useful to diagnose the bone metastases.	[Huang, Ping] Nanchang Univ, Affiliated Hosp 1, Dept Nutr, Nanchang, Jiangxi, Peoples R China; [Lan, Min; Yu, Qing-Fu; Chen, Wen-Zhao; Liu, Zhi-Li; Liu, Jia-Ming; Huang, Shan-Hu] Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China; [Peng, Ai-Fen] Jiangxi Univ Tradit Chinese Med, Sch Humanities, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Jiangxi University of Traditional Chinese Medicine	Liu, JM; Huang, SH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China.	liujiamingdr@hotmail.com; hsh869@126.com			Department of Science and Technology Program of Jiangxi Province, China [20162BCB22022, 20162BCB23057]	Department of Science and Technology Program of Jiangxi Province, China	This work was supported by the Department of Science and Technology Program of Jiangxi Province, China (no. 20162BCB22022, 20162BCB23057).	Bienz M, 2015, CURR OPIN SUPPORT PA, V9, P261, DOI 10.1097/SPC.0000000000000157; CORRIE D, 1988, CANCER, V61, P2453, DOI 10.1002/1097-0142(19880615)61:12<2453::AID-CNCR2820611211>3.0.CO;2-P; Glas AS, 2003, J UROLOGY, V169, P1975, DOI 10.1097/01.ju.0000067461.30468.6d; HANNISDAL E, 1993, RADIOTHER ONCOL, V27, P117, DOI 10.1016/0167-8140(93)90131-Q; Joeckel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-42; Kawai N, 2001, CANCER LETT, V171, P201, DOI 10.1016/S0304-3835(01)00595-X; Le Bricon T, 2010, J CLIN LAB ANAL, V24, P20, DOI 10.1002/jcla.20357; Leeming DJ, 2006, CANCER EPIDEM BIOMAR, V15, P32, DOI 10.1158/1055-9965.EPI-05-0492; Lim SM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2415-x; MICHEL F, 1991, THORAX, V46, P469, DOI 10.1136/thx.46.7.469; Mihai R, 2006, EJSO, V32, P511, DOI 10.1016/j.ejso.2006.02.009; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Rosen LS, 2004, CANCER, V100, P2613, DOI 10.1002/cncr.20308; Saylor PJ, 2013, EUR UROL, V63, P309, DOI 10.1016/j.eururo.2012.10.007; Selvaggi G, 2005, CRIT REV ONCOL HEMAT, V56, P365, DOI 10.1016/j.critrevonc.2005.03.011; Taher Azza N, 2006, J Egypt Natl Canc Inst, V18, P203; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Zhao H, 2011, MED SCI MONITOR, V17, pCR626, DOI 10.12659/MSM.882047	18	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183835	10.1371/journal.pone.0183835	http://dx.doi.org/10.1371/journal.pone.0183835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902911	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200020
J	Osland, MJ; Griffith, KT; Larriviere, JC; Feher, LC; Cahoon, DR; Enwright, NM; Oster, DA; Tirpak, JM; Woodrey, MS; Collini, RC; Baustian, JJ; Breithaupt, JL; Cherry, JA; Conrad, JR; Cormier, N; Coronado-Molina, CA; Donoghue, JF; Graham, SA; Harper, JW; Hester, MW; Howard, RJ; Krauss, KW; Kroes, DE; Lane, RR; McKee, KL; Mendelssohn, IA; Middleton, BA; Moon, JA; Piazza, SC; Rankin, NM; Sklar, FH; Steyer, GD; Swanson, KM; Swarzenski, CM; Vervaeke, WC; Willis, JM; Van Wilson, K				Osland, Michael J.; Griffith, Kereen T.; Larriviere, Jack C.; Feher, Laura C.; Cahoon, Donald R.; Enwright, Nicholas M.; Oster, David A.; Tirpak, John M.; Woodrey, Mark S.; Collini, Renee C.; Baustian, Joseph J.; Breithaupt, Joshua L.; Cherry, Julia A.; Conrad, Jeremy R.; Cormier, Nicole; Coronado-Molina, Carlos A.; Donoghue, Joseph F.; Graham, Sean A.; Harper, Jennifer W.; Hester, Mark W.; Howard, Rebecca J.; Krauss, Ken W.; Kroes, Daniel E.; Lane, Robert R.; McKee, Karen L.; Mendelssohn, Irving A.; Middleton, Beth A.; Moon, Jena A.; Piazza, Sarai C.; Rankin, Nicole M.; Sklar, Fred H.; Steyer, Greg D.; Swanson, Kathleen M.; Swarzenski, Christopher M.; Vervaeke, William C.; Willis, Jonathan M.; Van Wilson, K.			Assessing coastal wetland vulnerability to sea-level rise along the northern Gulf of Mexico coast: Gaps and opportunities for developing a coordinated regional sampling network	PLOS ONE			English	Article							HIGH-PRECISION MEASUREMENTS; RIVER DELTAIC PLAIN; SALT-MARSH; SURFACE ELEVATION; MANGROVE FORESTS; SEDIMENT ELEVATION; SPARTINA-ALTERNIFLORA; MISSISSIPPI DELTA; TIDAL WETLANDS; CLIMATE-CHANGE	Coastal wetland responses to sea-level rise are greatly influenced by biogeomorphic processes that affect wetland surface elevation. Small changes in elevation relative to sea level can lead to comparatively large changes in ecosystem structure, function, and stability. The surface elevation table-marker horizon (SET-MH) approach is being used globally to quantify the relative contributions of processes affecting wetland elevation change. Historically, SET-MH measurements have been obtained at local scales to address site-specific research questions. However, in the face of accelerated sea-level rise, there is an increasing need for elevation change network data that can be incorporated into regional ecological models and vulnerability assessments. In particular, there is a need for long-term, high-temporal resolution data that are strategically distributed across ecologically-relevant abiotic gradients. Here, we quantify the distribution of SET-MH stations along the northern Gulf of Mexico coast (USA) across political boundaries (states), wetland habitats, and ecologically-relevant abiotic gradients (i.e., gradients in temperature, precipitation, elevation, and relative sea-level rise). Our analyses identify areas with high SET-MH station densities as well as areas with notable gaps. Salt marshes, intermediate elevations, and colder areas with high rainfall have a high number of stations, while salt flat ecosystems, certain elevation zones, the mangrove-marsh ecotone, and hypersaline coastal areas with low rainfall have fewer stations. Due to rapid rates of wetland loss and relative sea-level rise, the state of Louisiana has the most extensive SET-MH station network in the region, and we provide several recent examples where data from Louisiana's network have been used to assess and compare wetland vulnerability to sea-level rise. Our findings represent the first attempt to examine spatial gaps in SET-MH coverage across abiotic gradients. Our analyses can be used to transform a broadly disseminated and unplanned collection of SET-MH stations into a coordinated and strategic regional network. This regional network would provide data for predicting and preparing for the responses of coastal wetlands to accelerated sea-level rise and other aspects of global change.	[Osland, Michael J.; Feher, Laura C.; Enwright, Nicholas M.; Cormier, Nicole; Howard, Rebecca J.; Krauss, Ken W.; McKee, Karen L.; Middleton, Beth A.; Steyer, Greg D.; Vervaeke, William C.] US Geol Survey, Lafayette, LA USA; [Griffith, Kereen T.] US Geol Survey, Griffith Consulting Serv, Lafayette, LA USA; [Larriviere, Jack C.] Five Rivers Serv, Lafayette, LA USA; [Cahoon, Donald R.] US Geol Survey, Patuxent River, MD USA; [Oster, David A.; Tirpak, John M.] US Fish & Wildlife Serv, Lafayette, LA USA; [Woodrey, Mark S.] Grand Bay Natl Estuarine Res Reserve, Moss Point, MS USA; [Collini, Renee C.] Northern Gulf Mexico Sentinel Site Cooperat, Dauphin Isl, AL USA; [Baustian, Joseph J.] Nature Conservancy, Baton Rouge, LA USA; [Breithaupt, Joshua L.] Univ S Florida, St Petersburg, FL USA; [Cherry, Julia A.] Univ Alabama, Tuscaloosa, AL USA; [Conrad, Jeremy R.] US Fish & Wildlife Serv, Sanibel, FL USA; [Coronado-Molina, Carlos A.; Sklar, Fred H.] South Florida Water Management Dist, W Palm Beach, FL USA; [Donoghue, Joseph F.] Univ Cent Florida, Orlando, FL 32816 USA; [Graham, Sean A.] Nicholls State Univ, Thibodaux, LA 70310 USA; [Harper, Jennifer W.] Apalachicola Natl Estuarine Res Reserve, Eastpoint, FL USA; [Hester, Mark W.; Willis, Jonathan M.] Univ Louisiana Lafayette, Lafayette, LA 70504 USA; [Kroes, Daniel E.; Piazza, Sarai C.; Swarzenski, Christopher M.] US Geol Survey, Baton Rouge, LA USA; [Lane, Robert R.; Mendelssohn, Irving A.] Louisiana State Univ, Baton Rouge, LA USA; [Moon, Jena A.] US Fish & Wildlife Serv, Winnie, TX USA; [Rankin, Nicole M.] US Fish & Wildlife Serv, Awendaw, SC USA; [Swanson, Kathleen M.] Mission Aransas Natl Estuarine Res Reserve, Port Aransas, TX USA; [Van Wilson, K.] US Geol Survey, Jackson, MS USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Nature Conservancy; State University System of Florida; University of South Florida; University of Alabama System; University of Alabama Tuscaloosa; United States Department of the Interior; US Fish & Wildlife Service; South Florida Water Management District; State University System of Florida; University of Central Florida; University of Louisiana System; Nicholls State University; University of Louisiana Lafayette; United States Department of the Interior; United States Geological Survey; Louisiana State University System; Louisiana State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Osland, MJ (corresponding author), US Geol Survey, Lafayette, LA USA.	mosland@usgs.gov	Vervaeke, William/AAS-3293-2020; Breithaupt, Joshua L./G-9841-2012; McKee, Karen L/D-1365-2014; Osland, Michael J./D-1814-2014	Vervaeke, William/0000-0002-1518-5197; Breithaupt, Joshua L./0000-0003-0963-3253; McKee, Karen L/0000-0001-7042-670X; Osland, Michael J./0000-0001-9902-8692; Cherry, Julia/0000-0003-2854-4731; Kroes, Daniel/0000-0001-9104-9077; Cormier, Nicole/0000-0003-2453-9900; Tirpak, John/0000-0003-1937-9754	USFWS; USGS Ecosystems Mission Area, USGS Climate and Land Use Change; USGS Greater Everglades Priority Ecosystems Science	USFWS(US Fish & Wildlife Service); USGS Ecosystems Mission Area, USGS Climate and Land Use Change; USGS Greater Everglades Priority Ecosystems Science	This inventory was the result of an effort between individuals at the USGS Wetland and Aquatic Research Center and the NOM Northern Gulf of Mexico Sentinel Site Cooperative, who worked with scientists from other state, federal, and academic organizations to compile this information. The participation of David Oster was supported by the USFWS Directorate Resource Assistant Fellows Program. We thank the Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative for hosting the inventory results on their conservation planning atlas. This research was partially funded by the USGS Ecosystems Mission Area, USGS Climate and Land Use Change R&D Program, and the USGS Greater Everglades Priority Ecosystems Science Program.	Alizad K, 2016, EARTHS FUTURE, V4, P483, DOI 10.1002/2016EF000385; Alizad K, 2016, ECOL MODEL, V327, P29, DOI 10.1016/j.ecolmodel.2016.01.013; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2012, GLOBAL CHANGE FUNCTI, DOI DOI 10.1007/978-94-007-4494-3_2; [Anonymous], 2013, 20131163 US GEOL SUR; Asbridge E, 2015, CURR FOR REP, V1, P178, DOI 10.1007/s40725-015-0018-4; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Baustian JJ, 2012, GLOBAL CHANGE BIOL, V18, P3377, DOI 10.1111/j.1365-2486.2012.02792.x; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; BOUMANS RMJ, 1993, ESTUARIES, V16, P375, DOI 10.2307/1352509; Breithaupt JL, 2014, J GEOPHYS RES-BIOGEO, V119, P2032, DOI 10.1002/2014JG002715; BUCHER D, 1994, AQUAT CONSERV, V4, P1, DOI 10.1002/aqc.3270040102; Buffington KJ, 2016, REMOTE SENS ENVIRON, V186, P616, DOI 10.1016/j.rse.2016.09.020; Cahoon D. R., 1997, MANGROVES SALT MARSH, V1, P173, DOI [10.1023/A:1009904816246, DOI 10.1023/A:1009904816246]; Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Cahoon DR, 2015, ESTUAR COAST, V38, P1077, DOI 10.1007/s12237-014-9872-8; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Cahoon DR, 2002, J SEDIMENT RES, V72, P734, DOI 10.1306/020702720734; Cahoon DR, 2002, J SEDIMENT RES, V72, P730, DOI 10.1306/020702720730; CAHOON DR, 1995, MAR GEOL, V128, P1, DOI 10.1016/0025-3227(95)00087-F; Callaway JC, 1997, J COASTAL RES, V13, P181; Callaway JC, 2013, SSSA BOOK S, V10, P901, DOI 10.2136/sssabookser10.c46; Cavanaugh KC, 2015, GLOBAL CHANGE BIOL, V21, P1928, DOI 10.1111/gcb.12843; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Center for International Earth Science Information Network (CIESIN) Columbia University, 2018, GRIDDED POPULATION W, DOI DOI 10.1023/A:1009900724172; Cherry JA, 2015, METHODS ECOL EVOL, V6, P1443, DOI 10.1111/2041-210X.12441; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Cooper HM, 2013, PROG PHYS GEOG, V37, P745, DOI 10.1177/0309133313496835; Couvillion BR, 2013, J COASTAL RES, P29, DOI 10.2112/SI_67_3; Cowardin LM., 2005, WATER ENCY; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; DELAUNE RD, 1978, NATURE, V275, P532, DOI 10.1038/275532a0; Doyle TW, 2010, FOREST ECOL MANAG, V259, P770, DOI 10.1016/j.foreco.2009.10.023; Duke NC, 2017, MAR FRESHW RES; ELEUTERIUS LN, 1979, B MAR SCI, V29, P394; Engle VD, 2011, WETLANDS, V31, P179, DOI 10.1007/s13157-010-0132-9; Enwright NM, 2016, FRONT ECOL ENVIRON, V14, P307, DOI 10.1002/fee.1282; Eslami-Andargoli L, 2009, ESTUAR COAST SHELF S, V85, P292, DOI 10.1016/j.ecss.2009.08.011; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Gabler CA, 2017, NAT CLIM CHANGE, V7, P142, DOI [10.1038/nclimate3203, 10.1038/NCLIMATE3203]; Graham SA, 2014, ECOLOGY, V95, P3271, DOI 10.1890/14-0196.1; Howard RJ, 2017, RESTOR ECOL, V25, P471, DOI 10.1111/rec.12452; Jankowski KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14792; Kidwell DM, 2017, EARTHS FUTURE, V5, P2, DOI 10.1002/2016EF000493; Kintisch E, 2013, SCIENCE, V341, P480, DOI 10.1126/science.341.6145.480; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kirwan ML, 2015, ECOSYSTEMS, V18, P903, DOI 10.1007/s10021-015-9870-0; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Krauss KW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01224-2; Krauss KW, 2014, NEW PHYTOL, V202, P19, DOI 10.1111/nph.12605; Krauss KW, 2010, ECOSYSTEMS, V13, P129, DOI 10.1007/s10021-009-9307-8; Lane RR, 2006, WETLANDS, V26, P1130, DOI 10.1672/0277-5212(2006)26[1130:WSEVAA]2.0.CO;2; Langley JA, 2013, GLOBAL CHANGE BIOL, V19, P1495, DOI 10.1111/gcb.12147; Longley W.L., 1995, IMPACT GLOBAL WARMIN, P88; Lovelock CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01927-6; Lovelock CE, 2015, NATURE, V526, P559, DOI 10.1038/nature15538; Lugo A.E., 1974, ECOLOGY MANGROVES, V5, P39; LYNCH JC, 1989, ESTUARIES, V12, P284, DOI 10.2307/1351907; Lynch JC., 2015, NPSNCBNNRR20151078; Marcy D, 2011, SOLUTIONS COASTAL DI, P474, DOI [DOI 10.1061/41185(417)42, 10.1061/9780784411858]; McKee KL, 2011, ESTUAR COAST SHELF S, V91, P475, DOI 10.1016/j.ecss.2010.05.001; Medeiros S, 2015, REMOTE SENS-BASEL, V7, P3507, DOI 10.3390/rs70403507; MENDELSSOHN IA, 1980, ESTUAR COAST MAR SCI, V11, P27, DOI 10.1016/S0302-3524(80)80027-2; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Montagna P.A., 2007, CHANGING CLIMATE S T, P57; Morris J. T., 2007, Principles and standards for measuring primary production, P106; Morris JT, 2007, HYDROBIOLOGIA, V577, P161, DOI 10.1007/s10750-006-0425-4; Morris JT, 2016, EARTHS FUTURE, V4, P110, DOI 10.1002/2015EF000334; Morris JT, 2013, OCEANOGRAPHY, V26, P78, DOI 10.5670/oceanog.2013.48; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; NYMAN JA, 1990, ESTUAR COAST SHELF S, V31, P57, DOI 10.1016/0272-7714(90)90028-P; ODUM WE, 1982, FWSOBS8124 OFF BIOL; Osland MJ, 2017, ECOL MONOGR, V87, P341, DOI 10.1002/ecm.1248; Osland MJ, 2017, ECOLOGY, V98, P125, DOI 10.1002/ecy.1625; Osland MJ, 2016, GLOBAL CHANGE BIOL, V22, P1, DOI 10.1111/gcb.13084; Osland MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00042.1; Osland MJ, 2014, ECOLOGY, V95, P2789, DOI 10.1890/13-1269.1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parker BB, 2003, J COASTAL RES, P44; PARKINSON RW, 1994, J COASTAL RES, V10, P1077; Passeri DL, 2015, EARTHS FUTURE, V3, P159, DOI 10.1002/2015EF000298; Perillo G. M. E., 2009, COASTAL WETLANDS INT; Raposa KB, 2016, BIOL CONSERV, V204, P263, DOI 10.1016/j.biocon.2016.10.015; Rasser MK, 2013, WETLANDS, V33, P575, DOI 10.1007/s13157-013-0398-9; RICHARDSON CJ, 1994, WETLANDS, V14, P1, DOI 10.1007/BF03160616; Rogers K., 2005, Wetlands Ecology and Management, V13, P587, DOI 10.1007/s11273-004-0003-3; Ross MS, 2009, GLOBAL CHANGE BIOL, V15, P1817, DOI 10.1111/j.1365-2486.2009.01900.x; Schile LM, 2017, ECOL EVOL, V7, P1276, DOI 10.1002/ece3.2758; SCHOLL DW, 1964, MAR GEOL, V1, P344, DOI 10.1016/0025-3227(64)90020-9; Schoot PM, 1982, SEDIMENTATIE EROSIE; Smith TJ, 2009, WETLANDS, V29, P24, DOI 10.1672/08-40.1; Snedden GA, 2015, ECOL ENG, V81, P133, DOI 10.1016/j.ecoleng.2015.04.035; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Steyer GD, 2003, ENVIRON MONIT ASSESS, V81, P107, DOI 10.1023/A:1021368722681; Su J, 2006, PHOTOGRAMM ENG REM S, V72, P1265, DOI 10.14358/PERS.72.11.1265; Thieler ER, 2000, 00179 US GULF MEX CO; Turner RE, 2006, ESTUAR COAST SHELF S, V69, P352, DOI 10.1016/j.ecss.2006.05.005; Twilley RR, 2016, SUSTAIN SCI, V11, P711, DOI 10.1007/s11625-016-0374-4; VANEERDT MM, 1985, VEGETATIO, V62, P367; Ward Raymond D., 2016, Ecosystem Health and Sustainability, V2, pe01211, DOI 10.1002/ehs2.1211; Webb EL, 2013, NAT CLIM CHANGE, V3, P458, DOI [10.1038/NCLIMATE1756, 10.1038/nclimate1756]; Whelan KRT, 2009, WETLANDS, V29, P16, DOI 10.1672/08-125.1; Whelan KRT, 2005, ESTUARIES, V28, P833, DOI 10.1007/BF02696013; Withers Kim, 2002, P114; Woodroffe CD, 2016, ANNU REV MAR SCI, V8, P243, DOI 10.1146/annurev-marine-122414-034025; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685	109	27	27	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183431	10.1371/journal.pone.0183431	http://dx.doi.org/10.1371/journal.pone.0183431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902904	Green Published, gold			2022-12-26	WOS:000410669200012
J	Mezzasalma, V; Sandionigi, A; Bruni, I; Bruno, A; Lovicu, G; Casiraghi, M; Labra, M				Mezzasalma, Valerio; Sandionigi, Anna; Bruni, Ilaria; Bruno, Antonia; Lovicu, Gianni; Casiraghi, Maurizio; Labra, Massimo			Grape microbiome as a reliable and persistent signature of field origin and environmental conditions in Cannonau wine production	PLOS ONE			English	Article							RNA GENES DIFFERENTIATION; SOIL BACTERIAL DIVERSITY; FERMENTATION; CULTIVARS; TERROIR; POPULATION; SEQUENCES; VINEYARDS; DATABASE; MARKERS	Grape berries harbor a wide range of microbes originating from the vineyard environment, many of which are recognized for their role in the must fermentation process shaping wine quality. To better clarify the contribution of the microbiome of grape fruits during wine fermentation, we used high-throughput sequencing to identify bacterial and fungi communities associated with berries and musts of Cannonau. This is the most important cultivar-wine of Sardinia (Italy) where most vineyards are cultivated without phytochemical treatments. Results suggested that microbiomes of berries collected at four different localities share a core composition characterized by Enterobacteriales, Pseudomonadales, Bacillales, and Rhodospirillales. However, any area seems to enrich berries microbiome with peculiar microbial traits. For example, berries belonging to the biodynamic vineyards of Mamoiada were rich in Bacillales typical of manure (i.e. Lysinibacillus, Bacillus, and Sporosarcina), whereas in the Santadi locality, berries showed soil bacteria such as Pasteurellales and Bacteroidales as well as Rhodospirillales and Lactobacillales which are commonly involved in wine fermentation. In the case of fungi, the most abundant taxa were Dothioraceae, Pleosporaceae, and Saccharomycodaceae, and although the proportion of these families varied among localities, they occurred ubiquitously in all vineyards. During vinification processes performed at the same wine cellar under controlled conditions and without using any yeast starter, more than 50% of bacteria groups of berries reached musts, and each locality had its own private bacteria signature, even if Saccharomyces cerevisiae represented the most abundant fungal species. This work suggests that natural berries microbiome could be influenced by pedoclimatic and anthropologic conditions (e.g., farming management), and the fruits' microorganisms persist during the fermentation process. For these reasons, a reliable wine genotyping should include the entire holobiont (plant and all its symbionts), and bioprospecting activities on grape microbiota could lead to improved viticulture yields and wine quality.	[Mezzasalma, Valerio; Sandionigi, Anna; Bruni, Ilaria; Bruno, Antonia; Casiraghi, Maurizio; Labra, Massimo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Zooplantlab, Milan, Italy; [Mezzasalma, Valerio] FEM2 Ambiente Srl, Milan, Italy; [Lovicu, Gianni] Agr Res Agcy Sardinia AGRIS, Sassari, Italy	University of Milano-Bicocca	Labra, M (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Zooplantlab, Milan, Italy.	massimo.labra@unimib.it	Sandionigi, Anna/H-8815-2016; Bruno, Antonia/ABB-7605-2020; Casiraghi, Maurizio/E-7273-2011; Mezzasalma, Valerio/B-3753-2016	Sandionigi, Anna/0000-0002-5257-0027; Bruno, Antonia/0000-0002-1929-6652; Casiraghi, Maurizio/0000-0002-2733-2094; Mezzasalma, Valerio/0000-0001-7651-4567; Bruni, Ilaria/0000-0002-9947-0963	SardegnaRicerche [CUP B81H11001320002]; FEM2-Ambiente	SardegnaRicerche(Regione Sardegna); FEM2-Ambiente	This work was supported by SardegnaRicerche (www.sardegnamerche.it) in the framework of the project AKINAS (CUP B81H11001320002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FEM2-Ambiente s.r.l. provided support in the form of a salary for author Valerio Mezzasalma but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of research materials. The specific roles of this author is articulated in the 'author contributions' section.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Arbizu PM, 2016, RESEARCHGATE; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Belda I, INBIO WEB C, V9; Belda I, 2017, MOLECULES, V22, DOI 10.3390/molecules22020189; Bell SJ, 2005, AUST J GRAPE WINE R, V11, P242, DOI 10.1111/j.1755-0238.2005.tb00028.x; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bokulich NA, 2016, MBIO, V7, DOI 10.1128/mBio.00631-16; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Bruno A, 2017, SCI REPORTS, P7; Bruno A, 2016, MICROBIOLOGYOPEN; Bulgari D, 2009, J MICROBIOL, V47, P393, DOI 10.1007/s12275-009-0082-1; Burns KN, 2016, SOIL BIOL BIOCHEM, V103, P337, DOI 10.1016/j.soilbio.2016.09.007; Burns KN, 2015, SOIL BIOL BIOCHEM, V91, P232, DOI 10.1016/j.soilbio.2015.09.002; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capozzi V, 2015, MICROBIOL RES, V181, P75, DOI 10.1016/j.micres.2015.10.005; Ciani M, 2016, FRONTIERS MICROBIOLO, P7; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; De Mattia F, 2009, J HORTIC SCI BIOTECH, V84, P65, DOI 10.1080/14620316.2009.11512481; De Mattia F, 2007, J INT SCI VIGNE VIN, V41, P175; De Mattia F, 2008, REND LINCEI-SCI FIS, V19, P223, DOI 10.1007/s12210-008-0016-6; de Oliveira AF, 2016, AUST J GRAPE WINE R, V22, P96, DOI 10.1111/ajgw.12174; Portillo MD, 2016, INT J FOOD MICROBIOL, V219, P56, DOI 10.1016/j.ijfoodmicro.2015.12.002; Ding Guo-Chun, 2014, PLoS One, V9, pe92958, DOI 10.1371/journal.pone.0092958; du Toit M, 2011, FOOD BIOPROCESS TECH, V4, P876, DOI 10.1007/s11947-010-0448-8; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faissal AZ, 2017, SAUDI J BIOL SCI; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Fossati T, 2001, THEOR APPL GENET, V102, P200, DOI 10.1007/s001220051636; Garofalo C, 2015, J APPL MICROBIOL, V118, P1395, DOI 10.1111/jam.12789; Genomics BE, CALCULATE DRAW CUSTO; Gilbert JA, 2014, P NATL ACAD SCI USA, V111, P5, DOI 10.1073/pnas.1320471110; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Lasik M, 2013, EUR FOOD RES TECHNOL, V237, P843, DOI 10.1007/s00217-013-2083-x; Leveau JHJ, 2011, ACTA HORTIC, V905, P31; Lovanh N, 2007, POULTRY SCI, V86, P1840, DOI 10.1093/ps/86.9.1840; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Martinez-Luscher J, 2015, PLANT SCI, V232, P13, DOI 10.1016/j.plantsci.2014.12.013; Martins G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073013; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meng B., 2017, GRAPEVINE VIRUSES MO, DOI [10.1007/978-3-319-57706-7, DOI 10.1007/978-3-319-57706-7_2]; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Patrignani F, 2017, ANN MICROBIOL, V67, P99, DOI 10.1007/s13213-016-1241-3; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pinto C, 2016, BIOCONTROL, V61, P243, DOI 10.1007/s10526-016-9725-4; Pinto C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00905; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Rana A, 2011, ANN MICROBIOL, V61, P893, DOI 10.1007/s13213-011-0211-z; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Santamaria P, 2005, INT J FOOD MICROBIOL, V103, P49, DOI 10.1016/j.ijfoodmicro.2004.11.024; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; Van Leeuwen Cornelis, 2006, Journal of Wine Research, V17, P1, DOI 10.1080/09571260600633135; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zecca G, 2010, PLANT BIOLOGY, V12, P558, DOI 10.1111/j.1438-8677.2009.00226.x	64	57	59	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184615	10.1371/journal.pone.0184615	http://dx.doi.org/10.1371/journal.pone.0184615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892512	Green Submitted, Green Published, gold			2022-12-26	WOS:000410243200019
J	Fernandes, LDD; Netto, EBF; Coutinho, R				de Almeida Fernandes, Lohengrin Dias; Fagundes Netto, Eduardo Barros; Coutinho, Ricardo		PELD-RECA	Inter-annual cascade effect on marine food web: A benthic pathway lagging nutrient supply to pelagic fish stock	PLOS ONE			English	Article							CABO FRIO BRAZIL; TOP-DOWN; SOUTHWESTERN ATLANTIC; TROPHIC STRUCTURE; UPWELLING SYSTEM; BOTTOM-UP; PHYTOPLANKTON; PLANKTON; SOUTH; CLIMATE	Currently, spatial and temporal changes in nutrients availability, marine planktonic, and fish communities are best described on a shorter than inter-annual (seasonal) scale, primarily because the simultaneous year-to-year variations in physical, chemical, and biological parameters are very complex. The limited availability of time series datasets furnishing simultaneous evaluations of temperature, nutrients, plankton, and fish have limited our ability to describe and to predict variability related to short-term process, as species-specific phenology and environmental seasonality. In the present study, we combine a computational time series analysis on a 15-year (1995-2009) weekly-sampled time series (high-resolution long-term time series, 780 weeks) with an Autoregressive Distributed Lag Model to track non-seasonal changes in 10 potentially related parameters: sea surface temperature, nutrient concentrations (NO2, NO3, NH4 and PO4), phytoplankton biomass (as in situ chlorophyll a biomass), meroplankton (barnacle and mussel larvae), and fish abundance (Mugil liza and Caranx latus). Our data demonstrate for the first time that highly intense and frequent upwelling years initiate a huge energy flux that is not fully transmitted through classical size-structured food web by bottom-up stimulus but through additional ontogenetic steps. A delayed inter-annual sequential effect from phytoplankton up to top predators as carnivorous fishes is expected if most of energy is trapped into benthic filter feeding organisms and their larval forms. These sequential events can explain major changes in ecosystem food web that were not predicted in previous short-term models.	[de Almeida Fernandes, Lohengrin Dias; Coutinho, Ricardo] Brazilian Navy, Inst Estudos Mar Almirante Paulo Moreira IEAPM, Dept Biotechnol, Arraial Do Cabo, RJ, Brazil; [de Almeida Fernandes, Lohengrin Dias; Fagundes Netto, Eduardo Barros; Coutinho, Ricardo] Marine Biotechnol Postgrad Program, Arraial Do Cabo, RJ, Brazil; [Fagundes Netto, Eduardo Barros] Brazilian Navy, Dept Oceanog, Inst Estudos Mar Almirante Paulo Moreira IEAPM, Arraial Do Cabo, RJ, Brazil; [de Almeida Fernandes, Lohengrin Dias] Inst Estudos Mar Almirante Paulo Moreira, Arraial Do Cabo, RJ, Brazil		Fernandes, LDD (corresponding author), Brazilian Navy, Inst Estudos Mar Almirante Paulo Moreira IEAPM, Dept Biotechnol, Arraial Do Cabo, RJ, Brazil.; Fernandes, LDD (corresponding author), Marine Biotechnol Postgrad Program, Arraial Do Cabo, RJ, Brazil.; Fernandes, LDD (corresponding author), Inst Estudos Mar Almirante Paulo Moreira, Arraial Do Cabo, RJ, Brazil.	lohengrin@marinha.mil.br	coutinho, ricardo/AAW-2458-2020; DA Fernandes, Lohengrin/C-2334-2009	coutinho, ricardo/0000-0001-5430-2176; DA Fernandes, Lohengrin/0000-0002-8579-2363	Fundacao Carlos Chagas Filho de Amparo a Ciencia [FAPERJ - E26/110.220/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through "Programa de Pesquisa Ecologica de Longa Duracao PELD - RECA" [441525/2016-4]	Fundacao Carlos Chagas Filho de Amparo a Ciencia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through "Programa de Pesquisa Ecologica de Longa Duracao PELD - RECA"	Financial support was provided by Fundacao Carlos Chagas Filho de Amparo a Ciencia (FAPERJ - E26/110.220/2011) (LDAF) through the "Estrutura e Dinamica Trofica em Assembleias Micropelagicas Marinhas em Area de Ressurgencia no Norte Fluminense" project, and also by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through "Programa de Pesquisa Ecologica de Longa Duracao PELD - RECA" (RC). (Proc. 441525/2016-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAKUN A, 1991, ICES J MAR SCI, V48, P343, DOI 10.1093/icesjms/48.3.343; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Carbonel CAA, 1999, ECOL MODEL, V116, P135, DOI 10.1016/S0304-3800(98)00201-4; Carvalho W.F., 2004, BRAZ J OCEANOGR, V52, P35; CGFAP/ DBFLO/ IBAMA, 2007, EST PESCA 2007; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cibic T, 2009, J EXP MAR BIOL ECOL, V370, P144, DOI 10.1016/j.jembe.2008.12.006; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CLOERN JE, 1982, MAR ECOL PROG SER, V9, P191, DOI 10.3354/meps009191; Coelho-Souza SA, 2012, J OCEANOGR, V60, P353; Corbisier TN, 2014, MAR ECOL PROG SER, V512, P23, DOI 10.3354/meps10947; DALLAGNOLO R., 2010, BRAZILIAN J AQUATIC, V14, P95; Darriba S, 2005, ICES J MAR SCI, V62, P886, DOI 10.1016/j.icesjms.2005.02.010; Fernandes LDD, 2012, J PLANKTON RES, V34, P236, DOI 10.1093/plankt/fbr106; Desai DV, 2006, MAR BIOL, V149, P1431, DOI 10.1007/s00227-006-0315-3; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; Gigliotti ES, 2010, J FISH BIOL, V77, P2248, DOI 10.1111/j.1095-8649.2010.02802.x; GONZALEZRODRIGUEZ E, 1994, HYDROBIOLOGIA, V294, P145, DOI 10.1007/BF00016855; Guenther M, 2008, OECOLOGIA BRASILIENS, V12, P172, DOI DOI 10.4257/0EC0.2008.1201.15; Guenther M, 2008, MAR ECOL PROG SER, V363, P109, DOI 10.3354/meps07458; Haimovici M., 1991, ATLANTICA RIO GRANDE, V13, P189; Halpern BS, 2006, SCIENCE, V312, P1230, DOI 10.1126/science.1128613; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Highfield JM, 2010, J PLANKTON RES, V32, P681, DOI 10.1093/plankt/fbp139; Horn H, 2008, LIMNOLOGICA, V38, P302, DOI 10.1016/j.limno.2008.05.007; Isangedighi IA, 2009, J AGR FOOD ENV, V5, P10; Jablonski S, 2004, SCI MAR, V68, P385, DOI 10.3989/scimar.2004.68n3385; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Kerimoglu O, 2013, OIKOS, V122, P223, DOI 10.1111/j.1600-0706.2012.20603.x; Landry MR, 2004, ICES J MAR SCI, V61, P501, DOI 10.1016/j.icesjms.2004.03.011; Le Moigne FAC, 2013, BIOGEOSCIENCES, V10, P281, DOI 10.5194/bg-10-281-2013; Levinton JS, 2013, PROCESSES OPEN SEA, P225; Lopez-Urrutia A, 2015, LIMNOL OCEANOGR, V60, P733, DOI 10.1002/lno.10049; Manriquez K, 2009, J PLANKTON RES, V31, P1075, DOI 10.1093/plankt/fbp053; Matsuura Y, 1996, S AFR J MARINE SCI, V17, P29; McManus GB, 2007, HYDROBIOLOGIA, V575, P69, DOI 10.1007/s10750-006-0279-9; Memery L, 2000, PROG OCEANOGR, V47, P69, DOI 10.1016/S0079-6611(00)00032-X; Modou S. S., 2014, International Journal of Agricultural Policy and Research, V2, P125; Monteiro-Ribas W., 2006, Braz. J. Biol., V66, P109, DOI 10.1590/S1519-69842006000100014; Mousing EA, 2014, MAR ECOL PROG SER, V497, P25, DOI 10.3354/meps10583; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pesaran M.H., 1998, EC SOC MONOGR, V31, P371, DOI DOI 10.1017/CCOL521633230.011; Rueda PS, 2002, REV BIOL TROP, V50, P245; SAZIMA I, 1986, J FISH BIOL, V29, P53, DOI 10.1111/j.1095-8649.1986.tb04926.x; Skinner LF, 2011, BRAZ J OCEANOGR, V59, P349, DOI 10.1590/S1679-87592011000400005; Skogen MD, 2007, ICES J MAR SCI, V64, P889, DOI 10.1093/icesjms/fsm063; SMITH SV, 1984, LIMNOL OCEANOGR, V29, P1149, DOI 10.4319/lo.1984.29.6.1149; Soares LSH, 2014, MAR ECOL PROG SER, V512, P9, DOI 10.3354/meps10948; Sommer U, 2002, ECOL RES, V17, P161, DOI 10.1046/j.1440-1703.2002.00476.x; Steinberg DK, 2017, ANNU REV MAR SCI, V9, P413, DOI 10.1146/annurev-marine-010814-015924; Straile D, 2007, CLIM RES, V34, P259, DOI 10.3354/cr00702; Thompson SA, 2012, PROG OCEANOGR, V101, P106, DOI 10.1016/j.pocean.2012.02.001; VALENTIN JL, 1986, ANN I OCEANOGR PARIS, V62, P117; Valentin JL, 2001, ECOL STU AN, V144, P97; VALENTIN JL, 1990, ECOL MODEL, V52, P103, DOI 10.1016/0304-3800(90)90011-5; VALENTIN JL, 1984, HYDROBIOLOGIA, V113, P183, DOI 10.1007/BF00026607; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; VILLALOBOS CR, 1979, REV BIOL TROP, V27, P293	69	5	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184512	10.1371/journal.pone.0184512	http://dx.doi.org/10.1371/journal.pone.0184512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886162	Green Published, gold			2022-12-26	WOS:000410001100143
J	Zhang, CL; Acosta-Sampson, L; Yu, VY; Cate, JHD				Zhang, Chenlu; Acosta-Sampson, Ligia; Yu, Vivian Yaci; Cate, Jamie H. D.			Screening of transporters to improve xylodextrin utilization in the yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; GLUCOSE TRANSPORTERS; BIOFUEL PRODUCTION; D-XYLOSE; BIOTECHNOLOGY; CONSUMPTION; ENZYMES; BIOMASS	The economic production of cellulosic biofuel requires efficient and full utilization of all abundant carbohydrates naturally released from plant biomass by enzyme cocktails. Recently, we reconstituted the Neurospora crassa xylodextrin transport and consumption system in Saccharomyces cerevisiae, enabling growth of yeast on xylodextrins aerobically. However, the consumption rate of xylodextrin requires improvement for industrial applications, including consumption in anaerobic conditions. As a first step in this improvement, we report analysis of orthologues of the N. crassa transporters CDT-1 and CDT-2. Transporter ST16 from Trichoderma virens enables faster aerobic growth of S. cerevisiae on xylodextrins compared to CDT-2. ST16 is a xylodextrin-specific transporter, and the xylobiose transport activity of ST16 is not inhibited by cellobiose. Other transporters identified in the screen also enable growth on xylodextrins including xylotriose. Taken together, these results indicate that multiple transporters might prove useful to improve xylodextrin utilization in S. cerevisiae. Efforts to use directed evolution to improve ST16 from a chromosomally-integrated copy were not successful, due to background growth of yeast on other carbon sources present in the selection medium. Future experiments will require increasing the baseline growth rate of the yeast population on xylodextrins, to ensure that the selective pressure exerted on xylodextrin transport can lead to isolation of improved xylodextrin transporters.	[Zhang, Chenlu] Tsinghua Univ, Dept Life Sci, Beijing, Peoples R China; [Acosta-Sampson, Ligia; Yu, Vivian Yaci; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA	Tsinghua University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA.	jcate@lbl.gov		Cate, Jamie/0000-0001-5965-7902	Energy Biosciences Institute; China Scholarship Council	Energy Biosciences Institute; China Scholarship Council(China Scholarship Council)	This work was supported by Energy Biosciences Institute (ttp://energybiosciencesinstitute.org/); China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank British Petroleum for the library of CDT-1 and CDT-2 orthologues. This work was supported by the Energy Biosciences Institute. C.Z. was supported by the China Scholarship Council.	Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Cai PL, 2015, J BIOL CHEM, V290, P788, DOI 10.1074/jbc.M114.609875; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Henderson PJF, 2013, NAT STRUCT MOL BIOL, V20, P654, DOI 10.1038/nsmb.2604; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Katahira S, 2004, APPL ENVIRON MICROB, V70, P5407, DOI 10.1128/AEM.70.9.5407-5414.2004; Kell DB, 2015, TRENDS BIOTECHNOL, V33, P237, DOI 10.1016/j.tibtech.2015.02.001; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Li HB, 2016, APPL MICROBIOL BIOT, V100, P10215, DOI 10.1007/s00253-016-7879-8; Li X, 2015, ELIFE, P4; Lin YP, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0126-6; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Nijland JG, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0168-9; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sen A, 2016, APPL ENVIRON MICROB, V82, P7074, DOI 10.1128/AEM.02148-16; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wei N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3580	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184730	10.1371/journal.pone.0184730	http://dx.doi.org/10.1371/journal.pone.0184730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886200	gold, Green Submitted, Green Published			2022-12-26	WOS:000410001100183
J	Yamaguchi, H; Du, Y; Nakai, K; Ding, M; Chang, SS; Hsu, JL; Yao, J; Wei, Y; Nie, L; Jiao, S; Chang, WC; Chen, CH; Yu, Y; Hortobagyi, GN; Hung, MC				Yamaguchi, H.; Du, Y.; Nakai, K.; Ding, M.; Chang, S-S; Hsu, J. L.; Yao, J.; Wei, Y.; Nie, L.; Jiao, S.; Chang, W-C; Chen, C-H; Yu, Y.; Hortobagyi, G. N.; Hung, M-C			EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer	ONCOGENE			English	Article							EPITHELIAL OVARIAN-CANCER; B-CELL LYMPHOMAS; SUPPRESSES METHYLATION; PROSTATE-CANCER; MAMMARY-TUMORS; DNA-DAMAGE; STEM-CELLS; BRCA1; PHOSPHORYLATION; RESISTANCE	Inhibitors against poly (ADP-ribose) polymerase (PARP) are promising targeted agents currently used to treat BRCA-mutant ovarian cancer and are in clinical trials for other cancer types, including BRCA-mutant breast cancer. To enhance the clinical response to PARP inhibitors (PARPis), understanding the mechanisms underlying PARPi sensitivity is urgently needed. Here, we show enhancer of zeste homolog 2 (EZH2), an enzyme that catalyzes H3 lysine trimethylation and associates with oncogenic function, contributes to PARPi sensitivity in breast cancer cells. Mechanistically, upon oxidative stress or alkylating DNA damage, PARP1 interacts with and attaches poly-ADP-ribose (PAR) chains to EZH2. PARylation of EZH2 by PARP1 then induces PRC2 complex dissociation and EZH2 downregulation, which in turn reduces EZH2-mediated H3 trimethylation. In contrast, inhibition of PARP by PARPi attenuates alkylating DNA damage-induced EZH2 downregulation, thereby promoting EZH2-mediated gene silencing and cancer stem cell property compared with PARPi-untreated cells. Moreover, the addition of an EZH2 inhibitor sensitizes the BRCA-mutant breast cells to PARPi. Thus, these results may provide a rationale for combining PARP and EZH2 inhibition as a therapeutic strategy for BRCA-mutated breast and ovarian cancers.	[Yamaguchi, H.; Du, Y.; Nakai, K.; Chang, S-S; Hsu, J. L.; Yao, J.; Wei, Y.; Nie, L.; Jiao, S.; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA; [Ding, M.; Yu, Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX USA; [Chang, W-C; Chen, C-H] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Chang, W-C; Hung, M-C] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chang, W-C; Hung, M-C] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Hortobagyi, G. N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Hung, M-C] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; NAKAI, KATSUYA/0000-0003-4142-8508; Ding, Ming/0000-0002-9135-9275	National Institutes of Health [CA211615, CCSG CA016672, GM114160]; Patel Memorial Breast Cancer Endowment Fund; National Breast Cancer Foundation, Inc.; Breast Cancer Research Foundation; University of Texas MD Anderson Cancer Center-China Medical University; University of Texas MD Anderson Cancer Center-Hospital Sister Institution Fund; Ministry of Science and Technology; International Research-intensive Centers of Excellence in Taiwan (I-RiCE) [MOST 105-2911-I-002-302]; Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence [MOHW106-TDU-B-212-144003]; Center for Biological Pathways; UT Southwestern Endowed Scholar Program; Welch Foundation [I-1800]; NATIONAL CANCER INSTITUTE [R01CA109311, P01CA099031, R01CA211615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patel Memorial Breast Cancer Endowment Fund; National Breast Cancer Foundation, Inc.; Breast Cancer Research Foundation; University of Texas MD Anderson Cancer Center-China Medical University(China Medical University); University of Texas MD Anderson Cancer Center-Hospital Sister Institution Fund; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); International Research-intensive Centers of Excellence in Taiwan (I-RiCE); Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence; Center for Biological Pathways; UT Southwestern Endowed Scholar Program; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the following: the National Institutes of Health (CA211615 and CCSG CA016672); Patel Memorial Breast Cancer Endowment Fund; National Breast Cancer Foundation, Inc.; Breast Cancer Research Foundation; The University of Texas MD Anderson Cancer Center-China Medical University and Hospital Sister Institution Fund; Ministry of Science and Technology; International Research-intensive Centers of Excellence in Taiwan (I-RiCE; MOST 105-2911-I-002-302); Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence (MOHW106-TDU-B-212-144003); Center for Biological Pathways; The UT Southwestern Endowed Scholar Program, the Welch Foundation (I-1800) and National Institutes of Health (GM114160) to YY. Dr YY is a Virginia Murchison Linthicum Scholar in Medical Research and a CPRIT Scholar in Cancer Research.	Alekseyenko AA, 2014, P NATL ACAD SCI USA, V111, P2488, DOI 10.1073/pnas.1400648111; Barber LJ, 2013, J PATHOL, V229, P422, DOI 10.1002/path.4140; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Campbell S, 2013, CELL CYCLE, V12, P2675, DOI 10.4161/cc.25795; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; de Vries NA, 2015, CELL REP, V10, P383, DOI 10.1016/j.celrep.2014.12.028; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Donizy P, 2014, ONCOL REP, V31, P1777, DOI 10.3892/or.2014.3024; Du Y, 2016, NAT MED, V22, P194, DOI 10.1038/nm.4032; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Ledermann JA, 2015, BRIT J CANCER, V113, pS10, DOI 10.1038/bjc.2015.395; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Li JL, 2013, NAT NEUROSCI, V16, P1745, DOI 10.1038/nn.3564; Li T, 2014, CANCER BIOL THER, V15, P271, DOI 10.4161/cbt.27306; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu C, 2013, NUCLEIC ACIDS RES, V41, P1698, DOI 10.1093/nar/gks1278; Martin KA, 2015, MOL CELL BIOL, V35, P3934, DOI 10.1128/MCB.00635-15; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Polotskaia A, 2015, P NATL ACAD SCI USA, V112, pE1220, DOI 10.1073/pnas.1416318112; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Wang L, 2017, CLIN RES HEPATOL GAS, V2017, P1, DOI DOI 10.1371/J0URNAL.P0NE.01; Wang L, 2013, EMBO J, V32, P1584, DOI 10.1038/emboj.2013.95; Wang L, 2013, INT J BIOL SCI, V9, P472, DOI 10.7150/ijbs.5855; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Xu JH, 2010, BREAST CANCER RES TR, V120, P593, DOI 10.1007/s10549-009-0422-1; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yang CC, 2015, AM J TRANSL RES, V7, P1009; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	66	56	57	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					208	217		10.1038/onc.2017.311	http://dx.doi.org/10.1038/onc.2017.311			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28925391	Green Accepted			2022-12-26	WOS:000422631700007
J	Sakurai, S; Shimizu, T; Ohto, U				Sakurai, Shunya; Shimizu, Toshiyuki; Ohto, Umeharu			The crystal structure of the AhRR-ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; X-ASSOCIATED PROTEIN-2; DIOXIN RECEPTOR; MICE LACKING; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ACTIVATION; MECHANISM; BINDING; DIMERIZATION; TOXICITY	2,3,7,8-Tetrachlorodibenzo-p-dioxin and related compounds are extraordinarily potent environmental toxic pollutants. Most of the 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicities are mediated by aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor belonging to the basic helix-loop-helix (bHLH) Per-ARNT-Sim (PAS) family. Upon ligand binding, AhR forms a heterodimer with AhR nuclear translocator (ARNT) and induces the expression of genes involved in various biological responses. One of the genes induced by AhR encodes AhR repressor (AhRR), which also forms a heterodimer with ARNT and represses the activation of AhR-dependent transcription. The control of AhR activation is critical for managing AhR-mediated diseases, but the mechanisms by which AhRR represses AhR activation remain poorly understood, because of the lack of structural information. Here, we determined the structure of the AhRR-ARNT heterodimer by X-ray crystallography, which revealed an asymmetric intertwined domain organization presenting structural features that are both conserved and distinct among bHLH-PAS family members. The structures of AhRR-ARNT and AhR-ARNT were similar in the bHLH-PAS-A region, whereas the PAS-B of ARNT in the AhRR-ARNT complex exhibited a different domain arrangement in this family reported so far. The structure clearly disclosed that AhRR competitively represses AhR binding to ARNT and target DNA and further suggested the existence of an AhRR-ARNT-specific repression mechanism. This study provides a structural basis for understanding the mechanism by which AhRR represses AhR-mediated gene transcription.	[Sakurai, Shunya; Shimizu, Toshiyuki; Ohto, Umeharu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Shimizu, Toshiyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Shimizu, T; Ohto, U (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp; umeji@mol.f.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Naito Foundation; Grants-in-Aid for Scientific Research [16H02494] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to U. O. and T. S.), the Takeda Science Foundation (to U. O. and T. S.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to U. O.), the Daiichi Sankyo Foundation of Life Science (to U. O.), and the Naito Foundation (to U. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox MB, 2002, TOXICOL LETT, V129, P13, DOI 10.1016/S0378-4274(01)00465-9; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oshima M, 2007, BIOCHEM BIOPH RES CO, V364, P276, DOI 10.1016/j.bbrc.2007.09.131; Oshima M, 2009, J BIOL CHEM, V284, P11017, DOI 10.1074/jbc.M808694200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schulte KW, 2017, STRUCTURE, V25, P1025, DOI 10.1016/j.str.2017.05.008; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Wu DL, 2017, CURR OPIN STRUC BIOL, V43, P1, DOI 10.1016/j.sbi.2016.09.011; Wu DL, 2016, ELIFE, V5, DOI 10.7554/eLife.18790; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13	39	27	30	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17609	17616		10.1074/jbc.M117.812974	http://dx.doi.org/10.1074/jbc.M117.812974			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28904176	hybrid, Green Published			2022-12-26	WOS:000414013000004
J	Martin, A; Gremse, C; Selhorst, T; Bandick, N; Muller-Graf, C; Greiner, M; Lahrssen-Wiederholt, M				Martin, Annett; Gremse, Carl; Selhorst, Thomas; Bandick, Niels; Mueller-Graf, Christine; Greiner, Matthias; Lahrssen-Wiederholt, Monika			Hunting of roe deer and wild boar in Germany: Is non-lead ammunition suitable for hunting?	PLOS ONE			English	Article							LEAD-FREE; RIFLE AMMUNITION; EXPOSURE; BULLETS	Background Non-lead hunting ammunition is an alternative to bullets that contain lead. The use of lead ammunition can result in severe contamination of game meat, thus posing a health risk to consumers. With any kind of ammunition for hunting, the terminal effectiveness of bullets is an animal welfare issue. Doubts about the effectiveness of non-lead bullets for a humane kill of game animals in hunting have been discussed. The length of the escape distance after the shot has been used previously as an indicator for bullet performance. Objective The object of this study was to determine how the bullet material (lead or non-lead) influences the observed escape distances. Methods 1,234 records of the shooting of roe deer (Capreolus capreolus) and 825 records of the shooting of wild boar (Sus scrofa) were evaluated. As the bullet material cannot be regarded as the sole cause of variability of escape distances, interactions of other potential influencing variables like shot placement, shooting distance, were analyzed using conditional regression trees and two-part hurdle models. Results The length of the escape distance is not influenced by the use of lead or non-lead ammunition with either roe deer or wild boar. With roe deer, the length of the escape distance is influenced significantly by the shot placement and the type of hunting. Increasing shooting distances increased the length of the escape distance. With wild boar, shot placement and the age of the animals were found to be a significant influencing factor on the length of the escape distance. Conclusions The length of the escape distance can be used as an indicator for adequate bullet effectiveness for humane killings of game animals in hunting. Non-lead bullets already exist which have an equally reliable killing effect as lead bullets.	[Martin, Annett; Selhorst, Thomas; Mueller-Graf, Christine; Greiner, Matthias] BfR Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany; [Gremse, Carl; Lahrssen-Wiederholt, Monika] BfR Fed Inst Risk Assessment, Dept Safety Food Chain, Berlin, Germany; [Bandick, Niels] BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Federal Institute for Risk Assessment; Federal Institute for Risk Assessment; Federal Institute for Risk Assessment	Martin, A (corresponding author), BfR Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany.	annett.martin@bfr.bund.de	Greiner, Matthias/D-2812-2013	Greiner, Matthias/0000-0003-4974-5970; Muller-Graf, Christine/0000-0002-0122-7528; Gremse, Carl/0000-0002-9936-4255	Federal Ministry of Food and Agriculture (BMEL) in Germany; Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development); European Poultry, Egg and Game Association (EPEGA); Federal Ministry of Food and Agriculture (BMEL); German Hunting Association (DJV); Bavarian Hunting Association (BJV); Association of German Professional Hunters (BDB); Federation of Hunting and Sport Weapon and Ammunition Manufacturers; German Lander of Mecklen-burg-West Pomerania; German Lander of Lower Saxony; German Lander of Saxony-Anhalt; German Lander of Bavaria; German Lander of Hessen; German Lander of North Rhine-Westphalia; German Lander of Hamburg; German Lander of Bremen	Federal Ministry of Food and Agriculture (BMEL) in Germany; Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development); European Poultry, Egg and Game Association (EPEGA); Federal Ministry of Food and Agriculture (BMEL); German Hunting Association (DJV); Bavarian Hunting Association (BJV); Association of German Professional Hunters (BDB); Federation of Hunting and Sport Weapon and Ammunition Manufacturers; German Lander of Mecklen-burg-West Pomerania; German Lander of Lower Saxony; German Lander of Saxony-Anhalt; German Lander of Bavaria; German Lander of Hessen; German Lander of North Rhine-Westphalia; German Lander of Hamburg; German Lander of Bremen	The study was supported mainly by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript.; We would like to thank the following project partners for their support and financial assistance:; The Federal Ministry of Food and Agriculture (BMEL), the German Lander of Mecklen-burg-West Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hessen, North Rhine-Westphalia, Hamburg and Bremen, the German Hunting Association (DJV), the Bavarian Hunting Association (BJV), the Association of German Professional Hunters (BDB), and the industry stakeholders, represented by the European Poultry, Egg and Game Wholesale and Import Society (EPEGA), as well as the Federation of Hunting and Sport Weapon and Ammunition Manufacturers. A lot of people were involved in this project and we would like to thank them for their valuable contributions especially Dr. Antje Gerofke, Daniela Schlichting, Christine Sommerfeld, Dr. Markus Spolders, Dr. Ellen Ulbig and Dr. Helmut Schaffi to name only a few.	Alexander J, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1570; Bahr B, 2013, BFR S FORSCH ZUM THE; Berrens K, 1996, U JAGD LEXIKON; BfR, 2014, RES PROJ SAF GAM MEA; Brodowski G, 1998, FLEISCHWIRTSCHAFT, V78, P1298; Caudell Joe N., 2012, Human-Wildlife Interactions, V6, P105; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Deutscher Jagdverband, 2016, JAHR BUND DEUTSCHL; DEVA Deutsche Versuchs-und Pruf-Anstalt fur Jagd-und Sportwaffen e. V, 2011, SCHL ZUM FORSCH 1 AB; Doring V, 2007, PRAKTISCHE WILDBRETH, P17; Drees E., 2008, WILDBRETHYGIENE BEGL, P29; Gawlick H, 1975, ZIELBALLISTISCHE UNT; Gottlein A, 2013, BFR S FORSCH ZUM THE; Gremse C, 2012, ABSCHLUSSBERICHT 1 E; Gremse C, 2015, ENTWICKLUNG BEGRU E; Gremse C, 2014, ENTSCHEIDUNGSHILFEVO; Gremse F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102015; Hacklander K., 2015, EIGNUNG BLEIFREIER B; Haseder IE, 2000, KNAURS GROSSES JAGDL; Hoffmann D, 2013, BFR S FORSCH ZUM THE; Hothorn T, 2015, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Kanstrup N, 2016, EUR J WILDLIFE RES, V62, P333, DOI 10.1007/s10344-016-1006-0; Knott Jeff, 2009, Conservation Evidence, V6, P71; Krone O., 2009, INGESTION LEAD SPENT; Lahrssen-Wiederholt M, 2013, BFR S FORSCH ZUM THE; Lahrssen-Wiederhott M, 2015, FLEISCHWIRTSCHAFT, V95, P99; Langgemach T, 2006, NATUR LANDSCHAFT, V81, P320; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Muller-Graf C, 2017, GAME MEAT HYGIENE: FOOD SAFETY AND SECURITY, P201, DOI 10.3920/978-90-8686-840-7_12; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Pfannenstiel HD, 2014, TOTUNGSWIRKUNG TIERS; Spicher V, 2008, BLEIVERGIFTUNGEN BEI, P81; Steinhauser N., 2014, GESCHOSSWIRKUNG KUGE; Tavecchia G, 2001, J APPL ECOL, V38, P1197, DOI 10.1046/j.0021-8901.2001.00684.x; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Trinogga A, 2013, SCI TOTAL ENVIRON, V443, P226, DOI 10.1016/j.scitotenv.2012.10.084; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; [TVT Tierarztlichen Vereinigung fur Tierschutz e. V.], 2011, 123 TVT; Ulbig E, 2013, BFR S FORSCH ZUM THE; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	43	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185029	10.1371/journal.pone.0185029	http://dx.doi.org/10.1371/journal.pone.0185029			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926620	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600062
J	Kumar, D; Al Hassan, M; Naranjo, MA; Agrawal, V; Boscaiu, M; Vicente, O				Kumar, Dinesh; Al Hassan, Mohamad; Naranjo, Miguel A.; Agrawal, Veena; Boscaiu, Monica; Vicente, Oscar			Effects of salinity and drought on growth, ionic relations, compatible solutes and activation of antioxidant systems in oleander (Nerium oleander L.)	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; SALT STRESS; LIPID-PEROXIDATION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; NACL STRESS; PROLINE; HALOPHYTES; BIOSYNTHESIS	Nerium oleander is an ornamental species of high aesthetic value, grown in arid and semiarid regions because of its drought tolerance, which is also considered as relatively resistant to salt; yet the biochemical and molecular mechanisms underlying oleander's stress tolerance remain largely unknown. To investigate these mechanisms, one-year-old oleander seedlings were exposed to 15 and 30 days of treatment with increasing salt concentrations, up to 800 mM NaCl, and to complete withholding of irrigation; growth parameters and biochemical markers characteristic of conserved stress-response pathways were then determined in stressed and control plants. Strong water deficit and salt stress both caused inhibition of growth, degradation of photosynthetic pigments, a slight (but statistically significant) increase in the leaf levels of specific osmolytes, and induction of oxidative stress - as indicated by the accumulation of malondialdehyde (MDA), a reliable oxidative stress marker - accompanied by increases in the levels of total phenolic compounds and antioxidant flavonoids and in the specific activities of ascorbate peroxidase (APX) and glutathione reductase (GR). High salinity, in addition, induced accumulation of Na + and Cl -in roots and leaves and the activation of superoxide dismutase (SOD) and catalase (CAT) activities. Apart from anatomical adaptations that protect oleander from leaf dehydration at moderate levels of stress, our results indicate that tolerance of this species to salinity and water deficit is based on the constitutive accumulation in leaves of high concentrations of soluble carbohydrates and, to a lesser extent, of glycine betaine, and in the activation of the aforementioned antioxidant systems. Moreover, regarding specifically salt stress, mechanisms efficiently blocking transport of toxic ions from the roots to the aerial parts of the plant appear to contribute to a large extent to tolerance in Nerium oleander.	[Kumar, Dinesh; Al Hassan, Mohamad; Naranjo, Miguel A.; Vicente, Oscar] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia, Spain; [Kumar, Dinesh; Agrawal, Veena] Univ Delhi, Dept Bot, Delhi, India; [Boscaiu, Monica] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Valencia, Spain; [Al Hassan, Mohamad] New Zealand Inst Plant & Food Res Ltd PFR, Auckland, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Delhi; Universitat Politecnica de Valencia; New Zealand Institute for Plant & Food Research Ltd	Boscaiu, M (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Valencia, Spain.	mobosnea@eaf.upv.es	Vicente, Oscar/A-3858-2009; Boscaiu, Monica/H-7878-2015; Al Hassan, Mohamad/E-3097-2017	Vicente, Oscar/0000-0001-5076-3784; Boscaiu, Monica/0000-0002-9691-4223; Al Hassan, Mohamad/0000-0002-2297-3394	Polytechnic University of Valencia; NAMASTE fellowship from the European Union; Erasmus Mundus pre-doctoral scholarship; European Commission (Welcome Consortium)	Polytechnic University of Valencia; NAMASTE fellowship from the European Union; Erasmus Mundus pre-doctoral scholarship; European Commission (Welcome Consortium)	This work was financed by internal funds of the Polytechnic University of Valencia to Monica Boscaiu and Oscar Vicente. Dinesh Kumar's stay in Valencia was financed by a NAMASTE fellowship from the European Union, and Mohamad Al Hassan was a recipient of an Erasmus Mundus pre-doctoral scholarship financed by the European Commission (Welcome Consortium).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al Hassan M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00473; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Ashraf M, 2010, BIOTECHNOL ADV, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bautista I, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2025-2; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Blainski A, 2013, MOLECULES, V18, P6852, DOI 10.3390/molecules18066852; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caverzan A, 2016, GENET MOL BIOL, V39, P1, DOI 10.1590/1678-4685-GMB-2015-0109; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; Cicevan R, 2016, PEERJ, V4, DOI 10.7717/peerj.2133; Cicevan R, 2015, PROPAG ORNAM PLANTS, V15, P63; CONNELL JP, 1986, PLANT PHYSIOL, V82, P351, DOI 10.1104/pp.82.2.351; Croser C, 2001, ENVIRON POLLUT, V115, P9, DOI 10.1016/S0269-7491(01)00097-5; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; delRio LA, 1996, BIOCHEM SOC T, V24, P434, DOI 10.1042/bst0240434; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Field C. B, 2014, IPCC CLIMATE CHANGE; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Fita A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00978; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; FLOWERS TJ, 1986, Q REV BIOL, V61, P313, DOI 10.1086/415032; Gil R, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu049; Gil R, 2013, FUNCT PLANT BIOL, V40, P805, DOI 10.1071/FP12359; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomez JM, 2004, J EXP BOT, V55, P119, DOI 10.1093/jxb/erh013; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Gunes A, 2007, J PLANT INTERACT, V2, P105, DOI 10.1080/17429140701529399; HAJJI M, 1979, PHYSIOL VEG, V17, P517; Hamamoto S, 2015, CURR OPIN BIOTECH, V32, P113, DOI 10.1016/j.copbio.2014.11.025; HERRERA J, 1991, BOT J LINN SOC, V106, P147, DOI 10.1111/j.1095-8339.1991.tb02289.x; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hussain I, 2014, PLANT BIOSYST, V148, P1016, DOI 10.1080/11263504.2013.798369; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jisha KC, 2016, RICE SCI, V23, P242, DOI 10.1016/j.rsci.2016.08.002; Lenzi A, 2009, SCI HORTIC-AMSTERDAM, V122, P426, DOI 10.1016/j.scienta.2009.05.022; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lokhande V.H., 2012, ENV ADAPTATIONS STRE, P29, DOI DOI 10.1007/978-1-4614-0815-4_2; Lopez Gonzalez G, 1993, REGENERACION CUBIERT, P95; Manousaki E, 2011, IND ENG CHEM RES, V50, P656, DOI 10.1021/ie100270x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ozgur R, 2013, FUNCT PLANT BIOL, V40, P832, DOI 10.1071/FP12389; Pagen FJJ, 1988, OLEANDERS NERIUM L O; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Quartacci MF, 2001, J EXP BOT, V52, P77, DOI 10.1093/jexbot/52.354.77; Saed-Moucheshi A, 2014, J PLANT NUTR, V37, P1573, DOI 10.1080/01904167.2013.868483; Santos CV, 2004, SCI HORTIC-AMSTERDAM, V103, P93, DOI 10.1016/j.scienta.2004.04.009; Schiop ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135419; Shabala L, 2005, PLANTA, V222, P1041, DOI 10.1007/s00425-005-0074-2; Shabala S, 2003, FUNCT PLANT BIOL, V30, P507, DOI 10.1071/FP03016; Shankar V, 2016, APPL BIOCHEM BIOTECH, V178, P267, DOI 10.1007/s12010-015-1870-1; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; Soussi M, 1998, J EXP BOT, V49, P1329, DOI 10.1093/jexbot/49.325.1329; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Taffouo V. D., 2010, International Journal of Botany, V6, P53; Taibi K, 2016, S AFR J BOT, V105, P306, DOI 10.1016/j.sajb.2016.03.011; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Volkov V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00873; WEIMBERG R, 1987, PHYSIOL PLANTARUM, V70, P381, DOI 10.1111/j.1399-3054.1987.tb02832.x; Wu L, 2001, STUDIES SALT TOLERAN; Yan K, 2017, PLANT PHYSIOL BIOCH, V112, P326, DOI 10.1016/j.plaphy.2017.01.020; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	79	77	79	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185017	10.1371/journal.pone.0185017	http://dx.doi.org/10.1371/journal.pone.0185017			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922384	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300053
J	Arcarons, N; Morato, R; Vendrell, M; Yeste, M; Lopez-Bejar, M; Rajapaksha, K; Anzar, M; Mogas, T				Arcarons, Nuria; Morato, Roser; Vendrell, Meritxell; Yeste, Marc; Lopez-Bejar, Manel; Rajapaksha, Kosala; Anzar, Muhammad; Mogas, Teresa			Cholesterol added prior to vitrification on the cryotolerance of immature and in vitro matured bovine oocytes	PLOS ONE			English	Article							METHYL-BETA-CYCLODEXTRIN; PLASMA-MEMBRANE CHOLESTEROL; EARLY EMBRYO DEVELOPMENT; DEVELOPMENTAL COMPETENCE; BLASTOCYST DEVELOPMENT; BODIPY-CHOLESTEROL; GERMINAL VESICLE; CRYOPRESERVATION; EXPRESSION; IMPROVE	This study examines whether incorporating cholesterol-loaded methyl-beta-cyclodextrin (CLC) in the bovine oocyte plasma membrane improves oocyte tolerance to vitrification. In vitro matured oocytes were incubated with 2 mg/ml BODIPY-labeled CLC for different time intervals in FCS or PVA supplemented medium or exposed to different CLC concentrations to examine the subcellular localization of cholesterol by confocal microscopy live-cell imaging. Subsequently, the effects of optimized CLC concentrations and incubation times prior to vitrification on early embryo development were assessed. Then, we evaluated the effects of pretreatment with 2 mg/ml CLC for 30 min before the vitrification of immature (GV) and in vitro matured (MII) oocytes on developmental competence and gene expression. Our results indicate a high plasma membrane labeling intensity after 30 min of incubation with 2 mg/ml CLC for 30 min, regardless of the holding medium used. When oocytes were incubated with 1 mg/ml, 2 mg/ml and 3 mg/ml of CLC, intense labeling was observed at the plasma membrane after 40, 30 and 20 min, respectively. CLC pre-treatment before the vitrification of bovine oocytes did not affect subsequent cleavage and embryo development rates irrespective of CLC concentrations, incubation times or meiotic stage. However, pretreatment seems to improve the quality of embryos derived from vitrified oocytes, mainly when oocytes were vitrified at the GV stage.	[Arcarons, Nuria; Morato, Roser; Vendrell, Meritxell; Mogas, Teresa] Univ Autonomous Barcelona, Dept Anim Med & Surg, Cerdanyola Del Valles, Spain; [Vendrell, Meritxell; Lopez-Bejar, Manel] Univ Autonomous Barcelona, Dept Anim Hlth & Anat, Cerdanyola Del Valles, Spain; [Yeste, Marc] Univ Girona, Inst Food & Agr Technol, Girona, Spain; [Rajapaksha, Kosala; Anzar, Muhammad] Univ Saskatchewan, Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Rajapaksha, Kosala; Anzar, Muhammad] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK, Canada	Universitat de Girona; Agriculture & Agri Food Canada; University of Saskatchewan; University of Saskatchewan	Mogas, T (corresponding author), Univ Autonomous Barcelona, Dept Anim Med & Surg, Cerdanyola Del Valles, Spain.	teresa.mogas@uab.cat	Lopez-Bejar, Manel/S-2429-2019; Yeste, Marc/G-5945-2012; Mogas, Teresa/M-3746-2015	Lopez-Bejar, Manel/0000-0001-9490-6126; Yeste, Marc/0000-0002-2209-340X; Mogas, Teresa/0000-0002-6733-1328	Spanish Ministry of Science and Innovation [AGL2013-46769]; Generalitat de Catalunya [2014 SGR 547]; FPU scholarship [FPU12-01419]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FPU scholarship(Spanish Government)	This study was supported by: the Spanish Ministry of Science and Innovation (Project AGL2013-46769), http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem. 7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid=83b192b9036c2210VgM/CM1000001d04140 aRCRD, to TM and MLB; The Generalitat de Catalunya (Project No. 2014 SGR 547), http://agaur.gencat.catteniinici/index.html, to TM and MLB; and NA was supported by FPU scholarship (FPU12-01419), http://www.mecd.gob.es/servicios-alciudadano-mecd/en/catalogo/general/education/998758/ficha.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jonathan Lamarre, from the University of Guelph, for his valuable comments on this manuscript. This study was supported by the Spanish Ministry of Science and Innovation (Project AGL2013-46769) and Generalitat de Catalunya (Project No. 2014 SGR 547). NA was supported by FPU scholarship (FPU12-01419).	Agca Y, 2000, MOL REPROD DEV, V55, P212, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;212::AID-MRD11&gt;3.0.CO;2-M; Agca Y, 1998, MOL REPROD DEV, V49, P408, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;408::AID-MRD8&gt;3.0.CO;2-R; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arcarons N, 2015, REPROD FERT DEVELOP, V28, P1560; Ariola FS, 2009, BIOPHYS J, V96, P2696, DOI 10.1016/j.bpj.2008.12.3922; Balasubramanian S, 2007, THERIOGENOLOGY, V68, P265, DOI 10.1016/j.theriogenology.2007.05.044; Buschiazzo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062919; Christian AE, 1997, J LIPID RES, V38, P2264; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Horvath G, 2006, THERIOGENOLOGY, V66, P1026, DOI 10.1016/j.theriogenology.2006.03.004; Jimenez-Trigos E, 2013, CRYOBIOLOGY, V67, P106, DOI 10.1016/j.cryobiol.2013.05.006; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 1999, J LIPID RES, V40, P2264; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Lopera-Vasquez R, 2015, REPROD FERTILITY DEV; Morato R, 2008, CRYOBIOLOGY, V57, P137, DOI 10.1016/j.cryobiol.2008.07.003; Morato R, 2011, CRYOBIOLOGY, V63, P240, DOI 10.1016/j.cryobiol.2011.09.002; MULDREW K, 1994, BIOPHYS J, V66, P532, DOI 10.1016/S0006-3495(94)80806-9; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Opiela J, 2009, ANN ANIM SCI, V9, P3; Prentice-Biensch JR, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-73; Purdy PH, 2004, BIOL REPROD, V71, P522, DOI 10.1095/biolreprod.103.025577; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Rizos D, 2001, THERIOGENOLOGY, V56, P1, DOI 10.1016/S0093-691X(01)00538-6; ROTTEM S, 1973, BIOCHIM BIOPHYS ACTA, V323, P495, DOI 10.1016/0005-2736(73)90158-2; RUFFING NA, 1993, CRYOBIOLOGY, V30, P562, DOI 10.1006/cryo.1993.1059; Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021; Salinas-Flores L, 2008, CRYOLETTERS, V29, P391; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Seidel GE, 2006, THERIOGENOLOGY, V65, P228, DOI 10.1016/j.theriogenology.2005.09.025; Shirazi A, 2016, THERIOGENOLOGY, V86, P2136, DOI 10.1016/j.theriogenology.2016.07.005; Shirazi A, 2014, ZYGOTE, V22, P165, DOI 10.1017/S096719941200038X; Spricigo JFW, 2012, CRYOBIOLOGY, V65, P319, DOI 10.1016/j.cryobiol.2012.09.001; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Wustner D, 2011, CHEM PHYS LIPIDS, V164, P221, DOI 10.1016/j.chemphyslip.2011.01.004; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Zeron Y, 1999, CRYOBIOLOGY, V38, P35, DOI 10.1006/cryo.1998.2139; Zhang H, 2014, MOL REPROD DEV, V81, P87, DOI 10.1002/mrd.22287; Zhao MT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104471; Zhou GB, 2013, ANIM BIOTECHNOL, V24, P94, DOI 10.1080/10495398.2012.755466; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	51	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184714	10.1371/journal.pone.0184714	http://dx.doi.org/10.1371/journal.pone.0184714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910399	Green Published, gold			2022-12-26	WOS:000410859200083
J	Horswill, C; Trathan, PN; Ratcliffe, N				Horswill, Cat; Trathan, Philip N.; Ratcliffe, Norman			Linking extreme interannual changes in prey availability to foraging behaviour and breeding investment in a marine predator, the macaroni penguin	PLOS ONE			English	Article							BREATH-HOLD DIVERS; ROCKHOPPER PENGUINS; EUDYPTES-CHRYSOLOPHUS; PROVISIONING BEHAVIOR; SOUTH GEORGIA; VARIABILITY; PERFORMANCE; CHRYSOCOME; SURVIVAL; CLIMATE	Understanding the mechanisms that link prey availability to predator behaviour and population change is central to projecting how a species may respond to future environmental pressures. We documented the behavioural responses and breeding investment of macaroni penguins Eudyptes chrysolophus across five breeding seasons where local prey density changed by five-fold; from very low to highly abundant. When prey availability was low, foraging trips were significantly longer and extended overnight. Birds also foraged farther from the colony, potentially in order to reach more distant foraging grounds and allow for increased search times. These extended foraging trips were also linked to a marked decrease in fledgling weights, most likely associated with reduced rates of provisioning. Furthermore, by comparing our results with previous work on this population, it appears that lowered first-year survival rates associated, at least partially, with fledging masses were also evident for this cohort. This study integrates a unique set of prey density, predator behaviour and predator breeding investment data to highlight a possible behavioural mechanism linking perturbations in prey availability to population demography.	[Horswill, Cat; Trathan, Philip N.; Ratcliffe, Norman] NERC, British Antarctic Survey, Cambridge, England; [Horswill, Cat] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Glasgow	Horswill, C (corresponding author), NERC, British Antarctic Survey, Cambridge, England.; Horswill, C (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	catrsw@gmail.com		Horswill, Cat/0000-0002-1795-0753	National Environmental Research Council [NE/152797/X]; NERC PhD studentship grant [NE/I52797/X]; NERC [bas0100035] Funding Source: UKRI; Natural Environment Research Council [bas0100035] Funding Source: researchfish	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC PhD studentship grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by National Environmental Research Council, http://www.nerc.ac.uk/, Grant No. NE/152797/X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the research assistants at Bird Island, South Georgia (2001-2005). We also thank Sophie Fielding for many discussions regarding krill density and distribution around South Georgia, Brendan F. Godley, Tom Hart and Jon A. Green for reading various earlier versions of this manuscript, Jason Matthiopoulos, Esther L. Jones and Debbie J. F. Russell for technical advice on early model development and coding, as well as Helen Peat and Jenny Thomas for data management. This paper is a contribution to the Ecosystems programme of the British Antarctic Survey. This analysis was funded by a NERC PhD studentship grant number NE/I52797/X.	Barlow KE, 2002, MAR ECOL PROG SER, V232, P291, DOI 10.3354/meps232291; Barlow KE, 2002, IBIS, V144, P248, DOI 10.1046/j.1474-919X.2002.00046.x; Baylis AMM, 2013, POLAR BIOL, V36, P1007, DOI 10.1007/s00300-013-1324-6; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Bost CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9220; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Cimino MA, 2014, MAR ECOL PROG SER, V513, P253, DOI 10.3354/meps10928; Crossin GT, 2015, MAR ECOL PROG SER, V530, P163, DOI 10.3354/meps11320; CROXALL JP, 1993, J ZOOL, V230, P31, DOI 10.1111/j.1469-7998.1993.tb02670.x; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; Dehnhard N, 2014, IBIS, V156, P548, DOI 10.1111/ibi.12167; Fielding S, 2014, ICES J MAR SCI, V71, P2578, DOI 10.1093/icesjms/fsu104; Fox J, 2015, PACKAGE CAR V 2 0 25; Green JA, 2009, POLAR BIOL, V32, P645, DOI 10.1007/s00300-008-0568-z; Hart T, 2010, ANIM BEHAV, V79, P845, DOI 10.1016/j.anbehav.2009.12.033; Hart T, 2010, MAR BIOL, V157, P1543, DOI 10.1007/s00227-010-1428-2; Hennicke JC, 2005, MAR ECOL PROG SER, V296, P173, DOI 10.3354/meps296173; Horswill C, 2016, ECOLOGY, V97, P1919, DOI 10.1002/ecy.1452; Horswill C, 2016, MAR ECOL PROG SER, V548, P233, DOI 10.3354/meps11626; Horswill C, 2014, J ANIM ECOL, V83, P1057, DOI 10.1111/1365-2656.12229; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kock K-H., 1992, ANTARCTIC FISH FISHE; Morrison KW, 2016, BEHAV ECOL SOCIOBIOL, V70, P467, DOI 10.1007/s00265-016-2060-z; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Olsson O, 1997, POLAR BIOL, V18, P161, DOI 10.1007/s003000050172; Pinheiro J, 2016, NLME LINEAR MIXED EF; Putz K, 2002, AQUAT CONSERV, V12, P75, DOI 10.1002/aqc.478; Ratcliffe N, 2014, J BIOGEOGR, V41, P1183, DOI 10.1111/jbi.12279; Reid K, 1996, POLAR BIOL, V16, P105, DOI 10.1007/BF02390431; Rey AR, 2007, IBIS, V149, P826; Senner NR, 2015, J ANIM ECOL, V84, P1164, DOI 10.1111/1365-2656.12381; Sherley RB, 2017, CURR BIOL, V27, P563, DOI 10.1016/j.cub.2016.12.054; Sherley RB, 2013, MAR ECOL PROG SER, V473, P291, DOI 10.3354/meps10070; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Sparling CE, 2007, ANIM BEHAV, V74, P207, DOI 10.1016/j.anbehav.2006.06.022; Sumner M, 2013, TRIP SPATIAL ANAL AN; Sumner MD, 2013, TRIPESTIMATION METRO; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; Trathan PN, 2003, FISH OCEANOGR, V12, P569, DOI 10.1046/j.1365-2419.2003.00268.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Waluda CM, 2012, MAR ECOL PROG SER, V466, P261, DOI 10.3354/meps09930; Whitehead TO, 2017, MAR ECOL PROG SER, V565, P227, DOI 10.3354/meps12017; Williams T.D., 1995, PENGUINS; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Zimmer I, 2011, DOES FORAGING PERFOR, V6; Zuur Alain F., 2009, P1	52	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184114	10.1371/journal.pone.0184114	http://dx.doi.org/10.1371/journal.pone.0184114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910405	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000410859200032
J	Huizer, K; Mustafa, DAM; Spelt, JC; Kros, JM; Sacchetti, A				Huizer, Karin; Mustafa, Dana A. M.; Spelt, J. Clarissa; Kros, Johan M.; Sacchetti, Andrea			Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CORD BLOOD; ANGIOGENIC CYTOKINES; MICROPARTICLES; DISTINCT; BIOLOGY; NEOVASCULARIZATION; IDENTIFICATION; INFLAMMATION; ENUMERATION	The characterization of circulating endothelial progenitor cells (EPCs) is fundamental to any study related to angiogenesis. Unfortunately, current literature lacks consistency in the definition of EPC subsets due to variations in isolation strategies and inconsistencies in the use of lineage markers. Here we address critical points in the identification of hematopoietic progenitor cells (HPCs), circulating endothelial cells (CECs), and culture-generated outgrowth endothelial cells (OECs) from blood samples of healthy adults (AB) and umbilical cord (UCB). Peripheral blood mononuclear cells (PBMCs) were enriched using a Ficoll-based gradient followed by an optimized staining and gating strategy to enrich for the target cells. Sorted EPC populations were subjected to RT-PCR for tracing the expression of markers beyond the limits of cell surface-based immunophenotyping. Using CD34, CD133 and c-kit staining, combined with FSC and SSC, we succeeded in the accurate and reproducible identification of four HPC subgroups and found significant differences in the respective populations in AB vs. UCB. Co-expression analysis of endothelial markers on HPCs revealed a complex pattern characterized by various subpopulations. CECs were identified by using CD34, KDR, CD45, and additional endothelial markers, and were subdivided according to their apoptotic state and expression of c-kit. Comparison of UCB-CECs vs. AB-CECs revealed significant differences in CD34 and KDR levels. OECs were grown from PBMC-fractions We found that viable c-kit(+) CECs are a candidate circulating precursor for CECs. RT-PCR to angiogenic factors and receptors revealed that all EPC subsets expressed angiogenesis-related molecules. Taken together, the improvements in immunophenotyping and gating strategies resulted in accurate identification and comparison of better defined cell populations in a single procedure.	[Huizer, Karin; Mustafa, Dana A. M.; Spelt, J. Clarissa; Kros, Johan M.; Sacchetti, Andrea] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kros, JM (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	j.m.kros@erasmusmc.nl	Mustafa, Dana/AAQ-6530-2021	Mustafa, Dana/0000-0003-0644-078X				Ackermann Bradley L., 2002, Current Topics in Medicinal Chemistry, V2, P53, DOI 10.2174/1568026023394605; Alvarez P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/312656; Becher MU, 2010, HERZ, V35, P342, DOI 10.1007/s00059-010-3360-0; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fang S, 2012, PLOS BIOL, V10; Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Hristov M, 2012, J IMMUNOL METHODS, V381, P9, DOI 10.1016/j.jim.2012.04.003; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Kraan J, 2012, DRUG DISCOV TODAY, V17, P710, DOI 10.1016/j.drudis.2012.01.011; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Lopez-Holgado N, 2007, CYTOTHERAPY, V9, P14, DOI 10.1080/14653240601047726; Matsuoka Y, 2011, STEM CELLS, V29, P1783, DOI 10.1002/stem.721; Mayani H, 2003, ARCH MED RES, V34, P476, DOI 10.1016/j.arcmed.2003.08.004; MAYANI H, 1992, EUR J HAEMATOL, V49, P225; Mayani H, 2010, EXPERT REV HEMATOL, V3, P401, DOI 10.1586/EHM.10.37; Mayr M, 2011, AM J MED, V124, P489, DOI 10.1016/j.amjmed.2011.01.015; Mund JA, 2013, ANGIOGENESIS, V16, P953, DOI 10.1007/s10456-013-9368-3; Mund JA, 2012, ARTERIOSCL THROM VAS, V32, P1045, DOI 10.1161/ATVBAHA.111.244210; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Popa ER, 2006, J MOL CELL CARDIOL, V41, P86, DOI 10.1016/j.yjmcc.2006.04.021; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Schewe M, 2016, CELL STEM CELL, V19, P38, DOI 10.1016/j.stem.2016.05.023; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Schmidt-Lucke C, 2010, ATHEROSCLEROSIS, V211, P249, DOI 10.1016/j.atherosclerosis.2010.02.007; Shaked Y, 2006, J CLIN ONCOL, V24, P4040, DOI 10.1200/JCO.2006.07.1175; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Singh N, 2012, J AM COLL CARDIOL, V60, P324, DOI 10.1016/j.jacc.2012.02.065; Smythe J, 2008, TISSUE ENG PT C-METH, V14, P59, DOI 10.1089/tec.2007.0251; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Tura O, 2013, STEM CELLS, V31, P338, DOI 10.1002/stem.1280; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Vaughan Erin E, 2012, Methods Mol Biol, V916, P351, DOI 10.1007/978-1-61779-980-8_25; Vroling L, 2010, BRIT J CANCER, V102, P268, DOI 10.1038/sj.bjc.6605477; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433	52	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184895	10.1371/journal.pone.0184895	http://dx.doi.org/10.1371/journal.pone.0184895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910385	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200113
J	Muire, PJ; Hanson, LA; Wills, R; Petrie-Hanson, L				Muire, Preeti J.; Hanson, Larry A.; Wills, Robert; Petrie-Hanson, Lora			Differential gene expression following TLR stimulation in rag1(-/-) mutant zebrafish tissues and morphological descriptions of lymphocyte-like cell populations	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DOUBLE-STRANDED-RNA; HUMAN NK CELLS; INTERFERON-GAMMA GENES; TOLL-LIKE-RECEPTOR; IMMUNE-RESPONSES; IFN-GAMMA; RAINBOW-TROUT; BETA-GLUCANS; T-BET	In the absence of lymphocytes, rag1(-/)-mutant zebrafish develop protective immunity to bacteria. In mammals, induction of protection by innate immunity can be mediated by macrophages or natural killer (NK) cells. To elucidate potential responsive cell populations, we morphologically characterized lymphocyte-like cells (LLCs) from liver, spleen and kidney hematopoietic tissues. In fish, these cells include NK cells and Non-specific cytotoxic cells (NCCs). We also evaluated the transcriptional expression response of select genes that are important indicators of NK and macrophage activation after exposure to specific TLR ligands. The LLC cell populations could be discriminated by size and further discriminated by the presence of cytoplasmic granules. Expression levels of mx, tnfa, ifny, t-bet and nitr9 demonstrated dynamic changes in response to intra-coelomically administered beta glucan (a TLR2/6 ligand), Poly I: C (a TLR3 ligand) and resiquimod (R848) (a TLR7/8 ligand). Following TLR 2/6 stimulation, there was a greater than 100 fold increase in ifn. in liver, kidney and spleen and moderate increases in tnfa in liver and kidney. TLR3 stimulation caused broad up regulation of mx, down-regulation of tnfa in kidney and spleen tissues and up regulation of nitr9 in the kidney. Following TLR 7/8 stimulation, there was a greater than 100 fold increase in ifn. in liver and kidney and t-bet in liver. Our gene expression findings suggest that LLCs and macrophages are stimulated following beta glucan exposure. Poly I: C causes type I interferon response and mild induction of LLC in the kidney and R-848 exposure causes the strongest LLC stimulation. Overall, the strongest NK like gene expression occurred in the liver. These differential effects of TLR ligands in rag1 (-/-)mutant zebrafish shows strong NK cell-like gene expression responses, especially in the liver, and provides tools to evaluate the basis for protective immunity mediated by the innate immune cells of fish.	[Muire, Preeti J.; Hanson, Larry A.; Petrie-Hanson, Lora] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Wills, Robert] Mississippi State Univ, Coll Vet Med, Dept Pathobiol & Populat Med, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Petrie-Hanson, L (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lora@cvm.msstate.edu		Hanson, Larry/0000-0001-9362-7416	Office of Research and Graduate Studies; Department of Basic Sciences, College of Veterinary Medicine, MSU; College of Veterinary Medicine; Mississippi State University	Office of Research and Graduate Studies; Department of Basic Sciences, College of Veterinary Medicine, MSU; College of Veterinary Medicine; Mississippi State University	This work was funded by the Office of Research and Graduate Studies and the Department of Basic Sciences, College of Veterinary Medicine, MSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nitr9 monoclonal antibody 90.10.5 was provided by Dr. J. Yoder. Myxovirus resistance A (Mx) NM_182942.4 primers and probe sequences were designed using Beacon Design software (BioRad) and kindly provided by Dr. Du Ngoc Nguyen. This research was funded by the College of Veterinary Medicine and Mississippi State University.	Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Albeituni SH, 2013, ANTI-CANCER AGENT ME, V13, P689, DOI 10.2174/1871520611313050003; Albuquerque A, 2008, FISH SHELLFISH IMMUN, P24; Andersson M, 1996, VET IMMUNOL IMMUNOP, V54, P123, DOI 10.1016/S0165-2427(96)05677-2; [Anonymous], 2004, AZ QUANT PCR; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Das BK, 2009, FISH SHELLFISH IMMUN, V26, P40, DOI 10.1016/j.fsi.2008.03.009; DIRENZO L, 1991, EUR J IMMUNOL, V21, P1755, DOI 10.1002/eji.1830210726; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Elibol-Fleming B., 2006, THESIS; Estepa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135483; Falco A, 2014, FISH SHELLFISH IMMUN, V36, P494, DOI 10.1016/j.fsi.2013.12.005; Fernandez-Trujillo A, 2008, FISH SHELLFISH IMMUN, V24, P279, DOI 10.1016/j.fsi.2007.11.008; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Fischer U, 2013, FISH SHELLFISH IMMUN, V35, P197, DOI 10.1016/j.fsi.2013.04.018; Garcia-Castillo J, 2002, IMMUNOGENETICS, V54, P200, DOI 10.1007/s00251-002-0451-y; Garcia-Valtanen P, 2017, MULTIGENE FAMILIES I, P8; Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046; HARRIS DT, 1992, DEV COMP IMMUNOL, V16, P395, DOI 10.1016/0145-305X(92)90041-A; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hida TH, 2009, INFLAMM RES, V58, P9, DOI 10.1007/s00011-008-8141-3; Hohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044451; Janeway C., 2008, JANEWAY IMMUNOBIOL; Ju BS, 1999, DEV GENET, V25, P158, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;158::AID-DVG10&gt;3.0.CO;2-6; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kim JO, 2012, FISH PATHOL, V47, P137, DOI 10.3147/jsfp.47.137; Korkea-aho TL, 2012, J APPL MICROBIOL, V113, P24, DOI 10.1111/j.1365-2672.2012.05325.x; Krishnavajhala A, 2017, INT J IMMUNOLOGY, V5, P20; Kumari J, 2015, FRONT IMMUNOL, P6; Leong J, 1988, VACCINATION INFECT H, P193; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Milev-Milovanovic I, 2006, IMMUNOGENETICS, V58, P70, DOI 10.1007/s00251-006-0081-x; Mitra S, 2010, FEBS J, V277, P128, DOI 10.1111/j.1742-4658.2009.07460.x; Moss LD, 2009, DEV COMP IMMUNOL, V33, P1077, DOI 10.1016/j.dci.2009.05.009; Mulero I, 2007, AQUACULTURE, V268, P244, DOI 10.1016/j.aquaculture.2007.04.046; Netea MG, 2013, EUR J CLIN INVEST, V43, P881, DOI 10.1111/eci.12132; Overturf K, 2006, J FISH DIS, V29, P215, DOI 10.1111/j.1365-2761.2006.00707.x; Palti Y, 2010, DEV COMP IMMUNOL, V34, P219, DOI 10.1016/j.dci.2009.10.002; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Parhi J, AQUACULTURE REPORTS; Petrie-Hanson L, 1999, FISH SHELLFISH IMMUN, V9, P579, DOI 10.1006/fsim.1999.0215; Petrie-Hanson L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-8; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Pisegna S, 2004, BLOOD, V104, P4157, DOI 10.1182/blood-2004-05-1860; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Rodriguez I, 2009, FISH SHELLFISH IMMUN, V27, P369, DOI 10.1016/j.fsi.2009.02.007; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Sepulcre MP, 2007, MOL IMMUNOL, V44, P2009, DOI 10.1016/j.molimm.2006.09.022; Shah RN, 2012, ADV HEMATOLOGY, P2012; Sieger D, 2009, DIS MODEL MECH, V2, P571, DOI 10.1242/dmm.003509; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Strandskog G, 2008, VACCINE, V26, P4704, DOI 10.1016/j.vaccine.2008.06.054; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Svingerud T, 2012, J IMMUNOL, V189, P5912, DOI 10.4049/jimmunol.1201188; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vetvicka Vaclav, 2013, N Am J Med Sci, V5, P580, DOI 10.4103/1947-2714.120792; Vojtech LN, 2009, INFECT IMMUN, V77, P914, DOI 10.1128/IAI.01201-08; Wang J, 2005, CELL MOL IMMUNOL, V2, P449; Wang L, 2013, FISH PHYSIOL BIOCHEM, V39, P793, DOI 10.1007/s10695-012-9741-y; Wei S, 2007, IMMUNOGENETICS, V59, P813, DOI 10.1007/s00251-007-0250-6; Wu JJ, 2004, ANTIVIR RES, V64, P79, DOI 10.1016/j.antiviral.2004.07.002; Zhou ZX, 2015, DEV COMP IMMUNOL, V49, P113, DOI 10.1016/j.dci.2014.11.018; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484	80	9	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184077	10.1371/journal.pone.0184077	http://dx.doi.org/10.1371/journal.pone.0184077			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910320	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200029
J	Tanaka, C; Tagami, T; Matsumoto, H; Matsuda, K; Kim, S; Moroe, Y; Fukuda, R; Unemoto, K; Yokota, H				Tanaka, Chie; Tagami, Takashi; Matsumoto, Hisashi; Matsuda, Kiyoshi; Kim, Shiei; Moroe, Yuta; Fukuda, Reo; Unemoto, Kyoko; Yokota, Hiroyuki			Recent trends in 30-day mortality in patients with blunt splenic injury: A nationwide trauma database study in Japan	PLOS ONE			English	Article							ENDOVASCULAR BALLOON OCCLUSION; PRACTICE MANAGEMENT GUIDELINE; HOSPITAL CARDIAC-ARREST; NONOPERATIVE MANAGEMENT; EASTERN ASSOCIATION; COMPUTED-TOMOGRAPHY; SURGERY; ADULTS; EMBOLIZATION; EXPERIENCE	Background Splenic injury frequently occurs after blunt abdominal trauma; however, limited epidemiological data regarding mortality are available. We aimed to investigate mortality rate trends after blunt splenic injury in Japan. Methods We retrospectively identified 1,721 adults with blunt splenic injury (American Association for the Surgery of Trauma splenic injury scale grades III-V) from the 2004-2014 Japan Trauma Data Bank. We grouped the records of these patients into 3 time phases: phase I (2004-2008), phase II (2009-2012), and phase III (2013-2014). Over the 3 phases, we analysed 30-day mortality rates and investigated their association with the prevalence of certain initial interventions (Mantel-Haenszel trend test). We further performed multiple imputation and multivariable analyses for comparing the characteristics and outcomes of patients who underwent TAE or splenectomy/splenorrhaphy, adjusting for known potential confounders and for within-hospital clustering using generalised estimating equation. Results Over time, there was a significant decrease in 30-day mortality after splenic injury (p < 0.01). Logistic regression analysis revealed that mortality significantly decreased over time (from phase I to phase II, odds ratio: 0.39, 95% confidence interval: 0.22-0.67; from phase I to phase III, odds ratio: 0.34, 95% confidence interval: 0.19-0.62) for the overall cohort. While the 30-day mortality for splenectomy/splenorrhaphy diminished significantly over time (p = 0.01), there were no significant differences regarding mortality for non-operative management, with or without transcatheter arterial embolisation (p = 0.43, p = 0.29, respectively). Conclusions In Japan, in-hospital 30-day mortality rates decreased significantly after splenic injury between 2004 and 2014, even after adjustment for within-hospital clustering and other factors independently associated with mortality. Over time, mortality rates decreased significantly after splenectomy/splenorrhaphy, but not after non-operative management. This information is useful for clinicians when making decisions about treatments for patients with blunt splenic injury.	[Tanaka, Chie; Tagami, Takashi; Moroe, Yuta; Fukuda, Reo; Unemoto, Kyoko] Nippon Med Sch, Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Tagami, Takashi] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Matsumoto, Hisashi] Nippon Med Sch, Chiba Hokusoh Hosp, Dept Emergency & Crit Care Med, Chiba, Japan; [Matsuda, Kiyoshi; Yokota, Hiroyuki] Musashikosugi Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Kawasaki, Kanagawa, Japan; [Kim, Shiei] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan	Nippon Medical School; University of Tokyo; Nippon Medical School; Nippon Medical School; Nippon Medical School	Tagami, T (corresponding author), Nippon Med Sch, Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan.; Tagami, T (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.	t-tagami@nms.ac.jp	Tagami, Takashi/HGA-3038-2022	Tagami, Takashi/0000-0001-6953-1932	Suzuki Foundation Science Research Fund;  [KAKENHI-15H05685]	Suzuki Foundation Science Research Fund; 	This work was supported by funds from the Grants-in-Aid for Scientific Research, Japan (grant number: KAKENHI-15H05685) and the Suzuki Foundation Science Research Fund to Takashi Tagami. The funders had no role in the execution of this study or interpretation of the results.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bhullar IS, 2012, J TRAUMA ACUTE CARE, V72, P1127, DOI 10.1097/TA.0b013e3182569849; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Chikuda H, 2014, EMERG MED J, V31, P201, DOI 10.1136/emermed-2012-202058; Cirocchi R, 2013, CRIT CARE, V17, DOI 10.1186/cc12868; Cirocchi R, 2014, ULUS TRAVMA ACIL CER, V20, P91, DOI 10.5505/tjtes.2014.99442; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eastern Association for the Surgery of Trauma (EAST), 2003, AD HOC COMM PRACT MA; El-Matbouly M, 2016, SURG-J R COLL SURG E, V14, P52, DOI 10.1016/j.surge.2015.08.001; Haan JM, 2005, J TRAUMA, V58, P492, DOI 10.1097/01.TA.0000154575.49388.74; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Hoff WS, 2002, J TRAUMA, V53, P602, DOI 10.1097/00005373-200209000-00038; Hondo K, 2013, J AM COLL SURGEONS, V217, P850, DOI 10.1016/j.jamcollsurg.2013.05.026; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Inoue J, 2016, J TRAUMA ACUTE CARE, V80, P559, DOI 10.1097/TA.0000000000000968; Jacoby RC, 2008, TRAUMA, P661; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Kimura A, 2013, J TRAUMA ACUTE CARE, V75, P202, DOI 10.1097/TA.0b013e3182905ef7; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mashiko Kunihiro, 2005, Journal of Nippon Medical School, V72, P194, DOI 10.1272/jnms.72.194; Medicine AftAoA, 2008, ABBREVIATED INJURY S; Moore EE, 2010, J TRAUMA, V69, P1600, DOI 10.1097/TA.0b013e318201124e; Moore FA, 2008, J TRAUMA, V65, P1007, DOI 10.1097/TA.0b013e31818a93bf; Norii T, 2015, J TRAUMA ACUTE CARE, V78, P721, DOI 10.1097/TA.0000000000000578; Olthof DC, 2013, J TRAUMA ACUTE CARE, V74, P546, DOI 10.1097/TA.0b013e31827d5e3a; Peitzman AB, 2005, J AM COLL SURGEONS, V201, P179, DOI 10.1016/j.jamcollsurg.2005.03.037; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Raza M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-14; Richardson JD, 2005, J AM COLL SURGEONS, V200, P648, DOI 10.1016/j.jamcollsurg.2004.11.005; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sabe AA, 2009, J TRAUMA, V67, P565, DOI 10.1097/TA.0b013e3181b17010; Scarborough JE, 2016, J AM COLL SURGEONS, V223, P249, DOI 10.1016/j.jamcollsurg.2016.03.043; SOS- KANTO_ 2012_ study_ group, 2015, RESUSCITATION, V97, P76; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Surgeons ACo, 2008, ADV TRAUM LIF SUPP P; Suzuki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145963; Tagami T, 2015, ACUTE MED SURG, V2, P225, DOI 10.1002/ams2.102; Tagami T, 2013, CIRCULATION, V127, pE567, DOI 10.1161/CIRCULATIONAHA.112.154773; TEASDALE G, 1974, LANCET, V2, P81; van der Vlies CH, 2010, CARDIOVASC INTER RAD, V33, P1079, DOI 10.1007/s00270-010-9943-6; Velmahos GC, 2010, MANAGEMENT MOST SEVE	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184690	10.1371/journal.pone.0184690	http://dx.doi.org/10.1371/journal.pone.0184690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910356	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200078
J	Hancock, AM; Frostig, RD				Hancock, Aneeka M.; Frostig, Ron D.			Testing the effects of sensory stimulation as a collateral-based therapeutic for ischemic stroke in C57BL/6J and CD1 mouse strains	PLOS ONE			English	Article							BLOOD-FLOW; MICROCIRCULATION; ARCHITECTURE; DETERMINANT; CHLORIDE; ANATOMY; BRAIN; MICE	Utilizing a rat model of ischemic stroke, we have previously shown that sensory stimulation can completely protect rats from impending ischemic damage of cortex if this treatment is delivered within the first two hours post-permanent middle cerebral artery occlusion (pMCAo). The current study sought to extend our findings in rats to mice, which would allow new avenues of research not available in rats. Thus, young adult C57BL/6J and CD1 mice were tested for protection from ischemic stroke with the same protective sensory stimulation-based treatment. Cortical activity and blood flow were assessed with intrinsic signal optical imaging (ISOI) and laser speckle imaging (LSI), respectively, and histological analysis (TTC) was performed at the completion of the experiments. Standing in stark contrast to the positive results observed in rats, in both strains we found that there were no differences between treated and untreated mice at 24 hours post-pMCAo in terms of infarct volume, negative functional imaging results, and major reduction in retrograde collateral blood flow as compared to pre-pMCAo baseline and surgical controls. Also, no differences were found between the strains in terms of theses variables. Potential reasons for the differences between rats and mice are discussed.	[Hancock, Aneeka M.; Frostig, Ron D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Frostig, Ron D.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Frostig, Ron D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Frostig, RD (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.; Frostig, RD (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA.; Frostig, RD (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	rfrostig@uci.edu			National Institute of Neurological Disorders and Stroke [NS-066001]; Fondation Leducq [15CVD02]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fondation Leducq(Leducq Foundation)	This work was supported by the following funding sources: The National Institute of Neurological Disorders and Stroke (NS-066001 to RDF; https://www.ninds.nih.gov/), and Fondation Leducq (15CVD02 to RDF; https://www.fondationleducq.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Baran U, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025006; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chalothorn D, 2010, J MOL CELL CARDIOL, V49, P251, DOI 10.1016/j.yjmcc.2010.03.014; Chalothorn D, 2009, CIRC RES, V105, P89, DOI 10.1161/CIRCRESAHA.109.197145; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789; Cristofaro B, 2013, DEVELOPMENT, V140, P1720, DOI 10.1242/dev.092304; Davis MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50418; Davis MF, 2011, STROKE, V42, P792, DOI 10.1161/STROKEAHA.110.607135; Doyle KP, 2012, J NEUROSCI METH, V207, P31, DOI 10.1016/j.jneumeth.2012.03.003; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Hussein HM, 2010, AM J NEURORADIOL, V31, P454, DOI 10.3174/ajnr.A2006; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Kochanek KD, 2013, NCHS DATA BRIEF, V2014, P1; Lay CC, 2014, EUR J NEUROSCI, P1, DOI DOI 10.1111/EJN.12387; Lay CC, 2013, EUR J NEUROSCI, V38, P2445, DOI 10.1111/ejn.12217; Lay CC, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001255; Lay CC, 2011, J NEUROSCI, V31, P11495, DOI 10.1523/JNEUROSCI.1741-11.2011; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liebeskind DS, 2008, STROKE, V39, pE187, DOI 10.1161/STROKEAHA.108.522888; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Urban A, 2015, NAT METHODS, V12, P873, DOI [10.1038/nmeth.3482, 10.1038/NMETH.3482]; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Wang-Fischer Y, 2009, MANUAL STROKE MODELS; Winship IR, 2015, MICROCIRCULATION, V22, P228, DOI 10.1111/micc.12177; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183909	10.1371/journal.pone.0183909	http://dx.doi.org/10.1371/journal.pone.0183909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902897	Green Submitted, gold, Green Published			2022-12-26	WOS:000410669200024
J	Kaida, A; Iritani, N; Yamamoto, SP; Kanbayashi, D; Hirai, Y; Togawa, M; Amo, K; Kohdera, U; Nishigaki, T; Shiomi, M; Asai, S; Kageyama, T; Kubo, H				Kaida, Atsushi; Iritani, Nobuhiro; Yamamoto, Seiji P.; Kanbayashi, Daiki; Hirai, Yuki; Togawa, Masao; Amo, Kiyoko; Kohdera, Urara; Nishigaki, Toshinori; Shiomi, Masashi; Asai, Sadasaburo; Kageyama, Tsutomu; Kubo, Hideyuki			Distinct genetic clades of enterovirus D68 detected in 2010, 2013, and 2015 in Osaka City, Japan	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; CHILDREN; NETHERLANDS; EMERGENCE; OUTBREAK	The first upsurge of enterovirus D68 (EV-D68), a causative agent of acute respiratory infections (ARIs), in Japan was reported in Osaka City in 2010. In this study, which began in 2010, we surveyed EV-D68 in children with ARIs and analyzed sequences of EV-D68 strains detected. Real-time PCR of 19 respiratory viruses or subtypes of viruses, including enterovirus, was performed on 2,215 specimens from ARI patients (< 10 years of age) collected between November 2010 and December 2015 in Osaka City, Japan. EV-D68 was identified in 18 enterovirus-positive specimens (n = 4 in 2013, n = 1 in 2014, and n = 13 in 2015) by analysis of viral protein 1 (VP1) or VP4 sequences, followed by a BLAST search for similar sequences. All EV-D68 strains were detected between June and October (summer to autumn), except for one strain detected in 2014. A phylogenetic analysis of available VP1 sequences revealed that the Osaka strains detected in 2010, 2013, and 2015 belonged to distinct clusters (Clades C, A, and B [Subclade B3], respectively). Comparison of the 50 untranslated regions of these viruses showed that Osaka strains in Clades A, B (Subclade B3), and C commonly had deletions at nucleotide positions 681-703 corresponding to the prototype Fermon strain. Clades B and C had deletions from nucleotide positions 713-724. Since the EV-D68 epidemic in 2010, EV-D68 re-emerged in Osaka City, Japan, in 2013 and 2015. Results of this study indicate that distinct clades of EV-D68 contributed to re-emergences of this virus in 2010, 2013, and 2015 in this limited region.	[Kaida, Atsushi; Iritani, Nobuhiro; Yamamoto, Seiji P.; Kanbayashi, Daiki; Hirai, Yuki; Kubo, Hideyuki] Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan; [Togawa, Masao; Amo, Kiyoko] Osaka City Gen Hosp, Osaka, Japan; [Kohdera, Urara] Nakano Childrens Hosp, Osaka, Japan; [Nishigaki, Toshinori] Osaka Police Hosp, Osaka, Japan; [Shiomi, Masashi] Aizenbashi Hosp, Osaka, Japan; [Asai, Sadasaburo] Asai Childrens Clin, Osaka, Japan; [Kageyama, Tsutomu] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan	Osaka Prefectural Institute of Public Health; Osaka City General Hospital; Osaka Police Hospital; National Institute of Infectious Diseases (NIID)	Kaida, A (corresponding author), Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan.	a-kaida@iph.osaka.jp	Iritani, Nobuhiro/ABI-1062-2020	Kanbayashi, Daiki/0000-0002-9526-2411	JSPS KAKENHI [26460819]; Japan Agency for Medical Research and Development	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was partially supported by JSPS KAKENHI Grant Number 26460819 to AK and the Japan Agency for Medical Research and Development to TK.	Bottcher S, 2016, EUROSURVEILLANCE, V21, P16, DOI 10.2807/1560-7917.ES.2016.21.19.30227; De Jesus N, 2005, J VIROL, V79, P14235, DOI 10.1128/JVI.79.22.14235-14243.2005; Du J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144208; Dunn JJ, 2003, J INFECT DIS, V187, P1552, DOI 10.1086/374877; Fields B. N., 2007, FIELDS VIROLOGY; Gong YN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004416; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2015, REV MED VIROL, V25, P102, DOI 10.1002/rmv.1820; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Kaida A, 2014, JPN J INFECT DIS, V67, P469, DOI 10.7883/yoken.67.469; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kira R., 2016, CLIN VIROLOGY, V44, P107; Knoester M, 2017, EMERG INFECT DIS, V23, P140, DOI 10.3201/eid2301.161313; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Lau SKP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25147; Levy A, 2015, J CLIN VIROL, V69, P117, DOI 10.1016/j.jcv.2015.06.079; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Maloney JA, 2015, AM J NEURORADIOL, V36, P245, DOI 10.3174/ajnr.A4188; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Meijer A, 2014, EUROSURVEILLANCE, P19; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Pallansch M.A., 2007, FIELDS VIROLOGY, V6th, P490; Pfeiffer HC, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21062; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15; Taya K., 2016, CLIN VIROLOGY, V44, P101; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Xiang ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27800	36	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184335	10.1371/journal.pone.0184335	http://dx.doi.org/10.1371/journal.pone.0184335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902862	Green Submitted, Green Published, gold			2022-12-26	WOS:000410669200031
J	Leal, MF; dos Santos, LC; de Oliveira, AM; Belangero, PS; Figueiredo, EA; Cohen, C; Alves, FD; Yanaguizawa, WH; Andreoli, CV; Pochini, AD; Ejnisman, B; Smith, MC; Alves, MTD; Cohen, M				Leal, Mariana Ferreira; dos Santos, Leonardo Caires; de Oliveira, Adrielle Martins; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Alves, Felipe de Seixas; Yanaguizawa, Wania Hiromi; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Smith, Marilia Cardoso; de Seixas Alves, Maria Teresa; Cohen, Moises			Epigenetic regulation of metalloproteinases and their inhibitors in rotator cuff tears	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; SUPRASPINATUS TENDINOPATHY; GENE-EXPRESSION; DNA METHYLATION; TENDON; TISSUE; DEGENERATION; DISEASE; INFLAMMATION; COLLAGEN	Rotator cuff tear is a common orthopedic condition. Metalloproteinases (MMP) and their inhibitors (TIMP) seem to play a role in the development of joint injuries and in the failure of tissue healing. However, the mechanisms of regulation of gene expression in tendons are still unknown. Epigenetic mechanisms, such as DNA methylation and microRNAs regulation, are involved in the dynamic control of gene expression. Here, the mRNA expression and DNA methylation status of MMPs (MMP1, MMP2, MMP3, MMP9, MMP13, and MMP14) and TIMPs (TIMP1-3) and the expression of miR-29 family members in ruptured supraspinatus tendons were compared with non-injured tendons of individuals without this lesion. Additionally, the gene expression and methylation status at the edge of the ruptured tendon were compared with macroscopically non-injured rotator cuff tendon samples from the anterior and posterior regions of patients with tendon tears. Moreover, the possible associations between the molecular alterations and the clinical and histologic characteristics were investigated. Dysregulated expression and DNA methylation of MMP and TIMP genes were found across the rotator cuff tendon samples of patients with supraspinatus tears. These alterations were influenced at least in part by age at surgery, sex, smoking habit, tear size, and duration of symptoms. Alterations in the studied MMP and TIMP genes may contribute to the presence of microcysts, fissures, necrosis, and neovascularization in tendons and may thus be involved in the tendon healing process. In conclusion, MMPs and their inhibitors are regulated by epigenetic modifications and may play a role in rotator cuff tears.	[Leal, Mariana Ferreira; de Oliveira, Adrielle Martins; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Alves, Felipe de Seixas; Yanaguizawa, Wania Hiromi; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira; dos Santos, Leonardo Caires; de Oliveira, Adrielle Martins; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, SP, Brazil; [Alves, Felipe de Seixas; Yanaguizawa, Wania Hiromi; de Seixas Alves, Maria Teresa] Univ Fed Sao Paulo, Dept Patol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil.; Leal, MF (corresponding author), Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Leal, Mariana/C-4010-2012; Chen, Elizabeth/G-1598-2012; Andreoli, Carlos Vicente/AAW-1228-2021; Belangero, Paulo/AAD-8299-2021; Ejnisman, Benno/J-1556-2015; Smith, Marilia/C-4397-2012	Leal, Mariana/0000-0003-4375-2563; Chen, Elizabeth/0000-0002-3573-0164; Martins de Oliveira, Adrielle/0000-0003-0173-6872; Seixas Alves, Maria Teresa/0000-0002-5268-7612; Ejnisman, Benno/0000-0002-3301-1457; Smith, Marilia/0000-0002-1441-1033	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/22548-2, 2012/14768-5, 2016/01392-8, 2016/15785-1, 2013/10691-0, 2013/10791-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as grant #2011/22548-2 (PI: MFL) and fellowships #2012/14768-5 (MFL), #2016/01392-8 (AMO), #2016/15785-1 (AMO), #2013/10691-0 (FSA), #2013/10791-5 (WHY) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): fellowship to MC and MCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alvarez K, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-431; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell CG, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1051-8; Blevins FT, 1997, ORTHOP CLIN N AM, V28, P1, DOI 10.1016/S0030-5898(05)70260-1; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Chaudhury S, 2016, J SHOULDER ELBOW SUR; Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7; COFIELD RH, 1982, SURG GYNECOL OBSTET, V154, P667; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dean BJF, 2012, BONE JOINT RES, V1, P158, DOI 10.1302/2046-3758.17.2000115; Dines JS, 2007, J SHOULDER ELB SURG, V16, p204S, DOI 10.1016/j.jse.2007.03.004; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gotoh M, 1997, J ORTHOP RES, V15, P33, DOI 10.1002/jor.1100150106; Hart DA, 1998, CLIN ORTHOP RELAT R, P44; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Klatte-Schulz F, 2015, INT J MOL SCI, V16, P13141, DOI 10.3390/ijms160613141; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lakemeier S, 2011, KNEE SURG SPORT TR A, V19, P1760, DOI 10.1007/s00167-010-1367-y; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-271; Leal MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118821; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lichtenberg, 2006, CLASSIFICATIONS SCOR; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2008, CLIN ORTHOP RELAT R, V466, P1569, DOI 10.1007/s11999-008-0265-9; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Oliva Francesco, 2014, Muscles Ligaments Tendons J, V4, P309; Oliva Francesco, 2013, Muscles Ligaments Tendons J, V3, P201; OPDENAKKER G, 1992, CYTOKINE, V4, P251, DOI 10.1016/1043-4666(92)90064-X; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Reuther KE, 2013, J BIOMECH, V46, P1818, DOI 10.1016/j.jbiomech.2013.05.007; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; Riley GP, 1996, AM J PATHOL, V149, P933; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Slusarz A, 2015, J CARDIOVASC MED, V16, P480, DOI 10.2459/JCM.0000000000000246; Tillander B, 2002, J ORTHOP RES, V20, P1358, DOI 10.1016/S0736-0266(02)00057-8; White JJE, 2014, BONE JOINT J, V96B, P350, DOI 10.1302/0301-620X.96B3.32336; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006; Yuan J, 2003, CLIN SPORT MED, V22, P693, DOI 10.1016/S0278-5919(03)00049-8	46	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184141	10.1371/journal.pone.0184141	http://dx.doi.org/10.1371/journal.pone.0184141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902861	gold, Green Submitted, Green Published			2022-12-26	WOS:000410669200028
J	Seminati, E; Talamas, DC; Young, M; Twiste, M; Dhokia, V; Bilzon, JLJ				Seminati, Elena; Talamas, David Canepa; Young, Matthew; Twiste, Martin; Dhokia, Vimal; Bilzon, James L. J.			Validity and reliability of a novel 3D scanner for assessment of the shape and volume of amputees' residual limb models	PLOS ONE			English	Article							CONTEMPORARY CAD/CAM SYSTEM; TRANSTIBIAL AMPUTATION; BODY-COMPOSITION; PRECISION; ACCURACY; PROSTHETICS; AGREEMENT; PEOPLE	Background Objective assessment methods to monitor residual limb volume following lower-limb amputation are required to enhance practitioner-led prosthetic fitting. Computer aided systems, including 3D scanners, present numerous advantages and the recent Artec Eva scanner, based on laser free technology, could potentially be an effective solution for monitoring residual limb volumes. Purpose The aim of this study was to assess the validity and reliability of the Artec Eva scanner (practical measurement) against a high precision laser 3D scanner (criterion measurement) for the determination of residual limb model shape and volume. Methods Three observers completed three repeat assessments of ten residual limb models, using both the scanners. Validity of the Artec Eva scanner was assessed (mean percentage error <2%) and Bland-Altman statistics were adopted to assess the agreement between the two scanners. Intra and inter-rater reliability (repeatability coefficient <5%) of the Artec Eva scanner was calculated for measuring indices of residual limb model volume and shape (i.e. residual limb cross sectional areas and perimeters). Results Residual limb model volumes ranged from 885 to 4399 ml. Mean percentage error of the Artec Eva scanner (validity) was 1.4% of the criterion volumes. Correlation coefficients between the Artec Eva and the Romer determined variables were higher than 0.9. Volume intra-rater and inter-rater reliability coefficients were 0.5% and 0.7%, respectively. Shape percentage maximal error was 2% at the distal end of the residual limb, with intra-rater reliability coefficients presenting the lowest errors (0.2%), both for cross sectional areas and perimeters of the residual limb models. Conclusion The Artec Eva scanner is a valid and reliable method for assessing residual limb model shapes and volumes. While the method needs to be tested on human residual limbs and the results compared with the current system used in clinical practice, it has the potential to quantify shape and volume fluctuations with greater resolution.	[Seminati, Elena; Bilzon, James L. J.] Univ Bath, Dept Hlth, Bath, Avon, England; [Seminati, Elena; Young, Matthew; Bilzon, James L. J.] Univ Bath, CAMERA Ctr, Bath, Avon, England; [Talamas, David Canepa; Dhokia, Vimal] Univ Bath, Dept Mech Engn, Bath, Avon, England; [Twiste, Martin] Univ Salford, Sch Hlth Sci, Salford, Lancs, England; [Twiste, Martin] Univ Salford, UNIPOD, Salford, Lancs, England	University of Bath; University of Bath; University of Bath; University of Salford; University of Salford	Bilzon, JLJ (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.; Bilzon, JLJ (corresponding author), Univ Bath, CAMERA Ctr, Bath, Avon, England.	j.bilzon@bath.ac.uk		Young, Matthew/0000-0003-4868-3878; Dhokia, Vimal/0000-0002-6343-6958; Bilzon, James/0000-0002-6701-7603; Seminati, Elena/0000-0002-6736-893X	Engineering and Physical Sciences Research Council UKs Impact Acceleration Account [RC-FH1136]; Engineering and Physical Sciences Research Council [EP/M023281/1] Funding Source: researchfish; EPSRC [EP/M023281/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council UKs Impact Acceleration Account(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the Engineering and Physical Sciences Research Council UKs Impact Acceleration Account (RC-FH1136).	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bolt A, 2010, AM J PHYS MED REHAB, V89, P376, DOI 10.1097/PHM.0b013e3181d3ea94; Buis AWP, 2006, J REHABIL RES DEV, V43, P883, DOI 10.1682/JRRD.2005.08.0145; Coltman CE, 2016, ERGONOMICS IN PRESS, P1; Colyer SL, 2016, PHYSIOL MEAS, V37, P596, DOI 10.1088/0967-3334/37/4/596; Commean PK, 1996, ARCH PHYS MED REHAB, V77, P477, DOI 10.1016/S0003-9993(96)90037-4; Commean PK, 1998, ARCH PHYS MED REHAB, V79, P772, DOI 10.1016/S0003-9993(98)90355-0; de Boer-Wilzing VG, 2011, ARCH PHYS MED REHAB, V92, P941, DOI 10.1016/j.apmr.2011.01.007; Dickinson AS, 2016, J REHABIL RES DEV, V53, P207, DOI 10.1682/JRRD.2014.10.0272; FERNIE GR, 1982, ARCH PHYS MED REHAB, V63, P162; Geil MD, 2007, J REHABIL RES DEV, V44, P515, DOI 10.1682/JRRD.2006.08.0088; Golbranson F L, 1988, J Rehabil Res Dev, V25, P11; He P, 1999, J REHABIL RES DEV, V36, P86; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, SPREADSHEET ANAL VAL; Hopkins WG, PRECISION MEASUREMEN; Johansson S, 1998, J REHABIL RES DEV, V35, P27; Karmarkar AM, 2009, J REHABIL RES DEV, V46, P567, DOI 10.1682/JRRD.2008.08.0102; LILJA M, 1995, J REHABIL RES DEV, V32, P141; Lilja M., 1997, JPO J PROSTHET ORTHO, V9, P90, DOI [10.1097/00008526-199700920-00009, DOI 10.1097/00008526-199700920-00009]; McGarry T, 2008, PROSTHET ORTHOT INT, V32, P145, DOI 10.1080/03093640802015920; McGarry T, 2007, PROSTHET ORTHOT INT, V31, P27, DOI 10.1080/03093640600942101; McGarry T, 2005, PROSTHET ORTHOT INT, V29, P221, DOI 10.1080/03093640500199497; Menditto A, 2007, ACCREDIT QUAL ASSUR, V12, P45, DOI 10.1007/s00769-006-0191-z; Mirtich B., 1996, J GRAPH TOOLS, V1, P31, DOI DOI 10.1080/10867651.1996.10487458; Modabber A, 2016, J CRANIOMAXILLOFAC S; Nana A, 2013, MED SCI SPORT EXER, V45, P178, DOI 10.1249/MSS.0b013e31826c9cfd; OBERG K, 1989, J PROSTHET ORTHOT, V1, P139; Paulus S, 2014, BIOSYST ENG, V121, P1, DOI 10.1016/j.biosystemseng.2014.01.010; Portney LG., 2014, FDN CLIN RES APPL PR; Sanders JE, 2005, J BIOMECH, V38, P1566, DOI 10.1016/j.jbiomech.2004.08.008; Sanders JE, 2011, J REHABIL RES DEV, V48, P949, DOI 10.1682/JRRD.2010.09.0189; Sanders JE, 2009, PROSTHET ORTHOT INT, V33, P378, DOI 10.3109/03093640903214067; Schreiner R. E., 1995, IEEE Transactions on Rehabilitation Engineering, V3, P242, DOI 10.1109/86.413197; SUKUL DMKSK, 1993, J BIOMED ENG, V15, P477, DOI 10.1016/0141-5425(93)90062-4; Tantua AT, 2014, J REHABIL RES DEV, V51, P1119, DOI 10.1682/JRRD.2013.11.0243; Yamamoto S, 2016, J ORAL MAXIL SURG OF; Zachariah SC, 2004, J REHABIL RES DEV, V41, P683, DOI 10.1682/JRRD.2003.10.0153; Zachariah SG, 2005, IEEE T NEUR SYS REH, V13, P551, DOI 10.1109/TNSRE.2005.858459; Zheng YP, 2001, J REHABIL RES DEV, V38, P487	40	32	32	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184498	10.1371/journal.pone.0184498	http://dx.doi.org/10.1371/journal.pone.0184498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886154	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100140
J	Wu, L; Lin, HD; Gao, J; Li, XM; Xia, MF; Wang, D; Aleteng, Q; Ma, H; Pan, BS; Gao, X				Wu, Li; Lin, Huandong; Gao, Jian; Li, Xiaoming; Xia, Mingfeng; Wang, Dan; Aleteng, Qiqige; Ma, Hui; Pan, Baishen; Gao, Xin			Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; PREVALENCE; HBA(1C); MELLITUS; TRENDS; ADULTS; ERYTHROCYTES; INDIVIDUALS; PEOPLE	Background and aims Glycated hemoglobin A1c (HbA1c) >= 6.5% (or 48mmol/mol) has been recommended as a new diagnostic criterion for diabetes; however, limited literature is available regarding the effect of age on the HbA1c for diagnosing diabetes and the causes for this age effect remain unknown. In this study, we investigated whether and why age affects the diagnostic efficiency of HbA1c for diabetes in a community-based Chinese population. Methods In total, 4325 participants without previously known diabetes were enrolled in this study. Participants were stratified by age. Receiver operating characteristic curve (ROC) was plotted for each age group and the area under the curve (AUC) represented the diagnostic efficiency of HbA1c for diabetes defined by the plasma glucose criteria. The area under the ROC curve in each one-year age group was defined as AUCage. Multiple regression analyses were performed to identify factors inducing the association between age and AUCage based on the changes in the beta and P values of age. Results The current threshold of HbA1c (>= 6.5% or 48mmol/mol) showed low sensitivity (35.6%) and high specificity (98.9%) in diagnosing diabetes. ROC curve analyses showed that the diagnostic efficiency of HbA1c in the >= 75 years age group was significantly lower than that in the 45-54 years age group (AUC: 0.755 vs. 0.878; P<0.001). Pearson correlation analysis showed that the AUCage of HbA1c was negatively correlated with age (r = -0.557, P = 0.001). When adjusting the red blood cell (RBC) count in the multiple regression model, the negative association between age and AUCage disappeared, with the regression coefficient of age reversed to 0.001 and the P value increased to 0.856. Conclusions The diagnostic efficiency of HbA1c for diabetes decreased with aging, and this age effect was induced by the decreasing RBC count with age. HbA1c is unsuitable for diagnosing diabetes in elderly individuals because of their physiologically decreased RBC count.	[Wu, Li; Lin, Huandong; Li, Xiaoming; Xia, Mingfeng; Wang, Dan; Aleteng, Qiqige; Ma, Hui; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Wu, Li; Lin, Huandong; Xia, Mingfeng; Gao, Xin] Fudan Inst Metab Dis, Shanghai, Peoples R China; [Lin, Huandong] Fudan Univ, Res Ctr Aging & Med, Shanghai, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Dept Clin Nutr, Shanghai, Peoples R China; [Pan, Baishen] Fudan Univ, Zhongshan Hosp, Dept Lab Med, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Gao, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.; Gao, X (corresponding author), Fudan Inst Metab Dis, Shanghai, Peoples R China.	happy20061208@126.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796	Shanghai Science and Technology Committee (STCSM) Foundation [16411954800]; Shanghai Health and Family Planning Commission Foundation [2013ZYJB0802, 15GWZK0801]	Shanghai Science and Technology Committee (STCSM) Foundation; Shanghai Health and Family Planning Commission Foundation	This work was supported by grants from Shanghai Science and Technology Committee (STCSM) Foundation (16411954800 to Xin Gao), the Shanghai Health and Family Planning Commission Foundation (Grant No. 2013ZYJB0802 to Xin Gao and 15GWZK0801 to Xin Gao and Huandong Lin). 2013ZYJB0802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, TURK J ENDOCRINOL ME, V14, P11; ARAKI K, 1980, J GERONTOL, V35, P499, DOI 10.1093/geronj/35.4.499; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; BROSCHE T, 1990, EXP GERONTOL, V25, P23, DOI 10.1016/0531-5565(90)90005-M; Committee C, 2007, DIABETOLOGIA, V50, P2042, DOI 10.1007/s00125-007-0789-7; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Drawz P, 2015, ANN INTERN MED, V162, DOI 10.7326/AITC201506020; Ferrucci L, 2006, ARCH INTERN MED, V166, P1380, DOI 10.1001/archinte.166.13.1380; Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6; GERSHON H, 1988, BLOOD CELLS, V14, P93; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; HASHIMOTO Y, 1995, DIABETES CARE, V18, P1337, DOI 10.2337/diacare.18.10.1337; Huang H, 2013, PREV MED, V57, P345, DOI 10.1016/j.ypmed.2013.06.012; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Ji CJ, 2015, CLIN LAB, V61, P1831, DOI 10.7754/Clin.Lab.2015.150423; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Lahousen T, 2004, WORLD J GASTROENTERO, V10, P2284; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Lin H, 2016, EUROPEAN J EPIDEMIOL; [吕雪梅 Lv Xuemei], 2013, [中国糖尿病杂志, Chinese Journal of Diabetes], V21, P686; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; MULKERRIN EC, 1992, AGE AGEING, V21, P175, DOI 10.1093/ageing/21.3.175; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Nuttall FQ, 1999, J LAB CLIN MED, V134, P451, DOI 10.1016/S0022-2143(99)90165-8; Organization WH, 2008, WORLD HLTH REP 2008, V25, P617; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498; WHO Guidelines Approved by the Guidelines Review Committee, 2011, US GLYC HAEM HBA1C D; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang LY, 2015, CLIN ENDOCRINOL, V82, P205, DOI 10.1111/cen.12494; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988	37	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184607	10.1371/journal.pone.0184607	http://dx.doi.org/10.1371/journal.pone.0184607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886160	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100165
J	Anjanappa, M; Hao, Y; Simpson, ER; Bhat-Nakshatri, P; Nelson, JB; Tersey, SA; Mirmira, RG; Cohen-Gadol, AA; Saadatzadeh, MR; Li, L; Fang, F; Nephew, KP; Miller, KD; Liu, Y; Nakshatri, H				Anjanappa, M.; Hao, Y.; Simpson, E. R.; Bhat-Nakshatri, P.; Nelson, J. B.; Tersey, S. A.; Mirmira, R. G.; Cohen-Gadol, A. A.; Saadatzadeh, M. R.; Li, L.; Fang, F.; Nephew, K. P.; Miller, K. D.; Liu, Y.; Nakshatri, H.			A system for detecting high impact-low frequency mutations in primary tumors and metastases	ONCOGENE			English	Article							BREAST-CANCER CELLS; H3K4 MONOMETHYLATION; THERAPEUTIC TARGETS; EARLY DISSEMINATION; BRANCHED EVOLUTION; BRAIN METASTASES; STEM-CELLS; IDENTIFICATION; METABOLISM; REVEALS	Tumor complexity and intratumor heterogeneity contribute to subclonal diversity. Despite advances in next-generation sequencing (NGS) and bioinformatics, detecting rare mutations in primary tumors and metastases contributing to subclonal diversity is a challenge for precision genomics. Here, in order to identify rare mutations, we adapted a recently described epithelial reprograming assay for short-term propagation of epithelial cells from primary and metastatic tumors. Using this approach, we expanded minor clones and obtained epithelial cell-specific DNA/RNA for quantitative NGS analysis. Comparative Ampliseq Comprehensive Cancer Panel sequence analyses were performed on DNA from unprocessed breast tumor and tumor cells propagated from the same tumor. We identified previously uncharacterized mutations present only in the cultured tumor cells, a subset of which has been reported in brain metastatic but not primary breast tumors. In addition, whole-genome sequencing identified mutations enriched in liver metastases of various cancers, including Notch pathway mutations/chromosomal inversions in 5/5 liver metastases, irrespective of cancer types. Mutations/rearrangements in FHIT, involved in purine metabolism, were detected in 4/5 liver metastases, and the same four liver metastases shared mutations in 32 genes, including mutations of different HLA-DR family members affecting OX40 signaling pathway, which could impact the immune response to metastatic cells. Pathway analyses of all mutated genes in liver metastases showed aberrant tumor necrosis factor and transforming growth factor signaling in metastatic cells. Epigenetic regulators including KMT2C/MLL3 and ARID1B, which are mutated in >50% of hepatocellular carcinomas, were also mutated in liver metastases. Thus, irrespective of cancer types, organ-specific metastases may share common genomic aberrations. Since recent studies show independent evolution of primary tumors and metastases and in most cases mutation burden is higher in metastases than primary tumors, the method described here may allow early detection of subclonal somatic alterations associated with metastatic progression and potentially identify therapeutically actionable, metastasis-specific genomic aberrations.	[Anjanappa, M.; Bhat-Nakshatri, P.; Nakshatri, H.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Hao, Y.; Simpson, E. R.; Li, L.; Liu, Y.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Nelson, J. B.; Tersey, S. A.; Mirmira, R. G.; Saadatzadeh, M. R.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Cohen-Gadol, A. A.] Indiana Univ Sch Med, Dept Neurosurg, Indianapolis, IN 46202 USA; [Li, L.; Liu, Y.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Fang, F.; Nephew, K. P.] Indiana Univ, Med Sci Program, Bloomington, IN USA; [Miller, K. D.] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Nakshatri, H.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nakshatri, H.] Roudebush VA Med Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Liu, Y; Nakshatri, H (corresponding author), Indiana Univ Sch Med, Surg Biochem Mol Biol, C218C,980 West Walnut St, Indianapolis, IN 46202 USA.	Yunliu@iu.edu; hnakshat@iupui.edu	Simpson, Edward/G-1912-2015; Mirmira, Raghavendra G/AAD-7592-2020	Simpson, Edward/0000-0001-9015-9864; Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361; Cohen-Gadol, Aaron/0000-0002-4946-1524; Nakshatri, Harikrishna/0000-0001-8876-0052	IUPUI Signature Center for the Cure of Glioblastoma; Susan G Komen for the Cure [SAC110025]; Indiana CTSI Project development pilot grant; IU Simon Cancer Center Breast Cancer Program Pilot grant; National Institutes of Health [P30 DK097512]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER	IUPUI Signature Center for the Cure of Glioblastoma; Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Indiana CTSI Project development pilot grant; IU Simon Cancer Center Breast Cancer Program Pilot grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank tissue collection team at the IU Simon Cancer Center, Clinical Research Office and Neurooncology Center at IU School of Medicine for collection of fresh tissues for the study. We also thank the flow cytometry core at the IU Simon Cancer Center. Excellent support from New York Genome Center, particularly Mr Benjamin Hubert, is highly appreciated. IUPUI Signature Center for the Cure of Glioblastoma supported brain metastases tissue collection. Susan G Komen for the Cure (SAC110025 to HN), Indiana CTSI Project development pilot grant (to HN, LL and KNP) and IU Simon Cancer Center Breast Cancer Program Pilot grant (to YL and HN) supported this study. This study utilized core services by National Institutes of Health Grant P30 DK097512 to the Indiana University School of Medicine.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arun B, 2005, CANCER EPIDEM BIOMAR, V14, P1681, DOI 10.1158/1055-9965.EPI-04-0278; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brodt P, 2016, CLIN CANCER RES, V22, P5971, DOI 10.1158/1078-0432.CCR-16-0460; Burnett RM, 2015, ONCOTARGET, V6, P12682, DOI 10.18632/oncotarget.3707; Buxton ILO, 2010, CANCER LETT, V291, P131, DOI 10.1016/j.canlet.2009.09.021; Cejalvo JM, 2017, CANCER RES, V77, P2213, DOI 10.1158/0008-5472.CAN-16-2717; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DW, 2015, ONCOTARGET, V6, P40815, DOI 10.18632/oncotarget.5886; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cheung LWT, 2014, CANCER CELL, V26, P479, DOI 10.1016/j.ccell.2014.08.017; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Collins DC, 2017, TRENDS PHARMACOL SCI, V38, P25, DOI 10.1016/j.tips.2016.10.012; Cormier S, 2004, GENE EXPR PATTERNS, V4, P713, DOI 10.1016/j.modgep.2004.04.003; de Brachene AC, 2016, CELL MOL LIFE SCI, V73, P1159, DOI 10.1007/s00018-015-2112-y; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Fisher MM, 2015, DIABETES, V64, P3867, DOI 10.2337/db15-0430; Flowers M, 2017, CANCER RES, V77, P3386, DOI 10.1158/0008-5472.CAN-17-0232; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giampieri R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072843; Gruber TA, 2015, BLOOD, V126, P943, DOI 10.1182/blood-2015-05-567859; Hao YY, 2017, J COMPUT BIOL, V24, P637, DOI 10.1089/cmb.2017.0057; Hao YY, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2905-x; Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Hu X, 2015, INT J MOL MED, V35, P1219, DOI 10.3892/ijmm.2015.2132; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Kishi N, 2001, INT J DEV NEUROSCI, V19, P21, DOI 10.1016/S0736-5748(00)00071-X; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kostadinov R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004413; Kumar R, 2006, MOL CANCER RES, V4, P655, DOI 10.1158/1541-7786.MCR-05-0249; Linch SN, 2016, P NATL ACAD SCI USA, V113, pE319, DOI 10.1073/pnas.1510518113; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; McCreery MQ, 2015, NAT MED, V21, P1514, DOI 10.1038/nm.3979; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Miller CA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12498; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Nakshatri H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13526; Odore E, 2016, CLIN PHARMACOKINET, V55, P397, DOI 10.1007/s40262-015-0327-6; Park JT, 2015, ONCOGENE, V34, P2801, DOI 10.1038/onc.2014.223; Pepe C, 2007, BREAST CANCER RES TR, V103, P29, DOI 10.1007/s10549-006-9349-y; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Petit FM, 2013, HUM REPROD, V28, P852, DOI 10.1093/humrep/des452; Prasad V, 2016, LANCET ONCOL, V17, pE81, DOI 10.1016/S1470-2045(15)00620-8; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Sebestyen E, 2015, NUCLEIC ACIDS RES, V43, P1345, DOI 10.1093/nar/gku1392; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sholl LM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87062; Sinha R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060142; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Vainchenker W, 2017, BLOOD, V129, P667, DOI 10.1182/blood-2016-10-695940; van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Yan W, 2016, SCI REP-UK, V6, DOI 10.1038/srep19303; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zhang Z, 2016, CELL REP, V16, P3146, DOI 10.1016/j.celrep.2016.08.048	65	14	15	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					185	196		10.1038/onc.2017.322	http://dx.doi.org/10.1038/onc.2017.322			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28892047	Green Accepted, Green Submitted			2022-12-26	WOS:000422631700005
J	Kitahara, K; Hayashi, Y; Yano, S; Kondo, T				Kitahara, Kosuke; Hayashi, Yoshikatsu; Yano, Shiro; Kondo, Toshiyuki			Target-directed motor imagery of the lower limb enhances event-related desynchronization	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; EEG; CLASSIFICATION; STIMULATION; MOVEMENTS	Event-related desynchronization/synchronization (ERD/S) is an electroencephalogram (EEG) feature widely used as control signals for Brain-Computer Interfaces (BCIs). Nevertheless, the underlying neural mechanisms and functions of ERD/S are largely unknown, thus investigating them is crucial to improve the reliability of ERD/S-based BCIs. This study aimed to identify Motor Imagery (MI) conditions that enhance ERD/S. We investigated following three questions: 1) whether target-directed MI affects ERD/S, 2) whether MI with sound imagery affects ERD/S, and 3) whether ERD/S has a body part dependency of MI. Nine participants took part in the experiments of four MI conditions; they were asked to imagine right foot dorsiflexion (F), right foot dorsiflexion and the sound of a bass drum when the sole touched the floor (FS), right leg extension (L), and right leg extension directed toward a soccer ball (LT). Statistical comparison revealed that there were significant differences between conditions L and LT in beta-band ERD and conditions F and L in beta-band ERS. These results suggest that mental rehearsal of target-directed lower limb movement without real sensory stimuli can enhance beta-band ERD; furthermore, MI of foot dorsiflexion induces significantly larger beta-band ERS than that of leg extension. These findings could be exploited for the training of BCIs such as powered prosthetics for disabled person and neurorehabilitation system for stroke patients.	[Kitahara, Kosuke; Yano, Shiro; Kondo, Toshiyuki] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Koganei, Tokyo, Japan; [Hayashi, Yoshikatsu] Univ Reading, Sch Biol Sci, Biomed Engn, Reading, Berks, England	Tokyo University of Agriculture & Technology; University of Reading	Kitahara, K (corresponding author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Koganei, Tokyo, Japan.	kitahara@livingsys.lab.tuat.ac.jp	Kondo, Toshiyuki/B-9972-2013; Hayashi, Yoshikatsu/R-4543-2019; Yano, Shiro/F-2940-2015	Kondo, Toshiyuki/0000-0001-8200-9276; Hayashi, Yoshikatsu/0000-0002-9207-6322; Yano, Shiro/0000-0002-7094-5996; Hayashi, Yoshikastu/0000-0001-5876-1417	Japan Society for the Promotion of Science KAKENHI [JP26120005, JP16H03219]; Grants-in-Aid for Scientific Research [16H03219] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was partially supported by Japan Society for the Promotion of Science KAKENHI (https.//www.jsps.go.jp/english/index.html) (Grant number JP26120005 and JP16H03219), and TK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimardani M, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00052; Avanzini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037534; Carlson T, 2013, IEEE ROBOT AUTOM MAG, V20, P65, DOI 10.1109/MRA.2012.2229936; Cassady K, 2014, TECHNOLOGY, V2, P254, DOI 10.1142/S233954781450023X; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Graimann B, 2002, CLIN NEUROPHYSIOL, V113, P43, DOI 10.1016/S1388-2457(01)00697-6; Hanakawa T, 2016, NEUROSCI RES, V104, P56, DOI 10.1016/j.neures.2015.11.003; Hashimoto Y, 2013, CLIN NEUROPHYSIOL, V124, P2153, DOI 10.1016/j.clinph.2013.05.006; Hashimoto Y, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-117; Hayashi Y, 2012, P IEEE RAS-EMBS INT, P1733, DOI 10.1109/BioRob.2012.6290919; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; KALCHER J, 1995, ELECTROEN CLIN NEURO, V94, P381, DOI 10.1016/0013-4694(95)00040-6; Kitahara K, 2015, IEEE ENG MED BIO, P6630, DOI 10.1109/EMBC.2015.7319913; Kondo T, 2015, HUM MOVEMENT SCI, V43, P239, DOI 10.1016/j.humov.2014.08.014; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kwak NS, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056009; Leeb Robert, 2007, Comput Intell Neurosci, P79642, DOI 10.1155/2007/79642; Li LQ, 2015, INT J FUZZY SYST, V2015, P12, DOI [DOI 10.1371/J0URNAL.P0NE.0144256, DOI 10.1016/J.ARCH0RALBI0.2015.12.002]; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Nakayashiki K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-90; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Ortner R, 2012, P IEEE RAS-EMBS INT, P219, DOI 10.1109/BioRob.2012.6290800; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Prasad G, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-60; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Royer AS, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016005; Vuckovic A, 2013, CLIN NEUROPHYSIOL, V124, P1586, DOI 10.1016/j.clinph.2013.02.016; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Yeo SS, 2013, NEUROREHABILITATION, V32, P861, DOI 10.3233/NRE-130910; Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397	36	8	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184245	10.1371/journal.pone.0184245	http://dx.doi.org/10.1371/journal.pone.0184245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926593	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000411166600012
J	Weh, E; Takeuchi, H; Muheisen, S; Haltiwanger, RS; Semina, EV				Weh, Eric; Takeuchi, Hideyuki; Muheisen, Sanaa; Haltiwanger, Robert S.; Semina, Elena V.			Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome	PLOS ONE			English	Article							ER QUALITY-CONTROL; O-FUCOSYLATION; B3GALTL MUTATION; C-MANNOSYLATION; PROTEIN; IDENTIFICATION; DEFICIENCY; MEMBRANE; PATIENT; FAMILY	Peters Plus Syndrome (PPS) is a rare autosomal recessive disease characterized by ocular defects, short stature, brachydactyly, characteristic facial features, developmental delay and other highly variable systemic defects. Classic PPS is caused by loss-of-function mutations in the B3GLCT gene encoding for a beta 3-glucosyltransferase that catalyzes the attachment of glucose via a beta 1-3 glycosidic linkage to O-linked fucose on thrombospondin type 1 repeats (TSRs). B3GLCT was shown to participate in a non-canonical ER quality control mechanism; however, the exact molecular processes affected in PPS are not well understood. Here we report the identification and characterization of two zebrafish orthologs of the human B3GLCT gene, b3glcta and b3glctb. The b3glcta and b3glctb genes encode for 496-aa and 493-aa proteins with 65% and 57% identity to human B3GLCT, respectively. Expression studies demonstrate that both orthologs are widely expressed with strong presence in embryonic tissues affected in PPS. In vitro glucosylation assays demonstrated that extracts from wildtype embryos contain active b3glct enzyme capable of transferring glucose from UDP-glucose to an O-fucosylated TSR, indicating functional conservation with human B3GLCT. To determine the developmental role of the zebrafish genes, single and double b3glct knockouts were generated using TALEN-induced genome editing. Extracts from double homozygous b3glct(-/-) embryos demonstrated complete loss of in vitro b3glct activity. Surprisingly, b3glct(-/-) homozygous fish developed normally. Transcriptome analyses of head and trunk tissues of b3glct(-/-) 24-hpf embryos identified 483 shared differentially regulated transcripts that may be involved in compensation for b3glct function in these embryos. The presented data show that both sequence and function of B3GLCT/b3glct genes is conserved in vertebrates. At the same time, complete b3glct deficiency in zebrafish appears to be inconsequential and possibly compensated for by a yet unknown mechanism.	[Weh, Eric; Muheisen, Sanaa; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Weh, Eric; Muheisen, Sanaa; Semina, Elena V.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Weh, Eric; Semina, Elena V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Semina, Elena V.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Weh, Eric] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Takeuchi, Hideyuki] Nagoya Univ, Sch Med, Dept Mol Biochem, Nagoya, Aichi, Japan	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University System of Georgia; University of Georgia; Medical College of Wisconsin; University of Michigan System; University of Michigan; Nagoya University	Semina, EV (corresponding author), Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA.; Semina, EV (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA.; Semina, EV (corresponding author), Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA.	esemina@mcw.edu	Takeuchi, Hideyuki/AAZ-9210-2020	Semina, Elena/0000-0003-0531-3586	National Institutes of Health [R01EY015518, R01GM061126, P30EY001931]; Children's Hospital of Wisconsin; NATIONAL EYE INSTITUTE [R01EY015518, P30EY001931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Wisconsin; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health awards R01EY015518 (EVS), R01GM061126 (RSH), and P30EY001931 as well as funds provided by the Children's Hospital of Wisconsin (EVS).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Al-Gazali L, 2009, AM J MED GENET A, V149A, P251, DOI 10.1002/ajmg.a.32626; Aldahmesh MA, 2013, HUM MUTAT, V34, P1195, DOI 10.1002/humu.22374; Aliferis K, 2010, OPHTHALMIC GENET, V31, P205, DOI 10.3109/13816810.2010.512355; Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795; Carvalho A, 2017, EUR J PHARM; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chou JY, 2014, CURR TOP MEMBR, V73, P357, DOI 10.1016/B978-0-12-800223-0.00010-4; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Corso-Diaz X, 2012, MOL VIS, V18, P2770; D'Osualdo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130635; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dassie-Ajdid J, 2009, CLIN GENET, V76, P490, DOI 10.1111/j.1399-0004.2009.01253.x; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; DEALMEIDA JCC, 1991, J MED GENET, V28, P277, DOI 10.1136/jmg.28.4.277; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Faletra F, 2011, OPHTHALMIC GENET, V32, P256, DOI 10.3109/13816810.2011.587082; Gosselin P, 2013, NUCLEIC ACIDS RES, V41, P7783, DOI 10.1093/nar/gkt569; Gu Y, 2012, ACTA PHARMACOL SIN, V33, P941, DOI 10.1038/aps.2012.60; Guo CX, 2015, J CELL MOL MED, V19, P2273, DOI 10.1111/jcmm.12619; Haldeman-Englert CR, 2009, AM J MED GENET A, V149A, P1842, DOI 10.1002/ajmg.a.32980; Hanna NN, 2010, J AAPOS, V14, P181, DOI 10.1016/j.jaapos.2010.02.003; Harissi-Dagher Mona, 2008, Int Ophthalmol Clin, V48, P35, DOI 10.1097/IIO.0b013e318169526c; Hay DL, 2016, BIOCHEM SOC T, V44, P568, DOI 10.1042/BST20150237; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Kapoor S, 2008, INDIAN J PEDIATR, V75, P635, DOI 10.1007/s12098-008-0122-6; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Le Goff C, 2011, HUM MOL GENET, V20, pR163, DOI 10.1093/hmg/ddr361; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Motoyama O, 2010, CLIN EXP NEPHROL, V14, P381, DOI 10.1007/s10157-010-0283-2; Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7; Nishizaka H, 1996, J IMMUNOL, V156, P2309; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Planells-Ferrer L, 2016, J NEUROCHEM, V139, P11, DOI 10.1111/jnc.13729; Preissler S, 2017, NAT STRUCT MOL BIOL, V24, P23, DOI 10.1038/nsmb.3337; Reis LM, 2008, AM J MED GENET A, V146A, P2603, DOI 10.1002/ajmg.a.32498; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Shimizu R, 2010, CONGENIT ANOM, V50, P197, DOI 10.1111/j.1741-4520.2010.00282.x; Siala O, 2012, GENE, V507, P68, DOI 10.1016/j.gene.2012.06.052; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Tuli N, 2009, CASES J, V2; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241; Wenniger-Prick LJJMMD, 2002, ANN GENET-PARIS, V45, P97; WESTBERG J, 1995, GENOMICS, V29, P1, DOI 10.1006/geno.1995.1208; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yang Y, 2005, MOL CELLS, V20, P173; Yiu WH, 2010, CELL BIOCHEM FUNCT, V28, P31, DOI 10.1002/cbf.1613	70	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184903	10.1371/journal.pone.0184903	http://dx.doi.org/10.1371/journal.pone.0184903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926587	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600051
J	Ahn, D; Yeo, CK; Han, SY; Kim, JK				Ahn, Dongbin; Yeo, Chang Ki; Han, Soon Yong; Kim, Jeong Kyu			The accessory parotid gland and facial process of the parotid gland on computed tomography	PLOS ONE			English	Article							AGE; MANAGEMENT; TUMORS	The purpose of this study was to determine the incidence of an anterior extension of the parotid gland, such as an accessory parotid gland (APG) or facial process (FP) and to evaluate its characteristics on computed tomography (CT) scans. We reviewed CT scans of 1,600 parotid glands from 800 patients. An APG on CT was defined as a soft-tissue mass of the same density as the main parotid gland, located at the anterior part of the main parotid gland, and completely separate from the main parotid gland. An FP was defined as a lobe of the parotid gland protruding anteriorly over the anterior edge of the ramus of the mandible on CT and showing continuity with the main gland. The overall incidence rates and characteristics of APGs and FPs were evaluated according to age, sex, and side. The incidence rates of APGs and FPs were 10.2% (163/1,600) and 28.3% (452/1,600), respectively. The mean size of an APG was 15.8 mm x 5.0 mm and the mean distance from the main parotid gland was 10.5 mm. The FP reached anteriorly between the anterior edge of the mandibular ramus and the anterior border of the masseter muscle in 405 (89.6%) cases, while it extended over the anterior border of the masseter muscle in 47 (10.4%) cases. The incidence rates of APGs and FPs decreased and increased, respectively, with increasing age, showing significant linear correlations. However, the incidence of an anterior extension of the parotid gland (either an APG or an FP) was similar across all age groups. The present study showed that CT might be helpful in identifying anterior extensions of the parotid gland including APGs and FPs. The anatomical information gained from this study contributes to a better understanding of APGs and FPs and how their incidence changes with age.	[Ahn, Dongbin] Kyungpook Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea; [Yeo, Chang Ki; Han, Soon Yong] Keimyung Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea; [Kim, Jeong Kyu] Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea	Kyungpook National University; Keimyung University; Catholic University of Daegu	Kim, JK (corresponding author), Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea.	doctorjkkim@cu.ac.kr	Vlantis, Alexander/J-9785-2017	Vlantis, Alexander/0000-0003-3109-5236				BATSAKIS JG, 1988, ANN OTO RHINOL LARYN, V97, P434, DOI 10.1177/000348948809700420; Choi JS, 2013, ARCH ORAL BIOL, V58, P1635, DOI 10.1016/j.archoralbio.2013.07.008; FROMMER J, 1977, ORAL SURG ORAL MED O, V43, P671, DOI 10.1016/0030-4220(77)90049-4; Klotz DA, 2000, LARYNGOSCOPE, V110, P1627, DOI 10.1097/00005537-200010000-00010; Kurabayashi T, 1997, DENTOMAXILLOFAC RAD, V26, P347, DOI 10.1038/sj.dmfr.4600301; Lin DT, 2004, LARYNGOSCOPE, V114, P1652, DOI 10.1097/00005537-200409000-00028; Mahne A, 2007, SEMIN NUCL MED, V37, P88, DOI 10.1053/j.semnuclmed.2006.10.003; Newberry TR, 2014, AM J OTOLARYNG, V35, P48, DOI 10.1016/j.amjoto.2013.08.018; SCOTT J, 1987, J ORAL PATHOL MED, V16, P505, DOI 10.1111/j.1600-0714.1987.tb00681.x; TOH H, 1993, ANAT REC, V236, P586, DOI 10.1002/ar.1092360319; Toh H, 1988, Fukuoka Shika Daigaku Gakkai Zasshi, V14, P389; Yang X, 2011, ORAL SURG ORAL MED O, V112, P290, DOI 10.1016/j.tripleo.2010.10.023	12	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184633	10.1371/journal.pone.0184633	http://dx.doi.org/10.1371/journal.pone.0184633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915265	Green Published, Green Submitted, gold			2022-12-26	WOS:000410861600012
J	Abe, M; Hamano, T; Wada, A; Nakai, S; Masakane, I				Abe, Masanori; Hamano, Takayuki; Wada, Atsushi; Nakai, Shigeru; Masakane, Ikuto		Renal Data Registry Comm; Japanese Soc Dialysis Therapy	Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry	PLOS ONE			English	Article							SERUM BETA(2)-MICROGLOBULIN LEVEL; THERAPY CLINICAL GUIDELINE; PREDICT MORTALITY; ASSOCIATION; SOCIETY; BETA-2-MICROGLOBULIN; INFLAMMATION; MORBIDITY; QUALITY; SYSTEM	Background Little information is available regarding which type of dialyzer membrane results in good prognosis in patients on chronic hemodialysis. Therefore, we conducted a cohort study from a nationwide registry of hemodialysis patients in Japan to establish the association between different dialyzer membranes and mortality rates. Methods We followed 142,412 patients on maintenance hemodialysis (female, 39.1%; mean age, 64.8 +/- 12.3 years; median dialysis duration, 7[4-12] years) for a year from 2008 to 2009. We included patients treated with seven types of high-flux dialyzer membranes at baseline, including cellulose triacetate (CTA), ethylene vinyl alcohol (EVAL), polyacrylonitrile (PAN), polyester polymer alloy (PEPA), polyethersulfone (PES), polymethylmethacrylate (PMMA), and polysulfone (PS). Cox regression was used to estimate the association between baseline dialyzers and all-cause mortality as hazard ratios (HRs) and 95% confidence intervals for 1-year mortality adjusting for potential confounders, and propensity score matching analysis was performed. Results The distribution of patients treated with each membrane was as follows: PS (56.0%), CTA (17.3%), PES (12.0%), PEPA (7.5%), PMMA (4.9%), PAN (1.2%), and EVAL (1.1%). When data were adjusted using basic factors, with PS as a reference group, the mortality rate was significantly higher in all groups except for the PES group. When data were further adjusted groups. When the data were further adjusted for nutrition-and inflammation-related factors, HRs were significantly lower for the PMMA and PES groups compared with the PS group. After propensity score matching, HRs were significantly lower for the PMMA group than for the PS group. Conclusion The results suggest that the use of different membrane types may affect mortality in hemodialysis patients. However, further long-term prospective studies are needed to clarify these findings, including whether the use of the PMMA membrane can improve prognosis.	[Abe, Masanori] Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan; [Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Osaka, Japan; [Wada, Atsushi] Kitasaito Hosp, Dept Nephrol, Asahikawa, Hokkaido, Japan; [Nakai, Shigeru] Fujita Hlth Univ, Dept Clin Engn, Toyoake, Aichi, Japan; [Masakane, Ikuto] Yabuki Hosp, Yamagata, Japan; [Abe, Masanori] Nihon Univ, Sch Med, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan	Nihon University; Osaka University; Fujita Health University; Nihon University	Abe, M (corresponding author), Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan.; Abe, M (corresponding author), Nihon Univ, Sch Med, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan.	abe.masanori@nihon-u.ac.jp	Hamano, TAKAYUKI/AAZ-4837-2021	Hamano, TAKAYUKI/0000-0002-2100-9106				Aucella F, 2007, NEPHROL DIAL TRANSPL, V22, P8, DOI 10.1093/ndt/gfm293; Aucella F, 2013, BLOOD PURIFICAT, V35, P42, DOI 10.1159/000350847; Cheung AK, 2008, CLIN J AM SOC NEPHRO, V3, P69, DOI 10.2215/CJN.02340607; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272, DOI 10.1016/S0272-6386(12)80984-X; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; HAKIM RM, 1994, AM J KIDNEY DIS, V23, P661, DOI 10.1016/S0272-6386(12)70276-7; Higuchi T, 2015, SLEEP MED, V16, P941, DOI 10.1016/j.sleep.2015.03.025; Iseki K, 2011, NEPHROL DIAL TRANSPL, V26, P963, DOI 10.1093/ndt/gfq507; Koda Y, 1997, KIDNEY INT, V52, P1096, DOI 10.1038/ki.1997.434; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; Kreusser W, 2010, CLIN KIDNEY J, V3, pI12, DOI 10.1093/ndtplus/sfq032; Lin YC, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0380-7; Lin YK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/234245; Liu CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00080-4; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; MacLeod A.M., 2005, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD003234.PUB2; Masakane I, 2015, THER APHER DIAL, V19, P540, DOI 10.1111/1744-9987.12378; Masakane I, 2010, CLIN KIDNEY J, V3, pI28, DOI 10.1093/ndtplus/sfq034; Masakane I, 2009, BLOOD PURIFICAT, V27, P11, DOI 10.1159/000213491; Nakai S, 2001, AM J KIDNEY DIS, V38, pS212, DOI 10.1053/ajkd.2001.27449; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; National Kidney Foundation, 2006, AM J KIDNEY DIS, V48, ps12; Okuno S, 2009, NEPHROL DIAL TRANSPL, V24, P571, DOI 10.1093/ndt/gfn521; Saito A, 2011, CONTRIB NEPHROL, V173, P1, DOI 10.1159/000328938; Sakai Y, 2011, CONTRIB NEPHROL, V173, P137, DOI 10.1159/000329052; Santoro A, 2013, BLOOD PURIFICAT, V35, P5, DOI 10.1159/000350837; Schiffl H, 2001, NEPHROL DIAL TRANSPL, V17, P1814; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Shinzato T, 1997, NEPHROL DIAL TRANSPL, V12, P884, DOI 10.1093/ndt/12.5.884; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Tattersall J, 2007, NEPHROL DIAL TRANSPL, V22, P5, DOI 10.1093/ndt/gfm022; Traut M, 2007, BLOOD PURIFICAT, V25, P432, DOI 10.1159/000110069; Watanabe Y, 2015, THER APHER DIAL, V19, P67, DOI 10.1111/1744-9987.12294; Watanabe Y, 2015, THER APHER DIAL, V19, P93, DOI 10.1111/1744-9987.12293; Yamashita AC, 2011, CONTRIB NEPHROL, V173, P95, DOI 10.1159/000328946	41	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184424	10.1371/journal.pone.0184424	http://dx.doi.org/10.1371/journal.pone.0184424			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910324	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200046
J	DiMarzio, M; Rusconi, B; Yennawar, NH; Eppinger, M; Patterson, AD; Dudley, EG				DiMarzio, Michael; Rusconi, Brigida; Yennawar, Neela H.; Eppinger, Mark; Patterson, Andrew D.; Dudley, Edward G.			Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-beta-MCA	PLOS ONE			English	Article							BILE-SALT HYDROLASE; BIFIDOBACTERIUM-LONGUM; FUNCTIONAL-ANALYSIS; WEIGHT-GAIN; ACIDS; MICROBIOME; BACTERIA; METABOLISM; GENOMES	Bile salt hydrolase (BSH) activity against the bile acid tauro-beta-muricholic acid (T-beta-MCA) was recently reported to mediate host bile acid, glucose, and lipid homeostasis via the farnesoid X receptor (FXR) signaling pathway. An earlier study correlated decreased Lactobacillus abundance in the cecum with increased concentrations of intestinal T-beta-MCA, an FXR antagonist. While several studies have characterized BSHs in lactobacilli, deconjugation of T-beta-MCA remains poorly characterized among members of this genus, and therefore it was unclear what strain(s) were responsible for this activity. Here, a strain of L. johnsonii with robust BSH activity against T-beta-MCA in vitro was isolated from the cecum of a C57BL/6J mouse. A screening assay performed on a collection of 14 Lactobacillus strains from nine different species identified BSH substrate specificity for T-beta-MCA only in two of three L. johnsonii strains. Genomic analysis of the two strains with this BSH activity revealed the presence of three bsh genes that are homologous to bsh genes in the previously sequenced humanassociated strain L. johnsonii NCC533. Heterologous expression of several bsh genes in E. coli followed by enzymatic assays revealed broad differences in substrate specificity even among closely related bsh homologs, and suggests that the phylogeny of these enzymes does not closely correlate with substrate specificity. Predictive modeling allowed us to propose a potential mechanism driving differences in BSH activity for T-beta-MCA in these homologs. Our data suggests that L. johnsonii regulates T-beta-MCA levels in the mouse intestinal environment, and that this species may play a central role in FXR signaling in the mouse.	[DiMarzio, Michael; Dudley, Edward G.] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA; [Rusconi, Brigida; Eppinger, Mark] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Rusconi, Brigida; Eppinger, Mark] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Yennawar, Neela H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dudley, EG (corresponding author), Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.	egd100@psu.edu	Patterson, Andrew/ABF-1575-2020	Patterson, Andrew/0000-0003-2073-0070	U.S Department of Agriculture [2012-38420-19284]; Swiss National Science Foundation [2012-38420-19284]	U.S Department of Agriculture(United States Department of Agriculture (USDA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by U.S Department of Agriculture (WWW.usda.gov); 2012-38420-19284, to MD; Swiss National Science Foundation (WWW.snf.ch). 2012-38420-19284, to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bathena SPR, 2013, J CHROMATOGR B, V942, P53, DOI 10.1016/j.jchromb.2013.10.019; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; CHIKAI T, 1987, LIPIDS, V22, P669, DOI 10.1007/BF02533948; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geng W, 2016, ANIM HEALTH RES REV, V17, P148, DOI 10.1017/S1466252316000153; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Han J, 2015, ANAL CHEM, V87, P1127, DOI 10.1021/ac503816u; HOFMANN AF, 1984, HEPATOLOGY, V4, pS4, DOI 10.1002/hep.1840040803; Jamroz M, 2013, NUCLEIC ACIDS RES, V41, pW427, DOI 10.1093/nar/gkt332; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; KAYAHARA T, 1994, LIPIDS, V29, P289, DOI 10.1007/BF02536334; Killer J, 2014, INT J SYST EVOL MICR, V64, P1526, DOI 10.1099/ijs.0.054924-0; Kim GB, 2004, J DAIRY SCI, V87, P258, DOI 10.3168/jds.S0022-0302(04)73164-1; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kumar RS, 2006, J BIOL CHEM, V281, P32516, DOI 10.1074/jbc.M604172200; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; McAuliffe O, 2005, APPL ENVIRON MICROB, V71, P4925, DOI 10.1128/AEM.71.8.4925-4929.2005; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; ROGOSA M, 1951, J BACTERIOL, V62, P132, DOI 10.1128/JB.62.1.132-133.1951; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uchida K, 1999, LIPIDS, V34, P269, DOI 10.1007/s11745-999-0363-y; Young VB, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j831; Zhang LM, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00070-16; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183564	10.1371/journal.pone.0183564	http://dx.doi.org/10.1371/journal.pone.0183564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910295	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200012
J	Hranilovic, A; Bely, M; Masneuf-Pomarede, I; Jiranek, V; Albertin, W				Hranilovic, Ana; Bely, Marina; Masneuf-Pomarede, Isabelle; Jiranek, Vladimir; Albertin, Warren			The evolution of Lachancea thermotolerans is driven by geographical determination, anthropisation and flux between different ecosystems	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-THERMOTOLERANS; MICROSATELLITE MARKERS; POPULATION GENOMICS; ACID PRODUCTION; R PACKAGE; YEAST; WINE; FERMENTATION; DIVERSITY	The yeast Lachancea thermotolerans (formerly Kluyveromyces thermotolerans) is a species with remarkable, yet underexplored, biotechnological potential. This ubiquist occupies a range of natural and anthropic habitats covering a wide geographic span. To gain an insight into L. thermotolerans population diversity and structure, 172 isolates sourced from diverse habitats worldwide were analysed using a set of 14 microsatellite markers. The resultant clustering revealed that the evolution of L. thermotolerans has been driven by the geography and ecological niche of the isolation sources. Isolates originating from anthropic environments, in particular grapes and wine, were genetically close, thus suggesting domestication events within the species. The observed clustering was further validated by several means including, population structure analysis, F-statistics, Mantel's test and the analysis of molecular variance (AMOVA). Phenotypic performance of isolates was tested using several growth substrates and physicochemical conditions, providing added support for the clustering. Altogether, this study sheds light on the genotypic and phenotypic diversity of L. thermotolerans, contributing to a better understanding of the population structure, ecology and evolution of this non-Saccharomyces yeast.	[Hranilovic, Ana; Jiranek, Vladimir] Australian Res Council Training Ctr Innovat Wine, Adelaide, SA, Australia; [Hranilovic, Ana; Jiranek, Vladimir] Univ Adelaide, Dept Wine & Food Sci, Urbrrae, SA, Australia; [Bely, Marina; Masneuf-Pomarede, Isabelle; Albertin, Warren] Univ Bordeaux, Inst Sci Vigne & Vin, Unite Rech Enol, Villenave Dornon, France; [Masneuf-Pomarede, Isabelle] Bordeaux Sci Agro, Gradignan, France; [Albertin, Warren] Bordeaux INP, ENSCBP, Pessac, France	University of Adelaide; UDICE-French Research Universities; Universite de Bordeaux	Albertin, W (corresponding author), Univ Bordeaux, Inst Sci Vigne & Vin, Unite Rech Enol, Villenave Dornon, France.; Albertin, W (corresponding author), Bordeaux INP, ENSCBP, Pessac, France.	warren.albertin@u-bordeaux.fr		Albertin, Warren/0000-0002-7385-9882; Masneuf-Pomarede, Isabelle/0000-0002-8806-8944	Wine Australia; ISW; Wine Australia [AGT1524]	Wine Australia(Australian Grape and Wine Authority); ISW; Wine Australia(Australian Grape and Wine Authority)	This research was conducted by the Australian Research Council Industrial Transformation Training Centre for Innovative Wine Production (Project IC130100005) to VJ with support from the Wine Australia and industry partners. AH received an ISW Travel Grant and Wine Australia Travel Grant (AGT1524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2016, FRONTIERS MICROBIOLO; Albertin W, 2014, FOOD MICROBIOL, V42, P188, DOI 10.1016/j.fm.2014.03.012; Albertin W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094246; Almeida P, 2015, MOL ECOL, V24, P5412, DOI 10.1111/mec.13341; Banilas G, 2016, MICROBIOL RES, V193, P1, DOI 10.1016/j.micres.2016.08.010; Benito A, 2016, FOOD TECHNOL BIOTECH, V54, P135, DOI 10.17113/ftb.54.02.16.4220; Boone C, 2014, GENETICS, V198, P435, DOI 10.1534/genetics.114.169128; Borneman AR, 2016, G3-GENES GENOM GENET, V6, P957, DOI 10.1534/g3.115.025692; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chessel D., 2004, R NEWS, V4, P5; Clark L, 2017, MOL ECOLOGY RESOURCE; DEQUIN S, 1994, BIO-TECHNOL, V12, P173, DOI 10.1038/nbt0294-173; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Francesca N, 2012, ENV MICROBIOL REP, V4, P105, DOI 10.1111/j.1758-2229.2011.00310.x; Freely KC, 2014, GENOME BIOL EVOL, V6, P2586, DOI 10.1093/gbe/evu203; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gobbi M, 2013, FOOD MICROBIOL, V33, P271, DOI 10.1016/j.fm.2012.10.004; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Jolly NP, 2014, FEMS YEAST RES, V14, P215, DOI 10.1111/1567-1364.12111; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kapsopoulou K, 2007, WORLD J MICROB BIOT, V23, P735, DOI 10.1007/s11274-006-9283-5; Kelly DE, 2001, COMPAR FUNCT GENOM, V2, P236, DOI 10.1002/cfg.95; Knight S, 2015, ISME J, V9, P361, DOI 10.1038/ismej.2014.132; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P511, DOI 10.1016/B978-0-444-52149-1.00041-0; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Lemon J., 2006, R R NEWS; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Malpertuy A, 2000, FEBS LETT, V487, P113, DOI 10.1016/S0014-5793(00)02290-0; MANTEL N, 1967, CANCER RES, V27, P209; Masneuf-Pomarede I, 2015, FRONTIERS MICROBIOLO; Masneuf-Pomarede I, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow002; Masneuf-Pomarede I, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov045; MORA J, 1990, AM J ENOL VITICULT, V41, P156; Naumova ES, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1356, DOI 10.1134/S0006297907120097; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pebesma E.J., 2005, R NEWS, V5; Prosperi MC, 2011, NATURE COMMUNICATION; RCore Team, 2020, R LANG ENV STAT COMP; Ristic R., 2016, Wine and Viticulture Journal, V31, P33; Robinson HA, 2016, ECOL EVOL, V6, P1236, DOI 10.1002/ece3.1919; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer M, 2010, BIOTECHNOL GENET ENG, V27, P229, DOI 10.1080/02648725.2010.10648152; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Sipiczki M., 2016, FRONTIERS MICROBIOLO; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Strope PK, 2015, GENOME RES, V25, P762, DOI 10.1101/gr.185538.114; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; WITTE V, 1989, J BASIC MICROB, V29, P707, DOI 10.1002/jobm.3620291014	59	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184652	10.1371/journal.pone.0184652	http://dx.doi.org/10.1371/journal.pone.0184652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910346	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200072
J	Moore, EA; Xu, YZ				Moore, Elaine Ann; Xu, Yao-Zhong			The effect of S-substitution at the O6-guanine site on the structure and dynamics of a DNA oligomer containing a G: T mismatch	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; FORCE-FIELD; DUPLEX DNA; REPAIR; 6-THIOGUANINE; THIOGUANINE; MECHANISMS; SYSTEM; DAMAGE; WATER	The effect of S-substitution on the O-6 guanine site of a 13-mer DNA duplex containing a G: T mismatch is studied using molecular dynamics. The structure, dynamic evolution and hydration of the S-substituted duplex are compared with those of a normal duplex, a duplex with S-substitution on guanine, but no mismatch and a duplex with just a G: T mismatch. The S-substituted mismatch leads to cell death rather than repair. One suggestion is that the G: T mismatch recognition protein recognises the S-substituted mismatch (G(S) : T) as G: T. This leads to a cycle of futile repair ending in DNA breakage and cell death. We find that some structural features of the helix are similar for the duplex with the G: T mismatch and that with the S-substituted mismatch, but differ from the normal duplex, notably the helical twist. These differences arise from the change in the hydrogen-bonding pattern of the base pair. However a marked feature of the S-substituted G: T mismatch duplex is a very large opening. This showed considerable variability. It is suggested that this enlarged opening would lend support to an alternative model of cell death in which the mismatch protein attaches to thioguanine and activates downstream damage-response pathways. Attack on the sulphur by reactive oxygen species, also leading to cell death, would also be aided by the large, variable opening.	[Moore, Elaine Ann; Xu, Yao-Zhong] Open Univ, Sch Life Hlth & Chem Sci, STEM Fac, Milton Keynes, Bucks, England	Open University - UK	Moore, EA (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, STEM Fac, Milton Keynes, Bucks, England.	e.a.moore@open.ac.uk		Xu, Yao/0000-0002-5713-8030; Moore, Elaine/0000-0003-4418-0536	 [CHEM449]		This work was supported by CHEM449, http://www.nscas.ac.uk, provision of computer time 20 000 hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Salgado F, 2006, MAGN RESON CHEM, V44, P1081, DOI 10.1002/mrc.1902; [Anonymous], 2008, AMBER 10; Bohon J, 2003, NUCLEIC ACIDS RES, V31, P1331, DOI 10.1093/nar/gkg203; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; El Hassan MA, 1998, J MOL BIOL, V282, P331, DOI 10.1006/jmbi.1998.1994; Gueranger Q, 2014, J INVEST DERMATOL, V134, P1408, DOI 10.1038/jid.2013.509; Houlleberghs H, 2016, P NATL ACAD SCI USA, V113, P4128, DOI 10.1073/pnas.1520813113; Isaacs RJ, 2004, J AM CHEM SOC, V126, P583, DOI 10.1021/ja037333r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Kryachko E, 2001, J PHYS CHEM A, V105, P3379, DOI 10.1021/jp003703b; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; Li GM, 1999, ONCOL RES, V11, P393; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider B, 1995, BIOPHYS J, V69, P2661, DOI 10.1016/S0006-3495(95)80136-0; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Somerville L, 2003, J BIOL CHEM, V278, P1005, DOI 10.1074/jbc.M204243200; Spackova N, 2004, J AM CHEM SOC, V126, P14642, DOI 10.1021/ja0468628; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tessmer I, 2008, J BIOL CHEM, V283, P36646, DOI 10.1074/jbc.M805712200; Villani G, 2009, J PHYS CHEM B, V113, P2128, DOI 10.1021/jp807670f; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b	31	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184801	10.1371/journal.pone.0184801	http://dx.doi.org/10.1371/journal.pone.0184801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910418	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000410859200096
J	Puffe, L; Dittrich, K; Klauer, KC				Puffe, Lydia; Dittrich, Kerstin; Klauer, Karl Christoph			The influence of the Japanese waving cat on the joint spatial compatibility effect: A replication and extension of Dolk, Hommel, Prinz, and Liepelt (2013)	PLOS ONE			English	Article							S-R COMPATIBILITY; DUAL-PROCESS MODEL; RESPONSE CORRESPONDENCE; SIMON; STIMULUS; TASK; PERCEPTION; FRAMEWORK; OWN; TEC	In a joint go/no-go Simon task, each of two participants is to respond to one of two non-spatial stimulus features by means of a spatially lateralized response. Stimulus position varies horizontally and responses are faster and more accurate when response side and stimulus position match (compatible trial) than when they mismatch (incompatible trial), defining the social Simon effect or joint spatial compatibility effect. This effect was originally explained in terms of action/task co-representation, assuming that the co-actor's action is automatically co-represented. Recent research by Dolk, Hommel, Prinz, and Liepelt (2013) challenged this account by demonstrating joint spatial compatibility effects in a task-setting in which non-social objects like a Japanese waving cat were present, but no real co-actor. They postulated that every sufficiently salient object induces joint spatial compatibility effects. However, what makes an object sufficiently salient is so far not well defined. To scrutinize this open question, the current study manipulated auditory and/or visual attention-attracting cues of a Japanese waving cat within an auditory (Experiment 1) and a visual joint go/no-go Simon task (Experiment 2). Results revealed that joint spatial compatibility effects only occurred in an auditory Simon task when the cat provided auditory cues while no joint spatial compatibility effects were found in a visual Simon task. This demonstrates that it is not the sufficiently salient object alone that leads to joint spatial compatibility effects but instead, a complex interaction between features of the object and the stimulus material of the joint go/no-go Simon task.	[Puffe, Lydia; Dittrich, Kerstin; Klauer, Karl Christoph] Albert Ludwigs Univ Freiburg, Dept Psychol, Freiburg, Germany	University of Freiburg	Puffe, L (corresponding author), Albert Ludwigs Univ Freiburg, Dept Psychol, Freiburg, Germany.	lydia.puffe@psychologie.uni-freiburg.de			Baden-Wurttemberg Stiftung; German Research Foundation (DFG); University of Freiburg	Baden-Wurttemberg Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The research reported in this paper was supported by a grant of the Baden-Wurttemberg Stiftung to the second author (https://www.bwstiftung.de/bildung/programme/hochschule/eliteprogramm-fuer-postdocs/). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing (https://www.ub.uni-freiburg.de/unterstuetzung/elektronisch-publizieren/open-access/publikationsfonds/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge U, 2004, J EXP PSYCHOL HUMAN, V30, P365, DOI 10.1037/0096-1523.30.2.365; Bundesen C, 1998, PHILOS T ROY SOC B, V353, P1271, DOI 10.1098/rstb.1998.0282; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Dittrich K, 2014, PSYCHOL RES-PSYCH FO, V78, P387, DOI 10.1007/s00426-014-0551-y; Dittrich K, 2013, ATTEN PERCEPT PSYCHO, V75, P1725, DOI 10.3758/s13414-013-0524-z; Dittrich K, 2012, ATTEN PERCEPT PSYCHO, V74, P911, DOI 10.3758/s13414-012-0304-1; Dolk T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00974; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dolk T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00084; Eder AB, 2008, J EXP PSYCHOL GEN, V137, P262, DOI 10.1037/0096-3445.137.2.262; Eid M, 2010, STAT FORSCHUNGSMETHO, P99; EIMER M, 1995, ACTA PSYCHOL, V90, P301, DOI 10.1016/0001-6918(95)00022-M; Guagnano D, 2010, COGNITION, V114, P348, DOI 10.1016/j.cognition.2009.10.008; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, Q J EXP PSYCHOL-A, V49, P546, DOI 10.1080/027249896392496; Hommel B, 2009, PSYCHOL SCI, V20, P794, DOI 10.1111/j.1467-9280.2009.02367.x; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Kiernan D, 2012, PSYCHON B REV, V19, P914, DOI 10.3758/s13423-012-0283-1; Klempova B, 2015, J PSYCHOL RES, V80, P449; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lammertyn J, 2007, EXP PSYCHOL, V54, P202, DOI 10.1027/1618-3169.54.3.202; Lien MC, 2016, PSYCHOL RES-PSYCH FO, V80, P912, DOI 10.1007/s00426-015-0699-0; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prinz W, 2012, OPEN MINDS: THE SOCIAL MAKING OF AGENCY AND INTENTIONALITY, P1; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Schwarz W, 2012, PSYCHON B REV, V19, P555, DOI 10.3758/s13423-012-0254-6; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; SIMON JR, 1970, J EXP PSYCHOL, V86, P97, DOI 10.1037/h0029783; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Stenzel A, 2016, ATTEN PERCEPT PSYCHO, V78, P143, DOI 10.3758/s13414-015-0994-2; Stenzel A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00595; Tsai CC, 2006, EXP BRAIN RES, V175, P353, DOI 10.1007/s00221-006-0557-9; van Steenbergen H., 2007, THESIS; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Voss A, 2007, BEHAV RES METHODS, V39, P797, DOI 10.3758/BF03192971; Wenke D, 2011, REV PHILOS PSYCHOL, V2, P147, DOI 10.1007/s13164-011-0057-0; Zhang J, 1997, J EXP PSYCHOL HUMAN, V23, P1543, DOI 10.1037/0096-1523.23.5.1543	41	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184844	10.1371/journal.pone.0184844	http://dx.doi.org/10.1371/journal.pone.0184844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910413	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200105
J	Amaral, KB; Silva, TP; Dias, FF; Malta, KK; Rosa, FM; Costa-Neto, SF; Gentile, R; Melo, RCN				Amaral, Katia B.; Silva, Thiago P.; Dias, Felipe F.; Malta, Kassia K.; Rosa, Florence M.; Costa-Neto, Socrates F.; Gentile, Rosana; Melo, Rossana C. N.			Histological assessment of granulomas in natural and experimental Schistosoma mansoni infections using whole slide imaging	PLOS ONE			English	Article							NECTOMYS-SQUAMIPES; MURINE SCHISTOSOMIASIS; HELMINTH INFECTION; EOSINOPHILS; PATHOLOGY; MICE; PERSPECTIVES; EGGS	The pathology of schistosomiasis mansoni, a neglected tropical disease of great clinical and socioeconomic importance, results from the parasite eggs that become trapped in host tissues, particularly in the liver and intestines. Continuous antigenic stimulation from these eggs leads to recruitment of inflammatory cells to the sites of infection with formation of periovular granulomas. These complex structures have variable size and composition and are the most striking histopathological feature of schistosomiasis mansoni. However, evaluation of granulomas by conventional microscopy methods is time-consuming and limited, especially in large-scale studies. Here, we used high resolution Whole Slide Imaging (WSI), which allows fast scanning of entire histological slides, and multiple morphometric evaluations, to assess the granulomatous response elicited in target organs (liver, small and large intestines) of two models of schistosomiasis mansoni. One of the advantages of WSI, also termed virtual microscopy, is that it generates images that simultaneously offer high resolution and a wide field of observation. By using a model of natural (Nectomys squamipes, a wild reservoir captured from endemic areas in Brazil) and experimental (Swiss mouse) infection with Schistosoma mansoni, we provided the first detailed WSI characterization of granulomas and other pathological aspects. WSI and quantitative analyses enabled a fast and reliable assessment of the number, evolutional types, frequency and areas of granulomas and inflammatory infiltrates and revealed that target organs are differentially impacted by inflammatory responses in the natural and experimental infections. Remarkably, high-resolution analysis of individual eosinophils, key cells elicited by this helminthic infection, showed a great difference in eosinophil numbers between the two infections. Moreover, features such as the intestinal egg path and confluent granulomas were uncovered. Thus, WSI may be a suitable tool for detailed and precise histological analysis of granulomas and other pathological aspects for clinical and research studies of schistosomiasis.	[Amaral, Katia B.; Silva, Thiago P.; Dias, Felipe F.; Malta, Kassia K.; Melo, Rossana C. N.] Fed Univ Juiz De Fora UFJF, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil; [Rosa, Florence M.] Fed Univ Juiz De Fora UFJF, Dept Parasitol Microbiol & Immunol, Lab Parasitol, Juiz De Fora, MG, Brazil; [Costa-Neto, Socrates F.; Gentile, Rosana] Fundacao Oswaldo Cruz, Lab Biol & Parasitol Wild Reservoir Mammals, Rio De Janeiro, RJ, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Fundacao Oswaldo Cruz	Melo, RCN (corresponding author), Fed Univ Juiz De Fora UFJF, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil.	rossana.melo@ufjf.edu.br	Dias, Felipe F/P-1324-2016; Gentile, Rosana/C-3101-2013; Malta, Kássia K./A-7938-2019; Dias, Felipe Ferraz/K-4549-2019; Silva, Thiago/B-3293-2018; Melo, Rossana C. N./B-8248-2013	Dias, Felipe F/0000-0002-3493-6929; Gentile, Rosana/0000-0001-9160-1204; Malta, Kássia K./0000-0003-2203-2719; Dias, Felipe Ferraz/0000-0002-3493-6929; Silva, Thiago/0000-0001-7122-3015; Melo, Rossana C. N./0000-0003-1736-0806; Amaral, Katia/0000-0001-9812-8093	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Fundacao Oswaldo Cruz (FIOCRUZ, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ, Brazil)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil) and Fundacao Oswaldo Cruz (FIOCRUZ, Brazil).	Abdul-Ghani RA, 2010, PARASITOL RES, V107, P1, DOI 10.1007/s00436-010-1855-5; Al-Janabi S, 2012, HUM PATHOL, V43, P2318, DOI 10.1016/j.humpath.2012.03.027; Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Amaral KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166979; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Lins RAB, 2008, REV SOC BRAS MED TRO, V41, P173, DOI 10.1590/S0037-86822008000200008; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Cheever AW, 2002, MEM I OSWALDO CRUZ, V97, P917, DOI 10.1590/S0074-02762002000700002; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Costa-Silva M, 2002, MEM I OSWALDO CRUZ, V97, P129, DOI 10.1590/S0074-02762002000900026; D'Andrea PS, 2000, PARASITOLOGY, V120, P573, DOI 10.1017/S0031182099005892; Dee FR, 2009, HUM PATHOL, V40, P1112, DOI 10.1016/j.humpath.2009.04.010; Fabrino DL, 2011, J INNATE IMMUN, V3, P71, DOI 10.1159/000320641; Farris AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161019; Gentile R, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000900018; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Hoffman WA, 1934, PUERTO RICO J PUB HL, V9, P283; HSU SYL, 1972, J RETICULOENDOTH SOC, V12, P418; Huang L, 2016, TRENDS PARASITOL, V32, P798, DOI 10.1016/j.pt.2016.05.004; JUNQUEIRA LCU, 1986, ANN TROP MED PARASIT, V80, P27, DOI 10.1080/00034983.1986.11811981; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058344; Lambertucci JR, 2010, MEM I OSWALDO CRUZ, V105, P422, DOI 10.1590/S0074-02762010000400012; Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034; Lenzi HL, 1997, MEM I OSWALDO CRUZ, V92, P19, DOI 10.1590/S0074-02761997000800005; LENZI HL, 1987, BRAZ J MED BIOL RES, V20, P433; Lenzi HL, 1998, MEM I OSWALDO CRUZ, V93, P141, DOI 10.1590/S0074-02761998000700020; Raso P, 2012, REV SOC BRAS MED TRO, V45, P627, DOI 10.1590/S0037-86822012000500016; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Shin MH, 2009, KOREAN J PARASITOL, V47, pS125, DOI 10.3347/kjp.2009.47.S.S125; Silva LM, 2000, MEM I OSWALDO CRUZ, V95, P353, DOI 10.1590/S0074-02762000000300010; SILVA RRE, 1992, MEM I OSWALDO CRUZ, V87, P271, DOI 10.1590/S0074-02761992000500051; SILVA TMC, 1989, MEM I OSWALDO CRUZ, V84, P227, DOI 10.1590/S0074-02761989000200011; SMITHERS SR, 1965, PARASITOLOGY, V55, P701, DOI 10.1017/S003118200008625X; Souza ALS, 2011, INFECT IMMUN, V79, P1741, DOI 10.1128/IAI.00502-10; Tweyongyere R, 2016, PARASITE IMMUNOL, V38, P516, DOI 10.1111/pim.12336; WEINSTOCK JV, 1983, J IMMUNOL, V130, P418; WHO, 2020, SCHISTOSOMIASIS; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014	41	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184696	10.1371/journal.pone.0184696	http://dx.doi.org/10.1371/journal.pone.0184696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902908	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200054
J	Maraz, A; Borbala, H; Urban, R; Demetrovics, Z				Maraz, Aniko; Borbala Hende; Urban, Robert; Demetrovics, Zsolt			Pathological grooming: Evidence for a single factor behind trichotillomania, skin picking and nail biting	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; HAIR PULLING DISORDER; BRIEF SYMPTOM INVENTORY; MOTOR INHIBITION; COMORBIDITY; PERSONALITY; IMPULSIVITY; MODEL; ONYCHOPHAGIA; BEHAVIORS	Although trichotillomania (TTM), skin picking (SP), and nail biting (NB) have been receiving growing scientific attention, the question as to whether these disorders can be regarded as separate entities or they are different manifestations of the same underlying tendency is unclear. Data were collected online in a community survey, yielding a sample of 2705 participants (66% women, mean age: 29.1, SD:8.6). Hierarchical factor analysis was used to identify a common latent factor and the multiple indicators and multiple causes (MIMIC) modelling was applied to test the predictive effect of borderline personality disorder symptoms, impulsivity, distress and self-esteem on pathological grooming. Pearson correlation coefficients between TTM, SP and NB were between 0.13 and 0.29 (p < 0.01). The model yielded an excellent fit to the data (CFI = 0.992, TLI = 0.991, chi(2) = 696.65, p < 0.001, df = 222, RMSEA = 0.030, Cfit of RMSEA = 1.000), supporting the existence of a latent factor. The MIMIC model indicated an adequate fit (CFI = 0.993, TLI = 0.992, chi(2) = 655.8, p < 0.001, df = 307, RMSEA = 0.25, CI: 0.022-0.028, pclose = 1.000). TTM, SP and NB each were loaded significantly on the latent factor, indicating the presence of a general grooming factor. Impulsivity, psychiatric distress and contingent self-esteem had significant predictive effects, whereas borderline personality disorder had a nonsignificant predictive effect on the latent factor. We found evidence that the category of pathological grooming is meaningful and encompasses three symptom manifestations: trichotillomania, skin picking and nail biting. This latent underlying factor is not better explained by indicators of psychopathology, which supports the notion that the urge to self-groom, rather than general psychiatric distress, impulsivity, self-esteem or borderline symptomatology, is what drives individual grooming behaviours.	[Maraz, Aniko; Borbala Hende; Urban, Robert; Demetrovics, Zsolt] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Borbala Hende] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Maraz, A (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.	aniko.maraz@ppk.elte.hu	Demetrovics, Zsolt/F-8613-2010	Demetrovics, Zsolt/0000-0001-5604-7551; Maraz, Aniko/0000-0002-0846-0728	Hungarian National Research, Development and Innovation Office [K111938]	Hungarian National Research, Development and Innovation Office	This work was supported by Hungarian National Research, Development and Innovation Office (Grant number: K111938). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIAGN STAT MAN MENT; Arnold LM, 2001, CNS DRUGS, V15, P351, DOI 10.2165/00023210-200115050-00002; Baumeister R.F., 1997, REV GEN PSYCHOL, V1, P145, DOI [10.1037/1089-2680.1.2.145, DOI 10.1037/1089-2680.1.2.145]; Bertsch K, 2013, HORM BEHAV, V63, P424, DOI 10.1016/j.yhbeh.2012.11.013; Bienvenu OJ, 2009, AM J MED GENET B, V150B, P710, DOI 10.1002/ajmg.b.30897; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Blasco-Fontecilla H, 2016, FRONTIERS PSYCHIAT, V7; Bohne A, 2002, BEHAV MODIF, V26, P320, DOI 10.1177/0145445502026003002; Bohne A, 2008, J PSYCHIATR RES, V42, P141, DOI 10.1016/j.jpsychires.2006.11.008; Bohne Antje, 2005, Ann Clin Psychiatry, V17, P227, DOI 10.1080/10401230500295354; Bray N., 2016, NATURE REV NEUROSCIE, V17, P138; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Chamberlain SR, 2008, BRIT J PSYCHIAT, V193, P216, DOI 10.1192/bjp.bp.107.048314; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Cheng H, 2003, PERS INDIV DIFFER, V34, P921, DOI 10.1016/S0191-8869(02)00078-8; Christenson GA, 1991, J CLIN PSYCHIAT; COHEN LJ, 1995, J CLIN PSYCHIAT, V56, P319; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Diamantopoulos A, 2011, MIS QUART, V35, P335; du Toit PL, 2001, COMPR PSYCHIAT, V42, P291, DOI 10.1053/comp.2001.24586; Feusner JD, 2009, CNS SPECTRUMS, V14, P503, DOI 10.1017/S1092852900023567; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Flessner CA, 2012, PSYCHIAT RES, V199, P151, DOI 10.1016/j.psychres.2012.03.039; Franklin ME, 2008, J DEV BEHAV PEDIATR, V29, P493, DOI 10.1097/DBP.0b013e31818d4328; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Johnson M., 2007, INDIVIDUAL DIFFERENC, V5, P300; Jokinen J, 2012, PSYCHONEUROENDOCRINO, V37, P482, DOI 10.1016/j.psyneuen.2011.07.016; JOLLES J, 1979, BEHAV NEURAL BIOL, V25, P563, DOI 10.1016/S0163-1047(79)90362-5; JORESKOG KG, 1975, J AM STAT ASSOC, V70, P631, DOI 10.2307/2285946; Kaburu SSK, 2012, AFR ZOOL, V47, P74, DOI 10.3377/004.047.0111; Keuthen NJ, 2000, PSYCHOSOMATICS, V41, P210, DOI 10.1176/appi.psy.41.3.210; KEUTHEN NJ, 1995, PSYCHOTHER PSYCHOSOM, V64, P141, DOI 10.1159/000289003; Lawrence KA, 2010, J PERS DISORD, V24, P785, DOI 10.1521/pedi.2010.24.6.785; Lee JA, 2010, PROG NEURO-PSYCHOPH, V34, P1250, DOI 10.1016/j.pnpbp.2010.06.031; LENANE MC, 1992, J CHILD PSYCHOL PSYC, V33, P925, DOI 10.1111/j.1469-7610.1992.tb01966.x; LEONARD HL, 1991, ARCH GEN PSYCHIAT, V48, P821; LEUNG AKC, 1990, CLIN PEDIATR, V29, P690, DOI 10.1177/000992289002901201; Lochner C, 2002, DEPRESS ANXIETY, V15, P83, DOI 10.1002/da.10034; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Mueller A, 2011, COMPR PSYCHIAT, V52, P420, DOI 10.1016/j.comppsych.2010.09.001; Muthen B., 2010, MPLUS USERS GUIDE; NEALE MC, 1995, AM J HUM GENET, V57, P935; Novak CE, 2009, AM J MED GENET B, V150B, P944, DOI 10.1002/ajmg.b.30922; Odlaug BL, 2008, GEN HOSP PSYCHIAT, V30, P61, DOI 10.1016/j.genhosppsych.2007.07.009; Odlaug BL, 2007, J CLIN PSYCHOPHARM, V27, P227, DOI 10.1097/01.jcp.0000264976.86990.00; Odlaug BL, 2010, J ANXIETY DISORD, V24, P823, DOI 10.1016/j.janxdis.2010.06.004; Odlaug BL, 2008, ANN CLIN PSYCHIATRY, V20, P57, DOI 10.1080/10401230802017027; Offord DR, 1996, CAN J PSYCHIAT, V41, P559, DOI 10.1177/070674379604100904; Pacan P, 2009, ACTA DERM-VENEREOL, V89, P278, DOI 10.2340/00015555-0646; Park HJ, 2010, PERS INDIV DIFFER, V48, P469, DOI 10.1016/j.paid.2009.11.024; PENNINGTON LA, 1945, AM J PSYCHIAT, V102, P241, DOI 10.1176/ajp.102.2.241; Penzel F, 2003, HAIR PULLING PROBLEM; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Silva-Netto R, 2014, REV BRAS PSIQUIATR, V36, P98, DOI 10.1590/1516-4446-2013-1154; Simeon D, 1997, J NERV MENT DIS, V185, P117, DOI 10.1097/00005053-199702000-00009; Snorrason I, 2012, CLIN PSYCHOL REV, V32, P618, DOI 10.1016/j.cpr.2012.05.008; Snorrason I, 2011, BEHAV THER, V42, P521, DOI 10.1016/j.beth.2010.12.002; Stein DJ, 2006, CNS SPECTRUMS, V11, P824, DOI 10.1017/S1092852900014978; Stein DJ, 2010, DEPRESS ANXIETY, V27, P611, DOI 10.1002/da.20700; STEIN DJ, 1992, J CLIN PSYCHIAT, V53, P123; STEIN DJ, 1995, J CLIN PSYCHIAT, V56, P28; SWEDO SE, 1989, NEW ENGL J MED, V321, P497, DOI 10.1056/NEJM198908243210803; Tanaka OM, 2008, AM J ORTHOD DENTOFAC, V134, P305, DOI 10.1016/j.ajodo.2006.06.023; Urban R, 2014, BEHAV RES METHODS, V46, P488, DOI 10.3758/s13428-013-0391-5; Urban R, 2014, PSYCHIAT RES, V216, P146, DOI 10.1016/j.psychres.2014.01.027; Varga G., 2015, BARRATT IMPULS UNPUB; Vazire S, 2006, PERS SOC PSYCHOL REV, V10, P154, DOI 10.1207/s15327957pspr1002_4; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wilhelm S, 1999, J CLIN PSYCHIAT, V60, P454, DOI 10.4088/JCP.v60n0707; Woods DW, 2006, PSYCHIAT CLIN N AM, V29, P487, DOI 10.1016/j.psc.2006.02.009; Zanarini MC, 2003, AM J PSYCHIAT, V160, P274, DOI 10.1176/appi.ajp.160.2.274	74	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183806	10.1371/journal.pone.0183806	http://dx.doi.org/10.1371/journal.pone.0183806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902896	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200019
J	Sbracia, M; McKinnon, B; Scarpellini, F; Marconi, D; Rossi, G; Simmilion, C; Mueller, MD; Barnea, ER; Mueller, M				Sbracia, Marco; McKinnon, Brett; Scarpellini, Fabio; Marconi, Daniela; Rossi, Gabriele; Simmilion, Cedric; Mueller, Michael D.; Barnea, Eytan R.; Mueller, Martin			PreImplantation Factor in endometriosis: A potential role in inducing immune privilege for ectopic endometrium	PLOS ONE			English	Article							REGULATORY T-CELLS; ACTIVATING PEPTIDE-78 ENA-78; STROMAL CELLS; TNF-ALPHA; EPITHELIAL-CELLS; PATHOGENESIS; RECEPTOR; NEUROPROTECTION; CIRCULATION; SURVIVAL	Endometriosis is a chronic inflammatory condition characterised by the growth of endometrial epithelial and stromal cells outside the uterine cavity. In addition to Sampson's theory of retrograde menstruation, endometriosis pathogenesis is facilitated by a privileged inflammatory microenvironment, with T regulatory FoxP3(+) expressing T cells (Tregs) being a significant factor. PreImplantation Factor (PIF) is a peptide essential for pregnancy recognition and development. An immune modulatory function of the synthetic PIF analog (sPIF) has been successfully confirmed in multiple animal models. We report that PIF is expressed in the epithelial ectopic cells in close proximity to FoxP3(+) stromal cells. We provide evidence that PIF interacts with FoxP3(+) cells and modulates cell viability, dependent on cell source and presence of inflammatory mediators. Our finding represent a novel PIF-based mechanism in endometriosis that has potential for novel therapeutics.	[Sbracia, Marco; Scarpellini, Fabio] Hungaria Ctr Endocrinol & Reprod Med, Rome, Italy; [McKinnon, Brett; Simmilion, Cedric; Mueller, Michael D.; Mueller, Martin] Univ Bern, Dept Clin Res, Bern, Switzerland; [Marconi, Daniela; Rossi, Gabriele] Univ Roma Tor Vergata, Dept Obstet & Gynecol, Rome, Italy; [Mueller, Michael D.; Mueller, Martin] Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland; [Barnea, Eytan R.] SIEP, Cherry Hill, NJ 08003 USA; [Barnea, Eytan R.] BioIncept LLC, Dept Res & Dev, Cherry Hill, NJ 08003 USA; [Mueller, Martin] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	University of Bern; University of Rome Tor Vergata; University of Bern; University Hospital of Bern; Yale University	Mueller, M (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.; Mueller, M (corresponding author), Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland.; Barnea, ER (corresponding author), SIEP, Cherry Hill, NJ 08003 USA.; Barnea, ER (corresponding author), BioIncept LLC, Dept Res & Dev, Cherry Hill, NJ 08003 USA.; Mueller, M (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	eytan.barnea@bioincept.com; martin.mueller@insel.ch	Barnea, Eytan/AAC-9910-2021; Barnea, Eytan/AAK-9467-2021; Mueller, Martin/J-9682-2019; McKinnon, Brett/I-5125-2013	Barnea, Eytan/0000-0003-4677-4370; Mueller, Martin/0000-0001-5594-0532; McKinnon, Brett/0000-0002-9881-1252	Biolncept	Biolncept	Dr. Eytan R. Barnea is the (uncompensated) Chief Scientist for Biolncept, LLC. Martin Mueller received an unrestricted grant from Biolncept. This grant aims to prepare PIF clinical trial in the field of neonatal brain injuries. Biolncept, LLC did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the authors is articulated in the 'author contributions' section.	Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2015, PHARMACOL THERAPEUT, V156, P10, DOI 10.1016/j.pharmthera.2015.10.008; Barnea ER, 2016, IMMUNOBIOLOGY, V221, P778, DOI 10.1016/j.imbio.2016.02.004; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Barnea ER, 2012, AM J OBSTET GYNECOL, V206, pS36, DOI 10.1016/j.ajog.2011.10.083; Berbic M, 2011, J REPROD IMMUNOL, V88, P149, DOI 10.1016/j.jri.2010.11.004; Berbic M, 2010, HUM REPROD, V25, P900, DOI 10.1093/humrep/deq020; Bergmann C, 2011, EUR J IMMUNOL, V41, P3564, DOI 10.1002/eji.201141532; Bersinger NA, 2008, FERTIL STERIL, V89, P1530, DOI 10.1016/j.fertnstert.2007.05.075; Bersinger NA, 2011, ARCH GYNECOL OBSTET, V283, P1291, DOI 10.1007/s00404-010-1520-3; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Budiu RA, 2009, DIS MODEL MECH, V2, P593, DOI 10.1242/dmm.002535; Canis M, 1997, FERTIL STERIL, V67, P817; Chen YC, 2016, THROMB HAEMOSTASIS, V115, P1010, DOI 10.1160/TH15-08-0640; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Di Simone N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180642; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Hornung D, 1997, J CLIN ENDOCR METAB, V82, P1621, DOI 10.1210/jc.82.5.1621; Kocbek V, 2016, MOL HUM REPROD, V22, P768, DOI 10.1093/molehr/gaw054; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Li MQ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.414; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McKinnon B, 2012, FERTIL STERIL, V97, P373, DOI 10.1016/j.fertnstert.2011.11.011; McKinnon BD, 2015, TRENDS ENDOCRIN MET, V26, P1, DOI 10.1016/j.tem.2014.10.003; McKinnon BD, 2013, J CLIN ENDOCR METAB, V98, P2469, DOI 10.1210/jc.2013-1019; Migliara G, 2017, ONCOTARGET, V8, P21834, DOI 10.18632/oncotarget.15662; Moindjie H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119156; Mueller M, 2015, CELL DEATH DIFFER, V22, P2078, DOI 10.1038/cdd.2015.55; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Nakahashi-Oda C, 2016, NAT IMMUNOL, V17, P441, DOI 10.1038/ni.3345; Olkowska-Truchanowicz J, 2013, HUM REPROD, V28, P119, DOI 10.1093/humrep/des346; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sampson JA, 1927, AM J PATHOL, V3, P93; Santi A, 2011, FERTIL STERIL, V96, P663, DOI 10.1016/j.fertnstert.2011.06.039; Sbracia M, 2016, REPROD SCI, V23, P81, DOI 10.1177/1933719115594019; Shainer R, 2016, ONCOTARGET; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Tagashira Y, 2009, FERTIL STERIL, V91, P2185, DOI 10.1016/j.fertnstert.2008.04.052; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Wang W, 2012, INT J CANCER, V131, pE928, DOI 10.1002/ijc.27613; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5	53	8	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184399	10.1371/journal.pone.0184399	http://dx.doi.org/10.1371/journal.pone.0184399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902871	gold, Green Submitted, Green Published			2022-12-26	WOS:000410669200035
J	Wijeratne, PA; Hipwell, JH; Hawkes, DJ; Stylianopoulos, T; Vavourakis, V				Wijeratne, Peter A.; Hipwell, John H.; Hawkes, David J.; Stylianopoulos, Triantafyllos; Vavourakis, Vasileios			Multiscale biphasic modelling of peritumoural collagen microstructure: The effect of tumour growth on permeability and fluid flow	PLOS ONE			English	Article							SOLID STRESS; VASCULAR NORMALIZATION; MECHANICAL-BEHAVIOR; CANCER MODEL; PRESSURE; INVASION; MURINE; ARRAYS; DRUG	We present an in-silico model of avascular poroelastic tumour growth coupled with a multi-scale biphasic description of the tumour-host environment. The model is specified to in-vitro data, facilitating biophysically realistic simulations of tumour spheroid growth into a dense collagen hydrogel. We use the model to first confirm that passive mechanical remodelling of collagen fibres at the tumour boundary is driven by solid stress, and not fluid pressure. The model is then used to demonstrate the influence of collagen microstructure on peritumoural permeability and interstitial fluid flow. Our model suggests that at the tumour periphery, remodelling causes the peritumoural stroma to become more permeable in the circumferential than radial direction, and the interstitial fluid velocity is found to be dependent on initial collagen alignment. Finally we show that solid stresses are negatively correlated with peritumoural permeability, and positively correlated with interstitial fluid velocity. These results point to a heterogeneous, microstructure-dependent force environment at the tumour-peritumoural stroma interface.	[Wijeratne, Peter A.] UCL, Dept Comp Sci, London, England; [Hipwell, John H.; Hawkes, David J.; Vavourakis, Vasileios] UCL, Dept Med Phys & Biomed Engn, London, England; [Stylianopoulos, Triantafyllos] Univ Cyprus, Dept Mech & Mfg Engn, Nicosia, Cyprus	University of London; University College London; University of London; University College London; University of Cyprus	Wijeratne, PA (corresponding author), UCL, Dept Comp Sci, London, England.	p.wijeratne@ucl.ac.uk	Stylianopoulos, Triantafyllos/AGF-9544-2022	Stylianopoulos, Triantafyllos/0000-0002-3093-1696; Vavourakis, Vasileios/0000-0002-4102-2084; Wijeratne, Peter/0000-0002-4885-6241	EPSRC [EP/K020439/1]; EU [601040]; Marie-Curie Fellowship [627025]; European Research Council [336839]; Engineering and Physical Sciences Research Council [EP/K020439/1, EP/H046410/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10143] Funding Source: researchfish; EPSRC [EP/H046410/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); Marie-Curie Fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	PAW, JHH, DJH received funding from EPSRC grant "MIMIC": EP/K020439/1 and EU FP7 Virtual Physiological Human grant: "VPH-PRISM" (FP7-ICT-2011-9, 601040). W received funding from Marie-Curie Fellowship (FP7-PEOPLE-2013-IEF, 627025). TS received funding from the European Research Council (FP7/2007-2013)/ERC Grant No. 336839-ReEngineeringCancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EDGARD S., 1997, Comput Methods Biomech Biomed Engin, V1, P25, DOI 10.1080/01495739708936693; Balay S, 1997, MODERN SOFTWARE TOOLS FOR SCIENTIFIC COMPUTING, P163; Baldock AL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00062; Bathe K.-J., 2006, FINITE ELEMENT PROCE; BOUCHER Y, 1990, CANCER RES, V50, P4478; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chandran PL, 2008, MULTISCALE MODEL SIM, V7, P22, DOI 10.1137/070689504; Charoen KM, 2014, BIOMATERIALS, V35, P2264, DOI 10.1016/j.biomaterials.2013.11.038; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; Detournay E, 1993, FUNDAMENTALS POROELA, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; DRUMMOND JE, 1984, INT J MULTIPHAS FLOW, V10, P515, DOI 10.1016/0301-9322(84)90079-X; Frieboes HB, 2011, CANCER RES, V71, P298, DOI 10.1158/0008-5472.CAN-10-2676; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Girard YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075345; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hori M, 1999, MECH MATER, V31, P667, DOI 10.1016/S0167-6636(99)00020-4; Jackson TL, 2002, MATH BIOSCI, V180, P307; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Kam Y, 2012, J CELL PHYSIOL, V227, P431, DOI 10.1002/jcp.22766; Kirk BS, 2006, ENG COMPUT-GERMANY, V22, P237, DOI 10.1007/s00366-006-0049-3; Leu AJ, 2000, CANCER RES, V60, P4324; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mohamed A, 2005, LECT NOTES COMPUT SC, V3749, P400; Mpekris F, 2015, BIOMECH MODEL MECHAN; Netti PA, 2000, CANCER RES, V60, P2497; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ricketts KPM, 2014, SMALL, V10, P3954, DOI 10.1002/smll.201400194; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; SANGANI AS, 1982, INT J MULTIPHAS FLOW, V8, P193, DOI 10.1016/0301-9322(82)90029-5; Sciume G, 2013, ARCH COMPUT METHOD E, V20, P327, DOI 10.1007/s11831-013-9090-8; Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387; Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Stylianopoulos T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3021477; Sugii Y, 2005, MEAS SCI TECHNOL, V16, P1126, DOI 10.1088/0957-0233/16/5/011; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vavourakis V, 2017, PLOS COMPUTATIONAL B; Voutouri C, 2014, PLOS ONE, P9; Wijeratne PA, 2016, BIOMECH MODEL MECHAN, V15, P1079, DOI 10.1007/s10237-015-0745-2; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Xu J, 2016, PLOS ONE, V11; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	46	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184511	10.1371/journal.pone.0184511	http://dx.doi.org/10.1371/journal.pone.0184511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902902	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200041
J	Hajjar, R; Bassatne, A; Cheaito, MA; El Dine, RN; Traboulsy, S; Haddadin, F; Honein-AbouHaidar, G; Aki, EA				Hajjar, Rima; Bassatne, Aya; Cheaito, Mohamad Ali; El Dine, Rabie Naser; Traboulsy, Sarah; Haddadin, Fadi; Honein-AbouHaidar, Gladys; Aki, Elie A.			Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study	PLOS ONE			English	Article							DRUG PROMOTION; PAYMENTS; HEALTH; SALES	Background Studies around the world have shown that interactions between pharmaceutical companies, pharmacists and physicians have a great influence on prescribing and drug dispensing practices. In middle-income countries, the nature and extent of these interactions have not been well researched. Our objectives were to qualitatively explore the nature of the interactions between pharmaceutical companies, physicians and pharmacists, their impact on drug prescription and dispensing practices in Lebanon. Methods and findings We used grounded theory approach as well as the known sponsor, purposive, and snowballing sampling strategies to identify interviewees from the three respective groups: physicians, pharmacists, and pharmaceutical representatives. We conducted semi-structured and analyzed transcripts thematically. This study encompassed 6 pharmaceutical representatives, 13 physicians and 13 pharmacists. The following themes emerged: purpose and driver for the interactions, nature of the interactions, incentives, impact on prescription practices, ethical considerations, and suggestions for managing the interactions. The main purposes for the interaction were educational, promotional, and monitoring prescription practices and dispensing, while the main drivers for these interactions were market potential and neighborhood socio-economic status. Physicians, pharmacists and pharmaceutical representatives who engage in these interactions benefit from a variety of incentives, some of which were characterized as unethical. It appears that pharmaceutical companies give prominence to selected physicians within their communities. Although members of the three interviewed groups refer to some of the interactions as being problematic, they described a culture of acceptance of gift giving. We developed a framework that depicts the prevailing politico-cultural environment, the interactions between the three professional groups, and their impact on drug prescription. Underreporting is the main limitation of this study. Conclusion Interactions between physicians, pharmacists and pharmaceutical representatives are frequent. Although these interactions can be beneficial, they still have a substantial effect on drug prescription and dispensing practices. Hence, the need for new policies that regulate these interactions and penalize any misconduct.	[Hajjar, Rima; Bassatne, Aya; Cheaito, Mohamad Ali; El Dine, Rabie Naser; Traboulsy, Sarah; Haddadin, Fadi; Aki, Elie A.] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Honein-AbouHaidar, Gladys] Amer Univ Beirut, Hariri Sch Med, Beirut, Lebanon	American University of Beirut; American University of Beirut	Aki, EA (corresponding author), Amer Univ Beirut, Fac Med, Beirut, Lebanon.	ea32@aub.edu.lb	Akl, Elie/K-5269-2019; Honein-AbouHaidar, Gladys N./M-4308-2013; Akl, Elie A./R-2079-2016	Honein-AbouHaidar, Gladys N./0000-0001-6208-7859; Cheaito, Mohamad Ali/0000-0001-6653-8848; Traboulsy, Sarah/0000-0001-6876-1066; Akl, Elie A./0000-0002-3444-8618				Agrawal S, 2016, NEW ENGL J MED, V374, P906, DOI 10.1056/NEJMp1509103; Alssageer MA, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.132.2598; Blominvest Bank, 2016, PHARM HEALTHC LEB NU; Brax H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175493; Buchman S, 2012, CAN FAM PHYSICIAN, V58, P229; DeAngelis CD, 2014, MILBANK Q, V92, P195, DOI 10.1111/1468-0009.12052; El-Jardali F, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0556-1; Francer J, 2014, PHILOS ETHICS HUM ME, V9, DOI 10.1186/1747-5341-9-7; Fugh-Berman A, 2008, J GEN INTERN MED, V23, P1277, DOI 10.1007/s11606-008-0630-0; Ghaith A., 2013, EUR J SOCIAL SCI, V36, P528; Goodley S., 2014, GUARDIAN; Grouse L, 2014, J THORAC DIS, V6, P558, DOI 10.3978/j.issn.2072-1439.2014.01.25; Kamal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140457; Lai Taavi, 2013, HLTH SYSTEMS TRANSIT, V15; Lakoff A, 2004, SOC STUD SCI, V34, P247, DOI 10.1177/0306312704042624; Lotfi T, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1299-4; Mello MM, 2011, NEW ENGL J MED, V365, P1248, DOI 10.1056/NEJMhle1107678; Mikhael E., 2014, PHARM PHARMACOL-RUSS, V5, P705, DOI [10.4236/pp.2014.57080, DOI 10.4236/PP.2014.57080]; Ministry of Public Health, 2016, COD ETH MED PROD PRO; Oldani MJ, 2004, MED ANTHROPOL Q, V18, P325, DOI 10.1525/maq.2004.18.3.325; Pham-Kanter G, 2017, J GEN INTERN MED, V32, P767, DOI 10.1007/s11606-017-4012-3; Publishing O, 2013, HLTH GLANC 2013; Rothman DJ, 2014, MILBANK Q, V92, P471, DOI 10.1111/1468-0009.12074; Strauss A., 1998, BASICS QUALITATIVE R; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Zaki NM, 2014, SAUDI PHARM J, V22, P528, DOI 10.1016/j.jsps.2014.02.008	26	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184662	10.1371/journal.pone.0184662	http://dx.doi.org/10.1371/journal.pone.0184662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG6AR	28898296	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500041
J	Sulli, M; Mandolino, G; Sturaro, M; Onofri, C; Diretto, G; Parisi, B; Giuliano, G				Sulli, Maria; Mandolino, Giuseppe; Sturaro, Monica; Onofri, Chiara; Diretto, Gianfranco; Parisi, Bruno; Giuliano, Giovanni			Molecular and biochemical characterization of a potato collection with contrasting tuber carotenoid content	PLOS ONE			English	Article							TOMATO FRUIT; XANTHOPHYLL ESTERIFICATION; ACCUMULATION; STORAGE; L.; BIOSYNTHESIS; CULTIVARS; REVEALS; SUBERIN; PLANTS	After wheat and rice, potato is the third most important staple food worldwide. A collection of ten tetraploid )Solanum tuberosum) and diploid )S. phureja and S. chacoense) genotypes with contrasting carotenoid content was subjected to molecular characterization with respect to candidate carotenoid loci and metabolic profiling using LC-HRMS. Irrespective of ploidy and taxonomy, tubers of these genotypes fell into three groups: yellow-fleshed, characterized by high levels of epoxy-xanthophylls and xanthophyll esters and by the presence of at least one copy of a dominant allele of the beta-Carotene Hydroxylase 2 )CHY2) gene; white-fleshed, characterized by low carotenoid levels and by the presence of recessive chy2 alleles; and orange-fleshed, characterized by high levels of zeaxanthin but low levels of xanthophyll esters, and homozygosity for a Zeaxanthin Epoxidase )ZEP) recessive allele. Novel CHY2 and ZEP alleles were identified in the collection. Multivariate analysis identified several groups of co-regulated non-polar compounds, and resulted in the grouping of the genotypes according to flesh color, suggesting that extensive cross-talk exists between the carotenoid pathway and other metabolite pathways in tubers. Postharvest traits like tuber dormancy and weight loss during storage showed little correlation with tuber carotenoid content, with the exception of zeaxanthin and its esters. Other tuber metabolites, such as glucose, monogalactosyldiacyglycerol )a glycolipid), or suberin precursors, showed instead significant correlations with both traits.	[Sulli, Maria; Diretto, Gianfranco; Giuliano, Giovanni] ENEA, Casaccia Res Ctr, Via Anguillarese 301, Rome, Italy; [Sulli, Maria] Scuola Super Sant Anna, Piazza Martin della Liberta 33, Pisa, Italy; [Mandolino, Giuseppe; Onofri, Chiara; Parisi, Bruno] CREA Ctr Cerealicoltura & Colture Ind, Sede Bologna, Via Corticella 133, Bologna, Italy; [Sturaro, Monica] CREA Ctr Cerealicoltura & Colture Ind, Sede Bergamo, Via Stezzano 24, Bergamo, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Scuola Superiore Sant'Anna	Giuliano, G (corresponding author), ENEA, Casaccia Res Ctr, Via Anguillarese 301, Rome, Italy.	giovanni.giuliano@enea.it	Diretto, Gianfranco/L-9279-2017; Mandolino, Giuseppe/H-7915-2019; Giuliano, Giovanni/A-2701-2012	Diretto, Gianfranco/0000-0002-1441-0233; Mandolino, Giuseppe/0000-0003-1956-7392; Giuliano, Giovanni/0000-0002-2486-0510; Sulli, Maria/0000-0002-6875-2546	Italian Ministry of Agriculture (ALISAL project); Italian Ministry of Agriculture (NUTRISOL project); European Commission (G2P-SOL project) [677379]; Scuola Superiore San-t'Anna (Pisa)	Italian Ministry of Agriculture (ALISAL project); Italian Ministry of Agriculture (NUTRISOL project); European Commission (G2P-SOL project); Scuola Superiore San-t'Anna (Pisa)	This work was supported by the Italian Ministry of Agriculture (ALISAL and NUTRISOL projects), the European Commission (G2P-SOL project, contract n. 677379) and benefited from the networking activities within the European Cooperation in Science and Technology Action CM 5136 (EUROCAROTEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Italian Ministry of Agriculture (ALISAL and NUTRISOL projects), the European Commission (G2P-SOL project, contract n. 677379) and benefited from the networking activities within the European Cooperation in Science and Technology Action CA15136 (EUROCAROTEN). Maria Sulli acknowledges the Scuola Superiore San-t'Anna (Pisa) for a doctoral fellowship and Prof. Enrico Pe for supervision of her thesis work.	Alboresi  A., 2016, PLANT PHYSIOL; Ariizumi T, 2014, PLANT J, V79, P453, DOI 10.1111/tpj.12570; Aversano R, 2017, PHYTOCHEMISTRY, V137, P42, DOI 10.1016/j.phytochem.2017.02.011; Bernards MA, 2001, PHYTOCHEMISTRY, V57, P1115, DOI 10.1016/S0031-9422(01)00046-2; Biemelt S, 2000, POTATO RES, V43, P371, DOI 10.1007/BF02360541; Breithaupt DE, 2002, J AGR FOOD CHEM, V50, P7175, DOI 10.1021/jf0257953; Brown CR, 2006, AM J POTATO RES, V83, P365, DOI 10.1007/BF02872013; BROWN CR, 1993, J AM SOC HORTIC SCI, V118, P145, DOI 10.21273/JASHS.118.1.145; Burgos G, 2009, J FOOD COMPOS ANAL, V22, P503, DOI 10.1016/j.jfca.2008.08.008; Campbell R, 2014, THEOR APPL GENET, V127, P1917, DOI 10.1007/s00122-014-2349-0; Carputo D, 2005, ANN APPL BIOL, V146, P71, DOI 10.1111/j.1744-7348.2005.04070.x; D'Esposito D, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1008-4; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; Fasano C, 2016, NEW PHYTOLOGIST; Fernandez-Orozco R, 2013, FOOD CHEM, V141, P2864, DOI 10.1016/j.foodchem.2013.05.016; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; Fiore A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-50; Ghislain M, 2006, THEOR APPL GENET, V113, P1515, DOI 10.1007/s00122-006-0399-7; Giuliano G, 2008, TRENDS BIOTECHNOL, V26, P139, DOI 10.1016/j.tibtech.2007.12.003; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Giuliano G, 2014, CURR OPIN PLANT BIOL, V19, P111, DOI 10.1016/j.pbi.2014.05.006; Gomez-Gomez L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010076; Graca J, 2010, PHYTOCHEM REV, V9, P85, DOI 10.1007/s11101-009-9138-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kloosterman B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-158; Liu MC, 2014, NEW PHYTOL, V203, P206, DOI 10.1111/nph.12771; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Maalekuu K, 2006, POSTHARVEST BIOL TEC, V42, P248, DOI 10.1016/j.postharvbio.2006.06.012; Morris WL, 2004, J EXP BOT, V55, P975, DOI 10.1093/jxb/erh121; Nesterenko S, 2003, HORTSCIENCE, V38, P1173, DOI 10.21273/HORTSCI.38.6.1173; Norkus EP, 2010, J AM COLL NUTR, V29, P575, DOI 10.1080/07315724.2010.10719896; Rodriguez-Amaya D.B., 2001, GUIDE CAROTENOID ANA; Romer S, 2002, METAB ENG, V4, P263, DOI 10.1006/mben.2002.0234; Schweiggert U, 2007, EUR FOOD RES TECHNOL, V225, P261, DOI 10.1007/s00217-006-0413-y; Sonnewald U, 2001, TRENDS PLANT SCI, V6, P333, DOI 10.1016/S1360-1385(01)02020-9; Spooner DM, 2010, AM J BOT, V97, P2049, DOI 10.3732/ajb.1000277; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0495-4; Suttle JC, 2004, AM J POTATO RES, V81, P253, DOI 10.1007/BF02871767; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Vreugdenhil D., 2007, Potato Research, V50, P371, DOI 10.1007/s11540-008-9068-3; Wolters AMA, 2010, PLANT MOL BIOL, V73, P659, DOI 10.1007/s11103-010-9647-y	47	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184143	10.1371/journal.pone.0184143	http://dx.doi.org/10.1371/journal.pone.0184143			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898255	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500014
J	Petoumenos, K; Huang, R; Hoy, J; Bloch, M; Templeton, DJ; Baker, D; Giles, M; Law, MG; Cooper, DA				Petoumenos, Kathy; Huang, Robin; Hoy, Jennifer; Bloch, Mark; Templeton, David J.; Baker, David; Giles, Michelle; Law, Matthew G.; Cooper, David A.			Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MINERAL DENSITY; CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; LIFE EXPECTANCY; MYOCARDIAL-INFARCTION; POPULATION-IMPACT	In Australia, almost half of HIV-positive people are now aged over 50 and are predominately gay and bisexual men (GBM). Compared to the general HIV-negative population, GBM engage more in behaviours that may increase the risk of age-related comorbidities, including smoking, high alcohol consumption and recreational drug use. The objective of APPLES was to compare comorbidities and risk factors in HIV-positive older GBM with an appropriate control group of HIV-negative GBM. We undertook a prospectively recruited cross-sectional sample of HIV-positive and HIV-negative GBM >= 55 years. Detailed data collection included clinic data, a health and lifestyle survey, and blood sample collection. We report key demographic, laboratory markers and self-reported comorbidities by HIV status. For selected comorbidities we also adjust HIV status a priori for age, smoking and body mass index. Over 16 months 228 HIV-positive and 218 HIV-negative men were recruited. Median age was 63 years (IQR: 59-67). Although more HIV-positive men reported having ever smoked, smoking status was not statistically different between HIV positive and HIV negative men (p = 0.081). Greater alcohol use was reported by HIV-negative men (p = 0.002), and recreational drug use reported more often by HIV-positive men (p<0.001). After adjustment, HIV-positive men had significantly increased odds of diabetes (adjusted Odds ratio (aOR): 1.97, p = 0.038), thrombosis (aOR: 3.08, p = 0.007), neuropathy (aOR: 34.6, P<0.001), and non-significantly increased odds for heart-disease (aOR: 1.71, p = 0.077). In conclusion, HIV-positive GBM have significantly increased odds for key self-reported comorbidities. This study underscores the importance of an appropriate HIV-negative control group for more accurate evaluation of the risk and attribution of age-related comorbidities in HIV-positive people.	[Petoumenos, Kathy; Huang, Robin; Bloch, Mark; Templeton, David J.; Law, Matthew G.; Cooper, David A.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Hoy, Jennifer] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Hoy, Jennifer] Monash Univ, Melbourne, Vic, Australia; [Bloch, Mark] Holdsworth House Med Practice, Darlinghurst, NSW, Australia; [Templeton, David J.] Univ Sydney, Sydney Local Hlth Dist & Cent Clin Sch, RPA Sexual Hlth, Camperdown, NSW, Australia; [Baker, David] East Sydney Doctors, Darlinghurst, NSW, Australia; [Giles, Michelle] Monash Hlth, Dept Infect Dis, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Sydney	Petoumenos, K (corresponding author), UNSW Sydney, Kirby Inst, Sydney, NSW, Australia.	kpetoumenos@kirby.unsw.edu.au	Hoy, Jennifer/AAK-7968-2020	Giles, Michelle/0000-0003-3007-1822; Law, Matthew/0000-0002-3540-8837; Petoumenos, Kathy/0000-0001-7534-7154; Hoy, Jennifer/0000-0002-6948-7086; Templeton, David/0000-0003-2157-9587	Gilead Sciences Australia	Gilead Sciences Australia(Gilead Sciences)	This study was funded by an unrestricted research grant by Gilead Sciences Australia. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Australian HIV Observational Database, 2002, HIV Med, V3, P28; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Correll PK, 1998, MED J AUSTRALIA, V169, P469, DOI 10.5694/j.1326-5377.1998.tb123370.x; De Francesco D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1970-8; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Glass TR, 2006, HIV MED, V7, P404, DOI 10.1111/j.1468-1293.2006.00400.x; Grierson J, 2004, MONOGRAPH SERIES, V48; Grierson J, 2009, MONOGRAPH SERIES, V74; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gueler A, 2017, AIDS, V31, P427, DOI 10.1097/QAD.0000000000001335; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kooij KW, 2015, J INFECT DIS, V211, P539, DOI 10.1093/infdis/jiu499; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Law MG, 2000, AIDS, V14, P197, DOI 10.1097/00002030-200001280-00016; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V71, P413, DOI 10.1097/QAI.0000000000000881; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Moore AL, 2001, AIDS, V15, P1731, DOI 10.1097/00002030-200109070-00019; Murray JM, 2009, SEX HEALTH, V6, P83, DOI 10.1071/SH08063; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petoumenos K, 2016, CURR OPIN HIV AIDS, V11, P514, DOI 10.1097/COH.0000000000000306; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Prestage G, 2009, J SEX MED, V6, P2311, DOI 10.1111/j.1743-6109.2009.01323.x; Rasmussen L, 2015, LANCET HIV; Rose H, 2006, METABOLISM, V55, P90, DOI 10.1016/j.metabol.2005.07.012; Schouten J, 2012, 19 INT AIDS C JUL 22; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Smith CJ, 2004, HIV MED, V5, P88, DOI 10.1111/j.1468-1293.2004.00191.x; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Teeraananchai S, 2017, HIV MED, V18, P256, DOI 10.1111/hiv.12421; Templeton DJ, 2014, SEX HEALTH, V11, P217, DOI 10.1071/SH14003; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Trickey A, LANCET HIV; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	52	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184583	10.1371/journal.pone.0184583	http://dx.doi.org/10.1371/journal.pone.0184583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886173	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100163
J	Raedle-Hurst, T; Mueller, M; Meinitzer, A; Maerz, W; Dschietzig, T				Raedle-Hurst, Tanja; Mueller, Marieke; Meinitzer, Andreas; Maerz, Winfried; Dschietzig, Thomas			Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; NITRIC-OXIDE; ARGININE; DIMETHYLARGININE; DYSFUNCTION; EXPRESSION; BIOMARKERS; MORTALITY; ARGINASE; SYNTHASE	Background Homoarginine (hArg) has been shown to be of prognostic value in patients with chronic left heart failure. The present study aims to assess the clinical utility and prognostic value of hArg levels in patients with complex congenital heart disease (CHD). Methods Plasma hArg levels were measured in 143 patients with complex CHD and compared to clinical status, echocardiographic and laboratory parameters as well as the occurrence of adverse cardiac events. Results Median hArg levels were 1.5 mu mol/l in CHD patients as compared to 1.70 mu mol/l in healthy controls (p = 0.051). Median hArg levels were lowest in patients with Fontan palliation (1.27 mu mol/l) and Eisenmenger physiology (0.99 mu mol/l) and decreased with the severity of adverse cardiac events with lowest values found in patients prior to death or overt heart failure (0.89 mu mol/l). According to ROC analysis, the most important predictors of adverse cardiac events were hArg levels (AUC 0.837, p< 0.001, CI 0.726-0.947), NYHA class (AUC 0.800, p< 0.001, CI 0.672-0.928) and NT-proBNP levels (AUC 0.780, p< 0.001, CI 0.669-0.891). The occurrence of overt heart failure or death due to progressive heart failure were best predicted by NYHA class (AUC 0.945, p< 0.001, CI 0.898-0.992), hArg levels (AUC 0.911, p< 0.001, CI 0.850-0.971) and NT-proBNP levels (AUC 0.877, p< 0.001, CI 0.791-0.962), respectively. Conclusion In patients with complex CHD, hArg levels can predict adverse cardiac events as reliably as or even better than NT-proBNP levels and thus might be of prognostic value in this subset of patients.	[Raedle-Hurst, Tanja; Mueller, Marieke] Saarland Univ, Med Ctr, Dept Pediat Cardiol, Homburg, Germany; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Heidelberg Univ, Med Clin Nephrol Hypertensiol Rheumatol Endocrino, Med Fac Mannheim, Mannheim, Germany; [Maerz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Augsburg, Germany; [Dschietzig, Thomas] Charite, Med Clin Cardiol & Angiol, Campus Mitte, Berlin, Germany; [Dschietzig, Thomas] Immundiagnost GmbH, Bensheim, Germany	Universitatsklinikum des Saarlandes; Medical University of Graz; Ruprecht Karls University Heidelberg; SYNLAB Group; SYNLAB Group; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Raedle-Hurst, T (corresponding author), Saarland Univ, Med Ctr, Dept Pediat Cardiol, Homburg, Germany.	tanja.raedle-hurst@uks.eu		Dschietzig, Thomas Bernd/0000-0003-1186-8713				Alonso-Gonzalez R, 2013, EXPERT REV CARDIOVAS, V11, P773, DOI [10.1586/ERC.13.14, 10.1586/erc.13.14]; Alsaied T, 2015, HEART, V101, P1731, DOI 10.1136/heartjnl-2015-307930; Atzler D, 2015, CURR OPIN CLIN NUTR, V18, P83, DOI 10.1097/MCO.0000000000000123; Atzler D, 2013, INT J CARDIOL, V168, P4907, DOI 10.1016/j.ijcard.2013.07.099; Cullen ME, 2006, CIRCULATION, V114, pI16, DOI 10.1161/CIRCULATIONAHA.105.000448; Drechsler C, 2011, EUR J HEART FAIL, V13, P852, DOI 10.1093/eurjhf/hfr056; Giannakoulas G, 2015, HEART, V101, P1523, DOI 10.1136/heartjnl-2015-308045; Giannakoulas G, 2010, AM J CARDIOL, V105, P869, DOI 10.1016/j.amjcard.2009.11.041; Henaine R, 2013, J THORAC CARDIOV SUR, V146, P522, DOI 10.1016/j.jtcvs.2012.11.031; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; HRABAK A, 1994, BIOCHEM BIOPH RES CO, V198, P206, DOI 10.1006/bbrc.1994.1029; Huynh NN, 2006, CLIN EXP PHARMACOL P, V33, P1, DOI 10.1111/j.1440-1681.2006.04316.x; Khambadkone S, 2003, CIRCULATION, V107, P3204, DOI 10.1161/01.CIR.0000074210.49434.40; Levy M, 2003, J THORAC CARDIOV SUR, V125, P1083, DOI 10.1067/mtc.2003.193; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Nir A, 2012, BIOMARK MED, V6, P827, DOI [10.2217/BMM.12.73, 10.2217/bmm.12.73]; Oechslin E, 2005, CIRCULATION, V112, P1106, DOI 10.1161/CIRCULATIONAHA.105.534073; Ohuchi H, 2004, CIRCULATION, V110, P2601, DOI 10.1161/01.CIR.0000145545.83564.51; Paulus WJ, 2004, AM J PHYSIOL-HEART C, V287, pH8, DOI 10.1152/ajpheart.01147.2003; Popelova JR, 2015, AM J CARDIOL, V116, P1425, DOI 10.1016/j.amjcard.2015.07.070; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; SHREENIWAS R, 1991, J CELL PHYSIOL, V146, P8, DOI 10.1002/jcp.1041460103; Tsutamoto T, 2006, J AM COLL CARDIOL, V47, P582, DOI 10.1016/j.jacc.2005.10.038; Tutarel O, 2013, INT J CARDIOL, V168, P4415, DOI 10.1016/j.ijcard.2013.05.030; Tutarel O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033795; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; WYATT HL, 1980, AM HEART J, V100, P821, DOI 10.1016/0002-8703(80)90062-9	30	5	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184333	10.1371/journal.pone.0184333	http://dx.doi.org/10.1371/journal.pone.0184333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886170	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100098
J	Shinde, MY; Sidoli, S; Kulej, K; Mallory, MJ; Radens, CM; Reicherter, AL; Myers, RL; Barash, Y; Lynch, KW; Garcia, BA; Klein, PS				Shinde, Mansi Y.; Sidoli, Simone; Kulej, Katarzyna; Mallory, Michael J.; Radens, Caleb M.; Reicherter, Amanda L.; Myers, Rebecca L.; Barash, Yoseph; Lynch, Kristen W.; Garcia, Benjamin A.; Klein, Peter S.			Phosphoproteomics reveals that glycogen synthase kinase-3 phosphorylates multiple splicing factors and is associated with alternative splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; embryonic stem cell; glycogen synthase kinase 3 (GSK-3); leukemia; phosphoproteomics; spliceosome; Wnt signaling; SILAC; lithium	POLYPOSIS-COLI APC; MULTISITE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; SUBSTRATE-SPECIFICITY; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; STRUCTURAL BASIS; GLOBAL ANALYSIS; C-JUN; CELL	Glycogen synthase kinase-3 (GSK-3) is a constitutively active, ubiquitously expressed protein kinase that regulates multiple signaling pathways. In vitro kinase assays and genetic and pharmacological manipulations of GSK-3 have identified more than 100 putative GSK-3 substrates in diverse cell types. Many more have been predicted on the basis of a recurrent GSK-3 consensus motif ((pS/pT)XXX(S/T)), but this prediction has not been tested by analyzing the GSK-3 phosphoproteome. Using stable isotope labeling of amino acids in culture (SILAC) and MS techniques to analyze the repertoire of GSK-3-dependent phosphorylation in mouse embryonic stem cells (ESCs), we found that approximate to 2.4% of (pS/pT)XXX(S/T) sites are phosphorylated in a GSK-3-dependent manner. A comparison of WT and Gsk3a;Gsk3b knock-out (Gsk3 DKO) ESCs revealed prominent GSK-3-dependent phosphorylation of multiple splicing factors and regulators of RNA biosynthesis as well as proteins that regulate transcription, translation, and cell division. Gsk3 DKO reduced phosphorylation of the splicing factors RBM8A, SRSF9, and PSF as well as the nucleolar proteins NPM1 and PHF6, and recombinant GSK-3 phosphorylated these proteins in vitro. RNA-Seq of WT and Gsk3 DKO ESCs identified approximate to 190 genes that are alternatively spliced in a GSK-3-dependent manner, supporting a broad role for GSK-3 in regulating alternative splicing. The MS data also identified posttranscriptional regulation of protein abundance by GSK-3, with approximate to 47 proteins (1.4%) whose levels increased and approximate to 78 (2.4%) whose levels decreased in the absence of GSK-3. This study provides the first unbiased analysis of the GSK-3 phosphoproteome and strong evidence that GSK-3 broadly regulates alternative splicing.	[Shinde, Mansi Y.; Myers, Rebecca L.; Klein, Peter S.] Univ Penn, Pharmacol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sidoli, Simone; Kulej, Katarzyna; Garcia, Benjamin A.] Univ Penn, Penn Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sidoli, Simone; Kulej, Katarzyna; Mallory, Michael J.; Lynch, Kristen W.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Radens, Caleb M.; Klein, Peter S.] Univ Penn, Cell & Mol Biol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reicherter, Amanda L.; Klein, Peter S.] Univ Penn, Dept Med Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barash, Yoseph] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, 9-103 SCTR,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	pklein@pennmedicine.upenn.edu	Sidoli, Simone/AAC-2196-2019	Sidoli, Simone/0000-0001-9073-6641	 [1290]; NATIONAL CANCER INSTITUTE [P01CA196539, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115517, T32GM008076, R01GM110174, R35GM118048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046544] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Bradley Doble and James Woodgett for generously providing the wild-type and DKO mESCs. We also thank Drs. Judy Meinkoth, Paul Gadue, and Ed Morrisey for helpful discussions. Data presented herein were obtained at the Genomics Division of the Iowa Institute of Human Genetics, which is supported, in part, by the University of Iowa Carver College of Medicine. RNA-Seq data were deposited in the Gene Expression Omnibus repository (GEO accession number GSE90921). MS raw files are available at https://chorusproject.org<SUP>3</SUP> at project number 1290.	Acebron SP, 2016, TRENDS CELL BIOL, V26, P956, DOI 10.1016/j.tcb.2016.07.009; Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Adamia S, 2014, CLIN CANCER RES, V20, P1135, DOI 10.1158/1078-0432.CCR-13-0956; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Box JK, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0073-9; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Chen XC, 2016, J BIOL CHEM, V291, P14761, DOI 10.1074/jbc.M116.722751; Cole BS, 2015, RNA, V21, P2053, DOI 10.1261/rna.052969.115; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crews LA, 2016, CELL STEM CELL, V19, P599, DOI 10.1016/j.stem.2016.08.003; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Guezguez B, 2016, CANCER CELL, V29, P61, DOI 10.1016/j.ccell.2015.11.012; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Huang YL, 2015, P NATL ACAD SCI USA, V112, P5732, DOI 10.1073/pnas.1423533112; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Inoue D, 2016, GENE DEV, V30, P989, DOI 10.1101/gad.278424.116; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Ishigaki Y, 2015, EXP BIOL MED, V240, P438, DOI 10.1177/1535370214556945; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Kinoshita E, 2005, J SEP SCI, V28, P155, DOI 10.1002/jssc.200401833; Koch S, 2015, CELL, V163, P1225, DOI 10.1016/j.cell.2015.10.029; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Martinez NM, 2015, GENE DEV, V29, P2054, DOI 10.1101/gad.267245.115; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Noh KT, 2011, EXP CELL RES, V317, P1663, DOI 10.1016/j.yexcr.2011.03.022; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; Saldi T, 2016, J MOL BIOL, V428, P2623, DOI 10.1016/j.jmb.2016.04.017; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schimizzi GV, 2015, CURR BIOL, V25, pR445, DOI 10.1016/j.cub.2015.02.034; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Thingholm TE, 2016, METHODS MOL BIOL, V1355, P135, DOI 10.1007/978-1-4939-3049-4_9; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Top D, 2016, CELL REP, V16, P357, DOI 10.1016/j.celrep.2016.06.005; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Valvezan AJ, 2014, DIS MODEL MECH, V7, P63, DOI 10.1242/dmm.012625; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Vaquero-Garcia J, 2016, ELIFE, V5, DOI 10.7554/eLife.11752; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZHANG WM, 1993, ARCH BIOCHEM BIOPHYS, V304, P219, DOI 10.1006/abbi.1993.1342	92	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18240	18255		10.1074/jbc.M117.813527	http://dx.doi.org/10.1074/jbc.M117.813527			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28916722	Green Published, hybrid			2022-12-26	WOS:000414458200021
J	Silvers, MA; Deja, S; Singh, N; Egnatchik, RA; Sudderth, J; Luo, XQ; Beg, MS; Burgess, SC; DeBerardinis, RJ; Boothman, DA; Merritt, ME				Silvers, Molly A.; Deja, Stanislaw; Singh, Naveen; Egnatchik, Robert A.; Sudderth, Jessica; Luo, Xiuquan; Beg, Muhammad S.; Burgess, Shawn C.; DeBerardinis, Ralph J.; Boothman, David A.; Merritt, Matthew E.			The NQO1 bioactivatable drug, -lapachone, alters the redox state of NQO1+pancreatic cancer cells, causing perturbation in central carbon metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anaerobic glycolysis; drug metabolism; energy metabolism; isotopic tracer; nicotinamide adenine dinucleotide (NAD); nuclear magnetic resonance (NMR); oxidation-reduction (redox); oxidative stress; pyruvate; pyruvate dehydrogenase complex (PDC)	OXIDOREDUCTASE(1) DT-DIAPHORASE; BETA-LAPACHONE; PANCREATIC-CANCER; MAGNETIC-RESONANCE; C-13 NMR; EXPRESSION; GROWTH; APOPTOSIS; BIOMARKER; EXCHANGE	Many cancer treatments, such as those for managing recalcitrant tumors like pancreatic ductal adenocarcinoma, cause off-target toxicities in normal, healthy tissue, highlighting the need for more tumor-selective chemotherapies. -Lapachone is bioactivated by NAD(P)H:quinone oxidoreductase 1 (NQO1). This enzyme exhibits elevated expression in most solid cancers and therefore is a potential cancer-specific target. -Lapachone's therapeutic efficacy partially stems from the drug's induction of a futile NQO1-mediated redox cycle that causes high levels of superoxide and then peroxide formation, which damages DNA and causes hyperactivation of poly(ADP-ribose) polymerase, resulting in extensive NAD(+)/ATP depletion. However, the effects of this drug on energy metabolism due to NAD(+) depletion were never described. The futile redox cycle rapidly consumes O-2, rendering standard assays of Krebs cycle turnover unusable. In this study, a multimodal analysis, including metabolic imaging using hyperpolarized pyruvate, points to reduced oxidative flux due to NAD(+) depletion after -lapachone treatment of NQO1+ human pancreatic cancer cells. NAD(+)-sensitive pathways, such as glycolysis, flux through lactate dehydrogenase, and the citric acid cycle (as inferred by flux through pyruvate dehydrogenase), were down-regulated by -lapachone treatment. Changes in flux through these pathways should generate biomarkers useful for in vivo dose responses of -lapachone treatment in humans, avoiding toxic side effects. Targeting the enzymes in these pathways for therapeutic treatment may have the potential to synergize with -lapachone treatment, creating unique NQO1-selective combinatorial therapies for specific cancers. These findings warrant future studies of intermediary metabolism in patients treated with -lapachone.	[Silvers, Molly A.; Singh, Naveen; Luo, Xiuquan; Boothman, David A.] Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Silvers, Molly A.; Singh, Naveen; Luo, Xiuquan; Boothman, David A.] Simmons Comprehens Canc Ctr, Dept Radiat Oncol, Dallas, TX 75390 USA; [Deja, Stanislaw; Burgess, Shawn C.] Simmons Comprehens Canc Ctr, Adv Imaging Res Ctr AIRC, Div Metab Mech Dis, Dallas, TX 75390 USA; [Egnatchik, Robert A.; Sudderth, Jessica; DeBerardinis, Ralph J.] Simmons Comprehens Canc Ctr, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Beg, Muhammad S.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Texas Southwestern Med Ctr Dallas, AIRC, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Florida	Boothman, DA (corresponding author), Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA.; Boothman, DA (corresponding author), Simmons Comprehens Canc Ctr, Dept Radiat Oncol, Dallas, TX 75390 USA.; Merritt, ME (corresponding author), Univ Texas Southwestern Med Ctr Dallas, AIRC, Dallas, TX 75390 USA.; Merritt, ME (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	David.Boothman@utsouthwestern.edu; matthewmerritt@ufl.edu	Boothman, David/Q-7776-2019; Deja, Stanislaw/AAI-7526-2020	Deja, Stanislaw/0000-0002-7714-2547; Singh, Naveen/0000-0003-3465-8591; Merritt, Matthew/0000-0003-4617-9651	Robert A. Welch Foundation [I-1804]; National Institutes of Health [P41 EB015908, R01DK078184, R01CA157996-06]; AACR/PanCan Rising Tide Grant [14-65-25-BOOT]; NCI, National Institutes of Health [R01CA102792-19, R01CA221158-01]; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087977, R01DK078184, U24DK097209, R01DK105346] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR/PanCan Rising Tide Grant; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Robert A. Welch Foundation Grant I-1804 and National Institutes of Health Grant P41 EB015908.; Supported by National Institutes of Health Grant R01DK078184.; Supported by National Institutes of Health Grant R01CA157996-06.; Supported by AACR/PanCan Rising Tide Grant 14-65-25-BOOT and NCI, National Institutes of Health, Grants R01CA102792-19 and R01CA221158-01. To whom correspondence may be addressed. E-mail: David.Boothman@utsouthwestern.edu.	Allison SJ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.16; Awadallah NS, 2008, APPL IMMUNOHISTO M M, V16, P24, DOI 10.1097/pai.0b013e31802e91d0; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Bey E. A., 2016, STRATEGIES ENHANCE T, P225; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Bey EA, 2013, MOL CANCER THER, V12, P2110, DOI 10.1158/1535-7163.MCT-12-0962; Cao LF, 2014, ANTIOXID REDOX SIGN, V21, P237, DOI 10.1089/ars.2013.5462; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakrabarti G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17066; Chakrabarti G, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0137-1; CRESTEIL T, 1991, BIOCHEM PHARMACOL, V42, P1021, DOI 10.1016/0006-2952(91)90284-C; Cunningham CH, 2016, CIRC RES, V119, P1177, DOI 10.1161/CIRCRESAHA.116.309769; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dong Y, 2010, CANCER RES, V70, P8088, DOI 10.1158/0008-5472.CAN-10-1418; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; Huang XM, 2016, CANCER CELL, V30, P940, DOI 10.1016/j.ccell.2016.11.006; Huang XM, 2012, CANCER RES, V72, P3038, DOI 10.1158/0008-5472.CAN-11-3135; JOSEPH P, 1994, ONCOL RES, V6, P525; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Keshari KR, 2013, CANCER RES, V73, P529, DOI 10.1158/0008-5472.CAN-12-3461; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Khemtong C, 2015, MAGN RESON MED, V74, P312, DOI 10.1002/mrm.25419; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Li LS, 2011, CLIN CANCER RES, V17, P275, DOI 10.1158/1078-0432.CCR-10-1983; Logsdon CD, 2003, CANCER RES, V63, P2649; Lumata L, 2015, METHOD ENZYMOL, V561, P73, DOI 10.1016/bs.mie.2015.04.006; Ma XP, 2015, J DRUG TARGET, V23, P672, DOI 10.3109/1061186X.2015.1073296; Ma XP, 2015, J CONTROL RELEASE, V200, P201, DOI 10.1016/j.jconrel.2014.12.027; Madajewski B, 2016, MOL CANCER RES, V14, P14, DOI 10.1158/1541-7786.MCR-15-0207-T; Moore Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.564; Murphy TA, 2013, BIOTECHNOL BIOENG, V110, P1748, DOI 10.1002/bit.24836; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Ough M, 2005, CANCER BIOL THER, V4, P95; Park JM, 2016, NMR BIOMED, V29, P650, DOI 10.1002/nbm.3509; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Planchon SM, 2001, EXP CELL RES, V267, P95, DOI 10.1006/excr.2001.5234; Purmal C, 2014, AM J PHYSIOL-HEART C, V307, pH1134, DOI 10.1152/ajpheart.00407.2014; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reinicke KE, 2005, CLIN CANCER RES, V11, P3055, DOI 10.1158/1078-0432.CCR-04-2185; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Ross D, 2004, METHOD ENZYMOL, V382, P115; Salamanca-Cardona L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0136-2; Serrao EM, 2016, GUT, V65, P465, DOI 10.1136/gutjnl-2015-310114; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sriram R, 2015, NMR BIOMED, V28, P1141, DOI 10.1002/nbm.3354; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegner A, 2014, ANAL CHEM, V86, P2221, DOI 10.1021/ac403879d; Wilson DM, 2010, J MAGN RESON, V205, P141, DOI 10.1016/j.jmr.2010.04.012; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637	60	50	52	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18203	18216		10.1074/jbc.M117.813923	http://dx.doi.org/10.1074/jbc.M117.813923			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28916726	Green Published, hybrid			2022-12-26	WOS:000414458200018
J	Reyna, KS; Burggren, WW				Reyna, Kelly S.; Burggren, Warren W.			Altered embryonic development in northern bobwhite quail (Colinus virginianus) induced by pre-incubation oscillatory thermal stresses mimicking global warming predictions	PLOS ONE			English	Article							EGG STORAGE; INCUBATION-TEMPERATURE; CHICKEN EMBRYOS; SYNCHRONIZATION; RESPONSES; TIME; HATCHABILITY; PATTERN; GROWTH; TURKEY	Global warming is likely to alter reproductive success of ground-nesting birds that lay eggs normally left unattended for days or even weeks before actual parental incubation, especially in already warm climates. The native North American bobwhite quail (Colinus virginianus) is such a species, and pre-incubation quail eggs may experience temperatures >= 45 degrees C. Yet, almost nothing is known about embryonic survival after such high pre-incubation temperatures. Freshly laid bobwhite quail eggs were exposed during a 12 day pre-incubation period to one of five thermal regimes: low oscillating temperatures (25-40 degrees C, mean = 28.9 degrees C), high oscillating temperatures (30-45 degrees C, mean = 33.9 degrees C), low constant temperatures (28.85 degrees C), high constant temperatures (mean = 33.9 degrees C), or commercially employed pre-incubation temperatures (20 degrees C). After treatment, eggs were then incubated at a standard 37.5 degrees C to determine subsequent effects on embryonic development rate, survival, water loss, hatching, and embryonic oxygen consumption. Both quantity of heating degree hours during pre-incubation and specific thermal regime (oscillating vs. non-oscillating) profoundly affected important aspects of embryo survival and indices of development and growth Pre-incubation quail eggs showed a remarkable tolerance to constant high temperatures (up to 45 degrees C), surviving for 4.5 +/- 0.3 days of subsequent incubation, but high oscillating pre-incubation temperature increased embryo survival (mean survival 12.2 +/- 1.8 days) and led to more rapid development than high constant temperature (maximum 38.5 degrees C), even though both groups experienced the same total heating degree-hours. Oxygen consumption was similar to 200-300 mu l O-2.egg.min(-1) at hatching in all groups, and was not affected by pre-incubation conditions. Oscillating temperatures, which are the norm for pre-incubation quail eggs in their natural habitat, thus enhanced survival at higher temperatures. However, a 5 degrees C increase in pre-incubation temperature, which equates to the predicted long-term increases of 5 degrees C or more, nonetheless reduced hatching rate by approximately 50%. Thus, while pre-incubation bobwhite eggs may be resiliant to moderate oscillating temperature increases, global warming will likely severely impact wild bobwhite quail populations, especially in their strongholds in southern latitudes.	[Reyna, Kelly S.; Burggren, Warren W.] Univ North Texas, Dept Biol Sci, Dev Integrat Biol Res Grp, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Reyna, KS (corresponding author), Univ North Texas, Dept Biol Sci, Dev Integrat Biol Res Grp, Denton, TX 76203 USA.	Kelly.Reyna@unt.edu	Burggren, Warren W/A-1561-2016	Burggren, Warren W/0000-0001-8023-420X; Reyna, Kelly/0000-0003-3202-2135	National Science Foundation [IOS 1543301]	National Science Foundation(National Science Foundation (NSF))	This research was funded by National Science Foundation grant IOS 1543301 to W. Burggren. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan S, 2013, ARC TIERZ, V18, P789; Alsop FM, 1919, ANAT REC, V15, P307; Alvine T, 2014, J COMP PHYSIOL B, V184, P107, DOI 10.1007/s00360-013-0777-9; Apanius V., 1998, AVIAN GROWTH DEV EVO; ARORA KL, 1966, POULTRY SCI, V45, P958, DOI 10.3382/ps.0450958; Beitinger TL, 2006, BIOSTATISTICS HELPBO; Branum SR, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12712; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; DECUYPERE E, 1992, WORLD POULTRY SCI J, V48, P28, DOI 10.1079/WPS19920004; Diamond SE, 2016, ANN NEW YORK ACAD SC; Dillon ME, 2016, INTEGR COMP BIOL, V56, P14, DOI 10.1093/icb/icw024; Dozier W, 2010, BOBWHITE QUAIL PRODU; El-Tarabany MS, 2016, J THERM BIOL, V61, P38, DOI 10.1016/j.jtherbio.2016.08.004; Fasenko GM, 2007, POULTRY SCI, V86, P1020, DOI 10.1093/ps/86.5.1020; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; French NA, 1997, POULTRY SCI, V76, P124, DOI 10.1093/ps/76.1.124; Gill F. B., 1999, ORNITHOLOGY; Guthery F.S., 2000, ON BOBWHITES; Guthery FS, 2004, WILDLIFE MONOGR, V159, P1; Guthery FS, 2000, QUAIL 4 4 NAT QUAIL; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamidu JA, 2011, POULTRY SCI, V90, P1749, DOI 10.3382/ps.2011-01361; Haron A, 2017, COMP BIOCHEM PHYS A, V203, P32, DOI 10.1016/j.cbpa.2016.08.015; HENDRICKX AG, 1965, BIOL BULL-US, V129, P523, DOI 10.2307/1539730; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOSIN IL, 1956, POULTRY SCI, V35, P1384, DOI 10.3382/ps.0351384; Lawson CR, 2015, ECOL LETT, V18, P724, DOI 10.1111/ele.12437; Loyau T, 2015, ANIMAL, V9, P76, DOI 10.1017/S1751731114001931; Maatjens CM, 2016, POULTRY SCI, V95, P956, DOI 10.3382/ps/pev447; MATHER CM, 1976, BRIT POULTRY SCI, V17, P471, DOI 10.1080/00071667608416302; MAYES FJ, 1984, WORLD POULTRY SCI J, V40, P131, DOI 10.1079/WPS19840011; MILLER ER, 1975, POULTRY SCI, V54, P901, DOI 10.3382/ps.0540901; Mortola JP, 2012, RESP PHYSIOL NEUROBI, V181, P109, DOI 10.1016/j.resp.2012.02.002; Mueller CA, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P739; Narinc D, 2016, ANIMAL, V10, P1328, DOI 10.1017/S1751731116000276; OPPENHEIM RW, 1975, DEV PSYCHOBIOL, V8, P103, DOI 10.1002/dev.420080203; PANI PK, 1969, POULTRY SCI, V48, P665, DOI 10.3382/ps.0480665; Pendlebury CJ, 2004, J EXP BIOL, V207, P2065, DOI 10.1242/jeb.00999; Proudfoot FG., 1969, FERTILITY HATCHABILI, P127; Reijrink IAM, 2010, POULTRY SCI, V89, P1225, DOI 10.3382/ps.2009-00182; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Reyna KS., 2012, P NATL QUAIL S, V7, P138; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; Stoddard H.L., 1931, BOBWHITE QUAIL ITS H; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; Tazawa Hiroshi, 2000, P617, DOI 10.1016/B978-012747605-6/50025-0; VINCE MA, 1964, NATURE, V203, P1192, DOI 10.1038/2031192a0; VINCE MA, 1984, J EXP ZOOL, V229, P273, DOI 10.1002/jez.1402290213; VINCE MA, 1968, ANIM BEHAV, V16, P332, DOI 10.1016/0003-3472(68)90017-1; VISSCHEDIJK AH, 1968, BRIT POULTRY SCI, V9, P173, DOI 10.1080/00071666808415707; VLECK CM, 1980, AM ZOOL, V20, P405; Warkentin KM., 2007, COMP BIOCH PHYSL A; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WILLIAMS JB, 1988, CONDOR, V90, P187, DOI 10.2307/1368447; WILSON HR, 1991, POULT SCI S, V22, P145; Zar JH, 1999, BIOSTATISTICAL ANAL	56	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184670	10.1371/journal.pone.0184670	http://dx.doi.org/10.1371/journal.pone.0184670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926597	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600030
J	Askovich, PS; Ramsey, SA; Diercks, AH; Kennedy, KA; Knijnenburg, TA; Aderem, A				Askovich, Peter S.; Ramsey, Stephen A.; Diercks, Alan H.; Kennedy, Kathleen A.; Knijnenburg, Theo A.; Aderem, Alan			Identifying novel transcription factors involved in the inflammatory response by using binding site motif scanning in genomic regions defined by histone acetylation	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; SYSTEMS BIOLOGY; GENE-EXPRESSION; REGULATORY CIRCUIT; INNATE IMMUNITY; IDENTITY; LPS; LIPOPOLYSACCHARIDE; IDENTIFICATION; REPRESENTATION	The innate immune response to pathogenic challenge is a complex, multi-staged process involving thousands of genes. While numerous transcription factors that act as master regulators of this response have been identified, the temporal complexity of gene expression changes in response to pathogen-associated molecular pattern receptor stimulation strongly suggest that additional layers of regulation remain to be uncovered. The evolved pathogen response program in mammalian innate immune cells is understood to reflect a compromise between the probability of clearing the infection and the extent of tissue damage and inflammatory sequelae it causes. Because of that, a key challenge to delineating the regulators that control the temporal inflammatory response is that an innate immune regulator that may confer a selective advantage in the wild may be dispensable in the lab setting. In order to better understand the complete transcriptional response of primary macrophages to the bacterial endotoxin lipopolysaccharide (LPS), we designed a method that integrates temporally resolved gene expression and chromatin-accessibility measurements from mouse macrophages. By correlating changes in transcription factor binding site motif enrichment scores, calculated within regions of accessible chromatin, with the average temporal expression profile of a gene cluster, we screened for transcriptional factors that regulate the cluster. We have validated our predictions of LPS-stimulated transcriptional regulators using ChIP-seq data for three transcription factors with experimentally confirmed functions in innate immunity. In addition, we predict a role in the macrophage LPS response for several novel transcription factors that have not previously been implicated in immune responses. This method is applicable to any experimental situation where temporal gene expression and chromatin-accessibility data are available.	[Askovich, Peter S.; Diercks, Alan H.; Kennedy, Kathleen A.; Aderem, Alan] Ctr Infect Dis Res, Seattle, WA 98109 USA; [Ramsey, Stephen A.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Knijnenburg, Theo A.] Inst Syst Biol, Seattle, WA USA; [Kennedy, Kathleen A.] Mol Med Res Inst, Flora Biosci, Sunnyvale, CA USA	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Oregon State University; Institute for Systems Biology (ISB)	Askovich, PS; Aderem, A (corresponding author), Ctr Infect Dis Res, Seattle, WA 98109 USA.	peter.askovich@cidresearch.org; alan.aderem@cidresearch.org			National Institutes of Health [U19 AI100627, R01 AI032972, R01 AI025032, HL098807]; National Science Foundation [1557605-DMS, 1553728-DBI]; Medical Research Foundation of Oregon; PhRMA Foundation; Oregon State University Division of Health Sciences; Div Of Biological Infrastructure [1553728] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Medical Research Foundation of Oregon; PhRMA Foundation; Oregon State University Division of Health Sciences; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Institutes of Health (nih.gov/) awards U19 AI100627, R01 AI032972, and R01 AI025032 to A. A. and HL098807 to S.A.R., the National Science Foundation (nsf.gov/) awards 1557605-DMS and 1553728-DBI to S.A.R., the Medical Research Foundation of Oregon (ohsu.edu/xd/about/foundation/about/medical-research-foundation/) New Investigator Grant award to S.A.R., the PhRMA Foundation (phrmafoundation.org/) Informatics Grant award to S.A.R., and Oregon State University Division of Health Sciences (health.oregonstate.edu/) Interdisciplinary Research Grant award to S.A.R.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Askovich PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074863; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Choudhury M, 2016, GENE REGUL SYST BIO, V10, P105, DOI 10.4137/GRSB.S40768; D'Alessio AC, 2015, STEM CELL REP, V5, P763, DOI 10.1016/j.stemcr.2015.09.016; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Gat-Viks I, 2013, NAT BIOTECHNOL, V31, P342, DOI 10.1038/nbt.2519; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Gottschalk RA, 2013, SEMIN IMMUNOL, V25, P201, DOI 10.1016/j.smim.2012.11.002; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Knijnenburg TA, 2014, NAT METHODS, V11, P689, DOI [10.1038/NMETH.2924, 10.1038/nmeth.2924]; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu YL, 2014, HUM MOL GENET, V23, P2145, DOI 10.1093/hmg/ddt610; Ly LL, 2013, AM J CANCER RES, V3, P339; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Mancino A, 2015, GENE DEV, V29, P394, DOI 10.1101/gad.257592.114; MCKUSICK VA, 1980, AM J MED, V69, P267, DOI 10.1016/0002-9343(80)90388-5; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi ST, 1999, INFLAMM RES, V48, P613, DOI 10.1007/s000110050511; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ramsey SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004828; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Raza S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-36; RIPLEY B., 2001, MSOR CONNECTIONS NEW, V1, P23, DOI [10.11120/msor.2001.01010023, DOI 10.11120/MSOR.2001.01010023, DOI 10.11120/MS0R.2001.01010023]; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Shang XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135971; Sun K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02404-w; Sun K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084500; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033474; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zhang Z, 2010, GENES IMMUN, V11, P124, DOI 10.1038/gene.2009.66	57	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184850	10.1371/journal.pone.0184850	http://dx.doi.org/10.1371/journal.pone.0184850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922390	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300034
J	Chu, SY; Chen, Q; Chen, Y; Bao, YX; Wu, M; Zhang, J				Chu, Shuyuan; Chen, Qian; Chen, Yan; Bao, Yixiao; Wu, Min; Zhang, Jun			Cesarean section without medical indication and risk of childhood asthma, and attenuation by breastfeeding	PLOS ONE			English	Article							ALLERGIC DISEASES; DELIVERY; CHINA; MODE	Background Previous studies suggest that caesarean section (CS) may increase the risk of asthma in children, but none of them could preclude potential confounding effects of underlying medical indications for CS. We aim to assess the association between CS itself (without medical indications) and risk of childhood asthma. Methods We conducted a hospital-based case-control study on childhood asthma with 573 cases and 812 controls in Shanghai. Unconditional logistic regression models in SAS were employed to control for potential confounders. Results Our study found that CS without medical indication was significantly associated with elevated asthma risk (adjusted OR = 1.58 [95% CI 1.17-2.13]). However, this risk was attenuated in children fed by exclusive breastfeeding in the first six months after birth (adjusted OR = 1.39 [95% CI 0.92-2.10]). In contrast, the risk was more prominent in children with non-exclusive breastfeeding or bottle feeding (adjusted OR = 1.91 [95% CI 1.22-2.99]). Conclusions CS without medical indication was associated with an increased risk of childhood asthma. Exclusive breastfeeding in infancy may attenuate this risk.	[Chu, Shuyuan] Guilin Med Univ, Lab Resp Dis, Affiliated Hosp, Guilin, Peoples R China; [Chu, Shuyuan; Chen, Qian; Chen, Yan; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Chen, Yan; Bao, Yixiao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat, Shanghai, Peoples R China; [Wu, Min] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Zhang, Jun] Guilin Med Univ, Sch Publ Hlth, Guilin, Peoples R China	Guilin Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guilin Medical University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China.; Zhang, J (corresponding author), Guilin Med Univ, Sch Publ Hlth, Guilin, Peoples R China.	zhangjun@xinhuamed.com.cn			National Natural Science Foundation of China [81273091, 81530086]; Shanghai Municipal Health and Family Planning Commission [GWIV-26, 15GWZK0401]; Shanghai Science and Technology Commission [14XD1403300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health and Family Planning Commission; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	The work was supported by the National Natural Science Foundation of China (81273091, 81530086); Shanghai Municipal Health and Family Planning Commission (GWIV-26; 15GWZK0401); Shanghai Science and Technology Commission (14XD1403300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Black M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001973; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Leung JYY, 2015, CLIN EXP ALLERGY, V45, P1109, DOI 10.1111/cea.12548; Ma JQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-568; Munblit D, 2016, CURR OPIN ALLERGY CL, V16, P427, DOI 10.1097/ACI.0000000000000303; Politis I, 2008, ADV EXP MED BIOL, V606, P253, DOI 10.1007/978-0-387-74087-4_10; Soto-Ramirez N, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-11; Sou SC, 2006, J CLIN EPIDEMIOL, V59, P429, DOI 10.1016/j.jclinepi.2005.08.010; Tedner SG, 2012, CLIN EXP ALLERGY, V42, P1430, DOI 10.1111/j.1365-2222.2012.03997.x; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Turner SW, 2010, THORAX, V65, P391, DOI 10.1136/thx.2008.111385; Wong GWK, 2013, ALLERGY ASTHMA IMMUN, V5, P251, DOI 10.4168/aair.2013.5.5.251; Zhang J, 2008, OBSTET GYNECOL, V111, P1077, DOI 10.1097/AOG.0b013e31816e349e	18	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184920	10.1371/journal.pone.0184920	http://dx.doi.org/10.1371/journal.pone.0184920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922410	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300043
J	Puengel, T; Krenkel, O; Kohlhepp, M; Lefebvre, E; Luedde, T; Trautwein, C; Tacke, F				Puengel, Tobias; Krenkel, Oliver; Kohlhepp, Marlene; Lefebvre, Eric; Luedde, Tom; Trautwein, Christian; Tacke, Frank			Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; PHARMACOLOGICAL INHIBITION; MACROPHAGE INFILTRATION; HEPATIC RECRUITMENT; FIBROSIS; HOMEOSTASIS; RESIDENT; PHASE; CCR2	A hallmark of acute hepatic injury is the recruitment of neutrophils, monocytes and lymphocytes, including natural killer (NK) or T cells, towards areas of inflammation. The recruitment of leukocytes from their reservoirs bone marrow or spleen into the liver is directed by chemokines such as CCL2 (for monocytes) and CCL5 (for lymphocytes). We herein elucidated the impact of chemokine receptor inhibition by the dual CCR2 and CCR5 inhibitor cenicriviroc (CVC) on the composition of myeloid and lymphoid immune cell populations in acute liver injury. CVC treatment effectively inhibited the migration of bone marrow monocytes and splenic lymphocytes (NK, CD4 T-cells) towards CCL2 or CCL5 in vitro. When liver injury was induced by an intraperitoneal injection of carbon tetrachloride (CCl4) in mice, followed by repetitive oral application of CVC, flow cytometric and unbiased t-SNE analysis of intrahepatic leukocytes demonstrated that dual CCR2/CCR5 inhibition in vivo significantly decreased numbers of monocyte derived macrophages in acutely injured livers. CVC also reduced numbers of Kupffer cells (KC) or monocyte derived macrophages with a KC-like phenotype, respectively, after injury. In contrast to the inhibitory effects in vitro, CVC had no impact on the composition of hepatic lymphoid cell populations in vivo. Effective inhibition of monocyte recruitment was associated with reduced inflammatory macrophage markers and moderately ameliorated hepatic necroses at 36h after CCl4. In conclusion, dual CCR2/CCR5 inhibition primarily translates into reduced monocyte recruitment in acute liver injury in vivo, suggesting that this strategy will be effective in reducing inflammatory macrophages in conditions of liver disease.	[Puengel, Tobias; Krenkel, Oliver; Kohlhepp, Marlene; Luedde, Tom; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Lefebvre, Eric] Allergan Plc, San Francisco, CA USA	RWTH Aachen University; RWTH Aachen University Hospital; AbbVie; Allergan	Tacke, F (corresponding author), RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Tacke, Frank/ABF-2212-2020; Luedde, Tom/AAE-9135-2022	Luedde, Tom/0000-0002-6288-8821; Puengel, Tobias/0000-0003-2662-6127; Tacke, Frank/0000-0001-6206-0226	German Research Foundation (DFG) [Ta434/5-1, SFB/TRR57]; Interdisciplinary Center for Clinical Research (IZKF) Aachen	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Aachen	This work was supported by the German Research Foundation (DFG; Ta434/5-1 and SFB/TRR57) and the Interdisciplinary Center for Clinical Research (IZKF) Aachen. The funder provided support in the form of salaries for authors [EL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; This work was supported by the German Research Foundation (DFG; Ta434/5-1 and SFB/ TRR57) and the Interdisciplinary Center for Clinical Research (IZKF) Aachen.	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Chalmers SA, 2015, DISCOV MED, V20, P43; Choi DY, 2015, ARCH TOXICOL, V89, P211, DOI 10.1007/s00204-014-1253-3; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Friedman S, 2016, CONTEMP CLIN TRIALS, V47, P356, DOI 10.1016/j.cct.2016.02.012; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Jakubzick CV, 2017, MONOCYTE DIFFERENTIA; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Krenkel Oliver, 2014, Hepatobiliary Surg Nutr, V3, P331, DOI 10.3978/j.issn.2304-3881.2014.11.01; Lefebvre E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158156; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Mohs A, 2017, J HEPATOL, V66, P743, DOI 10.1016/j.jhep.2016.12.011; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Perez-Martinez L, 2014, J ANTIMICROB CHEMOTH, V69, P1903, DOI 10.1093/jac/dku071; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Tacke F., 2017, J HEPATOL; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; You Q, 2013, BIOCHEM PHARMACOL, V86, P836, DOI 10.1016/j.bcp.2013.07.006; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	33	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184694	10.1371/journal.pone.0184694	http://dx.doi.org/10.1371/journal.pone.0184694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910354	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200080
J	Wroblewska-Seniuk, K; Greczka, G; Dabrowski, P; Szyfter-Harris, J; Mazela, J				Wroblewska-Seniuk, Katarzyna; Greczka, Grazyna; Dabrowski, Piotr; Szyfter-Harris, Joanna; Mazela, Jan			Hearing impairment in premature newborns-Analysis based on the national hearing screening database in Poland	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; INTERVENTION PROGRAMS; AUDITORY FUNCTION; RISK-FACTORS; FOLLOW-UP; INFANTS; CHILDREN; PREVALENCE	Objectives The incidence of sensorineural hearing loss is between 1 and 3 per 1000 in healthy neonates and 2-4 per 100 in high-risk infants. The national universal neonatal hearing screening carried out in Poland since 2002 enables selection of infants with suspicion and/or risk factors of hearing loss. In this study, we assessed the incidence and risk factors of hearing impairment in infants <= 33 weeks' gestational age (wga). Methods We analyzed the database of the Polish Universal Newborns Hearing Screening Program from 2010 to 2013. The study group involved 11438 infants born before 33 wga, the control group-1487730 infants. Screening was performed by means of transient evoked otoacoustic emissions. The risk factors of hearing loss were recorded. Infants who failed the screening test and/or had risk factors were referred for further audiological evaluation. Results Hearing deficit was diagnosed in 11% of infants <= 25 wga, 5% at 26-27 wga, 3.46% at 28 wga and 2-3% at 29-32 wga. In the control group the incidence of hearing deficit was 0.2% (2.87% with risk factors). The most important risk factors were craniofacial malformations, very low birth weight, low Apgar score and mechanical ventilation. Hearing screening was positive in 22.42% newborns <= 28 wga and 10% at 29-32 wga and in the control group. Conclusions Hearing impairment is a severe consequence of prematurity. Its prevalence is inversely related to the maturity of the baby. Premature infants have many concomitant risk factors which influence the occurrence of hearing deficit.	[Wroblewska-Seniuk, Katarzyna; Mazela, Jan] Poznan Univ Med Sci, Dept Newborns Infect Dis, Poznan, Poland; [Greczka, Grazyna; Dabrowski, Piotr; Szyfter-Harris, Joanna] Poznan Univ Med Sci, Dept Otolaryngol & Oncol Laryngol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Wroblewska-Seniuk, K (corresponding author), Poznan Univ Med Sci, Dept Newborns Infect Dis, Poznan, Poland.	kwroblewska@post.pl	Wróblewska-Seniuk, Katarzyna/U-3292-2019	Wroblewska-Seniuk, Katarzyna/0000-0003-3908-6617				Antoni M, 2016, EUR ANN OTORHINOLARY, V133, P95, DOI 10.1016/j.anorl.2015.10.001; Biernath KR, 2010, AM FAM PHYSICIAN, V81, P124; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Borkoski-Barreiro SA, 2013, ACTA OTORRINOLAR ESP, V64, P403, DOI 10.1016/j.otorri.2013.05.002; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Coenraad S, 2010, INT J PEDIATR OTORHI, V74, P999, DOI 10.1016/j.ijporl.2010.05.024; Cristobal R, 2008, ARCH DIS CHILD-FETAL, V93, P1462, DOI 10.1136/adc.2007.124214; D'Agostino Jo Ann, 2004, Adv Neonatal Care, V4, P344, DOI 10.1016/j.adnc.2004.09.007; DEVRIES LS, 1987, EARLY HUM DEV, V15, P269, DOI 10.1016/0378-3782(87)90050-8; Fausti SA, 1999, EAR HEARING, V20, P497, DOI 10.1097/00003446-199912000-00005; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Greczka G, 2017, ANAL FOLLOW DIAGNOST; HAUPT H, 1993, EUR ARCH OTO-RHINO-L, V250, P396; Helfand M., 2001, NEWBORN HEARING SCRE; Hille ETM, 2007, ACTA PAEDIATR, V96, P1155, DOI 10.1111/j.1651-2227.2007.00398.x; Konkle D F, 1993, J Am Acad Audiol, V4, P351; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Meyer C, 1999, PEDIATRICS, V104, P900, DOI 10.1542/peds.104.4.900; Norton SJ, 2000, EAR HEAR, V21; Ohl C, 2009, INT J PEDIATR OTORHI, V73, P1691, DOI 10.1016/j.ijporl.2009.08.027; Robertson CMT, 2009, PEDIATRICS, V123, pE797, DOI 10.1542/peds.2008-2531; Shapiro SM, 2001, J PERINATOL S1, V21, pS59, DOI DOI 10.1038/SJ.JP.7210635; Sokol Jennifer, 2002, Pediatr Rev, V23, P155, DOI 10.1542/pir.23-5-155; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Szyfter W, 2013, EPIDEMIOLOGY, V24, P333, DOI 10.1097/EDE.0b013e31827b23a3; White KR, 2010, SEMIN PERINATOL, V34, P170, DOI 10.1053/j.semperi.2009.12.009; Wrobel MJ, 2014, INT J PEDIATR OTORHI, V78, P209, DOI 10.1016/j.ijporl.2013.10.052; Wroblewska-Seniuk K, 2005, INT J PEDIATR OTORHI, V69, P1351, DOI 10.1016/j.ijporl.2005.03.023; Yoon PJ, 2003, INT J PEDIATR OTORHI, V67, P353, DOI 10.1016/S0165-5876(02)00400-7; Yoshinaga-Itano C, 1999, OTOLARYNG CLIN N AM, V32, P1089, DOI 10.1016/S0030-6665(05)70196-1	31	30	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184359	10.1371/journal.pone.0184359	http://dx.doi.org/10.1371/journal.pone.0184359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910311	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200042
J	Fresquet-Corrales, S; Roque, E; Sarrion-Perdigones, A; Rochina, M; Lopez-Gresa, MP; Diaz-Mula, HM; Belles, JM; Tomas-Barberan, F; Beltran, JAP; Canas, LA				Fresquet-Corrales, Sandra; Roque, Edelin; Sarrion-Perdigones, Alejandro; Rochina, Maricruz; Lopez-Gresa, Maria P.; Diaz-Mula, Huertas M.; Belles, Jose M.; Tomas-Barberan, Francisco; Beltran, Jose A. P.; Canas, Luis A.			Metabolic engineering to simultaneously activate anthocyanin and proanthocyanidin biosynthetic pathways in Nicotiana spp.	PLOS ONE			English	Article							R2R3-MYB TRANSCRIPTION FACTOR; TRANSGENIC TOBACCO PLANTS; SECRETORY ANTIBODIES; MEDICAGO-TRUNCATULA; CONDENSED TANNINS; EXPRESSION; GENES; PIGMENTATION; ARABIDOPSIS; REDUCTASE	Proanthocyanidins (PAs), or condensed tannins, are powerful antioxidants that remove harmful free oxygen radicals from cells. To engineer the anthocyanin and proanthocyanidin biosynthetic pathways to de novo produce PAs in two Nicotiana species, we incorporated four transgenes to the plant chassis. We opted to perform a simultaneous transformation of the genes linked in a multigenic construct rather than classical breeding or retransformation approaches. We generated a GoldenBraid 2.0 multigenic construct containing two Antirrhinum majus transcription factors (AmRosea1 and AmDelila) to upregulate the anthocyanin pathway in combination with two Medicago truncatula genes (MtLAR and MtANR) to produce the enzymes that will derivate the biosynthetic pathway to PAs production. Transient and stable transformation of Nicotiana benthamiana and Nicotiana tabacum with the multigenic construct were respectively performed. Transient expression experiments in N. benthamiana showed the activation of the anthocyanin pathway producing a purple color in the agroinfiltrated leaves and also the effective production of 208.5 nmol (-) catechin/g FW and 228.5 nmol (-) epicatechin/g FW measured by the p-dimethylaminocinnamaldehyde (DMACA) method. The integration capacity of the four transgenes, their respective expression levels and their heritability in the second generation were analyzed in stably transformed N. tabacum plants. DMACA and phoroglucinolysis/HPLC-MS analyses corroborated the activation of both pathways and the effective production of PAs in T0 and T1 transgenic tobacco plants up to a maximum of 3.48 mg/g DW. The possible biotechnological applications of the GB2.0 multigenic approach in forage legumes to produce "bloatsafe" plants and to improve the efficiency of conversion of plant protein into animal protein (ruminal protein bypass) are discussed.	[Fresquet-Corrales, Sandra; Roque, Edelin; Sarrion-Perdigones, Alejandro; Rochina, Maricruz; Lopez-Gresa, Maria P.; Belles, Jose M.; Beltran, Jose A. P.; Canas, Luis A.] CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Sarrion-Perdigones, Alejandro] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Diaz-Mula, Huertas M.; Tomas-Barberan, Francisco] CSIC, CEBAS, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Baylor College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Canas, LA (corresponding author), CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain.	lcanas@ibmcp.upv.es	Roque, Edelin/K-7576-2015; Tomás-Barberán, Francisco/D-6686-2011; Diaz-Mula, Huertas Maria/L-4559-2013; Gresa, María Pilar López/N-8830-2013; Cañas, Luis A./F-7147-2015	Roque, Edelin/0000-0002-2422-8128; Tomás-Barberán, Francisco/0000-0002-0790-1739; Diaz-Mula, Huertas Maria/0000-0002-9289-2856; Gresa, María Pilar López/0000-0001-9251-0160; Canas, Luis/0000-0003-4177-4777; ROCHINA PENALVER, MARI CRUZ/0000-0002-7327-0437	Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2012-39849-C02-01, BIO2016-75485-R]; JAE-CSIC	Spanish Ministry of Economy and Competitiveness (MINECO); JAE-CSIC	This work was supported by grants BIO2012-39849-C02-01 and BIO2016-75485-R from the Spanish Ministry of Economy and Competitiveness (MINECO) (http://www.idi.mineco.gob.es/portal/site/MICINN) to LAC and a fellowship of the JAE-CSIC program to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Barry TN, 1999, BRIT J NUTR, V81, P263, DOI 10.1017/S0007114599000501; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; BINNS AN, 1988, ANNU REV MICROBIOL, V42, P575, DOI 10.1146/annurev.mi.42.100188.003043; Buendia B, 2010, J AGR FOOD CHEM, V58, P3916, DOI 10.1021/jf9030597; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Capell T, 2004, CURR OPIN BIOTECH, V15, P148, DOI 10.1016/j.copbio.2004.01.009; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Datta K, 2002, THEOR APPL GENET, V106, P1, DOI 10.1007/s00122-002-1014-1; de Pascual-Teresa S, 1998, J AGR FOOD CHEM, V46, P4209, DOI 10.1021/jf980255k; DELCOUR JA, 1985, J I BREWING, V91, P37, DOI 10.1002/j.2050-0416.1985.tb04303.x; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Dixon RA, 2012, CURR OPIN BIOTECH, V24, P1; Dixon RA, 2010, PLANT PHYSIOL, V154, P453, DOI 10.1104/pp.110.161430; Du H, 2010, APPL MICROBIOL BIOT, V86, P1293, DOI 10.1007/s00253-010-2512-8; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FISHER DK, 1995, PLANT MOL BIOL REP, V13, P278, DOI 10.1007/BF02670906; Gong ZZ, 1999, PLANT MOL BIOL, V41, P33, DOI 10.1023/A:1006237529040; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HALL JW, 1994, CAN VET J, V35, P702; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Kim HU, 1998, MOL CELLS, V8, P310; Kitamura S., 2006, SCI FLAVONOIDS, P123; Laitinen RAE, 2008, J EXP BOT, V59, P3691, DOI 10.1093/jxb/ern216; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Li HH, 2007, PLANTA, V226, P1243, DOI 10.1007/s00425-007-0573-4; Li PH, 2016, NEW PHYTOL, V210, P905, DOI 10.1111/nph.13816; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;89::AID-JSFA470&gt;3.0.CO;2-N; Liu CG, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.182, 10.1038/nplants.2016.182]; Liu CG, 2014, PLANT PHYSIOL, V165, P1424, DOI 10.1104/pp.114.241877; Liu Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-202; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380; Magnani E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-46; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Muir AD, 2000, BASIC LIFE SCI, V66, P867; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Niezen JH, 1998, VET PARASITOL, V80, P15, DOI 10.1016/S0304-4017(98)00202-7; NIEZEN JH, 1995, J AGR SCI, V125, P281, DOI 10.1017/S0021859600084422; Orzaez D, 2009, PLANT PHYSIOL, V150, P1122, DOI 10.1104/pp.109.139006; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Park KI, 2007, PLANT J, V49, P641, DOI 10.1111/j.1365-313X.2006.02988.x; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Polturak G, 2016, NEW PHYTOL, V210, P269, DOI 10.1111/nph.13796; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Ramsay NA, 2003, PLANT MOL BIOL, V52, P679, DOI 10.1023/A:1024852021124; Robbins MP, 2003, J EXP BOT, V54, P239, DOI 10.1093/jxb/erg022; Sarrion-Perdigones A, 2014, DNA CLONING ASSEMBLY, V1116; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Vafaee Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110222; Vallejo F, 2012, FOOD CHEM, V130, P485, DOI 10.1016/j.foodchem.2011.07.032; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; WAGHORN GC, 1990, MICROBIAL PLANT OPPO, P137; Wieland WH, 2006, J BIOTECHNOL, V122, P382, DOI 10.1016/j.jbiotec.2005.12.020; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.02655.x; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; ZAMBRYSKI P, 1988, ANNU REV GENET, V22, P1, DOI 10.1146/annurev.ge.22.120188.000245; Zhang YJ, 2015, MOLECULES, V20, P21138, DOI 10.3390/molecules201219753; Zhou ML, 2015, APPL MICROBIOL BIOT, V99, P3797, DOI 10.1007/s00253-015-6533-1	78	12	14	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184839	10.1371/journal.pone.0184839	http://dx.doi.org/10.1371/journal.pone.0184839			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902886	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200071
J	Salazar, CL; Reyes, C; Atehortua, S; Sierra, P; Correa, MM; Paredes-Sabja, D; Best, E; Fawley, WN; Wilcox, M; Gonzalez, A				Lina Salazar, Clara; Reyes, Catalina; Atehortua, Santiago; Sierra, Patricia; Maria Correa, Margarita; Paredes-Sabja, Daniel; Best, Emma; Fawley, Warren N.; Wilcox, Mark; Gonzalez, Angel			Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia	PLOS ONE			English	Article							RIO-DE-JANEIRO; RISK-FACTORS; INFECTION; DIARRHEA; EPIDEMIOLOGY; INPATIENTS; DIAGNOSIS; STILL	In Colombia, the epidemiology and circulating genotypes of Clostridium difficile have not yet been described. Therefore, we molecularly characterized clinical isolates of C.difficile from patients with suspicion of C.difficile infection (CDI) in three tertiary care hospitals. C.difficile was isolated from stool samples by culture, the presence of A/B toxins were detected by enzyme immunoassay, cytotoxicity was tested by cell culture and the antimicrobial susceptibility determined. After DNA extraction, tcdA, tcdB and binary toxin (CDTa/CDTb) genes were detected by PCR, and PCR-ribotyping performed. From a total of 913 stool samples collected during 2013-2014, 775 were included in the study. The frequency of A/B toxins-positive samples was 9.7% (75/775). A total of 143 isolates of C.difficile were recovered from culture, 110 (76.9%) produced cytotoxic effect in cell culture, 100 (69.9%) were tcdA +/tcdB+, 11 (7.7%) tcdA-/tcdB+, 32 (22.4%) tcdA-/tcdB-and 25 (17.5%) CDTa+/CDTb+. From 37 ribotypes identified, ribotypes 591 (20%), 106 (9%) and 002 (7.9%) were the most prevalent; only one isolate corresponded to ribotype 027, four to ribotype 078 and four were new ribotypes (794,795, 804,805). All isolates were susceptible to vancomycin and metronidazole, while 85% and 7.7% were resistant to clindamycin and moxifloxacin, respectively. By multivariate analysis, significant risk factors associated to CDI were, staying in orthopedic service, exposure to third-generation cephalosporins and staying in an ICU before CDI symptoms; moreover, steroids showed to be a protector factor. These results revealed new C. difficile ribotypes and a high diversity profile circulating in Colombia different from those reported in America and European countries.	[Lina Salazar, Clara] Univ Antioquia, Sch Microbiol, Res Grp Anaerob Bacteria GIBA, Medellin, Colombia; [Reyes, Catalina; Gonzalez, Angel] Univ Antioquia, Basic & Appl Microbiol Res Grp MICROBA, Sch Microbiol, Medellin, Colombia; [Atehortua, Santiago] Univ Hosp, San Vicente Fdn, Medellin, Colombia; [Sierra, Patricia] Univ Antioquia, IPS Univ, Clin Leon XIII, Medellin, Colombia; [Maria Correa, Margarita] Univ Antioquia, Sch Microbiol, Mol Microbiol Grp, Medellin, Colombia; [Paredes-Sabja, Daniel] Univ Andres Bello, Dept Ciencias Biol, Microbiota Host Interact & Clostridia Res Grp, Santiago, Chile; [Best, Emma; Fawley, Warren N.; Wilcox, Mark] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad Andres Bello; University of Leeds	Gonzalez, A (corresponding author), Univ Antioquia, Basic & Appl Microbiol Res Grp MICROBA, Sch Microbiol, Medellin, Colombia.	angel.gonzalez@udea.edu.co	Paredes-Sabja, Daniel/ABI-4293-2020; Gonzalez, Angel/ABG-7914-2020	Gonzalez, Angel/0000-0002-7052-7938	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia [485-2012, 1115569344410]; Estrategia para la Sostenibilidad de Grupos de Investigacion, UdeA, Universidad de Antioquia [ES84160123]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia; Estrategia para la Sostenibilidad de Grupos de Investigacion, UdeA, Universidad de Antioquia	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia, Project 485-2012 (Code number 1115569344410). MMC received funding from Estrategia para la Sostenibilidad de Grupos de Investigacion 2016-2017, UdeA, code No. ES84160123, Universidad de Antioquia. The funders had no role in study design, analysis and interpretation of experiments, decision to publish, or preparation of the manuscript.	Ashwin H, 2014, 24 EUR C CLIN MICR I; Balassiano IT, 2012, J MED MICROBIOL, V61, P169, DOI 10.1099/jmm.0.037077-0; Balassiano IT, 2011, ANTON LEEUW INT J G, V99, P249, DOI 10.1007/s10482-010-9483-8; Balassiano IT, 2009, ANAEROBE, V15, P61, DOI 10.1016/j.anaerobe.2008.12.007; Becerra María Gabriela, 2011, Infect., V15, P220; Bloomfield MG, 2012, J HOSP INFECT, V82, P1, DOI 10.1016/j.jhin.2012.05.008; Chia JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075471; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Crabtree T, 2007, ANN THORAC SURG, V83, P1396, DOI 10.1016/j.athoracsur.2006.10.067; Davies KA, 2016, EUROSURVEILLANCE, V21, P37, DOI 10.2807/1560-7917.ES.2016.21.29.30294; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dong DF, 2013, INT J ANTIMICROB AG, V41, P80, DOI 10.1016/j.ijantimicag.2012.08.011; Dudukgian H, 2010, J GASTROINTEST SURG, V14, P315, DOI 10.1007/s11605-009-1093-2; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; Elliott B, 2009, ANAEROBE, V15, P249, DOI 10.1016/j.anaerobe.2009.08.006; Faleck DM, 2016, AM J GASTROENTEROL, V111, P1641, DOI 10.1038/ajg.2016.343; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Feher C, 2016, INFECT DIS THER, V5, P207, DOI 10.1007/s40121-016-0122-1; Foster N F, 2014, New Microbes New Infect, V2, P64, DOI 10.1002/nmi2.43; Foster NF, 2012, PATHOLOGY, V44, P354, DOI 10.1097/PAT.0b013e328353a235; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gutierrez J, 2016, PREVALENCIA FACTORES; Halstead DC, 2016, J INFECT DEV COUNTR, V10, P62, DOI 10.3855/jidc.6634; Hecht DW, 2007, ANTIMICROB AGENTS CH, V51, P2716, DOI 10.1128/AAC.01623-06; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Hernandez-Rocha C, 2013, DIAGN MICR INFEC DIS, V75, P361, DOI 10.1016/j.diagmicrobio.2012.12.010; Karanika S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv186; KATO N, 1991, J CLIN MICROBIOL, V29, P33, DOI 10.1128/JCM.29.1.33-37.1991; Kim HB, 2016, J MICROBIOL BIOTECHN, V26, P567, DOI 10.4014/jmb.1512.12017; Krutova M, 2016, INT J MED MICROBIOL, V306, P479, DOI 10.1016/j.ijmm.2016.07.003; Kuehne SA, 2011, GUT MICROBES, V2, P711; Legaria MC, 2003, ANAEROBE, V9, P113, DOI 10.1016/S1075-9964(03)00088-X; Leibovitz A, 2016, AM J INFECT CONTROL, V44, P1158, DOI 10.1016/j.ajic.2016.03.069; Lopardo G, 2015, BRAZ J INFECT DIS, V19, P8, DOI 10.1016/j.bjid.2014.07.004; Lopez-Urena D, 2014, J MED MICROBIOL, V63, P322, DOI 10.1099/jmm.0.066399-0; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Monteiro AD, 2014, BRAZ J INFECT DIS, V18, P672, DOI 10.1016/j.bjid.2014.08.004; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Sunkesula VCK, 2013, CLIN INFECT DIS, V57, P494, DOI 10.1093/cid/cit286; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; Tickler IA, 2014, ANTIMICROB AGENTS CH, V58, P4214, DOI 10.1128/AAC.02775-13; Tleyjeh IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050836; Wijarnpreecha K, 2016, DIGEST LIVER DIS, V48, P468, DOI 10.1016/j.dld.2016.01.012; Wilcox MH, 2017, J ANTIMICROB CHEMOTH, V72, P1, DOI 10.1093/jac/dkw385; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184689	10.1371/journal.pone.0184689	http://dx.doi.org/10.1371/journal.pone.0184689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902923	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200053
J	Fausther, M; Lavoie, EG; Dranoff, JA				Fausther, Michel; Lavoie, Elise G.; Dranoff, Jonathan A.			Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants	PLOS ONE			English	Article							MOLECULAR-CLONING; FIBROTIC LIVER; CANCER; FIBROSIS; CHOLANGIOCARCINOMA; IMMUNOTHERAPY; TRANSCRIPTION; PROGRESSION; PROGNOSIS; CARCINOMA	Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and functions. For instance, liver myofibroblasts express cell markers that are universally represented such as, ItgaV and Pdgfr beta, or restricted to a given subpopulation such as, Lrat exclusively expressed in hepatic stellate cells, and Gpm6a in mesothelial cells. To study liver myofibroblasts in vitro, we have previously generated and characterized a SV40-immortalized polyclonal rat activated portal fibroblast cell line called RGF-N2 expressing multiple mesothelin mRNA transcripts. Mesothelin, a cell-surface molecule expressed in normal mesothelial cells and overexpressed in several cancers such as, mesothelioma and cholangiocarcinoma, was recently identified as a key regulator of portal myofibroblast proliferation, and fibrosis progression in the setting of chronic cholestatic liver disease. Here, we identify novel mesothelin splice variants expressed in rat activated portal fibroblasts. RGF-N2 portal fibroblast cDNA was used as template for insertion of hemagglutinin tag consensus sequence into the complete open reading frame of rat mesothelin variant coding sequences by extension PCR. Purified amplicons were subsequently cloned into an expression vector for in vitro translation and transfection in monkey COS7 fibroblasts, before characterization of fusion proteins by immunoblot and immunofluorescence. We show that rat activated portal fibroblasts, hepatic stellate cells, and cholangiocarcinoma cells express wild-type mesothelin and additional splice variants, while mouse activated hepatic stellate cells appear to only express wild-type mesothelin. Notably, rat mesothelin splice variants differ from the wild-type isoform by their protein properties and cellular distribution in transfected COS7 fibroblasts. We conclude that mesothelin is a marker of activated murine liver myofibroblasts. Mesothelin gene expression and regulation may be critical in liver myofibroblasts functions and fibrosis progression.	[Fausther, Michel; Lavoie, Elise G.; Dranoff, Jonathan A.] Univ Arkansas Med Sci, Dept Internal Med, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA; [Fausther, Michel; Lavoie, Elise G.; Dranoff, Jonathan A.] Cent Arkansas Vet Adm Hlth Syst, Res Serv, Little Rock, AR 72114 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Fausther, M (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA.; Fausther, M (corresponding author), Cent Arkansas Vet Adm Hlth Syst, Res Serv, Little Rock, AR 72114 USA.	mfausther@uams.edu		Fausther, Michel/0000-0002-5673-9360	NCATS NIH HHS [UL1 TR000039] Funding Source: Medline; NIDDK NIH HHS [R56 DK076735] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Einama Takahiro, 2016, World J Gastrointest Pathophysiol, V7, P218, DOI 10.4291/wjgp.v7.i2.218; Fausther M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121161; Fausther M, 2012, AM J PHYSIOL-GASTR L, V303, pG904, DOI 10.1152/ajpgi.00015.2012; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hassan R, 2016, J CLIN ONCOL, V34, P4171, DOI 10.1200/JCO.2016.68.3672; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Kawamata F, 2012, INT J ONCOL, V41, P2109, DOI 10.3892/ijo.2012.1662; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Koyama Y, 2017, J CLIN INVEST, V127, P1254, DOI 10.1172/JCI88845; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Leshem Y, 2017, CANCER IMMUNOL RES, V5, P685, DOI 10.1158/2326-6066.CIR-16-0330; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Meurer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056116; Nomura R, 2013, INT SURG, V98, P164, DOI 10.9738/INTSURG-D-13-00001.1; Pastan I, 2014, CANCER RES, V74, P2907, DOI 10.1158/0008-5472.CAN-14-0337; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Sirica AE, 2008, HEPATOLOGY, V47, P1178, DOI 10.1002/hep.22088; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Thomas A, 2015, ONCOTARGET, V6, P11694, DOI 10.18632/oncotarget.3429; Vogel S, 2000, J LIPID RES, V41, P882; Yu LP, 2010, J CANCER, V1, P141; Zhang JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104388	36	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184499	10.1371/journal.pone.0184499	http://dx.doi.org/10.1371/journal.pone.0184499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898276	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500031
J	Marin, MM; Schober, R; Gingras, B; Leder, H				Marin, Manuela M.; Schober, Raphaela; Gingras, Bruno; Leder, Helmut			Misattribution of musical arousal increases sexual attraction towards opposite-sex faces in females	PLOS ONE			English	Article							MATE PREFERENCES; CONCEPTION; ABILITY; LOVE	Several theories about the origins of music have emphasized its biological and social functions, including in courtship. Music may act as a courtship display due to its capacity to vary in complexity and emotional content. Support for music's reproductive function comes from the recent finding that only women in the fertile phase of the reproductive cycle prefer composers of complex melodies to composers of simple ones as short-term sexual partners, which is also in line with the ovulatory shift hypothesis. However, the precise mechanisms by which music may influence sexual attraction are unknown, specifically how music may interact with visual attractiveness cues and affect perception and behaviour in both genders. Using a crossmodal priming paradigm, we examined whether listening to music influences ratings of facial attractiveness and dating desirability of opposite-sex faces. We also tested whether misattribution of arousal or pleasantness underlies these effects, and explored whether sex differences and menstrual cycle phase may be moderators. Our sample comprised 64 women in the fertile or infertile phase (no hormonal contraception use) and 32 men, carefully matched for mood, relationship status, and musical preferences. Musical primes (25 s) varied in arousal and pleasantness, and targets were photos of faces with neutral expressions (2 s). Group-wise analyses indicated that women, but not men, gave significantly higher ratings of facial attractiveness and dating desirability after having listened to music than in the silent control condition. High-arousing, complex music yielded the largest effects, suggesting that music may affect human courtship behaviour through induced arousal, which calls for further studies on the mechanisms by which music affects sexual attraction in real-life social contexts.	[Marin, Manuela M.; Schober, Raphaela; Leder, Helmut] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Gingras, Bruno] Univ Innsbruck, Dept Psychol, Innsbruck, Austria	University of Vienna; University of Innsbruck	Marin, MM (corresponding author), Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	manuela.marin@uibk.ac.at	Marin, Manuela M/G-8693-2012; Marin, Manuela M./Q-4496-2017	Marin, Manuela M./0000-0002-9657-1507	University of Vienna	University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The Open Access Fund pays for the publication cost.; This article was supported by the Open Access Publishing Fund of the University of Vienna.	Becker J., 2010, HDB MUSIC EMOTION TH, P127; Blacking J. D, 1973, HOW MUSICAL IS MAN; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CANTOR JR, 1973, J GEN PSYCHOL, V89, P97, DOI 10.1080/00221309.1973.9710822; Caplan P., 1987, CULTURAL CONSTRUCTIO, P1; Charlton BD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0403; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035626; Chivers ML, 2017, ARCH SEX BEHAV, V46, P1161, DOI 10.1007/s10508-016-0897-x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darwin C, 2006, SO SIMPLE BEGINNING; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher H., 2016, THE ANATOMY OF LOVE; Foster CA, 1998, J PERS SOC PSYCHOL, V74, P86, DOI 10.1037/0022-3514.74.1.86; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 2016, EVOL HUM BEHAV, V37, P85, DOI 10.1016/j.evolhumbehav.2015.09.001; Garza R, 2017, EVOL PSYCHOL-US, V15, DOI 10.1177/1474704917690741; Gerdes ABM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01351; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Gingras B, 2014, Q J EXP PSYCHOL, V67, P1428, DOI 10.1080/17470218.2013.863954; Gueguen N, 2014, PSYCHOL MUSIC, V42, P545, DOI 10.1177/0305735613482025; Herdt Gilbert, 1999, SAMBIA SEXUAL CULTUR; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Jones BC, 2007, J EVOL PSYCHOL, V5, P119, DOI DOI 10.1556/JEP.2007.1001; Kamiyama KS, 2013, NEUROPSYCHOLOGIA, V51, P500, DOI 10.1016/j.neuropsychologia.2012.11.031; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Little AC, 2014, WIRES COGN SCI, V5, P621, DOI 10.1002/wcs.1316; Marin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072412; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; MAY J L, 1980, Motivation and Emotion, V4, P217, DOI 10.1007/BF00995420; Meston CM, 2003, ARCH SEX BEHAV, V32, P537, DOI 10.1023/A:1026037527455; Miller G, 2000, ORIGINS OF MUSIC, P329; Mosing MA, 2015, EVOL HUM BEHAV, V36, P359, DOI 10.1016/j.evolhumbehav.2015.02.004; Patel A.D., 2010, EMERGING DISCIPLINES, P41; Reddy PG, 2009, INDIAN J SEXOLOGY, V1, P10; Rentfrow PJ, 2012, SOC PERSONAL PSYCHOL, V6, P402, DOI 10.1111/j.1751-9004.2012.00434.x; Roder S, 2016, PERS INDIV DIFFER, V101, P1, DOI 10.1016/j.paid.2016.05.025; ROEDERER JG, 1984, MUSIC PERCEPT, V1, P350; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Singh J, 2012, RES J, V6, P37; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; Steyer R., 1994, DIAGNOSTICA, V40, P320; Sychareun V, 2011, CULT HEALTH SEX, V13, pS249, DOI 10.1080/13691058.2011.634924; Talle A, 2007, AFRICA, V77, P351, DOI 10.1353/afr.2007.0062; Tifferet S., 2012, LETT EVOLUTIONARY BE, V3, P4, DOI DOI 10.5178/LEBS.2012.18; TURINO T, 1983, LAT AM MUSIC REV, V4, P81, DOI 10.2307/780281; Watkins CD, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160955; WHITE GL, 1981, J PERS SOC PSYCHOL, V41, P56, DOI 10.1037/0022-3514.41.1.56; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Wood W, 2014, PSYCHOL BULL, V140, P1265, DOI 10.1037/a0036722; Wood W, 2014, EMOT REV, V6, P229, DOI 10.1177/1754073914523073; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8	55	18	19	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183531	10.1371/journal.pone.0183531	http://dx.doi.org/10.1371/journal.pone.0183531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892486	Green Published, Green Submitted, gold			2022-12-26	WOS:000410243200005
J	Carson, S; Shackell, N; Flemming, JM				Carson, Stuart; Shackell, Nancy; Flemming, Joanna Mills			Local overfishing may be avoided by examining parameters of a spatio-temporal model	PLOS ONE			English	Article							COD GADUS-MORHUA; ATLANTIC COD; NORTHERN COD; STOCK ASSESSMENT; GAUSSIAN MODELS; FISH; ABUNDANCE; FISHERIES; DYNAMICS; DENSITY	Spatial erosion of stock structure through local overfishing can lead to stock collapse because fish often prefer certain locations, and fisheries tend to focus on those locations. Fishery managers are challenged to maintain the integrity of the entire stock and require scientific approaches that provide them with sound advice. Here we propose a Bayesian hierarchical spatio-temporal modelling framework for fish abundance data to estimate key parameters that define spatial stock structure: persistence (similarity of spatial structure over time), connectivity (coherence of temporal pattern over space), and spatial variance (variation across the seascape). The consideration of these spatial parameters in the stock assessment process can help identify the erosion of structure and assist in preventing local overfishing. We use Atlantic cod (Gadus morhua) in eastern Canada as a case study an examine the behaviour of these parameters from the height of the fishery through its collapse. We identify clear signals in parameter behaviour under circumstances of destructive stock erosion as well as for recovery of spatial structure even when combined with a non-recovery in abundance. Further, our model reveals the spatial pattern of areas of high and low density persists over the 41 years of available data and identifies the remnant patches. Models of this sort are crucial to recovery plans if we are to identify and protect remaining sources of recolonization for Atlantic cod. Our method is immediately applicable to other exploited species.	[Carson, Stuart; Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada; [Shackell, Nancy] Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1035, Dartmouth, NS B2Y 4T3, Canada	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Carson, S (corresponding author), Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada.	st925638@dal.ca	Shackell, Nancy L/AAF-8209-2019	Shackell, Nancy L/0000-0001-5128-948X; Mills Flemming, Joanna/0000-0002-3517-3089	National Sciences and Engineering Research Council (NSERC) of Canada [NETGP 375118-08]	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Sciences and Engineering Research Council (NSERC) of Canada Research Grant (NETGP 375118-08).	Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Cadrin S. X., 2014, STOCK IDENTIFICATION; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; Cameletti M, 2011, ENVIRONMETRICS, V22, P985, DOI 10.1002/env.1139; Campana SE, 1995, CAN J FISH AQUAT SCI, V52, P2445, DOI 10.1139/f95-835; Carson S, 2014, ECOL MODEL, V291, P175, DOI 10.1016/j.ecolmodel.2014.07.022; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Corten A, 2013, ICES J MAR SCI, V70, P1, DOI 10.1093/icesjms/fss187; Cosandey-Godin A, 2015, CAN J FISH AQUAT SCI, V72, P186, DOI 10.1139/cjfas-2014-0159; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fu CH, 2001, CAN J FISH AQUAT SCI, V58, P1613, DOI 10.1139/f01-095; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GEISSER S, 1979, J AM STAT ASSOC, V74, P153, DOI 10.2307/2286745; Pennino MG, 2014, J SEA RES, V90, P44, DOI 10.1016/j.seares.2014.03.001; Pennino MG, 2013, J SEA RES, V83, P209, DOI 10.1016/j.seares.2013.03.005; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hedger R, 2004, FISH RES, V70, P17, DOI 10.1016/j.fishres.2004.07.002; Hendrichsen D.K., 2012, J ENV STAT, V3; Horsman TL, 2009, DFO CAN TECH REP FIS, V2835; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Lindgren F, 2015, J STAT SOFTWARE, V63; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Maury O, 2001, AQUAT LIVING RESOUR, V14, P203, DOI 10.1016/S0990-7440(01)01115-9; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Munoz F, 2013, STOCH ENV RES RISK A, V27, P1171, DOI 10.1007/s00477-012-0652-3; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; OBIS, 2014, DFO STOT SUMM RES TR; Paradinas I, 2015, MAR ECOL PROG SER, V528, P245, DOI 10.3354/meps11281; Quiroz ZC, 2014, BIOMETRICS; R Core Team, 2021, R LANGUAGE ENV STAT; Reubens JT, 2013, MAR ENVIRON RES, V90, P128, DOI 10.1016/j.marenvres.2013.07.001; Reuchlin-Hugenholtz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120500; Ricard D, 2013, DFO CAN TECH REP FIS, V3012; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Safina C, 2005, SCIENCE, V309, P707, DOI 10.1126/science.1113725; Shackell NL, 1997, ICES J MAR SCI, V54, P383, DOI 10.1006/jmsc.1996.0173; Shackell NL, 2005, ECOL APPL, V15, P1440, DOI 10.1890/04-0642; Shelton AO, 2014, CAN J FISH AQUAT SCI, V71, P1655, DOI 10.1139/cjfas-2013-0508; Simpson D. P., 2015, PENALISING MODEL COM; Simpson D, 2012, SPAT STAT-NETH, V1, P16, DOI 10.1016/j.spasta.2012.02.003; Simpson D, 2012, ENVIRONMETRICS, V23, P65, DOI 10.1002/env.1137; Smith CD, 2013, CDN MANUSCRIPT RPT F, V3013; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svedang H, 2003, ICES J MAR SCI, V60, P32, DOI 10.1006/jmsc.2002.1330; SWAIN DP, 1993, CAN J FISH AQUAT SCI, V50, P725, DOI 10.1139/f93-083; Tamdrari H, 2010, ICES J MAR SCI, V67, P1676, DOI 10.1093/icesjms/fsq108; Taylor BM, 2012, INLA MCMC TUTORIAL C; Thorson JT, 2014, ICES J MARINE SCI; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008; Zuur Alain F., 2009, P1	62	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184427	10.1371/journal.pone.0184427	http://dx.doi.org/10.1371/journal.pone.0184427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886179	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100119
J	Mihalitsis, M; Bellwood, DR				Mihalitsis, Michalis; Bellwood, David R.			A morphological and functional basis for maximum prey size in piscivorous fishes	PLOS ONE			English	Article							LIONFISH PTEROIS-VOLITANS; MICROPTERUS-SALMOIDES; LARGEMOUTH BASS; HANDLING TIME; FEEDING MECHANISM; CICHLID FISHES; MARINE FISH; REEF FISHES; HABITAT USE; BODY-SIZE	Fish predation is important in shaping populations and community structure in aquatic systems. These predator-prey interactions can be influenced by environmental, behavioural and morphological factors. Morphological constraints influence the feeding performance of species, and interspecific differences can thus affect patterns of resource use. For piscivorous fishes that swallow prey whole, feeding performance has traditionally been linked to three key morphological constraints: oral gape, pharyngeal gape, and the cleithral gape. However, other constraints may be important. We therefore examine 18 potential morphological constraints related to prey capture and processing, on four predatory species (Cephalopholis urodeta, Paracirrhites forsteri, Pterois volitans, Lates calcarifer). Aquarium-based experiments were then carried out to determine capture and processing behaviour and maximum prey size in two focal species, C. urodeta and P. forsteri. All four species showed a progressive decrease in gape measurements from anterior to posterior with oral gape >= buccal >= pharyngeal >= pectoral girdle >= esophagus >= stomach. C. urodeta was able to process prey with a maximum depth of 27% of the predators' standard length; for P. forsteri it was 20%. C. urodeta captured prey head-first in 79% of successful strikes. In P. forsteri head-first was 16.6%, mid-body 44.4%, and tail-first 38.8%. Regardless of capture mode, prey were almost always swallowed head first and horizontally in both focal species. Most internal measurements appeared too small for prey to pass through. This may reflect the compressibility of prey, i.e. their ability to be dorsoventrally compressed during swallowing movements. Despite examining all known potential morphological constraints on prey size, horizontal maxillary oral gape in a mechanically stretched position appears to be the main morphological variable that is likely to affect maximum prey size and resource use by these predatory species.	[Mihalitsis, Michalis; Bellwood, David R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Mihalitsis, Michalis; Bellwood, David R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia	James Cook University; James Cook University	Mihalitsis, M (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.; Mihalitsis, M (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.	mike.mihalitsis@my.jcu.edu.au	Mihalitsis, Michalis/AAG-8919-2020		Australian Research Council (DRB) [CE140100020]	Australian Research Council (DRB)(Australian Research Council)	This study was funded by the Australian Research Council (DRB: grant number CE140100020. URL: http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Bellwood D, 2014, P R SOC B; Bellwood DR, 2017, CURR BIOL, V27, pR13, DOI 10.1016/j.cub.2016.11.018; Burress ED, 2016, ECOL FRESHW FISH, V25, P590, DOI 10.1111/eff.12236; Choat J.H., 1991, P39; Christensen B, 1996, OIKOS, V76, P368, DOI 10.2307/3546209; Feitl KE, 2010, J EXP BIOL, V213, P3131, DOI 10.1242/jeb.045518; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; Gidmark NJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1181; Goatley CHR, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1858; Graeb BDS, 2005, CAN J FISH AQUAT SCI, V62, P2010, DOI 10.1139/F05-112; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; HAMBRIGHT KD, 1991, T AM FISH SOC, V120, P500, DOI 10.1577/1548-8659(1991)120<0500:EAOPSB>2.3.CO;2; Hixon M.A., 1991, P475; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hobson E.S., 1979, PREDATOR PREY SYSTEM, P231; HOYLE JA, 1987, CAN J ZOOL, V65, P1972, DOI 10.1139/z87-300; HOYLE JA, 1988, CAN J ZOOL, V66, P540, DOI 10.1139/z88-079; Juanes Francis, 1994, Belle W. Baruch Library in Marine Science, V18, P79; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; LAWRENCE J. M., 1958, PROC ANN CONF SOUTHEASTERN ASSOC GAME AND FISH COMM, V11, P220; Lesmeister C., 2015, MASTERING MACHINE LE; LIEM KF, 1978, J MORPHOL, V158, P323, DOI 10.1002/jmor.1051580305; LUCZKOVICH JJ, 1995, ENVIRON BIOL FISH, V44, P79, DOI 10.1007/BF00005908; McGee MD, 2015, SCIENCE, V350, P1077, DOI 10.1126/science.aab0800; MITTELBACH GG, 1981, ECOLOGY, V62, P1370, DOI 10.2307/1937300; MOODY RC, 1983, ENVIRON BIOL FISH, V8, P61, DOI 10.1007/BF00004947; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; NILSSON PA, 1995, OECOLOGIA, V104, P291, DOI 10.1007/BF00328363; NORTON SF, 1995, ENVIRON BIOL FISH, V44, P287, DOI 10.1007/BF00005921; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; REIMCHEN TE, 1991, CAN J ZOOL, V69, P2912, DOI 10.1139/z91-410; RICHARD BA, 1995, J EXP BIOL, V198, P419; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SHPIGEL M, 1989, ENVIRON BIOL FISH, V24, P67, DOI 10.1007/BF00001611; St John J, 1999, MAR ECOL PROG SER, V180, P233, DOI 10.3354/meps180233; Stewart WJ, 2013, J EXP BIOL, V216, P388, DOI 10.1242/jeb.072751; Therneau Terry., 2017, RPART RECURSIVE PART; Truemper HA, 2005, J FISH BIOL, V66, P135, DOI 10.1111/j.0022-1112.2005.00588.x; Vincent SE, 2006, OECOLOGIA, V147, P204, DOI 10.1007/s00442-005-0258-2; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; WAINWRIGHT PC, 1987, J ZOOL, V213, P283, DOI 10.1111/j.1469-7998.1987.tb03704.x; WAINWRIGHT PC, 1991, AM ZOOL, V31, P680; WAINWRIGHT PC, 1988, ECOLOGY, V69, P635, DOI 10.2307/1941012; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright PC, 2001, J EXP BIOL, V204, P3039; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; Wainwright PC, 2017, CURR BIOL, V27, pR550, DOI 10.1016/j.cub.2017.03.044; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; WERNER EE, 1974, J FISH RES BOARD CAN, V31, P1531, DOI 10.1139/f74-186; WERNER EE, 1977, AM NAT, V111, P553, DOI 10.1086/283184; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289	57	44	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184679	10.1371/journal.pone.0184679	http://dx.doi.org/10.1371/journal.pone.0184679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886161	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000410001100177
J	Corkery, DP; Clarke, LE; Gebremeskel, S; Salsman, J; Pinder, J; Le Page, C; Meunier, L; Xu, Z; Mes-Masson, AM; Berman, JN; Johnston, B; Dellaire, G				Corkery, D. P.; Clarke, L. E.; Gebremeskel, S.; Salsman, J.; Pinder, J.; Le Page, C.; Meunier, L.; Xu, Z.; Mes-Masson, A-M; Berman, J. N.; Johnston, B.; Dellaire, G.			Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking	ONCOGENE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER; MALIGNANT ASCITES; DOWN-REGULATION; CELL-SURVIVAL; EGF RECEPTOR; SR PROTEINS; SPLICING FACTORS; TYROSINE KINASE	Anoikis acts as a critical barrier to metastasis by inducing cell death upon cancer cell detachment from the extracellular matrix (ECM), thereby preventing tumor cell dissemination to secondary sites. The induction of anoikis requires the lysosomal-mediated downregulation of epidermal growth factor receptors (EGFRs) leading to termination of pro-survival signaling. In this study, we demonstrate that depletion of pre-mRNA splicing factor 4 kinase (PRP4K; also known as PRPF4B) causes dysregulation of EGFR trafficking and anoikis resistance. We also report a novel cytoplasmic localization of PRP4K at the late endosome, and demonstrate both nuclear and cytoplasmic localization in breast, lung and ovarian cancer tissue. Mechanistically, depletion of PRP4K leads to reduced EGFR degradation following cell detachment from the ECM and correlates with increased TrkB, vimentin and Zeb1 expression. As a result, PRP4K loss promotes sustained growth factor signaling and increased cellular resistance to anoikis in vitro and in a novel zebrafish xenotransplantation model of anoikis sensitivity, as well as increased metastasis in a mouse model of ovarian cancer. Thus, PRP4K may serve as a potential biomarker of anoikis sensitivity in ovarian and other epithelial cancers.	[Corkery, D. P.; Dellaire, G.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Corkery, D. P.; Clarke, L. E.; Salsman, J.; Pinder, J.; Xu, Z.; Berman, J. N.; Johnston, B.; Dellaire, G.] Dalhousie Univ, Dept Pathol, POB 15000, Halifax, NS B3H 4R2, Canada; [Gebremeskel, S.; Berman, J. N.; Johnston, B.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Le Page, C.; Meunier, L.; Mes-Masson, A-M] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Le Page, C.; Meunier, L.; Mes-Masson, A-M] Inst Canc Montreal, Montreal, PQ, Canada; [Mes-Masson, A-M] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Berman, J. N.] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Berman, J. N.; Johnston, B.; Dellaire, G.] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada; [Johnston, B.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Dalhousie University; Dalhousie University	Dellaire, G (corresponding author), Dalhousie Univ, Dept Pathol, POB 15000, Halifax, NS B3H 4R2, Canada.; Johnston, B (corresponding author), Dalhousie Univ, Dept Microbiol, POB 15000, Halifax, NS B3H 4R2, Canada.; Johnston, B (corresponding author), Dalhousie Univ, Dept Immunol, POB 15000, Halifax, NS B3H 4R2, Canada.	brent.johnston@dal.ca; dellaire@dal.ca	gebremeskel, Simon/AAZ-3334-2020; Le Page, Cecile/B-3215-2010; Johnston, Brent/E-2607-2013; Dellaire, Graham/L-9948-2014	gebremeskel, Simon/0000-0002-8484-8177; Le Page, Cecile/0000-0002-8020-1544; Johnston, Brent/0000-0001-5456-2824; Dellaire, Graham/0000-0002-3466-6316; Corkery, Dale/0000-0001-7930-0134; Mes-Masson, Anne-Marie/0000-0002-6498-266X	Cancer Research Network Tissue Bank of the Fonds de recherche du Quebec-Sante (FRQS); Canadian Breast Cancer Foundation (CBCF); Breast Cancer Society/QEII Foundation; Canadian Institutes of Health Research (CIHR) [MOP-110988, PJT-153285]; BHCRI; CBCF-Atlantic; Canadian Cancer Society, Nova Scotia Division as part of The Terry Fox Foundation Strategic Health Research Training (STIHR) Program in Cancer Research at the CIHR; Killam Trusts; CIHR	Cancer Research Network Tissue Bank of the Fonds de recherche du Quebec-Sante (FRQS); Canadian Breast Cancer Foundation (CBCF); Breast Cancer Society/QEII Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BHCRI; CBCF-Atlantic; Canadian Cancer Society, Nova Scotia Division as part of The Terry Fox Foundation Strategic Health Research Training (STIHR) Program in Cancer Research at the CIHR; Killam Trusts; CIHR(Canadian Institutes of Health Research (CIHR))	We thank the Gynecology-Oncology and Pathology services of the CHUM-Hopital Notre-Dame for tumor procurement, Gretchen Wagner for fish care, and Monique Bernard for technical assistance. Ovarian and breast tumor banking was supported by the Cancer Research Network Tissue Bank of the Fonds de recherche du Quebec-Sante (FRQS). This work was funded by research grants from the Canadian Breast Cancer Foundation (CBCF) and the Breast Cancer Society/QEII Foundation awarded to GD, and research grants to BJ from the Canadian Institutes of Health Research (CIHR) (MOP-110988, PJT-153285). GD, JB and BJ are Senior Scientists of the Beatrice Hunter Cancer Research Institute (BHCRI), and DPC, LC, JS and JP were supported by trainee awards from the BHCRI with funds provided by CBCF-Atlantic, The Canadian Cancer Society, Nova Scotia Division as part of The Terry Fox Foundation Strategic Health Research Training (STIHR) Program in Cancer Research at the CIHR. SG is the recipient of doctoral awards from the Killam Trusts, CIHR, and BHCRI.	Adam RA, 2004, J AM COLL SURGEONS, V198, P999, DOI 10.1016/j.jamcollsurg.2004.01.035; Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Ayantunde AA, 2007, ANN ONCOL, V18, P945, DOI 10.1093/annonc/mdl499; Bedard K, 2009, HUM MUTAT, V30, P1123, DOI 10.1002/humu.21029; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bookman MA, 1996, J CLIN ONCOL, V14, P1895, DOI 10.1200/JCO.1996.14.6.1895; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corkery DP, 2015, CELL CYCLE, V14, P1059, DOI 10.1080/15384101.2015.1007775; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; EARP HS, 1986, J BIOL CHEM, V261, P4777; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FELDMAN GB, 1972, CANCER RES, V32, P1663; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GARRISON RN, 1986, ANN SURG, V203, P644, DOI 10.1097/00000658-198606000-00009; Gebremeskel S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.995562; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Grassian AR, 2011, J BIOL CHEM, V286, P79, DOI 10.1074/jbc.M110.169821; Gross T, 1997, NUCLEIC ACIDS RES, V25, P1028, DOI 10.1093/nar/25.5.1028; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Herzog TJ, 2004, CLIN CANCER RES, V10, P7439, DOI 10.1158/1078-0432.CCR-04-0683; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kojima T, 2001, J BIOL CHEM, V276, P32247, DOI 10.1074/jbc.M103790200; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Le Page C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038541; Letourneau IJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-379; MARKMAN M, 1992, J CLIN ONCOL, V10, P1485, DOI 10.1200/JCO.1992.10.9.1485; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nguyen LN, 2006, CLIN CANCER RES, V12, P6952, DOI 10.1158/1078-0432.CCR-06-0317; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Parsons SL, 1996, EUR J SURG ONCOL, V22, P237, DOI 10.1016/S0748-7983(96)80009-6; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Scharaw S, 2016, J CELL BIOL, V215, P543, DOI 10.1083/jcb.201601090; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	65	9	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					174	184		10.1038/onc.2017.318	http://dx.doi.org/10.1038/onc.2017.318			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28892043	Green Published, hybrid			2022-12-26	WOS:000422631700004
J	Sheikh, MO; Thieker, D; Chalmers, G; Schafer, CM; Ishihara, M; Azadi, P; Woods, RJ; Glushka, JN; Bendiak, B; Prestegard, JH; West, CM				Sheikh, M. Osman; Thieker, David; Chalmers, Gordon; Schafer, Christopher M.; Ishihara, Mayumi; Azadi, Parastoo; Woods, Robert J.; Glushka, John N.; Bendiak, Brad; Prestegard, James H.; West, Christopher M.			O-2 sensing-associated glycosylation exposes the F-box-combining site of the Dictyostelium Skp1 subunit in E3 ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate structure; Dictyostelium; E3 ubiquitin ligase; glycoprotein structure; glycosylation; mathematical modeling; molecular dynamics; nuclear magnetic resonance (NMR)	MOLECULAR-DYNAMICS SIMULATIONS; NUCLEAR-MAGNETIC-RESONANCE; COMPUTER-PROGRAM CASPER; MODEL-FREE APPROACH; PROLYL 4-HYDROXYLASE; SYMBOL NOMENCLATURE; PROMOTES FORMATION; NMR-SPECTROSCOPY; PROTEIN SKP1; OLIGOSACCHARIDES	Skp1 is a conserved protein linking cullin-1 to F-box proteins in SCF (Skp1/Cullin-1/F-box protein) E3 ubiquitin ligases, which modify protein substrates with polyubiquitin chains that typically target them for 26S proteasome-mediated degradation. In Dictyostelium (a social amoeba), Toxoplasma gondii (the agent for human toxoplasmosis), and other protists, Skp1 is regulated by a unique pentasaccharide attached to hydroxylated Pro-143 within its C-terminal F-box-binding domain. Prolyl hydroxylation of Skp1 contributes to O-2-dependent Dictyostelium development, but full glycosylation at that position is required for optimal O-2 sensing. Previous studies have shown that the glycan promotes organization of the F-box-binding region in Skp1 and aids in Skp1's association with F-box proteins. Here, NMR and MS approaches were used to determine the glycan structure, and then a combination of NMR and molecular dynamics simulations were employed to characterize the impact of the glycan on the conformation and motions of the intrinsically flexible F-box-binding domain of Skp1. Molecular dynamics trajectories of glycosylated Skp1 whose calculated monosaccharide relaxation kinetics and rotational correlation times agreed with the NMR data indicated that the glycan interacts with the loop connecting two -helices of the F-box-combining site. In these trajectories, the helices separated from one another to create a more accessible and dynamic F-box interface. These results offer an unprecedented view of how a glycan modification influences a disordered region of a full-length protein. The increased sampling of an open Skp1 conformation can explain how glycosylation enhances interactions with F-box proteins in cells.	[Sheikh, M. Osman; Woods, Robert J.; Prestegard, James H.; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Sheikh, M. Osman; Thieker, David; Chalmers, Gordon; Ishihara, Mayumi; Azadi, Parastoo; Woods, Robert J.; Glushka, John N.; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Chalmers, Gordon] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Sheikh, M. Osman; Schafer, Christopher M.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Bendiak, Brad] Univ Colorado Anschutz Med Campus, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Colorado System; University of Colorado Anschutz Medical Campus	West, CM (corresponding author), 120 E Green St,Davison Life Sci A310, Athens, GA 30602 USA.	westcm@uga.edu		Thieker, David/0000-0003-0786-8278; Aoki, Mayumi/0000-0002-8368-8546; Sheikh, Mohammed/0000-0002-9481-8318; Woods, Robert/0000-0002-2400-6293	National Institutes of Health [R01 GM037539, U01 CA207824, P41 GM103390, P41 RR018502]; NATIONAL CANCER INSTITUTE [U01CA207824] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM037539, P41GM103490] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01 GM037539, U01 CA207824, P41 GM103390, and P41 RR018502. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almond A, 2004, BIOCHEMISTRY-US, V43, P5853, DOI 10.1021/bi0354886; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold U, 1997, BIOCHEMISTRY-US, V36, P2166, DOI 10.1021/bi962723u; Barb AW, 2015, BIOCHEMISTRY-US, V54, P313, DOI 10.1021/bi501380t; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Boutet Emmanuel, 2007, V406, P89; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER 12; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P333, DOI 10.1016/B978-012164491-8/50007-5; Chalmers G, 2016, J MAGN RESON, V265, P1, DOI 10.1016/j.jmr.2016.01.006; Chinoy ZS, 2015, CHEM-EUR J, V21, P11779, DOI 10.1002/chem.201501598; Dantu SC, 2016, PROTEINS, V84, P159, DOI 10.1002/prot.24963; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Goddard D., 2008, SPARKY 3; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HURD RE, 1990, J MAGN RESON, V87, P422, DOI 10.1016/0022-2364(90)90021-Z; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kachariya NN, 2016, BIOMOL NMR ASSIGN, V10, P351, DOI 10.1007/s12104-016-9699-2; Kapaev RR, 2015, ANAL CHEM, V87, P7006, DOI 10.1021/acs.analchem.5b01413; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Levitt M., 2008, SPIN DYNAMICS BASICS, P543; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Martin-Pastor M, 2000, BIOCHEMISTRY-US, V39, P4674, DOI 10.1021/bi992050q; Mosadeghi R, 2016, ELIFE, V5, DOI 10.7554/eLife.12102; NEUROHR KJ, 1980, BIOPHYS J, V32, P931, DOI 10.1016/S0006-3495(80)85027-2; Owens NW, 2007, J AM CHEM SOC, V129, P11670, DOI 10.1021/ja073488d; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pochapsky T. C, 2007, NMR PHYS BIOL SCI, P95; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ronnols J, 2013, CARBOHYD RES, V380, P156, DOI 10.1016/j.carres.2013.06.026; Schafer CM, 2014, J BIOL CHEM, V289, P9076, DOI 10.1074/jbc.M113.528679; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Sheikh MO, 2015, MOL CELL PROTEOMICS, V14, P66, DOI 10.1074/mcp.M114.044560; Sheikh MO, 2014, BIOCHEMISTRY-US, V53, P1657, DOI 10.1021/bi401707y; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Spencer N.D., 2001, ENCY CHEM PHYS PHYS; Takeuchi H, 2017, J BIOL CHEM, V292, P15964, DOI 10.1074/jbc.M117.800102; Taylor M. E, 2011, INTRO GLYCOBIOLOGY; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Thieker DF, 2016, GLYCOBIOLOGY, V26, P786, DOI 10.1093/glycob/cww076; Thrippleton MJ, 2003, ANGEW CHEM INT EDIT, V42, P3938, DOI 10.1002/anie.200351947; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Venkatramani L, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-7; Wang XY, 2012, J PHYS CHEM B, V116, P11570, DOI 10.1021/jp304116d; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; West CM, 1996, J BIOL CHEM, V271, P12024, DOI 10.1074/jbc.271.20.12024; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Woods R. J., 2014, GLYCAM WEB; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Yen JL, 2012, MOL CELL, V48, P288, DOI 10.1016/j.molcel.2012.08.015; Yumimoto K, 2013, J BIOL CHEM, V288, P32766, DOI 10.1074/jbc.M113.511303; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021; Zierke M, 2013, J AM CHEM SOC, V135, P13464, DOI 10.1021/ja4054702; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	78	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18897	18915		10.1074/jbc.M117.809160	http://dx.doi.org/10.1074/jbc.M117.809160			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28928219	Green Published, hybrid			2022-12-26	WOS:000415848000015
J	Ouyang, WM; Guo, PF; Fang, H; Frucht, DM				Ouyang, Weiming; Guo, Pengfei; Fang, Hui; Frucht, David M.			Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-KINASE; ACTIVATION; PATHWAY; CELLS; FRA-1; MKK7; RAS; PHOSPHORYLATION; INACTIVATION; ANGIOGENESIS	Anthrax is a life-threatening disease caused by infection with Bacillus anthracis, which expresses lethal factor and the receptor-binding protective antigen. These two proteins combine to form anthrax lethal toxin (LT), whose proximal targets are mitogen-activated kinase kinases (MKKs). However, the downstream mediators of LT toxicity remain elusive. Here we report that LT exposure rapidly reduces the levels of c-Jun, a key regulator of cell proliferation and survival. Blockade of proteasome-dependent protein degradation with the 26S proteasome inhibitor MG132 largely restored c-Jun protein levels, suggesting that LT promotes degradation of c-Jun protein. Using the MKK1/2 inhibitor U0126, we further show that MKK1/2-Erk1/2 pathway inactivation similarly reduces c-Jun protein, which was also restored by MG132 pre-exposure. Interestingly, c-Jun protein rebounded to normal levels 4 h following U0126 exposure but not after LT exposure. The restoration of c-Jun in U0126-exposed cells was associated with increased c-Jun mRNA levels and was blocked by inactivation of the JNK1/2 signaling pathway. These results indicate that LT reduces c-Jun both by promoting c-Jun protein degradation via inactivation of MKK1/2Erk1/2 signaling and by blocking c-Jun gene transcription via inactivation of MKK4-JNK1/2 signaling. In line with the known functions of c-Jun, LT also inhibited cell proliferation. Ectopic expression of LT-resistant MKK2 and MKK4 variants partially restored Erk1/2 and JNK1/2 signaling in LT-exposed cells, enabling the cells to maintain relatively normal c-Jun protein levels and cell proliferation. Taken together, these findings indicate that LT reduces c-Jun protein levels via two distinct mechanisms, thereby inhibiting critical cell functions, including cellular proliferation.	[Ouyang, Weiming; Guo, Pengfei; Fang, Hui; Frucht, David M.] US FDA, Div Biotechnol Review & Res 2, Off Biotechnol Prod, Off Pharmaceut Qual,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Frucht, DM (corresponding author), US FDA, Div Biotechnol Review & Res 2, Off Biotechnol Prod, Off Pharmaceut Qual,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	david.frucht@fda.hhs.gov	Guo, pengfei/GPK-2872-2022; Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019		internal Food and Drug Administration	internal Food and Drug Administration	This work was partially supported by an internal Food and Drug Administration medical countermeasures grant. The authors declare that they have no conflicts of interest with the contents of this article. This manuscript reflects the views of the authors and should not be construed to represent FDA's views or policies.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Alfano RW, 2008, CELL CYCLE, V7, P745, DOI 10.4161/cc.7.6.5627; Alfano RW, 2009, MOL CANCER RES, V7, P452, DOI 10.1158/1541-7786.MCR-08-0451; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; CAVALIERI F, 1985, VIROLOGY, V143, P680, DOI 10.1016/0042-6822(85)90412-X; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Depeille P, 2007, CLIN CANCER RES, V13, P5926, DOI 10.1158/1078-0432.CCR-07-0732; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; King JW, 2014, FUTURE ONCOL, V10, P1559, DOI [10.2217/FON.14.89, 10.2217/fon.14.89]; Lee CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017165; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Ouyang WM, 2014, J BIOL CHEM, V289, P4180, DOI 10.1074/jbc.M113.530006; Pakay JL, 2012, ONCOGENE, V31, P1817, DOI 10.1038/onc.2011.375; Peters DE, 2014, TOXICOL APPL PHARM, V279, P220, DOI 10.1016/j.taap.2014.06.010; Phillips DD, 2013, J BIOL CHEM, V288, P9058, DOI 10.1074/jbc.M113.452110; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sun C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033583; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zhang Z, 2017, P NATL ACAD SCI USA, V114, P3903, DOI 10.1073/pnas.1621177114; Zhu ZQ, 2016, CRIT REV ONCOL HEMAT, V99, P91, DOI 10.1016/j.critrevonc.2015.12.002	57	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17919	17927		10.1074/jbc.M117.805648	http://dx.doi.org/10.1074/jbc.M117.805648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893904	Green Published, hybrid			2022-12-26	WOS:000414013000027
J	Xu, Y; Chen, GQ; Greer, MS; Caldo, KMP; Ramakrishnan, G; Shah, S; Wu, LM; Lemieux, MJ; Ozga, J; Weselake, RJ				Xu, Yang; Chen, Guanqun; Greer, Michael S.; Caldo, Kristian Mark P.; Ramakrishnan, Geetha; Shah, Saleh; Wu, Limin; Lemieux, M. Joanne; Ozga, Jocelyn; Weselake, Randall J.			Multiple mechanisms contribute to increased neutral lipid accumulation in yeast producing recombinant variants of plant diacylglycerol acyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFORMED GENETIC MANIPULATION; METABOLIC-CONTROL ANALYSIS; SEED OIL CONTENT; SUBSTRATE-INHIBITION; DIRECTED EVOLUTION; BRASSICA-NAPUS; TRIACYLGLYCEROL ACCUMULATION; OVER-EXPRESSION; CAMELINA-SATIVA; OILSEED RAPE	The apparent bottleneck in the accumulation of oil during seed development in some oleaginous plant species is the formation of triacylglycerol (TAG) by the acyl-CoA-dependent acylation of sn-1,2-diacylglycerol catalyzed by diacylglycerol acyltransferase (DGAT, EC 2.3.1.20). Improving DGAT activity using protein engineering could lead to improvements in seed oil yield (e.g. in canola-type Brassica napus). Directed evolution of B. napus DGAT1 (BnaDGAT1) previously revealed that one of the regions where amino acid residue substitutions lead to higher performance in BnaDGAT1 is in the ninth predicted transmembrane domain (PTMD9). In this study, several BnaDGAT1 variants with amino acid residue substitutions in PTMD9 were characterized. Among these enzyme variants, the extent of yeast TAG production was affected by different mechanisms, including increased enzyme activity, increased polypeptide accumulation, and possibly reduced substrate inhibition. The kinetic properties of the BnaDGAT1 variants were affected by the amino acid residue substitutions, and a new kinetic model based on substrate inhibition and sigmoidicity was generated. Based on sequence alignment and further biochemical analysis, the amino acid residue substitutions that conferred increased TAG accumulation were shown to be present in the DGAT1-PTMD9 region of other higher plant species. When amino acid residue substitutions that increased BnaDGAT1 enzyme activity were introduced into recombinant Camelina sativa DGAT1, they also improved enzyme performance. Thus, the knowledge generated from directed evolution of DGAT1 in one plant species can be transferred to other plant species and has potentially broad applications in genetic engineering of oleaginous crops and microorganisms.	[Xu, Yang; Chen, Guanqun; Greer, Michael S.; Caldo, Kristian Mark P.; Ramakrishnan, Geetha; Shah, Saleh; Ozga, Jocelyn; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [Caldo, Kristian Mark P.; Lemieux, M. Joanne] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Wu, Limin] InnoTech Alberta, Crop Pathol & Biotechnol, Vegreville, AB T9C 1T4, Canada	University of Alberta; University of Alberta	Weselake, RJ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca	Chen, Guanqun/K-7009-2012; Caldo, Kristian/AAM-8663-2020	Chen, Guanqun/0000-0001-5790-3903; Xu, Yang/0000-0001-7587-2194; Lemieux, Joanne/0000-0003-4745-9153	Alberta Innovates Bio Solutions; Natural Science and Engineering Research Council of Canada [RGPIN-2014-04585, RGPIN-2016-05926]; Canada Research Chairs Program; National Research Strategy BioEconomy Program of the Federal Ministry of Education and Research (Germany); MITACS Elevate Award; Alberta Innovates Technology Futures	Alberta Innovates Bio Solutions; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); National Research Strategy BioEconomy Program of the Federal Ministry of Education and Research (Germany); MITACS Elevate Award; Alberta Innovates Technology Futures	This work was supported by Alberta Innovates Bio Solutions, Natural Science and Engineering Research Council of Canada Grants RGPIN-2014-04585 (to R. J. W.) and RGPIN-2016-05926 (to G. C.), and the Canada Research Chairs Program. This work was also supported by the National Research Strategy BioEconomy Program of the Federal Ministry of Education and Research (Germany), MITACS Elevate Award (to G. R.), and Alberta Innovates Technology Futures. The authors declare that they have no conflicts of interest with the contents of this article.	Aznar-Moreno JA, 2017, PLANT CELL PHYSIOL, V58, P1260, DOI 10.1093/pcp/pcx058; BAFOR M, 1990, J AM OIL CHEM SOC, V67, P217, DOI 10.1007/BF02540647; Bansal S, 2016, BIOCHIMIE, V120, P9, DOI 10.1016/j.biochi.2015.06.009; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt C, 2016, BIOCHEM BIOPH RES CO, V475, P264, DOI 10.1016/j.bbrc.2016.05.071; Caldo KMP, 2017, PLANT PHYSIOL, V175, P667, DOI 10.1104/pp.17.00934; Caldo KMP, 2015, FEBS LETT, V589, P773, DOI 10.1016/j.febslet.2015.02.008; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Chapman KD, 2012, J BIOL CHEM, V287, P2288, DOI 10.1074/jbc.R111.290072; Chen GQ, 2017, PLANT J, V92, P167, DOI 10.1111/tpj.13652; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Cheng F, 2015, CHEM COMMUN, V51, P9760, DOI 10.1039/c5cc01594d; Chung MY, 2006, PLANTA MED, V72, P267, DOI 10.1055/s-2005-916178; Cohen G. N., 2014, MICROBIAL BIOCH, P59; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Efimov I, 2012, J AM CHEM SOC, V134, P3034, DOI 10.1021/ja208694g; Elamin AA, 2011, MOL MICROBIOL, V81, P1577, DOI 10.1111/j.1365-2958.2011.07792.x; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Gidda SK, 2011, TRAFFIC, V12, P452, DOI 10.1111/j.1600-0854.2011.01160.x; Harwood JL, 2013, EUR J LIPID SCI TECH, V115, P1239, DOI 10.1002/ejlt.201300257; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karim AS, 2013, FEMS YEAST RES, V13, P107, DOI 10.1111/1567-1364.12016; Kim H, 2016, PLANT BIOTECHNOL REP, V10, P141, DOI 10.1007/s11816-016-0394-7; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Liao JL, 2016, BIOSCI BIOTECH BIOCH, V80, P1747, DOI 10.1080/09168451.2015.1136884; LITTLE D, 1994, BIOCHEM J, V304, P951, DOI 10.1042/bj3040951; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Lopes JLS, 2014, BBA-BIOMEMBRANES, V1838, P3145, DOI 10.1016/j.bbamem.2014.08.017; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Misra A, 2013, PHYTOCHEMISTRY, V96, P37, DOI 10.1016/j.phytochem.2013.09.020; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Roesler K, 2016, PLANT PHYSIOL, V171, P878, DOI 10.1104/pp.16.00315; Ruiz-Lopez N, 2010, PLANT PHYSIOL BIOCH, V48, P73, DOI 10.1016/j.plaphy.2009.12.001; Salas JJ, 2014, PROG LIPID RES, V55, P30, DOI 10.1016/j.plipres.2014.05.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siloto RMP, 2008, BIOCHEM BIOPH RES CO, V373, P350, DOI 10.1016/j.bbrc.2008.06.031; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Siloto RMP, 2009, PLANT PHYSIOL BIOCH, V47, P456, DOI 10.1016/j.plaphy.2008.12.019; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234; Stoveken T, 2005, J BACTERIOL, V187, P1369, DOI 10.1128/JB.187.4.1369-1376.2005; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Taylor DC, 2009, BOTANY, V87, P533, DOI 10.1139/B08-101; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Weselake RJ, 2008, J EXP BOT, V59, P3543, DOI 10.1093/jxb/ern206; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	61	17	18	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17819	17831		10.1074/jbc.M117.811489	http://dx.doi.org/10.1074/jbc.M117.811489			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28900030	Green Published, hybrid			2022-12-26	WOS:000414013000019
J	Kawade, K; Tsukaya, H				Kawade, Kensuke; Tsukaya, Hirokazu			Probing the stochastic property of endoreduplication in cell size determination of Arabidopsis thaliana leaf epidermal tissue	PLOS ONE			English	Article							PROTEIN EXPRESSION; DEVELOPING LEAVES; GENE-EXPRESSION; CYCLE ARREST; GROWTH; PROLIFERATION; PLANTS; NOISE; TRANSCRIPTOME; MECHANISMS	Cell size distribution is highly reproducible, whereas the size of individual cells often varies greatly within a tissue. This is obvious in a population of Arabidopsis thaliana leaf epidermal cells, which ranged from 1,000 to 10,000 mu m(2) in size. Endoreduplicationis a specialized cell cycle in which nuclear genome size (ploidy) is doubled in the absence of cell division. Although epidermal cells require endoreduplication to enhance cellular expansion, the issue of whether this mechanism is sufficient for explaining cell size distribution remains unclear due to a lack of quantitative understanding linking the occurrence of endoreduplication with cell size diversity. Here, we addressed this question by quantitatively summarizing ploidy profile and cell size distribution using a simple theoretical framework. We first found that endoreduplication dynamics is a Poisson process through cellular maturation. This finding allowed us to construct a mathematical model to predict the time evolution of a ploidy profile with a single rate constant for endoreduplication occurrence in a given time. We reproduced experimentally measured ploidy profile in both wild-type leaf tissue and endoreduplication-related mutants with this analytical solution, further demonstrating the probabilistic property of endoreduplication. We next extended the mathematical model by incorporating the element that cell size is determined according to ploidy level to examine cell size distribution. This analysis revealed that cell size is exponentially enlarged 1.5 times every endoreduplication round. Because this theoretical simulation successfully recapitulated experimentally observed cell size distributions, we concluded that Poissonian endoreduplication dynamics and exponential size-boosting are the sources of the broad cell size distribution in epidermal tissue. More generally, this study contributes to a quantitative understanding whereby stochastic dynamics generate steady-state biological heterogeneity.	[Kawade, Kensuke; Tsukaya, Hirokazu] Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Kawade, Kensuke] Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Kawade, Kensuke] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Tsukaya, Hirokazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo	Kawade, K (corresponding author), Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan.; Kawade, K (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi, Japan.; Kawade, K (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	kawa-ken@ribb.ac.jp	Tsukaya, Hirokazu/A-2614-2013	Tsukaya, Hirokazu/0000-0002-4430-4538; Kawade, Kensuke/0000-0003-1701-4567	BIO-NEXT project from Okazaki Institute for Integrative Bioscience; Sumitomo Foundation [150238]; Japan Society for the Promotion of Science [17K15147, 25113002]; Grants-in-Aid for Scientific Research [17K15147, 25113002] Funding Source: KAKEN	BIO-NEXT project from Okazaki Institute for Integrative Bioscience; Sumitomo Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by BIO-NEXT project from Okazaki Institute for Integrative Bioscience (K.K. and H.T.), Grant for Basic Science Research Projects from The Sumitomo Foundation (150238) (K.K.), and Grants-in-aid for Young scientists (B) (17K15147) (K.K.) and Scientific research on innovation areas (25113002) (H.T.) from Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bertin N, 2007, J EXP BOT, V58, P1903, DOI 10.1093/jxb/erm052; Boettiger AN, 2013, BIOPHYS J, V105, P2629, DOI 10.1016/j.bpj.2013.10.033; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; Boudolf V, 2009, PLANT PHYSIOL, V150, P1482, DOI 10.1104/pp.109.140269; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elsner J, 2012, ANN BOT-LONDON, V109, P897, DOI 10.1093/aob/mcs005; Floyd DL, 2010, BIOPHYS J, V99, P360, DOI 10.1016/j.bpj.2010.04.049; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Hervieux N, 2016, CURR BIOL, V26, P1019, DOI 10.1016/j.cub.2016.03.004; Hong LL, 2016, DEV CELL, V38, P15, DOI 10.1016/j.devcel.2016.06.016; Imai KK, 2006, PLANT CELL, V18, P382, DOI 10.1105/tpc.105.037309; Javelle M, 2011, NEW PHYTOL, V189, P17, DOI 10.1111/j.1469-8137.2010.03514.x; Kalve S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00362; Katagiri Y, 2016, DEVELOPMENT, V143, P1120, DOI 10.1242/dev.130021; Kawade K, 2013, CURR BIOL, V23, P788, DOI 10.1016/j.cub.2013.03.044; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Meyer HM, 2017, ELIFE, V6, DOI [10.7554/elife.19131, 10.7554/eLife.19131]; Modi S, 2017, BIOPHYS J, V112, P2408, DOI 10.1016/j.bpj.2017.04.050; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Narukawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134547; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; POETHIG S, 1989, TRENDS GENET, V5, P273, DOI 10.1016/0168-9525(89)90101-7; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Sako K, 2010, PLANT SIGNAL BEHAV, V5, P1119, DOI 10.4161/psb.5.9.12479; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Serrano-Mislata A, 2015, CURR BIOL, V25, P2991, DOI 10.1016/j.cub.2015.10.008; Skirycz A, 2011, PLANT CELL, V23, P1876, DOI 10.1105/tpc.111.084160; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Sugiyama M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003957; Szymkowiak EJ, 1996, ANNU REV PLANT PHYS, V47, P351, DOI 10.1146/annurev.arplant.47.1.351; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; White DE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002952; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107	44	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185050	10.1371/journal.pone.0185050	http://dx.doi.org/10.1371/journal.pone.0185050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926847	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600064
J	Buonomo, OC; Caredda, E; Portarena, I; Vanni, G; Orlandi, A; Bagni, C; Petrella, G; Palombi, L; Orsaria, P				Buonomo, Oreste Claudio; Caredda, Emanuele; Portarena, Ilaria; Vanni, Gianluca; Orlandi, Augusto; Bagni, Claudia; Petrella, Giuseppe; Palombi, Leonardo; Orsaria, Paolo			New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes	PLOS ONE			English	Article							DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; HER-2 NEU ONCOGENE; TUMOR SIZE; PROGNOSTIC-FACTORS; ESTROGEN-RECEPTOR; SURVIVAL; CARCINOMA; TRASTUZUMAB; EXPRESSION; OUTCOMES	Despite advances in treatment, up to 30% of patients with early breast cancer (BC) experience distant disease relapse. However, a comprehensive understanding of tumor spread and site-specific recurrence patterns remains lacking. This retrospective case-control study included 103 consecutive patients with metastatic BC admitted to our institution (2000-2013). Cases were matched according to age, tumor biology, and clinicopathological features to 221 patients with non-metastatic BC (control group). The median follow-up period among the 324 eligible patients was 7.3 years. While relatively low values for sensitivity (71%) and specificity (56%) were found for axillary lymph node (ALN) involvement as an indicator of risk and pattern of distant relapse, nodal status remained the most powerful predictor of metastases (OR: 3.294; CL: 1.9-5.5). Rates of dissemination and metastatic efficiency differed according to molecular subtype. HER2-positive subtypes showed a stronger association with systemic spread (OR: 2.127; CL: 1.2-3.8) than other subgroups. Classification as Luminal or Non-Luminal showed an increased risk of lung and distant nodal recurrence, and a decreased risk in bone metastases in the Non-Luminal group (OR: 2.9, 3.345, and 0.2, respectively). Tumors with HER2 overexpression had a significantly high risk for distant relapse (OR: 2.127) compared with HER2-negative tumors and also showed higher central nervous system (CNS) and lung metastatic potential (OR: 5.6 and 2.65, respectively) and low risk of bone disease progression (OR: 0.294). Furthermore, we found significant associations between biological profiles and sites of recurrence. A new process of clinical/diagnostic staging, including molecular subtypes, could better predict the likelihood of distant relapses and their anatomical location. Recognition and appreciation of clinically distinct molecular subtypes may assist in evaluation of the probability of distant relapses and their sites. Our analysis provides new insights into management of metastatic disease behavior, to lead to an optimal disease-tailored approach and appropriate follow-up.	[Buonomo, Oreste Claudio; Vanni, Gianluca; Petrella, Giuseppe; Orsaria, Paolo] Tor Vergata Univ Hosp, Dept Surg, Rome, Italy; [Caredda, Emanuele; Bagni, Claudia; Palombi, Leonardo] Tor Vergata Univ Hosp, Dept Biomed & Prevent, Rome, Italy; [Portarena, Ilaria] Tor Vergata Univ Hosp, Dept Internal Med, Med Oncol Unit, Rome, Italy; [Orlandi, Augusto] Tor Vergata Univ Hosp, Dept Biomed & Prevent, Anat Pathol, Rome, Italy	University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata	Palombi, L (corresponding author), Tor Vergata Univ Hosp, Dept Biomed & Prevent, Rome, Italy.	leonardo.palombi@gmail.com	Vanni, Gianluca/AAJ-9743-2020; Palombi, Leonardo/I-4043-2019; Orlandi, Augusto/AHE-8753-2022; Caredda, Emanuele/AAB-5230-2020; Orsaria, Paolo/AAX-7057-2021	Palombi, Leonardo/0000-0003-1806-5278; Caredda, Emanuele/0000-0002-2828-6202; Orsaria, Paolo/0000-0002-6224-7784; Bagni, Claudia/0000-0002-4419-210X; vanni, gianluca/0000-0002-3006-5855				ANBAZHAGAN R, 1991, ANN ONCOL, V2, P47, DOI 10.1093/oxfordjournals.annonc.a057824; Arriagada R, 2006, CANCER-AM CANCER SOC, V106, P743, DOI 10.1002/cncr.21659; ARRIAGADA R, 1992, BREAST CANCER RES TR, V21, P101, DOI 10.1007/BF01836956; Atahan IL, 2008, ACTA ONCOL, V47, P232, DOI 10.1080/02841860701678761; Azzato EM, 2009, BRIT J CANCER, V100, P1806, DOI 10.1038/sj.bjc.6605062; BARNES DM, 1988, BRIT J CANCER, V58, P448, DOI 10.1038/bjc.1988.238; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bonadonna G, 2003, MED ONCOLOGICA; BORG A, 1990, CANCER RES, V50, P4332; BUZZONI R, 1991, J CLIN ONCOL, V9, P2134, DOI 10.1200/JCO.1991.9.12.2134; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; Clayton AJ, 2004, BRIT J CANCER, V91, P639, DOI 10.1038/sj.bjc.6601970; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Duan XF, 2013, INT J CLIN ONCOL, V18, P26, DOI 10.1007/s10147-011-0336-x; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Gajdos C, 1999, ANN SURG, V230, P692, DOI 10.1097/00000658-199911000-00012; Fernandez AG, 2012, BREAST, V21, P366, DOI 10.1016/j.breast.2012.03.004; Ge QD, 2012, ASIAN PAC J CANC PRE, V13; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montemurro F, 2013, ANN ONCOL, V24, P2715, DOI 10.1093/annonc/mdt287; Nabholtz JM PT, 2002, P AN M AM SOC CLIN, V21, p36a; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Olson EM, 2013, BREAST, V22, P525, DOI 10.1016/j.breast.2012.12.006; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saip P, 2008, BREAST, V17, P451, DOI 10.1016/j.breast.2008.03.004; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smalley RV, 1997, CANCER, V40, P625; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; SPYRATOS F, 1992, J NATL CANCER I, V84, P1266, DOI 10.1093/jnci/84.16.1266; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127	49	61	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184680	10.1371/journal.pone.0184680	http://dx.doi.org/10.1371/journal.pone.0184680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922402	Green Submitted, Green Published, gold			2022-12-26	WOS:000411059300022
J	Clerc, A; Reynaud, Q; Durupt, S; Chapuis-Cellier, C; Nove-Josserand, R; Durieu, I; Lega, JC				Clerc, Axelle; Reynaud, Quitterie; Durupt, Steaphane; Chapuis-Cellier, Colette; Nove-Josserand, Raphaeele; Durieu, Isabelle; Lega, Jean Christophe			Elevated IgG4 serum levels in patients with cystic fibrosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SUBCLASS LEVELS; BETA-LACTAMASE; LUNG-DISEASE; IMMUNOGLOBULIN; ASSOCIATION; INHIBITION; ANTIBODIES; INFECTION; ADULTS	Objective Serum immunoglobulin (Ig) G4 elevation has been associated with several pathological conditions other than IgG4-related disease (IgG4-RD). In cystic fibrosis (CF), an elevation of specific IgG4 has been associated with colonization and infection by Pseudomonas aeruginosa. IgG4 elevation may be a marker of chronic infection or inflammatory stimulation. The aim of this study was to explore the prevalence of elevated IgG4 levels in CF and its correlation with the major clinical and microbiological features found in CF patients. Methods In a cross-sectional study, we analyzed data from a large cohort of adult CF patients attending the CF center of Lyon University Hospital. An elevated IgG4 level was defined as being above the cut-off value of 135 mg/dL. Results One hundred and sixty-five CF patients were analyzed. An IgG4 elevation was detected in 43 patients (26%). Compared with the control group (<= 135 mg/dL), high IgG4 patients exhibited a greater prevalence of Staphylococcus aureus colonization and higher IgG, IgG1, IgG2 and IgE levels. No significant differences were observed in terms of pulmonary function, colonization with Pseudomonas aeruginosa, or the annual rate of bronchial exacerbations. Conclusion An elevated IgG4 serum level was frequently detected in adult CF patients and did not appear to be associated with poor lung function. We suggest that IgG4 elevation is a marker of the activation of tolerance. Its clinical significance remains to be demonstrated.	[Clerc, Axelle; Reynaud, Quitterie; Durupt, Steaphane; Nove-Josserand, Raphaeele; Durieu, Isabelle; Lega, Jean Christophe] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Med Interne, Pierre Benite, France; [Clerc, Axelle; Reynaud, Quitterie; Durupt, Steaphane; Nove-Josserand, Raphaeele; Durieu, Isabelle; Lega, Jean Christophe] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Reference Mucoviscidose, Pierre Benite, France; [Reynaud, Quitterie; Durieu, Isabelle] EA Hlth Serv & Performance Res HESPER, F-7425 Lyon, France; [Reynaud, Quitterie; Durieu, Isabelle; Lega, Jean Christophe] Univ Claude Bernard Lyon 1, Lyon, France; [Chapuis-Cellier, Colette] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Immunol, Pierre Benite, France; [Durieu, Isabelle; Lega, Jean Christophe] Claude Bernard Univ Lyon 1, Lab Biometrie & Biol Evolut, Equipe Evaluat & Modelisat Essais Therapeut, UMR 5558, Lyon, France	CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Reynaud, Q (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Med Interne, Pierre Benite, France.; Reynaud, Q (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Reference Mucoviscidose, Pierre Benite, France.; Reynaud, Q (corresponding author), EA Hlth Serv & Performance Res HESPER, F-7425 Lyon, France.	quitterie.reynaud@chu-lyon.fr						Bernardi DM, 2013, J PEDIAT-BRAZIL, V89, P40, DOI 10.1016/j.jped.2013.02.007; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; BRETT MM, 1986, ARCH DIS CHILD, V61, P1114, DOI 10.1136/adc.61.11.1114; Ciofu O, 1997, CLIN EXP IMMUNOL, V108, P88, DOI 10.1046/j.1365-2249.1997.d01-994.x; Ebbo M, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/602809; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Garside JP, 2005, PEDIATR PULM, V39, P135, DOI 10.1002/ppul.20050; James LK, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0600-2; Lachenal F, 2009, EUR RESPIR J, V34, P1079, DOI 10.1183/09031936.00006009; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; MATTHEWS WJ, 1980, NEW ENGL J MED, V302, P245, DOI 10.1056/NEJM198001313020501; Moffitt KL, 2014, J CYST FIBROS, V13, P63, DOI 10.1016/j.jcf.2013.06.002; MOSS RB, 1988, NEW ENGL REG ALLERGY, V9, P57; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; Petersen TD, 1996, THORAX, V51, P733, DOI 10.1136/thx.51.7.733; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Proesmans M, 2011, J CYST FIBROS, V10, P128, DOI 10.1016/j.jcf.2010.12.004; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; SHAKIB F, 1976, CLIN ALLERGY, V6, P237, DOI 10.1111/j.1365-2222.1976.tb01902.x; SHRYOCK TR, 1986, J CLIN MICROBIOL, V23, P513, DOI 10.1128/JCM.23.3.513-516.1986; WHEELER WB, 1984, J PEDIATR-US, V104, P695, DOI 10.1016/S0022-3476(84)80946-4; Yun J, 2014, ASIA PAC ALLERGY, V4, P172, DOI 10.5415/apallergy.2014.4.3.172	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0181888	10.1371/journal.pone.0181888	http://dx.doi.org/10.1371/journal.pone.0181888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922375	Green Published, gold, Green Submitted			2022-12-26	WOS:000411059300002
J	Perry, T; Laffin, M; Fedorak, RN; Thiesen, A; Dicken, B; Madsen, KL				Perry, Troy; Laffin, Michael; Fedorak, Richard N.; Thiesen, Aducio; Dicken, Bryan; Madsen, Karen L.			Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis	PLOS ONE			English	Article							DENDRITIC CELLS; NATURAL-HISTORY; CROHNS-DISEASE; MACROPHAGES; MICROBIOTA; SUBSETS	Ileocolic resection (ICR) is the most common intestinal resection performed for Crohn's disease, with recurrences commonly occurring at the site of the anastomosis. This study used an animal model of ICR in wild-type mice to examine immunologic changes that developed around the surgical anastomosis and how these changes impacted gut responses to minor acute injury. ICR was performed in adult 129S1/SvlmJ mice and results compared with mice receiving sham or no surgery. Dextran sodium sulfate was given either on post-operative day 9 or day 24 to evaluate immune responses in the intestine both immediately following surgery and after a period of healing. Fecal occult blood measurements and animal weights were taken daily. Cytokine levels were measured in ileal and colonic tissue. Bacterial load in the neo-terminal ileum was measured using qPCR. Immune cell populations in the intestinal tissue, mesenteric lymph nodes, and spleen were assessed using flow cytometry. Cytokine secretion in response to microbial products was measured in isolated mesenteric lymph nodes and spleen cells. ICR resulted in an initial elevation of inflammatory markers in the terminal ileum and colon followed by enhanced levels of bacterial growth in the neo-terminal ileum. Intestinal surgical resection resulted in the recruitment of innate immune cells into the colon that exhibited a non-responsiveness to microbial stimuli. DSS colitis phenotype was more severe in the ileocolic resection groups and this was associated with local and systemic immunosuppression as evidenced by a reduced cytokine responses to microbial stimuli. This study reveals the development of an immune non-responsiveness to microbial products following ileocolic resection that is associated with enhanced levels of bacterial growth in the neo-terminal ileum. These surgical-induced altered immune-microbial interactions in the intestine may contribute to disease recurrence at the surgical anastomosis site following ileocolic resections in patients with Crohn's disease.	[Perry, Troy; Laffin, Michael; Dicken, Bryan] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Fedorak, Richard N.; Madsen, Karen L.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Fedorak, Richard N.; Madsen, Karen L.] Univ Alberta, CEGIIR, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Madsen, KL (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.; Madsen, KL (corresponding author), Univ Alberta, CEGIIR, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Madsen, Karen L/H-5898-2011	Laffin, Michael/0000-0003-4933-2789	Canadian Institutes for Health Research; Alberta Innovates; Alberta IBD Consortium; Canadian Surgical Research Fund; Edmonton Civic Employees Research Assistance Fund; Alberta Innovates Technology; Innovates Centre of Research Excellence (iCORE)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates; Alberta IBD Consortium; Canadian Surgical Research Fund; Edmonton Civic Employees Research Assistance Fund; Alberta Innovates Technology; Innovates Centre of Research Excellence (iCORE)	This study was financially supported by the Canadian Institutes for Health Research; Alberta Innovates; Alberta IBD Consortium; Canadian Surgical Research Fund; the Edmonton Civic Employees Research Assistance Fund; Alberta Innovates Technology; and the Innovates Centre of Research Excellence (iCORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buisson A, 2012, ALIMENT PHARM THER, V35, P625, DOI 10.1111/j.1365-2036.2012.05002.x; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Cruz P, 2015, J GASTROEN HEPATOL, V30, P268, DOI 10.1111/jgh.12694; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Goldfarb Y, 2011, ANN SURG, V253, P798, DOI 10.1097/SLA.0b013e318211d7b5; Horowitz M, 2015, NAT REV CLIN ONCOL, V12, P213, DOI 10.1038/nrclinonc.2014.224; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kish L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062220; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; Perry T, 2014, JOVE-J VIS EXP, DOI 10.3791/52106; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Sakuraba A, 2009, GASTROENTEROLOGY, V137, P1736, DOI 10.1053/j.gastro.2009.07.049; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van der Bij GJ, 2009, ANN SURG, V249, P727, DOI 10.1097/SLA.0b013e3181a3ddbd; Weisser SB, 2011, J LEUKOCYTE BIOL, V90, P483, DOI 10.1189/jlb.0311124	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184660	10.1371/journal.pone.0184660	http://dx.doi.org/10.1371/journal.pone.0184660			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922370	Green Published, gold, Green Submitted			2022-12-26	WOS:000411059300021
J	Buffet, C; Hecale-Perlemoine, K; Bricaire, L; Dumont, F; Baudry, C; Tissier, F; Bertherat, J; Cochand-Priollet, B; Raffin-Sanson, ML; Cormier, F; Groussin, L				Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cochand-Priollet, Beatrix; Raffin-Sanson, Marie-Laure; Cormier, Francoise; Groussin, Lionel			DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers	PLOS ONE			English	Article							FEEDBACK INHIBITION; CARCINOMA CELLS; BIOLOGICAL CHARACTERIZATION; THERAPEUTIC IMPLICATIONS; KINASE PHOSPHATASES; PCCL3 CELLS; PAPILLARY; EXPRESSION; THYROTROPIN; APOPTOSIS	Background Molecular alterations of the MAPK pathway are frequently observed in papillary thyroid carcinomas (PTCs). It leads to a constitutive activation of the signalling pathway through an increase in MEK and ERK phosphorylation. ERK is negatively feedback-regulated by Dual Specificity Phosphatases (DUSPs), especially two ERK-specific DUSPs, DUSP5 (nuclear) and DUSP6 (cytosolic). These negative MAPK regulators may play a role in thyroid carcinogenesis. Methods MAPK pathway activation was analyzed in 11 human thyroid cancer cell lines. Both phosphatases were studied in three PCCL3 rat thyroid cell lines that express doxycycline inducible PTC oncogenes (RET/PTC3, H-RAS (V12) or BRAF (V600E)). Expression levels of DUSP5 and DUSP6 were quantified in 39 human PTCs. The functional role of DUSP5 and DUSP6 was investigated through their silencing in two human BRAF (V600E) carcinoma cell lines. Results BRAF (V600E) human thyroid cancer cell lines expressed higher phospho-MEK levels but not higher phospho-ERK levels. DUSP5 and DUSP6 are specifically induced by the MEK-ERK pathway in the three PTC oncogenes inducible thyroid cell lines. This negative feedback loop explains the tight regulation of p-ERK levels. DUSP5 and DUSP6 mRNA are overexpressed in human PTCs, especially in BRAF (V600E) mutated PTCs. DUSP5 and/or DUSP6 siRNA inactivation did not affect proliferation in two BRAF (V600E) mutated cell lines, which may be explained by a compensatory increase in other phosphatases. In the light of this, we observed a marked DUSP6 upregulation upon DUSP5 inactivation. Despite this, DUSP5 and DUSP6 positively control cell migration and invasion. Conclusions Our results are in favor of a stronger activation of the MAPK pathway in BRAF(V600E) PTCs. DUSP5 and DUSP6 have pro-tumorigenic properties in two BRAF (V600E) PTC cell line models.	[Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cormier, Francoise; Groussin, Lionel] INSERM, Inst Cochin, U1016, Paris, France; [Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cormier, Francoise; Groussin, Lionel] CNRS, UMR8104, Paris, France; [Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cormier, Francoise; Groussin, Lionel] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Tissier, Frederique] Hop La Pitie Salpetriere, Dept Pathol, Paris, France; [Bertherat, Jerome; Groussin, Lionel] Cochin Hosp, Dept Endocrinol, Paris, France; [Cochand-Priollet, Beatrix] Cochin Hosp, Dept Pathol, Paris, France; [Raffin-Sanson, Marie-Laure] Ambroise Pare Hop, Dept Endocrinol, Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Buffet, C (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.; Buffet, C (corresponding author), CNRS, UMR8104, Paris, France.; Buffet, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	camille.buffet@aphp.fr		BERTHERAT, Jerome/0000-0003-2551-3008; Groussin, Lionel/0000-0003-1476-475X; Cormier, Francoise/0000-0002-6904-5122	American Thyroid Association [ATA R06059KK]; French Fondation ARC pour la Recherche contre le Cancer; French National Academy of Medicine; Ile de France Regional Health Agency	American Thyroid Association; French Fondation ARC pour la Recherche contre le Cancer; French National Academy of Medicine; Ile de France Regional Health Agency	This work was supported by the American Thyroid Association [ATA R06059KK], a predoctoral fellowship from the French Fondation ARC pour la Recherche contre le Cancer, the French National Academy of Medicine and a predoctoral and doctoral fellowship from the Ile de France Regional Health Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Bluthgen N, 2009, FEBS J, V276, P1024, DOI 10.1111/j.1742-4658.2008.06846.x; Buffet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145484; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chung SH, 2002, JPN J CANCER RES, V93, P1358, DOI 10.1111/j.1349-7006.2002.tb01245.x; Degl'Innocenti D, 2013, ENDOCR-RELAT CANCER, V20, P23, DOI 10.1530/ERC-12-0078; Dultz LA, 2013, SURGERY, V154, P1239, DOI 10.1016/j.surg.2013.06.024; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; GIOANNI J, 1991, B CANCER, V78, P1053; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Gustavsson B, 1996, MOL CELL ENDOCRINOL, V121, P143, DOI 10.1016/0303-7207(96)03859-2; HELDIN NE, 1991, ENDOCRINOLOGY, V129, P2187, DOI 10.1210/endo-129-4-2187; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kurebayashi J, 2000, J CLIN ENDOCR METAB, V85, P2889, DOI 10.1210/jc.85.8.2889; Lee JJ, 2007, THYROID, V17, P289, DOI 10.1089/thy.2006.0246; Lee JU, 2012, EUR J ENDOCRINOL, V167, P93, DOI 10.1530/EJE-12-0010; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Mitsiades CS, 2007, MOL CANCER THER, V6, P1070, DOI 10.1158/1535-7163.MCT-06-0449; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Nunes-Xavier C, 2011, ANTI-CANCER AGENT ME, V11, P109, DOI 10.2174/187152011794941190; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ricarte JC, 2013, J CLIN INVEST, V123, P4935, DOI 10.1172/JCI69766; Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112; Salerno P, 2010, J CLIN ENDOCR METAB, V95, P450, DOI 10.1210/jc.2009-0373; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shin SH, 2013, AM J PATHOL, V182, P1275, DOI 10.1016/j.ajpath.2013.01.004; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; TANAKA J, 1987, VIROLOGY, V161, P62, DOI 10.1016/0042-6822(87)90171-1; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xu XL, 2003, CANCER RES, V63, P4561; Yano Y, 2007, ONCOL REP, V18, P441; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zuo H, 2007, PATHOL INT, V57, P12, DOI 10.1111/j.1440-1827.2007.02050.x	44	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184861	10.1371/journal.pone.0184861	http://dx.doi.org/10.1371/journal.pone.0184861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910386	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200110
J	Kydd, E; McGreevy, P				Kydd, Erin; McGreevy, Paul			Sex differences in the herding styles of working sheepdogs and their handlers	PLOS ONE			English	Article							DOGS; OWNERS	Working sheepdog trials test the attributes of dogs as well as the dogmanship and stockmanship skills of handlers. They generally include standard elements such as outrun, lift, fetch, drive, shed, pen and single to test all facets of the work that dogs perform on a farm. While both male and female handlers participate, these trials are traditionally dominated by male handlers. Both male and female dogs compete on equal terms within the same events. Drawing data from files (n = 60) downloaded from YouTube, the current study explores whether behaviours of dogs and their handlers during sheepdog trials differ between handler gender and dog sex at different levels of competition. It compared the stalking, crouching, chasing and stationary behaviours of dogs in open (n = 28 dogs: 10 females, 18 males) and not-open trials (n = 32 dogs: 20 females, 12 males). The dogs in this study had male (n = 38) and female (n = 22) handlers, whose movement and use of vocal cues and arm elevations were also compared. However, the small sample size and limitations of these videos as a data source should be noted before the results are generalised to the broader field of working-dog behaviour. The results of an REstricted Maximum Likelihood test showed that male handlers spent, on average, significantly more time in the fetch and drive elements than female handlers, but this difference between sexes was present only in not-open events (mean time to Fetch, female handler = 44.07s, male handler = 124.00s, P<0.001, mean time to Drive, female handler = 95.8s, male handler = 152.4, P = 0.010). This may suggest that female handlers of less experienced dogs are better at the early training of these elements. The results showed that male dogs spent more time stationary than female dogs, but only in open competition (male dog predicted mean 6.17s, P = 0.014). Revealing differences between men/women, and between dogs/bitches in this context may identify pairings that complement each other and improve selection, training and handling of working dogs. It is also hoped that ultimately, it will lead to improved welfare for dogs and the livestock with which they interact.	[Kydd, Erin; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia	University of Sydney	Kydd, E (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia.	erin.kydd@students.mq.edu.au		McGreevy, Paul/0000-0001-7220-8378				Arnott ER, ANIMAL WELFARE, V23, P189; Daliblard GH, 2009, J VET BEHAV, V4, P19, DOI 10.1016/j.jveb.2008.08.008; Early J, J VET BEHAV CLIN APP, V9, pe17; Early JB, J VET BEHAV CLIN APP, V9, P370; Entin P, 2007, PHYSIOLOGY, V4, P135; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Kilgour R, 1970, NZ SOC ANIM PROD PRO; McGreevy Paul, 2007, CARROTS STICKS PRINC; McGreevy PD, 2008, APPL ANIM BEHAV SCI, V109, P320, DOI 10.1016/j.applanim.2007.04.001; Prato-Previde E, 2006, ETHOLOGY, V112, P64, DOI 10.1111/j.1439-0310.2006.01123.x; Serpell JA, 2005, ANTHROZOOS, V18, P196, DOI 10.2752/089279305785594135; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Udell MA, ANIMAL BEHAV, V89, P99; Wells DL, 1999, APPL ANIM BEHAV SCI, V61, P341, DOI 10.1016/S0168-1591(98)00202-0	16	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184072	10.1371/journal.pone.0184072	http://dx.doi.org/10.1371/journal.pone.0184072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910326	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200028
J	Li, ZH; Kuhn, G; Schirmer, M; Muller, R; Ruffoni, D				Li, Zihui; Kuhn, Gisela; Schirmer, Michael; Mueller, Ralph; Ruffoni, Davide			Impaired bone formation in ovariectomized mice reduces implant integration as indicated by longitudinal in vivo micro-computed tomography	PLOS ONE			English	Article							TRABECULAR BONE; CAUDAL VERTEBRAE; CORTICAL BONE; MECHANICAL STIMULATION; POSTMENOPAUSAL WOMEN; ESTROGEN DEFICIENCY; OSTEOPOROTIC BONE; CANCELLOUS BONE; TAIL VERTEBRAE; TITANIUM-ALLOY	Although osteoporotic bone, with low bone mass and deteriorated bone architecture, provides a less favorable mechanical environment than healthy bone for implant fixation, there is no general agreement on the impact of osteoporosis on peri-implant bone (re) modeling, which is ultimately responsible for the long term stability of the bone-implant system. Here, we inserted an implant in a mouse model mimicking estrogen deficiency-induced bone loss and we monitored with longitudinal in vivo micro-computed tomography the spatio-temporal changes in bone (re) modeling and architecture, considering the separate contributions of trabecular, endocortical and periosteal surfaces. Specifically, 12 week-old C57BL/6J mice underwent OVX/SHM surgery; 9 weeks after we inserted special metal-ceramics implants into the 6th caudal vertebra and we measured bone response with in vivo micro-CT weekly for the following 6 weeks. Our results indicated that ovariectomized mice showed a reduced ability to increase the thickness of the cortical shell close to the implant because of impaired peri-implant bone formation, especially at the periosteal surface. Moreover, we observed that healthy mice had a significantly higher loss of trabecular bone far from the implant than estrogen depleted animals. Such behavior suggests that, in healthy mice, the substantial increase in peri-implant bone formation which rapidly thickened the cortex to secure the implant may raise bone resorption elsewhere and, specifically, in the trabecular network of the same bone but far from the implant. Considering the already deteriorated bone structure of estrogen depleted mice, further bone loss seemed to be hindered. The obtained knowledge on the dynamic response of diseased bone following implant insertion should provide useful guidelines to develop advanced treatments for osteoporotic fracture fixation based on local and selective manipulation of bone turnover in the peri-implant region.	[Li, Zihui; Kuhn, Gisela; Mueller, Ralph; Ruffoni, Davide] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Schirmer, Michael] Pfm Med Titanium Gmbh, Nurnberg, Germany; [Ruffoni, Davide] Univ Liege, Dept Aerosp & Mech Engn, Mech Biol & Bioinspired Mat Res Unit, Liege, Belgium	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Liege	Ruffoni, D (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Ruffoni, D (corresponding author), Univ Liege, Dept Aerosp & Mech Engn, Mech Biol & Bioinspired Mat Res Unit, Liege, Belgium.	druffoni@ulg.ac.be	Ruffoni, Davide/GQP-0042-2022; Müller, Ralph/A-1198-2008	Müller, Ralph/0000-0002-5811-7725; Ruffoni, Davide/0000-0003-3714-7594; LI, ZIHUI/0000-0002-8506-7356	Chinese Scholarship Council; DR of the European Calcified Tissue Society	Chinese Scholarship Council(China Scholarship Council); DR of the European Calcified Tissue Society	ZL acknowledges support of the Chinese Scholarship Council and DR of the European Calcified Tissue Society Postdoctoral Fellowship 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman AR, 2015, BONE, V81, P370, DOI 10.1016/j.bone.2015.07.037; Basler SE, 2013, MED ENG PHYS, V35, P1442, DOI 10.1016/j.medengphy.2013.03.016; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Birkhold AI, 2014, BONE, V66, P15, DOI 10.1016/j.bone.2014.05.013; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; Chatterjee M, 2015, OSTEOPOROSIS INT, V26, P281, DOI 10.1007/s00198-014-2824-0; Cheung WH, 2016, INJURY, V47, pS21, DOI 10.1016/S0020-1383(16)47004-X; CHOW JWM, 1993, AM J PHYSIOL, V265, pE340, DOI 10.1152/ajpendo.1993.265.2.E340; Farr JN, 2015, NAT REV ENDOCRINOL, V11, P513, DOI 10.1038/nrendo.2015.89; Fini M, 1997, INT J ARTIF ORGANS, V20, P291, DOI 10.1177/039139889702000510; Fini M, 2002, INT J ORAL MAX IMPL, V17, P28; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Funk JF, 2009, CLIN ORTHOP RELAT R, V467, P3199, DOI 10.1007/s11999-009-0902-y; Gabet Y, 2010, J BONE MINER RES, V25, P575, DOI 10.1359/jbmr.090808; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Goldhahn J, 2008, OSTEOPOROSIS INT, V19, P761, DOI 10.1007/s00198-007-0515-9; Heaney RP, 2003, OSTEOPOROSIS INT, V14, pS12, DOI 10.1007/s00198-003-1466-4; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Irish J, 2013, J ORTHOP RES, V31, P800, DOI 10.1002/jor.22294; Jariwala SH, 2016, J ORTHOP RES; Jenny G, 2016, J BIOMED MATER RES A, V104, P2898, DOI 10.1002/jbm.a.35805; Kettenberger U, 2014, BIOMATERIALS, V35, P9995, DOI 10.1016/j.biomaterials.2014.09.005; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Kurth AHA, 2005, BONE, V37, P204, DOI 10.1016/j.bone.2004.12.017; Lambers F, 2011, FUNCTIONAL BONE IMAG; Lambers FM, 2015, J BIOMECH, V48, P1179, DOI 10.1016/j.jbiomech.2014.11.020; Lambers FM, 2013, BONE, V55, P325, DOI 10.1016/j.bone.2013.04.016; Lambers FM, 2012, CALCIFIED TISSUE INT, V90, P108, DOI 10.1007/s00223-011-9553-6; Lambers FM, 2011, BONE, V49, P1340, DOI 10.1016/j.bone.2011.08.035; Li ZH, 2015, BONE, V81, P468, DOI 10.1016/j.bone.2015.08.017; Lu YT, 2016, J BIOMECH, V49, P2095, DOI 10.1016/j.jbiomech.2016.05.022; Lukas C, 2013, BONE, V56, P55, DOI 10.1016/j.bone.2013.05.005; Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008; Marquezan M, 2012, CLIN ORAL IMPLAN RES, V23, P767, DOI 10.1111/j.1600-0501.2011.02228.x; MUELLER M, 1991, J BONE MINER RES, V6, P401; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Rocca M, 2002, BIOMATERIALS, V23, P1017, DOI 10.1016/S0142-9612(01)00213-7; Ruffoni D, 2012, BIOMECH MODEL MECHAN, V11, P313, DOI 10.1007/s10237-011-0312-4; Ruffoni D, 2012, BONE, V50, P733, DOI 10.1016/j.bone.2011.11.027; Ruffoni D, 2008, J BONE MINER RES, V23, P1905, DOI 10.1359/JBMR.080711; Schulte FA, 2014, COMPUT METHOD BIOMEC, V17, P539, DOI 10.1080/10255842.2012.699526; Schulte FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062172; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Szulc P, 2006, J BONE MINER RES, V21, P1856, DOI 10.1359/JBMR.060904; Tarantino U, 2011, AGING CLIN EXP RES, V23, P62; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Verdelis K, 2011, BONE, V49, P580, DOI 10.1016/j.bone.2011.05.013; Vidigal GM, 2009, CLIN ORAL IMPLAN RES, V20, P1272, DOI 10.1111/j.1600-0501.2009.01739.x; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089343; Webster D, 2010, BIOMECH MODEL MECHAN, V9, P737, DOI 10.1007/s10237-010-0210-1; Webster DJ, 2008, COMPUT METHOD BIOMEC, V11, P435, DOI 10.1080/10255840802078014; Weigt C., 2013, INTERACTION MECH LOA; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8	61	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184835	10.1371/journal.pone.0184835	http://dx.doi.org/10.1371/journal.pone.0184835			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910363	Green Published, gold			2022-12-26	WOS:000410859200103
J	Mezmur, M; Navaneetham, K; Letamo, G; Bariagaber, H				Mezmur, Markos; Navaneetham, Kannan; Letamo, Gobopamang; Bariagaber, Hadgu			Individual, household and contextual factors associated with skilled delivery care in Ethiopia: Evidence from Ethiopian demographic and health surveys	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SERVICES	Despite evidence that social contexts are key determinants of health, research into factors associated with maternal health service utilization in Ethiopia has often focused on individual and household factors. The downside is that this underestimates the importance of taking contextual factors into account when planning appropriate interventions in promoting safe motherhood in the country. The purpose of this study is to fill this knowledge gap drawing attention to the largely unexplored contextual factors affecting the uptake of skilled attendance at delivery in a nationally representative sample. Data for the study comes from two rounds of the Ethiopian Demographic and Health Surveys (EDHS) conducted in the year 2005 and 2011. Analysis was done using a two-level multivariable multilevel logistic regression model with data from 14, 242 women who had a live birth in the five years preceding the surveys clustered within 540 (in the year 2005) and 624 (in the year 2011) communities. The results of the study point to multiple levels of measured and unmeasured factors affecting the uptake of skilled delivery care in the country. At community level, place of residence, community level of female education and fertility significantly predict the uptake of skilled delivery care. At individual and household level, maternal age, birth order, maternal education, household wealth and access to media predict the uptake of such service. Thus, there is a need to consider community contexts in the design of maternal health programs and employ multi-sectorial approach to addressing barriers at different levels. For example, improving access and availability of skilled delivery care should eventually enhance the uptake of such services at community level in Ethiopia. At individual level, efforts to promote the uptake of such services should constitute targeted interventions paying special attention to the needs of the youth, the multiparous, the less educated and women in the poorest households.	[Mezmur, Markos; Navaneetham, Kannan; Letamo, Gobopamang; Bariagaber, Hadgu] Univ Botswana, Dept Populat Studies, Gaborone, Botswana	University of Botswana	Navaneetham, K (corresponding author), Univ Botswana, Dept Populat Studies, Gaborone, Botswana.	Kannan.Navaneetham@mopipi.ub.bw	Letamo, Gobopamang/AAC-9390-2021; Navaneetham, Kannan/K-6390-2014	Letamo, Gobopamang/0000-0001-7256-4700; Navaneetham, Kannan/0000-0002-5847-4669; Satihal, Dayanand/0000-0002-9575-8265				Abeje G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-22; Achia TNO, 2015, WOMEN HEALTH, V55, P203, DOI 10.1080/03630242.2014.979971; Adjiwanou V, 2014, HEALTH PLACE, V29, P67, DOI 10.1016/j.healthplace.2014.06.001; Ali J., 2012, J HEALTH DEV, V26, P265; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Aremu O, 2012, INT J PREVENTIVE MED, V3, P278; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Babalola SO, 2014, REV PANAM SALUD PUBL, V36, P1; Birmeta K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-256; Fekadu M, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.29; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gage A, 2007, SOC SCI MED, V06; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kruk ME, 2010, HEALTH POLICY, V97, P209, DOI 10.1016/j.healthpol.2010.05.002; Osorio AM, 2014, CAD SAUDE PUBLICA, V30, P1079, DOI 10.1590/0102-311X00073513; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Ombaka JH., 2015, AM J PUBLIC HLTH RES, V3, P21, DOI DOI 10.12691/AJPHR-3-1-4; Ononokpono D, 2014, PAN AFR MED, P17; Pearson L, 2011, INT J GYNAECOL OBSTE, V115; Prusty R, 2015, INT J POPULATION RES, V2015, P531; Sepehri A, 2008, SOC SCI MED, V67, P1009, DOI 10.1016/j.socscimed.2008.06.005; Singh P, 2013, HLTH POLICY PLAN, V1, P18; Snijers T, 1999, MULTILEVEL ANAL INTR; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P1, DOI DOI 10.1016/J.HEALTHPLACE.2011.12.006; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	32	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184688	10.1371/journal.pone.0184688	http://dx.doi.org/10.1371/journal.pone.0184688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910341	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200077
J	Nakayama, M; Itami, N; Suzuki, H; Hamada, H; Osaka, N; Yamamoto, R; Tsunoda, K; Nakano, H; Watanabe, K; Zhu, WJ; Maruyama, Y; Terawaki, H; Kabayama, S; Nakazawa, R; Miyazaki, M; Ito, S				Nakayama, Masaaki; Itami, Noritomo; Suzuki, Hodaka; Hamada, Hiromi; Osaka, Naoyuki; Yamamoto, Ryo; Tsunoda, Kazumasa; Nakano, Hirofumi; Watanabe, Kimio; Zhu, Wan-Jun; Maruyama, Yukio; Terawaki, Hiroyuki; Kabayama, Shigeru; Nakazawa, Ryoichi; Miyazaki, Mariko; Ito, Sadayoshi			Possible clinical effects of molecular hydrogen (H-2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation	PLOS ONE			English	Article							ELECTROLYZED-REDUCED WATER; RENAL-DISEASE PATIENTS; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; UREMIC PRURITUS; CARDIOVASCULAR-DISEASE; CONTROLLED-TRIAL; INFLAMMATION; THERAPY; FATIGUE	Background and aim It is supposed that enhanced oxidative stress and inflammation are involved with the poor clinical outcomes in patients on chronic dialysis treatment. Recent studies have shown that molecular hydrogen (H-2) is biologically active as an anti-inflammatory agent. Thus, we developed a novel hemodialysis (E-HD) system which delivers H-2 (30 to 80 ppb)-enriched dialysis solution, to conduct a prospective observational study (UMIN000004857) in order to compare the long-term outcomes between E-HD and conventional-HD (C-HD) in Japan. The present interim analysis aimed to look at potential clinical effects of E-HD during the first 12 months observation. Subjects and method 262 patients (140, E-HD; 122, C-HD) were subjected for analysis for comprehensive clinical profiles. They were all participating in the above mentioned study, and they had been under the respective HD treatment for 12 consecutive months without hospitalization. Collected data, such as, physical and laboratory examinations, medications, and self-assessment questionnaires on subjective symptoms (i. e., fatigue and pruritus) were compared between the two groups. Results In a 12-month period, no clinical relevant differences were found in dialysis-related parameters between the two groups. However, there were differences in the defined daily dose of anti-hypertensive agents, and subjective symptoms, such as severe fatigue, and pruritus, which were all less in the E-HD group. Multivariate analysis revealed E-HD was an independent significant factor for the reduced use of anti-hypertensive agents as well as the absence of severe fatigue and pruritus at 12 months after adjusting for confounding factors. Conclusion The data indicates E-HD could have substantial clinical benefits beyond conventional HD therapy, and support the rationale to conduct clinical trials of H-2 application to HD treatment.	[Nakayama, Masaaki; Watanabe, Kimio; Zhu, Wan-Jun; Kabayama, Shigeru; Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ, United Ctr Adv Res & Translat Med, Ctr Adv & Integrated Renal Sci, Sendai, Miyagi, Japan; [Nakayama, Masaaki; Zhu, Wan-Jun; Miyazaki, Mariko] Tohoku Univ Hosp, Res Div Chron Kidney Dis & Dialysis Treatment, Sendai, Miyagi, Japan; [Nakayama, Masaaki; Terawaki, Hiroyuki] Fukushima Med Univ, Dept Nephrol & Hypertens, Fukushima, Japan; [Itami, Noritomo; Hamada, Hiromi] Nikko Memorial Hosp, Kidney Ctr, Muroran, Hokkaido, Japan; [Itami, Noritomo; Hamada, Hiromi] Higashi Muroran Satellite Clin, Muroran, Hokkaido, Japan; [Suzuki, Hodaka] Horai Higashi Clin, Fukushima, Japan; [Osaka, Naoyuki] Gumyoji Jin Clin, Yokohama, Kanagawa, Japan; [Yamamoto, Ryo] Tateishi Jin Clin, Tokyo, Japan; [Tsunoda, Kazumasa] Noboribetsu Mem Hosp, Noboribetsu, Japan; [Nakano, Hirofumi] Kashima Hosp, Dialysis Ctr, Iwaki, Fukushima, Japan; [Zhu, Wan-Jun; Kabayama, Shigeru] Trim Med Inst Co Ltd, Osaka, Japan; [Maruyama, Yukio] Tokyo Jikei Univ, Sch Med, Dept Nephrol & Hypertens, Tokyo, Japan; [Nakazawa, Ryoichi] Tokatsu Clin Mirai, Matsudo, Chiba, Japan; [Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ Hosp, Div Blood Purificat, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Fukushima Medical University; Jikei University; Tohoku University	Nakayama, M (corresponding author), Tohoku Univ, United Ctr Adv Res & Translat Med, Ctr Adv & Integrated Renal Sci, Sendai, Miyagi, Japan.; Nakayama, M (corresponding author), Tohoku Univ Hosp, Res Div Chron Kidney Dis & Dialysis Treatment, Sendai, Miyagi, Japan.; Nakayama, M (corresponding author), Fukushima Med Univ, Dept Nephrol & Hypertens, Fukushima, Japan.	masaaki.nakayama.c1@tohoku.ac.jp		Ito, Sadayoshi/0000-0002-5092-3626	Nihon Trim Co. Ltd.; Generalbincorporated association of Electrolyzed Water-Hemodialysis Study group	Nihon Trim Co. Ltd.; Generalbincorporated association of Electrolyzed Water-Hemodialysis Study group	The study was conducted by funds from Nihon Trim Co. Ltd., (www.hihon-trim.co.jp), and Generalbincorporated association of Electrolyzed Water-Hemodialysis Study group (www.ew-hd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artom M, 2014, KIDNEY INT, V86, P497, DOI 10.1038/ki.2014.86; Aslam S, 2006, KIDNEY INT, V70, P2109, DOI 10.1038/sj.ki.5001983; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Bossola M, 2015, J PAIN SYMPTOM MANAG, V49, P578, DOI 10.1016/j.jpainsymman.2014.07.009; Bossola Maurizio, 2009, Blood Purif, V28, P245, DOI 10.1159/000231985; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Cardinal JS, 2010, KIDNEY INT, V77, P101, DOI 10.1038/ki.2009.421; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Huang KC, 2006, KIDNEY INT, V70, P391, DOI 10.1038/sj.ki.5001576; Huang KC, 2003, KIDNEY INT, V64, P704, DOI 10.1046/j.1523-1755.2003.00118.x; Huang KC, 2010, NEPHROL DIAL TRANSPL, V25, P2730, DOI 10.1093/ndt/gfq082; Jhamb M, 2008, AM J KIDNEY DIS, V52, P353, DOI 10.1053/j.ajkd.2008.05.005; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Kendrick J, 2008, NAT CLIN PRACT NEPHR, V4, P672, DOI 10.1038/ncpneph0954; Kimmel M, 2006, NEPHROL DIAL TRANSPL, V21, P749, DOI 10.1093/ndt/gfi204; Koyama H, 2010, CLIN J AM SOC NEPHRO, V5, P659, DOI 10.2215/CJN.08151109; Mathur VS, 2010, CLIN J AM SOC NEPHRO, V5, P1410, DOI 10.2215/CJN.00100110; Mettang T, 2002, NEPHROL DIAL TRANSPL, V17, P1558, DOI 10.1093/ndt/17.9.1558; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nakayama M, 2010, NEPHROL DIAL TRANSPL, V25, P3026, DOI 10.1093/ndt/gfq196; Nakayama Masaaki, 2007, Hemodial Int, V11, P322, DOI 10.1111/j.1542-4758.2007.00187.x; Nakayama M, 2009, NEPHRON CLIN PRACT, V112, pC9, DOI 10.1159/000210569; Narita I, 2006, KIDNEY INT, V69, P1626, DOI 10.1038/sj.ki.5000251; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Sela S, 2005, J AM SOC NEPHROL, V16, P2431, DOI 10.1681/ASN.2004110929; Shirahata S, 1997, BIOCHEM BIOPH RES CO, V234, P269, DOI 10.1006/bbrc.1997.6622; Tepel M, 2003, CIRCULATION, V107, P992, DOI 10.1161/01.CIR.0000050628.11305.30; Terawaki H, 2014, HEMODIAL INT, V18, P459, DOI 10.1111/hdi.12112; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Virga G, 2002, NEPHROL DIAL TRANSPL, V17, P2164, DOI 10.1093/ndt/17.12.2164; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; WERTHEIMER A I, 1986, Hospital Pharmacy, V21, P233; Wood KC, 2007, NAT MED, V13, P673, DOI 10.1038/nm0607-673; World Health Organization, 1993, GUID CONS MED PLANTS, P1; Yngman-Uhlin P, 2011, SCAND J UROL NEPHROL, V45, P206, DOI 10.3109/00365599.2011.557025; Zhu WJ, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-26; Zhu WJ, 2011, NEPHROL DIAL TRANSPL, V26, P2112, DOI 10.1093/ndt/gfq727; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184535	10.1371/journal.pone.0184535	http://dx.doi.org/10.1371/journal.pone.0184535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902900	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200045
J	Weber, IP; Rana, M; Thomas, PBM; Dimov, IB; Franze, K; Rajan, MS				Weber, Isabell P.; Rana, Mrinal; Thomas, Peter B. M.; Dimov, Ivan B.; Franze, Kristian; Rajan, Madhavan S.			Effect of vital dyes on human corneal endothelium and elasticity of Descemet's membrane	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; POSTERIOR LAMELLAR KERATOPLASTY; LENS CAPSULE; TRYPAN BLUE; TRANSPLANTATION; COLLAGENS; REJECTION	The purpose of this study was to evaluate the effects of vital dyes on human Descemet's membranes (DMs) and endothelia. DMs of 25 human cadaveric corneas with research consent were treated with dyes routinely used in Descemet membrane endothelial keratoplasty (DMEK), 0.05% Trypan blue (TB) or a combination of 0.15% Trypan blue, 0.025% Brilliant blue and 4% Polyethylene glycol (commercial name Membrane Blue Dual; MB). The effects of these two dyes on (i) endothelial cell viability, (ii) DM mechanical properties as assessed by atomic force microscopy, and iii) qualitative DM dye retention were tested for two varying exposure times (one or four minutes). No significant differences in cell toxicity were observed between treatments with TB and MB at the two different exposure times (P = 0.21). Further, both dyes led to a significant increase in DM stiffness: exposure to TB and MB for one minute increased the apparent elastic modulus of the DM by 11.2% (P = 8*10(-3)) and 17.7%, respectively (P = 4*10(-6)). A four-minute exposure led to an increase of 8.6% for TB (P = 0.004) and 13.6% for MB (P = 0.03). Finally, at 25 minutes, the dye retention of the DM was considerably better for MB compared to TB. Taken together, a one-minute exposure to MB was found to improve DM visibility compared to TB, with a significant increase in DM stiffness and without detrimental effects on endothelial cell viability. The use of MB could therefore improve (i) visibility of the DM scroll, and (ii) intraoperative unfolding, enhancing the probability of successful DMEK surgery.	[Weber, Isabell P.; Dimov, Ivan B.; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Anat Bldg, Cambridge, England; [Rana, Mrinal; Thomas, Peter B. M.; Rajan, Madhavan S.] Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England; [Rajan, Madhavan S.] Anglia Ruskin Univ, VERU, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Anglia Ruskin University	Rajan, MS (corresponding author), Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England.; Rajan, MS (corresponding author), Anglia Ruskin Univ, VERU, Cambridge, England.	Madhavan.rajan@addenbrookes.nhs.uk		Rajan, Madhavan/0000-0003-2223-5364; Thomas, Peter/0000-0003-1681-7659; Dimov, Ivan/0000-0003-3513-583X; Franze, Kristian/0000-0002-8425-7297	EMBO Long Term Fellowship (European Commission FP7 (Marie Curie Actions)) [ALTF 1263-2015, LTFC0FUND2013, GA-2013-609409]; EPSRC Cambridge NanoDTC [EP/L015978/1]; UK Medical Research Council [G1100312/1]; Human Frontier Science Programme [RGY0074/2013]; Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health [R21HD080585]; MRC [G1100312] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1494601] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080585] Funding Source: NIH RePORTER	EMBO Long Term Fellowship (European Commission FP7 (Marie Curie Actions)); EPSRC Cambridge NanoDTC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Programme(Human Frontier Science Program); Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	IPW is a recipient of an EMBO Long Term Fellowship (ALTF 1263-2015; European Commission FP7 (Marie Curie Actions, LTFC0FUND2013, GA-2013-609409)). This work was further supported by the EPSRC Cambridge NanoDTC, EP/L015978/1, UK Medical Research Council (Career Development Award G1100312/1 to KF), the Human Frontier Science Programme (Young Investigator Award RGY0074/2013 to KF) and the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R21HD080585 (to KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Chaurasia SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037456; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Danielsen CC, 2004, EXP EYE RES, V79, P343, DOI 10.1016/j.exer.2004.05.014; Dapena I, 2011, CORNEA, V30, P1341, DOI 10.1097/ICO.0b013e31820d8540; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; DUHAMEL RC, 1983, COLLAGEN REL RES, V3, P195; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Franz CM, 2008, CELL MOL BIOENG, V1, P289, DOI 10.1007/s12195-008-0037-3; Franze K, 2011, CURR OPIN GENET DEV, V21, P530, DOI 10.1016/j.gde.2011.07.001; Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k; Georgiou CD, 2008, ANAL BIOANAL CHEM, V391, P391, DOI 10.1007/s00216-008-1996-x; Haritoglou C, 2013, J CATARACT REFR SURG, V39, P1749, DOI 10.1016/j.jcrs.2013.02.057; Heinzelmann S, 2014, CORNEA, V33, P644, DOI 10.1097/ICO.0000000000000106; John T, 2016, CORNEA, V35, P1401, DOI 10.1097/ICO.0000000000000986; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012; Majmudar PA, 2017, CORNEA, V36, P217, DOI 10.1097/ICO.0000000000001074; MARSHALL GE, 1993, BRIT J OPHTHALMOL, V77, P515, DOI 10.1136/bjo.77.8.515; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 1999, AM J OPHTHALMOL, V127, P340, DOI 10.1016/S0002-9394(98)00324-9; Melles GRJ, 2002, CORNEA, V21, P325, DOI 10.1097/00003226-200204000-00018; Melles GRJ, 2002, CORNEA, V21, P415, DOI 10.1097/00003226-200205000-00016; Mohr A, 2013, OPHTHALMOLOGICA, V230, P51, DOI 10.1159/000353870; Parker J., 2013, US OPHTHAL REV, V06, P29; Rajan MS, 2014, EYE, V28, P196, DOI 10.1038/eye.2013.279; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2; Siebelmann S, 2017, CORNEA, V36, P440, DOI 10.1097/ICO.0000000000001140; Terry MA, 2001, CORNEA, V20, P239, DOI 10.1097/00003226-200104000-00001; Terry MA, 2012, CORNEA, V31, P469, DOI 10.1097/ICO.0b013e31823f8ee2; Thomas PBM, 2013, CORNEA, V32, pE173, DOI 10.1097/ICO.0b013e3182912fd2; WILLIAMS KA, 1995, EYE, V9, P219, DOI 10.1038/eye.1995.43; Wollensak G, 2004, J CATARACT REFR SURG, V30, P1526, DOI 10.1016/j.jcrs.2003.11.031	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184375	10.1371/journal.pone.0184375	http://dx.doi.org/10.1371/journal.pone.0184375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902856	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200033
J	Bonamigo, T; Campos, JF; Oliveira, AS; Torquato, HFV; Balestieri, JBP; Cardoso, CAL; Paredes-Gamero, EJ; Souza, KD; dos Santos, EL				Bonamigo, Thaliny; Campos, Jaqueline Ferreira; Oliveira, Alex Santos; Vieira Torquato, Heron Fernandes; Perrella Balestieri, Jose Benedito; Lima Cardoso, Claudia Andrea; Paredes-Gamero, Edgar Julian; Souza, Kely de Picoli; dos Santos, Edson Lucas			Antioxidant and cytotoxic activity of propolis of Plebeia droryana and Apis mellifera (Hymenoptera, Apidae) from the Brazilian Cerrado biome	PLOS ONE			English	Article							ACID PHENETHYL ESTER; CHEMICAL-COMPOSITION; BIOLOGICAL-ACTIVITY; ANTICANCER ACTIVITY; CELL-DEATH; CANCER; INHIBITION; APOPTOSIS; DAMAGE	Propolis is a complex bioactive mixture produced by bees, known to have different biological activities, especially in countries where there is a rich biodiversity of plant species. The objective of this study was to determine the chemical composition and evaluate the antioxidant and cytotoxic properties of Brazilian propolis from the species Plebeia droryana and Apis mellifera found in Mato Grosso do Sul, Brazil. In the ethanolic extracts of P. droryana propolis (ExEP-P) and A. mellifera (ExEP-A) acids, phenolic compounds, terpenes and tocopherol were identified as major compounds. Both extracts presented antioxidant activity against the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical, the maximum activities being 500 mu g/mL (ExEP-P) and 300 mu g/mL (ExEP-A). However, only ExEP-A was able to inhibit lipid peroxidation induced by the oxidizing agent 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH), which inhibited oxidative hemolysis and reduced the levels of malondialdehyde (MDA) in human erythrocytes for 4 h of incubation. The extracts also reduced the cell viability of the K562 erythroleukemia tumour line, with a predominance of necrotic death. Thus, it is concluded that the propolis produced by P. droryana and A. mellifera contain important compounds capable of minimizing the action of oxidizing substances in the organism and reducing the viability of erythroleukemia cells.	[Bonamigo, Thaliny; Campos, Jaqueline Ferreira; Oliveira, Alex Santos; Perrella Balestieri, Jose Benedito; Souza, Kely de Picoli; dos Santos, Edson Lucas] Fed Univ Grande Dourados, Res Grp Biotechnol & Bioprospecting Appl Metab GE, Dourados, MS, Brazil; [Vieira Torquato, Heron Fernandes] Braz Cubes Univ, Fac Pharm, Francisco Rodrigues Filho Ave, Mogi Das Cruzes, SP, Brazil; [Vieira Torquato, Heron Fernandes] Univ Fed Sao Paulo, Dept Biochem, R Tres de Maio 100, Sao Paulo, SP, Brazil; [Lima Cardoso, Claudia Andrea; Paredes-Gamero, Edgar Julian] Univ Estado Mato Grosso, Course Chem, Dourados, MS, Brazil; [Paredes-Gamero, Edgar Julian] Univ Mogi das Cruzes, Ctr Interdisciplinary Res Biochem, Av Dr Candido Xavier de Almeida Souza, Mogi Das Cruzes, SP, Brazil	Universidade Federal da Grande Dourados; Universidade Federal de Sao Paulo (UNIFESP); Universidade do Estado de Mato Grosso; Universidade de Mogi das Cruzes	dos Santos, EL (corresponding author), Fed Univ Grande Dourados, Res Grp Biotechnol & Bioprospecting Appl Metab GE, Dourados, MS, Brazil.	edsonsantosphd@gmail.com	Cardoso, Claudia Andrea Lima/AAK-5578-2020; de Picoli Souza, Kely/I-1248-2015; de Picoli Souza, Kely/AAU-5978-2020; dos Santos, Edson Lucas/AAU-5857-2020; Torquato, Heron/AAQ-2462-2020; Paredes-Gamero, Edgar J/C-4791-2012	Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; de Picoli Souza, Kely/0000-0001-5764-2125; de Picoli Souza, Kely/0000-0001-5764-2125; dos Santos, Edson Lucas/0000-0002-6557-7914; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Oliveira, Alex/0000-0002-2097-6655	Development of Education, Science and Technology of Mato Grosso do Sul State - FUNDECT; Brazilian National Research Council - CNPq; Instituto Nacional de Pesquisa do Pantanal - INPP; Fundacao de Amparo e Desenvolvimento da Pesquisa - Fadesp; FUNDECT; CAPES	Development of Education, Science and Technology of Mato Grosso do Sul State - FUNDECT; Brazilian National Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Pesquisa do Pantanal - INPP; Fundacao de Amparo e Desenvolvimento da Pesquisa - Fadesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Foundation to Support to Development of Education, Science and Technology of Mato Grosso do Sul State - FUNDECT and Brazilian National Research Council - CNPq, Instituto Nacional de Pesquisa do Pantanal - INPP, and Fundacao de Amparo e Desenvolvimento da Pesquisa - Fadesp. Thaliny Bonamigo was supported by FUNDECT and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luis Carlos Rossini from Apiarios Carbonari, for assistance in collect of propolis samples from A. mellifera in the state of Mato Grosso do Sul. This work was supported by Grants from Foundation to Support to Development of Education, Science and Technology of Mato Grosso do Sul State-FUNDECT and Brazilian National Research Council-CNPq, Instituto Nacional de Pesquisa do Pantanal-INPP, and Fundacao de Amparo e Desenvolvimento da Pesquisa-Fadesp. Thaliny Bonamigo was supported by FUNDECT and CAPES.	Afrouzan H, 2012, AFR J MICROBIOL RES, V6, P421, DOI 10.5897/AJMR11.1183; Al Shaal L, 2011, INT J PHARMACEUT, V420, P133, DOI 10.1016/j.ijpharm.2011.08.018; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; [Anonymous], PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0174888; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Awale S, 2008, BIOORGAN MED CHEM, V16, P181, DOI 10.1016/j.bmc.2007.10.004; Bak MJ, 2017, CANCER PREV RES, V10, P1; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Bao YY, 2013, FUTURE ONCOL, V9, P1353, DOI 10.2217/fon.13.84; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Boyle SP, 2000, EUR J CLIN NUTR, V54, P774, DOI 10.1038/sj.ejcn.1601090; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bueno-Silva B., 2016, NAT PRODUCT RES, P1; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Camargo JMF, 2014, CATALOGUE BEES HYMEN; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Carocho M, 2013, ANTI-CANCER AGENT ME, V13, P1236, DOI 10.2174/18715206113139990301; Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5; Chang WC, 2010, TAIWAN J OBSTET GYNE, V49, P419, DOI 10.1016/S1028-4559(10)60092-7; Cinegaglia NC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/737386; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cortopassi-Laurino M, 2006, APIDOLOGIE, V37, P275, DOI 10.1051/apido:2006027; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; De Marco S, 2017, EVID-BASED COMPL ALT, V2017, P1; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duthie GG, 2003, P NUTR SOC, V62, P599, DOI 10.1079/PNS2003275; Ewnetu Y, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-269; Franchi GC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/918956; Funakoshi-Tago M, 2015, INT IMMUNOPHARMACOL, V25, P189, DOI 10.1016/j.intimp.2015.01.012; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Sawaya ACHF, 2007, APIDOLOGIE, V38, P93, DOI 10.1051/apido:2006058; Hong JF, 2016, MOL MED REP, V13, P4541, DOI 10.3892/mmr.2016.5105; Huang SA, 2014, MOLECULES, V19, P19610, DOI 10.3390/molecules191219610; Jin UH, 2008, MOL CELL BIOCHEM, V310, P43, DOI 10.1007/s11010-007-9663-7; Kasai H, 2006, ANTIOXID REDOX SIGN, V8, P981, DOI 10.1089/ars.2006.8.981; Kostova I, 2006, MINI-REV MED CHEM, V6, P365, DOI 10.2174/138955706776361457; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Lopez BGC, 2015, J APPL MICROBIOL, V119, P677, DOI 10.1111/jam.12874; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Machado JL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/157652; Moraes VWR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.190; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Queiroz MJRP, 2014, BIOMED RES INT, V2014, P1; Cabral ISR, 2009, QUIM NOVA, V32, P1523, DOI 10.1590/S0100-40422009000600031; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; Salatino A, 2005, EVID-BASED COMPL ALT, V2, P33, DOI 10.1093/ecam/neh060; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.5603/FHC.2012.0004, 10.2478/18693]; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0012-5; Teerasripreecha D, 2012, BMC COMPLEM ALTERN M, V12, P2; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Velikova M, 2000, Z NATURFORSCH C, V55, P785; Zizic JB, 2013, J SCI FOOD AGR, V93, P3001, DOI 10.1002/jsfa.6132	58	16	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183983	10.1371/journal.pone.0183983	http://dx.doi.org/10.1371/journal.pone.0183983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898258	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500009
J	van Ditzhuijzenl, NS; Kurata, M; van den Heuvel, M; Sorop, O; van Duin, RWB; Krabbendam-Peters, I; Ligthart, J; Witberg, K; Murawska, M; Bouma, B; Villiger, M; Garcia-Garcia, HM; Serruys, PW; Zipstra, F; van Soest, G; Duncker, DJ; Regar, E; van Beusekom, HMM				van Ditzhuijzenl, Nienke S.; Kurata, Mie; van den Heuvel, Mieke; Sorop, Oana; van Duin, Richard W. B.; Krabbendam-Peters, Ilona; Ligthart, Jurgen; Witberg, Karen; Murawska, Magdalena; Bouma, Brett; Villiger, Martin; Garcia-Garcia, Hector M.; Serruys, Patrick W.; Zipstra, Felix; van Soest, Gijs; Duncker, Dirk-Jan; Regar, Evelyn; van Beusekom, Heleen M. M.			Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERY MODEL; DRUG-ELUTING STENTS; CHOLESTEROL CRYSTALS; PART I; ABSORB; DYSFUNCTION; DISEASE; SYSTEM; ATHEROSCLEROSIS	Background DM remains a risk factor for poor outcome after stent-implantation, but little is known if and how DM affects the vascular response to BVS. Aim The aim of our study was to examine coronary responses to bioresorbable vascular scaffolds (BVS) in swine with and without diabetes mellitus fed a 'fast-food' diet (FF-DM and FF-NDM, respectively) by sequential optical coherence tomography (OCT)-imaging and histology. Methods Fifteen male swine were evaluated. Eight received streptozotocin-injection to induce DM. After 9 months (M), 32 single BVS were implanted in epicardial arteries with a stent to artery (S/A)-ratio of 1.1:1 under quantitative coronary angiography (QCA) and OCT guidance. Lumen, scaffold, neointimal coverage and composition were assessed by QCA, OCT and near-infrared spectroscopy (NIRS) pre- and/or post-procedure, at 3M and 6M. Additionally, polarization-sensitive (PS)-OCT was performed in 7 swine at 6M. After sacrifice at 3M and 6M, histology and polymer degradation analysis were performed. Results Late lumen loss was high (similar to 60%) within the first 3M after BVS-implantation (P<0.01 FF-DM vs. FF-NDM) and stabilized between 3M and 6M (<5% change in FF-DM, similar to 10% in FF-NDM; P>0.20). Neointimal coverage was highly heterogeneous in all swine ( DM vs. NDM P>0.05), with focal lipid accumulation, irregular collagen distribution and neointimal calcification. Likewise, polymer mass loss was low (similar to 2% at 3M, similar to 5% at 6M; P>0.20) and not associated with DM or inflammation. Conclusion Scaffold coverage showed signs of neo-atherosclerosis in all FF-DM and FF-NDM swine, scaffold polymer was preserved and the vascular response to BVS was not influenced by diabetes.	[van Ditzhuijzenl, Nienke S.; Kurata, Mie; van den Heuvel, Mieke; Sorop, Oana; van Duin, Richard W. B.; Krabbendam-Peters, Ilona; Ligthart, Jurgen; Witberg, Karen; Zipstra, Felix; van Soest, Gijs; Duncker, Dirk-Jan; Regar, Evelyn; van Beusekom, Heleen M. M.] Erasmus Univ, Med Ctr, Dept Cardiol, Thoraxctr,Cardiovasc Res Sch COEUR, Rotterdam, Netherlands; [Murawska, Magdalena] Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands; [Bouma, Brett; Villiger, Martin] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA USA; [Garcia-Garcia, Hector M.; Serruys, Patrick W.] Cardialysis BV, Rotterdam, Netherlands; [Regar, Evelyn] Univ Hosp Zurich, Dept Cardiovasc Surg, Zurich, Switzerland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardialysis; University of Zurich; University Zurich Hospital	van Beusekom, HMM (corresponding author), Erasmus Univ, Med Ctr, Dept Cardiol, Thoraxctr,Cardiovasc Res Sch COEUR, Rotterdam, Netherlands.	h.vanbeusekom@erasmusmc.nl	Regar, E/ABA-3301-2020; Regar, Evelyn/AAD-8201-2019; van Soest, Gijs/B-4881-2008; Garcia-Garcia, Hector Manuel/AAG-7471-2020	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; van Duin, Richard/0000-0003-4037-726X; Kurata, Mie/0000-0001-6596-2436; van Soest, Gijs/0000-0001-6474-3100	Abbott Vascular; European commission (FP7, MEDIA)	Abbott Vascular(Abbott Laboratories); European commission (FP7, MEDIA)	This study was supported in part by Abbott Vascular and by the European commission (FP7, MEDIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gomez-Lara J, 2011, EUR HEART J, V32, P294, DOI 10.1093/eurheartj/ehq458; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Karanasos A, 2015, CIRCULATION CARDIOVA, V8; Karanasos A, 2014, J AM COLL CARDIOL, V64, P2343, DOI 10.1016/j.jacc.2014.09.029; Kereiakes DJ, 2017, JACC-CARDIOVASC INTE, V10, P42, DOI 10.1016/j.jcin.2016.10.019; Koopmans SJ, 2006, METABOLISM, V55, P960, DOI 10.1016/j.metabol.2006.03.004; Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Oberhauser James P, 2009, EuroIntervention, V5 Suppl F, pF15, DOI 10.4244/EIJV5IFA3; Onuma Y, 2010, CIRCULATION, V122, P2288, DOI 10.1161/CIRCULATIONAHA.109.921528; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Qin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072710; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scheen AJ, 2004, EUR HEART J, V25, P2167, DOI 10.1016/j.ehj.2004.07.041; Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033; Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Serruys PW, 2013, EUROINTERVENTION; van Beusekom Heleen M M, 2003, Cardiovasc Radiat Med, V4, P186, DOI 10.1016/j.carrad.2004.02.004; van Beusekom HMM, 1998, J AM COLL CARDIOL, V32, P1109, DOI 10.1016/S0735-1097(98)00348-9; van den Heuvel M, 2012, AM J PHYSIOL-HEART C, V302, pH85, DOI 10.1152/ajpheart.00311.2011; van Ditzhuijzen NS, 2014, INT J CARDIOVAS IMAG, V30, P1013, DOI 10.1007/s10554-014-0447-3; van Soest G, 2011, JACC-CARDIOVASC IMAG, V4, P810, DOI 10.1016/j.jcmg.2011.01.022; VANBEUSEKOM HMM, 1993, J AM COLL CARDIOL, V21, P45, DOI 10.1016/0735-1097(93)90715-D; Waxman S, 2009, JACC-CARDIOVASC IMAG, V2, P858, DOI 10.1016/j.jcmg.2009.05.001	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183419	10.1371/journal.pone.0183419	http://dx.doi.org/10.1371/journal.pone.0183419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898243	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000410449500004
J	Chen, C; Barbieri, JT				Chen, Chen; Barbieri, Joseph T.			When Escherichia coli doesn't fit the mold: A pertussis-like toxin with altered specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CATALYZED ADP-RIBOSYLATION	Bacterial toxins introduce protein modifications such as ADP-ribosylation to manipulate host cell signaling and physiology. Several general mechanisms for toxin function have been established, but the extent to which previously uncharacterized toxins utilize these mechanisms is unknown. A study of an Escherichia coli pertussis-like toxin demonstrates that this protein acts on a known toxin substrate but displays distinct and dual chemoselectivity, suggesting this E. coli pertussis-like toxin may serve as a unique tool to study G-protein signaling in eukaryotic cells.	[Chen, Chen; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.	jtb01@mcw.edu			National Institutes of Health [AI030162, AI118389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by National Institutes of Health Grants AI030162 and AI118389.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; CARROLL SF, 1985, P NATL ACAD SCI USA, V82, P7237, DOI 10.1073/pnas.82.21.7237; Ganesan AK, 1999, J BIOL CHEM, V274, P9503, DOI 10.1074/jbc.274.14.9503; Littler DR, 2017, J BIOL CHEM, V292, P15143, DOI 10.1074/jbc.M117.796094; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; MOSS J, 1984, J RECEPTOR RES, V4, P459, DOI 10.3109/10799898409042567; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; WEST RE, 1985, J BIOL CHEM, V260, P4428	10	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15159	15160		10.1074/jbc.H117.796094	http://dx.doi.org/10.1074/jbc.H117.796094			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28887436	Green Published, hybrid			2022-12-26	WOS:000409902100037
J	Li, XJ; Jiang, XL; Chen, XD; Song, J; Ren, CC; Xiao, YJ; Gao, XH; Ru, ZG				Li, Xiaojun; Jiang, Xiaoling; Chen, Xiangdong; Song, Jie; Ren, Cuicui; Xiao, Yajuan; Gao, Xiaohui; Ru, Zhengang			Molecular cytogenetic identification of a novel wheat-Agropyron elongatum chromosome translocation line with powdery mildew resistance	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TRITICUM-AESTIVUM L.; THINOPYRUM-INTERMEDIUM DERIVATIVES; FUSARIUM HEAD BLIGHT; CONFERRING RESISTANCE; MULTICOLOR GISH; COMMON WHEAT; BREAD WHEAT; STEM RUST; PARTIAL AMPHIPLOIDS	Agropyron elongatum (Host.) Neviski (synonym, Thinopyrum ponticum Podp., 2n = 70) has been used extensively as a valuable source for wheat breeding. Numerous chromosome fragments containing valuable genes have been successfully translocated into wheat from A. elongatum. However, reports on the transfer of powdery mildew resistance from A. elongatum to wheat are rare. In this study, a novel wheat-A. elongatum translocation line, 11-20-1, developed and selected from the progenies of a sequential cross between wheat varieties (Lankaoaizaoba, Keyu 818 and BainongAK 58) and A. elongatum, was evaluated for disease resistance and characterized using molecular cytogenetic methods. Cytological observations indicated that 11-20-1 had 42 chromosomes and formed 21 bivalents at meiotic metaphase I. Genomic in situ hybridization analysis using whole genomic DNA from A. elongatum as a probe showed that the short arms of a pair of wheat chromosomes were replaced by a pair of A. elongatum chromosome arms. Fluorescence in situ hybridization, using wheat D chromosome specific sequence pAs1 as a probe, suggested that the replaced chromosome arms of 11-20-1 were 5DS. This was further confirmed by wheat SSR markers specific for 5DS. ESTSSR and EST-STS multiple loci markers confirmed that the introduced A. elongatum chromosome arms belonged to homoeologous group 5. Therefore, it was deduced that 11-20-1 was a wheat-A. elongatum T5DL.5AgS translocation line. Both resistance observation and molecular marker analyses using two specific markers (BE443538 and CD452608) of A. elongatum in a F-2 population from a cross between line 11-20-1 and a susceptible cultivar Yannong 19 verified that the A. elongatum chromosomes were responsible for the powdery mildew resistance. This work suggests that 11-20-1 likely contains a novel resistance gene against powdery mildew. We expect this line to be useful for the genetic improvement of wheat.	[Li, Xiaojun; Jiang, Xiaoling; Chen, Xiangdong; Song, Jie; Ren, Cuicui; Xiao, Yajuan; Gao, Xiaohui; Ru, Zhengang] Henan Inst Sci & Technol, Coll Life Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology	Ru, ZG (corresponding author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China.	rzgh58@163.com			Natural Science Foundation of China [31571752]; Key Research and Development Plan of China [2017YFD0100705]; Project of Henan Provincial Youth Backbone Teachers	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Plan of China; Project of Henan Provincial Youth Backbone Teachers	This work was supported by the Natural Science Foundation of China (No. 31571752), Key Research and Development Plan of China (No. 2017YFD0100705) and Project of Henan Provincial Youth Backbone Teachers.	An DG, 2013, CHROMOSOME RES, V21, P419, DOI 10.1007/s10577-013-9366-8; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Ding YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122128; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053921; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; FRIEBE B, 1994, CROP SCI, V34, P400, DOI 10.2135/cropsci1994.0011183X003400020018x; Fu BS, 2013, THEOR APPL GENET, V126, P913, DOI 10.1007/s00122-012-2025-1; Fu SL, 2012, J GENET GENOMICS, V39, P103, DOI 10.1016/j.jgg.2011.11.008; GRIFFEY CA, 1993, PLANT DIS, V77, P618, DOI 10.1094/PD-77-0618; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; Han FP, 2003, GENOME, V46, P490, DOI [10.1139/g03-032, 10.1139/G03-032]; Hao WeiWei, 2012, Scientia Agricultura Sinica, V45, P3240; He F, 2017, J GENET, V96, P165, DOI 10.1007/s12041-017-0754-2; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Hu LJ, 2011, J APPL GENET, V52, P279, DOI 10.1007/s13353-011-0038-0; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; Ji J, 2009, CEREAL RES COMMUN, V37, P217, DOI 10.1556/CRC.37.2009.2.8; Jing Fan, 2015, Journal of Agricultural Biotechnology, V23, P561; Knott D. R., 1987, Wheat and wheat improvement., P462; Li HJ, 2004, GENOME, V47, P215, DOI 10.1139/G03-095; Li HongJie, 2013, Acta Agronomica Sinica, V39, P999, DOI 10.3724/SP.J.1006.2013.00999; Li HJ, 2009, J GENET GENOMICS, V36, P557, DOI 10.1016/S1673-8527(08)60147-2; Li Xiao-Feng, 2012, Chinese Journal of Plant Ecology, V36, P109, DOI 10.3724/SP.J.1258.2012.00109; Lin ZS, 2007, EUPHYTICA, V158, P109, DOI 10.1007/s10681-007-9435-1; Liu Z, 2007, J INTEGR PLANT BIOL, V49, P1080, DOI 10.1111/j.1672-9072.2007.00462.x; Ma HQ, 2011, THEOR APPL GENET, V123, P1099, DOI 10.1007/s00122-011-1651-3; MCINTOSH RA, 1970, EUPHYTICA, V19, P71, DOI 10.1007/BF01904668; Miranda LM, 2007, THEOR APPL GENET, V114, P1451, DOI 10.1007/s00122-007-0530-4; Miranda LM, 2006, THEOR APPL GENET, V113, P1497, DOI 10.1007/s00122-006-0397-9; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Niu Z, 2014, THEOR APPL GENET, V127, P969, DOI 10.1007/s00122-014-2272-4; Oliver RE, 2006, THEOR APPL GENET, V112, P1473, DOI 10.1007/s00122-006-0250-1; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Peng YY, 2005, SCI AGR SIN, V38; Qi LL, 2011, THEOR APPL GENET, V123, P159, DOI 10.1007/s00122-011-1574-z; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Qiu YC, 2006, CEREAL RES COMMUN, V34, P1267, DOI 10.1556/CRC.34.2006.4.268; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Si Q. M., 1987, Scientia Agricultura Sinica, V20, P64; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tang ZX, 2008, CEREAL RES COMMUN, V36, P451, DOI 10.1556/CRC.36.2008.3.9; Wang J, 2005, PLANTA, V221, P277, DOI 10.1007/s00425-004-1443-y; Wang RRC, 1995, GENOME, V38, P1221, DOI 10.1139/g95-160; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Zhan HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113455; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Zhang ZY, 2001, GENOME, V44, P1129, DOI 10.1139/gen-44-6-1129; Zhao JX, 2013, EUPHYTICA, V190, P45, DOI 10.1007/s10681-012-0772-3; Zheng Q, 2009, J GENET GENOMICS, V36, P575, DOI 10.1016/S1673-8527(08)60149-6; Zhu ZD, 2006, EUPHYTICA, V150, P149, DOI 10.1007/s10681-006-9103-x; Zou JingWei, 2017, Acta Agronomica Sinica, V43, P332	55	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184462	10.1371/journal.pone.0184462	http://dx.doi.org/10.1371/journal.pone.0184462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886152	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100127
J	Park, S; Jang, H; Kim, BS; Hwang, C; Jeong, GS; Park, Y				Park, Siwan; Jang, Hwanseok; Kim, Byung Soo; Hwang, Changmo; Jeong, Gi Seok; Park, Yongdoo			Directional migration of mesenchymal stem cells under an SDF-1 alpha gradient on a microfluidic device	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL-CELLS; PROSTATE-CANCER; RHO-GTPASES; METASTASIS; INHIBITOR; MICE; CHEMOTAXIS; ACTIVATION; PLATFORM	Homing of peripheral stem cells is regulated by one of the most representative homing factors, stromal cell-derived factor 1 alpha (SDF-1 alpha), which specifically binds to the plasma membrane receptor CXCR4 of mesenchymal stem cells (MSCs) in order to initiate the signaling pathways that lead to directional migration and homing of stem cells. This complex homing process and directional migration of stem cells have been mimicked on a microfluidic device that is capable of generating a chemokine gradient within the collagen matrix and embedding endothelial cell (EC) monolayers to mimic blood vessels. On the microfluidic device, stem cells showed directional migration toward the higher concentration of SDF-1 alpha, whereas treatment with the CXCR4 antagonist AMD3100 caused loss of directionality of stem cells. Furthermore, inhibition of stem cell's main migratory signaling pathways, RhoROCK and Rac pathways, caused blockage of actomyosin and lamellipodia formation, decreasing the migration distance but maintaining directionality. Stem cell homing regulated by SDF-1 alpha caused directional migration of stem cells, while the migratory ability was affected by the activation of migration-related signaling pathways.	[Park, Siwan; Jang, Hwanseok; Park, Yongdoo] Korea Univ, Coll Med, Biomed Sci Brain Korea 21, Dept Biomed Engn, Seoul, South Korea; [Kim, Byung Soo] Korea Univ, Grad Sch Med, Dept Biomed Sci, Seoul, South Korea; [Hwang, Changmo; Jeong, Gi Seok] Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center	Park, Y (corresponding author), Korea Univ, Coll Med, Biomed Sci Brain Korea 21, Dept Biomed Engn, Seoul, South Korea.; Jeong, GS (corresponding author), Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul, South Korea.	gsjeong@amc.seoul.kr; ydpark67@korea.ac.kr	Jeong, Gi Seok/AAB-2830-2021	Park, Yongdoo/0000-0003-3822-4651; Jang, Hwanseok/0000-0002-1700-5962	National Research Foundation of Korea grant - Korean government [NRF-2014R1A2A1A11051879]; Korea University Grant	National Research Foundation of Korea grant - Korean government; Korea University Grant	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (NRF-2014R1A2A1A11051879), (http://www.nrf.re.kr/index) and a Korea University Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2002, J PHYSIOL-LONDON, V539, P295, DOI 10.1113/jphysiol.2001.013117; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Chen YC, 2003, CANCER RES, V63, P4801; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Chung S, 2009, ADV MATER, V21, P4863; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jeong GS, 2011, ANAL CHEM, V83, P8454, DOI 10.1021/ac202170e; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Liao YX, 2013, INT J MOL MED, V32, P1239, DOI 10.3892/ijmm.2013.1521; Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; Matthys P, 2001, J IMMUNOL, P167; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rao JN, 2001, AM J PHYSIOL-CELL PH, V280, pC993, DOI 10.1152/ajpcell.2001.280.4.C993; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tonges L, 2011, ROCKING REGENERATION; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404	43	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184595	10.1371/journal.pone.0184595	http://dx.doi.org/10.1371/journal.pone.0184595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886159	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100164
J	Xia, L; Xiao, X; Liu, WL; Song, Y; Liu, TJJ; Li, YJ; Zacksenhaus, E; Hao, XJ; Ben-David, Y				Xia, L.; Xiao, X.; Liu, W. L.; Song, Y.; Liu, T. J. J.; Li, Y. J.; Zacksenhaus, E.; Hao, X. J.; Ben-David, Y.			Coactosin-like protein CLP/Cot11 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGF beta signaling	ONCOGENE			English	Article							ANCHORAGE-INDEPENDENT GROWTH; MAMMARY-TUMOR CELLS; EXPRESSION; MDA-7/IL-24; APOPTOSIS; 5-LIPOXYGENASE; MEDIATOR; COTL1; SMAD4; LINES	Coactosin-like protein (CLP, or Cotl1), is an F-actin-binding protein, whose role in cancer is largely unknown. Here we show that CLP/Cotl1 is highly expressed in a rat epithelial breast cancer cell line (FE1.3) compared with its mesenchymal counterpart (FE1.2). Knockdown of CLP/Cotl1 in FE1.3 cells increased cell proliferation, whereas its overexpression in FE1.2 cells inhibited proliferation in culture and reduced tumor growth in xenograft assays in mice. Mechanistically, we identified two major pathways through which CLP/Cotl1 exerts its suppressive effects. First, CLP/Cotl1 re-expression in FE1.2 and in human MCF7 breast cancer cells induced expression of the growth-suppressor gene interleukin-24 (IL-24), which independently of p53 upregulates the tumor-suppressor genes p53 apoptosis effector related to PMP-22 (PERP) and p21(cip1). Second, overexpression of CLP/Cotl1 potentiated the growthsuppressive effect of transforming growth factor-beta 1 (TGF beta 1), leading to downregulation of TGF beta-responsive genes vascular growth factor A/B (VEGFA/VEGFB), hypoxia inducing factor 1 alpha (HIF-1 alpha) and trombospondin 1 (TSP1), which mediate various hallmarks of cancer progression including angiogenesis, invasion and metastasis. CLP/Cotl1 inhibited TGF beta signaling via a non-canonical signaling involving IL-24-instigated inhibition of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) phosphorylation and subsequent post-transcriptional downregulation of SMAD2 and SMAD4. We also showed that CLP/ COTL1 expression sensitizes breast cancer cells to chemotherapeutic drugs, and this was further enhanced by addition of exogenous TGF beta 1. CLP/Cotl1 expression is lost in many human malignancies including prostate, uterine and breast cancers. Thus, our results uncover a novel tumor-suppressor role for CLP/Cotl1 and identify the downstream effectors interleukin 24 (IL-24)/PERP and IL-24/MAPK/ERK/TGF beta as potential targets for precision therapy.	[Xia, L.; Xiao, X.; Liu, W. L.; Song, Y.; Liu, T. J. J.; Hao, X. J.; Ben-David, Y.] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guiyang, Guizhou, Peoples R China; [Xia, L.; Xiao, X.; Liu, W. L.; Song, Y.; Liu, T. J. J.; Hao, X. J.; Ben-David, Y.] Key Lab Chem Nat Prod Guizhou Prov, Guiyang, Guizhou, Peoples R China; [Xia, L.; Xiao, X.; Liu, W. L.; Song, Y.; Liu, T. J. J.; Hao, X. J.; Ben-David, Y.] Chinese Acad Sci, Guiyang, Guizhou, Peoples R China; [Xia, L.; Hao, X. J.] Guizhou Univ, Sch Pharmaceut Sci, Guiyang, Guizhou, Peoples R China; [Li, Y. J.] Jilin Univ, Dept Anat, Norman Bethune Coll Med, Changchun, Jilin, Peoples R China; [Zacksenhaus, E.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Zacksenhaus, E.] Univ Hlth Network, Toronto Gen Res Inst, Div Adv Diagnost, Toronto, ON, Canada	Guizhou Medical University; Chinese Academy of Sciences; Guizhou University; Jilin University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Ben-David, Y (corresponding author), State Key Lab Funct & Applicat Med Plants, Guiyang 550014, Guizhou, Peoples R China.	yaacovbendavid@hotmail.com	Zacksenhaus, Eldad/AAD-3584-2020		National Natural Science Foundation of China [81472609]; Science and Technology Department of Guizhou Province Innovation and Project Grant [2013-6012]; Thousand Talent Program of China [WQ20135200171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Guizhou Province Innovation and Project Grant; Thousand Talent Program of China	This work was supported by research grants from the National Natural Science Foundation of China (81472609), the Science and Technology Department of Guizhou Province Innovation and Project Grant (2013-6012) and Thousand Talent Program of China (WQ20135200171) and to YBD.	Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Dai HM, 2006, BBA-PROTEINS PROTEOM, V1764, P1688, DOI 10.1016/j.bbapap.2006.06.017; Dai HM, 2004, J BIOMOL NMR, V29, P455, DOI 10.1023/B:JNMR.0000032550.18424.aa; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Gubin MM, 2014, CELL CYCLE, V9, P3357; Guo SQ, 2017, ONCOTARGET, V8, P644, DOI 10.18632/oncotarget.13501; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Kim JA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085445, 10.1371/journal.pone.0091940]; LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971; Li XM, 2004, ACTA CRYSTALLOGR D, V60, P2387, DOI [10.1107/S0907444904028112, 10.1107/S097444904028112]; Li XM, 2004, PROTEIN SCI, V13, P2845, DOI 10.1110/ps.04937304; Li YJ, 2003, ONCOGENE, V22, P3452, DOI 10.1038/sj.onc.1206411; Li YJ, 2015, ONCOTARGET, V6, P36943, DOI 10.18632/oncotarget.6046; Liu L, 2004, ACTA CRYSTALLOGR D, V60, P1651, DOI 10.1107/S0907444904016701; Luo K, 2017, COLD SPRING HARB PER, V9; Menezes ME, 2015, ONCOTARGET, V6, P36928, DOI 10.18632/oncotarget.6047; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Nakatsura T, 2002, EUR J IMMUNOL, V32, P826, DOI 10.1002/1521-4141(200203)32:3<826::AID-IMMU826>3.0.CO;2-Y; Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Provost P, 2001, BIOCHEM J, V359, P255, DOI 10.1042/0264-6021:3590255; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; Sainz-Perez A, 2008, J IMMUNOL, V181, P6051, DOI 10.4049/jimmunol.181.9.6051; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Sun WJ, 2012, J INVEST MED, V60, P689, DOI 10.2310/JIM.0b013e31824963b6; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang CJ, 2010, ONCOL RES, V18, P561, DOI 10.3727/096504010X12767359113929; Wurthner JU, 2001, J BIOL CHEM, V276, P19495, DOI 10.1074/jbc.M006473200; Wylie-Sears J, 2014, BIOCHEM BIOPH RES CO, V446, P870, DOI 10.1016/j.bbrc.2014.03.014; Xia L, 2016, MOL CLIN ONCOL, V5, P717, DOI 10.3892/mco.2016.1059; Xuan WL, 2009, MOL CANCER RES, V7, P433, DOI 10.1158/1541-7786.MCR-08-0252; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	38	16	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					323	331		10.1038/onc.2017.342	http://dx.doi.org/10.1038/onc.2017.342			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28925397				2022-12-26	WOS:000422753900005
J	Chan, JSK; Sng, MK; Teo, ZQ; Chong, HC; Twang, JS; Tan, NS				Chan, J. S. K.; Sng, M. K.; Teo, Z. Q.; Chong, H. C.; Twang, J. S.; Tan, N. S.			Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors	ONCOGENE			English	Article							METASTATIC COLORECTAL-CANCER; RESISTANT PROSTATE-CANCER; PHASE-II TRIAL; RETINOIC ACID; CELL; PROGRESSION; TRANILAST; MICROENVIRONMENT; HYPOXIA; DISEASE	Most anticancer therapies to date focus on druggable features of tumor epithelia. Despite the increasing repertoire of treatment options, patient responses remain varied. Moreover, tumor resistance and relapse remain persistent clinical challenges. These observations imply an incomplete understanding of tumor heterogeneity. The tumor microenvironment is a major determinant of disease progression and therapy outcome. Cancer-associated fibroblasts (CAFs) are the dominant cell type within the reactive stroma of tumors. They orchestrate paracrine pro-tumorigenic signaling with adjacent tumor cells, thus exacerbating the hallmarks of cancer and accelerating tumor malignancy. Although CAF-derived soluble factors have been investigated for tumor stroma-directed therapy, the underlying transcriptional programs that enable the oncogenic functions of CAFs remain poorly understood. Nuclear receptors (NRs), a large family of ligand-responsive transcription factors, are pharmacologically viable targets for the suppression of CAF-facilitated oncogenesis. In this study, we defined the expression profiles of NRs in CAFs from clinical cutaneous squamous cell carcinoma (SCC) biopsies. We further identified a cluster of driver NRs in CAFs as important modifiers of CAF function with profound influence on cancer cell invasiveness, proliferation, drug resistance, energy metabolism and oxidative stress status. Importantly, guided by the NR profile of CAFs, retinoic acid receptor beta and androgen receptor antagonists were identified for concurrent therapy with cisplatin, resulting in the inhibition of chemoresistance in recurred SCC: CAF xenografts. Our work demonstrates that treatments targeting both the tumor epithelia and the surrounding CAFs can extend the efficacy of conventional chemotherapy.	[Chan, J. S. K.; Sng, M. K.; Teo, Z. Q.; Chong, H. C.; Twang, J. S.; Tan, N. S.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Sng, M. K.; Tan, N. S.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Tan, N. S.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Tan, N. S.] KK Womens & Children Hosp, Singapore, Singapore; [Chong, H. C.] DeNova Sci Pte Ltd, 16 Nanyang Dr, Singapore 637722, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); KK Women's & Children's Hospital	Chan, JSK; Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	CHAN0693@e.ntu.edu.sg; nstan@ntu.edu.sg	Tan, Nguan Soon/A-2220-2011; Sng, Ming Keat/J-7266-2013	Tan, Nguan Soon/0000-0003-0136-7341; Sng, Ming Keat/0000-0002-5529-4371	Singapore Ministry of Education [MOE2014-T2-1-012]; Singapore Ministry of Education (AcRF Tier 1) [RG134/15]; Nanyang President Graduate Scholarship	Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Education (AcRF Tier 1)(Ministry of Education, Singapore); Nanyang President Graduate Scholarship	The work was supported by grants from the Singapore Ministry of Education (MOE2014-T2-1-012 and AcRF Tier 1 RG134/15) to NST. JSKC is a recipient of the Nanyang President Graduate Scholarship.	Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; Bizzarri M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934038; Byun JS, 2013, AM J PATHOL, V182, P1055, DOI 10.1016/j.ajpath.2013.01.009; Chen YY, 2007, BIOMED CHROMATOGR, V21, P628, DOI 10.1002/bmc.798; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Ghandadi M, 2016, CURR PHARM DESIGN, V22, P518, DOI 10.2174/1381612822666151124234417; Hofheinz RD, 2003, ONKOLOGIE, V26, P44, DOI 10.1159/000069863; Hong K, 2014, IMMUNOL LETT, V162, P34, DOI 10.1016/j.imlet.2014.06.011; Hong LZ, 2013, ONCOL LETT, V6, P1595, DOI 10.3892/ol.2013.1590; Izumi K, 2010, ANTICANCER RES, V30, P3077; Izumi K, 2009, PROSTATE, V69, P1222, DOI 10.1002/pros.20975; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Lam CRI, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.339; Lisanti MP, 2010, CANCER BIOL THER, V10, P537, DOI 10.4161/cbt.10.6.13370; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Ohshio Y, 2014, SCAND J IMMUNOL, V80, P408, DOI 10.1111/sji.12242; Paulsson J, 2014, FUTURE ONCOL, V10, P1695, DOI [10.2217/FON.14.83, 10.2217/fon.14.83]; Redmond Aisling M, 2009, Genome Biol, V10, P311, DOI 10.1186/gb-2009-10-7-311; Rieger S, 2015, CELL BIOCHEM FUNCT, V33, P1, DOI 10.1002/cbf.3086; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Rothaeusler K, 2007, CURR PROTOC CYTOM, V7, P31; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Simkova D, 2016, BIOMED PAP, V160, P467, DOI 10.5507/bp.2016.037; Sladek FM, 2003, EXPERT OPIN THER TAR, V7, P679; Sonnenschein C, 2016, PROG BIOPHYS MOL BIO, V122, P70, DOI 10.1016/j.pbiomolbio.2016.07.004; Spaw M, 2017, MOL CARCINOGEN, V56, P1199, DOI 10.1002/mc.22583; SUZAWA H, 1992, JPN J PHARMACOL, V60, P91, DOI 10.1254/jjp.60.91; Tan NS, 2016, PROG LIPID RES, V64, P98, DOI 10.1016/j.plipres.2016.09.001; Tesei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062657; Thomas C, 2013, MOL CANCER THER, V12, P2342, DOI 10.1158/1535-7163.MCT-13-0032; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vazquez-Villa F, 2015, TUMOR BIOL, V36, P2213, DOI 10.1007/s13277-015-3295-4; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang YB, 2017, EBIOMEDICINE, V17, P45, DOI 10.1016/j.ebiom.2017.02.019; Yan CH, 2013, BBA-REV CANCER, V1835, P76, DOI 10.1016/j.bbcan.2012.11.002; Yin K, 2016, CELL MOL LIFE SCI, V73, P3789, DOI 10.1007/s00018-016-2329-4; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	50	44	44	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					160	173		10.1038/onc.2017.319	http://dx.doi.org/10.1038/onc.2017.319			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28892046	Green Published, hybrid			2022-12-26	WOS:000422631700003
J	Maltz, MR; Treseder, KK; McGuire, KL				Maltz, Mia R.; Treseder, Kathleen K.; McGuire, Krista L.			Links between plant and fungal diversity in habitat fragments of coastal shrubland	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; LANDSCAPE FRAGMENTATION; FUNCTIONAL DIVERSITY; MICROBIAL DIVERSITY; CHITINASE ACTIVITY; SOIL MICROBES; BIODIVERSITY; FOREST; CELLULOSE; RESPONSES	Habitat fragmentation is widespread across ecosystems, detrimentally affecting biodiversity. Although most habitat fragmentation studies have been conducted on macroscopic organisms, microbial communities and fungal processes may also be threatened by fragmentation. This study investigated whether fragmentation, and the effects of fragmentation on plants, altered fungal diversity and function within a fragmented shrubland in southern California. Using fluorimetric techniques, we assayed enzymes from plant litter collected from fragments of varying sizes to investigate enzymatic responses to fragmentation. To isolate the effects of plant richness from those of fragment size on fungi, we deployed litter bags containing different levels of plant litter diversity into the largest fragment and incubated in the field for one year. Following field incubation, we determined litter mass loss and conducted molecular analyses of fungal communities. We found that leaf-litter enzyme activity declined in smaller habitat fragments with less diverse vegetation. Moreover, we detected greater litter mass loss in litter bags containing more diverse plant litter. Additionally, bags with greater plant litter diversity harbored greater numbers of fungal taxa. These findings suggest that both plant litter resources and fungal function may be affected by habitat fragmentation's constraints on plants, possibly because plant species differ chemically, and may thus decompose at different rates. Diverse plant assemblages may produce a greater variety of litter resources and provide more ecological niche space, which may support greater numbers of fungal taxa. Thus, reduced plant diversity may constrain both fungal taxa richness and decomposition in fragmented coastal shrublands. Altogether, our findings provide evidence that even fungi may be affected by human-driven habitat fragmentation via direct effects of fragmentation on plants. Our findings underscore the importance of restoring diverse vegetation communities within larger coastal sage scrub fragments and suggest that this may be an effective way to improve the functional capacity of degraded sites.	[Maltz, Mia R.] Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; [Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [McGuire, Krista L.] Univ Oregon, Dept Biol, Eugene, OR 97403 USA	University of California System; University of California Riverside; University of California System; University of California Irvine; University of Oregon	Maltz, MR (corresponding author), Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA.	mmaltz@uci.edu	Treseder, Kathleen K/E-5148-2011	Treseder, Kathleen K/0000-0003-2847-6935; McGuire Meliora, Krista/0000-0002-8970-8827	Kearney Foundation of Soil Science; U.S. National Science Foundation [DEB-1256896, DEB-1457160, EAR-1411942]; Office of Biological and Environmental Research of the Office of Science, U.S. Department of Energy [DE-SC0016410]; Mycological Society of America (Forest Fungal Ecology Research Award); Mycological Society of America (Translational Mycology Postdoctoral Award)	Kearney Foundation of Soil Science; U.S. National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research of the Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Mycological Society of America (Forest Fungal Ecology Research Award); Mycological Society of America (Translational Mycology Postdoctoral Award)	This project was funded by research grants from the Kearney Foundation of Soil Science, the U.S. National Science Foundation (DEB-1256896, DEB-1457160, and EAR-1411942), grant DE-SC0016410 from the Office of Biological and Environmental Research of the Office of Science, U.S. Department of Energy, and the Mycological Society of America (Forest Fungal Ecology Research Award and the Translational Mycology Postdoctoral Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego N, 2014, FUNGAL ECOL, V8, P18, DOI 10.1016/j.funeco.2013.12.007; Alexopoulos CJ, 1979, INTRO MYCOLOGY; Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2007, SOIL ENZYMES LINKING; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00109; Ashford OS, 2013, SOIL BIOL BIOCHEM, V62, P5, DOI 10.1016/j.soilbio.2013.03.001; Aziz NH, 2002, FOOD CONTROL, V13, P281, DOI 10.1016/S0956-7135(02)00028-2; Baldrian P, 2008, BR MYCOL SY, V28, P19; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; BENGTSSON G, 1993, OECOLOGIA, V93, P296, DOI 10.1007/BF00317684; Berlemont R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00639; Billings SA, 2008, LANDSCAPE ECOL, V23, P581, DOI 10.1007/s10980-008-9218-7; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Burkey TV, 1997, AM NAT, V150, P568, DOI 10.1086/286082; Caesar-TonThat TC, 2000, BIOL FERT SOILS, V32, P374, DOI 10.1007/s003740000263; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CHRISTENSEN M, 1989, MYCOLOGIA, V81, P1, DOI 10.2307/3759446; Dighton J., 2016, FUNGI ECOSYSTEM PROC, V2nd; Edman M, 2004, OIKOS, V104, P35, DOI 10.1111/j.0030-1299.2004.12454.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Flores-Renteria D, 2016, SOIL BIOL BIOCHEM, V92, P79, DOI 10.1016/j.soilbio.2015.09.015; Flores-Renteria D, 2015, MICROB ECOL, V69, P798, DOI 10.1007/s00248-015-0584-9; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gao Hui, 2007, Journal of Ecology and Rural Environment, V23, P24; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Glassman SI, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1677; Grilli G, 2012, PLANT ECOL, V213, P155, DOI 10.1007/s11258-011-9966-3; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grinnell J., 1917, Auk Cambridge Mass, V34; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; HARDER W, 1983, ANNU REV MICROBIOL, V37, P1, DOI 10.1146/annurev.mi.37.100183.000245; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hely C, 2000, CAN J FOREST RES, V30, P674, DOI 10.1139/cjfr-30-5-674; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Hynson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138158; Ibanez I, 2014, J ECOL, V102, P882, DOI 10.1111/1365-2745.12223; Irwin EG, 2007, P NATL ACAD SCI USA, V104, P20672, DOI 10.1073/pnas.0705527105; Ives AR, 1995, AM NAT, V146, P911, DOI 10.1086/285831; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; KroonBatenburg LMJ, 1997, GLYCOCONJUGATE J, V14, P677, DOI 10.1023/A:1018509231331; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leeflang BR, 2006, ACS SYM SER, V930, P133; Leyva C, 2006, NAT AREA J, V26, P117, DOI 10.3375/0885-8608(2006)26[117:CLFBTD]2.0.CO;2; Loreau M, 1998, P ROY SOC B-BIOL SCI, V265, P33, DOI 10.1098/rspb.1998.0260; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Malmivaara-Lamsa M, 2008, SOIL BIOL BIOCHEM, V40, P1612, DOI 10.1016/j.soilbio.2008.01.013; Mangan SA, 2004, OECOLOGIA, V141, P687, DOI 10.1007/s00442-004-1684-2; McCaull J, 1994, NATURAL COMMUNITY CO; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068278; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Morin PJ, 2000, NATURE, V403, P718, DOI 10.1038/35001706; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Nol E, 2005, CONSERV BIOL, V19, P836, DOI 10.1111/j.1523-1739.2005.00367.x; Norden J, 2013, J ECOL, V101, P701, DOI 10.1111/1365-2745.12085; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Raghubanshi AS, 2009, TROP ECOL, V50, P57; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Riutta T, 2012, SOIL BIOL BIOCHEM, V49, P124, DOI 10.1016/j.soilbio.2012.02.028; RODRIGUEZKABANA R, 1983, PLANT SOIL, V75, P95, DOI 10.1007/BF02178617; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Schimel J, 2013, FRONT ECOL ENVIRON, V11, P405, DOI 10.1890/13.WB.016; Searle KR, 2010, OECOLOGIA, V163, P815, DOI 10.1007/s00442-010-1610-8; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Shay PE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01097; SINSABAUGH RL, 1991, AGR ECOSYST ENVIRON, V34, P43, DOI 10.1016/0167-8809(91)90092-C; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; Sinsabaugh RL, 2002, BOOK SOIL P, P249; SINSABAUGH RL, 2005, FUNGAL COMMUNITY ITS, P349, DOI DOI 10.1201/9781420027891.CH17; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sirulnik AG, 2007, APPL SOIL ECOL, V36, P1, DOI 10.1016/j.apsoil.2006.11.004; SOULE ME, 1992, OIKOS, V63, P39, DOI 10.2307/3545514; Soulee ME, 1987, VIABLE POPULATIONS C; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; Staff SS, 1999, AGR USDO; Syphard AD, 2007, LANDSCAPE ECOL, V22, P431, DOI 10.1007/s10980-006-9025-y; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391	98	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184991	10.1371/journal.pone.0184991	http://dx.doi.org/10.1371/journal.pone.0184991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926606	gold, Green Published			2022-12-26	WOS:000411166600060
J	Morrison, D; Wang, HY; Hahne, AC; Jones, BC; DeBruine, LM				Morrison, Danielle; Wang, Hongyi; Hahne, Amanda C.; Jones, Benedict C.; DeBruine, Lisa M.			Predicting the reward value of faces and bodies from social perception	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; BODY; VIEW	Social judgments of faces are thought to be underpinned by two perceptual components: valence and dominance. Recent work using a standard key-press task to assess reward value found that these valence and dominance components were both positively related to the reward value of faces. Although bodies play an important role in human social interaction, the perceptual dimensions that underpin social judgments of bodies and their relationship to the reward value of bodies are not yet known. The current study investigated these issues. We replicated previous studies showing that valence and dominance underpin social judgments of faces and that both components are positively related to the reward value of faces. By contrast, social judgments of bodies were underpinned by a single component that reflected aspects of both perceived valence and perceived dominance and was positively correlated with the reward value of bodies. These results highlight differences in how observers process faces and bodies.	[Morrison, Danielle; Wang, Hongyi; Jones, Benedict C.; DeBruine, Lisa M.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Hahne, Amanda C.] Humboldt State Univ, Psychol Dept, Arcata, CA 95521 USA	University of Glasgow; California State University System; California State Polytechnic University, Humboldt	Morrison, D (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	d.morrison.4@research.gla.ac.uk	DeBruine, Lisa M/A-6990-2008; Jones, Benedict/A-7850-2008	DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict/0000-0001-7777-0220				Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2001, J STAT SOFTW, V67, P1; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Emerson J.D., 1983, TRANSFORMING DATA UN, P97; Emerson JD., 1983, MATH ASPECTS TRANSFO, P247; Hahn AC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0978; Hahn AC, 2014, NEUROSCI BIOBEHAV R, V46, P591, DOI 10.1016/j.neubiorev.2014.08.015; Honekopp J, 2007, EVOL HUM BEHAV, V28, P106, DOI 10.1016/j.evolhumbehav.2006.09.001; Kret ME, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00028; KUZNETSOVA A, 2016, IMERTEST TESTS LINEA; McAleer P., 2014, PLOONE PUBLIC LIB, V9, P1, DOI [10.1371/journal.pone.0090779, DOI 10.1371/J0URNAL.P0NE.0090779]; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Sell A, 2012, HUM NATURE-INT BIOS, V23, P30, DOI 10.1007/s12110-012-9131-2; Thornhill R, 1999, EVOL HUM BEHAV, V20, P105, DOI 10.1016/S1090-5138(98)00044-0; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161114	20	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185093	10.1371/journal.pone.0185093	http://dx.doi.org/10.1371/journal.pone.0185093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926615	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000411166600069
J	Yuan, MM; Feng, C; Wang, SY; Zhang, WW; Chen, M; Jiang, H; Feng, XS				Yuan, Mingmei; Feng, Cong; Wang, Shouyun; Zhang, Weiwei; Chen, Mo; Jiang, Hong; Feng, Xuesong			Selection of possible signature peptides for the detection of bovine lactoferrin in infant formulas by LC-MS/MS	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; MILK; PROTEINS; QUANTIFICATION; TRANSFERRIN; PRODUCTS	An LC-MS/MS assay based on a signature peptide was developed and fully validated for the quantitation of bovine lactoferrin in infant formulas. Three unreported signature peptides were derived and identified from the tryptic peptides of bovine lactoferrin. The peptide ETTVFENLPEK was used for quantification based on assay performance. The blank matrix camel milk powder and bovine lactoferrin protein standards were mixed and spiked with stable isotope-labeled internal standard to establish a calibration curve. The established method was extensively validated by determining the linearity (R-2 > 0.999), sensitivity (limit of quantitation, 0.16 mg/100 g), recovery (83.1-91.6%), precision (RSD < 5.4%) and repeatability (RSD < 7.7%). To validate the applicability of the method, four different brands of infant formulas in China were analysed. The acquired contents of bovine lactoferrin were 52.60-150.56 mg/100 g.	[Yuan, Mingmei; Wang, Shouyun; Feng, Xuesong] China Med Univ, Sch Pharm, Dept Pharmaceut Anal, Shenyang, Liaoning, Peoples R China; [Feng, Cong; Zhang, Weiwei; Chen, Mo; Jiang, Hong] China Med Univ, Sch Publ Hlth, Dept Hlth Lab Technol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Jiang, H (corresponding author), China Med Univ, Sch Publ Hlth, Dept Hlth Lab Technol, Shenyang, Liaoning, Peoples R China.	hjiang@cmu.edu.cn			Medical Education and Research Projects; Society of Medical Education; China Medical Association; China Association of Higher Education [2016A-YF002]; 13th Five-year Plan Project of Liaoning Higher Education Institute [GHZD160007]	Medical Education and Research Projects; Society of Medical Education; China Medical Association; China Association of Higher Education; 13th Five-year Plan Project of Liaoning Higher Education Institute	This work was financially supported by Medical Education and Research Projects in 2016, Society of Medical Education, China Medical Association and China Association of Higher Education (2016A-YF002). Also, it was part of a project funded by the 13th Five-year Plan Project of Liaoning Higher Education Institute (GHZD160007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; AISEN P, 1972, BIOCHIM BIOPHYS ACTA, V257, P314, DOI 10.1016/0005-2795(72)90283-8; Ansari P, 2011, ANAL BIOANAL CHEM, V399, P1105, DOI 10.1007/s00216-010-4422-0; Christoph Czerwenka, 2007, ANAL CHEM, V79, P5165; E.M. Agency, 2012, DRUG EVALUATION RES, V35, P396; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7; IYER S, 1993, EUR J CLIN NUTR, V47, P232; Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x; Kappeler SR, 1999, INT DAIRY J, V9, P481, DOI 10.1016/S0958-6946(99)00117-X; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lonnerdal B, 2016, J PEDIATR-US, V173, pS4, DOI 10.1016/j.jpeds.2016.02.070; Lutter P, 2011, J AOAC INT, V94, P1043; Maneva A, 2016, Z NATURFORSCH C, V58, P256; Manzoni P, 2016, J PEDIATR-US, V173, pS43, DOI 10.1016/j.jpeds.2016.02.075; Nowak P, 2013, J CHROMATOGR A, V1321, P127, DOI 10.1016/j.chroma.2013.10.073; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Pattamatta U, 2013, CURR EYE RES, V38, P1110, DOI 10.3109/02713683.2013.811259; Qu J, 2006, ANAL CHEM, V78, P4543, DOI 10.1021/ac0521697; Tsakali E, 2014, J DAIRY SCI, V97, P4832, DOI 10.3168/jds.2013-7526; van Altena SEC, 2016, VET IMMUNOL IMMUNOP, V174, P11, DOI 10.1016/j.vetimm.2016.04.005; van den Broek I, 2013, J CHROMATOGR B, V929, P161, DOI 10.1016/j.jchromb.2013.04.030; Velona T, 1999, PEDIATR RES, V45, P658, DOI 10.1203/00006450-199905010-00008; Wakabayashi H, 2006, INT DAIRY J, V16, P1241, DOI 10.1016/j.idairyj.2006.06.013; Yiping Ren, 2010, Analytica Chimica Acta, V667, P96; Zhang JS, 2014, ANAL CHIM ACTA, V829, P33, DOI 10.1016/j.aca.2014.04.025	26	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184152	10.1371/journal.pone.0184152	http://dx.doi.org/10.1371/journal.pone.0184152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926582	gold, Green Submitted, Green Published			2022-12-26	WOS:000411166600010
J	Edwardson, DW; Boudreau, J; Mapletoft, J; Lanner, C; Kovala, AT; Parissenti, AM				Edwardson, Derek W.; Boudreau, Justin; Mapletoft, Jonathan; Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.			Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; P-GLYCOPROTEIN EXPRESSION; EPITHELIAL OVARIAN-CANCER; EARLY BREAST-CANCER; NF-KAPPA-B; MULTIDRUG-RESISTANCE; IN-VITRO; LIPID-A; SIGNAL-TRANSDUCTION; ADJUVANT DOCETAXEL	Tumor Necrosis Factor alpha (TNF-alpha) has been shown to be released by tumor cells in response to docetaxel, and lipopolysaccharides (LPS), the latter through activation of toll-like receptor 4 (TLR4). However, it is unclear whether the former involves TLR4 receptor activation through direct binding of the drug to TLR4 at the cell surface. The current study was intended to better understand drug-induced TNF-a production in tumor cells, whether from short-term drug exposure or in cells selected for drug resistance. ELISAs were employed to measure cytokine release from breast and ovarian tumor cells in response to several structurally distinct chemotherapy agents and/or TLR4 agonists or antagonists. Drug uptake and drug sensitivity studies were also performed. We observed that several drugs induced TNF-arelease from multiple tumor cell lines. Docetaxel-induced cytokine production was distinct from that of LPS in both MyD88-positive (MCF-7) and MyD88-deficient (A2780) cells. The acquisition of docetaxel resistance was accompanied by increased constitutive production of TNF-alpha and CXCL1, which waned at higher levels of resistance. In docetaxel-resistant MCF-7 and A2780 cell lines, the production of TNF-a could not be significantly augmented by docetaxel without the inhibition of P-gp, a transporter protein that promotes drug efflux from tumor cells. Pretreatment of tumor cells with LPS sensitized MyD88positive cells (but not MyD88-deficient) to docetaxel cytotoxicity in both drug-naive and drug-resistant cells. Our findings suggest that taxane-induced inflammatory cytokine production from tumor cells depends on the duration of exposure, requires cellular drug-accumulation, and is distinct from the LPS response seen in breast tumor cells. Also, stimulation of the LPS-induced pathway may be an attractive target for treatment of drug-resistant disease.	[Edwardson, Derek W.; Kovala, A. Thomas; Parissenti, Amadeo M.] Laurentian Univ, PhD Program Biomol Sci, Sudbury, ON, Canada; [Boudreau, Justin; Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.] Laurentian Univ, Dept Biol, Sudbury, ON, Canada; [Mapletoft, Jonathan; Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada; [Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [Parissenti, Amadeo M.] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Parissenti, Amadeo M.] Univ Ottawa, Div Oncol, Fac Med, Ottawa, ON, Canada	Laurentian University; Laurentian University; Laurentian University; Northern Ontario School of Medicine; Health Sciences North; Northern Ontario School of Medicine; University of Ottawa	Parissenti, AM (corresponding author), Laurentian Univ, PhD Program Biomol Sci, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Univ Ottawa, Div Oncol, Fac Med, Ottawa, ON, Canada.	aparissenti@laurentian.ca		Kovala, A. Thomas/0000-0002-2908-5613	Northern Cancer Foundation of Sudbury from Northern Ontario School of Medicine	Northern Cancer Foundation of Sudbury from Northern Ontario School of Medicine	The study was supported by a grant from the Northern Cancer Foundation of Sudbury, along with additional support for the purchase of reagents through a grant to Tom Kovala from the Northern Ontario School of Medicine, https://www.ncfsudbury.com/; http://www.nosm.ca/research/default.aspx.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Ardestani S, 2013, CANCER RES, V73, P3938, DOI 10.1158/0008-5472.CAN-13-0002; Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; Armstrong SR, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-40; Baker SD, 2004, CLIN CANCER RES, V10, P1976, DOI 10.1158/1078-0432.CCR-0842-03; Baldridge JR, 2002, J ENDOTOXIN RES, V8, P453, DOI 10.1179/096805102125001064; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; BERKOVA N, 1995, ANTICANCER RES, V15, P863; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BIEDLER JL, 1970, CANCER RES, V30, P1174; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOGDAN C, 1992, J LEUKOCYTE BIOL, V52, P119, DOI 10.1002/jlb.52.1.119; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Buoncervello M, 2012, NEOPLASIA, V14, P855, DOI 10.1593/neo.121020; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Dowling JK, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.22; Eltahir A, 1998, AM J SURG, V175, P127, DOI 10.1016/S0002-9610(97)00279-1; Erba E, 2000, BRIT J CANCER, V82, P1732; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Globocan, 2012, EST CANC INC MORT PR; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Jeyaseelan S, 2010, J IMMUNOL J IMMUNOL, V185, P6214; JOHNSON AG, 1956, J EXP MED, V103, P225, DOI 10.1084/jem.103.2.225; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Lu L, 2015, J CONTROL RELEASE, V210, P134, DOI 10.1016/j.jconrel.2015.05.282; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Markauskas A, 2014, INT J GYNECOL CANCER, V24, P1420, DOI 10.1097/IGC.0000000000000241; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martin M, 2010, NEW ENGL J MED, V363, P2200, DOI 10.1056/NEJMoa0910320; Masereeuw R, 2010, J BIOMED BIOTECHNOL, V2010; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; MILLER TP, 1991, J CLIN ONCOL, V9, P17, DOI 10.1200/JCO.1991.9.1.17; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Moore A, 1999, VACCINE, V17, P2517, DOI 10.1016/S0264-410X(99)00062-6; NIEHORSTER M, 1990, BIOCHEM PHARMACOL, V40, P1601, DOI 10.1016/0006-2952(90)90461-S; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Nobili S, 2014, LEUKEMIA LYMPHOMA, V55, P2071, DOI 10.3109/10428194.2013.866665; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; PARKER MM, 1983, JAMA-J AM MED ASSOC, V250, P3324, DOI 10.1001/jama.250.24.3324; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Ran S, 2015, CANCER RES, V75, P2405, DOI 10.1158/0008-5472.CAN-14-3525; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Reed K, 2008, EPIGENETICS-US, V3, P270, DOI 10.4161/epi.3.5.6868; Reife RA, 2005, J IMMUNOL REF, V175, P4490; Resman N, 2008, FEBS LETT, V582, P3929, DOI 10.1016/j.febslet.2008.10.037; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Sharma B, 2013, MOL CANCER THER, V12, P799, DOI 10.1158/1535-7163.MCT-12-0529; Shi Z, 2012, BREAST CANCER RES TR, V135, P737, DOI 10.1007/s10549-012-2196-0; Shirakawa K, 1999, JPN J CANCER RES, V90, P1380, DOI 10.1111/j.1349-7006.1999.tb00723.x; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Smith IE, 2006, BRIT MED J, V332, P223, DOI 10.1136/bmj.332.7535.223; Smith IE, 2006, BMJ-BRIT MED J, V332, P34, DOI 10.1136/bmj.332.7532.34; Sprowl JA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3083; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Taylor CW, 1997, BREAST CANCER RES TR, V42, P7, DOI 10.1023/A:1005716214718; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598; Trock BJ, 1997, J NATL CANCER I, V89, P917, DOI 10.1093/jnci/89.13.917; Tunggal JK, 2000, INT J CANCER, V86, P101, DOI 10.1002/(SICI)1097-0215(20000401)86:1<101::AID-IJC16>3.0.CO;2-I; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Visintin A, 2005, PHARM INHIBITION END; Vitiello M, 2004, CYTOKINE, V27, P15, DOI 10.1016/j.cyto.2004.03.010; Wang AC, 2014, ONCOL LETT, V7, P871, DOI 10.3892/ol.2013.1759; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wu Z, 2015, EUR J PAIN, V19, P889, DOI 10.1002/ejp.613; Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yu CH, 2007, CELL PHYSIOL BIOCHEM, V20, P853, DOI 10.1159/000110445; Zhang YT, 2012, CELL BIOL TOXICOL, V28, P269, DOI 10.1007/s10565-012-9221-2; Zimmer SM, 2008, J BIOL CHEM, V283, P27916, DOI 10.1074/jbc.M802826200	96	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0183662	10.1371/journal.pone.0183662	http://dx.doi.org/10.1371/journal.pone.0183662			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915246	Green Published, Green Submitted, gold			2022-12-26	WOS:000410861600004
J	Monostori, P; Klinke, G; Richter, S; Barath, A; Fingerhut, R; Baumgartner, MR; Kolker, S; Hoffmann, GF; Gramer, G; Okun, JG				Monostori, Peter; Klinke, Glynis; Richter, Sylvia; Barath, Akos; Fingerhut, Ralph; Baumgartner, Matthias R.; Koelker, Stefan; Hoffmann, Georg F.; Gramer, Gwendolyn; Okun, Juergen G.			Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; FALSE-POSITIVE RATE; VITAMIN-B-12 DEFICIENCY; ELECTROSPRAY-IONIZATION; 2-METHYLCITRIC ACID; TOTAL HOMOCYSTEINE; LIQUID-CHROMATOGRAPHY; PHENOTYPIC SPECTRUM; ORGANIC ACIDURIAS; INBORN-ERRORS	Background and aims Increased propionylcarnitine levels in newborn screening are indicative for a group of potentially severe disorders including propionic acidemia (PA), methylmalonic acidemias and combined remethylation disorders (MMACBL). This alteration is relatively non-specific, resulting in the necessity of confirmation and differential diagnosis in subsequent tests. Thus, we aimed to develop a multiplex approach for concurrent determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid from the same dried blood spot (DBS) as in primary screening (second-tier test). We also set out to validate the method using newborn and follow-up samples of patients with confirmed PA or MMACBL. Methods The assay was developed using liquid chromatography-tandem mass spectrometry and clinically validated with retrospective analysis of DBS samples from PA or MMACBL patients. Results Reliable determination of all three analytes in DBSs was achieved following simple and fast (< 20 min) sample preparation without laborious derivatization or any additional pipetting steps. The method clearly distinguished the pathological and normal samples and differentiated between PA and MMACBL in all stored newborn specimens. Methylcitric acid was elevated in all PA samples; 3-hydroxypropionic acid was also high in most cases. Methylmalonic acid was increased in all MMACBL specimens; mostly together with methylcitric acid. Conclusions A liquid chromatography-tandem mass spectrometry assay allowing simultaneous determination of the biomarkers 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in DBSs has been developed. The assay can use the same specimen as in primary screening (second-tier test) which may reduce the need for repeated blood sampling. The presented preliminary findings suggest that this method can reliably differentiate patients with PA and MMACBL in newborn screening. The validated assay is being evaluated prospectively in a pilot project for extension of the German newborn screening panel ("Newborn screening 2020"; Newborn Screening Center, University Hospital Heidelberg).	[Monostori, Peter; Klinke, Glynis; Richter, Sylvia; Koelker, Stefan; Hoffmann, Georg F.; Gramer, Gwendolyn; Okun, Juergen G.] Univ Hosp Heidelberg, Div Neuropediat & Metab Med, Dept Gen Pediat, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Barath, Akos] Univ Szeged, Dept Pediat, Szeged, Hungary; [Fingerhut, Ralph; Baumgartner, Matthias R.] Univ Childrens Hosp Zurich, Childrens Res Ctr, Div Metab, Zurich, Switzerland	Ruprecht Karls University Heidelberg; Szeged University; University Children's Hospital Zurich	Monostori, P (corresponding author), Univ Hosp Heidelberg, Div Neuropediat & Metab Med, Dept Gen Pediat, Ctr Pediat & Adolescent Med, Heidelberg, Germany.	monostoripeter@gmail.com	Baumgartner, Matthias/Q-2855-2017; Fingerhut, Ralph/AAY-5061-2021	Baumgartner, Matthias/0000-0002-9270-0826; Fingerhut, Ralph/0000-0002-9674-8931; Gramer, Gwendolyn/0000-0001-7596-6529	Dietmar Hopp Foundation, St. Leon Rot; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Dietmar Hopp Foundation, St. Leon Rot; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work and the pilot study "Newborn screening 2020" at the Newborn Screening Center of the University Hospital Heidelberg are generously supported by the Dietmar Hopp Foundation, St. Leon Rot (http://dietmar-hopp-stiftung.de). We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dirbashi OY, 2017, J MED SCREEN, V24, P58, DOI 10.1177/0969141316645824; Al-Dirbashi OY, 2014, JIMD REP, V16, P65, DOI 10.1007/8904_2014_321; Baumgartner MR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0130-8; de Sain-van der Velden MGM, 2015, ANAL CHIM ACTA, V853, P435, DOI 10.1016/j.aca.2014.10.043; Dhondt JL, 2010, J INHERIT METAB DIS, V33, pS211, DOI 10.1007/s10545-010-9138-y; Dietzen DJ, 2009, CLIN CHEM, V55, P1615, DOI 10.1373/clinchem.2009.131300; Estrella J, 2014, J INHERIT METAB DIS, V37, P881, DOI 10.1007/s10545-014-9727-2; Fingerhut R, 2009, ANAL CHEM, V81, P3571, DOI 10.1021/ac8022235; Fu XW, 2013, JIMD REP, V10, P69, DOI 10.1007/8904_2012_205; Goldenberg AJ, 2016, MATERN CHILD HLTH J, V20, P693, DOI 10.1007/s10995-015-1869-9; Heringer J, 2016, J INHERIT METAB DIS, V39, P341, DOI 10.1007/s10545-015-9907-8; Hinton CF, 2010, J PEDIATR-US, V157, P162, DOI 10.1016/j.jpeds.2010.03.006; Horster F, 2017, JIMD REP, V32, P105, DOI 10.1007/8904_2016_537; Jain R, 2015, J CHILD NEUROL, V30, P641, DOI 10.1177/0883073813516194; Kolker S, 2015, J INHERIT METAB DIS, V38, P1059, DOI 10.1007/s10545-015-9840-x; Kolker S, 2015, J INHERIT METAB DIS, V38, P1041, DOI 10.1007/s10545-015-9839-3; Krawczyk H, 2007, J INHERIT METAB DIS, V30, P263, DOI 10.1007/s10545-007-0420-6; La Marca G, 2007, CLIN CHEM, V53, P1364, DOI 10.1373/clinchem.2007.087775; Lim JS, 2014, MOL GENET METAB, V113, P53, DOI 10.1016/j.ymgme.2014.07.018; Lindner M, 2008, J INHERIT METAB DIS, V31, P379, DOI 10.1007/s10545-008-0892-z; Lo SY, 2016, CLIN BIOCHEM, V49, P967, DOI 10.1016/j.clinbiochem.2016.05.010; Loeber JG, 2012, J INHERIT METAB DIS, V35, P603, DOI 10.1007/s10545-012-9483-0; Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y; Papp F, 2011, EGESZSEGTUDOMANY, V55, P19; Podebrad F, 1999, HRC-J HIGH RES CHROM, V22, P604; Remane D, 2010, RAPID COMMUN MASS SP, V24, P859, DOI 10.1002/rcm.4459; Roschinger W, 2015, MONATSSCHR KINDERH, V163, P142, DOI 10.1007/s00112-014-3297-0; Schroder TH, 2014, J NUTR, V144, P1658, DOI 10.3945/jn.114.194829; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Scolamiero E, 2014, CLIN BIOCHEM, V47, P312, DOI 10.1016/j.clinbiochem.2014.08.020; Shigematsu Y, 2010, J INHERIT METAB DIS, V33, pS283, DOI 10.1007/s10545-010-9111-9; Singh G, 2016, PEDIATR BLOOD CANCER, V63, P740, DOI 10.1002/pbc.25828; Slaughter JL, 2010, PEDIATRICS, V126, P910, DOI 10.1542/peds.2010-0943; Strnadova KA, 2007, CLIN CHEM, V53, P717, DOI 10.1373/clinchem.2006.076679; Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002; Torresani T, 2007, PAEDIATRICA, V18, P56; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957; Wagner M, 2016, MASS SPECTROM REV, V35, P361, DOI 10.1002/mas.21441; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x	39	35	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184897	10.1371/journal.pone.0184897	http://dx.doi.org/10.1371/journal.pone.0184897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915261	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000410861600022
J	Ripka, WL; Ulbricht, L; Gewehr, PM				Ripka, Wagner Luis; Ulbricht, Leandra; Gewehr, Pedro Miguel			Body composition and prediction equations using skinfold thickness for body fat percentage in Southern Brazilian adolescents	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; WAIST CIRCUMFERENCE; CHILDREN; OBESITY; PREVALENCE; OVERWEIGHT; CHILDHOOD; FATNESS; MODEL; RISK	Objectives The purpose of this study was to: a) determine the nutritional status of Brazilian adolescents, and; b) present a skinfold thickness model (ST) to estimate body fat developed with Brazilian samples, using dual energy x-ray absorptiometry (DXA) as reference method. Methods The main study group was composed of 374 adolescents, and further 42 adolescents for the validation group. Weight, height, waist circumference measurements, and body mass index (BMI) were collected, as well as nine ST-biceps (BI), triceps (TR), chest (CH), axillary (AX) subscapularis (SB), abdominal (AB), suprailiac (SI), medial thigh (TH), calf (CF), and fat percentage (%BF) obtained by DXA. Results The prevalence of overweight in adolescents was 20.9%, and obesity 5.8%. Regression analysis through ordinary least square method (OLS) allowed obtainment of three equations with values of R-2 = 0.935, 0.912 and 0.850, standard error estimated = 1.79, 1.78 and 1.87, and bias = 0.06, 0.20 and 0.05, respectively. Conclusion the innovation of this study lies in presenting new regression equations for predicting body fat in Southern Brazilian adolescents based on a representative and heterogeneous sample from DXA.	[Ripka, Wagner Luis; Gewehr, Pedro Miguel] Univ Tecnol Fed Parana, Grad Program Elect & Comp Engn, Curitiba, Parana, Brazil; [Ulbricht, Leandra] Univ Tecnol Fed Parana, Grad Program Biomed Engn, Curitiba, Parana, Brazil	Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana	Ripka, WL (corresponding author), Univ Tecnol Fed Parana, Grad Program Elect & Comp Engn, Curitiba, Parana, Brazil.	ripka.w@gmail.com	Ripka, Wagner/J-7503-2015; Ulbricht, Leandra/H-8535-2012	Ripka, Wagner/0000-0002-6191-1188; Ulbricht, Leandra/0000-0002-9514-2938; gewehr, pedro miguel/0000-0002-9694-7906	Programa de Pesquisa para o Sistema Unico de Salide: Gestao Compartilhada em SaUde PPSUS [41614 - FA]; Federal University of Technology-Parana [982/2013]	Programa de Pesquisa para o Sistema Unico de Salide: Gestao Compartilhada em SaUde PPSUS; Federal University of Technology-Parana	This project received funding from Programa de Pesquisa para o Sistema Unico de Salide: Gestao Compartilhada em SaUde PPSUS edition 04/2012, project number: 41614 - FA, agreement 982/2013 with Federal University of Technology-Parana. The funders had no role in the study design, data collection and analysis, decision to publish, preparation of the manuscript, and none of the authors received a salary. The resources were used to cover the expenses of the adolescents' DXA assessment.	Bacopoulou F, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0366-z; Cicek B, 2014, J PAK MED ASSOC, V64, P1154; De Miguel-Etayo P, 2013, WORLD REV NUTR DIET, V108, P98, DOI 10.1159/000351493; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dismuke C., 2006, METHODS OUTCOMES RES, V93, P93; Feldmann L.R.A., 2012, RBONE REV BRASILEIRA, V3, P225; Flavel NA, 2012, ACTA PAEDIATR, V101, P1253, DOI 10.1111/apa.12024; Freedman DS, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0493-6; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Hussain Z, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004194; ICB Almeida AMd Santos AS Barbosa DBVbody mass index and of waist circumference on adolescents, 2008, ARQUIVOS BRASILEIROS, V90, P426; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20; Klimek-Piotrowska W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122274; Lohman TG, 1992, CAD SAUDE PUBLICA, pS116; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Lyra CO, 2012, ANN HUM BIOL, V39, P275, DOI 10.3109/03014460.2012.685106; Machado-Rodrigues AM, 2016, J SCHOOL HEALTH, V86, P54, DOI 10.1111/josh.12350; Marfell-Jones M., 2006, INT SOC ADVANCEMENT; Maroco J., 2007, STAT ANAL SPSS APPL; Nooyens ACJ, 2007, AM J CLIN NUTR, V85, P1533, DOI 10.1093/ajcn/85.6.1533; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Perini Talita Adão, 2005, Rev Bras Med Esporte, V11, P81, DOI 10.1590/S1517-86922005000100009; Rank M, 2013, J PEDIATR-US, V163, P137, DOI 10.1016/j.jpeds.2013.01.020; Rodriguez G, 2005, EUR J CLIN NUTR, V59, P1158, DOI 10.1038/sj.ejcn.1602226; Schommer VA, 2014, ARQ BRAS CARDIOL, V102, P312, DOI 10.5935/abc.20140038; Sigulem D M, 2000, J Pediatr (Rio J), V76 Suppl 3, pS275; Silva DRP, 2013, REV ASSOC MED BRAS, V59, P475, DOI [10.1016/j.ramb.2013.03.006, 10.1016/S2255-4823(13)70507-1]; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Sopher AB, 2004, PEDIATRICS, V113, P1285, DOI 10.1542/peds.113.5.1285; WHO, 2006, WHO CHILD GROWTH STA; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2015, ADOLESCENT HEALTH	33	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184854	10.1371/journal.pone.0184854	http://dx.doi.org/10.1371/journal.pone.0184854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910398	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200108
J	Ye, YQ; Li, ZH; Feng, Q; Chen, ZM; Wu, ZG; Wang, JY; Ye, XS; Zhang, DH; Liu, L; Gao, W; Zhang, LH; Wang, B				Ye, Yongqin; Li, Zhihan; Feng, Qi; Chen, Zimin; Wu, Zhouguang; Wang, Jianyao; Ye, Xiaoshuo; Zhang, Dahao; Liu, Lei; Gao, Wei; Zhang, Lihui; Wang, Bin			Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3	PLOS ONE			English	Article							SUSCEPTIBILITY; PROLIFERATION; PATHOGENESIS; HEPATITIS; ADHESION	Background and objectives Biliary atresia (BA) is a pediatric liver disease characterized by fibro-obliteration and obstruction of the extrahepatic biliary system, that invariably leads to cirrhosis and even death, if left untreated for extended time. However, its pathology and etiology still remained unknown. In this study, we tested the expression of adducin 3 (ADD3), the gene identified as a susceptibility gene in BA by GWAS, and uncovered its upstream regulatory microRNA in the pathogenesis of BA. Methods In this study, 14 infants with BA and 14 infants with choledochal cyst (CC) were enrolled as experimental group and control group, respectively. ADD3 and microRNA-145 (miR-145) expression profiles in liver tissues of BA and CC were determined using qPCR. Luciferase reporter assay was performed to verify the direct interaction between miR-145-5p and ADD3 3' Untranslated Regions (3' UTR). The Lentiviral vectors containing miR-145, miR-145-3p inhibitor, miR-145-5p inhibitor, empty vector were transfected into human hepatic stellate cell line (LX-2) to determine the functional effect of miR-145 on ADD3 expression at both mRNA and protein level. Results MiR-145 was shown to be down-regulated in liver tissues of infants with BA compared to CC (p = 0.0267). ADD3, verified as a target of miR-145-5p, was shown to be overexpressed in infants with BA at the mRNA level (p = 0.0118). Transfection of lentiviruses containing miR-145 into LX-2 cells decreased the expression of ADD3 at both mRNA and protein level compared to negative control group, and suppressed the expression of p-Akt at protein level. Conclusions Our study has shown that overexpressed ADD3 and downregulated miR-145 were detected in BA liver tissues. MiR-145-5p was confirmed to target ADD3 by luciferase reporter assay. The downregulation of miR-145 may contribute to liver fibrosis in BA by upregulating the expression of ADD3.	[Ye, Yongqin; Li, Zhihan; Zhang, Dahao] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China; [Ye, Yongqin; Li, Zhihan; Feng, Qi; Chen, Zimin; Wu, Zhouguang; Wang, Jianyao; Ye, Xiaoshuo; Zhang, Dahao; Wang, Bin] Shenzhen Childrens Hosp, Dept Gen Surg, Shenzhen, Guangdong, Peoples R China; [Liu, Lei] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Hepatobiliary Dis, Shenzhen, Guangdong, Peoples R China; [Gao, Wei] Tianjin First Ctr Hosp, Dept Organ Transplatat, Tianjin, Peoples R China; [Zhang, Lihui] Shenzhen Childrens Hosp, Dept Tradit Chinese Med, Shenzhen, Guangdong, Peoples R China	Shantou University	Wang, B (corresponding author), Shenzhen Childrens Hosp, Dept Gen Surg, Shenzhen, Guangdong, Peoples R China.; Gao, W (corresponding author), Tianjin First Ctr Hosp, Dept Organ Transplatat, Tianjin, Peoples R China.; Zhang, LH (corresponding author), Shenzhen Childrens Hosp, Dept Tradit Chinese Med, Shenzhen, Guangdong, Peoples R China.	gao-wei@medmail.com.cn; 13602576251@126.com; szwb1967@126.com	Wu, Zhouguang/AAQ-1534-2020; Liu, lei/V-9405-2018	Liu, lei/0000-0001-9612-6844	Shenzhen Science and Technology Innovation Committee [JCYJ20150403100317072, JCYJ20160429174611494]	Shenzhen Science and Technology Innovation Committee	This work is jointly supported by Shenzhen Science and Technology Innovation Committee (Grant numbers: JCYJ20150403100317072 and JCYJ20160429174611494), https//wwwszsti.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AG, 2016, NEURO-ONCOLOGY, V18, P656, DOI 10.1093/neuonc/nov196; Asai A, 2015, NAT REV GASTRO HEPAT, V12, P342, DOI 10.1038/nrgastro.2015.74; Bai GP, 2016, ONCOL REP, V36, P2902, DOI 10.3892/or.2016.5078; Citterio L, 2003, BIOCHEM BIOPH RES CO, V309, P359, DOI 10.1016/j.bbrc.2003.08.011; Cronin DC, 2013, PEDIATRICS, V131, P141, DOI 10.1542/peds.2012-0567; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; Duellman T, 2014, NUCLEIC ACIDS RES, V42, P5518, DOI 10.1093/nar/gku197; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Gradilone SA, 2015, SEMIN LIVER DIS, V35, P26, DOI 10.1055/s-0034-1397346; He Weichun, 2015, Curr Pathobiol Rep, V3, P183; Huang JF, 2011, HEPATOL RES, V41, P430, DOI 10.1111/j.1872-034X.2011.00786.x; Lee M, 2016, MEDICINE, V95, pe2741, DOI 10. 1097/MD. 0000000000002741; MATSUI A, 1994, LANCET, V343, P925, DOI 10.1016/S0140-6736(94)90052-3; Mezina A, 2015, DIGEST DIS, V33, P408, DOI 10.1159/000371694; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Nio M, 2003, J PEDIATR SURG, V38, P997, DOI 10.1016/S0022-3468(03)00178-7; OSHIO C, 1981, SCIENCE, V212, P1041, DOI 10.1126/science.7015506; Panebianco C, 2016, CLIN EXPT MED; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Petersen C, 2008, EUR J PEDIATR SURG, V18, P111, DOI 10.1055/s-2008-1038479; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reich M, 2016, GUT, V65, P487, DOI 10.1136/gutjnl-2015-309458; Schmitt MMN, 2014, CIRCULATION, V129, P66, DOI 10.1161/CIRCULATIONAHA.113.004149; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Shteyer E, 2006, J PEDIATR GASTR NUTR, V42, P93, DOI 10.1097/01.mpg.0000189324.80323.a6; Tsai EA, 2014, HUM GENET, V133, P235, DOI 10.1007/s00439-013-1368-2; Varma V, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/121862; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376; Zeng SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107977; Zhang XL, 2016, MOL MED REP, V14, P5699, DOI 10.3892/mmr.2016.5960; Zhou DD, 2016, MOL IMMUNOL, V75, P151, DOI 10.1016/j.molimm.2016.05.018	32	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0180896	10.1371/journal.pone.0180896	http://dx.doi.org/10.1371/journal.pone.0180896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902846	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200001
J	Angkasekwinai, P; Sodthawon, W; Jeerawattanawart, S; Hansakon, A; Pattanapanyasat, K; Wang, YH				Angkasekwinai, Pornpimon; Sodthawon, Wichuda; Jeerawattanawart, Siranart; Hansakon, Adithap; Pattanapanyasat, Kovit; Wang, Yui-Hsi			ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; T-CELLS; IMMUNITY; IDENTIFICATION; IL-13; INFLAMMATION; MECHANISMS; EXPRESSION; INDUCTION; RESPONSES	IL-25, an IL-17 family cytokine, derived from epithelial cells was shown to regulate Th2-and Th9-type immune responses. We previously reported that IL-25 was important in promoting efficient protective immunity against T. spiralis infection; however, the cellular targets of IL25 to elicit type-2 immunity during infection have not yet been addressed. Here, we investigated IL-25-responding cells and their involvement in mediating type-2 immune response during T. spiralis infection. ILC2 and CD4(+) Th2 cells residing in the gastrointestinal tract of T. spiralis infected mice were found to express high levels of surface interleukin-17 receptor B ( IL-17RB), a component of the IL-25 receptor. Following T. spiralis infection, activated ILC2s upregulated surface MHCII expression and enhanced capacity of effector T helper cell in producing antigen-specific Th2 and Th9 cytokines through MHCII-dependent interactions. Reciprocally, lack of CD4(+) T helper cells impaired ILC2 function to produce type 2-associated cytokines in responding to IL-25 during T. spiralis infection. Furthermore, mice deficient in IL-17RB showed markedly reduced ILC2 numbers and antigen-specific Th2 and Th9 cytokine production during T. spiralis infection. The Il17rb(-/-)mice failed to mount effective antigen specific Th2 and Th9 functions resulting in diminished goblet cell and mast cell responses, leading to delayed worm expulsion in the intestines and muscles. Thus, our data indicated that ILC2s and CD4 + Th2 cells are the predominant cellular targets of IL-25 following T. spiralis infection and their collaborative interactions may play a key role in mounting effective antigen-specific Th2 and Th9 cytokine responses against T. spiralis infection.	[Angkasekwinai, Pornpimon; Sodthawon, Wichuda; Jeerawattanawart, Siranart; Hansakon, Adithap] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani, Thailand; [Angkasekwinai, Pornpimon; Jeerawattanawart, Siranart; Hansakon, Adithap] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand; [Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Ctr Excellence Flow Cytometry, Off Res & Dev,Fac Med, Bangkok, Thailand; [Wang, Yui-Hsi] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH USA	Thammasat University; Thammasat University; Mahidol University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Angkasekwinai, P (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani, Thailand.; Angkasekwinai, P (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand.	upornpim@tu.ac.th	Angkasekwinai, Pornpimon/AAX-6124-2020	Angkasekwinai, Pornpimon/0000-0003-0303-9544; Hansakon, Adithap/0000-0003-1693-4900	Thailand Research Fund Grant for New Researcher (Thailand Research Fund (TRF)); Thailand Research Fund Grant for New Researcher (Thammasat University) [TRG5780021]; Kovit Pattanapanyasat (Thailand research Fund) [DPG5980001]; Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant; Faculty of Allied Health Sciences, Thammasat University; Thammasat university	Thailand Research Fund Grant for New Researcher (Thailand Research Fund (TRF))(Thailand Research Fund (TRF)); Thailand Research Fund Grant for New Researcher (Thammasat University); Kovit Pattanapanyasat (Thailand research Fund)(Thailand Research Fund (TRF)); Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant; Faculty of Allied Health Sciences, Thammasat University; Thammasat university	This work was supported by the Thailand Research Fund Grant for New Researcher (co-funded by the Thailand Research Fund (TRF) and Thammasat University, TRG5780021), Kovit Pattanapanyasat (Thailand research Fund, DPG5980001). Siranart Jeerawattanawart receives a Ph.D. Scholarship from Thammasat university and Adithap Hansakon was sponsored by a Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Wanchai Maleewong (Department of Parasitology, Faculty of Medicine, Khon Kaen University) and Dr. Wanpen Chaicumpa (Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University) for providing T. spiralis, the Drug Discovery and Development Center, Thammasat University and Flow Cytometry Laboratory, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital for use of flow cytometry facilities and the Faculty of Allied Health Sciences, Thammasat University for their support.	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; GRENCIS RK, 1985, IMMUNOLOGY, V56, P213; Helmby H, 2002, J IMMUNOL, V169, P2553, DOI 10.4049/jimmunol.169.5.2553; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lee JB, 2016, J ALLERGY CLIN IMMUN, V137, P1216, DOI 10.1016/j.jaci.2015.09.019; Liu B, 2015, J IMMUNOL, V194, P3583, DOI 10.4049/jimmunol.1400951; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; POZIO E, 1989, TROP MED PARASITOL, V40, P73; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Vallance BA, 1999, INFECT IMMUN, V67, P6090, DOI 10.1128/IAI.67.11.6090-6097.1999; Vallance BA, 1998, AM J PHYSIOL-GASTR L, V275, pG1157, DOI 10.1152/ajpgi.1998.275.5.G1157; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	34	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184684	10.1371/journal.pone.0184684	http://dx.doi.org/10.1371/journal.pone.0184684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898280	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500044
J	Rowson-Hodel, AR; Wald, JH; Hatakeyama, J; O'Neal, WK; Stonebraker, JR; VanderVorst, K; Saldana, MJ; Borowsky, AD; Sweeney, C; Carraway, KL				Rowson-Hodel, A. R.; Wald, J. H.; Hatakeyama, J.; O'Neal, W. K.; Stonebraker, J. R.; VanderVorst, K.; Saldana, M. J.; Borowsky, A. D.; Sweeney, C.; Carraway, K. L., III			Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer	ONCOGENE			English	Article							SIALOMUCIN COMPLEX; PANCREATIC-CANCER; MUC4/SIALOMUCIN COMPLEX; INTRAMEMBRANE MODULATOR; MESENCHYMAL TRANSITION; TRANSGENIC MICE; EXPRESSION; GROWTH; HER2; OVEREXPRESSION	Mucin-4 (Muc4) is a large cell surface glycoprotein implicated in the protection and lubrication of epithelial structures. Previous studies suggest that aberrantly expressed Muc4 can influence the adhesiveness, proliferation, viability and invasiveness of cultured tumor cells, as well as the growth rate and metastatic efficiency of xenografted tumors. Although it has been suggested that one of the major mechanisms by which Muc4 potentiates tumor progression is via its engagement of the ErbB2/HER2 receptor tyrosine kinase, other mechanisms exist and remain to be delineated. Moreover, the requirement for endogenous Muc4 for tumor growth progression has not been previously explored in the context of gene ablation. To assess the contribution of endogenous Muc4 to mammary tumor growth properties, we first created a genetically engineered mouse line lacking functional Muc4 (Muc4(ko)), and then crossed these animals with the NDL (Neu DeLetion mutant) model of ErbB2-induced mammary tumorigenesis. We observed that Muc4ko animals are fertile and develop normally, and adult mice exhibit no overt tissue abnormalities. In tumor studies, we observed that although some markers of tumor growth such as vascularity and cyclin D1 expression are suppressed, primary mammary tumors from Muc4(ko)/NDL female mice exhibit similar latencies and growth rates as Muc4(wt)/NDL animals. However, the presence of lung metastases is markedly suppressed in Muc4(ko)/NDL mice. Interestingly, histological analysis of lung lesions from Muc4(ko)/NDL mice revealed a reduced association of disseminated cells with platelets and white blood cells. Moreover, isolated cells derived from Muc4(ko)/NDL tumors interact with fewer blood cells when injected directly into the vasculature or diluted into blood from wild type mice. We further observed that blood cells more efficiently promote the viability of non-adherent Muc4(wt)/NDL cells than Muc4(ko)/NDL cells. Together, our observations suggest that Muc4 may facilitate metastasis by promoting the association of circulating tumor cells with blood cells to augment tumor cell survival in circulation.	[Rowson-Hodel, A. R.; Wald, J. H.; Hatakeyama, J.; VanderVorst, K.; Saldana, M. J.; Sweeney, C.; Carraway, K. L., III] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Res Bldg 3,Room 1100B,4645 2nd Ave, Sacramento, CA 95817 USA; [Rowson-Hodel, A. R.; Wald, J. H.; Hatakeyama, J.; VanderVorst, K.; Saldana, M. J.; Sweeney, C.; Carraway, K. L., III] Univ Calif Davis, Sch Med, UC Davis Comprehens Canc Ctr, Res Bldg 3,Room 1100B,4645 2nd Ave, Sacramento, CA 95817 USA; [O'Neal, W. K.; Stonebraker, J. R.] Univ North Carolina Chapel Hill, Sch Med, UNC Cyst Fibrosis Res Ctr, Marsico Lung Inst, Chapel Hill, NC USA; [Borowsky, A. D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Res Bldg 3,Room 1100B,4645 2nd Ave, Sacramento, CA 95817 USA.; Carraway, KL (corresponding author), Univ Calif Davis, Sch Med, UC Davis Comprehens Canc Ctr, Res Bldg 3,Room 1100B,4645 2nd Ave, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu	Rowson-Hodel, Ashley/AAE-2619-2022	Rowson-Hodel, Ashley/0000-0003-0531-9929; Hatakeyama, Jason/0000-0001-8690-5107	NIH [R01 CA166412, R01 CA118384, P01 HL110873, T32 CA108459, F31 CA210467, F31 CA165758, P30 CA093373, P30 DK065988]; Department of Defense fellowship [W81XWH-111-0065]; Cystic Fibrosis Foundation [BOUCHE15R0]; NATIONAL CANCER INSTITUTE [R01CA166412, R01CA118384, P30CA093373, T32CA108459] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense fellowship(United States Department of Defense); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to thank the histology core facility at UC Davis for embedding services and slide preparation, the UC Davis animal facilities for routine management of mouse colonies, the UC Davis Mouse Biology Program for breeding assistance, and Lakmal Kotelawala, Maxine Umeh-Garcia, and Heather Workman for technical assistance. These studies were supported by NIH grants R01 CA166412 (KLC), R01 CA118384 (CS), and P01 HL110873 (WKO), NIH fellowships and training grants T32 CA108459 (ARRH), F31 CA210467 (KVV), and F31 CA165758 (JH), NIH Center grants P30 CA093373 and P30 DK065988, Department of Defense fellowship W81XWH-111-0065 (JHW), and a grant from the Cystic Fibrosis Foundation BOUCHE15R0 (WKO).	Boimel PJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3108; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Carraway KL, 2002, PROG NUCLEIC ACID RE, V71, P149, DOI 10.1016/S0079-6603(02)71043-X; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fujita N, 2012, J BIOCHEM, V152, P407, DOI 10.1093/jb/mvs108; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hauselmann I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00028; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hu QY, 2015, ADV MATER, V27, P7043, DOI 10.1002/adma.201503323; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; Komatsu M, 2001, ONCOGENE, V20, P461, DOI 10.1038/sj.onc.1204106; Komatsu M, 1999, CANCER RES, V59, P2229; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Kumar R, 2001, SEMIN ONCOL, V28, P27, DOI 10.1016/S0093-7754(01)90279-9; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Li JH, 2016, J CONTROL RELEASE, V228, P38, DOI 10.1016/j.jconrel.2016.02.036; Li JH, 2016, BIOMATERIALS, V76, P52, DOI 10.1016/j.biomaterials.2015.10.046; Lorusso G, 2012, SEMIN CANCER BIOL, V22, P226, DOI 10.1016/j.semcancer.2012.03.007; Lundmark A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18475; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mohanty S, 2010, EXPT METASTASIS ASSA, pe1942; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1711; Ponnusamy MP, 2008, BRIT J CANCER, V99, P520, DOI 10.1038/sj.bjc.6604517; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ponnusamy MP, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-7; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rachagani S, 2012, CARCINOGENESIS, V33, P1953, DOI 10.1093/carcin/bgs225; Rowson-Hodel AR, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1572-7; Rowson-Hodel AR, 2016, CANCER LETT, V375, P62, DOI 10.1016/j.canlet.2016.02.042; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Tan M, 1997, CANCER RES, V57, P1199; Wald JH, 2017, ONCOGENE, V36, P5158, DOI 10.1038/onc.2017.126; Workman HC, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2364; Workman HC, 2009, CANCER RES, V69, P2845, DOI 10.1158/0008-5472.CAN-08-2089; Yokdang N, 2016, ONCOGENE, V35, P2932, DOI 10.1038/onc.2015.345; Zhang J, 2005, J CELL PHYSIOL, V204, P166, DOI 10.1002/jcp.20277; Zhang J, 2006, CURR EYE RES, V31, P1011, DOI 10.1080/02713680601052155; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhi XF, 2014, CANCER LETT, V346, P104, DOI 10.1016/j.canlet.2013.12.021	56	27	28	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					197	207		10.1038/onc.2017.327	http://dx.doi.org/10.1038/onc.2017.327			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28892049	Green Submitted, Green Accepted			2022-12-26	WOS:000422631700006
J	Klein, RH; Hu, W; Kashgari, G; Lin, ZG; Nguyen, T; Doan, M; Andersen, B				Klein, Rachel Herndon; Hu, William; Kashgari, Ghaidaa; Lin, Ziguang; Nguyen, Tuyen; Doan, Michael; Andersen, Bogi			Characterization of enhancers and the role of the transcription factor KLF7 in regulating corneal epithelial differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; chromatin; epithelial cell; eye; gene regulation; Kruppel-like factor 4 (KLF4); KLF7; corneal epithelium; superenhancer	SUPER-ENHANCERS; CELL IDENTITY; MOUSE CORNEA; HUMAN GENOME; ETS FAMILY; FACTOR EHF; IDENTIFICATION; EXPRESSION; REGIONS; DISEASE	During tissue development, transcription factors bind regulatory DNA regions called enhancers, often located at great distances from the genes they regulate, to control gene expression. The enhancer landscape during embryonic stem cell differentiation has been well characterized. By contrast, little is known about the shared and unique enhancer regulatory mechanisms in different ectodermally derived epithelial cells. Here we use ChIP sequencing (ChIP-seq) to identify domains enriched for the histone marks histone H3 lysine 4 trimethylation, histone H3 lysine 4 monomethylation, and histone H3 lysine 27 acetylation (H3K4me3, H3K4me1, and H3K27ac) and define, for the first time, the super enhancers and typical enhancers active in primary human corneal epithelial cells. We show that regulatory regions are often shared between cell types of the ectodermal lineage and that corneal epithelial super enhancers are already marked as potential regulatory domains in embryonic stem cells. Kruppel-like factor (KLF) motifs were enriched in corneal epithelial enhancers, consistent with the important roles of KLF4 and KLF5 in promoting corneal epithelial differentiation. We now show that the Kruppel family member KLF7 promotes the corneal progenitor cell state; on many genes, KLF7 antagonized the corneal differentiation-promoting KLF4. Furthermore, we found that two SNPs linked previously to corneal diseases, astigmatism, and Stevens-Johnson syndrome fall within corneal epithelial enhancers and alter their activity by disrupting transcription factor motifs that overlap these SNPs. Taken together, our work defines regulatory enhancers in corneal epithelial cells, highlights global gene-regulatory relationships shared among different epithelial cells, identifies a role for KLF7 as a KLF4 antagonist in corneal epithelial cell differentiation, and explains how two SNPs may contribute to corneal diseases.	[Klein, Rachel Herndon; Hu, William; Kashgari, Ghaidaa; Lin, Ziguang; Nguyen, Tuyen; Doan, Michael; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Andersen, Bogi] Univ Calif Irvine, Dept Med, Div Endocrinol, Irvine, CA 92697 USA; [Klein, Rachel Herndon; Nguyen, Tuyen] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), 839 Hlth Sci Dr, Irvine, CA 92697 USA.	bogi@uci.edu			National Institutes of Health [R01EY019413, R01AR44882]; National Library of Medicine [T15LM00744]; NCI, National Institutes of Health [5T32CA09054-38]; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01EY019413 and R01AR44882 (to B. A.), National Library of Medicine Grant T15LM00744 (to R. H. K.), and NCI, National Institutes of Health Grant 5T32CA09054-38 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Cavazza A, 2016, STEM CELL REP, V6, P618, DOI 10.1016/j.stemcr.2016.03.003; Courville CB, 2004, EXP EYE RES, V78, P417, DOI 10.1016/j.exer.2003.10.012; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Erokhin M, 2015, CELL MOL LIFE SCI, V72, P2361, DOI 10.1007/s00018-015-1871-9; Fan Q, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002402; Fossum SL, 2017, J BIOL CHEM, V292, P10938, DOI 10.1074/jbc.M117.775304; Foster J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106556; Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kenchegowda D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044771; Klein RH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006745; Klein RH, 2016, J BIOL CHEM, V291, P13271, DOI 10.1074/jbc.M115.709386; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Ritchey ER, 2012, EXP EYE RES, V99, P1, DOI 10.1016/j.exer.2012.03.019; Robertson DM, 2011, CURR EYE RES, V36, P706, DOI 10.3109/02713683.2011.582662; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Walford GA, 2016, DIABETES, V65, P3200, DOI 10.2337/db16-0199; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Yoon Jinny J, 2014, World J Stem Cells, V6, P391, DOI 10.4252/wjsc.v6.i4.391; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhang ZW, 2013, ACTA BIOCH BIOPH SIN, V45, P280, DOI 10.1093/abbs/gmt010; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	55	14	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18937	18950		10.1074/jbc.M117.793117	http://dx.doi.org/10.1074/jbc.M117.793117			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28916725	hybrid, Green Published			2022-12-26	WOS:000415848000018
J	Interlandi, G; Yakovenko, O; Tu, AY; Harris, J; Le, J; Chen, JM; Lopez, JA; Thomas, WE				Interlandi, Gianluca; Yakovenko, Olga; Tu, An-Yue; Harris, Jeff; Le, Jennie; Chen, Junmei; Lopez, Jose A.; Thomas, Wendy E.			Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; hemostasis; molecular dynamics; thrombosis; von Willebrand factor; dynamic flow assay; parasteric inhibition; protein binding	GLYCOPROTEIN IB-ALPHA; FACTOR A1 DOMAIN; MOLECULAR-DYNAMICS SIMULATIONS; FORMS CATCH BONDS; VONWILLEBRAND-FACTOR; DEPENDENT BINDING; CRYSTAL-STRUCTURE; FORCE-FIELDS; IIB-IIIA; DISEASE	The plasma protein von Willebrand factor (VWF) is essential for hemostasis initiation at sites of vascular injury. The platelet-binding A1 domain of VWF is connected to the VWF N-terminally located DD3 domain through a relatively unstructured amino acid sequence, called here the N-terminal linker. This region has previously been shown to inhibit the binding of VWF to the platelet surface receptor glycoprotein Ib (GpIb). However, the molecular mechanism underlying the inhibitory function of the N-terminal linker has not been elucidated. Here, we show that an aspartate at position 1261 is the most critical residue of the N-terminal linker for inhibiting binding of the VWF A1 domain to GpIb on platelets in blood flow. Through a combination of molecular dynamics simulations, mutagenesis, and A1-GpIb binding experiments, we identified a network of salt bridges between Asp(1261) and the rest of A1 that lock the N-terminal linker in place such that it reduces binding to GpIb. Mutations aimed at disrupting any of these salt bridges activated binding unless the mutated residue also formed a salt bridge with GpIb, in which case the mutations inhibited the binding. These results show that interactions between charged amino acid residues are important both to directly stabilize the A1-GpIb complex and to indirectly destabilize the complex through the N-terminal linker.	[Interlandi, Gianluca; Yakovenko, Olga; Tu, An-Yue; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA; [Harris, Jeff; Le, Jennie; Chen, Junmei; Lopez, Jose A.] Bloodworks Res Inst, Seattle, WA 98102 USA; [Lopez, Jose A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lopez, Jose A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lopez, Jose A.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Interlandi, G; Thomas, WE (corresponding author), Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA.	gianluca@u.washington.edu; wendyt@uw.edu		Thomas, Wendy/0000-0001-8602-0819	National Science Foundation [TG-MCB060069N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106074, R21HL129526, R01HL112633, R01HL117639, K25HL118137] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dominic Chung for helpful and interesting discussions and John Kulman for providing the pBIG expression vector. The simulations were performed on the Ranger supercomputer at the Texas Advanced Computing Center thanks to an allocation on the Extreme Science and Engineering Development Environment with Grant TG-MCB060069N, which is made available in part through support from the National Science Foundation.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chung DW, 2016, BLOOD, V127, P637, DOI 10.1182/blood-2014-09-599530; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doggett TA, 2003, BLOOD, V102, P152, DOI 10.1182/blood-2003-01-0072; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Ju LN, 2013, J BIOL CHEM, V288, P32289, DOI 10.1074/jbc.M113.504001; Kada G, 1999, BBA-GEN SUBJECTS, V1427, P33, DOI 10.1016/S0304-4165(98)00178-0; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Kisiela DI, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004857; Konstantopoulos K, 2003, CURR BIOL, V13, pR611, DOI 10.1016/S0960-9822(03)00529-3; Kulman JD, 2007, PROTEIN EXPRES PURIF, V52, P320, DOI 10.1016/j.pep.2006.09.011; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miyata S, 1996, J BIOL CHEM, V271, P9046, DOI 10.1074/jbc.271.15.9046; Miyata S, 1999, J BIOL CHEM, V274, P6586, DOI 10.1074/jbc.274.10.6586; PETERSON DM, 1987, BLOOD, V69, P625; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; RUGGERI ZM, 1980, NEW ENGL J MED, V302, P1047, DOI 10.1056/NEJM198005083021902; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; SUGIMOTO M, 1993, J BIOL CHEM, V268, P12185; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	37	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18608	18617		10.1074/jbc.M117.797456	http://dx.doi.org/10.1074/jbc.M117.797456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924049	Green Published, hybrid			2022-12-26	WOS:000414958100018
J	Woolger, N; Bournazos, A; Sophocleous, RA; Evesson, FJ; Lek, A; Driemer, B; Sutton, RB; Cooper, ST				Woolger, Natalie; Bournazos, Adam; Sophocleous, Reece A.; Evesson, Frances J.; Lek, Angela; Driemer, Birgit; Sutton, R. Bryan; Cooper, Sandra T.			Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; protein conformation; protein domain; proteolysis; tertiary structure; dysferlin; patient missense variant	GIRDLE MUSCULAR-DYSTROPHY; INNER DYSF DOMAIN; MEMBRANE REPAIR; MIYOSHI MYOPATHY; C2 DOMAINS; BINDING PROPERTIES; VESICLE FUSION; PROTEIN; CALCIUM; GENE	Dysferlin is a large transmembrane protein that plays a key role in cell membrane repair and underlies a recessive form of inherited muscular dystrophy. Dysferlinopathy is characterized by absence or marked reduction of dysferlin protein with 43% of reported pathogenic variants being missense variants that span the length of the dysferlin protein. The unique structure of dysferlin, with seven tandem C2 domains separated by linkers, suggests dysferlin may dynamically associate with phospholipid membranes in response to Ca2+ signaling. However, the overall conformation of the dysferlin protein is uncharacterized. To dissect the structural architecture of dysferlin, we have applied the method of limited proteolysis, which allows nonspecific digestion of unfolded peptides by trypsin. Using five antibodies spanning the dysferlin protein, we identified a highly reproducible jigsaw map of dysferlin fragments protected from digestion. Our data infer a modular architecture of four tertiary domains: 1) C2A, which is readily removed as a solo domain; 2) midregion C2B-C2C-Fer-DysF, commonly excised as an intact module, with subdigestion to different fragments suggesting several dynamic folding options; 3) C-terminal four-C2 domain module; and 4) calpain-cleaved mini-dysferlin(C72), which is particularly resistant to proteolysis. Importantly, we reveal a patient missense variant, L344P, that largely escapes proteasomal surveillance and shows subtle but clear changes in tertiary conformation. Accompanying evidence from immunohistochemistry and flow cytometry using antibodies with conformationally sensitive epitopes supports proteolysis data. Collectively, we provide insight into the structural topology of dysferlin and show how a single missense mutation within dysferlin can exert local changes in tertiary conformation.	[Woolger, Natalie; Sophocleous, Reece A.; Evesson, Frances J.; Lek, Angela; Driemer, Birgit; Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Kids Res Inst, Locked Bag 4001, Westmead, NSW 2145, Australia; [Woolger, Natalie; Bournazos, Adam; Sophocleous, Reece A.; Evesson, Frances J.; Lek, Angela; Driemer, Birgit; Cooper, Sandra T.] Univ Sydney, Fac Med, Discipline Child & Adolescent Hlth, Sydney, NSW 2006, Australia; [Sutton, R. Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	University of Sydney; University of Sydney; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Cooper, ST (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Kids Res Inst, Locked Bag 4001, Westmead, NSW 2145, Australia.; Cooper, ST (corresponding author), Univ Sydney, Fac Med, Discipline Child & Adolescent Hlth, Sydney, NSW 2006, Australia.	sandra.cooper@sydney.edu.au	Sophocleous, Reece/ABE-4539-2020	Sophocleous, Reece/0000-0002-8339-9090; Bournazos, Adam/0000-0002-6464-4548; Cooper, Sandra/0000-0002-7314-5097	Australian National Health and Medical Research Council [APP1048814, APP1103618, APP1048816]; Jain Foundation; University of Sydney; NIAMS, National Institutes of Health Grant [R01AR063634]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063634] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jain Foundation; University of Sydney(University of Sydney); NIAMS, National Institutes of Health Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Australian National Health and Medical Research Council Project Grants APP1048814 and APP1103618 (to S. T. C.) and Career Development Fellowship APP1048816 (to S. T. C.), the Jain Foundation (to S. T. C.), University of Sydney postgraduate award funding (to N. W.), and NIAMS, National Institutes of Health Grant R01AR063634 (to R. B. S). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492; Achanzar WE, 1997, J CELL SCI, V110, P1073; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barohn RJ, 1998, NEUROMUSCULAR DISORD, V8, P309, DOI 10.1016/S0960-8966(98)00030-3; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Choi ER, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-31; Cooper ST, 2015, NEUROSCIENTIST, V21, P653, DOI 10.1177/1073858414558336; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Diaz J, 2016, MUSCLE NERVE, V54, P203, DOI 10.1002/mus.25045; Espinoza-Fonseca LM, 2016, MOL BIOSYST, V12, P973, DOI 10.1039/c5mb00772k; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Evesson FJ, 2010, J BIOL CHEM, V285, P28529, DOI 10.1074/jbc.M110.111120; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fuson K, 2014, STRUCTURE, V22, P104, DOI 10.1016/j.str.2013.10.001; Gallardo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029061; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Ho MF, 2002, ANN NEUROL, V51, P129, DOI 10.1002/ana.10080; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Linssen WHJP, 1997, BRAIN, V120, P1989, DOI 10.1093/brain/120.11.1989; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Marty NJ, 2013, BIOCHEMISTRY-US, V52, P5585, DOI 10.1021/bi400432f; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Pramono ZAD, 2006, HUM GENET, V120, P410, DOI 10.1007/s00439-006-0230-1; Pramono ZAD, 2009, HUM GENET, V125, P413, DOI 10.1007/s00439-009-0632-y; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Redpath GMI, 2016, TRAFFIC, V17, P245, DOI 10.1111/tra.12370; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rosales XQ, 2010, MUSCLE NERVE, V42, P14, DOI 10.1002/mus.21650; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sula A, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-3; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wenzel K, 2007, J MOL MED, V85, P1203, DOI 10.1007/s00109-007-0253-7; Woudt L, 2016, MUSCLE NERVE, V53, P49, DOI 10.1002/mus.24685; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Yin X, 2015, INT J CLIN EXP PATHO, V8, P3069	49	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18577	18591		10.1074/jbc.M117.790014	http://dx.doi.org/10.1074/jbc.M117.790014			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28904177	hybrid, Green Published			2022-12-26	WOS:000414958100016
J	Munera-Bedoya, OD; Cassoli, LD; Machado, PF; Ceron-Munoz, MF				David Munera-Bedoya, Oscar; Cassoli, Laerte D.; Machado, Paulo F.; Fernando Ceron-Munoz, Mario			Influence of attitudes and behavior of milkers on the hygienic and sanitary quality of milk	PLOS ONE			English	Article							MANAGEMENT-PRACTICES; MASTITIS; PREVALENCE; FARMERS	Recognizing how human behaviors affect the milk process can be useful to understand variations in hygienic and sanitary parameters in bulk tank milk. Furthermore, this knowledge could be used to design management programs that guarantee milk quality, favoring the optimization of such processes. Forty-six milkers from the same number of dairy farms in Antioquia province (Colombia) were interviewed to establish the main factors associated to milk quality. Technical knowledge, motivations, and behavior of the personnel and its effect on hygienic and sanitary quality of milk were evaluated. Quality was assessed in terms of colony-forming units (CFU) and somatic cell count (SCC) in bulk tank milk. Two factors from a multivariate mixed data analysis were evaluated. One of those factors explained 9.51% of the total variability, related with in-farm availability and use of tools and the relationships between milker and manager. The other factor, associated with work environment and recognition, explained 6.97% of the total variability. The variables that best explained CFU levels were Knowledge of the udder condition at milking, and Milking type (parlor or pasture). The SCC was associated to knowledge of animal handling, schooling of milkers, milking site, and the groups derived from the cluster analysis by farm. In conclusion, milker attitudes and behaviors can affect CFU and SCC in bulk tank milk.	[David Munera-Bedoya, Oscar; Fernando Ceron-Munoz, Mario] Univ Antioquia, Fac Ciencias Agr, Medellin, Antioquia, Colombia; [David Munera-Bedoya, Oscar; Fernando Ceron-Munoz, Mario] Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia; [Cassoli, Laerte D.; Machado, Paulo F.] Univ Sao Paulo, Clin Leite, ESALQ, Piracicaba, SP, Brazil	Universidad de Antioquia; Universidad de Antioquia; Universidade de Sao Paulo	Munera-Bedoya, OD (corresponding author), Univ Antioquia, Fac Ciencias Agr, Medellin, Antioquia, Colombia.; Munera-Bedoya, OD (corresponding author), Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia.	grupogamma@udea.edu.co	Cerón-Muñoz, Mario Fernando/AAD-9778-2020; Cassoli, Laerte/H-2038-2012	Cerón-Muñoz, Mario Fernando/0000-0002-7233-6625; 	Secretaria de Agricultura y Desarrollo Rural de Antioquia; Universidad Nacional de Colombia; Universidad de Antioquia; Sistema General de Regalias-SGR [2012AS180031]; Comite para el Desarrollo de la Investigacion - CODI [ES84160119]; COLCIENCIAS Doctoral Study Program in Colombia [567]; General Royalties System-GRS (Colombia) [2012AS180031]; Committee for research development-CODI [2016 ES84160119]	Secretaria de Agricultura y Desarrollo Rural de Antioquia; Universidad Nacional de Colombia; Universidad de Antioquia; Sistema General de Regalias-SGR; Comite para el Desarrollo de la Investigacion - CODI; COLCIENCIAS Doctoral Study Program in Colombia; General Royalties System-GRS (Colombia); Committee for research development-CODI	This work was supported by Secretaria de Agricultura y Desarrollo Rural de Antioquia, Universidad Nacional de Colombia (Sede Medellin), Universidad de Antioquia, Sistema General de Regalias-SGR, agreement No 2012AS180031; and Comite para el Desarrollo de la Investigacion - CODI, agreement Estrategia de Sustentabilidad ES84160119 GaMMA group. COLCIENCIAS Doctoral Study Program in Colombia (agreement 567 of 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article is part of the project "Strengthening dairy chain productivity in the Northern Antioquia district", agreement No 2012AS180031, signed by the Secretary of Agriculture and Rural Development of Antioquia, Universidad Nacional de Colombia (Medellin), and Universidad de Antioquia, with funding from the General Royalties System-GRS (Colombia). This study received financial support from the Committee for research development-CODI (a Strategy for Sustainability 2016 ES84160119 GaMMA research group) and COLCIENCIAS Doctoral Study Program in Colombia (call 567 of 2012).	Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; BIGRASPOULIN M, 1985, PREV VET MED, V3, P241, DOI 10.1016/0167-5877(85)90019-4; Blowey R, 2010, MASTITIS CONTROL IN DAIRY HERDS, 2ND EDITION, P1, DOI 10.1079/9781845935504.0000; Calderon A, 2008, REV COLOMB CIENC PEC, V21, P582; Ceron-Munoz M. F., 2007, Revista Colombiana de Ciencias Pecuarias, V20, P472; Dufour S, 2011, J DAIRY SCI, V94, P563, DOI 10.3168/jds.2010-3715; Elmoslemany AM, 2009, J DAIRY SCI, V92, P2634, DOI 10.3168/jds.2008-1812; Husson F., 2010, PRINCIPAL COMPONENT, P1; Jansen J, 2009, PREV VET MED, V92, P210, DOI 10.1016/j.prevetmed.2009.08.015; Jansen J, 2012, 8 SEM INT LECH CARN, P63; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leach KA, 2010, RES VET SCI, V89, P318, DOI 10.1016/j.rvsc.2010.02.017; Lind A.-K., 2012, ACTA VET SCAND, V54, P1; PP J, 2004, REV STAT APPL, V52, P93; R Core Team, 2013, R LANG ENV STAT COMP; Ramírez Vásquez Nicolás, 2011, Rev. Med. Vet., P31; Reyes J, 2010, REV ELEC VET, V11, p[1, 10]; Santana R, 2009, B INIA, V148, P1; TARABLA HD, 1990, BRIT VET J, V146, P157, DOI 10.1016/0007-1935(90)90008-Q; Trujillo CM, 2011, REV COLOMB CIENC PEC, V24, P11; Valeeva NI, 2007, J DAIRY SCI, V90, P4466, DOI 10.3168/jds.2007-0095	22	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184640	10.1371/journal.pone.0184640	http://dx.doi.org/10.1371/journal.pone.0184640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926583	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600028
J	Zens, TJ; Danobeitia, JS; Chlebeck, PJ; Zitur, LJ; Odorico, S; Brunner, K; Coonen, J; Capuano, S; D'Alessandrol, AM; Matkowskyj, K; Zhong, WX; Torrealba, J; Fernandez, L				Zens, Tiffany J.; Danobeitia, Juan S.; Chlebeck, Peter J.; Zitur, Laura J.; Odorico, Scott; Brunner, Kevin; Coonen, Jennifer; Capuano, Saverio; D'Alessandrol, Anthony M.; Matkowskyj, Kristina; Zhong, Weixiong; Torrealba, Jose; Fernandez, Luis			Guidelines for the management of a brain death donor in the rhesus macaque: A translational transplant model	PLOS ONE			English	Article							DECEASED ORGAN DONORS; CARE MEDICINE/AMERICAN COLLEGE; CHEST PHYSICIANS/ASSOCIATION; ICU SOCIETY; PRETREATMENT; PROCUREMENT; KIDNEY; INFLAMMATION; DOPAMINE	Introduction The development of a translatable brain death animal model has significant potential to advance not only transplant research, but also the understanding of the pathophysiologic changes that occur in brain death and severe traumatic brain injury. The aim of this paper is to describe a rhesus macaque model of brain death designed to simulate the average time and medical management described in the human literature. Methods Following approval by the Institutional Animal Care and Use Committee, a brain death model was developed. Non-human primates were monitored and maintained for 20 hours after brain death induction. Vasoactive agents and fluid boluses were administered to maintain hemodynamic stability. Endocrine derangements, particularly diabetes insipidus, were aggressively managed. Results A total of 9 rhesus macaque animals were included in the study. The expected hemodynamic instability of brain death in a rostral to caudal fashion was documented in terms of blood pressure and heart rate changes. During the maintenance phase of brain death, the animal's temperature and hemodynamics were maintained with goals of mean arterial pressure greater than 60mmHg and heart rate within 20 beats per minute of baseline. Resuscitation protocols are described so that future investigators may reproduce this model. Conclusion We have developed a reproducible large animal primate model of brain death which simulates clinical scenarios and treatment. Our model offers the opportunity for researchers to have translational model to test the efficacy of therapeutic strategies prior to human clinical trials.	[Zens, Tiffany J.; Danobeitia, Juan S.; Chlebeck, Peter J.; Zitur, Laura J.; Odorico, Scott; D'Alessandrol, Anthony M.; Fernandez, Luis] Univ Wisconsin, Dept Surg, Div Transplantat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brunner, Kevin; Coonen, Jennifer; Capuano, Saverio] Univ Wisconsin, Wisconsin Primate Res Ctr, Madison, WI USA; [Matkowskyj, Kristina; Zhong, Weixiong] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Torrealba, Jose] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fernandez, L (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	luisf@surgery.wisc.edu	Danobeitia, Juan/AAC-5327-2020	Danobeitia, Juan/0000-0003-1641-3822; ZITUR, LAURA/0000-0002-1238-2726	National Institutes of Health NIH [1-R01-A1110617-01A1]; NIH [T32 AI125231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110617, T32AI125231] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health NIH #1-R01-A1110617-01A1 (PI: Luis Fernandez) and an NIH training grant NIH #T32 AI125231 is funding Dr. Danobeitia's postdoctoral research fellowship in the lab.; This work was supported by National Institutes of Health NIH #1-R01-AI110617-01A1 (PI: LAF) and NIH # T32 AI125231 training grant. We would also like to acknowledge the National Primate Center at the University of Wisconsin for the excellent technical support on the care of our animals and Alpha Genesis for the kind support on providing animals and resources for our research.	Amatschek S, 2012, J HEPATOL, V56, P1305, DOI 10.1016/j.jhep.2012.01.020; Blasco V, 2007, CRIT CARE, V11, DOI 10.1186/cc6120; Blasi-Ibanez A, 2009, ANESTHESIOLOGY, V110, P333, DOI 10.1097/ALN.0b013e318194ca8a; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Chen L, 2016, TRANSPL P, V48, P205, DOI 10.1016/j.transproceed.2016.01.007; Danobeitia JS, 2015, CELL TRANSPLANT, V24, P1863, DOI 10.3727/096368914X681045; Floerchinger B, 2012, TRANSPLANT REV-ORLAN, V26, P54, DOI 10.1016/j.trre.2011.10.001; Frontera JA, 2010, NEUROCRIT CARE, V12, P103, DOI 10.1007/s12028-009-9292-y; Goarin JP, 1996, ANESTH ANALG, V83, P41, DOI 10.1097/00000539-199607000-00008; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Kolkert JLP, 2007, LAB ANIM-UK, V41, P363, DOI 10.1258/002367707781282848; Kotloff RM, 2015, CRIT CARE MED, V43, P1291, DOI 10.1097/CCM.0000000000000958; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; Marasco S, 2013, TRANSPL P, V45, P33, DOI 10.1016/j.transproceed.2012.08.008; Marques RG, 2004, TRANSPL P, V36, P1048, DOI 10.1016/j.transproceed.2004.04.043; Minambres E, 2010, NEPHROL DIAL TRANSPL, V25, P2352, DOI 10.1093/ndt/gfq054; Muller E, 2015, TRANSPLANTATION, V99, P1743, DOI 10.1097/TP.0000000000000896; Niemann CU, 2015, NEW ENGL J MED, V373, P2687, DOI 10.1056/NEJMc1511744; Nijboer WN, 2010, CRIT CARE MED, V38, P1155, DOI 10.1097/CCM.0b013e3181cf6e78; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Plurad DS, 2012, AM J SURG, V204, P856, DOI 10.1016/j.amjsurg.2012.05.011; Remuzzi G, 1999, J AM SOC NEPHROL, V10, P2591; Spindler RS, 2015, TRANSPLANTATION, V99, P935, DOI 10.1097/TP.0000000000000577; Uno Y, 2015, DRUG METAB PHARMACOK, V30, P130, DOI 10.1016/j.dmpk.2014.10.002; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Valenza F, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-12; Westphal GA, 2016, CLIN TRANSPLANT, V30, P138, DOI 10.1111/ctr.12667; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Wood KE, 2007, CURR OPIN ANESTHESIO, V20, P97, DOI 10.1097/ACO.0b013e3280895ac8; Youn TS, 2014, CRIT CARE CLIN, V30, P813, DOI 10.1016/j.ccc.2014.06.010; Yuan QP, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-52; Zhang SJ, 2014, EXP CLIN TRANSPLANT, V12, P469, DOI 10.6002/ect.2013.0229	33	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0182552	10.1371/journal.pone.0182552	http://dx.doi.org/10.1371/journal.pone.0182552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926566	Green Submitted, gold, Green Published			2022-12-26	WOS:000411166600002
J	Yen, CH; Hung, CL; Lee, PY; Tsai, JP; Lai, YH; Su, CH; Yeh, HI; Hou, CJY; Chien, KL				Yen, Chih-Hsuan; Hung, Chung-Lieh; Lee, Ping-Ying; Tsai, Jui-Peng; Lai, Yau-Huei; Su, Cheng-Huang; Yeh, Hung-I; Hou, Charles Jia-Yin; Chien, Kuo-Liong			Segmental arterial stiffness in relation to B-type natriuretic peptide with preserved systolic heart function	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; CARDIOVASCULAR RISK; DIASTOLIC FUNCTION; EJECTION FRACTION; AORTIC STIFFNESS; BLOOD-PRESSURE; FAILURE; DISEASE; INDEX; HYPERTENSION	Background Central arterial stiffness has been shown to play a key role in cardiovascular disease. However, evidence regarding such arterial stiffness from various arterial segments in relation to B-type natriuretic peptide (BNP) remains elusive. Methods A total of 1255 participants (47.8% men; mean age: 62.6 +/- 12.3 [SD] years) with preserved left ventricular function (ejection fraction >= 50%) and >= 1 risk factors were consecutively studied. Arterial pulse wave velocity (PWV) by automatic device (VP-2000; Omron Healthcare) for heart-femoral (hf-PWV), brachial-ankle (ba-PWV), and heart-carotid (hc-PWV) segments were obtained and related to BNP concentrations (Abbott Diagnostics, Abbott Park, IL, USA). Results Subjects in the highest hf-PWV quartile were older and had worse renal function and higher blood pressure (all P < 0.05). Elevated PWV (m/s) was correlated with elevated BNP (pg/ml) (beta coefficient = 19.3, 12.4, 5.9 for hf-PWV, ba-PWV, hc-PWV respectively, all p < 0.05). After accounting for clinical co-variates and left ventricle mass index (LVMI), both hf-PWV and ba-PWV were correlated with higher BNP (beta coefficient = 8.3, 6.4 respectively, P < 0.01 for each). Adding both hf-PWV and ba-PWV to LVMI significantly expanded ROC in predicting abnormal BNP>100 pg/ml (both P < 0.01), but only hf-PWV presented significant integrated discrimination improvement to predict risk for BNP concentrations (0.7%, P = 0.029). Conclusion A significant segmental PWV associated with biomarker BNP concentrations suggests that arterial stiffness is associated with myocardial damage.	[Yen, Chih-Hsuan; Hung, Chung-Lieh; Lee, Ping-Ying; Tsai, Jui-Peng; Lai, Yau-Huei; Su, Cheng-Huang; Yeh, Hung-I; Hou, Charles Jia-Yin] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yen, Chih-Hsuan; Hung, Chung-Lieh; Lee, Ping-Ying; Tsai, Jui-Peng; Lai, Yau-Huei; Su, Cheng-Huang; Hou, Charles Jia-Yin] Nursing & Management Coll, Mackay Med, Taipei, Taiwan; [Yen, Chih-Hsuan; Tsai, Jui-Peng; Chien, Kuo-Liong] Natl Taiwan Univ, Sch Publ Hlth, Inst Prevent Med, Taipei, Taiwan; [Yeh, Hung-I] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ, Med Coll, Dept Internal Med Cardiol, Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taiwan University; Mackay Medical College; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Sch Publ Hlth, Inst Prevent Med, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ, Med Coll, Dept Internal Med Cardiol, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	klchien@ntu.edu.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; CHIEN, KUO-LIONG/0000-0003-4979-8351	Ministry of Science and Technology (Taiwan) [NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3, NSC102-2314-B-002-046-MY3]; Mackay Memorial Hospital [10271, 10248, 10220, 10253, 10375, 10358, E-102003]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This research supported by Ministry of Science and Technology (Taiwan) (NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3, NSC102-2314-B-002-046-MY3), and funds from Mackay Memorial Hospital (10271, 10248, 10220, 10253, 10375, 10358,E-102003).	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Bueno H, 2010, JAMA; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Chen CH, 1998, J AM COLL CARDIOL, V32, P1221, DOI 10.1016/S0735-1097(98)00374-X; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; de Simone G, 1999, HYPERTENSION, V33, P800, DOI 10.1161/01.HYP.33.3.800; Greenland P, 2010, CIRCULATION, V122, pe584; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Guyton AC, 1986, PA WB SAUNDERS, P206; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Kang S, 2010, EUR HEART J, V31, P2799, DOI 10.1093/eurheartj/ehq296; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; Koji Y, 2004, AM J CARDIOL, V94, P868, DOI 10.1016/j.amjcard.2004.06.020; Kullo IJ, 2007, J AM COLL CARDIOL, V49, P1413, DOI 10.1016/j.jacc.2006.11.039; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Liao ZY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003053; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mahmud A, 2005, HYPERTENSION, V46, P1118, DOI 10.1161/01.HYP.0000185463.27209.b0; Mahmud A, 2002, AM J HYPERTENS, V15, P1092, DOI 10.1016/S0895-7061(02)02982-5; Maisel AS, 2012, J AM COLL CARDIOL, V60, P277, DOI 10.1016/j.jacc.2012.03.057; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; OROURKE M, 1990, HYPERTENSION, V15, P339, DOI 10.1161/01.HYP.15.4.339; Qiu H, 2007, CIRCULATION, V116, P669, DOI 10.1161/CIRCULATIONAHA.107.689208; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Ryabov V., 2012, POLSKI PRZEGLAD KARD, V14, P165; Shroff GR, 2009, J HUM HYPERTENS, V23, P783, DOI 10.1038/jhh.2009.17; Sung SH, 2009, AM J CARDIOL, V103, P1411, DOI 10.1016/j.amjcard.2009.01.355; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Takami T, 2003, HYPERTENS RES, V26, P609, DOI 10.1291/hypres.26.609; Tang WHW, 2008, J AM COLL CARDIOL, V52, P1671, DOI 10.1016/j.jacc.2008.08.026; Tartiere JM, 2006, J HUM HYPERTENS, V20, P213, DOI 10.1038/sj.jhh.1001965; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; Vlachopoulos C., 2010, JACC, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Yambe M, 2004, HYPERTENS RES, V27, P625, DOI 10.1291/hypres.27.625; Yu WC, 2008, J HUM HYPERTENS, V22, P24, DOI 10.1038/sj.jhh.1002259; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183747	10.1371/journal.pone.0183747	http://dx.doi.org/10.1371/journal.pone.0183747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922407	Green Submitted, Green Published, gold			2022-12-26	WOS:000411059300006
J	Jayachandran, M; Garovic, VD; Mielke, MM; Bailey, KR; Lahr, BD; Miller, VM				Jayachandran, Muthuvel; Garovic, Vesna D.; Mielke, Michelle M.; Bailey, Kent R.; Lahr, Brian D.; Miller, Virginia M.			Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women	PLOS ONE			English	Article							BLOOD-BORNE MICROVESICLES; CIRCULATING MICROPARTICLES; CARDIOVASCULAR RISK; NORMAL-PREGNANCY; HISTORY; PREECLAMPSIA; ESTROGEN	Objective Mechanisms and interactions among intravascular cells contributing to development of subclinical atherosclerosis are poorly understood. In women, both menopausal status and pregnancy history influence progression of atherosclerosis. This study examined activation and interactions among blood elements with subclinical atherosclerosis in menopausal women with known pregnancy histories. Methods Carotid intima-media thickness (CIMT), as a marker of subclinical atherosclerosis, was measured using B-mode ultrasound in age-and parity-matched women [40 with and 40 without a history of preeclampsia] 35 years after the index pregnancy. Interactions among intravascular cells (38 parameters) were measured by flow cytometry in venous blood. Data analysis was by principal component which retained 7 independent dimensions accounting for 63% of the variability among 38 parameters. Results CIMT was significantly greater in women with a history of preeclampsia (P = 0.004). Platelet aggregation and platelet interactions with granulocytes and monocytes positively associated with CIMT in postmenopausal women independent of their pregnancy history (rho = 0.258, P<0.05). However, the association of the number of platelets, platelet activation and mono-cyteplatelet interactions with CIMT differed significantly depending upon pregnancy history (test for interaction, P<0.001). Conclusion Interactions among actived intravascular cells and their association with subclinical atherosclerosis differ in women depending upon their pregnancy histories.	[Jayachandran, Muthuvel; Miller, Virginia M.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Jayachandran, Muthuvel; Miller, Virginia M.] Mayo Clin, Physiol & Biomed Engn, Rochester, MN 55905 USA; [Garovic, Vesna D.] Mayo Clin, Div Nephrol & Hypertens, Gen Internal Med, Rochester, MN USA; [Mielke, Michelle M.; Bailey, Kent R.; Lahr, Brian D.] Mayo Clin, Div Epidemiol, Hlth Sci Res, Rochester, MN USA; [Mielke, Michelle M.] Mayo Clin, Neurol, Rochester, MN USA; [Bailey, Kent R.; Lahr, Brian D.] Mayo Clin, Div Biostat, Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Miller, VM (corresponding author), Mayo Clin, Dept Surg, Rochester, MN 55905 USA.; Miller, VM (corresponding author), Mayo Clin, Physiol & Biomed Engn, Rochester, MN 55905 USA.	miller.virginia@mayo.edu	Jayachandran, Muthuvel/AAG-6532-2019	Jayachandran, Muthuvel/0000-0002-3007-0769; Mielke, Michelle/0000-0001-7177-1185	National Institutes of Health (NIH) [P50 AG044170, R01 AG034676, UL1 TR000135]; Department of Surgery; Mayo Foundation; American Heart Association [12GRNT12050147]; National Center for Advancing Translational Sciences, a component of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [P50AG044170] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery; Mayo Foundation; American Heart Association(American Heart Association); National Center for Advancing Translational Sciences, a component of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (NIH) P50 AG044170, R01 AG034676, UL1 TR000135 (a Mayo Clinic Clinical and Translational Science Award), the Department of Surgery, the Mayo Foundation, and the American Heart Association grant 12GRNT12050147. The Mayo Clinic Clinical and Translational Science Award is from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Bretelle F, 2003, THROMB HAEMOSTASIS, V89, P486, DOI 10.1055/s-0037-1613378; Campello E, 2015, THROMB RES, V136, P427, DOI 10.1016/j.thromres.2015.05.029; Cronqvist T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090020; Garcia M, 2016, MAYO CLIN PROC, V91, P226, DOI 10.1016/j.mayocp.2015.11.001; Garovic VD, 2013, CURR HYPERTENS REP, V15, P114, DOI 10.1007/s11906-013-0329-4; Gilani SI, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0678-x; Goynumer G, 2013, J CLIN ULTRASOUND, V41, P145, DOI 10.1002/jcu.21962; Gustafson CM, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0028-8; Hamad RR, 2009, THROMB RES, V123, P580, DOI 10.1016/j.thromres.2008.03.022; Harman SM, 2014, ANN INTERN MED, V161, P249, DOI 10.7326/M14-0353; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Holthe MR, 2005, PLATELETS, V16, P91, DOI 10.1080/09537100400004355; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Jayachandran M, 2011, J CARDIOVASC TRANSL, V4, P811, DOI 10.1007/s12265-011-9296-9; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lok CAR, 2009, AM J REPROD IMMUNOL, V61, P346, DOI 10.1111/j.1600-0897.2009.00701.x; Luppi P, 2006, CLIN IMMUNOL, V118, P268, DOI 10.1016/j.clim.2005.11.001; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; McDonald SD, 2013, ATHEROSCLEROSIS, V229, P234, DOI 10.1016/j.atherosclerosis.2013.04.020; Mellembakken JR, 2001, OBSTET GYNECOL, V97, P371, DOI 10.1016/S0029-7844(00)01179-0; Milic NM, 2017, ULTRASOUND OBST GYN, V49, P110, DOI 10.1002/uog.17367; Miller VM, 2007, CLIN EXP PHARMACOL P, V34, P814, DOI 10.1111/j.1440-1681.2007.04685.x; Miller VM, 2016, ATHEROSCLEROSIS, V253, P150, DOI 10.1016/j.atherosclerosis.2016.09.006; Miller VM, 2015, PLATELETS, V27, P1; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Rainger GE, 2015, PLATELETS, V26, P507, DOI 10.3109/09537104.2015.1064881; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Tatsumi K, 2015, J ATHEROSCLER THROMB, V22, P543, DOI 10.5551/jat.30940; Toldi G, 2015, AM J REPROD IMMUNOL, V74, P110, DOI 10.1111/aji.12380; White WM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.003; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025504; Xiong J, 2012, J CARDIOVASC PHARM, V59, P124, DOI 10.1097/FJC.0b013e31820c6254; Zoet GA, 2015, MATURITAS, V82, P153, DOI 10.1016/j.maturitas.2015.07.004	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183159	10.1371/journal.pone.0183159	http://dx.doi.org/10.1371/journal.pone.0183159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910282	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200007
J	Karlsson, J; Gouveia-Figueira, S; Alhouayek, M; Fowler, CJ				Karlsson, Jessica; Gouveia-Figueira, Sandra; Alhouayek, Mireille; Fowler, Christopher J.			Effects of tumour necrosis factor alpha upon the metabolism of the endocannabinoid anandamide in prostate cancer cells	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOID ANANDAMIDE; N-ACYLETHANOLAMINES; CELLULAR UPTAKE; TNF-ALPHA; CARCINOMA-CELLS; PHOSPHOLIPASE-D; EXPRESSION; 2-ARACHIDONOYLGLYCEROL; INHIBITION	Tumour necrosis factor a (TNF alpha) is involved in the pathogenesis of prostate cancer, a disease where disturbances in the endocannabinoid system are seen. In the present study we have investigated whether treatment of DU145 human prostate cancer cells affects anandamide (AEA) catabolic pathways. Additionally, we have investigated whether cyclooxygenase- 2 (COX-2) can regulate the uptake of AEA into cells. Levels of AEA synthetic and catabolic enzymes were determined by qPCR. AEA uptake and hydrolysis in DU145 and RAW264.7 macrophage cells were assayed using AEA labeled in the arachidonic and ethanolamine portions of the molecule, respectively. Levels of AEA, related N-acylethanolamines (NAEs), prostaglandins (PG) and PG-ethanolamines (PG-EA) in DU145 cells and medium were quantitated by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) analysis. TNF alpha treatment of DU145 cells increased mRNA levels of PTSG2 (gene of COX-2) and decreased the mRNA of the AEA synthetic enzyme N-acylphosphatidylethanolamine selective phospholipase D. mRNA levels of the AEA hydrolytic enzymes fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase were not changed. AEA uptake in both DU145 and RAW264.7 cells was inhibited by FAAH inhibition, but not by COX-2 inhibition, even in RAW264.7 cells where the expression of this enzyme had greatly been induced by lipopolysaccharide + interferon. treatment. AEA and related NAEs were detected in DU145 cells, but PGs and PGE(2)-EA were only detected when the cells had been preincubated with 100 nM AEA. The data demonstrate that in DU145 cells, TNFa treatment changes the relative expression of the enzymes involved in the hydrolytic and oxygenation catabolic pathways for AEA. In RAW264.7 cells, COX-2, in contrast to FAAH, does not regulate the cellular accumulation of AEA. Further studies are necessary to determine the extent to which inflammatory mediators are involved in the abnormal endocannabinoid signalling system in prostate cancer.	[Karlsson, Jessica; Alhouayek, Mireille; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden; [Gouveia-Figueira, Sandra] Umea Univ, Dept Chem, Umea, Sweden; [Gouveia-Figueira, Sandra] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences	Karlsson, J (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden.	jessica.karlsson@umu.se	Fowler, Christopher J./M-6313-2019; Alhouayek, Mireille/R-5058-2018	Fowler, Christopher J./0000-0002-6658-7874; Alhouayek, Mireille/0000-0002-9193-0718; Karlsson, Jessica/0000-0001-8572-5841	Swedish Medical Research Council [12158]; Cancer Research Fund Norrland / Lion's Cancer Research Fund [LP 16-2129]; Umea University Medical Faculty	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Cancer Research Fund Norrland / Lion's Cancer Research Fund; Umea University Medical Faculty	This work was supported by grants from the Swedish Medical Research Council (Grant no. 12158, medicine, to CJF) (https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Cancer Research Fund Norrland / Lion's Cancer Research Fund (Grant no. LP 16-2129, to CJF) (http://www.cancerforskningsfonden.se) and the Research Funds of Umea University Medical Faculty (to CJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Brown KL, 2013, BBA-MOL CELL BIOL L, V1831, P1098, DOI 10.1016/j.bbalip.2013.03.006; Cipriano M, 2013, EUR J PHARMACOL, V720, P383, DOI 10.1016/j.ejphar.2013.09.065; Curran-Everett D, 2012, ADV PHYSIOL EDUC, V36, P181, DOI 10.1152/advan.00072.2012; De Petrocellis L, 1998, P NATL ACAD SCI USA, V95, P8375, DOI 10.1073/pnas.95.14.8375; Denkert C, 2007, PROSTATE, V67, P361, DOI 10.1002/pros.20467; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; Fernandes JV, 2015, PATHOL ONCOL RES, V21, P527, DOI 10.1007/s12253-015-9913-z; Fernandez-Solari J, 2006, ANN NY ACAD SCI, V1008, P238; Field A, 2012, DISCOVERING STAT USI, P617; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Fowler CJ, 2017, ENDOCANNABI IN PRESS, V80; Gabrielsson L, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.300; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Glass M, 2005, J LIPID RES, V46, P1364, DOI 10.1194/jlr.C500006-JLR200; Gouveia-Figueira S, 2015, PROSTAG OTH LIPID M, V121, P110, DOI 10.1016/j.prostaglandins.2015.06.003; Gouveia-Figueira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139212; Jacobsson SOP, 2001, J PHARMACOL EXP THER, V299, P951; Jayasooriya RGPT, 2013, ONCOL LETT, V5, P341, DOI 10.3892/ol.2012.968; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Ligresti A, 2016, PHYSIOL REV, V96, P1593, DOI 10.1152/physrev.00002.2016; Liu YS, 2014, MOL CELL PROTEOMICS, V13, P1753, DOI 10.1074/mcp.M114.038273; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Madaan S, 2000, BJU INT, V86, P736, DOI 10.1046/j.1464-410x.2000.00867.x; McKinney MK, 2006, BIOCHEMISTRY-US, V45, P9016, DOI 10.1021/bi0608010; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; MolinaHolgado F, 1997, NEUROREPORT, V8, P1929, DOI 10.1097/00001756-199705260-00027; Morelli MB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-921; Nicolussi S, 2015, VITAM HORM, V98, P441, DOI 10.1016/bs.vh.2014.12.011; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Petersen G, 2005, J NEUROCHEM, V93, P299, DOI 10.1111/j.1471-4159.2005.03013.x; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Rodriguez-Berriguete G, 2013, CYTOKINE, V64, P555, DOI 10.1016/j.cyto.2013.09.003; Ruiz-Llorente L, 2004, BRIT J PHARMACOL, V141, P457, DOI 10.1038/sj.bjp.0705628; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Schmid PC, 2002, LIPIDS, V37, P907, DOI 10.1007/s11745-002-0978-z; SCHMID PC, 1995, FEBS LETT, V375, P117, DOI 10.1016/0014-5793(95)01194-J; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; So OY, 1998, J BIOL CHEM, V273, P5801, DOI 10.1074/jbc.273.10.5801; Subbarayan V, 2001, CANCER RES, V61, P2720; Tanasescu R, 2010, IMMUNOBIOLOGY, V215, P588, DOI 10.1016/j.imbio.2009.12.005; Team RC, 2016, R LANG ENV STAT COMP, V3.3.2; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Galheigo MRU, 2016, PROSTATE, V76, P917, DOI 10.1002/pros.23181; Wang J, 2006, J BIOL CHEM, V281, P12325, DOI 10.1074/jbc.M512359200; Wang J, 2008, J BIOCHEM, V144, P685, DOI 10.1093/jb/mvn122; Yang YY, 2010, J HEPATOL, V53, P298, DOI 10.1016/j.jhep.2010.03.011	59	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0185011	10.1371/journal.pone.0185011	http://dx.doi.org/10.1371/journal.pone.0185011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910408	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200126
J	Leiva, A; Contreras-Duarte, S; Amigo, L; Sepulveda, E; Boric, M; Quinones, V; Busso, D; Rigotti, A				Leiva, Andrea; Contreras-Duarte, Susana; Amigo, Ludwig; Sepulveda, Esteban; Boric, Mauricio; Quinones, Veronica; Busso, Dolores; Rigotti, Attilio			Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR SR-BI; FARNESOID-X-RECEPTOR; E-DEFICIENT MICE; SCAVENGER RECEPTOR; APOLIPOPROTEIN-E; MYOCARDIAL-INFARCTION; CARDIAC DYSFUNCTION; HDL METABOLISM; CHOLESTEROL	For proper cholesterol metabolism, normal expression and function of scavenger receptor class B type I (SR-BI), a high-density lipoprotein (HDL) receptor, is required. Among the factors that regulate overall cholesterol homeostasis and HDL metabolism, the nuclear farnesoid X receptor plays an important role. Guggulsterone, a bioactive compound present in the natural product gugulipid, is an antagonist of this receptor. This natural product is widely used globally as a natural lipid-lowering agent, although its anti-atherogenic cardiovascular benefit in animal models or humans is unknown. The aim of this study was to determine the effects of gugulipid on cholesterol homeostasis and development of mild and severe atherosclerosis in male mice. For this purpose, we evaluated the impact of gugulipid treatment on liver histology, plasma lipoprotein cholesterol, endothelial function, and development of atherosclerosis and/or ischemic heart disease in wild-type mice; apolipoprotein E knockout mice, a model of atherosclerosis without ischemic complications; and SR-B1 knockout and atherogenic-diet-fed apolipoprotein E hypomorphic (SR-BI KO/ApoER61 h/h) mice, a model of lethal ischemic heart disease due to severe atherosclerosis. Gugulipid administration was associated with histological abnormalities in liver, increased alanine aminotransferase levels, lower hepatic SR-BI content, hypercholesterolemia due to increased HDL cholesterol levels, endothelial dysfunction, enhanced atherosclerosis, and accelerated death in animals with severe ischemic heart disease. In conclusion, our data show important adverse effects of gugulipid intake on HDL metabolism and atherosclerosis in male mice, suggesting potential and unknown deleterious effects on cardiovascular health in humans. In addition, these findings reemphasize the need for rigorous preclinical and clinical studies to provide guidance on the consumption of natural products and regulation of their use in the general population.	[Leiva, Andrea; Contreras-Duarte, Susana] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynaecol, CMPL, Santiago, Chile; [Amigo, Ludwig] Pontificia Univ Catolica Chile, Sch Med, Dept Gastroenterol, Santiago, Chile; [Sepulveda, Esteban; Boric, Mauricio] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile; [Quinones, Veronica; Busso, Dolores; Rigotti, Attilio] Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Santiago, Chile; [Rigotti, Attilio] Pontificia Univ Catolica Chile, Sch Med, Ctr Mol Nutr & Chron Dis, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Leiva, A (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynaecol, CMPL, Santiago, Chile.; Rigotti, A (corresponding author), Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Santiago, Chile.; Rigotti, A (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Ctr Mol Nutr & Chron Dis, Santiago, Chile.	aaleiva@uc.cl; arigotti@med.puc.cl	Busso, Dolores/K-7375-2012; Boric, Mauricio P/G-1574-2013; Busso, Dolores/AAF-2568-2020	Busso, Dolores/0000-0003-2113-1926; Boric, Mauricio P/0000-0001-6735-6675; Contreras Duarte, Susana/0000-0002-4198-7011	Chilean National Research and Technology Commission (Comision Nacional de Investigacion Cientifica y Tecnologica, CONICYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico [1070634, 1150399, 1150344]; CONICYT Ph.D. fellowships	Chilean National Research and Technology Commission (Comision Nacional de Investigacion Cientifica y Tecnologica, CONICYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Ph.D. fellowships	This work was funded by the Chilean National Research and Technology Commission (Comision Nacional de Investigacion Cientifica y Tecnologica, CONICYT), Fondo Nacional de Desarrollo Cientifico y Tecnologico grant #1070634 (A. Rigotti), #1150399 (A. Rigotti), # 1150344 (A. Leiva) and CONICYT Ph.D. fellowships (A. Leiva, E. Sepulveda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amigo L, 2000, GASTROENTEROLOGY, V118, P772, DOI 10.1016/S0016-5085(00)70147-8; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Braun A, 2008, CURR DRUG TARGETS, V9, P217; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011; Chander Ramesh, 2003, Indian J Clin Biochem, V18, P71, DOI 10.1007/BF02867370; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Das Gupta R, 1990, J Indian Med Assoc, V88, P346; Morales MG, 2010, LIVER INT, V30, P887, DOI 10.1111/j.1478-3231.2010.02230.x; Ghorai M, 2000, PHYTOTHER RES, V14, P200, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;200::AID-PTR548&gt;3.0.CO;2-T; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grieco A, 2009, J HEPATOL, V50, P1273, DOI 10.1016/j.jhep.2009.02.021; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Hag AMF, 2008, BIOCHEM BIOPH RES CO, V377, P689, DOI 10.1016/j.bbrc.2008.10.037; Hasani-Ranjbar S, 2010, CURR PHARM DESIGN, V16, P2935, DOI 10.2174/138161210793176464; Jain S, 2014, WORLD J PHARM RES, V3, P1616; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Lata S, 1991, J Postgrad Med, V37, P132; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Mardones P, 2001, J LIPID RES, V42, P170; Masten SA, 2005, GUM GUGGUL SOME STER, V2, P1; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Nityanand S, 1989, J Assoc Physicians India, V37, P323; Nohr LA, 2009, COMPLEMENT THER MED, V17, P16, DOI 10.1016/j.ctim.2008.07.001; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Russell A, 2000, J PHARMACOL EXP THER, V294, P598; Sairkar PK, 2017, J PHARM BIOALLIED SC, V9, P1, DOI 10.4103/0975-7406.206225; Sane RT, 1990, INDIAN DRUGS, V28, P86; Sarup P, 2015, SCIENTIFICA, V2015, DOI 10.1155/2015/138039; SETH R, 1991, LANCET, V338, P83, DOI 10.1016/0140-6736(91)90077-3; Shah R, 2012, PHYTOTHER RES, V26, P1594, DOI 10.1002/ptr.4647; SINGH RB, 1994, CARDIOVASC DRUG THER, V8, P659, DOI 10.1007/BF00877420; SINGH V, 1990, PHARMACOL RES, V22, P37, DOI 10.1016/1043-6618(90)90741-U; Szapary PO, 2003, JAMA-J AM MED ASSOC, V290, P765, DOI 10.1001/jama.290.6.765; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Ulbricht C, 2005, COMPLEMENT THER MED, V13, P279, DOI 10.1016/j.ctim.2005.08.003; Urizar NL, 2003, ANNU REV NUTR, V23, P303, DOI 10.1146/annurev.nutr.23.011702.073102; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Xu WX, 2017, FEBS J, V284, P114, DOI 10.1111/febs.13956; Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001; Yang DF, 2012, J LIPID RES, V53, P529, DOI 10.1194/jlr.M014688; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563	55	4	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184280	10.1371/journal.pone.0184280	http://dx.doi.org/10.1371/journal.pone.0184280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910310	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200036
J	Stathopoulou, C; Kapsetaki, M; Stratigi, K; Spilianakis, C				Stathopoulou, Chrysoula; Kapsetaki, Manouela; Stratigi, Kalliopi; Spilianakis, Charalampos			Long non-coding RNA SeT and miR-155 regulate the Tnf alpha gene allelic expression profile	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; INFLAMMATORY RESPONSE; X-INACTIVATION; MICRORNA; IMMUNE; MECHANISMS; MACROPHAGES; DEFICIENT; MICE; STIMULATION	It is becoming increasingly appreciated that the non-coding genome may have a great impact on the regulation of chromatin structure and gene expression. The innate immune response can be mediated upon lipopolysaccharide stimulation of macrophages which leads to immediate transcriptional activation of early responsive genes including tumor necrosis factor alpha (Tnf alpha). The functional role of non-coding RNAs, such as lncRNAs and microRNAs, on the transcriptional activation of proinflammatory genes and the subsequent regulation of the innate immune response is still lacking mechanistic insights. In this study we wanted to unravel the functional role of the lncRNA SeT, which is encoded from the murine Tnfa gene locus, and miR-155 on the transcriptional regulation of the Tnfa gene. We utilized genetically modified mice harboring either a deletion of the SeT promoter elements or the mature miR-155 and studied the response of macrophages to lipopolysaccharide (LPS) stimulation. We found that decreased expression of the lncRNA SeT in murine primary macrophages resulted in increased mortality of mice challenged with LPS, which was corroborated by increased Tnfa steady state mRNA levels and a higher frequency of biallelically expressing macrophages. On the contrary, miR-155 deletion resulted in reduced Tnfa mRNA levels supported by a lower frequency of biallelically expressing macrophages upon stimulation with LPS. In both cases, in the absence of either lncRNA SeT or miR-155 we observed a deregulation of the Tnfa allele homologous pairing, previously shown to regulate the switch from mono-to bi-allelic gene expression. Although lncRNA SeT was not found to be a direct target of miR-155 its stability was increased upon miR-155 deletion. This study suggests a role of the non-coding genome in mediating Tnfa mRNA dosage control based on the regulation of homologous pairing of gene alleles and their subsequent biallelic expression.	[Stathopoulou, Chrysoula] Dept Mol Biol & Genet, Bldg 10 Univ Campus, Dragana Alexandroupolis, Greece; [Stathopoulou, Chrysoula; Kapsetaki, Manouela; Stratigi, Kalliopi; Spilianakis, Charalampos] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Nikolaou Plastira 100, Iraklion, Greece; [Stratigi, Kalliopi; Spilianakis, Charalampos] Univ Crete, Dept Biol, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Spilianakis, C (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Nikolaou Plastira 100, Iraklion, Greece.; Spilianakis, C (corresponding author), Univ Crete, Dept Biol, Iraklion, Greece.	spiliana@imbb.forth.gr	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923	FONDATION SANTE; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES	FONDATION SANTE; European Union (European Social Fund ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES	This work was supported by a FONDATION SANTE research grant and has been cofinanced by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a FONDATION SANTE research grant and has been co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES. We thank Despoina Tsoukatou for help with the in vivo experiments and Anastassios Oulas for performing the in silico analysis for potential miR-155 seed sequences identified on SeT 1ncRNA sequence.	Ahadi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24922; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; ARNOLDUS EPJ, 1989, HUM GENET, V83, P231, DOI 10.1007/BF00285162; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Burgess DJ, 2011, NAT REV GENET, V12; Cai B, 2014, NEOPLASMA, V61, P379, DOI 10.4149/neo_2014_075; Chisholm KM, 2012, PLOS ONE, V7; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Deligianni C, 2012, EMBO REP, V13, P819, DOI 10.1038/embor.2012.112; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Doxaki C, 2015, J IMMUNOL, V195, P5750, DOI 10.4049/jimmunol.1500615; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; Hu YL, 2010, NUCLEIC ACIDS RES, V38, P5472, DOI 10.1093/nar/gkq337; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matsui M, 2013, NUCLEIC ACIDS RES, V41, P10086, DOI 10.1093/nar/gkt777; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Migeon BR, 1996, AM J HUM GENET, V58, P161; Monajembashi S, 2005, BIOPHYS J, V88, P2309, DOI 10.1529/biophysj.104.048728; Moran N.C., 2012, GENE DEV, V25, P1915; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Oulas A, 2012, RNA BIOL, V9, P1196, DOI 10.4161/rna.21725; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Qian M, 2016, TUMOR BIOL, V37, P3879, DOI 10.1007/s13277-015-3838-8; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Roberts TC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.40; Scadden D, 2009, MOL CELL, V35, P395, DOI 10.1016/j.molcel.2009.08.005; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Stratigi K, 2015, P NATL ACAD SCI USA, V112, pE1577, DOI 10.1073/pnas.1502182112; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yang L, 2016, GENE DEV, V30, P1747, DOI 10.1101/gad.281162.116; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoon JH, 2014, SEMIN CELL DEV BIOL, V34, P9, DOI 10.1016/j.semcdb.2014.05.015; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhang Y, 2016, CELL MOL IMMUNOL, V13, P138, DOI 10.1038/cmi.2015.68; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	89	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184788	10.1371/journal.pone.0184788	http://dx.doi.org/10.1371/journal.pone.0184788			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910376	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200095
J	Li, Q; Hegge, R; Bridges, PJ; Matthews, JC				Li, Qing; Hegge, Raquel; Bridges, Phillip J.; Matthews, James C.			Pituitary genomic expression profiles of steers are altered by grazing of high vs. low endophyte-infected tall fescue forages	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; GROWTH-HORMONE; PROLACTIN SECRETION; GENE-EXPRESSION; PLASMA-CONCENTRATIONS; ORGANIC FORMS; TRANSCRIPTION; ACTIVATION; BINDING; PROTEIN	Consumption of ergot alkaloid-containing tall fescue grass impairs several metabolic, vascular, growth, and reproductive processes in cattle, collectively producing a clinical condition known as "fescue toxicosis." Despite the apparent association between pituitary function and these physiological parameters, including depressed serum prolactin; no reports describe the effect of fescue toxicosis on pituitary genomic expression profiles. To identify candidate regulatory mechanisms, we compared the global and selected targeted mRNA expression patterns of pituitaries collected from beef steers that had been randomly assigned to undergo summer-long grazing (89 to 105 d) of a high-toxic endophyte-infected tall fescue pasture (HE; 0.746 mu g/g ergot alkaloids; 5.7 ha; n = 10; BW = 267 +/- 14.5 kg) or a low-toxic endophyte tall fescue-mixed pasture (LE; 0.023 mu g/g ergot alkaloids; 5.7 ha; n = 9; BW = 266 +/- 10.9 kg). As previously reported, in the HE steers, serum prolactin and body weights decreased and a potential for hepatic gluconeogenesis from amino acid-derived carbons increased. In this manuscript, we report that the pituitaries of HE steers had 542 differentially expressed genes (P < 0.001, false discovery rate <= 4.8%), and the pattern of altered gene expression was dependent (P < 0.001) on treatment. Integrated Pathway Analysis revealed that canonical pathways central to prolactin production, secretion, or signaling were affected, in addition to those related to corticotropin-releasing hormone signaling, melanocyte development, and pigmentation signaling. Targeted RT-PCR analysis corroborated these findings, including decreased (P < 0.05) expression of DRD2, PRL, POU1F1, GAL, and VIP and that of POMC and PCSK1, respectively. Canonical pathway analysis identified HE-dependent alteration in signaling of additional pituitary-derived hormones, including growth hormone and GnRH. We conclude that consumption of endophyte-infected tall fescue alters the pituitary transcriptome profiles of steers in a manner consistent with their negatively affected physiological parameters.	[Li, Qing; Hegge, Raquel; Bridges, Phillip J.; Matthews, James C.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA	University of Kentucky	Matthews, JC (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA.	jmatthew@uky.edu	Matthews, James Clyde/Y-1849-2019	Matthews, James/0000-0003-3219-9758	United States Department of Agriculture-Agricultural Research Service Cooperative Agreement (JCM); National Institute of Food and Agriculture, U.S. Department of Agriculture [KY007095]	United States Department of Agriculture-Agricultural Research Service Cooperative Agreement (JCM); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work is supported by a United States Department of Agriculture-Agricultural Research Service Cooperative Agreement (JCM) and by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch project No. KY007095 (JCM, PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aiken GE, 2013, J ANIM SCI, V91, P2369, DOI 10.2527/jas.2012-5948; ALDRICH CG, 1993, J ANIM SCI, V71, P164, DOI 10.2527/1993.711164x; Beardwell C, 1981, PITUITARY; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; BJORO T, 1987, MOL CELL ENDOCRINOL, V49, P119, DOI 10.1016/0303-7207(87)90205-X; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BREDOW S, 1994, BRAIN RES, V660, P301, DOI 10.1016/0006-8993(94)91303-X; Bridges PJ, 2012, ENDOCRINOLOGY, V153, P1925, DOI 10.1210/en.2011-1900; Brown KR, 2009, J ANIM SCI, V87, P748, DOI 10.2527/jas.2008-1108; Browning R, 1997, J ANIM SCI, V75, P796; Browning R, 1998, J ANIM SCI, V76, P1644; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Fliss MS, 1999, MOL ENDOCRINOL, V13, P644, DOI 10.1210/me.13.4.644; FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069; FRAWLEY LS, 1981, NEUROENDOCRINOLOGY, V33, P79, DOI 10.1159/000123206; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; GOURDJI D, 1979, FEBS LETT, V104, P165, DOI 10.1016/0014-5793(79)81107-2; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; HURLEY WL, 1980, J ANIM SCI, V51, P374, DOI 10.2527/jas1980.512374x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson JJ, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00077; KOSHIYAMA H, 1987, NEUROSCI LETT, V75, P49, DOI 10.1016/0304-3940(87)90073-5; LAMBERTS SWJ, 1990, PHYSIOL REV, V70, P279, DOI 10.1152/physrev.1990.70.2.279; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Larson BT, 1999, J ANIM SCI, V77, P942; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Liao SF, 2015, J ANIM SCI, V93, P5659, DOI 10.2527/jas.2015-9193; LIPHAM LB, 1989, J ANIM SCI, V67, P1090, DOI 10.2527/jas1989.6741090x; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looper ML, 2010, J ANIM SCI, V88, P4133, DOI 10.2527/jas.2010-3192; Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005; MACNAMEE MC, 1986, GEN COMP ENDOCR, V62, P470, DOI 10.1016/0016-6480(86)90057-2; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; Matthews JC, 2014, ANIM PROD SCI, V54, P1594, DOI 10.1071/AN14274; Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; MURDOCH GH, 1982, NATURE, V300, P192, DOI 10.1038/300192a0; Naef L, 2007, ENDOCRINOLOGY, V148, P5977, DOI 10.1210/en.2007-0442; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; SAMSON WK, 1980, PEPTIDES, V1, P325, DOI 10.1016/0196-9781(80)90010-8; Schuenemann Gustavo M, 2005, Reprod Biol, V5, P137; Siegel MR, 1994, BIOTECHNOLOGY ENDOPH, P135; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3130, DOI 10.1073/pnas.88.8.3130; Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478; Thompson IM, 2011, J ANIM SCI, V89, P1338, DOI 10.2527/jas.2010-3559; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WATERMAN ML, 1988, MOL ENDOCRINOL, V2, P14, DOI 10.1210/mend-2-1-14; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wynick D, 1998, P NATL ACAD SCI USA, V95, P12671, DOI 10.1073/pnas.95.21.12671	55	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184612	10.1371/journal.pone.0184612	http://dx.doi.org/10.1371/journal.pone.0184612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902910	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200049
J	del Pozo-Cruz, B; Gant, N; del Pozo-Cruz, J; Maddison, R				del Pozo-Cruz, Borja; Gant, Nicholas; del Pozo-Cruz, Jesus; Maddison, Ralph			Relationships between sleep duration, physical activity and body mass index in young New Zealanders: An isotemporal substitution analysis	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; INSULIN-RESISTANCE; CHILDREN; HEALTH; RISK; TIME; FITNESS; INDICATORS; ADIPOSITY; INTENSITY	Background The evidence regarding the unique effect of sedentary behaviour on obesity among children is unclear. Moreover, the effect of substituting sedentary behaviour with physical activity of different intensities on the body composition of children has received limited empirical study. Objective To examine the mathematical effects on Body Mass Index (BMI) of substituting sedentary behaviours with physical activities of different intensities on children and youth aged 5-14 years old in New Zealand. Methods Secondary analysis of accelerometer data from the National Survey of Children and Young People's Physical Activity and Dietary Behaviours in New Zealand (2008/09) was conducted. A total of 1812 children and youth aged 5-24 years provided accelerometer-derived data on daily sedentary time (SB), light intensity physical activity (LPA) and moderate to vigorous physical activity (MVPA). Sleep time was assessed with a validated computerised use-of-time tool. BMI was assessed using anthropometric measurements. Multiple linear regression models were used to examine the independent associations of SB, Sleep time, LPA, and MVPA on BMI. The isotemporal substitution approach was used to ascertain the mathematical effect of substituting each of the other behaviours on BMI. Analyses were stratified by age groups. Results SB showed a unique (inverse) association with BMI across all age groups (p<0.05) but 20-24 years (p>0.05). Similarly, MVPA was positively associated (p<0.001) across all age groups. Among age groups 5-9 years, 10-14 years and 15-19 years, the estimated impact of replacing 60 min/day of SB with the same amount of MVPA time resulted in decreased BMI for all age groups (p<0.001), ranging from -1.26 (5-9 years) to -1.43 units (15-19 years). Similar results were achieved when SB was replaced with LPA or sleeping time for children (5-19 years). In young people (age group 20-24), the impact of replacing 30 min/day of SB with MVPA resulted in an estimated -1 BMI units decrease (p<0.001). Conclusion MVPA and SB have a unique effect on BMI. Further, substituting SB with LPA or MVPA was associated with a favourable effect on BMI across all age groups; with MVPA having the strongest association.	[del Pozo-Cruz, Borja; Gant, Nicholas] Univ Auckland, Fac Sci, Dept Exercise Sci, TAMAKI Bldg 731,Level 3,Tamaki Campus Gate 1, Auckland, New Zealand; [del Pozo-Cruz, Jesus] Univ Seville, Dept Phys Educ & Sports, Pirotecnia S-N, Seville, Spain; [Maddison, Ralph] Deakin Univ, Fac Hlth Sci, Sch Exercise & Nutr, Geelong, Vic, Australia	University of Auckland; University of Sevilla; Deakin University	del Pozo-Cruz, B (corresponding author), Univ Auckland, Fac Sci, Dept Exercise Sci, TAMAKI Bldg 731,Level 3,Tamaki Campus Gate 1, Auckland, New Zealand.	b.delpozocruz@auckland.acnz	Maddison, Ralph/K-3418-2019; del Pozo-Cruz, Jesus/F-9934-2016	Maddison, Ralph/0000-0001-8564-5518; del Pozo Cruz, Borja/0000-0002-9728-1317; del Pozo-Cruz, Jesus/0000-0002-8553-5818; , Borja/0000-0003-3944-2212	Sport and Recreation New Zealand; Ministry of Health; Ministry of Education; Ministry of Youth; Health Research Council, Sir Charles Hercus Fellowship	Sport and Recreation New Zealand; Ministry of Health; Ministry of Education; Ministry of Youth; Health Research Council, Sir Charles Hercus Fellowship	The current study was not specifically funded. However, The national survey was funded by Sport and Recreation New Zealand, the Ministry of Health, the Ministry of Education and the Ministry of Youth, and was managed by the Clinical Trials Research Unit (now the National Institute for health Innovation), The University of Auckland and Synovate. Professor Maddison was supported by a Health Research Council, Sir Charles Hercus Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio D, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0249-6; Banda JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150534; Cliff DP, 2016, OBES REV, V17, P330, DOI 10.1111/obr.12371; Dempsey PC, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0522-0; Edelson LR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2791-9; Foley LS, 2013, PEDIATRICS, V131, P276, DOI 10.1542/peds.2012-1651; Foley LS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-132; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Herzig KH, 2014, INT J OBESITY, V38, P1089, DOI 10.1038/ijo.2013.224; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Leppanen MH, 2016, INT J OBESITY, V40, P1126, DOI 10.1038/ijo.2016.54; Loprinzi PD, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0175-9; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Morrissey B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2913-4; Norton K, 1996, ANTHROPOMETRICA TXB; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Ridley K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-10; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Sardinha LB, 2016, PEDIAT OBES; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Saunders TJ, 2014, CAN J DIABETES, V38, P53, DOI 10.1016/j.jcjd.2013.08.266; Sluggett L, 2016, CHILD OBES, V12, P325, DOI 10.1089/chi.2015.0214; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Taveras EM, 2012, PREV MED, V55, P418, DOI 10.1016/j.ypmed.2012.08.016; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Waleh MQ, 2016, PRIMARY CARE, V43, P97, DOI 10.1016/j.pop.2015.08.014; Welk G., 2002, PHYS ACTIVITY ASSESS	31	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184472	10.1371/journal.pone.0184472	http://dx.doi.org/10.1371/journal.pone.0184472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898295	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500029
J	Jordan-Alvarez, S; Santana, E; Casas-Tinto, S; Acebes, A; Ferrus, A				Jordan-Alvarez, Sheila; Santana, Elena; Casas-Tinto, Sergio; Acebes, Angel; Ferrus, Alberto			The equilibrium between antagonistic signaling pathways determines the number of synapses in Drosophila	PLOS ONE			English	Article							REGULATES SYNAPTIC GROWTH; FGF RECEPTOR HOMOLOG; N-TERMINAL KINASE; WISHFUL-THINKING; II-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; ALZHEIMERS-DISEASE; LOCAL INTERNEURONS; BMP; SYNAPTOGENESIS	The number of synapses is a major determinant of behavior and many neural diseases exhibit deviations in that number. However, how signaling pathways control this number is still poorly understood. Using the Drosophila larval neuromuscular junction, we show here a PI3K-dependent pathway for synaptogenesis which is functionally connected with other previously known elements including the Wit receptor, its ligand Gbb, and the MAPkinases cascade. Based on epistasis assays, we determined the functional hierarchy within the pathway. Wit seems to trigger signaling through PI3K, and Ras85D also contributes to the initiation of synaptogenesis. However, contrary to other signaling pathways, PI3K does not require Ras85D binding in the context of synaptogenesis. In addition to the MAPK cascade, Bsk/JNK undergoes regulation by Puc and Ras85D which results in a narrow range of activity of this kinase to determine normalcy of synapse number. The transcriptional readout of the synaptogenesis pathway involves the Fos/Jun complex and the repressor Cic. In addition, we identified an antagonistic pathway that uses the transcription factors Mad and Medea and the microRNA bantam to down-regulate key elements of the pro-synaptogenesis pathway. Like its counterpart, the anti-synaptogenesis signaling uses small GTPases and MAPKs including Ras64B, Ras-like-a, p38a and Licorne. Bantam downregulates the pro-synaptogenesis factors PI3K, Hiw, Ras85D and Bsk, but not AKT. AKT, however, can suppress Mad which, in conjunction with the reported suppression of Mad by Hiw, closes the mutual regulation between both pathways. Thus, the number of synapses seems to result from the balanced output from these two pathways.	[Jordan-Alvarez, Sheila; Santana, Elena; Casas-Tinto, Sergio; Acebes, Angel; Ferrus, Alberto] Inst Cajal CSIC, Madrid, Spain; [Jordan-Alvarez, Sheila] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Acebes, Angel] Univ La Laguna, Inst Biomed Technol, Ctr Biomed Res Canary Isl, Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de la Laguna	Acebes, A; Ferrus, A (corresponding author), Inst Cajal CSIC, Madrid, Spain.; Acebes, A (corresponding author), Univ La Laguna, Inst Biomed Technol, Ctr Biomed Res Canary Isl, Tenerife, Spain.	aacebesv@ull.es; aferrus@cajal.csic.es	Jordán-Álvarez, Sheila/AAP-3219-2021; Jordan-Alvarez, Sheila/AAA-8006-2020; Casas-Tinto, Sergio/G-8220-2015; Acebes, Angel/I-2127-2015	Jordán-Álvarez, Sheila/0000-0002-7701-4457; Casas-Tinto, Sergio/0000-0002-9589-9981; Acebes, Angel/0000-0003-0020-1913; Santana, Elena/0000-0002-2444-9908; Ferrus, Alberto/0000-0002-0346-0489	Ministry of Economy [BFU2012-3819]; PhD fellowship [BES-2007-1659]; Ramon y Cajal program [RYC-2012-11410]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Ministry of Economy; PhD fellowship; Ramon y Cajal program(Spanish Government); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was funded by a grant from the Ministry of Economy (BFU2012-3819 to AF) and a PhD fellowship (BES-2007-1659 to SJA). S.C.-T. holds a contract from the Ramon y Cajal program RYC-2012-11410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Acebes A, 2012, J NEUROSCI, V32, P417, DOI 10.1523/JNEUROSCI.2921-11.2012; Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Alexander PB, 2015, FRONT MED-PRC, V9, P134, DOI 10.1007/s11684-015-0396-9; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Asha H, 2003, GENETICS, V163, P203; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Ballard SL, 2014, J CELL BIOL, V204, P1157, DOI 10.1083/jcb.201308115; Banerjee S, 2017, MOL CELL NEUROSCI, V78, P9, DOI 10.1016/j.mcn.2016.11.004; Bangi E, 2006, DEVELOPMENT, V133, P3295, DOI 10.1242/dev.02513; Bao H, 2005, J NEUROPHYSIOL, V94, P1888, DOI 10.1152/jn.00080.2005; Baonza A, 2000, DEVELOPMENT, V127, P2383; Baydyuk M, 2015, J NEUROSCI, V35, P4676, DOI 10.1523/JNEUROSCI.2695-14.2015; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Berke B, 2013, J NEUROSCI, V33, P17937, DOI 10.1523/JNEUROSCI.6075-11.2013; Bernardinelli Y, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00123; Borgen M, 2017, GENETICS, V205, P1229, DOI 10.1534/genetics.116.197343; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Budnik V, 2006, FLY NEUROMUSCULAR JU; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; Chazeau A, 2015, MOL BIOL CELL, V26, P859, DOI 10.1091/mbc.E14-06-1086; Chen X, 2012, J CELL BIOL, V196, P529, DOI 10.1083/jcb.201109044; Ciapponi L, 2002, MECH DEVELOP, V115, P35, DOI 10.1016/S0925-4773(02)00093-X; Collins CA, 2004, NEURON, V41, P489, DOI 10.1016/S0896-6273(04)00078-9; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cuesto G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118475; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Demontis F, 2014, CELL REP, V7, P1481, DOI 10.1016/j.celrep.2014.05.001; Dobens LL, 2001, DEVELOPMENT, V128, P1845; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; Etter PD, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-39; Flores CE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00327; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gass P, 2004, MOL BRAIN RES, V130, P16, DOI 10.1016/j.molbrainres.2004.07.004; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Gleason MR, 2003, NAT NEUROSCI, V6, P217, DOI 10.1038/nn1011; Gonda RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042369; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hipfner DR, 2002, GENETICS, V161, P1527; James RE, 2014, DEV CELL, V31, P586, DOI 10.1016/j.devcel.2014.10.006; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; Karkali K, 2012, BIOCHEM BIOPH RES CO, V418, P301, DOI 10.1016/j.bbrc.2012.01.015; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kim NC, 2010, DEV DYNAM, V239, P2413, DOI 10.1002/dvdy.22368; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; KORDYLEWSKI L, 1979, Z MIKROSK ANAT FORSC, V93, P1038; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; LEWIS ER, 1980, BRAIN RES, V191, P35, DOI 10.1016/0006-8993(80)90313-3; Li WH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006062; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Messeant J, 2017, DEVELOPMENT; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Middei S, 2014, NEUROBIOL LEARN MEM, V115, P108, DOI 10.1016/j.nlm.2014.08.001; Nagaoka T, 2014, CELL REP, V6, P916, DOI 10.1016/j.celrep.2014.01.044; Navarro AI, 2014, CURR OPIN NEUROBIOL, V27, P89, DOI 10.1016/j.conb.2014.03.002; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Parker L, 2006, DEVELOPMENT, V133, P4981, DOI 10.1242/dev.02673; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Peled ES, 2014, CURR BIOL, V24, P484, DOI 10.1016/j.cub.2014.01.022; Pfleger CM, 2017, CURR TOP DEV BIOL, V123, P181, DOI 10.1016/bs.ctdb.2016.12.001; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Ruiz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067161; Sakuma C, 2016, CELL REP, V16, P2289, DOI 10.1016/j.celrep.2016.07.066; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Seeger G, 2005, J NEURAL TRANSM, V112, P751, DOI 10.1007/s00702-004-0226-8; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Spilker C, 2010, EUR J NEUROSCI, V32, P1, DOI 10.1111/j.1460-9568.2010.07273.x; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Szuts D, 2000, P NATL ACAD SCI USA, V97, P5351, DOI 10.1073/pnas.97.10.5351; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vonhoff F, 2013, DEVELOPMENT, V140, P606, DOI 10.1242/dev.089235; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang SHJ, 2014, J NEUROSCI, V34, P12745, DOI 10.1523/JNEUROSCI.1280-14.2014; Wharton KA, 1999, GENETICS, V152, P629; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhao HF, 2015, INT J ONCOL, V47, P429, DOI 10.3892/ijo.2015.3052; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	130	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184238	10.1371/journal.pone.0184238	http://dx.doi.org/10.1371/journal.pone.0184238			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892511	gold, Green Published, Green Submitted			2022-12-26	WOS:000410243200012
J	Cieslak, M; Wahli, T; Diserens, N; Haenen, OLM; Schutze, H				Cieslak, Michael; Wahli, Thomas; Diserens, Nicolas; Haenen, Olga L. M.; Schutze, Heike			Phylogeny of the infectious hematopoietic necrosis virus in European aquaculture	PLOS ONE			English	Article							FISH RHABDOVIRUS; RAINBOW-TROUT; SOFTWARE; SEQUENCE; DISEASE; IHNV	Infectious hematopoietic necrosis (IHN)-a highly lethal infectious salmonid disease-has caused substantial economic losses in the European production of rainbow trout (Oncorhynchus mykiss) since the late 1980s. The causal agent of IHN is the IHN virus (IHNV) introduced from overseas. However, until today, its phylogeographic spread in Europe remains poorly understood. We therefore sought to elucidate this unresolved topic by using the largest ever compiled dataset of European IHNV isolates (E isolates) (193 GenBank E isolates and 100 isolates from this study) for the complete glycoprotein (G) gene sequence. Our results clearly revealed that the active trout trade has left its traces in the E phylogeny. For example, the spread by trade of IHNV-infected trout was apparently the cause for the exposure of the E lineage to different local scenarios of selection and genetic drift, and therefore has led to the split of this lineage into various subordinated lineages. Accordingly, we also found evidence for E isolates being mixed Europe-wide by cross-border introduction events. Moreover, there were indications that this propagation of the E lineage within Europe corresponded with an extensive and rapid spread event, already during or shortly after its formation. Finally, in accordance with the high substitution rate of IHNV determined by previous studies, our dataset indicates that the mean period of occurrence of a single E haplotype is typically not longer than one calendar year.	[Cieslak, Michael; Schutze, Heike] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol IMED, Insel Riems, Germany; [Wahli, Thomas; Diserens, Nicolas] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Haenen, Olga L. M.] NRL Fish Shellfish & Crustacean Dis, Wageningen Biovet Res, Wageningen, Netherlands	Friedrich Loeffler Institute; University of Bern; Wageningen University & Research	Cieslak, M (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol IMED, Insel Riems, Germany.	cieslak-michael@gmx.de	Diserens, Nicolas/ABC-2030-2021	Diserens, Nicolas/0000-0002-8352-1076; Cieslak, Michael/0000-0002-6111-658X	EMIDA-ERA Net (EU 7th Framework programme); German Federal Office for Agriculture and Food [2811ERA174]; Dutch Ministry of Economic Affairs [1600074-01]	EMIDA-ERA Net (EU 7th Framework programme); German Federal Office for Agriculture and Food; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by EMIDA-ERA Net (EU 7th Framework programme), German Federal Office for Agriculture and Food (2811ERA174), and Dutch Ministry of Economic Affairs (CVI project no. 1600074-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadi M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01306; AMEND DF, 1969, T AM FISH SOC, V98, P796, DOI 10.1577/1548-8659(1969)98[796:AHVDOR]2.0.CO;2; Asl Adel Haghighi Khiabanian, 2007, Pak J Biol Sci, V10, P230, DOI 10.3923/pjbs.2007.230.234; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bootland LM, 1999, FISH DISEASES AND DISORDERS, VOL 3, P57; Bovo G., 1987, Bulletin of the European Association of Fish Pathologists, V7, P124; Breyta R, 2014, DIS AQUAT ORGAN, V112, P17, DOI 10.3354/dao02781; Cieslak M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164475; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Enzmann PJ, 2010, DIS AQUAT ORGAN, V89, P9, DOI 10.3354/dao02182; Foreman MGG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130951; Haenen OLM, 2016, J FISH DIS, V39, P971, DOI 10.1111/jfd.12434; He M, 2013, INFECT GENET EVOL, V18, P145, DOI 10.1016/j.meegid.2013.05.014; Holmes EC, 2002, J VIROL, V76, P460, DOI 10.1128/JVI.76.1.460-462.2002; Humphries EM, 2010, MOL PHYLOGENET EVOL, V54, P88, DOI 10.1016/j.ympev.2009.07.023; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurath G, 2003, J GEN VIROL, V84, P803, DOI 10.1099/vir.0.18771-0; KURATH G, 1985, J VIROL, V53, P469, DOI 10.1128/JVI.53.2.469-476.1985; Laurencin F.B., 1987, Bulletin of the European Association of Fish Pathologists, V7, P104; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin GN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S2; MORZUNOV SP, 1995, VIRUS RES, V38, P175, DOI 10.1016/0168-1702(95)00056-V; Niu L, 1988, J FISHERIES CHINA, V1, P351; OIE, 2016, MANUAL DIAGNOSTIC TE; PARK MA, 1993, J FISH DIS, V16, P471, DOI 10.1111/j.1365-2761.1993.tb00880.x; ROSS A. J., 1960, TRANS AMER FISH SOC, V89, P160, DOI 10.1577/1548-8659(1960)89[160:AVDOCS]2.0.CO;2; Rudakova SL, 2007, DIS AQUAT ORGAN, V75, P1, DOI 10.3354/dao075001; Sano T, 1977, Journal Tokyo Univ Fish, V63, P81; SCHUTZE H, 1995, J GEN VIROL, V76, P2519, DOI 10.1099/0022-1317-76-10-2519; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yu Zh, 2014, AQUAC RES, P1	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184490	10.1371/journal.pone.0184490	http://dx.doi.org/10.1371/journal.pone.0184490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886189	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100137
J	Breasson, L; Sardi, C; Becattini, B; Zani, F; Solinas, G				Breasson, Ludovic; Sardi, Claudia; Becattini, Barbara; Zani, Fabio; Solinas, Giovanni			PI3K gamma ablation does not promote diabetes in db/db mice, but improves insulin sensitivity and reduces pancreatic beta-cell apoptosis	FASEB JOURNAL			English	Article						phosphoinositide 3-kinase; macrophage activation; neutrophils	3-KINASE GAMMA; SECRETION; INFLAMMATION; OBESITY; PHOSPHORYLATION; INHIBITION; P110-GAMMA; RESISTANCE; ELEVATION; BLOCKADE	PI3K gamma has emerged as a promising target for the treatment of obesity and insulin resistance; however, previous studies have indicated that PI3K gamma activity in pancreatic beta cells is required for normal insulin secretion in response to glucose. Hence, a possible deterioration of insulin secretion capacity in patients who are predisposed to the failure of pancreatic beta-cell function is a major concern for the pharmacologic inhibition of PI3K gamma. To address this issue, we investigated the effects of PI3K gamma ablation in db/db diabetic mice, a genetic model of obesity-driven beta-cell failure and diabetes. Mice that lacked PI3K gamma were backcrossed into db/+ mice C57BL/KS (>10 generations) to obtain db/db-PI3K gamma(-/-) mice. db/db-PI3K gamma(-/-) mice and control db/db mice were phenotyped for glucose homeostasis, insulin sensitivity, insulin secretion, steatosis, metabolic inflammation, pancreatic islet morphometry, islet cellular composition, and inflammation. Pancreatic beta-cell apoptosis and proliferation were also evaluated. db/db-PI3K gamma(-/-) mice and control db/db mice developed similar body weight, steatosis, glycemia, and insulin levels after a glucose load; however, db/db-PI3K gamma(-/-) mice displayed improved insulin tolerance, higher levels of fasting seruminsulin, and lower pancreatic insulin content. In db/db-PI3K gamma(-/-) mice, the number of adipose tissue macrophages was similar to control, but displayed reduced adipose tissue neutrophils and M2-polarized adipose tissue gene expression. Finally, db/db-PI3K gamma(-/-) mice have more pancreatic beta cells and larger islets than db/db mice, despite displaying similar islet inflammation. This phenotype could be explained by reduced beta-cell apoptosis in db/db-PI3K gamma(-/-) mice compared with control db/db mice. Our results are consistent with the concept that the beneficial action of PI3K gamma ablation in obesity-driven glucose intolerance is largely a result of its leptin-dependent effects on adiposity and, to a lesser extent, the promotion of adipose tissue neutrophil recruitment and M1 polarization of gene expression. Of importance, our data challenge the concept that PI3K gamma is required for insulin secretion in response to glucose in vivo, and indicate that PI3K gamma ablation protects db/db mice from beta-cell apoptosis and improves fasting insulin levels. We conclude that PI3K gamma inhibition in obese patients who are predisposed to beta-cell failure is not expected to produce adverse effects on insulin secretion.	[Breasson, Ludovic; Sardi, Claudia; Becattini, Barbara; Solinas, Giovanni] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Bruna Straket 16, S-41345 Gothenburg, Sweden; [Zani, Fabio] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland	University of Gothenburg; Beatson Institute	Solinas, G (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Bruna Straket 16, S-41345 Gothenburg, Sweden.	giovanni.solinas@wlab.gu.se	Solinas, Giovanni/R-4777-2019	Solinas, Giovanni/0000-0002-0140-2621; Breasson, Ludovic/0000-0003-2168-976X; Becattini, Barbara/0000-0002-1002-6891	Swedish Research Council [2014-3019]; Swedish Diabetes Foundation [DIA2014-069]; Novo Nordisk Foundation [NNF14OC0010919]; University of Gothenburg; European Foundation for the Study of Diabetes Diabetes and Cancer Research Programme; Swiss National Science Foundation [152998]; Swiss National Science Foundation Sinergia [154499]; Novo Nordisk Fonden [NNF14OC0010919] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Gothenburg; European Foundation for the Study of Diabetes Diabetes and Cancer Research Programme; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council (Grant 2014-3019), the Swedish Diabetes Foundation (Grant DIA2014-069), the Novo Nordisk Foundation (Grant NNF14OC0010919), a startup fund from the University of Gothenburg, the European Foundation for the Study of Diabetes Diabetes and Cancer Research Programme, the Swiss National Science Foundation project (Grant 152998), and the Swiss National Science Foundation Sinergia (Grant 154499; to G.S.). The authors declare no conflicts of interest.	Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Breasson L, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf2969; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Kolic J, 2016, MOL METAB, V5, P459, DOI 10.1016/j.molmet.2016.05.003; Kolic J, 2014, J BIOL CHEM, V289, P32109, DOI 10.1074/jbc.M114.577510; Lanuza-Masdeu J, 2013, DIABETES, V62, P2308, DOI 10.2337/db12-1097; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Lopez-Guadamillas E, 2016, AGING-US, V8, P2747, DOI 10.18632/aging.101075; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; Ortega-Molina A, 2015, CELL METAB, V21, P558, DOI 10.1016/j.cmet.2015.02.017; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Perino A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005485; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037	25	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					319	+		10.1096/fj.201700372RR	http://dx.doi.org/10.1096/fj.201700372RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904022				2022-12-26	WOS:000419172700029
J	Williams, JK; Shcherbakov, AA; Wang, J; Hong, M				Williams, Jonathan K.; Shcherbakov, Alexander A.; Wang, Jun; Hong, Mei			Protonation equilibria and pore-opening structure of the dual-histidine influenza B virus M2 transmembrane proton channel from solid-state NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A VIRUS; TRYPTOPHAN RESIDUE; CONDUCTION; MECHANISM; PROTEIN; CONFORMATION; SPECTROSCOPY; EXCHANGE; INHIBITION; RESONANCE	The influenza A and B viruses are the primary cause of seasonal flu epidemics. Common to both viruses is the M2 protein, a homotetrameric transmembrane proton channel that acidifies the virion after endocytosis. Although influenza A M2 (AM2) and B M2 (BM2) are functional analogs, they have little sequence homology, except for a conserved HXXXW motif, which is responsible for proton selectivity and channel gating. Importantly, BM2contains a second titratable histidine, His-27, in the tetrameric transmembrane domain that forms a reverse WXXXH motif with the gating tryptophan. To understand how His-27 affects the proton conduction property of BM2, we have used solid-state NMR to characterize the pH-dependent structure and dynamics of His-27. In cholesterol-containing lipid membranes mimicking the virus envelope, N-15 NMR spectra show that the His-27 tetrad protonates with higher pKa values than His-19, indicating that the solvent-accessible His-27 facilitates proton conduction of the channel by increasing the proton dissociation rates of His-19. AM2is inhibited by the amantadine class of antiviral drugs, whereas BM2 has no known inhibitors. Wemeasured the N-terminal interhelical separation of the BM2 channel using fluorinated Phe-5. The interhelical F-19-F-19 distances show a bimodal distribution of a short distance of 7 angstrom and a long distance of 15-20 angstrom, indicating that the phenylene rings do not block small-molecule entry into the channel pore. These results give insights into the lack of amantadine inhibition of BM2 and reveal structural diversities in this family of viral proton channels.	[Williams, Jonathan K.; Shcherbakov, Alexander A.; Hong, Mei] MIT, Dept Chem, 170 Albany St, Cambridge, MA 02139 USA; [Wang, Jun] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Williams, Jonathan K.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Massachusetts Institute of Technology (MIT); University of Arizona; Rutgers State University New Brunswick	Hong, M (corresponding author), MIT, Dept Chem, 170 Albany St, Cambridge, MA 02139 USA.	meihong@mit.edu	Wang, Jun/G-6504-2010; Williams, Jonathan/AAO-2040-2020	Wang, Jun/0000-0002-4845-4621; Hong, Mei/0000-0001-5255-5858; Shcherbakov, Alexander/0000-0002-5728-7175; Williams, Jonathan/0000-0002-7272-6885	National Institutes of Health [GM088204]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI119187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088204 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Andreas LB, 2015, J AM CHEM SOC, V137, P14877, DOI 10.1021/jacs.5b04802; Betakova T, 2006, ACTA VIROL, V50, P187; Cady SD, 2011, J AM CHEM SOC, V133, P4274, DOI 10.1021/ja102581n; deAzevedo ER, 1999, J AM CHEM SOC, V121, P8411, DOI 10.1021/ja992022v; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hong M, 1999, J MAGN RESON, V136, P86, DOI 10.1006/jmre.1998.1631; Hong M, 1998, J AM CHEM SOC, V120, P7113, DOI 10.1021/ja980775w; Hong M, 2012, PROTEIN SCI, V21, P1620, DOI 10.1002/pro.2158; Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Li SH, 2011, J AM CHEM SOC, V133, P1534, DOI 10.1021/ja108943n; Liao SY, 2015, J AM CHEM SOC, V137, P6067, DOI 10.1021/jacs.5b02510; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo W, 2006, J AM CHEM SOC, V128, P7242, DOI 10.1021/ja0603406; Ma CL, 2008, J BIOL CHEM, V283, P15921, DOI 10.1074/jbc.M710302200; Mandela VS, 2017, J MOL BIOL, V429, P2192, DOI 10.1016/j.jmb.2017.05.015; Mould JA, 2003, DEV CELL, V5, P175, DOI 10.1016/S1534-5807(03)00190-4; Otomo K, 2009, J BIOCHEM, V145, P543, DOI 10.1093/jb/mvp009; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Schmidt-Rohr K., 2007, EMAGRES, DOI [10.1002/9780470034590.emrstm0063, DOI 10.1002/9780470034590.EMRSTM0063]; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Thomaston JL, 2015, P NATL ACAD SCI USA, V112, P14260, DOI 10.1073/pnas.1518493112; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Williams JK, 2016, J AM CHEM SOC, V138, P8143, DOI 10.1021/jacs.6b03142; Williams JK, 2013, J AM CHEM SOC, V135, P9885, DOI 10.1021/ja4041412; Williams JK, 2013, BIOPHYS J, V104, P1698, DOI 10.1016/j.bpj.2013.02.054	33	20	20	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17876	17884		10.1074/jbc.M117.813998	http://dx.doi.org/10.1074/jbc.M117.813998			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893910	Green Published, hybrid			2022-12-26	WOS:000414013000023
J	Wang, XH; Marks, CR; Perfitt, TL; Nakagawa, T; Lee, A; Jacobson, DA; Colbran, RJ				Wang, Xiaohan; Marks, Christian R.; Perfitt, Tyler L.; Nakagawa, Terunaga; Lee, Amy; Jacobson, David A.; Colbran, Roger J.			A novel mechanism for Ca2+/calmodulin-dependent protein kinase II targeting to L-type Ca2+ channels that initiates long-range signaling to the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED GENE-EXPRESSION; CALCIUM-CHANNELS; BETA-SUBUNIT; CAM KINASE; SYNAPTIC-TRANSMISSION; CREB PHOSPHORYLATION; CALMODULIN; CA(V)1.3; BINDING; DISTINCT	Neuronal excitation can induce new mRNA transcription, a phenomenon called excitation-transcription (E-T) coupling. Among several pathways implicated in E-T coupling, activation of voltage-gated L-type Ca2+ channels (LTCCs) in the plasma membrane can initiate a signaling pathway that ultimately increases nuclear CREB phosphorylation and, in most cases, expression of immediate early genes. Initiation of this long-range pathway has been shown to require recruitment of Ca2+-sensitive enzymes to a nanodomain in the immediate vicinity of the LTCC by an unknown mechanism. Here, we show that activated Ca2+/calmodulin-dependent protein kinase II (CaMKII) strongly interacts with a novel binding motif in the N-terminal domain of Ca(V)1 LTCC alpha 1 subunitsthat is not conserved in Ca(V)2 or Ca(V)3 voltage-gated Ca2+ channel subunits. Mutations in the Ca(V)1.3 alpha 1 subunit N-terminal domain or in the CaMKII catalytic domain that largely prevent the in vitrointeraction also disrupt CaMKII association with intact LTCC complexes isolated by immunoprecipitation. Furthermore, these same mutations interfere with E-T coupling in cultured hippocampal neurons. Taken together, our findings define a novel molecular interaction with the neuronal LTCC that is required for the initiation of a long-range signal to the nucleus that is critical for learning and memory.	[Wang, Xiaohan; Nakagawa, Terunaga; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Marks, Christian R.; Perfitt, Tyler L.; Nakagawa, Terunaga; Jacobson, David A.; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Iowa; University of Iowa; University of Iowa	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Rm 702 Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Wang, Xiaohan/V-3920-2019	Colbran, Roger/0000-0001-7401-8244; Wang, Xiaohan/0000-0001-7895-2333; Perfitt, Tyler/0000-0002-2381-3341; Lee, Amy/0000-0001-8021-0443; Jacobson, David A./0000-0003-1816-5375	National Institutes of Health [CA68485, DK20593, DK58404, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543, U54HD083211] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK058404, R01DK097392, P30DK020593, U2CDK059637, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH109196, R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078291, R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Kevin P.M. Currie for helpful discussions, Nicholas C. Vierra for help with whole-cell patch clamp, Keeley Spiess for assistance with Ca<SUP>2+</SUP> imaging, and Elena I. Zaika for assistance with rat hippocampal neuron cultures. We also thank Diane Lipscombe, William Thiel, Gerald W. Zamponi, Aaron Fox, Edward Perez-Reyes, Winship Herr, and Luk Van Parijs for providing various plasmids, as detailed throughout. Confocal imaging and analysis were performed in part through the use of the Vanderbilt Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Baucum AJ, 2015, ACS CHEM NEUROSCI, V6, P615, DOI 10.1021/cn500337u; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Cohen SM, 2016, NEURON, V90, P292, DOI 10.1016/j.neuron.2016.03.001; Cohen SM, 2015, BIOCHEM BIOPH RES CO, V460, P88, DOI 10.1016/j.bbrc.2015.02.146; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; Hetzenauer A, 2006, NEUROSCIENCE, V139, P1005, DOI 10.1016/j.neuroscience.2006.01.059; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; Jin DZ, 2013, J NEUROSCI, V33, P3402, DOI 10.1523/JNEUROSCI.3192-12.2013; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Li BX, 2016, SCIENCE, V351, P863, DOI 10.1126/science.aad3647; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Ludwig A, 1997, J NEUROSCI, V17, P1339; Ma HK, 2014, P IEEE SEMICOND THER, P159, DOI 10.1109/SEMI-THERM.2014.6892233; Ma H, 2013, BIOSCIENCE REP, V33, P97, DOI 10.1042/BSR20120099; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Sala C, 2003, J NEUROSCI, V23, P6327; Simms BA, 2015, PFLUG ARCH EUR J PHY, V467, P677, DOI 10.1007/s00424-014-1538-7; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Stephenson JR, 2017, J NEUROSCI, V37, P2216, DOI 10.1523/JNEUROSCI.2068-16.2017; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	52	16	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17324	17336		10.1074/jbc.M117.788331	http://dx.doi.org/10.1074/jbc.M117.788331			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28916724	Green Published, hybrid			2022-12-26	WOS:000414009300015
J	Hara, K; Hamada, C; Wakabayashi, K; Kanda, R; Kaneko, K; Horikoshi, S; Tomino, Y; Suzuki, Y				Hara, Kazuaki; Hamada, Chieko; Wakabayashi, Keiichi; Kanda, Reo; Kaneko, Kayo; Horikoshi, Satoshi; Tomino, Yasuhiko; Suzuki, Yusuke			Scavenging of reactive oxygen species by astaxanthin inhibits epithelial-mesenchymal transition in high glucose-stimulated mesothelial cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; PERITONEAL-DIALYSIS; TRANSGENIC RATS; FACTOR-BETA; IN-VITRO; INFLAMMATION; MEMBRANE; ESTABLISHMENT	Background High glucose concentrations influence the functional and structural development of the peritoneal membrane. We previously reported that the oral administration of astaxanthin (AST) suppressed peritoneal fibrosis (PF) as well as inhibited oxidative stress, inflammation, and epithelial-mesenchymal transition (EMT) of peritoneal mesothelial cells (PMCs) in a chlorhexidine-induced PF rat model. This suggests that oxidative stress induction of EMT is a key event during peritoneal damage. The present study evaluated the therapeutic effect of AST in suppressing EMT, in response to glucose-induced oxidative stress. Methods Temperature-sensitive mesothelial cells (TSMCs) were cultured in the presence or absence of AST and then treated with 140 mM glucose for 3 or 12 hours. Expression levels of TNF-alpha, TGF-alpha, and VEGF were determined at the mRNA and protein levels, and nuclear factor kappa B (NF-kappa B) activity was evaluated. We measured NO2-/NO3- concentrations in cellular supernatants and determined 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in mitochondrial and nuclear DNA. The expressions of E-cadherin and alpha-smooth muscle actin (alpha-SMA) were evaluated by double immunofluorescence and protein levels. Results High glucose concentrations induced overproduction of reactive oxidative species (ROS), increasing 8-OHdG mitochondrial DNA and cytokine levels. The NF-kappa B pathway was activated in response to high glucose concentrations, whereas de novo a-SMA expression was observed with decreased E-cadherin expression. AST treatment attenuated ROS production, inflammatory cytokine production, NF-kappa B activation, and EMT. Conclusion The findings of the present study indicate that AST may have an anti-EMT effect due to anti-oxidative and anti-inflammatory activities by scavenging glucose-induced ROS from mitochondria in PMCs. AST may be an efficacious treatment for PF.	[Hara, Kazuaki; Hamada, Chieko; Wakabayashi, Keiichi; Kanda, Reo; Kaneko, Kayo; Horikoshi, Satoshi; Tomino, Yasuhiko; Suzuki, Yusuke] Juntendo Univ, Fac Med, Dept Nephrol, Bunkyo Ku, Tokyo, Japan; [Kanda, Reo; Tomino, Yasuhiko] Ikegami Gen Hosp, Tokyo, Japan	Juntendo University	Hamada, C (corresponding author), Juntendo Univ, Fac Med, Dept Nephrol, Bunkyo Ku, Tokyo, Japan.	chieko@juntendo.ac.jp			Japan Society for Promotion of Science KAKENHI [26461260]; Medical Corporation SHOWAKAI	Japan Society for Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Corporation SHOWAKAI	This work was supported by the Japan Society for Promotion of Science KAKENHI (Grant Number 26461260). Medical Corporation SHOWAKAI provided support in the form of salaries for authors RK and YT. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Bhuvaneswari S, 2014, CELL STRESS CHAPERON, V19, P183, DOI 10.1007/s12192-013-0443-x; Byun J, 1999, FEBS LETT, V455, P243, DOI 10.1016/S0014-5793(99)00893-5; Ciszewicz M, 2011, INT J ARTIF ORGANS, V34, P489, DOI 10.5301/IJAO.2011.8467; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Ding Y, 2007, J LEUKOCYTE BIOL, V81, P520, DOI 10.1189/jlb.0406262; Fassett RG, 2011, MAR DRUGS, V9, P447, DOI 10.3390/md9030447; Ferrier ML, 2001, KIDNEY INT, V60, P2343, DOI 10.1046/j.1523-1755.2001.00050.x; Fukawa T, 2012, EXP CELL RES, V318, P1926, DOI 10.1016/j.yexcr.2012.05.023; Guerra BA, 2012, DIABETES RES CLIN PR, V98, P108, DOI 10.1016/j.diabres.2012.07.004; Ha H, 2005, NEPHROLOGY, V10, pS7, DOI 10.1111/j.1440-1797.2005.00448.x; Hamada C, 2015, J ARTIF ORGANS, V18, P243, DOI 10.1007/s10047-015-0822-4; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Hotta Y, 2010, NEPHROL DIAL TRANSPL, V25, P1825, DOI 10.1093/ndt/gfp742; Hsu CC, 2005, J DIABETES COMPLICAT, V19, P96, DOI 10.1016/j.jdiacomp.2004.06.004; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; Kanda R, 2014, NEPHROL DIAL TRANSPL, V29, P289, DOI 10.1093/ndt/gft397; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; Kishimoto Y, 2010, EUR J NUTR, V49, P119, DOI 10.1007/s00394-009-0056-4; Kozuki Y, 2000, CANCER LETT, V151, P111, DOI 10.1016/S0304-3835(99)00418-8; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Liu XX, 2014, CHIN J INTEGR MED, V20, P667, DOI 10.1007/s11655-012-1176-x; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; MIKI W, 1991, PURE APPL CHEM, V63, P141, DOI 10.1351/pac199163010141; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; Satoh A, 2009, J CLIN BIOCHEM NUTR, V44, P280, DOI 10.3164/jcbn.08-238; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwenger V, 2006, J AM SOC NEPHROL, V17, P199, DOI 10.1681/ASN.2005020155; Seo MJ, 2001, PERITON DIALYSIS INT, V21, pS35; Szeto CC, 2002, PERITON DIALYSIS INT, V22, P265; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takahashi R, 1999, EXP ANIM TOKYO, V48, P255, DOI 10.1538/expanim.48.255; Uchiyama K, 2002, REDOX REP, V7, P290, DOI 10.1179/135100002125000811; Wakabayashi K, 2015, PERITON DIALYSIS INT, V35, P506, DOI 10.3747/pdi.2013.00317; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; ZEMEL D, 1994, KIDNEY INT, V46, P1422, DOI 10.1038/ki.1994.414; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	42	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184332	10.1371/journal.pone.0184332	http://dx.doi.org/10.1371/journal.pone.0184332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926603	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600015
J	Bentley, SJ; Boshoff, A				Bentley, Stephen J.; Boshoff, Aileen			Hsp70/J-protein machinery from Glossina morsitans morsitans, vector of African trypanosomiasis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; EXTENDS LIFE-SPAN; ER DNAJ HOMOLOG; ENDOPLASMIC-RETICULUM; DROSOPHILA-MELANOGASTER; TSETSE-FLIES; MOLECULAR CHAPERONES; MEMBRANE ASSOCIATION; SLEEPING SICKNESS; HSP70 CHAPERONES	Tsetse flies (Glossina spp.) are the sole vectors of the protozoan parasites of the genus Trypanosoma, the causative agents of African Trypanosomiasis. Species of Glossina differ in vector competence and Glossina morsitans morsitans is associated with transmission of Trypanosoma brucei rhodesiense, which causes an acute and often fatal form of African Trypanosomiasis. Heat shock proteins are evolutionarily conserved proteins that play critical roles in proteostasis. The activity of heat shock protein 70 (Hsp70) is regulated by interactions with its J-protein (Hsp40) co-chaperones. Inhibition of these interactions are emerging as potential therapeutic targets. The assembly and annotation of the G. m. morsitans genome provided a platform to identify and characterize the Hsp70s and J-proteins, and carry out an evolutionary comparison to its well-studied eukaryotic counterparts, Drosophila melanogaster and Homo sapiens, as well as Stomoxys calcitrans, a comparator species. In our study, we identified 9 putative Hsp70 proteins and 37 putative J-proteins in G. m. morsitans. Phylogenetic analyses revealed three evolutionarily distinct groups of Hsp70s, with a closer relationship to orthologues from its blood-feeding dipteran relative Stomoxys calcitrans. G. m. morsitans also lacked the high number of heat inducible Hsp70s found in D. melanogaster. The potential localisations, functions, domain organisations and Hsp70/J-protein partnerships were also identified. A greater understanding of the heat shock 70 (Hsp70) and J-protein (Hsp40) families in G. m. morsitans could enhance our understanding of the cell biology of the tsetse fly.	[Bentley, Stephen J.; Boshoff, Aileen] Rhodes Univ, Biotechnol Innovat Ctr, Grahamstown, South Africa	Rhodes University	Boshoff, A (corresponding author), Rhodes Univ, Biotechnol Innovat Ctr, Grahamstown, South Africa.	A.Boshoff@ru.ac.za			National Research Foundation (NRF) [87663]; NRF	National Research Foundation (NRF); NRF	This work was funded by a grant from the National Research Foundation (NRF); grant number 87663. S.J.B. is the recipient of an NRF Doctoral Innovation Scholarship.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ahrendt E, 2010, CHANNELS, V4, P335, DOI 10.4161/chan.4.5.13090; Aksoy S, 2003, VET PARASITOL, V115, P125, DOI 10.1016/S0304-4017(03)00203-6; Alsan M, 2015, AM ECON REV, V105, P382, DOI 10.1257/aer.20130604; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Benoit JB, 2015, ANNU REV ENTOMOL, V60, P351, DOI 10.1146/annurev-ento-010814-020834; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Burgoyne RD, 2015, SEMIN CELL DEV BIOL, V40, P153, DOI 10.1016/j.semcdb.2015.03.008; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Choi J, 2014, CELL STRESS CHAPERON, V19, P439, DOI 10.1007/s12192-013-0471-6; Christoffels A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003024; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colinet H, 2013, INSECT BIOCHEM MOLEC, V43, P352, DOI 10.1016/j.ibmb.2013.01.006; CRAIG EA, 1983, DEV BIOL, V99, P418, DOI 10.1016/0012-1606(83)90291-9; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Feder ME, 1998, AM ZOOL, V38, P503; Fitzsimons HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083903; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Fogg PCM, 2014, J BIOL CHEM, V289, P34341, DOI 10.1074/jbc.M114.606392; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Girard M, 2008, FEBS LETT, V582, P961, DOI 10.1016/j.febslet.2008.02.042; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Gooding RH, 2005, ANNU REV ENTOMOL, V50, P101, DOI 10.1146/annurev.ento.50.071803.130443; Goodman AG, 2011, VIROLOGY, V417, P27, DOI 10.1016/j.virol.2011.04.020; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Han CF, 2007, BIOCHEM BIOPH RES CO, V353, P280, DOI 10.1016/j.bbrc.2006.12.013; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu C, 2012, PLANT PHYSIOL, V158, P747, DOI 10.1104/pp.111.187674; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Iliopoulos I, 1997, BIOL CHEM, V378, P1177; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P525, DOI 10.1073/pnas.79.2.525; Iosefson O, 2012, CELL STRESS CHAPERON, V17, P57, DOI 10.1007/s12192-011-0285-3; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kaschner LA, 2015, BBA-MOL CELL RES, V1853, P1035, DOI 10.1016/j.bbamcr.2015.01.014; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Krafsur ES, 2009, INFECT GENET EVOL, V9, P124, DOI 10.1016/j.meegid.2008.09.010; Kroczynska B, 2004, J BIOL CHEM, V279, P11432, DOI 10.1074/jbc.M310903200; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuo Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.351; KURZIKDUMKE U, 1995, DEV GENET, V16, P64, DOI 10.1002/dvg.1020160110; Lakhotia SC, 2002, J EXP BIOL, V205, P345; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Li WN, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0038-5; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lindquist S., 1993, TRANSLATIONAL REGULA; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Lo JF, 2004, MOL CELL BIOL, V24, P2226, DOI 10.1128/MCB.24.6.2226-2236.2004; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Matetovici I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3283-0; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McAlpine JF, 1989, MONOGRAPH, V3, P1397; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nikolaidis N, 2004, MOL BIOL EVOL, V21, P498, DOI 10.1093/molbev/msh041; Niu G, 2015, J BIOL CHEM, V290, P18102, DOI 10.1074/jbc.M115.665950; Odiit M, 1997, E AFR MED J, V74, P792; Oka SI, 2009, J MOL MED, V87, P785, DOI 10.1007/s00109-009-0471-2; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rampelt H, 2011, METHODS MOL BIOL, V787, P83, DOI 10.1007/978-1-61779-295-3_7; Rogers David J., 2004, P139, DOI 10.1079/9780851994758.0139; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Severson DW, 2004, INSECT BIOCHEM MOLEC, V34, P715, DOI 10.1016/j.ibmb.2004.03.024; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Skowronek MH, 1999, BIOL CHEM, V380, P1133, DOI 10.1515/BC.1999.142; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Stetina T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128976; Stocker AJ, 2012, G3-GENES GENOM GENET, V2, P287, DOI 10.1534/g3.111.001354; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Watanabe J, 2014, SCIENCE, V344, P380, DOI 10.1126/science.1249656; Waterhouse RM, 2008, INSECT MOL BIOL, V17, P1, DOI 10.1111/j.1365-2583.2008.00772.x; Welburn SC, 2009, PARASITOLOGY, V136, P1943, DOI 10.1017/S0031182009006416; Whitaker R, 2013, AGING-US, V5, P682, DOI 10.18632/aging.100599; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yu HY, 2015, FEBS LETT, V589, P2825, DOI 10.1016/j.febslet.2015.07.040; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; ZHU JK, 1993, P NATL ACAD SCI USA, V90, P8557, DOI 10.1073/pnas.90.18.8557	133	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183858	10.1371/journal.pone.0183858	http://dx.doi.org/10.1371/journal.pone.0183858			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902917	Green Submitted, Green Published, gold			2022-12-26	WOS:000410669200021
J	Cai, NL; Lau, ATY; Yu, FY; Wu, DD; Dai, LJ; Mo, HY; Lin, CM; Xu, YM				Cai, Na-Li; Lau, Andy T. Y.; Yu, Fei-Yuan; Wu, Dan-Dan; Dai, Li-Juan; Mo, Hai-Ying; Lin, Chang-Min; Xu, Yan-Ming			Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer	PLOS ONE			English	Article							PROTEIN MAP KINASE; ERK8; PHOSPHORYLATION; ACTIVATION	Extracellular signal-regulated kinase 8 (ERK8), proposed as a novel potential therapeutic target for cancer, has been implicated in cell transformation, apoptosis, the protection of genomic integrity, and autophagy. To facilitate ERK8 research, a highly specific anti-ERK8 antibody is needed. In this article, we use the Immune Epitope Database and Analysis Resource online tool to predict B-cell epitopes of human ERK8 protein, and choose a 28 aa-peptide sequence to generate the GST-ERK8(28aa) fusion protein as the antigen for developing polyclonal antibody against ERK8. The specificity and sensitivity of anti-ERK8 antibody were robustly validated by immunoblotting, immunocytochemical and immunohistochemical analyses; and we found that both the endogenous and ectopically-expressed human ERK8 proteins can be recognized by our anti-ERK8 antibody. This suggested that our characterized anti-ERK8 antibody will be a valuable tool for the elucidation of the distribution of ERK8 at cellular and histological levels. Finally, our tissue array analysis also demonstrated that the ERK8 protein was localized in both the nucleus and cytoplasm of human lung cancers.	[Cai, Na-Li; Lau, Andy T. Y.; Yu, Fei-Yuan; Wu, Dan-Dan; Dai, Li-Juan; Mo, Hai-Ying; Xu, Yan-Ming] Shantou Univ, Med Coll, Dept Cell Biol & Genet, Lab Canc Biol & Epigenet, Shantou, Guangdong, Peoples R China; [Lin, Chang-Min] Shantou Univ, Med Coll, Dept Histol & Embryol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Xu, YM (corresponding author), Shantou Univ, Med Coll, Dept Cell Biol & Genet, Lab Canc Biol & Epigenet, Shantou, Guangdong, Peoples R China.	amyymxu@stu.edu.cn	Lau, Andy Tao Yin/AAX-9980-2021	Lau, Andy Tao Yin/0000-0002-7146-7789; Xu, Yan-Ming/0000-0003-1124-0045; Wu, Dan-Dan/0000-0002-8515-2614	National Natural Science Foundation of China [31271445, 31771582]; Science and Technology Planning Project of Guangdong Province of China [2016A020215144]; Guangdong Natural Science Foundation of China [2017A030313131, S2012030006289]; "Thousand, hundred, and ten" project of The Department of Education of Guangdong Province [124]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province of China; Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); "Thousand, hundred, and ten" project of The Department of Education of Guangdong Province; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	This work was supported by the grants from the National Natural Science Foundation of China (Nos. 31271445 and 31771582), the Science and Technology Planning Project of Guangdong Province of China (No. 2016A020215144), the Guangdong Natural Science Foundation of China (Nos. 2017A030313131 and S2012030006289), "Thousand, hundred, and ten" project of The Department of Education of Guangdong Province (No.124), and the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Cerone MA, 2011, CANCER RES, V71, P3328, DOI 10.1158/0008-5472.CAN-10-2734; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; Saelzler MP, 2006, J BIOL CHEM, V281, P16821, DOI 10.1074/jbc.M512418200; Wu DD, 2017, ONCOTARGET; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306	15	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184755	10.1371/journal.pone.0184755	http://dx.doi.org/10.1371/journal.pone.0184755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902877	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200062
J	Keating, SM; Dodge, JL; Norris, PJ; Heitman, J; Gange, SJ; French, AL; Glesby, MJ; Edlin, BR; Latham, PS; Villacres, MC; Greenblatt, RM; Peters, MG				Keating, Sheila M.; Dodge, Jennifer L.; Norris, Philip J.; Heitman, John; Gange, Stephen J.; French, Audrey L.; Glesby, Marshall J.; Edlin, Brian R.; Latham, Patricia S.; Villacres, Maria C.; Greenblatt, Ruth M.; Peters, Marion G.		Women's Interagency HIV Study	The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLE NONINVASIVE INDEX; C-VIRUS; LIVER FIBROSIS; T-LYMPHOCYTES; CHEMOKINES; PERSISTENCE; DISEASE; RECRUITMENT; MORTALITY	Hepatitis C virus infection induces inflammation and while it is believed that HIV co-infection enhances this response, HIV control may reduce inflammation and liver fibrosis in resolved or viremic HCV infection. Measurement of systemic biomarkers in co-infection could help define the mechanism of inflammation on fibrosis and determine if HIV control reduces liver pathology. A nested case-control study was performed to explore the relationship of systemic biomarkers of inflammation with liver fibrosis in HCV viremic and/or seropositive women with and without HIV infection. Serum cytokines, chemokines, growth factors and cell adhesion molecules were measured in HIV uninfected (HIV-, n = 18), ART-treated HIVcontrolled (ARTc, n = 20), uncontrolled on anti-retroviral therapy (ARTuc, n = 21) and elite HIV controllers (Elite, n = 20). All were HCV seroreactive and had either resolved (HCV RNA-; <50IU/mL) or had chronic HCV infection (HCV RNA+). In HCV and HIV groups, aspartate aminotransferase to platelet ratio (APRI) was measured and compared to serum cytokines, chemokines, growth factors and cell adhesion molecules. APRI correlated with sVCAM, sICAM, IL-10, and IP-10 levels and inversely correlated with EGF, IL-17, TGF-alpha and MMP-9 levels. Collectively, all HCV RNA+ subjects had higher sVCAM, sICAM and IP-10 compared to HCV RNA-. In the ART-treated HCV RNA+ groups, TNF-alpha, GRO, IP-10, MCP-1 and MDC were higher than HIV-, Elite or both. In ARTuc, FGF-2, MPO, soluble Eselectin, MMP-9, IL-17, GM-CSF and TGF-alpha are lower than HIV-, Elite or both. Differential expression of soluble markers may reveal mechanisms of pathogenesis or possibly reduction of fibrosis in HCV/HIV co-infection.	[Keating, Sheila M.; Norris, Philip J.; Heitman, John] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Keating, Sheila M.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Dodge, Jennifer L.] UCSF, Dept Surg, San Francisco, CA USA; [Norris, Philip J.; Peters, Marion G.] UCSF, Dept Med, San Francisco, CA USA; [Gange, Stephen J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [French, Audrey L.] John H Stroger Jr Hosp Cook Cty, CORE Ctr, Chicago, IL USA; [Glesby, Marshall J.; Edlin, Brian R.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY USA; [Edlin, Brian R.] SUNY Downstate, Dept Med, Brooklyn, NY USA; [Latham, Patricia S.] George Washington Univ, Med Ctr, Dept Pathol & Med, Washington, DC 20037 USA; [Villacres, Maria C.] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; George Washington University; University of Southern California; University of California System; University of California San Francisco	Keating, SM (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.; Keating, SM (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	skeating@bloodsystems.org	Dodge, Jennifer/AAY-2530-2020; Edlin, Brian R/F-2966-2018; Gange, Stephen/AGY-5004-2022	Edlin, Brian R/0000-0001-8172-8797; Gange, Stephen/0000-0001-7842-512X; Keating, Sheila/0000-0002-8324-3694	National Institutes of Health; UCSF Liver Center [P30 DK026743]; National Institute of Allergy and Infectious Diseases [U01-A1-35004, U01-Al 31834, U01-A1-34994, U01-A1-34989, U01-Al 34993, U01-A1-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI031834, U01AI034993, U01AI034994, P30AI027763, U01AI035004, U01AI042590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Liver Center; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health provided funding to establish the Chicago Early HIV Infection Study. This work was also supported by the Biostatistics Core of the UCSF Liver Center (P30 DK026743). Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange, Elizabeth Golub). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (U01-A1-35004, U01-Al 31834, U01-A1-34994, U01-A1-34989, U01-Al 34993, and U01-A1-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Aldamiz-Echevarria T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148537; Almodovar S, 2014, VIRAL IMMUNOL, V27, P186, DOI 10.1089/vim.2013.0130; Ansari AWW, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0341-8; Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bone-Larson CL, 2000, IMMUNOL REV, V177, P8, DOI 10.1034/j.1600-065X.2000.17703.x; Borchers AT, 2009, SEMIN IMMUNOPATHOL, V31, P309, DOI 10.1007/s00281-009-0167-2; CDC, 2013, HIV VIR HEP; Emu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085613; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; de Castro IF, 2010, AIDS, V24, P2059, DOI 10.1097/QAD.0b013e32833ce54d; Folgori A, 2006, GUT, V55, P1012, DOI 10.1136/gut.2005.080077; Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Harcourt G, 2006, GUT, V55, DOI 10.1136/gut.2005.083758; Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010; Hillan KJ, 1999, LIVER, V19, P509, DOI 10.1111/j.1478-3231.1999.tb00084.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Huang GC, 2012, LAB INVEST, V92, P703, DOI 10.1038/labinvest.2012.3; Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Keating SM, 2012, CYTOKINE GROWTH F R, V23, P193, DOI 10.1016/j.cytogfr.2012.05.006; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744; Konishi H, 2013, HEPATOL RES; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Larrubia JR, 2008, WORLD J GASTROENTERO, V14, P7149, DOI 10.3748/wjg.14.7149; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Ohyama T, 2011, LIVER INT, V31, P572, DOI 10.1111/j.1478-3231.2011.02475.x; Osburn WO, 2013, J VIRAL HEPATITIS, V20, P404, DOI 10.1111/jvh.12052; Peters L, 2014, J CLIN VIROL, V60, P295, DOI 10.1016/j.jcv.2014.03.017; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Preisser L, 2014, HEPATOLOGY, V60, P1879, DOI 10.1002/hep.27328; Reiberger T, 2008, ANTIVIR THER, V13, P969; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shields PL, 1999, J IMMUNOL, V163, P6236; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Takemura T, 2013, BIOCHEM BIOPH RES CO, V437, P185, DOI 10.1016/j.bbrc.2013.05.097; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tural C, 2009, CLIN GASTROENTEROL H, V7, P339, DOI 10.1016/j.cgh.2008.11.019; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821; Williams SK, 2014, J VIRAL HEPATITIS, V21, P251, DOI 10.1111/jvh.12141; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0181004	10.1371/journal.pone.0181004	http://dx.doi.org/10.1371/journal.pone.0181004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902848	gold, Green Submitted, Green Published			2022-12-26	WOS:000410669200002
J	Morishita, T; Hilliard, JD; Okun, MS; Neal, D; Nestor, KA; Peace, D; Hozouri, AA; Davidson, MR; Bova, FJ; Sporrer, JM; Oyama, G; Foote, KD				Morishita, Takashi; Hilliard, Justin D.; Okun, Michael S.; Neal, Dan; Nestor, Kelsey A.; Peace, David; Hozouri, Alden A.; Davidson, Mark R.; Bova, Francis J.; Sporrer, Justin M.; Oyama, Genko; Foote, Kelly D.			Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact	PLOS ONE			English	Article							HARDWARE-RELATED COMPLICATIONS; MOVEMENT; TERM; DIFFERENTIATION; DISPLACEMENT; DYSTONIA; NUCLEUS; DISEASE	Introduction Deep brain stimulation (DBS) is an effective treatment for multiple movement disorders and shows substantial promise for the treatment of some neuropsychiatric and other disorders of brain neurocircuitry. Optimal neuroanatomical lead position is a critical determinant of clinical outcomes in DBS surgery. Lead migration, defined as an unintended post-operative displacement of the DBS lead, has been previously reported. Despite several reports, however, there have been no systematic investigations of this issue. This study aimed to: 1) quantify the incidence of lead migration in a large series of DBS patients, 2) identify potential risk factors contributing to DBS lead migration, and 3) investigate the practical importance of this complication by correlating its occurrence with clinical outcomes. Methods A database of all DBS procedures performed at UF was queried for patients who had undergone multiple post-operative DBS lead localization imaging studies separated by at least two months. Bilateral DBS implantation has commonly been performed as a staged procedure at UF, with an interval of six or more months between sides. To localize the position of each DBS lead, a head CT is acquired -4 weeks after lead implantation and fused to the pre-operative targeting MRI. The fused targeting images (MR + stereotactic CT) acquired in preparation for the delayed second side lead implantation provide an opportunity to repeat the localization of the first implanted lead. This paradigm offers an ideal patient population for the study of delayed DBS lead migration because it provides a large cohort of patients with localization of the same implanted DBS lead at two time points. The position of the tip of each implanted DBS lead was measured on both the initial post-operative lead localization CT and the delayed CT. Lead tip displacement, intracranial lead length, and ventricular indices were collected and analyzed. Clinical outcomes were characterized with validated rating scales for all cases, and a comparison was made between outcomes of cases with lead migration versus those where migration of the lead did not occur. Results Data from 138 leads in 132 patients with initial and delayed lead localization CT scans were analyzed. The mean distance between initial and delayed DBS lead tip position was 2.2 mm and the mean change in intracranial lead length was 0.45 mm. Significant delayed migration (>3 mm) was observed in 17 leads in 16 patients (12.3% of leads, 12.1% of patients). Factors associated with lead migration were: technical error, repetitive dystonic head movement, and twiddler's syndrome. Outcomes were worse in dystonia patients with lead migration (p = 0.035). In the PD group, worse clinical outcomes trended in cases with lead migration. Conclusions Over 10% of DBS leads in this large single center cohort were displaced by greater than 3 mm on delayed measurement, adversely affecting outcomes. Multiple risk factors emerged, including technical error during implantation of the DBS pulse generator and failure of lead fixation at the burr hole site. We hypothesize that a change in surgical technique and a more effective lead fixation device might mitigate this problem.	[Morishita, Takashi] Fukuoka Univ, Dept Neurosurg, Fukuoka, Japan; [Hilliard, Justin D.; Neal, Dan; Peace, David; Hozouri, Alden A.; Bova, Francis J.; Sporrer, Justin M.; Foote, Kelly D.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Okun, Michael S.; Nestor, Kelsey A.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Davidson, Mark R.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Oyama, Genko] Juntendo Univ, Dept Neurol, Tokyo, Japan	Fukuoka University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Juntendo University	Foote, KD (corresponding author), Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA.	foote@neurosurgery.ufl.edu		Foote, Kelly/0000-0002-2436-4138	Center of Excellence Grant - National Parkinson Foundation; Tyler's Hope for a Dystonia Cure; Bahmann-Strauss Dystonia Parkinson Foundation; St. Luke's Life Science Institute of Japan; Japan Society for Promotion of Science; National Parkinson Foundation	Center of Excellence Grant - National Parkinson Foundation; Tyler's Hope for a Dystonia Cure; Bahmann-Strauss Dystonia Parkinson Foundation; St. Luke's Life Science Institute of Japan; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Parkinson Foundation	This study was supported by the Center of Excellence Grant - National Parkinson Foundation; Tyler's Hope for a Dystonia Cure; Bahmann-Strauss Dystonia Parkinson Foundation; St. Luke's Life Science Institute of Japan (https://cce.luke.ac.jp/subsidy/history/pdf/kako_josei2011.pdf); and Japan Society for Promotion of Science (#17, https://www/jsps.go.jp/j-ab/data/list/h25/08.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Center of Excellence grant from the National Parkinson Foundation, by Tyler's Hope for a Dystonia Cure, by Bachmann-Strauss Dystonia Parkinson Foundation, by a Grant-in Aid for Clinical Research from St. Luke's Life Science Institute of Japan and by a grant from Japan Society for Promotion of Science.	Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Beric A, 2001, STEREOT FUNCT NEUROS, V77, P73, DOI 10.1159/000064600; Blomstedt P, 2005, ACTA NEUROCHIR, V147, P1061, DOI 10.1007/s00701-005-0576-5; Boviatsis EJ, 2010, ACTA NEUROCHIR, V152, P2053, DOI 10.1007/s00701-010-0749-8; Burdick AP, 2010, STEREOT FUNCT NEUROS, V88, P353, DOI 10.1159/000319039; Carvallo JFB, 2012, STEREOT FUNCT NEUROS, V90, P300, DOI 10.1159/000338222; Chan DTM, 2009, ASIAN J SURG, V32, P258, DOI 10.1016/S1015-9584(09)60404-8; Constantoyannis C, 2005, CAN J NEUROL SCI, V32, P194, DOI 10.1017/S0317167100003966; Contarino MF, 2013, NEUROSURGERY, V73, P681, DOI 10.1227/NEU.0000000000000079; Doshi PK, 2011, STEREOT FUNCT NEUROS, V89, P89, DOI 10.1159/000323372; Ellis TM, 2008, NEUROSURGERY, V63, P754, DOI 10.1227/01.NEU.0000325492.58799.35; Falowski S, 2012, STEREOT FUNCT NEUROS, V90, P173, DOI 10.1159/000338254; Gelabert-Gonzalez M, 2010, ACTA NEUROCHIR, V152, P489, DOI 10.1007/s00701-009-0366-6; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; GYLDENSTED C, 1977, NEURORADIOLOGY, V14, P183, DOI 10.1007/BF00496982; Joint C, 2002, MOVEMENT DISORD, V17, pS175, DOI 10.1002/mds.10161; Kenney C, 2007, J NEUROSURG, V106, P621, DOI 10.3171/jns.2007.106.4.621; Kondziolka D, 2002, STEREOT FUNCT NEUROS, V79, P228, DOI 10.1159/000070836; Lyons KE, 2004, NEUROLOGY, V63, P612, DOI 10.1212/01.WNL.0000134650.91974.1A; Morishita T, 2010, PARKINSONISM RELAT D, V16, P153, DOI 10.1016/j.parkreldis.2009.10.003; Morishita T, 2010, J NEUROSURG, V112, P491, DOI 10.3171/2009.7.JNS09150; Morishita T, 2010, NAT REV NEUROL, V6, P52, DOI 10.1038/nrneurol.2009.195; Obuchi T, 2008, NEUROMODULATION, V11, P302, DOI 10.1111/j.1525-1403.2008.00180.x; Oh MY, 2002, NEUROSURGERY, V50, P1268; Okun MS, 2008, PARKINSONISM RELAT D, V14, P532, DOI 10.1016/j.parkreldis.2008.01.001; Okun MS, 2013, JAMA NEUROL, V70, P85, DOI 10.1001/jamaneurol.2013.580; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Ostrem JL, 2008, NEUROTHERAPEUTICS, V5, P320, DOI 10.1016/j.nurt.2008.01.002; Patel NV, 2012, J CLIN NEUROSCI, V19, P1715, DOI 10.1016/j.jocn.2012.02.017; Sudhyadhom Atchar, 2012, Open Neuroimag J, V6, P92, DOI 10.2174/1874440001206010092; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Toma AK, 2011, NEUROSURGERY, V68, P939, DOI 10.1227/NEU.0b013e318208f5e0; Uitti RJ, 2002, NEUROSURGERY, V51, P1423, DOI 10.1097/00006123-200212000-00012; van den Munckhof P, 2010, NEUROSURGERY, V67, P49, DOI 10.1227/01.NEU.0000370597.44524.6D; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Yianni J, 2004, J CLIN NEUROSCI, V11, P243, DOI 10.1016/j.jocn.2003.10.003	37	45	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e183711	10.1371/journal.pone.0183711	http://dx.doi.org/10.1371/journal.pone.0183711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902876	gold, Green Submitted, Green Published			2022-12-26	WOS:000410669200015
J	El-Hamoly, T; El-Sharawy, DM; El Refaye, MS; Abd El-Rahman, SS				El-Hamoly, Tarek; El-Sharawy, Dina M.; El Refaye, Marwa S.; Abd El-Rahman, Sahar S.			L-thyroxine modifies nephrotoxicity by regulating the apoptotic pathway: The possible role of CD38/ADP-ribosyl cyclase-mediated calcium mobilization	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PROXIMAL TUBULAR CELLS; POLY(ADP-RIBOSE) POLYMERASE-1; CISPLATIN NEPHROTOXICITY; THYROID-HORMONE; INJURY; PROTECTS; NEPHROPATHY; EXPRESSION; KIDNEY	Thyroid hormones are well-established as a key regulator of many cellular metabolic pathways developed in various pathogeneses. Here, we dedicated the current work to investigate the role of thyroid hormone analogue (L-thyroxine, L-TH) in regulating the renal cytotoxicity using in vivo and in vitro models. Swiss mice were exposed to gamma radiation (IRR, 6Gy) or treated with cisplatin (CIS, 15 mg/kg, i. p.) for induction of nephrotoxicity. Remarkably, pretreatment with L-TH (1 mu g/kg) ameliorated the elevated kidney function biomarkers, oxidative stress and protected the renal tissue from the subsequent cellular damage. Likewise, L-TH inhibited the apoptotic cascade by down-regulating the extreme consumption of the cellular energy (ATP), the expression of caspase-3 and Bax, and the stimulation of cyclic ADP ribose (cADPR)/calcium mobilization. Moreover, incubation with LTH (120nM/4h) significantly blocked the cytotoxicity of CIS on Vero cells and the depletion of NAD+ content as well as modified the ADP-ribose cyclase (CD38) enzymatic activity. High doses of L-TH (up to30 nM/4h) inversely increased the radiosensitivity of Vero cells towards IRR (up to 6Gy). On the other hand, L-TH did not interfere CIS-induced cytotoxicity of colorectal adenocarcinoma (Caco-2) cell line. In conclusion, pretreatment with L-TH could be a promising protective approach to the renal cellular damage induced during either CIS or IRR therapy by regulating the unbalanced oxidative status, the expression of proapoptotic biomarkers via modulation of cADPR mediated-calcium mobilization.	[El-Hamoly, Tarek] Atom Energy Author, Natl Ctr Radiat Res & Technol, Drug Radiat Res Dept, Cairo, Egypt; [El-Hamoly, Tarek; El-Sharawy, Dina M.; El Refaye, Marwa S.] Atom Energy Author, Ctr Nucl Res, Cyclotron Project, Cairo, Egypt; [Abd El-Rahman, Sahar S.] Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); National Center for Radiation Research & Technology; Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); Egyptian Knowledge Bank (EKB); Cairo University	Abd El-Rahman, SS (corresponding author), Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt.	saharsamirmah@cu.edu.eg	El-Rahman, Sahar S. Abd/A-1443-2016	Abd El-Rahman, Sahar S/0000-0001-8638-1737				APPENROTH D, 1990, J APPL TOXICOL, V10, P395, DOI 10.1002/jat.2550100603; Arsad SS, 2014, J CYTOL HISTOL, VS4, P1, DOI DOI 10.4172/2157-7099.S4-001; Banchroft J.D., 1996, THEORY PRACTICE HIST; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Chen CY, 2013, BIOCHIM BIOPHYS ACTA, P11; CHEN SM, 1995, INFECT IMMUN, V63, P647, DOI 10.1128/IAI.63.2.647-655.1995; Davis PJ, 2002, THYROID, V12, P459, DOI 10.1089/105072502760143827; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Guo Y, 2014, NEUROENDOCRINOLOGY L, V35; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; HARMSEN E, 1982, J CHROMATOGR, V230, P131, DOI 10.1016/S0378-4347(00)81439-5; Higashida H, 2016, J NEURAL TRANSM VIEN, V26, P1; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; Johnstone TC, 2014, ANTICANCER RES, V34, P471; Kim J, 2016, PHYSIOL RES, V65, P333, DOI 10.33549/physiolres.932948; Kouvaris JR, 2007, ONCOLOGIST, V12, P738, DOI 10.1634/theoncologist.12-6-738; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Kwakkel J, 2014, ENDOCRINOLOGY, P155; KWON YD, 2014, PLOS ONE, V9; Lakatos P, 2013, BBA-MOL CELL RES, V1833, P743, DOI 10.1016/j.bbamcr.2012.12.003; Laoag-Fernandez JB, 2004, J CLIN ENDOCR METAB, V89, P4069, DOI 10.1210/jc.2003-032208; Lee RH, 2001, BIOCHEM PHARMACOL, V62, P1013; LUCK H, 1963, METHOD ENZYMAT AN, P886; Ma P, 2015, AM J TRANSL RES, V7, P2105; Masaki H, 2004, J INVEST DERMATOL, V14, P50; Mohamed HA, 2015, INT J SCI RES PUBLIC, V5; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Pan H., 2015, PLOS ONE, V10; Peng QY, 2016, J SURG RES, V201, P480, DOI 10.1016/j.jss.2015.11.029; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Ravindra P, 2010, J CELL ANIMAL BIOL, V4, P108; Shang GG, 2013, BBA-MOL BASIS DIS, V1832, P674, DOI 10.1016/j.bbadis.2013.01.023; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Sinha RA, 2015, AUTOPHAGY, P23; Sukocheva OA, 2006, J ENDOCRINOL, V191, P447, DOI 10.1677/joe.1.07061; Sung MJ, 2008, KIDNEY INT, V74, P1538, DOI 10.1038/ki.2008.409; Videla LA, 2010, IUBMB LIFE, V62, P460, DOI 10.1002/iub.345; Yang JH, 2015, BIOCHEM BIOPH RES CO, V467, P704, DOI 10.1016/j.bbrc.2015.10.080; Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184157	10.1371/journal.pone.0184157	http://dx.doi.org/10.1371/journal.pone.0184157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892514	gold, Green Published, Green Submitted			2022-12-26	WOS:000410243200010
J	Deng, T; Mai, ZL; Cai, C; Duan, XL; Zhu, W; Zhang, T; Wu, WQ; Zeng, GH				Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua			Influence of weight status on 24-hour urine composition in adults without urolithiasis: A nationwide study based on a Chinese Han population	PLOS ONE			English	Article							STONE; OBESITY; IMPACT; PREVALENCE; OVERWEIGHT; RISK	Objectives This study sought to explore the influence of different body weight statuses on 24-hour urine compositions in adults without urolithiasis based on a nationwide study of a Chinese Han population. Material and methods Twenty-four-hour urine samples from 584 Chinese Han adults without urolithiasis in six cities were analyzed. The participants were divided into four body weight status types according to their body mass indices (BMIs) according to WHO guidelines. The baseline characteristics and 24-hour urine compositions of the standard weight group were compared with those of the underweight, overweight and obese groups. The influences of different body weight statuses on the 24-hour urine compositions were explored using univariate and multivariate logistic regressions. Results The numbers of participants in the underweight, standard weight, overweight and obese status groups were 24, 376, 149 and 35, respectively. The overweight and obese groups suffered significantly higher risks of hypertension and diabetes mellitus than the standard weight group. In the univariate analyses, compared with the standard weight group, the overweight group had significantly higher levels of urine citrate (mean difference [MD] = 0.51 mmol, 95% confidence interval [CI]: 0.15-0.87, P = 0.001), potassium (MD = 6.63 mmol, 95% CI: 1.13-12.14, P = 0.01) and magnesium (MD = 0.38 mmol, 95% CI: 0.08-0.69, P = 0.014). Significant increases in urine citrate (MD = 0.85 mmol, 95% CI: 0.01-1.68, P = 0.046), magnesium (MD = 0.69 mmol, 95% CI: 0.13-1.25, P = 0.016) and phosphate MD = 2.28 mmol, 95% CI: 0.03-4.54, P = 0.047) were found in the obese group. No significant differences were detected between the standard weight and underweight groups. In the multivariate logistic regression analyses, we only observed significantly higher levels of urine potassium (odds ratio [OR] = 1.02, 95% CI: 1.00-1.04, P = 0.03) in the overweight group and phosphate (OR = 1.32, 95% CI: 1.05-1.66, P = 0.018) in the obese group when compared with the standard weight group. Conclusions Nonstone-forming adults with overweight or obese statuses were at higher risks of hypertension and diabetes mellitus. Obese nonstone-formers might have a greater risk of urinary stone formation due to increased urinary phosphate excretion. Additionally, underweight status had no influence on 24-hour urine composition.	[Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua] Guangzhou Inst Urol, Guangzhou, Guangdong, Peoples R China; [Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, GH (corresponding author), Guangzhou Inst Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, GH (corresponding author), Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com		Deng, Tuo/0000-0003-0206-2179	China Postdoctoral Science Foundation [2017M612636]; National Natural Science Foundation of China [81370804, 81670643]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Postdoctoral Science Foundation [grant number 2017M612636]; National Natural Science Foundation of China [grant numbers 81370804, 81670643].	Al-Hayek S, 2013, J ENDOUROL, V27, P379, DOI 10.1089/end.2012.0275; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calvert RC, 2005, CURR OPIN UROL, V15, P113, DOI 10.1097/01.mou.0000160626.36236.22; De Pergola G, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0101-6; Eisner BH, 2010, UROLOGY, V75, P1289, DOI 10.1016/j.urology.2009.09.024; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Eisner BH, 2010, J UROLOGY, V183, P576, DOI 10.1016/j.juro.2009.10.011; Gyawali P R, 2011, Kathmandu Univ Med J (KUMJ), V9, P54; Hartman C, 2015, UROLOGY, V85, P539, DOI 10.1016/j.urology.2014.12.013; Jaipakdee Sudjai, 2004, Journal of the Medical Association of Thailand, V87, P255; Khand Fateh D., 1994, JPMA (Journal of the Pakistan Medical Association), V44, P179; Liu XL, 2017, J HYPERTENS, V35, P637, DOI 10.1097/HJH.0000000000001203; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Mydlo JH, 2004, UROL CLIN N AM, V31, P275, DOI 10.1016/j.ucl.2004.01.005; Parvin M, 2011, UROL J, V8, P99; Pierratos A, 2000, J UROLOGY, V164, P1486, DOI 10.1016/S0022-5347(05)67012-7; Pippitt K, 2016, AM FAM PHYSICIAN, V93, P103; Powell CR, 2000, UROLOGY, V55, P825, DOI 10.1016/S0090-4295(99)00617-2; Sarica K, 2009, UROLOGY, V73, P1003, DOI 10.1016/j.urology.2008.11.038; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Siener R, 2004, OBES RES, V12, P106, DOI 10.1038/oby.2004.14; Skolarikos A, 2015, EUR UROL, V67, P750, DOI 10.1016/j.eururo.2014.10.029; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2006, AM J KIDNEY DIS, V48, P905, DOI 10.1053/j.ajkd.2006.09.004; Tiselius HG, 2002, ENDOCRIN METAB CLIN, V31, P1031, DOI 10.1016/S0889-8529(02)00027-0; Wu WQ, 2014, UROLOGY, V83, P732, DOI 10.1016/j.urology.2013.11.012; Yachantha C, 2009, UROL RES, V37, P311, DOI 10.1007/s00240-009-0220-6; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150006	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184655	10.1371/journal.pone.0184655	http://dx.doi.org/10.1371/journal.pone.0184655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886192	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100173
J	Kimball, HL; Selmants, PC; Moreno, A; Running, SW; Giardina, CP				Kimball, Heather L.; Selmants, Paul C.; Moreno, Alvaro; Running, Steve W.; Giardina, Christian P.			Evaluating the role of land cover and climate uncertainties in computing gross primary production in Hawaiian Island ecosystems	PLOS ONE			English	Article							TERRESTRIAL GROSS; MODIS; VEGETATION; GPP; NPP	Gross primary production (GPP) is the Earth's largest carbon flux into the terrestrial biosphere and plays a critical role in regulating atmospheric chemistry and global climate. The Moderate Resolution Imaging Spectrometer (MODIS)-MOD17 data product is a widely used remote sensing-based model that provides global estimates of spatiotemporal trends in GPP. When the MOD17 algorithm is applied to regional scale heterogeneous landscapes, input data from coarse resolution land cover and climate products may increase uncertainty in GPP estimates, especially in high productivity tropical ecosystems. We examined the influence of using locally specific land cover and high-resolution local climate input data on MOD17 estimates of GPP for the State of Hawaii, a heterogeneous and discontinuous tropical landscape. Replacing the global land cover data input product (MOD12Q1) with Hawaiispecific land cover data reduced statewide GPP estimates by similar to 8%, primarily because the Hawaii-specific land cover map had less vegetated land area compared to the global land cover product. Replacing coarse resolution GMAO climate data with Hawaii-specific high-resolution climate data also reduced statewide GPP estimates by similar to 8% because of the higher spatial variability of photosynthetically active radiation (PAR) in the Hawaii-specific climate data. The combined use of both Hawaii-specific land cover and high-resolution Hawaii climate data inputs reduced statewide GPP by similar to 16%, suggesting equal and independent influence on MOD17 GPP estimates. Our sensitivity analyses within a heterogeneous tropical landscape suggest that refined global land cover and climate data sets may contribute to an enhanced MOD17 product at a variety of spatial scales.	[Kimball, Heather L.] Univ Hawaii, Coll Arts & Sci, Hilo, HI 96720 USA; [Selmants, Paul C.] US Geol Survey, Western Geog Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA; [Moreno, Alvaro; Running, Steve W.] Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA; [Giardina, Christian P.] US Forest Serv, USDA, Inst Pacific Isl Forestry, Hilo, HI USA; [Kimball, Heather L.] Pacific Sci Advocates, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service	Kimball, HL (corresponding author), Univ Hawaii, Coll Arts & Sci, Hilo, HI 96720 USA.; Kimball, HL (corresponding author), Pacific Sci Advocates, Hilo, HI 96720 USA.	Hkimball@hawaii.edu	Martínez, Álvaro Moreno/AAA-5778-2019; Giardina, Christian P/C-3120-2011	Martínez, Álvaro Moreno/0000-0003-2990-7768; Giardina, Christian P/0000-0002-3431-5073; Selmants, Paul/0000-0001-6211-3957	U.S. Geological Survey Biological Carbon Sequestration Program [G13PG00084]; USDA Forest Service Pacific Southwest Research Station; NASA Earth Observing System MODIS Project [NNX08AG87A];  [16-JV-11272136-056];  [12-JV- 11272139-047]	U.S. Geological Survey Biological Carbon Sequestration Program; USDA Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); NASA Earth Observing System MODIS Project; ; 	This work was funded by the U.S. Geological Survey Biological Carbon Sequestration Program (https://www2.usgs.gov/climate_landuse/land_carbon/) under an Interagency Agreement G13PG00084 to CPG with the USDA Forest Service Pacific Southwest Research Station (https://www.fs.fed.us/psw/). Research Joint Ventures 16-JV-11272136-056 to HK and 12-JV- 11272139-047 were awarded to PS. Funding was provided to AM and SR through the NASA Earth Observing System MODIS Project (https://earthdata.nasa.gov/), grant NNX08AG87A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Anav A, 2015, REV GEOPHYS, V53, P785, DOI 10.1002/2015RG000483; Anderson RG, 2015, AGR ECOSYST ENVIRON, V199, P216, DOI 10.1016/j.agee.2014.09.012; [Anonymous], 2014, PICT ONL; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Belward AS, 1999, PHOTOGRAMM ENG REM S, V65, P1013; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cracknell AP, 2013, INT J REMOTE SENS, V34, P7400, DOI 10.1080/01431161.2013.820367; Digital Globe, 2010, QUICKB WORLDVI UNPUB; Dong J, 2017, SCI REPORTS, V7; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gebremichael M, 2006, REMOTE SENS ENVIRON, V100, P150, DOI 10.1016/j.rse.2005.10.009; Giambelluca T. W., 2014, EVAPOTRANSPIRA UNPUB; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gilabert MA, 2015, ISPRS J PHOTOGRAMM, V102, P184, DOI 10.1016/j.isprsjprs.2015.01.017; Global Modeling and Assimilation Office, GEOS NEAR REAL TIM D; Gon S., 2006, HAWAII GAP ANAL PROJ; Hashimoto H, 2012, REMOTE SENS-BASEL, V4, P303, DOI 10.3390/rs4010303; Heinsch FA, 2006, IEEE T GEOSCI REMOTE, V44, P1908, DOI 10.1109/TGRS.2005.853936; Jacobi J. D., 2017, BASELINE PROJECTED F, DOI 10.3133/pp1834; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; Knyazikhin Y, 1998, J GEOPHYS RES ATMOSP, V103; Martinez B, 2013, INT J APPL EARTH OBS, V21, P463, DOI 10.1016/j.jag.2012.06.010; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Milesi C, 2005, GLOBAL PLANET CHANGE, V47, P221, DOI 10.1016/j.gloplacha.2004.10.020; Mitchell JF, 1990, CLIMATE CHANGE IPCC, V131, P172; Moreno A, 2014, REMOTE SENS-BASEL, V6, P8238, DOI 10.3390/rs6098238; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nightingale JM, 2007, CAN J REMOTE SENS, V33, P278, DOI 10.5589/m07-030; NOAA National Ocean Service Coastal Services Center, 2012, C CAP HAW 2005 LAND; Perez-Hoyos A, 2012, ISPRS J PHOTOGRAMM, V74, P185, DOI 10.1016/j.isprsjprs.2012.09.006; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; RUNNING SW, 1994, AMBIO, V23, P77; Running SW, 1999, REMOTE SENS ENVIRON, V70, P108, DOI 10.1016/S0034-4257(99)00061-9; Running SW, 2015, DAILY GPP ANN NPP M; Shim C, 2014, ADV SPACE RES, V54, P2296, DOI 10.1016/j.asr.2014.08.031; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017; U. S. Geological Survey, 2009, LANDFIRE HI 100EVC H; United Nations Framework Convention on Climate Change, 2015, AD AR AGR 21 C PART; Vitousek, 2004, NUTR CYCLING LIMITAT; Wang J, 2017, J GEOPHYS RES BIOGEO; Yan K, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050359; Zhang YJ, 2009, GLOBAL ECOL BIOGEOGR, V18, P280, DOI 10.1111/j.1466-8238.2008.00442.x; Zhang YQ, 2008, GLOBAL CHANGE BIOL, V14, P757, DOI 10.1111/j.1365-2486.2008.01538.x; Zhao M, 2006, COLLECTION 005 CHANG; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	51	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184466	10.1371/journal.pone.0184466	http://dx.doi.org/10.1371/journal.pone.0184466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886187	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100130
J	Kwon, W; Kim, HS; Jeong, J; Sung, Y; Choi, M; Park, S; Lee, J; Jang, S; Kim, SH; Lee, S; Kim, MO; Ryoo, ZY				Kwon, Wookbong; Kim, Hyeng-Soo; Jeong, Jain; Sung, Yonghun; Choi, Minjee; Park, Song; Lee, Jinhee; Jang, Soyoung; Kim, Sung Hyun; Lee, Sanggyu; Kim, Myoung Ok; Ryoo, Zae Young			Tet1 overexpression leads to anxiety-like behavior and enhanced fear memories via the activation of calcium-dependent cascade through Egr1 expression in mice	FASEB JOURNAL			English	Article						excitatory neurons; immediate early genes; stress-related behavior; transgenic mouse	ADULT HIPPOCAMPAL NEUROGENESIS; ACTIVE DNA DEMETHYLATION; GENE-EXPRESSION; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; NEURONAL CIRCUITS; CONTEXTUAL FEAR; C-FOS; TRANSCRIPTION; STRESS	Ten-eleven translocation methylcytosine dioxygenase 1 (Tet1) initiates DNA demethylation by converting 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) at CpG-rich regions of genes, which have key roles in adult neurogenesis and memory. In addition, the overexpression of Tet1 with 5-hmC alteration in patients with psychosis has also been reported, for instance in schizophrenia and bipolar disorders. The mechanism underlying Tet1 overexpression in the brain; however, is still elusive. In the present study, we found that Tet1-transgenic (Tet1-TG) mice displayed abnormal behaviors involving elevated anxiety and enhanced fear memories. We confirmed that Tet1 overexpression affected adult neurogenesis with oligodendrocyte differentiation in the hippocampal dentate gyrus of Tet1-TG mice. In addition, Tet1 overexpression induced the elevated expression of immediate early genes, such as Egr1, c-fos, Arc, and Bdnf, followed by the activation of intracellular calcium signals (i.e., CamKII, ERK, and CREB) in prefrontal and hippocampal neurons. The expression of GABA receptor subunits (Gabra2 and Gabra4) fluctuated in the prefrontal cortex and hippocampus. We evaluated the effects of Tet1 over-expression on intracellular calcium-dependent cascades by activating the Egr1 promoter in vitro. Tet1 enhanced Egr1 expression, which may have led to alterations in Gabra2 and Gabra4 expression in neurons. Taken together, we suggest that the Tet1 overexpression in our Tet1-TG mice can be applied as an effective model for studying various stress-related diseases that show hyperactivation of intracellular calcium-dependent cascades in the brain.	[Kwon, Wookbong; Kim, Hyeng-Soo; Jeong, Jain; Sung, Yonghun; Choi, Minjee; Park, Song; Lee, Jinhee; Jang, Soyoung; Lee, Sanggyu; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, 80 Daehakro, Daegu 41566, South Korea; [Kim, Hyeng-Soo; Kim, Sung Hyun] Kyungpook Natl Univ, Inst Life Sci & Biotechnol, Daegu, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Sch Anim Biotechnol BT Sci, 2559 Gyeongsang Daero, Sangju Si 37224, Gyeongsangbuk D, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, 80 Daehakro, Daegu 41566, South Korea.; Kim, MO (corresponding author), Kyungpook Natl Univ, Sch Anim Biotechnol BT Sci, 2559 Gyeongsang Daero, Sangju Si 37224, Gyeongsangbuk D, South Korea.	ok4325@knu.ac.kr; jaewoong64@knu.ac.kr	RYOO, ZAEYOUNG/AAQ-1573-2020	Jang, Soyoung/0000-0003-2673-4259; Kwon, Wookbong/0000-0002-0655-6531	Korean Ministry of Science, Information and Communications Technology; Future Planning (MSIP) National Research Foundation of Korea (NRF) [2016R1A2B4014686]	Korean Ministry of Science, Information and Communications Technology; Future Planning (MSIP) National Research Foundation of Korea (NRF)	This work was supported by the Korean Ministry of Science, Information and Communications Technology, and Future Planning (MSIP) National Research Foundation of Korea (NRF) (Grant 2016R1A2B4014686). The authors declare no conflicts of interest.	AKBARIAN S, 1995, CEREB CORTEX, V5, P550, DOI 10.1093/cercor/5.6.550; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Ambigapathy G, 2015, EPIGENETICS-US, V10, P981, DOI 10.1080/15592294.2015.1090072; ARNOLD FJL, 1992, NEUROSCIENCE, V51, P377, DOI 10.1016/0306-4522(92)90322-S; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Chakraborty T, 2016, BEHAV BRAIN RES, V302, P122, DOI 10.1016/j.bbr.2016.01.018; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Chuang HC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00280; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dong E, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.191; Dong E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.86; Edgar N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.34; Elliott E, 2016, J NEUROSCI, V36, P730, DOI 10.1523/JNEUROSCI.0971-15.2016; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frank CA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00040; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Grayson DR, 2013, NEUROPSYCHOPHARMACOL, V38, P138, DOI 10.1038/npp.2012.125; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hogan B, 1994, MANIPULATING MOUSE E; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Kim H, 2016, BIOCHEM BIOPH RES CO, V471, P437, DOI 10.1016/j.bbrc.2016.02.060; Ko Shanelle W., 2005, Shengli Xuebao, V57, P421; Leaderbrand K, 2014, NEUROBIOL LEARN MEM, V113, P35, DOI 10.1016/j.nlm.2013.09.005; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Mo J, 2015, J NEUROCHEM, V133, P489, DOI 10.1111/jnc.13077; Nakayama D, 2015, J NEUROSCI, V35, P819, DOI 10.1523/JNEUROSCI.2525-14.2015; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Papale LA, 2017, EPIGENETICS-US, V12, P264, DOI 10.1080/15592294.2017.1285986; Penke Z, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0159; Pierri JN, 1999, AM J PSYCHIAT, V156, P1709; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qin XK, 2015, J BIOL CHEM, V290, P29603, DOI 10.1074/jbc.M115.668889; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Saunderson EA, 2016, P NATL ACAD SCI USA, V113, P4830, DOI 10.1073/pnas.1524857113; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Vieira PA, 2015, NEUROBIOL LEARN MEM, V119, P52, DOI 10.1016/j.nlm.2014.12.012; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu LJ, 2008, NEUROCHEM RES, V33, P1925, DOI 10.1007/s11064-008-9679-8; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhang XH, 2015, DEPRESS ANXIETY, V32, P720, DOI 10.1002/da.22394; Zhao XH, 2014, GLIA, V62, P914, DOI 10.1002/glia.22649; Zimmerman G, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.4	64	12	12	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					390	403		10.1096/fj.201601340RR	http://dx.doi.org/10.1096/fj.201601340RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899881				2022-12-26	WOS:000419172700035
J	Hansson, H; Karkehabadi, S; Mikkelsen, N; Douglas, NR; Kim, S; Lam, A; Kaper, T; Kelemen, B; Meier, KK; Jones, SM; Solomon, EI; Sandgren, M				Hansson, Henrik; Karkehabadi, Saeid; Mikkelsen, Nils; Douglas, Nicholai R.; Kim, Steve; Lam, Anna; Kaper, Thijs; Kelemen, Brad; Meier, Katlyn K.; Jones, Stephen M.; Solomon, Edward I.; Sandgren, Mats			High-resolution structure of a lytic polysaccharide monooxygenase from Hypocrea jecorina reveals a predicted linker as an integral part of the catalytic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); enzyme mechanism; enzyme structure; Hypocrea jecorina; X-ray crystallography; auxiliary activity family 9 (AA9); lytic polysaccharide monooxygenase (LPMO)	GLYCOSIDE HYDROLASE FAMILY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CELLULOSE DEGRADATION; CELLOBIOHYDROLASE-I; COPPER SITE; EXPRESSION; GLUCOAMYLASE; ACTIVATION	For decades, the enzymes of the fungus Hypocrea jecorina have served as a model system for the breakdown of cellulose. Three-dimensional structures for almost all H. jecorina cellulose-degrading enzymes are available, except for HjLPMO9A, belonging to the AA9 family of lytic polysaccharide monooxygenases (LPMOs). These enzymes enhance the hydrolytic activity of cellulases and are essential for cost-efficient conversion of lignocellulosic biomass. Here, using structural and spectroscopic analyses, we found that native HjLPMO9A contains a catalytic domain and a family-1 carbohydrate-binding module (CBM1) connected via a linker sequence. A C terminally truncated variant of HjLPMO9A containing 21 residues of the predicted linker was expressed at levels sufficient for analysis. Here, using structural, spectroscopic, and biochemical analyses, we found that this truncated variant exhibited reduced binding to and activity on cellulose compared with the full-length enzyme. Importantly, a 0.95- resolution X-ray structure of truncated HjLPMO9A revealed that the linker forms an integral part of the catalytic domain structure, covering a hydrophobic patch on the catalytic AA9 module. We noted that the oxidized catalytic center contains a Cu(II) coordinated by two His ligands, one of which has a His-brace in which the His-1 terminal amine group also coordinates to a copper. The final equatorial position of the Cu(II) is occupied by a water-derived ligand. The spectroscopic characteristics of the truncated variant were not measurably different from those of full-length HjLPMO9A, indicating that the presence of the CBM1 module increases the affinity of HjLPMO9A for cellulose binding, but does not affect the active site.	[Hansson, Henrik; Karkehabadi, Saeid; Mikkelsen, Nils; Sandgren, Mats] Swedish Univ Agr Sci, Dept Chem & Biotechnol, POB 7015, SE-75007 Uppsala, Sweden; [Douglas, Nicholai R.; Kim, Steve; Lam, Anna; Kaper, Thijs; Kelemen, Brad] DuPont Ind Biosci, Palo Alto, CA 94304 USA; [Meier, Katlyn K.; Jones, Stephen M.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Swedish University of Agricultural Sciences; Stanford University	Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Chem & Biotechnol, POB 7015, SE-75007 Uppsala, Sweden.; Solomon, EI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	edward.solomon@stanford.edu; mats.sandgren@slu.se	; Meier, Katlyn/C-4478-2015	Sandgren, Mats/0000-0002-2358-4534; Hansson, Henrik/0000-0002-6003-2982; Solomon, Edward/0000-0003-0291-3199; Meier, Katlyn/0000-0002-8316-9199	Swedish Energy Agency [40144-1]; NIDDK of the National Institutes of Health [R01DK031450]; Ruth L. Kirschstein National Research Service Award from the NIGMS of the National Institutes of Health [F32GM116240]; Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences through the faculty research program MicroDrivE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116240] Funding Source: NIH RePORTER	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); NIDDK of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein National Research Service Award from the NIGMS of the National Institutes of Health; Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences through the faculty research program MicroDrivE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Swedish Energy Agency under award number 40144-1 (to M. S.), the NIDDK of the National Institutes of Health under Grant R01DK031450 (to E. I. S.), the Ruth L. Kirschstein National Research Service Award from the NIGMS of the National Institutes of Health under Grant F32GM116240 (to K. K. M.), and the Faculty for Natural Resources and Agriculture, Swedish University of Agricultural Sciences (to M. S., H. H., S. K., and N. M.) through the faculty research program MicroDrivE. N. D., S. T. K., A. L., and B. K. are employees of DuPont Industrial Biosciences, a producer of enzymes for industrial use. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Agirre J, 2016, ACTA CRYSTALLOGR D, V72, P254, DOI 10.1107/S2059798315024237; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; ALESHIN A, 1992, J BIOL CHEM, V267, P19291; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Bott R, 2008, BIOCHEMISTRY-US, V47, P5746, DOI 10.1021/bi702413k; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen P, 2004, BIOCHEMISTRY-US, V43, P5735, DOI 10.1021/bi0362830; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; GEWIRTH AA, 1988, J AM CHEM SOC, V110, P3811, DOI 10.1021/ja00220a015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee TM, 2011, PROTEIN SCI, V20, P1935, DOI 10.1002/pro.730; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Machonkin TE, 2001, J AM CHEM SOC, V123, P5507, DOI 10.1021/ja003975s; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moses V, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0655-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rojas J, 2011, J ADV PHARM TECHNOL, V2, P144, DOI 10.4103/2231-4040.85527; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Srisodsuk M, 1997, J BIOTECHNOL, V57, P49, DOI 10.1016/S0168-1656(97)00088-6; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tanghe M, 2015, MOL BIOTECHNOL, V57, P1010, DOI 10.1007/s12033-015-9887-9; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vejdovszky K, 2016, TOXICOL LETT, V241, P1, DOI 10.1016/j.toxlet.2015.10.024; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	57	37	39	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19099	19109		10.1074/jbc.M117.799767	http://dx.doi.org/10.1074/jbc.M117.799767			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28900033	hybrid, Green Published			2022-12-26	WOS:000415848000032
J	Green, JL; Wall, RJ; Vahokoski, J; Yusuf, NA; Ridzuan, MAM; Stanway, RR; Stock, J; Knuepfer, E; Brady, D; Martin, SR; Howell, SA; Pires, IP; Moon, RW; Molloy, JE; Kursula, I; Tewari, R; Holder, AA				Green, Judith L.; Wall, Richard J.; Vahokoski, Juha; Yusuf, Noor A.; Ridzuan, Mohd A. Mohd; Stanway, Rebecca R.; Stock, Jessica; Knuepfer, Ellen; Brady, Declan; Martin, Stephen R.; Howell, Steven A.; Pires, Isa P.; Moon, Robert W.; Molloy, Justin E.; Kursula, Inari; Tewari, Rita; Holder, Anthony A.			Compositional and expression analyses of the glideosome during the Plasmodium life cycle reveal an additional myosin light chain required for maximum motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-XIV MYOSIN; HOST-CELL INVASION; TOXOPLASMA-GONDII; MALARIA PARASITE; APICOMPLEXAN GLIDEOSOME; PROTEIN EXPRESSION; GLIDING MOTILITY; GENE DELETION; FALCIPARUM; MOTOR	Myosin A (MyoA) is a Class XIV myosin implicated in gliding motility and host cell and tissue invasion by malaria parasites. MyoA is part of a membrane-associated protein complex called the glideosome, which is essential for parasite motility and includes the MyoA light chain myosin tail domain-interacting protein (MTIP) and several glideosome-associated proteins (GAPs). However, most studies of MyoA have focused on single stages of the parasite life cycle. We examined MyoA expression throughout the Plasmodium berghei life cycle in both mammalian and insect hosts. In extracellular ookinetes, sporozoites, and merozoites, MyoA was located at the parasite periphery. In the sexual stages, zygote formation and initial ookinete differentiation precede MyoA synthesis and deposition, which occurred only in the developing protuberance. In developing intracellular asexual blood stages, MyoA was synthesized in mature schizonts and was located at the periphery of segmenting merozoites, where it remained throughout maturation, merozoite egress, and host cell invasion. Besides the known GAPs in the malaria parasite, the complex included GAP40, an additional myosin light chain designated essential light chain (ELC), and several other candidate components. This ELC bound theMyoAneck region adjacent to the MTIP-binding site, and both myosin light chains co-located to the glideosome. Coexpression of MyoA with its two light chains revealed that the presence of both light chains enhances MyoA-dependent actin motility. In conclusion, we have established a system to study the interplay and function of the three glideosome components, enabling the assessment of inhibitors that target this motor complex to block host cell invasion.	[Green, Judith L.; Yusuf, Noor A.; Ridzuan, Mohd A. Mohd; Knuepfer, Ellen; Moon, Robert W.; Holder, Anthony A.] Francis Crick Inst, Malaria Parasitol Lab, 1 Midland Rd, London NW1 1AT, England; [Martin, Stephen R.] Francis Crick Inst, Struct Biol, 1 Midland Rd, London NW1 1AT, England; [Howell, Steven A.] Francis Crick Inst, Mass Spectrometry Sci Technol Platforms, 1 Midland Rd, London NW1 1AT, England; [Molloy, Justin E.] Francis Crick Inst, Single Mol Enzymol Lab, 1 Midland Rd, London NW1 1AT, England; [Wall, Richard J.; Stock, Jessica; Brady, Declan; Tewari, Rita] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England; [Vahokoski, Juha; Kursula, Inari] Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Stanway, Rebecca R.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Pires, Isa P.; Kursula, Inari] Univ Oulu, Bioctr Oulu, Aapistie 7, SF-90220 Oulu, Finland; [Pires, Isa P.; Kursula, Inari] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, SF-90220 Oulu, Finland; [Wall, Richard J.] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Yusuf, Noor A.; Ridzuan, Mohd A. Mohd] Inst Med Res, Jalan Pahang, Kuala Lumpur 50588, Malaysia; [Stock, Jessica] Res Inst Mol Pathol, Campus Vienna Bioctr 1, A-1030 Vienna, Austria; [Moon, Robert W.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; University of Nottingham; University of Bergen; University of Bern; University of Oulu; University of Oulu; University of Dundee; Kementerian Kesihatan Malaysia; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; London School of Hygiene & Tropical Medicine	Green, JL; Holder, AA (corresponding author), Francis Crick Inst, Malaria Parasitol Lab, 1 Midland Rd, London NW1 1AT, England.	judith.green@crick.ac.uk; tony.holder@crick.ac.uk	Holder, Anthony A/A-7554-2013; Mohd Abd Razak, Mohd Ridzuan/GXZ-7049-2022; Moon, Robert/AAF-9808-2019; Kursula, Inari/AHB-9980-2022	Holder, Anthony A/0000-0002-8490-6058; Kursula, Inari/0000-0001-5236-7056; Pires, Isa/0000-0001-8359-9028; Mohd Abd Razak, Mohd Ridzuan/0000-0002-9589-5892; Tewari, Rita/0000-0003-3943-1847; Knuepfer, Ellen/0000-0002-6090-1877; Molloy, Justin/0000-0002-8307-2450; Moon, Robert/0000-0002-9070-4292; Wall, Richard J./0000-0003-3487-3187; Green, Judith/0000-0001-6825-9404	Francis Crick Institute - Cancer Research UK [FC001097, FC001119]; Medical Research Council (MRC) [FC001097, FC001119]; Wellcome Trust [FC001097, FC001119]; MRC Project [G0900278, MR/K011782/1]; School of Life Sciences, University of Nottingham; Faculty of Medicine and Dentistry, University of Bergen [2015/13383-EVR]; Faculty of Medicine and Dentistry, University of Bergen; BBSRC [BB/N017609/1] Funding Source: UKRI; MRC [MR/K011782/1, G0900109, G0900278, MR/N023048/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N017609/1] Funding Source: researchfish; Medical Research Council [G0900278, G0900109, MR/N023048/1, MR/K011782/1] Funding Source: researchfish; The Francis Crick Institute [10119, 10015, 10097] Funding Source: researchfish	Francis Crick Institute - Cancer Research UK; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); School of Life Sciences, University of Nottingham; Faculty of Medicine and Dentistry, University of Bergen; Faculty of Medicine and Dentistry, University of Bergen; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (Grants FC001097 and FC001119), the Medical Research Council (MRC) (Grants FC001097 and FC001119), and the the Wellcome Trust (Grants FC001097 and FC001119); by MRC Project Grant G0900278, MR/K011782/1; and small grant funding from the School of Life Sciences, University of Nottingham (2015) (to R. T.). This work was also supported by a research grant 2015/13383-EVR and postdoc fellowship from the Faculty of Medicine and Dentistry, University of Bergen (to J. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Buchs Mirjam, 2009, V498, P199, DOI 10.1007/978-1-59745-196-3_14; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Butt T, 2010, J BIOL CHEM, V285, P4964, DOI 10.1074/jbc.M109.044792; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; COPPEL RL, 1988, MOL BIOCHEM PARASIT, V31, P223, DOI 10.1016/0166-6851(88)90152-1; Diaz SA, 2014, MOL BIOCHEM PARASIT, V197, P9, DOI 10.1016/j.molbiopara.2014.09.006; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002554; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; Hellerschmied D, 2014, CURR OPIN STRUC BIOL, V25, P9, DOI 10.1016/j.sbi.2013.11.002; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1985, PARASITOLOGY, V91, P219, DOI 10.1017/S0031182000057322; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Knuepfer E, 2014, CELL MICROBIOL, V16, P657, DOI 10.1111/cmi.12181; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lasonder E, 2015, PROTEOMICS, V15, P2716, DOI 10.1002/pmic.201400508; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Marapana DS, 2012, TRAFFIC, V13, P1457, DOI 10.1111/j.1600-0854.2012.01402.x; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinder JC, 1998, J CELL SCI, V111, P1831; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; ROGER N, 1988, MOL BIOCHEM PARASIT, V27, P135, DOI 10.1016/0166-6851(88)90033-3; Roques M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005273; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Syamaladevi DP, 2012, BIOINFORM BIOL INSIG, V6, P11, DOI 10.4137/BBI.S8451; Takagi Y, 2014, P NATL ACAD SCI USA, V111, pE1833, DOI 10.1073/pnas.1320122111; Thomas JC, 2010, MOL BIOSYST, V6, P494, DOI 10.1039/b922093c; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10; Yusuf NA, 2015, J BIOL CHEM, V290, P12147, DOI 10.1074/jbc.M115.637694	72	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17857	17875		10.1074/jbc.M117.802769	http://dx.doi.org/10.1074/jbc.M117.802769			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893907	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000414013000022
J	Neupane, DP; Avalos, D; Fullam, S; Roychowdhury, H; Yukl, ET				Neupane, Durga P.; Avalos, Dante; Fullam, Stephanie; Roychowdhury, Hridindu; Yukl, Erik T.			Mechanisms of zinc binding to the solute-binding protein AztC and transfer from the metallochaperone AztD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREPONEMA-PALLIDUM TROA; TRANSPORT PROTEIN; METAL-BINDING; CRYSTAL-STRUCTURE; ZNUA; AFFINITY; ACQUISITION; HOMEOSTASIS; COMPONENT; REVEALS	Bacteria can acquire the essential metal zinc from extremely zinc-limited environments by using ATP-binding cassette (ABC) transporters. These transporters are critical virulence factors, relying on specific and high-affinity binding of zinc by a periplasmic solute-binding protein (SBP). As such, the mechanisms of zinc binding and release among bacterial SBPs are of considerable interest as antibacterial drug targets. Zinc SBPs are characterized by a flexible loop near the high-affinity zinc-binding site. The function of this structure is not always clear, and its flexibility has thus far prevented structural characterization by X-ray crystallography. Here, we present intact structures for the zinc-specific SBP AztC from the bacterium Paracoccus denitrificans in the zinc-bound and apo-states. A comparison of these structures revealed that zinc loss prompts significant structural rearrangements, mediated by the formation of a sodium-binding site in the apo-structure. We further show that the AztC flexible loop has no impact on zinc-binding affinity, stoichiometry, or protein structure, yet is essential for zinc transfer from the metallochaperone AztD. We also found that 3 His residues in the loop appear to temporarily coordinate zinc and then convey it to the high-affinity binding site. Thus, mutation of any of these residues to Ala abrogated zinc transfer from AztD. Our structural and mechanistic findings conclusively identify a role for the AztC flexible loop in zinc acquisition from the metallochaperone AztD, yielding critical insights into metal binding by AztC from both solution and AztD. These proteins are highly conserved in human pathogens, making this work potentially useful for the development of novel antibiotics.	[Neupane, Durga P.; Avalos, Dante; Fullam, Stephanie; Roychowdhury, Hridindu; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Roychowdhury, Hridindu] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	New Mexico State University; University of Wisconsin System; University of Wisconsin Madison	Yukl, ET (corresponding author), Dept Chem & Biochem, 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Avalos, Dante/0000-0002-9160-9713	National Institutes of Health; National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM111170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Berkeley Center for Structural Biology at Lawrence Berkeley National Laboratory. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.	Abate F, 2014, BIOSCIENCE REP, V34, P743, DOI 10.1042/BSR20140088; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bersch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081168; Bhubhani S, 2014, MICROBIOL-SGM, V160, P2452, DOI 10.1099/mic.0.082446-0; Cerasi M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00108; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Handali M, 2015, J BIOL CHEM, V290, P29984, DOI 10.1074/jbc.M115.684506; Handali M, 2015, J BIOL CHEM, V290, P11878, DOI 10.1074/jbc.M115.645853; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazlett KRO, 2003, J BIOL CHEM, V278, P20687, DOI 10.1074/jbc.M300781200; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ilari A, 2016, BBA-GEN SUBJECTS, V1860, P534, DOI 10.1016/j.bbagen.2015.12.006; Ilari A, 2014, BBA-GEN SUBJECTS, V1840, P535, DOI 10.1016/j.bbagen.2013.10.010; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Sharma N, 2015, J STRUCT BIOL, V189, P184, DOI 10.1016/j.jsb.2015.01.012; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	44	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17496	17505		10.1074/jbc.M117.804799	http://dx.doi.org/10.1074/jbc.M117.804799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28887302	Green Published, hybrid			2022-12-26	WOS:000414009300029
J	Dorofejeva, O; Barr, AJ				Dorofejeva, Olga; Barr, Alastair J.			Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin	PLOS ONE			English	Article							FLUORESCENCE COMPLEMENTATION BIFC; ENDOTHELIAL-CELL JUNCTIONS; ENDOPLASMIC-RETICULUM; LIVING CELLS; CD148; PTP; ACTIVATION; PHOSPHORYLATION; DIMERIZATION; SIGMA	Receptor-type protein tyrosine phosphatases (RPTPs) of the R3 subgroup play key roles in the immune, vascular and nervous systems. They are characterised by a large ectodomain comprising multiple FNIII-like repeats, a transmembrane domain, and a single intracellular phosphatase domain. The functional role of the extracellular region has not been clearly defined and potential roles in ligand interaction, dimerization, and regulation of cell-cell contacts have been reported. Here bimolecular fluorescence complementation (BiFC) in live cells was used to examine the molecular basis for the interaction of VE-PTP with VE-cadherin, two proteins involved in endothelial cell contact and maintenance of vascular integrity. The potential of other R3-PTPs to interact with VE-cadherin was also explored using this method. Quantitative BiFC analysis, using a VE-PTP construct expressing only the ectodomain and transmembrane domain, revealed a specific interaction with VE-cadherin, when compared with controls. Controls were sialophorin, an unrelated membrane protein with a large ectodomain, and a membrane anchored C-terminal Venus-YFP fragment, lacking both ectodomain and transmembrane domains. Truncation of the first 16 FNIII-like repeats from the ectodomain of VE-PTP indicated that removal of this region is not sufficient to disrupt the interaction with VE-cadherin, although it occurs predominantly in an intracellular location. A construct with a deletion of only the 17th domain of VE-PTP was, in contrast to previous studies, still able to interact with VE-cadherin, although this also was predominantly intracellular. Other members of the R3-PTP family (DEP-1, GLEPP1 and SAP-1) also exhibited the potential to interact with VE-cadherin. The direct interaction of DEP-1 with VE-cadherin is likely to be of physiological relevance since both proteins are expressed in endothelial cells. Together the data presented in the study suggest a role for both the ectodomain and transmembrane domain of R3-PTPs in interaction with VE-cadherin.	[Dorofejeva, Olga; Barr, Alastair J.] Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London, England	University of Westminster	Barr, AJ (corresponding author), Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London, England.	a.barr1@westminster.ac.uk		Barr, Alastair/0000-0001-7738-8419	University of Westminster	University of Westminster	This study was supported by a scholarship from the University of Westminster.; We thank Prof Yotis Senis for use of lab facilities, Nahla Idris for technical support and Prof A. Weiss for the DEP-1 expression construct. OD is a recipient of a University of Westminster scholarship.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Cordoba SP, 2013, BLOOD, V121, P4295, DOI 10.1182/blood-2012-07-442251; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; den Hertog J, 2008, FEBS J, V275, P831, DOI 10.1111/j.1742-4658.2008.06247.x; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Mohebiany AN, 2013, FEBS J, V280, P388, DOI 10.1111/j.1742-4658.2012.08653.x; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Rollin J, 2012, BLOOD, V120, P1309, DOI 10.1182/blood-2012-04-424044; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Strous GJ, 2002, FEBS LETT, V529, P102, DOI 10.1016/S0014-5793(02)03187-3; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Tangye SG, 1998, J IMMUNOL, V161, P3249; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Walchli S, 2005, BIOCHEM BIOPH RES CO, V331, P497, DOI 10.1016/j.bbrc.2005.03.196; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	49	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184574	10.1371/journal.pone.0184574	http://dx.doi.org/10.1371/journal.pone.0184574			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926625	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000411166600024
J	Hablot, J; Peyrin-Biroulet, L; Kokten, T; El Omar, R; Netter, P; Bastien, C; Jouzeau, JY; Sokol, H; Moulin, D				Hablot, Julie; Peyrin-Biroulet, Laurent; Kokten, Tunay; El Omar, Reine; Netter, Patrick; Bastien, Claire; Jouzeau, Jean-Yves; Sokol, Harry; Moulin, David			Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXTRAINTESTINAL MANIFESTATIONS; ANKYLOSING-SPONDYLITIS; GUT MICROBIOTA; DYSBIOSIS; SPONDYLOARTHRITIS; MANAGEMENT; IMMUNITY; FLORA	Amongst extraintestinal manifestations (EIM) occurring in IBD patients, rheumatologic manifestations are the most frequent. Understanding the relationships between arthritis and colitis is a prerequisite to improving the management of these patients. Microbiota of patients with IBD or rheumatologic diseases, like spondyloarthritis (SpA) is modified compared to healthy individual. Thus, we have evaluated the impact of colitis in the development of arthritis in mice and we have analyzed microbiota changes. Collagen-induced arthritis (CIA) was induced at day 0 in DBA1 mice exposed or not to Dextran Sodium Sulfate (DSS) to induce colitis between day 14 and day 21. Animals were monitored regularly for arthritis and colitis severity (clinical score, hindpaw edema). Fecal microbiota was studied by 16S rRNA deep sequencing at critical time points (D14, D14, D21 & D41). At day 41, histological scoring of the intestines and ankles were performed at the end of experiment. Induction of colitis slightly delayed arthritis onset (2 +/- 1 days of delay) and reduced its severity (5.75 +/- 1.62 in arthritis only group vs 4.00 +/- 1.48 in arthritis + colitis group (p = 0.02 at day 28) macroscopically and histologically. In contrast, colitis severity was not influenced by arthritis development. Induction of colitis promoted a modification of microbiota composition and a decrease of a-diversity. Fecal microbiota composition was different between "colitis" and "arthritis + colitis groups during colitis development. Interestingly a milder decrease of bacterial diversity in the +/- arthritis+ colitis group was observed. Concomitant experimental colitis protects mice against collagen-induced arthritis and this is associated with changes in gut microbiome composition.	[Hablot, Julie; El Omar, Reine; Netter, Patrick; Jouzeau, Jean-Yves; Moulin, David] Univ Lorraine, CNRS, IMoPA, UMR7365, Vandoeuvre Les Nancy, France; [Peyrin-Biroulet, Laurent; Kokten, Tunay] Univ Lorraine, UMR 5954, INSERM, NGERE, Vandoeuvre Les Nancy, France; [Peyrin-Biroulet, Laurent] CHRU Nancy, Serv Hepatogastroenterol, Vandoeuvre Les Nancy, France; [Bastien, Claire] CHRU Nancy, Serv Anatomopathol, Vandoeuvre Les Nancy, France; [Sokol, Harry] St Antoine Hosp, Dept Gastroenterol, Paris, France; [Sokol, Harry] UPMC Univ Paris 06, Sorbonne Univ, INSERM ERL 1157,St Antoine Hosp,AP HP, Avenir Team Gut Microbiota & Immun,UMR CNRS 7203, Paris, France; [Sokol, Harry] Univ Paris Saclay, AgroParisTech, UMR INRA, Micalis Inst, Jouy En Josas, France; [Moulin, David] CHRU Nancy, Contrat Interface, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CHU de Nancy	Moulin, D (corresponding author), Univ Lorraine, CNRS, IMoPA, UMR7365, Vandoeuvre Les Nancy, France.; Moulin, D (corresponding author), CHRU Nancy, Contrat Interface, Vandoeuvre Les Nancy, France.	david.moulin@univ-lorraine.fr	sokol, harry/ABA-8991-2020; MOULIN, David/J-3849-2014; Sokol, Harry/E-2290-2019	sokol, harry/0000-0002-2914-1822; MOULIN, David/0000-0001-6619-5769; Sokol, Harry/0000-0002-2914-1822; peyrin-biroulet, laurent/0000-0003-2536-6618; El Omar, Reine/0000-0002-8984-2022	Fondation Arthritis Courtin; Region Grand Est; Societe Frangaise de Rhumatologie	Fondation Arthritis Courtin; Region Grand Est; Societe Frangaise de Rhumatologie	This work has been partly funded by Fondation Arthritis Courtin, Societe Frangaise de Rhumatologie and Region Grand Est.	Ahl D, 2016, ACTA PHYSIOL, V217, P300, DOI 10.1111/apha.12695; [Anonymous], 2017, ROLE GUT INFLAMMATIO, V63, P1099; [Anonymous], 2017, FAECAL MICROBIOTA ST, V76, P1614; [Anonymous], 2014, TARGETING TH17 CELLS, V35, P493; Ardizzone S, 2008, DIGEST LIVER DIS, V40, pS253, DOI 10.1016/S1590-8658(08)60534-4; Asquith MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2151, DOI 10.1002/art.39681; Barrie A, 2007, INFLAMM BOWEL DIS, V13, P1424, DOI 10.1002/ibd.20196; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Chen LL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909514; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dorozynska I, 2014, PHARMACOL REP, V66, P250, DOI 10.1016/j.pharep.2013.09.007; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gill T, 2015, CURR OPIN RHEUMATOL, V27, P319, DOI 10.1097/BOR.0000000000000187; Gionchetti P, 2015, J RHEUMATOL, V42, P21, DOI 10.3899/jrheum.150628; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Koboziev I, 2014, FREE RADICAL BIO MED, V68, P122, DOI 10.1016/j.freeradbiomed.2013.11.008; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Liu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30594; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MONSEN U, 1990, AM J GASTROENTEROL, V85, P711; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Munyaka PM, 2016, J BASIC MICROB, V56, P986, DOI 10.1002/jobm.201500726; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; Orchard TR, 1998, GUT, V42, P387, DOI 10.1136/gut.42.3.387; Peluso R, 2015, THER ADV CHRONIC DIS, V6, P65, DOI 10.1177/2040622314563929; Peluso R, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/631408; Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308; SCHER JU, 2015, ARTHRITIS RHEUMA S10, V67; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2016, GUT; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stebbings S, 2002, RHEUMATOLOGY, V41, P1395, DOI 10.1093/rheumatology/41.12.1395; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Veloso FT, 2011, WORLD J GASTROENTERO, V17, P2702, DOI 10.3748/wjg.v17.i22.2702; Vieira-Sousa E, 2015, ARTHRITIS RHEUMATOL, V67, P2813, DOI 10.1002/art.39282; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Yeom Y, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1456-7; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184624	10.1371/journal.pone.0184624	http://dx.doi.org/10.1371/journal.pone.0184624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926599	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600026
J	Rahman, A; Lamberty, Y; Schenker, E; Cella, M; Languille, S; Bordet, R; Richardson, J; Pifferi, F; Aujard, F				Rahman, Anisur; Lamberty, Yves; Schenker, Esther; Cella, Massimo; Languille, Solene; Bordet, Regis; Richardson, Jill; Pifferi, Fabien; Aujard, Fabienne			Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)	PLOS ONE			English	Article							LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; ANTAGONIST MEMANTINE; WORKING-MEMORY; MODEL; MODERATE; BRAIN; PERFORMANCE; IMPAIRMENT	The development of novel therapeutics to prevent cognitive decline of Alzheimer's disease (AD) is facing paramount difficulties since the translational efficacy of rodent models did not resulted in better clinical results. Currently approved treatments, including the acetylcholinesterase inhibitor donepezil (DON) and the N-methyl-D-aspartate antagonist memantine (MEM) provide marginal therapeutic benefits to AD patients. There is an urgent need to develop a predictive animal model that is phylogenetically proximal to humans to achieve better translation. The non-human primate grey mouse lemur (Microcebus murinus) is increasingly used in aging research, but there is no published results related to the impact of known pharmacological treatments on age-related cognitive impairment observed in this primate. In the present study we investigated the effects of DON and MEM on sleep-deprivation (SD)-induced memory impairment in young and aged male mouse lemurs. In particular, spatial memory impairment was evaluated using a circular platform task after 8 h of total SD. Acute single doses of DON or MEM (0.1 and 1mg/kg) or vehicle were administered intraperitoneally 3 h before the cognitive task during the SD procedure. Results indicated that both doses of DON were able to prevent the SD-induced deficits in retrieval of spatial memory as compared to vehicle-treated animals, both in young and aged animals Likewise, MEM show a similar profile at 1 mg/kg but not at 0.1mg/kg. Taken together, these results indicate that two widely used drugs for mitigating cognitive deficits in AD were partially effective in sleep deprived mouse lemurs, which further support the translational potential of this animal model. Our findings demonstrate the utility of this primate model for further testing cognitive enhancing drugs in development for AD or other neuropsychiatric conditions.	[Rahman, Anisur; Languille, Solene; Pifferi, Fabien; Aujard, Fabienne] Museum Natl Hist Nat, Ctr Natl Rech Sci, UMR 7179, Brunoy, France; [Lamberty, Yves] UCB Pharma Sa, Neurosci Therapeut Area, Braine Lalleud, Belgium; [Schenker, Esther] Inst Rech Serv, Croissy Sur Seine, France; [Cella, Massimo] Chiesi Farmaceut, Global Clin Dev, Dept Clin Pharmacol, Parma, Italy; [Bordet, Regis] Univ Lille Nord France, Dept Pharmacol Med, UDSL, Fac Med,CHU, Lille, France; [Richardson, Jill] GlaxoSmithKline, Neurosci Therapeut Unit, Stevenage, Herts, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UCB Pharma SA; Chiesi Pharmaceuticals Inc; Universite de Lille - ISITE; CHU Lille; Universite de Lille; GlaxoSmithKline	Aujard, F (corresponding author), Museum Natl Hist Nat, Ctr Natl Rech Sci, UMR 7179, Brunoy, France.	fabienne.aujard@mnhn.fr	Cella, Massimo/K-8375-2019	Pifferi, Fabien/0000-0001-9316-1935	Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative [115009]	Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative	This work was financially supported as part of the Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative under Grant Agreement no. 115009. For further information please refer to www.pharmacog.org. The funder provided support in the form of salaries for authors YL, ES, MC and JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was financially supported as part of the Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative under Grant Agreement no. 115009. For further information please refer to http://www.pharmacog.org.	Alzoubi KH, 2012, BEHAV BRAIN RES, V226, P205, DOI 10.1016/j.bbr.2011.09.017; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Bakchine S, 2007, J ALZHEIMERS DIS, V11, P471; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Braida D, 1996, EUR J PHARMACOL, V302, P13, DOI 10.1016/0014-2999(96)00072-6; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Chen Z, 2002, ACTA PHARMACOL SIN, V23, P355; Chuah LYM, 2008, J NEUROSCI, V28, P11369, DOI 10.1523/JNEUROSCI.4045-08.2008; Chuah LYM, 2009, SLEEP, V32, P999, DOI 10.1093/sleep/32.8.999; Colavito V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00106; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006; DAVIES P, 1987, J CLIN PSYCHIAT, V48, P23; DAVIES P, 1976, LANCET, V2, P1403; DAWSON GR, 1993, BEHAV BRAIN RES, V57, P143, DOI 10.1016/0166-4328(93)90130-I; Easton A, 2013, PSYCHOPHARMACOLOGY, V230, P279, DOI 10.1007/s00213-013-3152-3; FLOOD JF, 1981, BRAIN RES, V215, P177, DOI 10.1016/0006-8993(81)90500-X; FRANCIS PT, 1993, ANN NY ACAD SCI, V695, P19, DOI 10.1111/j.1749-6632.1993.tb23021.x; FRS. D, 2006, US NONH PRIM RES; Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949; Geldmacher David S., 2003, Prim Care Companion J Clin Psychiatry, V5, P251; Gomolin IH, 2010, J AM GERIATR SOC, V58, P1812, DOI 10.1111/j.1532-5415.2010.03048.x; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hagewoud R, 2010, SLEEP, V33, P1465, DOI 10.1093/sleep/33.11.1465; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ihalainen J, 2011, NEUROPHARMACOLOGY, V61, P891, DOI 10.1016/j.neuropharm.2011.06.008; Kim EY, 2005, NEUROSCI LETT, V388, P163, DOI 10.1016/j.neulet.2005.06.057; Korostenskaja M, 2007, BRAIN RES BULL, V72, P275, DOI 10.1016/j.brainresbull.2007.01.007; Kurz A, 2014, EXPERT OPIN PHARMACO, V15, P1955, DOI 10.1517/14656566.2014.945907; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanctot K. L., 2003, CMAJ, V169; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Languille S, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00446; Laurijssens Bart, 2013, Drug Discov Today Technol, V10, pe319, DOI 10.1016/j.ddtec.2012.04.001; Lenz RA, 2012, PSYCHOPHARMACOLOGY, V220, P97, DOI 10.1007/s00213-011-2456-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Q, 2012, MOL MED REP, V6, P1450, DOI 10.3892/mmr.2012.1102; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Minkeviciene R, 2004, J PHARMACOL EXP THER, V311, P677, DOI 10.1124/jpet.104.071027; Nagakura A, 2013, EUR J PHARMACOL, V703, P53, DOI 10.1016/j.ejphar.2012.12.023; Ogura H, 2000, METHOD FIND EXP CLIN, V22, P89, DOI 10.1358/mf.2000.22.2.796070; Periclou A, 2006, CLIN PHARMACOL THER, V79, P134, DOI 10.1016/j.clpt.2005.10.005; Picq JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146238; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Pifferi F, 2012, CHRONOBIOL INT, V29, P261, DOI 10.3109/07420528.2011.654019; Prvulovic D, 2014, EXPERT OPIN DRUG MET, V10, P1039, DOI 10.1517/17425255.2014.915028; Rahman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064493; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rammsayer TH, 2001, LEARN MEMORY, V8, P20, DOI 10.1101/lm.33701; Reisberg B, 2006, ARCH NEUROL-CHICAGO, V63, P49, DOI 10.1001/archneur.63.1.49; Repantis D, 2010, PHARMACOL RES, V61, P473, DOI 10.1016/j.phrs.2010.02.009; Schneider JS, 2013, NEUROBIOL AGING, V34, P1126, DOI 10.1016/j.neurobiolaging.2012.10.020; Scholtzova H., 2008, J NEUROSCI RES, V224, P57; Schugens MM, 1997, NEUROSCI LETT, V224, P57, DOI 10.1016/S0304-3940(97)13452-8; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah RS, 2008, BIOMED PHARMACOTHER, V62, P199, DOI 10.1016/j.biopha.2008.02.005; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Strong R, 1998, GERIATRICS, V53, pS9; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tarragon E, 2014, NEUROPHARMACOLOGY, V85, P206, DOI 10.1016/j.neuropharm.2014.05.023; TOBLER I, 1990, BEHAV BRAIN RES, V36, P73, DOI 10.1016/0166-4328(90)90161-7; Umukoro S, 2014, Drug Res (Stuttg), V64, P236, DOI 10.1055/s-0033-1357126; Van Dam D, 2006, EUR NEUROPSYCHOPHARM, V16, P59, DOI 10.1016/j.euroneuro.2005.06.005; Volteau C., 2011, J ALZHEIMERS DIS, V23, P749; Windisch M, 2014, NEURODEGENER DIS, V13, P147, DOI 10.1159/000357568; Xia ZM, 2012, BRAIN RES, V1441, P27, DOI 10.1016/j.brainres.2012.01.008; Xie ML, 2015, BEHAV BRAIN RES, V286, P64, DOI 10.1016/j.bbr.2015.02.040	76	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184822	10.1371/journal.pone.0184822	http://dx.doi.org/10.1371/journal.pone.0184822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922421	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300031
J	Chen, P; Du, Q; Liu, XM; Zhou, L; Hussain, S; Lei, L; Song, C; Wang, XC; Liu, WG; Yang, F; Shu, K; Liu, J; Du, JB; Yang, WY; Yong, TW				Chen, Ping; Du, Qing; Liu, Xiaoming; Zhou, Li; Hussain, Sajad; Lei, Lu; Song, Chun; Wang, Xiaochun; Liu, Weiguo; Yang, Feng; Shu, Kai; Liu, Jiang; Du, Junbo; Yang, Wenyu; Yong, Taiwen			Effects of reduced nitrogen inputs on crop yield and nitrogen use efficiency in a long-term maize-soybean relay strip intercropping system	PLOS ONE			English	Article							INTERSPECIFIC INTERACTIONS; PHOSPHORUS APPLICATION; FOOD SECURITY; N-2 FIXATION; ROOT LENGTH; SOIL N; WHEAT; COMPETITION; GROWTH; PEA	The blind pursuit of high yields via increased fertilizer inputs increases the environmental costs. Relay intercropping has advantages for yield, but a strategy for N management is urgently required to decrease N inputs without yield loss in maize-soybean relay intercropping systems (IMS). Experiments were conducted with three levels of N and three planting patterns, and dry matter accumulation, nitrogen uptake, nitrogen use efficiency (NUE), competition ratio (CR), system productivity index (SPI), land equivalent ratio (LER), and crop root distribution were investigated. Our results showed that the CR of soybean was greater than 1, and that the change in root distribution in space and time resulted in an interspecific facilitation in IMS. The maximum yield of maize under monoculture maize (MM) occurred with conventional nitrogen (CN), whereas under IMS, the maximum yield occurred with reduced nitrogen (RN). The yield of monoculture soybean (MS) and of soybean in IMS both reached a maximum under RN. The LER of IMS varied from 1.85 to 2.36, and the SPI peaked under RN. Additionally, the NUE of IMS increased by 103.7% under RN compared with that under CN. In conclusion, the separation of the root ecological niche contributed to a positive interspecific facilitation, which increased the land productivity. Thus, maize-soybean relay intercropping with reduced N input provides a very useful approach to increase land productivity and avert environmental pollution.	[Chen, Ping; Du, Qing; Liu, Xiaoming; Zhou, Li; Hussain, Sajad; Wang, Xiaochun; Liu, Weiguo; Yang, Feng; Shu, Kai; Liu, Jiang; Du, Junbo; Yang, Wenyu; Yong, Taiwen] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Chen, Ping; Du, Qing; Liu, Xiaoming; Zhou, Li; Hussain, Sajad; Song, Chun; Wang, Xiaochun; Liu, Weiguo; Yang, Feng; Shu, Kai; Liu, Jiang; Du, Junbo; Yang, Wenyu; Yong, Taiwen] Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Sichuan, Peoples R China; [Lei, Lu] Renshou Weather Bur, Meishan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Yang, WY; Yong, TW (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.; Yang, WY; Yong, TW (corresponding author), Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Sichuan, Peoples R China.	mssiyangwy@sicau.edu.cn; yongtaiwen@sicau.edu.cn	Hussain, Sajad/GZL-5573-2022; Song, Chun/B-8298-2019; Hussain, Sajad/S-4261-2019	Song, Chun/0000-0001-9927-2599; Hussain, Sajad/0000-0001-9100-360X; Chen, Ping/0000-0002-9940-4528	National Key Research and Development Program of China [2016YFD0300202]; National Natural Science Foundation of China [31271669, 31671625]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Key Research and Development Program of China (grant numbers 2016YFD0300202), the National Natural Science Foundation of China (grant numbers 31271669, 31671625).	Amosse C, 2014, NUTR CYCL AGROECOSYS, V98, P1, DOI 10.1007/s10705-013-9591-8; BELCHER JW, 1995, J ECOL, V83, P673, DOI 10.2307/2261635; CHAN LM, 1980, AGRON J, V72, P35, DOI 10.2134/agronj1980.00021962007200010008x; Corre-Hellou G, 2006, PLANT SOIL, V282, P195, DOI 10.1007/s11104-005-5777-4; D'Amico EJ, 2001, BEHAV RES METH INS C, V33, P479, DOI 10.3758/BF03195405; Duan YH, 2014, FIELD CROP RES, V157, P47, DOI 10.1016/j.fcr.2013.12.012; Erisman JW, 2007, ENVIRON POLLUT, V150, P140, DOI 10.1016/j.envpol.2007.06.033; Fan FL, 2006, PLANT SOIL, V283, P275, DOI 10.1007/s11104-006-0019-y; FEHR W. R., 1971, Crop science, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fleischer, 2014, PLANT BIOTECHNOLOGY, P181, DOI [10.1007/978-3-319-06892-3, DOI 10.1007/978-3-319-06892-3]; Gan YB, 2002, NUTR CYCL AGROECOSYS, V62, P163, DOI 10.1023/A:1015528132642; Gandhi VP, 2014, FOOD RES INT, V63, P108, DOI 10.1016/j.foodres.2014.03.015; Gao Y, 2010, AGR WATER MANAGE, V98, P199, DOI 10.1016/j.agwat.2010.08.021; Garnett T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00936; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hauggaard-Nielsen H, 2001, FIELD CROP RES, V72, P185, DOI 10.1016/S0378-4290(01)00176-9; Li B, 2016, P NATL ACAD SCI USA, V113, P6496, DOI 10.1073/pnas.1523580113; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2014, NEW PHYTOL, V203, P63, DOI 10.1111/nph.12778; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169218; Lv Y, 2014, CROP SCI, V54, P914, DOI 10.2135/cropsci2013.06.0403; Ma L, 2010, J ENVIRON QUAL, V39, P1279, DOI 10.2134/jeq2009.0403; Neugschwandtner RW, 2015, FIELD CROP RES, V179, P113, DOI 10.1016/j.fcr.2015.04.018; Norse D, 2015, AGR ECOSYST ENVIRON, V209, P5, DOI 10.1016/j.agee.2015.02.014; Wang DJ, 2004, ENVIRON GEOCHEM HLTH, V26, P221, DOI 10.1023/B:EGAH.0000039584.35434.e0; Wang XC, 2017, FIELD CROP RES, V204, P12, DOI 10.1016/j.fcr.2016.12.020; Westerman R.L., 1990, SOIL TESTING PLANT A, Vthird, DOI [10.1097/00010694-198811000-00013, DOI 10.1097/00010694-198811000-00013]; Wu YS, 2016, PLANT PROD SCI, V19, P206, DOI 10.1080/1343943X.2015.1128095; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Xia HY, 2013, FIELD CROP RES, V150, P52, DOI 10.1016/j.fcr.2013.05.027; Xiao YB, 2004, PLANT SOIL, V262, P45, DOI 10.1023/B:PLSO.0000037019.34719.0d; Yamane K, 2016, PLANT PROD SCI, V19, P449, DOI 10.1080/1343943X.2016.1164574; Yang F, 2017, PLANT PROD SCI, V20, P1, DOI 10.1080/1343943X.2016.1224553; Yang F, 2017, FIELD CROP RES, V203, P16, DOI 10.1016/j.fcr.2016.12.007; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Yang JY, 2010, AGR ECOSYST ENVIRON, V137, P192, DOI 10.1016/j.agee.2010.02.004; Yang WT, 2013, FIELD CROP RES, V146, P44, DOI 10.1016/j.fcr.2013.03.008; Yong TW, 2015, PLANT PROD SCI, V18, P388, DOI 10.1626/pps.18.388; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006; Zhang L, 2007, FIELD CROP RES, V103, P178, DOI 10.1016/j.fcr.2007.06.002; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao X, 2012, AGR ECOSYST ENVIRON, V156, P1, DOI 10.1016/j.agee.2012.04.024; Zuo YM, 2015, FRONT AGRIC SCI ENG, V2, P134, DOI 10.15302/J-FASE-2015069	47	61	70	14	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184503	10.1371/journal.pone.0184503	http://dx.doi.org/10.1371/journal.pone.0184503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910355	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200053
J	Chromikova, V; Zaragoza, MA; Krammer, F				Chromikova, Veronika; Zaragoza, Maria A.; Krammer, Florian			Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody	PLOS ONE			English	Article							INFLUENZA; CYTOTOXICITY	Because of the broad neutralization and in vivo protection across influenza A and influenza B virus strains, monoclonal antibody CR9114 is widely used in influenza virus research as a positive control in many experiments. To produce amounts sufficient for the demand requires regular transient transfections, resulting in varying yield as well as differing batch to batch quality. Here, we report the development of a serum-free CHO DG44 cell line, stably producing a CR9114-like antibody with a potential to become a useful influenza virus research tool.	[Chromikova, Veronika; Zaragoza, Maria A.; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Zaragoza, Maria A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X	NIAID [U19 AI109946]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIAID grant U19 AI109946.; We would like to thank Dr. Yiannis Ioannou for kindly providing us with the CHO DG44 cells, Dr. Patrick Wilson for providing the vectors containing the CR9114 sequences and Paul Bunduc for his technical assistance during the screening and selection process of recombinant serum-free cell line. Funding was provided by NIAID grant U19 AI109946.	Ana-Sosa-Batiz F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154461; Chromikova V, 2015, CYTOTECHNOLOGY, V67, P343, DOI 10.1007/s10616-014-9693-4; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Cox F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00399; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; He WQ, 2016, P NATL ACAD SCI USA, V113, P11931, DOI 10.1073/pnas.1609316113; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Lattenmayer C, 2007, J BIOTECHNOL, V128, P716, DOI 10.1016/j.jbiotec.2006.12.016; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Leon PE, 2016, P NATL ACAD SCI USA, V113, pE5944, DOI 10.1073/pnas.1613225113; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; Vanderven HA, 2017, CURR OPIN VIROL, V22, P89, DOI 10.1016/j.coviro.2016.12.002; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943	22	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183315	10.1371/journal.pone.0183315	http://dx.doi.org/10.1371/journal.pone.0183315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910287	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200008
J	van Buel, EM; Sigrist, H; Seifritz, E; Fikse, L; Bosker, FJ; Schoevers, RA; Klein, HC; Pryce, CR; Eisel, ULM				van Buel, Erin M.; Sigrist, Hannes; Seifritz, Erich; Fikse, Lianne; Bosker, Fokko J.; Schoevers, Robert A.; Klein, Hans C.; Pryce, Christopher R.; Eisel, Ulrich L. M.			Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR PROTEIN; NG2-EXPRESSING GLIAL-CELLS; INDUCED MEMORY IMPAIRMENT; RAT MODEL; ACETYLCHOLINESTERASE ACTIVITY; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MESSENGER-RNA; GROWTH-FACTOR; RODENT BRAIN	Electroconvulsive therapy (ECT) is an effective treatment for depression, but can have negative side effects including amnesia. The mechanisms of action underlying both the antidepressant and side effects of ECT are not well understood. An equivalent manipulation that is conducted in experimental animals is electroconvulsive seizure (ECS). Rodent studies have provided valuable insights into potential mechanisms underlying the antidepressant and side effects of ECT. However, relatively few studies have investigated the effects of ECS in animal models with a depression-relevant manipulation such as chronic stress. In the present study, mice were first exposed to chronic social stress (CSS) or a control procedure for 15 days followed by ECS or a sham procedure for 10 days. Behavioral effects were investigated using an auditory fear conditioning (learning) and expression (memory) test and a treadmill-running fatigue test. Thereafter, immunohistochemistry was conducted on brain material using the microglial marker Iba-1 and the cholinergic fibre marker ChAT. CSS did not increase fear learning and memory in the present experimental design; in both the control and CSS mice ECS reduced fear learning and fear memory expression. CSS induced the expected fatigue-like effect in the treadmill-running test; ECS induced increased fatigue in CSS and control mice. In CSS and control mice ECS induced inflammation in hippocampus in terms of increased expression of Iba-1 in radiatum of CA1 and CA3. CSS and ECS both reduced acetylcholine function in hippocampus as indicated by decreased expression of ChAT in several hippocampal sub-regions. Therefore, CSS increased fatigue and reduced hippocampal ChAT activity and, rather than reversing these effects, a repeated ECS regimen resulted in impaired fear learning-memory, increased fatigue, increased hippocampal Iba-1 expression, and decreased hippocampal ChAT expression. As such, the current model does not provide insights into the mechanism of ECT antidepressant function but does provide evidence for pathophysiological mechanisms that might contribute to important ECT side-effects.	[van Buel, Erin M.; Fikse, Lianne; Eisel, Ulrich L. M.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands; [van Buel, Erin M.; Bosker, Fokko J.; Klein, Hans C.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [van Buel, Erin M.; Schoevers, Robert A.; Eisel, Ulrich L. M.] Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands; [Sigrist, Hannes; Seifritz, Erich; Pryce, Christopher R.] Univ Zurich, Psychiat Hosp, Preclin Lab Translat Res Affect Disorders PLaTRAD, Zurich, Switzerland; [Bosker, Fokko J.; Schoevers, Robert A.; Klein, Hans C.; Eisel, Ulrich L. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Zurich; University of Groningen	Eisel, ULM (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands.; Eisel, ULM (corresponding author), Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands.; Eisel, ULM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.	u.l.m.eisel@rug.nl		Klein, Hans/0000-0001-9429-828X; Schoevers, Robert A/0000-0003-0760-9866; van Buel, Erin/0000-0003-2031-3226; Eisel, Ulrich/0000-0003-4178-0384	Dutch ministry of Economic Affairs [PID_09_02/120329]; Swiss National Science Foundation [31003A-141137]; Boehringer Ingelheim Fonds Travel grant	Dutch ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds Travel grant(Boehringer Ingelheim)	This research was funded by a grant from the Dutch ministry of Economic Affairs (registered under grant number PID_09_02/120329), a grant from the Swiss National Science Foundation (31003A-141137 to CRP and ES), and a Boehringer Ingelheim Fonds Travel grant (to EMB).	Abbott CC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.124; Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8; Andrade C, 2002, J ECT, V18, P197, DOI 10.1097/00124509-200212000-00006; Andrade C, 2012, J NEURAL TRANSM, V119, P337, DOI 10.1007/s00702-011-0712-8; Angelucci F, 2002, J ECT, V18, P138, DOI 10.1097/00124509-200209000-00005; Anuradha H, 2010, PHARM BIOL, V48, P499, DOI 10.3109/13880200903188534; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Bergamini G, 2016, NEUROPHARMACOLOGY, V109, P306, DOI 10.1016/j.neuropharm.2016.03.048; Bocchio-Chiavetto L, 2006, EUR NEUROPSYCHOPHARM, V16, P620, DOI 10.1016/j.euroneuro.2006.04.010; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Carney S, 2003, LANCET, V361, P799; Cathomas F, 2015, BRAIN BEHAV IMMUN, V50, P125, DOI 10.1016/j.bbi.2015.06.184; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Dagyte G, 2011, BEHAV BRAIN RES, V221, P574, DOI 10.1016/j.bbr.2010.02.023; Dang HX, 2009, EXP BIOL MED, V234, P785, DOI 10.3181/0812-RM-354; Das A, 2005, LIFE SCI, V77, P2299, DOI 10.1016/j.lfs.2005.02.020; de Kloet ER, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6503162; Dougherty JP, 2016, JOVE-J VIS EXP, DOI 10.3791/54052; Duman RS, 1998, J ECT, V14, P181; Farzan F, 2014, J ECT, V30, P98, DOI 10.1097/YCT.0000000000000144; Fink M, 2014, J ECT, V30, P5, DOI 10.1097/YCT.0b013e3182a6ad0d; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Grandjean J, 2016, NEUROIMAGE, V142, P544, DOI 10.1016/j.neuroimage.2016.08.013; Gregory-Roberts EM, 2010, J AFFECT DISORDERS, V126, P39, DOI 10.1016/j.jad.2009.11.018; Heijnen WT, 2010, J CLIN PSYCHOPHARM, V30, P616, DOI 10.1097/JCP.0b013e3181ee0f5f; Hidaka N, 2013, EPILEPSY RES, V104, P181, DOI 10.1016/j.eplepsyres.2012.09.017; Hovens IB., 2014, NEUROIMMUNOL NEUROIN, V1, P82, DOI [10.4103/2347-8659.139719, DOI 10.4103/2347-8659.139719]; Hu YD, 2010, J ECT, V26, P121, DOI 10.1097/YCT.0b013e3181c18bbf; Husain MM, 2004, J CLIN PSYCHIAT, V65, P485; Jansson L, 2009, PROG NEURO-PSYCHOPH, V33, P1119, DOI 10.1016/j.pnpbp.2009.06.007; Jimenez-Vasquez PA, 2007, EUR NEUROPSYCHOPHARM, V17, P298, DOI 10.1016/j.euroneuro.2006.06.011; Jinno S, 2008, EXP NEUROL, V212, P440, DOI 10.1016/j.expneurol.2008.04.028; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kyeremanteng C, 2014, PROG NEURO-PSYCHOPH, V54, P170, DOI 10.1016/j.pnpbp.2014.05.012; Kyeremanteng C, 2012, PHARMACOPSYCHIATRY, V45, P244, DOI 10.1055/s-0032-1306278; Li BJ, 2007, LIFE SCI, V80, P1539, DOI 10.1016/j.lfs.2007.01.032; Luo J, 2014, NEUROPSYCH DIS TREAT, V10, P1847, DOI 10.2147/NDT.S67108; Luo J, 2012, PSYCHIAT RES, V198, P300, DOI 10.1016/j.psychres.2011.09.010; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Marano CM, 2007, J CLIN PSYCHIAT, V68, P512, DOI 10.4088/JCP.v68n0404; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McDaniel WW, 2006, J ECT, V22, P103, DOI 10.1097/00124509-200606000-00005; Minelli A, 2011, PROG NEURO-PSYCHOPH, V35, P1322, DOI 10.1016/j.pnpbp.2011.04.013; Mongiat LA, 2014, SCIENCE, V344, P594, DOI 10.1126/science.1254236; Nakagawa Y, 2015, PHARMACOL THERAPEUT, V154, P21, DOI 10.1016/j.pharmthera.2015.06.010; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Nissen C, 2010, BIOL PSYCHIAT, V68, P544, DOI 10.1016/j.biopsych.2010.05.026; Nordanskog P, 2010, J ECT, V26, P62, DOI 10.1097/YCT.0b013e3181a95da8; O'Donovan S, 2014, INT J NEUROPSYCHOPH, V17, P1477, DOI 10.1017/S1461145714000200; O'Donovan S, 2012, PROG NEURO-PSYCHOPH, V37, P147, DOI 10.1016/j.pnpbp.2011.12.012; Payne NA, 2009, J PSYCHIATR PRACT, V15, P346, DOI 10.1097/01.pra.0000361277.65468.ef; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Piccinni A, 2009, EUR NEUROPSYCHOPHARM, V19, P349, DOI 10.1016/j.euroneuro.2009.01.002; Pigot M, 2008, J ECT, V24, P57, DOI 10.1097/YCT.0b013e3181616c14; Pryce CR, 2012, NEUROPHARMACOLOGY, V62, P358, DOI 10.1016/j.neuropharm.2011.08.012; Reid IC, 1997, SEIZURE, V6, P351, DOI 10.1016/S1059-1311(97)80034-9; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Sakaida M, 2013, J PSYCHOPHARMACOL, V27, P1058, DOI 10.1177/0269881113497612; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Shapira B, 2000, J ECT, V16, P97, DOI 10.1097/00124509-200006000-00002; Srikumar BN, 2006, NEUROSCIENCE, V143, P679, DOI 10.1016/j.neuroscience.2006.08.041; Steward O, 1997, EXP NEUROL, V148, P100, DOI 10.1006/exnr.1997.6613; STEWART C, 1994, NEUROREPORT, V5, P1041, DOI 10.1097/00001756-199405000-00006; STEWART C, 1993, BRAIN RES, V620, P139, DOI 10.1016/0006-8993(93)90280-Z; STEWART CA, 1994, NEUROSCI LETT, V178, P11, DOI 10.1016/0304-3940(94)90277-1; Stryjer R, 2012, CLIN NEUROPHARMACOL, V35, P161, DOI 10.1097/WNF.0b013e31825e7945; Sunanda, 2000, NEUROCHEM RES, V25, P1547, DOI 10.1023/A:1026606201069; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; van Buel EM, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.100; Wennstrom M, 2006, BIOL PSYCHIAT, V59, P178, DOI 10.1016/j.biopsych.2005.08.032; Wennstrom M, 2004, BIOL PSYCHIAT, V55, P464, DOI 10.1016/j.biopsych.2003.11.011; Wennstrom M, 2003, BIOL PSYCHIAT, V54, P1015, DOI 10.1016/S0006-3223(03)00693-0; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Yao Z, 2010, NEUROSCIENCE, V168, P405, DOI 10.1016/j.neuroscience.2010.03.060; Yoosefi A, 2014, J ECT, V30, P15, DOI 10.1097/YCT.0b013e3182a4b4c6; Zhu XL, 2015, NEUROSCI LETT, V599, P32, DOI 10.1016/j.neulet.2015.05.022; Zyss T, 1997, BIOL PSYCHIAT, V42, P920, DOI 10.1016/S0006-3223(96)00518-5	80	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184603	10.1371/journal.pone.0184603	http://dx.doi.org/10.1371/journal.pone.0184603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910337	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200067
J	Lim, SH; Mburu, G; Bourne, A; Pang, J; Wickersham, JA; Wei, CKT; Yee, IA; Wang, BY; Cassolato, M; Azwa, I				Lim, Sin How; Mburu, Gitau; Bourne, Adam; Pang, Joselyn; Wickersham, Jeffrey A.; Wei, Clayton Koh Thuan; Yee, Ilias Adam; Wang, Bangyuan; Cassolato, Matteo; Azwa, Iskandar			Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; SEXUALLY-TRANSMITTED HIV; ASIA-PACIFIC REGION; TRANSGENDER WOMEN; HIGH-RISK; CONDOM USE; YOUNG MEN; PREP; ACCEPTABILITY; MSM	Objective We examined willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia. Methods An online survey of 990 MSM was conducted between March and April 2016. Eligibility criteria included being biological male, Malaysian citizen, 18 years of age or above, identifying as MSM, and being HIV negative or unknown status. Participants' demographics, sexual and drug use behaviors, attitudes towards PrEP, and preferences regarding future access to PrEP were collected. Bivariate analysis and logistic regression were performed to determine factors associated with willingness to use PrEP. Results Fewer than half of participants (44%) knew about PrEP before completing the survey. Overall, 39% of the sample were willing to take PrEP. Multivariate logistic regression indicated that Malay men (AOR: 1.73, 95% CI: 1.12, 2.70), having 2 or more male anal sex partners in the past 6 months (AOR: 1.98, 95% CI: 1.29, 3.05), previous knowledge of PrEP (AOR: 1.40, 95% CI: 1.06, 1.86), lack of confidence in practising safer sex (AOR: 1.36, 95% CI: 1.02, 1.81), and having ever paid for sex with a male partner (AOR: 1.39, 95% CI: 1.01, 1.91) were independently associated with greater willingness to use PrEP, while men who identified as heterosexual were less willing to use PrEP (AOR, 0.36, 95% CI: 0.13, 0.97). Majority of participants preferred to access PrEP at affordable cost below 100 Malaysian Ringgit (USD25) per month from community based organisations followed by private or government hospitals. Conclusions Overall, MSM in Malaysia reported a relatively low level of willingness to use PrEP, although willingness was higher among those previously aware of PrEP. There is a need to provide PrEP at affordable cost, increase demand and awareness of PrEP, and to provide access to this preventative medication via diverse, integrated and tailored sexual health services.	[Lim, Sin How; Wickersham, Jeffrey A.] Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia; [Mburu, Gitau; Wang, Bangyuan; Cassolato, Matteo] Univ Lancaster, Div Hlth Res, Lancaster, England; [Bourne, Adam] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Bourne, Adam] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Sigma Res, London, England; [Pang, Joselyn] Australian Federat AIDS Org, Int Programs, Bangkok, Thailand; [Wickersham, Jeffrey A.] Yale Sch Med, Dept Internal Med, Sect Infect Dis, AIDS Program, New Haven, CT USA; [Wei, Clayton Koh Thuan; Yee, Ilias Adam] Malaysian AIDS Council, Kuala Lumpur, Malaysia; [Azwa, Iskandar] Univ Malaya, Fac Med, Infect Dis Unit, Kuala Lumpur, Malaysia	Universiti Malaya; Lancaster University; La Trobe University; University of London; London School of Hygiene & Tropical Medicine; Yale University; Universiti Malaya	Lim, SH (corresponding author), Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia.	howie.ceria@gmail.com	Lim, Sin How/AAC-8004-2020; Azwa, Iskandar/N-9186-2017	Azwa, Iskandar/0000-0003-1977-6709; Mburu, Gitau/0000-0002-5812-0529	International HIV/AIDS Alliance; University of Malaya [HIRGA E000001-20001]; National Institute on Drug Abuse [KO1 DA038529]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA038529] Funding Source: NIH RePORTER	International HIV/AIDS Alliance; University of Malaya(Universiti Malaya); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funding from International HIV/AIDS Alliance through its Innovation Fund. Some authors (GM, BW, MC) were employed by the funder during the conduct of this research; however, the views expressed in this paper are those of the authors and not necessarily those of the funder. This work was additionally funded by University of Malaya grant HIRGA E000001-20001 to Dr. Lim Sin How, Dr. Iskandar Azwa, and the National Institute on Drug Abuse grant KO1 DA038529 to Dr. Jeffrey A Wickersham.	Aghaizu A, 2013, SEX TRANSM INFECT, V89, P207, DOI 10.1136/sextrans-2012-050648; Al-Tayyib AA, 2014, AIDS BEHAV, V18, pS340, DOI 10.1007/s10461-013-0553-6; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Ayala George, 2013, J Sex Transm Dis, V2013, P953123, DOI 10.1155/2013/953123; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Beyrer C, 2011, 3 M TECHN ADV GROUP; Bil JP, 2015, AIDS, V29, P955, DOI 10.1097/QAD.0000000000000639; Bourne A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21899; Brooks RA, 2015, INT J STD AIDS, V26, P1040, DOI 10.1177/0956462415570159; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Ding YY, 2016, BIOSCI TRENDS, V10, P113, DOI 10.5582/bst.2016.01035; Earnshaw VA, 2016, AIDS BEHAV, V20, P98, DOI 10.1007/s10461-015-1168-x; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Ferrer L, 2016, AIDS BEHAV, V20, P1423, DOI 10.1007/s10461-016-1379-9; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Frankis J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151385; Frankis JS, 2016, SEX TRANSM INFECT, V92, P279, DOI 10.1136/sextrans-2015-052101; Gersh J. K., 2014, Journal of AIDS and Clinical Research, V5, P335; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Gredig D, 2016, AIDS CARE, V28, P44, DOI 10.1080/09540121.2016.1146212; Hoagland B, 2017, AIDS BEHAV, V21, P1278, DOI 10.1007/s10461-016-1516-5; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Jackson T, 2012, AIDS BEHAV, V16, P1853, DOI 10.1007/s10461-012-0188-z; Kanter J, 2011, INT J STD AIDS, V22, P30, DOI 10.1258/ijsa.2010.010277; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Karuga RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151716; Kennedy C, 2014, WHOHIV20149; Kesler MA, 2016, AIDS CARE, V28, P1378, DOI 10.1080/09540121.2016.1178703; Ko NY, 2016, AIDS EDUC PREV, V28, P128, DOI 10.1521/aeap.2016.28.2.128; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Krishnaswamy S, 2009, ASIA-PAC J PUBLIC HE, V21, P442, DOI 10.1177/1010539509345862; Lebouche B, 2016, HIV MED, V17, P152, DOI 10.1111/hiv.12286; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Lim SH, 2015, DRUG ALCOHOL DEPEN, V151, P31, DOI 10.1016/j.drugalcdep.2015.02.040; Lim SH, 2013, SEX TRANSM INFECT, V89, P642, DOI 10.1136/sextrans-2012-050995; Lorente N, 2012, AIDS CARE, V24, P468, DOI 10.1080/09540121.2011.626394; Mansergh G, 2010, JAIDS-J ACQ IMM DEF, V55, pE14, DOI 10.1097/QAI.0b013e3181f27616; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Ministry of Health Malaysia, 2015, NAT STRAT PLAN END A; Mustanski B, 2013, AIDS BEHAV, V17, P2999, DOI 10.1007/s10461-013-0507-z; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Ngadiman S, 2016, GLOBAL AIDS RESPONSE; Oldenburg C, 2016, SEX HLTH; Oldenburg CE, 2014, AIDS PATIENT CARE ST, V28, P109, DOI 10.1089/apc.2013.0372; Peinado Jesus, 2013, J Int Assoc Provid AIDS Care, V12, P278, DOI 10.1177/1545109712473650; Peng P, 2017, AIDS BEHAV; Pitpitan EV, 2016, AIDS BEHAV, V20, P431, DOI 10.1007/s10461-015-1172-1; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Rampal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046365; Rocha LM, 2014, J INT AIDS SOC, V17, P150, DOI 10.7448/IAS.17.4.19734; Rosenthal E, 2014, AIDS CARE, V26, P176, DOI 10.1080/09540121.2013.803014; Rucinski KB, 2013, AIDS BEHAV, V17, P2180, DOI 10.1007/s10461-013-0443-y; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Sineath R Craig, 2013, J Int Assoc Provid AIDS Care, V12, P227, DOI 10.1177/2325957413488184; Stoove A M, 2015, HIV PREEXPOSURE PROP; Tavitian-Exley I, 2015, ADDICTION, V110, P572, DOI 10.1111/add.12846; Waclawski Eugene, 2012, Occup Med (Lond), V62, P477, DOI 10.1093/occmed/kqs075; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; White D, 2014, AM J MENS HEALTH, V8, P98, DOI 10.1177/1557988313489133; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; WHO, 2012, GUID PREEXPOSURE OR; World Health Organization, 2015, WHOHIV201548; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zablotska I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21119; Zhang Y, 2013, AIDS PATIENT CARE ST, V27, P137, DOI 10.1089/apc.2012.0412; Zhou F, 2012, PLOS ONE, V7	77	23	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182838	10.1371/journal.pone.0182838	http://dx.doi.org/10.1371/journal.pone.0182838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902857	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000410669200006
J	Belair, DG; Wolf, CJ; Wood, C; Ren, HZ; Grindstaff, R; Padgett, W; Swank, A; MacMillan, D; Fisher, A; Winnik, W; Abbott, BD				Belair, David G.; Wolf, Cynthia J.; Wood, Carmen; Ren, Hongzu; Grindstaff, Rachel; Padgett, William; Swank, Adam; MacMillan, Denise; Fisher, Anna; Winnik, Witold; Abbott, Barbara D.			Engineering human cell spheroids to model embryonic tissue fusion in vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR RECEPTOR; OSTEOGENIC DIFFERENTIATION; CLEFT-PALATE; STROMAL CELLS; EXPRESSION; BONE; MECHANISMS; GENE; PALATOGENESIS	Epithelial-mesenchymal interactions drive embryonic fusion events during development, and perturbations of these interactions can result in birth defects. Cleft palate and neural tube defects can result from genetic defects or environmental exposures during development, yet very little is known about the effect of chemical exposures on fusion events during human development because of a lack of relevant and robust human in vitro assays of developmental fusion behavior. Given the etiology and prevalence of cleft palate and the relatively simple architecture and composition of the embryonic palate, we sought to develop a three-dimensional culture system that mimics the embryonic palate and could be used to study fusion behavior in vitro using human cells. We engineered size-controlled human Wharton's Jelly stromal cell (HWJSC) spheroids and established that 7 days of culture in osteogenesis differentiation medium was sufficient to promote an osteogenic phenotype consistent with embryonic palatal mesenchyme. HWJSC spheroids supported the attachment of human epidermal keratinocyte progenitor cells (HPEKp) on the outer spheroid surface likely through deposition of collagens I and IV, fibronectin, and laminin by mesenchymal spheroids. HWJSC spheroids coated in HPEKp cells exhibited fusion behavior in culture, as indicated by the removal of epithelial cells from the seams between spheroids, that was dependent on epidermal growth factor signaling and fibroblast growth factor signaling in agreement with palate fusion literature. The method described here may broadly apply to the generation of three-dimensional epithelial-mesenchymal co-cultures to study developmental fusion events in a format that is amenable to predictive toxicology applications.	[Belair, David G.; Wolf, Cynthia J.; Wood, Carmen; Abbott, Barbara D.] US EPA, Tox Assessment Div, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Ren, Hongzu; Grindstaff, Rachel; Padgett, William; Swank, Adam; MacMillan, Denise; Fisher, Anna; Winnik, Witold] US EPA, Res Cores Unit, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Abbott, BD (corresponding author), US EPA, Tox Assessment Div, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	abbott.barbara@epa.gov	Belair, David/AAT-8237-2020	Belair, David/0000-0003-2145-3829; Abbott, Barbara/0000-0001-8996-5842	US Environmental Protection Agency	US Environmental Protection Agency(United States Environmental Protection Agency)	The information in this document has been funded wholly by the US Environmental Protection Agency. It has been subjected to review by the National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views of the Agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.	Abbott BD, 2010, BIRTH DEFECTS RES B, V89, P266, DOI 10.1002/bdrb.20252; Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5; Belair DG, 2017, TOXICOLOGY, V382, P93, DOI 10.1016/j.tox.2017.03.007; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Contador D, 2015, EXP BIOL MED, V240, P1235, DOI 10.1177/1535370214566565; Czajka CA, 2014, ANN BIOMED ENG, V42, P1049, DOI 10.1007/s10439-014-0986-8; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; De la Fuente A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010496; Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com; Dean DM, 2008, TISSUE ENG PT A, V14, P1989, DOI 10.1089/ten.tea.2007.0320; Deisenroth C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114133; Doherty KR, 2013, TOXICOL APPL PHARM, V272, P245, DOI 10.1016/j.taap.2013.04.027; Dudas M, 2004, DEV BIOL, V266, P96, DOI 10.1016/j.ydbio.2003.10.007; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Feng J, 2008, FASEB J, V22; Ge Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162522; Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741; Ghali O, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0056-6; Gittenberger-de Groot AC, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.002; Granchi D, 2010, TISSUE ENG PART C-ME, V16, P511, DOI [10.1089/ten.tec.2009.0405, 10.1089/ten.TEC.2009.0405]; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; He X, 2017, EXP CELL RES; Hemming S, 2016, STEM CELLS DEV, V25, P909, DOI 10.1089/scd.2015.0384; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hu LH, 2015, J CELL PHYSIOL, V230, P1212, DOI 10.1002/jcp.24856; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Jaager K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038833; Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101; Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; Kitase Y, 2013, INT J DEV BIOL, V57, P55, DOI 10.1387/ijdb.120117yk; Knudsen T.B., 2017, CHEM RES TOXICOL; Lane J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00258; Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt328; Levi B, 2011, PLAST RECONSTR SURG, V127, P1182, DOI 10.1097/PRS.0b013e3182043a07; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lobo SE, 2015, CELL TISSUE RES, V361, P477, DOI 10.1007/s00441-015-2116-9; Marga Francoise, 2007, Birth Defects Research, V81, P320, DOI 10.1002/bdrc.20109; Mastroiacovo P, 2011, CLEFT PALATE-CRAN J, V48, P66, DOI 10.1597/09-217; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; Nelson ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025847; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Onizuka S, 2016, J CELL BIOCHEM, V117, P2423, DOI 10.1002/jcb.25634; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Ray HJ, 2012, DEVELOPMENT, V139, P1701, DOI 10.1242/dev.068338; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Safadi FF, 2009, BONE PATHOLOGY, SECOND EDITION, P1, DOI 10.1007/978-1-59745-347-9_1; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Santos JM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0082-5; Saugspier M, 2010, STEM CELLS DEV, V19, P707, DOI [10.1089/scd.2010.0027, 10.1089/scd.2009.0027]; Schulze J, 2011, J BONE MINER RES, V26, P704, DOI 10.1002/jbmr.269; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762; Taya Y, 1999, DEVELOPMENT, V126, P3869; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Viale-Bouroncle S, 2015, BIOCHEM BIOPH RES CO, V457, P314, DOI 10.1016/j.bbrc.2014.12.107; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Wang JJ, 2009, J ZHEJIANG UNIV-SC B, V10, P355, DOI 10.1631/jzus.B0820252; Yamamoto T, 2003, DEV BIOL, V260, P512, DOI 10.1016/S0012-1606(03)00275-6; Yen CM, 2010, BIOMATERIALS, V31, P4341, DOI 10.1016/j.biomaterials.2010.02.014; Zeitouni S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-75	72	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184155	10.1371/journal.pone.0184155	http://dx.doi.org/10.1371/journal.pone.0184155			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898253	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500015
J	Zhang, MQ; Miao, YL; Chen, Q; Cai, M; Dong, WK; Dai, XX; Lu, YJ; Zhou, CY; Cui, ZK; Xiong, B				Zhang, Mianqun; Miao, Yilong; Chen, Qian; Cai, Meng; Dong, Wenkang; Dai, Xiaoxin; Lu, Yajuan; Zhou, Changyin; Cui, Zhaokang; Xiong, Bo			BaP exposure causes oocyte meiotic arrest and fertilization failure to weaken female fertility	FASEB JOURNAL			English	Article						environmental pollutant; oocyte quality; meiotic progression; fertilization ability; oxidative stress	POLYCYCLIC AROMATIC-HYDROCARBONS; SPINDLE ASSEMBLY CHECKPOINT; LYSOZYME-LIKE PROTEIN; IN-VITRO; ZONA-PELLUCIDA; HYDROXYLASE-ACTIVITY; GAMETE RECOGNITION; OXIDATIVE STRESS; SPERM BINDING; MOUSE OOCYTES	Benzo[a] pyrene (BaP) is a ubiquitous environmental pollutant and carcinogen that is frequently found in particulate matter, with a diameter of <= 2.5 mu m (PM2.5). It has been reported to interrupt the normal reproductive system, but the exact molecular basis has not been clearly defined. To understand the underlying mechanisms regarding how BaP exposure disrupts female fertility, we evaluated oocyte quality by assessing the critical regulators and events during oocyte meiotic maturation and fertilization. We found that BaP exposure compromised the mouse oocyte meiotic progression by disrupting normal spindle assembly, chromosome alignment, and kinetochore-microtubule attachment, consequently leading to the generation of aneuploid eggs. In addition, BaP administration significantly decreased the fertilization rate of mouse eggs by reducing the number of sperm binding to the zona pellucida, which was consistent with the premature cleavage of N terminus of zona pellucida sperm-binding protein 2 and precocious exocytosis of ovastacin. Furthermore, BaP exposure interfered with the gamete fusion process by perturbing the localization and protein level of Juno. Notably, we found that BaP exposure induced oxidative stress with an increased level of reactive oxygen species and apoptosis in oocytes and thereby led to the deterioration of critical regulators and events during oocyte meiotic progression and fertilization. Our data document that BaP exposure reduces female fertility via impairing oocyte maturation and fertilization ability induced by oxidative stress and early apoptosis in murine models.	[Zhang, Mianqun; Miao, Yilong; Chen, Qian; Cai, Meng; Dong, Wenkang; Dai, Xiaoxin; Lu, Yajuan; Zhou, Changyin; Cui, Zhaokang; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	xiongbo@njau.edu.cn			National Natural Science Foundation [31571545]; Natural Science Foundation of Jiangsu Province [BK20150677]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Dr. Shaochen Sun (Nanjing Agricultural University) for critical comments on the manuscript. This work was supported by National Natural Science Foundation Grant 31571545 (to B.X.) and Natural Science Foundation of Jiangsu Province Grant BK20150677(to B.X). The authors declare no conflicts of interest.	Agrawal M., 2017, REV ENV CONTAM TOXIC; Aravamudhan P, 2015, NAT CELL BIOL, V17, P868, DOI 10.1038/ncb3179; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595; Beal MA, 2015, MUTAT RES-FUND MOL M, V775, P26, DOI 10.1016/j.mrfmmm.2015.03.010; BERWALD Y, 1965, J NATL CANCER I, V35, P641; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BINNEMANN PH, 1979, Z LEBENSM UNTERS FOR, V169, P447, DOI 10.1007/BF01126748; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Bolden AL, 2017, REPROD TOXICOL, V73, P61, DOI 10.1016/j.reprotox.2017.07.012; Borman SM, 2000, TOXICOL APPL PHARM, V167, P191, DOI 10.1006/taap.2000.9006; Brunsch D, 1978, Krankenpflege (Frankf), V32, P6; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Chang WA, 2016, ONCOL LETT, V11, P1783, DOI 10.3892/ol.2016.4153; Chatkin J. M., 2014, PLOS ONE, V9; CHORAZY M, 1994, ENVIRON HEALTH PERSP, V102, P61, DOI 10.2307/3431932; CSABA G, 1993, J DEV PHYSIOL, V19, P217; Dai XX, 2017, HUM REPROD, V32, P598, DOI 10.1093/humrep/dew362; Dai X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126653; DIAMOND L, 1967, CANCER RES, V27, P890; Esengen S, 2000, J Am Med Dir Assoc, V1, P197; Ewa B, 2017, J APPL GENET, V58, P321, DOI 10.1007/s13353-016-0380-3; Fu PB, 2017, ENVIRON SCI TECHNOL, V51, P1587, DOI 10.1021/acs.est.6b04418; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Grayson P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150296; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; HUBERMAN E, 1974, INT J CANCER, V13, P326, DOI 10.1002/ijc.2910130308; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jin YT, 2016, CANCER INVEST, V34, P173, DOI 10.3109/07357907.2016.1156689; Kalthoff S, 2017, FREE RADICAL BIO MED, V108, P66, DOI 10.1016/j.freeradbiomed.2017.03.006; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Kummer V, 2013, J APPL TOXICOL, V33, P90, DOI 10.1002/jat.1714; Liang Jing, 2016, Zhongguo Zhong Xi Yi Jie He Za Zhi, V36, P234; Liu B, 2017, ENVIRON POLLUT, V220, P1171, DOI 10.1016/j.envpol.2016.11.018; Liu H, 2016, TRANSCR-AUSTIN, V7, P21, DOI 10.1080/21541264.2015.1127315; Luderer U, 2017, ENVIRON INT, V100, P110, DOI 10.1016/j.envint.2016.12.021; Lumpe D, 1979, US MED, V15, P11; Lybarger JA, 1999, RENAL FAILURE, V21, P263, DOI 10.3109/08860229909085088; MACKENZIE KM, 1981, BIOL REPROD, V24, P183, DOI 10.1095/biolreprod24.1.183; Madeen EP, 2017, REV ENVIRON HEALTH, V32, P73, DOI 10.1515/reveh-2016-0045; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; MATTISON DR, 1989, TOXICOL PATHOL, V17, P364, DOI 10.1177/019262338901700213; MATTISON DR, 1980, TOXICOL APPL PHARM, V56, P399, DOI 10.1016/0041-008X(80)90074-5; MATTISON DR, 1979, CANCER RES, V39, P3471; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Neal MS, 2008, REPROD TOXICOL, V25, P100, DOI 10.1016/j.reprotox.2007.10.012; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Radford SJ, 2017, CHROMOSOMA, V126, P351, DOI 10.1007/s00412-016-0618-1; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Ramesh A, 2002, POLYCYCL AROMAT COMP, V22, P969, DOI 10.1080/10406630290104121; Rekhadevi PV, 2014, HUM EXP TOXICOL, V33, P196, DOI 10.1177/0960327113489050; Rogula-Kozlowska W, 2016, AIR QUAL ATMOS HLTH, V9, P533, DOI 10.1007/s11869-015-0359-y; Rogula-Kozlowska W, 2013, B ENVIRON CONTAM TOX, V91, P349, DOI 10.1007/s00128-013-1060-1; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; Sadeu JC, 2011, REPROD TOXICOL, V31, P402, DOI 10.1016/j.reprotox.2010.12.006; Sadeu JC, 2011, FERTIL STERIL, V95, P2410, DOI 10.1016/j.fertnstert.2011.03.072; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmitt EE, 2017, MOL PHARMACOL, V91, P178, DOI 10.1124/mol.116.106740; Shomper M, 2014, CELL CYCLE, V13, P1171, DOI 10.4161/cc.28046; Sikdar S, 2014, ENVIRON TOXICOL PHAR, V37, P300, DOI 10.1016/j.etap.2013.12.004; Sikdar S, 2015, J PHARMACOPUNCT, V18, P86, DOI 10.3831/KPI.2015.18.019; Smith JN, 2017, TOXICOL LETT, V269, P23, DOI 10.1016/j.toxlet.2017.01.008; Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028; STEDMAN RL, 1968, CHEM IND-LONDON, P394; SULLIVAN JL, 1982, GERONTOLOGY, V28, P242, DOI 10.1159/000212539; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; Valentovic MA, 2006, TOXICOL LETT, V164, P214, DOI 10.1016/j.toxlet.2005.12.009; Viau C, 2000, INT ARCH OCC ENV HEA, V73, P331, DOI 10.1007/s004209900112; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; WEATHERSBEE PS, 1980, J REPROD MED, V25, P315; Wu ZW, 2014, EXP DERMATOL, V23, P260, DOI 10.1111/exd.12360; Wynne DJ, 2015, J CELL BIOL, V210, P899, DOI 10.1083/jcb.201506020; Xiong B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006580; Yu NX, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01769; Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122; Zhang B, 2017, NATURE, V542, P31, DOI 10.1038/542031a; Zhang MQ, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12396	84	42	42	3	89	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					342	352		10.1096/fj.201700514R	http://dx.doi.org/10.1096/fj.201700514R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904021				2022-12-26	WOS:000419172700031
J	Senghore, M; Otu, J; Witney, A; Gehre, F; Doughty, EL; Kaye, GL; Butcher, P; Salako, K; Kehinde, A; Onyejepu, N; Idigbe, E; Corrah, T; de Jong, B; Pollee, MJ; Antonio, M				Senghore, Madikay; Otu, Jacob; Witney, Adam; Gehre, Florian; Doughty, Emma L.; Kaye, Gemma L.; Butcher, Phillip; Salako, Kayode; Kehinde, Aderemi; Onyejepu, Nneka; Idigbe, Emmanuel; Corrah, Tumani; de Jong, Bouke; Pollee, Mark J.; Antonio, Martin			Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; DIVERSITY; CAMEROON; COMPLEX; WORLD; TOOL	Nigeria has an emerging problem with multidrug-resistant tuberculosis (MDR-TB). Whole-genome sequencing was used to understand the epidemiology of tuberculosis and genetics of multi-drug resistance among patients from two tertiary referral centers in Southwest Nigeria. In line with previous molecular epidemiology studies, most isolates of Mycobacterium tuberculosis from this dataset belonged to the Cameroon clade within the Euro-American lineage. Phylogenetic analysis showed this clade was undergoing clonal expansion in this region, and suggests that it was involved in community transmission of sensitive and multidrug-resistant tuberculosis. Five patients enrolled for retreatment were infected with pre-extensively drug resistant (pre-XDR) due to fluoroquinolone resistance in isolates from the Cameroon clade. In all five cases resistance was conferred through a mutation in the gyrA gene. In some patients, genomic changes occurred in bacterial isolates during the course of treatment that potentially led to decreased drug susceptibility. We conclude that inter-patient transmission of resistant isolates, principally from the Cameroon clade, contributes to the spread of MDR-TB in this setting, underscoring the urgent need to curb the spread of multidrug resistance in this region.	[Senghore, Madikay; Otu, Jacob; Gehre, Florian; Corrah, Tumani; Antonio, Martin] Med Res Council Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia; [Senghore, Madikay; Doughty, Emma L.; Kaye, Gemma L.; Pollee, Mark J.; Antonio, Martin] Univ Warwick, Microbiol & Infect Unit, Coventry, W Midlands, England; [Witney, Adam; Butcher, Phillip] St Georges Univ London, Inst Infect & Immun, London, England; [Gehre, Florian; de Jong, Bouke] Inst Trop Med, Antwerp, Belgium; [Salako, Kayode; Kehinde, Aderemi] Univ Coll Hosp, Dept Med Microbiol & Parasitol, Ibadan, Nigeria; [Onyejepu, Nneka; Idigbe, Emmanuel] Nigeria Inst Med Res, Natl TB Reference Lab, Lagos, Nigeria; [Pollee, Mark J.] Quadram Inst, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England; [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Warwick; St Georges University London; Institute of Tropical Medicine (ITM); University of Ibadan; University College Hospital, Ibadan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of London; London School of Hygiene & Tropical Medicine	Antonio, M (corresponding author), Med Res Council Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia.; Antonio, M (corresponding author), Univ Warwick, Microbiol & Infect Unit, Coventry, W Midlands, England.; Antonio, M (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	mantionio@mrc.gm	Doughty, Emma/AAA-7416-2021; de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Kay, Gemma/0000-0002-1176-8459; Butcher, Philip/0000-0003-1223-9097; Pallen, Mark/0000-0003-1807-3657; Witney, Adam/0000-0003-4561-7170	EDCTP-WANETAM [CB. 2007. 41700.007]; MRC [MR/L015080/1] Funding Source: UKRI; Medical Research Council [MR/L015080/1] Funding Source: researchfish	EDCTP-WANETAM; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the EDCTP-WANETAM grant No: CB. 2007. 41700.007. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurrahman ST, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.277.3906; Ani A, 2015, AFR J MICROBIOL RES, V9, P960; [Anonymous], 2013, EUROPEAN COMMUNICABL, V18; Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001; Barrera L, 2008, WHO GUIDELINES APPRO; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Drobniewski F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-190; Falzon D, 2015, EUR RESPIR J, V45, P150, DOI 10.1183/09031936.00101814; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Gagneux S, 2014, CURR TOP MICROBIOL, V374, P1, DOI 10.1007/82_2013_329; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gehre F, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0704-5; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; IBRAHIM LM, 2014, PAN AFR MED J, V17, P33095; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lawson L, 2010, ANN AFR MED, V9, P184, DOI 10.4103/1596-3519.68355; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Lee RS, 2015, J INFECT DIS, V211, P1905, DOI 10.1093/infdis/jiv011; Musa BM, 2015, ANN THORAC MED, V10, P185, DOI 10.4103/1817-1737.160838; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Walker TM, 2015, LANCET INFECT DIS; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; Yeboah-Manu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161892; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	46	16	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184510	10.1371/journal.pone.0184510	http://dx.doi.org/10.1371/journal.pone.0184510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926571	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600020
J	Spiegler, V; Hensel, A; Seggewiss, J; Lubisch, M; Liebau, E				Spiegler, Verena; Hensel, Andreas; Seggewiss, Jochen; Lubisch, Milena; Liebau, Eva			Transcriptome analysis reveals molecular anthelmintic effects of procyanidins in C. elegans	PLOS ONE			English	Article							CONDENSED TANNINS; HAEMONCHUS-CONTORTUS; GASTROINTESTINAL NEMATODES; CAENORHABDITIS-ELEGANS; PARASITIC NEMATODES; PLANT POLYPHENOLS; MEDICINAL-PLANTS; HELMINTH CONTROL; PRIMER DESIGN; FLAVONOIDS	Worldwide, more than 1 billion people are affected by infestations with soil-transmitted helminths and also in veterinary medicine helminthiases are a severe threat to livestock due to emerging resistances against the common anthelmintics. Proanthocyanidins have been increasingly investigated for their anthelmintic properties, however, except for an interaction with certain proteins of the nematodes, not much is known about their mode of action. To investigate the anthelmintic activity on a molecular level, a transcriptome analysis was performed in Caenorhabditis elegans after treatment with purified and fully characterized oligomeric procyanidins (OPC). The OPCs had previously been obtained from a hydro-ethanolic (1:1) extract from the leaves of Combretum mucronatum, a plant which is traditionally used in West Africa for the treatment of helminthiasis, therefore, also the crude extract was included in the study. Significant changes in differential gene expression were observed mainly for proteins related to the intestine, many of which were located extracellularly or within cellular membranes. Among the up-regulated genes, several hitherto undescribed orthologues of structural proteins in humans were identified, but also genes that are potentially involved in the worms' defense against tannins. For example, T22D1.2, an orthologue of human basic salivary proline-rich protein (PRB) 2, and numr-1 (nuclear localized metal responsive) were found to be strongly up-regulated. Down-regulated genes were mainly associated with lysosomal activity, glycoside hydrolysis or the worms' innate immune response. No major differences were found between the groups treated with purified OPCs versus the crude extract. Investigations using GFP reporter gene constructs of T22D1.2 and numr-1 corroborated the intestine as the predominant site of the anthelmintic activity. The current findings support previous hypotheses of OPCs interacting with intestinal surface proteins and provide the first insights into the nematode's response to OPCs on a molecular level as a base for the identification of future drug targets.	[Spiegler, Verena; Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, Munster, Germany; [Seggewiss, Jochen] Univ Hosp Munster, Inst Human Genet, Munster, Germany; [Lubisch, Milena; Liebau, Eva] Inst Anim Physiol, Dept Mol Physiol, Munster, Germany	University of Munster; University of Munster	Spiegler, V (corresponding author), Univ Munster, Inst Pharmaceut Biol & Phytochem, Munster, Germany.	verena.spiegler@uni-muenster.de			University of Munster	University of Munster	This work was supported by no external funding, only intramural grants from the University of Munster.	Agyare C, 2014, J ETHNOPHARMACOL, V158, P255, DOI 10.1016/j.jep.2014.10.029; [Anonymous], 2000, NEMATODE PARASITES V; Athanasiadou S, 2007, ANIMAL, V1, P1392, DOI 10.1017/S1751731107000730; Ayers S, 2008, PHYTOCHEMISTRY, V69, P541, DOI 10.1016/j.phytochem.2007.08.003; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barrau E, 2005, PARASITOLOGY, V131, P531, DOI 10.1017/S0031182005008024; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Berkowitz LA, 2008, J VIS EXP, P835; Berninsone P. M., 2006, WORMBOOK, DOI [10.1895/wormbook.1.125.1, DOI 10.1895/WORMBOOK.1.125.1]; Botura MB, 2013, VET PARASITOL, V192, P211, DOI 10.1016/j.vetpar.2012.10.012; BRENNER S, 1974, GENETICS, V77, P71; Brunet S, 2011, PARASITOL INT, V60, P419, DOI 10.1016/j.parint.2010.09.011; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Chan-Perez JI, 2016, VET PARASITOL, V217, P53, DOI 10.1016/j.vetpar.2015.11.001; D'Almeida RE, 2015, ACTA PARASITOL, V60, P164, DOI 10.1515/ap-2015-0023; da Silva VC, 2008, REV BRAS FARMACOGN, V18, P573, DOI 10.1590/S0102-695X2008000400013; Desrues O, 2016, PARASITOLOGY, V143, P444, DOI 10.1017/S0031182015001912; Ding YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067158; Duenas M, 2013, PHARMACOL RES, V76, P41, DOI 10.1016/j.phrs.2013.07.001; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Engels C, 2009, J AGR FOOD CHEM, V57, P7712, DOI 10.1021/jf901621m; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; FETTERER RH, 1993, VET PARASITOL, V46, P103, DOI 10.1016/0304-4017(93)90051-N; Ghafouri S, 2007, NEMATOLOGY, V9, P87, DOI 10.1163/156854107779969718; Hagerman A. E., 1989, CHEM SIGNIFICANCE CO, P323, DOI DOI 10.1007/978-1-4684-7511-1_20; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P2590, DOI 10.1021/jf971097k; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; Hoste H, 2012, VET PARASITOL, V186, P18, DOI 10.1016/j.vetpar.2011.11.042; Hoste H, 2006, TRENDS PARASITOL, V22, P253, DOI 10.1016/j.pt.2006.04.004; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048; Karamac M, 2009, INT J MOL SCI, V10, P5485, DOI 10.3390/ijms10125485; Ketzis JK, 2006, VET PARASITOL, V139, P321, DOI 10.1016/j.vetpar.2006.04.022; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kozan E, 2013, EXP PARASITOL, V134, P299, DOI 10.1016/j.exppara.2013.03.018; Lu Y, 1998, ARCH ORAL BIOL, V43, P717, DOI 10.1016/S0003-9969(98)00040-5; Luersen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060731; Malesev D, 2007, J SERB CHEM SOC, V72, P921, DOI 10.2298/JSC0710921M; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martinez-Ortiz-de-Montellano C, 2013, EXP PARASITOL, V133, P281, DOI 10.1016/j.exppara.2012.11.024; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; McElwee MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-698; MEHANSHO H, 1983, P NATL ACAD SCI-BIOL, V80, P3948, DOI 10.1073/pnas.80.13.3948; MEHANSHO H, 1987, ANNU REV NUTR, V7, P423, DOI 10.1146/annurev.nu.07.070187.002231; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; Mori T, 2000, J PESTIC SCI, V25, P405; Nguyen TM, 2005, ANIM FEED SCI TECH, V121, P77, DOI 10.1016/j.anifeedsci.2005.02.013; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; Novobilsky A, 2011, VET PARASITOL, V182, P213, DOI 10.1016/j.vetpar.2011.06.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pietsch Kerstin, 2012, Frontiers in Genetics, V3, P48, DOI 10.3389/fgene.2012.00048; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Ropiak HM, 2016, J AGR FOOD CHEM, V64, P8795, DOI 10.1021/acs.jafc.6b03842; ROUX DG, 1972, PHYTOCHEMISTRY, V11, P1219, DOI 10.1016/S0031-9422(00)90068-2; Shimada T, 2006, J CHEM ECOL, V32, P1149, DOI 10.1007/s10886-006-9077-0; SPENCER CM, 1988, PHYTOCHEMISTRY, V27, P2397, DOI 10.1016/0031-9422(88)87004-3; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Spiegler V, 2015, MOLECULES, V20, P14810, DOI 10.3390/molecules200814810; Stiernagle Theresa, 2006, WormBook, P1; Sweeney T, 2016, PARASITE IMMUNOL, V38, P569, DOI 10.1111/pim.12347; Tamhane AC, 2000, STAT DATA ANAL ELEME; Tamura T, 2016, CURR MICROBIOL, V73, P115, DOI 10.1007/s00284-016-1032-x; Thompson David P., 1995, P203, DOI 10.1016/B978-012473345-9/50013-1; Tvermoes BE, 2010, J CELL SCI, V123, P2123, DOI 10.1242/jcs.065433; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; van den Enden E, 2009, EXPERT OPIN PHARMACO, V10, P435, DOI [10.1517/14656560902722463, 10.1517/14656560902722463 ]; Waller PJ, 2006, VET PARASITOL, V139, P1, DOI 10.1016/j.vetpar.2006.02.036; WHITE T., 1957, Journal of the Science of Food and Agriculture, V8, P377, DOI 10.1002/jsfa.2740080702; Williams AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0518-2; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341; Yoneda S, 1998, J WOOD CHEM TECHNOL, V18, P193, DOI 10.1080/02773819809349576; Yoon YA, 2006, ARCH PHARM RES, V29, P582, DOI 10.1007/BF02969269; Yoshihara E, 2013, SEMIN-CIENC AGRAR, V34, P3935, DOI 10.5433/1679-0359.2013v34n6Supl2p3935	82	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e018465	10.1371/journal.pone.0184656	http://dx.doi.org/10.1371/journal.pone.0184656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926584	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600029
J	Sugimoto, K; Nakazato, K; Sato, A; Suzuki, S; Yoshihisa, A; Machida, T; Saitohl, S; Sekine, H; Takeishi, Y				Sugimoto, Koichi; Nakazato, Kazuhiko; Sato, Akihiko; Suzuki, Satoshi; Yoshihisa, Akiomi; Machida, Takeshi; Saitohl, Shu-ichi; Sekine, Hideharu; Takeishi, Yasuchika			Autoimmune disease mouse model exhibits pulmonary arterial hypertension	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; SURVIVIN; INHIBITION; DEFICIENCY; EXPRESSION; RESISTANCE; APOPTOSIS; THERAPY; LESIONS; AXIS	Background Pulmonary arterial hypertension is often associated with connective tissue disease. Although there are some animal models of pulmonary hypertension, an autoimmune disease-based model has not yet been reported. MRL/lpr mice, which have hypergammaglobulinemia, produce various autoimmune antibodies, and develop vasculitis and nephritis spontaneously. However, little is known about pulmonary circulation in these mice. In the present study, we examined the pulmonary arterial pressure in MRL/lpr mice. Methods and results We used female MRL/lpr mice aged between 12 and 14 weeks. Fluorescent immunostaining showed that there was no deposition of immunoglobulin or C3 in the lung tissue of the MRL/lpr mice. Elevation of interferon-gamma and interleukin-6 was recognized in the lung tissue of the MRL/lpr mice. Right ventricular systolic pressure, Fulton index and the ratio of right ventricular weight to body weight in the MRL/lpr mice were significantly higher than those in wild type mice with same background (C57BL/6). The medial smooth muscle area and the proportion of muscularized vessels in the lung tissue of the MRL/lpr mice were larger than those of the C57BL/6 mice. Western blot analysis demonstrated markedly elevated levels of prepro-endothelin-1 and survivin as well as decreased endothelial nitric oxide synthase phosphorylation in the lung tissue of the MRL/lpr mice. Terminal deoxynucleotidyl-transferase-mediated dUTP nick end-labeling assay showed the resistance against apoptosis of pulmonary arterial smooth muscle cells in the MRL/lpr mice. Conclusion We showed that MRL/lpr mice were complicated with pulmonary hypertension. MRL/lpr mice appeared to be a useful model for studying the mechanism of pulmonary hypertension associated with connective tissue diseases.	[Sugimoto, Koichi; Nakazato, Kazuhiko; Sato, Akihiko; Suzuki, Satoshi; Yoshihisa, Akiomi; Saitohl, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan; [Sugimoto, Koichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Pulm Hypertens, Fukushima, Japan; [Machida, Takeshi; Sekine, Hideharu] Fukushima Med Univ, Dept Immunol, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan.; Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Pulm Hypertens, Fukushima, Japan.	ksugi@fmu.ac.jp			Acterion Pharmaceuticals Japan	Acterion Pharmaceuticals Japan	Koichi Sugimoto belongs to endowed department sponsored by Acterion Pharmaceuticals Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors have not received any research funds for this research.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Chung L, 2010, CHEST, V138, P1383, DOI 10.1378/chest.10-0260; Dolff S, 2011, CLIN IMMUNOL, V141, P197, DOI 10.1016/j.clim.2011.08.005; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112; Horowitz JC, 2012, INT J BIOCHEM CELL B, V44, P158, DOI 10.1016/j.biocel.2011.10.011; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Miyamichi-Yamamoto S, 2011, CIRC J, V75, P2668, DOI 10.1253/circj.CJ-11-0473; Mouraret N, 2015, CIRCULATION, V131, P742, DOI 10.1161/CIRCULATIONAHA.114.013258; Nakanishi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12417; Nandi M, 2005, CIRCULATION, V111, P2086, DOI 10.1161/01.CIR.0000163268.32638.F4; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; Sekine H, 2011, ARTHRITIS RHEUM-US, V63, P1076, DOI 10.1002/art.30222; Shinohara T, 2015, AM J PHYSIOL-LUNG C, V308, pL523, DOI 10.1152/ajplung.00129.2014; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Skovsted GF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174119; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Sun XT, 2014, AM J RESP CELL MOL, V50, P1084, DOI 10.1165/rcmb.2013-0187OC; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Watanabe R, 2014, INTERNAL MED, V53, P627, DOI 10.2169/internalmedicine.53.0514; Yamauchi H, 2016, FREE RADICAL BIO MED, V94, P66, DOI 10.1016/j.freeradbiomed.2016.02.020; Zhang S, 2016, MOL MED REP, V13, P3415, DOI 10.3892/mmr.2016.4977	23	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184990	10.1371/journal.pone.0184990	http://dx.doi.org/10.1371/journal.pone.0184990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926602	Green Published, gold			2022-12-26	WOS:000411166600059
J	Fraiberk, M; Hajkova, M; Krulova, M; Kojzarova, M; Moravkova, AD; Psikal, I; Forstova, J				Fraiberk, Martin; Hajkova, Michaela; Krulova, Magdalena; Kojzarova, Martina; Moravkova, Alena Drda; Psikal, Ivan; Forstova, Jitka			Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; MULTISYSTEMIC WASTING SYNDROME; MAJOR CAPSID PROTEIN; RESPIRATORY SYNDROME VIRUS; HUMORAL IMMUNE-RESPONSES; TYPE-2 PCV2; EXPERIMENTAL REPRODUCTION; STRUCTURAL PROTEINS; EGFP-PSEUDOCAPSIDS; CONVENTIONAL PIGS	The aim of this study was to develop a suitable vaccine antigen against porcine circovirus 2 (PCV2), the causative agent of post-weaning multi-systemic wasting syndrome, which causes significant economic losses in swine breeding. Chimeric antigens containing PCV2b Cap protein sequences based on the mouse polyomavirus (MPyV) nanostructures were developed. First, universal vectors for baculovirus-directed production of chimeric MPyV VLPs or pentamers of the major capsid protein, VP1, were designed for their exploitation as vaccines against other pathogens. Various strategies were employed based on: A) exposure of selected immunogenic epitopes on the surface of MPyV VLPs by insertion into a surface loop of the VP1 protein, B) insertion of foreign protein molecules inside the VLPs, or C) fusion of a foreign protein or its part with the C-terminus of VP1 protein, to form giant pentamers of a chimeric protein. We evaluated these strategies by developing a recombinant vaccine against porcine circovirus 2. All candidate vaccines induced the production of antibodies against the capsid protein of porcine circovirus after immunization of mice. The candidate vaccine, Var C, based on fusion of mouse polyomavirus and porcine circovirus capsid proteins, could induce the production of antibodies with the highest PCV2 neutralizing capacity. Its ability to induce the production of neutralization antibodies was verified after immunization of pigs. The advantage of this vaccine, apart from its efficient production in insect cells and easy purification, is that it represents a DIVA (differentiating infected from vaccinated animals) vaccine, which also induces an immune response against the mouse polyoma VP1 protein and is thus able to distinguish between vaccinated and naturally infected animals.	[Fraiberk, Martin; Hajkova, Michaela; Krulova, Magdalena; Kojzarova, Martina; Moravkova, Alena Drda; Forstova, Jitka] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Psikal, Ivan] Dyntec Spol Sro, Terezin, Czech Republic	Charles University Prague	Forstova, J (corresponding author), Charles Univ Prague, Fac Sci, Prague, Czech Republic.	jitkaf@natur.cuni.cz	Hajkova, Michaela/U-8924-2017; Krulova, Magdalena/A-6255-2012	Hajkova, Michaela/0000-0003-1922-4891; Krulova, Magdalena/0000-0003-3622-376X	Technology Agency of the Czech Republic, TACR [TA03010700]; Specific University Research Grant of the Ministry of Education, Youth and Sports of CR [SVV-2017-260426]; National Sustainability Program II (Project BIOCEV-FAR); project "BIOCEV" the Ministry of Education, Youth and Sports of CR [LQ1604, CZ.1.05/1.1.00/02.0109]; Dyntec spol. s r.o.; Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR) [LQ1604, CZ.1.05/1.1.00/02.0109]	Technology Agency of the Czech Republic, TACR; Specific University Research Grant of the Ministry of Education, Youth and Sports of CR; National Sustainability Program II (Project BIOCEV-FAR); project "BIOCEV" the Ministry of Education, Youth and Sports of CR; Dyntec spol. s r.o.; Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR)	This work was supported by Technology Agency of the Czech Republic, TACR, project no. TA03010700, www.tacr.cz (MF, JF, ADM, IP); Specific University Research Grant of the Ministry of Education, Youth and Sports of CR, project no. SVV-2017-260426, www.msmt.cz (MF); National Sustainability Program II (Project BIOCEV-FAR) and by the project "BIOCEV" the Ministry of Education, Youth and Sports of CR, project no. LQ1604 and CZ.1.05/1.1.00/02.0109, www.msmt.cz (MF, JF); and Dyntec spol. s r.o., www.dyntec.cz (IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IP is an employee of Dyntec spol s r.o. Dyntec spol. s r.o. provided support in the form of salary for IP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions section".; Acknowledgment is made to Karel Harant from the Mass Spectrometry and Proteomics Service Laboratory of Charles University, Faculty of Science, Biological Section, where the proteomic and mass spectrometric part of this work was done. This work was supported by the Technology Agency of the Czech Republic, TACR, project no. TA03010700, Specific University Research Grant of the Ministry of Education, Youth and Sports of CR, project no. SVV-2017-260426 and by the Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR) LQ1604 and by the project "BIOCEV" (CZ.1.05/1.1.00/02.0109)."	Adeyemi OO, 2017, J VIROL, V91, DOI 10.1128/JVI.01586-16; Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan GM, 2000, ARCH VIROL, V145, P2421, DOI 10.1007/s007050070031; Alsharifi M, 2006, J IMMUNOL, V177, P3235, DOI 10.4049/jimmunol.177.5.3235; [Anonymous], 2015, VIRAL NANOTECHNOLOGY, DOI DOI 10.1201/B18596; Boura E, 2005, FEBS LETT, V579, P6549, DOI 10.1016/j.febslet.2005.10.062; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunborg IM, 2004, J VIROL METHODS, V122, P171, DOI 10.1016/j.jviromet.2004.08.014; Bucarey SA, 2009, VACCINE, V27, P5781, DOI 10.1016/j.vaccine.2009.07.061; CHANG DC, 1993, J VIROL, V67, P6327, DOI 10.1128/JVI.67.10.6327-6331.1993; CHANG DC, 1992, VIROLOGY, V189, P821, DOI 10.1016/0042-6822(92)90615-V; Cortey M, 2011, VET MICROBIOL, V149, P522, DOI 10.1016/j.vetmic.2010.11.009; Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Ellis JA, 2008, AM J VET RES, V69, P1608, DOI 10.2460/ajvr.69.12.1608; Finsterbusch T, 2009, VIRUS RES, V143, P177, DOI 10.1016/j.virusres.2009.02.009; FORSTOVA J, 1993, J VIROL, V67, P1405; FORSTOVA J, 1995, HUM GENE THER, V6, P297, DOI 10.1089/hum.1995.6.3-297; Fort M, 2007, VET MICROBIOL, V125, P244, DOI 10.1016/j.vetmic.2007.06.004; Franzo G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0361-x; Franzo G, 2015, VET MICROBIOL, V178, P158, DOI 10.1016/j.vetmic.2015.05.003; Fric J, 2008, VACCINE, V26, P3242, DOI 10.1016/j.vaccine.2008.04.006; Gao ZZ, 2014, VIRUS RES, V183, P56, DOI 10.1016/j.virusres.2014.01.024; Garcia ML, 2000, VIROLOGY, V272, P293, DOI 10.1006/viro.2000.0351; Gedvilaite A, 2004, VIRAL IMMUNOL, V17, P51, DOI 10.1089/088282404322875458; Grasland B, 2005, VET RES, V36, P685, DOI 10.1051/vetres:2005024; Guo LJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-273; Harms PA, 2001, VET PATHOL, V38, P528, DOI 10.1354/vp.38-5-528; Hines RK, PORCINE CIRCOVIRUS S; Hornikova L, 2011, J VIROL METHODS, V178, P229, DOI 10.1016/j.jviromet.2011.08.019; Hruskova V, 2009, INT J ONCOL, V35, P1247, DOI 10.3892/ijo_00000441; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Karuppannan AK, 2010, VIROLOGY, V398, P1, DOI 10.1016/j.virol.2009.11.028; Kennedy S, 2000, J COMP PATHOL, V122, P9, DOI 10.1053/jcpa.1999.0337; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Krakowka S, 2001, VET PATHOL, V38, P31, DOI 10.1354/vp.38-1-31; KRAUZEWICZ N, 1990, J VIROL, V64, P4414, DOI 10.1128/JVI.64.9.4414-4420.1990; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2016, MICROBIOL IMMUNOL, V60, P846, DOI 10.1111/1348-0421.12458; Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0; Lekcharoensuk P, 2004, J VIROL, V78, P8135, DOI 10.1128/JVI.78.15.8135-8145.2004; Liu J, 2006, J VIROL, V80, P5065, DOI 10.1128/JVI.80.10.5065-5073.2006; Liu YK, 2015, BIOTECHNOL LETT, V37, P1765, DOI 10.1007/s10529-015-1856-7; Lopez-Vidal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140039; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; Marcekova Z, 2009, J VIROL METHODS, V162, P133, DOI 10.1016/j.jviromet.2009.07.028; Meehan BM, 1998, J GEN VIROL, V79, P2171, DOI 10.1099/0022-1317-79-9-2171; Meerts Peter, 2006, BMC Vet Res, V2, P6, DOI 10.1186/1746-6148-2-6; Meshram CD, 2016, J VIROL; MONTROSS L, 1991, J VIROL, V65, P4991, DOI 10.1128/JVI.65.9.4991-4998.1991; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Nielsen SD, 1998, CLIN EXP IMMUNOL, V114, P66; Opriessnig T, 2004, VET PATHOL, V41, P624, DOI 10.1354/vp.41-6-624; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rovira A, 2002, J VIROL, V76, P3232, DOI 10.1128/JVI.76.7.3232-3239.2002; Rueda P, 2000, VACCINE, V19, P726, DOI 10.1016/S0264-410X(00)00259-0; Saha D, 2012, J GEN VIROL, V93, P1548, DOI 10.1099/vir.0.042085-0; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Shang SB, 2009, MOL IMMUNOL, V46, P327, DOI 10.1016/j.molimm.2008.10.028; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stehle T, 1993, STRUCT LOND ENGL, V4; Stokrova J, 1999, FEBS LETT, V445, P119, DOI 10.1016/S0014-5793(99)00003-4; Swanson PA, 2009, SEMIN CANCER BIOL, V19, P244, DOI 10.1016/j.semcancer.2009.02.003; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Teunissen EA, 2013, J CONTROL RELEASE, V172, P305, DOI 10.1016/j.jconrel.2013.08.026; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Trible BR, 2012, VIRUS RES, V164, P68, DOI 10.1016/j.virusres.2011.11.018; Wu PC, 2012, APPL MICROBIOL BIOT, V95, P1501, DOI 10.1007/s00253-012-4015-2; Xiao CT, 2015, J GEN VIROL, V96, P1830, DOI 10.1099/vir.0.000100	74	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184870	10.1371/journal.pone.0184870	http://dx.doi.org/10.1371/journal.pone.0184870			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922413	gold, Green Published, Green Submitted			2022-12-26	WOS:000411059300038
J	Fecchio, M; Pigorini, A; Comanducci, A; Sarasso, S; Casarotto, S; Premoli, I; Derchi, CC; Mazza, A; Russo, S; Resta, F; Ferrarelli, F; Mariotti, M; Ziemann, U; Massimini, M; Rosanova, M				Fecchio, Matteo; Pigorini, Andrea; Comanducci, Angela; Sarasso, Simone; Casarotto, Silvia; Premoli, Isabella; Derchi, Chiara-Camilla; Mazza, Alice; Russo, Simone; Resta, Federico; Ferrarelli, Fabio; Mariotti, Maurizio; Ziemann, Ulf; Massimini, Marcello; Rosanova, Mario			The spectral features of EEG responses to transcranial magnetic stimulation of the primary motor cortex depend on the amplitude of the motor evoked potentials	PLOS ONE			English	Article							CORTICAL EFFECTIVE CONNECTIVITY; TMS-EEG; ELECTRICAL-STIMULATION; NATURAL FREQUENCIES; NEURONAL-ACTIVITY; SENSORY FEEDBACK; BRAIN RESPONSES; EXCITABILITY; HUMANS; AREAS	Transcranial magnetic stimulation (TMS) of the primary motor cortex (M1) can excite both cortico-cortical and cortico-spinal axons resulting in TMS-evoked potentials (TEPs) and motor-evoked potentials (MEPs), respectively. Despite this remarkable difference with other cortical areas, the influence of motor output and its amplitude on TEPs is largely unknown. Here we studied TEPs resulting from M1 stimulation and assessed whether their waveform and spectral features depend on the MEP amplitude. To this aim, we performed two separate experiments. In experiment 1, single-pulse TMS was applied at the same supra-threshold intensity on primary motor, prefrontal, premotor and parietal cortices and the corresponding TEPs were compared by means of local mean field power and time-frequency spectral analysis. In experiment 2 we stimulated M1 at resting motor threshold in order to elicit MEPs characterized by a wide range of amplitudes. TEPs computed from high-MEP and low-MEP trials were then compared using the same methods applied in experiment 1. In line with previous studies, TMS of M1 produced larger TEPs compared to other cortical stimulations. Notably, we found that only TEPs produced by M1 stimulation were accompanied by a late event-related desynchronization (ERD-peaking at similar to 300 ms after TMS), whose magnitude was strongly dependent on the amplitude of MEPs. Overall, these results suggest that M1 produces peculiar responses to TMS possibly reflecting specific anatomo-functional properties, such as the re-entry of proprioceptive feedback associated with target muscle activation.	[Fecchio, Matteo; Pigorini, Andrea; Comanducci, Angela; Sarasso, Simone; Casarotto, Silvia; Derchi, Chiara-Camilla; Mazza, Alice; Russo, Simone; Mariotti, Maurizio; Massimini, Marcello; Rosanova, Mario] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Premoli, Isabella] Kings Coll London, Dept Basic & Clin Neurosci, IoPPN, London, England; [Premoli, Isabella; Ziemann, Ulf] Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Premoli, Isabella; Ziemann, Ulf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Resta, Federico] Hosp Luigi Sacco, Div Radiol, Milan, Italy; [Ferrarelli, Fabio] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; [Massimini, Marcello] IRCCS Fdn Don Gnocchi Onlus, Milan, Italy; [Rosanova, Mario] Fdn Europea Ric Biomed Onlus, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of London; King's College London; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Milan; Luigi Sacco Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosanova, M (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.; Rosanova, M (corresponding author), Fdn Europea Ric Biomed Onlus, Milan, Italy.	mario.rosanova@unimi.it	Ferrarelli, Fabio/D-3219-2019; Comanducci, Angela/AAB-9917-2019; Mazza, Alice/AAJ-8244-2021; Russo, Simone/Z-6077-2019; Derchi, Chiara Camilla/AAJ-1183-2021; Casarotto, Silvia/Q-9402-2019; Ziemann, Ulf/AAY-9125-2020; Sarasso, Simone/C-7817-2012; Rosanova, Mario/S-8440-2017; Pigorini, Andrea/ABC-8351-2021; Fecchio, Matteo/X-8209-2019; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Russo, Simone/0000-0002-7762-1900; Casarotto, Silvia/0000-0002-7548-7664; Sarasso, Simone/0000-0001-9984-4710; Rosanova, Mario/0000-0001-7486-7617; Pigorini, Andrea/0000-0002-1856-3413; Fecchio, Matteo/0000-0002-0347-8531; DERCHI, CHIARA CAMILLA/0000-0003-4573-2240; Mazza, Alice/0000-0002-5219-9846; Massimini, Marcello/0000-0003-2271-957X; Comanducci, Angela/0000-0001-6084-019X; Premoli, Isabella/0000-0002-2508-6440	LUMINOUS; European Union's Horizon Research and Innovation Programme [686764, 720270]; Swiss National Science Foundation [CRSII3_160803/1]; James S. McDonnell Foundation; Italian Ministry of Health [GR-2011-02352031]	LUMINOUS; European Union's Horizon Research and Innovation Programme; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); James S. McDonnell Foundation; Italian Ministry of Health(Ministry of Health, Italy)	This work has been partially funded by the LUMINOUS Project. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme H2020-FETOPEN-2014-2015-RIA under agreement No. 686764. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 720270 (HBP SGA1). This study has been partially funded by the grant "Sinergia" CRSII3_160803/1 by the Swiss National Science Foundation, the James S. McDonnell Foundation Scholar Award 2013, and the Grant "Giovani Ricercatori" GR-2011-02352031 from the Italian Ministry of Health (to MR).	Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Bonmassar G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1914; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Canali P, 2015, J AFFECT DISORDERS, V184, P111, DOI 10.1016/j.jad.2015.05.043; Casali AG, 2010, NEUROIMAGE, V49, P1459, DOI 10.1016/j.neuroimage.2009.09.026; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Casarotto S, 2013, BRAIN TOPOGR, V26, P326, DOI 10.1007/s10548-012-0256-8; Casarotto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010281; Casula EP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36191; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; CRACCO RQ, 1989, ELECTROEN CLIN NEURO, V74, P417, DOI 10.1016/0168-5597(89)90030-0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; Farzan F, 2013, NEUROIMAGE, V83, P120, DOI 10.1016/j.neuroimage.2013.06.059; Ferrarelli F, 2012, ARCH GEN PSYCHIAT, V69, P766, DOI 10.1001/archgenpsychiatry.2012.147; Ferreri F, 2017, NEUROSCI LETT, V647, P141, DOI 10.1016/j.neulet.2017.03.021; Ferreri F, 2013, REV NEUROSCIENCE, V24, P431, DOI 10.1515/revneuro-2013-0019; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Giambattistelli F, 2014, HUM BRAIN MAPP, V35, P1740, DOI 10.1002/hbm.22288; Gosseries O, 2015, BRAIN STIMUL, V8, P142, DOI 10.1016/j.brs.2014.10.008; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Harquel S, 2016, NEUROIMAGE, V135, P115, DOI 10.1016/j.neuroimage.2016.05.009; Herring JD, 2015, J NEUROSCI, V35, P14435, DOI 10.1523/JNEUROSCI.1833-15.2015; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Julkunen P, 2012, BRAIN STIMUL, V5, P526, DOI 10.1016/j.brs.2011.07.006; Kahkonen S, 2005, PSYCHOPHARMACOLOGY, V181, P16, DOI 10.1007/s00213-005-2197-3; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; KUHLMAN WN, 1978, ELECTROEN CLIN NEURO, V44, P83, DOI 10.1016/0013-4694(78)90107-4; Libet B, 1982, Hum Neurobiol, V1, P235; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Maki H, 2010, NEUROSCI LETT, V478, P24, DOI 10.1016/j.neulet.2010.04.059; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mattavelli G, 2013, NEUROIMAGE, V76, P24, DOI 10.1016/j.neuroimage.2013.03.020; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Muller GR, 2003, NEUROSCI LETT, V340, P143, DOI 10.1016/S0304-3940(03)00019-3; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; Pellicciari MC, 2016, CLIN NEUROPHYSIOL, V127, P621, DOI 10.1016/j.clinph.2015.03.002; Petrichella S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174879; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 1999, NEUROSCI LETT, V269, P153, DOI 10.1016/S0304-3940(99)00452-8; Premoli I, 2014, J NEUROSCI, V34, P5603, DOI 10.1523/JNEUROSCI.5089-13.2014; Preston D, 2012, ELECTROMYOGRAPHY NEU, P1320; Romei V, 2007, J NEUROSCI, V27, P11465, DOI 10.1523/JNEUROSCI.2827-07.2007; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Rossi S, 1998, NEUROIMAGE, V8, P163, DOI 10.1006/nimg.1998.0352; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Sejnowski TJ, 2014, NAT NEUROSCI, V17, P1440, DOI 10.1038/nn.3839; Shitara H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00554; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Stancak A, 2006, PROG BRAIN RES, V159, P237, DOI 10.1016/S0079-6123(06)59016-8; Taylor PCJ, 2010, HUM BRAIN MAPP, V31, P1408, DOI 10.1002/hbm.20941; ter Braack EM, 2015, BRAIN TOPOGR, V28, P520, DOI 10.1007/s10548-013-0312-z; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Virtanen J, 1999, MED BIOL ENG COMPUT, V37, P322, DOI 10.1007/BF02513307; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	65	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184910	10.1371/journal.pone.0184910	http://dx.doi.org/10.1371/journal.pone.0184910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910407	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200117
J	Hernandez-Lopez, R; Chavez-Gonzalez, A; Torres-Barrera, P; Moreno-Lorenzana, D; Lopez-DiazGuerrero, N; Santiago-German, D; Isordia-Salas, I; Smadja, D; Yoder, MC; Majluf-Cruz, A; Alvarado-Moreno, JA				Hernandez-Lopez, Rubicel; Chavez-Gonzalez, Antonieta; Torres-Barrera, Patricia; Moreno-Lorenzana, Dafne; Lopez-DiazGuerrero, Norma; Santiago-German, David; Isordia-Salas, Irma; Smadja, David; Yoder, Mervin C.; Majluf-Cruz, Abraham; Antonio Alvarado-Moreno, J.			Reduced proliferation of endothelial colonyforming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction	PLOS ONE			English	Article							COLONY-FORMING CELLS; CORONARY-ARTERY-DISEASE; PROGENITOR CELLS; OXIDATIVE STRESS; THERAPEUTIC OPPORTUNITIES; ACCELERATED SENESCENCE; PREMATURE SENESCENCE; ANGIOGENESIS; MECHANISMS; EXPRESSION	Background Venous thromboembolic disease (VTD) is a public health problem. We recently reported that endothelial colony-forming cells (ECFCs) derived from endothelial cells (EC) (ECFCECs) from patients with VTD have a dysfunctional state. For this study, we proposed that a dysfunctional status of these cells generates a reduction of its proliferative ability, which is also associated with senescence and reactive oxygen species (ROS). Methods and results Human mononuclear cells (MNCs) were obtained from peripheral blood from 40 healthy human volunteers (controls) and 50 patients with VTD matched by age (20-50 years) and sex to obtain ECFCs. We assayed their proliferative ability with plasma of patients and controls and supernatants of cultures from ECFC-ECs, senescence-associated beta-galactosidase (SA-beta-gal), ROS, and expression of ephrin-B2/ Eph-B4 receptor. Compared with cells from controls, cells from VTD patients showed an 8-fold increase of ECFCs that emerged 1 week earlier, reduced proliferation at long term (39%) and, in passages 4 and 10, a highly senescent rate (30 +/- 1.05% vs. 91.3 +/- 15.07%, respectively) with an increase of ROS and impaired expression of ephrin-B2/Eph-4 genes. Proliferation potential of cells from VTD patients was reduced in endothelial medium [ 1.4 +/- 0.22 doubling population (DP)], control plasma (1.18 +/- 0.31 DP), or plasma from VTD patients (1.65 +/- 0.27 DP). Conclusions As compared with controls, ECFC-ECs from individuals with VTD have higher oxidative stress, proliferation stress, cellular senescence, and low proliferative potential. These findings suggest that patients with a history of VTD are ECFC-ECs dysfunctional that could be associated to permanent risk for new thrombotic events.	[Hernandez-Lopez, Rubicel; Isordia-Salas, Irma; Majluf-Cruz, Abraham; Antonio Alvarado-Moreno, J.] Inst Mexicano Seguro Social, Unidad Invest Med Trombosis Hemostasia & Aterogen, Mexico City, DF, Mexico; [Hernandez-Lopez, Rubicel; Lopez-DiazGuerrero, Norma] Univ Autonoma Metropolitana, Posgrad Biol Expt, Mexico City, DF, Mexico; [Chavez-Gonzalez, Antonieta; Torres-Barrera, Patricia; Moreno-Lorenzana, Dafne] Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Oncol, Mexico City, DF, Mexico; [Santiago-German, David] Inst Mexicano Seguro Social, Serv Urgencias, Mexico City, DF, Mexico; [Smadja, David] Paris Descartes Univ, INSERM, Fac Pharm Paris, UMR S 1140, Paris, France; [Smadja, David] Hop Europeen Georges Pompidou, AP HP, Hematol Dept, Paris, France; [Yoder, Mervin C.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Instituto Mexicano del Seguro Social; Universidad Autonoma Metropolitana - Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Indiana University System; Indiana University Bloomington	Alvarado-Moreno, JA (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Med Trombosis Hemostasia & Aterogen, Mexico City, DF, Mexico.	alvarado_m01@yahoo.com.mx	Stefanadis, Christodoulos/ABH-2232-2020; HERNANDEZ, RUBICEL/AAF-3705-2020; Smadja, David/M-3872-2017	Stefanadis, Christodoulos/0000-0001-5974-6454; Yoder, Mervin/0000-0003-4354-7631; Hernandez-Lopez, Jose Rubicel/0000-0002-1281-5528; Smadja, David/0000-0001-7731-9202; Santiago German, David/0000-0002-6145-970X; LOPEZ DIAZ GUERRERO, NORMA EDITH/0000-0001-7470-9360; Moreno Lorenzana, Dafne Linda/0000-0003-3029-4241	Instituto Mexicano del Seguro Social (IMSS, Mexico) [FIS/IMSS/PROT/G15/1428]; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico) [SALUD-2016-273432]; Experimental Biology Department, Autonomous University of Mexico, Iztapalapa; CONACYT, Mexico [237229]; IMSS [98376215]	Instituto Mexicano del Seguro Social (IMSS, Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Experimental Biology Department, Autonomous University of Mexico, Iztapalapa; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IMSS	This study was partially supported by the grants FIS/IMSS/PROT/G15/1428 from the Instituto Mexicano del Seguro Social (IMSS, Mexico) and the grant SALUD-2016-273432 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico), provided funding for the study (JAA-M). RH-L received a grant from the Experimental Biology Department, Autonomous University of Mexico, Iztapalapa. CONACYT, Mexico: 237229 and IMSS: 98376215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou I, 2006, ATHEROSCLEROSIS, V189, P247, DOI 10.1016/j.atherosclerosis.2006.06.021; Alvarado-Moreno JA, 2016, THROMB RES, V137, P157, DOI 10.1016/j.thromres.2015.11.005; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baker CD, 2013, AM J PHYSIOL-LUNG C, V305, pL73, DOI 10.1152/ajplung.00400.2012; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Brito R, 2015, EXP CLIN ENDOCR DIAB, V123, P325, DOI 10.1055/s-0035-1548765; Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Gamberucci A, 1998, BIOCHEM J, V331, P623, DOI 10.1042/bj3310623; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f; Huang L, 2007, CELL TRANSPLANT, V16, P887, DOI 10.3727/096368907783338181; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Ingram DA, 2007, STEM CELLS, V25, P297, DOI 10.1634/stemcells.2006-0340; Jung EJ, 2011, BIOCHEM BIOPH RES CO, V404, P841, DOI 10.1016/j.bbrc.2010.12.072; Kim H, 2015, CYTOTHERAPY, V17, P579, DOI 10.1016/j.jcyt.2014.12.003; Kim KA, 2014, BIOL PHARM BULL, V37, P1248, DOI 10.1248/bpb.b14-00172; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kushner EJ, 2009, CLIN CHEM LAB MED, V47, P47, DOI 10.1515/CCLM.2009.016; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li WD, 2015, VASCUL PHARM; Li YF, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0130-8; Ligi I, 2014, J MATERN-FETAL NEO M, V27, P233, DOI 10.3109/14767058.2013.807237; Liu L, 2009, ATHEROSCLEROSIS, V202, P405, DOI 10.1016/j.atherosclerosis.2008.05.024; Liu Yan-rong, 2005, Zhejiang Da Xue Xue Bao Yi Xue Ban, V34, P163; Mena HA, J THROMBOSIS HAEMOST, V14, P397; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918; Muto A, 2011, J EXP MED, V208, P561, DOI 10.1084/jem.20101854; Patel RS, 2015, CIRC RES, V116, P289, DOI 10.1161/CIRCRESAHA.116.304187; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Peng J, 2015, J CARDIOVASC PHARM, V65, P80, DOI 10.1097/FJC.0000000000000166; Raskob GE, 2014, J THROMB HAEMOST, V12, P1580, DOI 10.1111/jth.12698; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Sipos PI, 2013, J CLIN ENDOCR METAB, V98, P4953, DOI 10.1210/jc.2013-2580; Sultan SA, 2015, J CELL PHYSIOL, V230, P2695, DOI 10.1002/jcp.24993; Tilling L, 2009, BRIT J CLIN PHARMACO, V68, P484, DOI 10.1111/j.1365-2125.2009.03486.x; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; van Ierssel SH, 2015, J NEUROSCI RES, V93, P866, DOI 10.1002/jnr.23566; Vassallo PF, 2014, BLOOD, V123, P2116, DOI 10.1182/blood-2013-02-484956; Vemparala K, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-104; Yao EH, 2006, CURR PHARM BIOTECHNO, V7, P101, DOI 10.2174/138920106776597685; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183827	10.1371/journal.pone.0183827	http://dx.doi.org/10.1371/journal.pone.0183827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910333	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200019
J	Peri, E; Ambrosini, E; Colombo, VM; van de Ruit, M; Grey, MJ; Monticone, M; Ferriero, G; Pedrocchi, A; Ferrigno, G; Ferrante, S				Peri, Elisabetta; Ambrosini, Emilia; Colombo, Vera Maria; van de Ruit, Mark; Grey, Michael J.; Monticone, Marco; Ferriero, Giorgio; Pedrocchi, Alessandra; Ferrigno, Giancarlo; Ferrante, Simona			Intra and inter-session reliability of rapid Transcranial Magnetic Stimulation stimulus-response curves of tibialis anterior muscle in healthy older adults	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; INPUT-OUTPUT PROPERTIES; ELECTRICAL-STIMULATION; CORTICOSPINAL PATHWAY; CORTICAL EXCITABILITY; CHRONIC STROKE; PLASTICITY; TMS; NEUROPLASTICITY	Objective The clinical use of Transcranial Magnetic Stimulation (TMS) as a technique to assess corticospinal excitability is limited by the time for data acquisition and the measurement variability. This study aimed at evaluating the reliability of Stimulus-Response (SR) curves acquired with a recently proposed rapid protocol on tibialis anterior muscle of healthy older adults. Methods Twenty-four neurologically-intact adults (age: 55-75 years) were recruited for this test-retest study. During each session, six SR curves, 3 at rest and 3 during isometric muscle contractions at 5% of maximum voluntary contraction (MVC), were acquired. Motor Evoked Potentials (MEPs) were normalized to the maximum peripherally evoked response; the coil position and orientation were monitored with an optical tracking system. Intra-and inter-session reliability of motor threshold (MT), area under the curve (AURC), MEPmax, stimulation intensity at which the MEP is mid-way between MEPmax and MEPmin (I50), slope in I50, MEP latency, and silent period (SP) were assessed in terms of Standard Error of Measurement (SEM), relative SEM, Minimum Detectable Change (MDC), and Intraclass Correlation Coefficient (ICC). Results The relative SEM was <= 10% for MT, I50, latency and SP both at rest and 5% MVC, while it ranged between 11% and 37% for AURC, MEPmax, and slope. MDC values were overall quite large; e.g., MT required a change of 12% MSO at rest and 10% MSO at 5% MVC to be considered a real change. Inter-sessions ICC were >0.6 for all measures but slope at rest and MEPmax and latency at 5% MVC. Conclusions Measures derived from SR curves acquired in <4 minutes are affected by similar measurement errors to those found with long-lasting protocols, suggesting that the rapid method is at least as reliable as the traditional methods. As specifically designed to include older adults, this study provides normative data for future studies involving older neurological patients (e.g. stroke survivors).	[Peri, Elisabetta; Ambrosini, Emilia; Colombo, Vera Maria; Pedrocchi, Alessandra; Ferrigno, Giancarlo; Ferrante, Simona] Politecn Milan, Dept Elect Informat & Bioengn, NearLab, Milan, Italy; [Ambrosini, Emilia; Monticone, Marco; Ferriero, Giorgio] Ist Clin Sci Maugeri, Sci Inst Lissone IRCCS, Dept Phys & Rehabilitat Med, Lissone, MB, Italy; [van de Ruit, Mark] Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Delft, Netherlands; [Grey, Michael J.] Univ East Anglia, Sch Hlth Sci, Acquired Brain Injury Rehabil Alliance, Norwich, Norfolk, England; [Monticone, Marco] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy	Polytechnic University of Milan; Istituti Clinici Scientifici Maugeri IRCCS; Delft University of Technology; University of East Anglia; University of Cagliari	Peri, E (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, NearLab, Milan, Italy.	elisabetta.peri@polimi.it	Monticone, Marco/AAC-4494-2022; van de Ruit, Mark/X-4872-2019; Ferriero, Giorgio/K-4217-2018; Pedrocchi, Alessandra/AAF-2655-2019; Colombo, Vera/R-3715-2019; , Giorgio/AAA-3522-2021; Ambrosini, Emilia/R-1371-2016	van de Ruit, Mark/0000-0003-3806-2031; Ferriero, Giorgio/0000-0002-7873-6777; Pedrocchi, Alessandra/0000-0001-9957-2786; Colombo, Vera/0000-0001-6648-1917; , Giorgio/0000-0002-7873-6777; Ambrosini, Emilia/0000-0002-6527-0779	Italian Ministry of Healthy [GR-2010-2312228]	Italian Ministry of Healthy(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Healthy (grant no.: GR-2010-2312228, project title "Fall prevention and locomotion recovery in post-stroke patients: a multimodal training towards a more autonomous daily life" (http://www.salute.gov.it/imos/C_17_pagineAree_4517_listaFile_itemName_7_file.pdt). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1939, J PHYSIOL-LONDON, V97, P153, DOI 10.1113/jphysiol.1939.sp003798; Ambrosini E, 2015, 7 IEEE EMBS C NEUR E; [Anonymous], 2015, NEUROSCI, V9, P335; Beaulieu LD, 2017, BRAIN STIMUL, V10, P196, DOI 10.1016/j.brs.2016.12.008; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Cacchio A, 2011, J NEUROL SCI, V303, P90, DOI 10.1016/j.jns.2011.01.004; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Carson RG, 2013, BRAIN STIMUL, V6, P760, DOI 10.1016/j.brs.2013.01.016; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cortes M, 2012, NEUROMODULATION, V15, P316, DOI 10.1111/j.1525-1403.2012.00459.x; DAY BL, 1987, BRAIN, V110, P1191, DOI 10.1093/brain/110.5.1191; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Everaert DG, 2010, NEUROREHAB NEURAL RE, V24, P168, DOI 10.1177/1545968309349939; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kamke MR, 2012, J NEUROSCI, V32, P7001, DOI 10.1523/JNEUROSCI.1028-12.2012; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Liu H, 2014, J NEUROL SCI, V341, P105, DOI 10.1016/j.jns.2014.04.012; Mathias JP, 2014, BRAIN STIMUL, V7, P59, DOI 10.1016/j.brs.2013.08.003; Meaney A, 2015, J CLIN NEUROSCI, V22, P1434, DOI 10.1016/j.jocn.2015.02.034; Peri E, 2016, IFMBE PROC, V57, P1069, DOI 10.1007/978-3-319-32703-7_211; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossini PM, 2013, CURR PHARM DESIGN, V19, P6426, DOI 10.2174/1381612811319360004; Rothwell J., 2005, MAGNETIC STIMULATION, V2nd ed., P43, DOI [10.1016/B978-0-7506-7373-0.50007-9, DOI 10.1016/B978-0-7506-7373-0.50007-9]; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Schmidt S, 2015, HUM BRAIN MAPP, V36, P40, DOI 10.1002/hbm.22611; Smith AE, 2011, J APPL PHYSIOL, V110, P206, DOI 10.1152/japplphysiol.00403.2010; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takechi U, 2014, CLIN NEUROPHYSIOL, V125, P2055, DOI 10.1016/j.clinph.2014.01.034; Tallent J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035930; Troni W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155268; van de Ruit M, 26 ANN M SOC NEUR CO; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Xu Y, 2015, NEURAL REGEN RES, V10, P2072, DOI 10.4103/1673-5374.172329	49	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184828	10.1371/journal.pone.0184828	http://dx.doi.org/10.1371/journal.pone.0184828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910370	Green Published, gold, Green Accepted			2022-12-26	WOS:000410859200100
J	Rollo, F; Latini, A; Pichi, B; Colafigli, M; Benevolo, M; Sinopoli, I; Sperduti, I; Laquintana, V; Fabbri, G; Frasca, M; Cristaudo, A; Giuliani, M; Dona, MG				Rollo, Francesca; Latini, Alessandra; Pichi, Barbara; Colafigli, Manuela; Benevolo, Maria; Sinopoli, Ilenia; Sperduti, Isabella; Laquintana, Valentina; Fabbri, Giulia; Frasca, Mirko; Cristaudo, Antonio; Giuliani, Massimo; Dona, Maria Gabriella			Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men	PLOS ONE			English	Article							HPV INFECTION; RISK-FACTORS; OROPHARYNGEAL CANCER; UNITED-STATES; POPULATION; NECK; HEAD; WOMEN; COHORT; HEALTH	Background Oral Human Papillomavirus (HPV) infection is rare in the general population but common in high-risk individuals. Recent data indicate that oral HPV is associated with the development of head and neck carcinomas. HPV16 infection, in particular, increases the risk of oropharyngeal cancer. Methods We evaluated oral HPV prevalence and determinants of infection in cancer-free HIVinfected and uninfected men who have sex with men (MSM) recruited among attendees of an STI/HIV centre. Oral rinse and gargles were collected using a mouthwash and analyzed with the Linear Array HPV Genotyping Test. Socio-demographic and behavioral data were collected through face-to-face interviews. Results Overall, 170 MSM participated: 98 HIV-uninfected and 72 HIV-infected (91.7% under cART). Oral HPV was detected in 17.3% and 27.8% of the subjects, respectively (p = 0.13). Non-carcinogenic HPVs were significantly more common among HIV-infected MSM (18.1% vs. 5.1%, p = 0.01). Prevalence of the HPV types included in the quadrivalent HPV vaccine was similar (6.1% vs. 8.3% for the HIV-negative and positive MSM, respectively, p = 0.76). HPV16 was the most frequent type in HIV-negative (5.1%), and HIV-positive individuals, in the latter group together with HPV18, 72 and 84 (4.2% each). Older age at first sex (AOR: 4.02, 95% CI: 1.17-13.86 for those older than 18 years of age at first intercourse, p = 0.027) and a higher lifetime number of receptive oral sex partners (AOR: 9.14, 95% CI: 2.49-33.62 for those with >50 compared to <= 50 partners, p<0.001) were determinants of oral HPV among HIV-infected MSM. Conclusion Oral HPV infection among MSM attending an urban STI center is very frequent compared to the general population. Sexual behavior appears to be the major determinant of infection among the HIV-infected individuals.	[Rollo, Francesca; Benevolo, Maria; Laquintana, Valentina; Fabbri, Giulia] IRCCS, IFO, Regina Elena Natl Canc Inst, Pathol Dept, Rome, Italy; [Latini, Alessandra; Colafigli, Manuela; Frasca, Mirko; Cristaudo, Antonio; Giuliani, Massimo; Dona, Maria Gabriella] IRCCS, IFO, San Gallicano Dermatol Inst, STI HIV Unit, Rome, Italy; [Pichi, Barbara; Sinopoli, Ilenia] IRCCS, IFO, Regina Elena Natl Canc Inst, Otolaryngol Head Neck Surg Dept, Rome, Italy; [Sperduti, Isabella] IRCCS, IFO, Regina Elena Natl Canc Inst, Biostat Unit, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Istituti Fisioterapici Ospitalieri (IFO)	Dona, MG (corresponding author), IRCCS, IFO, San Gallicano Dermatol Inst, STI HIV Unit, Rome, Italy.	mariagabriella.dona@ifo.gov.it	Benevolo, Maria/J-8491-2018; Dona', Maria Gabriella/J-7336-2018; Colafigli, Manuela/K-5167-2018; latini, alessandra/J-8186-2018; Giuliani, Massimo/J-2788-2018; Rollo, Francesca/I-5249-2018; Laquintana, Valentina/U-7577-2017; Rollo, Francesca/AAC-2775-2021; Sperduti, Isabella/K-8902-2016	Benevolo, Maria/0000-0003-1994-0935; Dona', Maria Gabriella/0000-0003-3250-1726; Colafigli, Manuela/0000-0003-1610-6347; Giuliani, Massimo/0000-0002-4523-8261; Rollo, Francesca/0000-0003-2724-872X; Laquintana, Valentina/0000-0002-7374-5279; Rollo, Francesca/0000-0003-2724-872X; Sperduti, Isabella/0000-0001-5115-3099; pichi, barbara/0000-0003-0955-4563; Latini, Alessandra/0000-0002-9421-6560	Italian Ministry of Health [GR-2011-02349732]	Italian Ministry of Health(Ministry of Health, Italy)	The work was funded by the Italian Ministry of Health (GR-2011-02349732 to MGD).	Agalliu I, 2016, JAMA ONCOL; Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Carlander ALF, 2017, EUR J CANCER, V70, P75, DOI 10.1016/j.ejca.2016.10.015; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Colon-Lopez V, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-7; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; Darwich L, 2014, CLIN MICROBIOL INFEC, V20, pO585, DOI 10.1111/1469-0691.12523; Del Mistro A, 2012, SEX TRANSM DIS, V39, P894, DOI 10.1097/OLQ.0b013e31826ef2da; Divaris K, 2010, CANCER CAUSE CONTROL, V21, P567, DOI 10.1007/s10552-009-9486-9; Dona MG, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.011; Eliot MN, 2013, CANCER CAUSE CONTROL, V24, P1315, DOI 10.1007/s10552-013-0209-x; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gaester K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06592; Garcia-Cuyas F, 2013, SEX TRANSM DIS, V40, P3; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Hang D, 2014, CANCER EPIDEM BIOMAR, V23, P2101, DOI 10.1158/1055-9965.EPI-14-0084; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; IARC, 2011, IARC MON EV CARC RIS, V100; King EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157976; King EM, 2015, SEX TRANSM INFECT, V91, P284, DOI 10.1136/sextrans-2014-051955; Lupato V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170091; Mazul AL, 2017, CANCER-AM CANCER SOC, V123, P71, DOI 10.1002/cncr.30312; Mooij SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098955; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Ong JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102138; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; Sammarco ML, 2016, J MED VIROL, V88, P911, DOI 10.1002/jmv.24406; Shiboski CH, 2016, AIDS, V30, P1573, DOI 10.1097/QAD.0000000000001072; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Bui TC, 2013, CANCER PREV RES, V6, P917, DOI 10.1158/1940-6207.CAPR-13-0081; Tinhofer I, 2015, EUR J CANCER, V51, P514, DOI 10.1016/j.ejca.2014.12.018; van Aar F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0668-z; van Rijn VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092208	41	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184623	10.1371/journal.pone.0184623	http://dx.doi.org/10.1371/journal.pone.0184623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910359	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200070
J	Aihara, T; Ogawa, T; Shimokawa, T; Yamashita, O				Aihara, Takatsugu; Ogawa, Takeshi; Shimokawa, Takeaki; Yamashita, Okito			Anodal transcranial direct current stimulation of the right anterior temporal lobe did not significantly affect verbal insight	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; RIGHT-HEMISPHERE; PERFORMANCE; ACTIVATION; TASK; TDCS	Humans often utilize past experience to solve difficult problems. However, if past experience is insufficient to solve a problem, solvers may reach an impasse. Insight can be valuable for breaking an impasse, enabling the reinterpretation or re-representation of a problem. Previous studies using between-subjects designs have revealed a causal relationship between the anterior temporal lobes (ATLs) and non-verbal insight, by enhancing the right ATL while inhibiting the left ATL using transcranial direct current stimulation (tDCS). In addition, neuro-imaging studies have reported a correlation between right ATL activity and verbal insight. Based on these findings, we hypothesized that the right ATL is causally related to both nonverbal and verbal insight. To test this hypothesis, we conducted an experiment with 66 subjects using a within-subjects design, which typically has greater statistical power than a between-subjects design. Subjects participated in tDCS experiments across 2 days, in which they solved both non-verbal and verbal insight problems under active or sham stimulation conditions. To dissociate the effects of right ATL stimulation from those of left ATL stimulation, we used two montage types; anodal tDCS of the right ATL together with cathodal tDCS of the left ATL (stimulating both ATLs) and anodal tDCS of the right ATL with cathodal tDCS of the left cheek (stimulating only the right ATL). The montage used was counterbalanced across subjects. Statistical analyses revealed that, regardless of the montage type, there were no significant differences between the active and sham conditions for either verbal or non-verbal insight, although the finding for non-verbal insight was inconclusive because of a lack of statistical power. These results failed to support previous findings suggesting that the right ATL is the central locus of insight.	[Aihara, Takatsugu; Shimokawa, Takeaki; Yamashita, Okito] Adv Telecommun Res Inst Int ATR, Neural Informat Anal Labs, Kyoto, Japan; [Ogawa, Takeshi] Adv Telecommun Res Inst Int ATR, Cognit Mech Labs, Kyoto, Japan	Advanced Telecommunications Research Institute International; Advanced Telecommunications Research Institute International	Aihara, T (corresponding author), Adv Telecommun Res Inst Int ATR, Neural Informat Anal Labs, Kyoto, Japan.	aihara@atr.jp	Yamashita, Okito/ABW-9839-2022	Yamashita, Okito/0000-0002-6039-3657	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology, Japan [24700617]	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). Takatsugu Aihara was supported by KAKENHI (24700617) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, JAPANESE J PSYCHOL; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Bowden EM, 1998, PSYCHOL SCI, V9, P435, DOI 10.1111/1467-9280.00082; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Chi RP, 2012, NEUROSCI LETT, V515, P121, DOI 10.1016/j.neulet.2012.03.012; Chi RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016655; Chu Y, 2011, J PROBL SOLVING, V3, P119, DOI 10.7771/1932-6246.1094; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Goel V, 2015, J PROBL SOLVING, V8, P23, DOI 10.7771/1932-6246.1172; GRAFMAN J, 1982, CORTEX, V18, P37, DOI 10.1016/S0010-9452(82)80017-8; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jones Kevin T, 2012, Front Psychiatry, V3, P81, DOI 10.3389/fpsyt.2012.00081; Jung YJ, 2013, BIOMED ENG LETT, V3, P39, DOI 10.1007/s13534-013-0087-x; Jung-Beeman M, 2004, PLOS BIOL, V4; Kasahara K, 2013, NEUROSCI LETT, V545, P86, DOI 10.1016/j.neulet.2013.04.022; Kawahito J., 2011, HIROSHIMA PSYCHOL RE, P225, DOI [DOI 10.15027/32396, 10.15027/32396, DOI 10.15027/32396(INJAPANESEWITHENGLISHABSTRACT)]; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Knoblich G, 1999, J EXP PSYCHOL LEARN, V25, P1534, DOI 10.1037/0278-7393.25.6.1534; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2014, ANNU REV PSYCHOL, V65, P71, DOI 10.1146/annurev-psych-010213-115154; Li LM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00181; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; Metuki N, 2012, BRAIN STIMUL, V5, P110, DOI 10.1016/j.brs.2012.03.002; Miniussi C., 2012, TRANSCRANIAL BRAIN S; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Ollinger M, 2008, EXP PSYCHOL, V55, P269, DOI 10.1027/1618-3169.55.4.269; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zmigrod S, 2015, CREATIVITY RES J, V27, P353, DOI 10.1080/10400419.2015.1087280	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184749	10.1371/journal.pone.0184749	http://dx.doi.org/10.1371/journal.pone.0184749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902872	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200061
J	Chang, J; Xia, YF; Wasserloos, K; Deng, MH; Blose, KJ; Vorp, DA; Turnquist, HR; Billiar, TR; Pitt, BA; Zhang, MZ; Zhang, LM				Chang, Jing; Xia, Yuefeng; Wasserloos, Karla; Deng, Meihong; Blose, Kory J.; Vorp, David A.; Turnquist, Heth R.; Billiar, Timothy R.; Pitt, Bruce A.; Zhang, Ma-Zhong; Zhang, Li-Ming			Cyclic stretch induced IL-33 production through HMGB1/TLR-4 signaling pathway in murine respiratory epithelial cells	PLOS ONE			English	Article							INDUCED LUNG INJURY; MECHANICAL STRETCH; CYSTIC-FIBROSIS; DUAL-FUNCTION; IN-VIVO; EXPRESSION; LIPOPOLYSACCHARIDE; INFLAMMATION; HMGB1; MICE	Interleukin 33 (IL-33), an inflammatory and mechanically responsive cytokine, is an important component of a TLR4-dependent innate immune process in mucosal epithelium. Although TLR4 also plays a role in sensing biomechanical stretch, a pathway of stretch-induced TLR4-dependent IL-33 biosynthesis has not been revealed. In the current study, we show that short term (6 h) cyclic stretch (CS) of cultured murine respiratory epithelial cells (MLE-12) increased intracellular IL-33 expression in a TLR4 dependent fashion. There was no detectable IL-33 in conditioned media in this interval. CS, however, increased release of the notable alarmin, HMGB1, and a neutralizing antibody (2G7) to HMGB1 completely abolished the CS mediated increase in IL-33. rHMGB1 increased IL-33 synthesis and this was partially abrogated by silencing TLR4 suggesting additional receptors for HMGB1 are involved in its regulation of IL-33. Collectively, these data reveal a HMGB1/TLR4/IL-33 pathway in the response of respiratory epithelium to mechanical stretch.	[Chang, Jing; Zhang, Ma-Zhong] Shanghai Jiao Tong Univ, Dept Anesthesiol, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China; [Chang, Jing; Wasserloos, Karla; Pitt, Bruce A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Chang, Jing; Zhang, Li-Ming] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Xia, Yuefeng] Cent S Univ, Hunan Canc Hosp, Dept Anesthesiol, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Deng, Meihong; Vorp, David A.; Turnquist, Heth R.; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Blose, Kory J.; Vorp, David A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Vorp, David A.] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA	Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, MZ (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China.; Zhang, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA.	zmzscmc@shsmu.edu.cn; ZhangL1@anes.upmc.edu	Turnquist, Heth R/L-2319-2016	Turnquist, Heth R/0000-0002-4173-4014; Pitt, Bruce/0000-0003-0099-6648	NIH [R01 -GM -108639, R01-GM-50441]; Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Foundation of China [2015ZB0106]; Shanghai Pudong New District Science and Technology Development Innovation Foundation of China [PKJ 2013-Y61]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122489, T32HL076124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Foundation of China; Shanghai Pudong New District Science and Technology Development Innovation Foundation of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was made possible by the following grants: NIH grants R01 -GM -108639 (LMZ) and R01-GM-50441(TRB); Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Foundation of China [2015ZB0106] (MZZ); Shanghai Pudong New District Science and Technology Development Innovation Foundation of China [PKJ 2013-Y61] (MZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chang Jing, 2016, Transl Perioper Pain Med, V1, P24; Diamond G, 1996, P NATL ACAD SCI USA, V93, P5156, DOI 10.1073/pnas.93.10.5156; Ding N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074633; Entezari M, 2012, MOL MED, V18, P477, DOI 10.2119/molmed.2012.00024; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; Fu J, 2016, INT IMMUNOPHARMACOL, V38, P267, DOI 10.1016/j.intimp.2016.06.010; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Gutschow MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053222; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17; John AE, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad5568; John G, 2011, EXP LUNG RES, V37, P319, DOI 10.3109/01902148.2011.569968; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kuhn H, 2014, RESPIROLOGY, V19, P67, DOI 10.1111/resp.12149; Li HH, 2012, AM J RESP CELL MOL, V47, P528, DOI 10.1165/rcmb.2012-0127OC; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Li J., 2016, STEM CELLS INT, V2016, P6, DOI DOI 10.1016/J.ENGGE0.2016.03.006; Lin SH, 2016, CLIN IMMUNOLOGY; Lundback P, 2016, HEPATOLOGY, V64, P1699, DOI 10.1002/hep.28736; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Martinez-Gonzalez I, 2013, AM J RESP CELL MOL, V49, P552, DOI 10.1165/rcmb.2012-0406OC; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Paris G, 2014, INT FORUM ALLERGY RH, V4, P15, DOI 10.1002/alr.21237; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sebag SC, 2013, J BIOL CHEM, V288, P7875, DOI 10.1074/jbc.M112.403220; Shyu KG, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-15; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Tao AB, 2015, BBA-MOL BASIS DIS, V1852, P2075, DOI 10.1016/j.bbadis.2015.07.015; Tao WW, 2015, INT IMMUNOPHARMACOL, V27, P138, DOI 10.1016/j.intimp.2015.05.005; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Ullah MA, 2014, J ALLERGY CLIN IMMUN, V134, P440, DOI 10.1016/j.jaci.2013.12.1035; Vande Geest Jonathan P, 2004, J Biomech, V37, P1923, DOI 10.1016/j.jbiomech.2004.02.022; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860; Wu XJ, 2013, MOL CELL BIOCHEM, V380, P249, DOI 10.1007/s11010-013-1680-0; Xia J, 2015, AM J PHYSIOL-LUNG C, V308, pL619, DOI 10.1152/ajplung.00305.2014; Xu J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002365; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108914; Yang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121391	48	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184770	10.1371/journal.pone.0184770	http://dx.doi.org/10.1371/journal.pone.0184770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898270	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500049
J	Morais, ER; Oliveira, KC; de Paula, RG; Ornelas, AMM; Moreira, EBC; Badoco, FR; Magalhaes, LG; Verjovski-Almeida, S; Rodrigues, V				Morais, Enyara R.; Oliveira, Katia C.; de Paula, Renato G.; Ornelas, Alice M. M.; Moreira, Erika B. C.; Badoco, Fernanda Rafacho; Magalhaes, Lizandra G.; Verjovski-Almeida, Sergio; Rodrigues, Vanderlei			Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni	PLOS ONE			English	Article							20S PROTEASOME; TRANSCRIPTOME ANALYSIS; REGULATORY PARTICLE; MICROARRAY; PATHWAY; GENE; APOPTOSIS; IDENTIFICATION; PROTEOLYSIS; CURCUMIN	Proteasome is a proteolytic complex responsible for intracellular protein turnover in eukaryotes, archaea and in some actinobacteria species. Previous work has demonstrated that in Schistosoma mansoni parasites, the proteasome inhibitor MG-132 affects parasite development. However, the molecular targets affected by MG-132 in S. mansoni are not entirely known. Here, we used expression microarrays to measure the genome-wide changes in gene expression of S. mansoni adult worms exposed in vitro to MG-132, followed by in silico functional analyses of the affected genes using Ingenuity Pathway Analysis (IPA). Scanning electron microscopy was used to document changes in the parasites' tegument. We identified 1,919 genes with a statistically significant (q-value <= 0.025) differential expression in parasites treated for 24 h with MG-132, when compared with control. Of these, a total of 1,130 genes were up-regulated and 790 genes were down-regulated. A functional gene interaction network comprised of MG-132 and its target genes, known from the literature to be affected by the compound in humans, was identified here as affected by MG-132. While MG-132 activated the expression of the 26S proteasome genes, it also decreased the expression of 19S chaperones assembly, 20S proteasome maturation, ubiquitin-like NEDD8 and its partner cullin-3 ubiquitin ligase genes. Interestingly, genes that encode proteins related to potassium ion binding, integral membrane component, ATPase and potassium channel activities were significantly down-regulated, whereas genes encoding proteins related to actin binding and microtubule motor activity were significantly up-regulated. MG132 caused important changes in the worm tegument; peeling, outbreaks and swelling in the tegument tubercles could be observed, which is consistent with interference on the ionic homeostasis in S. mansoni. Finally, we showed the down-regulation of Bax pro-apoptotic gene, as well as up-regulation of two apoptosis inhibitor genes, IAP1 and BRE1, and in contrast, down-regulation of Apaf-1 apoptotic activator, thus suggesting that apoptosis is deregulated in S. mansoni exposed to MG-132. A considerable insight has been gained concerning the potential of MG-132 as a gene expression modulator, and overall the data suggest that the proteasome might be an important molecular target for the design of new drugs against schistosomiasis.	[Morais, Enyara R.; de Paula, Renato G.; Ornelas, Alice M. M.; Moreira, Erika B. C.; Rodrigues, Vanderlei] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Oliveira, Katia C.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Dept Bioquim, Inst Quim, Sao Paulo, SP, Brazil; [Oliveira, Katia C.] Adolfo Lutz Inst, Ctr Parasitol & Micol, Nucleo Enteroparasitas, Sao Paulo, SP, Brazil; [Badoco, Fernanda Rafacho; Magalhaes, Lizandra G.] Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, Grp Pesquisa Prod Nat, Franca, SP, Brazil; [Verjovski-Almeida, Sergio] Inst Butantan, Lab Expressao Genica Eucariotos, Sao Paulo, SP, Brazil; [Morais, Enyara R.] Univ Fed Uberlandia, Inst Genet Bioquim, Campus Patos de Minas, Patos De Minas, MG, Brazil; [Oliveira, Katia C.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Discipline Parasitol, Sao Paulo, SP, Brazil; [Ornelas, Alice M. M.] Univ Fed Rio de Janeiro, Inst Biol, Ctr Ciencias & Saude, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz; Universidad de Franca; Instituto Butantan; Universidade Federal de Uberlandia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Morais, ER (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil.; Morais, ER (corresponding author), Univ Fed Uberlandia, Inst Genet Bioquim, Campus Patos de Minas, Patos De Minas, MG, Brazil.	ermorais@ufu.br	Oliveira, K C/B-9079-2012; DE PAULA, RENATO GRACIANO/T-8688-2019; Verjovski-Almeida, Sergio/E-4082-2012; Ornelas, Alice M M/K-1548-2018; RAFACHO BADOCO, FERNANDA/GOV-7103-2022; De Paula, Renato Graciano/Q-2222-2016; Badoco, Fernanda/GYD-8954-2022; Magalhães, Lizandra/B-9702-2014	Oliveira, K C/0000-0002-8535-0901; DE PAULA, RENATO GRACIANO/0000-0002-6712-437X; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ornelas, Alice M M/0000-0003-4131-4850; RAFACHO BADOCO, FERNANDA/0000-0001-9055-4143; De Paula, Renato Graciano/0000-0002-6712-437X; Badoco, Fernanda/0000-0001-9055-4143; Magalhães, Lizandra/0000-0003-2959-6752; Morais, Enyara/0000-0001-5193-889X				Almeida GT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004086; Anderson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004334; Bergquist R, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0286-2; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Botros S, 2003, ANTIMICROB AGENTS CH, V47, P3853, DOI 10.1128/AAC.47.12.3853-3858.2003; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Caffrey CR, 2015, FUTURE MED CHEM, V7, P675, DOI [10.4155/FMC.15.27, 10.4155/fmc.15.27]; Cai PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1947-x; Cai PF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004684; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Dai Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2036-5; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; de Paula R, 2015, PARASITOL RES, V114, P1747, DOI 10.1007/s00436-015-4360-z; de Paula RG, 2014, PARASITOL RES, V113, P2887, DOI 10.1007/s00436-014-3950-5; DeMarco R, 2006, MOL BIOCHEM PARASIT, V150, P123, DOI 10.1016/j.molbiopara.2006.07.002; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; Fitzpatrick JM, 2005, MOL BIOCHEM PARASIT, V141, P1, DOI 10.1016/j.molbiopara.2005.01.007; Gaczynska Maria, 2005, V301, P3; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Greenberg RM, 2014, CURR CLIN MICROBIOL, V1, P51, DOI 10.1007/s40588-014-0007-6; Griffin Thomas A., 2000, Molecular Cell Biology Research Communications, V3, P212, DOI 10.1006/mcbr.2000.0213; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Guerra-Sa R, 2005, EXP PARASITOL, V109, P228, DOI 10.1016/j.exppara.2005.01.002; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; Kasinathan RS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001425; Kasinathan RS, 2010, MOL BIOCHEM PARASIT, V173, P25, DOI 10.1016/j.molbiopara.2010.05.003; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Khare S, 2016, NATURE, V537, P229, DOI 10.1038/nature19339; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Leutner S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002532; Li H, 2016, NATURE, V530, P233, DOI 10.1038/nature16936; Li H, 2014, J AM CHEM SOC, V136, P13562, DOI 10.1021/ja507692y; Magalhaes LG, 2009, PARASITOL RES, V104, P1197, DOI 10.1007/s00436-008-1311-y; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Mathieson W, 2011, MOL BIOCHEM PARASIT, V175, P118, DOI 10.1016/j.molbiopara.2010.10.005; Morais ER, 2013, MOL BIOCHEM PARASIT, V187, P91, DOI 10.1016/j.molbiopara.2012.11.006; Nath SR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00078; Nehybova T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040729; Nkemgu-Njinkeng J, 2002, ANTIMICROB AGENTS CH, V46, P2038, DOI 10.1128/AAC.46.6.2038-2040.2002; Oliveira KC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000556; Park Ji Eun, 2017, PLoS One, V12, pe0173247, DOI 10.1371/journal.pone.0173247; Peng JB, 2010, PARASITOL RES, V106, P967, DOI 10.1007/s00436-010-1752-y; Pereira RV, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0957-4; Picard MAL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004930; Prasad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073530; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Robertson CD, 1999, MOL BIOCHEM PARASIT, V103, P49, DOI 10.1016/S0166-6851(99)00110-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rojo JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171677; Rosenberg SH, 2011, P NATL ACAD SCI USA, V108, P6695, DOI 10.1073/pnas.1104151108; Santiago EDF, 2014, ANTIMICROB AGENTS CH, V58, P352, DOI 10.1128/AAC.01900-13; Savulescu AF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.006890; Shaw MK, 2000, PARASITOLOGY, V121, P35, DOI 10.1017/S0031182099006071; Siddiqui AA, 2017, TRENDS PARASITOL, V33, P194, DOI 10.1016/j.pt.2016.10.010; Sidor-Kaczmarek J, 2017, CELL BIOL TOXICOL; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Tebeje BM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1799-4; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vale N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02582-16, 10.1128/aac.02582-16]; Verjovski-Almeida S, 2004, TRENDS PARASITOL, V20, P304, DOI 10.1016/j.pt.2004.04.012; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005; Vermeire JJ, 2006, MOL BIOCHEM PARASIT, V147, P39, DOI 10.1016/j.molbiopara.2006.01.006; Waisberg M, 2008, EXP PARASITOL, V120, P357, DOI 10.1016/j.exppara.2008.09.005; Waisberg M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-181; Walter D, 2010, J CELL SCI, V123, P1931, DOI 10.1242/jcs.065938; WHO, 2017, SCHIST MED CTR FACT; WHO, 2016, SCHIST MED CTR FACT; Wilck N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040781; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Zanotto A, 2012, INVEST NEW DRUG, V30, P2252, DOI 10.1007/s10637-012-9804-z	79	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184192	10.1371/journal.pone.0184192	http://dx.doi.org/10.1371/journal.pone.0184192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898250	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500017
J	Jung, J; Kim, S; Cho, H; Nam, K				Jung, JeYoung; Kim, Sunmi; Cho, Hyesuk; Nam, Kichun			Structural and functional correlates for language efficiency in auditory word processing	PLOS ONE			English	Article							VENTROLATERAL THALAMIC-STIMULATION; MILD COGNITIVE IMPAIRMENT; MIDDLE TEMPORAL GYRUS; SPEECH-PERCEPTION; TASK-PERFORMANCE; SEMANTIC SYSTEM; READING-ABILITY; WORKING-MEMORY; CORTICAL AREAS; VISUAL-CORTEX	This study aims to provide convergent understanding of the neural basis of auditory word processing efficiency using a multimodal imaging. We investigated the structural and functional correlates of word processing efficiency in healthy individuals. We acquired two structural imaging (T1-weighted imaging and diffusion tensor imaging) and functional magnetic resonance imaging (fMRI) during auditory word processing (phonological and semantic tasks). Our results showed that better phonological performance was predicted by the greater thalamus activity. In contrary, better semantic performance was associated with the less activation in the left posterior middle temporal gyrus (pMTG), supporting the neural efficiency hypothesis that better task performance requires less brain activation. Furthermore, our network analysis revealed the semantic network including the left anterior temporal lobe (ATL), dorsolateral prefrontal cortex (DLPFC) and pMTG was correlated with the semantic efficiency. Especially, this network acted as a neural efficient manner during auditory word processing. Structurally, DLPFC and cingulum contributed to the word processing efficiency. Also, the parietal cortex showed a significate association with the word processing efficiency. Our results demonstrated that two features of word processing efficiency, phonology and semantics, can be supported in different brain regions and, importantly, the way serving it in each region was different according to the feature of word processing. Our findings suggest that word processing efficiency can be achieved by in collaboration of multiple brain regions involved in language and general cognitive function structurally and functionally.	[Jung, JeYoung] Univ Manchester, Sch Biol Sci, Div Neurosci & Expt Psychol, Neurosci & Aphasia Res Unit, Manchester, Lancs, England; [Kim, Sunmi; Cho, Hyesuk; Nam, Kichun] Korea Univ, Wisdom Sci Ctr, Seoul, South Korea; [Nam, Kichun] Korea Univ, Dept Psychol, Seoul, South Korea	University of Manchester; Korea University; Korea University	Jung, J (corresponding author), Univ Manchester, Sch Biol Sci, Div Neurosci & Expt Psychol, Neurosci & Aphasia Res Unit, Manchester, Lancs, England.; Nam, K (corresponding author), Korea Univ, Wisdom Sci Ctr, Seoul, South Korea.; Nam, K (corresponding author), Korea Univ, Dept Psychol, Seoul, South Korea.	jeyoung.jung@manchester.ac.uk; kichun@korea.ac.kr		Jung, JeYoung/0000-0003-3739-7331	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1A2B4007876]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1A2B4007876). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HUMAN NEUROANATOMY T; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bartlett EL, 2013, BRAIN LANG, V126, P29, DOI 10.1016/j.bandl.2013.03.003; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Baumeister J, 2008, EUR J APPL PHYSIOL, V104, P625, DOI 10.1007/s00421-008-0811-x; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Bhatnagar SC, 2005, BRAIN LANG, V92, P1, DOI 10.1016/j.bandl.2004.05.002; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Booth JR, 2003, HUM BRAIN MAPP, V19, P155, DOI 10.1002/hbm.10111; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chee M, 2001, NEUROIMAGE, V13, pS516; Crittenden BM, 2014, CEREB CORTEX, V24, P532, DOI 10.1093/cercor/bhs333; De Schotten MT, 2012, LEARNING READ IMPROV; Delano-Wood L, 2012, J ALZHEIMERS DIS, V29, P589, DOI 10.3233/JAD-2012-102103; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Geschwind N., 1974, DISCONNEXION SYNDROM; Grogan A, 2012, NEUROPSYCHOLOGIA, V50, P1347, DOI 10.1016/j.neuropsychologia.2012.02.019; HAIER RJ, 1992, INTELLIGENCE, V16, P415, DOI 10.1016/0160-2896(92)90018-M; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hoffman P, 2012, APHASIOLOGY, V26, P1119, DOI 10.1080/02687038.2011.608838; Howell D. C., 2010, FUNDAMENTAL STAT BEH; Johnson MD, 2000, BRAIN COGNITION, V42, P218, DOI 10.1006/brcg.1999.1101; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kang YJ, 2015, LAB PHONOL, V6, P469, DOI 10.1515/lp-2015-0014; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kim S, 1993, KOREAN PRONUNCIATION; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee CC, 2013, BRAIN LANG, V126, P22, DOI 10.1016/j.bandl.2012.05.004; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Lim SJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00230; Maguire EA, 2004, NEUROIMAGE, V22, P171, DOI 10.1016/j.neuroimage.2003.12.036; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; MOORE O, 1991, SRA-J SOC RES ADMIN, V23, P45; Mori S., 2005, AM SOC NEURORADIOLOG; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Noonan KA, 2013, J COGN NEUROSCI; OJEMANN GA, 1975, BRAIN LANG, V2, P101, DOI 10.1016/S0093-934X(75)80057-5; OJEMANN GA, 1971, BRAIN, V94, P225, DOI 10.1093/brain/94.2.225; OJEMANN GA, 1985, APPL NEUROPHYSIOL, V48, P212; Penfield W., 1959, SPEECH BRAIN MECH; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1990, SCIENCE, V249, P1041, DOI 10.1126/science.2396097; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Timmann D, 2009, NEUROSCIENCE, V162, P836, DOI 10.1016/j.neuroscience.2009.01.040; Townsend J. T., 1983, STOCHASTIC MODELING; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Van Ettinger-Veenstra H, 2012, BRAIN LANG, V120, P395, DOI 10.1016/j.bandl.2011.10.002; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Vanderhasselt MA, 2009, PSYCHON B REV, V16, P609, DOI 10.3758/PBR.16.3.609; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Visser M, 2011, J COGNITIVE NEUROSCI, V23, P3121, DOI 10.1162/jocn_a_00007; Visser M, 2012, J COGNITIVE NEUROSCI, V24, P1766, DOI 10.1162/jocn_a_00244; Weber B, 2006, EPILEPSIA, V47, P880, DOI 10.1111/j.1528-1167.2006.00515.x; Wei T, 2012, J NEUROSCI, V32, P481, DOI 10.1523/JNEUROSCI.1953-11.2012; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Y-K Kim-Renaud, 1994, THEORETICAL ISSUES K	78	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184232	10.1371/journal.pone.0184232	http://dx.doi.org/10.1371/journal.pone.0184232			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892503	gold, Green Published, Green Submitted			2022-12-26	WOS:000410243200011
J	Chiang, GPK; Chen, ZG; Chan, MCW; Lee, SHM; Kwok, AK; Yeung, ACM; Nelson, EAS; Hon, KL; Leung, TF; Chan, PKS				Chiang, Grace P. K.; Chen, Zigui; Chan, Martin C. W.; Lee, Simon H. M.; Kwok, Angela K.; Yeung, Apple C. M.; Nelson, E. Anthony S.; Hon, Kam Lun; Leung, Ting Fan; Chan, Paul K. S.			Clinical features and seasonality of parechovirus infection in an Asian subtropical city, Hong Kong	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; ACUTE GASTROENTERITIS; YOUNG-CHILDREN; STOOL SAMPLES; ENTEROVIRUS; EPIDEMIOLOGY; PREVALENCE; GENOTYPES; INFANTS; CHINA	Background The epidemiology of human parechovirus (HPeV) in Asia remains obscure. We elucidated the prevalence, seasonality, type distribution and clinical presentation of HPeV among children in Hong Kong. Methods A 24-month prospective study to detect HPeV in children <= 36 months hospitalized for acute viral illnesses. Results 2.3% of the 3911 children examined had HPeV infection, with most (87.5%) concentrated in September-January (autumn-winter). 81.3% were HPeV1 and 12.5% were HPeV4, while HPeV3 was rare (2.5%). HPeV was a probable cause of the disease in 47.7% (42/88), mostly self-limiting including acute gastroenteritis, upper respiratory tract infection and maculopapular rash. A neonate developed severe sepsis-like illness with HPeV3 as the only pathogen detected. A high proportion (60.0%) of children coinfected with HPeV and other respiratory virus(es) had acute bronchiolitis or pneumonia. Six children with HPeV coinfections developed convulsion / pallid attack. Most rash illnesses exhibited a generalized maculopapular pattern involving the trunk and limbs, and were more likely associated with HPeV4 compared to other syndrome groups (36.4% vs. 3.1%, p = 0.011). Conclusions In Hong Kong, HPeV exhibits a clear seasonality (autumn-winter) and was found in a small proportion (2.3%) of young children (<= 36 months) admitted with features of acute viral illnesses. The clinical presentation ranged from mild gastroenteritis, upper respiratory tract infection and febrile rash to convulsion and severe sepsis-like illness. HPeV3, which is reported to associate with more severe disease in neonates, is rare in Hong Kong. HPeV coinfection might associate with convulsion and aggravate other respiratory tract infections.	[Chiang, Grace P. K.; Lee, Simon H. M.; Nelson, E. Anthony S.; Hon, Kam Lun; Leung, Ting Fan] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Fac Med, Shatin, Hong Kong, Peoples R China; [Chen, Zigui; Chan, Martin C. W.; Kwok, Angela K.; Yeung, Apple C. M.; Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Chan, Martin/B-3588-2009; Chan, Paul KS/J-9360-2013; Nelson, E Anthony S/ABF-4238-2020; LEUNG, Ting Fan/E-7728-2013; Chen, Zigui/E-8490-2017	Chan, Martin/0000-0002-1568-1596; Chan, Paul KS/0000-0002-6360-4608; Nelson, E Anthony S/0000-0002-2521-3403; LEUNG, Ting Fan/0000-0002-6469-1926; Chen, Zigui/0000-0002-8577-1298	Health and Medical Research Fund (HMRF) - Food and Health Bureau, Hong Kong Special Administrative Region [13120362]	Health and Medical Research Fund (HMRF) - Food and Health Bureau, Hong Kong Special Administrative Region	This research was supported by the Health and Medical Research Fund (HMRF, http://rfs1.fhb.gov.hk/english/welcome/welcome.html) granted by Food and Health Bureau, Hong Kong Special Administrative Region [project no. 13120362]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606; Cabrerizo M, 2016, J MED VIROL IN PRESS; Chen HF, 2014, ARCH VIROL, V159, P971, DOI 10.1007/s00705-013-1915-0; Cordey S, 2015, J CLIN VIROL, V68, P69, DOI 10.1016/j.jcv.2015.05.003; de Crom SCM, 2016, EUR J PEDIATR, V175, P1023, DOI 10.1007/s00431-016-2725-7; de Crom SCM, 2016, J CLIN VIROL, V77, P15, DOI 10.1016/j.jcv.2016.01.014; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Han TH, 2011, ARCH VIROL, V156, P1471, DOI 10.1007/s00705-011-0995-y; Harvala H, 2011, J MED VIROL, V83, P889, DOI 10.1002/jmv.22023; Harvala H, 2010, CURR OPIN INFECT DIS, V23, P224, DOI 10.1097/QCO.0b013e32833890ca; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; Locatelli G, 2000, J CLIN MICROBIOL, V38, P4042, DOI 10.1128/JCM.38.11.4042-4048.2000; Loi C, 2016, ARCH DIS CH IN PRESS; Nirei J, 2016, PEDIATR INT, V58, P400, DOI 10.1111/ped.12869; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Renaud C, 2015, INFECT DIS CLIN N AM, V29, P415, DOI 10.1016/j.idc.2015.05.005; Schuffenecker I, 2012, J CLIN VIROL, V54, P337, DOI 10.1016/j.jcv.2012.04.016; Shoji K, 2014, PEDIATR DERMATOL, V31, P258, DOI 10.1111/j.1525-1470.2012.01819.x; Shoji K, 2013, PEDIATR INFECT DIS J, V32, P233, DOI 10.1097/INF.0b013e31827b1fd0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; Tang JW, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.34.30326; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07; Wildenbeest JG, 2013, PEDIATRICS, V132, pE243, DOI 10.1542/peds.2012-1136; Yamamoto SP, 2015, J MED MICROBIOL, V64, P1415, DOI 10.1099/jmm.0.000167; Yip CCY, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-182; Zhong HQ, 2011, J MED VIROL, V83, P1428, DOI 10.1002/jmv.22114	34	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184533	10.1371/journal.pone.0184533	http://dx.doi.org/10.1371/journal.pone.0184533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886185	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100150
J	Michalicova, P; Mravec, F; Pekar, M				Michalicova, Petra; Mravec, Filip; Pekar, Miloslav			Fluorescence study of freeze-drying as a method for support the interactions between hyaluronan and hydrophobic species	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; AQUEOUS-SOLUTIONS; DELIVERY-SYSTEMS; IR SPECTROMETRY; DRUG-DELIVERY; ACID; WATER; SECONDARY; CD44; CONFORMATIONS	A freeze-drying method enabling solubilization of hydrophobic species in aqueous solutions of native hyaluronan is described. The method is based on opening the access to supposed hydrophobic patches on hyaluronan by disturbing its massive hydration shell. Hydrophobic and/or polarity-sensitive fluorescence probes were used as hydrophobic models or indicators of interactions with hydrophobic patches. Fluorescence parameters specific to individual probes confirmed the efficiency of the freeze-drying method. This work is the first step in developing biocompatible and biodegradable carriers for hydrophobic drugs with targeted distribution of the active compound from native, chemically non-modified hyaluronan.	[Pekar, Miloslav] Brno Univ Technol, Fac Chem, Inst Phys & Appl Chem, Brno, Czech Republic; Brno Univ Technol, Fac Chem, Mat Res Ctr, Brno, Czech Republic	Brno University of Technology; Brno University of Technology	Pekar, M (corresponding author), Brno Univ Technol, Fac Chem, Inst Phys & Appl Chem, Brno, Czech Republic.	pekar@fch.vut.cz	Mravec, Filip/G-7170-2015	Mravec, Filip/0000-0001-6114-4751; Pekar, Miloslav/0000-0002-3878-0917	Materials Research Centre at FCH BUT-Sustainability and Development [L01211, LO1211]; National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic)	Materials Research Centre at FCH BUT-Sustainability and Development; National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic)	This work was supported by the Materials Research Centre at FCH BUT-Sustainability and Development, L01211, with financial support from National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic) (http://www.msmt.cz/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Materials Research Centre at FCH BUT-Sustainability and Development, LO1211, with financial support from National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic).	Abdelwahed W, 2006, ADV DRUG DELIVERY RE, V58, P76; Adhikary R, 2009, J PHYS CHEM B, V113, P11999, DOI 10.1021/jp905139n; Almond A, 2003, GLYCOBIOLOGY, V13, P255, DOI 10.1093/glycob/cwg031; BETTELHEIM FA, 1992, CURR EYE RES, V11, P411, DOI 10.3109/02713689209001794; Brown T., 2008, CURRENT PHARM BIOTEC, V9, P421; Cowman MK, 2005, BIOPHYS J, V88, P590, DOI 10.1529/biophysj.104.049361; Creuzet C, 2006, POLYMER, V47, P2706, DOI 10.1016/j.polymer.2006.02.052; Franks F, 1998, EUR J PHARM BIOPHARM, V45, P221, DOI 10.1016/S0939-6411(98)00004-6; Garcia-Abuin A, 2011, CARBOHYD POLYM, V85, P500, DOI 10.1016/j.carbpol.2011.02.028; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0; Haxaire K, 2003, BIOPOLYMERS, V72, P149, DOI 10.1002/bip.10342; HEATLEY F, 1988, BIOCHEM J, V254, P489, DOI 10.1042/bj2540489; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jin Yu-Jin, 2010, Journal of Pharmaceutical Investigation, V40, P33, DOI 10.4333/KPS.2010.40.S.033; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z; Lasagna M, 1996, BIOCHEMISTRY-US, V35, P973, DOI 10.1021/bi951983t; Lee H, 2008, BIOCONJUGATE CHEM, V19, P1319, DOI 10.1021/bc8000485; LIAPIS AI, 1994, SEPAR TECHNOL, V4, P144, DOI 10.1016/0956-9618(94)80017-0; Lu KW, 2013, EXP LUNG RES, V39, P191, DOI 10.3109/01902148.2013.791893; Marechal Y, 2003, BIOPOLYMERS, V72, P162, DOI 10.1002/bip.10343; Ni N, 2001, INT J PHARM, V226, P39, DOI 10.1016/S0378-5173(01)00757-8; Ossipov DA, 2010, EXPERT OPIN DRUG DEL, V7, P681, DOI 10.1517/17425241003730399; Oyarzun-Ampuero FA, 2013, EUR J PHARM SCI, V49, P483, DOI 10.1016/j.ejps.2013.05.008; Peer D, 2004, NEOPLASIA, V6, P343, DOI 10.1593/neo.03460; Petrak K, 2005, DRUG DISCOV TODAY, V10, P1667, DOI 10.1016/S1359-6446(05)03698-6; Philippova OE, 2001, BIOMACROMOLECULES, V2, P483, DOI 10.1021/bm005649a; Prusova A, 2013, CARBOHYD POLYM, V95, P515, DOI 10.1016/j.carbpol.2013.03.031; Sanchez FG, 1996, J LUMIN, V69, P179, DOI 10.1016/S0022-2313(96)00116-0; SCOTT JE, 1992, EUR J BIOCHEM, V209, P675, DOI 10.1111/j.1432-1033.1992.tb17335.x; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Bicudo RCS, 2012, J NANOSCI NANOTECHNO, V12, P2849, DOI 10.1166/jnn.2012.5814; Spagnoli C, 2005, CARBOHYD RES, V340, P929, DOI 10.1016/j.carres.2005.01.024; Teagarden DL, 2002, EUR J PHARM SCI, V15, P115, DOI 10.1016/S0928-0987(01)00221-4; THALBERG K, 1989, J PHYS CHEM-US, V93, P1478, DOI 10.1021/j100341a058; Tokita Y, 1997, POLYM DEGRAD STABIL, V55, P159, DOI 10.1016/S0141-3910(96)00128-0; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Tsinontides SC, 2004, INT J PHARM, V280, P1, DOI 10.1016/j.ijpharm.2004.04.018; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; Vandamme E., 2002, BIOPOLYMERS POLYSACC; Wang W, 2012, CHINESE J CHEM ENG, V20, P551, DOI 10.1016/S1004-9541(11)60218-8; WEDLOCK DJ, 1983, INT J BIOL MACROMOL, V5, P186, DOI 10.1016/0141-8130(83)90036-3; Wittaya-Areekul S, 1998, J PHARM SCI, V87, P491, DOI 10.1021/js9702832	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184558	10.1371/journal.pone.0184558	http://dx.doi.org/10.1371/journal.pone.0184558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886150	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100154
J	Perego, M; Maurer, M; Wang, JX; Shaffer, S; Muller, AC; Parapatics, K; Li, L; Hristova, D; Shin, S; Keeney, F; Liu, S; Xu, X; Raj, A; Jensen, JK; Bennett, KL; Wagner, SN; Somasundaram, R; Herlyn, M				Perego, M.; Maurer, M.; Wang, J. X.; Shaffer, S.; Mueller, A. C.; Parapatics, K.; Li, L.; Hristova, D.; Shin, S.; Keeney, F.; Liu, S.; Xu, X.; Raj, A.; Jensen, J. K.; Bennett, K. L.; Wagner, S. N.; Somasundaram, R.; Herlyn, M.			A slow-cycling subpopulation of melanoma cells with highly invasive properties	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN-1; PROTEASE NEXIN-1; PROGNOSTIC-SIGNIFICANCE; PLASMINOGEN-ACTIVATOR; SAMPLE PREPARATION; INITIATING CELLS; MESSENGER-RNA; LOW NUMBER; CANCER; EXPRESSION	Melanoma is a heterogeneous tumor with different subpopulations showing different proliferation rates. Slow-cycling cells were previously identified in melanoma, but not fully biologically characterized. Using the label-retention method, we identified a subpopulation of slow-cycling cells, defined as label-retaining cells (LRC), with strong invasive properties. We demonstrate through live imaging that LRC are leaving the primary tumor mass at a very early stage and disseminate to peripheral organs. Through global proteome analyses, we identified the secreted protein SerpinE2/protease nexin-1 as causative for the highly invasive potential of LRC in melanomas.	[Perego, M.; Wang, J. X.; Li, L.; Hristova, D.; Shin, S.; Keeney, F.; Somasundaram, R.; Herlyn, M.] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Maurer, M.; Wagner, S. N.] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Shaffer, S.; Raj, A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Mueller, A. C.; Parapatics, K.; Bennett, K. L.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Liu, S.; Xu, X.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Jensen, J. K.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	The Wistar Institute; Medical University of Vienna; University of Pennsylvania; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Pennsylvania; Aarhus University	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.	herlynm@wistar.org	perego, michela/W-4650-2019	perego, michela/0000-0002-5671-928X; Mueller, Andre/0000-0002-0608-8176; Somasundaram, Rajasekharan/0000-0002-8444-8472; Shin, Sally/0000-0002-9306-2264; Liu, Shujing/0000-0002-2958-093X; Shaffer, Sydney/0000-0003-3539-9886	NIH [P01 CA114046, P01 CA025874, P30 CA010815, R01 CA047159, CA076674, CA182890]; Melanoma Research Alliance; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Vienna Science and Technology Fund (WWTF) [LS11-045]; Vienna Hans Mayr-Fund; APART fellowship of the Austrian Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA182890, P01CA025874, P30CA010815, R01CA047159, P01CA114046, P50CA174523, R01CA076674] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Vienna Science and Technology Fund (WWTF); Vienna Hans Mayr-Fund; APART fellowship of the Austrian Academy of Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Jeffrey Faust, Scott Weiss and Christopher Corcoran from Wistar's Flow Cytometry Facility; James Hayden from Wistar's Imaging Facility and Dmitri Gourevitch from Wistar's Histopathology Core Facility for technical support; and Rachel E Locke and Jessica L Kohn for editorial assistance. This work was supported by NIH grants P01 CA114046, P01 CA025874, P30 CA010815, R01 CA047159, CA076674, CA182890, by the Melanoma Research Alliance and by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Vienna Science and Technology Fund (WWTF through project LS11-045 to SNW), Vienna Hans Mayr-Fund, and by APART fellowship of the Austrian Academy of Sciences (OAW to MM).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Bianchi-Smiraglia A, 2017, ONCOGENE, V5, P36; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bouton MC, 2012, BLOOD, V119, P2452, DOI 10.1182/blood-2011-10-387464; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Buchholz M, 2003, CANCER RES, V63, P4945; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Cheli Y, 2001, ONCOGENE, V19, P30; Cheli Y, 2012, ONCOGENE, V10, P31; Chou CT, 2015, ANN SURG ONCOL, V22, P4335, DOI 10.1245/s10434-015-4505-4; Colinge J, 2006, J PROTEOME RES, V5, P619, DOI 10.1021/pr0504236; Croteau W, 2013, J CELL PHYSIOL, V228, P773, DOI 10.1002/jcp.24225; Czekay RP, 2009, J CELL PHYSIOL, V220, P655, DOI 10.1002/jcp.21806; Dembinski Jennifer L, 2010, Cancers (Basel), V2, P2011, DOI 10.3390/cancers2042011; EVANS DL, 1991, J BIOL CHEM, V266, P22307; Falletta P, 2017, GENE DEV, V1, P31; Fane ME, 2017, EBIOMEDICINE, V16, P63, DOI 10.1016/j.ebiom.2017.01.013; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Faries MB, 2013, J AM COLL SURGEONS, V217, P27, DOI 10.1016/j.jamcollsurg.2013.03.007; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Gao S, 2008, ORAL ONCOL, V44, P309, DOI 10.1016/j.oraloncology.2007.02.009; Garrigue-Antar L, 2001, J BIOL CHEM, V276, P26237, DOI 10.1074/jbc.M010814200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Goodall J, 2008, CANCER RES, V1, P68; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kersey P, 2000, BIOINFORMATICS, V16, P1048, DOI 10.1093/bioinformatics/16.11.1048; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kousted TM, 2014, THROMB HAEMOSTASIS, V111, P29, DOI 10.1160/TH13-04-0340; Kousted TM, 2012, ANDREASEN PAPROTEASE, P251; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Lee JJ, 2015, ONCOTARGET, V6, P37995, DOI 10.18632/oncotarget.6062; Leroy C, 2015, ONCOGENE, V34, P5593, DOI 10.1038/onc.2015.19; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Maurer M, 2014, J PROTEOME RES, V13, P2830, DOI 10.1021/pr401270y; Maurer M, 2013, J PROTEOME RES, V12, P1040, DOI 10.1021/pr301009u; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Neesse A, 2007, PANCREATOLOGY, V7, P380, DOI 10.1159/000107400; Olsen R, 2005, ANALYST, V130, P941, DOI 10.1039/b419145e; Ostyn P, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0052-z; Pagliara V, 2014, BBA-MOL CELL RES, V1843, P2631, DOI 10.1016/j.bbamcr.2014.07.008; Pierard-Franchimont C, 2014, ONCOL REV, V8, P54, DOI 10.4081/oncol.2014.252; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rossignol P, 2004, J BIOL CHEM, V279, P10346, DOI 10.1074/jbc.M310964200; Scott C F, 1985, Trans Assoc Am Physicians, V98, P344; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Vaillant C, 2007, DEVELOPMENT, V134, P1745, DOI 10.1242/dev.02840; Vaillant C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124870; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wang K, 2015, J CANCER RES CLIN, V141, P805, DOI 10.1007/s00432-014-1858-1; Webster MR, 2015, PIGM CELL MELANOMA R, V28, P184, DOI 10.1111/pcmr.12330; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wu QW, 2016, AM J TRANSL RES, V8, P1985; Wu X, 2014, ONCOGENE, V33, P1506, DOI 10.1038/onc.2013.108; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yang SF, 2009, NUCL MED BIOL, V36, P313, DOI 10.1016/j.nucmedbio.2008.12.007; Zhou MY, 2006, INVEST OPHTH VIS SCI, V47, P2997, DOI 10.1167/iovs.06-0130	75	41	42	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 18	2018	37	3					302	312		10.1038/onc.2017.341	http://dx.doi.org/10.1038/onc.2017.341			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS9QS	28925403	Green Published, hybrid			2022-12-26	WOS:000422753900003
J	Ohue-Kitano, R; Yasuoka, Y; Goto, T; Kitamura, N; Park, SB; Kishino, S; Kimura, I; Kasubuchi, M; Takahashi, H; Li, YJ; Yeh, YS; Jheng, HF; Iwase, M; Tanaka, M; Masuda, S; Inoue, T; Yamakage, H; Kusakabe, T; Tani, F; Shimatsu, A; Takahashi, N; Ogawa, J; Satoh-Asahara, N; Kawada, T				Ohue-Kitano, Ryuji; Yasuoka, Yumiko; Goto, Tsuyoshi; Kitamura, Nahoko; Park, Si-Bum; Kishino, Shigenobu; Kimura, Ikuo; Kasubuchi, Mayu; Takahashi, Haruya; Li, Yongjia; Yeh, Yu-Sheng; Jheng, Huei-Fen; Iwase, Mari; Tanaka, Masashi; Masuda, Shinya; Inoue, Takayuki; Yamakage, Hajime; Kusakabe, Toru; Tani, Fumito; Shimatsu, Akira; Takahashi, Nobuyuki; Ogawa, Jun; Satoh-Asahara, Noriko; Kawada, Teruo			alpha-Linolenic acid-derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40	FASEB JOURNAL			English	Article						omega-3 PUFA; probiotic bacteria; PPAR; intestinal mucosal immunity	SYMPATHETIC-NERVOUS-SYSTEM; WHITE ADIPOSE-TISSUE; CHAIN FATTY-ACIDS; PPAR-GAMMA; MICROBIAL METABOLITE; 10-HYDROXY-CIS-12-OCTADECENOIC ACID; ALTERNATIVE ACTIVATION; SIGNALING PATHWAYS; HEPG2 HEPATOCYTES; GENE-EXPRESSION	Among dietary fatty acids with immunologic effects, omega-3 polyunsaturated fatty acids, such as a-linolenic acid (ALA), have been considered as factors that contribute to the differentiation of M2-type macrophages (M2 macrophages). In this study, we examined the effect of ALA and its gut lactic acid bacteriametabolites 13-hydroxy-9(Z), 15(Z)-octadecadienoic acid (13-OH) and 13-oxo-9(Z), 15(Z)-octadecadienoic acid (13-oxo) on the differentiation of M2 macrophages from bone marrow-derived cells (BMDCs) and investigated the underlying mechanisms. BMDCs were stimulated with ALA, 13-OH, or 13-oxo in the presence of IL-4 or IL-13 for 24 h, and significant increases in M2 macrophage markers CD206 and Arginase-1 (Arg1) were observed. In addition, M2 macrophage phenotypes were less prevalent following cotreatment with GPCR40 antagonists or inhibitors of PLC-beta and MEK under these conditions, suggesting that GPCR40 signaling is involved in the regulation of M2 macrophage differentiation. In further experiments, remarkable M2 macrophage accumulation was observed in the lamina propria of the small intestine of C57BL/6 mice after intragastric treatmentswith ALA, 13-OH, or 13-oxo at 1 g/kg body weight per day for 3 d. These findings suggest a novel mechanism of M2 macrophage differentiation involving fatty acids from gut lactic acid bacteria and GPCR40 signaling.	[Ohue-Kitano, Ryuji; Tanaka, Masashi; Masuda, Shinya; Inoue, Takayuki; Yamakage, Hajime; Kusakabe, Toru; Satoh-Asahara, Noriko] Natl Hosp Org, Kyoto Med Ctr, Dept Endocrinol Metab & Hypertens, Kyoto, Japan; [Shimatsu, Akira] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan; [Ohue-Kitano, Ryuji; Yasuoka, Yumiko; Goto, Tsuyoshi; Takahashi, Haruya; Li, Yongjia; Yeh, Yu-Sheng; Jheng, Huei-Fen; Iwase, Mari; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Lab Mol Funct Food, Div Food Sci & Biotechnol, Grad Sch Agr, Uji, Kyoto 6110011, Japan; [Tani, Fumito] Kyoto Univ, Div Food Sci & Biotechnol, Lab Food Environm Sci, Grad Sch Agr, Uji, Kyoto, Japan; [Ohue-Kitano, Ryuji; Goto, Tsuyoshi; Takahashi, Nobuyuki; Ogawa, Jun; Kawada, Teruo] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Kyoto, Japan; [Kitamura, Nahoko; Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Div Appl Life Sci, Lab Fermentat Physiol & Appl Microbiol, Kyoto, Japan; [Park, Si-Bum] Kyoto Univ, Lab Ind Microbiol, Grad Sch Agr, Kyoto, Japan; [Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Tokyo University of Agriculture & Technology	Goto, T (corresponding author), Kyoto Univ, Lab Mol Funct Food, Div Food Sci & Biotechnol, Grad Sch Agr, Uji, Kyoto 6110011, Japan.	tgoto@kais.kyoto-u.ac.jp	Takahashi, Nobuyuki/AAX-8671-2021; Goto, Tsuyoshi/AAY-2344-2020; , Masashi/AAM-9856-2021; Yeh, Yu-Sheng/GZH-3004-2022; Iwase, Mari/GZH-2961-2022; Kimura, Ikuo/B-4193-2015; Shimatsu, Akira/I-3856-2019	Takahashi, Nobuyuki/0000-0002-9705-662X; Goto, Tsuyoshi/0000-0003-1283-147X; , Masashi/0000-0003-0719-8972; Yeh, Yu-Sheng/0000-0002-0099-2690; Iwase, Mari/0000-0002-6494-8787; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H02241, 16H02551, 16K14927, 16K07734]; Bio-Oriented Technology Research Advancement Institution of Japan [26002A]; Advanced Low Carbon Technology Research and Development Program of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [26002AB]; New Energy and Industrial Technology Development Organization (NEDO) Innovation Commercialization Venture [151016470]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution of Japan; Advanced Low Carbon Technology Research and Development Program of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; New Energy and Industrial Technology Development Organization (NEDO) Innovation Commercialization Venture	The authors thank M. Komori and S. Shinotoh (Kyoto University) for technical assistance and secretarial support. The authors also thank K. Muranaka and R. Shoda (Kyoto Medical Center) for their technical assistance. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants 15H02241, 16H02551, 16K14927, and 16K07734); the Bio-Oriented Technology Research Advancement Institution of Japan (Grant 26002A); the Advanced Low Carbon Technology Research and Development Program of Japan; the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan (Grant 26002AB), and the New Energy and Industrial Technology Development Organization (NEDO) Innovation Commercialization Venture Support Project (Grant 151016470). The authors declare no conflicts of interest.	Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031238; Bergamo P, 2014, J FUNCT FOODS, V11, P192, DOI 10.1016/j.jff.2014.10.007; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Christoffersen TE, 2014, PROBIOTICS ANTIMICRO, V6, P1, DOI 10.1007/s12602-013-9152-0; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Goto T, 2015, BIOCHEM BIOPH RES CO, V459, P597, DOI 10.1016/j.bbrc.2015.02.154; Goto T, 2012, J NUTR BIOCHEM, V23, P768, DOI 10.1016/j.jnutbio.2011.04.001; Hirata A, 2015, J LIPID RES, V56, P1340, DOI 10.1194/jlr.M059444; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Houthuijzen JM, 2017, FASEB J, V31, P2195, DOI 10.1096/fj.201601248R; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Im DS, 2016, EUR J PHARMACOL, V785, P36, DOI 10.1016/j.ejphar.2015.03.094; Iyer A, 2015, FASEB J, V29, P3612, DOI 10.1096/fj.15-271155; Jang SE, 2013, J APPL MICROBIOL, V115, P888, DOI 10.1111/jam.12273; Ji J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24838; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; McCarthy C, 2013, FASEB J, V27, P499, DOI 10.1096/fj.12-215442; Miyamoto J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040450; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohue R, 2012, CYTOTECHNOLOGY, V64, P221, DOI 10.1007/s10616-011-9351-z; Ohue R, 2011, J INNATE IMMUN, V3, P605, DOI 10.1159/000330786; Pini M, 2016, FASEB J, V30, P241, DOI 10.1096/fj.15-276675; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Song MY, 2016, MOL NUTR FOOD RES, V60, P2481, DOI 10.1002/mnfr.201600014; Sosa-Alvarado C, 2015, EUR J PHARMACOL, V768, P108, DOI 10.1016/j.ejphar.2015.10.038; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Tang XL, 2015, MOL CELL ENDOCRINOL, V413, P78, DOI 10.1016/j.mce.2015.06.013; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Vieira WA, 2016, CELL MOL LIFE SCI, V73, P3665, DOI 10.1007/s00018-016-2263-5; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang SB, 2015, J BIOL CHEM, V290, P19544, DOI 10.1074/jbc.M115.638924; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004; Zizzo G, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0081-4	56	49	49	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					304	318		10.1096/fj.201700273R	http://dx.doi.org/10.1096/fj.201700273R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904023				2022-12-26	WOS:000419172700028
J	Huang, LH; Lin, PH; Tsai, KW; Wang, LJ; Huang, YH; Kuo, HC; Li, SC				Huang, Lien-Hung; Lin, Pei-Hsien; Tsai, Kuo-Wang; Wang, Liang-Jen; Huang, Ying-Hsien; Kuo, Ho-Chang; Li, Sung-Chou			The effects of storage temperature and duration of blood samples on DNA and RNA qualities	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION; MESSENGER-RNA; STABILITY; BIOMARKER; MICRORNA; CXCL10; CELLS; HEPATITIS; DISEASE	DNA and RNA samples from blood are the common examination target for non-invasive physical tests and/or biomedical studies. Since high-quality DNA and RNA samples guarantee the correctness of these tests and/or studies, we investigated the effects of storage temperature and storage duration of whole blood on DNA and RNA qualities. Subjects were enrolled to donate blood samples which were stored for different durations and at different temperatures, followed by the examinations on RNA quality, qPCR, DNA quality and DNA methylation. For RNA, we observed obvious quality decline with storage duration longer than 24 hours. Storage at low temperature does not keep RNA samples from degradation. And, storing whole blood samples in freezer dramatically damage RNA. For DNA, quality decline was not observed even with storage duration for 15 days. However, DNA methylation significantly altered with storage duration longer than three days. Storage duration within 24 hours is critical for collecting high-quality RNA samples for next-generation sequencing (NGS) assays (RIN >= 8). If microarray assays are expected (RIN >= 7), storage duration within 32 hours is acceptable. Although DNA is resistant within 15 days when kept in whole blood, DNA quantity dramatically decreases owing to WBC lysis. In addition, duration for more than three days significantly alter DNA methylation status, globally and locally. Our result provides a reference for dealing with blood samples.	[Huang, Lien-Hung; Li, Sung-Chou] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan; [Huang, Lien-Hung; Wang, Liang-Jen; Huang, Ying-Hsien; Kuo, Ho-Chang; Li, Sung-Chou] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Pei-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Tsai, Kuo-Wang] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wang, Liang-Jen] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Huang, Ying-Hsien; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Huang, Ying-Hsien; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Huang, Ying-Hsien] Chiayi Chang Gung Mem Hosp, Dept Pediat, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Li, SC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan.; Kuo, HC; Li, SC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan.; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	erickuo48@yahoo.com.tw; raymond.pinus@gmail.com	Wang, Liang-Jen/AAR-1089-2020; Kuo, Ho-Chang/AAQ-6644-2020; Li, Sung-Chou/AGZ-8626-2022	Wang, Liang-Jen/0000-0002-5320-1151; Kuo, Ho-Chang/0000-0002-3295-2984; Li, Sung-Chou/0000-0002-3016-9718; Huang, Lien-Hung/0000-0001-8641-9897; Tsai, Kuo-Wang/0000-0002-9028-9834	Ministry of Science and Technology, Taiwan [MOST 106-2311-B-182A-002]; Chang Gung Memorial Hospital [CMRPG8F0591, CLRPG8D0113]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This article was funded by the grants from the Ministry of Science and Technology, Taiwan (MOST 106-2311-B-182A-002) and from Chang Gung Memorial Hospital (CMRPG8F0591 and CLRPG8D0113).	Antonelli A, 2014, CYTOKINE GROWTH F R, V25, P57, DOI 10.1016/j.cytogfr.2014.01.006; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; BEUTLER E, 1990, BIOTECHNIQUES, V9, P166; Chou NH, 2016, ANTICANCER RES, V36, P3983; Cuhadar S, 2012, BIOCHEM MEDICA, V22, P202; Ferrari SM, 2015, ADV MED SCI-POLAND, V60, P349, DOI 10.1016/j.advms.2015.07.011; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Hrustincova A, 2015, FOLIA BIOL-PRAGUE, V61, P203; Ivanova NV, 2013, MOL ECOL RESOUR, V13, P890, DOI 10.1111/1755-0998.12134; Jaeger T, 2016, THROMB RES, V144, P215, DOI 10.1016/j.thromres.2016.06.034; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; Kremlev SG, 2007, J NEUROSCI RES, V85, P2450, DOI 10.1002/jnr.21380; Kuo HC, 2016, J ALLERGY CLIN IMMUN, V138, P1227, DOI 10.1016/j.jaci.2016.04.050; Kuo HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154943; Lee EY, 2013, AUTOIMMUN REV, V12, P554, DOI 10.1016/j.autrev.2012.10.001; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Li SC, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0197-2; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Lv YH, 2014, J FORENSIC SCI, V59, P1286, DOI 10.1111/1556-4029.12447; Margaritelis NV, 2015, BIOMARKERS, V20, P97, DOI 10.3109/1354750X.2014.1002807; STORCH GA, 1994, J CLIN MICROBIOL, V32, P2581, DOI 10.1128/JCM.32.10.2581-2583.1994; Tang SC, 2015, J NEUROL SCI, V348, P174, DOI 10.1016/j.jns.2014.11.035; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van den Borne P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/893106; Vilahur N, 2013, EPIGENOMICS-UK, V5, P341, DOI [10.2217/EPI.13.29, 10.2217/epi.13.29]; WANG JT, 1992, J CLIN MICROBIOL, V30, P750, DOI 10.1128/JCM.30.3.750-753.1992; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Yang CM, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0291-5; Yang YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010192	31	53	54	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184692	10.1371/journal.pone.0184692	http://dx.doi.org/10.1371/journal.pone.0184692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926588	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600035
J	Blanco, MJ; Rodriguez-Martin, I; Learte, AIR; Clemente, C; Montalvo, MG; Seiki, M; Arroyo, AG; Sanchez-Camacho, C				Jose Blanco, Maria; Rodriguez-Martin, Ivan; Learte, Ana I. R.; Clemente, Cristina; Gregoria Montalvo, Maria; Seiki, Motoharu; Arroyo, Alicia G.; Sanchez-Camacho, Cristina			Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo	PLOS ONE			English	Article							SOMITE-DERIVED ANGIOBLASTS; OSTEOPONTIN MESSENGER-RNA; DEVELOPING RAT-BRAIN; MATRIX METALLOPROTEINASES; PROTEOLYTIC ACTIVITY; SONIC-HEDGEHOG; AXON GUIDANCE; IN-VIVO; LIMB; CANCER	Matrix metalloproteinases (MMPs) constitute a large group of endoproteases that play important functions during embryonic development, tumor metastasis and angiogenesis by degrading components of the extracellular matrix. Within this family, we focused our study on Mt4-mmp (also called Mmp17) that belongs to a distinct subset that is anchored to the cell surface via a glycosylphosphatidylinositol (GPI) moiety and with the catalytic site exposed to the extracellular space. Information about its function and substrates is very limited to date, and little has been reported on its role in the developing embryo. Here, we report a detailed expression analysis of Mt4-mmp during mouse embryonic development by using a LacZ reporter transgenic mouse line. We showed that Mt4-mmp is detected from early stages of development to postnatal stages following a dynamic and restricted pattern of expression. Mt4-mmp was first detected at E8.5 limited to the intersomitic vascularization, the endocardial endothelium and the dorsal aorta. Mt4-mmp(LacZ/+) cells were also observed in the neural crest cells, somites, floor plate and notochord at early stages. From E10.5, expression localized in the limb buds and persists during limb development. A strong expression in the brain begins at E12.5 and continues to postnatal stages. Specifically, staining was observed in the olfactory bulb, cerebral cortex, hippocampus, striatum, septum, dorsal thalamus and the spinal cord. In addition, LacZ-positive cells were also detected during eye development, initially at the hyaloid artery and later on located in the lens and the neural retina. Mt4-mmp expression was confirmed by quantitative RT-PCR and western blot analysis in some embryonic tissues. Our data point to distinct functions for this metalloproteinase during embryonic development, particularly during brain formation, angiogenesis and limb development.	[Jose Blanco, Maria; Rodriguez-Martin, Ivan; Learte, Ana I. R.] Univ Europea Madrid, Basic Biomed Sci Dept, Madrid, Spain; [Clemente, Cristina; Arroyo, Alicia G.; Sanchez-Camacho, Cristina] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Gregoria Montalvo, Maria; Sanchez-Camacho, Cristina] Univ Europea Madrid, Doctoral Studies & Res Sch, Madrid, Spain; [Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan	European University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); European University of Madrid; University of Tokyo	Sanchez-Camacho, C (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Sanchez-Camacho, C (corresponding author), Univ Europea Madrid, Doctoral Studies & Res Sch, Madrid, Spain.	cristina.sanchez-camacho@universidadeuropea.es	Clemente, Cristina/Q-3523-2019; Arroyo, Alicia G./L-2796-2014; Arroyo, Alicia G/M-2507-2018; Sanchez-Camacho, Cristina/K-6871-2014	Clemente, Cristina/0000-0002-5831-9132; Arroyo, Alicia G./0000-0002-1536-3846; Arroyo, Alicia G/0000-0002-1536-3846; Sanchez-Camacho, Cristina/0000-0001-7756-0426	Universidad Europea de Madrid [2016UEM04]; Ministry of Economy, Industry and Competitiveness (MIEC) [SAF2014-20520R]; MIEC; Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence [SEV-2015-0505]	Universidad Europea de Madrid; Ministry of Economy, Industry and Competitiveness (MIEC); MIEC; Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence	This work was supported by a grant from the Universidad Europea de Madrid (2016UEM04) to C.S.C. and grant SAF2014-20520R from the Ministry of Economy, Industry and Competitiveness (MIEC) to A.G.A. The CNIC is supported by the MIEC and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Ambler CA, 2001, DEV BIOL, V234, P352, DOI 10.1006/dbio.2001.0267; Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Choi JS, 2004, EXP BRAIN RES, V154, P275, DOI 10.1007/s00221-003-1657-4; Clements KM, 2011, ANN RHEUM DIS, V70, P683, DOI 10.1136/ard.2010.130757; CURRY T E JR, 1989, Steroids, V54, P501, DOI 10.1016/0039-128X(89)90044-5; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199; Fortunato SJ, 2002, J ASSIST REPROD GEN, V19, P483, DOI 10.1023/A:1020362519981; Funatsu N, 2004, CEREB CORTEX, V14, P1031, DOI 10.1093/cercor/bhh063; Giachelli CM, 1998, AM J PATHOL, V152, P353; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Host L, 2012, INT J CANCER, V131, P1537, DOI 10.1002/ijc.27436; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hu JKH, 2012, GENE DEV, V26, P2088, DOI 10.1101/gad.187385.112; Huang AH, 2015, J ORTHOP RES, V33, P800, DOI 10.1002/jor.22834; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Janssens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052915; Kajita M, 1999, FEBS LETT, V457, P353, DOI 10.1016/S0014-5793(99)01065-0; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kolkenbrock H, 1999, BIOL CHEM, V380, P1103, DOI 10.1515/BC.1999.137; Lee MY, 2001, CELL TISSUE RES, V306, P179, DOI 10.1007/s004410100456; Leigh NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076484; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin-Alonso M, 2015, CIRC RES, V117, pE13, DOI 10.1161/CIRCRESAHA.117.305108; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; McFarlane S, 2003, NEURON, V37, P559, DOI 10.1016/S0896-6273(03)00089-8; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Paye A, 2014, CANCER RES, V74, P6758, DOI 10.1158/0008-5472.CAN-13-2994; Puente XS, 1996, CANCER RES, V56, P944; Rikimaru A, 2007, GENES CELLS, V12, P1091, DOI 10.1111/j.1365-2443.2007.01110.x; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rychter Z., 1972, FOLIA MORPHOL WARSZ, V20; Sanchez-Camacho C, 2011, DEV NEUROBIOL, V71, P337, DOI 10.1002/dneu.20865; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Srichai MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017099; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866; Webber CA, 2002, J NEUROSCI, V22, P8091; Yamamoto M, 2012, BIOL OPEN, V1, P458, DOI 10.1242/bio.2012638; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yvernogeau L, 2012, DEVELOPMENT, V139, P277, DOI 10.1242/dev.067678; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	53	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184767	10.1371/journal.pone.0184767	http://dx.doi.org/10.1371/journal.pone.0184767			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926609	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600038
J	Kong, HS; Lee, J; Youm, HW; Kim, SK; Lee, JR; Suh, CS; Kim, SH				Kong, Hyun Sun; Lee, Jaewang; Youm, Hye Won; Kim, Seul Ki; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun			Effect of treatment with angiopoietin-2 and vascular endothelial growth factor on the quality of xenografted bovine ovarian tissue in mice	PLOS ONE			English	Article							FOLLICULAR SURVIVAL; POSTNATAL NEOVASCULARIZATION; DIFFERENT CRYOPROTECTANTS; STRUCTURAL PRESERVATION; SCID MICE; TRANSPLANTATION; ANGIOGENESIS; CRYOPRESERVATION; VEGF; VITRIFICATION	Cryopreservation and transplantation of ovarian tissue (OT) represents a method for fertility preservation. However, as the transplantation is performed without vessel anastomosis, unavoidable ischemic damage occurs. To reduce this ischemic damage and improve outcomes after transplantation, we used two kind of angiogenic factors, angiopoietin-2 (ang-2) and vascular endothelial growth factor (VEGF). Fresh or vitrified-warmed bovine OTs were prepared for xenotransplantation (XT). Fresh OTs were immediately xenografted into nude mice (XT-Fresh). Vitrified-warmed OTs were xenografted into four subgroups of mice, which were injected intraperitoneally before XT with saline (XT-Vitri), Ang-2 (XT-Ang-2), VEGF (XT-VEGF), and a combination of Ang-2 and VEGF (XT-Combined). Seven or 28 days post-grafting, grafted OTs and blood samples were collected for evaluation. Follicle normality was higher in the angiogenic factor-treated groups than in the XT-Vitri group. The XT-VEGF and the XT-Combined showed higher (P<0.05) follicular density than the XT-Vitri group. The highest apoptotic follicle ratio was observed in the XT-Vitri group on day 7; this was decreased (P<0.05) in the XT-Combined group. Microvessel densities were higher in the angiogenic factor-treated groups than in the XT-Vitri group. The largest fibrotic area was showed in the XT-Vitri group on day 28, and it was decreased (P<0.05) in the XT-combined group. Based on these results, administration of Ang-2 and VEGF to recipients prior to XT appeared to alleviate ischemic damage by enhancing angiogenesis, which resulted in the maintenance of follicle integrity and density, and reduced follicle apoptosis and OT fibrosis.	[Kong, Hyun Sun; Lee, Jaewang; Youm, Hye Won; Kim, Seul Ki; Lee, Jung Ryeol] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea; [Kong, Hyun Sun; Kim, Seul Ki; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Jaewang] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Northwestern University; Feinberg School of Medicine	Lee, JR (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea.; Lee, JR; Suh, CS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Suh, CS (corresponding author), Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea.	leejrmd@snu.ac.kr; suhcs@snu.ac.kr		Lee, Jung Ryeol/0000-0003-3743-2934; Lee, Jaewang/0000-0001-6801-7149	Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI12C0055]; National Research Foundation of Korea [NRF-2017R1C1B2003897]; Seoul National University Bundang Hospital Research Fund [02-2014-013]; Seoul National University Bundang Hospital Research Fund	Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Bundang Hospital Research Fund; Seoul National University Bundang Hospital Research Fund	This work was supported by the Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [grant number HI12C0055], National Research Foundation of Korea [grant number NRF-2017R1C1B2003897] and Seoul National University Bundang Hospital Research Fund [grant number 02-2014-013]. Ministry of Health and Welfare: http://www.mohw.go.kr/eng/index.jsp, Seoul National University Bundang Hospital Research Fund: https://www.snubh.org/dh/en/, National Research Foundation of Korea: http://www.nrf.re.kr/eng/main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves KA, 2017, REPROD FERT DEVELOP, V29, P867, DOI 10.1071/RD15402; Amorim CA, 2013, HUM REPROD, V28, P2146, DOI 10.1093/humrep/det103; Amorim CA, 2011, REPROD BIOMED ONLINE, V23, P160, DOI 10.1016/j.rbmo.2011.04.005; [Anonymous], NON TRADITIONAL REF; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; BAMBANG LS, 1995, J THORAC CARDIOV SUR, V110, P998, DOI 10.1016/S0022-5223(05)80167-9; Borges EN, 2009, CRYOBIOLOGY, V59, P195, DOI 10.1016/j.cryobiol.2009.07.003; Damous LL, 2016, REPROD SCI, V23, P803, DOI 10.1177/1933719115620493; Dath C, 2010, HUM REPROD, V25, P1734, DOI 10.1093/humrep/deq131; DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gavish Z, 2014, HUM REPROD, V29, P989, DOI 10.1093/humrep/deu015; GOSDEN RG, 1994, J REPROD FERTIL, V101, P619, DOI 10.1530/jrf.0.1010619; Hernandez-Fonseca H, 2004, FERTIL STERIL, V81, P888, DOI 10.1016/j.fertnstert.2003.10.017; Herraiz S, 2014, FERTIL STERIL, V101, P775, DOI 10.1016/j.fertnstert.2013.11.016; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Isidori AM, 2016, J ENDOCRINOL INVEST, V39, P1235, DOI 10.1007/s40618-016-0502-0; Jensen AK, 2017, J ASSIST REPROD GEN, V34, P324, DOI 10.1007/s10815-016-0843-9; Kang BJ, 2016, J ASSIST REPROD GEN, V33, P281, DOI 10.1007/s10815-015-0628-6; Kong HS, 2016, REPROD SCI, V23, P51, DOI 10.1177/1933719115594021; Labied S, 2013, TRANSPLANTATION, V95, P426, DOI 10.1097/TP.0b013e318279965c; Langbeen A, 2016, ANIM REPROD SCI, V168, P73, DOI 10.1016/j.anireprosci.2016.02.029; Lee J.H., 2015, BIOMED RES INT, V2015, P10, DOI DOI 10.1155/2015/137020; Lee J, 2016, HUM REPROD, V31, P1827, DOI 10.1093/humrep/dew144; Lee J, 2015, THERIOGENOLOGY, V83, P285, DOI 10.1016/j.theriogenology.2014.09.027; Lee JR, 2014, EUR J OBSTET GYN R B, V178, P16, DOI 10.1016/j.ejogrb.2014.04.040; Li S, 2009, REPROD DOMEST ANIM, V44, P764, DOI 10.1111/j.1439-0531.2008.01069.x; Li SH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081237; Liu J, 2002, HUM REPROD, V17, P605, DOI 10.1093/humrep/17.3.605; Lucci CM, 2004, THERIOGENOLOGY, V61, P1101, DOI 10.1016/j.theriogenology.2003.06.004; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; Mahmoodi M, 2014, REPRODUCTION, V147, P733, DOI 10.1530/REP-13-0379; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Schmidt KT, 2010, BJOG-INT J OBSTET GY, V117, P163, DOI 10.1111/j.1471-0528.2009.02408.x; Schubert B, 2008, FERTIL STERIL, V89, P1787, DOI 10.1016/j.fertnstert.2007.03.101; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Teitelbaum AA, 2013, EUROINTERVENTION, V8, P1081, DOI 10.4244/EIJV8I9A165; Torrents E, 2003, HUM REPROD UPDATE, V9, P471, DOI 10.1093/humupd/dmg036; Van Eyck AS, 2009, FERTIL STERIL, V92, P374, DOI 10.1016/j.fertnstert.2008.05.012; Wang L, 2013, J ASSIST REPROD GEN, V30, P1301, DOI 10.1007/s10815-013-0043-9; Wang YR, 2012, REPROD BIOMED ONLINE, V24, P646, DOI 10.1016/j.rbmo.2012.02.025; Wu DD, 2010, ANAT REC, V293, P2154, DOI 10.1002/ar.21228; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Youm HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166782; Youm HW, 2014, HUM REPROD, V29, P720, DOI 10.1093/humrep/det449	50	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184546	10.1371/journal.pone.0184546	http://dx.doi.org/10.1371/journal.pone.0184546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915249	Green Published, gold, Green Submitted			2022-12-26	WOS:000410861600011
J	Brown, HE; Desai, T; Murphy, AJ; Pancholi, H; Schmidt, ZW; Swahn, H; Liebl, EC				Brown, Hannah E.; Desai, Trishna; Murphy, Allison J.; Pancholi, Harshida; Schmidt, Zachary W.; Swahn, Hannah; Liebl, Eric C.			The function of Drosophila larval class IV dendritic arborization sensory neurons in the larval-pupal transition is separable from their function in mechanical nociception responses	PLOS ONE			English	Article							BODY-SIZE; BEHAVIOR; PICKPOCKET1; PROTEIN; GENES	The sensory and physiological inputs which govern the larval-pupal transition in Drosophila, and the neuronal circuity that integrates them, are complex. Previous work from our laboratory identified a dosage-sensitive genetic interaction between the genes encoding the Rho-GEF Trio and the zinc-finger transcription factor Sequoia that interfered with the larval-pupal transition. Specifically, we reported heterozygous mutations in sequoia (seq) dominantly exacerbated the trio mutant phenotype, and this seq-enhanced trio mutant genotype blocked the transition of third instar larvae from foragers to wanderers, a requisite behavioral transition prior to pupation. In this work, we use the GAL4-UAS system to rescue this phenotype by tissue-specific trio expression. We find that expressing trio in the class IV dendritic arborization (da) sensory neurons rescues the larval-pupal transition, demonstrating the reliance of the larval-pupal transition on the integrity of these sensory neurons. As nociceptive responses also rely on the functionality of the class IV da neurons, we test mechanical nociceptive responses in our mutant and rescued larvae and find that mechanical nociception is separable from the ability to undergo the larval-pupal transition. This demonstrates for the first time that the roles of the class IV da neurons in governing two critical larval behaviors, the larval-pupal transition and mechanical nociception, are functionally separable from each other.	[Brown, Hannah E.; Desai, Trishna; Murphy, Allison J.; Pancholi, Harshida; Schmidt, Zachary W.; Swahn, Hannah; Liebl, Eric C.] Denison Univ, Dept Biol, Granville, OH 43023 USA; [Brown, Hannah E.] Duke Univ, Sch Med, Dept Mol Genet, Durham, NC USA; [Brown, Hannah E.] Duke Univ, Sch Med, Dept Microbiol, Durham, NC USA; [Desai, Trishna] Cleveland Fdn, Cleveland, OH USA; [Murphy, Allison J.] Univ Rochester, Sch Med & Dent, Neurosci Grad Program, Rochester, NY USA; [Pancholi, Harshida] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53233 USA; [Swahn, Hannah] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Denison University; Duke University; Duke University; University of Rochester; Marquette University; Case Western Reserve University	Liebl, EC (corresponding author), Denison Univ, Dept Biol, Granville, OH 43023 USA.	liebl@denison.edu		Pancholi, Harshida/0000-0003-4375-6919; Murphy, Allison/0000-0002-9097-3687; Schmidt, Zachary/0000-0003-0824-6315; Brown, Hannah/0000-0002-9175-8209	Denison's Department of Biology, Leon & Grace Greene Academic Venture Fund; Lisska Center for Scholarly Engagement, Office of the Provost and R.C; Ohio State Campus Microscopy and Imaging Facility [P30 CA016058]	Denison's Department of Biology, Leon & Grace Greene Academic Venture Fund; Lisska Center for Scholarly Engagement, Office of the Provost and R.C; Ohio State Campus Microscopy and Imaging Facility	TD and ZWS were supported by Denison's J. Reid and Polly Anderson Endowed Fund and the Laurie Bukovac and David Hodgson Endowed Fund during the summer of 2016. Denison's Department of Biology, Leon & Grace Greene Academic Venture Fund, Lisska Center for Scholarly Engagement, Office of the Provost and R.C. Good Faculty Fellowship provided funding for this work. The Ohio State Campus Microscopy and Imaging Facility is supported in part by grant P30 CA016058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Deak P, 1997, GENETICS, V147, P1697; Dean KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084149; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Iyer SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033634; Jayakumar S, 2016, ELIFE, V5, DOI 10.7554/eLife.17495; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Pahi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142226; Robertson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078704; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shivalkar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033737; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Valzania L, 2016, DEV BIOL, V410, P14, DOI 10.1016/j.ydbio.2015.12.021; Vandersmissen HP, 2014, GEN COMP ENDOCR, V209, P135, DOI 10.1016/j.ygcen.2014.08.006; Wegman LJ, 2010, DEV BIOL, V345, P170, DOI 10.1016/j.ydbio.2010.07.004; Weiner AT, 2016, CYTOSKELETON, V73, P35, DOI 10.1002/cm.21270; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xie XJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002207; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184950	10.1371/journal.pone.0184950	http://dx.doi.org/10.1371/journal.pone.0184950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910410	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200123
J	Kobayashi, M; Iwase, T; Yamamoto, K; Ra, E; Murotani, K; Terasaki, H				Kobayashi, Misato; Iwase, Takeshi; Yamamoto, Kentaro; Ra, Eimei; Murotani, Kenta; Terasaki, Hiroko			Perioperative factors that are significantly correlated with final visual acuity in eyes after successful rhegmatogenous retinal detachment surgery	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR DETACHMENT; PRIMARY VITRECTOMY; SCLERAL BUCKLE; REPAIR; REATTACHMENT; RECOVERY; DURATION; HEIGHT	Purpose To determine the perioperative factors that are significantly correlated with the final visual acuity following reattachment of a macula-off rhegmatogenous retinal detachment (RRD) by vitrectomy. Methods Twenty-nine eyes of 29 patients with a successfully reattached RRD by vitrectomy were retrospectively analyzed. Spectral-domain optical coherence tomographic images of the macular regions were used to measure the thicknesses of the retinal layers and the integrity of the microstructures of the photoreceptors at 2 weeks, 1, 2, 3, 6, 9, and 12 months following the vitrectomy. The best-corrected visual acuities (BCVA) were evaluated at the same times. Results The improvement of the BCVA from the preoperative BCVA to that at postoperative Week 2 (-0.67 +/- 0.69 logMAR units) was the largest change between adjacent observation periods for the entire study duration. It was significantly greater than the improvement between Week 2 and Month 12 (-0.32 +/- 0.22 logMAR units; P<0.001). The thickness of the ellipsoid zone (EZ)-retinal pigment epithelium (RPE) increased significantly with time (P<0.001). The final BCVA was significantly correlated with the BCVA at Week 2 (r = 0.61, P<0.001), the EZ-RPE thickness at Week 2 (r = -0.40, P = 0.035), the integrity of the external limiting membrane (ELM) (r = -0.61, P = 0.003), and an intact EZ (r = -0.66, P = 0.001) at Week 2. Multiple stepwise regression analyses of the final BCVA showed that the BCVA at Week 2 (P = 0.017) and the integrity of the EZ at Week 2 (P = 0.006) were independent predictors of the final BCVA. Conclusions The significantly better BCVA and presence of an intact EZ at 2 weeks following vitrectomy and their significant correlations with the BCVA at Month 12 indicate that these perioperative values can be used to predict the BCVA at Month 12 after a reattachment of macula-off RRD following vitrectomy.	[Kobayashi, Misato; Iwase, Takeshi; Yamamoto, Kentaro; Ra, Eimei; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan; [Murotani, Kenta] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Iwase, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan.	tiwase@med.nagoya-u.ac.jp						Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; dell'Omo R, 2015, INVEST OPHTH VIS SCI, V56, P1040, DOI 10.1167/iovs.14-15633; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Gharbiya M, 2012, RETINA-J RET VIT DIS, V32, P43, DOI 10.1097/IAE.0b013e3182180114; Goto T, 2013, ACTA OPHTHALMOL, V91, P552, DOI 10.1111/j.1755-3768.2012.02455.x; GRIZZARD WS, 1994, GRAEF ARCH CLIN EXP, V232, P1, DOI 10.1007/BF00176431; Hasegawa T, 2014, RETINA-J RET VIT DIS, V34, P1848, DOI 10.1097/IAE.0000000000000160; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Jackson TL, 2003, INVEST OPHTH VIS SCI, V44, P4026, DOI 10.1167/iovs.02-1264; Kobayashi M, 2016, INVEST OPHTH VIS SCI, V57, P889, DOI 10.1167/iovs.15-18403; Lewis GP, 2002, INVEST OPHTH VIS SCI, V43, P2412; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; Mervin K, 1999, AM J OPHTHALMOL, V128, P155, DOI 10.1016/S0002-9394(99)00104-X; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; Oshima Y, 2000, JPN J OPHTHALMOL, V44, P538, DOI 10.1016/S0021-5155(00)00205-7; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; SABATES NR, 1989, AM J OPHTHALMOL, V108, P22, DOI 10.1016/S0002-9394(14)73255-6; Sakai T, 2003, INVEST OPHTH VIS SCI, V44, P416, DOI 10.1167/iovs.02-0633; Schocket LS, 2006, OPHTHALMOLOGY, V113, P666, DOI 10.1016/j.ophtha.2006.01.003; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; Smith AJ, 2008, OPHTHALMOLOGY, V115, P1923, DOI 10.1016/j.ophtha.2008.05.025; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tan HS, 2013, BRIT J OPHTHALMOL, V97, P80, DOI 10.1136/bjophthalmol-2012-302140; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; Terauchi G, 2015, BR J OPHTHALMOL; Wakabayashi T, 2009, OPHTHALMOLOGY, V116, P519, DOI 10.1016/j.ophtha.2008.10.001	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184783	10.1371/journal.pone.0184783	http://dx.doi.org/10.1371/journal.pone.0184783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902881	Green Submitted, gold, Green Published			2022-12-26	WOS:000410669200066
J	Soghigian, J; Livdahl, T				Soghigian, John; Livdahl, Todd			Differential response to mosquito host sex and parasite dosage suggest mixed dispersal strategies in the parasite Ascogregarina taiwanensis	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; APICOMPLEXA LECUDINIDAE; LIFE-CYCLE; ULTRASTRUCTURE; TRANSMISSION; INFECTIONS; CULICIDAE; EVOLUTION; AEGYPTI	Mixed dispersal strategies are a form of bet hedging in which a species or population utilizes different dispersal strategies dependent upon biotic or abiotic conditions. Here we provide an example of a mixed dispersal strategy in the Aedes albopictus / Ascogregarina taiwanensis host/parasite system, wherein upon host emergence, the gregarine parasite is either carried with an adult mosquito leaving the larval habitat, or released back into the larval habitat. We show that the parasite invests a larger proportion of its dispersing (oocyst) life stage into adult female mosquitoes as opposed to adult male mosquitoes at low parasite exposure levels. However, as the exposure level of parasite increases, so does the parasite investment in adult males, whereas there is no change in the proportion of oocysts in the adult female, regardless of dose. Thus, A. taiwanensis is utilizing several dispersal strategies, depending upon host sex and intraspecific density. Furthermore, we demonstrate that this parasite reduces body size, increases time to emergence in females, and leads to a reduction in estimates of per capita growth rate of the host.	[Soghigian, John; Livdahl, Todd] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Soghigian, John] Connecticut Agr Expt Stn, Dept Environm Sci, New Haven, CT 06504 USA	Clark University; Connecticut Agricultural Experiment Station	Livdahl, T (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	tlivdahl@clarku.edu			NIH [1R15A1092577]; NSF [1311535]; Biology Department of Clark University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI092577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Biology Department of Clark University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was partially funded by NIH grant 1R15A1092577, NSF grant #1311535, and the Biology Department of Clark University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Rohani, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P138; Aliabadi Brianna W., 2002, Biological Invasions, V4, P283, DOI 10.1023/A:1020933705556; ANDREADIS TG, 1979, J PROTOZOOL, V26, P444, DOI 10.1111/j.1550-7408.1979.tb04651.x; Andreadis TG, 2012, J INVERTEBR PATHOL, V109, P59, DOI 10.1016/j.jip.2011.09.011; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier JC, 1985, GREGARINE PARASITES; Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Chen WJ, 1999, PARASITOL TODAY, V15, P153, DOI 10.1016/S0169-4758(99)01418-0; Chen WJ, 1997, J EUKARYOT MICROBIOL, V44, P326, DOI 10.1111/j.1550-7408.1997.tb05674.x; Chen WJ, 1997, J EUKARYOT MICROBIOL, V44, P101, DOI 10.1111/j.1550-7408.1997.tb05945.x; Chen WJ, 1996, J MED ENTOMOL, V33, P212, DOI 10.1093/jmedent/33.2.212; Comiskey NM, 1999, J MED ENTOMOL, V36, P55, DOI 10.1093/jmedent/36.1.55; DENNO RF, 1991, AM NAT, V138, P1513, DOI 10.1086/285298; Denno RF, 2012, PLANTHOPPERS THEIR E; Erthal JA, 2012, J MED ENTOMOL, V49, P1109, DOI 10.1603/ME12018; Fellous S, 2009, J EVOLUTION BIOL, V22, P582, DOI 10.1111/j.1420-9101.2008.01665.x; Fox J., 2018, R COMPANION APPL REG, VThird; Friedenberg NA, 2003, ECOL LETT, V6, P953, DOI 10.1046/j.1461-0248.2003.00524.x; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; JARVINEN O, 1976, HEREDITAS, V84, P61; Kaplan L, 2010, BIOL INVASIONS; LANDIN J, 1977, OIKOS, V29, P156, DOI 10.2307/3543307; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Mitchell A, 2016, FUNCT ECOL, V30, P733, DOI 10.1111/1365-2435.12535; MUNSTERMANN LE, 1990, J AM MOSQUITO CONTR, V6, P235; MURAJI M, 1988, RES POPUL ECOL, V30, P315, DOI 10.1007/BF02513252; Navarro DJ, 2015, LEARNING STAT R TUTO; O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x; Passos R. A, 2008, J INVERTEBR PATHOL, V97, P230, DOI DOI 10.1016/J.JIP; R Core Team, 2016, R FDN STAT COMP; Reyes-Villanueva F, 2003, J INVERTEBR PATHOL, V84, P47, DOI 10.1016/S0022-2011(03)00119-8; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Roychoudhury S, 2006, J AM MOSQUITO CONTR, V22, P29, DOI 10.2987/8756-971X(2006)22[29:NFOTDP]2.0.CO;2; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Soghigian J, 2017, ECOL EVOL, V7, P1453, DOI 10.1002/ece3.2748; Stonedahl GM, 1982, GERRIDAE WATER STRID; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Tseng M, 2004, P ROY SOC B-BIOL SCI, V271, pS186, DOI 10.1098/rsbl.2003.0139; Tseng M., 2017, J MED ENTOMOL; Tseng M, 2007, J AM MOSQUITO CONTR, V23, P30, DOI 10.2987/8756-971X(2007)23[30:APAPBA]2.0.CO;2; Vepsalainen K., 1978, P218; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184573	10.1371/journal.pone.0184573	http://dx.doi.org/10.1371/journal.pone.0184573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902912	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200047
J	Toral-Granda, MV; Causton, CE; Jager, H; Trueman, M; Izurieta, JC; Araujo, E; Cruz, M; Zander, KK; Izurieta, A; Garnett, ST				Toral-Granda, M. Veronica; Causton, Charlotte E.; Jager, Heinke; Trueman, Mandy; Carlos Izurieta, Juan; Araujo, Eddy; Cruz, Marilyn; Zander, Kerstin K.; Izurieta, Arturo; Garnett, Stephen T.			Alien species pathways to the Galapagos Islands, Ecuador	PLOS ONE			English	Article							SANTA-CRUZ; CONSERVATION; TOURISM; THREATS; ACCUMULATION; ERADICATION; DISPERSAL; INVASIONS; DISEASES; IMPACTS	Alien species, one of the biggest threats to natural ecosystems worldwide, are of particular concern for oceanic archipelagos such as Gala A pagos. To enable more effective management of alien species, we reviewed, collated and analysed all available records of alien species for Gala A pagos. We also assembled a comprehensive dataset on pathways to and among the Gala A pagos Islands, including tourist and resident numbers, tourist vessels, their itineraries and visitation sites, aircraft capacity and occupancy, air and sea cargo and biosecurity interceptions. So far, 1,579 alien terrestrial and marine species have been introduced to Gala A pagos by humans. Of these, 1,476 have become established. Almost half of these were intentional introductions, mostly of plants. Most unintentional introductions arrived on plants and plant associated material, followed by transport vehicles, and commodities (in particular fruit and vegetables). The number, frequency and geographic origin of pathways for the arrival and dispersal of alien species to and within Gala A pagos have increased over time, tracking closely the increase in human population (residents and tourists) on the islands. Intentional introductions of alien species should decline as biosecurity is strengthened but there is a danger that unintentional introductions will increase further as tourism on Gala A pagos expands. This unique world heritage site will only retain its biodiversity values if the pathways for invasion are managed effectively.	[Toral-Granda, M. Veronica; Trueman, Mandy; Izurieta, Arturo; Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia; [Causton, Charlotte E.; Jager, Heinke; Izurieta, Arturo] Charles Darwin Fdn, Puerto Ayora, Galapagos Islan, Ecuador; [Carlos Izurieta, Juan] Minist Turismo Ecuador, Observ Turismo Galapagos, Puerto Ayora, Galapagos Islan, Ecuador; [Araujo, Eddy] Direcc Parque Nacl Galapagos, Puerto Ayora, Galapagos Islan, Ecuador; [Cruz, Marilyn] Agencia Bioseguridad Galapagos, Puerto Ayora, Galapagos Islan, Ecuador; [Zander, Kerstin K.] Charles Darwin Univ, Northern Inst, Casuarina, NT, Australia	Charles Darwin University; Charles Darwin University	Toral-Granda, MV (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia.	veronica.toral-granda@cdu.edu.au	Jäger, Heinke/ABH-5731-2020; Zander, Kerstin/M-2888-2013	Jäger, Heinke/0000-0001-9065-4048; Zander, Kerstin/0000-0002-2237-1801; Toral-Granda, M. Veronica/0000-0002-0324-1833	International Postgraduate Research Scholarship (IPRS); Australian Postgraduate Award (APA) scholarship; Galapagos Conservancy	International Postgraduate Research Scholarship (IPRS)(Australian Government); Australian Postgraduate Award (APA) scholarship(Australian Government); Galapagos Conservancy	MVTG is supported by an International Postgraduate Research Scholarship (IPRS) and an Australian Postgraduate Award (APA) scholarship to Charles Darwin University. CEC and HJ are supported by the Galapagos Conservancy https//www.galapagos.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MT, JCI, EA, MC, KKZ, Al, STG received no specific funding for this work.; This project was supported by an Australian Research Training Program scholarship to the Charles Darwin University and by the Galapagos Conservancy. We greatly appreciate the assistance and cooperation of the Ecuadorian Ministry of Environment through the Directorate of the Galapagos National Park and the Galapagos Biosecurity Agency; the Ministry of Tourism through the Tourism Monitoring System (Observatorio de Turismo de Galapagos), the Ecuadorian Civil Aviation Directorate and the Charles Darwin Foundation who kindly provided the databases underpinning this study. Special thanks to Hanno Seebens and Franz Essl who provided useful insights and comments to the manuscript; and to Inti Keith, Gustavo Jimenez, Diana Flores, Henri Herrera, Patricia Jaramillo, Brad Sinclair, Leon Baert, Brand Phillips, Alan Tye, Anne Guezou, Patricia Parker, Sharon Deem, Ingrid Jaramillo, Ginger Lozano, Sandra Gamboa, Danny Rueda, Galo Quezada, Christian Sevilla, Jorge Ramirez, Edgar Navas, Fanny Soto, Rocio Arias, Victor Carrion, Manuel Mejia, Monica Ramos, Marcelo Montesdeoca, Erika Guerrero, Nancy Duran, Alex Fonseca, Marco Echeverria, Duglas Acuria, Rafael Conde, Rommel Iturbide, Ronal Azuero, Viviana Duque, Alberto Velez and all of the ABG personnel for their invaluable help with species identification, data collection, input or suggestions. Thanks to personnel at DGNP for support in collections. Ian Leiper designed Fig 1. Tom Poulsom and Mark Gardener provided key ideas that prompted further discussion. This publication is contribution number 2144 of the Charles Darwin Foundation for the Galapagos Islands.	Amador E., 1996, PLAN MANEJO PARQUE N; [Anonymous], 2015, WORKSH DEV ACT PLAN; [Anonymous], [No title captured]; Atkinson R., 2012, ROLE SCI CONSERVATIO, P183; Baine M, 2007, OCEAN COAST MANAGE, V50, P148, DOI 10.1016/j.ocecoaman.2006.04.001; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Bataille A, 2009, P NATL ACAD SCI USA, V106, P10230, DOI 10.1073/pnas.0901308106; Benitez-Capistros F, 2014, ECOL INDIC, V38, P113, DOI 10.1016/j.ecolind.2013.10.019; Buddenhagen C. E., 2006, Pacific Conservation Biology, V12, P272; Bungartz F, 2009, C DARWING FDN GALAPA; Campbell ML, 2015, MANAG BIOL INVASION, V6, P227, DOI 10.3391/mbi.2015.6.3.01; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Causton C. E., 2000, NOT GALAPAGOS, V61, P10; Causton CE, 2004, BIOL CONTROL, V29, P315, DOI 10.1016/j.biocontrol.2003.07.002; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Causton CE, LATEST RECORDS INTRO; Causton CE, 2008, GALAPAGOS REPORT 200, P142; Causton CE, 2007, GALAPAGOS REPORT 200, P55; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Convention on Biological Diversity, 2014, PATHW INTR INV SPEC; Cruz D, 2008, GALAPAGOS REPORT 200, P48; Deem SL, 2012, ANIM CONSERV, V15, P73, DOI 10.1111/j.1469-1795.2011.00489.x; Deem SL, 2012, J WILDLIFE DIS, V48, P39, DOI 10.7589/0090-3558-48.1.39; Deem SL, 2008, GALAPAGOS REPORT 200, P125; DEGROOT RS, 1983, BIOL CONSERV, V26, P291, DOI 10.1016/0006-3207(83)90093-9; Epler B, 2007, TOURISM EC POPULATIO; Essl F, 2015, BIOSCIENCE, V65, P769, DOI 10.1093/biosci/biv082; Gardener MR, 2011, GLOB ENVIRON STUD, P73, DOI 10.1007/978-4-431-53989-6_6; Gilbert B, 2013, P NATL ACAD SCI USA, V110, P1744, DOI 10.1073/pnas.1212375110; Global Invasive Species Database, 2017, GLOBAL INVASIVE SPEC; Gonzalez JA, 2008, ECOL SOC, V13; Grenier C., 2012, ROLE SCI CONSERVATIO, P256; Guezou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010276; Haralambopoulos N, 1996, ANN TOURISM RES, V23, P503, DOI 10.1016/0160-7383(95)00075-5; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; [INEC Censos INdEy], 2016, PRINC RES CENS POBL, P22; IUCN, 2000, GUIDELINES PREVENTIO; Jeschke JM, 2014, CONSERV BIOL, V28, P1188, DOI 10.1111/cobi.12299; Keith Inti, 2016, Pacific Conservation Biology, V22, P377, DOI 10.1071/PC15020; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Larrea I., 2011, CLIMATE CHANGE VULNE; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leadley P. W., 2014, TECHNICAL SERIES, V78; Leishman MR, 2015, DIVERS DISTRIB, V21, P848, DOI 10.1111/ddi.12338; Levy JK, 2008, J VET INTERN MED, V22, P60, DOI 10.1111/j.1939-1676.2007.0034.x; Liebhold Andrew M., 2006, American Entomologist, V52, P48; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Lundh J. P., 2006, Galapagos Research, V64, P12; Ma MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128479; Machuca-Mestanza J., 2004, CRONOLOGIA HIST GALA; McGeoch MA, 2016, BIOL INVASIONS, V18, P299, DOI 10.1007/s10530-015-1013-1; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orellana D, 2016, INT ARCH PHOTOGRAMME; Parque Nacional Galapagos, 2014, PLAN MAN AR PROT GAL; Peck Stewart B., 1998, American Entomologist, V44, P218; Phillips RB, 2012, BIOL CONSERV, V147, P264, DOI 10.1016/j.biocon.2012.01.013; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Ramirez J, 2015, INFORME GALAPAGOS 20, P118; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rosero O, 2015, OPTIMIZACION FLOTA E; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Segura Ronquillo SC, 2016, REV EMPRESARIAL ICE, V10, P56; SENPLADES, 2010, GAL AG BUEN VIV PROP, P1; Sharma Gyan P., 2010, S. Afr. j. sci., V106, P1; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Taylor J.E., 2006, ECOTOURISM EC GROWTH; Trueman M, 2010, BIOL INVASIONS, V12, P3949, DOI 10.1007/s10530-010-9822-8; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2008, GALAPAGOS REPORT 200, P153; TYE A, 2002, BIODIVERSITY VISION, P12; UNESCO-IUCN. Gala A pagos Islands, 2007, GAL ISL EC REACT MON; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; Mejia CV, 2015, ECOL ECON, V117, P1, DOI 10.1016/j.ecolecon.2015.05.014; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wikelski M, 2004, ECOL SOC, V9; World Tourism Organization, 2015, UNWTO ANN REP 2014; Zapata CE, 2008, GALAPAGOS REPORT 200, P60; Zapata-Erazo F, 2010, INFORME GALAPAGOS 20, P19	79	48	52	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184379	10.1371/journal.pone.0184379	http://dx.doi.org/10.1371/journal.pone.0184379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902860	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200034
J	Vange, P; Bruland, T; Doseth, B; Fossmark, R; Sousa, MML; Beisvag, V; Sordal, O; Qvigstad, G; Waldum, HL; Sandvik, AK; Bakke, I				Vange, Pal; Bruland, Torunn; Doseth, Berit; Fossmark, Reidar; Sousa, Mirta M. L.; Beisvag, Vidar; Sordal, Oystein; Qvigstad, Gunnar; Waldum, Helge L.; Sandvik, Arne K.; Bakke, Ingunn			The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival	PLOS ONE			English	Article							POLYPEPTIDE-EXPRESSING METAPLASIA; BETA-SUBUNIT-DEFICIENT; PARIETAL-CELLS; PROGNOSTIC-SIGNIFICANCE; INTESTINAL METAPLASIA; ADENOCARCINOMA CELLS; HELICOBACTER-PYLORI; MONGOLIAN GERBILS; EPITHELIAL-CELLS; GENE-EXPRESSION	The cytoprotective protein clusterin is often dysregulated during tumorigenesis, and in the stomach, upregulation of clusterin marks emergence of the oxyntic atrophy (loss of acid-producing parietal cells)-associated spasmolytic polypeptide-expressing metaplasia (SPEM). The hormone gastrin is important for normal function and maturation of the gastric oxyntic mucosa and hypergastrinemia might be involved in gastric carcinogenesis. Gastrin induces expression of clusterin in adenocarcinoma cells. In the present study, we examined the expression patterns and gastrin-mediated regulation of clusterin in gastric tissue from: humans; rats treated with proton pump (H+/K+-ATPase) inhibitors and/or a gastrin receptor (CCK2R) antagonist; H+/K+-ATPase beta-subunit knockout (H/K-beta KO) mice; and Mongolian gerbils infected with Helicobacter pylori and given a CCK2R antagonist. Biological function of secretory clusterin was studied in human gastric cancer cells. Clusterin was highly expressed in neuroendocrine cells in normal oxyntic mucosa of humans and rodents. In response to hypergastrinemia, expression of clusterin increased significantly and its localization shifted to basal groups of proliferative cells in the mucous neck cell-chief cell lineage in all animal models. That shift was partially inhibited by antagonizing the CCK2R in rats and gerbils. The oxyntic mucosa of H/K-beta KO mice contained areas with clusterin-positive mucous cells resembling SPEM. In gastric adenocarcinomas, clusterin mRNA expression was higher in diffuse tumors containing signet ring cells compared with diffuse tumors without signet ring cells, and clusterin seemed to be secreted by tumor cells. In gastric cancer cell lines, gastrin increased secretion of clusterin, and both gastrin and secretory clusterin promoted survival after starvation-and chemotherapy-induced stress. Overall, our results indicate that clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and stimulates gastric cancer cell survival.	[Vange, Pal; Bruland, Torunn; Doseth, Berit; Fossmark, Reidar; Sousa, Mirta M. L.; Beisvag, Vidar; Sordal, Oystein; Qvigstad, Gunnar; Waldum, Helge L.; Sandvik, Arne K.; Bakke, Ingunn] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, NTNU, Trondheim, Norway; [Bruland, Torunn; Doseth, Berit; Bakke, Ingunn] St Olavs Univ Hosp, Med Clin, Trondheim, Norway; [Fossmark, Reidar; Sordal, Oystein; Qvigstad, Gunnar; Waldum, Helge L.; Sandvik, Arne K.] St Olavs Univ Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway; [Sandvik, Arne K.] NTNU, Ctr Mol Inflammat Res CEMIR, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Bakke, I (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, NTNU, Trondheim, Norway.	ingunn.bakke@ntnu.no	Bluland, Torunn/AAT-5730-2021; Fossmark, Reidar/AAP-6442-2021; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Fossmark, Reidar/0000-0002-5365-9357; Bakke, Ingunn/0000-0003-0356-6184; Bruland, Torunn/0000-0002-1568-2476; Waldum, Helge/0000-0002-3137-0843	Liaison Committee; Faculty of Medicine and Health Sciences at NTNU; Cancer Fund at St. Olav's University Hospital, Trondheim, Norway; Familien Blix fond til fremme av medisinskforskning; Central Norway Regional Health Authority	Liaison Committee; Faculty of Medicine and Health Sciences at NTNU; Cancer Fund at St. Olav's University Hospital, Trondheim, Norway; Familien Blix fond til fremme av medisinskforskning; Central Norway Regional Health Authority	This work was supported by The Liaison Committee between the Central Norway Regional Health Authority and NTNU, Norwegian University of Science and Technology (https://innisida.ntnu. no/wiki/-/wiki/Norsk/Felles+forskningsutvalg+og +Felles+utdanningsutvalg+for+St.+Olavs+Hospital +og+Fakultet+for+medisin+og+helse), The Faculty of Medicine and Health Sciences at NTNU (http:// www.ntnu.edu/mh), The Cancer Fund at St. Olav's University Hospital, Trondheim, Norway (https:// stolav.no/en) and "Familien Blix fond til fremme av medisinskforskning". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wahida Afroz, Anne Kristensen and Bjorn Munkvold for skillful technical assistance. We owe special gratitude to the medical students Kari Thune Uglane, Eline Buran Wesche and Magnus Grinna Normann for performing their Master theses in Medicine on topics related to this paper. Uglane and Normann contributed to in vitro experiments and Wesche to the examination of clusterin expression in oxyntic mucosa of H+/K+-ATPase beta-subunit knockout mice. We thank Dr. Steve Warrington for language editing the manuscript. We thank the animal unit Comparative Medicine Core facility (CMC), NTNU for assistance with animal models. The imaging analyses were performed in collaboration with Dr. Bjornar Sporsheim at Cellular & Molecular Imaging Core Facility (CMIC), NTNU. Proteomic analyses were performed in collaboration with Proteomics and Metabolomics Core Facility (PRO-MEC), NTNU and The Proteomics Unit at the University of Bergen (PROBE). The microarray and bioinformatics analysis were provided in collaboration with Arnar Flatberg and the Genomics Core Facility (GCF), NTNU. All core facilities (CMC, CMIC, PROMEC and GCF) at NTNU are funded by the Faculty of Medicine and Health Sciences at NTNU and the Central Norway Regional Health Authority.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; Alnasser HA, 2016, AM J PHYSIOL-RENAL, V310, pF160, DOI 10.1152/ajprenal.00304.2015; Andersen CL, 2007, MOL CELL PROTEOMICS, V6, P1039, DOI 10.1074/mcp.M600261-MCP200; Bakkelund KE, 2010, SCAND J GASTROENTERO, V45, P1042, DOI 10.3109/00365521.2010.490952; Bhandari S, 2016, BIOCHEM BIOPH RES CO, V475, P119, DOI 10.1016/j.bbrc.2016.05.052; Bi J, 2010, NEOPLASMA, V57, P191, DOI 10.4149/neo_2010_03_191; Bringeland EA, 2014, BRIT J SURG, V101, P1712, DOI 10.1002/bjs.9650; Burclaff J, 2017, GASTROENTEROLOGY, V152, P762, DOI 10.1053/j.gastro.2016.12.001; Burkitt MD, 2009, WORLD J GASTROENTERO, V15, P1, DOI 10.3748/wjg.15.1; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Choi E, 2014, GUT, V63, P1711, DOI 10.1136/gutjnl-2013-305964; CORREA P, 1975, LANCET, V2, P58; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dimaline R, 2014, J PHYSIOL-LONDON, V592, P2951, DOI 10.1113/jphysiol.2014.272435; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Forster S, 2011, MODERN PATHOL, V24, P1390, DOI 10.1038/modpathol.2011.99; Fossmark R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/975479; Franic TV, 2005, J PATHOL, V207, P43, DOI 10.1002/path.1811; Franic TV, 2001, AM J PHYSIOL-GASTR L, V281, pG1502, DOI 10.1152/ajpgi.2001.281.6.G1502; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Hayakawa Y, 2016, CURR OPIN PHARMACOL, V31, P31, DOI 10.1016/j.coph.2016.08.013; Hayakawa Y, 2015, GUT, V64, P544, DOI 10.1136/gutjnl-2014-307190; Henderson-Jackson EB, 2013, PANCREAS, V42, P967, DOI 10.1097/MPA.0b013e318293734b; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Humphries JM, 2014, BBA-PROTEINS PROTEOM, V1844, P1051, DOI 10.1016/j.bbapap.2014.01.018; Karam SM, 2003, STEM CELLS, V21, P322, DOI 10.1634/stemcells.21-3-322; KIM JP, 1994, SURG ONCOL, V3, P221, DOI 10.1016/0960-7404(94)90037-X; KLEVELAND PM, 1985, SCAND J GASTROENTERO, V20, P569, DOI 10.3109/00365528509089698; Lenferink AEG, 2010, ONCOGENE, V29, P831, DOI 10.1038/onc.2009.399; Lennerz JKM, 2010, AM J PATHOL, V177, P1514, DOI 10.2353/ajpath.2010.100328; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu WT, 2012, CLIN CHIM ACTA, V413, P1098, DOI 10.1016/j.cca.2012.03.003; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mourra N, 2014, HISTOPATHOLOGY, V65, P642, DOI 10.1111/his.12450; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nomura S, 2005, AM J PHYSIOL-GASTR L, V288, pG362, DOI 10.1152/ajpgi.00160.2004; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Penno MAS, 2012, J PROTEOMICS, V77, P40, DOI 10.1016/j.jprot.2012.07.002; Rao SV, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3055-5; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Rohne Philipp, 2016, BioMolecular Concepts, V7, P1, DOI 10.1515/bmc-2015-0026; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seishima R, 2015, CANCER PREV RES, V8, P492, DOI 10.1158/1940-6207.CAPR-15-0025-T; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; SOLCIA E, 1988, DIGESTION, V41, P185, DOI 10.1159/000199786; Sordal O, 2013, HELICOBACTER, V18, P397, DOI 10.1111/hel.12066; Taghavi S, 2012, J CLIN ONCOL, V30, P3493, DOI 10.1200/JCO.2012.42.6635; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Takaishi S, 2009, AM J PATHOL, V175, P365, DOI 10.2353/ajpath.2009.081165; Trougakos IP, 2013, GERONTOLOGY, V59, P514, DOI 10.1159/000351207; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Vange P, 2015, J PATHOL, V237, P447, DOI 10.1002/path.4591; Waldum HL, 2009, SCAND J GASTROENTERO, V44, P390, DOI 10.1080/00365520802624219; Watson SA, 2006, NAT REV CANCER, V6, P936, DOI 10.1038/nrc2014; Weis VG, 2014, AM J PHYSIOL-GASTR L, V307, pG777, DOI 10.1152/ajpgi.00169.2014; Weis VG, 2013, GUT, V62, P1270, DOI 10.1136/gutjnl-2012-302401; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi H, 2002, DIGEST DIS SCI, V47, P573, DOI 10.1023/A:1017920220149; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yoo MW, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600332; Yoshizawa N, 2007, LAB INVEST, V87, P1265, DOI 10.1038/labinvest.3700682; Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6775; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang M, 2010, J GASTROINTEST SURG, V14, P601, DOI 10.1007/s11605-009-1127-9; Zhang Y, 2017, HUM PATHOL, V63, P128, DOI 10.1016/j.humpath.2017.02.016; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	72	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184514	10.1371/journal.pone.0184514	http://dx.doi.org/10.1371/journal.pone.0184514			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902909	gold, Green Submitted, Green Published			2022-12-26	WOS:000410669200042
J	Zhu, HB; Lemos, H; Bhatt, B; Islam, BN; Singh, A; Gurav, A; Huang, L; Browning, DD; Mellor, A; Fulzele, S; Singh, N				Zhu, Huabin; Lemos, Henrique; Bhatt, Brinda; Islam, Bianca N.; Singh, Abhijit; Gurav, Ashish; Huang, Lei; Browning, Darren D.; Mellor, Andrew; Fulzele, Sadanand; Singh, Nagendra			Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity	PLOS ONE			English	Article								Carbidopa is a drug that blocks conversion of levodopa to dopamine outside of central nervous system (CNS) and thus inhibits unwanted side effects of levodopa on organs located outside of CNS during management of Parkinson's Disease (PD). PD is associated with increased expression of inflammatory genes in peripheral and central nervous system (CNS), infiltration of immune cells into brain, and increased numbers of activated/memory T cells. Animal models of PD have shown a critical role of T cells in inducing pathology in CNS. However, the effect of carbidopa on T cell responses in vivo is unknown. In this report, we show that carbidopa strongly inhibited T cell activation in vitro and in vivo. Accordingly, carbidopa mitigated myelin oligodendrocyte glycoprotein peptide fragment 35-55 (MOG35-55) induced experimental autoimmune encephalitis (EAE) and collagen induced arthritis in animal models. The data presented here suggest that in addition to blocking peripheral conversion of levodopa, carbidopa may inhibit T cell responses in PD individuals and implicate a potential therapeutic use of carbidopa in suppression of T cell mediated pathologies.	[Zhu, Huabin; Bhatt, Brinda; Islam, Bianca N.; Browning, Darren D.; Singh, Nagendra] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Lemos, Henrique; Huang, Lei; Mellor, Andrew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Singh, Abhijit] Augusta Univ, Dept Emergency Med, Med Coll Georgia, Augusta, GA USA; [Gurav, Ashish] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Fulzele, Sadanand] Augusta Univ, Dept Orthoped Surg, Med Coll Georgia, Augusta, GA USA	University System of Georgia; Augusta University; Newcastle University - UK; University System of Georgia; Augusta University; University of Pennsylvania; University System of Georgia; Augusta University	Singh, N (corresponding author), Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	nasingh@augusta.edu	de Paula Lemos, Henrique/AAI-2698-2020	de Paula Lemos, Henrique/0000-0002-0539-3283; Browning, Darren/0000-0003-0497-7620; Zhu, Huabin/0000-0002-4557-795X	National Institutes of Health [R01DK103576]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grant R01DK103576 to NS.	Baisakhi Saha ACM, 2001, NEUROIMMUNOMODULAT, V9, P11; Baisakhi Saha ACM, 2001, INT IMMUNOPHARMACOL, V1, P12; Barnes JGaNM, 2003, TRENDS IMMUNOL, V24, P6; Biswarup Basu CS, 2010, J BIOL CHEM, V285, P7; Christine S., 2016, AUTOIMMUNITY, V49, P14; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; FISZER U, 1994, ACTA NEUROL SCAND, V90, P160; George T., 2013, J PARKINSON DIS, V3, P12; Greengard LBaP, 2014, FRONT NEUROANAT, V8, P16; Henrique Lemos LH, 2014, J IMMUNOL, V192, P8; Ioanna Kokkinou EN, 2008, BLOOD CELL MOL DIS, V42, P7; Joans Bergquist AT, 1994, P NATL ACAD SCI USA, V91, P5; Jonathan Kipnis MC, 2004, J NEUROSCI, V2004, P11; Julie Rowin MT, 2012, MUSCLE NERVE, V46, P5; Kazuhisa Nakano TH, 2009, INT IMMUNOLOGY, V21, P10; Lars Brichta PG, 2013, TRENDS NEUROSCI, V36, P12; Lesch RMsaK-P, 1998, ROLE SEROTONIN IMMUN, V12, P23; Levite M., 2008, CURRENT OPINION PHAR, V8, P12; Lindstrom aJS, 1983, ENDOCRINOLOGY, V112, P6; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Marco Cosentino AMF, 2007, BLOOD, V109, P11; Matilde Leon-Ponte GPAaPJOC, 2007, BLOOD, V109, P9; Michal J., 2005, TNF J NEUROIMMUNOLOG, V169, P11; Musso SB, 1996, J CLIN ENDOCR METAB, V81, P5; Palash Bhattacharya IB, 2015, J INTERFERON CYTOKIN, V35, P15; Palash Bhattacharya MT, 2015, CYTOKINE, V75, P11; Peta J., 2006, BLOOD, V107, P9; Przedborski WDaS, 2003, NEURON, V39, P21; Regina Katzenschlager AJL, 2002, J NEUROL S2, V249, P7; Saunders JAH, 2012, J NEUROIMMUNE PHARM, V7, P927, DOI 10.1007/s11481-012-9402-z; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shukkur M., 2014, J CELL MOL MED, V18, P7; Shukkur M., 2012, PLOS ONE, V7, P6; Shukkur M., 2013, CNS NEUROSCIENCE THE, V19, P8; Shukkur M, 2014, BRAIN BEHAV IMMUN, V42, P5; Stanley Fahn DO, 2004, NEW ENGL J MED, V351, P11; William R., 1986, CLIN EXPT PHARM PHYS, V13, P7; Yoshiko Watanabe TN, 2006, J IMMUNOL, V176, P10	38	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183484	10.1371/journal.pone.0183484	http://dx.doi.org/10.1371/journal.pone.0183484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898256	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500006
J	Tan, SH; Nusse, R				Tan, Si Hui; Nusse, Roel			In vivo lineage tracing reveals Axin2-expressing, long-lived cortical thymic epithelial progenitors in the postnatal thymus	PLOS ONE			English	Article							MEDULLARY EPITHELIUM; BETA-CATENIN; ADULT THYMUS; CELLS; DIFFERENTIATION; IDENTIFICATION; ORGANOGENESIS; TRANSCRIPTION; POPULATION	In the thymus, cortical and medullary thymic epithelial cells (TECs) are instrumental for generating a repertoire of functional T cells. Hence, there has been much interest in the ontogeny of TECs. While medullary TEC (mTEC) and bipotent progenitors have been identified, the existence of a cortical TEC (cTEC) progenitor remains ambiguous. In this study, we used lineage tracing based on a target gene of the Wnt pathway, Axin2. We found that Axin2 initially labels cells in both the cortical and medullary compartments. Using Axin2CreERT2 mice to track the fate of labelled cells, we identified long-lived cortical TEC progenitors that give rise to expanding clones and contribute to homeostasis in postnatal thymus. In contrast, no clonal expansion was found in the medullary or in the K5K8-double positive compartments. The identification of cTEC progenitors and their regulation by Wnt signaling have important implications for our understanding of thymus physiology during homeostasis and TEC-related disorders.	[Tan, Si Hui] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA USA; [Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu		Tan, Si Hui/0000-0002-0809-0085	National Science Scholarship from A*STAR, Singapore	National Science Scholarship from A*STAR, Singapore	S.T. was supported by a National Science Scholarship from A*STAR, Singapore.	Balciunaite G, 2002, NATURE; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Brunk F, 2015, J IMMUNOLOGY; Ge Q, 2013, DEV COMP IMMUNOL, V39, P85, DOI 10.1016/j.dci.2012.01.002; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hamazaki Y, 2015, EUR J IMMUNOL, V45, P2985, DOI 10.1002/eji.201545844; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Liang CC, 2013, IMMUNOL CELL BIOL, V91, P511, DOI 10.1038/icb.2013.34; Lustig B, 2002, CELLULAR BIOL; Mayer CE, 2016, EUR J IMMUNOL, V46, P846, DOI 10.1002/eji.201545995; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohigashi I, 2015, CELL REP, V13, P1432, DOI 10.1016/j.celrep.2015.10.012; Onder L, 2015, EUR J IMMUNOL, V45, P2218, DOI 10.1002/eji.201545677; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Sun L, 2014, BIOMED RES INT, V2014; Takahama Y., 2006, NAT REV IMMUNOL; Ulyanchenko S, 2016, CELL REP, V14, P2819, DOI 10.1016/j.celrep.2016.02.080; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184582	10.1371/journal.pone.0184582	http://dx.doi.org/10.1371/journal.pone.0184582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886197	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100162
J	Debruyne, DN; Turchi, L; Burel-Vandenbos, F; Fareh, M; Almairac, F; Virolle, V; Figarella-Branger, D; Baeza-Kallee, N; Lagadec, P; Kubiniek, V; Paquis, P; Fontaine, D; Junier, MP; Chneiweiss, H; Virolle, T				Debruyne, D. N.; Turchi, L.; Burel-Vandenbos, F.; Fareh, M.; Almairac, F.; Virolle, V.; Figarella-Branger, D.; Baeza-Kallee, N.; Lagadec, P.; Kubiniek, V.; Paquis, P.; Fontaine, D.; Junier, M-P; Chneiweiss, H.; Virolle, T.			DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression	ONCOGENE			English	Article							CANCER STEM-CELL; GLIOMA-INITIATING CELLS; NANOG; TUMORS	Glioblastomas (GBM) are lethal primitive brain tumours characterized by a strong intra-tumour heterogeneity. We observed in GBM tissues the coexistence of functionally divergent micro-territories either enriched in more differentiated and non-mitotic cells or in mitotic undifferentiated OLIG2 positive cells while sharing similar genomic abnormalities. Understanding the formation of such functionally divergent micro-territories in glioblastomas (GBM) is essential to comprehend GBM biogenesis, plasticity and to develop therapies. Here we report an unexpected anti-proliferative role of beta-catenin in non-mitotic differentiated GBM cells. By cell type specific stimulation of miR-302, which directly represses cyclin D1 and stemness features, beta-catenin is capable to change its known proliferative function. Nuclear beta-catenin accumulation in non-mitotic cells is due to a feed forward mechanism between DOCK4 and beta-catenin, allowed by increased GSK3-beta activity. DOCK4 over expression suppresses selfrenewal and tumorigenicity of GBM stem-like cells. Accordingly in the frame of GBM median of survival, increased level of DOCK4 predicts improved patient survival.	[Debruyne, D. N.; Turchi, L.; Burel-Vandenbos, F.; Fareh, M.; Almairac, F.; Virolle, V.; Lagadec, P.; Paquis, P.; Virolle, T.] Univ Cote dAzur, Nice, France; [Debruyne, D. N.; Turchi, L.; Burel-Vandenbos, F.; Fareh, M.; Almairac, F.; Virolle, V.; Lagadec, P.; Paquis, P.; Virolle, T.] CNRS, UMR7277, Nice, France; [Debruyne, D. N.; Turchi, L.; Burel-Vandenbos, F.; Fareh, M.; Almairac, F.; Virolle, V.; Lagadec, P.; Paquis, P.; Virolle, T.] INSERM, U1091, Nice, France; [Turchi, L.; Almairac, F.; Paquis, P.; Fontaine, D.] CHU Nice, Hop Pasteur, Serv Neurchirurg, Nice, France; [Burel-Vandenbos, F.] CHU Nice, Hop Pasteur, Serv Anatomopathol, Nice, France; [Figarella-Branger, D.; Baeza-Kallee, N.] Aix Marseille Univ, Fac Med Timone, Marseille, France; [Figarella-Branger, D.; Baeza-Kallee, N.] INSERM, UMR 911, CRO2, Marseille, France; [Figarella-Branger, D.] CHU Timone, Dept Pathol, Marseille 5, France; [Kubiniek, V.] Univ Hosp Nice, Lab Solid Tumors Genet, Nice, France; [Junier, M-P; Chneiweiss, H.] CNRS, Neurosci Paris Seine IBPS UMR8246, 7 Quai St Bernard, Paris, France; [Junier, M-P; Chneiweiss, H.] Team Glial Plast, 7 Quai St Bernard, Paris, France; [Junier, M-P; Chneiweiss, H.] INSERM, U1130, Neurosci Paris Seine IBPS, 7 Quai St Bernard, Paris, France; [Junier, M-P; Chneiweiss, H.] Univ Paris 06, UMCR18, Neurosci Paris Seine IBPS, 7 Quai St Bernard, Paris, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Virolle, T (corresponding author), Univ Nice Sophia Antipolis, Inst Biol, iBV, UFR Sci, Batiment Sci Nat,Parc Valrose,28 Ave Valrose, F-06108 Nice 2, France.	Virolle@unice.fr	LAGADEC, Patricia/P-4538-2016; herve, chneiweiss/Q-6818-2019; Virolle, Thierry/E-5838-2016	LAGADEC, Patricia/0000-0002-5105-782X; herve, chneiweiss/0000-0001-7675-5061; Fontaine, Denys/0000-0001-5012-6769; Turchi, Laurent/0000-0003-2020-5831; Fareh, Mohamed/0000-0001-9551-8213	Association pour la Recherche sur le Cancer [3161]; Association Sauvons Laura; ADerTU; Association Dimitri Bessiere; Agence Nationale pour la Recherche (ANR Jeunes Chercheurs, Jeunes Chercheuses, "GLIOMIRSTEM project"); Fondation de France; ARC projet [SFI20111203773]; INCA PLBIO; ITMO CANCER plan cancer; INSERM; UNSA	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association Sauvons Laura; ADerTU; Association Dimitri Bessiere; Agence Nationale pour la Recherche (ANR Jeunes Chercheurs, Jeunes Chercheuses, "GLIOMIRSTEM project")(French National Research Agency (ANR)); Fondation de France(Fondation de France); ARC projet; INCA PLBIO; ITMO CANCER plan cancer; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UNSA	This work was supported by grants from the Association pour la Recherche sur le Cancer (subvention 3161), Association Sauvons Laura, ADerTU, Association Dimitri Bessiere, Agence Nationale pour la Recherche (ANR Jeunes Chercheurs, Jeunes Chercheuses, "GLIOMIRSTEM project"), Fondation de France, ARC projet (SFI20111203773), INCA PLBIO2012, ITMO CANCER plan cancer, INSERM, UNSA. We thank A Borderie, S Bestree, C Hagnere, F Frassinetti, S Rekima, AC Peyron and F Keslair for their technical assistance and C. Colin for the statistical analysis. We thank Doctor Enzo Lalli for providing the PKF115-584 inhibitor and Doctor Andreas Schedl for the mYhBCATf and the TopFlash reporter plasmid. We thank Doctor Ellen Van Obberghen-Schilling for grammatical corrections.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Dahan P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.509; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fareh M, 2012, CELL DEATH DIFFER, V19, P232, DOI 10.1038/cdd.2011.89; Farhana L, 2012, J ONCOL, V2012, DOI 10.1155/2012/796729; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Germano I, 2010, NEUROPHARMACOLOGY, V58, P903, DOI 10.1016/j.neuropharm.2009.12.019; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Johannessen TCA, 2012, EXPERT REV ANTICANC, V12, P635, DOI [10.1586/era.12.37, 10.1586/ERA.12.37]; Kleppe M, 2012, CELL STEM CELL, V10, P351, DOI 10.1016/j.stem.2012.03.006; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086; Lee M, 2012, INT J GYNECOL CANCER, V22, P1489, DOI 10.1097/IGJ.0b013e3182738307; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Nagata T, 2014, BREAST CANCER-TOKYO, V21, P96, DOI 10.1007/s12282-012-0357-y; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Singh SK, 2003, CANCER RES, V63, P5821; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sottoriva A, 2013, CANCER RES, V73, P41, DOI 10.1158/0008-5472.CAN-12-2273; Turchi L, 2013, STEM CELLS, V31, P1252, DOI 10.1002/stem.1373; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	32	17	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					241	254		10.1038/onc.2017.323	http://dx.doi.org/10.1038/onc.2017.323			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28925399				2022-12-26	WOS:000422631700010
J	Hector, AJ; McGlory, C; Damas, F; Mazara, N; Baker, SK; Phillips, SM				Hector, Amy J.; McGlory, Chris; Damas, Felipe; Mazara, Nicole; Baker, Steven K.; Phillips, Stuart M.			Pronounced energy restriction with elevated protein intake results in no change in proteolysis and reductions in skeletal muscle protein synthesis that are mitigated by resistance exercise	FASEB JOURNAL			English	Article						muscle protein turnover; weight loss; dietary protein	FAT-FREE MASS; WEIGHT-LOSS; IN-VIVO; DIETARY-PROTEIN; AMINO-ACIDS; OLDER MEN; DEFICIT; HUMANS; MYOFIBRILLAR; INGESTION	Preservation of lean body mass (LBM) may be important during dietary energy restriction (ER) and requires equal rates of muscle protein synthesis(MPS) and muscle protein breakdown(MPB). Currently, the relative contribution of MPS and MPB to the loss of LBM during ER in humans is unknown. We aimed to determine the impact of dietary protein intake and resistance exercise on MPS and MPB during a controlled short-term energy deficit. Adult men (body mass index, 28.66 +/- 0.6 kg/m(2); age 22 +/- 1 yr) underwent 10 d of 40%-reduced energy intake while performing unilateral resistance exercise and consuming lower protein (1.2 g/kg/d, n = 12) or higher protein (2.4 g/kg/d, n = 12). Pre- and postintervention testing included dual-energy X-ray absorptiometry, primed constant infusion of ring-[C-13(6)] phenylalanine, and (15)[N] phenylalanine to measure acute postabsorptive MPS and MPB; D2O to measure integrated MPS; and gene and protein expression. There was a decrease in acute MPS after ER (higher protein, 0.059 +/- 0.006 to 0.051 +/- 0.009%/h; lower protein, 0.061 +/- 0.005 to 0.045 +/- 0.006%/h; P < 0.05) that was attenuated with resistance exercise (higher protein, 0.067 +/- 0.01%/h; lower protein, 0.061 +/- 0.006%/hr), and integrated MPS followed a similar pattern. There was no change in MPB (energy balance, 0.080 +/- 0.01%/hr; ER rested legs, 0.078 +/- 0.008%/hr; ER exercised legs, 0.079 +/- 0.006%/hr). We conclude that a reduction in MPS is the main mechanism that underpins LBM loss early in ER in adult men.	[Hector, Amy J.; McGlory, Chris; Mazara, Nicole; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Baker, Steven K.] McMaster Univ, Div Phys Med & Rehabil, Dept Med, Hamilton, ON, Canada; [Damas, Felipe] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil	McMaster University; McMaster University; Universidade de Sao Paulo	Phillips, SM (corresponding author), McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	phillis@mcmaster.ca	Damas, Felipe/S-7122-2019; Damas, Felipe/F-1143-2013; Phillips, Stuart/B-2343-2009	Damas, Felipe/0000-0001-9049-3598; Damas, Felipe/0000-0001-9049-3598; Phillips, Stuart/0000-0002-1956-4098; McGlory, Chris/0000-0003-4853-4960	National Science and Engineering Research Council of Canada; Canada Research Chairs Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by a grant from the National Science and Engineering Research Council of Canada (to S.M.P.). S.M.P. was supported by the Canada Research Chairs Program and greatly acknowledges that funding. The authors thank Todd Prior (McMaster University) for technical assistance during laboratory analyses. The authors declare no conflicts of interest.	Areta JL, 2014, AM J PHYSIOL-ENDOC M, V306, pE989, DOI 10.1152/ajpendo.00590.2013; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Burd NA, 2012, J APPL PHYSIOL, V113, P896, DOI 10.1152/japplphysiol.00513.2012; Burd NA, 2009, J APPL PHYSIOL, V106, P1692, DOI 10.1152/japplphysiol.91351.2008; Burke LM, 2011, J SPORT SCI, V29, pS17, DOI 10.1080/02640414.2011.585473; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO; Carbone JW, 2014, APPL PHYSIOL NUTR ME, V39, P960, DOI 10.1139/apnm-2013-0433; Carbone JW, 2013, FASEB J, V27, P5104, DOI 10.1096/fj.13-239228; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Hammond KM, 2016, MED SCI SPORT EXER, V48, P2108, DOI 10.1249/MSS.0000000000001009; Hector AJ, 2015, J NUTR, V145, P246, DOI 10.3945/jn.114.200832; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Heymsfield SB, 2011, OBES REV, V12, pe348, DOI 10.1111/j.1467-789X.2010.00767.x; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longland TM, 2016, AM J CLIN NUTR, V103, P738, DOI 10.3945/ajcn.115.119339; Margolis LM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00445; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Murphy C. J., 2016, THESIS; Murphy CH, 2016, AM J CLIN NUTR, V104, P1594, DOI 10.3945/ajcn.116.136424; Murphy CH, 2015, EUR J SPORT SCI, V15, P21, DOI 10.1080/17461391.2014.936325; Pasiakos SM, 2015, FASEB J, V29, P1136, DOI 10.1096/fj.14-266890; Pasiakos SM, 2013, FASEB J, V27, P3837, DOI 10.1096/fj.13-230227; Pasiakos SM, 2010, J NUTR, V140, P745, DOI 10.3945/jn.109.118372; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Smiles WJ, 2015, AM J PHYSIOL-REG I, V309, pR603, DOI 10.1152/ajpregu.00413.2014; Stefanetti RJ, 2015, PFLUG ARCH EUR J PHY, V467, P1523, DOI 10.1007/s00424-014-1587-y; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Zhang XJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE759, DOI 10.1152/ajpendo.1996.270.5.E759	36	50	50	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					265	275		10.1096/fj.201700158RR	http://dx.doi.org/10.1096/fj.201700158RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899879				2022-12-26	WOS:000419172700025
J	Chung, HS; Kim, JS; Lee, SM; Park, SJ				Chung, Hye-Shin; Kim, Ji-Sun; Lee, Sang Mee; Park, Soon Jae			Role of the P2 residue of human alpha 1-antitrypsin in determining target protease specificity	PLOS ONE			English	Article							ALPHA-1-PROTEINASE INHIBITOR; SERINE PROTEINASES; SERPIN STRUCTURE; FACTOR-XII; ELASTASE; SUPERFAMILY; KALLIKREIN; MECHANISM; COMPLEX; SITE	Alpha 1-antitrypsin (A1AT) is a serine protease inhibitor that mainly inhibits neutrophil elastase in the lungs. A variant of A1AT at the P1 position with methionine 358 to arginine (A1AT-Pittsburgh) is a rapid inhibitor of thrombin with greatly diminished anti-elastase activity. The P2 residue (position 357) of A1AT-Pittsburgh has been shown to play an important role in interactions with thrombin and kallikrein, but the role of P2 residue in wild-type A1AT has largely been unraveled. Here, we investigated the effects of P2 proline substitutions in wild-type A1AT on interactions with porcine pancreatic elastase (PPE) and human neutrophil elastase (HNE). The mutant A1AT proteins (P357A, P357D, P357K, P357L, P357N, P357S, and P357W) were less efficient than the wild-type A1AT at inhibiting PPE and HNE. Among the mutants, P357D did not form a complex with PPE, whereas P357L, P357N, and P357W showed significantly reduced complex formation with PPE. Surprisingly, mass spectrometry analysis revealed that P357D had two cleavage sites after the P9 alanine and the P3 isoleucine residues. Our results indicate that the size and negative charge of the R group of the P2 residue influence the interaction with elastases. Specifically, the negative charge at the P2 residue is disfavored and the resulting conformational changes in the reactive center loop upon interaction with PPE lead to cleavage at new sites. Overall, the results of this study demonstrate a previously unknown role for P2 residue in determining inhibitory specificity of A1AT.	[Chung, Hye-Shin; Kim, Ji-Sun; Lee, Sang Mee; Park, Soon Jae] Alteogen Inc, Daejeon, South Korea; [Chung, Hye-Shin] Hannam Univ, Dept Biol Sci & Biotechnol, Daejeon, South Korea	Hannam University	Park, SJ (corresponding author), Alteogen Inc, Daejeon, South Korea.	park@alteogen.com			Alteogen Inc.	Alteogen Inc.	Alteogen Inc. provided support in the form of salaries for authors [H-SC, J-SK, SML, and SJP] and research materials/instruments but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARDELT W, 1985, BIOCHEMISTRY-US, V24, P5313, DOI 10.1021/bi00341a007; BEATTY K, 1980, J BIOL CHEM, V255, P3931; Berg J. M., 2015, BIOCHEMISTRY; BLOW AMJ, 1977, BIOCHEM J, V161, P13, DOI 10.1042/bj1610013; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRANTLY M, 1988, AM J MED, V84, P13; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; Chung HS, 2016, GLYCOCONJUGATE J, V33, P201, DOI 10.1007/s10719-016-9657-3; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; FAGERHOL MK, 1967, CLIN CHIM ACTA, V16, P199, DOI 10.1016/0009-8981(67)90181-7; Gettins PGW, 2016, BIOCHEM J, V473, P2273, DOI 10.1042/BCJ20160014; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; HOPKINS PCR, 1995, J BIOL CHEM, V270, P11866, DOI 10.1074/jbc.270.20.11866; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Kim SJ, 2001, J MOL BIOL, V306, P109, DOI 10.1006/jmbi.2000.4357; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee KJ, 2013, GLYCOCONJUGATE J, V30, P537, DOI 10.1007/s10719-012-9453-7; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHAPIRA M, 1987, J CLIN INVEST, V80, P582, DOI 10.1172/JCI113108; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT CF, 1986, J CLIN INVEST, V77, P631, DOI 10.1172/JCI112346; SHOTTON D M, 1970, Nature (London), V225, P802, DOI 10.1038/225802a0; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185074	10.1371/journal.pone.0185074	http://dx.doi.org/10.1371/journal.pone.0185074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922398	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300056
J	Ugwu, DI; Okoro, UC; Ahmad, H				Ugwu, David Izuchukwu; Okoro, Uchechukwu Chris; Ahmad, Hilal			New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: Design, synthesis and structureactivity relationship	PLOS ONE			English	Article								Sixteen new carboxamide derivatives bearing substituted benzenesulphonamide moiety (7a-p) were synthesized by boric acid mediated amidation of appropriate benzenesulphonamide with 2-amino-4-picoline and tested for anti-inflammatory activity. One compound 7c showed more potent anti-inflammatory activity than celecoxib at 3 h in carrageenan-induced rat paw edema bioassay. Compounds 7g and 7k also showed good anti-inflammatory activity comparable to celecoxib. Compound 7c appeared selectivity index (COX-2/COX-1) better than celecoxib. Compound 7k appeared selectivity index (COX-2/COX-1) a little higher than the half of celecoxib while compound 7g is non-selective for COX-2. The LD50 of compounds 7c, 7g and 7k were comparable to celecoxib.	[Ugwu, David Izuchukwu; Okoro, Uchechukwu Chris] Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Nigeria; [Ugwu, David Izuchukwu; Ahmad, Hilal] Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India	University of Nigeria; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Ugwu, DI (corresponding author), Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Nigeria.; Ugwu, DI (corresponding author), Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India.	izuchukwu.ugwu@unn.edu.ng	Ugwu, David Izuchukwu/AAV-8960-2020	Ugwu, David Izuchukwu/0000-0002-2370-6191				Abdel-Aziz HA, 2014, EUR J MED CHEM, V80, P416, DOI 10.1016/j.ejmech.2014.04.065; Aissaoui H, 2008, BIOORG MED CHEM LETT, V18, P5729, DOI 10.1016/j.bmcl.2008.09.079; ANANTHANARAYANAN VS, 1993, J MED CHEM, V36, P1324, DOI 10.1021/jm00062a004; Bano S, 2011, EUR J MED CHEM, V46, P5763, DOI 10.1016/j.ejmech.2011.08.015; Bashir R, 2011, BIOORG MED CHEM LETT, V21, P4301, DOI 10.1016/j.bmcl.2011.05.061; Bhat M. A., 2006, Indian Journal of Pharmaceutical Sciences, V68, P120; Cairns JA, 2007, CANADIAN J CARDIOLOG, V23, P131; DEGASPARO M, 1995, REGUL PEPTIDES, V59, P303, DOI 10.1016/0167-0115(95)00085-P; Ghorab MM, 2014, ACTA PHARM, V64, P431; Ghosh MN, 1984, FUNDAMENTALS EXPT PH, P153; Graul A, 1997, DRUGS FUTURE, V22, P968, DOI DOI 10.1358/D0F.1997.022.09.423212; Hogan BL, 2000, J PHARMACEUT BIOMED, V23, P637, DOI 10.1016/S0731-7085(00)00342-3; Jainswal M., 2004, BIOORG MED CHEM LETT, V14, P5666, DOI [DOI 10.1016/J.BMCL.2004.08.051, 10.1016/j.bmcl.2004.08.051]; Jallow S, 2009, J CLIN MICROBIOL, V47, P2200, DOI 10.1128/JCM.01654-08; Kalgutkar AS, 1999, EXPERT OPIN THER PAT, V9, P831, DOI 10.1517/13543776.9.7.831; Lee SH, 2004, BIOL PHARM BULL, V27, P786, DOI 10.1248/bpb.27.786; Mistry BD, 2015, INDIAN J CHEM B, V54, P128; Montalbetti CAGN, 2005, TETRAHEDRON, V61, P10827, DOI 10.1016/j.tet.2005.08.031; Nakayama T, 2005, ANTICANCER RES, V25, P157; Nouraddin H, 2013, IRAN J PHARM RES, V12, P330; Pasinetti GM, 1998, J NEUROSCI RES, V54, P1; PATCHETT AA, 1993, J MED CHEM, V36, P2051, DOI 10.1021/jm00067a001; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V309, P709, DOI 10.1016/j.bbrc.2003.08.055; Shet P., 2013, RES J CHEM SCI, V3, P15; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Talley JJ, 1999, PROGR MED CHEM, V36, P201, DOI 10.1016/S0079-6468(08)70048-1; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vane JR, 1971, NATURE, V231, P235; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183807	10.1371/journal.pone.0183807	http://dx.doi.org/10.1371/journal.pone.0183807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922386	gold, Green Published, Green Submitted			2022-12-26	WOS:000411059300007
J	Chen, Y; Meyer, JN; Hill, HZ; Lange, G; Condon, MR; Klein, JC; Ndirangu, D; Falvo, MJ				Chen, Yang; Meyer, Joel N.; Hill, Helene Z.; Lange, Gudrun; Condon, Michael R.; Klein, Jacquelyn C.; Ndirangu, Duncan; Falvo, Michael J.			Role of mitochondrial DNA damage and dysfunction in veterans with Gulf War Illness	PLOS ONE			English	Article							MUSCLE INSULIN-RESISTANCE; POPULATION-BASED SURVEY; HUMAN SKELETAL-MUSCLE; DEET N,N-DIETHYL-M-TOLUAMIDE; PARKINSONS-DISEASE; COMBINED EXPOSURE; OXIDATIVE STRESS; HEALTH; SYMPTOMS; RECOVERY	Gulf War Illness (GWI) is a chronic multi-symptom illness not currently diagnosed by standard medical or laboratory test that affects 30% of veterans who served during the 1990-1991 Gulf War. The clinical presentation of GWI is comparable to that of patients with certain mitochondrial disorders-i.e., clinically heterogeneous multisystem symptoms. Therefore, we hypothesized that mitochondrial dysfunction may contribute to both the symptoms of GWI as well as its persistence over time. We recruited 21 cases of GWI (CDC and Kansas criteria) and 7 controls to participate in this study. Peripheral blood samples were obtained in all participants and a quantitative polymerase chain reaction (QPCR) based assay was performed to quantify mitochondrial and nuclear DNA lesion frequency and mitochondrial DNA (mtDNA) copy number (mtDNAcn) from peripheral blood mononuclear cells. Samples were also used to analyze nuclear DNA lesion frequency and enzyme activity for mitochondrial complexes I and IV. Both mtDNA lesion frequency (p = 0.015, d = 1.13) and mtDNAcn (p = 0.001; d = 1.69) were elevated in veterans with GWI relative to controls. Nuclear DNA lesion frequency was also elevated in veterans with GWI (p = 0.344; d = 1.41), but did not reach statistical significance. Complex I and IV activity (p > 0.05) were similar between groups and greater mtDNA lesion frequency was associated with reduced complex I (r(2) = -0.35, p = 0.007) and IV (r(2) = -0.28, p < 0.01) enzyme activity. In conclusion, veterans with GWI exhibit greater mtDNA damage which is consistent with mitochondrial dysfunction.	[Chen, Yang; Klein, Jacquelyn C.; Ndirangu, Duncan; Falvo, Michael J.] Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA; [Chen, Yang; Hill, Helene Z.; Condon, Michael R.; Falvo, Michael J.] Univ Med & Dent New Jersey, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Lange, Gudrun] Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA; [Lange, Gudrun] Albert Einstein Med Ctr, New York, NY USA; [Condon, Michael R.] Vet Affairs New Jersey Hlth Care Syst, Surg Serv, E Orange, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Falvo, MJ (corresponding author), Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA.; Falvo, MJ (corresponding author), Univ Med & Dent New Jersey, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA.	Michael.Falvo@va.gov	Meyer, Joel/G-9836-2017	Meyer, Joel/0000-0003-1219-0983; Falvo, Michael/0000-0001-9348-6676				Abdullah L, 2016, TOXICOLOGY, V372, P22, DOI 10.1016/j.tox.2016.10.012; Abu-Qare A, 2000, TOXICOL LETT, V117, P151, DOI 10.1016/S0378-4274(00)00257-5; Abu-Qare AW, 2001, J TOXICOL ENV HEAL A, V63, P243, DOI 10.1080/15287390151143640; Abu-Qare AW, 2001, TOXICOL LETT, V123, P51, DOI 10.1016/S0378-4274(01)00380-0; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; BACKER JM, 1982, CANCER RES, V42, P2764; Ballinger SW, 1996, CANCER RES, V56, P5692; Binns J., 2014, GULF WAR ILLNESS HLT; Binns JH, 2008, GULF WAR ILLNESS HLT; Budnik LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064413; Byun HM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-18; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Cohen BH, 2010, DEV DISABIL RES REV, V16, P189, DOI 10.1002/ddrr.106; Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; Doebbeling BN, 2000, AM J MED, V108, P695, DOI 10.1016/S0002-9343(00)00405-8; Engelbrecht JP, 2009, INHAL TOXICOL, V21, P297, DOI [10.1080/08958370802464273, 10.1080/08958370802464273 ]; Falvo MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1124; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Genter MB, 2006, BIOCHEM BIOPH RES CO, V342, P1375, DOI 10.1016/j.bbrc.2006.02.121; Golomb BA, 2002, MITOCHONDRIAL FUNCTI; Golomb BA, 2014, NEURAL COMPUT, V26, P2594, DOI 10.1162/NECO_a_00659; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Gonzalez-Hunt Claudia P, 2016, Curr Protoc Toxicol, V67, DOI 10.1002/0471140856.tx2011s67; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; KEMP GJ, 1993, NMR BIOMED, V6, P66, DOI 10.1002/nbm.1940060111; Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001; Koslik HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092887; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Li L, 2001, TOXICOL APPL PHARM, V177, P17, DOI 10.1006/taap.2001.9283; Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x; Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Medicine Io, 2014, CHR MULT ILL GULF WA; Meyer J.N, 2017, TOXICOLOGY; Meyer JN, 2013, TOXICOLOGICAL SCI; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Omura T, 2006, CHEM-BIOL INTERACT, V163, P86, DOI 10.1016/j.cbi.2006.06.008; Rose MR, 2004, NEUROLOGY, V63, P1681, DOI 10.1212/01.WNL.0000142600.17167.0E; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521; Soltaninejad K, 2009, MED SCI MONITOR, V15, pRA75; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wittkopp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064444; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhong J, 2016, CIRCULATION, V133, P378, DOI 10.1161/CIRCULATIONAHA.115.018802	60	34	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184832	10.1371/journal.pone.0184832	http://dx.doi.org/10.1371/journal.pone.0184832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910366	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200101
J	Jegousse, C; Yang, YD; Zhan, J; Wang, JH; Zhou, YQ				Jegousse, Clara; Yang, Yuedong; Zhan, Jian; Wang, Jihua; Zhou, Yaoqi			Structural signatures of thermal adaptation of bacterial ribosomal RNA, transfer RNA, and messenger RNA	PLOS ONE			English	Article							OPTIMAL-GROWTH TEMPERATURE; SYNONYMOUS CODON USAGE; GENOMIC G+C CONTENT; PROTEIN; STABILITY; SEQUENCES; MECHANISM; ELUCIDATION; PROKARYOTES; PREDICTION	Temperature adaptation of bacterial RNAs is a subject of both fundamental and practical interest because it will allow a better understanding of molecular mechanism of RNA folding with potential industrial application of functional thermophilic or psychrophilic RNAs. Here, we performed a comprehensive study of rRNA, tRNA, and mRNA of more than 200 bacterial species with optimal growth temperatures (OGT) ranging from 4 degrees C to 95 degrees C. We investigated temperature adaptation at primary, secondary and tertiary structure levels. We showed that unlike mRNA, tRNA and rRNA were optimized for their structures at compositional levels with significant tertiary structural features even for their corresponding randomly permutated sequences. tRNA and rRNA are more exposed to solvent but remain structured for hyperthermophiles with nearly OGT-independent fluctuation of solvent accessible surface area within a single RNA chain. mRNA in hyperthermophiles is essentially the same as random sequences without tertiary structures although many mRNA in mesophiles and psychrophiles have well-defined tertiary structures based on their low overall solvent exposure with clear separation of deeply buried from partly exposed bases as in tRNA and rRNA. These results provide new insight into temperature adaptation of different RNAs.	[Jegousse, Clara] Univ Nantes, UFR Sci & Tech, 2 Rue Houssiniere, Nantes, France; [Jegousse, Clara; Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Jegousse, Clara; Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Qld, Australia; [Wang, Jihua; Zhou, Yaoqi] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Biophys, Dezhou, Peoples R China	Nantes Universite; Griffith University; Griffith University; Dezhou University	Zhou, YQ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.; Zhou, YQ (corresponding author), Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Qld, Australia.; Zhou, YQ (corresponding author), Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Biophys, Dezhou, Peoples R China.	yaoqi.zhou@griffith.edu.au	Jian, Zhan/AAM-2759-2021; Zhou, Yaoqi/B-3284-2009; Yang, Yuedong/C-9394-2009	Jian, Zhan/0000-0003-0856-2385; Zhou, Yaoqi/0000-0002-9958-5699; Yang, Yuedong/0000-0002-6782-2813; Jegousse, Clara/0000-0003-3213-2510	National Natural Science Foundation of China [61671107, 61540025]; Taishan Scholars Program of Shandong province of China; National Health and Medical Research Council [1059775, 1083450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong province of China; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Natural Science Foundation of China (61671107) to YY and JW, by the Taishan Scholars Program of Shandong province of China, National Natural Science Foundation of China (61540025), and National Health and Medical Research Council (1059775 and 1083450) of Australia to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by National Natural Science Foundation of China (61671107) to YY and JW, by the Taishan Scholars Program of Shandong province of China, National Natural Science Foundation of China (61540025), and National Health and Medical Research Council (1059775 and 1083450) of Australia to YZ. We also gratefully acknowledge the use of the High Performance Computing Cluster "Gowonda" to complete this research. This research/project has also been undertaken with the aid of the research cloud resources provided by the Queensland Cyber Infrastructure Foundation (QCIF).	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bouzas TD, 2006, PROTEIN PEPTIDE LETT, V13, P645, DOI 10.2174/092986606777790548; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chakravarty S, 2000, FEBS LETT, V470, P65, DOI 10.1016/S0014-5793(00)01267-9; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; Dutta A, 2010, FEMS MICROBIOL LETT, V305, P100, DOI 10.1111/j.1574-6968.2010.01922.x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Furtig B, 2010, ACS CHEM BIOL, V5, P753, DOI 10.1021/cb100025a; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Herschlag D, 2015, CURR OPIN STRUC BIOL, V30, P125, DOI 10.1016/j.sbi.2015.02.006; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; HURLEY TD, 1992, J MOL BIOL, V227, P1255, DOI 10.1016/0022-2836(92)90536-S; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Koonin EV, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-27; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lambros RJ, 2003, EXTREMOPHILES, V7, P443, DOI 10.1007/s00792-003-0353-4; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lobry JR, 2006, GENE, V385, P128, DOI 10.1016/j.gene.2006.05.033; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Mallik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069898; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Miao ZC, 2015, RNA, V21, P1066, DOI 10.1261/rna.049502.114; Nakashima H, 2003, J BIOCHEM, V133, P507, DOI 10.1093/jb/mvg067; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; Puton T, 2014, NUCLEIC ACIDS RES, V42, P5403, DOI 10.1093/nar/gku208; Querol E, 1996, PROTEIN ENG, V9, P265, DOI 10.1093/protein/9.3.265; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Rozov A, 2016, NUCLEIC ACIDS RES, V44, P6434, DOI 10.1093/nar/gkw431; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Schwartzman DW, 2004, BIOCHEM SOC T, V32, P168, DOI 10.1042/BST0320168; Seetin Matthew G, 2012, Methods Mol Biol, V905, P99, DOI 10.1007/978-1-61779-949-5_8; Siddiqui KS, 2015, BIOTECHNOL ADV, V33, P1912, DOI 10.1016/j.biotechadv.2015.11.001; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Sohngen C, 2016, NUCLEIC ACIDS RES, V44, pD581, DOI 10.1093/nar/gkv983; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang HC, 2006, BIOCHEM BIOPH RES CO, V342, P681, DOI 10.1016/j.bbrc.2006.02.037; Wang HC, 2006, J MOL EVOL, V63, P120, DOI 10.1007/s00239-005-0255-4; Workman C, 1999, NUCLEIC ACIDS RES, V27, P4816, DOI 10.1093/nar/27.24.4816; Xu Xiaojun, 2015, Biophys Rep, V1, P2; Yang YD, 2017, RNA, V23, P14, DOI 10.1261/rna.057364.116; Yano JK, 2003, CURR OPIN BIOTECH, V14, P360, DOI 10.1016/S0958-1669(03)00075-2; Zhao HY, 2014, PROTEINS, V82, P640, DOI 10.1002/prot.24441; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	55	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184722	10.1371/journal.pone.0184722	http://dx.doi.org/10.1371/journal.pone.0184722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910383	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200085
J	Ortega, MT; Foote, DJ; Nees, N; Erdmann, JC; Bangs, CD; Rosenfeld, CS				Ortega, Madison T.; Foote, Dustin J.; Nees, Nicholas; Erdmann, Jason C.; Bangs, Charles D.; Rosenfeld, Cheryl S.			Karyotype analysis and sex determination in Australian Brush-turkeys (Alectura lathami)	PLOS ONE			English	Article							TOKUDAIA-TOKUNOSHIMENSIS; MATERNAL CONDITION; RATIO; BIRDS; CHROMOSOME; ALLOCATION; GALLIFORMES; AVES; INVESTMENT; OSIMENSIS	Sexual differentiation across taxa may be due to genetic sex determination (GSD) and/or temperature sex determination (TSD). In many mammals, males are heterogametic (XY); whereas females are homogametic (XX). In most birds, the opposite is the case with females being heterogametic (ZW) and males the homogametic sex (ZZ). Many reptile species lack sex chromosomes, and instead, sexual differentiation is influenced by temperature with specific temperatures promoting males or females varying across species possessing this form of sexual differentiation, although TSD has recently been shown to override GSD in Australian central beaded dragons (Pogona vitticeps). There has been speculation that Australian Brush-turkeys (Alectura lathami) exhibit TSD alone and/or in combination with GSD. Thus, we sought to determine if this species possesses sex chromosomes. Blood was collected from one sexually mature female and two sexually mature males residing at Sylvan Heights Bird Park (SHBP) and shipped for karyotype analysis. Karyotype analysis revealed that contrary to speculation, Australian Brush-turkeys possess the classic avian ZW/ZZ sex chromosomes. It remains a possibility that a biased primary sex ratio of Australian Brush-turkeys might be influenced by maternal condition prior to ovulation that result in her laying predominantly Z- or W-bearing eggs and/or sex-biased mortality due to higher sensitivity of one sex in environmental conditions. A better understanding of how maternal and extrinsic factors might differentially modulate ovulation of Z- or W-bearing eggs and hatching of developing chicks possessing ZW or ZZ sex chromosomes could be essential in conservation strategies used to save endangered members of Megapodiidae.	[Ortega, Madison T.; Rosenfeld, Cheryl S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Ortega, Madison T.; Rosenfeld, Cheryl S.] Univ Missouri, Biomed Sci, Columbia, MO 65211 USA; [Foote, Dustin J.; Nees, Nicholas] Sylvan Hts Bird Pk, Scotland Neck, NC USA; [Foote, Dustin J.] East Carolina Univ, Dept Biol, Greenville, NC USA; [Erdmann, Jason C.; Bangs, Charles D.] Stanford Hlth Care, Cytogenet Lab, Palo Alto, CA USA; [Rosenfeld, Cheryl S.] Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of North Carolina; East Carolina University; Stanford University; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Biomed Sci, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO 65211 USA.	rosenfeldc@missouri.edu		Rosenfeld, Cheryl/0000-0002-4137-3933	National Institute of General Medical Science (NIGMS), a component of the National Institutes of Health (NIH) [R25GM056901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056901] Funding Source: NIH RePORTER	National Institute of General Medical Science (NIGMS), a component of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Madison T. Ortega was supported by the IMSD EXPRESS Fellows Program (via grant number R25GM056901 from the National Institute of General Medical Science (NIGMS), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; Baeta R, 2012, BIOL LETTERS, V8, P401, DOI 10.1098/rsbl.2011.1009; BELTERMAN RHR, 1984, GENETICA, V65, P39, DOI 10.1007/BF00056765; Bowers EK, 2017, EVOL BIOL, V44, P11, DOI 10.1007/s11692-016-9380-9; CRACRAFT J, 1981, AUK, V98, P681; DEBOER LEM, 1981, GENETICA, V54, P225, DOI 10.1007/BF00135038; Deveson IW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700731; Douhard M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0510; Dowling DK, 2006, J EVOLUTION BIOL, V19, P440, DOI 10.1111/j.1420-9101.2005.01017.x; DUTRILLAUX B, 1975, HUMANGENETIK, V28, P113, DOI 10.1007/BF00735743; Eiby YA, 2008, P ROY SOC B-BIOL SCI, V275, P2703, DOI 10.1098/rspb.2008.0954; Eiby YA, 2009, J COMP PHYSIOL B, V179, P875, DOI 10.1007/s00360-009-0370-4; Elliott A., 1992, HDB BIRDS WORLD ALIV; Goerlich VC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P490, DOI 10.1086/651315; Goerlich-Jansson VC, 2013, INTEGR COMP BIOL, V53, P902, DOI 10.1093/icb/ict056; Goth A, 2008, GEN COMP ENDOCR, V155, P742, DOI 10.1016/j.ygcen.2007.11.004; Goth A, 2005, BIOL LETTERS, V1, P31, DOI 10.1098/rsbl.2004.0247; Goth A, 2007, AUSTRAL ECOL, V32, P378, DOI 10.1111/j.1442-9993.2007.01709.x; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Harrison GJ, 2006, CLIN AVIAN MED; Henderson LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110858; Houck ML, 2017, ANIMAL CYTOGENETICS; HUNGERFORD DA, 1965, STAIN TECHNOL, V40, P333, DOI 10.3109/10520296509116440; Kan XZ, 2010, GENET MOL RES, V9, P1625, DOI 10.4238/vol9-3gmr898; Kuroiwa A, 2011, CHROMOSOME RES, V19, P635, DOI 10.1007/s10577-011-9223-6; Ladjali-Mohammedi K, 1999, CYTOGENET CELL GENET, V86, P271, DOI 10.1159/000015318; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nakamura T, 2007, CHROMOSOME RES, V15, P799, DOI 10.1007/s10577-007-1163-9; Pereira SL, 2006, MOL PHYLOGENET EVOL, V38, P499, DOI 10.1016/j.ympev.2005.07.007; Prior GL, 2011, BIOL LETTERS, V7, P958, DOI 10.1098/rsbl.2011.0264; Pryke SR, 2011, EVOLUTION, V65, P2792, DOI 10.1111/j.1558-5646.2011.01391.x; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Rosenfeld CS, 2012, REPROD FERT DEVELOP, V24, P45, DOI 10.1071/RD11906; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Rubenstein DR, 2007, AM NAT, V170, P155, DOI 10.1086/518671; Ryan CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111052; Schindler S, 2015, NATURE, V526, P249, DOI 10.1038/nature14968; SEABRIGH.M, 1971, LANCET, V2, P971; STOCK AD, 1982, CYTOGENET CELL GENET, V34, P136, DOI 10.1159/000131802; Yamauchi Y, 2016, SCIENCE, V351, P514, DOI 10.1126/science.aad1795	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0185014	10.1371/journal.pone.0185014	http://dx.doi.org/10.1371/journal.pone.0185014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910392	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200127
J	Tug, S; Tross, AK; Hegen, P; Neuberger, EWI; Helmig, S; Schollhorn, W; Simon, P				Tug, Suzan; Tross, Anna-Katharina; Hegen, Patrick; Neuberger, Elmo Wanja Immanuel; Helmig, Susanne; Schoellhorn, Wolfgang; Simon, Perikles			Acute effects of strength exercises and effects of regular strength training on cell free DNA concentrations in blood plasma	PLOS ONE			English	Article							INFLAMMATION; MARKERS; TRAPS	Creatine kinase (CK) is a marker for muscle cell damage with limited potential as marker for training load in strength training. Recent exercise studies identified cell free DNA (cfDNA) as a marker for aseptic inflammation and cell damage. Here we overserved in a pilot study the acute effects during strength exercise and chronic effects of regular strength training on cfDNA concentrations over a period of four weeks in three training groups applying conservation training (CT) at 60% of the 1 repetition maximum, high intensity-low repetition training (HT) at 90% of the 1 repetition maximum and differential training (DT) at 60% of the 1 repetition maximum. EDTA-plasma samples were collected before every training session, and on the first and last training day repeatedly after every set of exercises. CfDNA increased significantly by 1.62-fold (mean (+/- SD) before first exercise: 8.31 (2.84) ng/ml, after last exercise 13.48 (4.12) ng/ml) across all groups within a single training session (p < 0.001). The increase was 1.77-fold higher (mean (+/- SD) before first exercise: 12.23 (6.29) ng/ml, after last exercise 17.73 (11.24) ng/ml) in HT compared to CT (mean (+/- SD) before first exercise: 6.79 (1.28) ng/ml, after last exercise 10.05 (2.89) ng/ml) (p = 0.01). DNA size analysis suggested predominant release of short, mononucleosomal DNA-fragments in the acute exercise setting, while we detected an increase of mostly longer, polynucleosomal cfDNA-fragments at rest before the training session only at day two with a subsequent return to baseline (p < 0.001). In contrast, training procedures did not cause any alterations in CK. Our results suggest that during strength exercise short-fragmented cfDNA is released, reflecting a fast, aseptic inflammatory response, while elevation of longer fragments at baseline on day two seemed to reflect mild cellular damage due to a novel training regime. We critically discuss the implications of our findings for future evaluations of cfDNA as a marker for training load in strength training.	[Tug, Suzan; Tross, Anna-Katharina; Neuberger, Elmo Wanja Immanuel; Helmig, Susanne; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, Mainz, Germany; [Hegen, Patrick; Schoellhorn, Wolfgang] Johannes Gutenberg Univ Mainz, Inst Training & Movement Sci, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, Mainz, Germany.	simonpe@uni-mainz.de	Schoellhorn, Wolfgang/AGY-7067-2022; Simon, Perikles D/B-2293-2013	Schoellhorn, Wolfgang/0000-0002-4558-1991; Simon, Perikles D/0000-0002-7996-4034				ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; Baechle TR, 2008, ESSENTIALS STRENGTH; Beiter T, 2015, SPORTS MED, V45, P625, DOI 10.1007/s40279-014-0296-1; Beiter T, 2014, J APPL PHYSIOL, V117, P325, DOI 10.1152/japplphysiol.00173.2014; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; BRAITH RW, 1993, MED SCI SPORT EXER, V25, P132, DOI 10.1249/00005768-199301000-00018; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Breitbach S, 2014, J APPL PHYSIOL, V117, P119, DOI 10.1152/japplphysiol.00002.2014; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; CHOUDHURY NA, 1991, J SURG RES, V51, P392, DOI 10.1016/0022-4804(91)90139-D; Fatouros IG, 2006, CLIN CHEM, V52, P1820, DOI 10.1373/clinchem.2006.070417; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Fisher-wellman K, 2009, ACUTE EXERCISE OXIDA, V25, P1; Hegen P, 2015, EUR COLLAGE SPORT SC, V20; MAYHEW JL, 1991, J SPORT MED PHYS FIT, V31, P135; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Reis E, 1995, INT J SPORTS MED, V16, P545, DOI 10.1055/s-2007-973052; Schollhorn WI, 2000, ACTA ACAD OLYMPIQUAE; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Tug S, 2016, INT J SPORT PHYSIOL, P1; URHAUSEN A, 1995, SPORTS MED, V20, P251, DOI 10.2165/00007256-199520040-00004; Velders M, 2014, CLIN BIOCHEM, V47, P471, DOI 10.1016/j.clinbiochem.2013.12.017; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	27	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184668	10.1371/journal.pone.0184668	http://dx.doi.org/10.1371/journal.pone.0184668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910365	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200075
J	Bai, SH; Darby, I; Nevenimo, T; Hannet, G; Hannet, D; Poienou, M; Grant, E; Brooks, P; Walton, D; Randall, B; Wallace, HM				Bai, Shahla Hosseini; Darby, Ian; Nevenimo, Tio; Hannet, Godfrey; Hannet, Dalsie; Poienou, Matthew; Grant, Elektra; Brooks, Peter; Walton, David; Randall, Bruce; Wallace, Helen M.			Effects of roasting on kernel peroxide value, free fatty acid, fatty acid composition and crude protein content	PLOS ONE			English	Article							NUTS; TEMPERATURE; ALMONDS; OIL; HAZELNUTS; NUTRIENT; PROFILE; IMPACT; SOIL; RAW	Roasting nuts may alter their chemical composition leading to changes in their health benefits. However, the presence of testa may alleviate the negative effects of thermal treatments. Hence, this study aimed to explore the effects of roasting on kernel chemical quality and colour development of Canarium indicum and examine to what extent testa would protect kernels against damage from roasting. Roasting decreased peroxide value but increased free fatty acid, probably due to increased cell destruction and lack of enzyme inactivation, respectively. Protein content of kernels significantly decreased after roasting compared to raw kernels. However, testa-on kernels contained significantly higher protein content compared to testa-off kernels. Whilst colour development and mottling were observed in temperatures beyond 120 degrees C, roasting did not alter fatty acid compositions of kernels. The mild roasting and presence of testa in kernels can be used to enhance health benefits of kernels.	[Bai, Shahla Hosseini; Darby, Ian; Grant, Elektra; Brooks, Peter; Walton, David; Randall, Bruce; Wallace, Helen M.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol, Maroochydore, Qld, Australia; [Nevenimo, Tio; Hannet, Godfrey; Hannet, Dalsie; Poienou, Matthew] Isl Reg Ctr Keravat, Natl Agr Res Inst, Kokopo, East New Britai, Papua N Guinea	University of the Sunshine Coast	Bai, SH (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol, Maroochydore, Qld, Australia.	shossein@usc.edu.au	Bai, Shahla/H-6757-2013; Wallace, Helen/AAB-3162-2019	Bai, Shahla/0000-0001-8646-6423; Wallace, Helen/0000-0002-8801-4401; Brooks, Peter/0000-0003-4915-4986; Darby, Ian/0000-0002-6173-2083	Australian Centre for International Agricultural Research [FST/2014/099]	Australian Centre for International Agricultural Research	Financial support was provided by the Australian Centre for International Agricultural Research (project FST/2014/099).; The authors would like to thank the National Agriculture Research Institute and Papua New Guinea Government for allowing this research and access to the experimental sites especially National Agriculture Research Institute (NARI) in Kerevat, New East Britain. The authors would like to thank NARI staff who contributed in sample collection, processing and analysis. Financial support was provided by the Australian Centre for International Agricultural Research (project FST/2014/099).	Alamprese C, 2009, J FOOD ENG, V95, P272, DOI 10.1016/j.jfoodeng.2009.05.001; Alasalvar C, 2006, J AGR FOOD CHEM, V54, P10177, DOI 10.1021/jf061702w; Alasalvar C, 2010, INT J FOOD SCI NUTR, V61, P630, DOI 10.3109/09637481003691820; Alasalvar C, 2010, J AGR FOOD CHEM, V58, P8674, DOI 10.1021/jf101039f; Amaral JS, 2006, J AGR FOOD CHEM, V54, P1315, DOI 10.1021/jf052287v; AOAC. AOAC official method 940.28, 2003, FATT AC FREE CRUD RE; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; AYATSE JO, 1983, FOOD CHEM, V12, P135, DOI 10.1016/0308-8146(83)90024-9; Bai SH, 2017, AGR ECOSYST ENVIRON, V246, P134, DOI 10.1016/j.agee.2017.06.003; Bai SH, 2015, ENVIRON SCI POLLUT R, V22, P3803, DOI 10.1007/s11356-014-3649-2; Buransompob A, 2003, J FOOD PROCESS PRES, V27, P445, DOI 10.1111/j.1745-4549.2003.tb00529.x; Chew LY, 2011, J FOOD COMPOS ANAL, V24, P670, DOI 10.1016/j.jfca.2011.01.006; Chukwumah Y, 2007, J AGR FOOD CHEM, V55, P9266, DOI 10.1021/jf071877l; Ciemniewska-Zytkiewicz H, 2015, FOOD ANAL METHOD, V8, P2465, DOI 10.1007/s12161-015-0133-7; Crews C, 2005, J AGR FOOD CHEM, V53, P4843, DOI 10.1021/jf047836w; Das I, 2014, J STORED PROD RES, V59, P152, DOI 10.1016/j.jspr.2014.07.005; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Granvogl M, 2006, J AGR FOOD CHEM, V54, P5933, DOI 10.1021/jf061150h; Griel AE, 2006, BRIT J NUTR, V96, pS68, DOI 10.1017/BJN20061866; Hamilton K, 2010, NUTR DIET, V67, P182, DOI 10.1111/j.1747-0080.2010.01453.x; Hannah L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072590; Johns T., 2006, Unasylva (English ed.), V57, P34; KEME T, 1983, REV CHOC CONFECT BAK, V8, P24; Kita A., 2007, POL J FOOD NUTR SCI, V57, P89; Kodad O, 2008, J AGR FOOD CHEM, V56, P4096, DOI 10.1021/jf8001679; Labuza T. P., 1971, CRC Critic. Rev. Fd Technol., V2, P355, DOI 10.1080/10408397109527127; Leakey R, 2008, AGROFOREST SYST, V73, P77, DOI 10.1007/s10457-007-9103-4; Li XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159061; Liaotrakoon W, 2016, INT FOOD RES J, V23, P986; Lin JT, 2016, FOOD CHEM, V190, P520, DOI 10.1016/j.foodchem.2015.06.004; Locatelli M, 2015, J AGR FOOD CHEM, V63, P7294, DOI 10.1021/acs.jafc.5b03201; Metwalli S, 1983, J AGR RES TANTA U; Nevenimo T, 2007, AGROFOREST SYST, V69, P117, DOI 10.1007/s10457-006-9024-7; Ozdemir M, 2001, FOOD CHEM, V73, P185, DOI 10.1016/S0308-8146(00)00260-0; Randall BW, 2016, ACTA HORTIC, V1109, P169, DOI 10.17660/ActaHortic.2016.1109.28; Rengel A., 2015, Natural Science, V7, P535, DOI 10.4236/ns.2015.712054; Rogel-Castillo C, 2015, J AGR FOOD CHEM, V63, P8234, DOI 10.1021/acs.jafc.5b03121; Ros E, 2010, NUTRIENTS, V2, P652, DOI 10.3390/nu2070652; Saklar S, 2003, FOOD RES INT, V36, P19, DOI 10.1016/S0963-9969(02)00103-5; Saklar S, 2001, INT J FOOD SCI TECH, V36, P271, DOI 10.1046/j.1365-2621.2001.00457.x; Schlormann W, 2015, FOOD CHEM, V180, P77, DOI 10.1016/j.foodchem.2015.02.017; Severini C, 2000, J AGR FOOD CHEM, V48, P4635, DOI 10.1021/jf0000575; Seyhan F, 2002, J FOOD ENG, V52, P387, DOI 10.1016/S0260-8774(01)00130-3; Tan CP, 2001, J AM OIL CHEM SOC, V78, P1227, DOI 10.1007/s11745-001-0418-5; Thomson L.A., 2006, TRADITIONAL TREES PA, P209; Wallace H, 2016, ACTA HORTIC, V1128, P145, DOI 10.17660/ActaHortic.2016.1128.20; Walton DA, 2016, ACTA HORTIC, V1109, P43, DOI 10.17660/ActaHortic.2016.1109.7; Walton DA, 2016, ACTA HORTIC, V1109, P17, DOI 10.17660/ActaHortic.2016.1109.3; Walton DA, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3010024; Walton DA, 2010, J SCI FOOD AGR, V90, P2163, DOI 10.1002/jsfa.4063; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021	51	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184279	10.1371/journal.pone.0184279	http://dx.doi.org/10.1371/journal.pone.0184279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902859	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200030
J	Meng, Z; Klinngam, W; Edman, MC; Hamm-Alvarez, SF				Meng, Zhen; Klinngam, Wannita; Edman, Maria C.; Hamm-Alvarez, Sarah F.			Interferon-gamma-treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjogren's Syndrome	PLOS ONE			English	Article							MHC CLASS-II; NONOBESE DIABETIC MICE; REGULATORY FACTOR-I; DRY-EYE DISEASE; SALIVARY-GLAND; EPITHELIAL-CELLS; HLA-DR; PROINFLAMMATORY CYTOKINES; DENDRITIC CELLS; EXPRESSION	Inflammation and impaired secretion by lacrimal and salivary glands are hallmarks of the autoimmune disease, Sjogren's Syndrome. These changes in the lacrimal gland promote dryness and inflammation of the ocular surface, causing pain, irritation and corneal damage. The changes that initiate and sustain autoimmune inflammation in the lacrimal gland are not well-established. Here we demonstrate that interferon-gamma (IFN-gamma) is significantly elevated in lacrimal gland and tears of the male NOD mouse, a model of autoimmune dacryoadenitis which exhibits many ocular characteristics of Sjogren's Syndrome, by 12 weeks of age early in lacrimal gland inflammation. Working either with primary cultured lacrimal gland acinar cells from BALB/c mice and/or rabbits, in vitro IFN-gamma treatment for 48 hr decreased expression of Rab3D concurrent with increased expression of cathepsin S. Although total cellular cathepsin S activity was not commensurately increased, IFN-gamma treated lacrimal gland acinar cells showed a significant increase in carbachol-stimulated secretion of cathepsin S similar to the lacrimal gland in disease. In vitro IFN-gamma treatment did not increase the expression of most components of major histocompatibility complex (MHC) class II-mediated antigen presentation although antigen presentation was slightly but significantly stimulated in primary cultured lacrimal gland acinar cells. However, exposure of cultured human corneal epithelial cells to IFN-gamma more robustly increased expression and activity of cathepsin S in parallel with increased expression and function of MHC class II-mediated antigen presentation. We propose that early elevations in IFN-gamma contribute to specific features of ocular disease pathology in Sjogren's Syndrome.	[Meng, Zhen; Klinngam, Wannita; Hamm-Alvarez, Sarah F.] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA; [Edman, Maria C.; Hamm-Alvarez, Sarah F.] Univ Southern Calif, Dept Ophthalmol, USC Roski Eye Inst, Los Angeles, CA 90089 USA; [Edman, Maria C.; Hamm-Alvarez, Sarah F.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Hamm-Alvarez, SF (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.; Hamm-Alvarez, SF (corresponding author), Univ Southern Calif, Dept Ophthalmol, USC Roski Eye Inst, Los Angeles, CA 90089 USA.; Hamm-Alvarez, SF (corresponding author), Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	shalvar@usc.edu	EDMAN, MARIA C./K-6624-2019	EDMAN, MARIA C./0000-0001-7399-4358; Hamm-Alvarez, Sarah/0000-0001-8195-5703	National Institutes of Health [R01 EY011386]; esearch to Prevent Blindness (RPB), New York, NY [10022]; NIH [R01 EY011386]; Cell & Tissue Imaging Core at the Research Center for Liver Disease, University of Southern California [P30 DK048522]; NATIONAL EYE INSTITUTE [R01EY011386, R01EY026635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); esearch to Prevent Blindness (RPB), New York, NY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell & Tissue Imaging Core at the Research Center for Liver Disease, University of Southern California; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 EY011386 to SHA and by an unrestricted departmental grant from Research to Prevent Blindness (RPB), New York, NY 10022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH R01 EY011386 to SHA and by an unrestricted departmental grant from Research to Prevent Blindness (RPB), New York, NY 10022. We thank Francie Yarber for primary rabbit LGAC preparations. We acknowledge the support of the Cell & Tissue Imaging Core at the Research Center for Liver Disease, University of Southern California (P30 DK048522) for their laser capture microscopy services.	ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Bahamondes V, 2011, ARTHRITIS RHEUM-US, V63, P3126, DOI 10.1002/art.30500; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Cha S, 2004, SCAND J IMMUNOL, V60, P552, DOI 10.1111/j.0300-9475.2004.01508.x; DAIBATA M, 1994, MOL IMMUNOL, V31, P255, DOI 10.1016/0161-5890(94)90122-8; Delaleu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3313; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; ELASRAR AMA, 1989, BRIT J OPHTHALMOL, V73, P587, DOI 10.1136/bjo.73.8.587; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; FOX RI, 1994, J IMMUNOL, V152, P5532; FOX RI, 1986, ARTHRITIS RHEUM, V29, P1105, DOI 10.1002/art.1780290908; FRANCO A, 1987, CLIN EXP RHEUMATOL, V5, P199; Gierow JP, 1996, AM J PHYSIOL-CELL PH, V271, pC1685, DOI 10.1152/ajpcell.1996.271.5.C1685; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Hamano H, 1996, PATHOBIOLOGY, V64, P255, DOI 10.1159/000164056; Hamm-Alvarez SF, 2014, ARTHRITIS RHEUMATOL, V66, P1872, DOI 10.1002/art.38633; Hunger RE, 1998, J CLIN INVEST, V101, P1300, DOI 10.1172/JCI1230; Jackson DC, 2016, INVEST OPHTH VIS SCI, V57, P4824, DOI 10.1167/iovs.16-19757; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Kang EH, 2011, CLIN EXP RHEUMATOL, V29, P970; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Li XD, 2010, INVEST OPHTH VIS SCI, V51, P5019, DOI 10.1167/iovs.09-4523; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Maubach G, 2007, BBA-MOL CELL RES, V1773, P219, DOI 10.1016/j.bbamcr.2006.11.005; Mavragani CP, 2014, ANNU REV PATHOL-MECH, V9, P273, DOI 10.1146/annurev-pathol-012513-104728; Meng Z, 2016, AM J PHYSIOL-CELL PH; MIRCHEFF AK, 1991, INVEST OPHTH VIS SCI, V32, P2302; Mulder DJ, 2011, AM J PATHOL, V178, P744, DOI 10.1016/j.ajpath.2010.10.027; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; REYES VE, 1991, J IMMUNOL, V146, P3877; Riese RJ, 2001, IMMUNITY, V15, P909, DOI 10.1016/S1074-7613(01)00247-3; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Roescher N, 2012, ORAL DIS, V18, P96, DOI 10.1111/j.1601-0825.2011.01852.x; Roescher N, 2009, ORAL DIS, V15, P519, DOI 10.1111/j.1601-0825.2009.01582.x; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Schenke-Layland K, 2010, EXP EYE RES, V90, P223, DOI 10.1016/j.exer.2009.10.008; Shen L, 2012, CLIN IMMUNOL, V145, P251, DOI 10.1016/j.clim.2012.09.013; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Tripathi T, 2014, INVEST OPHTH VIS SCI, V55, P3912, DOI 10.1167/iovs.14-14486; van Woerkom JM, 2005, ANN RHEUM DIS, V64, P1474, DOI 10.1136/ard.2004.031781; van's Gravesande KS, 2002, J IMMUNOL, V168, P4488, DOI 10.4049/jimmunol.168.9.4488; Wu AJ, 1997, J CELL PHYSIOL, V173, P110, DOI 10.1002/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M; Wu KJ, 2009, EXP EYE RES, V89, P319, DOI 10.1016/j.exer.2009.03.020; Yamano S, 1999, CLIN IMMUNOL, V92, P265, DOI 10.1006/clim.1999.4759; Youinou P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3348; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zoukhri D, 2002, INVEST OPHTH VIS SCI, V43, P1429; Zywalewska-Gorna Nella, 2007, Klin Oczna, V109, P435	52	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184781	10.1371/journal.pone.0184781	http://dx.doi.org/10.1371/journal.pone.0184781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902875	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200065
J	Dirnbock, T; Djukic, I; Kitzler, B; Kobler, J; Mol-Dijkstra, JP; Posch, M; Reinds, GJ; Schlutow, A; Starlinger, F; Wamelink, WGW				Dirnboeck, Thomas; Djukic, Ika; Kitzler, Barbara; Kobler, Johannes; Mol-Dijkstra, Janet P.; Posch, Max; Reinds, Gert Jan; Schlutow, Angela; Starlinger, Franz; Wamelink, Wieger G. W.			Climate and air pollution impacts on habitat suitability of Austrian forest ecosystems	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; NITROGEN DEPOSITION; ATMOSPHERIC DEPOSITION; SOIL ACIDIFICATION; GLOBAL ASSESSMENT; FLOOR VEGETATION; PLANT DIVERSITY; SEA-SALT; TERRESTRIAL; SENSITIVITY	Climate change and excess deposition of airborne nitrogen (N) are among the main stressors to floristic biodiversity. One particular concern is the deterioration of valuable habitats such as those protected under the European Habitat Directive. In future, climate-driven shifts (and losses) in the species potential distribution, but also N driven nutrient enrichment may threaten these habitats. We applied a dynamic geochemical soil model (VSD+) together with a novel niche-based plant response model (PROPS) to 5 forest habitat types (18 forest sites) protected under the EU Directive in Austria. We assessed how future climate change and N deposition might affect habitat suitability, defined as the capacity of a site to host its typical plant species. Our evaluation indicates that climate change will be the main driver of a decrease in habitat suitability in the future in Austria. The expected climate change will increase the occurrence of thermophilic plant species while decreasing cold-tolerant species. In addition to these direct impacts, climate change scenarios caused an increase of the occurrence probability of oligotrophic species due to a higher N immobilisation in woody biomass leading to soil N depletion. As a consequence, climate change did offset eutrophication from N deposition, even when no further reduction in N emissions was assumed. Our results show that climate change may have positive side-effects in forest habitats when multiple drivers of change are considered.	[Dirnboeck, Thomas; Djukic, Ika; Kobler, Johannes] Environm Agcy Austria, Dept Ecosyst Res & Environm Informat Management, Spittelauer Lande 5, Vienna, Austria; [Kitzler, Barbara; Starlinger, Franz] Austrian Res Ctr Forests BFW, Vienna, Austria; [Mol-Dijkstra, Janet P.; Reinds, Gert Jan; Wamelink, Wieger G. W.] Alterra, Wageningen, Netherlands; [Posch, Max] RIVM, Coordinat Ctr Effects, Bilthoven, Netherlands; [Schlutow, Angela] OEKO DATA Ecosyst Anal & Environm Data Management, Strausberg, Germany	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Dirnbock, T (corresponding author), Environm Agcy Austria, Dept Ecosyst Res & Environm Informat Management, Spittelauer Lande 5, Vienna, Austria.	thomas.dirnboeck@umweltbundesamt.at	Kitzler, Barbara/ACM-1987-2022; Kobler, Johannes/E-7042-2012; Forests, ICP/F-7626-2019; Kitzler, Barbara/HGF-0438-2022; Djukic, Ika/N-6684-2018	Djukic, Ika/0000-0002-5144-9321; Dirnbock, Thomas/0000-0002-8294-0690; Kitzler, Barbara/0000-0002-1617-9186; Kobler, Johannes/0000-0003-0052-4245	Austrian Climate Research Program [ACRP5 - CCN-Adapt - KR12AC5K01308]; Austrian Federal Ministry of Agriculture, Forestry	Austrian Climate Research Program; Austrian Federal Ministry of Agriculture, Forestry	The study was funded by the Austrian Climate Research Program (ACRP5 - CCN-Adapt - KR12AC5K01308) and by the Austrian Federal Ministry of Agriculture, Forestry. We are grateful to the data providers of the UNECE-CLRTAP International Cooperative Programmes ICP Forests and ICP Integrated Monitoring.	Adriaenssens S, 2013, BIOGEOCHEMISTRY, V116, P215, DOI 10.1007/s10533-013-9846-0; Aherne J, 2012, BIOGEOCHEMISTRY, V107, P471, DOI 10.1007/s10533-010-9569-4; Akselsson C, 2013, SCI TOTAL ENVIRON, V444, P271, DOI 10.1016/j.scitotenv.2012.11.106; [Anonymous], 2007, AR4WG1 IPCC; [Anonymous], 2014, CH2014IMPACTS; [Anonymous], 2014, MODELLING MAPPING IM; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Belyazid S, 2011, ENVIRON POLLUT, V159, P789, DOI 10.1016/j.envpol.2010.11.005; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bonten LTC, 2016, ENVIRON MODELL SOFTW, V79, P75, DOI 10.1016/j.envsoft.2016.01.009; Butler SM, 2012, OECOLOGIA, V168, P819, DOI 10.1007/s00442-011-2133-7; Butterbach-Bahl K., 2011, EUROPEAN NITROGEN AS, P99, DOI 10.1017/CBO9780511976988.009; Coleman K., 2005, MODEL DESCRIPTION US; Cools N, 2014, FOREST ECOL MANAG, V311, P3, DOI 10.1016/j.foreco.2013.06.047; Cools N, 2011, IFOREST, P4; De Vries W, 2010, ECOL APPL, V20, P60, DOI 10.1890/08-1019.1; de Vries W, 2011, ENVIRON POLLUT, V159, P2289, DOI 10.1016/j.envpol.2010.11.023; Delbaere B., 2009, BIOSCORE TOOL ASSESS; Dirnbock T, 2014, GLOBAL CHANGE BIOL, V20, P429, DOI 10.1111/gcb.12440; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; European Commission DG Environment, 2013, EUR28 EUR COMM DG EN; Gaudio N, 2015, ECOL MODEL, V306, P24, DOI 10.1016/j.ecolmodel.2014.10.002; Gilliam FS, 2006, J ECOL, V94, P1176, DOI 10.1111/j.1365-2745.2006.01155.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Hulber K, 2008, APPL VEG SCI, V11, P395, DOI 10.3170/2008-7-18489; Jandl R., 2012, Applied and Environmental Soil Science, V2012, P632602; Jonard M, 2015, GLOBAL CHANGE BIOL, V21, P418, DOI 10.1111/gcb.12657; Jost G, 2011, WATER AIR SOIL POLL, V218, P633, DOI 10.1007/s11270-010-0674-8; Kirk GJD, 2010, GLOBAL CHANGE BIOL, V16, P3111, DOI 10.1111/j.1365-2486.2009.02135.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lexer MJ, 2002, FOREST ECOL MANAG, V162, P53, DOI 10.1016/S0378-1127(02)00050-6; Loibl W., 2011, RECLIP CENTURY 1 MOD; Maes SL, 2014, PLANT ECOL, V215, P899, DOI 10.1007/s11258-014-0341-z; Marschall J., HILTSTATELN FORSTEIN; Matzner E, 2004, ECOL STU AN, V172, P339; McDonnell TC, 2014, ENVIRON POLLUT, V187, P55, DOI 10.1016/j.envpol.2013.12.021; Meunier CL, 2016, GLOBAL CHANGE BIOL, V22, P164, DOI 10.1111/gcb.12967; Millenium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mulder C, 2015, BIOGEOSCIENCES, V12, P4113, DOI 10.5194/bg-12-4113-2015; Mutsch, 2013, PROJEKT BIOSOIL EURO; Neumann M, 2001, FOREST CONDITION MON; OECD, 2015, CLIMATE CHANGE RISKS, DOI [10.1787/9789264238787-en, DOI 10.1787/9789264238787-EN]; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Porter EM, 2013, BIOGEOCHEMISTRY, V114, P93, DOI 10.1007/s10533-012-9803-3; Posch M., 2014, MODELLING MAPPING IM, P41; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reinds GJ, 2008, GEODERMA, V146, P475, DOI 10.1016/j.geoderma.2008.06.022; Reinecke J, 2014, J VEG SCI, V25, P113, DOI 10.1111/jvs.12069; Rizzetto S, 2016, ENVIRON POLLUT, V213, P1016, DOI 10.1016/j.envpol.2015.12.048; Rowe EC, 2016, BIOL CONSERVATION; Rowe EC, 2015, ENVIRON POLLUT SER, V25, P297, DOI 10.1007/978-94-017-9508-1_11; Rowe EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161085; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Schlutow A, 2015, ENVIRON POLLUT SER, V25, P381, DOI 10.1007/978-94-017-9508-1_14; Schopp W, 2003, HYDROL EARTH SYST SC, V7, P436, DOI 10.5194/hess-7-436-2003; Simpson D, 2012, ATMOS CHEM PHYS, V12, P7825, DOI 10.5194/acp-12-7825-2012; Stockle CO, 1999, CLIMGEN MANUAL; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Team RC, 2015, R LANG ENV STAT COMP; Templer PH, 2012, ECOLOGY, V93, P1816, DOI 10.1890/11-1146.1; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tuxen R., 1956, ANGEW PFLANZENSOZIOL, V13, P5; UNECE, 1999, 1999 GOTH PROT AB AC; Vanhellemont M, 2014, PLANT ECOL EVOL, V147, P22, DOI 10.5091/plecevo.2014.921; Vet R, 2014, ATMOS ENVIRON, V93, P3, DOI 10.1016/j.atmosenv.2013.10.060; Wamelink GWW, 2009, FOREST ECOL MANAG, V258, P1774, DOI 10.1016/j.foreco.2008.10.024; Wohlgemuth T, 2015, ANN FOREST SCI, V72, DOI 10.1007/s13595-015-0474-9; Zechmeister HG, 2007, ENVIRON POLLUT, V147, P696, DOI 10.1016/j.envpol.2006.09.008; Zechmeister-Boltenstern S, 2015, ECOL MONOGR, V85, P133, DOI 10.1890/14-0777.1	74	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184194	10.1371/journal.pone.0184194	http://dx.doi.org/10.1371/journal.pone.0184194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898262	gold, Green Published, Green Submitted			2022-12-26	WOS:000410449500018
J	Cavas-Martinez, F; Bataille, L; Fernandez-Pacheco, DG; Canavate, FJF; Alio, JL				Cavas-Martinez, Francisco; Bataille, Laurent; Fernandez-Pacheco, Daniel G.; Canavate, Francisco J. F.; Alio, Jorge L.			A new approach to keratoconus detection based on corneal morphogeometric analysis	PLOS ONE			English	Article							SUBCLINICAL KERATOCONUS; SCHEIMPFLUG PHOTOGRAPHY; ANTERIOR; SUSPECT; SHAPE; ABERRATIONS; TOMOGRAPHY; PARAMETERS; TOPOGRAPHY; PACHYMETRY	Purpose To characterize corneal structural changes in keratoconus using a new morphogeometric approach and to evaluate its potential diagnostic ability. Methods Comparative study including 464 eyes of 464 patients (age, 16 and 72 years) divided into two groups: control group (143 healthy eyes) and keratoconus group (321 keratoconus eyes). Topographic information (Sirius, CSO, Italy) was processed with SolidWorks v2012 and a solid model representing the geometry of each cornea was generated. The following parameters were defined: anterior (Aant) and posterior (Apost) corneal surface areas, area of the cornea within the sagittal plane passing through the Z axis and the apex (Aapexant, Aapexpost) and minimum thickness points (Amctant, Amctpost) of the anterior and posterior corneal surfaces, and average distance from the Z axis to the apex (Dapexant, Dapexpost) and minimum thickness points (Dmctant, Dmctpost) of both corneal surfaces. Results Significant differences among control and keratoconus group were found in Aapexant, Aapexpost, Amctant, Amctpost, Dapexant, Dapexpost ( all p< 0.001), Apost ( p = 0.014), and Dmctpost (p = 0.035). Significant correlations in keratoconus group were found between Aant and Apost (r = 0.836), Amctant and Amctpost (r = 0.983), and Dmctant and Dmctpost (r = 0.954, all p< 0.001). A logistic regression analysis revealed that the detection of keratoconus grade I (Amsler Krumeich) was related to Apost, Atot, Aapexant, Amctant, Amctpost, Dapexpost, Dmctant and Dmctpost (Hosmer- Lemeshow: p> 0.05, R 2 Nagelkerke: 0.926). The overall percentage of cases correctly classified by the model was 97.30%. Conclusions Our morphogeometric approach based on the analysis of the cornea as a solid is useful for the characterization and detection of keratoconus.	[Cavas-Martinez, Francisco; Bataille, Laurent; Fernandez-Pacheco, Daniel G.; Canavate, Francisco J. F.] Tech Univ Cartagena, Dept Graph Express, Cartagena, Spain; [Bataille, Laurent] Vissum Corp Alicante, Res & Dev Dept, Alicante, Spain; [Bataille, Laurent; Alio, Jorge L.] Vissum Corp Alicante, Keratoconus Unit, Alicante, Spain; [Alio, Jorge L.] Univ Miguel Hernandez, Div Ophthalmol, Alicante, Spain; [Alio, Jorge L.] Vissum Corp Alicante, Dept Refract Surg, Alicante, Spain	Universidad Politecnica de Cartagena; VISSUM; VISSUM; Universidad Miguel Hernandez de Elche; VISSUM	Cavas-Martinez, F (corresponding author), Tech Univ Cartagena, Dept Graph Express, Cartagena, Spain.	francisco.cavas@upct.es	Bataille, laurent/AAU-4164-2021; Cavas-Martínez, Francisco/L-3143-2014; Fernández-Pacheco, Daniel G./K-9725-2015	Bataille, laurent/0000-0003-4882-6859; Cavas-Martínez, Francisco/0000-0002-8391-0688; Fernández-Pacheco, Daniel G./0000-0002-1504-8475	Carlos III Health Institute-General Subdirection of Networks and Cooperative Investigation Centers (R&D&I National Plan) [RD12/0034/0007, RD16/0008/0012]; European Regional Development Fund (FEDER)	Carlos III Health Institute-General Subdirection of Networks and Cooperative Investigation Centers (R&D&I National Plan); European Regional Development Fund (FEDER)(European Commission)	This publication has been carried out in the framework of the Thematic Network for Co-Operative Research in Health (RETICS) reference number RD12/0034/0007 and RD16/0008/0012, financed by the Carlos III Health Institute-General Subdirection of Networks and Cooperative Investigation Centers (R&D&I National Plan 2008-2011) and the European Regional Development Fund (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Ameerh MA, 2014, INT J OPHTHALMOL-CHI, V7, P714, DOI 10.3980/j.issn.2222-3959.2014.04.24; Alio JL, 2011, J CATARACT REFR SURG, V37, P552, DOI 10.1016/j.jcrs.2010.10.046; Arbelaez MC, 2012, OPHTHALMOLOGY, V119, P2231, DOI 10.1016/j.ophtha.2012.06.005; Auffarth GU, 2000, J CATARACT REFR SURG, V26, P222, DOI 10.1016/S0886-3350(99)00355-7; Cavas-Martinez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110249; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; Gordon-Shaag A, 2012, OPTOMETRY VISION SCI, V89, P411, DOI 10.1097/OPX.0b013e318249d727; Jafarinasab Mohammad Reza, 2015, J Ophthalmic Vis Res, V10, P10, DOI 10.4103/2008-322X.156085; Jonuscheit S, 2015, OPHTHAL PHYSL OPT, V35, P45, DOI 10.1111/opo.12179; Kocamis SI, 2016, SEMIN OPHTHALMOL, V31, P203, DOI 10.3109/08820538.2014.914234; Kozobolis V, 2012, EUR J OPHTHALMOL, V22, P920, DOI 10.5301/ejo.5000184; Mahmoud AM, 2013, AM J OPHTHALMOL, V156, P1102, DOI 10.1016/j.ajo.2013.07.018; Montalban R, 2013, CORNEA, V32, P916, DOI 10.1097/ICO.0b013e3182904950; Montalban R, 2013, GRAEF ARCH CLIN EXP, V251, P1547, DOI 10.1007/s00417-013-2261-3; Montalban R, 2013, J CATARACT REFR SURG, V39, P211, DOI 10.1016/j.jcrs.2012.10.033; Pinero DP, 2012, J CATARACT REFR SURG, V38, P2167, DOI 10.1016/j.jcrs.2012.10.022; Pinero DP, 2010, J CATARACT REFR SURG, V36, P814, DOI 10.1016/j.jcrs.2009.11.012; Prakash G, 2012, EYE, V26, P650, DOI 10.1038/eye.2011.365; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Ramos-Lopez D, 2013, OPTOMETRY VISION SCI, V90, P335, DOI 10.1097/OPX.0b013e3182843f2a; Vazquez PRR, 2014, AM J OPHTHALMOL, V158, P32, DOI 10.1016/j.ajo.2014.03.018; Saad A., 2012, INT J KERATOCONUS EC, V1, P100, DOI [DOI 10.5005/JP-J0UR-NALS-10025-1019, 10.5005/jp-journals-10025-1019, DOI 10.5005/JP-JOURNALS-10025-1019]; Steinberg J, 2015, ACTA OPHTHALMOL, V93, pe199, DOI 10.1111/aos.12590; Tomidokoro A, 2000, OPHTHALMOLOGY, V107, P1328, DOI 10.1016/S0161-6420(00)00159-7; Touboul D, 2011, J CATARACT REFR SURG, V37, P2144, DOI 10.1016/j.jcrs.2011.06.029; Ucakhan OO, 2011, J CATARACT REFR SURG, V37, P1116, DOI 10.1016/j.jcrs.2010.12.049; Wahba SS, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6392472	27	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184569	10.1371/journal.pone.0184569	http://dx.doi.org/10.1371/journal.pone.0184569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886157	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100158
J	Festa, S; Coppotelli, BM; Madueno, L; Loviso, CL; Macchi, M; Tauil, RMN; Valacco, MP; Morelli, IS				Festa, Sabrina; Marina Coppotelli, Bibiana; Madueno, Laura; Lorena Loviso, Claudia; Macchi, Marianela; Neme Tauil, Ricardo Martin; Pia Valacco, Maria; Susana Morelli, Irma			Assigning ecological roles to the populations belonging to a phenanthrene-degrading bacterial consortium using omic approaches	PLOS ONE			English	Article							RING-HYDROXYLATING OXYGENASES; CONTAMINATED SOIL; BIODEGRADATION; BURKHOLDERIA; BIOAUGMENTATION; DEGRADATION; STRAIN; SPHINGOMONAS; ENUMERATION; REMEDIATION	The present study describes the behavior of a natural phenanthrene-degrading consortium (CON), a synthetic consortium (constructed with isolated strains from CON) and an isolated strain form CON (Sphingobium sp. AM) in phenanthrene cultures to understand the interactions among the microorganisms present in the natural consortium during phenanthrene degradation as a sole carbon and energy source in liquid cultures. In the contaminant degradation assay, the defined consortium not only achieved a major phenanthrene degradation percentage (> 95%) but also showed a more efficient elimination of the intermediate metabolite. The opposite behavior occurred in the CON culture where the lowest phenanthrene degradation and the highest HNA accumulation were observed, which suggests the presence of positive and also negative interaction in CON. To consider the uncultured bacteria present in CON, a metagenomic library was constructed with total CON DNA. One of the resulting scaffolds (S1P3) was affiliated with the Betaproteobacteria class and resulted in a significant similarity with a genome fragment from Burkholderia sp. HB1 chromosome 1. A complete gene cluster, which is related to one of the lower pathways (meta-cleavage of catechol) involved in PAH degradation (ORF 31-43), mobile genetic elements and associated proteins, was found. These results suggest the presence of at least one other microorganism in CON besides Sphingobium sp. AM, which is capable of degrading PAH through the meta-cleavage pathway. Burkholderiales order was further found, along with Sphingomonadales order, by a metaproteomic approach, which indicated that both orders were metabolically active in CON. Our results show the presence of negative interactions between bacterial populations found in a natural consortium selected by enrichment techniques; moreover, the synthetic syntrophic processing chain with only one microorganism with the capability of degrading phenanthrene was more efficient in contaminant and intermediate metabolite degradation than a generalist strain (Sphingobium sp. AM).	[Festa, Sabrina; Marina Coppotelli, Bibiana; Madueno, Laura; Macchi, Marianela; Susana Morelli, Irma] UNLP, CINDEFI, Ctr Invest Desarrollo Fermentac Ind, La Plata, Buenos Aires, Argentina; [Festa, Sabrina; Marina Coppotelli, Bibiana; Madueno, Laura; Macchi, Marianela; Susana Morelli, Irma] Consejo Nacl Invest Cient & Tecn, CCT La Plata, La Plata, Buenos Aires, Argentina; [Lorena Loviso, Claudia] Consejo Nacl Invest Cient & Tecn, CENPAT, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Neme Tauil, Ricardo Martin; Pia Valacco, Maria] UBA, CONICET, IQUIBICEN, Fac Ciencias Exactas & Nat,Ctr Estudios Quim & Bi, Buenos Aires, DF, Argentina; [Susana Morelli, Irma] Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Comision de Investigaciones Cientificas	Festa, S (corresponding author), UNLP, CINDEFI, Ctr Invest Desarrollo Fermentac Ind, La Plata, Buenos Aires, Argentina.; Festa, S (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT La Plata, La Plata, Buenos Aires, Argentina.	sabrinafesta@yahoo.com.ar		Macchi, Marianela/0000-0002-7339-3795; Coppotelli, Bibiana/0000-0003-3439-5170	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2013-0103]; CONICET; FYPF; CIC	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FYPF; CIC	This research was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT2013-0103) http://www.agencia.mincyt.gob.ar/ CONICET, FYPF and CIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Atllas R, 1998, MICROBIAL ECOLOGY FU; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Celiker H, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.54; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chakraborty J, 2014, ENV MICROBIOL REP, V6, P519, DOI 10.1111/1758-2229.12182; Chakraborty R, 2012, CURR OPIN BIOTECH, V23, P483, DOI 10.1016/j.copbio.2012.01.015; Chauhan A, 2010, BIODEGRADATION, V21, P861, DOI 10.1007/s10532-010-9361-0; Chen Y., 2010, 2010 AS PAC POW EN E, P1, DOI 10.1109/APPEEC.2010.5448560; Chistoserdova L, 2014, MICROB BIOTECHNOL, V7, P1, DOI 10.1111/1751-7915.12077; Coenye T, 2007, BURKHOLDERIA MOLECUL; De Roy K, 2014, ENVIRON MICROBIOL, V16, P1472, DOI 10.1111/1462-2920.12343; Desai C, 2010, BIORESOURCE TECHNOL, V101, P1558, DOI 10.1016/j.biortech.2009.10.080; El Amrani A, 2015, ENVIRON SCI TECHNOL, V49, P11281, DOI 10.1021/acs.est.5b01740; Entcheva P, 2001, APPL ENVIRON MICROB, V67, P89, DOI 10.1128/AEM.67.1.89-99.2001; Escalante AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00143; Festa S, 2016, APPL SOIL ECOL, V98, P8, DOI 10.1016/j.apsoil.2015.08.025; Festa S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw125; Festa S, 2013, INT BIODETER BIODEGR, V85, P42, DOI 10.1016/j.ibiod.2013.06.006; Fuentes MS, 2014, BIOREMEDIATION IN LATIN AMERICA: CURRENT RESEARCH AND PERSPECTIVES, P267, DOI 10.1007/978-3-319-05738-5_17; Fuentes MS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392573; Ghevariya CM, 2011, METHODOLOGY BIORESOU, V102; Gieg LM, 2014, CURR OPIN BIOTECH, V27, P21, DOI 10.1016/j.copbio.2013.09.002; Goldschmidt F, 2016, ROLE METABOLIC INTER; Huang X, 2008, MAR POLLUT BULL, V57, P538, DOI 10.1016/j.marpolbul.2007.12.013; Izmalkova T Yu, 2013, Genetika, V49, P703; Janbandhu A, 2011, J HAZARD MATER, V187, P333, DOI 10.1016/j.jhazmat.2011.01.034; Jiang HL, 2007, APPL MICROBIOL BIOT, V75, P1191, DOI 10.1007/s00253-007-0917-9; Joshi VV, 2015, BIOREMEDIAT J, V19, P160, DOI 10.1080/10889868.2014.995369; Kang H, 2003, CAN J MICROBIOL, V49, P139, DOI 10.1139/W03-009; Khara P, 2014, FEBS OPEN BIO, V4, P290, DOI 10.1016/j.fob.2014.03.001; Khomenkov V G, 2005, Prikl Biokhim Mikrobiol, V41, P298; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kunze M, 2009, MICROBIOL-SGM, V155, P4069, DOI 10.1099/mic.0.032110-0; Laurie AD, 1999, J BACTERIOL, V181, P531, DOI 10.1128/JB.181.2.531-540.1999; Liu DM, 2015, MICROB BIOTECHNOL, V8, P950, DOI 10.1111/1751-7915.12290; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; NELSON MJK, 1987, APPL ENVIRON MICROB, V53, P949, DOI 10.1128/AEM.53.5.949-954.1987; Ohtsubo Y, 2015, AM SOC MICROBIOLOGY, V3; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Ren HJ, 2012, CHEM RES CHINESE U, V28, P666; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Schneider T, 2010, PROTEOMICS, V10, P785, DOI 10.1002/pmic.200900450; Seo JS, 2007, BIODEGRADATION, V18, P123, DOI 10.1007/s10532-006-9048-8; Sharma P, 2008, INDIAN J MICROBIOL, V48, P173, DOI 10.1007/s12088-008-0031-4; Stump SM, 2016, J THEOR BIOL, V404, P348, DOI 10.1016/j.jtbi.2016.06.019; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Tao XQ, 2007, PROCESS BIOCHEM, V42, P401, DOI 10.1016/j.procbio.2006.09.018; Tauler M, 2016, APPL MICROBIOL BIOT, V100, P3321, DOI 10.1007/s00253-015-7195-8; Tiwari JN, 2010, WORLD J MICROB BIOT, V26, P1727, DOI 10.1007/s11274-010-0350-6; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Waigi MG, 2015, INT BIODETER BIODEGR, V104, P333, DOI 10.1016/j.ibiod.2015.06.008; Wang C, 2016, INT J FUTUR GENER CO, V9, P1, DOI 10.14257/ijfgcn.2016.9.3.01; Wang J, 2007, PETROL SCI, V4, P68, DOI 10.1007/s12182-007-0012-y; Williams MA, 2010, SOIL BIOL BIOCHEM, V42, P1148, DOI 10.1016/j.soilbio.2010.03.021; Wongwilaiwalin S, 2013, APPL MICROBIOL BIOT, V97, P8941, DOI 10.1007/s00253-013-4699-y; Wrenn BA, 1996, CAN J MICROBIOL, V42, P252, DOI 10.1139/m96-037	61	20	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184505	10.1371/journal.pone.0184505	http://dx.doi.org/10.1371/journal.pone.0184505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886166	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100141
J	Must, K; Hytonen, MK; Orro, T; Lohi, H; Jokelainen, P				Must, Kart; Hytonen, Marjo K.; Orro, Toomas; Lohi, Hannes; Jokelainen, Pikka			Toxoplasma gondii seroprevalence varies by cat breed	PLOS ONE			English	Article							FELINE INFECTIOUS PERITONITIS; FATAL TOXOPLASMOSIS; OTOCOLOBUS-MANUL; PREVALENCE; FINLAND; DISEASE; SERIES; HOST	Toxoplasma gondii is a widespread zoonotic parasite that is relevant for veterinary and public health. The domestic cat, the definitive host species with the largest worldwide population, has become evolutionarily and epidemiologically the most important host of T. gondii. The outcome of T. gondii infection is influenced by congenital and acquired host characteristics. We detected differences in T. gondii seroprevalence by cat breed in our previous studies. The aims of this study were to estimate T. gondii seroprevalence in selected domestic cat breeds, and to evaluate whether being of a certain breed is associated with T. gondii seropositivity, when the age and lifestyle of the cat are taken into account. The studied breeds were the Birman, British Shorthair, Burmese, Korat, Norwegian Forest Cat, Ocicat, Persian, and Siamese. Plasma samples were analyzed for the presence of immunoglobulin G antibodies against T. gondii with a commercial direct agglutination test at dilution 1: 40. The samples were accompanied by owner-completed questionnaires that provided background data on the cats. Overall, 41.12% of the 1121 cats tested seropositive, and the seroprevalence increased with age. The Burmese had the lowest seroprevalence (18.82%) and the Persian had the highest (60.00%). According to the final multivariable logistic regression model, the odds to test seropositive were four to seven times higher in Birmans, Ocicats, Norwegian Forest Cats, and Persians when compared with the Burmese, while older age and receiving raw meat were also risk factors for T. gondii seropositivity. This study showed that T. gondii seroprevalence varies by cat breed and identified being of certain breeds, older age, and receiving raw meat as risk factors for seropositivity.	[Must, Kart; Orro, Toomas; Jokelainen, Pikka] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Tartu, Estonia; [Hytonen, Marjo K.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Hytonen, Marjo K.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Hytonen, Marjo K.; Lohi, Hannes; Jokelainen, Pikka] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Jokelainen, Pikka] Statens Serum Inst, Copenhagen, Denmark	Estonian University of Life Sciences; University of Helsinki; University of Helsinki; Statens Serum Institut	Must, K (corresponding author), Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Tartu, Estonia.	k2rtmust@gmail.com	Jokelainen, Pikka/U-7238-2019; Lohi, Hannes/F-4596-2011; Orro, Toomas/I-3727-2018	Jokelainen, Pikka/0000-0002-3035-5094; Lohi, Hannes/0000-0003-1087-5532; Orro, Toomas/0000-0002-4895-8029; Hytonen, Marjo/0000-0003-1976-5874; Must, Kart/0000-0001-9174-9591	Finnish Cat Association; Estonian University of Life Sciences [M14143VLVP]; Base Financing of Estonian University of Life Sciences [8P160014VLVP]	Finnish Cat Association; Estonian University of Life Sciences; Base Financing of Estonian University of Life Sciences	The study was supported by the Finnish Cat Association, by project funding M14143VLVP from the Strategic Development Fund of the Estonian University of Life Sciences, and by project funding 8P160014VLVP from Base Financing of Estonian University of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman S, 2007, MED MYCOL, V45, P449, DOI 10.1080/13693780701377170; Alvarado-Esquivel C, 2015, EUR J MICROBIOL IMMU, V5, P112, DOI [10.1556/EUJMI-D-15-00004, 10.1556/EuJMI-D-15-00004]; Basso W, 2005, PARASITOLOGY, V130, P293, DOI 10.1017/S0031182004006584; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Cavailles P, 2006, P NATL ACAD SCI USA, V103, P744, DOI 10.1073/pnas.0506643103; Cornelissen JBWJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104740; Dean AG, OPENEPI OPEN SOURCE; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Gazzinelli RT, 2014, CELL HOST MICROBE, V15, P132, DOI 10.1016/j.chom.2014.01.004; Golovko L, 2013, VIRUS RES, V175, P58, DOI 10.1016/j.virusres.2013.04.006; Gustafsson K, 1997, J COMP PATHOL, V117, P361, DOI 10.1016/S0021-9975(97)80083-7; Jokelainen P, 2013, J WILDLIFE DIS, V49, P527, DOI 10.7589/2011-12-352; Jokelainen P, 2012, J VET DIAGN INVEST, V24, P1115, DOI 10.1177/1040638712461787; Jokelainen P, 2012, J WILDLIFE DIS, V48, P454, DOI 10.7589/0090-3558-48.2.454; Jokelainen P, 2011, J WILDLIFE DIS, V47, P154, DOI 10.7589/0090-3558-47.1.154; Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008; Ketz-Riley CJ, 2003, J ZOO WILDLIFE MED, V34, P239, DOI 10.1638/01-112; Maubon D, 2008, TRENDS PARASITOL, V24, P299, DOI 10.1016/j.pt.2008.03.012; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morley EK, 2005, PARASITOLOGY, V131, P181, DOI 10.1017/S0031182005007614; Must K, 2015, VECTOR-BORNE ZOONOT, V15, P597, DOI 10.1089/vbz.2015.1809; Pas A, 2008, J ZOO WILDLIFE MED, V39, P362, DOI 10.1638/2007-0149.1; Pesteanu-Somogyi LD, 2006, J FELINE MED SURG, V8, P1, DOI 10.1016/j.jfms.2005.04.003; Rochet E, 2015, INFECT IMMUN, V83, P2109, DOI 10.1128/IAI.02985-14; Sergent W, 2005, INFECT IMMUN, V73, P6990, DOI 10.1128/IAI.73.10.6990-6997.2005; Sneidere A, 2017, VECTOR BORNE ZOONOTI; Spycher A, 2011, J VET DIAGN INVEST, V23, P104, DOI 10.1177/104063871102300117; Subauste CS, 2011, OCUL IMMUNOL INFLAMM, V19, P297, DOI 10.3109/09273948.2010.605198; Yap GS, 2006, MICROBES INFECT, V8, P1174, DOI 10.1016/j.micinf.2005.10.031	29	21	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184659	10.1371/journal.pone.0184659	http://dx.doi.org/10.1371/journal.pone.0184659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886182	gold, Green Submitted, Green Published			2022-12-26	WOS:000410001100175
J	Huffaker, TB; Lee, SH; Tang, WW; Wallace, JA; Alexander, M; Runtsch, MC; Larsen, DK; Thompson, J; Ramstead, AG; Voth, WP; Hu, RZ; Round, JL; Williams, MA; O'Connell, RM				Huffaker, Thomas B.; Lee, Soh-Hyun; Tang, William W.; Wallace, Jared A.; Alexander, Margaret; Runtsch, Marah C.; Larsen, Dane K.; Thompson, Jacob; Ramstead, Andrew G.; Voth, Warren P.; Hu, Ruozhen; Round, June L.; Williams, Matthew A.; O'Connell, Ryan M.			Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; leukocyte; microRNA (miRNA); tumor immunology; tumor microenvironment; T cell; miR-155	TUMOR-ASSOCIATED MACROPHAGES; UNTREATED MELANOMA; SUPPRESSOR-CELLS; MIR-155; CANCER; IPILIMUMAB; EXPRESSION; NIVOLUMAB; MICRORNAS; THERAPY	MicroRNA-155 (miR-155) regulates antitumor immune responses. However, its specific functions within distinct immune cell types have not been delineated in conditional KO mouse models. In this study, we investigated the role of miR-155 specifically within T cells during the immune response to syngeneic tumors. We found that miR-155 expression within T cells is required to limit syngeneic tumor growth and promote IFN production by T cells within the tumor microenvironment. Consequently, we found that miR-155 expression by T cells is necessary for proper tumor-associated macrophage expression of IFN-inducible genes. We also found that immune checkpoint-blocking (ICB) antibodies against programmed cell death protein 1/programmed death ligand 1 (PD-1/PD-L1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) restored antitumor immunity in miR-155 T cell-conditional KO mice. We noted that these ICB antibodies rescued the levels of IFN-expressing T cells, expression of multiple activation and effector genes expressed by tumor-infiltrating CD8(+) and CD4(+) T cells, and tumor-associated macrophage activation. Moreover, the ICB approach partially restored expression of several derepressed miR-155 targets in tumor-infiltrating, miR-155-deficient CD8(+) T cells, suggesting that miR-155 and ICB regulate overlapping pathways to promote antitumor immunity. Taken together, our findings highlight the multifaceted role of miR-155 in T cells, in which it promotes antitumor immunity. These results suggest that the augmentation of miR-155 expression could be used to improve anticancer immunotherapies.	[Huffaker, Thomas B.; Lee, Soh-Hyun; Tang, William W.; Wallace, Jared A.; Alexander, Margaret; Runtsch, Marah C.; Larsen, Dane K.; Thompson, Jacob; Ramstead, Andrew G.; Voth, Warren P.; Hu, Ruozhen; Round, June L.; Williams, Matthew A.; O'Connell, Ryan M.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	O'Connell, RM (corresponding author), Univ Utah, Sch Med, Dept Pathol, 15 N Med Dr E,JMRB4280, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu		Tang, William/0000-0001-7036-6460; Williams, Matthew/0000-0002-4721-4482; Thompson, Jacob/0000-0002-0952-5765; Larsen, Dane/0000-0002-9841-1443; Alexander, Margaret/0000-0003-2972-7521	American Cancer Society scholar award; NIA, National Institutes of Health Grant [RO1AG047956]; NCI, National Institutes of Health Grant [F30CA189731]; NATIONAL CANCER INSTITUTE [F30CA189731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047956] Funding Source: NIH RePORTER	American Cancer Society scholar award(American Cancer Society); NIA, National Institutes of Health Grant; NCI, National Institutes of Health Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this research was provided by an American Cancer Society scholar award (to R. M. O.); NIA, National Institutes of Health Grant RO1AG047956 (to R. M. O.); and NCI, National Institutes of Health Grant F30CA189731 (to T. B. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cai X, 2012, J MOL CELL BIOL, V4, P341, DOI 10.1093/jmcb/mjs044; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen SQ, 2015, CANCER RES, V75, P519, DOI 10.1158/0008-5472.CAN-14-2331; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hu RZ, 2014, IMMUNITY, V41, P605, DOI 10.1016/j.immuni.2014.09.015; Hu RZ, 2013, J IMMUNOL, V190, P5972, DOI 10.4049/jimmunol.1300351; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Ji Y, 2015, P NATL ACAD SCI USA, V112, P476, DOI 10.1073/pnas.1422916112; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wang JF, 2015, INT J CANCER, V136, pE602, DOI 10.1002/ijc.29151; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yu F, 2013, MOL CANCER RES, V11, P923, DOI 10.1158/1541-7786.MCR-12-0686; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306	40	52	56	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18530	18541		10.1074/jbc.M117.808121	http://dx.doi.org/10.1074/jbc.M117.808121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28912267	Green Published, hybrid			2022-12-26	WOS:000414958100012
J	Yanda, MK; Liu, QN; Cebotaru, V; Guggino, WB; Cebotaru, L				Yanda, Murali K.; Liu, Qiangni; Cebotaru, Valeriu; Guggino, William B.; Cebotaru, Liudmila			Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL-CYCLASE; CELL-PROLIFERATION; EPITHELIAL-CELLS; TUMOR PROMOTER; GROWTH; TUBULIN; THAPSIGARGIN; CALMODULIN; TRANSPORT; CHANNELS	Autosomal dominant polycystic kidney disease (ADPKD) is associated with progressive enlargement of multiple renal cysts, often leading to renal failure that cannot be prevented by a current treatment. Two proteins encoded by two genes are associated with ADPKD: PC1 (pkd1), primarily a signaling molecule, and PC2 (pkd2), a Ca2+ channel. Dysregulation of cAMP signaling is central to ADPKD, but the molecular mechanism is unresolved. Here, we studied the role of histone deacetylase 6 (HDAC6) in regulating cyst growth to test the possibility that inhibiting HDAC6 might help manage ADPKD. Chemical inhibition of HDAC6 reduced cyst growth in PC1-knock-out mice. In proximal tubule-derived, PC1-knock-out cells, adenylyl cyclase 6 and 3 (AC6 and-3) are both expressed. AC6 protein expression was higher in cells lacking PC1, compared with control cells containing PC1. Intracellular Ca2+ was higher in PC1knock-out cells than in control cells. HDAC inhibition caused a drop in intracellular Ca(2+)and increased ATP-simulated Ca2+ release. HDAC6 inhibition reduced the release of Ca(2+)from the endoplasmic reticulum induced by thapsigargin, an inhibitor of endoplasmic reticulum Ca2+-ATPase. HDAC6 inhibition and treatment of cells with the intracellular Ca2+ chelator 1,2-bis(2aminophenoxy) ethane-N, N, N', N'-tetraacetic acid tetrakis(acetoxymethyl ester) reduced cAMP levels in PC1-knock-out cells. Finally, the calmodulin inhibitors W-7 and W-13 reduced cAMPlevels, andW-7reduced cyst growth, suggesting thatAC3 is involved in cyst growth regulated by HDAC6. We conclude that HDAC6 inhibition reduces cell growth primarily by reducing intracellular cAMP and Ca2+ levels. Our results provide potential therapeutic targets that may be useful as treatments for ADPKD.	[Yanda, Murali K.; Liu, Qiangni; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Cebotaru, Valeriu] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Cebotaru, L (corresponding author), Johns Hopkins Univ, Dept Med, Div Gastroenterol & Hepatol, Wood Basic Sci Bldg,Rm 414,725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Yanda, Murali K/N-2324-2019	Yanda, Murali K/0000-0002-4913-470X	National Institutes of Health [P30 DK079310]; NIDDK [P30 DK090868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, P30DK090868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Debbie McClellan for editing the manuscript. We are grateful to S. Somlo for kindly providing the PH2 and PN18 cells though the George M. O'Brien Kidney Center at Yale University (supported by National Institutes of Health Grant P30 DK079310). These studies utilized resources provided by the NIDDK-sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center (Grant P30 DK090868).	Aalbers CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130612; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Cebotaru L, 2016, KIDNEY INT, V90, P90, DOI 10.1016/j.kint.2016.01.026; Chang MY, 2013, BRIT J CLIN PHARMACO, V76, P524, DOI 10.1111/bcp.12136; Chappe V, 1998, BRIT J PHARMACOL, V123, P683, DOI 10.1038/sj.bjp.0701648; CONIGRAVE AD, 1995, CELL CALCIUM, V17, P111, DOI 10.1016/0143-4160(95)90080-2; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Li H, 2015, EUR J PHARMACOL, V750, P14, DOI 10.1016/j.ejphar.2014.12.026; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Liu WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042408; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Mangolini Alessandra, 2016, World J Nephrol, V5, P76, DOI 10.5527/wjn.v5.i1.76; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qamar S, 2007, BIOCHEM SOC T, V35, P124, DOI 10.1042/BST0350124; Rees S, 2014, J AM SOC NEPHROL, V25, P232, DOI 10.1681/ASN.2013010077; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF701, DOI 10.1152/ajprenal.00656.2013; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Schwiebert EM, 2002, AM J PHYSIOL-RENAL, V282, pF763, DOI 10.1152/ajprenal.0337.2000; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Seidel C, 2015, EPIGENOMICS-UK, V7, P103, DOI [10.2217/EPI.14.69, 10.2217/epi.14.69]; Shen TS, 1997, AM J PHYSIOL-CELL PH, V273, pC323, DOI 10.1152/ajpcell.1997.273.1.C323; Silva M, 2017, CURR BIOL, V27, P968, DOI 10.1016/j.cub.2017.02.039; Simoes-Pires CA, 2017, EXPERT OPIN THER PAT, V27, P229, DOI 10.1080/13543776.2017.1282945; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Strait KA, 2010, AM J PHYSIOL-RENAL, V298, pF859, DOI 10.1152/ajprenal.00109.2009; Su Min, 2010, Sheng Li Ke Xue Jin Zhan, V41, P112; Terryn S, 2011, BBA-MOL BASIS DIS, V1812, P1314, DOI 10.1016/j.bbadis.2011.01.011; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres V E, 2007, Minerva Med, V98, P669; Torres VE, 2015, ANNU REV MED, V66, P195, DOI 10.1146/annurev-med-050913-022838; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Wallace DP, 1996, KIDNEY INT, V50, P1327, DOI 10.1038/ki.1996.445; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Wilson PD, 1999, EXP NEPHROL, V7, P114; Woodward OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012305; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhou X, 2014, HUM MOL GENET, V23, P1644, DOI 10.1093/hmg/ddt556	55	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17897	17908		10.1074/jbc.M117.803775	http://dx.doi.org/10.1074/jbc.M117.803775			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887310	Green Published, hybrid			2022-12-26	WOS:000414013000025
J	Briggs, JW; Ren, L; Chakrabarti, KR; Tsai, YC; Weissman, AM; Hansen, RJ; Gustafson, DL; Khan, YA; Dinman, JD; Khanna, C				Briggs, Joseph W.; Ren, Ling; Chakrabarti, Kristi R.; Tsai, Yien Che; Weissman, Allan M.; Hansen, Ryan J.; Gustafson, Daniel L.; Khan, Yousuf A.; Dinman, Jonathan D.; Khanna, Chand			Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; STRESSED ENDOPLASMIC-RETICULUM; INDUCED GENE-EXPRESSION; P70 S6 KINASE; RIBOSOMAL-SUBUNIT; MAMMALIAN TARGET; BINDING PARTNER; TRANSLOCON PORE; CANCER-THERAPY; ER STRESS	Activation of the unfolded protein response (UPR) in eukaryotic cells represents an evolutionarily conserved response to physiological stress. Here, we report that the mTOR inhibitors rapamycin (sirolimus) and structurally related temsirolimus are capable of inducing UPR in sarcoma cells. However, this effect appears to be distinct from the classical role for these drugs as mTOR inhibitors. Instead, we detected these compounds to be associated with ribosomes isolated from treated cells. Specifically, temsirolimus treatment resulted in protection from chemical modification of several rRNA residues previously shown to bind rapamycin in prokaryotic cells. As an application for these findings, we demonstrate maximum tumor cell growth inhibition occurring only at doses which induce UPR and which have been shown to be safely achieved in human patients. These results are significant because they challenge the paradigm for the use of these drugs as anticancer agents and reveal a connection to UPR, a conserved biological response that has been implicated in tumor growth and response to therapy. As a result, eIF2 alpha phosphorylation and Xbp-1 splicing may serve as useful biomarkers of treatment response in future clinical trials using rapamycin and rapalogs.	[Briggs, Joseph W.; Ren, Ling; Chakrabarti, Kristi R.; Khanna, Chand] NCI, Tumor Metastasis Biol Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, NIH, Frederick, MD 20892 USA; [Hansen, Ryan J.; Gustafson, Daniel L.] Colorado State Univ, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA; [Briggs, Joseph W.; Khan, Yousuf A.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chakrabarti, Kristi R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Khanna, Chand] Ethos Vet Hlth, Woburn, MA USA; [Hansen, Ryan J.] Sierra Oncol, Vancouver, BC, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Colorado State University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Briggs, JW (corresponding author), NCI, Tumor Metastasis Biol Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA.; Briggs, JW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	briggsjw@umd.edu		Tsai, Yien Che/0000-0001-9624-1092; Khan, Yousuf/0000-0003-0201-2796; Briggs, Joseph/0000-0001-6375-6348	Intramural Research Program of the National Institutes of Health; National Cancer Institute, Center for Cancer Research (CK) [5R01HL119439-03]; National Heart, Lung and Blood Institute, National Institutes of Health (JDD) [3R01HL119439-03S1]; National Heart, Lung and Blood Institute, National Institutes of Health (JDD, JWB); Howard Hughes Medical Institute/University of Maryland College Park (YAK); NATIONAL CANCER INSTITUTE [F30CA196075, ZIABC009392, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research (CK); National Heart, Lung and Blood Institute, National Institutes of Health (JDD); National Heart, Lung and Blood Institute, National Institutes of Health (JDD, JWB); Howard Hughes Medical Institute/University of Maryland College Park (YAK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (CK) 5R01HL119439-03 National Heart, Lung and Blood Institute, National Institutes of Health (JDD) 3R01HL119439-03S1 National Heart, Lung and Blood Institute, National Institutes of Health (JDD, JWB), and partly supported by an undergraduate fellowship from the Howard Hughes Medical Institute/University of Maryland College Park (YAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS MW, 1993, ANN NY ACAD SCI, V696, P54; Amit M, 2005, FEBS LETT, V579, P3207, DOI 10.1016/j.febslet.2005.03.023; [Anonymous], [No title captured]; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boni J, 2007, J CLIN PHARMACOL, V47, P1430, DOI 10.1177/0091270007306957; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; BROSTROM MA, 1995, J BIOL CHEM, V270, P4127, DOI 10.1074/jbc.270.8.4127; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gingras AC, 2001, GENE DEV, V15, P2852; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jenni S, 2003, CURR OPIN STRUC BIOL, V13, P212, DOI 10.1016/S0959-440X(03)00034-4; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Larsson SL, 2001, BIOCHEMISTRY-US, V40, P3222, DOI 10.1021/bi002286q; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McConkey DJ, 2017, BIOCHEM BIOPH RES CO, V482, P450, DOI 10.1016/j.bbrc.2016.11.047; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Niwa M, 2005, GENOME BIOL, V6; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Raymond E, 2004, J CLIN ONCOL, V22, P2336, DOI 10.1200/JCO.2004.08.116; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; STADE K, 1994, NUCLEIC ACIDS RES, V22, P1394, DOI 10.1093/nar/22.8.1394; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185089	10.1371/journal.pone.0185089	http://dx.doi.org/10.1371/journal.pone.0185089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926611	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600068
J	DeVallance, E; Riggs, D; Jackson, B; Parkulo, T; Zaslau, S; Chantler, PD; Olfertl, IM; Bryner, RW				DeVallance, Evan; Riggs, Dale; Jackson, Barbara; Parkulo, Travis; Zaslau, Stanley; Chantler, Paul D.; Olfertl, I. Mark; Bryner, Randy W.			Effect of chronic stress on running wheel activity in mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; DIABETIC FATTY RAT; PHYSICAL-ACTIVITY; RESTRAINT STRESS; FOOD-INTAKE; MODEL; DEPRESSION; BEHAVIOR; RESPONSIVENESS; NEUROENDOCRINE	Acute and chronic stress have been reported to have differing effects on physical activity in rodents, but no study has examined a chronic stress protocol that incorporates stressors often experienced by rodents throughout a day. To examine this, the effects of the Unpredictable Chronic Mild Stress (UCMS) protocol on voluntary running wheel activity at multiple time points, and/or in response to acute removal of chronic stress was determined. Twenty male Balb/c mice were given access and accustomed to running wheels for 4 weeks, after which they were randomized into 2 groups; exercise (EX, n = 10) and exercise with chronic stress using a modified UCMS protocol for 7 hours/day (8: 00 a.m.-3: 00p.m.), 5 days/week for 8 weeks (EXS, n = 10). All mice were given access to running wheels from approximately 3: 30 p.m. to 7: 30 a. m. during the weekday, however during weekends mice had full-time access to running wheels (a time period of no stress for the EXS group). Daily wheel running distance and time were recorded. The average running distance, running time, and work each weekday was significantly lower in EXS compared to EX mice, however, the largest effect was seen during week one. Voluntary wheel running deceased in all mice with increasing age; the pattern of decline appeared to be similar between groups. During the weekend (when no stress was applied), EXS maintained higher distance compared to EX, as well as higher daily distance, time, and work compared to their weekday values. These results indicate that mild chronic stress reduces total spontaneous wheel running in mice during the first week of the daily stress induction and maintains this reduced level for up to 8 consecutive weeks. However, following five days of UCMS, voluntary running wheel activity rebounds within 2-3 days.	[DeVallance, Evan; Parkulo, Travis; Chantler, Paul D.; Olfertl, I. Mark; Bryner, Randy W.] WVU Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA; [Riggs, Dale; Jackson, Barbara; Zaslau, Stanley] WVU Sch Med, Dept Surg, Morgantown, WV USA	West Virginia University; West Virginia University	Bryner, RW (corresponding author), WVU Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA.	rbryner@hsc.ovve.edu			West Virginia University [3-R-046R]	West Virginia University	This work was supported by West Virginia University through the James & Emily LaRosa Urology Research Fund (fund number 3-R-046R).; This project was supported by funding from West Virginia University through the James & Emily LaRosa Urology Research Fund (fund number 3-R-046R).	Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Bates HE, 2008, ENDOCRINOLOGY, V149, P2990, DOI 10.1210/en.2007-1473; Bates HE, 2007, METABOLISM, V56, P1065, DOI 10.1016/j.metabol.2007.03.015; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Chang CH, 2014, BIOL PSYCHIAT, V76, P223, DOI 10.1016/j.biopsych.2013.09.020; DALLMAN MF, 1993, TRENDS ENDOCRIN MET, V4, P62, DOI 10.1016/S1043-2760(05)80017-7; Demirtas T, 2014, INFLAMMATION, V37, P1432, DOI 10.1007/s10753-014-9867-4; Di Chiara G, 1999, BIOL PSYCHIAT, V46, P1624, DOI 10.1016/S0006-3223(99)00236-X; Ducottet C, 2005, BEHAV BRAIN RES, V156, P153, DOI 10.1016/j.bbr.2004.05.018; Gavrilovic L, 2012, J BIOL REG HOMEOS AG, V26, P367; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; GRIFFITHS J, 1992, PHARMACOL BIOCHEM BE, V42, P219, DOI 10.1016/0091-3057(92)90519-L; Grippo AJ, 2005, PHYSIOL BEHAV, V84, P697, DOI 10.1016/j.physbeh.2005.02.011; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Grippo AJ, 2003, PHYSIOL BEHAV, V78, P703, DOI 10.1016/S0031-9384(03)00050-7; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Hill MN, 2012, NEUROSCI BIOBEHAV R, V36, P2085, DOI 10.1016/j.neubiorev.2012.07.001; Hruschka DJ, 2005, PSYCHONEUROENDOCRINO, V30, P698, DOI 10.1016/j.psyneuen.2005.03.002; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Kyrou L, 2008, HORM-INT J ENDOCRINO, V7, P287, DOI 10.14310/horm.2002.1209; Li S, 2007, LIFE SCI, V80, P1373, DOI 10.1016/j.lfs.2006.12.027; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; Malisch JL, 2016, PHYSIOL BIOCHEM ZOOL, V89, P546, DOI 10.1086/688660; Malisch JL, 2009, BEHAV GENET, V39, P192, DOI 10.1007/s10519-008-9246-8; Mann EA, 2015, PHYSIOL BEHAV, V150, P83, DOI 10.1016/j.physbeh.2015.02.021; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Pan Y, 2013, PSYCHONEUROENDOCRINO, V38, P122, DOI 10.1016/j.psyneuen.2012.05.007; Papp M, 1996, EUR J PHARMACOL, V296, P129, DOI 10.1016/0014-2999(95)00697-4; Parker KJ, 2003, HORM BEHAV, V43, P60, DOI 10.1016/S0018-506X(02)00016-8; Popescu S, 2016, CLIN INTERV AGING, V11, P313, DOI 10.2147/CIA.S97295; PRZEGALINSKI E, 1995, NEUROPHARMACOLOGY, V34, P1305, DOI 10.1016/0028-3908(95)00102-C; Rogoz Z, 2012, PHARMACOL REP, V64, P1391, DOI 10.1016/S1734-1140(12)70936-2; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Willner P, 1996, PHYSIOL BEHAV, V60, P129, DOI 10.1016/0031-9384(95)02256-2; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Zhang X, 2007, CHIN J INTEGR MED, V13, P46, DOI 10.1007/s11655-007-0046-4; Zhu SW, 2006, BEHAV BRAIN RES, V167, P1, DOI 10.1016/j.bbr.2005.02.038	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184829	10.1371/journal.pone.0184829	http://dx.doi.org/10.1371/journal.pone.0184829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926614	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600044
J	Kydd, E; Padalino, B; Henshall, C; McGreevy, P				Kydd, Erin; Padalino, Barbara; Henshall, Cathrynne; McGreevy, Paul			An analysis of equine round pen training videos posted online: Differences between amateur and professional trainers	PLOS ONE			English	Article							EQUUS-CABALLUS; HORSES; BEHAVIOR; EQUITATION; ATTENTION; RESPONSES; ROLES; STATE	Natural Horsemanship is popular among many amateur and professional trainers and as such, has been the subject of recent scientific enquiry. One method commonly adopted by Natural Horsemanship (NH) trainers is that of round pen training (RPT). RPT sessions are usually split into a series of bouts; each including two phases: chasing/flight and chasing off-set/flight offset. However, NH training styles are heterogeneous. This study investigated online videos of RPT to explore the characteristics of RPT sessions and test for differences in techniques and outcomes between amateurs and professionals (the latter being defined as those with accompanying online materials that promote clinics, merchandise or a service to the public). From more than 300 candidate videos, we selected sample files for individual amateur (n = 24) and professional (n = 21) trainers. Inclusion criteria were: training at liberty in a Round Pen; more than one bout and good quality video. Sessions or portions of sessions were excluded if the trainer attached equipment, such as a lunge line, directly to the horse or the horse was saddled, mounted or ridden. The number of bouts and duration of each chasing and non-chasing phase were recorded, and the duration of each RPT session was calculated. General weighted regression analysis revealed that, when compared with amateurs, professionals showed fewer arm movements per bout (p<0.05). Poisson regression analysis showed that professionals spent more time looking up at their horses, when transitioning between gaits, than amateurs did (p<0.05). The probability of horses following the trainer was not significantly associated with amount of chasing, regardless of category. Given that, according to some practitioners, the following response is a goal of RPT, this result may prompt caution in those inclined to give chase. The horses handled by professionals showed fewer conflict behaviours (e.g. kicking, biting, stomping, head-tossing, defecating, bucking and attempting to escape), and fewer oral and head movements (e.g. head-lowering, licking and chewing) than those horses handled by amateurs Overall, these findings highlight the need for selectivity when using the internet as an educational source and the importance of trainer skill and excellent timing when using negative reinforcement in horse training.	[Kydd, Erin; Padalino, Barbara; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia; [Padalino, Barbara] Univ Bari, Dept Vet Med, Bari, Italy; [Padalino, Barbara] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga, NSW, Australia; [Henshall, Cathrynne] Hillydale Equine, Inverary Rd, Bungonia, NSW, Australia	University of Sydney; Universita degli Studi di Bari Aldo Moro; Charles Sturt University	Kydd, E (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia.	erin.kydd@students.mq.edu.au	Padalino, Barbara/AAJ-7498-2020	McGreevy, Paul/0000-0001-7220-8378; PADALINO, BARBARA/0000-0002-7630-8285				Anderson C., 2010, LESSONS WELL LEARNED; Anderson C, 2004, C ANDERSONS DOWNUNDE; Baragli P, 2011, J VET BEHAV, V6, P31, DOI 10.1016/j.jveb.2010.08.020; Birke L, 2011, APPL ANIM BEHAV SCI, V134, P56, DOI 10.1016/j.applanim.2011.06.002; Bourjade M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126344; Brannaman B, 2001, FARAWAY HORSES ADVEN; Domjan MP, 2014, PRINCIPLES LEARNING; Dorrance T, 2010, TRUE UNITY WILLING C; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Fowler V, 2012, ANTHROZOOS, V25, P301, DOI 10.2752/175303712X13403555186217; Fureix C, 2009, BEHAV PROCESS, V82, P359, DOI 10.1016/j.beproc.2009.08.007; Hall C, 2008, J APPL ANIM WELF SCI, V11, P249, DOI 10.1080/10888700802101130; Henshall C, 2014, APPL ANIM BEHAV SCI, V155, P1, DOI 10.1016/j.applanim.2014.03.004; Hunt R., 1978, THINK HARMONY HORSES; Kedzierski W, 2012, J EQUINE VET SCI, V32, P752, DOI 10.1016/j.jevs.2012.03.002; Krueger K, 2007, APPL ANIM BEHAV SCI, V104, P162, DOI 10.1016/j.applanim.2006.04.021; Krueger K, 2011, ANIM COGN, V14, P187, DOI 10.1007/s10071-010-0352-7; Lieberman DA, 2000, LEARNING BEHAV COGNI; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Loftus L, 2016, ANIMALS, V6, DOI 10.3390/ani6090055; Lyons J, 1991, LYONS HORSES J LYONS; Maros K, 2010, INTERACT STUD, V11, P410, DOI 10.1075/is.11.3.05mar; McDonnell S, 2005, LICKING CHEWING LEAR; McDonnell S.M., 2003, PRACTICAL FIELD GUID; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; McGreevy P, 2006, 2 INT EQ SCI S MIL I; McGreevy P., 2010, EQUITATION SCI, V1st ed.; McGreevy PD, 2009, VET J, V181, P12, DOI 10.1016/j.tvjl.2009.03.005; McGreevy Paul, 2007, CARROTS STICKS PRINC; McGreevy PD, 2007, J VET BEHAV, V2, P108, DOI 10.1016/j.jveb.2007.05.003; McGreevy PD, 2014, J VET BEHAV, V9, P382, DOI 10.1016/j.jveb.2014.06.006; McGreevy PD, 2009, J VET BEHAV, V4, P193, DOI 10.1016/j.jveb.2008.08.001; Muller P, 2016, PSYCHOLOGY, V7, P480; Nicholls L, 2014, EFFECT MANE PULLING; Parelli P., 1993, NATURAL HORSE MAN SH; Payne E, 2015, VET J, V204, P247, DOI 10.1016/j.tvjl.2015.04.004; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Roberts M, 1997, MAN WHO LISTENS HORS; Seaman SC, 2002, APPL ANIM BEHAV SCI, V78, P175, DOI 10.1016/S0168-1591(02)00095-3; Sighieri C, 2003, ANIM WELFARE, V12, P705; Starling Melissa J., 2013, Animals, V3, P300, DOI 10.3390/ani3020300; Vervill S, 2008, J EQUINE VET SCI, V28, P309, DOI 10.1016/j.jevs.2008.03.006; Visser EK, 2009, VET J, V181, P48, DOI 10.1016/j.tvjl.2009.03.009; Waran N, 2002, ANIMAL WEL, V1, P151; Waring G.H., 2003, HORSE BEHAV, V2; Warren-Smith AK, 2008, J APPL ANIM WELF SCI, V11, P285, DOI 10.1080/10888700802101304; Wilk I, 2015, J VET BEHAV, V10, P231, DOI 10.1016/j.jveb.2015.01.001; Wilson A, 2004, TOP HORSE TRAINING M	48	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184851	10.1371/journal.pone.0184851	http://dx.doi.org/10.1371/journal.pone.0184851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922395	Green Published, gold, Green Submitted			2022-12-26	WOS:000411059300035
J	Liu, MY; Pan, YS; Zhou, LC; Wang, YJ				Liu, Mingyong; Pan, Yuesong; Zhou, Lichun; Wang, Yongjun			Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; INTRAVENOUS THROMBOLYSIS; ALTEPLASE 3; RISK; THERAPY; AGE; IMPLEMENTATION; OUTCOMES; SCALE	Background and purpose Predictors of symptomatic intracranial hemorrhage (sICH) in Chinese patients with acute ischemic stroke treated with recombinant tissue plasminogen activator remain unclear. Methods Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China) study were assessed to explore risk factors for symptomatic intracranial hemorrhage after intravenous thrombolysis. Three candidate sICH definitions were analyzed. Results Among 1128 patients with acute ischemic stroke treated with intravenous rtPA within 4.5 hours of symptom onset, 23 (2.0%), 44(3.9%) and 61 (5.4%) experienced modified mSITS-MOST, ECASS II, and NINDS defined sICH, respectively. Multivariate logistic regression revealed independent risk factors for sICH were age. 70 years-old(sICH per NINDS, adjusted OR = 1.73[95% CI1.02-2.95], p = 0.04), diabetes(sICH per SITS-MOST, adjusted OR = 3.50 [95% CI1.34-9.16], p = 0.01), serum glucose on admission >9.0mmol/L(sICH per ECASS II, adjusted OR = 2.84[95% CI1.48-5.46], p = 0.002), NIHSS on admission>20(sICH per SITS-MOST, adjusted OR = 5.06[95% CI1.68-15.20], p = 0.004 or sICH per NINDS, adjusted OR 2.81[95% CI1.42-5.57], p = 0.003) and cardioembolism(sICH per SITS-MOST, adjusted OR = 7.09[95% CI2.41-20.87], p<0.001 or sICH per ECASS II, adjusted OR = 4.99 [95% CI2.53-9.84], p<0.001) or sICH per NINDS, adjusted OR = 2.47[95% CI1.39-4.39], p = 0.002). Conclusion Cardioembolism, NIHSS on admission higher than 20, serum glucose on admission higher than 9.0 mmol/L and age >= 70 years were independent risk factors for symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke treated with recombinant tissue plasminogen activator.	[Liu, Mingyong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Ctr Stroke, Beijing, Peoples R China; [Liu, Mingyong; Wang, Yongjun] Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Liu, Mingyong; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Liu, Mingyong; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Liu, Mingyong; Zhou, Lichun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China; [Pan, Yuesong] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Pan, Yuesong] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Ctr Stroke, Beijing, Peoples R China.; Wang, YJ (corresponding author), Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, YJ (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, YJ (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Zhou, LC (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	13701279076@163.com; yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020; Mingyong, Liu/D-1500-2014	Pan, Yuesong/0000-0003-3082-6789; Mingyong, Liu/0000-0001-6187-8587	National Science and Technology Major Project of China [2011BA108602]; State Key Development Program of Basic Research of China [2009CB521905]	National Science and Technology Major Project of China; State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China)	This study was funded by the National Science and Technology Major Project of China (2011BA108602) and the State Key Development Program of Basic Research of China (2009CB521905) to YW.	Al-Khaled M, 2014, J STROKE CEREBROVASC, V23, P7, DOI 10.1016/j.jstrokecerebrovasdis.2012.04.004; Anderson CS, 2016, NEW ENGL J MED, V374, P2313, DOI 10.1056/NEJMoa1515510; Brown DL, 2005, ANN EMERG MED, V46, P56, DOI 10.1016/j.annemergmed.2004.12.025; Costello CA, 2012, J CLIN NEUROSCI, V19, P360, DOI 10.1016/j.jocn.2011.08.014; Cronin CA, 2012, STROKE, V43, P1684, DOI 10.1161/STROKEAHA.112.656587; Cucchiara Brett, 2008, J Stroke Cerebrovasc Dis, V17, P331, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.012; Dharmasaroja PA, 2013, J STROKE CEREBROVASC, V22, P227, DOI 10.1016/j.jstrokecerebrovasdis.2011.08.001; Dharmasaroja PA, 2012, J CLIN NEUROSCI, V19, P799, DOI 10.1016/j.jocn.2011.08.035; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ginsberg MD, 2015, INT J STROKE, V10, P494, DOI 10.1111/ijs.12476; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Kono S, 2013, J STROKE CEREBROVASC, V22, P190, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.016; Lee HJ, 2017, J STROKE, V19, P229, DOI 10.5853/jos.2016.01109; Liao XL, 2013, CNS NEUROSCI THER, V19, P43, DOI 10.1111/cns.12031; Liao XL, 2014, STROKE, V45, P2354, DOI 10.1161/STROKEAHA.114.005989; Lin QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153486; Lindley RI, 2015, STROKE, V46, P746, DOI 10.1161/STROKEAHA.114.006573; Lou M, 2008, NEUROLOGY, V71, P1417, DOI 10.1212/01.wnl.0000330297.58334.dd; Matsuo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110444; Matute MC, 2012, CEREBROVASC DIS, V33, P231, DOI 10.1159/000334662; Mazya M, 2012, STROKE, V43, P1524, DOI 10.1161/STROKEAHA.111.644815; Menon BK, 2012, STROKE, V43, P2293, DOI 10.1161/STROKEAHA.112.660415; Mosimann PJ, 2013, STROKE, V44, P806, DOI 10.1161/STROKEAHA.112.675678; Muengtaweepongsa S, 2015, ANN INDIAN ACAD NEUR, V18, P181, DOI 10.4103/0972-2327.150592; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; Orlando A, 2016, J STROKE CEREBROVASC, V25, P969, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.003; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Seet RCS, 2012, CEREBROVASC DIS, V34, P106, DOI 10.1159/000339675; Strbian D, 2011, Neurology, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Strbian D, 2014, STROKE, V45, P752, DOI 10.1161/STROKEAHA.113.003806; Strbian D, 2012, ANN NEUROL, V71, P634, DOI 10.1002/ana.23546; Sung SF, 2013, STROKE, V44, P1561, DOI 10.1161/STROKEAHA.111.000651; Tong X, 2014, INT J STROKE, V9, P728, DOI 10.1111/ijs.12155; Ueshima S, 2002, THROMB HAEMOSTASIS, V87, P544, DOI 10.1055/s-0037-1613042; Urra X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059420; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Xian Y, 2012, JAMA-J AM MED ASSOC, V307, P2600, DOI 10.1001/jama.2012.6756	37	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184646	10.1371/journal.pone.0184646	http://dx.doi.org/10.1371/journal.pone.0184646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922363	Green Submitted, gold, Green Published			2022-12-26	WOS:000411059300020
J	Weaver, SR; Prichard, AS; Maerz, NL; Prichard, AP; Endres, EL; Hernandez-Castellano, LE; Akins, MS; Bruckmaier, RM; Hernandez, LL				Weaver, Samantha R.; Prichard, Allan S.; Maerz, Noah L.; Prichard, Austin P.; Endres, Elizabeth L.; Hernandez-Castellano, Lorenzo E.; Akins, Matthew S.; Bruckmaier, Rupert M.; Hernandez, Laura L.			Elevating serotonin pre-partum alters the Holstein dairy cow hepatic adaptation to lactation	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR CANCER; LIVER-REGENERATION; CIRCULATING SEROTONIN; HEPATOCYTE APOPTOSIS; PERIPHERAL SEROTONIN; SUBCLINICAL KETOSIS; PARTIAL-HEPATECTOMY; TRANSITION PERIOD; ENERGY-BALANCE; PREGNANCY	Serotonin is known to regulate energy and calcium homeostasis in several mammalian species. The objective of this study was to determine if pre-partum infusions of 5-hydroxytryptophan (5-HTP), the immediate precursor to serotonin synthesis, could modulate energy homeostasis at the level of the hepatocyte in post-partum Holstein and Jersey dairy cows. Twelve multiparous Holstein cows and twelve multiparous Jersey cows were intravenously infused daily for approximately 7 d pre-partum with either saline or 1 mg/kg bodyweight of 5-HTP. Blood was collected for 14 d post-partum and on d30 post-partum. Liver biopsies were taken on d1 and d7 post-partum. There were no changes in the circulating concentrations of glucose, insulin, glucagon, non-esterified fatty acids, or urea nitrogen in response to treatment, although there were decreased beta-hydroxybutyrate concentrations with 5-HTP treatment around d6 to d10 post-partum, particularly in Jersey cows. Cows infused with 5-HTP had increased hepatic serotonin content and increased mRNA expression of the serotonin 2B receptor on d1 and d7 post-partum. Minimal changes were seen in the hepatic mRNA expression of various gluconeogenic enzymes. There were no changes in the mRNA expression profile of cell-cycle progression marker cyclin-dependent kinase 4 or apoptotic marker caspase 3, although proliferating cell nuclear antigen expression tended to be increased in Holstein cows infused with 5-HTP on d1 post-partum. Immunofluorescence assays showed an increased number of CASP3-and Ki67-positive cells in Holstein cows infused with 5-HTP on d1 post-partum. Given the elevated hepatic serotonin content and increased mRNA abundance of 5HTR2B, 5-HTP infusions may be stimulating an autocrine-paracrine adaptation to lactation in the Holstein cow liver.	[Weaver, Samantha R.; Prichard, Allan S.; Maerz, Noah L.; Prichard, Austin P.; Endres, Elizabeth L.; Hernandez, Laura L.] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA; [Hernandez-Castellano, Lorenzo E.; Bruckmaier, Rupert M.] Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland; [Akins, Matthew S.] Univ Wisconsin Marshfield, Dept Dairy Sci, Marshfield, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Bern	Hernandez, LL (corresponding author), Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Castellano, Lorenzo E. Hernández/T-1034-2016	Castellano, Lorenzo E. Hernández/0000-0003-2729-0434; Hernandez, Laura/0000-0001-7591-5203	USDA-HATCH Formula Fund [142-PRJ74RD]; USDA-Hatch funding [WIS01732]; Wisconsin Consortium for Extension and Research in Agriculture and Natural Resources (CERANR); University of Wisconsin Madison; National Science Foundation Graduate Research Fellowship Program [DGE-1256259]	USDA-HATCH Formula Fund; USDA-Hatch funding; Wisconsin Consortium for Extension and Research in Agriculture and Natural Resources (CERANR); University of Wisconsin Madison; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	The reported study was supported by the USDA-HATCH Formula Fund, grant 142-PRJ74RD and USDA-Hatch funding #WIS01732, as well as funding provided by the Wisconsin Consortium for Extension and Research in Agriculture and Natural Resources (CERANR) and Graduate School funding provided by the University of Wisconsin Madison. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1256259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuyi AA, 2005, VET QUART, V27, P117, DOI 10.1080/01652176.2005.9695192; Al-Trad B, 2010, J ANIM SCI, V88, P2998, DOI 10.2527/jas.2009-2463; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Balasubramanian S, 1998, HEPATOLOGY, V27, P62, DOI 10.1002/hep.510270111; Baldwin RL, 2004, J DAIRY SCI, V87, P2977, DOI 10.3168/jds.S0022-0302(04)73429-3; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Collier RJ, 2012, ANIMAL, V6, P403, DOI 10.1017/S1751731111002461; DONKIN SS, 1995, J ANIM SCI, V73, P546; Donovan MH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00036; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; French PD, 2006, J DAIRY SCI, V89, P1057, DOI 10.3168/jds.S0022-0302(06)72173-7; Hauso O, 2007, REGUL PEPTIDES, V143, P39, DOI 10.1016/j.regpep.2007.02.009; KARKALAS J, 1985, J SCI FOOD AGR, V36, P1019, DOI 10.1002/jsfa.2740361018; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Laporta J, 2015, DOMEST ANIM ENDOCRIN, V51, P65, DOI 10.1016/j.domaniend.2014.11.005; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Laporta J, 2015, J ENDOCRINOL, V226, P43, DOI 10.1530/JOE-14-0693; Laporta J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110190; Laubenthal L, 2016, J DAIRY SCI, V99, P1571, DOI 10.3168/jds.2015-9847; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Lesurtel M, 2014, HEPATOLOGY, V60, P30, DOI 10.1002/hep.27067; Li Y, 2016, J ANIM PHYSIOL AN N, V100, P844, DOI 10.1111/jpn.12454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McLeod KR, 2000, J ANIM SCI, V78, P760; Merens W, 2007, J AFFECT DISORDERS, V103, P43, DOI 10.1016/j.jad.2007.01.032; Moore SAE, 2015, J DAIRY SCI, V98, P3754, DOI 10.3168/jds.2014-8841; Oh CM, 2016, DIABETES METAB J, V40, P89, DOI 10.4093/dmj.2016.40.2.89; Oh CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7794; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Olson KM, 2011, J DAIRY SCI, V94, P507, DOI 10.3168/jds.2010-3433; Papadimas GK, 2006, LIVER INT, V26, P352, DOI 10.1111/j.1478-3231.2005.01230.x; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; SMITH NE, 1974, J DAIRY SCI, V57, P1055, DOI 10.3168/jds.S0022-0302(74)85008-3; Soll C, 2012, CLIN CANCER RES, V18, P5902, DOI 10.1158/1078-0432.CCR-11-1813; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Starlinger P, 2014, HEPATOLOGY, V60, P257, DOI 10.1002/hep.26950; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Tharwat M, 2012, CAN J VET RES, V76, P241; Tharwat M, 2012, RES VET SCI, V93, P1281, DOI 10.1016/j.rvsc.2012.03.011; Tzirogiannis KN, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0201-2; Vicari T, 2008, DOMEST ANIM ENDOCRIN, V34, P74, DOI 10.1016/j.domaniend.2006.11.002; Walsh RB, 2007, J DAIRY SCI, V90, P2788, DOI 10.3168/jds.2006-560; Watanabe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088058; Weaver SR, 2016, J DAIRY SCI, V99, P842, DOI 10.3168/jds.2015-9828; Weaver SR, 2016, J ENDOCRINOL, V230, P105, DOI 10.1530/JOE-16-0038; White HM, 2016, J DAIRY SCI, V99, P812, DOI 10.3168/jds.2015-9953; White HM, 2015, ANIMALS BASEL, V18, P793; Wylie ARG, 2008, J DAIRY SCI, V91, P577, DOI 10.3168/jds.2007-0388; Zhang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08098	55	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184939	10.1371/journal.pone.0184939	http://dx.doi.org/10.1371/journal.pone.0184939			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922379	Green Published, gold, Green Submitted			2022-12-26	WOS:000411059300048
J	Kim, DJ; Norden, PR; Salvador, J; Barry, DM; Bowers, SLK; Cleaver, O; Davis, GE				Kim, Dae Joong; Norden, Pieter R.; Salvador, Jocelynda; Barry, David M.; Bowers, Stephanie L. K.; Cleaver, Ondine; Davis, George E.			Src- and Fyn-dependent apical membrane trafficking events control endothelial lumen formation during vascular tube morphogenesis	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; BLOOD-VESSEL FORMATION; IN-VITRO; CAPILLARY LUMEN; COLLAGEN MATRIX; CELL POLARITY; MURAL CELLS; TUBULOGENESIS; ANGIOGENESIS; REQUIRES	Here we examine the question of how endothelial cells (ECs) develop their apical membrane surface domain during lumen and tube formation. We demonstrate marked apical membrane targeting of activated Src kinases to this apical domain during early and late stages of this process. Immunostaining for phosphotyrosine or phospho-Src reveals apical membrane staining in intracellular vacuoles initially. This is then followed by vacuole to vacuole fusion events to generate an apical luminal membrane, which is similarly decorated with activated phospho-Src kinases. Functional blockade of Src kinases completely blocks EC lumen and tube formation, whether this occurs during vasculogenic tube assembly or angiogenic sprouting events. Multiple Src kinases participate in this apical membrane formation process and siRNA suppression of Src, Fyn and Yes, but not Lyn, blocks EC lumen formation. We also demonstrate strong apical targeting of Src-GFP and Fyn-GFP fusion proteins and increasing their expression enhances lumen formation. Finally, we show that Src- and Fyn-associated vacuoles track and fuse along a subapically polarized microtubule cytoskeleton, which is highly acetylated. These vacuoles generate the apical luminal membrane in a stereotypically polarized, perinuclear position. Overall, our study identifies a critical role for Src kinases in creating and decorating the EC apical membrane surface during early and late stages of lumen and tube formation, a central event in the molecular control of vascular morphogenesis.	[Kim, Dae Joong; Norden, Pieter R.; Salvador, Jocelynda; Bowers, Stephanie L. K.; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Barry, David M.; Cleaver, Ondine] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA	University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Davis, GE (corresponding author), Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	davisgeo@health.missouri.edu		Salvador, Jocelynda/0000-0002-5992-9135; Norden, Pieter/0000-0002-5960-5245	National Heart, Lung and Blood Institute [HL126518, HL128584]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136139, R01HL128584] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute (HL126518) "GTPases as molecular gatekeepers of cytoskeletal and cellular polarization during endothelial tubulogenesis"; and National Heart, Lung and Blood Institute (HL128584) "Novel growth factor and signaling requirements for human capillary tube assembly.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barry DM, 2016, CIRC RES, V119, P810, DOI 10.1161/CIRCRESAHA.116.309094; Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bowers SLK, 2016, ADV PHARMACOL, V77, P241, DOI 10.1016/bs.apha.2016.04.005; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Davis GE, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P205, DOI 10.1007/978-3-319-14463-4_9; Davis GE, 2015, CONNECT TISSUE RES, V56, P392, DOI 10.3109/03008207.2015.1066781; Davis GE, 2014, DEV CELL, V31, P140, DOI 10.1016/j.devcel.2014.10.011; Davis GE, 2013, METHODS MOL BIOL, V1066, P17, DOI 10.1007/978-1-62703-604-7_2; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Hoang MV, 2010, MICROVASC RES; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koo Y, 2016, ANGIOGENESIS, V19, P173, DOI 10.1007/s10456-016-9498-5; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; MarieCardine A, 1995, EUR J IMMUNOL, V25, P3290, DOI 10.1002/eji.1830251214; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Norden PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147758; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Salazar R, 1999, EXP CELL RES, V249, P22, DOI 10.1006/excr.1999.4460; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Smith AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085147; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Stratman AN, 2017, DEVELOPMENT, V144, P115, DOI 10.1242/dev.143131; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	52	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184461	10.1371/journal.pone.0184461	http://dx.doi.org/10.1371/journal.pone.0184461			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910325	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200048
J	Kiso, K; Yoshifuji, H; Oku, T; Hikida, M; Kitagori, K; Hirayama, Y; Nakajima, T; Haga, H; Tsuruyama, T; Miyagawa-Hayashino, A				Kiso, Kaori; Yoshifuji, Hajime; Oku, Takuma; Hikida, Masaki; Kitagori, Koji; Hirayama, Yoshitaka; Nakajima, Toshiki; Haga, Hironori; Tsuruyama, Tatsuaki; Miyagawa-Hayashino, Aya			Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients	PLOS ONE			English	Article							ACTIN CYTOSKELETON; RECEPTOR; CANCER; CALCINEURIN; LYMPHOMA; PROTEINS; TAGLN2; LINES; NFAT	Transgelin-2 (TAGLN2) is an actin-binding protein that controls actin stability and promotes T cell activation. TAGLN2 is also expressed on B-cells but its function in B-cells is unknown. We found that TAGLN2-expressing B-cells were localized in the germinal center (GC) of secondary lymphoid tissues and TAGLN2 mRNA was significantly upregulated after IgM +IgG stimulation in primary human B-cells, suggesting that TAGLN2 was upregulated upon B-cell activation. In support of this, lymph nodes (LNs) from patients with systemic lupus erythematosus (SLE), in which the intense GC activity have been recognized, showed increased TAGLN2 expression in B-cells compared to control LNs. Moreover, TAGLN2(+)B-cells were distributed widely not only in the GC but also in the perifollicular areas in SLE LNs. In contrast, CD19(+) B-cells and CD19(+)CD27(+) memory-B cells in peripheral blood of SLE patients showed no increase in TAGLN2 mRNA. Two-photon excitation microscopy of Raji cells demonstrated that TAGLN2 colocalized with F-actin and moved together to the periphery upon stimulation. TAGLN2-knockdown in Raji cells resulted in impaired phosphorylation of PLC gamma 2 leading to inhibition of cell migration. Microarray analysis of TAGLN2-knockdown Raji cells showed decreased expression of the genes associated with immune function including CCR6 and as well as of those associated with regulation of the actin cytoskeleton including ABI2, compared to controls. These results suggest that TAGLN2 might regulate activation and migration of B-cells, in particular, the entry of activated B-cells into the follicle. We also suggest that TAGLN2 could be used as a marker for activated B-cells.	[Kiso, Kaori; Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Ctr Anat Pathol & Forens Med Res, Kyoto, Japan; [Yoshifuji, Hajime; Kitagori, Koji; Nakajima, Toshiki] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Oku, Takuma; Hikida, Masaki; Kitagori, Koji; Hirayama, Yoshitaka; Miyagawa-Hayashino, Aya] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Oku, Takuma; Hirayama, Yoshitaka] Astellas Pharma Inc, Res Portfolio & Sci, Drug Discovery Res, Tsukuba, Ibaraki, Japan; [Hikida, Masaki] Akita Univ, Dept Life Sci, Lab Mol Cell Physiol, Akita, Japan; [Haga, Hironori; Miyagawa-Hayashino, Aya] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan; [Miyagawa-Hayashino, Aya] Kansai Med Univ, Dept Clin Pathol, Osaka, Japan	Kyoto University; Kyoto University; Kyoto University; Astellas Pharmaceuticals; Akita University; Kyoto University; Kansai Medical University	Miyagawa-Hayashino, A (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.; Miyagawa-Hayashino, A (corresponding author), Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan.; Miyagawa-Hayashino, A (corresponding author), Kansai Med Univ, Dept Clin Pathol, Osaka, Japan.	ayam@kuhp.kyoto-u.ac.jp	Yoshifuji, Hajime/AAZ-1657-2020	Haga, Hironori/0000-0003-4322-9561; Farne, Kaori/0000-0002-2589-4659	Japanese Government; Astellas Pharma Inc.; Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Astellas Pharma Inc	Japanese Government; Astellas Pharma Inc.(Astellas Pharmaceuticals); Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Astellas Pharma Inc(Astellas Pharmaceuticals)	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Japanese Government to AMH and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program grants from the Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma. Takuma Oku and Yoshitaka Hirayama are employed by Astellas Pharma Inc. Astellas Pharma Inc provided support in the form of salaries for authors TO and YH, and approved publication of this article, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Dvorakova M, 2014, EXPERT REV PROTEOMIC, V11, P149, DOI 10.1586/14789450.2014.860358; Ek S, 2005, LEUKEMIA RES, V29, P205, DOI 10.1016/j.leukres.2004.06.009; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Elsner M, 2012, J PROTEOMICS, V75, P4693, DOI 10.1016/j.jprot.2012.02.012; Fleischer SJ, 2016, ARTHRITIS RHEUMATOL, V68, P1210, DOI 10.1002/art.39559; Frances R, 2006, MOL IMMUNOL, V43, P2124, DOI 10.1016/j.molimm.2005.12.011; Gez S, 2007, BBA-PROTEINS PROTEOM, V1774, P1173, DOI 10.1016/j.bbapap.2007.06.011; Hannah J, 2016, AUTOIMMUN REV, V15, P93, DOI 10.1016/j.autrev.2015.09.006; Hao SL, 2003, EMBO J, V22, P4166, DOI 10.1093/emboj/cdg401; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jang SH, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0070-9; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kojima M, 2000, PATHOL INT, V50, P304, DOI 10.1046/j.1440-1827.2000.01052.x; Markopoulou A, 2013, CLIN IMMUNOL, V148, P359, DOI 10.1016/j.clim.2012.09.009; Na BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156429; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Reimer D, 2017, IMMUNOL CELL BIOL, V95, P33, DOI 10.1038/icb.2016.68; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Song WX, 2014, BBA-BIOMEMBRANES, V1838, P569, DOI 10.1016/j.bbamem.2013.07.016; Song WX, 2013, IMMUNOL REV, V256, P177, DOI 10.1111/imr.12113; Stanton RJ, 2014, CELL HOST MICROBE, V16, P201, DOI 10.1016/j.chom.2014.07.005; Wiede F, 2013, IMMUNOL CELL BIOL, V91, P335, DOI 10.1038/icb.2013.14; Wong CK, 2009, J CLIN IMMUNOL, V29, P738, DOI 10.1007/s10875-009-9318-4; Xiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046510; Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zheng XW, 2015, CANCER BIOL THER, V16, P1407, DOI 10.1080/15384047.2015.1070990; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184738	10.1371/journal.pone.0184738	http://dx.doi.org/10.1371/journal.pone.0184738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910360	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200088
J	Mangan, AM; Pejchar, L; Werner, SJ				Mangan, Anna M.; Pejchar, Liba; Werner, Scott J.			Bird use of organic apple orchards: Frugivory, pest control and implications for production	PLOS ONE			English	Article							SERVICES; DAMAGE; DIVERSITY; SIZE	As the largest terrestrial biomes, crop and pasturelands can have very large positive or negative impacts on biodiversity and human well-being. Understanding how animals use and impact agroecosystems is important for making informed decisions that achieve conservation and production outcomes. Yet, few studies examine the tradeoffs associated with wildlife in agricultural systems. We examined bird use of organic apple orchards as well as how birds influence fruit production positively through control of an economically important insect pest (codling moth (Cydia pomonella)) and negatively through fruit damage. We conducted transect surveys, observed bird frugivory and assessed bird and insect damage with an exclosure experiment in small organic farms in western Colorado. We found that organic apple orchards in this region provide habitat for a large number of both human-adapted and human-sensitive species and that the species in orchards were relatively similar to adjacent hedgerow habitats. Habitat use did not vary as a function of orchard characteristics, and apple damage by both birds and C. pomonella was consistent within and across apple blocks that varied in size. A small subset of bird species was observed foraging on apples yet the effect of birds as agents of fruit damage appeared rather minor and birds did not reduce C. pomonella damage. Our results demonstrate that organic apple orchards have the potential to provide habitat for diverse bird communities, including species typically sensitive to human activities, with little apparent effect on production.	[Mangan, Anna M.; Werner, Scott J.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA; [Mangan, Anna M.; Pejchar, Liba] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	Mangan, AM (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA.; Mangan, AM (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	anna.mangan@aphis.usda.gov		Pejchar, Liba/0000-0002-9253-9884	National Wildlife Research Center; United States Department of Agriculture; Wildlife Services; Arkion(R) Life Sciences; Colorado State University Center for Collaborative Conservation; Colorado Field Ornithologists; Animal and Plant Health Inspection Service	National Wildlife Research Center(United States Department of Agriculture (USDA)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Wildlife Services; Arkion(R) Life Sciences; Colorado State University Center for Collaborative Conservation; Colorado Field Ornithologists; Animal and Plant Health Inspection Service	This project was funded in part by the National Wildlife Research Center, a unit within the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services (https://www.aphis.usda.gov/aphis/ourfocus/wildlifedamage/programs/nwm) and by Arkion (R) Life Sciences (http://www.arkionls.com/). The Colorado State University Center for Collaborative Conservation (www.collaborativeconservaton.org/ccc-fellows-program-overview) and the Colorado Field Ornithologists (http://cobirds.org/CFO/Grants/) also contributed small grants to AM M to support this research. Corporate collaborations do not imply endorsement by the United States Department of Agriculture. Co-authors at the National Wildlife Research Center and Colorado State University had input on the study design, data collection, analysis, writing and submission of this paper.	Agnello A, 1996, CORNELL COOPERATIVE; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Anderson A, 2013, CROP PROT, V52, P103, DOI 10.1016/j.cropro.2013.05.019; Anderson D. R., 2008, MODEL BASED INFERENC; Bailey L, 2005, GEOLOGICAL SURVEY, P2327; BAILEY PT, 1979, AUST J EXP AGR, V19, P247, DOI 10.1071/EA9790247; Baumgartner JA, 1999, BIRD ARTHROPOD PREDA; Belfrage K, 2005, AMBIO, V34, P582, DOI 10.1639/0044-7447(2005)034[0582:TEOFSA]2.0.CO;2; Bouvier JC, 2011, ENVIRON TOXICOL CHEM, V30, P212, DOI 10.1002/etc.377; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Caprile JL, 2011, PEST NOTES CODLING M; Cranshaw WS, 2013, CODLING MOTH CONTROL; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; ESRI, 2014, ARCGIS 10 3 DESKTOP; Farr CM, 2017, ECOL APPL; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garfinkel M, 2015, AGR ECOSYST ENVIRON, V211, P24, DOI 10.1016/j.agee.2015.04.023; Henderson J., 1913, PRACTICAL VALUE BIRD; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Irvin E, 2013, J WILDLIFE MANAGE, V77, P1564, DOI 10.1002/jwmg.609; Jedlicka JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027347; Karp DS, 2014, ECOLOGY, V95, P1065, DOI 10.1890/13-1012.1; Klonsky K., 2014, SAMPLE COSTS PRODUCE; Kross SM, 2016, AGR ECOSYST ENVIRON, V225, P140, DOI 10.1016/j.agee.2016.03.043; Kross SM, 2012, CONSERV BIOL, V26, P142, DOI 10.1111/j.1523-1739.2011.01756.x; Laake JL, 2013, 7600 Sand Point Way NE, Patent No. 98115; Lindell Catherine A., 2012, Human-Wildlife Interactions, V6, P283; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Mazerolle M. J., 2016, PACKAGE AICCMODAVG; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Naccari C, 2009, ENVIRON INT, V35, P594, DOI 10.1016/j.envint.2008.11.002; Peisley RK, 2016, PEERJ, V4, DOI 10.7717/peerj.2179; PEISLEY RK, 2015, SPRINGER SCI REV, V3, P113, DOI DOI 10.1007/S40362-015-0035-5; Pimentel David, 2005, Environment Development and Sustainability, V7, P229, DOI 10.1007/s10668-005-7314-2; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R-Core-Team, 2015, LANG ENV STAT COMP; Reese GC, 2013, METHODS ECOL EVOL, V4, P891, DOI 10.1111/2041-210X.12070; Rodriguez EN, 1995, INTEGRATED STRATEGY; Rosenberg KV, 2014, STATE BIRDS; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Simpson R, 2013, CARTOGRAPHERS COLORA; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tracey J., 2007, MANAGING BIRD DAMAGE; Tracey JP, 2010, CROP PROT, V29, P435, DOI 10.1016/j.cropro.2009.10.008; USDA, 2012, 2012 CENS AGR COL ST; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	54	13	14	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183405	10.1371/journal.pone.0183405	http://dx.doi.org/10.1371/journal.pone.0183405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910290	Green Published, gold			2022-12-26	WOS:000410859200010
J	Merrill, NM; Schipper, JL; Karnes, JB; Kauffman, AL; Martin, KR; MacKeigan, JP				Merrill, Nathan M.; Schipper, Joshua L.; Karnes, Jonathan B.; Kauffman, Audra L.; Martin, Katie R.; MacKeigan, Jeffrey P.			PI3K-C2 alpha knockdown decreases autophagy and maturation of endocytic vesicles	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; CLATHRIN; PROTEIN; PHOSPHATIDYLINOSITOL; TRAFFICKING; ULK1; ATG9; BECLIN-1; PI3K; PHOSPHORYLATION	Phosphoinositide 3-kinase (PI3K) family members are involved in diverse cellular fates including cell growth, proliferation, and survival. While many molecular details are known about the Class I and III PI3Ks, less is known about the Class II PI3Ks. To explore the function of all eight PI3K isoforms in autophagy, we knock down each gene individually and measure autophagy. We find a significant decrease in autophagy following siRNA-mediated PIK3C2A (encoding the Class 2 PI3K, PI3K-C2 alpha) knockdown. This defective autophagy is rescued by exogenous PI3K-C2 alpha, but not kinase-dead PI3K-C2 alpha. Using confocal microscopy, we probe for markers of endocytosis and autophagy, revealing that PI3K-C2 alpha colocalizes with markers of endocytosis. Though endocytic uptake is intact, as demonstrated by transferrin labeling, PIK3C2A knockdown results in vesicle accumulation at the recycling endosome. We isolate distinct membrane sources and observe that PI3K-C2 alpha interacts with markers of endocytosis and autophagy, notably ATG9. Knockdown of either PIK3C2A or ATG9A/B, but not PI3KC3, results in an accumulation of transferrin-positive clathrin coated vesicles and RAB11-positive vesicles at the recycling endosome. Taken together, these results support a role for PI3K-C2 alpha in the proper maturation of endosomes, and suggest that PI3K-C2 alpha may be a critical node connecting the endocytic and autophagic pathways.	[Merrill, Nathan M.; Karnes, Jonathan B.; MacKeigan, Jeffrey P.] Van Andel Inst, Grad Sch, Grand Rapids, MI 49503 USA; [Merrill, Nathan M.; Schipper, Joshua L.; Karnes, Jonathan B.; Kauffman, Audra L.; Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Ctr Canc Cell Biol, Grand Rapids, MI 49503 USA; [MacKeigan, Jeffrey P.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA	Van Andel Institute; Van Andel Institute; Michigan State University; Michigan State University College of Human Medicine	MacKeigan, JP (corresponding author), Van Andel Inst, Grad Sch, Grand Rapids, MI 49503 USA.; MacKeigan, JP (corresponding author), Van Andel Res Inst, Ctr Canc Cell Biol, Grand Rapids, MI 49503 USA.; MacKeigan, JP (corresponding author), Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA.	mackeig1@msu.edu		MacKeigan, Jeffrey/0000-0002-0198-5679; Martin, Katie/0000-0002-3689-4814; Merrill, Nathan/0000-0003-0757-3680	Van Andel Institute; National Cancer Institute [R01CA197398]	Van Andel Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Van Andel Institute Graduate School fellowship to N.M. M., and award number R01CA197398 from the National Cancer Institute to J.P.M. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aki S, 2015, J BIOL CHEM, V290, P6086, DOI 10.1074/jbc.M114.601484; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; BEAULATION J, 1977, J MORPHOL, V154, P39, DOI 10.1002/jmor.1051540104; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Campa CC, 2015, FEBS LETT, V589, P1552, DOI 10.1016/j.febslet.2015.05.001; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; ERICSSON JL, 1969, EXP CELL RES, V56, P393, DOI 10.1016/0014-4827(69)90030-5; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gallagher LE, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020024; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947; Goodall ML, 2014, AUTOPHAGY, V10, P1120, DOI 10.4161/auto.28594; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2009, AUTOPHAGY, V5, P385, DOI 10.4161/auto.5.3.7699; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Imai K, 2016, J CELL SCI, V129, P3781, DOI 10.1242/jcs.196196; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kiel JAKW, 1999, YEAST, V15, P741, DOI 10.1002/(SICI)1097-0061(19990630)15:9<741::AID-YEA416>3.0.CO;2-O; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2014, AUTOPHAGY, V10, P549, DOI 10.4161/auto.28448; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129; Krag C, 2010, J CELL SCI, V123, P4240, DOI 10.1242/jcs.071712; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081; Leibiger B, 2015, CELL REP, V13, P15, DOI 10.1016/j.celrep.2015.08.058; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Marat AL, 2017, SCIENCE, V356, P968, DOI 10.1126/science.aaf8310; Martin KR, 2013, AUTOPHAGY, V9, P74, DOI 10.4161/auto.22532; Martin KR, 2011, J CELL SCI, V124, P812, DOI 10.1242/jcs.080341; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2015, METHODS, V75, P19, DOI 10.1016/j.ymeth.2014.11.005; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; NOVIKOFF AB, 1962, J CELL BIOL, V15, P140, DOI 10.1083/jcb.15.1.140; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Pavel M, 2017, FEBS J, V284, P672, DOI 10.1111/febs.13931; Popovic D, 2014, EMBO REP, V15, P392, DOI 10.1002/embr.201337995; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Prior I A, 1999, Mol Cell Biol Res Commun, V1, P162, DOI 10.1006/mcbr.1999.0126; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang B, 2017, CURR OPIN CELL BIOL, V45, P47, DOI 10.1016/j.ceb.2017.02.011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yu XL, 2015, AUTOPHAGY, V11, P1711, DOI 10.1080/15548627.2015.1043076; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098067; Zhao YQ, 2007, J BIOL CHEM, V282, P1249, DOI 10.1074/jbc.M606998200; Zhou C, 2017, APPL MICROBIOL BIOT, V9, P1; Zhou CQ, 2017, CELL RES, V27, P184, DOI 10.1038/cr.2016.146	86	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184909	10.1371/journal.pone.0184909	http://dx.doi.org/10.1371/journal.pone.0184909			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910396	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200116
J	Agostini, VO; Ritter, MD; Macedo, AJ; Muxagata, E; Erthal, F				Agostini, Vanessa Ochi; Ritter, Matias do Nascimento; Macedo, Alexandre Jose; Muxagata, Erik; Erthal, Fernando			What determines sclerobiont colonization on marine mollusk shells?	PLOS ONE			English	Article							MICRO-TEXTURED SURFACES; INVERTEBRATE LARVAE; MYTILUS-GALLOPROVINCIALIS; FLOW-CYTOMETRY; TEMPORAL RESOLUTION; DEATH ASSEMBLAGES; BIOFILM FORMATION; SETTLEMENT; ATTACHMENT; TOPOGRAPHY	Empty mollusk shells may act as colonization surfaces for sclerobionts depending on the physical, chemical, and biological attributes of the shells. However, the main factors that can affect the establishment of an organism on hard substrates and the colonization patterns on modern and time-averaged shells remain unclear. Using experimental and field approaches, we compared sclerobiont (i.e., bacteria and invertebrate) colonization patterns on the exposed shells (internal and external sides) of three bivalve species (Anadara brasiliana, Mactra isabelleana, and Amarilladesma mactroides) with different external shell textures. In addition, we evaluated the influence of the host characteristics (mode of life, body size, color alteration, external and internal ornamentation and mineralogy) of sclerobionts on dead mollusk shells (bivalve and gastropod) collected from the Southern Brazilian coast. Finally, we compared field observations with experiments to evaluate how the biological signs of the present-day invertebrate settlements are preserved in molluscan death assemblages (incipient fossil record) in a subtropical shallow coastal setting. The results enhance our understanding of sclerobiont colonization over modern and paleoecology perspectives. The data suggest that sclerobiont settlement is enhanced by (i) high(er) biofilm bacteria density, which is more attracted to surfaces with high ornamentation; (ii) heterogeneous internal and external shell surface; (iii) shallow infaunal or attached epifaunal life modes; (iv) colorful or post-mortem oxidized shell surfaces; (v) shell size (<50 mm(2) or >1,351 mm(2)); and (vi) calcitic mineralogy. Although the biofilm bacteria density, shell size, and texture are considered the most important factors, the effects of other covarying attributes should also be considered. We observed a similar pattern of sclerobiont colonization frequency over modern and paleoecology perspectives, with an increase of invertebrates occurring on textured bivalve shells. This study demonstrates how bacterial biofilms may influence sclerobiont colonization on biological hosts (mollusks), and shows how ecological relationships in marine organisms may be relevant for interpreting the fossil record of sclerobionts.	[Agostini, Vanessa Ochi; Muxagata, Erik] Univ Fed Rio Grande FURG, Inst Oceanog, Lab Zooplancton, Rio Grande, RS, Brazil; [Agostini, Vanessa Ochi] Univ Fed Rio Grande FURG, Inst Oceanog, Programa Posgrad Oceanog Biol, Rio Grande, RS, Brazil; [Ritter, Matias do Nascimento] Univ Fed Rio Grande do Sul, Inst Geociencias, Programa Posgrad Geociencias, Porto Alegre, RS, Brazil; [Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Erthal, Fernando] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Ritter, MD (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Programa Posgrad Geociencias, Porto Alegre, RS, Brazil.	mnritter@gmail.com	Agostini, Vanessa VOA/L-2497-2018; Erthal, Fernando/C-5941-2013; Muxagata, Erik/M-6563-2015; Macedo, Alexandre J/C-5178-2013; do Nascimento Ritter, Matias/A-1500-2013	Agostini, Vanessa VOA/0000-0002-8325-254X; Erthal, Fernando/0000-0001-8036-192X; Muxagata, Erik/0000-0002-4210-5252; Macedo, Alexandre J/0000-0002-8951-4029; do Nascimento Ritter, Matias/0000-0001-8150-4443	FAPERGS [1982-2551/13-7]; CNPq [141217/2014-6, 140568/2014-0]; International Ocean Discovery Program [CAPES 0195/2016-02-BEX]	FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Ocean Discovery Program	This study was partially supported by the FAPERGS (1982-2551/13-7). Additional funds were covered by the CNPq (141217/2014-6 to VOA and 140568/2014-0 to MNR), and by the International Ocean Discovery Program (CAPES 0195/2016-02-BEX to MNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Vanessa Ochi, 2016, Marine Biodiversity Records, V9, P84, DOI 10.1186/s41200-016-0061-2; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2006, ATLANTICA; Azevedo FBB, 2006, BRAZ ARCH BIOL TECHN, V49, P263, DOI 10.1590/S1516-89132006000300012; Bao WY, 2007, MAR BIOL, V150, P565, DOI 10.1007/s00227-006-0383-4; Barclay KM, 2013, PALAEOGEOGR PALAEOCL, V383, P79, DOI 10.1016/j.palaeo.2013.05.007; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; Ben Abdallah L. Gargouri, 2012, Transitional Waters Bulletin, V6, P20; Berntsson KM, 2000, BIOFOULING, V16, P245, DOI 10.1080/08927010009378449; Berntsson KM, 2000, J EXP MAR BIOL ECOL, V251, P59, DOI 10.1016/S0022-0981(00)00210-0; Bers AV, 2004, BIOFOULING, V20, P43, DOI 10.1080/08927010410001655533; Best MMR, 2008, PALAIOS, V23, P796, DOI 10.2110/palo.2005.p05-076r; Bouvier T, 2001, CYTOMETRY, V44, P188, DOI 10.1002/1097-0320(20010701)44:3<188::AID-CYTO1111>3.0.CO;2-C; Brett CE, 2011, PALAEOGEOGR PALAEOCL, V312, P278, DOI 10.1016/j.palaeo.2011.05.019; Bromley RG, 2006, PALAEOGEOGR PALAEOCL, V232, P429, DOI 10.1016/j.palaeo.2005.07.007; Buckup L, 1999, CRUSTACEOS RIO GRAND; 고수근, 2011, Fisheries and Aquatic Sciences, V14, P339; Bush AM, 2011, ANNU REV EARTH PL SC, V39, P241, DOI 10.1146/annurev-earth-040809-152556; CACERESMARTINEZ J, 1994, MAR ECOL PROG SER, V112, P107, DOI 10.3354/meps112107; Callender WR, 2002, PALAIOS, V17, P50, DOI 10.1669/0883-1351(2002)017<0050:TTAAFS>2.0.CO;2; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; CHIA FS, 1979, J MORPHOL, V160, P275, DOI 10.1002/jmor.1051600303; Correa ICS, 1978, AN 30 C BRAS GEOL RE, V2, P851; Dobretsov S, 2006, J EXP MAR BIOL ECOL, V333, P263, DOI 10.1016/j.jembe.2006.01.019; Dobretsov S, 2013, BIOFOULING, V29, P423, DOI 10.1080/08927014.2013.776042; Dreanno C, 2007, J EXP MAR BIOL ECOL, V351, P276, DOI 10.1016/j.jembe.2007.07.003; Faimali M, 2004, J EXP MAR BIOL ECOL, V306, P37, DOI 10.1016/j.jembe.2003.12.019; Feng GP, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.22; Ferguson N, 2013, ECOLOGY, V94, P126, DOI 10.1890/12-0795.1; Freckelton ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep42557; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; Gollner S, 2006, CAH BIOL MAR, V47, P397; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harper EM, 2003, PALAEOGEOGR PALAEOCL, V210, P185, DOI 10.1016/S0031-0182(03)00624-2; HELDAL M, 1994, J MICROBIOL METH, V20, P255; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hills JM, 1998, BIOFOULING, V12, P57, DOI 10.1080/08927019809378346; Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12; Jenkins SR, 2003, HYDROBIOLOGIA, V503, P143, DOI 10.1023/B:HYDR.0000008496.68710.22; Johnson William S., 2012, P1; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; Kelley PH, 2003, PREDATOR PREY INTERA, P113; Keough MJ, 1998, J EXP MAR BIOL ECOL, V231, P1, DOI 10.1016/S0022-0981(98)00073-2; Khandeparker L, 2011, MAR ECOL-EVOL PERSP, V32, P509, DOI 10.1111/j.1439-0485.2011.00439.x; Kidwell SM, 2013, PALAEONTOLOGY, V56, P487, DOI 10.1111/pala.12042; Klompmaker AA, 2017, SCIENCE, V356, P1178, DOI 10.1126/science.aam7468; Kowalewski Michal, 2002, Paleontological Society Papers, V8, P3; Kowalewski Michal, 2003, Topics in Geobiology, V21, P1; Lescinsky HL, 2002, PALAIOS, V17, P171, DOI 10.1669/0883-1351(2002)017<0171:MSEABR>2.0.CO;2; Liow LH, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0981; Lopes R.P., 2012, SOC BRASILEIRA PALEO, V2, P179; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; Marshall DJ, 2003, MAR ECOL PROG SER, V255, P145, DOI 10.3354/meps255145; Martin-Rodriguez AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123652; Mieszkin S, 2013, BIOFOULING, V29, P1097, DOI 10.1080/08927014.2013.828712; Mikkelsen PM, 2008, SEASHELLS SO FLORIDA; MONTEFORTE M, 1994, HYDROBIOLOGIA, V291, P21, DOI 10.1007/BF00024236; Norland S., 1993, HDB METHODS AQUATIC; Olszewski TD, 2004, PALAIOS, V19, P39, DOI 10.1669/0883-1351(2004)019<0039:MTIOTD>2.0.CO;2; Petrone L, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0047; Picot J, 2012, CYTOTECHNOLOGY, V64, P109, DOI 10.1007/s10616-011-9415-0; Rios E.C., 2009, COMPENDIUM BRAZILIAN; Ritter MD, 2017, PALAIOS, V32, P572, DOI 10.2110/palo.2017.003; Rodland DL, 2006, J GEOL, V114, P313, DOI 10.1086/501221; Rodland DL, 2014, PALAIOS, V29, P170, DOI 10.2110/palo.2013.033; Rodland DL, 2004, PALAIOS, V19, P381, DOI 10.1669/0883-1351(2004)019<0381:COALWE>2.0.CO;2; Santos A, 2008, GEOBIOS-LYON, V41, P43, DOI 10.1016/j.geobios.2007.01.009; Sarmento VC, 2012, J MAR BIOL ASSOC UK, V92, P1117, DOI 10.1017/S0025315411001718; Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391; Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717; Stanley S.M., 1970, MEM GEOL SOC AM, V125, P1, DOI DOI 10.1130/MEM125-P1; STANLEY STEVEN M., 1968, J PALEONTOL, V42, P214; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; SVANE I, 1995, J EXP MAR BIOL ECOL, V187, P51, DOI 10.1016/0022-0981(94)00171-9; Tait K, 2013, MOL ECOL, V22, P2588, DOI 10.1111/mec.12273; Tamburri MN, 2008, J SHELLFISH RES, V27, P601, DOI 10.2983/0730-8000(2008)27[601:SOCALE]2.0.CO;2; Taylor PD, 2016, PALAEONTOLOGY, V59, P481, DOI 10.1111/pala.12239; Taylor PD, 2003, EARTH-SCI REV, V62, P1, DOI 10.1016/S0012-8252(02)00131-9; Taylor PD, 2002, PALAIOS, V17, P522, DOI 10.1669/0883-1351(2002)017<0522:ANTFMO>2.0.CO;2; Tsuchiya M, 2002, HELGOLAND MAR RES, V56, P31, DOI 10.1007/s10152-001-0099-2; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; VERMEIJ G J, 1977, Paleobiology, V3, P245; Visscher JP, 1928, BIOL BULL-US, V54, P336, DOI 10.2307/1537021; Vladkova T., 2008, SURFACE MODIFICATION, P135, DOI [10.1007/978-3-540-69796-1_7, DOI 10.1007/978-3-540-69796-1_7]; Walker S, 2012, GLOBAL BIODIVERSITY, P129, DOI DOI 10.1007/978-90-481-3428-1_; Walker SE, 1995, LETHAIA, V28, P371, DOI 10.1111/j.1502-3931.1995.tb01829.x; Whalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117675; Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003; YULE AB, 1984, J MAR BIOL ASSOC UK, V64, P429, DOI 10.1017/S0025315400030101; ZARITSKY A, 1975, J THEOR BIOL, V54, P243, DOI 10.1016/S0022-5193(75)80129-9	90	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184745	10.1371/journal.pone.0184745	http://dx.doi.org/10.1371/journal.pone.0184745			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902894	Green Published, gold			2022-12-26	WOS:000410669200059
J	Hughes, K; Fosgate, GT; Budke, CM; Ward, MP; Kerry, R; Ingram, B				Hughes, Kristen; Fosgate, Geoffrey T.; Budke, Christine M.; Ward, Michael P.; Kerry, Ruth; Ingram, Ben			Modeling the spatial distribution of African buffalo (Syncerus caffer) in the Kruger National Park, South Africa	PLOS ONE			English	Article							MOUTH-DISEASE; AUTOREGRESSIVE MODELS; BOVINE TUBERCULOSIS; GROUP-SIZE; SELECTION; WILDLIFE; PATTERNS; HABITAT; LIVESTOCK; BOUNDARY	The population density of wildlife reservoirs contributes to disease transmission risk for domestic animals. The objective of this study was to model the African buffalo distribution of the Kruger National Park. A secondary objective was to collect field data to evaluate models and determine environmental predictors of buffalo detection. Spatial distribution models were created using buffalo census information and archived data from previous research. Field data were collected during the dry (August 2012) and wet (January 2013) seasons using a random walk design. The fit of the prediction models were assessed descriptively and formally by calculating the root mean square error (rMSE) of deviations from field observations. Logistic regression was used to estimate the effects of environmental variables on the detection of buffalo herds and linear regression was used to identify predictors of larger herd sizes. A zero-inflated Poisson model produced distributions that were most consistent with expected buffalo behavior. Field data confirmed that environmental factors including season (P = 0.008), vegetation type (P = 0.002), and vegetation density (P = 0.010) were significant predictors of buffalo detection. Bachelor herds were more likely to be detected in dense vegetation (P = 0.005) and during the wet season (P = 0.022) compared to the larger mixed-sex herds. Static distribution models for African buffalo can produce biologically reasonable results but environmental factors have significant effects and therefore could be used to improve model performance. Accurate distribution models are critical for the evaluation of disease risk and to model disease transmission.	[Hughes, Kristen; Fosgate, Geoffrey T.] Univ Pretoria, Dept Prod Anim Studies, Onderstepoort, South Africa; [Budke, Christine M.] Texas A&M Univ, Vet Integrat Biosci, College Stn, TX USA; [Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Kerry, Ruth] Brigham Young Univ, Dept Geog, Provo, UT 84602 USA; [Ingram, Ben] Univ Talca, Fac Ingn, Curico, Chile	University of Pretoria; Texas A&M University System; Texas A&M University College Station; University of Sydney; Brigham Young University; Universidad de Talca	Fosgate, GT (corresponding author), Univ Pretoria, Dept Prod Anim Studies, Onderstepoort, South Africa.	geoffrey.fosgate@up.ac.za	Ward, Michael Patrick/W-1897-2019; Ward, Michael Patrick/GRX-1851-2022; Ward, Michael/C-5758-2009; Fosgate, Geoffrey T/N-8700-2014; Ingram, Ben/P-5777-2017	Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; Fosgate, Geoffrey T/0000-0002-9432-0042; Ingram, Ben/0000-0003-4557-4342; Kerry, Ruth/0000-0001-9174-0167	Research Development Programme at the University of Pretoria [A0T384]; National Research Foundation [76734]	Research Development Programme at the University of Pretoria; National Research Foundation	This work was funded by the Research Development Programme (Project No. A0T384) at the University of Pretoria and Incentive Funding for Rated Researchers from the National Research Foundation (Project No. 76734). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayebazibwe C, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-54; Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Bastos ADS, 2003, J GEN VIROL, V84, P1595, DOI 10.1099/vir.0.18859-0; Bauer JJ, 2014, SOCIOL METHOD RES, V43, P519, DOI 10.1177/0049124114521150; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; Brahmbhatt DP, 2012, PREV VET MED, V103, P16, DOI 10.1016/j.prevetmed.2011.08.003; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Cross PC, 2004, ANN ZOOL FENN, V41, P879; FUNSTON PJ, 1994, AFR J ECOL, V32, P100, DOI 10.1111/j.1365-2028.1994.tb00562.x; Gertenbach WPD, 1984, KOEDOE, V26, P9; Highfield L, 2008, VET RES, V39, DOI 10.1051/vetres:2007055; Jori F, 2011, PREV VET MED, V100, P210, DOI 10.1016/j.prevetmed.2011.03.015; Jori F, 2009, REV SCI TECH OIE, V28, P917, DOI 10.20506/rst.28.3.1932; Kerry R, 2013, INT J GEOGR INF SCI, V27, P47, DOI 10.1080/13658816.2012.663917; Kerry R, 2010, GEOGR ANAL, V42, P53, DOI 10.1111/j.1538-4632.2010.00782.x; Korte LM, 2008, J ZOOL, V275, P229, DOI 10.1111/j.1469-7998.2008.00430.x; Lanzas C, 2015, PREV VET MED, V118, P207, DOI 10.1016/j.prevetmed.2014.09.012; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; McDowell A, 2003, STATA J, V3, P178, DOI 10.1177/1536867X0300300207; Michel AL, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.453; Mloszewski M.J., 1983, pi; Monestiez P, 2006, ECOL MODEL, V193, P615, DOI 10.1016/j.ecolmodel.2005.08.042; Neelon B, 2013, J R STAT SOC A STAT, V176, P389, DOI 10.1111/j.1467-985X.2012.01039.x; Owen-Smith N, 2012, WILDLIFE RES, V39, P452, DOI 10.1071/WR12062; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; Pearson K., 1905, NATURE, V72, P1; Premashthira Sith, 2011, Animal Health Research Reviews, V12, P225, DOI 10.1017/S146625231100017X; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Seydack Armin H., 2012, Koedoe, V54, P1; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Tekleghiorghis T, 2016, TRANSBOUND EMERG DIS, V63, P136, DOI 10.1111/tbed.12248; Thomson GR, 2003, VIRUS RES, V91, P145, DOI 10.1016/S0168-1702(02)00263-0; van Schalkwyk OL, 2016, TRANSBOUND EMERG DIS, V63, P333, DOI 10.1111/tbed.12280; Ward MP, 2015, AUST VET J, V93, P4, DOI 10.1111/avj.12278; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1	40	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182903	10.1371/journal.pone.0182903	http://dx.doi.org/10.1371/journal.pone.0182903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902858	gold, Green Published			2022-12-26	WOS:000410669200008
J	Shetty, R; Sharma, A; Pahuja, N; Chevour, P; Padmajan, N; Dhamodaran, K; Jayadev, C; Nuijts, RMMA; Ghosh, A; Nallathambi, J				Shetty, Rohit; Sharma, Anupam; Pahuja, Natasha; Chevour, Priyanka; Padmajan, Neeraja; Dhamodaran, Kamesh; Jayadev, Chaitra; Nuijts, Rudy M. M. A.; Ghosh, Arkasubhra; Nallathambi, Jeyabalan			Oxidative stress induces dysregulated autophagy in corneal epithelium of keratoconus patients	PLOS ONE			English	Article							GENE-EXPRESSION; REACTIVE OXYGEN; GUIDELINES; APOPTOSIS; ASSAYS; DAMAGE	Oxidative stress is one of the key factors that contributes to the pathogenesis of keratoconus (KC). Macroautophagy is a vital cellular mechanism that is activated in response to oxidative stress. The aim of this study was to understand the role of the autophagic lysosomal pathway in the oxidative damage of KC corneal epithelium and the human corneal epithelial cell line (HCE). The corneal epithelium was collected from 78 KC patients undergoing corneal cross-linking or topography guided photorefractive keratectomy. We performed microarray, qPCR and western blot analysis for the expression of autophagy markers on this epithelium from patients with different clinical grades of KC. A differential expression pattern of autophagy related markers was observed in the diseased corneal cone-specific epithelium compared to matched peripheral epithelium from KC patients with increasing clinical severity. Human corneal epithelial cells exposed to oxidative stress were analyzed for the expression of key proteins associated with KC pathogenesis and the autophagic pathway. Oxidative stress led to an increase in reactive oxygen species and an imbalanced expression of autophagy markers in the HCE cells. Further, reduced levels of Akt/p70S6 Kinase, which is a known target of the mTOR pathway was observed in HCE cells under oxidative stress as well as in KC epithelium. Our results suggest that an altered expression of proteins suggestive of defective autophagy and is a consequence of oxidative damage. This could play a possible role in the pathogenesis of KC.	[Shetty, Rohit; Pahuja, Natasha; Jayadev, Chaitra] Narayana Hlth City, Narayana Nethralaya Eye Hosp, Dept Cornea & Refract Surg, Bangalore, Karnataka, India; [Sharma, Anupam; Chevour, Priyanka; Padmajan, Neeraja; Dhamodaran, Kamesh; Ghosh, Arkasubhra; Nallathambi, Jeyabalan] Narayana Nethralaya Fdn, GROW Res Lab, Bangalore, Karnataka, India; [Nuijts, Rudy M. M. A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands	Maastricht University	Ghosh, A; Nallathambi, J (corresponding author), Narayana Nethralaya Fdn, GROW Res Lab, Bangalore, Karnataka, India.	arkasubhra@narayananethralaya.com; drnallathambi@narayananethralaya.com		Ghosh, Arkasubhra/0000-0002-6570-5891	Department of Science and Technology (DST)-SERB, New Delhi, India [SBNS/LS-68/2013]; Department of Atomic Energy (DAE), Board of Research in Nuclear Sciences (BRNS), Mumbai, India [37(1)/14/11/2016]; Narayana Nethralaya Foundation, Bangalore, India	Department of Science and Technology (DST)-SERB, New Delhi, India(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Department of Atomic Energy (DAE), Board of Research in Nuclear Sciences (BRNS), Mumbai, India; Narayana Nethralaya Foundation, Bangalore, India	This study was supported by Department of Science and Technology (DST)-SERB (SBNS/LS-68/2013), New Delhi, India; Department of Atomic Energy (DAE), Board of Research in Nuclear Sciences (BRNS), (37(1)/14/11/2016) Mumbai, India; Narayana Nethralaya Foundation, Bangalore, India.	Arnal E, 2011, INVEST OPHTH VIS SCI, V52, P8592, DOI 10.1167/iovs.11-7732; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Behndig A, 2001, INVEST OPHTH VIS SCI, V42, P2293; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Cejkova J, 2012, HISTOL HISTOPATHOL, V27, P1029, DOI 10.14670/HH-27.1029; Cejkova J, 2010, HISTOL HISTOPATHOL, V25, P1403, DOI 10.14670/HH-25.1403; Choi SI, 2014, BIOCHEM BIOPH RES CO, V450, P1505, DOI 10.1016/j.bbrc.2014.07.035; Choi SI, 2012, AUTOPHAGY, V8, P1782, DOI 10.4161/auto.22067; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Dabir SS, 2014, INDIAN J OPHTHALMOL, V62, P66, DOI 10.4103/0301-4738.126186; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Gordon-Shaag A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795738; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Iqbal O, 2013, CORNEA, V32, P702, DOI 10.1097/ICO.0b013e318282987a; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Kenney M. Cristina, 2000, CLAO Journal, V26, P10; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Krumeich JH, 1998, J CATARACT REFR SURG, V24, P456, DOI 10.1016/S0886-3350(98)80284-8; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Nishtala K, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0051-9; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Oh S, 2008, CELL STRESS CHAPERON, V13, P447, DOI 10.1007/s12192-008-0041-5; Olivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134830; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pahuja N, 2016, INVEST OPHTH VIS SCI, V57, P5372, DOI 10.1167/iovs.16-19677; Porter K, 2013, AUTOPHAGY, V9, P581, DOI 10.4161/auto.23568; Pulliero A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098106; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Shetty R, 2015, MOL VIS, V21, P12; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sugar J, 2012, CORNEA, V31, P716, DOI 10.1097/ICO.0b013e31823f8c72; Sykakis E, 2012, PATHOLOGY, V44, P234, DOI 10.1097/PAT.0b013e3283511b42; Trocoli A, 2014, CELL DEATH DIFFER, V21, P1852, DOI 10.1038/cdd.2014.102; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; Winkler BS, 1999, MOL VIS, V5; You J, 2015, J OPHTHALMOLOGY, V2015; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	54	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184628	10.1371/journal.pone.0184628	http://dx.doi.org/10.1371/journal.pone.0184628			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902914	Green Submitted, Green Published, gold			2022-12-26	WOS:000410669200051
J	Ding, SJ; Zhu, LB; Tian, YH; Zhu, TH; Huang, XF; Zhang, XM				Ding, Shaojie; Zhu, Libo; Tian, Yonghong; Zhu, Tianhong; Huang, Xiufeng; Zhang, Xinmei			P2X3 receptor involvement in endometriosis pain via ERK signaling pathway	PLOS ONE			English	Article							INCREASED MICROVASCULAR DENSITY; PERITONEAL ENDOMETRIOSIS; NERVE-FIBERS; EXPRESSION; WOMEN; HYPERALGESIA; INNERVATION; NOCICEPTORS; ACTIVATION; DISCOVERY	The purinergic receptor P2X ligand-gated ion channel 3 (P2X3) is crucially involved in peripheral nociceptive processes of somatic and visceral pain. Endometriosis pain is considered as a kind of inflammatory and neuropathic pain. However, whether P2X3 is involved in endometriosis pain has not been reported up to date. Here, we aimed to determine whether P2X3 expression in endometriotic lesions is involved in endometriosis pain, which is regulated by inflammatory mediators through extracellular regulated protein kinases (ERK) signalling pathway. We found that P2X3 expressions in endometriosis endometrium and endometriotic lesions were both significantly higher as compared with control endometrium (P< 0.05), and both positively correlated with pain (P< 0.05). The expression levels of phosphorylated -ERK (p-ERK), phosphorylated-cAMP-response element binding protein (p-CREB), and P2X3 in endometriotic stromal cells (ESCs) were all significantly increased in comparison to the initial levels after treated with interleukin (IL)-1 beta (P< 0.05) or adenosine triphosphate (ATP) (P< 0.05), respectively, and did not increase after the ESCs were pre-treated with ERK1/ 2 inhibitor. Additionally, P2X3 and calcitonin gene related peptide (CGRP) were co-expressed in endometriotic lesions. These obtained results suggest that P2X3 might be involved in endometriosis pain signal transduction via ERK signal pathway.	[Ding, Shaojie; Zhu, Libo; Tian, Yonghong; Zhu, Tianhong; Huang, Xiufeng; Zhang, Xinmei] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, XM (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.	zxm20130729@163.com		zhang, xinmei/0000-0001-7122-6435	National Nature Science Foundation of China [81270672, 81471433, 81471495, 81671429]; Zhejiang Key Medical Sciences (Minimally Invasive Gynecology)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Key Medical Sciences (Minimally Invasive Gynecology)	We appreciate the financial support of the National Nature Science Foundation of China (Grant Nos. 81270672, 81471433, 81471495 and 81671429), and Zhejiang Key Medical Sciences (Minimally Invasive Gynecology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2012, BRAIN BEHAV IMMUN, V26, P132, DOI 10.1016/j.bbi.2011.08.004; Birt JA, 2013, REPROD SCI, V20, P514, DOI 10.1177/1933719113477479; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Burnstock G, 2013, EUR J PHARMACOL, V716, P24, DOI 10.1016/j.ejphar.2013.01.078; Cantin LD, 2012, BIOORG MED CHEM LETT, V22, P2565, DOI 10.1016/j.bmcl.2012.01.124; Chaban Victor, 2013, Curr Trends Neurol, V7, P51; Cho T, 2012, NEUROREPORT, V23, P530, DOI 10.1097/WNR.0b013e328353fabc; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; de Arellano MLB, 2013, EUR J PAIN, V17, P1425, DOI 10.1002/j.1532-2149.2013.00323.x; Edelmayer RM, 2014, BIOCHEM PHARMACOL, V87, P390, DOI 10.1016/j.bcp.2013.11.019; Fabbretti E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00236; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; Greaves E, 2014, J CLIN ENDOCR METAB, V99, pE1738, DOI 10.1210/jc.2014-2282; Huang XF, 2012, EUR J OBSTET GYN R B, V165, P104, DOI 10.1016/j.ejogrb.2012.06.034; Joseph EK, 2013, J NEUROSCI, V33, P2849, DOI 10.1523/JNEUROSCI.3229-12.2013; Kajitani T, 2013, ENDOCR J, V60, P1155; Kobayashi H, 2014, ARCH GYNECOL OBSTET, V289, P13, DOI 10.1007/s00404-013-3049-8; Lin CL, 2013, PURINERG SIGNAL, V9, P249, DOI 10.1007/s11302-012-9347-y; Liu JG, 2012, REPROD SCI, V19, P1110, DOI 10.1177/1933719112443876; Mansfield KJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182862; McAllister SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031758; McKinnon BD, 2016, HUM REPROD UPDATE, V22, P382, DOI 10.1093/humupd/dmv060; McKinnon BD, 2015, TRENDS ENDOCRIN MET, V26, P1, DOI 10.1016/j.tem.2014.10.003; Mo G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-47; Nie J, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.035; Nirgianakis K, 2013, EUR J OBSTET GYN R B, V170, P550, DOI 10.1016/j.ejogrb.2013.08.010; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Prado FC, 2013, NEUROPHARMACOLOGY, V67, P252, DOI 10.1016/j.neuropharm.2012.11.011; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Sikora J, 2012, AM J REPROD IMMUNOL, V68, P138, DOI 10.1111/j.1600-0897.2012.01147.x; Song Nan, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P333; STRATHY JH, 1982, FERTIL STERIL, V38, P667; Vilotti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081138; Wang GY, 2009, HUM REPROD, V24, P827, DOI 10.1093/humrep/den464; Wickiewicz D, 2013, ARCH GYNECOL OBSTET, V288, P805, DOI 10.1007/s00404-013-2828-6; Wu JJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0828-3; Xu GY, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-60; Yasuda M, 2012, NEUROSCI LETT, V528, P67, DOI 10.1016/j.neulet.2012.08.067; Zhang XM, 2010, FERTIL STERIL, V94, P730, DOI 10.1016/j.fertnstert.2009.03.026; Zhang XM, 2010, FERTIL STERIL, V93, P2362, DOI 10.1016/j.fertnstert.2008.12.142; Zhang XM, 2010, HUM REPROD, V25, P392, DOI 10.1093/humrep/dep427; Zhang XM, 2009, FERTIL STERIL, V92, P1799, DOI 10.1016/j.fertnstert.2009.05.016; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou WD, 2010, HUM REPROD, V25, P3110, DOI 10.1093/humrep/deq287	45	30	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184647	10.1371/journal.pone.0184647	http://dx.doi.org/10.1371/journal.pone.0184647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898282	Green Submitted, gold, Green Published			2022-12-26	WOS:000410449500038
J	Elderman, M; Sovran, B; Hugenholtz, F; Graversen, K; Huijskes, M; Houtsma, E; Belzer, C; Boekschoten, M; de Vos, P; Dekker, J; Wells, J; Faas, M				Elderman, Marlies; Sovran, Bruno; Hugenholtz, Floor; Graversen, Katrine; Huijskes, Myrte; Houtsma, Eva; Belzer, Clara; Boekschoten, Mark; de Vos, Paul; Dekker, Jan; Wells, Jerry; Faas, Marijke			The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT-MICROBIOTA; GASTROINTESTINAL-TRACT; BARRIER; CELLS; HOMEOSTASIS; SYSTEM; PATHOGENESIS; ANTIGENS; COLITIS	A mucus layer covers and protects the intestinal epithelial cells from direct contact with microbes. This mucus layer not only prevents inflammation but also plays an essential role in microbiota colonization, indicating the complex interplay between mucus composition-microbiota and intestinal health. However, it is unknown whether the mucus layer is influenced by age or sex and whether this contributes to reported differences in intestinal diseases in males and females or with ageing. Therefore, in this study we investigated the effect of age on mucus thickness, intestinal microbiota composition and immune composition in relation to sex. The ageing induced shrinkage of the colonic mucus layer was associated with bacterial penetration and direct contact of bacteria with the epithelium in both sexes. Additionally, several genes involved in the biosynthesis of mucus were downregulated in old mice, especially in males, and this was accompanied by a decrease in abundances of various Lactobacillus species and unclassified Clostridiales type IV and XIV and increase in abundance of the potential pathobiont Bacteroides vulgatus. The changes in mucus and microbiota in old mice were associated with enhanced activation of the immune system as illustrated by a higher percentage of effector T cells in old mice. Our data contribute to a better understanding of the interplay between mucus-microbiota-and immune responses and ultimately may lead to more tailored design of strategies to modulate mucus production in targeted groups.	[Elderman, Marlies; Sovran, Bruno; Hugenholtz, Floor; Belzer, Clara; Boekschoten, Mark; de Vos, Paul; Dekker, Jan; Wells, Jerry] Top Inst Food & Nutr, Wageningen, Netherlands; [Elderman, Marlies; Houtsma, Eva; de Vos, Paul; Faas, Marijke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands; [Sovran, Bruno; Graversen, Katrine; Huijskes, Myrte; Dekker, Jan; Wells, Jerry] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Hugenholtz, Floor; Belzer, Clara] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Boekschoten, Mark] Wageningen Univ, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Faas, Marijke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Groningen	Elderman, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Elderman, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands.	m.e.elderman@umcg.nl	de Vos, Paul/A-3170-2013; Belzer, Clara/P-6500-2018; Boekschoten, Mark/AAS-4597-2021	Belzer, Clara/0000-0001-6922-836X; Boekschoten, Mark/0000-0002-2139-0795; de vos, paul/0000-0001-9618-2408; Graversen, Katrine Baekby/0000-0002-9965-5845; Elderman, Marlies/0000-0002-4661-9808	Top Institute Food and Nutrition, Wageningen, The Netherlands;  [GH002]	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government); 	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grant (GH002) was given to P.dV.	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Butto LF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00555; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Ha CY, 2014, NAT REV GASTRO HEPAT, V11, P128, DOI 10.1038/nrgastro.2013.241; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johansson MEV, 2014, INFLAMM BOWEL DIS, V20, P2124, DOI 10.1097/MIB.0000000000000117; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Lahti L, 2011, IEEE ACM T COMPUT BI, V217, P225; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lim MA, 2014, EXP GERONTOL, V49, P55, DOI 10.1016/j.exger.2013.10.006; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Man AL, 2014, CELL IMMUNOL, V289, P112, DOI 10.1016/j.cellimm.2014.04.001; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Ouyang XS, 2011, CELL IMMUNOL, V266, P208, DOI 10.1016/j.cellimm.2010.10.007; Parekh PJ, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.16; Pigrau M, 2016, NEUROGASTROENT MOTIL, V28, P463, DOI 10.1111/nmo.12717; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rokhsefat S, 2016, DIG DIS SCI; RUSELERVANEMBDEN JGH, 1989, FEMS MICROBIOL LETT, V58, P37, DOI 10.1111/j.1574-6968.1989.tb03014.x; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Shiba T, 2003, MICROBIOL IMMUNOL, V47, P371, DOI 10.1111/j.1348-0421.2003.tb03368.x; Sovran B, 2016, INFLAMM BOWEL DIS, V22, P826, DOI 10.1097/MIB.0000000000000688; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Strugala V, 2003, P NUTR SOC, V62, P237, DOI 10.1079/PNS2002205; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Varum FJO, 2012, J PHARM PHARMACOL, V64, P218, DOI 10.1111/j.2042-7158.2011.01399.x; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; YAMABAYASHI S, 1987, HISTOCHEM J, V19, P565, DOI 10.1007/BF01687364; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	51	61	61	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184274	10.1371/journal.pone.0184274	http://dx.doi.org/10.1371/journal.pone.0184274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898292	Green Published, gold			2022-12-26	WOS:000410449500020
J	Telles, FJ; Corcobado, G; Trillo, A; Rodriguez-Girones, MA				Jane Telles, Francismeire; Corcobado, Guadalupe; Trillo, Alejandro; Rodriguez-Girones, Miguel A.			Multimodal cues provide redundant information for bumblebees when the stimulus is visually salient, but facilitate red target detection in a naturalistic background	PLOS ONE			English	Article							AFFECTS COLOR PREFERENCE; BOMBUS-TERRESTRIS; DECISION-MAKING; FLORAL SCENT; FORAGING SPEED; RECEPTOR NOISE; FLOWER SIZE; BEES; DISCRIMINATION; HONEYBEES	Our understanding of how floral visitors integrate visual and olfactory cues when seeking food, and how background complexity affects flower detection is limited. Here, we aimed to understand the use of visual and olfactory information for bumblebees (Bombus terrestris terrestris L.) when seeking flowers in a visually complex background. To explore this issue, we first evaluated the effect of flower colour (red and blue), size (8, 16 and 32 mm), scent (presence or absence) and the amount of training on the foraging strategy of bumblebees (accuracy, search time and flight behaviour), considering the visual complexity of our background, to later explore whether experienced bumblebees, previously trained in the presence of scent, can recall and make use of odour information when foraging in the presence of novel visual stimuli carrying a familiar scent. Of all the variables analysed, flower colour had the strongest effect on the foraging strategy. Bumblebees searching for blue flowers were more accurate, flew faster, followed more direct paths between flowers and needed less time to find them, than bumblebees searching for red flowers. In turn, training and the presence of odour helped bees to find inconspicuous (red) flowers. When bees foraged on red flowers, search time increased with flower size; but search time was independent of flower size when bees foraged on blue flowers. Previous experience with floral scent enhances the capacity of detection of a novel colour carrying a familiar scent, probably by elemental association influencing attention.	[Jane Telles, Francismeire; Rodriguez-Girones, Miguel A.] CSIC, EEZA, Dept Funct & Evolutionary Ecol, Almeria, Spain; [Corcobado, Guadalupe] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Trillo, Alejandro] Donana Biol Stn, Dept Integrat Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Masaryk University Brno; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Telles, FJ (corresponding author), CSIC, EEZA, Dept Funct & Evolutionary Ecol, Almeria, Spain.	meirecuesta@gmail.com	Rodriguez-Girones, Miguel A/H-1859-2015; Telles, Francismeire J/O-2856-2017	Rodriguez-Girones, Miguel A/0000-0002-5619-9819; Telles, Francismeire J/0000-0001-8507-6546; Trillo, Alejandro/0000-0002-6944-0923	Spanish Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional - FEDER [CGL2015-71396-P]; Spanish National Research Council (CSIC); European Social Fund [JAE: JAEPre033]; Spanish Ministerio de Ciencia e InnovaciOn/Fondo Europeo de Desarrollo Regional FEDER [CGL2015-71396-P]	Spanish Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional - FEDER; Spanish National Research Council (CSIC); European Social Fund(European Social Fund (ESF)); Spanish Ministerio de Ciencia e InnovaciOn/Fondo Europeo de Desarrollo Regional FEDER	This work was supported by the Spanish Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional - FEDER (grant number CGL2015-71396-P to M.A.R.G.) and a PhD studentship to F.J.T. from the Spanish National Research Council (CSIC), co-funded by the European Social Fund (grant number JAE: JAEPre033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shikhar Mann for the initial code of bee flight analysis and Andreas Kampgen for the development of the BeeTracker program and assistance during video analyses. This work was supported by the Spanish Ministerio de Ciencia e InnovaciOn/Fondo Europeo de Desarrollo Regional FEDER (grant number CGL2015-71396-P to M.A.R.G.) and a PhD studentship to F.J.T. from the Spanish National Research Council (CSIC), co-funded by the European Social Fund (grant number JAE: JAEPre033).	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2006, INT J COMP PSYCHOL; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; Ballantyne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043869; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergamo PJ, 2016, FUNCT ECOL, V30, P710, DOI 10.1111/1365-2435.12537; Bukovac Z, 2016, EVOLUTIONARY ECOLOGY, P1; Byers KJRP, 2014, J EXP BIOL, V217, P614, DOI 10.1242/jeb.092213; Carlsson MA, 2006, BIOLOGY OF FLORAL SCENT, P243; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2007, ARTHROPOD-PLANT INTE, V1, P37, DOI 10.1007/s11829-007-9001-8; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Cronk Q, 2008, J EXP BOT, V59, P715, DOI 10.1093/jxb/ern009; DAFNI A, 1990, ISRAEL J BOT, V39, P81; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; Dobson Heidi E.M., 1999, Plant Species Biology, V14, P153, DOI 10.1046/j.1442-1984.1999.00020.x; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Farre-Armengol G, 2013, PERSPECT PLANT ECOL, V15, P56, DOI 10.1016/j.ppees.2012.12.002; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; Galizia CG, 2005, BEHAV ECOL, V16, P159, DOI 10.1093/beheco/arh147; Garbuzov M, 2014, FUNCT ECOL, V28, P364, DOI 10.1111/1365-2435.12178; Gegear RJ, 2005, ANIM BEHAV, V69, P939, DOI 10.1016/j.anbehav.2004.06.029; Gegear RJ, 2017, ECOLOGY, V98, P489, DOI 10.1002/ecy.1661; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Giurfa M, 1998, J COMP PHYSIOL A, V183, P101, DOI 10.1007/s003590050238; Goodale E, 2014, NATURWISSENSCHAFTEN, V101, P523, DOI 10.1007/s00114-014-1188-9; Goulson D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1523, DOI 10.1007/s00265-007-0384-4; Goyret J, 2009, P ROY SOC B-BIOL SCI, V276, P2739, DOI 10.1098/rspb.2009.0456; Junker RR, 2015, J INDIAN I SCI, V95, P43; Katzenberger TD, 2013, BEHAV ECOL SOCIOBIOL, V67, P1587, DOI 10.1007/s00265-013-1570-1; Knauer AC, 2015, ECOL LETT, V18, P135, DOI 10.1111/ele.12386; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI 10.1098/rstb.1995.0017; Leonard A.S., 2011, EVOLUTION PLANT POLL, P261, DOI DOI 10.1016/J.ANBEHAV.2012.01.007; Leonard AS, 2014, J COMP PHYSIOL A, V200, P463, DOI 10.1007/s00359-014-0904-4; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; LUNAU K, 1991, ETHOLOGY, V88, P203, DOI 10.1111/j.1439-0310.1991.tb00275.x; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Martinez-Harms J, 2010, J EXP BIOL, V213, P564, DOI 10.1242/jeb.037622; Ne'eman Gidi, 2017, Journal of Pollination Ecology, V20, P1, DOI 10.26786/1920-7603(2017)one; Nouvian M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10247; Odell E, 1999, AM MIDL NAT, V142, P257, DOI 10.1674/0003-0031(1999)142[0257:BFRTVI]2.0.CO;2; Orban LL, 2014, INSECT SOC, V61, P325, DOI 10.1007/s00040-014-0366-2; Parachnowitsch AL, 2012, NEW PHYTOL, V195, P667, DOI 10.1111/j.1469-8137.2012.04188.x; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; R Core Team, 2021, R LANGUAGE ENV STAT; Raguso Robert A., 1999, Plant Species Biology, V14, P95, DOI 10.1046/j.1442-1984.1999.00014.x; Reisenman CE, 2008, ARTHROPOD-PLANT INTE, V2, P137, DOI 10.1007/s11829-008-9041-8; Rivest SA, 2017, EVOL ECOL, V31, P435, DOI 10.1007/s10682-017-9893-4; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rodriguez-Girones MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071551; Rohde K, 2013, J COMP PHYSIOL A, V199, P197, DOI 10.1007/s00359-012-0783-5; Sanchez D, 2011, INSECT SOC, V58, P575, DOI 10.1007/s00040-011-0181-y; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Telles FJ, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-014-1256-1; Vereecken NJ, 2009, ANN BOT-LONDON, V104, P1077, DOI 10.1093/aob/mcp208; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Zuur Alain F., 2009, P1	71	15	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184760	10.1371/journal.pone.0184760	http://dx.doi.org/10.1371/journal.pone.0184760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898287	gold, Green Published, Green Submitted			2022-12-26	WOS:000410449500047
J	Ereskovsky, AV; Richter, DJ; Lavrov, DV; Schippers, KJ; Nichols, SA				Ereskovsky, Alexander V.; Richter, Daniel J.; Lavrov, Dennis V.; Schippers, Klaske J.; Nichols, Scott A.			Transcriptome sequencing and delimitation of sympatric Oscarella species (O. carmela and O. pearsei sp nov) from California, USA	PLOS ONE			English	Article							PORIFERA; DEMOSPONGIAE; SPONGES; PLAKINIDAE; EVOLUTION; LOBULARIS; ACCURATE; ORIGIN; GENES; GENUS	The homoscleromorph sponge Oscarella carmela, first described from central California, USA is shown to represent two superficially similar but both morphologically and phylogenetically distinct species that are co-distributed. We here describe a new species as Oscarella pearsei, sp. nov. and re-describe Oscarella carmela; the original description was based upon material from both species. Further, we correct the identification of published genomic/transcriptomic resources that were originally attributed to O. carmela, and present new Illumina-sequenced transcriptome assemblies for each of these species, and the mitochondrial genome sequence for O. pearsei sp. nov. Using SSU and LSU ribosomal DNA and the mitochondrial genome, we report the phylogenetic relationships of these species relative to other Oscarella species, and find strong support for the placement of O. pearsei sp. nov. in a distinct clade within genus Oscarella defined by the presence of spherulous cells that contain paracrystalline inclusions; O. carmela lacks this cell type. Oscarella pearsei sp. nov and O. carmela can be tentatively distinguished based upon gross morphological differences such as color, surface texture and extent of mucus production, but can be more reliably identified using mitochondrial and nuclear barcode sequencing, ultrastructural characteristics of cells in the mesohyl, and the morphology of the follicle epithelium which surrounds the developing embryo in reproductively active individuals.	[Ereskovsky, Alexander V.] Avignon Univ, Aix Marseille Univ, Inst Mediterraneen Biodivers & Ecol Marine & Cont, CNRS,IRD,Stn Marine Endoume, Marseille, France; [Ereskovsky, Alexander V.] St Petersburg State Univ, Fac Biol, Dept Embryol, 7-9 Univ Skaya Emb, St Petersburg, Russia; [Richter, Daniel J.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Richter, Daniel J.] UPMC Univ Paris 06, Sorbonne Univ, Adaptat & Divers Milieu Marin, UMR 7144,CNRS,Equipe EPE,Stn Biol Roscoff, Roscoff, France; [Lavrov, Dennis V.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Schippers, Klaske J.; Nichols, Scott A.] Univ Denver, Dept Biol Sci, SGM 203, Denver, CO 80208 USA	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Saint Petersburg State University; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Iowa State University; University of Denver	Nichols, SA (corresponding author), Univ Denver, Dept Biol Sci, SGM 203, Denver, CO 80208 USA.	scott.nichols@du.edu	Ereskovsky, Alexander/B-3136-2013; Lavrov, Dennis/V-3699-2019; Ereskovsky, Alexander/W-1504-2019	Ereskovsky, Alexander/0000-0003-1079-7204; Lavrov, Dennis/0000-0002-2745-1704; Richter, Daniel/0000-0002-9238-5571; Nichols, Scott/0000-0002-4765-754X; Schippers, Klaske/0000-0002-1605-3372				Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bergquist PR, 2004, NEW ZEAL J MAR FRESH, V38, P51, DOI 10.1080/00288330.2004.9517217; Boury-Esnault N, 2013, INTEGR COMP BIOL, V53, P416, DOI 10.1093/icb/ict042; BOURYESNAULT N, 1995, OPHELIA, V43, P25, DOI 10.1080/00785326.1995.10430575; BOURYESNAULT N, 1992, J NAT HIST, V26, P271, DOI 10.1080/00222939200770131; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Ereskovsky AV, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1376.1.2; Ereskovsky AV, 2009, CAH BIOL MAR, V50, P369; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Gazave E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063976; Gazave E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014290; Gloeckner V, 2013, MAR BIOL, V160, P781, DOI 10.1007/s00227-012-2133-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Muricy G, 1996, CAN J ZOOL, V74, P881, DOI 10.1139/z96-102; Muricy Guilherme, 2004, Proceedings of the California Academy of Sciences, V55, P598; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nichols SA, 2012, P NATL ACAD SCI USA, V109, P13046, DOI 10.1073/pnas.1120685109; Pearson W R, 1994, Methods Mol Biol, V25, P365; Pena JF, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0050-x; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Pett W, 2013, INTEGR COMP BIOL, V53, P495, DOI 10.1093/icb/ict079; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; van Soest RWM, WORLD PORIFERA DATAB; Voigt O, 2016, ORG DIVERS EVOL, V16, P53, DOI 10.1007/s13127-015-0247-1; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468	38	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183002	10.1371/journal.pone.0183002	http://dx.doi.org/10.1371/journal.pone.0183002			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892487	Green Published, Green Submitted, gold			2022-12-26	WOS:000410243200003
J	Anderson, EN; Wharton, KA				Anderson, Edward N.; Wharton, Kristi A.			Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); cell signaling; Drosophila; O-GlcNAcylation; protein processing; transforming growth factor (TGF-); Glass bottom boat (Gbb); prodomain; proprotein convertase	REGULATES SYNAPTIC GROWTH; DROSOPHILA-MELANOGASTER; TGF-BETA; TWISTED-GASTRULATION; II RECEPTOR; DECAPENTAPLEGIC GENE; ACTIVITY GRADIENT; ECDYSIS BEHAVIOR; PRODOMAIN LEADS; PRO-DOMAINS	The family of TGF- and bone morphogenetic protein (BMP) signaling proteins has numerous developmental and physiological roles. They are made as proprotein dimers and then cleaved by proprotein convertases to release the C-terminal domain as an active ligand dimer. Multiple proteolytic processing sites in Glass bottom boat (Gbb), the Drosophila BMP7 ortholog, can produce distinct ligand forms. Cleavage at the S1 or atypical S0 site in Gbb produces Gbb15, the conventional small BMP ligand, whereas NS site cleavage produces a larger Gbb38 ligand. We hypothesized that the Gbb prodomain is involved not only in regulating the production of specific ligands but also their signaling output. We found that blocking NS cleavage increased association of the full-length prodomain with Gbb15, resulting in a concomitant decrease in signaling activity. Moreover, NS cleavage was required in vivo for Gbb-Decapentaplegic (Dpp) heterodimer-mediated wing vein patterning but not for Gbb15-Dpp heterodimer activity in cell culture. Gbb NS cleavage was also required for viability through its regulation of pupal ecdysis in a type II receptor Wishful thinking (Wit)-dependent manner. In fact, Gbb38-mediated signaling exhibits a preference for Wit over the other type II receptor Punt. Finally, we discovered that Gbb38 is produced when processing at the S1/S0 site is blocked by O-linked glycosylation in third instar larvae. Our findings demonstrate that BMP prodomain cleavage ensures that the mature ligand is not inhibited by the prodomain. Furthermore, alternative processing of BMP proproteins produces ligands that signal through different receptors and exhibit specific developmental functions.	[Anderson, Edward N.; Wharton, Kristi A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Wharton, KA (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	kristi_wharton@brown.edu		Anderson, Edward/0000-0002-2468-0851	National Institutes of Health NIGMS [R01GM068118]; Brown University Emerging Area of New Science DEANS Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068118] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537, P40OD010949] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brown University Emerging Area of New Science DEANS Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health NIGMS Grant R01GM068118, and by a Brown University Emerging Area of New Science DEANS Award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Araujo H, 2011, GENESIS, V49, P698, DOI 10.1002/dvg.20778; Gorostiza EA, 2013, J NEUROSCI, V33, P687, DOI 10.1523/JNEUROSCI.3448-12.2013; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Beckwith EJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001733; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; CHADFIELD CG, 1985, DEV GENET, V5, P103; Chen YJ, 2008, CURR OPIN STRUC BIOL, V18, P765, DOI 10.1016/j.sbi.2008.10.005; Constam DB, 2014, SEMIN CELL DEV BIOL, V32, P85, DOI 10.1016/j.semcdb.2014.01.008; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; DOCTOR JS, 1992, DEV BIOL, V151, P491, DOI 10.1016/0012-1606(92)90188-M; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P1; Fritsch C, 2012, J BIOL CHEM, V287, P5942, DOI 10.1074/jbc.M111.316745; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Haerry TE, 2010, MECH DEVELOP, V127, P358, DOI 10.1016/j.mod.2010.04.001; Haider SR, 2010, ANAL BIOANAL CHEM, V397, P655, DOI 10.1007/s00216-010-3588-9; Harrison CA, 2011, GROWTH FACTORS, V29, P174, DOI 10.3109/08977194.2011.608666; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hwang JR, 2000, J BIOL CHEM, V275, P17886, DOI 10.1074/jbc.M000032200; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Kuhfahl S, 2011, BIOCHEM BIOPH RES CO, V408, P300, DOI 10.1016/j.bbrc.2011.04.021; Kunnapuu J, 2014, DEV BIOL, V389, P149, DOI 10.1016/j.ydbio.2014.02.007; Lahr EC, 2012, J NEUROSCI, V32, P6819, DOI 10.1523/JNEUROSCI.5301-11.2012; Le VQ, 2012, DEV DYNAM, V241, P200, DOI 10.1002/dvdy.22779; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; Mace PD, 2006, BIOCHEM BIOPH RES CO, V351, P831, DOI 10.1016/j.bbrc.2006.10.109; Makanji Y, 2011, ENDOCRINOLOGY, V152, P3758, DOI 10.1210/en.2011-1052; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Ohsawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133713; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Ray RP, 2001, DEVELOPMENT, V128, P3913; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; Szuperak M, 2011, DEVELOPMENT, V138, P715, DOI 10.1242/dev.059477; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tilak A, 2014, DEVELOPMENT, V141, P3062, DOI 10.1242/dev.110130; Veverytsa L, 2012, P NATL ACAD SCI USA, V109, pE748, DOI 10.1073/pnas.1114710109; Veverytsa L, 2011, DEVELOPMENT, V138, P3147, DOI 10.1242/dev.064105; Vilmos P, 2005, EMBO REP, V6, P262, DOI 10.1038/sj.embor.7400347; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Wharton K, 1996, GENETICS, V142, P493; Wharton KA, 1999, GENETICS, V152, P629; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; Zhuang ZH, 2006, CELL SIGNAL, V18, P441, DOI 10.1016/j.cellsig.2005.05.013	88	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19160	19178		10.1074/jbc.M117.793513	http://dx.doi.org/10.1074/jbc.M117.793513			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28924042	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000416226700003
J	DeLigio, JT; Lin, G; Chalfant, CE; Park, MA				DeLigio, James T.; Lin, Grace; Chalfant, Charles E.; Park, Margaret A.			Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TRANSLATIONAL CONTROL; DEGRADATION; INHIBITION; ACTIVATION; EXPRESSION; ANOIKIS; GROWTH	The translational regulator cytosolic polyadenylation element-binding protein 2 (CPEB2) has two isoforms, CPEB2A and CPEB2B, derived by alternative splicing of RNA into a mature form that either includes or excludes exon 4. Previously, we reported that this splicing event is highly dysregulated in aggressive forms of breast cancers, which overexpress CPEB2B. The loss of CPEB2A with a concomitant increase in CPEB2B was also required for breast cancer cells to resist cell death because of detachment (anoikis resistance) and metastasize in vivo. To examine the mechanism by which CPEB2 isoforms mediate opposing effects on cancer-related phenotypes, we used next generation sequencing of triple negative breast cancer cells in which the isoforms were specifically down-regulated. Downregulation of the CPEB2B isoform inhibited pathways driving the epithelial-to-mesenchymal transition and hypoxic response, whereas down-regulation of the CPEB2A isoform did not have this effect. Examining key nodes of these pathways showed that CPEB2B induced the expression of regulatory DNA trans-factors (e.g. HIF1 alpha and TWIST1). Specifically, CPEB2B functioned as a translational activator of TWIST1 and HIF1 alpha. Functional studies showed that specific down-regulation of either HIF1 alpha or TWIST1 inhibited the ability of CPEB2B to induce the acquisition of anoikis resistance and drive metastasis. Overall, this study demonstrates that CPEB2 alternative splicing is a major regulator of key cellular pathways linked to anoikis resistance and metastasis.	[DeLigio, James T.; Lin, Grace; Chalfant, Charles E.; Park, Margaret A.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Canc Cell Signaling Program, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Hunter Holmes McGuire Vet Adm Med Ctr, Res Serv, Richmond, VA 23249 USA; [Chalfant, Charles E.] VCU Inst Mol Med, Richmond, VA 23298 USA; [Chalfant, Charles E.] VCU Johnson Ctr Crit Care & Pulm Res, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Chalfant, Charles E.; Park, Margaret A.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Chalfant, Charles E.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; H Lee Moffitt Cancer Center & Research Institute	Chalfant, CE; Park, MA (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	cechalfant@usf.edu; mapark@usf.edu			NCI, National Institutes of Health [P30 CA016059]; VCU Massey Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD087198] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA154314, P30CA016059, R01CA117950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); VCU Massey Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Services and products in support of the research project were generated by the VCU Massey Cancer Center Shared Resources supported, in part, with funding from NCI, National Institutes of Health, Cancer Center Support Grant P30 CA016059.	Anderson TMR, 2016, CANCER RES, V76, P1653, DOI 10.1158/0008-5472.CAN-15-2510; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Dai XF, 2015, AM J CANCER RES, V5, P2929; Finlay J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/382745; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Granados-Principal S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0527-x; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Haque R, 2012, CANCER EPIDEM BIOMAR, V21, P1848, DOI 10.1158/1055-9965.EPI-12-0474; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hsia TC, 2014, MOLECULES, V19, P19892, DOI 10.3390/molecules191219892; Johnson RM, 2015, J BIOL CHEM, V290, P25717, DOI 10.1074/jbc.M115.671206; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Mahara S, 2016, P NATL ACAD SCI USA, V113, pE3735, DOI 10.1073/pnas.1602079113; Nairismagi ML, 2012, ONCOGENE, V31, P4960, DOI 10.1038/onc.2011.650; Nairismagi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066070; Rhodes LV, 2015, ONCOTARGET, V6, P16638, DOI 10.18632/oncotarget.3184; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Shapiro BA, 2016, J BIOL CHEM, V291, P21669, DOI 10.1074/jbc.M116.737569; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Teo CSH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005927; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vu NT, 2016, CANCER RES, V76, P2977, DOI 10.1158/0008-5472.CAN-15-2512; Vu NT, 2013, J BIOL CHEM, V288, P8575, DOI 10.1074/jbc.M112.443333; Wang RH, 2016, BIOCHEM BIOPH RES CO, V470, P117, DOI 10.1016/j.bbrc.2016.01.005	28	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17909	17918		10.1074/jbc.M117.810127	http://dx.doi.org/10.1074/jbc.M117.810127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28904175	Green Published, hybrid			2022-12-26	WOS:000414013000026
J	Hara, K; Taharazako, S; Ikeda, M; Fujita, H; Mikami, Y; Kikuchi, S; Hishiki, A; Yokoyama, H; Ishikawa, Y; Kanno, S; Tanaka, K; Hashimoto, H				Hara, Kodai; Taharazako, Shota; Ikeda, Masanori; Fujita, Hiroki; Mikami, Yoshiko; Kikuchi, Sotaro; Hishiki, Asami; Yokoyama, Hideshi; Ishikawa, Yoshinobu; Kanno, Shin-ichiro; Tanaka, Kozo; Hashimoto, Hiroshi			Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ZETA; CRYSTAL-STRUCTURE; HUMAN REV7; COMPLEX; BINDING; MUTAGENESIS; INSIGHTS; GENE; ACTIVATION; INHIBITOR	Mitotic arrest deficient 2-like protein 2 (MAD2L2), also termed MAD2B or REV7, is involved in multiple cellular functions including translesion DNA synthesis (TLS), signal transduction, transcription, and mitotic events. MAD2L2 interacts with chromosome alignment-maintaining phosphoprotein (CAMP), a kinetochore-microtubule attachment protein in mitotic cells, presumably through a novel "WK" motif in CAMP. Structures of MAD2L2 in complex with binding regions of the TLS proteins REV3 and REV1 have revealed that MAD2L2 has two faces for protein-protein interactions that are regulated by its C-terminal region; however, the mechanisms underlying the MAD2L2-CAMP interaction and the mitotic role of MAD2L2 remain unknown. Here we have determined the structures of human MAD2L2 in complex with a CAMP fragment in two crystal forms. The overall structure of the MAD2L2-CAMP complex in both crystal forms was essentially similar to that of the MAD2L2-REV3 complex. However, the residue interactions between MAD2L2 and CAMP were strikingly different from those in the MAD2L2-REV3 complex. Furthermore, structure-based interaction analyses revealed an unprecedented mechanism involving CAMP's WK motif. Surprisingly, in one of the crystal forms, the MAD2L2-CAMP complex formed a dimeric structure in which the C-terminal region of MAD2L2 was swapped and adopted an immature structure. The structure provides direct evidence for the dynamic nature of MAD2L2 structure, which in turn may have implications for the protein-protein interaction mechanism and the multiple functions of this protein. This work is the first structural study of MAD2L2 aside from its role in TLS and might pave the way to clarify MAD2L2's function in mitosis.	[Hara, Kodai; Taharazako, Shota; Kikuchi, Sotaro; Hishiki, Asami; Ishikawa, Yoshinobu; Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228002, Japan; [Ikeda, Masanori; Fujita, Hiroki; Mikami, Yoshiko; Kanno, Shin-ichiro; Tanaka, Kozo] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Yokoyama, Hideshi] Tokyo Univ Sci, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan	University of Shizuoka; Tohoku University; Tokyo University of Science	Hashimoto, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228002, Japan.	hash@u-shizuoka-ken.ac.jp	Kanno, Shin-ichiro/AAE-4549-2019; Tanaka, Kozo/Y-6566-2018	hara, kodai/0000-0002-1586-6312; Tanaka, Kozo/0000-0001-6086-2858; Hashimoto, Hiroshi/0000-0003-1503-6789; Yokoyama, Hideshi/0000-0002-3137-2793	JSPS KAKENHI [25291017, 16H04755, 15K18491, 17K07314, 15H04368]; MEXT KAKENHI [25121728, 17H06014, 16H01296]; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [16H01296] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 25291017 and 16H04755, MEXT KAKENHI Grants 25121728 and 17H06014, The Takeda Science Foundation and Naito Foundation (to H. H.), JSPS KAKENHI Grants 15K18491 and 17K07314 (to K. H.), and JSPS KAKENHI Grant 15H04368, MEXT KAKENHI Grant 16H01296, and a grant from the Takeda Science Foundation (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhat A, 2015, CELL CYCLE, V14, P3929, DOI 10.1080/15384101.2015.1120922; Bluteau D, 2016, J CLIN INVEST, V126, P3580, DOI 10.1172/JCI88010; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Hanafusa T, 2010, GENES CELLS, V15, P281, DOI 10.1111/j.1365-2443.2009.01380.x; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; Hara M, 2015, P NATL ACAD SCI USA, V112, P11252, DOI 10.1073/pnas.1512197112; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Itoh G, 2011, EMBO J, V30, P130, DOI 10.1038/emboj.2010.276; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; LAWRENCE CW, 1985, MOL GEN GENET, V200, P86, DOI 10.1007/BF00383317; Listovsky T, 2013, J CELL BIOL, V203, P87, DOI 10.1083/jcb.201302060; Liu D, 2013, J MOL CELL BIOL, V5, P204, DOI 10.1093/jmcb/mjs061; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medendorp K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015128; Medendorp K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007020; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Tanaka AJ, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000661; Tomida J, 2015, NUCLEIC ACIDS RES, V43, P1000, DOI 10.1093/nar/gku1385; TORPEY LE, 1994, YEAST, V10, P1503, DOI 10.1002/yea.320101115; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Xie W, 2012, PROTEIN CELL, V3, P864, DOI 10.1007/s13238-012-2102-x; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	44	25	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17658	17667		10.1074/jbc.M117.804237	http://dx.doi.org/10.1074/jbc.M117.804237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887307	hybrid, Green Published			2022-12-26	WOS:000414013000008
J	Herold, M; Breuer, J; Hucke, S; Knolle, P; Schwab, N; Wiendl, H; Klotz, L				Herold, Martin; Breuer, Johanna; Hucke, Stephanie; Knolle, Percy; Schwab, Nicholas; Wiendl, Heinz; Klotz, Luisa			Liver X receptor activation promotes differentiation of regulatory T cells	PLOS ONE			English	Article							NERVOUS-SYSTEM AUTOIMMUNITY; TRYPTOPHAN CATABOLISM; NUCLEAR RECEPTORS; IMMUNE TOLERANCE; LIPID-METABOLISM; RETINOIC ACID; LXR-ALPHA; EXPRESSION; INFLAMMATION; COLITIS	The nuclear receptor Liver X Receptor (LXR) is a ligand-activated transcription factor that has been implicated in control of chronic inflammation by downregulating pro-inflammatory T cell responses. An impaired function of regulatory T cells, a subset of CD4+ T cells with a crucial role in maintaining lymphocytes homeostasis and immune regulation, is frequently observed in chronic inflammatory diseases. We observed that pharmacological activation of LXR in T cells not only resulted in a thorough suppression of Th1 and Th17 polarization in vitro, but also significantly induced regulatory T cells (Treg) cell differentiation in a receptor-specific fashion. In line with this, systemic LXR activation by oral treatment of mice with the LXR agonist GW3965 induced gut-associated regulatory T cells in vivo. Importantly, such LXR-activated Tregs had a higher suppressive capacity in functional in vitro coculture assays with effector T cells. Our data thus point towards a dual role of LXR-mediated control of inflammation by suppression of pro-inflammatory T cells and reciprocal induction of regulatory T cells.	[Herold, Martin; Breuer, Johanna; Hucke, Stephanie; Schwab, Nicholas; Wiendl, Heinz; Klotz, Luisa] Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, Munster, Germany; [Knolle, Percy] Tech Univ Munich, Inst Mol Immunol & Expt Oncol, Munich, Germany	University of Munster; Technical University of Munich	Klotz, L (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, Munster, Germany.	Luisa.klotz@ukmuenster.de	Klotz, Luisa/HCI-7635-2022; Wiendl, Heinz/AAX-6041-2021	Knolle, Percy A./0000-0003-2983-0414; Schwab, Nicholas/0000-0001-5494-9885; Wiendl, Heinz/0000-0003-4310-3432	German Research Foundation [CRC 128 A8, 704]; Interdisciplinary center for clinical research (IZKF) [KI2/015/14]	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary center for clinical research (IZKF)	This study was supported by the German Research Foundation Grant Number CRC 128 A8 and 704 to LK (http://www.stbtr128.de/; www.limes-institut-bonn.de/forschung/forschungsverbuende/sfb-704/) and the Interdisciplinary center for clinical research (IZKF) Grant Number KI2/015/14 to LK (https://campus. uni-muerster.de/izkf.html).	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Barreto M, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-5; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Breuer J, 2014, ANN NEUROL, V75, P739, DOI 10.1002/ana.24165; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen X, 2011, INT IMMUNOPHARMACOL, V11, P1489, DOI 10.1016/j.intimp.2011.05.018; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Dunn SE, 2010, J EXP MED, V207, P1599, DOI 10.1084/jem.20091663; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin L, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0187-3; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menning A, 2010, EUR J IMMUNOL, V40, P2539, DOI 10.1002/eji.200939938; Mohinta S, 2015, TOXICOL SCI, V145, P233, DOI 10.1093/toxsci/kfv046; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nomura T, 2005, CURR TOP MICROBIOL, V293, P287, DOI 10.1007/3-540-27702-1_13; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; SHINAR DM, 1994, GENE, V147, P273, DOI 10.1016/0378-1119(94)90080-9; Sidhu-Varma M, 2016, INFLAMM BOWEL DIS, V22, P548, DOI 10.1097/MIB.0000000000000653; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Walcher D, 2006, ARTERIOSCL THROM VAS, V26, P1022, DOI 10.1161/01.ATV.0000210278.67076.8f; Wang Y, 2014, GUT MICROBES, V5, P552, DOI 10.4161/gmic.29797; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600	55	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184985	10.1371/journal.pone.0184985	http://dx.doi.org/10.1371/journal.pone.0184985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926619	Green Submitted, gold, Green Published			2022-12-26	WOS:000411166600058
J	Ly, HJ; Lokugamage, N; Nishiyama, S; Ikegami, T				Ly, Hoai J.; Lokugamage, Nandadeva; Nishiyama, Shoko; Ikegami, Tetsuro			Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain	PLOS ONE			English	Article							GENUS PHLEBOVIRUS; HEMORRHAGIC-FEVER; GENETIC DIVERSITY; VIRUS; TRANSMISSION; RNA; TRANSCRIPTION; EPIDEMIOLOGY; EVOLUTIONARY; OUTBREAKS	Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Arabian Peninsula. The causative agent, Rift Valley fever phlebovirus (RVFV), belongs to the genus Phlebovirus in the family Phenuiviridae and causes high rates of abortions in ruminants, and hemorrhagic fever, encephalitis, or blindness in humans. Viral maintenance by mosquito vectors has led to sporadic RVF outbreaks in ruminants and humans in endemic countries, and effective vaccination of animals and humans may minimize the impact of this disease. A live-attenuated MP-12 vaccine strain is one of the best characterized RVFV strains, and was conditionally approved as a veterinary vaccine in the U.S. Live-attenuated RVF vaccines including MP-12 strain may form reassortant strains with other bunyavirus species. This study thus aimed to characterize the occurrence of genetic reassortment between the MP-12 strain and bunyavirus species closely related to RVFV. The Arumowot virus (AMTV) and Gouleako goukovirus (GOLV), are transmitted by mosquitoes in Africa. The results of this study showed that GOLV does not form detectable reassortant strains with the MP-12 strain in co-infected C6/36 cells. The AMTV also did not form any reassortant strains with MP-12 strain in co-infected C6/36 cells, due to the incompatibility among N, L, and Gn/Gc proteins. A lack of reassortant formation could be due to a functional incompatibility of N and L proteins derived from heterologous species, and due to a lack of packaging via heterologous Gn/Gc proteins. The MP-12 strain did, however, randomly exchange L-, M-, and S-segments with a genetic variant strain, rMP12-GM50, in culture cells. The MP-12 strain is thus unlikely to form any reassortant strains with AMTV or GOLV in nature.	[Ly, Hoai J.; Lokugamage, Nandadeva; Nishiyama, Shoko; Ikegami, Tetsuro] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA; [Nishiyama, Shoko] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Hokkaido University	Ikegami, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Ikegami, T (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Ikegami, T (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.	teikegam@utmb.edu	Ikegami, Tetsuro/H-1329-2013	Ikegami, Tetsuro/0000-0001-8318-2783	American people through the United States Agency for International Development (USAID) [26-3002-6062, AID-OAA-A-13-00084]; Kansas Bioscience Authority [S13027]; NIH/NIAID [R01 AI08764301-A1]; Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston; James W. McLaughlin Postdoctoral Fellowship at UTMB	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Kansas Bioscience Authority; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston; James W. McLaughlin Postdoctoral Fellowship at UTMB	This study was made possible by the generous support of the subcontract 26-3002-6062 from the American people through the United States Agency for International Development (USAID, AID-OAA-A-13-00084, http://research.utep.edu/Default.aspx?alias=research.utep.edu/riftvalleyfeverinnovationlab). The study was also partially supported by the Kansas Bioscience Authority (http://www.kansasbioauthority.org/) grant subcontract S13027, the NIH/NIAID (https://www.niaid.nih.gov/) grant R01 AI08764301-A1, and the funding from the Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston (https://www.utmb.edu/scvd/). SN was supported by the James W. McLaughlin Postdoctoral Fellowship at UTMB (https://www.utmb.edu/mclaughlin/index.htm). The contents do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi L, 2001, J GEN VIROL, V82, P781, DOI 10.1099/0022-1317-82-4-781; Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005; Berger S, 2016, RIFT VALLEY FEVER GL; Berthet N, 2016, VECTOR-BORNE ZOONOT, V16, P139, DOI 10.1089/vbz.2015.1830; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Chung HC, 2014, EMERG INFECT DIS, V20, P2072, DOI 10.3201/eid2012.131742; Freire CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11353; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; GONZALEZ JP, 1992, T ROY SOC TROP MED H, V86, P680, DOI 10.1016/0035-9203(92)90190-N; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2015, J VIROL, V89, P7262, DOI 10.1128/JVI.00135-15; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Junglen S, 2015, EMERG INFECT DIS, V21, P2190, DOI 10.3201/eid2112.141840; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Ly HJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0573-8; Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11; Marklewitz Marco, 2015, Proc Natl Acad Sci U S A, V112, P7536, DOI 10.1073/pnas.1502036112; Miller MM, 2015, CLIN VACCINE IMMUNOL, V22, P930, DOI 10.1128/CVI.00114-15; Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032; Muga GO, 2015, AM J TROP MED HYG, V92, P730, DOI 10.4269/ajtmh.14-0363; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65; SWANEPOEL R, 1986, J HYG-CAMBRIDGE, V97, P331, DOI 10.1017/S0022172400065426; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; TESH RB, 1988, ANNU REV ENTOMOL, V33, P169, DOI 10.1146/annurev.en.33.010188.001125; TURELL MJ, 1991, AM J TROP MED HYG, V44, P278, DOI 10.4269/ajtmh.1991.44.278; Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185194	10.1371/journal.pone.0185194	http://dx.doi.org/10.1371/journal.pone.0185194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926632	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600076
J	Westfall, DA; Krishnamoorthy, G; Wolloscheck, D; Sarkar, R; Zgurskaya, HI; Rybenkov, VV				Westfall, David A.; Krishnamoorthy, Ganesh; Wolloscheck, David; Sarkar, Rupa; Zgurskaya, Helen I.; Rybenkov, Valentin V.			Bifurcation kinetics of drug uptake by Gram-negative bacteria	PLOS ONE			English	Article							MULTIDRUG TRANSPORTER LMRP; ESCHERICHIA-COLI; OUTER-MEMBRANE; P-GLYCOPROTEIN; PSEUDOMONAS-AERUGINOSA; PERMEABILITY BARRIER; EFFLUX PUMPS; BETA-LACTAMS; ACRAB-TOLC; RESISTANCE	Cell envelopes of many bacteria consist of two membranes studded with efflux transporters. Such organization protects bacteria from the environment and gives rise to multidrug resistance. We report a kinetic model that accurately describes the permeation properties of this system. The model predicts complex non-linear patterns of drug uptake complete with a bifurcation, which recapitulate the known experimental anomalies. We introduce two kinetic parameters, the efflux and barrier constants, which replace those of Michaelis and Menten for trans-envelope transport. Both compound permeation and efflux display transitions, which delineate regimes of efficient and inefficient efflux. The first transition is related to saturation of the transporter by the compound and the second one behaves as a bifurcation and involves saturation of the outer membrane barrier. The bifurcation was experimentally observed in live bacteria. We further found that active efflux of a drug can be orders of magnitude faster than its diffusion into a cell and that the efficacy of a drug depends both on its transport properties and therapeutic potency. This analysis reveals novel physical principles in the behavior of the cellular envelope, creates a framework for quantification of small molecule permeation into bacteria, and should invigorate structure-activity studies of novel antibiotics.	[Westfall, David A.; Krishnamoorthy, Ganesh; Wolloscheck, David; Sarkar, Rupa; Zgurskaya, Helen I.; Rybenkov, Valentin V.] Univ Oklahoma, Dept Chem & Biochem, Stephenson Pkwy, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Zgurskaya, HI; Rybenkov, VV (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Stephenson Pkwy, Norman, OK 73019 USA.	elenaz@ou.edu; valya@ou.edu		Zgurskaya, Helen/0000-0001-8929-4727	Department of the Defense, Defense Threat Reduction Agency [HDTRA1-14-1-0019]	Department of the Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the award HDTRA1-14-1-0019 from the Department of the Defense, Defense Threat Reduction Agency to HIZ and WR. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASUQUO AE, 1993, J ANTIMICROB CHEMOTH, V31, P865, DOI 10.1093/jac/31.6.865; Bauer WR, 2006, P NATL ACAD SCI USA, V103, P11446, DOI 10.1073/pnas.0601769103; Bezrukov SM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766720; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; CHEN AY, 1993, CANCER RES, V53, P1332; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daury L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10731; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Eren E, 2013, J BIOL CHEM, V288, P12042, DOI 10.1074/jbc.M113.463570; Gutfreund H., 1975, Ontario Field Biologist, V29, P161; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krishnamoorthy G, 2016, ANTIMICROB AGENTS CH, V60, P7372, DOI 10.1128/AAC.01882-16; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Lomovskaya O, 2008, METHODS PRINCIPLES M, V33; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1033.2001.02041.x; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Mohammad MM, 2011, J BIOL CHEM, V286, P8000, DOI 10.1074/jbc.M110.197723; Muller H, 2007, BIOORGAN MED CHEM, V15, P7470, DOI 10.1016/j.bmc.2007.07.024; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nakae T, 1982, Tokai J Exp Clin Med, V7 Suppl, P141; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, V1; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Ohki S, 2004, STRUCTURE BIOL MEMBR; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Petrushenko ZM, 2011, MOL MICROBIOL, V81, P881, DOI 10.1111/j.1365-2958.2011.07763.x; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Pothula KR, 2016, BBA-BIOMEMBRANES, V1858, P1760, DOI 10.1016/j.bbamem.2015.12.020; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Ricci V, 2003, J ANTIMICROB CHEMOTH, V52, P605, DOI 10.1093/jac/dkg418; Rice LB, 2012, MAYO CLIN PROC, V87, P198, DOI 10.1016/j.mayocp.2011.12.003; Richmond GE, 2013, J ANTIMICROB CHEMOTH, V68, P1594, DOI 10.1093/jac/dkt052; Ruggerone P, 2013, CURR TOP MED CHEM, V13, P3079, DOI 10.2174/15680266113136660220; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Silver LL, 2016, BIOORGAN MED CHEM, V24, P6379, DOI 10.1016/j.bmc.2016.06.044; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Trusts PC, 2016, SCI ROADM ANT DISC S; Zgurskaya HI, 2015, ACS INFECT DIS, V1, P512, DOI 10.1021/acsinfecdis.5b00097; Zgurskaya HI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00100; Zhou Y, 2015, ANAL CHEM, V87, P3579, DOI 10.1021/ac504880r	52	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184671	10.1371/journal.pone.0184671	http://dx.doi.org/10.1371/journal.pone.0184671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926596	gold, Green Submitted, Green Published			2022-12-26	WOS:000411166600031
J	Huang, XB; Mu, XH; Wan, QL; He, XM; Wu, GS; Luo, HR				Huang, Xiao-Bing; Mu, Xiao-Hui; Wan, Qin-Li; He, Xiao-Ming; Wu, Gui-Sheng; Luo, Huai-Rong			Aspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STEM-CELLS; C. ELEGANS; REPRODUCTIVE-SYSTEM; SODIUM-SALICYLATE; FAT-METABOLISM; KAPPA-B; LONGEVITY; ACID; DISEASE	Aspirin is a prototypic cyclooxygenase inhibitor with a variety of beneficial effects on human health. It prevents age-related diseases and delays the aging process. Previous research has shown that aspirin might act through a dietary restriction-like mechanism to extend lifespan. To explore the mechanism of action of aspirin on aging, we determined the wholegenome expression profile of Caenorhabditis elegans treated with aspirin. Transcriptome analysis revealed the RNA levels of genes involved in metabolism were primarily increased. Reproduction has been reported to be associated with metabolism. We found that aspirin did not extend the lifespan or improve the heat stress resistance of germline mutants of glp1. Furthermore, Oil Red O staining showed that aspirin treatment decreased lipid deposition and increased expression of lipid hydrolysis and fatty acid beta-oxidation-related genes. The effect of germline ablation on lifespan was mainly mediated by DAF-12 and DAF-16. Next, we performed genetic analysis with a series of worm mutants and found that aspirin did not further extend the lifespans of daf-12 and daf-16 single mutants, glp-1; daf-12 and glp-1; daf16 double mutants, or glp-1; daf-12; daf-16 triple mutants. The results suggest that aspirin increase metabolism and regulate germline signalling to activate downstream DAF-12 and DAF-16 to extend lifespan.	[Huang, Xiao-Bing; Wan, Qin-Li; He, Xiao-Ming; Wu, Gui-Sheng; Luo, Huai-Rong] Southwest Med Univ, Sch Pharm, Dept Pharmacol, Key Lab Aging & Regenerat Med, Luzhou, Sichuan, Peoples R China; [Mu, Xiao-Hui; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Mu, Xiao-Hui; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming, Yunnan, Peoples R China; [Mu, Xiao-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China	Southwest Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Luo, HR (corresponding author), Southwest Med Univ, Sch Pharm, Dept Pharmacol, Key Lab Aging & Regenerat Med, Luzhou, Sichuan, Peoples R China.; Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.; Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming, Yunnan, Peoples R China.	lhr@swmu.edu.cn	Luo, Huai-Rong/ABE-7525-2021	Luo, Huai-Rong/0000-0001-8912-6694; wan, qinli/0000-0003-2864-912X	National Natural Science Foundation of China [81370453, 81671405]; Natural Science Foundation of Yunnan Province [2015FB172]; Science and Technology Cooperation Project of Luzhou and Southwest Medical University [2016LZXNYD-Z05]; National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Science and Technology Cooperation Project of Luzhou and Southwest Medical University; National Institutes of Health (NIH) Office of Research Infrastructure Programs	This work was supported by the National Natural Science Foundation of China (81370453 and 81671405), the Natural Science Foundation of Yunnan Province (2015FB172), and the Science and Technology Cooperation Project of Luzhou and Southwest Medical University (2016LZXNYD-Z05).; We thank the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440), for providing some of the Caenorhabditis elegans strains used in this work.	AD2000 Collaborative Grp, 2008, LANCET NEUROL, V7, P41, DOI 10.1016/S1474-4422(07)70293-4; Ai GQ, 2016, MOL MED REP, V14, P1726, DOI 10.3892/mmr.2016.5449; Amrit FRG, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005788; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Antebi A, 2013, EXP GERONTOL, V48, P596, DOI 10.1016/j.exger.2012.09.009; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ayyadevara S, 2017, ANTIOXID REDOX SIGNA; Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Bode-Boger SM, 2005, BIOCHEM BIOPH RES CO, V334, P1226, DOI 10.1016/j.bbrc.2005.07.014; Chakraborty K, 2003, PLATELETS, V14, P421, DOI 10.1080/095371032000158763; Choi HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143447; Dachineni R, 2016, MOL CANCER RES, V14, P241, DOI 10.1158/1541-7786.MCR-15-0360; Danilov A, 2015, ONCOTARGET, V6, P19428, DOI 10.18632/oncotarget.5118; Finamore F, 2015, J PROTEOMICS, V114, P125, DOI 10.1016/j.jprot.2014.11.005; Gallo Marco, 2010, Journal of Biology (London), V9, P7, DOI 10.1186/jbiol215; Ghazi A, 2013, GENESIS, V51, P1, DOI 10.1002/dvg.22345; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kaser-Pebernard S, 2014, STEM CELL REP, V2, P547, DOI 10.1016/j.stemcr.2014.02.007; Kamble P, 2013, EUR J PHARMACOL, V699, P55, DOI 10.1016/j.ejphar.2012.11.051; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lucanic M, 2013, AGEING RES REV, V12, P445, DOI 10.1016/j.arr.2012.06.006; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; McNellis RJ, 2016, AM FAM PHYSICIAN, V94, P661; Medeiros R, 2013, AM J PATHOL, V182, P1780, DOI 10.1016/j.ajpath.2013.01.051; Mitchell JA, 1997, MOL PHARMACOL, V51, P907, DOI 10.1124/mol.51.6.907; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Qin Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8107; Shirakawa K, 2016, ELIFE, V5, DOI 10.7554/eLife.11156; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Tatar Marc, 2002, Sci Aging Knowledge Environ, V2002, ppe2, DOI 10.1126/sageke.2002.3.pe2; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wan QL, 2013, EXP GERONTOL, V48, P499, DOI 10.1016/j.exger.2013.02.020; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005027; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105; Zheng SQ, 2014, AGE, V36, DOI 10.1007/s11357-014-9719-z	49	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184027	10.1371/journal.pone.0184027	http://dx.doi.org/10.1371/journal.pone.0184027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910305	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200027
J	Kirk, IK; Weinhold, N; Brunak, S; Belling, K				Kirk, Isa Kristina; Weinhold, Nils; Brunak, Soren; Belling, Kirstine			The impact of the protein interactome on the syntenic structure of mammalian genomes	PLOS ONE			English	Article							GENE; IDENTIFICATION; MOUSE; DRAFT; MAP	Conserved synteny denotes evolutionary preserved gene order across species. It is not well understood to which degree functional relationships between genes are preserved in syntenic blocks. Here we investigate whether protein-coding genes conserved in mammalian syntenic blocks encode gene products that serve the common functional purpose of interacting at protein level, i.e. connectivity. High connectivity among protein-protein interactions (PPIs) was only moderately associated with conserved synteny on a genome-wide scale. However, we observed a smaller subset of 3.6% of all syntenic blocks with high-confidence PPIs that had significantly higher connectivity than expected by random. Additionally, syntenic blocks with high-confidence PPIs contained significantly more chromatin loops than the remaining blocks, indicating functional preservation among these syntenic blocks. Conserved synteny is typically defined by sequence similarity. In this study, we also examined whether a functional relationship, here PPI connectivity, can identify syntenic blocks independently of orthology. While orthology-based syntenic blocks with high-confident PPIs and the connectivity-based syntenic blocks largely overlapped, the connectivity-based approach identified additional syntenic blocks that were not found by conventional sequence-based methods alone. Additionally, the connectivity-based approach enabled identification of potential orthologous genes between species. Our analyses demonstrate that subsets of syntenic blocks are associated with highly connected proteins, and that PPI connectivity can be used to detect conserved synteny even if sequence conservation drifts beyond what orthology algorithms normally can identify.	[Kirk, Isa Kristina; Brunak, Soren; Belling, Kirstine] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark; [Weinhold, Nils] Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA	Novo Nordisk Foundation; University of Copenhagen; Memorial Sloan Kettering Cancer Center	Belling, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark.	kirstine.belling@cpr.ku.dk	Belling, Kirstine/AAJ-6569-2021	Belling, Kirstine/0000-0001-5664-1948	SyBoSS (EU) [242129]; Novo Nordisk Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish	SyBoSS (EU); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation Center for Protein Research	This work was supported by FP7 grant SyBoSS (EU 7th Framework G.A. No 242129) (SB received the funding), and the Novo Nordisk Foundation (grant agreement NNF14CC0001) (SB received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge funding from the FP7 grant SyBoSS (EU 7th Framework G.A. No 242129) as well as the Novo Nordisk Foundation (grant agreement NNF14CC0001).	Anthon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-459; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Courcelle E, 2008, NUCLEIC ACIDS RES, V36, pD485, DOI 10.1093/nar/gkm805; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; Dogini DB, 2014, GENET MOL BIOL, V37, P285, DOI 10.1590/S1415-47572014000200014; Donthu Ravikiran, 2009, BMC Res Notes, V2, P148, DOI 10.1186/1756-0500-2-148; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Malewski Tadeusz, 2006, Animal Science Papers and Reports, V24, P39; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ruiz-Herrera A, 2012, HEREDITY, V108, P28, DOI 10.1038/hdy.2011.102; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89; Sankoff D, 1996, DISCRETE APPL MATH, V71, P247, DOI 10.1016/S0166-218X(96)00067-4; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winterbach W, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-90; YODER FE, 1974, AM J HUM GENET, V26, P535; Yuan ZD, 2013, INT J MOL SCI, V14, P20820, DOI 10.3390/ijms141020820; Zheng XH, 2005, BIOINFORMATICS, V21, P703, DOI 10.1093/bioinformatics/bti045	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0179112	10.1371/journal.pone.0179112	http://dx.doi.org/10.1371/journal.pone.0179112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910296	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200001
J	Kleineidam, CJ; Heeb, EL; Neupert, S				Kleineidam, Christoph Johannes; Heeb, Eva Linda; Neupert, Stefanie			Social interactions promote adaptive resource defense in ants	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; NESTMATE-RECOGNITION; TERRITORIAL MARKING; CAMPONOTUS-FELLAH; CATAGLYPHIS-NIGER; FORMICA-POLYCTENA; HARVESTER ANTS; ANTENNAL LOBE; WOOD-ANT; HYMENOPTERA	Social insects vigorously defend their nests against con-and heterospecific competitors. Collective defense is also seen at highly profitable food sources. Aggressive responses are elicited or promoted by several means of communication, e.g. alarm pheromones and other chemical markings. In this study, we demonstrate that the social environment and interactions among colony members (nestmates) modulates the propensity to engage in aggressive behavior and therefore plays an important role in allocating workers to a defense task. We kept Formica rufa workers in groups or isolated for different time spans and then tested their aggressiveness in one-on-one encounters with other ants. In groups of more than 20 workers that are freely interacting, individuals are aggressive in one-on-one encounters with non-nestmates, whereas aggressiveness of isolated workers decreases with increasing isolation time. We conclude that ants foraging collectively and interacting frequently, e.g. along foraging trails and at profitable food sources, remain in a social context and thereby maintain high aggressiveness against potential competitors. Our results suggest that the nestmate recognition system can be utilized at remote sites for an adaptive and flexible tuning of the response against competitors.	[Kleineidam, Christoph Johannes; Heeb, Eva Linda; Neupert, Stefanie] Univ Konstanz, Dept Biol, Behav Neurobiol, Constance, Germany	University of Konstanz	Kleineidam, CJ (corresponding author), Univ Konstanz, Dept Biol, Behav Neurobiol, Constance, Germany.	Christoph.Kleineidam@uni-konstanz.de	Kleineidam, Christoph J/A-6529-2009	Kleineidam, Christoph J/0000-0003-0671-1455	EUROPEAN COMMISSION Research Executive Agency Marie Curie Actions - International Research Staff Exchange Scheme [319015]; DAAD, PPPAustralien-Kleineidam [57219808]; IMPRS Organismal Biology, University of Konstanz [M.R8.A.ORNI0001 J]	EUROPEAN COMMISSION Research Executive Agency Marie Curie Actions - International Research Staff Exchange Scheme; DAAD, PPPAustralien-Kleineidam; IMPRS Organismal Biology, University of Konstanz	Funded by EUROPEAN COMMISSION Research Executive Agency Marie Curie Actions - International Research Staff Exchange Scheme Project No: 319015. http://ec.europa.eu/research/ maricurieactions/funded-projects/international-research-staff-exchange-scheme_en to CJK and SN. DAAD, PPPAustralien2015-Kleineidam. https://www.daad.de/de/ to CJK and SN Projekt 57219808. IMPRS Organismal Biology, University of Konstanz. http://www.orn.mpg.de/2453/Short_ portrait to SN. Projekt M.R8.A.ORNI0001 J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1990, ANIM BEHAV, V39, P321, DOI 10.1016/S0003-3472(05)80877-2; ALLOWAY TM, 1979, ANIM BEHAV, V27, P202, DOI 10.1016/0003-3472(79)90140-4; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Batchelor TP, 2010, ANIM BEHAV, V80, P443, DOI 10.1016/j.anbehav.2010.05.030; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Bos N, 2013, J EXP BIOL, V216, P3314, DOI 10.1242/jeb.087007; Boulay R, 2004, INSECT SOC, V51, P55, DOI 10.1007/s00040-003-0706-0; Boulay R, 2007, ANIM BEHAV, V74, P985, DOI 10.1016/j.anbehav.2007.02.013; Boulay R, 2010, ECOLOGY, V91, P3312, DOI 10.1890/09-1520.1; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Brandstaetter AS, 2011, J NEUROPHYSIOL, V106, P2437, DOI 10.1152/jn.01106.2010; Brandstaetter AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021383; Buczkowski G, 2005, ANIM BEHAV, V69, P741, DOI 10.1016/j.anbehav.2004.06.027; Cammaerts MC, 2000, J INSECT BEHAV, V13, P679, DOI 10.1023/A:1007891910530; Cammaerts MC, 2004, BEHAV PROCESS, V67, P417, DOI 10.1016/j.beproc.2004.07.002; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; d'Ettorre P, 2010, ANT ECOLOGY, P194; Davidson JD, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00115; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Fournier D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156440; Frizzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137919; Gelman A., 2007, DATA ANAL USING REGR; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; Holldobler B., 1990, pi; HORSTMANN K, 1983, Z NATURFORSCH C, V38, P508; JUTSUM AR, 1979, ANIM BEHAV, V27, P833, DOI 10.1016/0003-3472(79)90020-4; JUTSUM AR, 1979, ANIM BEHAV, V27, P839, DOI 10.1016/0003-3472(79)90021-6; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; Knaden M, 2004, SCIENCE, V305, P60, DOI 10.1126/science.1097165; Knaden M, 2003, J INSECT BEHAV, V16, P717, DOI 10.1023/B:JOIR.0000007706.38674.73; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; LeBoeuf AC, 2014, CURR OPIN INSECT SCI, V5, P16, DOI 10.1016/j.cois.2014.09.010; Lenoir A, 2001, PHYSIOL ENTOMOL, V26, P275, DOI 10.1046/j.0307-6962.2001.00244.x; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; LOFQVIST J, 1976, J INSECT PHYSIOL, V22, P1331, DOI 10.1016/0022-1910(76)90155-4; LUMSDEN CJ, 1983, J THEOR BIOL, V100, P81, DOI 10.1016/0022-5193(83)90093-0; MAYADE S, 1993, BEHAV PROCESS, V30, P131, DOI 10.1016/0376-6357(93)90003-A; Newey PS, 2010, BEHAV ECOL, V21, P381, DOI 10.1093/beheco/arp201; Nowbahari E, 2007, LEARN BEHAV, V35, P87, DOI 10.3758/BF03193043; ROEDER T, 1994, COMP BIOCHEM PHYS C, V107, P1, DOI 10.1016/1367-8280(94)90003-5; Sakata H, 2001, ECOL RES, V16, P395, DOI 10.1046/j.1440-1703.2001.00404.x; SKINNER GJ, 1980, J ANIM ECOL, V49, P381, DOI 10.2307/4253; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Szczuka A, 2013, ACTA NEUROBIOL EXP, V73, P495; Tanner CJ, 2008, ANIM BEHAV, V76, P1335, DOI 10.1016/j.anbehav.2008.04.022; Tanner CJ, 2006, P ROY SOC B-BIOL SCI, V273, P2737, DOI 10.1098/rspb.2006.3626; Tanner CJ, 2009, ANIM BEHAV, V77, P297, DOI 10.1016/j.anbehav.2008.10.016; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; Weidenmuller A, 2004, BEHAV ECOL, V15, P120, DOI 10.1093/beheco/arg101; Wenseleers T, 2002, J INSECT BEHAV, V15, P85, DOI 10.1023/A:1014484229639; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512	66	7	7	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183872	10.1371/journal.pone.0183872	http://dx.doi.org/10.1371/journal.pone.0183872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910322	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200021
J	Kowalczyk, M; Sawulski, S; Dabrowski, W; Grzycka-Kowalczyk, L; Kotlinska-Hasiec, E; Wronska-Sewruk, A; Florek, A; Rutyna, R				Kowalczyk, Michal; Sawulski, Slawomir; Dabrowski, Wojciech; Grzycka-Kowalczyk, Luiza; Kotlinska-Hasiec, Edyta; Wronska-Sewruk, Agnieszka; Florek, Artur; Rutyna, Rafal			Successful 1: 1 proportion ventilation with a unique device for independent lung ventilation using a double-lumen tube without complications in the supine and lateral decubitus positions. A pilot study	PLOS ONE			English	Article							HYPOXIC PULMONARY VASOCONSTRICTION; DIFFERENTIAL VENTILATION; SHUNT FRACTION; AIRWAY-CLOSURE; SELECTIVE PEEP; ANESTHESIA; ATELECTASIS; OXYGENATION; ISOFLURANE; PERFUSION	Introduction Adequate blood oxygenation and ventilation/perfusion matching should be main goal of anaesthetic and intensive care management. At present, one of the methods of improving gas exchange restricted by ventilation/perfusion mismatching is independent ventilation with two ventilators. Recently, however, a unique device has been developed, enabling ventilation of independent lungs in 1: 1, 2: 1, 3: 1, and 5: 1 proportions. The main goal of the study was to evaluate the device's utility, precision and impact on pulmonary mechanics. Secondly- to measure the gas distribution in supine and lateral decubitus position. Materials and methods 69 patients who underwent elective thoracic surgery were eligible for the study. During general anaesthesia, after double lumen tube intubation, the aforementioned control system was placed between the anaesthetic machine and the patient. In the supine and lateral decubitus (left/right) positions, measurements of conventional and independent (1: 1 proportion) ventilation were performed separately for each lung, including the following: tidal volume, peak pressure and dynamic compliance. Results Our results show that conventional ventilation using Robertshaw tube in the supine position directs 47% of the tidal volume to the left lung and 53% to the right lung. Furthermore, in the left lateral position, 44% is directed to the dependent lung and 56% to the non-dependent lung. In the right lateral position, 49% is directed to the dependent lung and 51% to the non-dependent lung. The control system positively affected non-dependent and dependent lung ventilation by delivering equal tidal volumes into both lungs with no adverse effects, regardless of patient's position. Conclusions We report that gas distribution is uneven during conventional ventilation using Robertshaw tube in the supine and lateral decubitus positions. However, this recently released control system enables precise and safe independent ventilation in the supine and the left and right lateral decubitus positions.	[Kowalczyk, Michal; Sawulski, Slawomir; Dabrowski, Wojciech; Kotlinska-Hasiec, Edyta; Wronska-Sewruk, Agnieszka; Florek, Artur; Rutyna, Rafal] Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland; [Grzycka-Kowalczyk, Luiza] Med Univ Lublin, Dept Radiol & Nucl Med 1, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Kowalczyk, M (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland.	michalkowalczyk@vp.pl	Dabrowski, Wojciech/AAN-8425-2020; Kowalczyk, Michał/AAN-1914-2021; Rutyna, Rafał/AAU-4585-2020	Dabrowski, Wojciech/0000-0003-0449-2375; Kowalczyk, Michał/0000-0002-1991-190X; Rutyna, Rafał/0000-0003-0769-719X				Abe K, 1998, ANESTH ANALG, V87, P1164; BAEHRENDTZ S, 1983, ACTA ANAESTH SCAND, V27, P311, DOI 10.1111/j.1399-6576.1983.tb01958.x; BAEHRENDTZ S, 1984, ANESTHESIOLOGY, V61, P511, DOI 10.1097/00000542-198411000-00006; BAEHRENDTZ S, 1984, ACTA ANAESTH SCAND, V28, P252, DOI 10.1111/j.1399-6576.1984.tb02054.x; BAEHRENDTZ S, 1983, ACTA ANAESTH SCAND, V27, P270, DOI 10.1111/j.1399-6576.1983.tb01950.x; BINDSLEV L, 1981, ACTA ANAESTH SCAND, V25, P297, DOI 10.1111/j.1399-6576.1981.tb01655.x; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bruells CS, 2011, EUR J ANAESTH, V28, P570, DOI 10.1097/EJA.0b013e32834942a3; CARLON GC, 1978, CRIT CARE MED, V6, P380, DOI 10.1097/00003246-197811000-00009; Chang H, 2002, J APPL PHYSIOL, V92, P745, DOI 10.1152/japplphysiol.00377.2001; Choi YS, 2007, J THORAC CARDIOV SUR, V134, P613, DOI 10.1016/j.jtcvs.2007.05.018; Darowski Marek, 2000, Frontiers of Medical and Biological Engineering, V10, P177, DOI 10.1163/15685570052062576; Futier E, 2014, MINERVA ANESTESIOL, V80, P726; Glapinski J, 2006, PROCEEDINGS OF THE 5TH WORLD CONGRESS OF BIOMECHANICS, P299; HEDENSTIERNA G, 1981, J APPL PHYSIOL, V50, P55, DOI 10.1152/jappl.1981.50.1.55; Hedenstierna G, 2012, MINERVA ANESTESIOL, V78, P1193; Karzai W, 2009, ANESTHESIOLOGY, V110, P1402, DOI 10.1097/ALN.0b013e31819fb15d; Lennon PF, 1996, ANESTHESIOLOGY, V84, P404, DOI 10.1097/00000542-199602000-00020; Nagendran J, 2006, CURR OPIN ANESTHESIO, V19, P34, DOI 10.1097/01.aco.0000192777.09527.9e; PICK RA, 1982, CHEST, V82, P345, DOI 10.1378/chest.82.3.345; Pilcher DV, 2007, J THORAC CARDIOV SUR, V133, P1071, DOI 10.1016/j.jtcvs.2006.10.028; Sankar A, 2014, BRIT J ANAESTH, V113, P424, DOI 10.1093/bja/aeu100; Sawulski Slawomir, 2010, Anestezjol Intens Ter, V42, P6; STRANDBERG A, 1986, ACTA ANAESTH SCAND, V30, P154, DOI 10.1111/j.1399-6576.1986.tb02387.x; Tokics L, 1996, J APPL PHYSIOL, V81, P1822, DOI 10.1152/jappl.1996.81.4.1822; TUXEN DV, 1987, AM REV RESPIR DIS, V136, P872, DOI 10.1164/ajrccm/136.4.872; WAHBA RWM, 1991, CAN J ANAESTH, V38, P384, DOI 10.1007/BF03007630; WEST JB, 1964, J APPL PHYSIOL, V19, P713, DOI 10.1152/jappl.1964.19.4.713	28	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184537	10.1371/journal.pone.0184537	http://dx.doi.org/10.1371/journal.pone.0184537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910340	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200057
J	Su, SF; Bao, H; Wang, XY; Wang, ZQ; Li, X; Zhang, MQ; Wang, JY; Jiang, H; Wang, WJ; Qu, SY; Liu, MN				Su, Shaofei; Bao, Han; Wang, Xinyu; Wang, Zhiqiang; Li, Xi; Zhang, Meiqi; Wang, Jiaying; Jiang, Hao; Wang, Wenji; Qu, Siyang; Liu, Meina			The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study	PLOS ONE			English	Article							UNIVERSAL HEALTH-INSURANCE; SOCIOECONOMIC-STATUS; CONSERVING SURGERY; CHINESE WOMEN; MASTECTOMY; RACE/ETHNICITY; PERFORMANCE; DISPARITIES; INDICATORS; THERAPY	Though evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This study aimed to examine the association between different proportions of reimbursement and quality of recommended breast cancer care, as well as length of hospital stay. In this retrospective study, 3669 patients diagnosed with invasive breast cancer between 1 June, 2011 and 30 June, 2013 were recruited. Seven quality indicators from preoperative diagnosis procedures to adjuvant therapy and one composite indicator were selected as dependent variables. Logistic regression and generalized linear models were used to explore the association between quality of care and length of hospital stay with different reimbursement rates. Compared with UEBMI (urban employment basic medical insurance), which represented high level reimbursement rate, patients with lower rates of reimbursement were less likely to receive core biopsy, HER-2 (human epidermal growth factor receptor-2) testing, BCS (breast conserving surgery), SLNB (sentinel lymph nodes biopsy), adjuvant therapy and hormonal treatment. No significant difference in preoperative length of hospital stay was observed among the three insurance schemes, however URBMI (urban resident basic medical insurance) insured patients stayed longer for total length of hospital stay. Significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement were observed. Patients with lower rate of reimbursement were less likely to receive recommended care. Our findings could provide important support for further healthcare reform and quality improvement in breast cancer care.	[Su, Shaofei; Wang, Xinyu; Li, Xi; Zhang, Meiqi; Wang, Jiaying; Jiang, Hao; Wang, Wenji; Qu, Siyang; Liu, Meina] Harbin Med Univ, Dept Biostat, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China; [Bao, Han] Inner Mongolia Med Univ, Dept Biostat, Publ Hlth Coll, Hohhot, Peoples R China; [Wang, Zhiqiang] Univ Queensland, Sch Med, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	Harbin Medical University; Inner Mongolia Medical University; Royal Brisbane & Women's Hospital; University of Queensland	Liu, MN (corresponding author), Harbin Med Univ, Dept Biostat, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China.	liumeina369@163.com	Wang, Zhiqiang/A-5835-2010	Wang, Zhiqiang/0000-0002-5839-743X; Wang, Xinyu/0000-0001-5377-0816	National Natural Science Foundation of China [81273183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (grant number 81273183), http://www.nsfe.gov.cni/.; This study was funded by National Natural Science Foundation of China (grant number 81273183).	[Anonymous], 2013, NATL EC SOCIAL DEV S; Badakhshi H, 2013, CANCER MED-US, V2, P712, DOI 10.1002/cam4.114; Bao H, 2016, J CANCER RES CLIN, V142, P1079, DOI 10.1007/s00432-015-2106-z; Bao H, 2015, INT J QUAL HEALTH C, V27, P291, DOI 10.1093/intqhc/mzv042; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Coburn N, 2008, BREAST J, V14, P128, DOI 10.1111/j.1524-4741.2007.00542.x; Eberth JM, 2014, J CLIN ONCOL, V32, P2206, DOI 10.1200/JCO.2013.52.8257; Freedman RA, 2011, CANCER-AM CANCER SOC, V117, P180, DOI 10.1002/cncr.25542; Fung KW, 2001, ANZ J SURG, V71, P202, DOI 10.1046/j.1440-1622.2001.02094.x; Gomez SL, 2004, ETHNIC DIS, V14, P134; Gray JE, 2011, J ONCOL PRACT, V7, P247, DOI 10.1200/JOP.2010.000174; Halpern MT, 2007, CANCER, V110, P403, DOI 10.1002/cncr.22786; Hargraves JL, 2003, HEALTH SERV RES, V38, P809, DOI 10.1111/1475-6773.00148; Hu RW, 2014, J IMMIGR MINOR HEALT, V16, P565, DOI 10.1007/s10903-013-9966-6; Jiong TU, 2014, 18 ISA WORLD C SOC; Jubelirer S J, 2001, W V Med J, V97, P144; Kimmick GG, 2015, J ONCOL PRACT, V11, pE9, DOI 10.1200/JOP.2014.001397; Lam WW, 2005, PSYCHO-ONCOLOGY, V14, P585, DOI 10.1002/pon.877; Lee MC, 2009, BREAST J, V15, P34, DOI 10.1111/j.1524-4741.2008.00668.x; Li C, 2011, SOC SCI MED, V73, P359, DOI 10.1016/j.socscimed.2011.06.002; Malin JL, 2006, J CLIN ONCOL, V24, P626, DOI 10.1200/JCO.2005.03.3365; Malin JL, 2002, J CLIN ONCOL, V20, P4381, DOI 10.1200/JCO.2002.04.020; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Moreland Amber, 2009, Am J Surg, V198, P787, DOI 10.1016/j.amjsurg.2009.05.031; Niu XL, 2013, CANCER MED-US, V2, P403, DOI 10.1002/cam4.84; Pan Y, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0102-4; Richardson LC, 2006, AM J PUBLIC HEALTH, V96, P160, DOI 10.2105/AJPH.2004.053579; Shi RH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1228-7; Stenehjem DD, 2014, BREAST CANCER-TARGET, V6, P169, DOI 10.2147/BCTT.S69416; Temple WJ, 2006, J CLIN ONCOL, V24, P3367, DOI 10.1200/JCO.2005.02.7771; Thompson B, 2008, ANN SURG ONCOL, V15, P443, DOI 10.1245/s10434-007-9584-4; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Wu XC, 2012, J CLIN ONCOL, V30, P142, DOI 10.1200/JCO.2011.36.8399; Yu H, 2015, HEALTH POLICY, V119, P1145, DOI 10.1016/j.healthpol.2015.07.008; Zhang L, 2012, PSYCHO-ONCOLOGY, V21, P488, DOI 10.1002/pon.1922	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184866	10.1371/journal.pone.0184866	http://dx.doi.org/10.1371/journal.pone.0184866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910357	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200111
J	Bonnefond, H; Grimaud, G; Rumin, J; Bougaran, G; Talec, A; Gachelin, M; Boutoute, M; Pruvost, E; Bernard, O; Sciandra, A				Bonnefond, Hubert; Grimaud, Ghjuvan; Rumin, Judith; Bougaran, Gael; Talec, Amelie; Gachelin, Manon; Boutoute, Marc; Pruvost, Eric; Bernard, Olivier; Sciandra, Antoine			Continuous selection pressure to improve temperature acclimation of Tisochrysis lutea	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; EVOLUTIONARY ADAPTATION; LIPID PRODUCTION; GROWTH; MICROALGAE; PHYTOPLANKTON; LIGHT; PRODUCTIVITY; METABOLISM; BENEFITS	Temperature plays a key role in outdoor industrial cultivation of microalgae. Improving the thermal tolerance of microalgae to both daily and seasonal temperature fluctuations can thus contribute to increase their annual productivity. A long term selection experiment was carried out to increase the thermal niche (temperature range for which the growth is possible) of a neutral lipid overproducing strain of Tisochrysis lutea. The experimental protocol consisted to submit cells to daily variations of temperature for 7 months. The stress intensity, defined as the amplitude of daily temperature variations, was progressively increased along successive selection cycles. Only the amplitude of the temperature variations were increased, the daily average temperature was kept constant along the experiment. This protocol resulted in a thermal niche increase by 3 degrees C (+16.5%), with an enhancement by 9% of the maximal growth rate. The selection process also affected T. lutea physiology, with a feature generally observed for 'cold-temperature' type of adaptation. The amount of total and neutral lipids was significantly increased, and eventually productivity was increased by 34%. This seven month selection experiment, carried out in a highly dynamic environment, challenges some of the hypotheses classically advanced to explain the temperature response of microalgae.	[Bonnefond, Hubert; Talec, Amelie; Gachelin, Manon; Boutoute, Marc; Pruvost, Eric; Sciandra, Antoine] UPMC Univ Paris 06, Sorbonne Univ, CNRS, INSU,LOV, Villefranche Sur Mer, France; [Grimaud, Ghjuvan; Bernard, Olivier] INRIA, BIOCORE, Sophia Antipolis, France; [Rumin, Judith; Bougaran, Gael] PBA, IFREMER, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Inria; Ifremer	Bernard, O (corresponding author), INRIA, BIOCORE, Sophia Antipolis, France.	olivier.bernard@inria.fr	Bernard, Olivier/J-1133-2014; Grimaud, Ghjuvan/AAP-3177-2021; Sciandra, Antoine/D-7625-2012	Bernard, Olivier/0000-0003-2539-9014; Grimaud, Ghjuvan/0000-0003-2752-4755; Bougaran, Gael/0000-0002-3463-7590	ADEME; ANR Facteur [4 ANR-12-BIME-0004]	ADEME; ANR Facteur(French National Research Agency (ANR))	This work was supported by grant income pre-graduated pHd, ADEME (https://appelsaprojets.ademe.fr/aap/AAC%20Th%C3%A8ses2016-10); and ANR Facteur 4 ANR-12-BIME-0004 (http://wwz.ifremer.fr/facteur4/Presentation).r H. Bonnefond acknowledges the support of an ADEME grant. The experiments were carried out in the framework of the ANR Facteur 4 ANR-12-BIME-0004. The authors gratefully acknowledge P. Chang for improvement of the English and T. Blasco for total carbon measurements.	Bechet Q, 2013, BIOTECHNOL ADV, V31, P1648, DOI 10.1016/j.biotechadv.2013.08.014; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; Bernard O., 2016, ODIN; Bernard O, 2012, BIORESOURCE TECHNOL, V123, P520, DOI 10.1016/j.biortech.2012.07.022; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bougaran G, 2012, BIOTECHNOL BIOENG, V109, P2737, DOI 10.1002/bit.24560; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Carrier G, 2014, PLOS ONE, V9; Chevin LM, 2011, BIOL LETTERS, V7, P210, DOI 10.1098/rsbl.2010.0580; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Costas E, 2014, OCEANOGR OPEN ACCESS, V2; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Devos N, 1998, J PHYCOL, V34, P655, DOI 10.1046/j.1529-8817.1998.340655.x; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; Eppley RW, 1972, FISH B, P70; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; Gigova L, 2012, J PHYCOL, V48, P85, DOI 10.1111/j.1529-8817.2011.01088.x; Grimaud GM, 2015, IFAC PAPERSONLINE, V48, P228, DOI 10.1016/j.ifacol.2015.05.059; Guillard R., 1975, CULT MAR INVERTEBR A, V1975; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HANSEN SR, 1980, SCIENCE, V207, P1491; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Kobayashi Y, 2014, GENOME BIOL EVOL, V6, P2731, DOI 10.1093/gbe/evu216; Lacour T, 2012, J PHYCOL, V48, P647, DOI 10.1111/j.1529-8817.2012.01154.x; LEVINS RICHARD, 1968; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Luria SE, 1943, GENETICS, V28, P491; Marchetti J, 2012, AQUACULTURE, V326, P106, DOI 10.1016/j.aquaculture.2011.11.020; Masci P, 2008, IFAC P VOLUMES IFAC, DOI [10.3182/20080706-5-KR-1001.3265, DOI 10.3182/20080706-5-KR-1001.3265]; MORRISON WR, 1964, J LIPID RES, V5, P600; MORTAINBERTRAND A, 1988, MAR BIOL, V100, P135, DOI 10.1007/BF00392963; Padfield D, 2016, ECOL LETT, V19, P133, DOI 10.1111/ele.12545; Ras M, 2013, REV ENVIRON SCI BIO, V12, P153, DOI 10.1007/s11157-013-9310-6; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Renaud SM, 1995, J APPL, P595; Roleda MY, 2013, BIORESOURCE TECHNOL, V129, P439, DOI 10.1016/j.biortech.2012.11.043; Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514; SRIHARAN S, 1991, APPL BIOCHEM BIOTECH, V28-9, P317, DOI 10.1007/BF02922611; THOMPSON PA, 1992, J PHYCOL, V28, P481, DOI 10.1111/j.0022-3646.1992.00481.x; Urban MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3085; Vitova A M, 2015, BIOTECHNOL ADV; Xu Y, 2003, J BACTERIOL, V185, P5519, DOI 10.1128/JB.185.18.5519-5526.2003	47	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183547	10.1371/journal.pone.0183547	http://dx.doi.org/10.1371/journal.pone.0183547			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902878	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200013
J	Moremi, N; Clause, H; Vogel, U; Mshana, SE				Moremi, Nyambura; Clause, Heike; Vogel, Ulrich; Mshana, Stephen E.			Faecal carriage of CTX-M extended-spectrum beta-lactamase-producing Enterobacteriaceae among street children dwelling in Mwanza city, Tanzania	PLOS ONE			English	Article							ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; EPIDEMIOLOGY; RESISTANCE; EMERGENCE; BLA(CTX-M-15); COMMUNITY; HUMANS; ST131	Background Data on ESBL carriage of healthy people including children are scarce especially in developing countries. We analyzed the prevalence and genotypes of ESBL-producing Enterobacteriaceae (EPE) in Tanzanian street children with rare contact to healthcare facilities but significant interactions with the environment, animals and other people. Methodology/Principle findings Between April and July 2015, stool samples of 107 street children, who live in urban Mwanza were analyzed for EPE. Intestinal carriage of EPE was found in 34 (31.8%, 95% CI; 22.7-40.3) children. Of the 36 isolates from 34 children, 30 (83.3%) were Escherichia coli (E. coli) and six Klebsiella pneumoniae (K. pneumoniae). Out of 36 isolates, 36 (100%), 35 (97%), 25 (69%) and 16 (44%) were resistant to tetracycline, trimethoprim-sulfamethoxazole, ciprofloxacin and gentamicin, respectively. Beta-lactamase genes and the multilocus sequence types of E. coli and K. pneumoniae were characterized. ESBL gene blaCTX-M-15 was detected in 75% (27/36) of ESBL isolates. Sequence types (STs) 131, 10, 448 and 617 were the most prevalent in E. coli. Use of local herbs (OR: 3.5, 95% CI: 1.51-8.08, P = 0.003) and spending day and night on streets (OR: 3.6, 95% CI: 1.44-8.97, P = 0.005) were independent predictors of ESBL carriage. Conclusions/Significance We observed a high prevalence of blaCTX-M-15 in EPE collected from street children in Tanzania. Detection of E. coli STs 131, 10, 38 and 648, which have been observed worldwide in animals and people, highlights the need for multidisciplinary approaches to understand the epidemiology and drivers of antimicrobial resistance in low-income countries.	[Moremi, Nyambura; Mshana, Stephen E.] Catholic Univ Hlth & Allied SciencesBugando, Dept Microbiol & Immunol, Mwanza, Tanzania; [Moremi, Nyambura; Clause, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany	University of Wurzburg	Moremi, N (corresponding author), Catholic Univ Hlth & Allied SciencesBugando, Dept Microbiol & Immunol, Mwanza, Tanzania.; Moremi, N (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	nyambura.moremi@stud-mail.uni-wuerzburg.de	Mshana, Stephen/AAE-1900-2022	Moremi, Nyambura/0000-0002-5303-1156				Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Beyene Y, 1997, E AFR MED J, V74, P85; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Centres for Disease Control and prevention (US), 2013, ANTIBIOTIC RESISTANC; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Feikin Daniel R, 2010, Int J Epidemiol, V39, P450, DOI 10.1093/ije/dyp374; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hernandez J, 2010, ENV MICROBIOL REP, V2, P329, DOI 10.1111/j.1758-2229.2010.00142.x; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Menke E M, 1997, Issues Compr Pediatr Nurs, V20, P153; Moremi N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01862; Moremi Nyambura, 2014, BMC Res Notes, V7, P211, DOI 10.1186/1756-0500-7-211; Mshana SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1527-x; Murray TS, 2015, CURR OPIN PEDIATR, V27, P124, DOI 10.1097/MOP.0000000000000182; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P524, DOI 10.1093/jac/dkp211; Pagani L, 2003, J CLIN MICROBIOL, V41, P4264, DOI 10.1128/JCM.41.9.4264-4269.2003; Pena C, 2001, J HOSP INFECT, V47, P53, DOI 10.1053/jhin.2000.0862; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Reddy P, 2007, CLIN INFECT DIS, V45, P846, DOI 10.1086/521260; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Seni J, 2016, FRONT MICROBIOL, V11, P7; Shi HQ, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0063-7; Tellevik MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168024; Veldman K, 2014, INT J FOOD MICROBIOL, V177, P72, DOI 10.1016/j.ijfoodmicro.2014.02.014; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13	39	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184592	10.1371/journal.pone.0184592	http://dx.doi.org/10.1371/journal.pone.0184592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898269	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500035
J	Zhao, J; Mysona, BA; Wang, J; Gonsalvez, GB; Smith, SB; Bollinger, KE				Zhao, Jing; Mysona, Barbara A.; Wang, Jing; Gonsalvez, Graydon B.; Smith, Sylvia B.; Bollinger, Kathryn E.			Sigma 1 receptor regulates ERK activation and promotes survival of optic nerve head astrocytes	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OXIDATIVE STRESS; GLIAL-CELLS; AUTORADIOGRAPHIC LOCALIZATION; LIGAND (+)-PENTAZOCINE; THERAPEUTIC TARGETS; NEURONAL DEATH; PROTEIN-KINASE; UP-REGULATION; IN-VITRO	The sigma 1 receptor (S1R) is a unique transmembrane protein that has been shown to regulate neuronal differentiation and cellular survival. It is expressed within several cell types throughout the nervous system and visceral organs, including neurons and glia within the eye. S1R ligands are therapeutic targets for diseases ranging from neurodegenerative conditions to neoplastic disorders. However, effects of S1R activation and inhibition within glia cells are not well characterized. Within the eye, the astrocytes at the optic nerve head are crucial to the health and survival of the neurons that send visual information to the brain. In this study, we used the S1R-specific agonist, (+)-pentazocine, to evaluate S1R activation within optic nerve head-derived astrocytes (ONHAs). Treatment of ONHAs with (+)-pentazocine attenuated the level and duration of stress-induced ERK phosphorylation following oxidative stress exposure and promoted survival of ONHAs. These effects were specific to S1R activation because they were not observed in ONHAs that were depleted of S1R using siRNA-mediated knockdown. Collectively, our results suggest that S1R activation suppresses ERK1/2 phosphorylation and protects ONHAs from oxidative stress-induced death.	[Zhao, Jing; Mysona, Barbara A.; Wang, Jing; Smith, Sylvia B.; Bollinger, Kathryn E.] James & Jean Culver Vis Discovery Inst, Augusta, GA 30912 USA; [Zhao, Jing; Mysona, Barbara A.; Smith, Sylvia B.; Bollinger, Kathryn E.] Augusta Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA; [Zhao, Jing; Mysona, Barbara A.; Wang, Jing; Gonsalvez, Graydon B.; Smith, Sylvia B.; Bollinger, Kathryn E.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bollinger, KE (corresponding author), James & Jean Culver Vis Discovery Inst, Augusta, GA 30912 USA.; Bollinger, KE (corresponding author), Augusta Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA.; Bollinger, KE (corresponding author), Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA.	kbollinger@augusta.edu		Wang, Jing/0000-0003-2891-670X; Mysona, Barbara/0000-0002-7632-5755	National Institutes of Health [5K08EY021758-03, R01 EY014560]; American Glaucoma Society Young Clinician Scientist Award; NATIONAL EYE INSTITUTE [R01EY028103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Glaucoma Society Young Clinician Scientist Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grants 5K08EY021758-03 and R01 EY014560, https://www.nih.gov/, and American Glaucoma Society Young Clinician Scientist Award http://americanglaucomasociety.net/(KEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Alonso G, 2000, NEUROSCIENCE, V97, P155, DOI 10.1016/S0306-4522(00)00014-2; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Behensky AA, 2013, J PHARMACOL EXP THER, V347, P458, DOI 10.1124/jpet.113.208348; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Canals S, 2003, MOL CELL NEUROSCI, V24, P1012, DOI 10.1016/j.mcn.2003.08.004; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Das D, 2016, BIOCHEM BIOPH RES CO, V470, P319, DOI 10.1016/j.bbrc.2016.01.055; DECOSTA BR, 1989, FEBS LETT, V251, P53, DOI 10.1016/0014-5793(89)81427-9; Do W, 2013, BIOCHEM BIOPH RES CO, V439, P215, DOI 10.1016/j.bbrc.2013.08.057; Dun Y, 2007, INVEST OPHTH VIS SCI, V48, P4785, DOI 10.1167/iovs.07-0343; Francardo V, 2014, NEURAL REGEN RES, V9, P1882, DOI 10.4103/1673-5374.145351; Francardo V, 2014, BRAIN, V137, P1998, DOI 10.1093/brain/awu107; Ha YJ, 2011, INVEST OPHTH VIS SCI, V52, P7749, DOI 10.1167/iovs.11-8169; Happy M, 2015, BIOCHEM BIOPH RES CO, V456, P683, DOI 10.1016/j.bbrc.2014.12.029; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Jiang GL, 2006, INVEST OPHTH VIS SCI, V47, P5576, DOI 10.1167/iovs.06-0608; Kim FJ, 2012, BIOCHEM BIOPH RES CO, V426, P177, DOI 10.1016/j.bbrc.2012.08.052; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Malik M, 2015, BRIT J PHARMACOL, V172, P2519, DOI 10.1111/bph.13076; Mandal A, 2010, INVEST OPHTH VIS SCI, V51, P3129, DOI 10.1167/iovs.09-4614; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Martin PM, 2004, MOL BRAIN RES, V123, P66, DOI 10.1016/j.molbrainres.2003.12.019; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mavlyutov TA, 2016, NEUROSCIENCE, V331, P148, DOI 10.1016/j.neuroscience.2016.06.030; Mavlyutov TA, 2011, MOL VIS, V17, P1034; Moon JY, 2014, BRIT J PHARMACOL, V171, P5881, DOI 10.1111/bph.12893; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Mueller BH, 2014, EXP EYE RES, V128, P156, DOI 10.1016/j.exer.2014.10.007; Mueller BH, 2013, EXP EYE RES, V107, P21, DOI 10.1016/j.exer.2012.11.002; Newman EA, 1998, J NEUROSCI, V18, P4022; Nguyen L, 2014, EUR J PHARMACOL, V743, P42, DOI 10.1016/j.ejphar.2014.09.022; Ola MS, 2001, MOL BRAIN RES, V95, P86; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Rosenberger J, 2001, J NEUROCHEM, V79, P35, DOI 10.1046/j.1471-4159.2001.00520.x; Schneider M, 2016, EXP EYE RES, V142, P49, DOI 10.1016/j.exer.2015.08.014; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Tan F, 2010, NEUROPHARMACOLOGY, V59, P416, DOI 10.1016/j.neuropharm.2010.05.014; Tehrani S, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14969; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; van Waarde A, 2015, BBA-BIOMEMBRANES, V1848, P2703, DOI 10.1016/j.bbamem.2014.08.022; Vargas JLC, 2016, NEURAL REGEN RES, V11, P424, DOI 10.4103/1673-5374.179053; Wang J, 2016, P NATL ACAD SCI USA, V113, pE3764, DOI 10.1073/pnas.1521749113; Wang J, 2015, FREE RADICAL BIO MED, V86, P25, DOI 10.1016/j.freeradbiomed.2015.04.009; Wang LX, 2005, INVEST OPHTH VIS SCI, V46, P1403, DOI 10.1167/iovs.04-1209; Whitlock BB, 1996, J NEUROIMMUNOL, V67, P83; Williams PA, 2017, EXPT EYE RES; WOLFE SA, 1989, ENDOCRINOLOGY, V124, P1160, DOI 10.1210/endo-124-3-1160; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Zhang Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0250-7; Zhao J, 2016, INVEST OPHTH VIS SCI, V57, P453, DOI 10.1167/iovs.15-18565; Zhao J, 2014, INVEST OPHTH VIS SCI, V55, P3375, DOI 10.1167/iovs.13-12823	62	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184421	10.1371/journal.pone.0184421	http://dx.doi.org/10.1371/journal.pone.0184421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898265	Green Submitted, gold, Green Published			2022-12-26	WOS:000410449500027
J	Hoque, DME; Kumari, V; Hoque, M; Ruseckaite, R; Romero, L; Evans, SM				Hoque, Dewan Md Emdadul; Kumari, Varuni; Hoque, Masuma; Ruseckaite, Rasa; Romero, Lorena; Evans, Sue M.			Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review	PLOS ONE			English	Review							ACUTE MYOCARDIAL-INFARCTION; NATIONAL REGISTRY; HEALTH-CARE; OF-CARE; STROKE REGISTRY; HEART-FAILURE; RHEUMATOID-ARTHRITIS; REPERFUSION THERAPY; DISEASE REGISTRIES; ISCHEMIC-STROKE	Background Clinical quality registries (CQRs) are playing an increasingly important role in improving health outcomes and reducing health care costs. CQRs are established with the purpose of monitoring quality of care, providing feedback, benchmarking performance, describing pattern of treatment, reducing variation and as a tool for conducting research. Objectives To synthesise the impact of clinical quality registries (CQRs) as an 'intervention' on (I) mortality/survival; (II) measures of outcome that reflect a process or outcome of health care; (III) health care utilisation; and (IV) healthcare-related costs. Methods The following electronic databases were searched: MEDLINE, EMBASE, CENTRAL, CINAHL and Google Scholar. In addition, a review of the grey literature and a reference check of citations and reference lists within articles was undertaken to identify relevant studies in English covering the period January 1980 to December 2016. The PRISMA-P methodology, checklist and standard search strategy using pre-defined inclusion and exclusion criteria and structured data extraction tools were used. Data on study design and methods, participant characteristics attributes of included registries and impact of the registry on outcome measures and/or processes of care were extracted. Results We identified 30102 abstracts from which 75 full text articles were assessed and finally 17 articles were selected for synthesis. Out of 17 studies, six focused on diabetes care, two on cardiac diseases, two on lung diseases and others on organ transplantations, rheumatoid arthritis, ulcer healing, surgical complications and kidney disease. The majority of studies were "before after" design (#11) followed by cohort design (#2), randomised controlled trial (#2), experimental non randomised study and one cross sectional comparison. The measures of impact of registries were multifarious and included change in processes of care, quality of care, treatment outcomes, adherence to guidelines and survival. Sixteen of 17 studies demonstrated positive findings in their outcomes after implementation of the registry. Conclusions Despite the large number of published articles using data derived from CQRs, few have rigorously evaluated the impact of the registry as an intervention on improving health outcomes. Those that have evaluated this impact have mostly found a positive impact on healthcare processes and outcomes.	[Hoque, Dewan Md Emdadul; Kumari, Varuni; Hoque, Masuma; Ruseckaite, Rasa; Evans, Sue M.] Monash Univ, Sch Publ Hlth & Prevent Med, Alfred Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Hoque, Dewan Md Emdadul] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Romero, Lorena] Alfred Ctr, Ian Potter Lib, Melbourne, Vic, Australia	Monash University; International Centre for Diarrhoeal Disease Research (ICDDR)	Hoque, DME (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Alfred Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Hoque, DME (corresponding author), Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh.	emdad.hoque@monash.edu	Ruseckaite, Rasa/H-4060-2014; Hoque, Dewan Md. Emdadul/J-1999-2019; Hoque, Dewan/O-3606-2015	Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Hoque, Dewan/0000-0001-8219-9196; Evans, Sue/0000-0003-2962-8400; Ruseckaite, Rasa/0000-0002-9078-2696	MIPRS; MGS; Monash Partners Academic Health Science Centre; Monash [25762931]	MIPRS; MGS; Monash Partners Academic Health Science Centre; Monash	DEH has received MIPRS for tuition fees and MGS scholarship for living costs and Monash ID: 25762931 for PhD Programme. SE has received funding support from Monash Partners Academic Health Science Centre. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSQHC, 2016, EC EV CLIN QUAL REG; Armstrong BK, 2007, MED J AUSTRALIA, V187, P485, DOI 10.5694/j.1326-5377.2007.tb01383.x; Asplund K, 2003, CEREBROVASC DIS, V15, P5, DOI 10.1159/000068203; Australian Commission on Safety and Quality in Health Care, 2012, LOG DES AUSTR CLIN Q; Autier P, 2011, LANCET, V377, P99, DOI 10.1016/S0140-6736(10)62347-1; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V303, P2188, DOI 10.1001/jama.2010.743; Black N, 2004, BMJ-BRIT MED J, V328, P1478, DOI 10.1136/bmj.328.7454.1478; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Breckenridge K, 2015, NEPHROL DIAL TRANSPL, V30, P1605, DOI 10.1093/ndt/gfv209; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Bufalino VJ, 2011, CIRCULATION, V123, P2167, DOI 10.1161/CIR.0b013e3182181529; Carlhed R, 2006, AM HEART J, V152, P1175, DOI 10.1016/j.ahj.2006.07.028; CfD Control Prevention, 2011, MMWR-MORBID MORTAL W, V60, P206; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Dall TM, 2009, POPUL HEALTH MANAG, V12, P103, DOI 10.1089/pop.2009.12203; Dokholyan RS, 2009, AM HEART J, V157, P971, DOI 10.1016/j.ahj.2009.03.023; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Evans SM, 2011, MED J AUSTRALIA, V194, P360, DOI 10.5694/j.1326-5377.2011.tb03007.x; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Franklin PD, 2014, J BONE JOINT SURG AM, V96A, P104, DOI 10.2106/JBJS.N.00328; French WJ, 2012, JAMA-J AM MED ASSOC, V308, P771, DOI 10.1001/jama.2012.9500; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; George Mary G., 2009, Morbidity and Mortality Weekly Report, V58, P1; Georgiou A, 2006, Aust Fam Physician, V35, P77; Geubbels ELPE, 2006, INT J QUAL HEALTH C, V18, P127, DOI 10.1093/intqhc/mzi103; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Gitt AK, 2010, EUROPEAN HEART J; Gliklich RE., 2014, REGISTRIES EVALUATIN, V3; Goldfracht M, 2011, INT J QUAL HEALTH C, V23, P674, DOI 10.1093/intqhc/mzr051; Grau AJ, 2010, STROKE, V41, P1495, DOI 10.1161/STROKEAHA.110.582239; Han W, 2015, J AM MED INFORM ASS; Harris MF, 2002, MED J AUSTRALIA, V177, P250, DOI 10.5694/j.1326-5377.2002.tb04757.x; Harrison JK, 2015, NEPHRON, V129, P209, DOI 10.1159/000371888; Hickey GL, 2013, EUROPEAN J CARDIOTHO; Hills NK, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-20; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Hong Yuling, 2006, Crit Pathw Cardiol, V5, P179, DOI 10.1097/01.hpc.0000243588.00012.79; Hoque DME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010654; Jakobsen E, 2013, J THORAC ONCOL, V8, P1238, DOI 10.1097/JTO.0b013e3182a4070f; Johnson SC, 2005, NEUROLOGY, V64, P654; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kapral MK, 2004, STROKE, V35, P1756, DOI 10.1161/01.STR.0000130423.50191.9f; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Larsson S, 2012, HEALTH AFFAIR, V31, P220, DOI 10.1377/hlthaff.2011.0762; Lim TO, 2008, NEPHROLOGY, V13, P745, DOI 10.1111/j.1440-1797.2008.01044.x; Lorenzoni L, 2014, LANCET, V384, P83, DOI 10.1016/S0140-6736(14)60571-7; Lundstrom M, 2014, INT J HEALTH CARE Q, V27, P140, DOI 10.1108/IJHCQA-10-2012-0101; Lyu H, 2015, J HEALTHCARE QUAL; Madhok R, 2002, BAYLOR U MED CTR P; Mallinson EKL, 2010, GUT, V59, P1378, DOI 10.1136/gut.2010.212449; McClellan M. B., 2008, EVIDENCE BASED MED C; McNeil JJ, 2010, MED J AUSTRALIA, V192, P244, DOI 10.5694/j.1326-5377.2010.tb03499.x; Mehra S, 2015, THYROID, V25, P157, DOI 10.1089/thy.2014.0270; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Oien R F, 2006, J Wound Care, V15, P259; Oien RF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003091; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Peterson ED, 2007, RES METHODS SPEED DE; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Pollard C, 2009, J RURAL HEALTH, V25, P77, DOI 10.1111/j.1748-0361.2009.00202.x; Popay J, 2006, PRODUCT ESRC METHODS, pb92, DOI DOI 10.13140/2.1.1018.4643; Registry ASC, 2014, ANN REPORT; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Roski J, 2003, PREV MED, V36, P291, DOI 10.1016/S0091-7435(02)00052-X; Salim A, 2010, J TRAUMA, V69, P451, DOI 10.1097/TA.0b013e3181e7847a; Schechter MS, 2014, BMJ QUAL SAF, V23, P9, DOI 10.1136/bmjqs-2013-002378; Schmittdiel J, 2005, J GEN INTERN MED, V20, P855, DOI 10.1111/j.1525-1497.2005.0171.x; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Scottish Intercollegiate Guidelines Network for RCT, COH CAS CONTR STUD; Shah Nipa R, 2015, J Registry Manag, V42, P3; Sorensen HT, 1996, INT J RISK SAFETY ME, V10, P1; Spertus JA, 2006, AM HEART J, V151, P589, DOI 10.1016/j.ahj.2005.05.026; Sposato LA, 2008, STROKE, V39, P3036, DOI 10.1161/STROKEAHA.108.521062; Stroebel Robert J, 2002, Jt Comm J Qual Improv, V28, P441; Thomas KG, 2007, J GEN INTERN MED, V22, P1740, DOI 10.1007/s11606-007-0431-x; Tottenborg SS, 2013, CLIN RESPIR J, V7, P319, DOI 10.1111/crj.12009; van der Veer SN, 2010, INT J MED INFORM, V79, P305, DOI 10.1016/j.ijmedinf.2010.01.011; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253; Young A, 2010, RHEUMATOLOGY	84	96	97	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183667	10.1371/journal.pone.0183667	http://dx.doi.org/10.1371/journal.pone.0183667			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886607	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100032
J	Wu, GR; Mu, TC; Gao, ZX; Wang, J; Sy, MS; Li, CY				Wu, Gui-Ru; Mu, Tian-Chen; Gao, Zhen-Xing; Wang, Jun; Sy, Man-Sun; Li, Chao-Yang			Prion protein is required for tumor necrosis factor (TNF)-triggered nuclear factor B (NF-B) signaling and cytokine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); melanoma; NF-B (NF-B); prion; tumor necrosis factor (TNF); CYLD; NF-B signaling; PrP; TNF	CARCINOMA CELL-LINE; KAPPA-B; FACTOR-ALPHA; INFLAMMATORY RESPONSE; EPITHELIAL-CELLS; PRO-PRION; ACTIVATION; CANCER; BINDING; MICE	The expression of normal cellular prion protein (PrP) is required for the pathogenesis of prion diseases. However, the physiological functions of PrP remain ambiguous. Here, we identified PrP as being critical for tumor necrosis factor (TNF) -triggered signaling in a human melanoma cell line, M2, and a pancreatic ductal cell adenocarcinoma cell line, BxPC-3. In M2 cells, TNF up-regulates the expression of p-IB-kinase / (p-IKK/), p-p65, and p-JNK, but down-regulates the IB protein, all of which are downstream signaling intermediates in the TNF receptor signaling cascade. When PRNP is deleted in M2 cells, the effects of TNF are no longer detectable. More importantly, p-p65 and p-JNK responses are restored when PRNP is reintroduced into the PRNP null cells. TNF also activates NF-B and increases TNF production in wild-type M2 cells, but not in PrP-null M2 cells. Similar results are obtained in the BxPC-3 cells. Moreover, TNF activation of NF-B requires ubiquitination of receptor-interacting serine/threonine kinase 1 (RIP1) and TNF receptor-associated factor 2 (TRAF2). TNF treatment increases the binding between PrP and the deubiquitinase tumor suppressor cylindromatosis (CYLD), in these treated cells, binding of CYLD to RIP1 and TRAF2 is reduced. We conclude that PrP traps CYLD, preventing it from binding and deubiquitinating RIP1 and TRAF2. Our findings reveal that PrP enhances the responses to TNF, promoting proinflammatory cytokine production, which may contribute to inflammation and tumorigenesis.	[Wu, Gui-Ru; Gao, Zhen-Xing; Wang, Jun; Li, Chao-Yang] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Hubei, Peoples R China; [Wu, Gui-Ru] Univ Chinese Acad Sci, Beijing 100000, Peoples R China; [Mu, Tian-Chen] Wuhan Univ, Dept Life Sci, Wuhan 430010, Hubei, Peoples R China; [Sy, Man-Sun] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Li, Chao-Yang] Wuhan Brain Hosp, 5 Huiji Rd, Wuhan 430010, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Case Western Reserve University	Li, CY (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Hubei, Peoples R China.	cyli@wh.iov.cn	Gao, Zhenxing/AAL-8244-2020	Mu, Tianchen/0000-0002-0271-0941; Li, Chaoyang/0000-0003-3582-4141; Gao, Zhenxing/0000-0002-2692-985X	Strategic Priority Research Program A of the Chinese Academy of Sciences [XDA12010309]; National Science Foundation of China [31670170]; Nature Science Foundation of Hubei Province [2015CFA087]; National Basic Research Priorities Program of China from the Ministry of Science and Technology of China [2013CB911102]	Strategic Priority Research Program A of the Chinese Academy of Sciences; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); National Basic Research Priorities Program of China from the Ministry of Science and Technology of China	This work was supported by Strategic Priority Research Program A of the Chinese Academy of Sciences Grant XDA12010309, National Science Foundation of China Grant 31670170, Nature Science Foundation of Hubei Province Grant 2015CFA087, and National Basic Research Priorities Program of China Grant 2013CB911102 from the Ministry of Science and Technology of China. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Besnier LS, 2015, MOL BIOL CELL, V26, P3313, DOI 10.1091/mbc.E14-11-1534; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brockes JP, 1999, CURR OPIN NEUROBIOL, V9, P571, DOI 10.1016/S0959-4388(99)00016-1; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campos LS, 2016, MOL CELL BIOL, V36, P320, DOI 10.1128/MCB.00554-15; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Dinarello CA, 2014, LANCET ONCOL, V15, P552, DOI 10.1016/S1470-2045(14)70164-0; Ding TJ, 2013, J MOL NEUROSCI, V51, P118, DOI 10.1007/s12031-013-9962-2; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Edenhofer F, 1996, J VIROL, V70, P4724, DOI 10.1128/JVI.70.7.4724-4728.1996; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Gao ZX, 2016, CELL SIGNAL, V28, P652, DOI 10.1016/j.cellsig.2016.03.010; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Hachiya NS, 2005, NEUROSCI LETT, V374, P98, DOI 10.1016/j.neulet.2004.10.044; Haddon DJ, 2009, J INFECT DIS, V200, P827, DOI 10.1086/605022; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Keshet GI, 2000, J NEUROCHEM, V75, P1889, DOI 10.1046/j.1471-4159.2000.0751889.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Li CY, 2007, BIOCHEM J, V406, P333, DOI 10.1042/BJ20061857; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu J, 2015, J MOL NEUROSCI, V55, P279, DOI 10.1007/s12031-014-0319-2; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mabbott NA, 1997, IMMUNOLOGY, V92, P161, DOI 10.1046/j.1365-2567.1997.00331.x; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mariante RM, 2012, J BIOL CHEM, V287, P35506, DOI 10.1074/jbc.M112.394924; Martin GR, 2011, AM J PATHOL, V179, P2290, DOI 10.1016/j.ajpath.2011.07.025; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nasu-Nishimura Y, 2008, ARCH VIROL, V153, P1007, DOI 10.1007/s00705-008-0086-x; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; Petit CSV, 2012, GASTROENTEROLOGY, V143, P122, DOI 10.1053/j.gastro.2012.03.029; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Rybner C, 2002, J CELL BIOCHEM, V84, P408, DOI 10.1002/jcb.10017; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saito K, 2004, STRUCTURE, V12, P1719, DOI 10.1016/j.str.2004.07.012; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yang LH, 2016, J BIOL CHEM, V291, P6785, DOI 10.1074/jbc.A115.705830; Yang Liheng, 2014, Virologica Sinica, V29, P228, DOI 10.1007/s12250-014-3480-4; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zhao YG, 2015, J BIOL CHEM, V290, P22076, DOI 10.1074/jbc.M115.658096; Zidi I, 2010, MED ONCOL, V27, P185, DOI 10.1007/s12032-009-9190-3	88	19	20	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18747	18759		10.1074/jbc.M117.787283	http://dx.doi.org/10.1074/jbc.M117.787283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28900035	hybrid, Green Published			2022-12-26	WOS:000415848000002
J	Rajvanshi, PK; Arya, M; Rajasekharan, R				Rajvanshi, Praveen Kumar; Arya, Madhuri; Rajasekharan, Ram			The stress-regulatory transcription factors Msn2 and Msn4 regulate fatty acid oxidation in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; lipotoxicity; peroxisome; stress response; transcription regulation; triacylglycerol; -oxidation; Msn2 and Msn4	PEROXISOMAL BETA-OXIDATION; KINASE-A ACTIVITY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; IN-VIVO; PROTEIN; GLUCOSE; SNF1; TOR	The transcription factors Msn2 and Msn4 (multicopy suppressor of SNF1 mutation proteins 2 and 4) bind the stress-response element in gene promoters in the yeast Saccharomyces cerevisiae. However, the roles of Msn2/4 in primary metabolic pathways such as fatty acid -oxidation are unclear. Here, in silico analysis revealed that the promoters of most genes involved in the biogenesis, function, and regulation of the peroxisome contain Msn2/4-binding sites. We also found that transcript levels of MSN2/MSN4 are increased in glucose-depletion conditions and that during growth in nonpreferred carbon sources, Msn2 is constantly localized to the nucleus in wild-type cells. Of note, the double mutant msn2msn4 exhibited a severe growth defect when grown with oleic acid as the sole carbon source and had reduced transcript levels of major -oxidation genes. ChIP indicated that Msn2 has increased occupancy on the promoters of -oxidation genes in glucose-depleted conditions, and in vivo reporter gene analysis indicated reduced expression of these genes in msn2msn4 cells. Moreover, mobility shift assays revealed that Msn4 binds -oxidation gene promoters. Immunofluorescence microscopy with anti-peroxisome membrane protein antibodies disclosed that the msn2msn4 strain had fewer peroxisomes than the wild type, and lipid analysis indicated that the msn2msn4 strain had increased triacylglycerol and steryl ester levels. Collectively, our data suggest that Msn2/Msn4 transcription factors activate expression of the genes involved in fatty acid oxidation. Because glucose sensing, signaling, and fatty acid -oxidation pathways are evolutionarily conserved throughout eukaryotes, the msn2msn4 strain could therefore be a good model system for further study of these critical processes.	[Rajvanshi, Praveen Kumar; Arya, Madhuri; Rajasekharan, Ram] Cent Food Technol Res Inst, CSIR, Dept Lipid Sci, Lipid Ctr, Mysuru 570020, Karnataka, India; [Rajvanshi, Praveen Kumar; Arya, Madhuri; Rajasekharan, Ram] Acad Sci & Innovat Res, CSIR, Cent Food Technol Res Inst, Mysuru 570020, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rajasekharan, R (corresponding author), CSIR, Cent Food Technol Res Inst, Mysuru 570020, Karnataka, India.	ram@cftri.com	Rajvanshi, Praveen Kumar/ABH-1375-2021; Rajasekharan, Ram/R-2257-2019	Rajvanshi, Praveen Kumar/0000-0001-6831-002X; Ram, Rajasekharan/0000-0002-4114-0654; Rajasekharan, Ram/0000-0002-2124-6013	Council of Scientific and Industrial Research (New Delhi, India) under the 12th 5-year plan project LIPIC (Lipidomic Center); Council of Scientific and Industrial Research; J. C. Bose national fellowship	Council of Scientific and Industrial Research (New Delhi, India) under the 12th 5-year plan project LIPIC (Lipidomic Center); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose national fellowship	This work was supported by the Council of Scientific and Industrial Research (New Delhi, India) under the 12th 5-year plan project LIPIC (Lipidomic Center). The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of fellowships from the Council of Scientific and Industrial Research.; Recipient of the J. C. Bose national fellowship. To whom correspondence should be addressed: Central Food Technological Research Institute, Council of Scientific and Industrial Research, Mysuru 570020, Karnataka, India. Tel.: 91-821-2517760; Fax: 91-821-2516308; E-mail: ram@cftri.com.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Carballeira NM, 2008, PROG LIPID RES, V47, P50, DOI 10.1016/j.plipres.2007.10.002; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Conway MK, 2012, G3-GENES GENOM GENET, V2, P1003, DOI 10.1534/g3.112.002808; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geisbrecht BV, 1998, J BIOL CHEM, V273, P33184, DOI 10.1074/jbc.273.50.33184; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gurvitz A, 1997, MOL MICROBIOL, V26, P675, DOI 10.1046/j.1365-2958.1997.5931969.x; Harmeyer KM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1347; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lefevre SD, 2013, AGING CELL, V12, P784, DOI 10.1111/acel.12113; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Norbeck J, 2000, YEAST, V16, P121, DOI 10.1002/(SICI)1097-0061(20000130)16:2<121::AID-YEA511>3.0.CO;2-A; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rani SH, 2013, MICROBIOL-SGM, V159, P155, DOI 10.1099/mic.0.063156-0; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; Seip J, 2013, APPL ENVIRON MICROB, V79, P7360, DOI 10.1128/AEM.02079-13; Skoneczny M, 1996, BIOCHIMIE, V78, P95, DOI 10.1016/0300-9084(96)82639-3; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Stewart-Ornstein J, 2013, CURR BIOL, V23, P2336, DOI 10.1016/j.cub.2013.09.043; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; Wierzbicki AS, 2002, J NEUROCHEM, V80, P727, DOI 10.1046/j.0022-3042.2002.00766.x; Yadav KK, 2016, FEBS LETT, V590, P3559, DOI 10.1002/1873-3468.12422; Yadav PK, 2016, J BIOL CHEM, V291, P18562, DOI 10.1074/jbc.M116.733378; Zipor G, 2009, P NATL ACAD SCI USA, V106, P19848, DOI 10.1073/pnas.0910754106	49	18	19	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18628	18643		10.1074/jbc.M117.801704	http://dx.doi.org/10.1074/jbc.M117.801704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924051	Green Published, hybrid			2022-12-26	WOS:000414958100020
J	Catozzi, C; Bonastre, AS; Francino, O; Lecchi, C; De Carlo, E; Vecchio, D; Martucciello, A; Fraulo, P; Bronzo, V; Cusco, A; D'Andreano, S; Ceciliani, F				Catozzi, Carlotta; Sanchez Bonastre, Armand; Francino, Olga; Lecchi, Cristina; De Carlo, Esterina; Vecchio, Domenico; Martucciello, Alessandra; Fraulo, Pasquale; Bronzo, Valerio; Cusco, Anna; D'Andreano, Sara; Ceciliani, Fabrizio			The microbiota of water buffalo milk during mastitis	PLOS ONE			English	Article							SOMATIC-CELL COUNT; BOVINE CLINICAL MASTITIS; INTRAMAMMARY INFECTION; DAIRY; CATTLE; IDENTIFICATION; RAW; MANAGEMENT; LACTATION; SEQUENCES	The aim of this study was to define the microbiota of water buffalo milk during sub-clinical and clinical mastitis, as compared to healthy status, by using high-throughput sequencing of the 16S rRNA gene. A total of 137 quarter samples were included in the experimental design: 27 samples derived from healthy, culture negative quarters, with a Somatic Cell Count (SCC) of less than 200,000 cells/ml; 27 samples from quarters with clinical mastitis; 83 samples were collected from quarters with subclinical mastitis, with a SCC number greater of 200,000 cells/ml and/or culture positive for udder pathogens, without clinical signs of mastitis. Bacterial DNA was purified and the 16S rRNA genes were individually amplified and sequenced. Significant differences were found in milk samples from healthy quarters and those with sub-clinical and clinical mastitis. The microbiota diversity of milk from healthy quarters was richer as compared to samples with sub-clinical mastitis, whose microbiota diversity was in turn richer as compared to those from clinical mastitis. The core microbiota of water buffalo milk, defined as the asset of microorganisms shared by all healthy milk samples, includes 15 genera, namely Micrococcus, Propionibacterium, 5-7N15, Solibacillus, Staphylococcus, Aerococcus, Facklamia, Trichococcus, Turicibacter, 02d06, SMB53, Clostridium, Acinetobacter, Psychrobacter and Pseudomonas. Only two genera (Acinetobacter and Pseudomonas) were present in all the samples from sub-clinical mastitis, and no genus was shared across all in clinical mastitis milk samples. The presence of mastitis was found to be related to the change in the relative abundance of genera, such as Psychrobacter, whose relative abundance decreased from 16.26% in the milk samples from healthy quarters to 3.2% in clinical mastitis. Other genera, such as SMB53 and Solibacillus, were decreased as well. Discriminant analysis presents the evidence that the microbial community of healthy and clinical mastitis could be discriminated on the background of their microbiota profiles.	[Catozzi, Carlotta; Lecchi, Cristina; Bronzo, Valerio; Ceciliani, Fabrizio] Univ Milan, Dipartimento Med Vet, Via Celoria 10, Milan, Italy; [Sanchez Bonastre, Armand; Francino, Olga] Univ Autonoma Barcelona, Vet Sch, Mol Genet Vet Serv SVGM, Barcelona, Spain; [De Carlo, Esterina; Vecchio, Domenico; Martucciello, Alessandra; Fraulo, Pasquale] Natl Reference Ctr Hyg & Technol Water Buffalo Fa, Ist Zooprofilatt Sperimentale Mezzogiorno, Via Calabrie, Salerno, Italy; [Cusco, Anna; D'Andreano, Sara] Vetgen Eureka PRUAB, Campus UAB, Barcelona, Spain	University of Milan; Autonomous University of Barcelona; IZS del Mezzogiorno; Autonomous University of Barcelona	Ceciliani, F (corresponding author), Univ Milan, Dipartimento Med Vet, Via Celoria 10, Milan, Italy.	fabrizio.ceciliani@unimi.it	Cusco, Anna/GRY-5131-2022; Ceciliani, Fabrizio/Q-6551-2017; Cusco, Anna/F-6262-2019; Vecchio, Domenico/I-4102-2013; Francino, Olga/K-5683-2017; Catozzi, Carlotta/AAC-1785-2019; De Carlo, Esterina/Q-1309-2016; Lecchi, Cristina/K-8729-2016	Cusco, Anna/0000-0002-9574-5755; Ceciliani, Fabrizio/0000-0002-9199-5757; Vecchio, Domenico/0000-0002-8766-7224; Francino, Olga/0000-0002-9022-3835; Catozzi, Carlotta/0000-0002-1028-1489; De Carlo, Esterina/0000-0001-7883-1283; Lecchi, Cristina/0000-0002-7262-1696	Ricerca Corrente MIUR [IZS ME 10/13 RC]	Ricerca Corrente MIUR	The present investigation was entirely carried out with the financial support of Grant IZS ME 10/13 RC - Ricerca Corrente 2013 MIUR. There was no additional external funding received for this study.; We thank Prof Paolo Moroni for the critical reading of the manuscript. We are also indebted to Mrs Chiara Gini for graphical editing of figures, and Dr Andrea Talenti for the support in statistical analysis. The present investigation was carried out with the financial support of Grant IZS ME 10/13 RC-Ricerca Corrente 2013 (AM) MIUR. There was no additional external funding received for this study.	Addis MF, 2016, MOL BIOSYST, V12, P2359, DOI 10.1039/c6mb00217j; Ali MA, 2011, J ANIM PLANT SCI-PAK, V21, P477; [Anonymous], 2016, FAO REPORT; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Braem G, 2014, J APPL MICROBIOL, V116, P1084, DOI 10.1111/jam.12447; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Capra E, 2014, LETT APPL MICROBIOL, V59, P642, DOI 10.1111/lam.12326; Cisak E, 2017, FOODBORNE PATHOG DIS, V14, P189, DOI 10.1089/fpd.2016.2203; De Carlo E, 2013, BUFFALO BULL, V32, P1066; De Filippis F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089680; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Fagiolo A, 2007, ITAL J ANIM SCI, V6, P200; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Faye B, 2012, INT DAIRY J, V24, P50, DOI 10.1016/j.idairyj.2011.12.011; Guccione J, 2016, J DAIRY SCI, V99, P2945, DOI 10.3168/jds.2015-10291; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hertl JA, 2011, J DAIRY SCI, V94, P4863, DOI 10.3168/jds.2010-4000; Hiitio H, 2016, J DAIRY SCI, V99, P6532, DOI 10.3168/jds.2015-10811; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Jiao JZ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01364; Kivaria FM, 2007, VET J, V173, P617, DOI 10.1016/j.tvjl.2006.01.008; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Li L, 2016, J DAIRY SCI, V99, P7016, DOI 10.3168/jds.2016-11041; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Locatelli C, 2013, J DAIRY SCI, V96, P3799, DOI 10.3168/jds.2012-6275; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; MADSEN M, 1992, VET MICROBIOL, V32, P81, DOI 10.1016/0378-1135(92)90009-I; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; Moroni P, 2006, J DAIRY SCI, V89, P998, DOI 10.3168/jds.S0022-0302(06)72165-8; Myer PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129174; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; NMC, 2017, LAB HDB BOVINE MASTI; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Papa R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01333; PYORALA S, 1992, BRIT VET J, V148, P54, DOI 10.1016/0007-1935(92)90067-B; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Rainard P, 2017, VET RES, V48, DOI 10.1186/s13567-017-0429-2; Rodrigues NF, 2015, GENET MOL RES, V14, P6518, DOI 10.4238/2015.June.12.4; Rogers GB, 2013, TRENDS MICROBIOL, V21, P271, DOI 10.1016/j.tim.2013.03.004; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sahin A, 2016, BUFFALO BULL, V35, P573; Sahin A, 2017, INDIAN J ANIM RES, V51, P35, DOI 10.18805/ijar.1146r; Sahin A, 2016, PAK J ZOOL, V48, P325; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Santos Thiago M A, 2012, PLoS One, V7, pe53048, DOI 10.1371/journal.pone.0053048; Scaccabarozzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142973; Sharma A, 2007, ITAL J ANIM SCI, V6, P965; Stubbendieck RM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01234; Taponen S, 2009, J DAIRY SCI, V92, P2610, DOI 10.3168/jds.2008-1729; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Vayssier-Taussat M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00029; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Wright EA, 2015, VET MICROBIOL, V175, P105, DOI 10.1016/j.vetmic.2014.11.011	64	40	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184710	10.1371/journal.pone.0184710	http://dx.doi.org/10.1371/journal.pone.0184710			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926595	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600036
J	Stanisavljevic, D; Petrovic, I; Vukovic, V; Schwirtlich, M; Gredic, M; Stevanovic, M; Popovic, J				Stanisavljevic, Danijela; Petrovic, Isidore; Vukovic, Vladanka; Schwirtlich, Marija; Gredic, Marija; Stevanovic, Milena; Popovic, Jelena			SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; DNA-DAMAGE; GENES; TRANSCRIPTION; PROMOTES; DEGRADATION; BINDING; DIFFERENTIATION; INHIBITION; EXPRESSION	SOX14 is a member of the SOX family of transcription factors mainly involved in the regulation of neural development. Recently, it became evident that SOX14 is one of four hyper-methylated genes in cervical carcinoma, considered as a tumor suppressor candidate in this type of malignancy. In this paper we elucidated the role of SOX14 in the regulation of malignant properties of cervical carcinoma cells in vitro. Functional analysis performed in HeLa cells revealed that SOX14 overexpression decreased viability and promoted apoptosis through altering the expression of apoptosis related genes. Our results demonstrated that overexpression of SOX14 initiated accumulation of p53, demonstrating potential cross-talk between SOX14 and the p53 signaling pathway. Further analysis unambiguously showed that SOX14 triggered posttranslational modification of p53 protein, as detected by the significantly increased level of phospho-p53 (Ser-15) in SOX14-overexpressing HeLa cells. Moreover, the obtained results revealed that SOX14 activated p53 protein, which was confirmed by elevated p21 Waf1/Cip1, a well known target gene of p53. This study advances our understanding about the role of SOX14 and might explain the molecular mechanism by which this transcription factor could exert tumor suppressor properties in cervical carcinoma.	[Stanisavljevic, Danijela; Petrovic, Isidore; Vukovic, Vladanka; Schwirtlich, Marija; Gredic, Marija; Stevanovic, Milena; Popovic, Jelena] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Stevanovic, Milena] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Stevanovic, Milena] Serbian Acad Arts & Sci, Belgrade, Serbia; [Gredic, Marija] UGMLC, JLUG, Excellence Cluster Cardiopulmonary Syst ECCPS, Giessen, Germany; [Gredic, Marija] German Ctr Lung Res DZL, Giessen, Germany	University of Belgrade; University of Belgrade; Serbian Academy of Sciences & Arts	Popovic, J (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.	jpopovic@imgge.bg.ac.rs	Popovic, Jelena/S-6304-2017	Popovic, Jelena/0000-0001-8565-1555; Schwirtlich, Marija/0000-0002-2183-0164; Gredic, Marija/0000-0001-6008-171X; Stevanovic, Milena/0000-0003-4286-7334; Petrovic, Isidora/0000-0002-9816-2184; Stanisavljevic Ninkovic, Danijela/0000-0003-0481-4004	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]; Serbian Academy of Sciences and Arts (Project: "Studying the molecular mechanisms involved in maintaining pluripotency and differentiation of stem cells" [F 24]; Northwestern University RHLCCC Flow Cytometry Facility; Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Ministry of Education, Science and Technological Development, Republic of Serbia; Serbian Academy of Sciences and Arts (Project: "Studying the molecular mechanisms involved in maintaining pluripotency and differentiation of stem cells"; Northwestern University RHLCCC Flow Cytometry Facility; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No. 173051) and by the Serbian Academy of Sciences and Arts (Project: "Studying the molecular mechanisms involved in maintaining pluripotency and differentiation of stem cells", No F 24).; Flow cytometry analysis was supported by the Northwestern University RHLCCC Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). We thank Paul Mehl for flow cytometry data analysis and Dr Snezana Kojic for the CDKN1A/ p21<SUP>Waf1/Cip1</SUP> promoter and p53 expression constructs.	Ajay AK, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-2; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Arsic N, 1998, CYTOGENET CELL GENET, V83, P139, DOI 10.1159/000015149; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015; DEFFIE A, 1993, MOL CELL BIOL, V13, P3415, DOI 10.1128/MCB.13.6.3415; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; Han F, 2015, ONCOGENE, V34, P4391, DOI 10.1038/onc.2014.370; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li F, 2015, INT J CLIN EXP PATHO, V8, P1698; Luo QY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020066; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; MIYASHITA T, 1995, CELL, V80, P293; Mowat MRA, 1998, ADV CANCER RES, V74, P25, DOI 10.1016/S0065-230X(08)60764-2; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Petrovic I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143591; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Popovic J, 2009, J GENET, V88, P15, DOI 10.1007/s12041-009-0003-4; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; Prives C, 1999, J PATHOL, V187, P112; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Senchenko VN, 2013, EPIGENETICS-US, V8, P409, DOI 10.4161/epi.24233; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tong Wei-Gang, 2010, Epigenetics, V5, P499; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Wang J, 2016, ONCOGENE, V35, P1692, DOI 10.1038/onc.2015.234; Wang R, 2016, ONCOTARGET; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhu YZ, 2012, INT J MOL SCI, V13, P15767, DOI 10.3390/ijms131215767	47	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184686	10.1371/journal.pone.0184686	http://dx.doi.org/10.1371/journal.pone.0184686			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926586	gold, Green Submitted, Green Published			2022-12-26	WOS:000411166600034
J	Sutton, BC; Birse, RT; Maggert, K; Ray, T; Hobbs, J; Ezenekwe, A; Kazmierczak, J; Mosko, M; Kish, J; Bullock, A; Shi, ZG; Stack, MS; Irwin, D				Sutton, Bobbie C.; Birse, Ryan T.; Maggert, Kevin; Ray, Tammy; Hobbs, Jessica; Ezenekwe, Amobi; Kazmierczak, Jason; Mosko, Michael; Kish, Joan; Bullock, Andrew; Shi, Zonggao; Stack, M. Sharon; Irwin, Darryl			Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX (R) HS, a new highly sensitive assay for the MassARRAY (R) System	PLOS ONE			English	Article							LUNG-CANCER	Increased early detection and personalized therapy for lung cancer have coincided with greater use of minimally invasive sampling techniques such as endobronchial ultrasound-guided biopsy (EBUS), endoscopic ultrasound-guided biopsy (EUS), and navigational biopsy, as well as thin needle core biopsies. As many lung cancer patients have late stage disease and other comorbidities that make open surgical procedures hazardous, the least invasive biopsy technique with the highest potential specimen yield is now the preferred first diagnostic study. However, use of these less invasive procedures generates significant analytical challenges for the laboratory, such as a requirement for robust detection of low level somatic mutations, particularly when the starting sample is very small or demonstrates few intact tumor cells. In this study, we assessed 179 clinical cases of non-small cell lung carcinoma (NSCLC) that had been previously tested for EGFR, KRAS, NRAS, and BRAF mutations using a novel multiplexed analytic approach that reduces wild-type signal and allows for detection of low mutation load approaching 1%, iPLEX (R) HS panel for the MassARRAY (R) System (Agena Bioscience, San Diego, CA). This highly sensitive system identified approximately 10% more KRAS, NRAS, EGFR and BRAF mutations than were detected by the original test platform, which had a sensitivity range of 5-10% variant allele frequency (VAF).	[Sutton, Bobbie C.; Maggert, Kevin; Ray, Tammy; Hobbs, Jessica; Ezenekwe, Amobi; Kish, Joan] South Bend Med Fdn, Pathol Dept, South Bend, IN USA; [Birse, Ryan T.; Kazmierczak, Jason; Mosko, Michael; Irwin, Darryl] Agena Biosci, San Diego, CA 92121 USA; [Bullock, Andrew; Shi, Zonggao; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA; [Sutton, Bobbie C.] True Hlth, Dept Womans Hlth, Frisco, TX USA	University of Notre Dame	Birse, RT; Irwin, D (corresponding author), Agena Biosci, San Diego, CA 92121 USA.	ryan.birse@agenabio.com; darry.irwin@agenabio.com			Agena Bioscience; Walther Cancer Foundation	Agena Bioscience; Walther Cancer Foundation	Agena Bioscience provided support in the form of salaries for authors RTB, JK, MM, DI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MSS was partially supported by grant funding from The Walther Cancer Foundation. Furthermore, the iPLEX (R) HS chemistry stated in this manuscript was developed and launched by Agena Bioscience as a commercial product in 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; [Anonymous], 2014, WORLD CANC REPORT; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chen GL, 2015, HUM PATHOL, V46, P113, DOI 10.1016/j.humpath.2014.09.014; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Henschke CI, 2008, ONCOLOGIST, V13, P65, DOI 10.1634/theoncologist.2007-0153; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; National Comprehensive Cancer Network, 2017, NAT COMPR CANC NETW, V4; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tol J, 2010, J CELL MOL MED, V14, P2122, DOI 10.1111/j.1582-4934.2009.00788.x	11	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0183715	10.1371/journal.pone.0183715	http://dx.doi.org/10.1371/journal.pone.0183715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926605	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600005
J	Pyne, R; Honig, J; Vaiciunas, J; Koroch, A; Wyenandt, C; Bonos, S; Simon, J				Pyne, Robert; Honig, Josh; Vaiciunas, Jennifer; Koroch, Adolfina; Wyenandt, Christian; Bonos, Stacy; Simon, James			A first linkage map and downy mildew resistance QTL discovery for sweet basil (Ocimum basilicum) facilitated by double digestion restriction site associated DNA sequencing (ddRADseq)	PLOS ONE			English	Article							PERONOSPORA-BELBAHRII; LACTUCA-SALIGNA; GENUS OCIMUM; L.; LETTUCE; GENOME; CONSTRUCTION; SEGREGATION; INHERITANCE; PATHOGEN	Limited understanding of sweet basil (Ocimum basilicum L.) genetics and genome structure has reduced efficiency of breeding strategies. This is evidenced by the rapid, worldwide dissemination of basil downy mildew (Peronospora belbahrii) in the absence of resistant cultivars. In an effort to improve available genetic resources, expressed sequence tag simple sequence repeat (EST-SSR) and single nucleotide polymorphism (SNP) markers were developed and used to genotype the MRI x SB22 F-2 mapping population, which segregates for response to downy mildew. SNP markers were generated from genomic sequences derived from double digestion restriction site associated DNA sequencing (ddRADseq). Disomic segregation was observed in both SNP and EST-SSR markers providing evidence of an O. basilicum allotetraploid genome structure and allowing for subsequent analysis of the mapping population as a diploid intercross. A dense linkage map was constructed using 42 EST-SSR and 1,847 SNP markers spanning 3,030.9 cM. Multiple quantitative trait loci (QTL) model (MQM) analysis identified three QTL that explained 37-55% of phenotypic variance associated with downy mildew response across three environments. A single major QTL, dm11.1 explained 21-28% of phenotypic variance and demonstrated dominant gene action. Two minor QTL dm9.1 and dm14.1 explained 5-16% and 4-18% of phenotypic variance, respectively. Evidence is provided for an additive effect between the two minor QTL and the major QTL dm11.1 increasing downy mildew susceptibility. Results indicate that ddRADseq-facilitated SNP and SSR marker genotyping is an effective approach for mapping the sweet basil genome.	[Pyne, Robert; Honig, Josh; Vaiciunas, Jennifer; Wyenandt, Christian; Bonos, Stacy; Simon, James] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA; [Koroch, Adolfina] CUNY, Dept Sci, Borough Manhattan Community Coll, New York, NY 10021 USA	Rutgers State University New Brunswick; City University of New York (CUNY) System	Simon, J (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.	jimsimon@rutgers.edu			United States United Department of Agriculture (USDA) Special Crops Research Initiative [2011-51181-30646]; USDA National Institute of Food and Agriculture [2016-68004-24931]; Binational Agricultural Research & Development (BARD) [US-4947-16R]; New Jersey Agricultural Experiment Station; New Use Agriculture and Natural Plant Products Program; Rutgers Cooperative Extension Service (NIFA HATCH) [NJAES 12131, 1005685]	United States United Department of Agriculture (USDA) Special Crops Research Initiative; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Binational Agricultural Research & Development (BARD); New Jersey Agricultural Experiment Station; New Use Agriculture and Natural Plant Products Program; Rutgers Cooperative Extension Service (NIFA HATCH)	Funds for this research and in support of a graduate assistantship/doctoral degree for RMP were provided by United States United Department of Agriculture (USDA) Special Crops Research Initiative Award No. 2011-51181-30646. Additional funds were provided by USDA National Institute of Food and Agriculture Award No. 2016-68004-24931, and the Binational Agricultural Research & Development (BARD) Award No. US-4947-16R. We thank the New Jersey Agricultural Experiment Station, the New Use Agriculture and Natural Plant Products Program and the Rutgers Cooperative Extension Service for also providing funds in support of this work (NIFA HATCH project reports NJAES 12131 and 1005685).; Funds for this research and in support of a graduate assistantship/doctoral degree for RMP were provided by United States United Department of Agriculture (USDA) Special Crops Research Initiative Award No.2011-51181-30646. Additional funds were provided by USDA National Institute of Food and Agriculture Award No. 2016-68004-24931, and the Binational Agricultural Research & Development (BARD) Award No. US-4947-16R. We thank the New Jersey Agricultural Experiment Station, the New Use Agriculture and Natural Plant Products Program and the Rutgers Cooperative Extension Service for also providing funds in support of this work (NIFA HATCH project reports NJAES 12131 and 1005685). We thank Dr. Todd Wehner (North Carolina State University) for his advice throughout the course of this project. We thank Mark Peacos, and Ed Dager for their assistance with greenhouse and field work.	Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; [Anonymous], 2006, JOINMAP SOFTWARE CAL; Ates D, 2016, PLOS ONE, V11, Patent No. 26978666; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Belbahri L, 2005, MYCOL RES, V109, P1276, DOI 10.1017/S0953756205003928; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Ben-Naim Y, 2015, PHYTOPATHOLOGY, V2710, Patent No. 25844828; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Blomquist CL, 2009, PLANT DIS, V93, P968, DOI 10.1094/PDIS-93-9-0968A; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2001, LAB ANIMAL, V30, P44; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaimovitsh D., 1983, PHYTOPATHOLOGY, V90, P58; Christensen KA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-325; Chu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116197; Clevenger J, 2015, MOL PLANT, V8, P831, DOI 10.1016/j.molp.2015.02.002; Cohen Y, 2013, PLANT DIS, V97, P692, DOI 10.1094/PDIS-12-12-1126-PDN; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; den Boer E, 2014, THEOR APPL GENET, V127, P1805, DOI 10.1007/s00122-014-2342-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Farahani-Kofoet RD, 2012, MYCOL PROG, V11, P961, DOI 10.1007/s11557-012-0816-z; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Garibaldi A, 2004, PLANT DIS, V88, P312, DOI 10.1094/PDIS.2004.88.3.312A; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Guo L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00925; Henning JA, 2016, EUPHYTICA, V208, P545, DOI 10.1007/s10681-015-1600-3; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Irish BM, 2008, PHYTOPATHOLOGY, V98, P894, DOI 10.1094/PHYTO-98-8-0894; Isobe SN, 2013, DNA RES, V20, P79, DOI 10.1093/dnares/dss035; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Jeuken M, 2002, THEOR APPL GENET, V105, P384, DOI 10.1007/s00122-002-0943-z; Kanetis L, 2014, PLANT DIS, V98, P283, DOI 10.1094/PDIS-07-13-0759-PDN; KHOSLA MK, 1985, CYTOLOGIA, V50, P253, DOI 10.1508/cytologia.50.253; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kong XY, 2015, PLANT DIS, V99, P1642, DOI 10.1094/PDIS-01-15-0077-PDN; Koroch AR, 2010, ISR J PLANT SCI, V58, P183, DOI 10.1560/IJPS.59.3-4.183; Li HT, 2013, THEOR APPL GENET, V126, P937, DOI 10.1007/s00122-012-2027-z; Logan-Young CJ, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400077; Manrique-Carpintero NC, 2016, G3-GENES GENOM GENET, V6, P2617, DOI 10.1534/g3.116.030031; McLeod A, 2006, PLANT DIS, V90, P1115, DOI 10.1094/PD-90-1115A; Nagy G, 2011, PLANT DIS, V95, P1034, DOI 10.1094/PDIS-04-11-0329; NATION RG, 1992, HORTSCIENCE, V27, P1221, DOI 10.21273/HORTSCI.27.11.1221; Olczak-Woltman H, 2011, J APPL GENET, V52, P249, DOI 10.1007/s13353-011-0030-8; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Phippen WB, 2000, J HERED, V91, P289, DOI 10.1093/jhered/91.4.289; Pintore I, 2016, PHYTOPARASITICA; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; PUSHPANGADAN P, 1982, CYTOLOGIA, V47, P575, DOI 10.1508/cytologia.47.575; Pyne RM, 2015, J AM SOC HORTIC SCI, V140, P396, DOI 10.21273/JASHS.140.5.396; Pyne RM, 2014, HORTSCIENCE, V49, P1041, DOI 10.21273/HORTSCI.49.8.1041; Rastogi S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1640-z; Reflinur, 2014, RICE, V7, DOI 10.1186/s12284-014-0003-8; Roberts PD, 2009, PLANT DIS, V93, P199, DOI 10.1094/PDIS-93-2-0199B; Rozen S, 2000, Methods Mol Biol, V132, P365; Saude C, 2013, PLANT DIS, V97, P1248, DOI 10.1094/PDIS-01-13-0026-PDN; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Simko I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02875; SIMON JE, 1990, ADVANCES IN NEW CROPS, P484; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; USDA, US DEP AGR CENS AGR; van Dijk T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-25; Vicente JG, 2012, PLANT PATHOL, V61, P600, DOI 10.1111/j.1365-3059.2011.02539.x; Wang Y, 2016, THEOR APPL GENET, V7120; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Wyenandt CA, 2015, PHYTOPATHOLOGY, V105, P885, DOI 10.1094/PHYTO-02-15-0032-FI; Wyenandt CA, 2010, HORTSCIENCE, V45, P1416, DOI 10.21273/HORTSCI.45.9.1416; Zhang NW, 2009, PLANT PATHOL, V58, P923, DOI 10.1111/j.1365-3059.2009.02066.x; Zhou XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-351	74	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184319	10.1371/journal.pone.0184319	http://dx.doi.org/10.1371/journal.pone.0184319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922359	Green Published, gold			2022-12-26	WOS:000411059300015
J	Wang, K; Melki, R; Kabani, M				Wang, Kai; Melki, Ronald; Kabani, Mehdi			A prolonged chronological lifespan is an unexpected benefit of the [PSI+] prion in yeast	PLOS ONE			English	Article							GENETIC-VARIATION; PROPAGATION; INHERITANCE; LEISHMANIASIS; DETERMINANT; HYPOTHESIS; MECHANISM; SEVERITY; SUP35P	Self-replicating 'proteinaceous infectious particles' or prions are responsible for complex heritable traits in the yeast Saccharomyces cerevisiae. Our current understanding of the biology of yeast prions stems from studies mostly done in the context of actively dividing cells in optimal laboratory growth conditions. Evidence suggest that fungal prions exist in the wild where most cells are in a non-dividing quiescent state, because of imperfect growth conditions, scarcity of nutrients and competition. We know little about the faithful transmission of yeast prions in such conditions and their physiological consequences throughout the lifespan of yeast cells. We addressed this issue for the [PSI+] prion that results from the self-assembly of the translation release factor Sup35p into insoluble fibrillar aggregates. [PSI+] leads to increased nonsense suppression and confers phenotypic plasticity in response to environmental fluctuations. Here, we report that while [PSI+] had little to no effect on growth per se, it dramatically improved the survival of yeast cells in stationary phase. Remarkably, prolonged chronological lifespan persisted even after [PSI+] was cured from the cells, suggesting that prions may facilitate the acquisition of complex new traits. Such an important selective advantage may contribute to the evolutionary conservation of the prion-forming ability of Sup35p orthologues in distantly related yeast species.	[Wang, Kai; Melki, Ronald; Kabani, Mehdi] Univ Paris Saclay, Paris Saclay Inst Neurosci, CNRS, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R; Kabani, M (corresponding author), Univ Paris Saclay, Paris Saclay Inst Neurosci, CNRS, Gif Sur Yvette, France.	Ronald.Melki@cnrs.fr; Mehdi.Kabani@cnrs.fr	Kabani, Mehdi/G-7456-2012	Kabani, Mehdi/0000-0001-7440-6394	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-12-13508-0013-02]; French Ministry of National Education, Research and Technology	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of National Education, Research and Technology	M.K. and R.M. are supported by the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR-12-13508-0013-02). K.W. was the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chih-Yen King for the generous gift of yeast strains and Tracy Bellande for excellent technical assistance. M.K. and R.M. are supported by the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR-12-B508-0013-02). K. W. was the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology.	Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Baudin-Baillieu A, 2014, CELL REP, V8, P438, DOI 10.1016/j.celrep.2014.06.036; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Daignan-Fornier B, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-20; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Garcia DM, 2014, FEMS YEAST RES, V14, P136, DOI 10.1111/1567-1364.12116; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; JULIANI MH, 1973, BIOCHEM BIOPH RES CO, V53, P531, DOI 10.1016/0006-291X(73)90694-3; Kabani M, 2014, MOL MICROBIOL, V92, P507, DOI 10.1111/mmi.12572; Kabani M, 2011, PRION, V5, P277, DOI [10.4161/pri.5.4.18070, 10.4161/pri.18070]; Kabani M, 2011, MOL MICROBIOL, V81, P640, DOI 10.1111/j.1365-2958.2011.07719.x; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Longo VD, 2012, SUBCELL BIOCHEM, V57, P101, DOI 10.1007/978-94-007-2561-4_5; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; O'Farrell PH, 2011, PHILOS T R SOC B, V366, P3498, DOI 10.1098/rstb.2011.0079; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Speldewinde SH, 2017, MICROB CELL, V4, P127, DOI 10.15698/mic2017.04.568; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2016, CELL, V167, P300, DOI 10.1016/j.cell.2016.09.036; Tuite MF, 2015, SEMIN CELL DEV BIOL, V44, P51, DOI 10.1016/j.semcdb.2015.08.016; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]	32	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184905	10.1371/journal.pone.0184905	http://dx.doi.org/10.1371/journal.pone.0184905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910422	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200114
J	Bouvier, M; Durrieu, S; Gosselin, F; Herpigny, B				Bouvier, Marc; Durrieu, Sylvie; Gosselin, Frederic; Herpigny, Basile			Use of airborne lidar data to improve plant species richness and diversity monitoring in lowland and mountain forests	PLOS ONE			English	Article							ASSESSING BIODIVERSITY; UNDERSTORY VEGETATION; LAYER VEGETATION; STATISTICAL TEST; SOIL ACIDITY; MODELS; MANAGEMENT; STAND; AREA; METAANALYSIS	We explored the potential of airborne laser scanner (ALS) data to improve Bayesian models linking biodiversity indicators of the understory vegetation to environmental factors. Biodiversity was studied at plot level and models were built to investigate species abundance for the most abundant plants found on each study site, and for ecological group richness based on light preference. The usual abiotic explanatory factors related to climate, topography and soil properties were used in the models. ALS data, available for two contrasting study sites, were used to provide biotic factors related to forest structure, which was assumed to be a key driver of understory biodiversity. Several ALS variables were found to have significant effects on biodiversity indicators. However, the responses of biodiversity indicators to forest structure variables, as revealed by the Bayesian model outputs, were shown to be dependent on the abiotic environmental conditions characterizing the study areas. Lower responses were observed on the lowland site than on the mountainous site. In the latter, shade-tolerant and heliophilous species richness was impacted by vegetation structure indicators linked to light penetration through the canopy. However, to reveal the full effects of forest structure on biodiversity indicators, forest structure would need to be measured over much wider areas than the plot we assessed. It seems obvious that the forest structure surrounding the field plots can impact biodiversity indicators measured at plot level. Various scales were found to be relevant depending on: the biodiversity indicators that were modelled, and the ALS variable. Finally, our results underline the utility of lidar data in abundance and richness models to characterize forest structure with variables that are difficult to measure in the field, either due to their nature or to the size of the area they relate to.	[Bouvier, Marc; Durrieu, Sylvie] Irstea, UMR TETIS, 500 Rue Jean Francois Breton, Montpellier, France; [Bouvier, Marc] Info Geo Drones, Pepiniere Entreprises Versailles Grand Parc, Versailles, France; [Gosselin, Frederic; Herpigny, Basile] Irstea, UR EFNO, Domaine Barres, Nogent Sur Vernisson, France	AgroParisTech; INRAE; INRAE	Bouvier, M (corresponding author), Irstea, UMR TETIS, 500 Rue Jean Francois Breton, Montpellier, France.	marc.bouvier@gmx.com	; Durrieu, Sylvie/G-5601-2017	Bouvier, Marc/0000-0002-1565-9524; Gosselin, Frederic/0000-0003-3737-106X; Durrieu, Sylvie/0000-0001-6145-9614	French National Research Agency (ANR)	French National Research Agency (ANR)(French National Research Agency (ANR))	This research was supported by the French National Research Agency (ANR) Grant within the Framework of the BIOLID project (INDECO 2012) through the Carnot facility.; The authors thank the Agence nationale pour la gestion des dechets radioactifs (Andra) for providing the ALS dataset for the lowland site. We also thank the Institut National de l'Information Geographique et Forestiere (IGN), the Institut des sciences et industries du vivant et de l'environnement (AgroParisTech), and the Institut National de la Recherche Agronomique (INRA) for providing field inventories. This study would not have been possible without the availability of ALS data on the Mountain site from the FORESEE project (ANR- 2010-BIOE-008), supported by the French National Research Agency (ANR).	Al Bassatneh Marwan Cheikh, 2007, Ecologia Mediterranea, V33, P29; Allen RG, 1997, J HYDROL ENG, V2, P56, DOI 10.1061/(ASCE)1084-0699(1997)2:2(56); Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Axelsson P., 2000, INT ARCH PHOTOGRAMME, V33, P111; Baragatti M, 2013, STAT COMPUT, V23, P323, DOI 10.1007/s11222-012-9313-0; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Barbier S, 2009, FOREST ECOL MANAG, V258, pS176, DOI 10.1016/j.foreco.2009.09.004; Bontemps JD, 2014, FORESTRY, V87, P109, DOI 10.1093/forestry/cpt034; Bouvier M, 2015, REMOTE SENS ENVIRON, V156, P322, DOI 10.1016/j.rse.2014.10.004; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; Brosofske KD, 2001, FOREST ECOL MANAG, V146, P75, DOI 10.1016/S0378-1127(00)00447-3; Brunet J, 1996, FOREST ECOL MANAG, V88, P259, DOI 10.1016/S0378-1127(96)03845-5; Camp RJ, 2008, ECOLOGY, V89, P1469, DOI 10.1890/07-0462.1; Carey AB, 1991, SPRING BIRD COMMUNIT; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Coops NC, 2016, ECOL INDIC, V67, P346, DOI 10.1016/j.ecolind.2016.02.057; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Dixon PM, 2005, ECOLOGY, V86, P1751, DOI 10.1890/04-1343; Dubayah R, 2000, LAND SURFACE CHARACT, P25; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; Durrieu S, REMOTE SENS IN PRESS, V2; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Gegout JC, 2005, J VEG SCI, V16, P257, DOI 10.1111/j.1654-1103.2005.tb02363.x; Gelman A., 2004, BAYESIAN DATA ANAL, V2; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Gobakken T, 2009, CAN J FOREST RES, V39, P1036, DOI 10.1139/X09-025; Gorgens EB, 2015, ANN FOREST SCI, V72, P489, DOI 10.1007/s13595-015-0457-x; Gregory PC, 2011, MON NOT R ASTRON SOC, V410, P94, DOI 10.1111/j.1365-2966.2010.17428.x; Harrell FE, 2001, REGRESSION MODELING; Herpigny B, 2015, ECOL INFORM, V26, P18, DOI 10.1016/j.ecoinf.2014.12.002; Hopkinson C, 2009, REMOTE SENS ENVIRON, V113, P275, DOI 10.1016/j.rse.2008.09.012; Joly D, 2010, CYBERGEO, DOI 10.4000/cybergeo.23155; Julve P., 1998, INDEX BOTANIQUE ECOL; Lahde E, 1999, FOREST ECOL MANAG, V115, P213, DOI 10.1016/S0378-1127(98)00400-9; Lesak AA, 2011, REMOTE SENS ENVIRON, V115, P2823, DOI 10.1016/j.rse.2011.01.025; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Lim K, 2003, CAN J REMOTE SENS, V29, P658, DOI 10.5589/m03-025; Lopatin J, 2014, GEOSCIENCE REMOTE SE, P1; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Magnusson M, 2007, FOREST SCI, V53, P619; MAJOR J, 1951, ECOLOGY, V32, P392, DOI 10.2307/1931718; MARTENS SN, 1993, FOREST ECOL MANAG, V61, P91, DOI 10.1016/0378-1127(93)90192-P; Muller J, 2014, FOREST ECOL MANAG, V312, P129, DOI 10.1016/j.foreco.2013.10.014; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Richardson S, 2002, J ROY STAT SOC A STA, V165, P549, DOI 10.1111/1467-985X.00252; Roberts GO, 2007, J APPL PROBAB, V44, P458, DOI 10.1239/jap/1183667414; Simonson WD, 2012, CONSERV BIOL, V26, P840, DOI 10.1111/j.1523-1739.2012.01869.x; Spies TA, 1998, NORTHWEST SCI, V72, P34; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; TYLER G, 1989, FOREST ECOL MANAG, V28, P101, DOI 10.1016/0378-1127(89)90063-7; Vega C, 2016, REMOTE SENS ENVIRON, V175, P32, DOI 10.1016/j.rse.2015.12.039; Verrelst J, 2009, INT J APPL EARTH OBS, V11, P83, DOI 10.1016/j.jag.2008.09.001; Vrugt JA, 2009, INT J NONLIN SCI NUM, V10, P273, DOI 10.1515/IJNSNS.2009.10.3.273; Wei LP, 2015, FOREST ECOL MANAG, V338, P20, DOI 10.1016/j.foreco.2014.11.018; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007; Wulder M, 1998, PROG PHYS GEOG, V22, P449, DOI 10.1177/030913339802200402; Zellweger F, 2014, BIODIVERS CONSERV, V23, P289, DOI 10.1007/s10531-013-0600-7; Zellweger F, 2013, FOREST ECOL MANAG, V307, P303, DOI [10.1016/j.foreco.2013.07.023, 10.1016/j.]; Zenner EK, 2008, FOREST ECOL MANAG, V256, P1785, DOI 10.1016/j.foreco.2008.05.030; Zilliox C, 2014, FOREST ECOL MANAG, V321, P105, DOI 10.1016/j.foreco.2013.07.049	64	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184524	10.1371/journal.pone.0184524	http://dx.doi.org/10.1371/journal.pone.0184524			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902920	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200043
J	Gupte, AN; Wong, ML; Msandiwa, R; Barnes, GL; Golub, J; Chaisson, RE; Hoffmann, CJ; Martinson, NA				Gupte, Akshay N.; Wong, Michelle L.; Msandiwa, Reginah; Barnes, Grace L.; Golub, Jonathan; Chaisson, Richard E.; Hoffmann, Christopher J.; Martinson, Neil A.			Factors associated with pulmonary impairment in HIV-infected South African adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHRONIC RESPIRATORY-DISEASE; ANTIRETROVIRAL THERAPY ERA; TREATMENT START TRIAL; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; RISK-FACTORS; GENERAL-POPULATION; TUBERCULOSIS; COPD	Background HIV-infected individuals have increased risk of developing obstructive lung disease (OLD). Studies from developed countries report high viral load, low CD4 counts, and anti-retroviral therapy (ART) to be associated with OLD; but these findings may not be generalizable to populations in resource-limited settings. Methods We conducted a prospective cohort study of lung function in 730 HIV-infected black South African adults. Pre-bronchodilator spirometry was performed at enrollment and repeated annually for three years. Logistic regression models were used to identify factors associated with OLD, defined as FEV1/FVC < 0.70, at enrollment. Excess annual declines in FEV1 and FVC were modelled as the product-term of follow-up time and exposures using random effects regression. Results Median (IQR) age at enrollment was 36 (32-41) years, 85% were female and 30% ever-smoked with a median (IQR) exposure of 3 (1-6) pack-years. Median (IQR) CD4 count and viral load at enrollment were 372 (261-518) cells/mm(3) and 2655 (91-13,548) copies/mL respectively. Overall, 25% were receiving ART at enrollment, 16% of whom reported at least 6 months of ART receipt. OLD was found in 35 (5%) at enrollment. Increasing age (aOR = 2.08 per 10-years [95% CI 1.22-3.57], p = 0.007), current smoking (aOR = 3.55 [95% CI 1.20-10.53], p = 0.02), and CRP (aOR = 1.01 per unit-increase [95% CI 1.00-1.03], p = 0.04) were significantly associated with OLD at enrollment; while increasing CD4 count (aOR = 1.02 per-100 cells/mm(3) [95% CI 0.85-1.22], p = 0.82), viral load (aOR = 0.67 per log-increase [95% CI 0.43-1.10], p = 0.12) and receipt of ART (aOR = 0.57 [95% CI 0.18-1.75], p = 0.32) were not. The median (IQR) follow-up time was 18 (12-24) months. Participants with a history of tuberculosis (TB) had a 35 mL (95% CI 2-68, p = 0.03) and 57 mL (95% CI 19-96, p = 0.003) per year excess loss of FEV1 and FVC respectively. Conclusion Prevalent OLD was associated with older age, current smoking and higher CRP levels, but not CD4 counts and ART, in HIV-infected South African adults. Better understanding of the long-term effects of TB, smoking and inflammation on lung function in HIV-infected populations is urgently needed.	[Gupte, Akshay N.; Golub, Jonathan; Chaisson, Richard E.; Hoffmann, Christopher J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Gupte, Akshay N.] Johns Hopkins Univ, Sch Med, CCGHE, Baltimore, MD 21205 USA; [Wong, Michelle L.] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Wong, Michelle L.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Msandiwa, Reginah; Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit PHRU, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Johannesburg, South Africa; [Barnes, Grace L.; Golub, Jonathan; Chaisson, Richard E.; Hoffmann, Christopher J.; Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Johns Hopkins University	Gupte, AN (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.; Gupte, AN (corresponding author), Johns Hopkins Univ, Sch Med, CCGHE, Baltimore, MD 21205 USA.	agupte1@jhmi.edu			National Institutes of Health [R01HL090312, P30A1094189]; Ujala Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ujala Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Participant recruitment and followup was funded by the National Institutes of Health grants R01HL090312 and P30A1094189. AG received salary support from the Ujala Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; Ahmadi-Abhari S, 2014, AM J EPIDEMIOL, V179, P48, DOI 10.1093/aje/kwt208; Akkara SA, 2013, INT J TUBERC LUNG D, V17, P810, DOI 10.5588/ijtld.12.0317; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Banu Rekha V V, 2009, Indian J Tuberc, V56, P132; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; BURROWS B, 1987, NEW ENGL J MED, V317, P1309, DOI 10.1056/NEJM198711193172103; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Cribbs SK, 2016, SEMIN RESP CRIT CARE, V37, P157, DOI 10.1055/s-0036-1572554; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; Drummond MB, 2013, AIDS, V27, P1303, DOI 10.1097/QAD.0b013e32835e395d; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Georgia, 2012, GLOBAL AIDS RESPONSE; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Harries AD, 2016, INT J TUBERC LUNG D, V20, P1010, DOI 10.5588/ijtld.16.0277; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Hooper R, 2012, EUR RESPIR J, V39, P1343, DOI 10.1183/09031936.00002711; Ko Y, 2015, INT J TUBERC LUNG D, V19, P589, DOI 10.5588/ijtld.14.0454; Kunisaki KM, 2015, HIV MED, V16, P119, DOI 10.1111/hiv.12240; Kunisaki KM, 2016, LANCET RESP MED, V4, P980, DOI 10.1016/S2213-2600(16)30319-8; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MOKOETLE KE, 1994, THORAX, V49, P340, DOI 10.1136/thx.49.4.340; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Nakamura H, 2014, J INFECT CHEMOTHER, V20, P361, DOI 10.1016/j.jiac.2014.02.001; Ngahane BHM, 2016, RESP MED, V114, P67, DOI 10.1016/j.rmed.2016.03.007; Osman RK, 2016, PUBLIC HEALTH ACTION, V6, P199, DOI 10.5588/pha.16.0030; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pefura-Yone EW, 2015, RESP MED, V109, P247, DOI 10.1016/j.rmed.2014.12.003; Pelkonen M, 2001, THORAX, V56, P703, DOI 10.1136/thorax.56.9.703; Radovic M, 2016, INT J CHRONIC OBSTR, V11, P1307, DOI 10.2147/COPD.S106875; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Twigg HL, 1999, AM J RESP CRIT CARE, V159, P1439, DOI 10.1164/ajrccm.159.5.9808031; UNAIDS, 2016, GLOB AIDS UPD; van Durme YMTA, 2009, AM J RESP CRIT CARE, V179, P375, DOI 10.1164/rccm.200810-1540OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	62	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184530	10.1371/journal.pone.0184530	http://dx.doi.org/10.1371/journal.pone.0184530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902919	gold, Green Published, Green Submitted			2022-12-26	WOS:000410669200044
J	Zanolli, C; Hourset, M; Esclassan, R; Mollereau, C				Zanolli, Clement; Hourset, Mathilde; Esclassan, Remi; Mollereau, Catherine			Neanderthal and Denisova tooth protein variants in present-day humans	PLOS ONE			English	Article							ENAMEL-DENTIN JUNCTION; AMELOGENESIS IMPERFECTA; STRUCTURAL ORGANIZATION; EVOLUTIONARY ANALYSIS; PLEISTOCENE SITE; GENOME SEQUENCE; THICKNESS; MOLAR; GENE; AMELOBLASTIN	Environment parameters, diet and genetic factors interact to shape tooth morphostructure. In the human lineage, archaic and modern hominins show differences in dental traits, including enamel thickness, but variability also exists among living populations. Several polymorphisms, in particular in the non-collagenous extracellular matrix proteins of the tooth hard tissues, like enamelin, are involved in dental structure variation and defects and may be associated with dental disorders or susceptibility to caries. To gain insights into the relationships between tooth protein polymorphisms and dental structural morphology and defects, we searched for non-synonymous polymorphisms in tooth proteins from Neanderthal and Denisova hominins. The objective was to identify archaic-specific missense variants that may explain the dental morphostructural variability between extinct and modern humans, and to explore their putative impact on present-day dental phenotypes. Thirteen non-collagenous extracellular matrix proteins specific to hard dental tissues have been selected, searched in the publicly available sequence databases of Neanderthal and Denisova individuals and compared with modern human genome data. A total of 16 non-synonymous polymorphisms were identified in 6 proteins (ameloblastin, amelotin, cementum protein 1, dentin matrix acidic phosphoprotein 1, enamelin and matrix Gla protein). Most of them are encoded by dentin and enamel genes located on chromosome 4, previously reported to show signs of archaic introgression within Africa. Among the variants shared with modern humans, two are ancestral (common with apes) and one is the derived enamelin major variant, T648I (rs7671281), associated with a thinner enamel and specific to the Homo lineage. All the others are specific to Neanderthals and Denisova, and are found at a very low frequency in modern Africans or East and South Asians, suggesting that they may be related to particular dental traits or disease susceptibility in these populations. This modern regional distribution of archaic dental polymorphisms may reflect persistence of archaic variants in some populations and may contribute in part to the geographic dental variations described in modern humans.	[Zanolli, Clement; Hourset, Mathilde; Esclassan, Remi; Mollereau, Catherine] Univ Toulouse, CNRS, UMR5288, Lab Anthropol Mol & Imagerie Synth AMIS, Toulouse, France; [Hourset, Mathilde; Esclassan, Remi] Univ Toulouse, Fac Chirurg Dentaire, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse	Zanolli, C; Mollereau, C (corresponding author), Univ Toulouse, CNRS, UMR5288, Lab Anthropol Mol & Imagerie Synth AMIS, Toulouse, France.	clement.zanolli@gmail.com; catherine.mollereau-manaute@ipbs.fr	Esclassan, Remi/K-5651-2019; esclassan, remi/ACX-5520-2022	Esclassan, Remi/0000-0002-6605-9967; Mollereau, Catherine/0000-0003-1543-5624; Zanolli, Clement/0000-0002-5617-1613	CNRS; IFRO; CNRS (PEPS)	CNRS(Centre National de la Recherche Scientifique (CNRS)); IFRO; CNRS (PEPS)(Centre National de la Recherche Scientifique (CNRS))	The authors received funding from the CNRS and IFRO.	Al-Hashimi N, 2009, J MOL EVOL, V69, P635, DOI 10.1007/s00239-009-9302-x; Alliot-Licht B, 2015, CR BIOL, V338, P48, DOI 10.1016/j.crvi.2014.10.001; Arnaud J, 2017, AM J PHYS ANTHROPOL, V162, P370, DOI 10.1002/ajpa.23111; Arzate H, 2015, PERIODONTOL 2000, V67, P211, DOI 10.1111/prd.12062; Bailey SE, 2013, ANTHR PERSPECTIVES T, P222, DOI DOI 10.1017/CBO9780511984464.010; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Castiblanco GA, 2015, EUR J ORAL SCI, V123, P390, DOI 10.1111/eos.12214; Chan HC, 2010, J DENT RES, V89, P695, DOI 10.1177/0022034510365662; Chaussain C, 2014, J DENT RES, V93, P360, DOI 10.1177/0022034514522060; Daubert DM, 2016, INT J ORAL SCI, V8, P93, DOI 10.1038/ijos.2016.1; Delsuc F, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0431-0; Dogan GE, 2016, ARCH ORAL BIOL, V70, P125, DOI 10.1016/j.archoralbio.2016.06.014; Feeney RNM, 2010, ANTHROPOL SCI, V118, P191, DOI 10.1537/ase.091006; Gadhia K, 2012, BRIT DENT J, V212, P377, DOI 10.1038/sj.bdj.2012.314; Gao B, 2007, J UROLOGY, V177, P2361, DOI 10.1016/j.juro.2007.01.118; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138802; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; Harjunmaa E, 2014, NATURE, V512, P44, DOI 10.1038/nature13613; Harris EF, 2001, AM J PHYS ANTHROPOL, V115, P223, DOI 10.1002/ajpa.1077; Hart TC, 2003, J MED GENET, V40, P900, DOI 10.1136/jmg.40.12.900; Herrero J, 2016, DATABASE; Horvath JE, 2014, J HUM EVOL, V73, P75, DOI 10.1016/j.jhevol.2014.01.005; Hsieh P, 2016, GENOME RES, V26, P291, DOI 10.1101/gr.196634.115; Jagr M, 2014, PHYSIOL RES, V63, pS141, DOI 10.33549/physiolres.932702; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kato A, 2014, AM J PHYS ANTHROPOL, V155, P447, DOI 10.1002/ajpa.22593; Kelley JL, 2008, GENETICS, V178, P1595, DOI 10.1534/genetics.107.077123; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Lopez-Valenzuela M, 2012, MOL BIOL EVOL, V29, P1797, DOI 10.1093/molbev/mss023; Lu XL, 2012, GENE, V511, P127, DOI 10.1016/j.gene.2012.09.112; Lu YF, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a008581; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Macchiarelli R, 2009, GEODIVERSITAS, V31, P851, DOI 10.5252/g2009n4a851; Marcus JH, 2016, BIOINFORMATICS; Martin RMG, 2017, J HUM EVOL, V103, P20, DOI 10.1016/j.jhevol.2016.12.004; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Opal S, 2015, AUST DENT J, V60, P2, DOI 10.1111/adj.12262; Paabo S, 2014, CELL, V157, P216, DOI 10.1016/j.cell.2013.12.036; Pampush JD, 2013, J HUM EVOL, V64, P216, DOI 10.1016/j.jhevol.2013.01.009; Pan L, 2016, J HUM EVOL, V96, P82, DOI 10.1016/j.jhevol.2016.05.003; Park JH, 2012, J HUM GENET, V57, P508, DOI 10.1038/jhg.2012.60; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Scott RG, 1997, ANTHR MODERN HUMAN T, P1; Seow WK, 2014, AUST DENT J, V59, P143, DOI 10.1111/adj.12104; Silvent J, 2013, J MOL EVOL, V76, P59, DOI 10.1007/s00239-013-9539-2; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2015, J HUM EVOL, V85, P35, DOI 10.1016/j.jhevol.2015.03.012; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Smith CEL, 2016, HUM MOL GENET, V25, P3578, DOI 10.1093/hmg/ddw203; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Suryadeva S, 2015, J CLIN DIAGN RES, V9, pZE9, DOI 10.7860/JCDR/2015/11067.5606; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Yoshizaki K, 2013, ORTHOD WAVES, V72, P1, DOI 10.1016/j.odw.2013.01.040; Zanolli C, 2017, AM J PHYS ANTHROPOL, V162, P533, DOI 10.1002/ajpa.23135; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004; Zilberman U, 2004, J HUM EVOL, V46, P647, DOI 10.1016/j.jhevol.2004.02.005	80	13	13	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183802	10.1371/journal.pone.0183802	http://dx.doi.org/10.1371/journal.pone.0183802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902892	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200017
J	Sharma-Poudyal, D; Schlatter, D; Yin, CT; Hulbert, S; Paulitz, T				Sharma-Poudyal, Dipak; Schlatter, Daniel; Yin, Chuntao; Hulbert, Scot; Paulitz, Timothy			Long-term no-till: A major driver of fungal communities in dryland wheat cropping systems	PLOS ONE			English	Article							CONSERVATION TILLAGE; PACIFIC-NORTHWEST; CROWN ROT; MICROBIAL BIOMASS; UNITED-STATES; SOIL-EROSION; COVER CROP; MANAGEMENT; DIVERSITY; CHINA	In the dryland Pacific Northwest wheat cropping systems, no-till is becoming more prevalent as a way to reduce soil erosion and fuel inputs. Tillage can have a profound effect on microbial communities and soilborne fungal pathogens, such as Rhizoctonia. We compared the fungal communities in long-term no-till (NT) plots adjacent to conventionally tilled (CT) plots, over three years at two locations in Washington state and one location in Idaho, US. We used pyrosequencing of the fungal ITS gene and identified 422 OTUs after rarefication. Fungal richness was higher in NT compared to CT, in two of the locations. Humicola nigrescens, Cryptococcus terreus, Cadophora spp. Hydnodontaceae spp., and Exophiala spp. were more abundant in NT, while species of Glarea, Coniochaetales, Mycosphaerella tassiana, Cryptococcus bhutanensis, Chaetomium perlucidum, and Ulocladium chartarum were more abundant in CT in most locations. Other abundant groups that did not show any trends were Fusarium, Mortierella, Penicillium, Aspergillus, and Macroventuria. Plant pathogens such as Rhizoctonia (Ceratobasidiaceae) were not abundant enough to see tillage differences, but Microdochium bolleyi, a weak root pathogen, was more abundant in NT. Our results suggest that NT fungi are better adapted at utilizing intact, decaying roots as a food source and may exist as root endophytes. CT fungi can utilize mature plant residues that are turned into the soil with tillage as pioneer colonizers, and then produce large numbers of conidia. But a larger proportion of the fungal community is not affected by tillage and may be niche generalists.	[Sharma-Poudyal, Dipak] Oregon Dept Agr, Salem, OR USA; [Schlatter, Daniel; Paulitz, Timothy] USDA ARS, Wheat Hlth, Genet & Qual Res Unit, Pullman, WA 99164 USA; [Yin, Chuntao; Hulbert, Scot; Paulitz, Timothy] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Paulitz, T (corresponding author), USDA ARS, Wheat Hlth, Genet & Qual Res Unit, Pullman, WA 99164 USA.; Paulitz, T (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	timothy.paulitz@ars.usda.gov		Paulitz, Timothy/0000-0002-8885-3803	USDA-ARS; REACCH (Regional Approaches to Climate Change Pacific Northwest Agriculture) from USDA National Institute for Food and Agriculture [2011-68002-30191]; USDA-ARS Postdoctoral Research Associate Program	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); REACCH (Regional Approaches to Climate Change Pacific Northwest Agriculture) from USDA National Institute for Food and Agriculture; USDA-ARS Postdoctoral Research Associate Program	This study was supported by USDA-ARS base funding to corresponding author's CRIS; and REACCH (Regional Approaches to Climate Change Pacific Northwest Agriculture) award #2011-68002-30191 from USDA National Institute for Food and Agriculture. Support for the second author was from USDA-ARS Postdoctoral Research Associate Program.	Agusti-Brisach C, 2013, PLANT SOIL, V364, P5, DOI 10.1007/s11104-012-1333-1; Alberton O, 2010, PLANT SOIL, V328, P459, DOI 10.1007/s11104-009-0125-8; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Bills GF, 1999, MYCOL RES, V103, P179, DOI 10.1017/S095375629800687X; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cannon PF, 2007, FUNGAL FAMILIES WORL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cummings JA, 2015, PLANT DIS, V99, P1284, DOI 10.1094/PDIS-10-14-1002-PDN; Degrune F, 2016, AGR ECOSYST ENVIRON, V224, P12, DOI 10.1016/j.agee.2016.03.017; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Detheridge AP, 2016, AGR ECOSYST ENVIRON, V228, P49, DOI 10.1016/j.agee.2016.04.022; Eichorst SA, 2012, APPL ENVIRON MICROB, V78, P2316, DOI 10.1128/AEM.07313-11; Fernandez MR, 2007, CAN J PLANT SCI, V87, P953, DOI 10.4141/CJPS07005; Fernandez MR, 2009, CAN J PLANT SCI, V89, P549, DOI 10.4141/CJPS08091; Gonzalez-Chavez MDA, 2010, SOIL TILL RES, V106, P285, DOI 10.1016/j.still.2009.11.008; Govaerts B, 2008, APPL SOIL ECOL, V38, P197, DOI 10.1016/j.apsoil.2007.10.009; Helgason BL, 2010, SOIL BIOL BIOCHEM, V42, P2192, DOI 10.1016/j.soilbio.2010.08.015; Hosseini-Nasabnia Z, 2016, CAN J PLANT PATHOL, V38, P325, DOI 10.1080/07060661.2016.1228697; Huggins DR, 2008, SCI AM; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jiang X, 2011, APPL SOIL ECOL, V48, P168, DOI 10.1016/j.apsoil.2011.03.009; Johnson-Maynard JL, 2007, SOIL TILL RES, V94, P338, DOI 10.1016/j.still.2006.08.011; Kendrick B, 2011, GENERA HYPHOMYCETES; Khastini RO, 2014, EUR J PLANT PATHOL, V139, P333, DOI 10.1007/s10658-014-0389-6; KNUDSEN IMB, 1995, PLANT PATHOL, V44, P467, DOI 10.1111/j.1365-3059.1995.tb01669.x; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lal R, 2007, SOIL TILL RES, V93, P1, DOI 10.1016/j.still.2006.11.004; LeBlanc N, 2017, MYCOLOGIA, V109, P128, DOI 10.1080/00275514.2017.1281697; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Mbuthia LW, 2015, SOIL BIOL BIOCHEM, V89, P24, DOI 10.1016/j.soilbio.2015.06.016; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Murugan R, 2014, BIOL FERT SOILS, V50, P487, DOI 10.1007/s00374-013-0871-x; Nallanchakravarthula S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111455; Paulitz TC, 2002, CAN J PLANT PATHOL, V24, P416; Penton CR, 2014, PLOS ONE, V9, P1, DOI DOI 10.1038/NMETH.F.303; Poll C, 2010, MICROB ECOL, V59, P130, DOI 10.1007/s00248-009-9541-9; Poole GJ, 2013, PHYTOPATHOLOGY, V103, P1130, DOI 10.1094/PHYTO-07-12-0181-R; Ritz K., 2004, Mycologist, V18, P52, DOI 10.1017/S0269915X04002010; Sale V, 2015, SOIL BIOL BIOCHEM, V84, P38, DOI 10.1016/j.soilbio.2015.02.005; Schillinger WF, 2014, PLANT DIS, V98, P389, DOI 10.1094/PDIS-04-13-0420-RE; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroeder KL, 2006, PLANT DIS, V90, P1247, DOI 10.1094/PD-90-1247; Schroeder KL, 2004, DISSERTATION; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Taheri AE, 2015, FUNGAL ECOL, V15, P73, DOI 10.1016/j.funeco.2015.03.005; Team RC, 2016, R LANG ENV STAT COMP; Tiscornia S, 2009, CRYPTOGAMIE MYCOL, V30, P363; Turrini A, 2016, BIOL FERT SOILS, V52, P643, DOI 10.1007/s00374-016-1106-8; United States Department of Agriculture, 2012, 2012 CENS AGR HIGHL; Uri ND, 1999, J SUSTAIN AGR, V14, P63, DOI 10.1300/J064v14n02_07; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; Wang ZT, 2016, APPL SOIL ECOL, V101, P132, DOI 10.1016/j.apsoil.2016.02.002; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wortmann CS, 2008, AGRON J, V100, P1681, DOI 10.2134/agronj2007.0317; Yarwood SA, 2010, MICROB ECOL, V60, P606, DOI 10.1007/s00248-010-9675-9; Yin CT, 2017, PHYTOBIOMES J, V1, P83, DOI 10.1094/PBIOMES-09-16-0008-R; Yin CT, 2013, APPL ENVIRON MICROB, V79, P7428, DOI 10.1128/AEM.01610-13; Young IM, 2000, SOIL TILL RES, V53, P201, DOI 10.1016/S0167-1987(99)00106-3; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004; Zhang SX, 2015, SOIL TILL RES, V149, P46, DOI 10.1016/j.still.2015.01.001; Zhang XX, 2015, PLANT DIS, V99, P1610, DOI 10.1094/PDIS-04-14-0422-RE	62	37	39	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184611	10.1371/journal.pone.0184611	http://dx.doi.org/10.1371/journal.pone.0184611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898288	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500037
J	Ajorloo, F; Vaezi, M; Saadat, A; Safaee, SR; Gharib, B; Ghanei, M; Siadat, SD; Vaziri, F; Fateh, A; Pazhouhandeh, M; Vaziri, B; Moazemi, R; Mahboudi, F; Jamnani, FR				Ajorloo, Faezeh; Vaezi, Mohammad; Saadat, Alireza; Safaee, Seyed Reza; Gharib, Behrouz; Ghanei, Mostafa; Siadat, Seyed Davar; Vaziri, Farzam; Fateh, Abolfazl; Pazhouhandeh, Mehrdad; Vaziri, Behrouz; Moazemi, Reza; Mahboudi, Fereidoun; Jamnani, Fatemeh Rahimi			A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; TOPOISOMERASE-II-ALPHA; CHOP-LIKE CHEMOTHERAPY; SIGNALING PATHWAYS; MAST-CELLS; PERIPHERAL NEUROPATHY; NEGATIVE REGULATOR; SOMATIC MUTATIONS; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR	Autoantibody profiling with a systems medicine approach can help identify critical dysregulated signaling pathways (SPs) in cancers. In this way, immunoglobulins G (IgG) purified from the serum samples of 92 healthy controls, 10 pre-treated (PR) non-Hodgkin lymphoma (NHL) patients, and 20 NHL patients who underwent chemotherapy (PS) were screened with a phage-displayed random peptide library. Protein-protein interaction networks of the PR and PS groups were analyzed and visualized by Gephi. The results indicated AXIN2, SENP2, TOP2A, FZD6, NLK, HDAC2, HDAC1, and EHMT2, in addition to CAMK2A, PLCG1, PLCG2, GRM5, GRIN2B, GRIN2D, CACNA2D3, and SPTAN1 as hubs in 11 and 7 modules of PR and PS networks, respectively. PR-and PS-specific hubs were evaluated in the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome databases. The PR-specific hubs were involved in Wnt SP, signaling by Notch1 in cancer, telomere maintenance, and transcriptional misregulation. In contrast, glutamate receptor SP, Fc receptor-related pathways, growth factors-related SPs, and Wnt SP were statistically significant enriched pathways, based on the pathway analysis of PS hubs. The results revealed that the most PR-specific proteins were associated with events involved in tumor development, while chemotherapy in the PS group was associated with side effects of drugs and/or cancer recurrence. As the findings demonstrated, PR-and PS-specific proteins in this study can be promising therapeutic targets in future studies.	[Ajorloo, Faezeh] Islamic Azad Univ, East Tehran Branch, Fac Sci, Dept Biol, Tehran, Iran; [Ajorloo, Faezeh; Ghanei, Mostafa; Siadat, Seyed Davar; Vaziri, Farzam; Fateh, Abolfazl; Pazhouhandeh, Mehrdad; Jamnani, Fatemeh Rahimi] Pasteur Inst Iran, Innovat Ctr, Human Antibody Lab, Tehran, Iran; [Vaezi, Mohammad] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Saadat, Alireza] Baqiyatallah Univ Med Sci, Dept Hematol & Oncol, Tehran, Iran; [Safaee, Seyed Reza] Univ Tehran Med Sci, Hematol & Oncol Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran; [Gharib, Behrouz] Qom Univ Med Sci, Dept Internal Med Hematol & Oncol, Qom, Iran; [Ghanei, Mostafa] Baqiyatallah Univ Med Sci, Chem Injuries Res Ctr, Tehran, Iran; [Siadat, Seyed Davar; Vaziri, Farzam; Fateh, Abolfazl; Jamnani, Fatemeh Rahimi] Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Microbiol Res Ctr, Tehran, Iran; [Vaziri, Behrouz; Moazemi, Reza; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran	Islamic Azad University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Jamnani, FR (corresponding author), Pasteur Inst Iran, Innovat Ctr, Human Antibody Lab, Tehran, Iran.; Jamnani, FR (corresponding author), Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Microbiol Res Ctr, Tehran, Iran.	Rahimi@pasteur.ac.ir	Fateh, Abolfazl/K-9507-2017; Rahimi Jamnani, Fatemeh/F-2752-2015; saadat, Alireza Reza/AHE-0812-2022; Siadat, Seyed Davar/A-2204-2012; Vaziri, Farzam/K-9535-2017; rahimi, fatemeh/HCH-7193-2022; Vaziri, Behrouz/B-4619-2009; Ghanei, Mostafa/V-1975-2019; Pazhouhandeh, Mehrdad/ABE-3323-2021	Fateh, Abolfazl/0000-0002-2043-8523; Rahimi Jamnani, Fatemeh/0000-0001-7172-8435; saadat, Alireza Reza/0000-0003-4192-0391; Siadat, Seyed Davar/0000-0002-6892-5603; Vaziri, Farzam/0000-0001-7788-2548; Ghanei, Mostafa/0000-0001-9372-0928; 	Iran National Science Foundation [92002095]	Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by grants from the Iran National Science Foundation (grant number 92002095).	Abbas S, 2014, HAEMATOLOGICA, V99, P848, DOI 10.3324/haematol.2013.095604; Ansari-Pour N, 2016, J PROTEOME RES, V15, P1011, DOI 10.1021/acs.jproteome.5b01080; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Beckham TH, 2013, ADV CANCER RES, V117, P1, DOI 10.1016/B978-0-12-394274-6.00001-7; Bilici A, 2012, J BUON, V17, P502; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; BRISTOW MR, 1980, J CARDIOVASC PHARM, V2, P487, DOI 10.1097/00005344-198009000-00002; Bruntz RC, 2014, PHARMACOL REV, V66, P1033, DOI 10.1124/pr.114.009217; Burger R, 2013, TRANSFUS MED HEMOTH, V40, P336, DOI 10.1159/000354194; Canta A, 2015, TOXICS, V3, P198, DOI 10.3390/toxics3020198; Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Crisafulli C, 2015, PROG NEURO-PSYCHOPH, V59, P21, DOI 10.1016/j.pnpbp.2014.12.009; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; de Oliveira GP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00216; de Sa Rodrigues LC, 2015, VET COMP ONCOLOGY; Debroas E, 2015, AIMS MOL SCI, V2, P175, DOI 10.3934/molsci.2015.2.175; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Diouf B, 2015, JAMA-J AM MED ASSOC, V313, P815, DOI 10.1001/jama.2015.0894; Dubielecka PM, 2005, BIOCHEM PHARMACOL, V69, P73, DOI 10.1016/j.bcp.2004.08.031; Elbaz Osama A-G HA, 2014, INT J CANC RES, V10, P96, DOI DOI 10.3923/IJCR.2014.96.105; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fisher RI, 2003, LEUKEMIA, V17, P1948, DOI 10.1038/sj.leu.2403096; Friedberg JW, 2011, HEMATOL-AM SOC HEMAT, P498, DOI 10.1182/asheducation-2011.1.498; Gao YJ, 2013, BIOMED REP, V1, P47, DOI 10.3892/br.2012.9; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Guo R, 2011, J CLIN ONCOL, V29, pE257, DOI 10.1200/JCO.2010.32.1802; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Han CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067033; Han YQ, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00156; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Heo TH, 2016, ONCOTARGET, V7, P15460, DOI 10.18632/oncotarget.7102; Hinrichsen I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-11; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Huang X, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-22; Hussner J, 2012, MOL PHARMACOL, V81, P679, DOI 10.1124/mol.111.075994; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Jantas D, 2008, NEUROCHEM INT, V52, P864, DOI 10.1016/j.neuint.2007.10.003; Jantas D, 2009, NEUROTOX RES, V15, P24, DOI 10.1007/s12640-009-9002-8; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang BY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-61; Jiang M, 2011, CELL DEATH DIFFER, V18, P1005, DOI 10.1038/cdd.2010.168; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Jung KH, 2010, J CELL BIOCHEM, V110, P687, DOI 10.1002/jcb.22579; Kim BK, 2015, BMB REP, V48, P360, DOI 10.5483/BMBRep.2015.48.6.031; Kim JT, 2013, CARCINOGENESIS, V34, P953, DOI 10.1093/carcin/bgt018; Kolla V, 2014, CANCER RES, V74, P652, DOI 10.1158/0008-5472.CAN-13-3056; Kuribayashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080773; Lattanzio Rossano, 2013, Advances in Biological Regulation, V53, P309, DOI 10.1016/j.jbior.2013.07.006; Li FZ, 2005, WORLD J SURG, V29, P306, DOI 10.1007/s00268-004-7813-6; Li Y, 2013, INT J EMERG TECHNOL, V8, P10, DOI 10.3991/ijet.v8i5.2904; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067181; Loh KC, 2011, ANTI-CANCER AGENT ME, V11, P782; Lohri A, 1997, J CLIN PATHOL, V50, P22, DOI 10.1136/jcp.50.1.22; Ludwig L, 2009, CANCER LETT, V275, P194, DOI 10.1016/j.canlet.2008.10.010; Luddecke S, 2016, ONCOGENE, V35, P2398, DOI 10.1038/onc.2015.290; M Bastian, 2009, INT AAAI C WEBL SOC; Ma LW, 2013, J ORAL PATHOL MED, V42, P47, DOI 10.1111/j.1600-0714.2012.01179.x; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Maluf FC, 2002, CANCER, V94, P3219, DOI 10.1002/cncr.10595; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Mehrotra AKR, 2015, INT J IMMUNOTHER CAN, V1; Minard-Colin V, 2015, J CLIN ONCOL, V33, P2963, DOI 10.1200/JCO.2014.59.5827; Monaco S, 2015, CELL SIGNAL, V27, P204, DOI 10.1016/j.cellsig.2014.11.007; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Munoz O, 2004, LEUKEMIA, V18, P2015, DOI 10.1038/sj.leu.2403485; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Palmieri C, 2012, BRIT J CANCER, V107, P375, DOI 10.1038/bjc.2012.231; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00013; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Pentheroudakis G, 2010, LEUKEMIA LYMPHOMA, V51, P1260, DOI 10.3109/10428194.2010.483749; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Pon JR, 2016, BLOOD, V127, P181, DOI 10.1182/blood-2015-07-658401; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Robinson WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/nrrheum.2014.220; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Sandhu V, 2016, MOL ONCOL, V10, P303, DOI 10.1016/j.molonc.2015.10.011; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao YT, 2016, TOXICOLOGY, V347, P29, DOI 10.1016/j.tox.2016.03.001; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Stanislaus A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-30; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Stubgen JP, 2015, J CLIN NEUROL, V11, P283, DOI 10.3988/jcn.2015.11.3.283; Svejda B, 2013, CANCER SCI, V104, P844, DOI 10.1111/cas.12174; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tai D, 2015, ONCOLOGIST, V20, P1189, DOI 10.1634/theoncologist.2015-0057; Tamura H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-220; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Teh Jessica, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P211; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Teke HU, 2014, J BUON, V19, P191; Theoharides TC, 2015, NEW ENGL J MED, V373, P1885, DOI 10.1056/NEJMc1510021; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Thier S, 2012, NEUROLOGY, V79, P243, DOI 10.1212/WNL.0b013e31825fdeed; Tiash S., 2015, J CANC METASTASIS TR, V1, P190, DOI [DOI 10.4103/2394-4722.163151, 10.4103/2394-4722.163151]; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wang J, 2014, MOLECULES, V19, P1912, DOI 10.3390/molecules19021912; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wang YY, 2015, ONCOTARGET, V6, P11725, DOI 10.18632/oncotarget.3955; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Wu X, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3182; Xie HJ, 2016, ONCOTARGET, V7, P1341, DOI 10.18632/oncotarget.6372; Xu YW, 2014, AM J GASTROENTEROL, V109, P36, DOI 10.1038/ajg.2013.384; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yamaguchi F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-468; Yang JS, 2015, COMPOS SCI TECHNOL, V115, P9, DOI 10.1016/j.compscitech.2015.04.015; Yashiro M, 2010, INT J CANCER, V126, P1004, DOI 10.1002/ijc.24763; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0; Zaenker P, 2016, AUTOIMMUN REV, V15, P477, DOI 10.1016/j.autrev.2016.01.017; Zelenetz AD, 2003, ANN ONCOL, V14, P5, DOI 10.1093/annonc/mdg702; Zhang J, 2015, ONCOTARGET, V6, P2917, DOI 10.18632/oncotarget.2784; Zhang QY, 2014, GASTROENTEROLOGY, V146, P461, DOI 10.1053/j.gastro.2013.10.011; Zhang YH, 2013, TUMOR BIOL, V34, P3147, DOI 10.1007/s13277-013-0883-z; Zhao R, 2012, LUNG CANCER, V76, P324, DOI 10.1016/j.lungcan.2011.11.019; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zou HY, 2015, GENET MOL RES, V14, P16546, DOI 10.4238/2015.December.11.1	148	9	9	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183969	10.1371/journal.pone.0183969	http://dx.doi.org/10.1371/journal.pone.0183969			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892521	Green Published, gold, Green Submitted			2022-12-26	WOS:000410243200007
J	McLoughlin, I; Zhang, HM; Xie, ZP; Song, Y; Xiao, W; Phan, H				McLoughlin, Ian; Zhang, Haomin; Xie, Zhipeng; Song, Yan; Xiao, Wei; Phan, Huy			Continuous robust sound event classification using time-frequency features and deep learning	PLOS ONE			English	Article							AUDIO CLASSIFICATION; IMAGE FEATURE	The automatic detection and recognition of sound events by computers is a requirement for a number of emerging sensing and human computer interaction technologies. Recent advances in this field have been achieved by machine learning classifiers working in conjunction with time-frequency feature representations. This combination has achieved excellent accuracy for classification of discrete sounds. The ability to recognise sounds under real-world noisy conditions, called robust sound event classification, is an especially challenging task that has attracted recent research attention. Another aspect of real-word conditions is the classification of continuous, occluded or overlapping sounds, rather than classification of short isolated sound recordings. This paper addresses the classification of noise-corrupted, occluded, overlapped, continuous sound recordings. It first proposes a standard evaluation task for such sounds based upon a common existing method for evaluating isolated sound classification. It then benchmarks several high performing isolated sound classifiers to operate with continuous sound data by incorporating an energy-based event detection front end. Results are reported for each tested system using the new task, to provide the first analysis of their performance for continuous sound event detection. In addition it proposes and evaluates a novel Bayesian-inspired front end for the segmentation and detection of continuous sound recordings prior to classification.	[McLoughlin, Ian] Univ Kent, Sch Comp, Medway, Kent, England; [McLoughlin, Ian; Zhang, Haomin; Xie, Zhipeng; Song, Yan] Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei, Anhui, Peoples R China; [Xiao, Wei] Huawei Technol Duesseldorf GmbH, European Res Ctr, Munich, Germany; [Phan, Huy] Univ Lubeck, Inst Signal Proc, Lubeck, Germany	University of Kent; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huawei Technologies; University of Lubeck	McLoughlin, I (corresponding author), Univ Kent, Sch Comp, Medway, Kent, England.; McLoughlin, I (corresponding author), Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei, Anhui, Peoples R China.	ivm@kent.ac.uk	McLoughlin, Ian/AAS-9081-2020	McLoughlin, Ian/0000-0001-7111-2008	Huawei Innovation Research Program under Machine Hearing and Perception Project [YB2012120147]; Huawei Technologies	Huawei Innovation Research Program under Machine Hearing and Perception Project(Huawei Technologies); Huawei Technologies(Huawei Technologies)	This work was supported by the Huawei Innovation Research Program under Machine Hearing and Perception Project Contract No. YB2012120147. Huawei Technologies provided support in the form of salaries for author WX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the Huawei Innovation Research Program under Machine Hearing and Perception Project Contract No. YB2012120147.	Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864; Ajmera J, 2003, ASRU'03: 2003 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING ASRU '03, P411, DOI 10.1109/ASRU.2003.1318476; [Anonymous], EUROSPEECH; Bouvrie J., 2006, NEURAL NETS; Cai R, 2006, IEEE T AUDIO SPEECH, V14, P1026, DOI 10.1109/TSA.2005.857575; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chechik G., 2008, P 1 ACM INT C MULT I, P105, DOI DOI 10.1145/1460096.1460115; Chen IF, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2298; Chen LH, 2014, IEEE-ACM T AUDIO SPE, V22, P1859, DOI 10.1109/TASLP.2014.2353991; Dennis J, 2013, PATTERN RECOGN LETT, V34, P1085, DOI 10.1016/j.patrec.2013.02.015; Dennis J.W., 2014, SOUND EVENT RECOGNIT; Dennis J, 2013, IEEE T AUDIO SPEECH, V21, P367, DOI 10.1109/TASL.2012.2226160; Dennis J, 2011, IEEE SIGNAL PROC LET, V18, P130, DOI 10.1109/LSP.2010.2100380; Guo GD, 2003, IEEE T NEURAL NETWOR, V14, P209, DOI 10.1109/TNN.2002.806626; Heittola T, 2011, WORKSH MACH LIST MUL, P36; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Phan H, 2016, IEEE-ACM T AUDIO SPE, V24, P807, DOI 10.1109/TASLP.2016.2530401; Phan H, 2015, IEEE-ACM T AUDIO SPE, V23, P20, DOI 10.1109/TASLP.2014.2367814; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; Lin CC, 2005, IEEE T SPEECH AUDI P, V13, P644, DOI 10.1109/TSA.2005.851880; Lyon RF, 2013, US Patent, Patent No. [8,463,719, 8463719]; Lyon RF, 2010, IEEE SIGNAL PROC MAG, V27, P131, DOI 10.1109/MSP.2010.937498; McLoughlin I., 2017, CONTINUOUS ROBUST SO; McLoughlin I, 2015, IEEE-ACM T AUDIO SPE, V23, P540, DOI 10.1109/TASLP.2015.2389618; Palm R. B., 2012, PREDICTION CANDIDATE; Phan H, 2014, 15 ANN C INT SPEECH, P1; Sainath TN, 2013, INT CONF ACOUST SPEE, P8614, DOI 10.1109/ICASSP.2013.6639347; Walters TC, 2011, AUDITORY BASED PROCE; Xu YY, 2018, CLIMATIC CHANGE, V146, P393, DOI 10.1007/s10584-015-1565-1; Zhang HM, 2015, INT CONF ACOUST SPEE, P559, DOI 10.1109/ICASSP.2015.7178031	31	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0182309	10.1371/journal.pone.0182309	http://dx.doi.org/10.1371/journal.pone.0182309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892478	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000410243200001
J	Ferrara, M; Sessa, G; Fiore, M; Bernard, F; Asteriti, IA; Cundari, E; Colotti, G; Ferla, S; Desideri, M; Buglioni, S; Trisciuoglio, D; Del Bufalo, D; Brancale, A; Degrassi, F				Ferrara, M.; Sessa, G.; Fiore, M.; Bernard, F.; Asteriti, I. A.; Cundari, E.; Colotti, G.; Ferla, S.; Desideri, M.; Buglioni, S.; Trisciuoglio, D.; Del Bufalo, D.; Brancale, A.; Degrassi, F.			Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization	ONCOGENE			English	Article							NDC80 COMPLEX; BINDING-SITE; SPINDLE; HEC1; ATTACHMENT; DYNAMICS; INSTABILITY; CATASTROPHE; ANEUPLOIDY; STABILITY	Highly expressed in cancer protein 1 (Hec1) is a subunit of the kinetochore (KT)-associated Ndc80 complex, which ensures proper segregation of sister chromatids at mitosis by mediating the interaction between KTs and microtubules (MTs). HEC1 mRNA and protein are highly expressed in many malignancies as part of a signature of chromosome instability. These properties render Hec1 a promising molecular target for developing therapeutic drugs that exert their anticancer activities by producing massive chromosome aneuploidy. A virtual screening study aimed at identifying small molecules able to bind at the Hec1-MT interaction domain identified one positive hit compound and two analogs of the hit with high cytotoxic, pro-apoptotic and anti-mitotic activities. The most cytotoxic analog (SM15) was shown to produce chromosome segregation defects in cancer cells by inhibiting the correction of erroneous KT-MT interactions. Live cell imaging of treated cells demonstrated that mitotic arrest and segregation abnormalities lead to cell death through mitotic catastrophe and that cell death occurred also from interphase. Importantly, SM15 was shown to be more effective in inducing apoptotic cell death in cancer cells as compared to normal ones and effectively reduced tumor growth in a mouse xenograft model. Mechanistically, cold-induced MT depolymerization experiments demonstrated a hyper-stabilization of both mitotic and interphase MTs. Molecular dynamics simulations corroborate this finding by showing that SM15 can bind the MT surface independently from Hec1 and acts as a stabilizer of both MTs and KT-MT interactions. Overall, our studies represent a clear proof of principle that MT-Hec1-interacting compounds may represent novel powerful anticancer agents.	[Ferrara, M.; Sessa, G.; Fiore, M.; Bernard, F.; Asteriti, I. A.; Cundari, E.; Colotti, G.; Trisciuoglio, D.; Degrassi, F.] CNR, Inst Mol Biol & Pathol, Natl Res Council, Via Apuli 4, I-00185 Rome, Italy; [Ferla, S.; Brancale, A.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Redwood Bldg,King Edward 7 Ave, Cardiff CF10 3XF, S Glam, Wales; [Desideri, M.; Buglioni, S.; Trisciuoglio, D.; Del Bufalo, D.] Regina Elena Inst Canc Res, Adv Diagnost & Technol Innovat Dept, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Cardiff University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Degrassi, F (corresponding author), CNR, Inst Mol Biol & Pathol, Natl Res Council, Via Apuli 4, I-00185 Rome, Italy.; Brancale, A (corresponding author), Cardiff Univ, Sch Pharm & Pharmaceut Sci, Redwood Bldg,King Edward 7 Ave, Cardiff CF10 3XF, S Glam, Wales.	brancalea@cf.ac.uk; francesca.degrassi@uniroma1.it	Colotti, Gianni/AAG-4918-2019; Colotti, Gianni/D-2015-2010; Brancale, Andrea/N-9445-2014; Del Bufalo, Donatella/K-8673-2016; trisciuoglio, daniela/AAL-4002-2021; Del Bufalo, Donatella/AAC-1594-2021; Ferla, Salvatore/F-7976-2016	Colotti, Gianni/0000-0002-9913-0635; Brancale, Andrea/0000-0002-9728-3419; Del Bufalo, Donatella/0000-0002-3148-6096; Del Bufalo, Donatella/0000-0002-3148-6096; buglioni, simonetta/0000-0002-5066-1523; Ferla, Salvatore/0000-0002-5918-9237	Life Science Research Net-work Wales through the Welsh Government's Ser Cymru program [NRNPGSep14008]; Italian Association for Cancer Research [IG 18560]; FIRC fellowship [18313]	Life Science Research Net-work Wales through the Welsh Government's Ser Cymru program; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); FIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	Live cell imaging experiments were performed at the Nikon Reference Centre, IBPM CNR. The authors thank G Guarguaglini and P Lavia for advice and support with live cell analysis, L Lanzetti, W Malorni and C Rinaldo for cell lines and reagents. AB acknowledges the support of the Life Science Research Net-work Wales grant no. NRNPGSep14008, an initiative funded through the Welsh Government's Ser Cymru program. Work in the laboratory of DDB is supported by grants from the Italian Association for Cancer Research (IG 18560). IAA is supported by a FIRC fellowship (18313).	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; [Anonymous], 2016, SCHROD REL 2016 1 MA; [Anonymous], 2015, MOL OP ENV MOE 2015; Avdoshina V, 2016, J NEUROCHEM, V137, P287, DOI 10.1111/jnc.13557; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2012, CURR OPIN CELL BIOL, V24, P48, DOI 10.1016/j.ceb.2011.11.003; Ferretti C, 2010, CELL CYCLE, V9, P4174, DOI 10.4161/cc.9.20.13457; Galimberti F, 2010, CLIN CANCER RES, V16, P109, DOI 10.1158/1078-0432.CCR-09-2151; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Janssen A, 2013, ONCOGENE, V32, P4459, DOI 10.1038/onc.2012.576; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Magnani M, 2009, FEBS J, V276, P2701, DOI 10.1111/j.1742-4658.2009.06994.x; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Orticello M, 2015, ONCOGENE, V34, P3325, DOI 10.1038/onc.2014.265; Sundin LJR, 2011, MOL BIOL CELL, V22, P759, DOI 10.1091/mbc.E10-08-0671; Tooley JG, 2011, MOL BIOL CELL, V22, P1217, DOI 10.1091/mbc.E10-07-0626; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170	33	13	13	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					231	240		10.1038/onc.2017.320	http://dx.doi.org/10.1038/onc.2017.320			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28925395	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000422631700009
J	Gonzalez, D; Luyten, A; Bartholdy, B; Zhou, QL; Kardosova, M; Ebralidze, A; Swanson, KD; Radomska, HS; Zhang, P; Kobayashi, SS; Welner, RS; Levantini, E; Steidl, U; Chong, G; Collombet, S; Choi, MH; Friedman, AD; Scott, LM; Alberich-Jorda, M; Tenen, DG				Gonzalez, David; Luyten, Annouck; Bartholdy, Boris; Zhou, Qiling; Kardosova, Miroslava; Ebralidze, Alex; Swanson, Kenneth D.; Radomska, Hanna S.; Zhang, Pu; Kobayashi, Susumu S.; Welner, Robert S.; Levantini, Elena; Steidl, Ulrich; Chong, Gilbert; Collombet, Samuel; Choi, Min Hee; Friedman, Alan D.; Scott, Linda M.; Alberich-Jorda, Meritxell; Tenen, Daniel G.			ZNF143 protein is an important regulator of the myeloid transcription factor C/EBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT-enhancer-binding protein (C; EBP); gene regulation; hematopoiesis; promoter; transcription factor; C; EBPalpha; ZNF143	SELENOCYSTEINE TRANSFER-RNA; TISSUE-SPECIFIC EXPRESSION; LUCIFERASE REPORTER GENE; DNA-BINDING PROTEINS; TUMOR-SUPPRESSOR; ZINC-FINGER; STEM-CELLS; ALPHA; LEUKEMIA; PROMOTER	The transcription factor C/EBP is essential for myeloid differentiation and is frequently dysregulated in acute myeloid leukemia. Although studied extensively, the precise regulation of its gene by upstream factors has remained largely elusive. Here, we investigated its transcriptional activation during myeloid differentiation. We identified an evolutionarily conserved octameric sequence, CCCAGCAG, approximate to 100 bases upstream of the CEBPA transcription start site, and demonstrated through mutational analysis that this sequence is crucial for C/EBP expression. This sequence is present in the genes encoding C/EBP in humans, rodents, chickens, and frogs and is also present in the promoters of other C/EBP family members. We identified that ZNF143, the human homolog of the Xenopus transcriptional activator STAF, specifically binds to this 8-bp sequence to activate C/EBP expression in myeloid cells through a mechanism that is distinct from that observed in liver cells and adipocytes. Altogether, our data suggest that ZNF143 plays an important role in the expression of C/EBP in myeloid cells.	[Gonzalez, David; Luyten, Annouck; Zhou, Qiling; Chong, Gilbert; Collombet, Samuel; Choi, Min Hee; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Gonzalez, David; Bartholdy, Boris; Ebralidze, Alex; Radomska, Hanna S.; Zhang, Pu; Kobayashi, Susumu S.; Welner, Robert S.; Levantini, Elena; Steidl, Ulrich; Tenen, Daniel G.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kardosova, Miroslava; Alberich-Jorda, Meritxell] ASCR, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic; [Kardosova, Miroslava; Alberich-Jorda, Meritxell] Charles Univ Prague, Childhood Leukaemia Invest Prague, Univ Hosp Motol, Fac Med 2, Prague 15006, Czech Republic; [Swanson, Kenneth D.; Radomska, Hanna S.; Kobayashi, Susumu S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Welner, Robert S.] Univ Alabama Birmingham, Hematol Oncol Dept, Birmingham, AL 35294 USA; [Levantini, Elena] CNR, Inst Biomed Technol, I-56124 Pisa, Italy; [Friedman, Alan D.] Johns Hopkins Univ, Baltimore, MD 21231 USA; [Scott, Linda M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Radomska, Hanna S.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Dept Med Oncol, New York, NY 10461 USA	National University of Singapore; Harvard University; Harvard Medical School; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Motol University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Johns Hopkins University; University of Queensland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Yeshiva University; Yeshiva University	Alberich-Jorda, M (corresponding author), ASCR, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic.; Tenen, DG (corresponding author), Natl Univ Singapore, Canc Sci Inst, Ctr Translat Med, 14 Med Dr 12-01, Singapore 11759, Singapore.	alberich@img.cas.cz; daniel.tenen@nus.edu.sg	Scott, Linda/D-9777-2012; collombet, Samuel/AAS-8227-2021; levantini, elena/AAK-7201-2021; Zhou, Qiling/AAB-2493-2021; Levantini, Elena/AGY-0242-2022; Jorda, Meritxell Alberich/G-3137-2014	Scott, Linda/0000-0003-0334-1479; levantini, elena/0000-0003-4612-3105; Jorda, Meritxell Alberich/0000-0002-8093-641X	Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative; National Institutes of Health [HL131477, CA66996, R21CA178301, R01CA169259]; IMG AS CR [RVO 68378050]; German Research Foundation (DFG) [BA 3771/1-1]; American Cancer Society [RSG-13-047-01]; Harvard Stem Cell Institute [DP-0110-12-00]; NATIONAL CANCER INSTITUTE [R21CA178301, P01CA066996, R01CA169259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131477] Funding Source: NIH RePORTER	Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centers of Excellence initiative(Ministry of Education, Singapore); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMG AS CR; German Research Foundation (DFG)(German Research Foundation (DFG)); American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (to D. G. T.) and by the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative; National Institutes of Health Grants HL131477 and CA66996 (to D. G. T.); institutional funding from the IMG AS CR (RVO 68378050) (to M. A.-J.); and German Research Foundation (DFG) Grant BA 3771/1-1 (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R21CA178301 and R01CA169259, American Cancer Society Grant RSG-13-047-01, and Harvard Stem Cell Institute Grant DP-0110-12-00.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Alberich-Jorda M, 2012, J CLIN INVEST, V122, P4490, DOI 10.1172/JCI65102; Avellino R, 2016, BLOOD, V127, P2991, DOI 10.1182/blood-2016-01-695759; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Grossman CE, 2004, J BIOL CHEM, V279, P12190, DOI 10.1074/jbc.M307039200; Guo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150809; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Halbig KM, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-3; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Holt EH, 2001, BIOCHEM BIOPH RES CO, V288, P752, DOI 10.1006/bbrc.2001.5846; Iwama A, 1999, MOL CELL BIOL, V19, P3940; Izumi H, 2010, CANCER SCI, V101, P2538, DOI 10.1111/j.1349-7006.2010.01725.x; Khanna-Gupta A, 2000, BLOOD, V95, P3734; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LopezRodriguez C, 1995, EUR J IMMUNOL, V25, P3496, DOI 10.1002/eji.1830251243; Maxam A M, 1980, Methods Enzymol, V65, P499; Mead PE, 1998, P NATL ACAD SCI USA, V95, P11251, DOI 10.1073/pnas.95.19.11251; Myslinski E, 1998, J BIOL CHEM, V273, P21998, DOI 10.1074/jbc.273.34.21998; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ngondo-Mbongo RP, 2013, NUCLEIC ACIDS RES, V41, P4000, DOI 10.1093/nar/gkt088; Niebuhr B, 2009, LEUKEMIA, V23, P978, DOI 10.1038/leu.2008.332; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OGAWA M, 1993, BLOOD, V81, P2844; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; PAHL HL, 1991, EXP HEMATOL, V19, P1038; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Schaub M, 2000, NUCLEIC ACIDS RES, V28, P2114, DOI 10.1093/nar/28.10.2114; Schaub M, 1999, J BIOL CHEM, V274, P25042, DOI 10.1074/jbc.274.35.25042; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; SCHUSTER C, 1995, EMBO J, V14, P3777, DOI 10.1002/j.1460-2075.1995.tb00047.x; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Todeschini AL, 2014, TRENDS GENET, V30, P211, DOI 10.1016/j.tig.2014.04.002; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; WILLIAMS M, 1992, NUCLEIC ACIDS RES, V20, P4935, DOI 10.1093/nar/20.18.4935; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.leukres.2008.06.023; Yuan CC, 2007, MOL CELL BIOL, V27, P8729, DOI 10.1128/MCB.00846-07; ZARET KS, 1990, MOL CELL BIOL, V10, P4582, DOI 10.1128/MCB.10.9.4582; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zheng G, 2004, J BIOL CHEM, V279, P42410, DOI 10.1074/jbc.M407287200	61	12	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18924	18936		10.1074/jbc.M117.811109	http://dx.doi.org/10.1074/jbc.M117.811109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28900037	hybrid, Green Published			2022-12-26	WOS:000415848000017
J	Lin, Y; Currie, SL; Rosen, MK				Lin, Yuan; Currie, Simon L.; Rosen, Michael K.			Intrinsically disordered sequences enable modulation of protein phase separation through distributed tyrosine motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cooperativity; fused in sarcoma (FUS); intrinsically disordered protein; posttranslational modification (PTM); Src homology 3 domain (SH3 domain); RNA granules; liquid-liquid phase separation; multivalency	2ND VIRIAL-COEFFICIENT; ELASTIN-LIKE POLYPEPTIDE; RNA-BINDING PROTEINS; INVERSE TEMPERATURE TRANSITION; LOW-COMPLEXITY DOMAINS; CELL-FREE FORMATION; ACID SIDE-CHAINS; ANTIBODY SOLUTIONS; STRESS GRANULES; LIQUID DROPLETS	Liquid-liquid phase separation (LLPS) is thought to contribute to the establishment of many biomolecular condensates, eukaryotic cell structures that concentrate diverse macromolecules but lack a bounding membrane. RNA granules control RNA metabolism and comprise a large class of condensates that are enriched in RNA-binding proteins and RNA molecules. Many RNA granule proteins are composed of both modular domains and intrinsically disordered regions (IDRs) having low amino acid sequence complexity. Phase separation of these molecules likely plays an important role in the generation and stability of RNA granules. To understand how folded domains and IDRs can cooperate to modulate LLPS, we generated a series of engineered proteins. These were based on fusions of an IDR derived from the RNA granule protein FUS (fused in sarcoma) to a multivalent poly-Src homology 3 (SH3) domain protein that phase-separates when mixed with a poly-proline-rich-motif (polyPRM) ligand. We found that the wild-type IDR promotes LLPS of the polySH3-polyPRM system, decreasing the phase separation threshold concentration by 8-fold. Systematic mutation of tyrosine residues in Gly/Ser-Tyr-Gly/Ser motifs of the IDR reduced this effect, depending on the number but not on the position of these substitutions. Mutating all tyrosines to non-aromatic residues or phosphorylating the IDR raised the phase separation threshold above that of the unmodified polySH3-polyPRM pair. These results show that low-complexity IDRs can modulate LLPS both positively and negatively, depending on the degree of aromaticity and phosphorylation status. Our findings provide plausible mechanisms by which these sequences could alter RNA granule properties on evolutionary and cellular timescales.	[Lin, Yuan; Currie, Simon L.; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Lin, Yuan; Currie, Simon L.; Rosen, Michael K.] Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), Howard Hughes Med Inst, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu		Currie, Simon/0000-0001-5083-1484	Howard Hughes Medical Institute; Welch Foundation [I-1544]; National Institutes of Health [R01-056322]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Howard Hughes Medical Institute, the Welch Foundation (I-1544), and National Institutes of Health Grant R01-056322. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auton M, 2007, METHOD ENZYMOL, V428, P397, DOI 10.1016/S0076-6879(07)28023-1; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/nphys3532, 10.1038/NPHYS3532]; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chow CK, 2016, MOL PHARMACEUT, V13, P915, DOI 10.1021/acs.molpharmaceut.5b00817; Christensen T, 2013, BIOMACROMOLECULES, V14, P1514, DOI 10.1021/bm400167h; Condon JE, 2017, SOFT MATTER, V13, P2907, DOI 10.1039/c6sm02874h; Connolly BD, 2012, BIOPHYS J, V103, P69, DOI 10.1016/j.bpj.2012.04.047; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Fasman G. D., 1976, HDB BIOCH MOL BIOL, V1, P115; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Flory P. J, 1953, PRINCIPLES POLYM CHE; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2; Haas C, 1999, J PHYS CHEM B, V103, P2808, DOI 10.1021/jp984035l; Halfmann R, 2016, CURR OPIN STRUC BIOL, V38, P18, DOI 10.1016/j.sbi.2016.05.002; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; HARDING SE, 1985, BIOCHEM J, V231, P543, DOI 10.1042/bj2310543; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Jonas S, 2013, GENE DEV, V27, P2628, DOI 10.1101/gad.227843.113; Kato M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023598; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lazaridis T., 2013, HYDROPHOBIC EFFECT, DOI [10.1002/9780470015902.a0002974.pub2, DOI 10.1002/9780470015902.A0002974.PUB2]; Lee CD, 2015, CELL REP, V11, P1638, DOI 10.1016/j.celrep.2015.05.014; Lehermayr C, 2011, J PHARM SCI-US, V100, P2551, DOI 10.1002/jps.22506; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Luo TZ, 2015, J AM CHEM SOC, V137, P15362, DOI 10.1021/jacs.5b09941; Mehta CM, 2012, BIOTECHNOL PROGR, V28, P163, DOI 10.1002/btpr.724; Meyer DE, 2001, BIOTECHNOL PROGR, V17, P720, DOI 10.1021/bp010049o; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neal BL, 1998, BIOPHYS J, V75, P2469, DOI 10.1016/S0006-3495(98)77691-X; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/nmat4418, 10.1038/NMAT4418]; Rant AS, 2015, MOL PHARMACEUT, V12, P3261, DOI 10.1021/acs.molpharmaceut.5b00256; Raut AS, 2015, J PHARM SCI-US, V104, P1263, DOI 10.1002/jps.24326; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Ringer AL, 2006, J PHYS CHEM A, V110, P10822, DOI 10.1021/jp0627401; Ruppert S, 2001, BIOTECHNOL PROGR, V17, P182, DOI 10.1021/bp0001314; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Saluja A, 2010, BIOPHYS J, V99, P2657, DOI 10.1016/j.bpj.2010.08.020; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Scherer M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004512; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sinnokrot MO, 2004, J AM CHEM SOC, V126, P7690, DOI 10.1021/ja049434a; Spector David L, 2006, Cell, V127, P1071, DOI 10.1016/j.cell.2006.11.026; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Trabbic-Carlson K, 2004, PROTEIN ENG DES SEL, V17, P57, DOI 10.1093/protein/gzh006; URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O; URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057; Urry DW, 1995, CIBA F SYMP, V192, P4; URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411; Vliegenthart GA, 2000, J CHEM PHYS, V112, P5364, DOI 10.1063/1.481106; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Waugh David S, 2016, Postepy Biochem, V62, P377; Weber SC, 2015, CURR BIOL, V25, P641, DOI 10.1016/j.cub.2015.01.012; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wills PR, 2015, ANAL BIOCHEM, V490, P55, DOI 10.1016/j.ab.2015.08.020; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yadav S, 2010, J PHARM SCI-US, V99, P1152, DOI 10.1002/jps.21898; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	98	178	182	12	85	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19110	19120		10.1074/jbc.M117.800466	http://dx.doi.org/10.1074/jbc.M117.800466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924037	hybrid, Green Published			2022-12-26	WOS:000415848000033
J	Lu, T; Wang, XL; Chai, Q; Sun, XJ; Sieck, GC; Katusic, ZS; Lee, HC				Lu, Tong; Wang, Xiao-Li; Chai, Qiang; Sun, Xiaojing; Sieck, Garry C.; Katusic, Zvonimir S.; Lee, Hon-Chi			Role of the endothelial caveolae microdomain in shear stress-mediated coronary vasorelaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; endothelial cell; ion channel; patch clamp; potassium channel; shear stress; transient receptor potential channels; TRP channels; TRPV4 channels; SK channel	CHANNEL ACTIVATION; DEPENDENT DILATION; SMALL-CONDUCTANCE; DOWN-REGULATION; CA2+ SIGNALS; K+-CHANNELS; BK CHANNELS; PROSTACYCLIN; CALCIUM; MECHANOTRANSDUCTION	In this study, we determined the role of caveolae and the ionic mechanisms that mediate shear stress-mediated vasodilation (SSD). We found that both TRPV4 and SK channels are targeted to caveolae in freshly isolated bovine coronary endothelial cells (BCECs) and that TRPV4 and KCa2.3 (SK3) channels are co-immunoprecipitated by anti-caveolin-1 antibodies. Acute exposure of BCECs seeded in a capillary tube to 10 dynes/cm(2) of shear stress (SS) resulted in activation of TRPV4 and SK currents. However, after incubation with HC067047 (TRPV4 inhibitor), SK currents could no longer be activated by SS, suggesting SK channel activation by SS was mediated through TRPV4. SK currents in BCECs were also activated by isoproterenol or by GSK1016790A (TRPV4 activator). In addition, preincubation of isolated coronary arterioles with apamin (SK inhibitor) resulted in a significant diminution of SSD whereas preincubation with HC067047 produced vasoconstriction by SS. Exposure of BCECs to SS (15 dynes/cm(2) 16 h) enhanced the production of nitric oxide and prostacyclin (PGI(2)) and facilitated the translocation of TRPV4 to the caveolae. Inhibition of TRPV4 abolished the SS-mediated intracellular Ca2+ ([Ca2+](i)) increase in BCECs. These results indicate a dynamic interaction in the vascular endothelium among caveolae TRPV4 and SK3 channels. This caveolae-TRPV4-SK3 channel complex underlies the molecular and ionic mechanisms that modulate SSD in the coronary circulation.	[Lu, Tong; Wang, Xiao-Li; Chai, Qiang; Sun, Xiaojing; Lee, Hon-Chi] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Sieck, Garry C.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Katusic, Zvonimir S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Chai, Qiang] Shandong Acad Med Sci, Inst Basic Med, Dept Physiol, Jinan 250062, Shandong, Peoples R China	Mayo Clinic; Mayo Clinic; Mayo Clinic; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Lee, HC (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	Lee.honchi@mayo.edu	Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643; sieck, gary/0000-0003-3040-9424	American Diabetes Association [1-12-BS-119, 1-16-IBS-195]; National Institutes of Health [HL-74180, HL-080118]; Mayo Clinic Department of Cardiovascular Diseases Prospective Research Award; National Natural Science Foundation of China [81470489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080118, R56HL074180, R01HL074180] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Department of Cardiovascular Diseases Prospective Research Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Diabetes Association Grants 1-12-BS-119 and 1-16-IBS-195, National Institutes of Health Grants HL-74180 and HL-080118, Mayo Clinic Department of Cardiovascular Diseases Prospective Research Award, and National Natural Science Foundation of China Grant 81470489. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Busse R, 2003, TRENDS PHARMACOL SCI, V24, P24, DOI 10.1016/S0165-6147(02)00005-6; Chai Q, 2015, PFLUG ARCH EUR J PHY, V467, P329, DOI 10.1007/s00424-014-1526-y; Chai Q, 2013, CARDIOVASC RES, V100, P151, DOI 10.1093/cvr/cvt157; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Flockerzi V., 2014, HDB EXPT PHARM, V1, pv; Frank PG, 2006, J CLIN INVEST, V116, P1222, DOI 10.1172/JCI28509; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; Gluais P, 2005, BRIT J PHARMACOL, V144, P477, DOI 10.1038/sj.bjp.0706003; Goedicke-Fritz S, 2015, EUR J CELL BIOL, V94, P391, DOI 10.1016/j.ejcb.2015.06.002; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Lu T, 2005, J BIOL CHEM, V280, P19097, DOI 10.1074/jbc.M414065200; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Makino A, 2008, AM J PHYSIOL-CELL PH, V295, pC221, DOI 10.1152/ajpcell.00433.2007; Malek Adel M., 1995, Methods in Cell Science, V17, P165, DOI 10.1007/BF00996123; Matsumoto T, 2012, PHARMACOL RES, V65, P537, DOI 10.1016/j.phrs.2012.02.004; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Merkus D, 2006, AM J PHYSIOL-HEART C, V291, pH2075, DOI 10.1152/ajpheart.01109.2005; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; Oriji GK, 1999, PROSTAG LEUKOTR ESS, V61, P45, DOI 10.1054/plef.1999.0072; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rosa AO, 2009, BBA-MOL CELL BIOL L, V1791, P697, DOI 10.1016/j.bbalip.2009.03.009; Sandow SL, 2012, ADV EXP MED BIOL, V740, P811, DOI 10.1007/978-94-007-2888-2_36; Santhanam AVR, 2007, CIRC RES, V100, P1379, DOI 10.1161/01.RES.0000265848.55035.5d; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Sullivan MN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005659; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Yi F, 2015, J BIOL CHEM, V290, P7016, DOI 10.1074/jbc.M114.607952; Yi F, 2014, J BIOL CHEM, V289, P10853, DOI 10.1074/jbc.M113.520940; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1	48	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19013	19023		10.1074/jbc.M117.786152	http://dx.doi.org/10.1074/jbc.M117.786152			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924052	Green Published, hybrid			2022-12-26	WOS:000415848000024
J	Lin, YH; Qiu, DC; Chang, WH; Yeh, YQ; Jeng, US; Liu, FT; Huang, JR				Lin, Yu-Hao; Qiu, De-Chen; Chang, Wen-Han; Yeh, Yi-Qi; Jeng, U-Ser; Liu, Fu-Tong; Huang, Jie-rong			The intrinsically disordered N-terminal domain of galectin-3 dynamically mediates multisite self-association of the protein through fuzzy interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOMER-DIMER EQUILIBRIUM; CARBOHYDRATE-RECOGNITION DOMAIN; RESIDUAL DIPOLAR COUPLINGS; N-15 NMR RELAXATION; BACKBONE DYNAMICS; PHASE-TRANSITION; STAPHYLOCOCCAL NUCLEASE; UNFOLDED PROTEINS; BINDING PROTEINS; ANIMAL LECTIN	Galectins are a family of lectins that bind beta-galactosides through their conserved carbohydrate recognition domain (CRD) and can induce aggregation with glycoproteins or glycolipids on the cell surface and thereby regulate cell activation, migration, adhesion, and signaling. Galectin-3 has an intrinsically disordered N-terminal domain and a canonical CRD. Unlike the other 14 known galectins in mammalian cells, which have dimeric or tandem-repeated CRDs enabling multivalency for various functions, galectin-3 is monomeric, and its functional multivalency therefore is somewhat of a mystery. Here, we used NMR spectroscopy, mutagenesis, small-angle X-ray scattering, and computational modeling to study the selfassociation- related multivalency of galectin-3 at the residuespecific level. We show that the disordered N-terminal domain (residues similar to 20-100) interacts with itself and with a part of the CRD not involved in carbohydrate recognition (beta-strands 7-9; residues similar to 200-220), forming a fuzzy complex via inter-and intramolecular interactions, mainly through hydrophobicity. These fuzzy interactions are characteristic of intrinsically disordered proteins to achieve liquid-liquid phase separation, and we demonstrated that galectin-3 can also undergo liquid-liquid phase separation. We propose that galectin-3 may achieve multivalency through this multisite self-association mechanism facilitated by fuzzy interactions.	[Lin, Yu-Hao; Qiu, De-Chen; Chang, Wen-Han; Huang, Jie-rong] Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2 Li Nong St, Taipei 11221, Taiwan; [Huang, Jie-rong] Natl Yang Ming Univ, Inst Biomed Informat, 155 Sect 2 Li Nong St, Taipei 11221, Taiwan; [Yeh, Yi-Qi; Jeng, U-Ser] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Jeng, U-Ser] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Synchrotron Radiation Research Center; National Tsing Hua University; Academia Sinica - Taiwan	Huang, JR (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2 Li Nong St, Taipei 11221, Taiwan.	jierongh@ym.edu.tw	Huang, Jie-rong/O-3661-2019; Liu, FU-TONG/A-5749-2019	Huang, Jie-rong/0000-0003-3674-2228; Liu, FU-TONG/0000-0002-3354-1001	Ministry of Science and Technology of Taiwan [104-2113-M-010-001-MY2, 106-2113-M-010-005-MY2, 106-2321-B-001-042]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan Grants 104-2113-M-010-001-MY2 and 106-2113-M-010-005-MY2 (to J. H.) and 106-2321-B-001-042 (to F.-T. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abyzov A, 2016, J AM CHEM SOC, V138, P6240, DOI 10.1021/jacs.6b02424; Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Bae SH, 2009, J AM CHEM SOC, V131, P6814, DOI 10.1021/ja809687r; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Berbis MA, 2014, BIOCHEM BIOPH RES CO, V443, P126, DOI 10.1016/j.bbrc.2013.11.063; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Birdsall B, 2001, BIOCHEMISTRY-US, V40, P4859, DOI 10.1021/bi002907f; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen TC, 2016, PROTEIN PEPTIDE LETT, V23, P967, DOI 10.2174/0929866523666160920100045; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diehl C, 2009, J BIOMOL NMR, V45, P157, DOI 10.1007/s10858-009-9356-5; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Goddard T. D., 2005, SPARKY 3; Gong HC, 1999, CANCER RES, V59, P6239; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Halimi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111836; HSU DK, 1992, J BIOL CHEM, V267, P14167; Huang JR, 2012, BIOCHEM SOC T, V40, P989, DOI 10.1042/BST20120187; Ippel H, 2016, GLYCOBIOLOGY, V26, P888, DOI 10.1093/glycob/cww021; Ippel H, 2015, BIOMOL NMR ASSIGN, V9, P59, DOI 10.1007/s12104-014-9545-3; Jensen MR, 2008, PROTEINS, V73, P161, DOI 10.1002/prot.22039; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Korchuganov DS, 2001, J AM CHEM SOC, V123, P2068, DOI 10.1021/ja0025447; Kuklinski S, 1998, J NEUROCHEM, V70, P814; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MEHUL B, 1994, J BIOL CHEM, V269, P18250; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Parigi G, 2014, J AM CHEM SOC, V136, P16201, DOI 10.1021/ja506820r; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pfuhl M, 1999, J BIOMOL NMR, V14, P307, DOI 10.1023/A:1008319917267; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rezaei-Ghaleh N, 2015, BIOINFORMATICS, V31, P1319, DOI 10.1093/bioinformatics/btu824; Rezaei-Ghaleh N, 2013, ANGEW CHEM INT EDIT, V52, P11410, DOI 10.1002/anie.201305094; ROFF CF, 1983, J BIOL CHEM, V258, P657; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Taylor J. R., 1997, INTRO ERROR ANAL; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yeh YQ, 2017, J PHYS CHEM LETT, V8, P470, DOI 10.1021/acs.jpclett.6b02722; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zangi R, 2009, J AM CHEM SOC, V131, P1535, DOI 10.1021/ja807887g; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	79	33	34	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17845	17856		10.1074/jbc.M117.802793	http://dx.doi.org/10.1074/jbc.M117.802793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893908	Green Published, hybrid			2022-12-26	WOS:000414013000021
J	Gao, Y; Wang, YR; Zhai, X; He, YF; Chen, R; Zhou, JJ; Li, M; Wang, QJ				Gao, Ye; Wang, Yiran; Zhai, Xiao; He, Yifei; Chen, Rong; Zhou, Jingjing; Li, Ming; Wang, Qijin			Publication trends of research on diabetes mellitus and T cells (1997-2016): A 20-year bibliometric study	PLOS ONE			English	Article							PATHOGENESIS; RESPONSES; ARTICLES; CHINA	Introduction Diabetes Mellitus (DM) is a huge burden for human health. Recent studies show the close relationship between DM and T cells. We investigated the trend in DM and T cells research. Methods Using the Web of Science database, we searched the publications on DM and T cells in 1997-2016, and studied the source data using bibliometric methodology. Excel 2016, GraphPad Prism 5, and VOSviewer software were used to analyze the publication trend in DM and T cells research. Results We found a total of 1077 publications with 38109 citations up to January 23, 2017. The highest contribution came from the United States, with 48.38% of the publications, 61.44% of the citations and the highest H-index (74). China had the 5th place for total publications, but ranked 11th both for citation frequency (604) and H-index (13). The inflection point of the global DM and T cells publications was in 2000. Journal of Immunology published the most related articles (164). Santamaria P. was the leading scholar in this field with the most publications (35). The keywords "regulatory T cell" and "autoimmune diabetes" were mentioned more than 300 times. Furthermore, type 2 (T2) DM, T cell immunoglobulin and mucin domain (TIM) and obesity are becoming popular research topics in this field. Conclusion The quantity of publications on DM and T cells grew rapidly around year 2000, but has relatively decreased recently. The United States had the leading position in global research. There was a discrepancy between productivity and quality of publications from China. Latest progress is most likely first published by the Journal of Immunology. Santamaria P.,Roep B. O. and Peakman M. were the pioneer scholars in this field. Most researchers have focused on "regulatory T cell" and "autoimmune diabetes" research. In future, T2DM, TIM and obesity may be the popular areas.	[Gao, Ye; Wang, Yiran] Second Mil Med Univ, Changhai Hosp, Grad Management Unit, Shanghai, Peoples R China; [Wang, Yiran] Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhai, Xiao; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [He, Yifei; Chen, Rong; Zhou, Jingjing; Wang, Qijin] Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Wang, QJ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China.	wangqijin8668601@163.com	Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022	Gao, Ye/0000-0002-6338-9602	National Natural Science Foundation of China [81670741]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81670741). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2016, J THORAC ONCOL, V11, P1040, DOI 10.1016/j.jtho.2016.03.010; Anderson DE, 2007, EXPERT OPIN THER TAR, V11, P1005, DOI 10.1517/14728222.11.8.1005; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Ekinci S, 2015, WORLD NEUROSURG, V84, P2072, DOI 10.1016/j.wneu.2014.12.003; Frankl JA, 2016, DIABETES-METAB RES, V32, P297, DOI 10.1002/dmrr.2720; Geaney F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133009; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Li T, 2008, NEUROSCI LETT, V441, P248, DOI 10.1016/j.neulet.2008.06.044; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lyu QJ, 2017, SCIENTOMETRICS, V110, P105, DOI 10.1007/s11192-016-2179-8; Narotsky D, 2012, EUR J GASTROEN HEPAT, V24, P1071, DOI 10.1097/MEG.0b013e328355a4ab; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seriwala HM, 2015, EXPERT REV RESP MED, V9, P817, DOI 10.1586/17476348.2015.1103649; Shuaib W, 2015, AM J CARDIOL, V115, P972, DOI 10.1016/j.amjcard.2015.01.029; Skyler JS, 2017, DIABETES, V66, P241, DOI 10.2337/db16-0806; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tang W, 2013, CELL PHYSIOL BIOCHEM, V32, P827, DOI 10.1159/000354485; Wang QJ, 2015, APMIS, V123, P146, DOI 10.1111/apm.12330; Wong FS, 1997, RES IMMUNOL, V148, P327, DOI 10.1016/S0923-2494(97)87242-2; Yang TT, 2015, EUR REV MED PHARMACO, V19, P2010; Yates T, 2016, NAT REV ENDOCRINOL, V12, P377, DOI 10.1038/nrendo.2016.74; Zetterqvist AV, 2013, PLOS ONE, V8, P14; Zhai X, 2016, LANCET, V387, P1722, DOI 10.1016/S0140-6736(16)30261-6; Zhang N, 2016, AUTOIMMUNITY, V49, P405, DOI 10.1080/08916934.2016.1196677; Zhao PQ, 2016, J DIABETES, V8, P199, DOI 10.1111/1753-0407.12276	28	49	51	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184869	10.1371/journal.pone.0184869	http://dx.doi.org/10.1371/journal.pone.0184869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926600	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600046
J	Bai, YR; Qiao, L; Xie, N; Shi, YQ; Liu, N; Wang, JH				Bai, Yuru; Qiao, Lu; Xie, Ning; Shi, Yongquan; Liu, Na; Wang, Jinhai			Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; BREAST-CANCER; LUNG ADENOCARCINOMA; GASTRIC-CANCER; CELL-PROLIFERATION; PROSTATE-CANCER; DOWN-REGULATION; TOB; METHYLATION; CARCINOMA	Background Despite advances in early diagnosis and treatment, cancer remains the major cause of mortality in the world. The Tob/BTG antiproliferative (APRO) protein family is reported to participate in diverse human diseases. However, there's little known about their expression and prognostic values in most human cancers. Methods We performed a detailed cancer vs. normal analysis. The mRNA expression levels of APRO family in various cancers were analyzed via the Oncomine database. Moreover, the Kaplan-Meier Plotter and PrognScan databases were used to evaluate the prognostic values. Results We observed that the mRNA expression levels of TOB1-2 and BTG2 were decreased in most cancers compared with normal tissues, while BTG3 was upregulated in most cancers. In survival analyses based on Kaplan-Meier Plotter, TOB1, BTG1 and BTG4 showed significant associations with survival outcome of different subtypes of breast cancer. Decreased BTG2 was related with poor relapse free survival (RFS) in all subtypes of breast cancer. Especially, besides RFS, reduced BTG2 also indicated worse overall survival and distant metastasis free survival in breast cancer patients who were classified as luminal A. Significant prognostic effects of the whole APRO family were also found in lung adenocarcinoma, but not in squamous cell lung carcinoma. In addition, potential correlations between some APRO family members and survival outcomes were also observed in ovarian, colorectal and brain cancer. Conclusions Some members of APRO family showed significant expression differences between cancer and normal tissues, and could be prognostic biomarkers for defined cancer types.	[Bai, Yuru; Qiao, Lu; Xie, Ning; Liu, Na; Wang, Jinhai] Xi An Jiao Tong Univ, Dept Gastroenterol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Shi, Yongquan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Shi, Yongquan; Liu, Na] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University	Liu, N; Wang, JH (corresponding author), Xi An Jiao Tong Univ, Dept Gastroenterol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.; Liu, N (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.	liunafmmu@163.com; jinhaiwang@hotmail.com	liu, na/W-7939-2019; Shi, Yongquan/AAE-3954-2020		National Natural Science Foundation of China [81370484]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant number 81370484 (Na Liu). The funder had been greatly helpful in study design, decision to publish, and modification of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Helms MW, 2009, CANCER RES, V69, P5049, DOI 10.1158/0008-5472.CAN-08-4154; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Ito Y, 2005, CANCER LETT, V220, P237, DOI 10.1016/j.canlet.2004.08.017; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Lee JC, 2015, CANCER LETT, V360, P310, DOI 10.1016/j.canlet.2015.02.034; Li BS, 2015, ONCOGENE, V34, P2556, DOI 10.1038/onc.2014.214; Ma LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070716; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nahta R, 2006, MOL CANCER THER, V5, P1593, DOI 10.1158/1535-7163.MCT-06-0133; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ren XL, 2015, J CANCER RES CLIN, V141, P397, DOI 10.1007/s00432-014-1826-9; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Takahashi F, 2011, ONCOGENE, V30, P3084, DOI 10.1038/onc.2011.24; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Tzachanis D, 2009, CELL CYCLE, V8, P1019, DOI 10.4161/cc.8.7.8033; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yu JW, 2008, GENE EXPRESSION, V14, P173; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zheng HC, 2015, ONCOTARGET, V6, P19685, DOI 10.18632/oncotarget.4081	42	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184902	10.1371/journal.pone.0184902	http://dx.doi.org/10.1371/journal.pone.0184902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922388	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300041
J	Chiu, APY; Lin, QY; He, DH				Chiu, Alice P. Y.; Lin, Qianying; He, Daihai			News trends and web search query of HIV/AIDS in Hong Kong	PLOS ONE			English	Article							ONLINE INFORMATION-SEEKING; PUBLIC-HEALTH; SURVEILLANCE; COVERAGE; HIV; COMPLEMENTARITY; IMPACT; MEDIA; MEN; SEX	Background The HIV epidemic in Hong Kong has worsened in recent years, with major contributions from high-risk subgroup of men who have sex with men (MSM). Internet use is prevalent among the majority of the local population, where they sought health information online. This study examines the impacts of HIV/AIDS and MSM news coverage on web search query in Hong Kong. Methods Relevant news coverage about HIV/AIDS and MSM from January 1st, 2004 to December 31st, 2014 was obtained from the WiseNews databse. News trends were created by computing the number of relevant articles by type, topic, place of origin and sub-populations. We then obtained relevant search volumes from Google and analysed causality between news trends and Google Trends using Granger Causality test and orthogonal impulse function. Results We found that editorial news has an impact on "HIV" Google searches on HIV, with the search term popularity peaking at an average of two weeks after the news are published. Similarly, editorial news has an impact on the frequency of "AIDS" searches two weeks after. MSM-related news trends have a more fluctuating impact on "MSM" Google searches, although the time lag varies anywhere from one week later to ten weeks later. Conclusions This infodemiological study shows that there is a positive impact of news trends on the online search behavior of HIV/AIDS or MSM-related issues for up to ten weeks after. Health promotional professionals could make use of this brief time window to tailor the timing of HIV awareness campaigns and public health interventions to maximise its reach and effectiveness.	[Chiu, Alice P. Y.; Lin, Qianying; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	daihai.he@polyu.edu.hk	Lin, Qianying/ABD-8415-2021; He, Daihai/AAT-8735-2021	He, Daihai/0000-0003-3253-654X	Hong Kong Polytechnic University; AIDS Trust Fund Hong Kong [MSS 236 R]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); AIDS Trust Fund Hong Kong	DH was supported by Start-up grant for new recruits of Hong Kong Polytechnic University and AIDS Trust Fund Hong Kong (MSS 236 R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Census and Statistics Department Hong Kong, 2013, 62 CENS STAT DEP; Chan K, 2016, HIV SURVEILLANCE REP; DeVilbiss EA, 2014, J AUTISM DEV DISORD, V44, P3271, DOI 10.1007/s10803-014-2160-4; Dutta-Bergman MJ, 2004, NEW MEDIA SOC, V6, P659, DOI 10.1177/146144804047086; Dutta-Bergman MJ, 2004, J BROADCAST ELECTRON, V48, P41, DOI 10.1207/s15506878jobem4801_3; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fleiss J.L., 2013, STAT METHODS RATES P; Gabarron E, 2016, STUD HEALTH TECHNOL, V228, P778, DOI 10.3233/978-1-61499-678-1-778; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECONOMETRICS, V14, P227, DOI 10.1016/0304-4076(80)90092-5; Jo CL, 2015, TOB CONTROL, V24, P395, DOI 10.1136/tobaccocontrol-2013-051261; KALICHMAN SC, 1994, AIDS EDUC PREV, V6, P542; Kerber KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00050; Ling Rebecca, 2016, JMIR Public Health Surveill, V2, pe156, DOI 10.2196/publichealth.6504; Linkov F, 2014, SURG OBES RELAT DIS, V10, P533, DOI 10.1016/j.soard.2013.10.007; M. Eichler, 2012, CAUSALITY STAT PERSP, P327, DOI [DOI 10.1002/9781119945710.CH22, 10.1002/9781119945710.ch22]; Niederdeppe J, 2008, J HEALTH COMMUN, V13, P181, DOI 10.1080/10810730701854110; Noar Seth M., 2013, Journal of the National Cancer Institute Monographs, P188, DOI 10.1093/jncimonographs/lgt017; Simmering JE, 2014, RES SOC ADMIN PHARM, V10, P896, DOI 10.1016/j.sapharm.2014.01.003; Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415; StatCounter Global Stats, SEARCH ENG MARK SHAR; Thompson LH, 2014, EPIDEMIOL INFECT, V142, P2397, DOI 10.1017/S0950268813003464; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Weeks BE, 2012, HEALTH COMMUN, V27, P158, DOI 10.1080/10410236.2011.571757; Yan YY, 2010, J MED SYST, V34, P147, DOI 10.1007/s10916-008-9226-9; Zheluk A, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2936	31	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185004	10.1371/journal.pone.0185004	http://dx.doi.org/10.1371/journal.pone.0185004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922376	Green Submitted, gold, Green Published			2022-12-26	WOS:000411059300052
J	Canakci, S; Toy, MF; Inci, AF; Liu, X; Kuzum, D				Canakci, Sadullah; Toy, Muhammed Faruk; Inci, Ahmet Fatih; Liu, Xin; Kuzum, Duygu			Computational analysis of network activity and spatial reach of sharp wave-ripples	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; FIELD POTENTIALS; INTERNEURONS; HIPPOCAMPUS; ORIGIN; MEMORY; MODEL; EEG	Network oscillations of different frequencies, durations and amplitudes are hypothesized to coordinate information processing and transfer across brain areas. Among these oscillations, hippocampal sharp wave-ripple complexes (SPW-Rs) are one of the most prominent. SPW-Rs occurring in the hippocampus are suggested to play essential roles in memory consolidation as well as information transfer to the neocortex. To-date, most of the knowledge about SPW-Rs comes from experimental studies averaging responses from neuronal populations monitored by conventional microelectrodes. In this work, we investigate spatiotemporal characteristics of SPW-Rs and how microelectrode size and distance influence SPWR recordings using a biophysical model of hippocampus. We also explore contributions from neuronal spikes and synaptic potentials to SPW-Rs based on two different types of network activity. Our study suggests that neuronal spikes from pyramidal cells contribute significantly to ripples while high amplitude sharp waves mainly arise from synaptic activity. Our simulations on spatial reach of SPW-Rs show that the amplitudes of sharp waves and ripples exhibit a steep decrease with distance from the network and this effect is more prominent for smaller area electrodes. Furthermore, the amplitude of the signal decreases strongly with increasing electrode surface area as a result of averaging. The relative decrease is more pronounced when the recording electrode is closer to the source of the activity. Through simulations of field potentials across a high-density microelectrode array, we demonstrate the importance of finding the ideal spatial resolution for capturing SPW-Rs with great sensitivity. Our work provides insights on contributions from spikes and synaptic potentials to SPWRs and describes the effect of measurement configuration on LFPs to guide experimental studies towards improved SPW-R recordings.	[Canakci, Sadullah] Boston Univ, Elect & Comp Engn Dept, Boston, MA 02215 USA; [Toy, Muhammed Faruk; Liu, Xin; Kuzum, Duygu] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Toy, Muhammed Faruk] Middle East Tech Univ, Elect & Elect Engn, Ankara, Turkey; [Inci, Ahmet Fatih] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Boston University; University of California System; University of California San Diego; Middle East Technical University; Sabanci University	Kuzum, D (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	dkuzum@eng.ucsd.edu	Inci, Ahmet/ABA-8606-2020; Liu, Xin/Q-5024-2019	Liu, Xin/0000-0003-3993-3505	Office of Naval Research Young Investigator Award; UC San Diego Frontiers of Innovation Scholars Program; UCSD Center for Multiscale Imaging of Brain Function	Office of Naval Research Young Investigator Award(Office of Naval Research); UC San Diego Frontiers of Innovation Scholars Program; UCSD Center for Multiscale Imaging of Brain Function	We would like to acknowledge Office of Naval Research Young Investigator Award and UC San Diego Frontiers of Innovation Scholars Program for funding this research. We also acknowledge UCSD Center for Multiscale Imaging of Brain Function for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Office of Naval Research Young Investigator Award and UC San Diego Frontiers of Innovation Scholars Program for funding this research. We also acknowledge UCSD Center for Multiscale Imaging of Brain Function for research support.	Barbier D, 2008, IEEE T; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Bedard C, 2014, J ELECTROMAGN ANAL A, V6, P296, DOI DOI 10.4236/JEMAA.2014.610029; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Brunel N, 2003, J NEUROPHYSIOL; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chatillon CE, 2013, CLIN NEUROPHYSIOL, V124, P1541, DOI 10.1016/j.clinph.2013.02.113; Csicsvari J, 2000, NEURON; de la Prida LM, 2015, J CLIN NEUROPHYSIOL, V32, P207, DOI 10.1097/WNP.0000000000000150; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Draguhn A, 2002, P PHYSL; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Fink CG, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0024-15.2015; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hajos N, 2013, J NEUROSCI, V33, P11677, DOI 10.1523/JNEUROSCI.5729-12.2013; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lempka SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059839; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; Linden H., 2014, FRONT NEUROINFORM, V7, P41, DOI DOI 10.3389/fninf.2013.00041; Malerba P, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004880; Malmivuo J, 1995, BIOELECTROMAGNETISM; Moffitt M, 2005, CLIN NEUROPHYSIOL; Nelson MJ, 2010, J NEUROPHYSIOL, V103, P2315, DOI 10.1152/jn.00157.2010; Ness TV, 2015, NEUROINFORMATICS, V13, P403, DOI 10.1007/s12021-015-9265-6; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Patel J, 2013, J NEUROSCI, V 33, P17029, DOI 10.1523/JNEUROSCI.2036-13.2013; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Schlingloff D, 2014, J NEUROSCI, V34, P11385, DOI 10.1523/JNEUROSCI.0867-14.2014; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Stark E, 2014, NEURON; Sullivan D, 2011, RELATIONSHIPS HIPPOC; Taxidis J, 2013, FRONT COMPUT NEUROSC, V7; Taxidis J, 2015, NEURON, V87, P590, DOI 10.1016/j.neuron.2015.07.014; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Traub R, 2000, J NEUROSCI; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Traub RD, 2012, EUR J NEUROSCI, V36, P2650, DOI 10.1111/j.1460-9568.2012.08184.x; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Van Quyen ML, 2008, CELL TYPE SPECIFIC F; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Worrell G, 2008, BRAIN; YLINEN A, 1995, J NEUROSCI, V15, P30; Zelmann R, 2012, CLIN NEUROPHYSIOL, V123, P106, DOI [10.1016/j.clinph.2011.06.006, 10.1016/j.clinph.2011.02.022]	56	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184542	10.1371/journal.pone.0184542	http://dx.doi.org/10.1371/journal.pone.0184542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915251	Green Published, gold, Green Submitted			2022-12-26	WOS:000410861600010
J	Onodera, S; Saito, A; Hasegawa, D; Morita, N; Watanabe, K; Nomura, T; Shibahara, T; Ohba, S; Yamaguchi, A; Azuma, T				Onodera, Shoko; Saito, Akiko; Hasegawa, Daigo; Morita, Nana; Watanabe, Katsuhito; Nomura, Takeshi; Shibahara, Takahiko; Ohba, Shinsuke; Yamaguchi, Akira; Azuma, Toshifumi			Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; SONIC HEDGEHOG; PTCH2; EXPRESSION; PATHWAY; BOC; MORPHOGENESIS; ACTIVATION; PROTEINS; RECEPTOR	Gorlin syndrome is a genetic disorder of autosomal dominant inheritance that predisposes the affected individual to a variety of disorders that are attributed largely to heterozygous germline patched1 (PTCH1) mutations. PTCH1 is a hedgehog (Hh) receptor as well as a repressor, mutation of which leads to constitutive activation of Hh pathway. Hh pathway encompasses a wide variety of cellular signaling cascades, which involve several molecules; however, no associated genotype-phenotype correlations have been reported. Recently, mutations in Suppressor of fused homolog (SUFU) or PTCH2 were reported in patients with Gorlin syndrome. These facts suggest that multi-layered mutations in Hh pathway may contribute to the development of Gorlin syndrome. We demonstrated multiple mutations of Hh-related genes in addition to PTCH1, which possibly act in an additive or multiplicative manner and lead to Gorlin syndrome. High-throughput sequencing was performed to analyze exome sequences in four unrelated Gorlin syndrome patient genomes. Mutations in PTCH1 gene were detected in all four patients. Specific nucleotide variations or frameshift variations of PTCH1 were identified along with the inferred amino acid changes in all patients. We further filtered 84 different genes which are closely related to Hh signaling. Fifty three of these had enough coverage of over x30. The sequencing results were filtered and compared to reduce the number of sequence variants identified in each of the affected individuals. We discovered three genes, PTCH2, BOC, and WNT9b, with mutations with a predicted functional impact assessed by MutationTaster2 or PolyPhen-2 (Polymorphism Phenotyping v2) analysis. It is noticeable that PTCH2 and BOC are Hh receptor molecules. No significant mutations were observed in SUFU. Multi-layered mutations in Hh pathway may change the activation level of the Hh signals, which may explain the wide phenotypic variability of Gorlin syndrome.	[Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Onodera, Shoko; Ohba, Shinsuke] Univ Tokyo, Grad Sch Med, Div Clin Biotechnol, Bunkyo Ku, Tokyo, Japan; [Onodera, Shoko; Ohba, Shinsuke] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Daigo; Watanabe, Katsuhito; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Morita, Nana; Nomura, Takeshi] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Chiba, Japan; [Yamaguchi, Akira; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; University of Tokyo; University of Tokyo; Tokyo Dental College; Tokyo Dental College; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan.	tazuma@tdc.ac.jp	Yamaguchi, Akira/AAX-9286-2020	Ohba, Shinsuke/0000-0002-6874-8539; Onodera, Shoko/0000-0003-0673-3400	Japan Society for the Promotion of Science [16K20427, 16K20428, 16K15791]; Tokyo Dental College President's Encouragement Research Grant [31580]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Dental College President's Encouragement Research Grant	This study was supported by Japan Society for the Promotion of Science: 16K20427, 16K20428, 16K15791; and Tokyo Dental College President's Encouragement Research Grant: 31580. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alfaro AC, 2014, DEVELOPMENT, V141, P3331, DOI 10.1242/dev.110056; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fujii K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/ped.12461; Fujii K, 2013, FAM CANCER, V12, P611, DOI 10.1007/s10689-013-9623-1; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jin YR, 2012, DEVELOPMENT, V139, P1821, DOI 10.1242/dev.075796; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kameda T, 1999, GENES CELLS, V4, P175, DOI 10.1046/j.1365-2443.1999.00250.x; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Klein RD, 2005, GENET MED, V7, P611, DOI 10.1097/01.gim.0000182879.57182.b4; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Morita K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140480; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nieuwenhuis E, 2006, MOL CELL BIOL, V26, P6609, DOI 10.1128/MCB.00295-06; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Regard JB, 2013, NAT MED, V19, P1505, DOI 10.1038/nm.3314; Robinson PN, 2011, CLIN GENET, V80, P127, DOI 10.1111/j.1399-0004.2011.01713.x; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Tang HM, 2016, GENETICS, V203, P635, DOI 10.1534/genetics.116.190033; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Wicking C, 1997, AM J HUM GENET, V60, P21; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zheng X, 2013, ONCOL REP, V30, P2020, DOI 10.3892/or.2013.2690; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239; Zhu XJ, 2016, DEV DYNAM, V245, P414, DOI 10.1002/dvdy.24376	47	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184702	10.1371/journal.pone.0184702	http://dx.doi.org/10.1371/journal.pone.0184702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915250	gold, Green Submitted, Green Published			2022-12-26	WOS:000410861600015
J	Zhou, AY; Baruch, M; Ajo-Franklin, CM; Maharbiz, MM				Zhou, Alyssa Y.; Baruch, Moshe; Ajo-Franklin, Caroline M.; Maharbiz, Michel M.			A portable bioelectronic sensing system (BESSY) for environmental deployment incorporating differential microbial sensing in miniaturized reactors	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS; BACTERIAL RESPIRATION; ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOSENSORS; SENSOR; MR-1; REDUCTION; NANOWIRES; PROTEIN	Current technologies are lacking in the area of deployable, in situ monitoring of complex chemicals in environmental applications. Microorganisms metabolize various chemical compounds and can be engineered to be analyte-specific making them naturally suited for robust chemical sensing. However, current electrochemical microbial biosensors use large and expensive electrochemistry equipment not suitable for on-site, real-time environmental analysis. Here we demonstrate a miniaturized, autonomous bioelectronic sensing system (BESSY) suitable for deployment for instantaneous and continuous sensing applications. We developed a 2x2 cm footprint, low power, two-channel, three-electrode electrochemical potentiostat which wirelessly transmits data for on-site microbial sensing. Furthermore, we designed a new way of fabricating self-contained, submersible, miniaturized reactors (m-reactors) to encapsulate the bacteria, working, and counter electrodes. We have validated the BESSY's ability to specifically detect a chemical amongst environmental perturbations using differential current measurements. This work paves the way for in situ microbial sensing outside of a controlled laboratory environment.	[Zhou, Alyssa Y.; Maharbiz, Michel M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Zhou, Alyssa Y.; Baruch, Moshe; Ajo-Franklin, Caroline M.] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA; [Ajo-Franklin, Caroline M.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA USA; [Maharbiz, Michel M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Maharbiz, Michel M.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Maharbiz, MM (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.; Maharbiz, MM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Maharbiz, MM (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	maharbiz@berkeley.edu	Ajo-Franklin, Caroline M/F-3405-2016		Office of Naval Research [N000141310551]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-ACO2-05CH11231]	Office of Naval Research(Office of Naval Research); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Naval Research (N000141310551) and performed at the Molecular Foundry and UC Berkeley. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-ACO2-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA Y, 1998, METH BIOTEC, V6, P225; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Chua EJ, 2016, FRONT MAR SCI FRONTI, V3, P1; Coursolle D, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00056; D'Souza SF, 2001, BIOSENS BIOELECTRON, V16, P337, DOI 10.1016/S0956-5663(01)00125-7; Di Lorenzo M, 2009, WATER RES, V43, P3145, DOI 10.1016/j.watres.2009.01.005; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Friedman ES, 2012, BIOSENS BIOELECTRON, V32, P309, DOI 10.1016/j.bios.2011.12.013; Goldbeck CP, 2013, ACS SYNTH BIOL, V2, P150, DOI 10.1021/sb300119v; Golitsch F, 2013, BIOSENS BIOELECTRON, V47, P285, DOI 10.1016/j.bios.2013.03.010; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400; Hanrahan G, 2004, J ENVIRON MONITOR, V6, P657, DOI 10.1039/b403975k; Jensen HM, 2016, ACS SYNTH BIOL, V5, P679, DOI 10.1021/acssynbio.5b00279; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Justino CIL, 2015, TRENDS ENVIRON ANAL, V6-7, P21, DOI 10.1016/j.teac.2015.02.001; Kotloski NJ, 2013, AM SOC MICROBIOLOGY, V4; Kroger S, 2005, BIOSENS BIOELECTRON, V20, P1903, DOI 10.1016/j.bios.2004.08.036; Larsen LH, 1997, ANAL CHEM, V69, P3527, DOI 10.1021/ac9700890; Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Mills G, 2012, SENSOR REV, V32, P17, DOI 10.1108/02602281211197116; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Peixoto L, 2011, BIOELECTROCHEMISTRY, V81, P99, DOI 10.1016/j.bioelechem.2011.02.002; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Rundel PW, 2009, NEW PHYTOL, V182, P589, DOI 10.1111/j.1469-8137.2009.02811.x; Schuetz B, 2009, APPL ENVIRON MICROB, V75, P7789, DOI 10.1128/AEM.01834-09; Shin HJ, 2011, APPL MICROBIOL BIOT, V89, P867, DOI 10.1007/s00253-010-2990-8; Simonian A.L., 1998, METH BIOTEC, P237; Stretton S, 1998, APPL ENVIRON MICROB, V64, P2554; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; TerAvest MA, 2016, BIOTECHNOL BIOENG, V113, P687, DOI 10.1002/bit.25723; TerAvest MA, 2014, CHEMELECTROCHEM, V1, P1874, DOI 10.1002/celc.201402194; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wang HM, 2013, BIOTECHNOL ADV, V31, P1796, DOI 10.1016/j.biotechadv.2013.10.001; Webster DP, 2014, BIOSENS BIOELECTRON, V62, P320, DOI 10.1016/j.bios.2014.07.003; Yang XP, 2002, SENSORS-BASEL, V2, P455, DOI 10.3390/s21100455; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003; Zhang YF, 2012, BIOSENS BIOELECTRON, V38, P189, DOI 10.1016/j.bios.2012.05.032; Zhang YF, 2011, BIOTECHNOL BIOENG, V108, P2339, DOI 10.1002/bit.23204; Zhou AY, 2015, IEEE ENG MED BIO, P7518, DOI 10.1109/EMBC.2015.7320131	45	16	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184994	10.1371/journal.pone.0184994	http://dx.doi.org/10.1371/journal.pone.0184994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915277	Green Published, gold			2022-12-26	WOS:000410861600025
J	Bloch, JS; Ruetz, M; Krautler, B; Locher, KP				Bloch, Joeel S.; Ruetz, Markus; Kraeutler, Bernhard; Locher, Kaspar P.			Structure of the human transcobalamin beta domain in four distinct states	PLOS ONE			English	Article							VITAMIN-B-12 TRANSPORT; INTRINSIC-FACTOR; COBALAMIN; BINDING; PROTEIN; ASSIMILATION; RECOGNITION; MECHANISMS; COBINAMIDE; ANALOGS	Vitamin B12 (cyanocobalamin, CNCbl) is an essential cofactor-precursor for two biochemical reactions in humans. When ingested, cobalamins (Cbl) are transported via a multistep transport system into the bloodstream, where the soluble protein transcobalamin (TC) binds Cbl and the complex is taken up into the cells via receptor mediated endocytosis. Crystal structures of TC in complex with CNCbl have been solved previously. However, the initial steps of holo-TC assembly have remained elusive. Here, we present four crystal structures of the beta domain of human TC (TC-beta) in different substrate-bound states. These include the apo and CNCbl-bound states, providing insight into the early steps of holo-TC assembly. We found that in vitro assembly of TC-alpha and TC-beta to a complex was Cbldependent. We also determined the structure of TC-beta in complex with cobinamide (Cbi), an alternative substrate, shedding light on the specificity of TC. We finally determined the structure of TC-beta in complex with an inhibitory antivitamin B12 (anti-B12). We used this structure to model the binding of anti-B12 into full-length holo-TC and could rule out that the inhibitory function of anti-B12 was based on an inability to form a functional complex with TC.	[Bloch, Joeel S.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Inst Organ Chem, Innsbruck, Austria; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Ctr Mol Biosci, Innsbruck, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Innsbruck; University of Innsbruck	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland.	locher@mol.biol.ethz.ch	Bloch, Joël/ABA-2181-2020	Bloch, Joël/0000-0002-5786-0488	Swiss National Science Foundation [SNF 310030B_166672]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source at the Paul Scherrer Institute in Villigen for great assistance with the data collection. This work was supported by the Swiss National Science Foundation (SNF 310030B_166672 to K.P.L.). The PDB accession codes are 5N00 (apo TC-beta), 5NP4 (CNCb1-bound TC-beta), 5NRP (Cbi-bound TC-beta), 5NSA (F2PhE-tyCbl-bound TC-beta).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2004, BIOCHEMISTRY-US, V43, P15095, DOI 10.1021/bi048924c; Fedosov SN, 1995, BIOCHEMISTRY-US, V34, P16082, DOI 10.1021/bi00049a023; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; FLODH H, 1968, INT J CANCER, V3, P694, DOI 10.1002/ijc.2910030518; Furger E, 2013, J BIOL CHEM, V288, P25466, DOI 10.1074/jbc.M113.483271; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOLHOUSE JF, 1977, J CLIN INVEST, V60, P1381, DOI 10.1172/JCI108899; Krautler B, 2015, CHEM-EUR J, V21, P11280, DOI 10.1002/chem.201502072; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lildballe DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046657; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41575; Mutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075312; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; RAPPAZZO ME, 1970, BRIT J HAEMATOL, V18, P425, DOI 10.1111/j.1365-2141.1970.tb01456.x; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Ruetz M., 2013, ANGEW CHEM, V125, P11617; Ruetz M, 2017, ANGEW CHEM INT EDIT, V56, P7387, DOI 10.1002/anie.201701583; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; TAYLOR RT, 1967, J BIOL CHEM, V242, P1509; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103	32	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184932	10.1371/journal.pone.0184932	http://dx.doi.org/10.1371/journal.pone.0184932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910388	Green Published, gold			2022-12-26	WOS:000410859200121
J	Schlinzig, T; Johansson, S; Stephansson, O; Hammarstrom, L; Zetterstrom, RH; von Dobeln, U; Cnattingius, S; Norman, M				Schlinzig, Titus; Johansson, Stefan; Stephansson, Olof; Hammarstrom, Lennart; Zetterstrom, Rolf H.; von Dobeln, Ulrika; Cnattingius, Sven; Norman, Mikael			Surge of immune cell formation at birth differs by mode of delivery and infant characteristics-A population-based cohort study	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; CESAREAN-SECTION; NEONATAL-MORTALITY; CHILDHOOD ASTHMA; NEWBORN-INFANT; RISK-FACTORS; DISEASES; GROWTH; AGE; ASSOCIATION	Background Birth by cesarean section is associated with increased risks of immune disorders. We tested whether establishment of immune function at birth relates to mode of delivery, taking other maternal and infant characteristics into account. Methods and findings Using a prospectively collected database, we retrieved information on maternal and infant characteristics of 6,014 singleton infants delivered from February to April 2014 in Stockholm, Sweden, with gestational age >= 35 weeks, Apgar scores >= 7, and without congenital malformations or any neonatal morbidity. We linked our data to blood levels of T-cell receptor excision circles (TREC) and.-deleting recombination excision circles (KREC), determined as part of a neonatal screening program for immune-deficiencies, and representing quantities of newly formed T-and B-lymphocytes. Multivariate logistic regression was used to calculate odds ratios (OR) with 95% confidence intervals (CI) for participants having TREC and KREC levels in the lowest quintile. Multivariate models were adjusted for postnatal age at blood sampling, and included perinatal (mode of delivery, infant sex, gestational age, and birth weight for gestational age), and maternal characteristics (age, parity, BMI, smoking, diabetes, and hypertensive disease). Low TREC was associated with cesarean section before labor (adjusted OR:1.32 [95% CI 1.08-1.62]), male infant sex (aOR:1.60 [1.41-1.83]), preterm birth at 35-36 weeks of gestation (aOR:1.89 [1.21-2.96]) and small for gestational age (aOR:1.67 [1.00-2.79]). Low KREC was associated with male sex (aOR:1.32 [1.15-1.50]), postterm birth at >= 42 weeks (aOR:1.43 [1.13-1.82]) and small for gestational age (aOR:2.89 [1.78-4.69]). Maternal characteristics showed no consistent associations with neonatal levels of either TREC or KREC. Conclusion Cesarean section before labor was associated with lower T-lymphocyte formation, irrespective of maternal characteristics, pregnancy, and neonatal risk factors. The significance of a reduced birth-related surge in lymphocyte formation for future immune function and health remains to be investigated.	[Schlinzig, Titus; Norman, Mikael] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Schlinzig, Titus] Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, Stockholm, Sweden; [Johansson, Stefan] Sodersjukhuset Karolinska Inst SOS, Dept Clin Sci & Educ, Stockholm, Sweden; [Johansson, Stefan; Stephansson, Olof; Cnattingius, Sven] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Hammarstrom, Lennart] Karolinska Inst, Div Clin Immunol, Dept Lab Med, Stockholm, Sweden; [Zetterstrom, Rolf H.; von Dobeln, Ulrika] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden; [Zetterstrom, Rolf H.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [von Dobeln, Ulrika] Karolinska Inst, Div Mol Metab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Norman, Mikael] Karolinska Univ Hosp, Dept Neonatal Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Schlinzig, T (corresponding author), Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.; Schlinzig, T (corresponding author), Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, Stockholm, Sweden.	titus.schlinzig@karolinska.se		Johansson, Stefan/0000-0001-8832-6918; Norman, Mikael/0000-0003-4191-3781; Stephansson, Olof/0000-0003-1528-4563; Zetterstrom, Rolf/0000-0002-3016-0019; Hammarstrom, Lennart/0000-0002-8635-9609	Stockholm County Council; Karolinska Institutet; Swedish Order of Freemasons' Foundation for Children's Welfare; Swedish Research Council [2013-2429]; Epidemiology at Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Order of Freemasons' Foundation for Children's Welfare; Swedish Research Council(Swedish Research CouncilEuropean Commission); Epidemiology at Karolinska Institutet	This project was supported by a regional agreement on clinical research between Stockholm County Council and Karolinska Institutet, and by the Swedish Order of Freemasons' Foundation for Children's Welfare. OS was supported by unrestricted grants from the Swedish Research Council (2013-2429) and the Strategic Research Program in Epidemiology at Karolinska Institutet. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.014; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Bager P, 2012, INFLAMM BOWEL DIS, V18, P857, DOI 10.1002/ibd.21805; Barbera M., 2016, J CLIN IMMUNOL, P1; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Cho CE, 2013, AM J OBSTET GYNECOL, V208, P249, DOI 10.1016/j.ajog.2012.08.009; CNATTINGIUS S, 1995, CANCER EPIDEM BIOMAR, V4, P441; Cook MB, 2008, INT J CANCER, V122, P2600, DOI 10.1002/ijc.23424; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Fischer J, 2015, INFECTION, V43, P399, DOI 10.1007/s15010-015-0791-9; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; GASPARONI A, 1992, BIOL NEONATE, V61, P137; Gitau R, 2001, EUR J OBSTET GYN R B, V98, P14, DOI 10.1016/S0301-2115(01)00298-6; Hakansson S, 2003, CLIN EXP ALLERGY, V33, P757, DOI 10.1046/j.1365-2222.2003.01667.x; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; HERSON VC, 1992, AM J PERINAT, V9, P285, DOI 10.1055/s-2007-994791; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Klein SL, 2016, SEX DIFFERENCES IMMU; Koenig JM, 2005, PEDIATR RES, V57, P424, DOI 10.1203/01.PDR.0000153945.49022.96; Kolokotroni O, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-179; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; LAGERCRANTZ H, 1977, PEDIATR RES, V11, P889, DOI 10.1203/00006450-197708000-00007; Laitinen J, 2004, EUR J CLIN NUTR, V58, P180, DOI 10.1038/sj.ejcn.1601765; Lee BW, 1996, CYTOMETRY, V26, P8, DOI 10.1002/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E; Lee HS, 2016, CIRCULATION S1, V133, pAP186; Lisse IM, 1997, J PEDIATR-US, V130, P77, DOI 10.1016/S0022-3476(97)70313-5; Lynch CD, 2013, AM J OBSTET GYNECOL, V208, P247, DOI 10.1016/j.ajog.2012.12.027; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Marchini G, 2000, ACTA PAEDIATR, V89, P1082, DOI 10.1080/713794557; Marild K, 2012, GASTROENTEROLOGY, V142, P39, DOI 10.1053/j.gastro.2011.09.047; McLaughlin CC, 2009, CANCER CAUSE CONTROL, V20, P289, DOI 10.1007/s10552-008-9243-5; Menacker F, 2006, SEMIN PERINATOL, V30, P235, DOI 10.1053/j.semperi.2006.07.002; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Olearo E, 2012, PRENATAL DIAG, V32, P662, DOI 10.1002/pd.3883; POCIOT F, 1993, DIABETOLOGIA, V36, P870, DOI 10.1007/BF00400364; Romero R, 2013, AM J OBSTET GYNECOL, V208, P243, DOI 10.1016/j.ajog.2012.12.026; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Steinborn A, 1999, CLIN EXP IMMUNOL, V117, P147; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Wirbelauer J, 2010, AM J PERINAT, V27, P819, DOI 10.1055/s-0030-1254547; Ye J, 2015, BJOG INT J OBSTET GY; Yektaei-Karin E, 2007, PEDIAT ALLERG IMM-UK, V18, P643, DOI 10.1111/j.1399-3038.2007.00578.x	53	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184748	10.1371/journal.pone.0184748	http://dx.doi.org/10.1371/journal.pone.0184748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910364	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200089
J	Yang, ZY; Zhang, YL; Jiang, YY; Zhu, FJ; Zeng, LG; Wang, YL; Lei, XQ; Yao, Y; Hou, YJ; Xu, LQ; Xiong, CX; Yang, XL; Hu, K				Yang, Zongying; Zhang, Yiliu; Jiang, Yingying; Zhu, Fengjiao; Zeng, Liugen; Wang, Yulan; Lei, Xiaoqing; Yao, Yi; Hou, Yujie; Xu, Liangqing; Xiong, Chunxian; Yang, Xianle; Hu, Kun			Transcriptional responses in the hepatopancreas of Eriocheir sinensis exposed to deltamethrin	PLOS ONE			English	Article							CHINESE MITTEN CRAB; MONOSEX NILE TILAPIA; PYRETHROID INSECTICIDES; OREOCHROMIS-NILOTICUS; RAINBOW-TROUT; ACETYLCHOLINESTERASE ACTIVITY; SPIROPLASMA-ERIOCHEIRIS; OXIDATIVE STRESS; PROTECTIVE ROLE; GENE DISCOVERY	Deltamethrin is an important pesticide widely used against ectoparasites. Deltamethrin contamination has resulted in a threat to the healthy breeding of the Chinese mitten crab, Eriocheir sinensis. In this study, we investigated transcriptional responses in the hepatopancreas of E. sinensis exposed to deltamethrin. We obtained 99,087,448, 89,086,478, and 100,117,958 raw sequence reads from control 1, control 2, and control 3 groups, and 92,094,972, 92,883,894, and 92,500,828 raw sequence reads from test 1, test 2, and test 3 groups, respectively. After filtering and quality checking of the raw sequence reads, our analysis yielded 79,228,354, 72,336,470, 81,859,826, 77,649,400, 77,194,276, and 75,697,016 clean reads with a mean length of 150 bp from the control and test groups. After deltamethrin treatment, a total of 160 and 167 genes were significantly upregulated and downregulated, respectively. Gene ontology terms "biological process," "cellular component, " and "molecular function" were enriched with respect to cell killing, cellular process, other organism part, cell part, binding, and catalytic. Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes showed that the metabolic pathways were significantly enriched. We found that the CYP450 enzyme system, carboxylesterase, glutathioneS- transferase, and material (including carbohydrate, lipid, protein, and other substances) metabolism played important roles in the metabolism of deltamethrin in the hepatopancreas of E. sinensis. This study revealed differentially expressed genes related to insecticide metabolism and detoxification in E. sinensis for the first time and will help in understanding the toxicity and molecular metabolic mechanisms of deltamethrin in E. sinensis.	[Yang, Zongying; Zhang, Yiliu; Jiang, Yingying; Zhu, Fengjiao; Yang, Xianle; Hu, Kun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China; [Yang, Zongying; Zeng, Liugen; Wang, Yulan; Lei, Xiaoqing; Yao, Yi; Hou, Yujie; Xu, Liangqing; Xiong, Chunxian] Nanchang Acad Agr Sci, Nanchang, Jiangxi, Peoples R China	Shanghai Ocean University	Hu, K (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	khu@shou.edu.cn	Yang, Xian/GVU-9087-2022		National 863 Program of China [2011AA10A216]; Special Fund for Agro-scientific Research in the Public Interest [201203085]; National Natural Resources Platform; Shanghai University Knowledge Service Platform	National 863 Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Resources Platform; Shanghai University Knowledge Service Platform	XLY received the National 863 Program of China [grant number 2011AA10A216], the Special Fund for Agro-scientific Research in the Public Interest [grant number 201203085], and Kun Hu received the National Natural Resources Platform, and the Shanghai University Knowledge Service Platform funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABALIS IM, 1986, J TOXICOL ENV HEALTH, V18, P13, DOI 10.1080/15287398609530844; Abdel-Daim MM, 2015, ECOTOXICOLOGY ENV SA, V111, P46; Abdel-Daim MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072991; ADRIAN RH, 1976, J PHYSIOL-LONDON, V258, P125, DOI 10.1113/jphysiol.1976.sp011410; Amin KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-45; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Banka L, 1997, J ENVIRON SCI HEAL B, V32, P789, DOI 10.1080/03601239709373113; BLOOMQUIST JR, 1986, NEUROTOXICOLOGY, V7, P11; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; BRADBURY SP, 1989, REV ENVIRON CONTAM T, V108, P133; Carcamo JG, 2017, COMP BIOCHEM PHYS C, V191, P129, DOI 10.1016/j.cbpc.2016.10.004; CASIDA JE, 1983, ANNU REV PHARMACOL, V23, P413, DOI 10.1146/annurev.pa.23.040183.002213; Cengiz EI, 2012, ECOTOX ENVIRON SAFE, V80, P381, DOI 10.1016/j.ecoenv.2012.04.012; Ceyhun SB, 2010, COMP BIOCHEM PHYS C, V152, P215, DOI 10.1016/j.cbpc.2010.04.008; Chavez-Mardones J, 2014, AQUACULTURE, V433, P421, DOI 10.1016/j.aquaculture.2014.06.017; CLARK JR, 1989, ENVIRON TOXICOL CHEM, V8, P393, DOI [10.1897/1552-8618(1989)8[393:TOPTMI]2.0.CO;2, 10.1002/etc.5620080505]; Dinu D, 2010, ARCH ENVIRON CON TOX, V58, P757, DOI 10.1007/s00244-009-9401-0; Djami-Tchatchou AT, 2012, J PHYTOPATHOL, V160, P449, DOI 10.1111/j.1439-0434.2012.01925.x; EDWARDS R, 1986, TOXICOL APPL PHARM, V84, P512, DOI 10.1016/0041-008X(86)90256-5; El-Sayed YS, 2007, ENVIRON TOXICOL PHAR, V24, P212, DOI 10.1016/j.etap.2007.05.006; El-Sayed YS, 2008, BASIC CLIN PHARMACOL, V102, P293, DOI 10.1111/j.1742-7843.2007.00157.x; Ensibi C, 2013, ENVIRON TOXICOL PHAR, V36, P384, DOI 10.1016/j.etap.2013.04.019; Erdogan O, 2011, GENE, V484, P13, DOI 10.1016/j.gene.2011.05.026; Feld M, 2005, BEHAV BRAIN RES, V158, P251, DOI 10.1016/j.bbr.2004.09.005; FORSHAW PJ, 1990, NEUROPHARMACOLOGY, V29, P75, DOI 10.1016/0028-3908(90)90086-7; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Guardiola FA, 2014, FISH SHELLFISH IMMUN, V36, P120, DOI 10.1016/j.fsi.2013.10.020; HAYA K, 1989, ENVIRON TOXICOL CHEM, V8, P381, DOI 10.1002/etc.5620080504; He L, 2012, PLOS ONE, V7; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Huang SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09116; Tu HT, 2012, CHEMOSPHERE, V86, P83, DOI 10.1016/j.chemosphere.2011.09.022; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Kan Y, 2012, ENVIRON TOXICOL PHAR, V34, P170, DOI 10.1016/j.etap.2012.03.009; L'Hotellier M., 1986, 1986 British Crop Protection Conference. Pests and diseases. Proceedings of a conference held at Brighton Metropole, England, November 17-20, 1986. Vol. 3., P1109; LAWRENCE LJ, 1985, NEUROTOXICOLOGY, V6, P87; Li XD, 2007, AQUACULTURE, V272, P361, DOI 10.1016/j.aquaculture.2007.08.029; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Lin MC, 2012, PEPTIDES, V38, P197, DOI 10.1016/j.peptides.2012.10.003; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; [马阿妮 Ma Ani], 2010, [生命科学, Chinese Bulletin of Life Sciences], V22, P978; Manunza B, 1997, CARBOHYD RES, V300, P89, DOI 10.1016/S0008-6215(97)00028-1; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Milam CD, 2000, ARCH ENVIRON CON TOX, V39, P324, DOI 10.1007/s002440010111; Olsvik PA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-48; Olsvik PA, 2014, COMP BIOCHEM PHYS C, V162, P23, DOI 10.1016/j.cbpc.2014.03.005; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Parvez S, 2006, CHEMOSPHERE, V62, P1324, DOI 10.1016/j.chemosphere.2005.07.025; Paul EA, 2006, B ENVIRON CONTAM TOX, V76, P614, DOI 10.1007/s00128-006-0964-4; Prasanthi K, 2005, FOOD CHEM TOXICOL, V43, P299, DOI 10.1016/j.fct.2004.10.005; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003; Ried C, 1996, J BIOL CHEM, V271, P28120, DOI 10.1074/jbc.271.45.28120; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Sakin F, 2011, FRESEN ENVIRON BULL, V20, P2806; SMITH TM, 1986, RESIDUE REV, V97, P93; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Song LS, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0112-y; TALESA V, 1992, COMP BIOCHEM PHYS C, V101, P499, DOI 10.1016/0742-8413(92)90077-K; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tu HT, 2009, ECOTOX ENVIRON SAFE, V72, P1463, DOI 10.1016/j.ecoenv.2009.04.008; Velisek J, 2007, ENVIRON TOXICOL PHAR, V23, P297, DOI 10.1016/j.etap.2006.11.006; Villarini M, 1998, TOXICOLOGY, V130, P129, DOI 10.1016/S0300-483X(98)00097-3; Wheelock CE, 2006, ENVIRON TOXICOL CHEM, V25, P973, DOI 10.1897/05-334R.1; World Health Organization (WHO), 1990, DEL ENV HLTH CRIT; Yonar ME, 2011, PESTIC BIOCHEM PHYS, V99, P226, DOI 10.1016/j.pestbp.2010.12.008; Zhu FJ, 2017, CAN J FISH AQUAT SCI, V74, P435, DOI 10.1139/cjfas-2016-0041	74	12	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184581	10.1371/journal.pone.0184581	http://dx.doi.org/10.1371/journal.pone.0184581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910412	gold, Green Submitted, Green Published			2022-12-26	WOS:000410859200064
J	Johansson, F; Halvarsson, P; Mikolajewski, DJ; Hoglund, J				Johansson, Frank; Halvarsson, Peter; Mikolajewski, Dirk J.; Hoeglund, Jacob			Phylogeography and larval spine length of the dragonfly Leucorhinia dubia in Europe	PLOS ONE			English	Article							LEUCORRHINIA-DUBIA; MORPHOLOGICAL DEFENSE; PREDATION; TRAIT; FISH; STICKLEBACKS; MANIPULATION; EVOLUTION; ODONATA; SHAPE	Presence or absence of predators selects for different kind of morphologies. Hence, we expect variation in traits that protect against predators to vary over geographical areas where predators vary in past and present abundance. Abdominal larval spines in dragonfly larvae provide protection against fish predators. We studied geographical variation in larval spine length of the dragonfly Leucorrhinia dubia across Western Europe using a phylogenetic approach. Larvae were raised in a common garden laboratory experiment in the absence of fish predators. Results show that larvae from northern Europe (Sweden and Finland) had significantly longer larval spines compared to larvae from western and central Europe. A phylogeny based on SNP data suggests that short larval spines is the ancestral stage in the localities sampled in this study, and that long spines have evolved in the Fenno-Scandian clade. The role of predators in shaping the morphological differences among the sampled localities is discussed.	[Johansson, Frank; Halvarsson, Peter; Hoeglund, Jacob] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Mikolajewski, Dirk J.] Free Univ Berlin, Inst Biol, Berlin, Germany	Uppsala University; Free University of Berlin	Johansson, F (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	frank.johansson@ebc.uu.se	Halvarsson, Peter/GWC-2612-2022	Halvarsson, Peter/0000-0002-6940-5634; Johansson, Frank/0000-0002-2302-2603	Swedish Research Council; Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [SNIC b2015095]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)	This work was supported by The Swedish Research Council and the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under Project SNIC b2015095 to Dr. Frank Johansson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; [Anonymous], 2014, TRACER V1 6; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; BENKE AC, 1970, ECOLOGY, V51, P328, DOI 10.2307/1933673; Bouckaert R. R., 2014, DENSITREE 2 SEEING T; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boudot J. -P., 2015, ATLAS EUROPEAN DRAGO; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; COOPER SM, 1986, OECOLOGIA, V68, P446, DOI 10.1007/BF01036753; Damm S, 2012, ORG DIVERS EVOL, V12, P267, DOI 10.1007/s13127-012-0079-1; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; EDMUNDS M, 1974, DEFENCE ANIMALS; Ge DY, 2011, P ROY SOC B-BIOL SCI, V278, P2133, DOI 10.1098/rspb.2010.1500; HAVEL JE, 1984, LIMNOL OCEANOGR, V29, P487, DOI 10.4319/lo.1984.29.3.0487; Hovmoller R, 2004, MOL PHYLOGENET EVOL, V30, P653, DOI 10.1016/S1055-7903(03)00226-4; JOHANSSON F, 1994, OECOLOGIA, V100, P74, DOI 10.1007/BF00317132; Johansson F, 2017, BIOL J LINN SOC, V121, P294, DOI 10.1093/biolinnean/blw033; Johansson F, 2003, J FRESHWATER ECOL, V18, P415, DOI 10.1080/02705060.2003.9663977; Johansson F, 2002, CAN J ZOOL, V80, P199, DOI 10.1139/Z01-225; Johansson F, 2002, CAN J ZOOL, V80, P944, DOI 10.1139/Z02-073; Johansson Frank, 2008, P127; Kishida O, 2007, ECOLOGY, V88, P1948, DOI 10.1890/07-0132.1; Kognitz S., 1998, LIBELLEN IN BAYERN; Large SI, 2013, OECOLOGIA, V171, P961, DOI 10.1007/s00442-012-2450-5; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McCauley SJ, 2007, OIKOS, V116, P121, DOI 10.1111/j.2006.0030-1299.15105.x; Mikolajewski DJ, 2010, EVOLUTION, V64, P3327, DOI 10.1111/j.1558-5646.2010.01078.x; Mikolajewski DJ, 2006, EVOLUTION, V60, P1306; Mikolajewski DJ, 2004, EVOL ECOL RES, V6, P619; Mikolajewski DJ, 2004, BEHAV ECOL, V15, P614, DOI 10.1093/beheco/arh061; PAJUNEN V. ILMARI, 1962, ANN ZOOL SOC ZOOL BOT FENNICAE VANAMO", V24, P1; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; Petrin Z, 2010, EVOL ECOL, V24, P1003, DOI 10.1007/s10682-010-9361-x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Walker JA, 2000, J ZOOL, V252, P293; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wildermuth H, 2005, LIBELLEN SCHWEIZ; Wittwer T, 2010, INSECT CONSERV DIVER, V3, P124, DOI 10.1111/j.1752-4598.2010.00083.x	47	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184596	10.1371/journal.pone.0184596	http://dx.doi.org/10.1371/journal.pone.0184596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902918	Green Submitted, gold, Green Published			2022-12-26	WOS:000410669200048
J	Worm, M; Kirschbaum, F; von der Emde, G				Worm, Martin; Kirschbaum, Frank; von der Emde, Gerhard			Social interactions between live and artificial weakly electric fish: Electrocommunication and locomotor behavior of Mormyrus rume proboscirostris towards a mobile dummy fish	PLOS ONE			English	Article							GNATHONEMUS-PETERSII MORMYRIDAE; POLLIMYRUS-ISIDORI CUVIER; ORGAN DISCHARGE PATTERNS; AGONISTIC BEHAVIOR; VALENCIENNES MORMYRIDAE; ELECTRORECEPTOR ORGANS; SPECIES RECOGNITION; SIGNALING BEHAVIOR; ECHO RESPONSE; LATERAL LINE	Mormyrid weakly electric fish produce short, pulse-type electric organ discharges for actively probing their environment and to communicate with conspecifics. Animals emit sequences of pulse-trains that vary in overall frequency and temporal patterning and can lead to time-locked interactions with the discharge activity of other individuals. Both active electrolocation and electrocommunication are additionally accompanied by stereotypical locomotor patterns. However, the concrete roles of electrical and locomotor patterns during social interactions in mormyrids are not well understood. Here we used a mobile fish dummy that was emitting different types of electrical playback sequences to study following behavior and interaction patterns (electrical and locomotor) between individuals of weakly electric fish. We confronted single individuals of Mormyrus rume proboscirostris with a mobile dummy fish designed to attract fish from a shelter and recruit them into an open area by emitting electrical playbacks of natural discharge sequences. We found that fish were reliably recruited by the mobile dummy if it emitted electrical signals and followed it largely independently of the presented playback patterns. While following the dummy, fish interacted with it spatially by displaying stereotypical motor patterns, as well as electrically, e.g. through discharge regularizations and by synchronizing their own discharge activity to the playback. However, the overall emission frequencies of the dummy were not adopted by the following fish. Instead, social signals based on different temporal patterns were emitted depending on the type of playback. In particular, double pulses were displayed in response to electrical signaling of the dummy and their expression was positively correlated with an animals' rank in the dominance hierarchy. Based on additional analysis of swimming trajectories and stereotypical locomotor behavior patterns, we conclude that the reception and emission of electrical communication signals play a crucial role in mediating social interactions in mormyrid weakly electric fish.	[Worm, Martin; von der Emde, Gerhard] Univ Bonn, Inst Zool, Dept Neuroethol Sensory Ecol, Bonn, Germany; [Kirschbaum, Frank] Humboldt Univ, Fac Life Sci, Biol & Ecol Fishes, Berlin, Germany	University of Bonn; Humboldt University of Berlin	Worm, M (corresponding author), Univ Bonn, Inst Zool, Dept Neuroethol Sensory Ecol, Bonn, Germany.	mworm@uni-bonn.de			Deutsche Forschungsgemeinschaft; Graduiertenkolleg Bionik [GR1572]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg Bionik	This study was funded by the Deutsche Forschungsgemeinschaft (wwv.dfg.de), Graduiertenkolleg Bionik (GR1572) to MW and GvdE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2013, BEHAV PROCESS, V100, P9, DOI 10.1016/j.beproc.2013.07.010; Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Altringham JD, 2003, SENSORY ECOLOGY COMM; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Arnegard ME, 2005, P ROY SOC B-BIOL SCI, V272, P1305, DOI 10.1098/rspb.2005.3101; Baier B, 2007, BEHAVIOUR, V144, P115, DOI 10.1163/156853907779947409; Baker CA, 2013, J EXP BIOL, V216, P2365, DOI 10.1242/jeb.082289; BASS AH, 1983, SCIENCE, V220, P971, DOI 10.1126/science.6844924; BAUER R, 1972, EXPERIENTIA, V28, P669, DOI 10.1007/BF01944968; BAUER R, 1974, BEHAVIOUR, V50, P306, DOI 10.1163/156853974X00507; BELL CC, 1989, J COMP NEUROL, V286, P391, DOI 10.1002/cne.902860309; BELL CC, 1989, J NEUROSCI, V9, P1029; BELL CC, 1974, J COMP PHYSIOL, V92, P201, DOI 10.1007/BF00694506; Bennett M.V.L., 1971, P493; Bohn Kirsten M., 2015, Journal of the Acoustical Society of America, V137, P2249, DOI 10.1121/1.4920204; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Butail S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076123; Carlson BA, 2004, ANIM BEHAV, V68, P867, DOI 10.1016/j.anbehav.2003.10.031; Carlson BA, 2004, J EXP BIOL, V207, P1073, DOI 10.1242/jeb.00851; Carlson BA, 2002, J PHYSIOLOGY-PARIS, V96, P405, DOI 10.1016/S0928-4257(03)00019-6; Carlson BA, 2000, HORM BEHAV, V38, P177, DOI 10.1006/hbeh.2000.1613; Carlson BA, 2016, J EXP BIOL, V219, P31, DOI 10.1242/jeb.127720; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; Ciali S, 1997, J FISH BIOL, V50, P1074, DOI 10.1006/jfbi.1996.0372; CROCKETT DP, 1986, J COMP PSYCHOL, V100, P3, DOI 10.1037/0735-7036.100.1.3; DERBIN C, 1968, J ULTRA MOL STRUCT R, V22, P469, DOI 10.1016/S0022-5320(68)90035-X; Donati E, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/6/066009; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; Gebhardt K, 2012, J FISH BIOL, V81, P2235, DOI 10.1111/j.1095-8649.2012.03448.x; Gebhardt K., 2012, THESIS; Gebhardt K, 2012, BEHAVIOUR, V149, P623, DOI 10.1163/156853912X649911; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hanika S, 2005, BEHAVIOUR, V142, P145, DOI 10.1163/1568539053627677; HARDER W, 1968, Z VERGL PHYSIOL, V59, P272; HEILIGENBERG W, 1976, J COMP PHYSIOL, V109, P357, DOI 10.1007/BF00663615; Hofmann V, 2013, J EXP BIOL, V216, P2487, DOI 10.1242/jeb.082420; Hollmann M, 2008, J ZOOL, V276, P149, DOI 10.1111/j.1469-7998.2008.00465.x; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; HOPKINS CD, 1981, AM ZOOL, V21, P211; HOPKINS CD, 1974, AM SCI, V62, P426; HOPKINS CD, 1988, ANNU REV NEUROSCI, V11, P497, DOI 10.1146/annurev.ne.11.030188.002433; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kareklas K, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0154-0; Khait V, 2009, J FISH BIOL, V75, P490, DOI 10.1111/j.1095-8649.2009.02250.x; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; KRAMER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P61, DOI 10.1007/BF00302561; KRAMER B, 1979, BEHAV ECOL SOCIOBIOL, V6, P67, DOI 10.1007/BF00293246; KRAMER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P45, DOI 10.1007/BF00299952; KRAMER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P425, DOI 10.1007/BF00299402; KRAMER B, 1974, J COMP PHYSIOL, V93, P203, DOI 10.1007/BF00607000; KRAMER B, 1994, ANIM BEHAV, V48, P435, DOI 10.1006/anbe.1994.1257; Kreysing M, 2012, SCIENCE, V336, P1700, DOI 10.1126/science.1218072; Landgraf Tim, 2014, Biomimetic and Biohybrid Systems. Third International Conference, Living Machines 2014. Proceedings. LNCS: 8608, P178; Landgraf T, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/1/015001; LUCKER H, 1981, BEHAV ECOL SOCIOBIOL, V9, P103, DOI 10.1007/BF00293581; Machnik P, 2011, J ETHOL, V29, P131, DOI 10.1007/s10164-010-0235-z; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; MOLLER P, 1980, TRENDS NEUROSCI, V3, P105, DOI 10.1016/0166-2236(80)90041-7; MOLLER P, 1976, SCIENCE, V193, P697, DOI 10.1126/science.948747; MOLLER P, 1989, ETHOLOGY, V82, P177; MOLLER P, 1973, ANIM BEHAV, V21, P501, DOI 10.1016/S0003-3472(73)80010-7; MOLLER P, 1982, ANIM BEHAV, V30, P641, DOI 10.1016/S0003-3472(82)80134-6; MOLLER P, 1970, ANIM BEHAV, V18, P768, DOI 10.1016/0003-3472(70)90026-6; Moller P, 1995, ELECT FISHES HIST BE, P17; Orlov AA, 2009, DOKLADY BIOL SCI; Phamduy P, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036021; PITCHER T, 1979, ANIM BEHAV, V27, P126, DOI 10.1016/0003-3472(79)90133-7; Pohlmann K, 2001, P NATL ACAD SCI USA, V98, P7371, DOI 10.1073/pnas.121026298; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077589; Riehl, 1995, FORTPFLANZUNGSBIOLOG, P81; Ruberto T, 2017, J EXP ANAL BEHAV, V107, P279, DOI 10.1002/jeab.247; Ruberto T, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160505; RUSSELL CJ, 1974, J COMP PHYSIOL, V92, P181, DOI 10.1007/BF00694505; SCHLUGER JH, 1987, J EXP BIOL, V130, P359; Schuster S, 2001, J EXP BIOL, V204, P1401; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; SZABO T, 1965, J MORPHOL, V117, P229, DOI 10.1002/jmor.1051170208; Terleph TA, 2004, J FISH BIOL, V64, P1373, DOI 10.1111/j.0022-1112.2004.00401.x; TEYSSEDRE C, 1986, BEHAV PROCESS, V12, P77, DOI 10.1016/0376-6357(86)90073-2; Tinbergen N., 1948, Wilson Bulletin, V60, P6; TOERRING MJ, 1979, BEHAV ECOL SOCIOBIOL, V4, P369, DOI 10.1007/BF00303243; Tyack PL, 2000, CETACEAN SOCIETIES, P270; von der Emde G, 2007, J EXP BIOL, V210, P3082, DOI 10.1242/jeb.005694; von der Emde G, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00026; von der Emde G, 2008, J PHYSIOL-PARIS, V102, P279, DOI 10.1016/j.jphysparis.2008.10.017; VONDEREMDE G, 1992, ETHOLOGY, V92, P177; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032411; Witzany G., 2013, BIOCOMMUNICATION ANI; Worm Martin, 2014, Biomimetic and Biohybrid Systems. Third International Conference, Living Machines 2014. Proceedings. LNCS: 8608, P446	97	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184622	10.1371/journal.pone.0184622	http://dx.doi.org/10.1371/journal.pone.0184622			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902915	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200050
J	Al-Barrak, L; Kanjo, E; Younis, EMG				Al-barrak, Lulwah; Kanjo, Eiman; Younis, Eman M. G.			NeuroPlace: Categorizing urban places according to mental states	PLOS ONE			English	Article							DIRECTED ATTENTION; BRAIN; SYSTEMS; STRESS; EEG	Urban spaces have a great impact on how people's emotion and behaviour. There are number of factors that impact our brain responses to a space. This paper presents a novel urban place recommendation approach, that is based on modelling in-situ EEG data. The research investigations leverages on newly affordable Electroencephalogram (EEG) headsets, which has the capability to sense mental states such as meditation and attention levels. These emerging devices have been utilized in understanding how human brains are affected by the surrounding built environments and natural spaces. In this paper, mobile EEG headsets have been used to detect mental states at different types of urban places. By analysing and modelling brain activity data, we were able to classify three different places according to the mental state signature of the users, and create an association map to guide and recommend people to therapeutic places that lessen brain fatigue and increase mental rejuvenation. Our mental states classifier has achieved accuracy of (%90.8). NeuroPlace breaks new ground not only as a mobile ubiquitous brain monitoring system for urban computing, but also as a system that can advise urban planners on the impact of specific urban planning policies and structures. We present and discuss the challenges in making our initial prototype more practical, robust, and reliable as part of our on-going research. In addition, we present some enabling applications using the proposed architecture.	[Al-barrak, Lulwah] Univ Bristol, Comp Dept, Bristol, Avon, England; [Kanjo, Eiman; Younis, Eman M. G.] Nottingham Trent Univ, Dept Comp & Technol, Nottingham, England; [Younis, Eman M. G.] Menia Univ, Fac Comp & Informat, Al Minya, Egypt	University of Bristol; Nottingham Trent University; Egyptian Knowledge Bank (EKB); Minia University	Kanjo, E (corresponding author), Nottingham Trent Univ, Dept Comp & Technol, Nottingham, England.	eiman.kanjo@ntu.ac.uk	Kanjo, Eiman/AAX-4677-2020	Kanjo, Eiman/0000-0002-1720-0661; Younis, Eman Mamdoh Gmal Eldeen/0000-0003-2778-4231	King Saud University	King Saud University(King Saud University)	This work was supported by King Saud University.	Al-Barrak L., 2013, P 4 AUG HUM INT C, P186; Al-Dowaihi D., 2013, AL DOW COMP MED APPL; Al-Husain L., 2013, SENSE SPACE MAPPING, P1321; Alajmi N., 2013, 5 INT WORKSH AFF INT; Alajmi N, 2013, INT CONF AFFECT, P745, DOI 10.1109/ACII.2013.138; Anderson TW., 2003, INTRO MULTIVARIATE S, V3; [Anonymous], 2009, EMOTIV SYSTEMS; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Campbell A. T., 2010, P 2 ACM SIGCOMM WORK; Carletta J., 1996, COMPUTATIONAL LINGUI, V22, P149; Carrico L., 2012, P 3 AUG HUM INT C ME; Chamberlain A, 2014, PERS UBIQUIT COMPUT, V18, P1775, DOI 10.1007/s00779-013-0756-x; Consolvo S., 2008, P SIGCHI C HUM FACT; Cresswell T., 2004, PLACE INTRO; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; Dodds S., 2011, PLOS ONE, V6; FERRI FJ, 1994, MACH INTELL PATT REC, V16, P403; Girden E, 1991, REPEATED MEASURES QU; Golbeck J., 2011, INT C PRIV SEC RISK; Hama Y, 2001, JPN PSYCHOL RES, V43, P218, DOI 10.1111/1468-5884.00179; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Kanjo E, 2018, INFORM FUSION, V40, P18, DOI 10.1016/j.inffus.2017.05.005; Kanjo E, 2015, PERS UBIQUIT COMPUT, V19, P1197, DOI 10.1007/s00779-015-0842-3; Kanjo E, 2010, MOBILE NETW APPL, V15, P562, DOI 10.1007/s11036-009-0217-y; Kanjo E, 2009, IEEE PERVAS COMPUT, V8, P50, DOI 10.1109/MPRV.2009.79; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kohlleppel T, 2002, HORTTECHNOLOGY, V12, P489, DOI 10.21273/HORTTECH.12.3.489; Lansdall-Welfare T., 2012, P 21 INT C COMP WWW; Lathia N., 2013, IEEE PERVASIVE COMPU, V2013; Lisetti CL, 2004, EURASIP J APPL SIG P, V2004, P1672, DOI 10.1155/S1110865704406192; Mawass N. El, 2013, SUPERMARKET STRESS M, P1043; Michael S., 2004, P WAMES; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Mostow J, 2011, ARTIFICIAL INTELLIGE; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; Oralhan Z, 2016, IETE J RES, V62, P795, DOI 10.1080/03772063.2016.1176543; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Purver M., 2012, P EACL AV FRANC; Reddy S, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1689239.1689243; Relph E., 1976, PLACE PLACELESSNESS; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Rish I., 2001, IJCAI 2001 WORKSH EM; Rosenbaum MS, 2009, J SERV MANAGE, V20, P173, DOI 10.1108/09564230910952762; Seigneur J-M, 2011, P 2 AUGM HUM INT C; Seo HS, 2008, J AGR FOOD CHEM, V56, P4665, DOI 10.1021/jf8001137; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Su L, 2013, MIND GARDEN BRAIN BO; Thrift N., 2003, KEY CONCEPTS GEOGRAP, P95; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Wang Q, 2010, CYB CW 2010 INT C; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wright F, 2010, EMOTIONAL INSTANT ME; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yazdani N., 2010, P 24 BCS INT SPEC GR; Zappi P., 2012, P 11 ACM IEEE C INF, P16	57	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183890	10.1371/journal.pone.0183890	http://dx.doi.org/10.1371/journal.pone.0183890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG6AR	28898244	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000410449500008
J	Fukada, I; Ito, Y; Kobayashi, K; Shibayama, T; Takahashi, S; Horii, R; Akiyama, F; Iwase, T; Ohno, S				Fukada, Ippei; Ito, Yoshinori; Kobayashi, Kokoro; Shibayama, Tomoko; Takahashi, Shunji; Horii, Rie; Akiyama, Futoshi; Iwase, Takuji; Ohno, Shinji			The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel	PLOS ONE			English	Article							RANDOMIZED PHASE-III; TAXANES; TAXOL; PHARMACOKINETICS; ASSOCIATION; TRIAL; RISK	Background Paclitaxel plays a central role in chemotherapy for breast cancer. Peripheral neuropathy, a well-known toxicity with paclitaxel, may be of interest in predicting the efficacy of paclitaxel therapy for patients with metastatic breast cancer. We performed a retrospective analysis assessing whether the early occurrence of peripheral neuropathy (EPN) was a predictive marker for better efficacy in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel. Patients and methods Between January 2000 and August 2008, we examined the records of 168 patients with metastatic breast cancer treated with paclitaxel in our hospital. EPN was defined as a symptom of Grade 2 or more during first three months of treatment. The overall response rate (ORR) and time to treatment failure (TTF) in each group were analyzed retrospectively. Results Of 168 patients with metastatic breast cancer who were treated with paclitaxel, EPN was documented in 101 patients (60.1%). The clinical benefit rate (CR, PR, and SD >= 6 months) was 72.3% in the EPN group and 49.3% in the non-EPN group (p = 0.002). The TTF of the EPN group (median 11.2 months, 95% CI: 9.5-12.9) was significantly longer than that of the non-EPN group (5.7 months, 95% CI: 4.6-6.8) (p<0.001). Multivariate analysis demonstrated that EPN (p<0.001), dose intensity of less than 70% (p<0.001), and the history of microtubule agents (p = 0.001) were the significant favorable prognostic factors for TTF. Conclusion The early onset of peripheral neuropathy might be a robust predictor for TTF in patients with metastatic breast cancer treated with paclitaxel.	[Fukada, Ippei; Ito, Yoshinori; Kobayashi, Kokoro; Shibayama, Tomoko] Japanese Fdn Canc Res, Breast Oncol Ctr, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan; [Takahashi, Shunji] Japanese Fdn Canc Res, Dept Med Oncol, Canc Inst Hosp, Tokyo, Japan; [Horii, Rie] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Canc Inst, Dept Pathol, Tokyo, Japan; [Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Dept Breast Surg Oncol, Tokyo, Japan; [Ohno, Shinji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Fukada, I (corresponding author), Japanese Fdn Canc Res, Breast Oncol Ctr, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan.	ippei.fukada@jfcror.jp						Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Fukada I, 2016, ONCOL LETT, V12, P663, DOI 10.3892/ol.2016.4627; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; HARRIS JW, 1994, CANCER RES, V54, P4026; Hershman DL, 2016, J CLIN ONCOL, V34, P3014, DOI 10.1200/JCO.2015.66.2346; Hertz DL, 2013, ANN ONCOL, V24, P1472, DOI 10.1093/annonc/mdt018; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Kumar G, 1995, CANCER CHEMOTH PHARM, V36, P129; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Mielke S, 2005, ANTICANCER RES, V25, P4423; Mielke S, 2005, CLIN CANCER RES, V11, P4843, DOI 10.1158/1078-0432.CCR-05-0298; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; RAHMAN A, 1994, CANCER RES, V54, P5543; Rivera E, 2015, CANCER CHEMOTH PHARM, V75, P659, DOI 10.1007/s00280-014-2607-5; Schneider BP, 2015, CLIN CANCER RES, V21, P5082, DOI 10.1158/1078-0432.CCR-15-0586; Schneider BP, 2012, J CLIN ONCOL, V30, P3051, DOI 10.1200/JCO.2011.39.8446; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA	20	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184322	10.1371/journal.pone.0184322	http://dx.doi.org/10.1371/journal.pone.0184322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898275	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500022
J	Larmonie, NSD; Arentsen-Peters, TCJM; Obulkasim, A; Valerio, D; Sonneveld, E; Danen-van Oorschot, AA; de Haas, V; Reinhardt, D; Zimmermann, M; Trka, J; Baruchel, A; Pieters, R; van den Heuvel-Eibrink, MM; Zwaan, CM; Fornerod, M				Larmonie, N. S. D.; Arentsen-Peters, T. C. J. M.; Obulkasim, A.; Valerio, D.; Sonneveld, E.; Danen-van Oorschot, A. A.; de Haas, V.; Reinhardt, D.; Zimmermann, M.; Trka, J.; Baruchel, A.; Pieters, R.; van den Heuvel-Eibrink, M. M.; Zwaan, C. M.; Fornerod, M.			MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; EXPRESSION; MUTATIONS; CELLS; MAINTENANCE; RESISTANCE; CHILDREN; PATTERNS; PROGRAMS	In acute myeloid leukemia (AML), specific genomic aberrations induce aberrant methylation, thus directly influencing the transcriptional programing of leukemic cells. Therefore, therapies targeting epigenetic processes are advocated as a promising therapeutic tool for AML treatment. However, to develop new therapies, a comprehensive understanding of the mechanism(s) driving the epigenetic changes as a result of acquired genetic abnormalities is necessary. This understanding is still lacking. In this study, we performed genome-wide CpG-island methylation profiling on pediatric AML samples. Six differentially methylated genomic regions within two genes, discriminating inv(16)(p13;q22) from non-inv(16) pediatric AML samples, were identified. All six regions had a hypomethylated phenotype in inv(16) AML samples, and this was most prominent at the regions encompassing the meningioma (disrupted in balanced translocation) 1 (MN1) oncogene. MN1 expression primarily correlated with the methylation level of the 3' end of the MN1 exon-1 locus. Decitabine treatment of different cell lines showed that induced loss of methylation at the MN1 locus can result in an increase of MN1 expression, indicating that MN1 expression is coregulated by DNA methylation. To investigate this methylation-associated mechanism, we determined the expression of DNA methyltransferases in inv(16) AML. We found that DNMT3B expression was significantly lower in inv(16) samples. Furthermore, DNMT3B expression correlated negatively with MN1 expression in pediatric AML samples. Importantly, depletion of DNMT3B impaired remethylation efficiency of the MN1 exon-1 locus in AML cells after decitabine exposure. These findings identify DNMT3B as an important coregulator of MN1 methylation. Taken together, this study shows that the methylation level of the MN1 exon-1 locus regulates MN1 expression levels in inv(16) pediatric AML. This methylation level is dependent on DNMT3B, thus suggesting a role for DNMT3B in leukemogenesis in inv(16) AML, through MN1 methylation regulation.	[Larmonie, N. S. D.; Arentsen-Peters, T. C. J. M.; Obulkasim, A.; Valerio, D.; Danen-van Oorschot, A. A.; Zwaan, C. M.; Fornerod, M.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Sonneveld, E.; de Haas, V.] DCOG, The Hague, Netherlands; [Reinhardt, D.; Zimmermann, M.] Med High Sch, Dept Pediat Oncol Hematol, Hannover, Germany; [Trka, J.] Charles Univ Prague, Med Sch 2, Pediat Hematol Oncol, Prague, Czech Republic; [Baruchel, A.] CHU Paris, Hop Robert Debre, Paris, France; [Pieters, R.; van den Heuvel-Eibrink, M. M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Dutch Childhood Oncology Group; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Fornerod, M (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol & Hematol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	m.fornerod@erasmusmc.nl	Reinhardt, Dirk/N-7003-2016; Trka, Jan/Y-4820-2019	Reinhardt, Dirk/0000-0002-7027-4483; Fornerod, Maarten/0000-0002-6166-3030	Children Cancer Free Foundation (KIKA) [64]	Children Cancer Free Foundation (KIKA)	We acknowledge L Verboon, NJ Basheer and JM Boer for technical support and advice. This project was supported by grants from the Children Cancer Free Foundation (KIKA), project no. 64, entitled: Aberrant signal transduction profiling in pediatric AML.	Alvarez S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012197; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P221, DOI 10.3324/haematol.2010.029660; Bernt KM, 2011, HEMATOL-AM SOC HEMAT, P354, DOI 10.1182/asheducation-2011.1.354; Bullinger L, 2010, CANCER CELL, V17, P1, DOI 10.1016/j.ccr.2009.12.033; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chowdhury B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09281; Coombes KR, 2009, CLASSES METHODS CLAS; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Duymich CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11453; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; FOA P, 1982, CELL TISSUE KINET, V15, P399, DOI 10.1111/j.1365-2184.1982.tb01057.x; Gaidzik VI, 2012, J CLIN ONCOL, V30, P1350, DOI 10.1200/JCO.2011.39.2886; Grosveld GC, 2007, BLOOD CELL MOL DIS, V39, P336, DOI 10.1016/j.bcmd.2007.06.009; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Hollink IHIM, 2009, BLOOD, V113, P5951, DOI 10.1182/blood-2008-09-177949; Im AP, 2014, LEUKEMIA, V28, P1774, DOI 10.1038/leu.2014.124; Inaba H, 2008, CANCER, V113, P522, DOI 10.1002/cncr.23581; KASPERS GJL, 1994, BRIT J CANCER, V70, P1047, DOI 10.1038/bjc.1994.446; Kastl L, 2010, INT J ONCOL, V36, P1235, DOI 10.3892/ijo_00000607; Kiyoi H, 1997, LEUKEMIA, V11, P1447, DOI 10.1038/sj.leu.2400756; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Larmonie NSD, 2014, GENES IMMUN, V15, P72, DOI 10.1038/gene.2013.63; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Mandoli A, 2014, LEUKEMIA, V28, P770, DOI 10.1038/leu.2013.257; Mitschka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11126; Moore AS, 2013, LEUKEMIA, V27, P1451, DOI 10.1038/leu.2013.106; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Qu XY, 2015, EPIGENETICS-US, V10, P526, DOI 10.1080/15592294.2015.1048060; R Core Team, 2013, LANG ENV STAT COMP; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saied MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033213; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Walton EL, 2011, EPIGENETICS-US, V6, P1373, DOI 10.4161/epi.6.11.17978; Wilop S, 2011, BRIT J HAEMATOL, V155, P65, DOI 10.1111/j.1365-2141.2011.08801.x; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Yan Pearlly S, 2002, Methods Mol Biol, V200, P87; Zwaan CM, 2015, J CLIN ONCOL, V33, P2949, DOI 10.1200/JCO.2015.62.8289	53	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					107	115		10.1038/onc.2017.293	http://dx.doi.org/10.1038/onc.2017.293			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28892045				2022-12-26	WOS:000422625000011
J	Zhang, WW; Xu, J; Fang, HH; Tang, L; Chen, WW; Sun, Q; Zhang, Q; Yang, F; Sun, ZJ; Cao, LL; Wang, YC; Guan, XX				Zhang, Wenwen; Xu, Jing; Fang, Hehui; Tang, Lin; Chen, Weiwei; Sun, Qian; Zhang, Qun; Yang, Fang; Sun, Zijia; Cao, Lulu; Wang, Yucai; Guan, Xiaoxiang			Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling	FASEB JOURNAL			English	Article						tumor microenvironment; chemokine; migration; invasion; targeting therapy	PLASMINOGEN-ACTIVATOR INHIBITOR-1; GESTATIONAL DIABETES-MELLITUS; TUMOR ANGIOGENESIS; SECRETED FACTORS; PHENOTYPE; DISEASE; MICROENVIRONMENT; EXPRESSION; APOPTOSIS; PLASMA	Endothelial cells (ECs) in the tumor microenvironment have been reported to play a more active role in solid tumor growth and metastatic dissemination than simply providing the physical structure to form conduits for blood flow; however, the involvement of ECs in the process of triple-negative breast cancer (TNBC) metastasis has not been addressed. Here, we demonstrate that ECs-when mixed with TNBC cells-could increase TNBC cell metastatic potency. After treatment with TGF-beta to induce endothelial-mesenchymal transition (EMT), TNBC cells could produce plasminogen activator inhibitor-1 (PAI-1) and stimulate the expression and secretion of the chemokine, CCL5, from ECs, which then acts in a paracrine fashion on TNBCcells to enhance their migration, invasion, and metastasis. CCL5, in turn, accelerates TNBC cell secretion of PAI-1 and promotes TNBC cell metastasis, thus forming a positive feedback loop. Moreover, this enhanced metastatic ability is reversible and dependent on CCL5 signaling via the chemokine receptor, CCR5. Of importance, key features of this pathway are manifested in patients with TNBC and in The Cancer Genome Atlas database. Taken together, our results suggest that ECs enhance EMT-induced TNBC cell metastasis via PAI-1 and CCL5 signaling and illustrate the potential of developing new PAI-1-and CCL5-targeting therapy for patients with TNBC.	[Zhang, Wenwen] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Xu, Jing; Guan, Xiaoxiang] Nanjing Med Univ, Jinling Hosp, Dept Med Oncol, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Wenwen; Fang, Hehui; Tang, Lin; Chen, Weiwei; Sun, Qian; Zhang, Qun; Yang, Fang; Sun, Zijia; Cao, Lulu; Guan, Xiaoxiang] Nanjing Univ, Jinling Hosp, Dept Med Oncol, Med Sch, Nanjing, Jiangsu, Peoples R China; [Wang, Yucai] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	Nanjing Medical University; Nanjing Medical University; Nanjing University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Guan, XX (corresponding author), Nanjing Med Univ, Jinling Hosp, Dept Med Oncol, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China.	xguan@nju.edu.cn	Zhang, Wenwen/ABF-4970-2021	Zhang, Wenwen/0000-0003-1285-3118; Guan, Xiaoxiang/0000-0001-6145-0046	National Natural Science Foundation of China [81470357]; Foundation for Clinical Medicine Science and Technology Special Project of the Jiangsu Province [BL2014071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Clinical Medicine Science and Technology Special Project of the Jiangsu Province	This study was supported by National Natural Science Foundation of China (Grant 81470357) and the Foundation for Clinical Medicine Science and Technology Special Project of the Jiangsu Province (Grant BL2014071). The authors declare no conflicts of interest.	Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; D'Esposito V, 2016, ONCOTARGET, V7, P24495, DOI 10.18632/oncotarget.8336; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Fertig EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12133; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Ghiabi P, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0386-3; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Isogai C, 2001, CANCER RES, V61, P5587; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khalid A, 2015, MINI-REV MED CHEM, V15, P1063, DOI 10.2174/138955751513150923094709; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lee E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5715; Liu GT, 2015, CANCER LETT, V357, P476, DOI 10.1016/j.canlet.2014.11.015; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Maishi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28039; Miao ZJ, 2016, PROTEOM CLIN APPL, V10, P1122, DOI 10.1002/prca.201600046; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Suarez-Carmona M, 2015, J PATHOL, V236, P491, DOI 10.1002/path.4546; Sun LC, 2016, AM J CANCER RES, V6, P2277; Sun Y, 2015, MOL CELL PROTEOMICS, V14, P1265, DOI 10.1074/mcp.M114.046946; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Tang S, 2016, CANCER LETT, V376, P137, DOI 10.1016/j.canlet.2016.03.034; Velasco-Velazquez M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23660; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; Virally M, 2010, DIABETES METAB, V36, P549, DOI 10.1016/j.diabet.2010.11.008; Witzel Isabell, 2014, Onco Targets Ther, V7, P2205, DOI 10.2147/OTT.S65344; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Zemzoum I, 2003, J CLIN ONCOL, V21, P1022, DOI 10.1200/JCO.2003.04.170; Zhang W., 2016, SCI REP, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Zhang WW, 2016, CELL CYCLE, V15, P1344, DOI 10.1080/15384101.2016.1160986; Zhang WW, 2015, ONCOTARGET, V6, P7608, DOI 10.18632/oncotarget.3263	44	51	54	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					276	+		10.1096/fj.201700237RR	http://dx.doi.org/10.1096/fj.201700237RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899878				2022-12-26	WOS:000419172700026
J	Zhao, X; Ouyang, WW; Chester, C; Long, SQ; Wang, NX; He, ZX				Zhao, Xing; Ouyang, Weiwei; Chester, Cariad; Long, Shiqi; Wang, Nianxue; He, Zhixu			Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus	PLOS ONE			English	Article							T-CELLS; IN-VIVO; VIRUS; IMMUNOTHERAPY; CANCER; TRIAL; CHEMOTHERAPY; COMBINATION; CARCINOMA; THERAPY	Oncolytic viruses (OV) have recently emerged as a promising therapeutic modality in cancer treatment. OV selectively infect and kill tumor cells, while sparing untransformed cells. The direct cytotoxic effects combined with the capacity to trigger an immune response make OV an appealing combination partner in the burgeoning field of cancer immunotherapy. One of the leading OV therapeutic candidates is the double-stranded RNA virus reovirus. In order to improve the oncolytic activity of reovirus and allow for systemic administration despite the prevalence of neutralizing antibodies, cytokine-induced killer (CIK) cells were explored as cell carriers for reovirus delivery. In this study, CIK cells were successfully loaded with reovirus ex vivo, and viral replication was limited in CIK cells. Confocal microscopy and flow cytometry demonstrated that CIK cells retained reovirus on the surface. Moreover, CIK cells could promote reovirus infection of tumor cells in the presence of neutralizing antibodies; meanwhile, cytotoxicity of CIK cells was increased after loading with reovirus. These findings support further investigation of reovirus and CIK combination for antitumor therapy.	[Zhao, Xing; He, Zhixu] Guizhou Med Univ, Stem Cell & Tissue Engn Res Ctr, Guiyang, Guizhou, Peoples R China; [Zhao, Xing; Long, Shiqi; Wang, Nianxue] Guizhou Med Univ, Dept Immunol, Guiyang, Guizhou, Peoples R China; [Ouyang, Weiwei] Guizhou Med Univ, Affiliated Hosp, Dept Thorac Oncol, Guiyang, Guizhou, Peoples R China; [Ouyang, Weiwei] Guizhou Canc Hosp, Guiyang, Guizhou, Peoples R China; [Chester, Cariad] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University; Stanford University	He, ZX (corresponding author), Guizhou Med Univ, Stem Cell & Tissue Engn Res Ctr, Guiyang, Guizhou, Peoples R China.	hzx@gmc.edu.cn			National Natural Science Foundation of China [81360346]; Social Developmental Research Foundation of Guizhou Province [SY (2012)3094]; Guizhou Province's Science and Technology Major Project, Qian-J-Zhong [[2015]2003]; National Natural Science Foundation of China (NSFC) [81360346]; Guizhou Province's Science and Technology Major Project [Qian-J-Zhong[2015]2003]; NICHD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Developmental Research Foundation of Guizhou Province; Guizhou Province's Science and Technology Major Project, Qian-J-Zhong; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guizhou Province's Science and Technology Major Project; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from National Natural Science Foundation of China (grant number 81360346, http://www.nsfc.gov.cn/); The Social Developmental Research Foundation of Guizhou Province [grant number SY (2012)3094, http://www.gzpopss.gov.cn/]; and Guizhou Province's Science and Technology Major Project, Qian-J-Zhong (grant number [2015]2003, http://kjzdzx.gzste.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is supported by the National Natural Science Foundation of China (NSFC, No. 81360346), Social Developmental Research Foundation of Guizhou Province [No. SY (2012)3094] and Guizhou Province's Science and Technology Major Project, Qian-J-Zhong[2015]2003. Anti-reovirus-sigma 3 primary antibody (deposited to the DSHB by Dermody, T.S.) was obtained from the Developmental Studies Hybridoma Bank (DSHB) developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Adair RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003578; Bhat R, 2011, INT J CANCER, V128, P908, DOI 10.1002/ijc.25415; Chakrabarty R, 2015, INVEST NEW DRUG, V33, P761, DOI 10.1007/s10637-015-0216-8; Clements D, 2014, ONCOLYTIC VIROTHER, V3, P69, DOI 10.2147/OV.S51321; El-Sherbiny YM, 2015, CLIN EXP IMMUNOL, V180, P98, DOI 10.1111/cei.12562; Gujar SA, 2011, MOL THER, V19, P797, DOI 10.1038/mt.2010.297; Harrington KJ, 2010, CLIN CANCER RES, V16, P3067, DOI 10.1158/1078-0432.CCR-10-0054; Ilett EJ, 2011, CLIN CANCER RES, V17, P2767, DOI 10.1158/1078-0432.CCR-10-3266; Jakel CE, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897214; Jennings VA, 2014, INT J CANCER, V134, P1091, DOI 10.1002/ijc.28450; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Kaufman HL, 2015, NAT REV DRUG DISCOV, V14, P642, DOI 10.1038/nrd4663; Li JJ, 2012, J IMMUNOTHER, V35, P189, DOI 10.1097/CJI.0b013e318241d9de; Liu L, 2012, CLIN CANCER RES, V18, P1751, DOI 10.1158/1078-0432.CCR-11-2442; LU PH, 1994, J IMMUNOL, V153, P1687; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Pievani A, 2011, BLOOD, V117, P510, DOI 10.1182/blood-2010-06-290858; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sborov DW, 2014, CLIN CANCER RES, V20, P5946, DOI 10.1158/1078-0432.CCR-14-1404; Steele L, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-20; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Weng DS, 2008, J IMMUNOTHER, V31, P63, DOI 10.1097/CJI.0b013e31815a121b; White CL, 2008, GENE THER, V15, P911, DOI 10.1038/gt.2008.21; Zhao X, 2016, MOL CANCER THER, V15, P767, DOI 10.1158/1535-7163.MCT-15-0695	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184816	10.1371/journal.pone.0184816	http://dx.doi.org/10.1371/journal.pone.0184816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922411	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300029
J	Lueders, I; Young, D; Maree, L; van der Horst, G; Luther, I; Botha, S; Tindall, B; Fosgate, G; Ganswindt, A; Bertschinger, HJ				Lueders, Imke; Young, Debbie; Maree, Liana; van der Horst, Gerhard; Luther, Ilse; Botha, Stephan; Tindall, Brendan; Fosgate, Geoffrey; Ganswindt, Andre; Bertschinger, Henk J.			Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; WHITE-TAILED DEER; TESTICULAR FUNCTION; AGGRESSIVE-BEHAVIOR; FEEDLOT PERFORMANCE; ACTIVE IMMUNIZATION; ENDOCRINE FUNCTION; FIELD CONDITIONS; SEXUAL-BEHAVIOR; MALE PIGS	Objectives Although the African elephant (Loxodonta africana) is classified as endangered by the International Union for Conservation of Nature (IUCN), in some isolated habitats in southern Africa, contraception is of major interest due to local overpopulation. GnRH vaccination has been promoted as a non-invasive contraceptive measure for population management of overabundant wildlife. We tested the efficacy of this treatment for fertility control in elephant bulls. Methods In total, 17 male African elephants that were treated with a GnRH vaccine were examined in two groups. In the prospective study group 1 (n = 11 bulls, ages: 8-36 years), semen quality, the testes, seminal vesicles, ampullae and prostate, which were all measured by means of transrectal ultrasound, and faecal androgen metabolite concentrations were monitored over a three-year period. Each bull in the prospective study received 5 ml of Improvac (R) (1000 mu g GnRH conjugate) intramuscularly after the first examination, followed by a booster six weeks later and thereafter every 5-7 months. In a retrospective study group (group 2, n = 6, ages: 19-33 years), one examination was performed on bulls which had been treated with GnRH vaccine for 5-11 years. Results In all bulls of group 1, testicular and accessory sex gland sizes decreased significantly after the third vaccination. In six males examined prior to vaccination and again after more than five vaccinations, the testis size was reduced by 57.5%. Mean testicular height and length decreased from 13.3 +/- 2.6 cm x 15.2 +/- 2.8 cm at the beginning to 7.6 +/- 2.1 cm x 10.2 +/- 1.8 cm at the end of the study. Post pubertal bulls (> 9 years, n = 6) examined prior to vaccination produced ejaculates with viable spermatozoa (volume: 8-175 ml, sperm concentration: 410-4000x10(6)/ml, total motility: 0-90%), while after 5-8 injections, only 50% of these bulls produced ejaculates with a small number of immotile spermatozoa. The ejaculates of group 2 bulls (vaccinated > 8 times) were devoid of spermatozoa. Faecal androgen metabolite concentrations measured in captive males decreased significantly after the fourth vaccination. None of the males entered musth during the treatment period. Conclusions Our results showed a marked decrease in semen quality, testicle and secondary sex gland sizes following repeated GnRH vaccinations. After 2-4 years of continuous treatment every 5-7 months, the effects were similar to surgical castration.	[Lueders, Imke] GEOlifes Anim Fertil & Reprod Res, Frohmestr 7, Hamburg, Germany; [Lueders, Imke; Ganswindt, Andre] Univ Pretoria, Fac Vet Sci, Dept Anat & Physiol, Endocrine Res Lab, Onderstepoort, South Africa; [Young, Debbie] African Elephant Res Unit, Plettenberg Bay, South Africa; [Maree, Liana; van der Horst, Gerhard; Luther, Ilse] Univ Western Cape, Dept Med Biosci, Bellville, South Africa; [Maree, Liana; van der Horst, Gerhard; Luther, Ilse] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [Botha, Stephan] African Lion Safari, Cambridge, ON, Canada; [Tindall, Brendan] Robberg Vet Clin, 56 Longships, Plettenberg Bay, South Africa; [Fosgate, Geoffrey; Bertschinger, Henk J.] Univ Pretoria, Dept Prod Anim Studies, Fac Vet Sci, Onderstepoort, South Africa	University of Pretoria; University of the Western Cape; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of Pretoria	Lueders, I (corresponding author), GEOlifes Anim Fertil & Reprod Res, Frohmestr 7, Hamburg, Germany.; Lueders, I (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Anat & Physiol, Endocrine Res Lab, Onderstepoort, South Africa.	imke.lueders@geolifes.com	Fosgate, Geoffrey T/N-8700-2014; Ganswindt, Andre/G-9856-2014; Van+der+Horst, Gerhard/AAB-7489-2020	Fosgate, Geoffrey T/0000-0002-9432-0042; Ganswindt, Andre/0000-0002-1474-7602; 	U.S. Fish and Wildlife Service [AFE 0705]; German Academic Exchange Service (DAAD) [D/11/45084]; International Elephant Foundation; Birmingham Zoo, USA; Technology Innovation Agency (Pretoria, South Africa)	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); International Elephant Foundation; Birmingham Zoo, USA; Technology Innovation Agency (Pretoria, South Africa)	I. Lueders and GvDH received a grant from the U.S. Fish and Wildlife Service- African elephant Fund #AFE 0705; I. Lueders received funding through the German Academic Exchange Service (DAAD) within the Postdoctoral Fellowship Program, Grant #D/11/45084; I. Lueders received project funding through the International Elephant Foundation and the Birmingham Zoo, USA; HJB received additional funding through the Technology Innovation Agency (Pretoria, South Africa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balet L, 2014, J DAIRY SCI, V97, P2193, DOI 10.3168/jds.2013-7602; Barth A. D., 1989, ABNORMAL MORPHOLOGY; Bertschinger Henk, 2008, P257; Bertschinger HJ, 2013, CONTRACEPTIVE APPL G; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Botha AE, 2008, WILDLIFE RES, V35, P548, DOI 10.1071/WR07136; BROWN JL, 1993, J REPROD FERTIL, V99, P627, DOI 10.1530/jrf.0.0990627; CAMPBELL R. C., 1956, Journal of Agricultural Science, V48, P1, DOI 10.1017/S002185960003029X; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Cook RB, 2000, J ANIM SCI, V78, P2778; Curtis Paul D., 2008, Human-Wildlife Conflicts, V2, P68; De Nys HM, 2010, J S AFR VET ASSOC, V81, P8; de Oliveira CA, 2004, J ZOO WILDLIFE MED, V35, P70, DOI 10.1638/02-091; Dowsett KF, 1996, AUST VET J, V74, P228, DOI 10.1111/j.1751-0813.1996.tb15410.x; Ferro VA, 2004, VET IMMUNOL IMMUNOP, V101, P73, DOI 10.1016/j.vetimm.2004.03.011; GABRILOVE JL, 1987, J CLIN ENDOCR METAB, V64, P1331, DOI 10.1210/jcem-64-6-1331; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Ghosal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084787; Gobello C, 2006, THERIOGENOLOGY, V66, P1560, DOI 10.1016/j.theriogenology.2006.02.005; Hermes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057616; Hildebrandt TB, 2000, ZOO BIOL, V19, P333, DOI 10.1002/1098-2361(2000)19:5&lt;333::AID-ZOO5&gt;3.0.CO;2-A; Hildebrandt TB, 1998, J ZOO WILDLIFE MED, V29, P114; HOWARD JG, 1984, J REPROD FERTIL, V72, P187, DOI 10.1530/jrf.0.0720187; Janett F, 2009, ANIM REPROD SCI, V115, P88, DOI 10.1016/j.anireprosci.2008.11.011; Jaros P, 2005, LIVEST PROD SCI, V92, P31, DOI 10.1016/j.livprodsci.2004.07.011; Johnson O. W., 1965, Journal of Mammalogy, V46, P373, DOI 10.2307/1377621; Karaconji B, 2015, AUST VET J, V93, P121, DOI 10.1111/avj.12307; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Kiyma Z, 2000, J ANIM SCI, V78, P2237; Laws R.M., 1975, ELEPHANTS THEIR HABI; Lincoln GA, 1996, J REPROD FERTIL, V108, P107, DOI 10.1530/jrf.0.1080107; Luders I, 2016, VET J, V209, P190, DOI 10.1016/j.tvjl.2015.07.014; Lueders I, 2014, J ZOO WILDLIFE MED, V45, P611, DOI 10.1638/2013-0233R.1; Malmgren L, 2001, EQUINE VET J, V33, P75, DOI 10.2746/042516401776767340; Marais HJ, 2013, J ZOO WILDLIFE MED, V44, pS18, DOI 10.1638/1042-7260-44.4S.S18; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Miller LA, 2004, J WILDLIFE DIS, V40, P725, DOI 10.7589/0090-3558-40.4.725; Miller LA, 2000, AM J REPROD IMMUNOL, V44, P266, DOI 10.1111/j.8755-8920.2000.440503.x; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Mutinda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091749; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Poole JH, 1994, DIFFERENCES SEXES, P331; Portas TJ, 2007, AUST VET J, V85, P425, DOI 10.1111/j.1751-0813.2007.00207.x; Quy RJ, 2014, WILDLIFE RES, V41, P185, DOI 10.1071/WR14035; Rajapaska RC, 2010, EU AS LINK PROJ S MA; Saragusty J, 2009, ANIM REPROD SCI, V115, P247, DOI 10.1016/j.anireprosci.2008.10.019; Schmitt DL, 1998, ANIM REPROD SCI, V53, P309, DOI 10.1016/S0378-4320(98)00120-1; Simms MS, 2000, BRIT J CANCER, V83, P443, DOI 10.1054/bjoc.2000.1315; Somgird C, 2016, ANIM REPROD SCI, V164, P111, DOI 10.1016/j.anireprosci.2015.11.019; van der Horst G, 2009, BIOTECH HISTOCHEM, V84, P299, DOI 10.3109/10520290902984274	51	17	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0178270	10.1371/journal.pone.0178270	http://dx.doi.org/10.1371/journal.pone.0178270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915245	Green Submitted, Green Published, gold			2022-12-26	WOS:000410861600002
J	Hoffmann, S; Devleesschauwer, B; Aspinall, W; Cooke, R; Corrigan, T; Havelaar, A; Angulo, F; Gibb, H; Kirk, M; Lake, R; Speybroeck, N; Torgerson, P; Hald, T				Hoffmann, Sandra; Devleesschauwer, Brecht; Aspinall, Willy; Cooke, Roger; Corrigan, Tim; Havelaar, Arie; Angulo, Frederick; Gibb, Herman; Kirk, Martyn; Lake, Robin; Speybroeck, Niko; Torgerson, Paul; Hald, Tine			Attribution of global foodborne disease to specific foods: Findings from a World Health Organization structured expert elicitation	PLOS ONE			English	Article							UNITED-STATES; ENTERIC PATHOGENS; OUTBREAK DATA; ILLNESSES; TRANSMISSION; SALMONELLOSIS; PROPORTION; JUDGMENT; BURDEN; MODEL	Background Recently the World Health Organization, Foodborne Disease Burden Epidemiology Reference Group (FERG) estimated that 31 foodborne diseases (FBDs) resulted in over 600 million illnesses and 420,000 deaths worldwide in 2010. Knowing the relative role importance of different foods as exposure routes for key hazards is critical to preventing illness. This study reports the findings of a structured expert elicitation providing globally comparable food source attribution estimates for 11 major FBDs in each of 14 world subregions. Methods and findings We used Cooke's Classical Model to elicit and aggregate judgments of 73 international experts. Judgments were elicited from each expert individually and aggregated using both equal and performance weights. Performance weighted results are reported as they increased the informativeness of estimates, while retaining accuracy. We report measures of central tendency and uncertainty bounds on food source attribution estimate. For some pathogens we see relatively consistent food source attribution estimates across subregions of the world; for others there is substantial regional variation. For example, for non-typhoidal salmonellosis, pork was of minor importance compared to eggs and poultry meat in the American and African subregions, whereas in the European and Western Pacific subregions the importance of these three food sources were quite similar. Our regional results broadly agree with estimates from earlier European and North American food source attribution research. As in prior food source attribution research, we find relatively wide uncertainty bounds around our median estimates. Conclusions We present the first worldwide estimates of the proportion of specific foodborne diseases attributable to specific food exposure routes. While we find substantial uncertainty around central tendency estimates, we believe these estimates provide the best currently available basis on which to link FBDs and specific foods in many parts of the world, providing guidance for policy actions to control FBDs.	[Hoffmann, Sandra] USDA, Econ Res Serv, Washington, DC 20250 USA; [Devleesschauwer, Brecht] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Aspinall, Willy] Aspinall & Associates, Tisbury, England; [Aspinall, Willy] Univ Bristol, Bristol, Avon, England; [Cooke, Roger] Resources Future Inc, Washington, DC USA; [Cooke, Roger] Delft Univ Technol, Delft, Netherlands; [Corrigan, Tim] WHO, Geneva, Switzerland; [Havelaar, Arie] Univ Florida, Gainesville, FL USA; [Havelaar, Arie] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Havelaar, Arie] Univ Utrecht, Utrecht, Netherlands; [Angulo, Frederick] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Gibb, Herman] Gibb Epidemiol Consulting LLC, Arlington, VA USA; [Kirk, Martyn] Australian Natl Univ, Canberra, ACT, Australia; [Lake, Robin] Inst Environm Sci & Res, Christchurch, New Zealand; [Speybroeck, Niko] Catholic Univ Louvain, Brussels, Belgium; [Torgerson, Paul] Univ Zurich, Zurich, Switzerland; [Hald, Tine] Tech Univ Denmark, Lyngby, Denmark	United States Department of Agriculture (USDA); University of Bristol; Resources for the Future; Delft University of Technology; World Health Organization; State University System of Florida; University of Florida; Netherlands National Institute for Public Health & the Environment; Utrecht University; Centers for Disease Control & Prevention - USA; Australian National University; Institute of Environmental Science & Research (ESR) - New Zealand; Universite Catholique Louvain; University of Zurich; Technical University of Denmark	Hoffmann, S (corresponding author), USDA, Econ Res Serv, Washington, DC 20250 USA.	shoffmann@ers.usda.gov	Torgerson, Paul R/M-4447-2013; Hald, Tine/B-5477-2016; Devleesschauwer, Brecht/G-9895-2018	Torgerson, Paul R/0000-0003-4277-9983; Hald, Tine/0000-0002-1115-9792; Devleesschauwer, Brecht/0000-0002-2867-6892; Speybroeck, Niko/0000-0003-3322-3502; Hoffmann, Sandra/0000-0003-2537-8731; Kirk, Martyn/0000-0001-5432-5984	Aspinall & Associates and Gibb Epidemio logy Consulting LLC; Natural Environment Research Council [NE/J017450/1] Funding Source: researchfish; NERC [NE/J017450/1] Funding Source: UKRI	Aspinall & Associates and Gibb Epidemio logy Consulting LLC; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was commissioned and paid for by the World Health Organization (WHO). Aspinall & Associates and Gibb Epidemio logy Consulting LLC provided support in the form of salaries for authors [WA, HJG], but did not have any additiona l role in the study design, data collection and analysis , decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributio ns' section.	[Anonymous], 2011, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2010.10.008; Aspinall W., 2013, RISK UNCERTAINTY ASS, P64, DOI DOI 10.1017/CBO9781139047562.005; Aspinall WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149817; Atkinson R., 2003, SAGE ENCY SOCIAL SCI; Bamber JL, 2016, CLIMATIC CHANGE, P1; Batz MB, 2005, EMERG INFECT DIS, V11, P993, DOI 10.3201/eid1107.040634; Batz MB, 2012, J FOOD PROTECT, V75, P1278, DOI 10.4315/0362-028X.JFP-11-418; Bunn D. W., 1975, OPERATIONAL RES Q, P449; Burgman M., 2015, TRUSTING JUDGEMENTS; Butler AJ, 2015, FOODBORNE PATHOG DIS, V12, P335, DOI 10.1089/fpd.2014.1856; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P657, DOI 10.1016/j.ress.2007.03.005; Davidson VJ, 2011, FOODBORNE PATHOG DIS, V8, P983, DOI 10.1089/fpd.2010.0786; De Knegt LV, 2015, EPIDEMIOL INFECT, V143, P1175, DOI 10.1017/S0950268814001903; De Waal CS, 2002, OUTBREAK ALERT, P57; Devleesschauwer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142498; Ebel ED, 2016, EMERG INFECT DIS, V22, P1193, DOI 10.3201/eid2207.150833; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flandoli F, 2011, RELIAB ENG SYST SAFE, V96, P1292, DOI 10.1016/j.ress.2011.05.012; Hald T, 2016, RISK ANAL, V36, P191, DOI 10.1111/risa.12385; Hald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145839; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoffmann S, 2007, J FOOD PROTECT, V70, P1220, DOI 10.4315/0362-028X-70.5.1220; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Painter JA, 2009, FOODBORNE PATHOG DIS, V6, P1259, DOI 10.1089/fpd.2009.0350; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Pires SM, 2009, FOODBORNE PATHOG MAY, P6; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P1463, DOI 10.1089/fpd.2010.0582; Scallan E, 2011, EMERG INFECT DIS, V17; Shokouhi M, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P963, DOI 10.1145/2766462.2767841; Tversky Amos., 1975, UTILITY PROBABILITY, P141, DOI [10.1007/978-94-010-1834-0_8, DOI 10.1017/CBO9780511809477.002, DOI 10.1007/978-94-010-1834-0_8]; Tyshenko M.G., 2012, INT J RISK ASSESS MA, V16, P48, DOI [10.1504/ijram.2012.047552, DOI 10.1504/IJRAM.2012.047552, 10.1504/IJRAM.2012.047552.]; Vally H, 2016, EPIDEMIOL INFECT, V144, P897, DOI 10.1017/S0950268815002435; Van der Fels-Klerx HJ, 2005, RISK ANAL, V25, P109, DOI 10.1111/j.0272-4332.2005.00571.x; WHO, 2017, CXCAC174018 WHO 5; World Health Organization, 2006, FOOD SAF RISK AN GUI; World Health Organization, WHO EST GLOB BURD FO	39	82	84	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183641	10.1371/journal.pone.0183641	http://dx.doi.org/10.1371/journal.pone.0183641			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910293	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000410859200013
J	Malpress, V; Bestley, S; Corney, S; Welsford, D; Labrousse, S; Sumner, M; Hindell, M				Malpress, Veda; Bestley, Sophie; Corney, Stuart; Welsford, Dirk; Labrousse, Sara; Sumner, Michael; Hindell, Mark			Bio-physical characterisation of polynyas as a key foraging habitat for juvenile male southern elephant seals (Mirounga leonina) in Prydz Bay, East Antarctica	PLOS ONE			English	Article							PHYTOPLANKTON DYNAMICS; ICE FORMATION; CIRCULATION; WATER; BEHAVIOR; OCEANOGRAPHY; TEMPERATURE; PREDATOR; SHELF; RATES	Antarctic coastal polynyas are persistent open water areas in the sea ice zone, and regions of high biological productivity thought to be important foraging habitat for marine predators. This study quantified southern elephant seal(Mirounga leonina) habitat use within and around the polynyas of the Prydz Bay region (63 degrees E E - 88 E degrees E) in East Antarctica, and examined the bio-physical characteristics structuring polynyas as foraging habitat. Output from a climatological regional ocean model was used to provide context for in situ temperature-salinity vertical profiles collected by tagged elephant seals and to characterise the physical properties structuring polynyas. Biological properties were explored using remotely-sensed surface chlorophyll (Chl-a) and, qualitatively, historical fish assemblage data. Spatially gridded residence time of seals was examined in relation to habitat characteristics using generalized additive mixed models. The results showed clear polynya usage during early autumn and increasingly concentrated usage during early winter. Bathymetry, Chl-a, surface net heat flux (representing polynya location), and bottom temperature were identified as significant bio-physical predictors of the spatio-temporal habitat usage. The findings from this study confirm that the most important marine habitats for juvenile male southern elephant seals within Prydz Bay region are polynyas. A hypothesis exists regarding the seasonal evolution of primary productivity, coupling from surface to subsurface productivity and supporting elevated rates of secondary production in the upper water column during summer-autumn. An advancement to this hypothesis is proposed here, whereby this bio-physical coupling is likely to extend throughout the water column as it becomes fully convected during autumn-winter, to also promote pelagic-benthic linkages important for benthic foraging within polynyas.	[Malpress, Veda; Bestley, Sophie; Labrousse, Sara; Hindell, Mark] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Malpress, Veda; Bestley, Sophie; Corney, Stuart; Sumner, Michael; Hindell, Mark] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Bestley, Sophie; Welsford, Dirk; Sumner, Michael] Australian Antarctic Div, Dept Environm, Kingston, Tas, Australia; [Labrousse, Sara] UPMC Univ, Sorbonne Univ, Paris 06, LOCEAN IPSL,UMR CNRS IRD MNHN 7159, Paris, France	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Malpress, V (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.; Malpress, V (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia.	vedam@utas.edu.au	Bestley, Sophie/AAN-2483-2021	Bestley, Sophie/0000-0001-9342-669X; Welsford, Dirk/0000-0001-5379-5052; Sumner, Michael/0000-0002-2471-7511; Hindell, Mark/0000-0002-7823-7185; Labrousse, Sara/0000-0002-8099-3254	Australian Government's Co-operative Research Centre's Program through Antarctic Climate and Ecosystems Cooperative Research Centre; Australia Research Council [FS110200057]	Australian Government's Co-operative Research Centre's Program through Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australia Research Council(Australian Research Council)	This work was supported by the Australian Government's Co-operative Research Centre's Program through the Antarctic Climate and Ecosystems Cooperative Research Centre. S. Bestley was supported by an Australia Research Council Super Science Fellowship FS110200057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2016, RAADTOOLS TOOLS SYNO; Arrigo KR, 2015, J GEOPHYS RES-OCEANS, V120, P5545, DOI 10.1002/2015JC010888; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Brauner N, 1998, AICHE J, V44, P603, DOI 10.1002/aic.690440311; Broyer CD, 2014, BIOGEOGRAPHIC ATLAS; Brzezinski A, 2009, J GEODYN, V48, P235, DOI 10.1016/j.jog.2009.09.021; Chapman EW, 2004, DEEP-SEA RES PT II, V51, P2261, DOI 10.1016/j.dsr2.2004.07.005; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Cottin M, 2012, MAR BIOL, V159, P1843, DOI 10.1007/s00227-012-1974-x; Cougnon EA, 2016, THESIS; Dinniman MS, 2011, DEEP-SEA RES PT II, V58, P1508, DOI 10.1016/j.dsr2.2010.11.013; Dinniman MS, 2004, DEEP-SEA RES PT II, V51, P2003, DOI 10.1016/j.dsr2.2004.07.030; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Erdmann ES, 2011, DEEP-SEA RES PT II, V58, P1710, DOI 10.1016/j.dsr2.2010.10.054; Field IC, 2012, MAR MAMMAL SCI, V28, pE325, DOI 10.1111/j.1748-7692.2011.00519.x; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Friedlaender AS, 2006, WHALE DISTRIBUTION R; Galton-Fenzi BK, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008214; Gill PC, 1997, POLAR BIOL, V17, P401, DOI 10.1007/s003000050134; Grebmeier JM, 2007, ELSEV OCEANOGR SERIE, V74, P363, DOI 10.1016/S0422-9894(06)74011-9; Herraiz-Borreguero L, 2015, J GEOPHYS RES-OCEANS, V120, P3098, DOI 10.1002/2015JC010697; Hibberd T, 2016, THESIS; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Johnson GC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004477; Johnson R, 2013, J GEOPHYS RES-OCEANS, V118, P3694, DOI 10.1002/jgrc.20270; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karnovsky N, 2007, ELSEV OCEANOGR SERIE, V74, P391, DOI 10.1016/S0422-9894(06)74012-0; Kavanaugh MT, 2015, EFFECT CONTIMENTAL S; Labrousse S, 2015, PROG OCEANOGR, V137, P52, DOI 10.1016/j.pocean.2015.05.023; Lehodey P, 1998, FISH OCEANOGR, V7, P317, DOI 10.1046/j.1365-2419.1998.00063.x; Liu G, 2009, ICES J MAR SCI, V66, P420, DOI 10.1093/icesjms/fsn219; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; Maxwell SM, 2012, MAR MAMMAL SCI, V28, pE333, DOI 10.1111/j.1748-7692.2011.00527.x; McMahon CR, 2008, J EXP MAR BIOL ECOL, V360, P71, DOI 10.1016/j.jembe.2008.03.012; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; Melbourne-Thomas J, 2015, DEEP-SEA RES PT II, V114, P64, DOI 10.1016/j.dsr2.2013.02.017; Menemenlis D., 2008, MERCAT OCEAN Q NEWSL, V31(October), P13; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Patterson TA, 2010, ECOLOGY, P91; Photopoulou T, 2015, ANIMAL BIOTELEMETRY, V3, P1; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J, R PACKAGE VERSION; Raymond B, 2015, ECOGRAPHY, V38, P121, DOI 10.1111/ecog.01021; Rey F, 2014, PLOS ONE, V9; Ribic CA, 2011, DEEP-SEA RES PT II, V58, P1695, DOI 10.1016/j.dsr2.2009.09.017; Roquet F, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.28; Roquet F, 2013, GEOPHYS RES LETT, V40, P6176, DOI 10.1002/2013GL058304; Saba GK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5318; Schofield O, 2013, OCEANOGRAPHY, V26, P204, DOI 10.5670/oceanog.2013.63; Shchepetkin AF, 2009, J COMPUT PHYS, V228, P8985, DOI 10.1016/j.jcp.2009.09.002; Stabeno PJ, 1998, J MAR RES, V56, P239, DOI 10.1357/002224098321836172; Sumner MD, 2015, TRIP TOOLS ANAL ANIM, P1; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Vaz RAN, 1996, DEEP-SEA RES PT I, V43, P603, DOI 10.1016/0967-0637(96)00028-3; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Williams D., 1999, AURORA AUSTRALIS VOY; Williams GD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12577; Williams GD, 2011, OCEAN SCI, V7, P185, DOI 10.5194/os-7-185-2011; Williams GD, 2003, DEEP-SEA RES PT II, V50, P1373, DOI 10.1016/S0967-0645(03)00074-2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	76	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184536	10.1371/journal.pone.0184536	http://dx.doi.org/10.1371/journal.pone.0184536			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902905	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000410669200046
J	Gursky, VV; Kozlov, KN; Kulakovskiy, IV; Zubair, A; Marjoram, P; Lawrie, DS; Nuzhdin, SV; Samsonova, MG				Gursky, Vitaly V.; Kozlov, Konstantin N.; Kulakovskiy, Ivan V.; Zubair, Asif; Marjoram, Paul; Lawrie, David S.; Nuzhdin, Sergey V.; Samsonova, Maria G.			Translating natural genetic variation to gene expression in a computational model of the Drosophila gap gene regulatory network	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; NONCODING DNA; CELLULAR RESOLUTION; REFERENCE PANEL; MELANOGASTER; EVOLUTION; SELECTION; SEGMENTATION; ENHANCERS; SEQUENCE	Annotating the genotype-phenotype relationship, and developing a proper quantitative description of the relationship, requires understanding the impact of natural genomic variation on gene expression. We apply a sequence-level model of gap gene expression in the early development of Drosophila to analyze single nucleotide polymorphisms (SNPs) in a panel of natural sequenced D. melanogaster lines. Using a thermodynamic modeling framework, we provide both analytical and computational descriptions of how single-nucleotide variants affect gene expression. The analysis reveals that the sequence variants increase (decrease) gene expression if located within binding sites of repressors (activators). We show that the sign of SNP influence (activation or repression) may change in time and space and elucidate the origin of this change in specific examples. The thermodynamic modeling approach predicts non-local and non-linear effects arising from SNPs, and combinations of SNPs, in individual fly genotypes. Simulation of individual fly genotypes using our model reveals that this non-linearity reduces to almost additive inputs from multiple SNPs. Further, we see signatures of the action of purifying selection in the gap gene regulatory regions. To infer the specific targets of purifying selection, we analyze the patterns of polymorphism in the data at two phenotypic levels: the strengths of binding and expression. We find that combinations of SNPs show evidence of being under selective pressure, while individual SNPs do not. The model predicts that SNPs appear to accumulate in the genotypes of the natural population in a way biased towards small increases in activating action on the expression pattern. Taken together, these results provide a systems-level view of how genetic variation translates to the level of gene regulatory networks via combinatorial SNP effects.	[Gursky, Vitaly V.] Ioffe Inst, Theoret Dept, St Petersburg, Russia; [Gursky, Vitaly V.; Kozlov, Konstantin N.; Samsonova, Maria G.] Peter Great St Petersburg Polytech Univ, Syst Biol & Bioinformat Lab, St Petersburg, Russia; [Kulakovskiy, Ivan V.] Engelhardt Inst Mol Biol, Moscow, Russia; [Kulakovskiy, Ivan V.] Vavilov Inst Gen Genet, Moscow, Russia; [Kulakovskiy, Ivan V.] Skolkovo Inst Sci & Technol, Ctr Data Intens Biomed & Biotechnol, Moscow, Russia; [Zubair, Asif; Marjoram, Paul; Lawrie, David S.; Nuzhdin, Sergey V.] Univ Southern Calif, Mol & Computat Biol, Los Angeles, CA USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Peter the Great St. Petersburg Polytechnic University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Vavilov Institute of General Genetics; Skolkovo Institute of Science & Technology; University of Southern California	Gursky, VV (corresponding author), Ioffe Inst, Theoret Dept, St Petersburg, Russia.; Gursky, VV (corresponding author), Peter Great St Petersburg Polytech Univ, Syst Biol & Bioinformat Lab, St Petersburg, Russia.	gursky@math.ioffe.ru	Zubair, Asif/X-3860-2019; Kozlov, Konstantin/N-6748-2013; Kulakovskiy, Ivan/A-1462-2014; Gursky, Vitaly V/A-9187-2014	Zubair, Asif/0000-0002-0958-700X; Kozlov, Konstantin/0000-0001-6765-236X; Kulakovskiy, Ivan/0000-0002-6554-8128; Gursky, Vitaly V/0000-0003-4094-1983; Lawrie, David/0000-0002-6782-9986	Russian Foundation for Basic Research [16-01-00648-a, 17-04-01665-a]; National Institute of Health [1U01GM103804]; Dynasty Foundation Fellowship	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dynasty Foundation Fellowship	VVG was supported by the Russian Foundation for Basic Research (http://www.rfbr.ru), grant number 16-01-00648-a; KNK and MGS were supported by the Russian Foundation for Basic Research (http://www.rfbr.ru), grant number 17-04-01665-a; AZ, VVG, SVN, and PM were supported by the National Institute of Health (https://www.nih.gov), grant number 1U01GM103804; IVK was supported by the Dynasty Foundation Fellowship (http://www.dynastyfdn.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Campo D, 2013, MOL ECOL, V22, P5084, DOI 10.1111/mec.12468; Clemente F, 2012, J EVOLUTION BIOL, V25, P1975, DOI 10.1111/j.1420-9101.2012.02580.x; Crombach A, 2016, MOL BIOL EVOL, V33, P1293, DOI 10.1093/molbev/msw013; Dresch JM, 2013, BBA-GENE REGUL MECH, V1829, P946, DOI 10.1016/j.bbagrm.2013.04.011; Drosophila 12 Genomes Consortium, 2007, NATURE, V450, P203; Duque T, 2014, MOL BIOL EVOL, V31, P184, DOI 10.1093/molbev/mst170; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gjuvsland AB, 2013, J PHYSIOL-LONDON, V591, P2055, DOI 10.1113/jphysiol.2012.248864; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; He X, 2012, MOL BIOL EVOL, V29, P1059, DOI 10.1093/molbev/msr277; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hoermann A, 2016, DEV BIOL, V411, P325, DOI 10.1016/j.ydbio.2016.01.005; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2012, CURR OPIN GENET DEV, V22, P533, DOI 10.1016/j.gde.2012.10.005; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Jiang P, 2015, DEV BIOL, V405, P173, DOI 10.1016/j.ydbio.2015.06.019; Kazemian M, 2014, GENOME BIOL EVOL, V6, P2301, DOI 10.1093/gbe/evu184; Kazemian M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000456; Kim AR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003243; Kozlov K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S6; Kulakovskiy I. V., 2009, Biophysics, V54, P667, DOI 10.1134/S0006350909060013; Kulakovskiy IV, 2009, BIOINFORMATICS, V25, P2318, DOI 10.1093/bioinformatics/btp434; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Li XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03737; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Lyman RF, 1996, GENETICS, V143, P277; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marjoram P, 2014, HEREDITY, V112, P79, DOI 10.1038/hdy.2013.52; Martinez C, 2014, MOL BIOL EVOL, V31, P903, DOI 10.1093/molbev/msu042; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Miles CM, 2011, EVOLUTION, V65, P33, DOI 10.1111/j.1558-5646.2010.01088.x; Mustonen V, 2008, P NATL ACAD SCI USA, V105, P12376, DOI 10.1073/pnas.0805909105; Palsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091924; Papatsenko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021145; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Samee MAH, 2015, CELL SYST, V1, P396, DOI 10.1016/j.cels.2015.12.002; Samee MA, 2013, METHODS, V62, P79, DOI 10.1016/j.ymeth.2013.03.005; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Schulz KN, 2015, GENOME RES, V25, P1715, DOI 10.1101/gr.192682.115; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharon E, 2014, GENOME RES, V24, P1698, DOI 10.1101/gr.168773.113; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Singh ND, 2009, MOL BIOL EVOL, V26, P1591, DOI 10.1093/molbev/msp071; Staller MV, 2015, P NATL ACAD SCI USA, V112, P785, DOI 10.1073/pnas.1413877112; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Wotton KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04785; Zabet NR, 2012, MOL BIOSYST, V8, P2815, DOI 10.1039/c2mb25201e; Zhen Y, 2012, METHODS MOL BIOL, V856, P141, DOI 10.1007/978-1-61779-585-5_6	68	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184657	10.1371/journal.pone.0184657	http://dx.doi.org/10.1371/journal.pone.0184657			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898266	Green Submitted, gold, Green Published			2022-12-26	WOS:000410449500040
J	Lin, HTV; Massam-Wu, T; Lin, CP; Wang, YJA; Shen, YC; Lu, WJ; Hsu, PH; Chen, YH; Borges-Walmsley, MI; Walmsley, AR				Lin, Hong-Ting Victor; Massam-Wu, Teresa; Lin, Chen-Ping; Wang, Yen-Jen Anna; Shen, Yu-Chi; Lu, Wen-Jung; Hsu, Pang-Hung; Chen, Yu-Hou; Borges-Walmsley, Maria Ines; Walmsley, Adrian Robert			The Vibrio cholerae var regulon encodes a metallo-beta-lactamase and an antibiotic efflux pump, which are regulated by VarR, a LysRtype transcription factor	PLOS ONE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; PSEUDOMONAS-AERUGINOSA; CITROBACTER-FREUNDII; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MACAB-TOLC; MEXAB-OPRM; MACROLIDE TRANSPORTER; CARBAPENEM RESISTANCE	The genome sequence of V. cholerae O1 Biovar Eltor strain N16961 has revealed a putative antibiotic resistance (var) regulon that is predicted to encode a transcriptional activator (VarR), which is divergently transcribed relative to the putative resistance genes for both a metallo-beta-lactamase (VarG) and an antibiotic efflux-pump (VarABCDEF). We sought to test whether these genes could confer antibiotic resistance and are organised as a regulon under the control of VarR. VarG was overexpressed and purified and shown to have beta-lactamase activity against penicillins, cephalosporins and carbapenems, having the highest activity against meropenem. The expression of VarABCDEF in the Escherichia coli (Delta acrAB) strain KAM3 conferred resistance to a range of drugs, but most significant resistance was to the macrolide spiramycin. A gel-shift analysis was used to determine if VarR bound to the promoter regions of the resistance genes. Consistent with the regulation of these resistance genes, VarR binds to three distinct intergenic regions, varRG, varGA and varBC located upstream and adjacent to varG, varA and varC, respectively. VarR can act as a repressor at the varRG promoter region; whilst this repression was relieved upon addition of beta-lactams, these did not dissociate the VarR/varRG-DNA complex, indicating that the derepression of varR by beta-lactams is indirect. Considering that the genomic arrangement of VarR-VarG is strikingly similar to that of AmpR-AmpC system, it is possible that V. cholerae has evolved a system for resistance to the newer beta-lactams that would prove more beneficial to the bacterium in light of current selective pressures.	[Lin, Hong-Ting Victor; Lin, Chen-Ping; Wang, Yen-Jen Anna; Shen, Yu-Chi; Lu, Wen-Jung] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Lin, Hong-Ting Victor] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Massam-Wu, Teresa; Borges-Walmsley, Maria Ines; Walmsley, Adrian Robert] Univ Durham, Dept Biosci, Durham, England; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Chen, Yu-Hou] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Borges-Walmsley, Maria Ines; Walmsley, Adrian Robert] Univ Fed Sao Paulo, UNIFESP, Dept Bioquim, Sao Paulo, Brazil	National Taiwan Ocean University; National Taiwan Ocean University; Durham University; National Taiwan Ocean University; Academia Sinica - Taiwan; Universidade Federal de Sao Paulo (UNIFESP)	Walmsley, AR (corresponding author), Univ Durham, Dept Biosci, Durham, England.; Walmsley, AR (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Bioquim, Sao Paulo, Brazil.	a.r.walmsley@dur.ac.uk	Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434; Walmsley, Adrian Robert/0000-0002-5136-0511; Massam-Wu, Teresa/0000-0002-4364-8734	Ministry of Science and Technology (Taiwan) [100-2313-B-019-001-MY2]; Wellcome Trust (UK) [084821/Z/08/Z]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Wellcome Trust (UK)(Wellcome Trust)	This work was supported by a grant from the Ministry of Science and Technology (Taiwan, R. O.C., 100-2313-B-019-001-MY2) and a grant from the Wellcome Trust (UK, 084821/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bagge N, 2002, ANTIMICROB AGENTS CH, V46, P3406, DOI 10.1128/AAC.46.11.3406-3411.2002; BARTOWSKY E, 1993, MOL MICROBIOL, V10, P555, DOI 10.1111/j.1365-2958.1993.tb00927.x; Begum Anowara, 2005, Microbiol Immunol, V49, P949; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chahboune A, 2005, ANTIMICROB AGENTS CH, V49, P1145, DOI 10.1128/AAC.49.3.1145-1149.2005; Chen SS, 2013, INT J ANTIMICROB AG, V41, P188, DOI 10.1016/j.ijantimicag.2012.10.008; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Choudhury D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133842; Chowdhury PR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00394; Colmer JA, 1998, MOL MICROBIOL, V27, P63, DOI 10.1046/j.1365-2958.1998.00657.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crawford PA, 2004, PROTEIN EXPRES PURIF, V36, P272, DOI 10.1016/j.pep.2004.04.017; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Fritsche TR, 2005, CLIN INFECT DIS, V41, pS276, DOI 10.1086/430790; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Huda MN, 2003, MICROBIOL IMMUNOL, V47, P419, DOI 10.1111/j.1348-0421.2003.tb03379.x; Huda MN, 2001, FEMS MICROBIOL LETT, V203, P235, DOI 10.1111/j.1574-6968.2001.tb10847.x; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1995, MOL MICROBIOL, V15, P553, DOI 10.1111/j.1365-2958.1995.tb02268.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; JAURIN B, 1982, EMBO J, V1, P875, DOI 10.1002/j.1460-2075.1982.tb01263.x; Jean SS, 2015, FUTURE MICROBIOL, V10, P407, DOI [10.2217/FMB.14.135, 10.2217/fmb.14.135]; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; KORFMANN G, 1989, ANTIMICROB AGENTS CH, V33, P1946, DOI 10.1128/AAC.33.11.1946; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Langaee TY, 2000, ANTIMICROB AGENTS CH, V44, P583, DOI 10.1128/AAC.44.3.583-589.2000; Li W, 2014, J BIOL CHEM, V289, P12633, DOI 10.1074/jbc.M113.536136; Li XZ, 1998, ANTIMICROB AGENTS CH, V42, P399; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDBERG F, 1985, P NATL ACAD SCI USA, V82, P4620, DOI 10.1073/pnas.82.14.4620; LINDBERG F, 1987, J BACTERIOL, V169, P758, DOI 10.1128/jb.169.2.758-763.1987; LINDQUIST S, 1989, MOL MICROBIOL, V3, P1091, DOI 10.1111/j.1365-2958.1989.tb00259.x; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Lodge JM, 1990, PSEUDOMONAS AERUGINO; Lu S, 2013, J BACTERIOL, V195, P4865, DOI 10.1128/JB.00756-13; Lu S, 2012, MOL MICROBIOL, V86, P1132, DOI 10.1111/mmi.12046; Lucas CE, 1997, J BACTERIOL, V179, P4123, DOI 10.1128/jb.179.13.4123-4128.1997; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Masuda N, 1999, ANTIMICROB AGENTS CH, V43, P400, DOI 10.1128/AAC.43.2.400; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Meletis G, 2012, HIPPOKRATIA, V16, P303; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Modali SD, 2011, MOL MICROBIOL, V81, P937, DOI 10.1111/j.1365-2958.2011.07744.x; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nakae T, 1999, ANTIMICROB AGENTS CH, V43, P1301, DOI 10.1128/AAC.43.5.1301; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Okamoto K, 2002, ANTIMICROB AGENTS CH, V46, P2696, DOI 10.1128/AAC.46.8.2696-2699.2002; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Rahman MM, 2007, MICROBIOL IMMUNOL, V51, P1061, DOI 10.1111/j.1348-0421.2007.tb04001.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sack DA., 2001, WHOCDSCSRDRS20018; Shakil S, 2011, J CHEMOTHERAPY, V23, P263, DOI 10.1179/joc.2011.23.5.263; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Taylor DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038208; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thomas PW, 2011, BIOCHEMISTRY-US, V50, P10102, DOI 10.1021/bi201449r; Thomson JM, 2005, CURR OPIN MICROBIOL, V8, P518, DOI 10.1016/j.mib.2005.08.014; Thomson JM, 2005, ANN NY ACAD SCI, V1277, P91; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Turlin E, 2014, MICROBIOLOGYOPEN, V3, P849, DOI 10.1002/mbo3.203; Tyski S., 2015, PLOS ONE, V10; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Woolley RC, 2005, J BACTERIOL, V187, P5500, DOI 10.1128/JB.187.15.5500-5503.2005; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu Y, 2012, BIOCHEMISTRY-US, V48, P5218; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yu Edward W., 2013, MICROBIAL EFFLUX PUM; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	94	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184255	10.1371/journal.pone.0184255	http://dx.doi.org/10.1371/journal.pone.0184255			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898293	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000410449500019
J	Saldias, MP; Fernandez, C; Morgan, A; Diaz, C; Morales, D; Jana, F; Gomez, A; Silva, A; Briceno, F; Oyarzun, A; Maldonado, F; Cerda, O; Smith, PC; Caceres, M				Paz Saldias, Maria; Fernandez, Christian; Morgan, Alejandra; Diaz, Catalina; Morales, Diego; Jana, Fabian; Gomez, Alvaro; Silva, Alonso; Briceno, Fernanda; Oyarzun, Alejandro; Maldonado, Felipe; Cerda, Oscar; Smith, Patricio C.; Caceres, Monica			Aged blood factors decrease cellular responses associated with delayed gingival wound repair	PLOS ONE			English	Article							GROWTH-FACTORS; DNA-DAMAGE; DONOR AGE; SENESCENCE; ALPHA; CELLS; BETA; SERUM; VEGF	Aging is a gradual biological process characterized by a decrease in cell and organism functions. Gingival wound healing is one of the impaired processes found in old rats. Here, we studied the in vivo wound healing process using a gingival repair rat model and an in vitro model using human gingival fibroblast for cellular responses associated to wound healing. To do that, we evaluated cell proliferation of both epithelial and connective tissue cells in gingival wounds and found decreased of Ki67 nuclear staining in old rats when compared to their young counterparts. We next evaluated cellular responses of primary gingival fibroblast obtained from young subjects in the presence human blood serum of individuals of different ages. Eighteen to sixty five years old masculine donors were classified into 3 groups: "young" from 18 to 22 years old, "middle-aged" from 30 to 48 years old and "aged" over 50 years old. Cell proliferation, measured through immunofluorescence for Ki67 and flow cytometry for DNA content, was decreased when middle-aged and aged serum was added to gingival fibroblast compared to young serum. Myofibroblastic differentiation, measured through alpha-smooth muscle actin (alpha-SMA), was stimulated with young but not middle-aged or aged serum both the protein levels and incorporation of alpha-SMA into actin stress fibers. High levels of PDGF, VEGF, IL-6R were detected in blood serum from young subjects when compared to middle-aged and aged donors. In addition, the pro-inflammatory cytokines MCP-1 and TNF were increased in the serum of aged donors. In old rat wound there is an increased of staining for TNF compared to young wound. Moreover, healthy gingiva (non injury) shows less staining compared to a wound site, suggesting a role in wound healing. Moreover, serum from middle-aged and aged donors was able to stimulate cellular senescence in young cells as determined by the expression of senescence associated beta-galactosidase and histone H2A.X phosphorylated at Ser139. Moreover, we detected an increased frequency of gamma-H2A. X-positive cells in aged rat gingival tissues. The present study suggests that serum factors present in middle-aged and aged individuals may be responsible, at least in part, for the altered responses observed during wound healing in aging.	[Paz Saldias, Maria; Fernandez, Christian; Morgan, Alejandra; Diaz, Catalina; Morales, Diego; Gomez, Alvaro; Silva, Alonso; Briceno, Fernanda; Cerda, Oscar; Caceres, Monica] Univ Chile, Inst Biomed Sci, Program Mol & Cell Biol, Fac Med, Santiago, Chile; [Jana, Fabian] Univ Aysen, Coyhaique, Chile; [Oyarzun, Alejandro] Univ Finis Terrae, Fac Dent, Santiago, Chile; [Maldonado, Felipe] Univ Chile, Hosp Clin, Dept Anesthesia, Fac Med, Santiago, Chile; [Cerda, Oscar; Caceres, Monica] Millennium Nucleus Ion Channels Associated Dis Mi, Santiago, Chile; [Smith, Patricio C.] Pontificia Univ Catolica Chile, Sch Dent, Fac Med, Santiago, Chile	Universidad de Chile; Universidad Finis Terrae; Universidad de Chile; Pontificia Universidad Catolica de Chile	Caceres, M (corresponding author), Univ Chile, Inst Biomed Sci, Program Mol & Cell Biol, Fac Med, Santiago, Chile.; Caceres, M (corresponding author), Millennium Nucleus Ion Channels Associated Dis Mi, Santiago, Chile.	monicacaceres@med.uchile.cl	Jaña, Fabián/D-9364-2017; Cerda, Oscar/N-3895-2018; Smith, Patricio C/I-5897-2014	Jaña, Fabián/0000-0001-7786-4569; Cerda, Oscar/0000-0003-2873-5722; Smith, Patricio C/0000-0001-7314-621X; Morales, Diego/0000-0002-5834-3685; Maldonado, Felipe/0000-0002-2633-4717; Fernandez, Christian/0000-0001-8157-5997; Gomez, Alvaro/0000-0001-9618-1755	National Fund for Science and Technology (Fondecyt) Grant [11140064]; Universidad de Chile [UINICIA 44051]; Fondecyt Grant [1160518]	National Fund for Science and Technology (Fondecyt) Grant; Universidad de Chile; Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by National Fund for Science and Technology (Fondecyt) Grant 11140064 (MC), UINICIA 44051 Grant from Universidad de Chile (MC) and Fondecyt Grant 1160518 (OC).; The present study was funded by a grant from the National Fund for Science and Technology (Fondecyt) Grant 11140064 (MC), Grant from Universidad de Chile UINICIA 44051 (MC) and Fondecyt Grant 1160518 (OC). The authors have stated explicitly that there are no conflicts of interest in connection with this article.	Arancibia R, 2013, J PERIODONTOL, V84, P683, DOI 10.1902/jop.2012.120225; Baht GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8131; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bayer ML, 2012, MECH AGEING DEV, V133, P246, DOI 10.1016/j.mad.2012.02.002; Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Caceres M, 2014, J DENT RES, V93, P691, DOI 10.1177/0022034514533126; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Czarkowska-Paczek B, 2006, J PHYSIOL PHARMACOL, V57, P189; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hubackova S, 2016, ONCOGENE, V35, P1236, DOI 10.1038/onc.2015.162; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liu RK, 2006, AM J PATHOL, V168, P757, DOI 10.2353/ajpath.2006.050907; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rozman P, 2007, ACTA DERMATOVEN ALP, V16, P156; Smith PC, 2006, J DENT RES, V85, P150, DOI 10.1177/154405910608500207; Takaishi K, 2000, J BIOCHEM-TOKYO, V127, P511, DOI 10.1093/oxfordjournals.jbchem.a022634; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jcms.2002.0285; Zhang CY, 2015, J CELL BIOL, V209, P289, DOI 10.1083/jcb.201409032; Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184189	10.1371/journal.pone.0184189	http://dx.doi.org/10.1371/journal.pone.0184189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898261	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500016
J	Lee, YJ; Choi, SM; Lee, YJ; Cho, YJ; Yoon, HI; Lee, JH; Lee, CT; Park, JS				Lee, Ye Jin; Choi, Sun Mi; Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae-Ho; Lee, Choon-Taek; Park, Jong Sun			Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL STATUS; HOSPITAL ANXIETY; SYMPTOM BURDEN; DISEASE; MANAGEMENT; COMORBIDITY; DYSPNEA	Background Although depression and anxiety represent significant yet treatable comorbidities in patients with idiopathic pulmonary fibrosis (IPF), their impact on the clinical course and prognosis of IPF remain unclear. Purpose We investigated the prevalence and clinical significance of depression and anxiety in patients with IPF. Methods The present study included a prospective cohort comprising 112 Korean patients with IPF who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. Results Symptoms of depression and anxiety were present in 25.9% and 21.4% of patients with IPF, respectively (HADS scores >= 8). No significant differences in demographic data, age, sex, smoking status, Modified Medical Research Council Dyspnea Scale (MMRC) scores, pulmonary function tests, or Gender-Age-Physiology Index for IPF were observed between patients with depression or anxiety and those without. However, in patients with anxiety, St. George's Respiratory Questionnaire (SGRQ) scores were significantly higher than those of patients without anxiety (40.5 versus 23.5; p = 0.003). The survival rate and total number of hospital admissions did not significantly differ between patients with depression/anxiety and those without. Conclusions Our findings indicate that depression and anxiety are relatively common in patients with IPF. Although no significant differences were noted with regard to survival rate and hospitalization, the present study suggests that depression and anxiety significantly influence quality of life in patients with IPF.	[Lee, Ye Jin; Choi, Sun Mi] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae-Ho; Lee, Choon-Taek; Park, Jong Sun] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seongnam, South Korea.	jspark.im@gmail.com	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462; Lee, Ye Jin/0000-0002-7290-0265	SNUBH Research Fund [11-2011-036]	SNUBH Research Fund	This study was supported by a grant (no. 11-2011-036) from the SNUBH Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar AA, 2013, CHRON RESP DIS, V10, P127, DOI 10.1177/1479972313493098; Amin A, 2014, AAMJ, V12; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bosley CM, 1996, EUR RESPIR J, V9, P2346, DOI 10.1183/09031936.96.09112346; Eisner MD, 2010, THORAX, V65, P229, DOI 10.1136/thx.2009.126201; Ferrell BR, 2006, PALLIATIVE NURSING, V19, P315; Glaspole IN, 2017, RESPIROLOGY, V22, P950, DOI 10.1111/resp.12989; Holland AE, 2014, RESPIROLOGY, V19, P1215, DOI 10.1111/resp.12360; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; King CS, 2017, LANCET RESP MED, V5, P72, DOI 10.1016/S2213-2600(16)30222-3; Kozu R, 2011, RESPIRATION, V81, P196, DOI 10.1159/000315475; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Lindell KO, 2010, HEART LUNG, V39, P304, DOI 10.1016/j.hrtlng.2009.08.005; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Ng TP, 2007, ARCH INTERN MED, V167, P60, DOI 10.1001/archinte.167.1.60; Oh SM, 1999, J KOREAN NEUROPSYCHI, V38, P289; Ozalevli S, 2010, MULTIDISCIP RESP MED, V5, P31, DOI 10.1186/2049-6958-5-1-31; Pink K, 2014, ADV RES, V2, P320; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ryerson CJ, 2012, RESPIROLOGY, V17, P525, DOI 10.1111/j.1440-1843.2011.02122.x; Ryerson CJ, 2011, CHEST, V139, P609, DOI 10.1378/chest.10-0608; Schneider C, 2010, CHEST, V137, P341, DOI 10.1378/chest.09-0614; Swigris JJ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0124-1; Xu WN, 2008, AM J RESP CRIT CARE, V178, P913, DOI 10.1164/rccm.200804-619OC; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; Yohannes AM, 2014, EUR RESPIR REV, V23, P345, DOI 10.1183/09059180.00007813; Yun YH, 2007, J CLIN EPIDEMIOL, V60, P1164, DOI 10.1016/j.jclinepi.2006.12.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184300	10.1371/journal.pone.0184300	http://dx.doi.org/10.1371/journal.pone.0184300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892504	gold, Green Submitted, Green Published			2022-12-26	WOS:000410243200013
J	Balaban, CL; Banchio, C; Ceccarelli, EA				Balaban, Cecilia L.; Banchio, Claudia; Ceccarelli, Eduardo A.			TAT-mediated transduction of bacterial redox proteins generates a cytoprotective effect on neuronal cells	PLOS ONE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; ESCHERICHIA-COLI; PENETRATING PEPTIDES; OXIDATIVE STRESS; HEME OXYGENASE; FERREDOXIN-NADP(+) REDUCTASE; LEPTOSPIRA-INTERROGANS; REACTIVE OXYGEN; IRON; DELIVERY	Cell penetrating peptides, also known as protein transduction domains, have the capacity to ubiquitously cross cellular membranes carrying many different cargos with negligible cytotoxicity. As a result, they have emerged as a powerful tool for macromolecular deliverybased therapies. In this study, catalytically active bacterial Ferredoxin-NADP(+) reductase (LepFNR) and Heme oxygenase (LepHO) fused to the HIV TAT-derived protein transduction peptide (TAT) were efficiently transduced to neuroblastoma SHSY-5Y cells. Proteins entered the cells through an endocytic pathway showing a time/concentration dependent mechanism that was clearly modulated by the nature of the cargo protein. Since ferredoxin NADP(+) reductases and heme oxygenases have been implicated in mechanisms of oxidative stress defense, neuroblastoma cells simultaneously transduced with TAT-LepFNR and TAT-LepHO were challenged by H2O2 incubations to judge the cytoprotective power of these bacterial enzymes. Accumulation of reactive oxygen species was significantly reduced in these transduced neuronal cells. Moreover, measurements of metabolic viability, membrane integrity, and cell survival indicated that these cells showed a better tolerance to oxidative stress. Our results open the possibility for the application of transducible active redox proteins to overcome the damage elicited by oxidative stress in cells and tissues.	[Balaban, Cecilia L.; Banchio, Claudia; Ceccarelli, Eduardo A.] Univ Nacl Rosario Ocampo & Esmeralda, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ceccarelli, EA (corresponding author), Univ Nacl Rosario Ocampo & Esmeralda, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina.	ceccarelli@ibr-conicet.gov.ar	Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina [PICT-2012-1841, PICT 2013-0820]; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 0345]	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from PICT-2012-1841 (To EAC) and PICT 2013-0820 (to CB), ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, http://www.agencia.mincyt.gob.ar Argentina and grant PIP 0345 (to EAC) from CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, http://www.conicet.gov.ar Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Belting Mattias, 2009, V480, P1, DOI 10.1007/978-1-59745-429-2_1; BOLES E, 1993, EUR J BIOCHEM, V217, P469, DOI 10.1111/j.1432-1033.1993.tb18266.x; Brumaghim JL, 2003, J BIOL CHEM, V278, P42495, DOI 10.1074/jbc.M306251200; Cunningham O, 2000, BIOCHEM J, V345, P393, DOI 10.1042/0264-6021:3450393; Dennery PA, 2014, ANTIOXID REDOX SIGN, V20, P1743, DOI 10.1089/ars.2013.5674; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Glogau R, 2012, J DRUGS DERMATOL, V11, P38; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Koeppen AH, 1995, J NEUROL SCI, V134, P1, DOI 10.1016/0022-510X(95)00202-D; Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0; Krapp AR, 1997, EUR J BIOCHEM, V249, P556, DOI 10.1111/j.1432-1033.1997.00556.x; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; MCDONAGH AF, 1990, CLIN PERINATOL, V17, P359, DOI 10.1016/S0095-5108(18)30572-4; Mediavilla MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013501; Nascimento AS, 2006, ACTA CRYSTALLOGR F, V62, P662, DOI 10.1107/S1744309106020136; Ollinger R, 2007, ANTIOXID REDOX SIGN, V9, P2175, DOI 10.1089/ars.2007.1807; Saliola M, 2012, EUKARYOT CELL, V11, P1503, DOI 10.1128/EC.00211-12; Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x; Singh SP, 2016, AM J PHYSIOL-CELL PH, V310, pC1, DOI 10.1152/ajpcell.00229.2015; Soldano A, 2014, BBA-GEN SUBJECTS, V1840, P3208, DOI 10.1016/j.bbagen.2014.07.021; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Walrant A, 2012, NANOMEDICINE-UK, V7, P133, DOI [10.2217/NNM.11.165, 10.2217/nnm.11.165]; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184617	10.1371/journal.pone.0184617	http://dx.doi.org/10.1371/journal.pone.0184617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886198	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100169
J	Pokorn, T; Radisek, S; Javornik, B; Stajner, N; Jakse, J				Pokorn, Tine; Radisek, Sebastjan; Javornik, Branka; Stajner, Natasa; Jakse, Jernej			Development of hop transcriptome to support research into host-viroid interactions	PLOS ONE			English	Article							SMALL RNAS; PHYTOHORMONE PATHWAYS; GLANDULAR TRICHOMES; GENE-EXPRESSION; HUMULUS-LUPULUS; ARABIDOPSIS; TARGETS; PLANTS; IDENTIFICATION; BIOSYNTHESIS	Viroids, the smallest known pathogens, unable to encode any proteins, can cause severe diseases in their host plants. One of the proposed mechanisms of their pathogenicity includes silencing the host's genes via viroid-derived small RNAs, which are products of the host's immune response to the viroid's double stranded RNA. Humulus lupulus (hop) plants are hosts to several viroids; two of them, HLVd and CBCVd, are interesting models for studying host-viroid interactions, due to the symptomless infection of the former and severe stunting disease caused by the latter. To study these interactions, we constructed a deep hop NGS transcriptome based on 35 Gb paired-end sequencing data assembled into over 74 Mb of contigs. These transcripts were used for in-silico prediction of target transcripts of vd-sRNA of the two aforementioned viroids, using two different software tools. Prediction models revealed that 1062 and 1387 hop transcripts share nucleotide similarities with HLVd-and CBCVd-derived small RNAs, respectively, so they could be silenced in an RNA interference process. Furthermore, we selected 17 transcripts from 4 groups of targets involved in the metabolism of plant hormones, small RNA biogenesis, transcripts with high complementarity with viroid-derived small RNAs and transcripts targeted by CBCVd-derived small RNAs with high cellular concentrations. Their expression was monitored by reverse transcription quantitative PCR performed using leaf, flower and cone samples. Additionally, the expression of 5 pathogenesis related genes was monitored. Expression analysis confirmed high expression levels of four pathogenesis related genes in leaves of HLVd and CBCVd infected hop plants. Expression fluctuations were observed for the majority of targets, with possible evidence of downregulation of GATA transcription factor by CBCVd- and of linoleate 13S-lipoxygenase by HLVd-derived small RNAs. These results provide a deep transcriptome of hop and the first insights into complex viroid-hop plant interactions.	[Pokorn, Tine; Javornik, Branka; Stajner, Natasa; Jakse, Jernej] Univ Ljubljana, Biotech Fac, Agron Dept, Ljubljana, Slovenia; [Radisek, Sebastjan] Slovenian Inst Hop Res & Brewing, Dept Plant Protect, Zhalec, Slovenia; [Pokorn, Tine] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia	University of Ljubljana; University of Ljubljana	Jakse, J (corresponding author), Univ Ljubljana, Biotech Fac, Agron Dept, Ljubljana, Slovenia.	jernej.jakse@bf.uni-lj.si		Jakse, Jernej/0000-0002-8907-1627	Slovenian Research Agency - ARRS [J4-4153, 1000-11-310098]; Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection [2321-12-210006]	Slovenian Research Agency - ARRS(Slovenian Research Agency - Slovenia); Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection	This work was supported by J4-4153, Slovenian Research Agency - ARRS, http://www.sicris.si/public/jqm/prj.aspx?lang=eng& P4-0077, Slovenian Research Agency - ARRS, http://www.sicris.si/public/jqm/prg.aspx?lang=eng& 1000-11-310098, Slovenian Research Agency - ARRS; 2321-12-210006, Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection.	ADAMS AN, 1992, ANN APPL BIOL, V121, P585, DOI 10.1111/j.1744-7348.1992.tb03468.x; Attoui H, 2011, 9 INT COMM TAX VIR; Avina-Padilla K, 2015, GENE, V564, P197, DOI 10.1016/j.gene.2015.03.076; BARBARA DJ, 1990, ANN APPL BIOL, V117, P359, DOI 10.1111/j.1744-7348.1990.tb04222.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Ben Abdallah H, 2016, METHODS MOL BIOL, V1363, P9, DOI 10.1007/978-1-4939-3115-6_2; Bernad L, 2006, MOL CELL PROBE, V20, P105, DOI 10.1016/j.mcp.2005.11.001; Bullock JM, 2016, THESIS; Busov VB, 2003, PLANT PHYSIOL, V132, P1283, DOI 10.1104/pp.103.020354; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Clark SM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-12; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cregeen S, 2015, PLANT MOL BIOL REP, V33, P689, DOI 10.1007/s11105-014-0767-4; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Denance A N, 2013, FRONT PLANT SCI, V4; Di Serio F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007539; DIENER TO, 1971, VIROLOGY, V45, P411, DOI 10.1016/0042-6822(71)90342-4; Dijkstra C, 2008, PLANT CELL REP, V27, P463, DOI 10.1007/s00299-007-0471-z; Eastwell KC, 2010, PLANT HLTH PROGR; Flores R, 2004, FEBS LETT, V567, P42, DOI 10.1016/j.febslet.2004.03.118; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Hataya Tatsuji, 1992, Annals of the Phytopathological Society of Japan, V58, P677, DOI 10.3186/jjphytopath.58.677; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iqbal N, 2013, PLANT PHYSIOL BIOCH, V73, P128, DOI 10.1016/j.plaphy.2013.09.011; Itaya A, 2002, MOL PLANT MICROBE IN, V15, P990, DOI 10.1094/MPMI.2002.15.10.990; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Jakse J, 2015, PLANT PATHOL, V64, P831, DOI 10.1111/ppa.12325; Kappagantu M, 2017, PLANT DIS, V101, P607, DOI 10.1094/PDIS-06-16-0884-RE; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Lacombe S, 2010, PLANT J, V61, P371, DOI 10.1111/j.1365-313X.2009.04062.x; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lei JK, 2014, BIOINFORMATICS, V30, P2837, DOI 10.1093/bioinformatics/btu380; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Lu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129010; Ma KW, 2016, PLANT MOL BIOL, V91, P713, DOI 10.1007/s11103-016-0452-0; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; Matousek J, 2003, PLANT SOIL ENVIRON, V49, P168, DOI 10.17221/4109-PSE; Minoia S, 2014, J VIROL, V88, P11933, DOI 10.1128/JVI.01404-14; Mishra AK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3271-4; Mishra AK, 2015, CRIT REV PLANT SCI, V34, P553, DOI 10.1080/07352689.2015.1078614; Moreton J, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00361; Nagel J, 2008, PLANT CELL, V20, P186, DOI 10.1105/tpc.107.055178; Natsume S, 2015, PLANT CELL PHYSIOL, V56, P428, DOI 10.1093/pcp/pcu169; Navarro B, 2012, PLANT J, V70, P991, DOI 10.1111/j.1365-313X.2012.04940.x; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; Owens RA, 2012, MOL PLANT MICROBE IN, V25, P582, DOI 10.1094/MPMI-09-11-0258; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Patzak J, 2001, BIOL PLANTARUM, V44, P579, DOI 10.1023/A:1013798821676; PUCHTA H, 1988, NUCLEIC ACIDS RES, V16, P4197, DOI 10.1093/nar/16.10.4197; Qu YT, 2015, INT J MOL SCI, V16, P9732, DOI 10.3390/ijms16059732; Radisek S, 2012, PLANT DIS, V96, P592, DOI 10.1094/PDIS-08-11-0640-PDN; Randles J. W., 2003, Viroids, P3; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rigal A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00373; Rivas S, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00104; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rodio ME, 2006, J GEN VIROL, V87, P231, DOI 10.1099/vir.0.81356-0; RODRIGO I, 1991, PLANT MOL BIOL, V16, P931, DOI 10.1007/BF00015088; Sano T, 2001, VIRUS GENES, V22, P53, DOI 10.1023/A:1008182302704; Sano Teruo, 2004, Journal of General Plant Pathology, V70, P181, DOI 10.1007/s10327-004-0105-z; SASAKI M, 1977, P JPN ACAD B-PHYS, V53, P103, DOI 10.2183/pjab.53.103; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Srivastava PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-348; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Tsuda K, 2004, PLANT CELL PHYSIOL, V45, P225, DOI 10.1093/pcp/pch017; Ui-Tei Kumiko, 2012, Frontiers in Genetics, V3, P101, DOI 10.3389/fgene.2012.00101; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Zhang C, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01237, 10.3389/fmicb.2015.01108]; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	80	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184528	10.1371/journal.pone.0184528	http://dx.doi.org/10.1371/journal.pone.0184528			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886174	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100148
J	Malecki, J; Jakobsson, ME; Ho, AYY; Moen, A; Rustan, AC; Falnes, PO				Malecki, Jedrzej; Jakobsson, Magnus E.; Ho, Angela Y. Y.; Moen, Anders; Rustan, Arild C.; Falnes, Pal O.			Uncovering human METTL12 as a mitochondrial methyltransferase that modulates citrate synthase activity through metabolite-sensitive lysine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; MESSENGER-RNA TRANSLATION; POSTTRANSLATIONAL MODIFICATIONS; HISTONE METHYLATION; BETA-SUBUNIT; ALPHA EEF1A; ETF-BETA; PROTEIN; SEQUENCE; IDENTIFICATION	Lysine methylation is an important and much-studied post-translational modification of nuclear and cytosolic proteins but is present also in mitochondria. However, the responsible mitochondrial lysine-specific methyltransferases (KMTs) remain largely elusive. Here, we investigated METTL12, a mitochondrial human S-adenosylmethionine (AdoMet)-dependent methyltransferase and found it to methylate a single protein in mitochondrial extracts, identified as citrate synthase (CS). Using several in vitro and in vivo approaches, we demonstrated that METTL12 methylates CS on Lys-395, which is localized in the CS active site. Interestingly, the METTL12-mediated methylation inhibited CS activity and was blocked by the CS substrate oxaloacetate. Moreover, METTL12 was strongly inhibited by the reaction product S-adenosylhomocysteine (AdoHcy). In summary, we have uncovered a novel human mitochondrial KMT that introduces a methyl modification into a metabolic enzyme and whose activity can be modulated by metabolic cues. Based on the established naming nomenclature for similar enzymes, we suggest that METTL12 be renamed CS-KMT (gene name CSKMT).	[Malecki, Jedrzej; Jakobsson, Magnus E.; Ho, Angela Y. Y.; Moen, Anders; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Rustan, Arild C.] Univ Oslo, Fac Math & Nat Sci, Sch Pharm, N-0316 Oslo, Norway; [Jakobsson, Magnus E.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Prote Program,Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	University of Oslo; University of Oslo; Novo Nordisk Foundation; University of Copenhagen	Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Rustan, Arild C./0000-0003-0963-5363; Malecki, Jedrzej/0000-0003-0825-7962; Falnes, Pal/0000-0001-8114-6025	Research Council of Norway [FRIMEDBIO-240009]; Norwegian Cancer Society [107744-PR-2007-0132]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Research Council of Norway (FRIMEDBIO-240009] and the Norwegian Cancer Society (107744-PR-2007-0132). The authors declare that they have no conflicts of interest with the contents of this article.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; BEECKMANS S, 1984, INT J BIOCHEM, V16, P341, DOI 10.1016/0020-711X(84)90131-9; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; EVANS CT, 1988, BIOCHEM BIOPH RES CO, V157, P1231, DOI 10.1016/S0006-291X(88)81006-4; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jakobsson ME, 2017, NUCLEIC ACIDS RES, V45, P8239, DOI 10.1093/nar/gkx432; Jakobsson ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11464; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; LANOUE KF, 1972, J BIOL CHEM, V247, P667; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2016, J BIOL CHEM, V291, P9581, DOI 10.1074/jbc.M115.709261; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mentch SJ, 2016, ANN NY ACAD SCI, V1363, P91, DOI 10.1111/nyas.12956; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Rhein VF, 2017, FEBS LETT, V591, P1641, DOI 10.1002/1873-3468.12649; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; SRERE PA, 1974, LIFE SCI, V15, P1695, DOI 10.1016/0024-3205(74)90172-6; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97	43	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17950	17962		10.1074/jbc.M117.808451	http://dx.doi.org/10.1074/jbc.M117.808451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887308	Green Published, hybrid			2022-12-26	WOS:000414013000030
J	Kadoda, K; Moriwaki, T; Tsuda, M; Sasanuma, H; Ishiai, M; Takata, M; Ide, H; Masunaga, S; Takeda, S; Tano, K				Kadoda, Kei; Moriwaki, Takahito; Tsuda, Masataka; Sasanuma, Hiroyuki; Ishiai, Masamichi; Takata, Minoru; Ide, Hiroshi; Masunaga, Shin-ichiro; Takeda, Shunichi; Tano, Keizo			Selective cytotoxicity of the anti-diabetic drug, metformin, in glucose-deprived chicken DT40 cells	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; DIABETES-MELLITUS; VERTEBRATE CELLS; REPAIR PATHWAY; FORMALDEHYDE; DEPRIVATION; INVOLVEMENT; TARGET; ALDH2	Metformin is a biguanide drug that is widely used in the treatment of diabetes. Epidemiological studies have indicated that metformin exhibits anti-cancer activity. However, the molecular mechanisms underlying this activity currently remain unclear. We hypothesized that metformin is cytotoxic in a tumor-specific environment such as glucose deprivation and/or low oxygen (O-2) tension. We herein demonstrated that metformin was highly cytotoxic under glucose-depleted, but not hypoxic (2% O-2) conditions. In order to elucidate the underlying mechanisms of this selective cytotoxicity, we treated exposed DNA repair-deficient chicken DT40 cells with metformin under glucose-depleted conditions and measured cellular sensitivity. Under glucose-depleted conditions, metformin specifically killed fancc and fancl cells that were deficient in FANCC and FANCL proteins, respectively, which are involved in DNA interstrand cross-link repair. An analysis of chromosomal aberrations in mitotic chromosome spreads revealed that a clinically relevant concentration of metformin induced DNA double-strand breaks (DSBs) in fancc and fancl cells under glucose-depleted conditions. In summary, metformin induced DNA damage under glucose-depleted conditions and selectively killed cells. This metformin-mediated selective toxicity may suppress the growth of malignant tumors that are intrinsically deprived of glucose.	[Kadoda, Kei; Moriwaki, Takahito; Masunaga, Shin-ichiro; Tano, Keizo] Kyoto Univ, Res Reactor Inst, Div Radiat Life Sci, Kumatori, Osaka, Japan; [Tsuda, Masataka; Sasanuma, Hiroyuki; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan; [Ishiai, Masamichi; Takata, Minoru] Kyoto Univ, Radiat Biol Ctr, Dept Late Effects Studies, Kyoto, Japan; [Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Japan; [Moriwaki, Takahito] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Hiroshima University; Kyoto University	Tano, K (corresponding author), Kyoto Univ, Res Reactor Inst, Div Radiat Life Sci, Kumatori, Osaka, Japan.	tano@rri.kyoto-u.ac.jp	Takata, Minoru/K-3772-2019; Ide, Hiroshi/G-9042-2019; Tsuda, Masataka/G-2505-2019	Tsuda, Masataka/0000-0002-1267-3777; Takeda, Shunichi/0000-0002-7924-7991; Takata, Minoru/0000-0002-4926-3675	JSPS KEKENHI [15K00537, 15H04295]	JSPS KEKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KEKENHI grant number 15K00537 to KT, http://www.jsps.go.jp/english/e-grants/index.html; and JSPS KEKENHI grant number 15H04295 to SM, http://www.jsps.go.jp/english/e-grants/index.html.	Amador RR, 2012, GENET MOL BIOL, V35, P153, DOI 10.1590/S1415-47572011005000060; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Frid A, 2010, DIABETES CARE, V33, P1291, DOI 10.2337/dc09-1284; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005; Kizaka-Kondoh S, 2003, CANCER SCI, V94, P1021, DOI 10.1111/j.1349-7006.2003.tb01395.x; McNeill DR, 2013, J BIOL CHEM, V288, P12426, DOI 10.1074/jbc.M113.456087; Moriwaki T, 2017, CHEM RES TOXICOL, V30, P699, DOI 10.1021/acs.chemrestox.6b00417; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; PERRIELLO G, 1994, DIABETES, V43, P920, DOI 10.2337/diabetes.43.7.920; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Pontel LB, 2015, MOL CELL, V60, P177, DOI 10.1016/j.molcel.2015.08.020; Qi XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35788; Ritz C, 2005, J STAT SOFTW, V12, P1; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Sui XB, 2015, MOL PHARMACEUT, V12, P3783, DOI 10.1021/acs.molpharmaceut.5b00577; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Yabe M, 2016, BRIT J HAEMATOL, V175, P457, DOI 10.1111/bjh.14243; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Zhang QS, 2016, BLOOD, V128, P2774, DOI 10.1182/blood-2015-11-683490; Zhu Y, 2013, ONCOGENE, V32, P2058, DOI 10.1038/onc.2012.223	31	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185141	10.1371/journal.pone.0185141	http://dx.doi.org/10.1371/journal.pone.0185141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926637	Green Published, Green Submitted, gold			2022-12-26	WOS:000411166600074
J	Kaur, A; Pati, PK; Pati, AM; Nagpal, AK				Kaur, Amritpreet; Pati, Pratap Kumar; Pati, Aparna Maitra; Nagpal, Avinash Kaur			In-silico analysis of cis-acting regulatory elements of pathogenesis-related proteins of Arabidopsis thaliana and Oryza sativa	PLOS ONE			English	Article							ABSCISIC-ACID; G-BOX; TRANSCRIPTIONAL ACTIVATION; MOLECULAR CHARACTERIZATION; FUNCTIONAL-ANALYSIS; PROMOTER ELEMENTS; GENE-EXPRESSION; GCC-BOX; IDENTIFICATION; DEFENSE	Pathogenesis related (PR) proteins are low molecular weight family of proteins induced in plants under various biotic and abiotic stresses. They play an important role in plant-defense mechanism. PRs have wide range of functions, acting as hydrolases, peroxidases, chitinases, anti-fungal, protease inhibitors etc. In the present study, an attempt has been made to analyze promoter regions of PR1, PR2, PR5, PR9, PR10 and PR12 of Arabidopsis thaliana and Oryza sativa. Analysis of cis-element distribution revealed the functional multiplicity of PRs and provides insight into the gene regulation. CpG islands are observed only in rice PRs, which indicates that monocot genome contains more GC rich motifs than dicots. Tandem repeats were also observed in 5'UTR of PR genes. Thus, the present study provides an understanding of regulation of PR genes and their versatile roles in plants.	[Kaur, Amritpreet; Nagpal, Avinash Kaur] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India; [Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Pati, Aparna Maitra] Inst Himalayan Bioresource Technol, CSIR, Planning Project Monitoring & Evaluat Cell, Palampur, Himachal Prades, India	Guru Nanak Dev University; Guru Nanak Dev University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Nagpal, AK (corresponding author), Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India.; Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.; Pati, AM (corresponding author), Inst Himalayan Bioresource Technol, CSIR, Planning Project Monitoring & Evaluat Cell, Palampur, Himachal Prades, India.	pkpati@yahoo.com; aparna@ihbt.res.in; avnagpal@yahoo.co.in	Nagpal, Avinash Kaur/J-9048-2018; bot, amrit/AAU-1660-2021	pati, pratap/0000-0001-9017-7608; Kaur, Amritpreet/0000-0001-5598-1318; Nagpal, Avinash Kaur/0000-0002-8036-9646	university grant commission (UGC), New Delhi, India	university grant commission (UGC), New Delhi, India(University Grants Commission, India)	Amritpreet Kaur received funding from university grant commission (UGC), New Delhi, India.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; ARIAS JA, 1993, PLANT CELL, V5, P485, DOI 10.1105/tpc.5.4.485; Ashikawa I, 2001, PLANT J, V26, P617, DOI 10.1046/j.1365-313x.2001.01062.x; Barrera V, 2012, NUCLEIC ACIDS RES, V40, P11490, DOI 10.1093/nar/gks928; BELL GI, 1992, COMPUT CHEM, V16, P135, DOI 10.1016/0097-8485(92)80040-7; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Caliskan Mahmut, 2000, Turkish Journal of Biology, V24, P717; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chan CS, 2001, PLANT MOL BIOL, V46, P131, DOI 10.1023/A:1010602031070; Che FS, 2002, PLANT SCI, V162, P449, DOI 10.1016/S0168-9452(01)00585-4; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Chow CN, 2015, NUCLEIC ACIDS RES; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Dolferus R, 2001, IUBMB LIFE, V51, P79, DOI 10.1080/15216540152122058; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Ferguson Ann A, 2011, Mob Genet Elements, V1, P135; Rodrigues MGF, 2017, SCI AGR, V74, P285, DOI [10.1590/1678-992x-2016-0195, 10.1590/1678-992X-2016-0195]; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Graham MY, 2003, PHYSIOL MOL PLANT P, V63, P141, DOI 10.1016/j.pmpp.2003.11.002; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Grimmig B, 2003, PLANT MOL BIOL, V51, P599, DOI 10.1023/A:1022385104386; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Hegde Y. R., 2013, Agricultural Reviews, V34, P145; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huda KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057803; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Jain S., 2015, ADV PLANTS AGR RES, V2, DOI DOI 10.15406/APAR.2015.02.00077; Jiang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129932; Kaur G, 2016, COMPUT BIOL CHEM, V62, P104, DOI 10.1016/j.compbiolchem.2016.04.002; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; Komarnytsky S, 2003, GENET ENG P, V25, P113; Krishnamurthy A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25761; Kundu S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-15; Lacerda AF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00116; Le Gourrierec J, 1999, PLANT J, V18, P663, DOI 10.1046/j.1365-313x.1999.00482.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lim DHK, 2010, OBSTET GYNAECOL, V12, P37, DOI 10.1576/toag.12.1.037.27556; Liu FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep18947; Liu JL, 2015, INT J MOL SCI, V16, P12131, DOI 10.3390/ijms160612131; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Lodhi N, 2008, BBA-GENE REGUL MECH, V1779, P634, DOI 10.1016/j.bbagrm.2008.07.010; LOGEMANN E, 1995, P NATL ACAD SCI USA, V92, P5905, DOI 10.1073/pnas.92.13.5905; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mazumder M, 2013, PLANT PHYSIOL BIOCH, V70, P43, DOI 10.1016/j.plaphy.2013.04.025; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Mongkolsiriwatana C., 2009, Kasetsart Journal, Natural Sciences, V43, P164; Nejad ES, 2012, PLANT OMICS, V5, P553; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Patthy L, 2008, INTRONS PHASE COMP; Petrov V, 2012, GENE, V499, P52, DOI 10.1016/j.gene.2012.02.035; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Rambani A, 2015, PLANT PHYSIOL, V168, P1364, DOI 10.1104/pp.15.00826; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rinerson CI, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2057-4; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Scherer NM, 2005, GENET MOL BIOL, V28, P645, DOI 10.1590/S1415-47572005000500001; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Singh R, 2013, TROP PLANT BIOL, V6, P85, DOI 10.1007/s12042-013-9123-3; Sudisha J, 2012, PROG BIOL CONTROL, V12, P379, DOI 10.1007/978-94-007-1933-0_17; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vinson C, 2012, EPIGENOMICS-UK, V4, P655, DOI [10.2217/EPI.12.55, 10.2217/epi.12.55]; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Wang PC, 2013, PLANT PHYSIOL, V161, P1392, DOI 10.1104/pp.112.210724; Wang PF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1204-7; Whalley HJ, 2013, NEW PHYTOL, V197, P690, DOI 10.1111/nph.12087; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Yoshihara T, 1996, FEBS LETT, V383, P213, DOI 10.1016/0014-5793(96)00233-5; YU LM, 1993, PLANT J, V3, P805, DOI 10.1111/j.1365-313X.1993.00805.x; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuo YC, 2011, GENOMICS, V97, P112, DOI 10.1016/j.ygeno.2010.11.002	90	71	73	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184523	10.1371/journal.pone.0184523	http://dx.doi.org/10.1371/journal.pone.0184523			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910327	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200056
J	Zhang, QF; Cheng, QR; Li, HX; Dong, X; Tu, WJ				Zhang, Qinfen; Cheng, Qirui; Li, Hongxin; Dong, Xuan; Tu, Wenjuan			Evaluation of auditory perception development in neonates by quantitative electroencephalography and auditory eventrelated potentials	PLOS ONE			English	Article							EEG POWER; AGE; CHILDHOOD; CHILDREN; INFANTS	Objective The present study was performed to investigate neonatal auditory perception function by quantitative electroencephalography (QEEG) and auditory event-related potentials (aERPs) and identify the characteristics of auditory perception development in newborns. Methods Fifty-three normal full-term neonates were divided into three groups according their age in days. An auditory oddball paradigm was used. QEEG (resting state and task state) and aERPs were performed. EEG d power in the resting and task states and at different ages was respectively analyzed. The N2 area and latency of aERPs at different ages were also compared. Results The four main findings of this study are as follows. First, the increase in the EEG d power was significantly greater in the task than resting state in Group 3 at the Fz lead (t = -3.371, P = 0.004) and in Groups 2 and 3 at the Cz lead (Group 2: t = -3.149, P = 0.005; Group 3: t = -3.609, P = 0.002). Second, the d power gradually increased from 1 to 10 days of age (Group 1), peaked at 11 to 20 days (Group 2), and gradually decreased from 21 to 28 days (Group 3). The data in the Fz lead during the task state and in the Cz lead during the resting and task states were statistically significant (F = 5.875, P = 0.005; F = 5.523, P = 0.007; and F = 5.402, P = 0.008, respectively). Third, the N2 area significantly increased with age by presentation of target stimuli (F = 5.26, P = 0.01). The N2 area increased most significantly from 21 to 28 days (Group 3). Finally, the N2 latency significantly decreased with age (Fz lead: F = 4.66, P = 0.023; Cz lead: F = 7.18, P = 0.005). The N2 latency decreased most significantly from 11 to 20 days of age (Group 2). Conclusion Rapid cognitive development occurs during the neonatal period. In the first several days after birth, the EEG delta power and N2 area manifested the characteristic performance of identifying task information. QEEG and aERP measurement can be used as objective indices with which to evaluate auditory perception development in neonates.	[Zhang, Qinfen; Li, Hongxin; Dong, Xuan; Tu, Wenjuan] Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China; [Cheng, Qirui] Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China		Dong, X; Tu, WJ (corresponding author), Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China.	dx6868@hotmail.com; tuwenjuan2008@163.com	ZHANG, QINFEN/GVT-5473-2022	ZHANG, QINFEN/0000-0001-7329-284X	Natural Science Foundation of Jiangsu Province [BK20161194]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20161194 to QinfenZhang).	Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bell MA, 2007, DEV NEUROPSYCHOL, V31, P21, DOI 10.1207/s15326942dn3101_2; Chipaux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079028; Cirelli C, 2015, BIOL PSYCHIAT, V77, P1071, DOI 10.1016/j.biopsych.2014.12.017; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; Cuevas K, 2011, INT J PSYCHOPHYSIOL, V80, P119, DOI 10.1016/j.ijpsycho.2011.02.009; Cunningham J, 2001, CLIN NEUROPHYSIOL, V112, P758, DOI 10.1016/S1388-2457(01)00465-5; Dong X, 2000, CHIN MED J, V80, P684; Guntekin B, 2015, INT J PSYCHOPHYSIOL, V2, P1, DOI DOI 10.1016/J.IJPSYCH0.2015.02.001; Holst M, 2005, CLIN NEUROPHYSIOL, V116, P1949, DOI 10.1016/j.clinph.2005.04.008; Hovel H, 2014, CLIN NEUROPHYSIOL, V125, P449, DOI 10.1016/j.clinph.2013.07.026; Kolb B, 2013, BRAIN PLASTICITY BEH, DOI 10.4324%2F9780203773765; Kushnerenko EV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00595; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Leipala JA, 2011, EARLY HUM DEV, V87, P89, DOI 10.1016/j.earlhumdev.2010.11.009; Lippe S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.048.2009; Marshall PJ, 2002, CLIN NEUROPHYSIOL, V113, P1199, DOI 10.1016/S1388-2457(02)00163-3; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Niemarkt HJ, 2011, PEDIATR RES, V70, P529, DOI 10.1203/PDR.0b013e31822d748b; Otero GA, 2011, EARLY HUM DEV, V87, P691, DOI 10.1016/j.earlhumdev.2011.05.010; Patel Salil H, 2005, Int J Med Sci, V2, P147; Picton TW, 2007, DEV NEUROPSYCHOL, V31, P249, DOI 10.1080/87565640701228732; Sankupellay M, 2011, CLIN NEUROPHYSIOL, V122, P236, DOI 10.1016/j.clinph.2010.06.030; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wronka E, 2007, ACTA NEUROBIOL EXP, V67, P155; Wunderlich JL, 2006, HEARING RES, V212, P185, DOI 10.1016/j.heares.2005.11.010	27	4	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183728	10.1371/journal.pone.0183728	http://dx.doi.org/10.1371/journal.pone.0183728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910297	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200014
J	Zhong, ZJ; Tian, YN; Li, W; Huang, XM; Deng, L; Cao, SZ; Geng, Y; Fu, HL; Shen, LH; Liu, HF; Peng, GN				Zhong, Zhijun; Tian, Yinan; Li, Wei; Huang, Xiangming; Deng, Lei; Cao, Suizhong; Geng, Yi; Fu, Hualin; Shen, Liuhong; Liu, Haifeng; Peng, Guangneng			Multilocus genotyping of Giardia duodenalis in captive non-human primates in Sichuan and Guizhou provinces, Southwestern China	PLOS ONE			English	Article							CRYPTOSPORIDIUM SPP.; MOLECULAR CHARACTERIZATION; ENTEROCYTOZOON-BIENEUSI; ASSEMBLAGE B; PREVALENCE; CHILDREN; ZOO	Giardia duodenalis is a common human and animal pathogen. It has been increasingly reported in wild and captive non-human primates (NHPs) in recent years. However, multilocus genotyping information for G. duodenalis infecting NHPs in southwestern China is limited. In the present study, the prevalence and multilocus genotypes (MLGs) of G. duodenalis in captive NHPs in southwestern China were determined. We examined 207 fecal samples from NHPs in Sichuan and Guizhou provinces, and 16 specimens were positive for G. duodenalis. The overall infection rate was 7.7%, and only assemblage B was identified. G. duodenalis was detect positive in northern white-cheeked gibbon (14/36, 38.9%), crab-eating macaque (1/60, 1.7%) and rhesus macaques (1/101, 0.9%). Multilocus sequence typing based on beta-giardin (bg), triose phosphate isomerase (tpi) and glutamate dehydrogenase (gdh) revealed nine different assemblage B MLGs (five known genotypes and four novel genotypes). Based on a phylogenetic analysis, one potentially zoonotic genotype of MLG SW7 was identified in a northern white-cheeked gibbon. A high degree of genetic diversity within assemblage B was observed in captive northern white-cheeked gibbons in Southwestern China, including a potentially zoonotic genotype, MLG SW7. To the best of our knowledge, this is the first report using a MLGs approach to identify G. duodenalis in captive NHPs in Southwestern China.	[Zhong, Zhijun; Tian, Yinan; Li, Wei; Deng, Lei; Cao, Suizhong; Geng, Yi; Fu, Hualin; Shen, Liuhong; Liu, Haifeng; Peng, Guangneng] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China; [Huang, Xiangming] Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu Res Base Giant Panda Breeding, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China.	pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	National Key Research and Development Program of China [2016YFD0501009]; National Natural Science Foundation of China [31272620]; Chengdu Giant Panda Breeding Research Foundation [CPF2015-4]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chengdu Giant Panda Breeding Research Foundation	This work was supported by the National Key Research and Development Program of China (2016YFD0501009); the National Natural Science Foundation of China (31272620); and the Chengdu Giant Panda Breeding Research Foundation (CPF2015-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2012, PARASITOL RES, V110, P1025, DOI 10.1007/s00436-011-2564-4; Beck R, 2011, VET PARASITOL, V175, P40, DOI 10.1016/j.vetpar.2010.09.026; Berrilli F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-199; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Du SZ, 2015, KOREAN J PARASITOL, V53, P395, DOI 10.3347/kjp.2015.53.4.395; Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489; Ehsan AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118239; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Huey CS, 2013, INFECT GENET EVOL, V17, P269, DOI 10.1016/j.meegid.2013.04.013; Jenkins EJ, 2013, ADV PARASIT, V82, P33, DOI 10.1016/B978-0-12-407706-5.00002-2; Johnston AR, 2012, PLOS NEGL TROP DIS, V6; Karim MR, 2015, INFECT GENET EVOL, V30, P82, DOI 10.1016/j.meegid.2014.12.013; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lee MF, 2016, PARASITOL RES, V116, P1; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Li JQ, 2017, INT J PARASITOL-PAR, V6, P8, DOI 10.1016/j.ijppaw.2016.12.003; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2015, CHINESE VET SCI, P156; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Sricharern W, 2016, INFECT GENET EVOL, V40, P310, DOI 10.1016/j.meegid.2016.02.004; Takumi K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-168; THOMPSON SC, 1994, J PAEDIATR CHILD H, V30, P202, DOI 10.1111/j.1440-1754.1994.tb00620.x; Wegayehu T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0706-7; Ye J, 2013, CHINA PARASITOL INT, V63, P132; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653	28	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184913	10.1371/journal.pone.0184913	http://dx.doi.org/10.1371/journal.pone.0184913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910395	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200119
J	Erkenswick, GA; Watsa, M; Pacheco, MA; Escalante, AA; Parker, PG				Erkenswick, Gideon A.; Watsa, Mrinalini; Pacheco, M. Andreina; Escalante, Ananias A.; Parker, Patricia G.			Chronic Plasmodium brasilianum infections in wild Peruvian tamarins	PLOS ONE			English	Article							SIMIAN MALARIA; NATURAL INFECTION; PRIMATE MALARIAS; PARASITES; HUMANS; RESERVOIRS; MARMOSET; CITY	There is an increased interest in potential zoonotic malarias. To date, Plasmodium malariae that infects humans remains indistinguishable from Plasmodium brasilianum, which is widespread among New World primates. Distributed throughout tropical Central and South America, the Callitrichidae are small arboreal primates in which detection of natural Plasmodium infection has been extremely rare. Most prior screening efforts have been limited to small samples, the use of low-probability detection methods, or both. Rarely have screening efforts implemented a longitudinal sampling design. Through an annual mark-recapture program of two sympatric callitrichids, the emperor (Saguinus imperator) and saddleback (Saguinus fuscicollis) tamarins, whole blood samples were screened for Plasmodium by microscopy and nested PCR of the cytochrome b gene across four consecutive years (2012-2015). Following the first field season, approximately 50% of the samples collected each subsequent year were from recaptured individuals. In particular, out of 245 samples from 129 individuals, 11 samples from 6 individuals were positive for Plasmodium, and all but one of these infections was found in S. imperator. Importantly, the cytochrome b sequences were 100% identical to former isolates of P. malariae from humans and P. brasilianum from Saimiri sp. Chronic infections were detected as evidenced by repeated infections (7) from two individuals across the 4-year study period. Furthermore, 4 of the 5 infected emperor tamarins were part of a single group spanning the entire study period. Overall, the low prevalence reported here is consistent with previous findings. This study identifies two new natural hosts for P. brasilianum and provides evidence in support of chronic infections in wildlife populations. Given that callitrichids are often found in mixed-species associations with other primates and can be resilient to human-disturbed environments, they could contribute to the maintenance of P. malariae populations if future work provides entomological and epidemiological evidence indicating human zoonotic infections.	[Erkenswick, Gideon A.; Parker, Patricia G.] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Erkenswick, Gideon A.; Parker, Patricia G.] Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA; [Erkenswick, Gideon A.; Watsa, Mrinalini] Field Projects Int, St Louis, MO USA; [Watsa, Mrinalini] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Pacheco, M. Andreina; Escalante, Ananias A.] Temple Univ, Dept Biol, Igem, Philadelphia, PA 19122 USA; [Parker, Patricia G.] St Louis Zoo, WildCare Inst, St Louis, MO USA	University of Missouri System; University of Missouri Saint Louis; University of Missouri System; University of Missouri Saint Louis; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Erkenswick, GA (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.; Erkenswick, GA (corresponding author), Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA.; Erkenswick, GA (corresponding author), Field Projects Int, St Louis, MO USA.	gaet4b@umsl.edu	Watsa, Mrinalini Erkenswick/AAP-1864-2020	Watsa, Mrinalini Erkenswick/0000-0002-8130-8810; Escalante, Ananias/0000-0002-1532-3430; Erkenswick, Gideon/0000-0001-6040-1170; Pacheco, Maria Andreina/0000-0002-5682-7299	Field Projects International; American Society of Mammologists; Sigma Xi Society; University of Missouri Trans World Airlines Scholarship Program; Whitney R. Harris World Ecology Center; University of Missouri-St. Louis	Field Projects International; American Society of Mammologists; Sigma Xi Society; University of Missouri Trans World Airlines Scholarship Program; Whitney R. Harris World Ecology Center; University of Missouri-St. Louis	Funding for this work was provided by Field Projects International (www.fieldprojects.org), the American Society of Mammologists (www. mammalsociety.org), Sigma Xi Society (www. sigmaxi.org), The University of Missouri Trans World Airlines Scholarship Program, Whitney R. Harris World Ecology Center (www.umsl.edu/similar to hwec/), and The Des Lee Collaborative Vision at the University of Missouri-St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga DAM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1724-0; Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180; BAERG DC, 1971, J PARASITOL, V57, P8, DOI 10.2307/3277745; Brunette GW, CDC YELL BOOK 2018 H; Buckner JC, 2015, MOL PHYLOGENET EVOL, V82, P413, DOI 10.1016/j.ympev.2014.04.031; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; CORREDOR V, 1994, GENETICS, V136, P857; Cox FEG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-5; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Soto-Calderon ID, 2016, AM J PRIMATOL, V78, P1272, DOI 10.1002/ajp.22581; de Arruda ME, 1985, MEM I O CRUZ, V80, P367, DOI DOI 10.1590/S0074-02761985000300015; DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805; DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001; Divis PCS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004888; Duval L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-157; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168; Fuentes-Ramirez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170704; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GEIMAN GM, 1969, AM J TROP MED HYG, V18, P351, DOI 10.4269/ajtmh.1969.18.351; Gordo M, 2013, DEV PRIMATOL-PROG PR, P357, DOI 10.1007/978-1-4614-8839-2_23; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hayakawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007412; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146; Leite GC, 2011, APPL ANIM BEHAV SCI, V132, P187, DOI 10.1016/j.applanim.2011.03.013; Lima GFMC, 2016, BLOOD TRANSFUS, V1-9; LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004; Matauschek C, 2011, AM J PHYS ANTHROPOL, V144, P564, DOI 10.1002/ajpa.21445; Mehlotra RK, 2000, AM J TROP MED HYG, V62, P225, DOI 10.4269/ajtmh.2000.62.225; Muehlenbein MP, 2015, MOL BIOL EVOL, V32, P422, DOI 10.1093/molbev/msu310; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Nunn C, 2005, BEHAV ECOL SOCIOBIOL, V59, P30, DOI 10.1007/s00265-005-0005-z; Nunn CL, 2005, GLOBAL MAMMAL PARASI; Pacheco MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-328; Figueiredo MAP, 2015, REV BRAS PARASITOL V, V24, P122, DOI 10.1590/S1984-29612015034; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Ramasamy R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00123; Rehg JA, 2006, INT J PRIMATOL, V27, P1399, DOI 10.1007/s10764-006-9076-6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosin Cooper, 2013, Neotropical Primates, V20, P25; Salazar-Castanon VH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/913696; Scuracchio P, 2011, REV INST MED TROP SP, V53, P55, DOI 10.1590/S0036-46652011000100010; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Volney B, 2002, ACTA TROP, V82, P11, DOI 10.1016/S0001-706X(02)00036-0; Watsa Mrinalini, 2015, Neotropical Primates, V22, P59; Watsa M, 2012, INT J PRIMATOL, V33, P1477, DOI 10.1007/s10764-012-9632-1; World Health Organization, 2016, BURNS FACT SHEET, P1; Yusof R, 2016, EMERG INFECT DIS, V22, P1371, DOI 10.3201/eid2208.151885	58	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184504	10.1371/journal.pone.0184504	http://dx.doi.org/10.1371/journal.pone.0184504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902879	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200040
J	Meyerhoff, HS; Gehrer, NA				Meyerhoff, Hauke S.; Gehrer, Nina A.			Visuo-perceptual capabilities predict sensitivity for coinciding auditory and visual transients in multi-element displays	PLOS ONE			English	Article							SPATIAL ATTENTION; INTEGRATION; SEARCH; INTELLIGENCE; CAPTURE; WINDOW; TIME; CUES; DISCRIMINATION; VENTRILOQUISM	In order to obtain a coherent representation of the outside world, auditory and visual information are integrated during human information processing. There is remarkable variance among observers in the capability to integrate auditory and visual information. Here, we propose that visuo-perceptual capabilities predict detection performance for audiovisually coinciding transients in multi-element displays due to severe capacity limitations in audiovisual integration. In the reported experiment, we employed an individual differences approach in order to investigate this hypothesis. Therefore, we measured performance in a useful-field-of-view task that captures detection performance for briefly presented stimuli across a large perceptual field. Furthermore, we measured sensitivity for visual direction changes that coincide with tones within the same participants. Our results show that individual differences in visuo-perceptual capabilities predicted sensitivity for the presence of audiovisually synchronous events among competing visual stimuli. To ensure that this correlation does not stem from superordinate factors, we also tested performance in an unrelated working memory task. Performance in this task was independent of sensitivity for the presence of audiovisually synchronous events. Our findings strengthen the proposed link between visuo-perceptual capabilities and audiovisual integration. The results also suggest that basic visuo-perceptual capabilities provide the basis for the subsequent integration of auditory and visual information.	[Meyerhoff, Hauke S.] Leibniz Inst Wissensmedien, Tubingen, Germany; [Gehrer, Nina A.] Univ Tubingen, Dept Psychol, Tubingen, Germany	Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen	Meyerhoff, HS (corresponding author), Leibniz Inst Wissensmedien, Tubingen, Germany.	h.meyerhoff@iwm-tuebingen.de		Meyerhoff, Hauke/0000-0003-1836-4737				BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Chen YC, 2010, COGNITION, V114, P389, DOI 10.1016/j.cognition.2009.10.012; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frings C, 2005, PERS INDIV DIFFER, V39, P1181, DOI 10.1016/j.paid.2005.02.024; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Lordanescu L, 2008, PSYCHON B REV, V15, P548, DOI 10.3758/PBR.15.3.548; Luciano M, 2005, BIOL PSYCHOL, V70, P1, DOI 10.1016/j.biopsycho.2004.11.011; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Meyerhoff HS, 2016, MEM COGNITION, V44, P390, DOI 10.3758/s13421-015-0575-6; Ngo MK, 2010, ATTEN PERCEPT PSYCHO, V72, P1654, DOI 10.3758/APP.72.6.1654; Olivers CNL, 2017, CAPACITY DETECT SYNC, V42, P2115; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PERROTT DR, 1990, PERCEPT PSYCHOPHYS, V48, P214, DOI 10.3758/BF03211521; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Santangelo V, 2006, EXP BRAIN RES, V173, P40, DOI 10.1007/s00221-006-0361-6; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Staufenbiel SM, 2011, EXP BRAIN RES, V213, P457, DOI 10.1007/s00221-011-2797-6; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; van den Brink RL, 2014, CEREB CORTEX, V24, P2169, DOI 10.1093/cercor/bht069; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2013, PSYCHOL SCI, V24, P345, DOI 10.1177/0956797612452865; Van der Burg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039137; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; VERNON PA, 1993, PERS INDIV DIFFER, V14, P35, DOI 10.1016/0191-8869(93)90172-Y; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Zou H, 2012, J VISION, V12, DOI 10.1167/12.5.2	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183723	10.1371/journal.pone.0183723	http://dx.doi.org/10.1371/journal.pone.0183723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902903	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200016
J	Lu, SR; Qian, Y; Huang, XY; Yu, H; Yang, J; Han, RQ; Su, J; Du, WC; Zhou, JY; Dong, MH; Yu, XJ; van Duijnhoven, FJB; Kampman, E; Wu, M				Lu, Shurong; Qian, Yun; Huang, Xingyu; Yu, Hao; Yang, Jie; Han, Renqiang; Su, Jian; Du, Wencong; Zhou, Jinyi; Dong, Meihua; Yu, Xiaojin; van Duijnhoven, Franzel J. B.; Kampman, Ellen; Wu, Ming			The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study	PLOS ONE			English	Article							NUTRITIONAL EPIDEMIOLOGY; RISK; MORTALITY; WOMEN; TRANSITION; SHANGHAI; COHORT; TRENDS	This study aims to examine the association of breast cancer with dietary patterns among Chinese women. A population-based case-control study was conducted in Jiangsu, China. Newly diagnosed primary breast cancer patients were recruited as cases (n = 818). Controls (n = 935), selected from the general population, were frequency matched to cases. A validated food frequency questionnaire was used to assess dietary intake. Dietary patterns were identified by factor analysis and multivariable odds ratios (OR) and 95% confidence intervals (CI) were estimated. Four dietary patterns were identified: salty, vegetarian, sweet and traditional Chinese. The traditional Chinese pattern was found to be robustly associated with a lower risk of breast cancer among both pre- and post-menopausal women (4th vs. 1st quartile: OR for pre- and post-menopausal women was 0.47 and 0.68, respectively). Women with high factor scores of the sweet pattern also showed a decreased risk of breast cancer (4th vs. 1st quartile: OR for pre-and post-menopausal women was 0.47 and 0.68, respectively). No marked association was observed between a vegetarian pattern or a salty pattern and breast cancer. These findings indicate that dietary patterns of the traditional Chinese and the sweet may favorably associate with the risk of breast cancer among Chinese women.	[Lu, Shurong; Yu, Hao; Yang, Jie; Han, Renqiang; Su, Jian; Du, Wencong; Zhou, Jinyi; Wu, Ming] Jiangsu Prov Ctr Dis Control & Prevent, Dept Chron Dis Control, Nanjing, Jiangsu, Peoples R China; [Qian, Yun; Dong, Meihua] Wuxi Ctr Dis Control & Prevent, Dept Chron Dis Control, Wuxi, Jiangsu, Peoples R China; [Huang, Xingyu; Yu, Xiaojin; Wu, Ming] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [van Duijnhoven, Franzel J. B.; Kampman, Ellen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Jiangsu Provincial Center for Disease Control & Prevention; Southeast University - China; Wageningen University & Research	Wu, M (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Chron Dis Control, Nanjing, Jiangsu, Peoples R China.; Wu, M (corresponding author), Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.; Kampman, E (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	ellen.kampman@wur.nl; jswuming@vip.sina.com	van Duijnhoven, Fränzel/GWC-0059-2022; Lu, Shurong/AAZ-3528-2020	Lu, Shurong/0000-0001-6730-4306	World Cancer Research Fund [WCRF 2011/RFA/473]	World Cancer Research Fund(World Cancer Research Fund International (WCRF))	This study was funded by World Cancer Research Fund, Grant number: WCRF 2011/RFA/473 (URL: http://www.wcrf.org/) to MW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agurs-Collins T, 2009, AM J CLIN NUTR, V90, P621, DOI 10.3945/ajcn.2009.27666; Albuquerque RCR, 2014, NUTR REV, V72, P1, DOI 10.1111/nure.12083; Bradshaw PT, 2009, CANCER CAUSE CONTROL, V20, P1509, DOI 10.1007/s10552-009-9343-x; Buck K, 2011, CANCER CAUSE CONTROL, V22, P273, DOI 10.1007/s10552-010-9695-2; Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572; Chajes V, 2014, MATURITAS, V77, P7, DOI 10.1016/j.maturitas.2013.10.004; Chan SG, 2007, J NUTR, V137, P2451, DOI 10.1093/jn/137.11.2451; Cottet V, 2009, AM J EPIDEMIOL, V170, P1257, DOI 10.1093/aje/kwp257; Couto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055374; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Demetriou CA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-113; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Edefonti V, 2009, NUTR REV, V67, P297, DOI 10.1111/j.1753-4887.2009.00203.x; Fung TT, 2005, INT J CANCER, V116, P116, DOI 10.1002/ijc.20999; Ge K, 2008, FOOD NUTR CHINA, P58; Ge K, 2011, ASIA PAC J CLIN NUTR, V20, P439; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Hirose K, 2007, CANCER SCI, V98, P1431, DOI 10.1111/j.1349-7006.2007.00540.x; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Huang Z, 2016, ANN ONCOL, V27, P1129, DOI 10.1093/annonc/mdw069; Jia MM, 2015, J THORAC DIS, V7, P1221, DOI 10.3978/j.issn.2072-1439.2015.05.15; Kim MK, 2004, INT J CANCER, V110, P435, DOI 10.1002/ijc.20132; Kojima R, 2017, BREAST CANCER-TOKYO, V24, P152, DOI 10.1007/s12282-016-0689-0; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Mannisto S, 2005, CANCER CAUSE CONTROL, V16, P725, DOI 10.1007/s10552-005-1763-7; Nkondjock A, 2005, CANCER LETT, V223, P85, DOI 10.1016/j.canlet.2004.11.034; Norat T CD, 2008, ASS FOOD NUTR PHYS A; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Sant M, 2007, INT J CANCER, V121, P911, DOI 10.1002/ijc.22714; Schulz M, 2008, BRIT J NUTR, V100, P942, DOI 10.1017/S0007114508966149; SEELY S, 1983, MED HYPOTHESES, V11, P319, DOI 10.1016/0306-9877(83)90095-6; Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109; Yan L, 2014, CHINESE J HLTH ED, V30, P387; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang CX, 2011, CANCER CAUSE CONTROL, V22, P115, DOI 10.1007/s10552-010-9681-8; Zhao WH, 2002, PUBLIC HEALTH NUTR, V5, P829, DOI 10.1079/PHN2002374	38	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184453	10.1371/journal.pone.0184453	http://dx.doi.org/10.1371/journal.pone.0184453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898273	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500028
J	Xiao, WB; Nazario, G; Wu, HM; Zhang, HM; Cheng, F				Xiao, WenBo; Nazario, Gina; Wu, HuaMing; Zhang, HuaMing; Cheng, Feng			A neural network based computational model to predict the output power of different types of photovoltaic cells	PLOS ONE			English	Article							HIDDEN NEURONS; SYSTEM; NUMBER; MODULE	In this article, we introduced an artificial neural network (ANN) based computational model to predict the output power of three types of photovoltaic cells, mono-crystalline (mono-), multi-crystalline (multi-), and amorphous (amor-) crystalline. The prediction results are very close to the experimental data, and were also influenced by numbers of hidden neurons. The order of the solar generation power output influenced by the external conditions from smallest to biggest is: multi-, mono-, and amor-crystalline silicon cells. In addition, the dependences of power prediction on the number of hidden neurons were studied. For multi-and amorphous crystalline cell, three or four hidden layer units resulted in the high correlation coefficient and low MSEs. For mono-crystalline cell, the best results were achieved at the hidden layer unit of 8.	[Xiao, WenBo; Wu, HuaMing; Zhang, HuaMing] Nanchang Hangkong Univ, Jiangxi Engn Lab Optoelect Testing Technol, Nanchang, Jiangxi, Peoples R China; [Nazario, Gina; Cheng, Feng] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA	Nanchang Hangkong University; State University System of Florida; University of South Florida	Xiao, WB (corresponding author), Nanchang Hangkong Univ, Jiangxi Engn Lab Optoelect Testing Technol, Nanchang, Jiangxi, Peoples R China.; Cheng, F (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA.	xiaowenbo1570@163.com; fcheng1@health.usf.edu	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090	Jiangxi Province Science Major Program [20143ACB21011]; Scientific Research Foundation of Jiangxi Provincial Department of Education [GJJ150729]	Jiangxi Province Science Major Program; Scientific Research Foundation of Jiangxi Provincial Department of Education	This work was in part supported Jiangxi Province Science Major Program for Youths under Grant No. 20143ACB21011, and the Scientific Research Foundation of Jiangxi Provincial Department of Education under Grant No. GJJ150729. The above grants can be found in our school's internal website. So, i can not provide the URLs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was in part supported Jiangxi Province Science Major Program for Youths under Grant No. 20143ACB21011, and the Scientific Research Foundation of Jiangxi Provincial Department of Education under Grant No. GJJ150729.	Fernandez-Jimenez LA, 2012, RENEW ENERG, V44, P311, DOI 10.1016/j.renene.2012.01.108; Bai JB, 2015, SOL ENERGY, V112, P41, DOI 10.1016/j.solener.2014.09.048; Camargo LS, 2001, NEURAL COMPUT, V13, P2673, DOI 10.1162/089976601317098484; Fadare DA, 2009, APPL ENERG, V86, P1410, DOI 10.1016/j.apenergy.2008.12.005; Fernandez EF, 2014, SOL ENERGY, V100, P148, DOI 10.1016/j.solener.2013.11.036; Gajowniczek K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174098; Ghoneim, 2011, ENERGY SCI TECHNOL, V2, P43; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; HUANG SC, 1991, IEEE T NEURAL NETWOR, V2, P47, DOI 10.1109/72.80290; Ismail HM, 2012, APPL ENERG, V92, P769, DOI 10.1016/j.apenergy.2011.08.027; Jiang N, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL I, PROCEEDINGS, P103, DOI 10.1109/IITA.2008.462; Kheirkhah A, 2013, COMPUT IND ENG, V64, P425, DOI 10.1016/j.cie.2012.09.017; KURKOVA V, 1992, NEURAL NETWORKS, V5, P501, DOI 10.1016/0893-6080(92)90012-8; Lei Z., 2014, IFAC P, V47, P3899, DOI DOI 10.3182/20140824-6-ZA-1003.00657; [李芬 Li Fen], 2011, [气候变化研究进展, Advances in Climate Change Research], V7, P136; Li XW, 2014, RENEW SUST ENERG REV, V37, P517, DOI 10.1016/j.rser.2014.05.056; Liu JT, 2015, PHYS CHEM CHEM PHYS, V17, P3303, DOI 10.1039/c4cp04717f; Mellit A, 2013, RENEW ENERG, V60, P71, DOI 10.1016/j.renene.2013.04.011; Mellit A, 2008, PROG ENERG COMBUST, V34, P574, DOI 10.1016/j.pecs.2008.01.001; Panchal G, 2011, INT J COMPUT THEORY, V3, P332, DOI DOI 10.7763/IJCTE.2011.V3.328; Singh GK, 2013, ENERGY, V53, P1, DOI 10.1016/j.energy.2013.02.057; Tsai HF, 2012, SOL ENERGY, V86, P654, DOI 10.1016/j.solener.2011.11.014; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Xiao WB, 2011, MOD PHYS LETT B, V25, P679, DOI 10.1142/S0217984911025948; Yona A, 2007, IEEE POWER ENG SOC, P3659; Yuan HC, 2003, COMPUT ELECTRON AGR, V40, P57, DOI 10.1016/S0168-1699(03)00011-5; ztopal A., 2012, SOL ENERGY, V86, P725	27	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184561	10.1371/journal.pone.0184561	http://dx.doi.org/10.1371/journal.pone.0184561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898271	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500034
J	Santos, RO; Rehage, JS; Adams, AJ; Black, BD; Osborne, J; Kroloff, EKN				Santos, Rolando O.; Rehage, Jennifer S.; Adams, Aaron J.; Black, Brooke D.; Osborne, Jason; Kroloff, Emily K. N.			Quantitative assessment of a data-limited recreational bonefish fishery using a time-series of fishing guides reports	PLOS ONE			English	Article							SEAGRASS DIE-OFF; FLORIDA BAY; ALBULA-VULPES; ECOLOGICAL THRESHOLDS; LENGTH LIMITS; CATCH; ABUNDANCE; CONNECTIVITY; BEHAVIOR; MORTALITY	Recreational fisheries can be prone to severe declines, yet these fisheries, particularly catch-and-release, are often data-limited, constraining our ability to conduct stock assessments. A combination of catch and effort indices derived from fisheries-dependent data (FDD) gathered from fishing logbooks could be a powerful approach to inform these data gaps. This study demonstrates the utility of using different catch metrics such as indices of abundance, species richness associated with reported catch, and the success rate of targeted trips, to assess historical shifts in the trajectory of the data-limited bonefish (Albula vulpes) fishery in Florida Bay, an economically-important recreational fishery within the Caribbean Basin. We used FDD from fishing guide reports submitted to Everglades National Park to determine temporal patterns in the bonefish population over the past 35 years. These reports indicated a decline in recreational catches in Florida Bay since the late 1980s, with an accelerated decline starting in the late 1990s-early 2000s. Analyses showed an overall 42% reduction in bonefish catches. Trends in the proportion of positive trips (i.e., the probability of catching success) followed the declining catch patterns, suggesting major population changes starting in 1999-2000. As bonefish catches declined, species richness in bonefish trips increased by 34%, suggesting a decrease in bonefish abundance and/or shift in fishing effort (e.g., giving-up time, changes in preferred species). Results provide additional resolution to a pattern of decline for bonefish in South Florida and highlight the value of reconstructing time-series for the development of hypotheses about the potential driving mechanisms of species decline. Further, the data-limited nature of most recreational fisheries, and the increase in a use of catch-and-release as a fisheries management strategy point to the need to develop further data integration tools to assess population trends and the sustainability of these fishery resources.	[Santos, Rolando O.; Rehage, Jennifer S.; Kroloff, Emily K. N.] Florida Int Univ, Earth & Environm Dept, Miami, FL 33199 USA; [Santos, Rolando O.; Rehage, Jennifer S.] Florida Int Univ, Southeast Environm Res Ctr, Miami, FL 33199 USA; [Adams, Aaron J.; Black, Brooke D.] Bonefish & Tarpon Trust, Coral Gables, FL USA; [Osborne, Jason] USNPS SFNRC, Everglades Natl Pk, Homestead, FL USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Santos, RO (corresponding author), Florida Int Univ, Earth & Environm Dept, Miami, FL 33199 USA.; Santos, RO (corresponding author), Florida Int Univ, Southeast Environm Res Ctr, Miami, FL 33199 USA.	rsantosc@fiu.edu		Santos, Rolando/0000-0002-3885-9406	Bonefish and Tarpon Trust; Comprehensive Everglades Restoration Plan (CERP); NSF [WSC-1204762]; FCE LTER [NSF DEB-1237517]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	Bonefish and Tarpon Trust; Comprehensive Everglades Restoration Plan (CERP); NSF(National Science Foundation (NSF)); FCE LTER; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by Bonefish and Tarpon Trust and the RECOVER (REstoration COordination & VERification) program of the Comprehensive Everglades Restoration Plan (CERP). The project was developed with additional support from NSF WSC-1204762 and in collaboration with the FCE LTER program (NSF DEB-1237517).	Adams AJ, 2014, FISH FISH, V15, P280, DOI 10.1111/faf.12017; Adams Aaron J., 2012, Gulf and Caribbean Research, V24, P13; Allen MS, 2013, FISHERIES MANAG ECOL, V20, P247, DOI 10.1111/j.1365-2400.2012.00871.x; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; [Anonymous], STRUCCHANGE R PACKAG; Arlinghaus R, 2013, FISHERIES MANAG ECOL, V20, P91, DOI 10.1111/fme.12027; Ault J.S, 2008, BIOL MANAGEMENT WORL; Beaudreau AH, 2014, ECOL APPL, V24, P244, DOI 10.1890/13-0817.1; Blaber SJM, 2013, ESTUAR COAST SHELF S, V135, P57, DOI 10.1016/j.ecss.2012.11.002; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Britten GL, 2014, ECOL LETT, V17, P1518, DOI 10.1111/ele.12354; Brownscombe JW, 2013, J EXP MAR BIOL ECOL, V440, P207, DOI 10.1016/j.jembe.2012.12.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell RA, 2004, FISH RES, V70, P209, DOI 10.1016/j.fishres.2004.08.026; Carlson JK, 2007, BIOL CONSERV, V136, P195, DOI 10.1016/j.biocon.2006.11.013; Cass-Calay Shannon L., 2009, Endangered Species Research, V7, P183, DOI 10.3354/esr00139; Coggins LG, 2007, FISH FISH, V8, P196, DOI 10.1111/j.1467-2679.2007.00247.x; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Cooke SJ, 2004, BIOL CONSERV, V118, P599, DOI 10.1016/j.biocon.2003.10.009; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crabtree RE, 1996, FISH B-NOAA, V94, P442; Crabtree RE, 1998, FISH B-NOAA, V96, P754; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Dallas LJ, 2010, J FISH BIOL, V77, P947, DOI 10.1111/j.1095-8649.2010.02738.x; Danylchuk SE, 2007, J EXP MAR BIOL ECOL, V346, P127, DOI 10.1016/j.jembe.2007.03.008; Development RC, 2010, R LANG ENV STAT COMP; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Fedler A, 2013, EC IMPACT FLORIDA KE; Fedler T., 2009, EC IMPACT HECREATION; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Finn JT, 2010, ECOL MODEL, V293, P139; Fonteneau A, 2003, MAR FRESHWATER RES, V54, P383, DOI 10.1071/MF01268; Fourqurean JW, 1999, ESTUARIES, V22, P345, DOI 10.2307/1353203; Frezza PE, 2015, ENVIRON BIOL FISH, V98, P2187, DOI 10.1007/s10641-015-0442-0; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hall MO, 2016, MAR ECOL PROG SER, V560, P243, DOI 10.3354/meps11923; Heck KL, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P537; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hughes RM, 2015, FISHERIES SCI, V81, P1, DOI 10.1007/s12562-014-0815-x; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Kough AS, 2013, PLOS ONE, P8; Kroloff E, 2016, ARE ALL BONEFISH USI; Larkin MF, 2010, FISHERIES MANAG ECOL, V17, P254, DOI 10.1111/j.1365-2400.2009.00718.x; Larkin MF, 2011, THESIS, P214; M?llmann C., 2012, ADV ECOL RES; Madden CJ, 2009, ECOL INDIC, V9, pS68, DOI 10.1016/j.ecolind.2009.02.004; Maunder MN, 2004, FISH RES, V70, P389, DOI 10.1016/j.fishres.2004.08.015; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Meynecke JO, 2008, BIOL CONSERV, V141, P981, DOI 10.1016/j.biocon.2008.01.018; Muehlstein L.K., 1992, Proceedings of the Gulf and Caribbean Fisheries Institute, V42, P55; Muller RG, 2013, CENTROPOMUS UNDECIMA, P161; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Olds AD, 2012, MAR ECOL PROG SER, V462, P191, DOI 10.3354/meps09849; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Osborne J., 2006, YEAR 2005 ANN MARINE; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Post JR, 2013, FISHERIES MANAG ECOL, V20, P99, DOI 10.1111/fme.12008; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Roughgarden J, 1996, P NATL ACAD SCI USA, V93, P5078, DOI 10.1073/pnas.93.10.5078; Rudnick DT, 2005, WETLANDS, V25, P870, DOI 10.1672/0277-5212(2005)025[0870:ACEMOF]2.0.CO;2; Santos RO, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1335; Schmidt T., 2002, YEAR 2001 ANN FISHER; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Sosin Mark, 2008, V9, P345; Stabenau E, 2012, SALINITY HYDROLOGY F; Sundelof A, 2015, POPUL ECOL, V57, P237, DOI 10.1007/s10144-014-0460-3; Tilmant JT, 1986, P 4 C RES NAT PARKS, P75; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Winker H, 2014, FISH RES, V155, P149, DOI 10.1016/j.fishres.2014.02.016; Winker H, 2013, FISH RES, V139, P118, DOI 10.1016/j.fishres.2012.10.014; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211; Zuur Alain F., 2009, P1	85	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184776	10.1371/journal.pone.0184776	http://dx.doi.org/10.1371/journal.pone.0184776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892509	Green Submitted, Green Published, gold			2022-12-26	WOS:000410243200022
J	Margulies, CM; Chaim, IA; Mazumder, A; Criscione, J; Samson, LD				Margulies, Carrie M.; Chaim, Isaac Alexander; Mazumder, Aprotim; Criscione, June; Samson, Leona D.			Alkylation induced cerebellar degeneration dependent on Aag and Parp1 does not occur via previously established cell death mechanisms	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MITOCHONDRIAL PERMEABILITY TRANSITION; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE-1; NAD(+) DEPLETION; PROGRAMMED NECROSIS; OXIDATIVE STRESS; GRANULE NEURONS; ABASIC SITES; ACTIVATION	Alkylating agents are ubiquitous in our internal and external environments, causing DNA damage that contributes to mutations and cell death that can result in aging, tissue degeneration and cancer. Repair of methylated DNA bases occurs primarily through the base excision repair (BER) pathway, a multi-enzyme pathway initiated by the alkyladenine DNA glycosylase (Aag, also known as Mpg). Previous work demonstrated that mice treated with the alkylating agent methyl methanesulfonate (MMS) undergo cerebellar degeneration in an Aag-dependent manner, whereby increased BER initiation by Aag causes increased tissue damage that is dependent on activation of poly (ADP-ribose) polymerase 1 (Parp1). Here, we dissect the molecular mechanism of cerebellar granule neuron (CGN) sensitivity to MMS using primary ex vivo neuronal cultures. We first established a high-throughput fluorescent imaging method to assess primary neuron sensitivity to treatment with DNA damaging agents. Next, we verified that the alkylation sensitivity of CGNs is an intrinsic phenotype that accurately recapitulates the in vivo dependency of alkylation-induced CGN cell death on Aag and Parp1 activity. Finally, we show that MMS-induced CGN toxicity is independent of all the cellular events that have previously been associated with Parp-mediated toxicity, including mitochondrial depolarization, AIF translocation, calcium fluxes, and NAD(+) consumption. We therefore believe that further investigation is needed to adequately describe all varieties of Parp-mediated cell death.	[Margulies, Carrie M.; Chaim, Isaac Alexander; Mazumder, Aprotim; Criscione, June; Samson, Leona D.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Margulies, Carrie M.; Chaim, Isaac Alexander; Mazumder, Aprotim; Criscione, June; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Samson, LD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Samson, LD (corresponding author), MIT, Ctr Environm Hlth Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Samson, LD (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Samson, LD (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsamson@mit.edu		/0000-0002-7112-1454; Mazumder, Aprotim/0000-0002-3443-3010	National Institutes of Health [R01-ES022872]; Ellison Medical Foundation Senior Scholar Award [AG-SS-3046-12]; National Institute of Environmental Health Sciences [P30-ES002109]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar Award(Lawrence Ellison Foundation); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health (https://www.edu.gov/) R01-ES022872 and an Ellison Medical Foundation Senior Scholar Award (AG-SS-3046-12) (http:// ellisonfoundation.org/); LDS is an American Cancer Society Research Professor. Imaging core facilities at the Center for Environmental Health Sciences were supported by P30-ES002109 from the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Calvo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003413; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Gray JJ, 2013, BRAIN RES, V1494, P28, DOI 10.1016/j.brainres.2012.12.001; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Heacock ML, 2010, DNA REPAIR, V9, P929, DOI 10.1016/j.dnarep.2010.05.007; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Horton JK, 2005, J BIOL CHEM, V280, P15773, DOI 10.1074/jbc.M413841200; Jelinic P, 2014, MOL CANCER THER, V13, P1645, DOI 10.1158/1535-7163.MCT-13-0906-T; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kedar PS, 2012, MOL CANCER RES, V10, P360, DOI 10.1158/1541-7786.MCR-11-0477; Kouzoukas DE, 2013, J NEUROCHEM, V124, P323, DOI 10.1111/jnc.12076; Lee HY, 2009, J VIS EXP; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Pankotai E, 2009, MITOCHONDRION, V9, P159, DOI 10.1016/j.mito.2009.01.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Prasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124269; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Sharma J, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-9; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Sousa FG, 2012, CARCINOGENESIS, V33, P1433, DOI 10.1093/carcin/bgs132; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weerasooriya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107915; Xu XS, 2010, BRAIN RES, V1343, P206, DOI 10.1016/j.brainres.2010.04.080; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Zhang FJ, 2012, TOXICOL SCI, V128, P103, DOI 10.1093/toxsci/kfs142	67	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184619	10.1371/journal.pone.0184619	http://dx.doi.org/10.1371/journal.pone.0184619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886188	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100170
J	Zahedi, K; Barone, S; Destefano-Shields, C; Brooks, M; Murray-Stewart, T; Dunworth, M; Li, WM; Doherty, JR; Hall, MA; Smith, RD; Cleveland, JL; Casero, RA; Soleimani, M				Zahedi, Kamyar; Barone, Sharon; Destefano-Shields, Christina; Brooks, Marybeth; Murray-Stewart, Tracy; Dunworth, Matthew; Li, Weimin; Doherty, Joanne R.; Hall, Mark A.; Smith, Roger D.; Cleveland, John L.; Casero, Robert A., Jr.; Soleimani, Manoocher			Activation of endoplasmic reticulum stress response by enhanced polyamine catabolism is important in the mediation of cisplatininduced acute kidney injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; LYSOSOMAL MEMBRANE PERMEABILIZATION; DNA-DAMAGE RESPONSE; HYDROGEN-PEROXIDE; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; ALDEHYDE LOAD; CELL-DEATH; REACTIVE ALDEHYDES; CEREBRAL-ISCHEMIA; SPERMINE OXIDASE	Cisplatin-induced nephrotoxicity limits its use in many cancer patients. The expression of enzymes involved in polyamine catabolism, spermidine/spermine N-1 - acetyltransferase (SSAT) and spermine oxidase (SMOX) increase in the kidneys of mice treated with cisplatin. We hypothesized that enhanced polyamine catabolism contributes to tissue damage in cisplatin acute kidney injury (AKI). Using gene knockout and chemical inhibitors, the role of polyamine catabolism in cisplatin AKI was examined. Deficiency of SSAT, SMOX or neutralization of the toxic products of polyamine degradation, H2O2 and aminopropanal, significantly diminished the severity of cisplatin AKI. In vitro studies demonstrated that the induction of SSAT and elevated polyamine catabolism in cells increases the phosphorylation of eukaryotic translation initiation factor 2 alpha(eIF2 alpha) and enhances the expression of binding immunoglobulin protein BiP/GRP78) and CCAAT-enhancer- binding protein homologous protein (CHOP/GADD153). The increased expression of these endoplasmic reticulum stress response (ERSR) markers was accompanied by the activation of caspase-3. These results suggest that enhanced polyamine degradation in cisplatin AKI may lead to tubular damage through the induction of ERSR and the consequent onset of apoptosis. In support of the above, we show that the ablation of the SSAT or SMOX gene, as well as the neutralization of polyamine catabolism products modulate the onset of ERSR (e.g. lower BiP and CHOP) and apoptosis (e.g. reduced activated caspase-3). These studies indicate that enhanced polyamine catabolism and its toxic products are important mediators of ERSR and critical to the pathogenesis of cisplatin AKI.	[Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Brooks, Marybeth; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Ctr Genet Transport, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Destefano-Shields, Christina; Murray-Stewart, Tracy; Dunworth, Matthew; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Li, Weimin] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL USA; [Li, Weimin; Doherty, Joanne R.; Hall, Mark A.; Cleveland, John L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Smith, Roger D.; Cleveland, John L.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; Johns Hopkins University; Johns Hopkins Medicine; H Lee Moffitt Cancer Center & Research Institute; Scripps Research Institute; University System of Ohio; University of Cincinnati	Zahedi, K; Soleimani, M (corresponding author), Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45220 USA.; Zahedi, K; Soleimani, M (corresponding author), Univ Cincinnati, Coll Med, Ctr Genet Transport, Cincinnati, OH 45220 USA.; Zahedi, K; Soleimani, M (corresponding author), Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA.	zahedika@ucmail.uc.edu; soleimm@ucmail.uc.edu	Stewart, Tracy Murray/B-6137-2017; 黎, 伟/GXM-4040-2022; soleimani, m/U-6889-2017; Doherty, Joanne/AAU-3288-2020; Zahedi, Kamyar/AAQ-3428-2021	Stewart, Tracy Murray/0000-0001-8679-6414; soleimani, m/0000-0002-3446-8870; Casero, Robert/0000-0001-5653-3306; Dunworth, Matthew/0000-0002-8852-169X; Doherty, Joanne/0000-0003-2705-5194; DeStefano Shields, Christina/0000-0003-4714-3423	National Institutes of Health [CA100603, CA-204345]; Maryland Cigarette Restitution Fund; Veterans Administration [5 I01 BX001000-06]; Center for Genetics of Transport and Epithelial Biology; NATIONAL CANCER INSTITUTE [R01CA204345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; Veterans Administration(US Department of Veterans Affairs); Center for Genetics of Transport and Epithelial Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health Grant CA100603 (JLC); National Institutes of Health Grant CA-204345 (RAC); Maryland Cigarette Restitution Fund (RAC); Veterans Administration 5 I01 BX001000-06 (MS); Center for Genetics of Transport and Epithelial Biology (MS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; BRUNK UT, 1995, FREE RADICAL BIO MED, V19, P813, DOI 10.1016/0891-5849(95)02001-Q; BRUNK UT, 1995, REDOX REP, V1, P267, DOI 10.1080/13510002.1995.11746997; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; HASAN R, 1995, FEBS LETT, V368, P27, DOI 10.1016/0014-5793(95)00591-V; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanova S, 2002, P NATL ACAD SCI USA, V99, P5579, DOI 10.1073/pnas.082609299; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Li SY, 2009, J MOL CELL CARDIOL, V47, P247, DOI 10.1016/j.yjmcc.2009.03.017; Liu H, 2005, J AM SOC NEPHROL, V16, P1985, DOI 10.1681/ASN.2004090768; Mandal A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25795; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mohammad MK, 2012, TOXICOL APPL PHARM, V265, P73, DOI 10.1016/j.taap.2012.09.021; Murray-Stewart T, 2016, ONCOGENE, V35, P5480, DOI 10.1038/onc.2016.91; Niiranen K, 2002, J BIOL CHEM, V277, P25323, DOI 10.1074/jbc.M203599200; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Pallepati P, 2011, BBA-MOL CELL RES, V1813, P1987, DOI 10.1016/j.bbamcr.2011.07.021; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Sun ZL, 2008, AM J PHYSIOL-RENAL, V294, pF491, DOI 10.1152/ajprenal.00263.2007; Tanel A, 2014, BBA-MOL CELL RES, V1843, P827, DOI 10.1016/j.bbamcr.2013.12.012; Wang ZH, 2004, J AM SOC NEPHROL, V15, P1844, DOI 10.1097/01.ASN.0000131525.77636.D5; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zahedi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110161; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008; Zhu SY, 2015, ARCH TOXICOL, V89, P2197, DOI 10.1007/s00204-015-1633-3	48	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184570	10.1371/journal.pone.0184570	http://dx.doi.org/10.1371/journal.pone.0184570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886181	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100159
J	Tu, Q; Hao, J; Zhou, X; Yan, L; Dai, H; Sun, B; Yang, D; An, S; Lv, L; Jiao, B; Chen, C; Lai, R; Shi, P; Zhao, X				Tu, Q.; Hao, J.; Zhou, X.; Yan, L.; Dai, H.; Sun, B.; Yang, D.; An, S.; Lv, L.; Jiao, B.; Chen, C.; Lai, R.; Shi, P.; Zhao, X.			CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A	ONCOGENE			English	Article							ONCOGENIC K-RAS; DUCTAL ADENOCARCINOMA; INDUCED SENESCENCE; ACINAR-CELLS; TGF-BETA; TRANSCRIPTION; P15(INK4B); COOPERATE; MOUSE; PROGRESSION	Pancreatic cancer is among the deadliest malignancies; however, the genetic events that lead to pancreatic carcinogenesis in adults remain unclear. In vivo models in which these genetic alterations occur in adult animals may more accurately reflect the features of human cancer. In this study, we demonstrate that inactivation of Cdkn2b (p15ink4b) is necessary for induction of pancreatic cancer by oncogenic KRAS(G12D) expression and inactivation of Tp53 and Cdkn2a in adult mouse pancreatic ductal cells (P60 or older). KRAS(G12D) overexpression in these cells activated transforming growth factor-beta signaling and expression of CDKN2B, which, along with CDKN2A, led to cellular senescence and protected cells from KRAS-mediated transformation via inhibition of retinoblastoma phosphorylation. These results show a critical role of CDKN2B inactivation in pancreatic carcinogenesis, and provide a useful adult animal model by genetic engineering via lentiviral delivery.	[Tu, Q.; Zhou, X.; Yan, L.; Dai, H.; Sun, B.; Yang, D.; An, S.; Chen, C.; Lai, R.; Zhao, X.] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, 32 East Jiaochang Rd, Kunming 650223, Yunnan, Peoples R China; [Tu, Q.; Zhou, X.; Sun, B.; Yang, D.; An, S.] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Hao, J.; Jiao, B.; Shi, P.] Chinese Acad Sci, Kunming Inst Zool, Lab Evolutionary & Funct Genom, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Yan, L.; Lv, L.; Zhao, X.] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China; [Zhao, X.] Soochow Univ, KIZ SU Joint Lab Anim Model & Drug Dev, Coll Pharmaceut Sci, Suzhou, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Soochow University - China	Shi, P; Zhao, X (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Key Lab Bioact Peptides Yunnan Prov, Kunming Inst Zool, 32 East Jiaochang Rd, Kunming 650223, Yunnan, Peoples R China.	ship@mail.kiz.ac.cn; zhaoxudong@mail.kiz.ac.cn	Shi, Peng/B-3372-2008	Shi, Peng/0000-0002-4075-4902; zhao, zhao xu dong/0000-0001-9126-7365; Sun, Bin/0000-0002-5663-4294	'Strategic Priority Research Program' of the Chinese Academy of Sciences [XDB13020400, XDA 01040403]; National Natural Science Foundation of China (NSFC) [81472862]; Top Talents Program of Yunnan Province, China [2012HA014]	'Strategic Priority Research Program' of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Top Talents Program of Yunnan Province, China	We thank Dr Ronald Depinho, Dr Gerry Chu and Dr Haoqiang Ying for constructive opinions on this study. We thank Dr Antonio Lavarone for the useful discussion on the regulation of CDKN2B. We thank Dr Jumin Zhou for manuscript revision. We thank Yujie Xia for technical assistance with the histological analysis. This work was supported by by the 'Strategic Priority Research Program' of the Chinese Academy of Sciences (grant no. XDB13020400 to PS and XDA 01040403 to XZ), the National Natural Science Foundation of China (NSFC, 81472862) and the Top Talents Program of Yunnan Province, China (2012HA014) to XZ.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bailey JM, 2016, ONCOGENE, V35, P4282, DOI 10.1038/onc.2015.441; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Ben-Chetrit N, 2013, CELL ADHES MIGR, V7, P33, DOI 10.4161/cam.22263; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; DiMauro T, 2010, CURR CANCER DRUG TAR, V10, P869, DOI 10.2174/156800910793357998; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gopinathan A, 2015, DIS MODEL MECH, V8, P1185, DOI 10.1242/dmm.021055; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Houbracken I, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-74; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohn D. F., 1997, ANESTHESIA ANALGESIA; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; McNeal AS, 2015, CANCER DISCOV, V5, P1072, DOI 10.1158/2159-8290.CD-15-0196; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Schuster K, 2014, MOL CANCER RES, V12, P912, DOI 10.1158/1541-7786.MCR-13-0620-T; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Singh SK, 2013, GUT, V62, P1364, DOI 10.1136/gutjnl-2012-302793; Tanaka H, 2010, CANCER SCI, V101, P341, DOI 10.1111/j.1349-7006.2009.01410.x; Tang Y, 2015, ONCOL LETT, V9, P55, DOI 10.3892/ol.2014.2684; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115	49	27	27	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					128	138		10.1038/onc.2017.316	http://dx.doi.org/10.1038/onc.2017.316			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28892048	Green Published, hybrid			2022-12-26	WOS:000422625000013
J	Aziz, Q; Li, YW; Anderson, N; Ojake, L; Tsisanova, E; Tinker, A				Aziz, Qadeer; Li, Yiwen; Anderson, Naomi; Ojake, Leona; Tsisanova, Elena; Tinker, Andrew			Molecular and functional characterization of the endothelial ATP-sensitive potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERIAL SMOOTH-MUSCLE; PROTEIN-KINASE-A; CORONARY-ARTERY; K+ CHANNEL; ADENOSINE; ACTIVATION; CELLS; SUBUNIT; KIR6.1; FLOW	ATP-sensitive potassium (K-ATP) channels are widely expressed in the cardiovascular system, where they regulate a range of biological activities by linking cellular metabolism with membrane excitability. K-ATP channels in vascular smooth muscle have a well-defined role in regulating vascular tone. K-ATP channels are also thought to be expressed in vascular endothelial cells, but their presence and function in this context are less clear. As a result, we aimed to investigate the molecular composition and physiological role of endothelial K-ATP channels. We first generated mice with an endothelial specific deletion of the channel subunit Kir6.1 (eKO) using cre-loxP technology. Data from qRT-PCR, patch clamp, ex vivo coronary perfusion Langendorff heart experiments, and endothelial cell Ca2+ imaging comparing eKO and wild-type mice show that Kir6.1-containing K-ATP channels are indeed present in vascular endothelium. An increase in intracellular [Ca2+], which is central to changes in endothelial function such as mediator release, at least partly contributes to the endothelium-dependent vasorelaxation induced by the K-ATP channel opener pinacidil. The absence of Kir6.1 did not elevate basal coronary perfusion pressure in eKO mice. However, vasorelaxation was impaired during hypoxia in the coronary circulation, and this resulted in greater cardiac injury during ischemia-reperfusion. The response to adenosine receptor stimulation was impaired in eKO mice in single cells in patch clamp recordings and in the intact coronary circulation. Our data support the existence of an endothelial K-ATP channel that contains Kir6.1, is involved in vascular reactivity in the coronary circulation, and has a protective role in ischemia reperfusion.	[Aziz, Qadeer; Li, Yiwen; Anderson, Naomi; Ojake, Leona; Tsisanova, Elena; Tinker, Andrew] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Heart Ctr, Charterhouse Sq, London EC1M 6BQ, England	University of London; Queen Mary University London	Tinker, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Heart Ctr, Charterhouse Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk	Tsisanova, Elena/P-5553-2018	Tsisanova, Elena/0000-0003-3927-7894; Aziz, Qadeer/0000-0002-7636-6813; Aziz, Qasim/0000-0002-2718-2065	British Heart Foundation [RG/15/15/31742]; British Heart Foundation [PG/17/59/33139] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grant RG/15/15/31742 and was facilitated by the National Institute for Health Research Biomedical Research Centre at Barts. The authors declare that they have no conflicts of interest with the contents of this article.	Aziz Q, 2015, CHANNELS, V9, P3, DOI 10.1080/19336950.2015.1004289; Aziz Q, 2014, HYPERTENSION, V64, P523, DOI 10.1161/HYPERTENSIONAHA.114.03116; Aziz Q, 2012, J BIOL CHEM, V287, P6196, DOI 10.1074/jbc.M111.243923; Bell RM, 2011, J MOL CELL CARDIOL, V50, P940, DOI 10.1016/j.yjmcc.2011.02.018; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cheng K. T., 2016, VASCULAR ION CHANNEL; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; DART C, 1993, J PHYSIOL-LONDON, V471, P767, DOI 10.1113/jphysiol.1993.sp019927; Edwards DH, 2008, ARTERIOSCL THROM VAS, V28, P1774, DOI 10.1161/ATVBAHA.108.172692; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Emerson GG, 2001, AM J PHYSIOL-HEART C, V280, pH160; Fedorov VV, 2011, J MOL CELL CARDIOL, V51, P215, DOI 10.1016/j.yjmcc.2011.04.016; Gao S, 2009, CARDIOVASC RES, V83, P444, DOI 10.1093/cvr/cvp099; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Katnik C, 1997, AM J PHYSIOL-HEART C, V272, pH2507, DOI 10.1152/ajpheart.1997.272.5.H2507; KATNIK C, 1995, J PHYSIOL-LONDON, V485, P595, DOI 10.1113/jphysiol.1995.sp020755; Kleppisch T, 1995, P NATL ACAD SCI USA, V92, P12441, DOI 10.1073/pnas.92.26.12441; KUO L, 1995, AM J PHYSIOL-HEART C, V269, pH541, DOI 10.1152/ajpheart.1995.269.2.H541; Langheinrich U, 1998, PFLUG ARCH EUR J PHY, V435, P435, DOI 10.1007/s004240050536; Li AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000365; Malester B, 2007, FASEB J, V21, P2162, DOI 10.1096/fj.06-7821com; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; NAKHOSTINE N, 1993, AM J PHYSIOL, V265, pH1289, DOI 10.1152/ajpheart.1993.265.4.H1289; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; Pagliaro P, 2000, CARDIOVASC RES, V45, P1001, DOI 10.1016/S0008-6363(99)00414-9; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; QUAYLE JM, 1994, J PHYSIOL-LONDON, V475, P9, DOI 10.1113/jphysiol.1994.sp020045; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; RANDALL MD, 1995, BRIT J PHARMACOL, V116, P3068, DOI 10.1111/j.1476-5381.1995.tb15965.x; Rossello X, 2016, J CARDIOVASC PHARM T, V21, P286, DOI 10.1177/1074248415604462; Schnitzler MMY, 2000, J PHYSIOL-LONDON, V525, P307, DOI 10.1111/j.1469-7793.2000.t01-1-00307.x; Seino S, 2004, J PHYSIOL-LONDON, V554, P295, DOI 10.1113/jphysiol.2003.047175; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; Tinker A, 2014, BRIT J PHARMACOL, V171, P12, DOI 10.1111/bph.12407; Wang H, 2007, CARDIOVASC RES, V73, P497, DOI 10.1016/j.cardiores.2006.10.007; Yoshida H, 2004, J MOL CELL CARDIOL, V37, P857, DOI 10.1016/j.yjmcc.2004.05.022	40	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17587	17597		10.1074/jbc.M117.810325	http://dx.doi.org/10.1074/jbc.M117.810325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893911	hybrid, Green Published			2022-12-26	WOS:000414013000002
J	Jafamezhadgero, AA; Shad, MM; Majlesi, M; Granacher, U				Jafamezhadgero, Amir Ali; Shad, Morteza Madadi; Majlesi, Mandi; Granacher, Urs			A comparison of running kinetics in children with and without genu varus: A cross sectional study	PLOS ONE			English	Article							GROUND REACTION FORCE; KNEE OSTEOARTHRITIS; PATELLOFEMORAL PAIN; FRONTAL-PLANE; RISK-FACTORS; LOADING RATE; FREE MOMENT; WALKING; GAIT; KINEMATICS	Introduction Varus knee alignment has been identified as a risk factor for the progression of medial knee osteoarthritis. However, the underlying mechanisms have not been elucidated yet in children. Thus, the aims of the present study were to examine differences in ground reaction forces, loading rate, impulses, and free moment values during running in children with and without genu varus. Methods Thirty-six boys aged 9-14 volunteered to participate in this study. They were divided in two age-matched groups (genu varus versus healthy controls). Body weight adjusted three dimensional kinetic data (Fx, Fy, Fz) were collected during running at preferred speed using two Kistler force plates for the dominant and non-dominant limb. Results Individuals with knee genu varus produced significantly higher (p = .01; d = 1.09; 95%) body weight adjusted ground reaction forces in the lateral direction (Fx) of the dominant limb compared to controls. On the non-dominant limb, genu varus patients showed significantly higher body weight adjusted ground reaction forces values in the lateral (p = .01; d = 1.08; 86%) and medial (p < .001; d = 1.55; 102%) directions (Fx). Further, genu varus patients demonstrated 55% and 36% greater body weight adjusted loading rates in the dominant (p < .001; d = 2.09) and non-dominant (p < .001; d = 1.02) leg, respectively. No significant between-group differences were observed for adjusted free moment values (p>.05). Discussion Higher mediolateral ground reaction forces and vertical loading rate amplitudes in boys with genu varus during running at preferred running speed may accelerate the development of progressive joint degeneration in terms of the age at knee osteoarthritis onset. Therefore, practitioners and therapists are advised to conduct balance and strength training programs to improve lower limb alignment and mediolateral control during dynamic movements.	[Jafamezhadgero, Amir Ali; Shad, Morteza Madadi] Univ Mohaghegh Ardabili, Dept Phys Educ & Sport Sci, Ardebil, Iran; [Majlesi, Mandi] Islamic Azad Univ, Hamedan Branch, Dept Sport Biomech, Fac Humanities, Hamadan, Iran; [Granacher, Urs] Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany	University of Mohaghegh Ardabili; Islamic Azad University; University of Potsdam	Granacher, U (corresponding author), Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany.	urs.granacher@uni-potsdam.de	Granacher, Urs/T-9900-2017; Granacher, Urs/N-1963-2019; Granacher, Urs/GXM-3858-2022; Jafarnezhadgero, AmirAli/AAE-2249-2019	Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Jafarnezhadgero, AmirAli/0000-0002-2739-4340; Majlesi, Mahdi/0000-0003-2032-4937	Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of University of Potsdam; Open Access Publishing Fund of University of Potsdam, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam; Open Access Publishing Fund of University of Potsdam, Germany	We acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of University of Potsdam. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank all children and their parents for their participation and cooperation in this study. We acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of University of Potsdam, Germany.	Ackerman IN, 2017, J ORTHOP SPORT PHYS, V47, P67, DOI 10.2519/jospt.2017.7286; Almosnino S., 2009, MED REHABIL, V1, P1, DOI DOI 10.1186/1758-2555-1-19; Anbarian M, 2015, GAIT POSTURE, V42, pS39; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Barrios JA, 2009, CLIN BIOMECH, V24, P850, DOI 10.1016/j.clinbiomech.2009.07.016; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Brouwer GM, 2007, ARTHRITIS RHEUM, V56, P1204, DOI 10.1002/art.22515; Burr DB, 2003, RHEUM DIS CLIN N AM, V29, P675, DOI 10.1016/S0889-857X(03)00061-9; Butler RJ, 2011, PHYS THER, V91, P1235, DOI 10.2522/ptj.20100324; Caine D, 2006, BRIT J SPORT MED, V40, P749, DOI 10.1136/bjsm.2005.017822; Cheung RTH, 2011, J ORTHOP SPORT PHYS, V41, P914, DOI 10.2519/jospt.2011.3771; Chockalingam N., 2008, SCOLIOSIS, V3, P1, DOI DOI 10.1186/1748-7161-3-10); Cohen J.E., 1988, STAT POWER ANAL BEHA; Crowell HP, 2011, CLIN BIOMECH, V26, P78, DOI 10.1016/j.clinbiomech.2010.09.003; Damavandi M, 2012, HUM MOVEMENT SCI, V31, P182, DOI 10.1016/j.humov.2011.06.004; Davis IS, 2010, MED SCI SPORT EXER, V42, P682, DOI 10.1249/01.MSS.0000385903.65728.85; Flatters K, 2017, J SCI MED SPORT, V20, pe30; Fukaya T, 2015, KNEE, V22, P213, DOI 10.1016/j.knee.2015.02.012; Gatti AA, 2017, J BIOMECH; Gay RE, 2008, CLIN BIOMECH, V23, P1, DOI 10.1016/j.clinbiomech.2007.08.006; Gruber AH, 2014, J SPORT HEALTH SCI, V3, P113, DOI 10.1016/j.jshs.2014.03.004; HOLDEN JP, 1991, J BIOMECH, V24, P887, DOI 10.1016/0021-9290(91)90167-L; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Jafarnezhadgero AA, 2017, GAIT POSTURE, V55, P75, DOI 10.1016/j.gaitpost.2017.04.011; Jafarnezhadgero AA, 2017, GAIT POSTURE, V53, P236, DOI 10.1016/j.gaitpost.2017.02.006; John CT, 2012, J BIOMECH, V45, P2438, DOI 10.1016/j.jbiomech.2012.06.037; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kubo M, 2006, GAIT POSTURE, V23, P512, DOI 10.1016/j.gaitpost.2005.06.007; Kuhman DJ, 2016, HUM MOVEMENT SCI, V47, P9, DOI 10.1016/j.humov.2016.01.013; LAFORTUNE MA, 1992, CLIN BIOMECH, V7, P181, DOI 10.1016/0268-0033(92)90034-2; Liikavainio T, 2010, KNEE, V17, P69, DOI 10.1016/j.knee.2009.05.003; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; MARKS R, 1994, J THEOR BIOL, V170, P283, DOI 10.1006/jtbi.1994.1189; Miller RH, 2015, GAIT POSTURE, V41, P326, DOI 10.1016/j.gaitpost.2014.10.009; Milner CE, 2006, J BIOMECH, V39, P2819, DOI 10.1016/j.jbiomech.2005.09.022; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; Pamukoff DN, 2016, CLIN BIOMECH, V33, P61, DOI 10.1016/j.clinbiomech.2016.02.007; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Robertson G, 2013, RES METHODS BIOMECHA; Rodrigues P, 2013, J APPL BIOMECH, V29, P141, DOI 10.1123/jab.29.2.141; Sheerin KR, 2012, PHYS THER SPORT, V13, P250, DOI 10.1016/j.ptsp.2012.01.003; Silva DD, 2015, CLIN BIOMECH, V30, P971, DOI 10.1016/j.clinbiomech.2015.06.021; Specogna Adrian V, 2004, J Knee Surg, V17, P203; Stief F, 2014, KNEE, V21, P688, DOI 10.1016/j.knee.2014.03.004; Stief F, 2011, GAIT POSTURE, V33, P490, DOI 10.1016/j.gaitpost.2011.01.001; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Tweed JL, 2008, J AM PODIAT MED ASSN, V98, P436, DOI 10.7547/0980436; Willems TM, 2006, GAIT POSTURE, V23, P91, DOI 10.1016/j.gaitpost.2004.12.004; Willwacher S, 2016, FOOTWEAR SCI, V8, P1, DOI 10.1080/19424280.2015.1119890; Wolf S, 2008, GAIT POSTURE, V27, P51, DOI 10.1016/j.gaitpost.2007.01.005; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	52	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185057	10.1371/journal.pone.0185057	http://dx.doi.org/10.1371/journal.pone.0185057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926635	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600065
J	Mei, YJ; Liu, H; Zhang, SX; Yang, M; Hu, C; Zhang, J; Shen, P; Chen, XD				Mei, Yunjun; Liu, Huan; Zhang, Shunxi; Yang, Ming; Hu, Chun; Zhang, Jian; Shen, Ping; Chen, Xiangdong			Effects of salinity on the cellular physiological responses of Natrinema sp.J7-2	PLOS ONE			English	Article							GENE-EXPRESSION DATA; HALOBACTERIUM-SALINARUM NRC-1; EXTREMELY HALOPHILIC BACTERIA; SALT STRESS; RNA-SEQ; ARCHAEA; OSMOADAPTATION; SPECTROSCOPY; ADAPTATION; SURVIVAL	The halophilic archaea (haloarchaea) live in hyersaline environments such as salt lakes, salt ponds and marine salterns. To cope with the salt stress conditions, haloarchaea have developed two fundamentally different strategies: the "salt-in" strategy and the "compatiblesolute" strategy. Although investigation of the molecular mechanisms underlying the tolerance to high salt concentrations has made outstanding achievements, experimental study from the aspect of transcription is rare. In the present study, we monitored cellular physiology of Natrinema sp.J7-2 cells incubated in different salinity media (15%, 25% and 30% NaCl) from several aspects, such as cellular morphology, growth, global transcriptome and the content of intracellular free amino acids. The results showed that the cells were polymorphic and fragile at a low salt concentration (15% NaCl) but had a long, slender rod shape at high salt concentrations (25% and 30% NaCl). The cells grew best in 25% NaCl, mediocre in 30% NaCl and struggled in 15% NaCl. An RNA-seq analysis revealed differentially expressed genes (DEGs) in various salinity media. A total of 1,148 genes were differentially expressed, consisting of 719 DEGs (348 up-regulated and 371 down-regulated genes) between cells in 15% vs 25% NaCl, and 733 DEGs (521 up-regulated and 212 down-regulated genes) between cells in 25% vs 30% NaCl. Moreover, 304 genes were commonly differentially expressed in both 15% vs 25% and 25% vs30% NaCl. The DEGs were enriched in different KEGG metabolic pathways, such as amino acids, glycerolipid, ribosome, nitrogen, protoporphyrin, porphyrin and porhiniods. The intracellular predominant free amino acids consisted of the glutamate family (Glu, Arg and Pro), aspartate family (Asp) and aromatic amino acids (Phe and Trp), especially Glu and Asp.	[Mei, Yunjun; Liu, Huan; Zhang, Shunxi; Yang, Ming; Hu, Chun; Zhang, Jian] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China; [Shen, Ping; Chen, Xiangdong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Wuhan Polytechnic University; Wuhan University	Mei, YJ (corresponding author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China.; Chen, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	meiyunjun_2000@163.com; xdchen@whu.edu.cn			National Natural Science Foundation of China [31270215, 31570174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by grants from the National Natural Science Foundation of China (Grants No. 31270215 to Y. Mei and 31570174 to X. Chen), http.//www.nsfc.gov.cn/.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chen Y, 2001, AMINO ACIDS BIOTIC R, V23, P47; Coker James A, 2007, Saline Syst, V3, P6, DOI 10.1186/1746-1448-3-6; da Costa M. S., 1998, V61, P117; Dawson KS, 2012, ORG GEOCHEM, V48, P1, DOI 10.1016/j.orggeochem.2012.04.003; Disalvo EA, 2008, BBA-BIOMEMBRANES, V1778, P2655, DOI 10.1016/j.bbamem.2008.08.025; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Fang SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1287-9; Fendrihan S, 2012, GEOBIOLOGY, V10, P424, DOI 10.1111/j.1472-4669.2012.00337.x; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041621; Ferrer C, 1996, J BACTERIOL, V178, P309, DOI 10.1128/jb.178.1.309-313.1996; Galinski E A, 1995, Adv Microb Physiol, V37, P272, DOI 10.1016/S0065-2911(08)60148-4; Goldstein JI, 1981, SCANNING ELECTRON MI, P495; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; IMHOFF JF, 1984, J BACTERIOL, V160, P478, DOI 10.1128/JB.160.1.478-479.1984; Jensen MW, 2015, EXTREMOPHILES, V19, P315, DOI 10.1007/s00792-014-0716-z; Joghee NN, 2014, BIOCHIMIE, V102, P102, DOI 10.1016/j.biochi.2014.02.015; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kellermann MY, 2016, BBA-BIOMEMBRANES, V1858, P2940, DOI 10.1016/j.bbamem.2016.08.010; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kokoeva MV, 2002, EMBO J, V21, P2312, DOI 10.1093/emboj/21.10.2312; Kurt-Kizildogan A, 2017, GENE, V601, P56, DOI 10.1016/j.gene.2016.11.042; KUSHWAHA SC, 1982, CAN J MICROBIOL, V28, P1365, DOI 10.1139/m82-203; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Leuko S, 2015, ASTROBIOLOGY, V15, P987, DOI 10.1089/ast.2015.1310; Leuko S, 2009, J PROTEOME RES, V8, P2218, DOI 10.1021/pr800663c; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; Mei YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123874; Moran-Reyna Coker JA, 2014, F1000RESEARCH, V3, P168; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Reina-Bueno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033587; ROBERTS MF, 1990, J BIOL CHEM, V265, P18207; Roberts MF, 2004, FRONT BIOSCI-LANDMRK, V9, P1999, DOI 10.2741/1366; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russell N. J., 1993, P163; RUSSELL NJ, 1989, J BIOENERG BIOMEMBR, V21, P93, DOI 10.1007/BF00762214; Shen P, 1994, Yi Chuan Xue Bao, V21, P409; STOECKENIUS W, 1967, J CELL BIOL, V34, P365, DOI 10.1083/jcb.34.1.365; Sun ZN, 2014, ANN APPL STAT, V8, P1022, DOI 10.1214/14-AOAS721; Vauclare P, 2015, EXTREMOPHILES, V19, P1099, DOI 10.1007/s00792-015-0782-x; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Woese CR., 1970, 20 S SOC GEN MICR, P39	50	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184974	10.1371/journal.pone.0184974	http://dx.doi.org/10.1371/journal.pone.0184974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926633	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600057
J	Wilms, T; Khan, G; Coates, PJ; Sgaramella, N; Fahraeus, R; Hassani, A; Philip, PS; Speak, LN; Califano, L; Colella, G; Olofsson, K; Loizou, C; Franco, R; Nylander, K				Wilms, Torben; Khan, Gulfaraz; Coates, Philip J.; Sgaramella, Nicola; Fahraeus, Robin; Hassani, Asma; Philip, Pretty S.; Speak, Lena Norberg; Califano, Luigi; Colella, Giuseppe; Olofsson, Katarina; Loizou, Christos; Franco, Renato; Nylander, Karin			No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue	PLOS ONE			English	Article							SUBTROPICAL ISLAND; SOUTHERN JAPAN; EXPRESSION; INFECTION; EBV; ASSOCIATION; PREVALENCE; PROTEIN; CANCER; HEAD	Squamous cell carcinoma of the head and neck (SCCHN) comprises a large group of cancers in the oral cavity and nasopharyngeal area that typically arise in older males in association with alcohol/tobacco usage. Within the oral cavity, the mobile tongue is the most common site for tumour development. The incidence of tongue squamous cell carcinoma (TSCC) is increasing in younger people, which has been suggested to associate with a viral aetiology. Two common human oncogenic viruses, human papilloma virus (HPV) and Epstein-Barr virus (EBV) are known causes of certain types of SCCHN, namely the oropharynx and nasopharynx, respectively. EBV infects most adults worldwide through oral transmission and establishes a latent infection, with sporadic productive viral replication and release of virus in the oral cavity throughout life. In view of the prevalence of EBV in the oral cavity and recent data indicating that it infects tongue epithelial cells and establishes latency, we examined 98 cases of primary squamous cell carcinoma of the mobile tongue and 15 cases of tonsillar squamous cell carcinoma for the presence of EBV-encoded RNAs (EBERs), EBV DNA and an EBV-encoded protein, EBNA-1. A commercially available in situ hybridisation kit targeting EBER transcripts (EBER-ISH) showed a positive signal in the cytoplasm and/or nuclei of tumour cells in 43% of TSCCs. However, application of control probes and RNase A digestion using in-house developed EBER-ISH showed identical EBER staining patterns, indicating non-specific signals. PCR analysis of the BamH1 W repeat sequences did not identify EBV genomes in tumour samples. Immunohistochemistry for EBNA-1 was also negative. These data exclude EBV as a potential player in TSCC in both old and young patients and highlight the importance of appropriate controls for EBER-ISH in investigating EBV in human diseases.	[Wilms, Torben; Speak, Lena Norberg; Olofsson, Katarina; Loizou, Christos] Umea Univ, Dept Clin Sci ENT, Umea, Sweden; [Khan, Gulfaraz; Hassani, Asma; Philip, Pretty S.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Tawam Hosp Campus, Al Ain, U Arab Emirates; [Coates, Philip J.; Fahraeus, Robin] Masaryk Mem Canc Inst, RECAMO, Zluty Kopec 7, Brno, Czech Republic; [Sgaramella, Nicola; Fahraeus, Robin; Nylander, Karin] Umea Univ, Dept Med Biosci, Umea, Sweden; [Fahraeus, Robin] Univ Paris Diderot, INSERM, UMRS1162, 27 Rue Juliette Dodu, Paris, France; [Califano, Luigi] Univ Naples Federico II, Dept Neurosci Reprod & Dent Sci, Naples, Italy; [Colella, Giuseppe] Univ Naples 2, Multidisciplinary Dept Med Surg & Dent Specialtie, Naples, Italy; [Franco, Renato] Univ Naples 2, Dipartimento Univ Anat Patol, Naples, Italy	Umea University; United Arab Emirates University; Masaryk Memorial Cancer Institute; Umea University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Naples Federico II; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Wilms, T (corresponding author), Umea Univ, Dept Clin Sci ENT, Umea, Sweden.; Nylander, K (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	Torben.wilms@vll.se; karin.nylander@umu.se	Loizou, Christos/S-1657-2019; Khan, Gulfaraz/AAC-2859-2022; Coates, Philip J/H-6854-2019; fahraeus, robin/K-8726-2014	Loizou, Christos/0000-0003-1247-8573; Khan, Gulfaraz/0000-0001-6836-1783; Coates, Philip J/0000-0003-1518-6306; , robin/0000-0003-0402-8492; Hassani, Asma/0000-0001-7792-2140	Lion's Cancer Research Foundation; Swedish Cancer Society [160336]; Vasterbotten County Council; Umea University; GACR [P206/12/G151]; UAEU [31M263, 31R090];  [MEYS-NPSI-L01413]	Lion's Cancer Research Foundation; Swedish Cancer Society(Swedish Cancer Society); Vasterbotten County Council; Umea University; GACR(Grant Agency of the Czech Republic); UAEU; 	This work was supported by Lion's Cancer Research Foundation, Umea University; the Swedish Cancer Society Contract number 160336; Vasterbotten County Council; Umea University; MEYS-NPSI-L01413; GACR P206/12/G151; and UAEU grants 31M263 and 31R090.; This study was supported by grants from Lion's Cancer Research Foundation, Umea. University; the Swedish Cancer Society Contract number 160336; Vasterbotten County Council; Umea. University; MEYS-NPSI-L01413; GACR P206/12/G151; and UAEU grants 31M263 and 31R090 awarded to GK.	Acharya S, 2015, J ORAL PATHOL MED, V44, P252, DOI 10.1111/jop.12231; Ahmed W, 2014, REV MED VIROL, V24, P3, DOI 10.1002/rmv.1763; CHEUNG A, 1982, J VIROL, V44, P286, DOI 10.1128/JVI.44.1.286-294.1982; COATES PJ, 1991, J CLIN PATHOL, V44, P115, DOI 10.1136/jcp.44.2.115; Cruz I, 1997, ORAL ONCOL, V33, P182, DOI 10.1016/S0964-1955(96)00054-1; Cruz I, 2000, INT J CANCER, V86, P356, DOI 10.1002/(SICI)1097-0215(20000501)86:3&lt;356::AID-IJC9&gt;3.0.CO;2-W; Daskalogianni C, 2015, J PATHOL, V235, P334, DOI 10.1002/path.4431; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Gondivkar SM, 2012, ORAL ONCOL, V48, P195, DOI 10.1016/j.oraloncology.2011.10.007; Gonzalez-Moles MA, 2002, LARYNGOSCOPE, V112, P482, DOI 10.1097/00005537-200203000-00014; Hassani A, 2015, EXP MOL PATHOL, V99, P558, DOI 10.1016/j.yexmp.2015.09.013; Hermann R M, 2004, Cancer Radiother, V8, P262, DOI 10.1016/j.canrad.2004.06.003; Higa M, 2003, ORAL ONCOL, V39, P405, DOI 10.1016/S1368-8375(02)00164-1; Higa M, 2002, J CLIN PATHOL, V55, P414, DOI 10.1136/jcp.55.6.414; Hutt-Fletcher LM, 2017, J VIROL, V91, DOI 10.1128/JVI.01677-16; Jiang R, 2012, ORAL ONCOL, V48, P836, DOI 10.1016/j.oraloncology.2012.03.017; Khammissa RAG, 2016, INT J DENT, V2016, DOI 10.1155/2016/4941783; KHAN G, 1992, AM J PATHOL, V140, P757; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Khan G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0260-1; Khan Gulfaraz, 2009, V511, P311, DOI 10.1007/978-1-59745-447-6_13; Kikuchi K, 2016, TUMOR BIOL, V37, P3389, DOI 10.1007/s13277-015-4167-7; Kis A, 2009, EUR J ORAL SCI, V117, P536, DOI 10.1111/j.1600-0722.2009.00660.x; Kobayashi I, 1999, J PATHOL, V189, P34, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;34::AID-PATH391&gt;3.0.CO;2-4; Lee N, 2016, P NATL ACAD SCI USA, V113, P3221, DOI 10.1073/pnas.1601773113; Llewellyn CD, 2001, ORAL ONCOL, V37, P401, DOI 10.1016/S1368-8375(00)00135-4; Loizou C, 2015, ONCOL LETT, V10, P3565, DOI 10.3892/ol.2015.3775; Longnecker R, 2013, FIELDS VIROLOGY, V2, P1898; Metgud R, 2012, ONCOL REV, V6, P164, DOI 10.4081/oncol.2012.e21; Nawandar DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005195; NIEDOBITEK G, 1991, J GEN VIROL, V72, P3035, DOI 10.1099/0022-1317-72-12-3035; Patel SC, 2011, J CLIN ONCOL, V29, P1488, DOI 10.1200/JCO.2010.31.7883; Prabhu SR, 2016, J CAN DENT ASSOC, V82; Sand L, 2014, MICROBES INFECT, V16, P371, DOI 10.1016/j.micinf.2014.02.009; Sgaramella N, 2015, BRIT J CANCER, V113, P321, DOI 10.1038/bjc.2015.207; Shamaa AA, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-45; Shimakage M, 2002, HUM PATHOL, V33, P608, DOI 10.1053/hupa.2002.129786; Tota JE, 2017, ORAL ONCOL, V67, P146, DOI 10.1016/j.oraloncology.2017.02.019; Tsao SW, 2015, J PATHOL, V235, P323, DOI 10.1002/path.4448; Vockerodt M, 2015, J PATHOL, V235, P312, DOI 10.1002/path.4459; Young LS, 2016, NAT REV CANCER, V16, P789, DOI 10.1038/nrc.2016.92; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991	43	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184201	10.1371/journal.pone.0184201	http://dx.doi.org/10.1371/journal.pone.0184201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926591	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600011
J	Jeeva, S; Pador, S; Voss, B; Ganaie, SS; Mir, MA				Jeeva, Subbiah; Pador, Sean; Voss, Brittany; Ganaie, Safder Saieed; Mir, Mohammad Ayoub			Crimean-Congo hemorrhagic fever virus nucleocapsid protein has dual RNA binding modes	PLOS ONE			English	Article							LA-CROSSE VIRUS; NUCLEOPROTEIN REVEALS; GLYCOPROTEINS GN; UUKUNIEMI VIRUS; TAIL DOMAINS; 5' TERMINUS; S-SEGMENT; CAP; REPLICATION; PANHANDLE	Crimean Congo hemorrhagic fever, a zoonotic viral disease, has high mortality rate in humans. There is currently no vaccine for Crimean Congo hemorrhagic fever virus (CCHFV) and chemical interventions are limited. The three negative sense genomic RNA segments of CCHFV are specifically encapsidated by the nucleocapsid protein into three ribonucleocapsids, which serve as templates for the viral RNA dependent RNA polymerase. Here we demonstrate that CCHFV nucleocapsid protein has two distinct binding modes for double and single strand RNA. In the double strand RNA binding mode, the nucleocapsid protein preferentially binds to the vRNA panhandle formed by the base pairing of complementary nucleotides at the 5' and 3' termini of viral genome. The CCHFV nucleocapsid protein does not have RNA helix unwinding activity and hence does not melt the duplex vRNA panhandle after binding. In the single strand RNA binding mode, the nucleocapsid protein does not discriminate between viral and non-viral RNA molecules. Binding of both vRNA panhandle and single strand RNA induce a conformational change in the nucleocapsid protein. Nucleocapsid protein remains in a unique conformational state due to simultaneously binding of structurally distinct vRNA panhandle and single strand RNA substrates. Although the role of dual RNA binding modes in the virus replication cycle is unknown, their involvement in the packaging of viral genome and regulation of CCHFV replication in conjunction with RdRp and host derived RNA regulators is highly likely.	[Jeeva, Subbiah; Pador, Sean; Voss, Brittany; Ganaie, Safder Saieed; Mir, Mohammad Ayoub] Western Univ Hlth Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Mir, MA (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.	mmir@westernu.edu	Ganaie, Safder/AAH-5010-2020; Ganaie, Safder/AAB-8857-2022		internal grant (WUCVMMIR) from the College of Veterinary Medicine, Western University of Health Sciences; College of Veterinary Medicine	internal grant (WUCVMMIR) from the College of Veterinary Medicine, Western University of Health Sciences; College of Veterinary Medicine	This work was supported by the internal grant (WUCVMMIR) from the College of Veterinary Medicine, Western University of Health Sciences.; This work was supported by the internal grant support from the College of Veterinary Medicine. The authors would like thank Dr. Griffon (Associate dean for research) for continuous support, especially for supporting the purchase of BLITZ instrument used in this work. All authors read the manuscript before submitting for publication.	Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Cheng E, 2014, J VIROL; Cheng E, 2012, J VIROL, V86, P10173, DOI 10.1128/JVI.05560-11; Cheng E, 2011, J BIOL CHEM, V286, P11814, DOI 10.1074/jbc.M110.210179; Elliot R.M., 2000, VIRUS TAXONOMY, P599; Flick R, 2002, J VIROL, V76, P10849, DOI 10.1128/JVI.76.21.10849-10860.2002; Ganaie SS, 2014, BIOCH J; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P19365, DOI 10.1073/pnas.1108515108; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Hepojoki J, 2010, J GEN VIROL, V91, P2341, DOI 10.1099/vir.0.021006-0; HEWLETT MJ, 1977, J VIROL, V21, P1085, DOI 10.1128/JVI.21.3.1085-1093.1977; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Macleod JML, 2015, J GEN VIROL, V96, P524, DOI 10.1099/vir.0.071332-0; Mir MA, 2006, J VIROL, V80, P6276, DOI 10.1128/JVI.00147-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2006, RNA, V12, P272, DOI 10.1261/rna.2101906; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Mourya DT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001653; OBIJESKI JF, 1976, J VIROL, V19, P985, DOI 10.1128/JVI.19.3.985-997.1976; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Richmond KE, 1998, VIROLOGY, V248, P6, DOI 10.1006/viro.1998.9223; Salim NN, 2016, J BIOL CHEM, V291, P24702, DOI 10.1074/jbc.M116.750729; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Stefan MI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003106; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; Swanepoel R., 1994, INFECT DIS LIVESTOCK, P723; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Yu Guo WW, 2012, PNAS, V109, P5046	45	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184935	10.1371/journal.pone.0184935	http://dx.doi.org/10.1371/journal.pone.0184935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922369	Green Submitted, gold, Green Published			2022-12-26	WOS:000411059300047
J	Lin, Q; Liang, JR; Huang, QQ; Luo, CS; Anderson, DM; Bowler, C; Chen, CP; Li, XS; Gao, YH				Lin, Qun; Liang, Jun-Rong; Huang, Qian-Qian; Luo, Chun-Shan; Anderson, Donald M.; Bowler, Chris; Chen, Chang-Ping; Li, Xue-Song; Gao, Ya-Hui			Differential cellular responses associated with oxidative stress and cell fate decision under nitrate and phosphate limitations in Thalassiosira pseudonana: Comparative proteomics	PLOS ONE			English	Article							MARINE DIATOM; PHOTOSYSTEM-II; HIGHER-PLANTS; DEATH; NITROGEN; PROTEIN; PHOSPHORUS; PHYTOPLANKTON; INSIGHTS; OXIDASE	Diatoms are important components of marine ecosystems and contribute greatly to the world's primary production. Despite their important roles in ecosystems, the molecular basis of how diatoms cope with oxidative stress caused by nutrient fluctuations remains largely unknown. Here, an isobaric tags for relative and absolute quantitation (iTRAQ) proteomic method was coupled with a series of physiological and biochemical techniques to explore oxidative stress- and cell fate decision-related cellular and metabolic responses of the diatom Thalassiosira pseudonana to nitrate (N) and inorganic phosphate (P) stresses. A total of 1151 proteins were detected; 122 and 56 were significantly differentially expressed from control under N- and P-limited conditions, respectively. In N- limited cells, responsive proteins were related to reactive oxygen species (ROS) accumulation, oxidative stress responses and cell death, corresponding to a significant decrease in photosynthetic efficiency, marked intracellular ROS accumulation, and caspase-mediated programmed cell death activation. None of these responses were identified in P-limited cells; however, a significant up-regulation of alkaline phosphatase proteins was observed, which could be the major contributor for P-limited cells to cope with ambient P deficiency. These findings demonstrate that fundamentally different metabolic responses and cellular regulations are employed by the diatom in response to different nutrient stresses and to keep the cells viable.	[Lin, Qun] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Lin, Qun; Liang, Jun-Rong; Huang, Qian-Qian; Luo, Chun-Shan; Chen, Chang-Ping; Li, Xue-Song; Gao, Ya-Hui] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Liang, Jun-Rong; Chen, Chang-Ping; Gao, Ya-Hui] Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Anderson, Donald M.] Woods Hole Oceanog Inst, Biol Dept, Woods Hole, MA 02543 USA; [Bowler, Chris] CNRS, INSERM, Ecol & Evolutionary Biol Sect, Ecole Normale Super,UMR8197,U1024,IBENS, 46 Rue Ulm, Paris, France	Xiamen University; Xiamen University; Xiamen University; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Liang, JR (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.; Liang, JR (corresponding author), Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China.	sunljr@xmu.edu.cn	Bowler, Chris/AAC-6256-2019; Chen, Changping/AAU-4352-2020	Chen, Changping/0000-0002-3332-2458; Bowler, Chris/0000-0003-3835-6187	National Natural Science Foundation of China [41576138, 41076080]; Woods Hole Center for Oceans and Human Health, National Science Foundation [OCE-1314642]; National Institute of Environmental Health Sciences [1-P01-ES021923-01]; ERC; ANR project DiaDomOil; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER; Division Of Ocean Sciences [1314642] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Woods Hole Center for Oceans and Human Health, National Science Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ERC(European Research Council (ERC)European Commission); ANR project DiaDomOil(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the National Natural Science Foundation of China (41576138, 41076080, 41576138) to Dr. un-Rong Liang; the Woods Hole Center for Oceans and Human Health, National Science Foundation (OCE-1314642) to Dr. Donald M Anderson; the National Institute of Environmental Health Sciences (1-P01-ES021923-01) to Dr. Donald M Anderson; and the ERC Advanced Award Diatomite and ANR project DiaDomOil to Dr. Chris Bowler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2015, ANNU REV MAR SCI, V7, P341, DOI 10.1146/annurev-marine-010213-135014; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Brussaard CPD, 1997, J PHYCOL, V33, P980, DOI 10.1111/j.0022-3646.1997.00980.x; BRUSSAARD CPD, 1995, MAR ECOL PROG SER, V123, P259, DOI 10.3354/meps123259; Casotti R, 2005, J PHYCOL, V41, P7, DOI 10.1111/j.1529-8817.2005.04052.x; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V10, P317; Chung CC, 2005, APPL ENVIRON MICROB, V71, P8744, DOI 10.1128/AEM.71.12.8744-8751.2005; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Cooper MS, 2010, J BIOSCI BIOENG, V109, P198, DOI 10.1016/j.jbiosc.2009.08.004; Cormann KU, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00157; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; de Carvalho MHC, 2016, NEW PHYTOL, V210, P497, DOI 10.1111/nph.13787; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Du C, 2014, J PROTEOME RES, V13, P720, DOI 10.1021/pr400803w; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; GAGE MA, 1985, FRESHWATER BIOL, V15, P227, DOI 10.1111/j.1365-2427.1985.tb00195.x; Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Ivancic I, 2016, PROG OCEANOGR, V146, P175, DOI 10.1016/j.pocean.2016.07.003; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Lauritano C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1574-5; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Li PF, 2013, NITRIC OXIDE-BIOL CH, V33, P88, DOI 10.1016/j.niox.2013.06.007; Li SJ, 2013, J BIOTECHNOL, V168, P1, DOI 10.1016/j.jbiotec.2013.08.003; Liang JR, 2013, J APPL PHYCOL, V25, P477, DOI 10.1007/s10811-012-9881-6; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Luo CS, 2014, J PROTEOME RES, V13, P5510, DOI 10.1021/pr5004664; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Meyer Y, 1999, TRENDS PLANT SCI, V4, P388, DOI 10.1016/S1360-1385(99)01475-2; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nedelcu AM, 2009, J MOL EVOL, V68, P256, DOI 10.1007/s00239-009-9201-1; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nunn BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075653; Orefice I, 2015, MAR GENOM, V24, P81, DOI 10.1016/j.margen.2015.06.008; Ou LJ, 2014, J SEA RES, V85, P499, DOI 10.1016/j.seares.2013.08.005; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Qiao JJ, 2012, J PROTEOME RES, V11, P5286, DOI 10.1021/pr300504w; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Rosenwasser S, 2014, P NATL ACAD SCI USA, V111, P2740, DOI 10.1073/pnas.1319773111; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Thamatrakoln K, 2012, ENVIRON MICROBIOL, V14, P67, DOI 10.1111/j.1462-2920.2011.02468.x; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Creveld SG, 2015, ISME J, V9, P385, DOI 10.1038/ismej.2014.136; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Wang HF, 2018, J X-RAY SCI TECHNOL, V26, P171, DOI 10.3233/XST-17302; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang ZK, 2014, J APPL PHYCOL, V26, P73, DOI 10.1007/s10811-013-0050-3; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	75	13	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184849	10.1371/journal.pone.0184849	http://dx.doi.org/10.1371/journal.pone.0184849			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910417	Green Submitted, gold, Green Published			2022-12-26	WOS:000410859200107
J	Bowler, D; Bohning-Gaese, K				Bowler, Diana; Boehning-Gaese, Katrin			Improving the community-temperature index as a climate change indicator	PLOS ONE			English	Article							BIRD POPULATIONS; HABITAT; FISH; IMPACTS	Climate change indicators are tools to assess, visualize and communicate the impacts of climate change on species and communities. Indicators that can be applied to different taxa are particularly useful because they allow comparative analysis to identify which kinds of species are being more affected. A general prediction, supported by empirical data, is that the abundance of warm-adapted species should increase over time, relative to the cool-adapted ones within communities, under increasing ambient temperatures. The community temperature index (CTI) is a community weighted mean of species' temperature preferences and has been used as an indicator to summarize this temporal shift. The CTI has the advantages of being a simple and generalizable indicator; however, a core problem is that temporal trends in the CTI may not only reflect changes in temperature. This is because species' temperature preferences often covary with other species attributes, and these other attributes may affect species response to other environmental drivers. Here, we propose a novel model-based approach that separates the effects of temperature preference from the effects of other species attributes on species' abundances and subsequently on the CTI. Using long-term population data of breeding birds in Denmark and demersal marine fish in the southeastern North Sea, we find differences in CTI trends with the original approach and our model-based approach, which may affect interpretation of climate change impacts. We suggest that our method can be used to test the robustness of CTI trends to the possible effects of other drivers of change, apart from climate change.	[Bowler, Diana; Boehning-Gaese, Katrin] Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany; [Boehning-Gaese, Katrin] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Bowler, D (corresponding author), Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.	diana.e.bowler@gmail.com	Böhning-Gaese, Katrin/W-2601-2019	Böhning-Gaese, Katrin/0000-0003-0477-5586; Bowler, Diana/0000-0002-7775-1668	German Research Foundation DFG [B0 1221/23-1]	German Research Foundation DFG(German Research Foundation (DFG))	Funded by German Research Foundation DFG: Grant no. BO 1221/23-1). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnagaud JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032819; BirdLifeInternational NatureServe, 2012, BIRD SPEC DISTR MAPS; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; De Frenne P, 2013, P NATL ACAD SCI USA, V110, P18561, DOI 10.1073/pnas.1311190110; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P638, DOI 10.1038/nclimate1668; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Doxa A, 2010, J APPL ECOL, V47, P1348, DOI 10.1111/j.1365-2664.2010.01869.x; Duque A, 2015, P NATL ACAD SCI USA, V112, P10744, DOI 10.1073/pnas.1506570112; Duru M, 2010, ANN BOT-LONDON, V106, P823, DOI 10.1093/aob/mcq178; Eskildsen Anne, 2013, DANSK ORNITOLOGISK FORENINGS TIDSSKRIFT, V107, P191; Filz KJ, 2013, EUR J ENTOMOL, V110, P633, DOI 10.14411/eje.2013.086; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Frishkoff LO, 2016, ECOL LETT, V19, P1081, DOI 10.1111/ele.12645; Froese R, FISHBASE; Godet L, 2011, BIOL LETTERS, V7, P714, DOI 10.1098/rsbl.2011.0152; Haylock M, 2008, J GEOPHYS RES-ATMOS, V1984-2012, P113; Heldbjerg Henning, 2005, Dansk Ornitologisk Forenings Tidsskrift, V99, P182; ICES, 2012, 1IBTS8 ICES SISP; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kaschner K., 2013, AQUAMAPS ENV DATASET; Larsen JL, 2011, ECOL INDIC, V11, P1459, DOI 10.1016/j.ecolind.2011.03.023; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Lindstrom A, 2013, ECOGRAPHY, V36, P313, DOI 10.1111/j.1600-0587.2012.07799.x; Muus B.J., 1999, SEA FISH; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Philippart CJM, 1998, ICES J MAR SCI, V55, P342, DOI 10.1006/jmsc.1997.0321; Prince K, 2015, GLOBAL CHANGE BIOL, V21, P572, DOI 10.1111/gcb.12740; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; Roth T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082490; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Stefanescu C, 2011, J INSECT CONSERV, V15, P83, DOI 10.1007/s10841-010-9325-z; Stephens PA, 2016, SCIENCE, V352, P84, DOI 10.1126/science.aac4858; Tayleur CM, 2016, DIVERS DISTRIB, V22, P468, DOI 10.1111/ddi.12412; Van Swaay C.A.M., 2012, VLINDERSTICHTING DUT; Virkkala R, 2014, GLOBAL CHANGE BIOL, V20, P2995, DOI [10.1111/gcb.12573, 10.1111/gcb.1]; Zografou K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087245	44	22	22	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184275	10.1371/journal.pone.0184275	http://dx.doi.org/10.1371/journal.pone.0184275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898285	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500021
J	Gimenez, J; Marcalo, A; Ramirez, F; Verborgh, P; Gauffier, P; Esteban, R; Nicolau, L; Gonzalez-Ortegon, E; Baldo, F; Vilas, C; Vingada, J; Forero, MG; de Stephanis, R				Gimenez, Joan; Marcalo, Ana; Ramirez, Francisco; Verborgh, Philippe; Gauffier, Pauline; Esteban, Ruth; Nicolau, Lidia; Gonzalez-Ortegon, Enrique; Baldo, Francisco; Vilas, Cesar; Vingada, Jose; Forero, Manuela G.; de Stephanis, Renaud			Diet of bottlenose dolphins (Tursiops truncatus) from the Gulf of Cadiz: Insights from stomach content and stable isotope analyses	PLOS ONE			English	Article							GRAPHICAL ANALYSIS; MEDITERRANEAN SEA; FEEDING STRATEGY; FISHING IMPACTS; MARINE MAMMALS; WESTERN SPAIN; MIXING MODELS; ECOLOGY; WATERS; ECOSYSTEM	The ecological role of species can vary among populations depending on local and regional differences in diet. This is particularly true for top predators such as the bottlenose dolphin (Tursiops truncatus), which exhibits a highly varied diet throughout its distribution range. Local dietary assessments are therefore critical to fully understand the role of this species within marine ecosystems, as well as its interaction with important ecosystem services such as fisheries. Here, we combined stomach content analyses (SCA) and stable isotope analyses (SIA) to describe bottlenose dolphins diet in the Gulf of Cadiz (North Atlantic Ocean). Prey items identified using SCA included European conger (Conger conger) and European hake (Merluccius merluccius) as the most important ingested prey. However, mass-balance isotopic mixing model (MixSIAR), using delta(13) C and delta(15) N, indicated that the assimilated diet consisted mainly on Sparidae species (e.g. seabream, Diplodus annularis and D. bellottii, rubberlip grunt, Plectorhinchus mediterraneus, and common pandora, Pagellus erythrinus) and a mixture of other species including European hake, mackerels (Scomber colias, S. japonicus and S. scombrus), European conger, red bandfish (Cepola macrophthalma) and European pilchard (Sardina pilchardus). These contrasting results highlight differences in the temporal and taxonomic resolution of each approach, but also point to potential differences between ingested (SCA) and assimilated (SIA) diets. Both approaches provide different insights, e.g. determination of consumed fish biomass for the management of fish stocks (SCA) or identification of important assimilated prey species to the consumer (SIA).	[Gimenez, Joan; Forero, Manuela G.] EBD CSIC, Dept Biol Conservac, Seville, Spain; [Marcalo, Ana; Nicolau, Lidia; Vingada, Jose] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Campus Univ Santiago, Aveiro, Portugal; [Marcalo, Ana; Nicolau, Lidia; Vingada, Jose] Univ Minho, Dept Biol, CBMA, SPVS, Campus Gualtar, Braga, Portugal; [Ramirez, Francisco] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain; [Verborgh, Philippe; Gauffier, Pauline; Esteban, Ruth; de Stephanis, Renaud] Conservat Informat & Res Cetaceans CIRCE, Cadiz, Spain; [Gonzalez-Ortegon, Enrique] Consejo Super Invest Cient ICMAN CSIC, Inst Ciencias Marinas Andalucia, Campus Univ Rio San Pedro, Cadiz, Spain; [Baldo, Francisco] Ctr Oceanog Cadiz, IEO, Cadiz, Spain; [Vilas, Cesar] Consejeria Agr Pesca & Desarrollo Local, Junta Andalucia, FAPA Ctr El Toruno, Inst Invest & Formac Agr & Pesquera, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Aveiro; Universidade do Minho; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Gimenez, J (corresponding author), EBD CSIC, Dept Biol Conservac, Seville, Spain.	gimenez.verdugo@gmail.com	Esteban, Ruth/Q-8492-2018; Gimenez, Joan/C-6107-2015; Marçalo, Ana/ABI-5648-2020; Gauffier, Pauline/W-8148-2019; de Stephanis, Renaud/AAA-5682-2019; Baldó, Francisco/B-1477-2016; Gauffier, Pauline/M-3952-2014; Vilas, Cesar/A-4162-2011; Ortegón, Enrique González/L-7292-2014; Ramírez, Francisco/I-3553-2014; Nicolau, Lídia/AAG-5009-2021; Vingada, Jose/K-1404-2015	Esteban, Ruth/0000-0002-8674-6940; Gimenez, Joan/0000-0001-9207-4792; Marçalo, Ana/0000-0002-0485-341X; Gauffier, Pauline/0000-0003-2984-6993; Baldó, Francisco/0000-0003-4220-4207; Gauffier, Pauline/0000-0003-2984-6993; Vilas, Cesar/0000-0002-6229-8880; Ortegón, Enrique González/0000-0002-0282-499X; Ramírez, Francisco/0000-0001-9670-486X; de Stephanis, Renaud/0000-0003-2522-7933; Vingada, Jose/0000-0003-1940-1683	Fundacion Loro Parque, CEPSA (Compania Espanola de Petroleos S.A.) [CGL2011-25543]; SafeSea EEA-Grants; European Commission's Life Programme [MarPro NAT/PT/00038]; Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R +D+1 [SEV-2012-0262]; Portuguese Foundation for Science and Technology [SFRH/BPD/64889/2009, SFRH/BD/51416/2011]; Consejeria de Economia, Innovacion y Ciencia - Junta de Andalucia [ECOBOGUE-P11RNM7467]	Fundacion Loro Parque, CEPSA (Compania Espanola de Petroleos S.A.); SafeSea EEA-Grants; European Commission's Life Programme; Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R +D+1; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Consejeria de Economia, Innovacion y Ciencia - Junta de Andalucia(Junta de Andalucia)	The study was funded by Fundacion Loro Parque, CEPSA (Compania Espanola de Petroleos S.A.), EcoCet Project [CGL2011-25543], SafeSea EEA-Grants and European Commission's Life Programme [MarPro NAT/PT/00038]. J.G. and R.dS. were funded by the Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R +D+1 [SEV-2012-0262]. A.M. and L.N. were partly supported by the Portuguese Foundation for Science and Technology [SFRH/BPD/64889/2009 and SFRH/BD/51416/2011]. Project ECOBOGUE-P11RNM7467 was funded by "Consejeria de Economia, Innovacion y Ciencia - Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; Torres MA, 2013, ECOL MODEL, V265, P26, DOI 10.1016/j.ecolmodel.2013.05.019; [Anonymous], 2007, J MAR BIOL ASSOC UK, V87, P213; Barros Nelio B., 2000, Aquatic Mammals, V26, P2; Santos MB, 2014, DEEP-SEA RES PT II, V106, P232, DOI 10.1016/j.dsr2.2013.09.040; Santos MB, 2013, MAR ECOL PROG SER, V481, P249, DOI 10.3354/meps10233; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Canty A., 2011, R PACKAGE VERSION, V1, P3; Chiaradia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092665; Clarke M.R, 1986, HDB IDENTIFICATION C; Coll M, 2014, FISH RES, V154, P179, DOI 10.1016/j.fishres.2014.01.013; Coll M, 2007, J MARINE SYST, V67, P119, DOI 10.1016/j.jmarsys.2006.10.002; COSTELLO MJ, 1990, J FISH BIOL, V36, P261, DOI 10.1111/j.1095-8649.1990.tb05601.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Fernandez R, 2011, MAR BIOL, V158, P1043, DOI 10.1007/s00227-011-1629-3; Gannon DP, 2004, MAR MAMMAL SCI, V20, P527, DOI 10.1111/j.1748-7692.2004.tb01177.x; Gimenez J, 2011, Vet Rec, V168, p101b, DOI 10.1136/vr.c5284; Gimenez J, 2016, J FISH BIOL; Gimenez J, 2016, J EXP MAR BIOL ECOL, V475, P54, DOI 10.1016/j.jembe.2015.11.001; Gladilina E. V., 2014, Vestnik Zoologii, V48, P83, DOI 10.2478/vzoo-2014-0009; Harkonen T.J., 1986, GUIDE OTOLITHS BONY, P256; Hernandez-Milian G., 2014, TROPHIC ROLE SMALL C; Hernandez-Milian G, 2015, AQUAT MAMM, V41, P226, DOI 10.1578/AM.41.2.2015.226; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jansen OE, 2013, MAR MAMMAL SCI, V29, pE295, DOI 10.1111/j.1748-7692.2012.00621.x; Kiszka JJ, 2014, MAR BIOL, V161, P953, DOI 10.1007/s00227-014-2395-9; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Lopez N, 2016, ESTUAR COAST SHELF S, V175, P15, DOI 10.1016/j.ecss.2016.03.007; Louis M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1558; Di Beneditto APM, 2011, MAR BIOL, V158, P2209, DOI 10.1007/s00227-011-1726-3; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; McIntosh RR, 2006, WILDLIFE RES, V33, P661, DOI 10.1071/WR06025; Mendez-Fernandez P, 2012, J EXP MAR BIOL ECOL, V413, P150, DOI 10.1016/j.jembe.2011.12.007; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Pinkas L., 1970, SCRIPPS I OCEANOGR, V152, P1; Querouil S, 2013, MAR BIOL, V160, P1325, DOI 10.1007/s00227-013-2184-x; Ramirez F, 2015, MAR ECOL PROG SER, V527, P221, DOI 10.3354/meps11282; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Santos MB, 2015, HYDROBIOLOGIA, V750, P13, DOI 10.1007/s10750-014-2164-2; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P873, DOI 10.1017/S0025315401004714; Silva L, 2002, FISH RES, V59, P117, DOI 10.1016/S0165-7836(01)00420-9; Silva MA, 1999, J MAR BIOL ASSOC UK, V79, P531, DOI 10.1017/S0025315498000654; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; Smith SC, 2000, MAR MAMMAL SCI, V16, P315, DOI 10.1111/j.1748-7692.2000.tb00927.x; Sobrino I, 1994, DESCRIPCION PESQUERI, V151; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; Spitz J, 2010, J EXP MAR BIOL ECOL, V390, P73, DOI 10.1016/j.jembe.2010.05.010; Stock B.C., 2013, MIXSIAR GUI USER MAN; Tollit DJ, 2009, ECOL APPL, V19, P889, DOI 10.1890/07-1701.1; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vespe M, 2016, J MAPS; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Walker JL, 1999, MAR MAMMAL SCI, V15, P335, DOI 10.1111/j.1748-7692.1999.tb00805.x; Watt J., 1997, ICES COOPERATIVE RES	63	32	32	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184673	10.1371/journal.pone.0184673	http://dx.doi.org/10.1371/journal.pone.0184673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898268	Green Submitted, Green Published, gold			2022-12-26	WOS:000410449500042
J	Peters, CH; Yu, A; Zhu, WD; Silva, JR; Ruben, PC				Peters, Colin H.; Yu, Alec; Zhu, Wandi; Silva, Jonathan R.; Ruben, Peter C.			Depolarization of the conductance-voltage relationship in the Na(V)1.5 mutant, E1784K, is due to altered fast inactivation	PLOS ONE			English	Article							LONG-QT SYNDROME; GATED SODIUM-CHANNELS; DESCRIBE SLOW INACTIVATION; ST-SEGMENT ELEVATION; NA+-CHANNEL; BRUGADA-SYNDROME; SCN5A MUTATIONS; MOLECULAR-MECHANISM; CALCIUM REGULATION; MAXIMAL EXERCISE	E1784K is the most common mixed long QT syndrome/Brugada syndrome mutant in the cardiac voltage-gated sodium channel Na(V)1.5. E1784K shifts the midpoint of the channel conductance-voltage relationship to more depolarized membrane potentials and accelerates the rate of channel fast inactivation. The depolarizing shift in the midpoint of the conductance curve in E1784K is exacerbated by low extracellular pH. We tested whether the E1784K mutant shifts the channel conductance curve to more depolarized membrane potentials by affecting the channel voltage-sensors. We measured ionic currents and gating currents at pH 7.4 and pH 6.0 in Xenopus laevis oocytes. Contrary to our expectation, the movement of gating charges is shifted to more hyperpolarized membrane potentials by E1784K. Voltage-clamp fluorimetry experiments show that this gating charge shift is due to the movement of the DIVS4 voltage-sensor being shifted to more hyperpolarized membrane potentials. Using a model and experiments on fast inactivation-deficient channels, we show that changes to the rate and voltage-dependence of fast inactivation are sufficient to shift the conductance curve in E1784K. Our results localize the effects of E1784K to DIVS4, and provide novel insight into the role of the DIV-VSD in regulating the voltage-dependencies of activation and fast inactivation.	[Peters, Colin H.; Yu, Alec; Ruben, Peter C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Zhu, Wandi; Silva, Jonathan R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Simon Fraser University; Washington University (WUSTL)	Ruben, PC (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	pruben@sfu.ca	Zhu, Wandi/AAD-2096-2020	Silva, Jonathan/0000-0002-3696-3955; Zhu, Wandi/0000-0003-0927-5687	Natural Sciences and Engineering Research Council of Canada Graduate Doctoral Scholarship [GXS0117]; American Heart Association [15PRE25080073]; Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award [394530]; Natural Sciences and Engineering Research Council of Canada grant [31611509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136553] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada Graduate Doctoral Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Heart Association(American Heart Association); Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CHP was supported by a Natural Sciences and Engineering Research Council of Canada Graduate Doctoral Scholarship (GXS0117). AY was supported by a Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award (394530). WZ was supported by an American Heart Association fellowship (15PRE25080073). The JRS lab was supported by an American Heart Association grant (16GRNT31200025). The PCR lab was supported by a Natural Sciences and Engineering Research Council of Canada grant (31611509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsayed M., 2015, J PHYSL; Allam S, 2001, ANAESTHESIA, V56, P385, DOI 10.1046/j.1365-2044.2001.01976-24.x; Amin AS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P531, DOI 10.1161/CIRCEP.109.862441; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Baranchuk A, 2012, ANN NONINVAS ELECTRO, V17, P299, DOI 10.1111/j.1542-474X.2012.00525.x; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bezzina C, 1999, CIRC RES, V85, P1206; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cheng JD, 2011, PHYSIOL GENOMICS, V43, P461, DOI 10.1152/physiolgenomics.00198.2010; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Garcia-Borbolla M, 2007, REV ESP CARDIOL, V60, P993, DOI 10.1157/13109656; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Gurkiewicz M, 2011, J NEUROPHYSIOL, V105, P1546, DOI 10.1152/jn.00703.2010; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Hick JL, 1999, ACAD EMERG MED, V6, P239, DOI 10.1111/j.1553-2712.1999.tb00164.x; Hsu EJ, 2017, J GEN PHYSL; Hu D., 2012, CIRCULATION, V126; Jones DK, 2013, BIOPHYS J, V105, P101, DOI 10.1016/j.bpj.2013.04.022; Jones DK, 2011, BIOPHYS J, V101, P2147, DOI 10.1016/j.bpj.2011.08.056; Jones DK, 2013, J BIOL CHEM, V288, P4782, DOI 10.1074/jbc.M112.434266; Labro AJ, 2012, J GEN PHYSIOL, V140, P481, DOI 10.1085/jgp.201210817; Lupoglazoff JM, 2001, CIRC RES, V89, pE16, DOI 10.1161/hh1401.095087; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Mizusawa Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P606, DOI 10.1161/CIRCEP.111.964577; Nekouzadeh A, 2008, BIOPHYS J, V95, P3510, DOI 10.1529/biophysj.108.136721; Ortega-Carnicer J, 2001, J ELECTROCARDIOL, V34, P345, DOI 10.1054/jelc.2001.26318; OSNES JB, 1972, J APPL PHYSIOL, V32, P59, DOI 10.1152/jappl.1972.32.1.59; Peters CH, 2016, PROG BIOPHYS MOL BIO, V120, P77, DOI 10.1016/j.pbiomolbio.2015.12.009; Potet F, 2015, CIRC-ARRHYTHMIA ELEC, V8, P933, DOI 10.1161/CIRCEP.115.002760; Priori SG, 2000, CIRCULATION, V102, P2509, DOI 10.1161/01.CIR.102.20.2509; Ruan YF, 2007, CIRCULATION, V116, P1137, DOI 10.1161/CIRCULATIONAHA.107.707877; Ruan YF, 2010, CIRC RES, V106, P1374, DOI 10.1161/CIRCRESAHA.110.218891; Ruan YF, 2008, CIRC-ARRHYTHMIA ELEC, V1, P290, DOI 10.1161/CIRCEP.108.795617; Rudokas MW, 2014, JOVE-J VIS EXP, DOI 10.3791/51040; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHAUF CL, 1976, BIOPHYS J, V16, P771, DOI 10.1016/S0006-3495(76)85727-X; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sheets MF, 2003, J GEN PHYSIOL, V121, P163, DOI 10.1085/jgp.20028651; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Shimizu W, 1999, J ELECTROCARDIOL, V32, P177, DOI 10.1016/S0022-0736(99)90077-8; Silva JR, 2013, J GEN PHYSIOL, V141, P309, DOI 10.1085/jgp.201210909; Silva JR, 2013, J GEN PHYSIOL, V141, P323, DOI 10.1085/jgp.201210910; Skinner JR, 2005, ARCH DIS CHILD, V90, P528, DOI 10.1136/adc.2004.058115; Stefani E, 1998, METHOD ENZYMOL, V293, P300; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Varga Z, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1228, DOI 10.1161/CIRCEP.115.003155; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Vilin YY, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00109; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Wang DW, 1996, P NATL ACAD SCI USA, V93, P13200, DOI 10.1073/pnas.93.23.13200; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wijeyeratne YD, 2014, EUROPACE, V16, piii7; Wilde AAM, 2010, J MOL CELL CARDIOL, V49, P543, DOI 10.1016/j.yjmcc.2010.07.012; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; YAN GX, 1992, CIRC RES, V71, P460, DOI 10.1161/01.RES.71.2.460; Zhang ZH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/408012; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	76	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184605	10.1371/journal.pone.0184605	http://dx.doi.org/10.1371/journal.pone.0184605			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898267	gold, Green Submitted, Green Published			2022-12-26	WOS:000410449500036
J	Jenkins, TP; Rathnayaka, Y; Perera, PK; Peachey, LE; Nolan, MJ; Krause, L; Rajakaruna, RS; Cantacessi, C				Jenkins, Timothy P.; Rathnayaka, Yasara; Perera, Piyumali K.; Peachey, Laura E.; Nolan, Matthew J.; Krause, Lutz; Rajakaruna, Rupika S.; Cantacessi, Cinzia			Infections by human gastrointestinal helminths are associated with changes in faecal microbiota diversity and composition	PLOS ONE			English	Article							EXPERIMENTAL HOOKWORM INFECTION; SOIL-TRANSMITTED HELMINTHS; GLUTEN CHALLENGES; GUT MICROBIOTA; COLONIZATION; TRANSMISSION; RESISTANCE; IMPACT	Investigations of the impact that patent infections by soil-transmitted gastrointestinal nematode parasites exert on the composition of the host gut commensal flora are attracting growing interest by the scientific community. However, information collected to date varies across experiments, and further studies are needed to identify consistent relationships between parasites and commensal microbial species. Here, we explore the qualitative and quantitative differences between the microbial community profiles of cohorts of human volunteers from Sri Lanka with patent infection by one or more parasitic nematode species (H +), as well as that of uninfected subjects (H-) and of volunteers who had been subjected to regular prophylactic anthelmintic treatment (Ht). High-throughput sequencing of the bacterial 16S rRNA gene, followed by bioinformatics and biostatistical analyses of sequence data revealed no significant differences in alpha diversity (Shannon) and richness between groups (P = 0.65, P = 0.13 respectively); however, beta diversity was significantly increased in H+ and Ht when individually compared to H-volunteers (P = 0.04). Among others, bacteria of the families Verrucomicrobiaceae and Enterobacteriaceae showed a trend towards increased abundance in H+, whereas the Leuconostocaceae and Bacteroidaceae showed a relative increase in H-and Ht respectively. Our findings add valuable knowledge to the vast, and yet little explored, research field of parasite - microbiota interactions and will provide a basis for the elucidation of the role such interactions play in pathogenic and immune-modulatory properties of parasitic nematodes in both human and animal hosts.	[Jenkins, Timothy P.; Peachey, Laura E.; Cantacessi, Cinzia] Univ Cambridge, Dept Vet Med, Cambridge, England; [Rathnayaka, Yasara; Perera, Piyumali K.; Rajakaruna, Rupika S.] Univ Peradeniya, Dept Zool, Peradeniya, Sri Lanka; [Nolan, Matthew J.] Univ London, Royal Vet Coll, N Mymms, England; [Krause, Lutz] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld, Australia	University of Cambridge; University of Peradeniya; University of London; University of London Royal Veterinary College; University of Queensland	Cantacessi, C (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	cc779@cam.ac.uk	Jenkins, Timothy P./B-4714-2019; Jenkins, Tim/V-7689-2019; Krause, Lutz/G-6283-2013; Cantacessi, Cinzia/B-7356-2014	Jenkins, Timothy P./0000-0003-2979-5663; Jenkins, Tim/0000-0003-2979-5663; Perera, Piyumali/0000-0003-2441-9028; Krause, Lutz/0000-0003-3806-0845; Cantacessi, Cinzia/0000-0001-6863-2950	University of Peradeniya [URG/2016/88/S]; Wellcome Trust; Isaac Newton Trust; University of Cambridge; Biotechnology and Biological Sciences Research Council; BBSRC [1643688] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1643688] Funding Source: researchfish	University of Peradeniya; Wellcome Trust(Wellcome Trust); Isaac Newton Trust; University of Cambridge(University of Cambridge); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants by University of Peradeniya, grant no. URG/2016/88/S to RSR and PKP; the Wellcome Trust/ Isaac Newton Trust/ University of Cambridge to CC; a Postgraduate Award by the Biotechnology and Biological Sciences Research Council to TPJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Brooker SJ, 2015, LANCET INFECT DIS, V15, P941, DOI 10.1016/S1473-3099(15)70042-3; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Campbell SJ, 2016, TRENDS PARASITOL, V32, P97, DOI 10.1016/j.pt.2015.10.006; Cantacessi C, 2014, J INFECT DIS, V210, P1431, DOI 10.1093/infdis/jiu256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Frank W, 1987, PARASITOLOGIE TRANSP; Gems D, 1996, P NATL ACAD SCI USA, V93, P1665, DOI 10.1073/pnas.93.4.1665; Giacomin P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36797; Giacomin P, 2016, TRENDS PARASITOL, V32, P664, DOI 10.1016/j.pt.2016.05.006; Giacomin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13797; Glendinning L, 2014, PARASITOLOGY, V141, P1255, DOI 10.1017/S0031182014000699; Gunawardena K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001341; Hausen MA, 2011, PARASITOL INT, V60, P54, DOI 10.1016/j.parint.2010.10.003; Holm JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125495; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ismail MM, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P127; Jayawardena R, 2013, PUBLIC HEALTH NUTR, V16, P653, DOI 10.1017/S1368980012003011; Jeffery IB, 2012, GUT MICROBES, V3, P572, DOI 10.4161/gmic.21772; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P1192, DOI 10.3748/wjg.14.1192; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Li RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20606; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McKenney EA, 2015, GUT MICROBES, V6, P182, DOI 10.1080/19490976.2015.1047128; Murray CJL, 2013, LANCET, V381, P628; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pearson MS, 2012, J ALLERGY CLIN IMMUN, V130, P13, DOI 10.1016/j.jaci.2012.05.029; Perera P, 2013, JNSF, V41; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Theodoropoulos G, 2001, TRENDS PARASITOL, V17, P130, DOI 10.1016/S1471-4922(00)01775-X; Truscott JE, 2016, ADV PARASIT, V94, P133, DOI 10.1016/bs.apar.2016.08.002; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; WHO, 2012, ACC WORK OV GLOB IMP, P13; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yoo JY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030173; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724	52	57	59	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184719	10.1371/journal.pone.0184719	http://dx.doi.org/10.1371/journal.pone.0184719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892494	Green Published, gold, Green Accepted			2022-12-26	WOS:000410243200021
J	Delius, J; Frank, O; Hofmann, T				Delius, Judith; Frank, Oliver; Hofmann, Thomas			Label-free quantitative H-1 NMR spectroscopy to study low-affinity ligand-protein interactions in solution: A contribution to the mechanism of polyphenol-mediated astringency	PLOS ONE			English	Article							SENSORY-GUIDED DECOMPOSITION; PROLINE-RICH PROTEIN; BLACK TEA INFUSIONS; SALIVARY PROTEINS; GREEN TEA; RED WINE; SUBMAXILLARY MUCINS; CONDENSED TANNINS; NMR; PRECIPITATION	Nuclear magnetic resonance (NMR) spectroscopy is well-established in assessing the binding affinity between low molecular weight ligands and proteins. However, conventional NMR-based binding assays are often limited to small proteins of high purity and may require elaborate isotopic labeling of one of the potential binding partners. As protein-polyphenol complexation is assumed to be a key event in polyphenol-mediated oral astringency, here we introduce a label-free, ligand-focused H-1 NMR titration assay to estimate binding affinities and characterize soluble complex formation between proteins and low molecular weight polyphenols. The method makes use of the effects of NMR line broadening due to protein- ligand interactions and quantitation of the non-bound ligand at varying protein concentrations by quantitative H-1 NMR spectroscopy (qHNMR) using electronic reference to access in vivo concentration (ERETIC 2). This technique is applied to assess the interaction kinetics of selected astringent tasting polyphenols and purified mucin, a major lubricating glycoprotein of human saliva, as well as human whole saliva. The protein affinity values (BC50) obtained are subsequently correlated with the intrinsic mouth-puckering, astringent oral sensation imparted by these compounds. The quantitative NMR method is further exploited to study the effect of carboxymethyl cellulose, a candidate-anti-astringent xi protein binding antagonist, on the polyphenol-protein interaction. Consequently, the NMR approach presented here proves to be a versatile tool to study the interactions between proteins and lowaffinity ligands in solution and may find promising applications in the discovery of bioactives.	[Delius, Judith; Frank, Oliver; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, Lise Meitner Str 34, Freising Weihenstephan, Germany	Technical University of Munich	Hofmann, T (corresponding author), Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, Lise Meitner Str 34, Freising Weihenstephan, Germany.	thomas.hofmann@tum.de	Frank, Oliver/AAO-9888-2021	Frank, Oliver/0000-0003-0437-5005				Bartolome B, 2000, J FOOD SCI, V65, P617, DOI 10.1111/j.1365-2621.2000.tb16060.x; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; BETTELHEIM FA, 1965, ARCH BIOCHEM BIOPHYS, V109, P259, DOI 10.1016/0003-9861(65)90360-7; Biegler M., 2016, BIOTRIBOLOGY, V6, P12, DOI [10.1016/j.biotri.2016.03.002, DOI 10.1016/J.BIOTRI.2016.03.002]; Brannan GD, 2001, J SENS STUD, V16, P261, DOI 10.1111/j.1745-459X.2001.tb00300.x; Brock A, 2008, CHEMOSENS PERCEPT, V1, P268, DOI 10.1007/s12078-008-9028-y; Cala O, 2010, FASEB J, V24, P4281, DOI 10.1096/fj.10-158741; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Charlton AJ, 2002, J AM CHEM SOC, V124, P9899, DOI 10.1021/ja0126374; Davis AL, 1996, MAGN RESON CHEM, V34, P887, DOI 10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U; de Freitas V, 2003, FOOD CHEM, V81, P503, DOI 10.1016/S0308-8146(02)00479-X; de Freitas V, 2012, CURR ORG CHEM, V16, P724, DOI 10.2174/138527212799958002; Delius J, 2017, J AGR FOOD CHEM, V65, P2147, DOI 10.1021/acs.jafc.7b00436; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Frank O, 2014, J AGR FOOD CHEM, V62, P2506, DOI 10.1021/jf405529b; Georgiades P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105302; Giordani E, 2011, FOOD RES INT, V44, P1752, DOI 10.1016/j.foodres.2011.01.036; Goncalves R, 2011, FOOD CHEM, V125, P665, DOI 10.1016/j.foodchem.2010.09.061; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hara K, 2012, EUR J ORAL SCI, V120, P132, DOI 10.1111/j.1600-0722.2012.00947.x; Henze A., 2009, THESIS; Horne J, 2002, CHEM SENSES, V27, P653, DOI 10.1093/chemse/27.7.653; Hufnagel JC, 2008, J AGR FOOD CHEM, V56, P1376, DOI 10.1021/jf073031n; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Kallithraka S, 2001, J SCI FOOD AGR, V81, P261, DOI 10.1002/1097-0010(20010115)81:2<261::AID-JSFA804>3.0.CO;2-T; Kallithraka S, 1998, J SENS STUD, V13, P29, DOI 10.1111/j.1745-459X.1998.tb00073.x; Monteleone E, 2004, FOOD QUAL PREFER, V15, P761, DOI 10.1016/j.foodqual.2004.06.002; MURRAY NJ, 1994, EUR J BIOCHEM, V219, P923, DOI 10.1111/j.1432-1033.1994.tb18574.x; OLSSON H, 1991, SCAND J DENT RES, V99, P316; Pascal C, 2009, BIOPOLYMERS, V91, P745, DOI 10.1002/bip.21221; Peleg H, 1999, FOOD QUAL PREFER, V10, P343, DOI 10.1016/S0950-3293(99)00009-9; Poncet-Legrand C, 2006, FOOD HYDROCOLLOID, V20, P687, DOI 10.1016/j.foodhyd.2005.06.009; RAMIREZMARTINEZ JR, 1977, J FOOD SCI, V42, P1201, DOI 10.1111/j.1365-2621.1977.tb14459.x; Rayment SA, 2000, J DENT RES, V79, P1765; Rinaldi A, 2012, FOOD CHEM, V135, P2498, DOI 10.1016/j.foodchem.2012.07.031; Sarni-Manchado P, 1999, J AGR FOOD CHEM, V47, P42, DOI 10.1021/jf9805146; Scharbert S, 2004, J AGR FOOD CHEM, V52, P3498, DOI 10.1021/jf049802u; Scharbert S, 2004, EUR FOOD RES TECHNOL, V218, P442, DOI 10.1007/s00217-004-0888-3; Schwarz B, 2008, EUR FOOD RES TECHNOL, V227, P1693, DOI 10.1007/s00217-008-0895-x; Schwarz B, 2007, J AGR FOOD CHEM, V55, P1394, DOI 10.1021/jf0629078; Sharp KA, 2016, P NATL ACAD SCI USA, V113, P1684, DOI 10.1073/pnas.1600098113; Soares S, 2012, J AGR FOOD CHEM, V60, P3966, DOI 10.1021/jf3002747; Soares SI, 2009, J AGR FOOD CHEM, V57, P4352, DOI 10.1021/jf900302r; Stark T, 2005, J AGR FOOD CHEM, V53, P5407, DOI 10.1021/jf050457y; Sun XL, 2009, PROTEOM CLIN APPL, V3, P810, DOI 10.1002/prca.200800242; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9; Thornton DJ, 1999, GLYCOBIOLOGY, V9, P293, DOI 10.1093/glycob/9.3.293; Troszynska A, 2010, FOOD QUAL PREFER, V21, P463, DOI 10.1016/j.foodqual.2009.12.005; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wollmann N, 2013, J AGR FOOD CHEM, V61, P2045, DOI 10.1021/jf3052576	52	14	15	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184487	10.1371/journal.pone.0184487	http://dx.doi.org/10.1371/journal.pone.0184487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886151	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100136
J	Sarkar, A; Stoneking, M; Nandineni, MR				Sarkar, Anujit; Stoneking, Mark; Nandineni, Madhusudan R.			Unraveling the human salivary microbiome diversity in Indian populations	PLOS ONE			English	Article							BACTERIAL; COMMUNITIES; SEQUENCES	The importance of studying the salivary microbiome has been highlighted for its connection to health and disease and as a potential tool for supplementing human genetic diversity studies. While the salivary microbiome has been studied in various world populations, Indian populations have not been examined. We therefore analyzed microbiome diversity in saliva samples from 92 volunteers from eight different sampling locations in India by amplifying and sequencing variable regions (V1 and V2) of the bacterial 16S rRNA gene. The results showed immense bacterial richness in Indian populations; we identified 165 bacterial genera and 785 unique Operational Taxonomic Units (OTUs), with substantial sharing among the populations. There were small, but significant correlations in the abundance of bacterial genera in sampling locations from the same geographic region. Most of the core OTUs detected were also observed previously in other populations, but Solobacterium spp., Lachnoanaerobaculum spp. and Alloprevotella spp. were observed to be a component of the saliva microbiome unique to Indian populations. Importantly, nine bacterial genera were observed that were not listed in the Human Oral Microbiome Database (HOMD). These results highlight the importance of analyzing underrepresented populations like those of India.	[Sarkar, Anujit; Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India; [Sarkar, Anujit] Manipal Univ, Grad Studies, Manipal, India; [Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE); Max Planck Society; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India.; Stoneking, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.; Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India.	stoneking@eva.mpg.de; nandineni@cdfd.org.in	Sarkar, Anujit/AAY-7250-2021	Sarkar, Anujit/0000-0003-3170-2542; Nandineni, Madhusudan Reddy/0000-0002-8933-4503	Department of Science and Technology, Government of India [IGSTC/MPG/PG (MR)/2011]; Max Planck Society [M.PG.A.EVAN0002]; University Grants Commission, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Max Planck Society(Max Planck Society); University Grants Commission, India(University Grants Commission, India)	This research was funded as part of the Max Planck Partner Group Programme to MRN from the Department of Science and Technology (http://www.dst.gov.in), Government of India (project No. IGSTC/MPG/PG (MR)/2011) and the Max Planck Society (https://www.mpg.de/en) (project No. M.PG.A.EVAN0002). A.S. was the recipient of Junior and Senior Research Fellowships of the University Grants Commission, India towards the pursuit of a Ph.D. degree of the Manipal University, Karnataka, India.	Acharya A., 2017, ORAL DIS; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Belstrom D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23609; Cameron SJS, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv091; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, P326; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; De Filippis F, 2014, PLOS ONE, P9; Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Foxman B, 2016, ANN EPIDEMIOL, V26, P348, DOI 10.1016/j.annepidem.2016.03.006; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Hedberg ME, 2012, INT J SYST EVOL MICR, V62, P2685, DOI 10.1099/ijs.0.033613-0; Henne K, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0190-3; Horz HP, 2012, ENV MICROBIOL REP, V4, P390, DOI 10.1111/j.1758-2229.2012.00340.x; Hu S, 2007, EXPERT REV PROTEOMIC, V4, P531, DOI 10.1586/14789450.4.4.531; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lazarevic V., 2011, J INTEGR OMICS, V1, P28, DOI [DOI 10.5584/JI0MICS.V1I1.43, 10.5584/jiomics.v1i1.43, DOI 10.5584/JIOMICS.V1I1.43]; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Li K, 2013, PLOS ONE, P8; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer M, 2010, COLD SPRING HARB PRO, P5; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Sato Y, 2015, PLOS ONE, V10, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shetty SA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-24; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stahringer SS, 2012, GENOME RES, V22, P2146, DOI 10.1101/gr.140608.112; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Wang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22943; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	51	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184515	10.1371/journal.pone.0184515	http://dx.doi.org/10.1371/journal.pone.0184515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886168	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100144
J	Storme, M; Semionov, A; Assayag, D; Lefson, M; Kitty, D; Dannenbaum, D; Torrie, J; Lejeune, P; Robinson, E; Khan, FA				Storme, Matthieu; Semionov, Alexandre; Assayag, Deborah; Lefson, Michael; Kitty, Darlene; Dannenbaum, David; Torrie, Jill; Lejeune, Pierre; Robinson, Elizabeth; Khan, Faiz Ahmad			Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Quebec	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PREVALENCE; DIAGNOSIS; SURVIVAL; EPIDEMIOLOGY; PNEUMONIA; UPDATE	Background Little is known about the epidemiology of interstitial lung disease (ILD) amongst Canada's Indigenous populations. Clinicians working in Eeyou Istchee (the Cree territory of the James Bay region of Quebec, population 17, 956) suspected that ILD was more common in this area. We sought to identify all prevalent and incident cases of ILD in Eeyou Istchee between 2006 and 2013, to describe characteristics of affected patients, distribution of subtypes, and estimate disease incidence. Methods Potential ILD cases amongst Eeyou Istchee residents were identified by searching hospitalization databases and lists of patients on long term home oxygen in the region's nine communities, and surveying physicians and nurses. Clinical, radiological and pathological data were reviewed. Potential cases were classified as 'Definite ILD' if an open lung biopsy demonstrated ILD or, in the absence of histopathologic confirmation, if their thoracic CT imaging was deemed consistent with ILD by a panel of two respirologists and a chest radiologist. Potential cases for whom CT images could not be retrieved for our review were not eligible for classification as Definite ILD, unless they had undergone open lung biopsy. The Definite ILD group was further categorized by subtype of ILD. For usual interstitial pneumonia and non-specific interstitial pneumonitis patterns, we assumed cases were idiopathic in the absence of documentation of connective tissue disease or occupational exposures in the medical chart. For Definite ILD and the most common subtype, we calculated the average annual incidence rates, age-standardized to the province of Quebec, for 2006 to 2013, using a gamma distribution to calculate 95% confidence intervals. Results Of 167 potential cases, 52 were categorized as Definite ILD: 14 on the basis of histopathology and 38 on the basis of CT imaging alone. Six patients had a prior history of connective tissue disease. Information on occupation was recorded in the charts of 18/52 (35%) cases, and missing in the remainder. We found the most common subtype was idiopathic pulmonary fibrosis (27/52, 52%), followed by idiopathic non-specific interstitial pneumonia (13/52, 25%), and secondary usual interstitial pneumonia associated with connective tissue diseases (5/52, 10%). The age-standardized annual incidence between 2006-2013 was 80 per 100,000 person-years observed (PYO) for ILD, and 46 per 100,000 PYO for idiopathic pulmonary fibrosis. Interpretation The incidence of ILD and of idiopathic pulmonary fibrosis in Eeyou Istchee may be higher than rates reported in other populations; however, cautious interpretation is required due to the lack of histopathological confirmation in the majority of cases, and our reliance on chart review to exclude secondary causes. A prospective study of incident cases with standardized assessments to establish the types of ILD and to assess for potential causes could overcome some of the limitations of the present analysis. Studies evaluating ILD incidence and subtype distribution in other Indigenous populations would also be of interest.	[Storme, Matthieu; Khan, Faiz Ahmad] McGill Univ, Div Resp Med, Montreal, PQ, Canada; [Semionov, Alexandre] McGill Univ, Hlth Ctr, Radiol Dept, Montreal, PQ, Canada; [Assayag, Deborah] Jewish Gen Hosp, Pulm Div, Montreal, PQ, Canada; [Lefson, Michael; Kitty, Darlene; Dannenbaum, David; Robinson, Elizabeth] Cree Board Hlth & Social Serv James Bay, Dept Med, Montreal, PQ, Canada; [Dannenbaum, David; Torrie, Jill; Lejeune, Pierre; Robinson, Elizabeth] Cree Board Hlth & Social Serv James Bay, Dept Publ Hlth, Montreal, PQ, Canada; [Robinson, Elizabeth] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Khan, Faiz Ahmad] McGill Univ, Hlth Ctr, Montreal Chest Inst, Montreal, PQ, Canada; [Khan, Faiz Ahmad] McGill Univ, Hlth Ctr, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit,Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Khan, FA (corresponding author), McGill Univ, Div Resp Med, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Hlth Ctr, Montreal Chest Inst, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Hlth Ctr, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit,Res Inst, Montreal, PQ, Canada.	faiz.ahmadkhan@mcgill.ca	Assayag, Deborah/ABE-4299-2021	Semionov, Alexandre/0000-0002-8255-3324	Cree Health Board; Fonds de Recherche Sante Quebec (FRQS)	Cree Health Board; Fonds de Recherche Sante Quebec (FRQS)	The study was funded by the Cree Health Board, members of whom are amongst the coauthors and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript. FAK received salary support from the Fonds de Recherche Sante Quebec (FRQS); the FRQS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz ZA, 2004, THORAX, V59, P506, DOI 10.1136/thx.2003.020396; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; de la Sante A et des Services Sociaux, 2015, SANT SERV SOC; Fay MP, 1997, STAT MED, V16, P791; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Garcia Christine Kim, 2011, Proc Am Thorac Soc, V8, P158, DOI 10.1513/pats.201008-056MS; Hodgson U, 2002, THORAX, V57, P338, DOI 10.1136/thorax.57.4.338; Hopkins RB, 2016, EUR RESPIR J, V48, P187, DOI 10.1183/13993003.01504-2015; Hunninghake GW, 2003, CHEST, V124, P1215, DOI 10.1378/chest.124.4.1215; Hunninghake GW, 2001, AM J RESP CRIT CARE, V164, P193, DOI 10.1164/ajrccm.164.2.2101090; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Hyldgaard C, 2014, RESP MED, V108, P793, DOI 10.1016/j.rmed.2013.09.002; Kaunisto J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-53; Martinez Fernando J, 2006, Proc Am Thorac Soc, V3, P81, DOI 10.1513/pats.200511-123JH; Ospina MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123204; Ospina MB, 2012, CAN RESPIR J, V19, P355, DOI 10.1155/2012/825107; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Public Health Agency of Canada, 2008, TUB CAN 2008; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Saad N, 2013, THORAX, V68, P361, DOI 10.1136/thoraxjnl-2012-201823; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Statistics Canada, 2015, CAN COMM HLTH SURV 2; Strand MJ, 2014, CHEST, V146, P775, DOI 10.1378/chest.13-2388; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Yamauchi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166168	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184548	10.1371/journal.pone.0184548	http://dx.doi.org/10.1371/journal.pone.0184548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886193	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100152
J	Zhao, T; Ding, XC; Yan, C; Du, H				Zhao, Ting; Ding, Xinchun; Yan, Cong; Du, Hong			Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; endothelial cell; lysosome; tumor metastasis; tumor microenvironment; Rab7 GTPase; lysosomal acid lipase	CANCER-CELL PROLIFERATION; SUPPRESSOR-CELLS; LAL(-/-) MICE; MTOR PATHWAY; ANGIOGENESIS; DISEASE; PROGRESSION; METABOLISM; ACTIVATION; PROMOTES	Tumors depend on their microenvironment for sustained growth, invasion, and metastasis. In this environment, endothelial cells (ECs) are an important stromal cell type interacting with malignant cells to facilitate tumor angiogenesis and cancer cell extravasation. Of note, lysosomal acid lipase (LAL) deficiency facilitates melanoma growth and metastasis. ECs from LAL-deficient (lal(-/-)) mice possess enhanced proliferation, migration, and permeability of inflammatory cells by activating the mammalian target of rapamycin (mTOR) pathway. Here we report that lal(-/-) ECs facilitated in vivo tumor angiogenesis, growth, and metastasis, largely by stimulating tumor cell proliferation, migration, adhesion, and transendothelial migration via increased expression of IL-6 and monocyte chemoattractant protein 1 (MCP-1). This prompted us to look for lysosomal proteins that are involved in lal(-/-) EC dysfunctions. We found that lal(-/-) ECs displayed increased expression of Rab7, a late endosome/lysosome-associated small GTPase. Moreover, Rab7 and mTOR were co-increased and co-localized to lysosomes and physically interacted in lal(-/-) ECs. Rab7 inhibition reversed lal(-/-) EC dysfunctions, including decreasing their enhanced migration and permeability of tumor-stimulatory myeloid cells, and suppressed EC-mediated stimulation of in vitro tumor cell transmigration, proliferation, and migration and in vivo tumor growth and metastasis. Finally, Rab7 inhibition reduced overproduction of reactive oxygen species and increased IL-6 and MCP-1 secretion in lal(-/-) ECs. Our results indicate that metabolic reprogramming resulting from LAL deficiency enhances the ability of ECs to stimulate tumor cell proliferation and metastasis through stimulation of lysosome-anchored Rab7 activity.	[Zhao, Ting; Ding, Xinchun; Yan, Cong; Du, Hong] Indiana Univ Sch Med, Dept Pathol & Lab Med, 975 W Walnut St,IB424G, Indianapolis, IN 46202 USA; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis	Yan, C; Du, H (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, 975 W Walnut St,IB424G, Indianapolis, IN 46202 USA.	coyan@iupui.edu; hongdu@iupui.edu			National Institutes of Health [HL087001, CA138759, CA152099]; NATIONAL CANCER INSTITUTE [R01CA152099, R01CA138759] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL087001 (to H. D.) and CA138759 and CA152099 (to C. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso-Curbelo D, 2014, CANCER CELL, V26, P61, DOI 10.1016/j.ccr.2014.04.030; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Ding XC, 2017, ONCOTARGET, V8, P30123, DOI 10.18632/oncotarget.16280; Ding XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121001; Ding XC, 2014, AM J PATHOL, V184, P397, DOI 10.1016/j.ajpath.2013.10.015; Farhan MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135245; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Grabowski G., 2014, ONLINE METABOLIC MOL; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Lee E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05853; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mulligan JK, 2010, J IMMUNOTHER, V33, P126, DOI 10.1097/CJI.0b013e3181b91c9c; Numrich J, 2014, BIOL CHEM, V395, P327, DOI 10.1515/hsz-2013-0258; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Reymond N, 2012, METHODS MOL BIOL, V827, P123, DOI 10.1007/978-1-61779-442-1_9; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yadav A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141602; Yan C, 2014, WORLD J IMMUNOL, V27, P42; Yan CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035076; Young MR, 2012, CANCER IMMUNOL IMMUN, V61, P1609, DOI 10.1007/s00262-012-1335-0; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang M, 2009, BIOSCIENCE REP, V29, P193, DOI 10.1042/BSR20090032; Zhao T, 2015, ONCOGENE, V34, P1938, DOI 10.1038/onc.2014.143; Zhao T, 2016, ONCOTARGET, V7, P61121, DOI 10.18632/oncotarget.11244; Zhao T, 2016, ONCOTARGET, V7, P1529, DOI 10.18632/oncotarget.6414; Zhao T, 2014, J IMMUNOL, V193, P1942, DOI 10.4049/jimmunol.1301941; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	11	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19198	19208		10.1074/jbc.M116.773093	http://dx.doi.org/10.1074/jbc.M116.773093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28924047	hybrid, Green Published			2022-12-26	WOS:000416226700005
J	Opalko, HE; Moseley, JB				Opalko, Hannah E.; Moseley, James B.			Dynamic regulation of Cdr1 kinase localization and phosphorylation during osmotic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; mitosis; protein kinase; protein phosphorylation; Schizosaccharomyces pombe; yeast; Cdr1; Wee1; osmotic stress	ACTIVATED PROTEIN-KINASE; NIM1/CDR1 MITOTIC INDUCER; REQUIRES P38 KINASE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; MAP KINASE; HYPERTONIC STRESS; FAMILY KINASE; CHECKPOINT	Environmental conditions modulate cell cycle progression in many cell types. A key component of the eukaryotic cell cycle is the protein kinase Wee1, which inhibits the cyclin-dependent kinase Cdk1 in yeast through human cells. In the fission yeast Schizosaccharomyces pombe, the protein kinase Cdr1 is a mitotic inducer that promotes mitotic entry by phosphorylating and inhibiting Wee1. Cdr1 and Wee1 both localize to punctate structures, termed nodes, on the medial cortex, but it has been unknown whether node localization can be altered by physiological signals. Here we investigated how environmental conditions regulate Cdr1 signaling for cell division. Osmotic stress induced hyperphosphorylation of the mitotic inducer Cdr1 for several hours, and cells delayed division for the same time period. This stress-induced hyperphosphorylation required both Cdr1 autophosphorylation and the stress-activated protein kinase Sty1. During osmotic stress, Cdr1 exited cortical nodes and localized in the cytoplasm. Using a series of truncation mutants, we mapped a C-terminal domain that is necessary and sufficient for Cdr1 node localization and found that Sty1 directly phosphorylates this domain in vitro. Sty1 was not required for Cdr1 exit from nodes, indicating the existence of additional regulatory signals. Both Cdr1 phosphorylation and node localization returned to basal levels when cells adapted to osmotic conditions and resumed cell cycle progression. In summary, we identified a mechanism that prevents Cdr1 colocalization with its inhibitory target Wee1 during osmotic stress. Dynamic regulation of protein localization to cortical nodes might represent a strategy to modulate entry into mitosis under differing environmental conditions.	[Opalko, Hannah E.; Moseley, James B.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA	Dartmouth College	Moseley, JB (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.	james.b.moseley@dartmouth.edu		opalko, hannah/0000-0002-5629-789X	National Institutes of Health [R01 GM099774]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099774 (to J. B. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Degols G, 1996, MOL CELL BIOL, V16, P2870; Deng L, 2013, MOL BIOL CELL, V24, P1872, DOI 10.1091/mbc.E13-02-0104; Dmitrieva NI, 2002, P NATL ACAD SCI USA, V99, P184, DOI 10.1073/pnas.231623498; Greenfield E. A., 2014, ANTIBODIES LAB MANUA; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kelkar M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9445; King K, 2013, MOL BIOL CELL, V24, P914, DOI 10.1091/mbc.E12-11-0812; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; Lopez-Aviles S, 2008, MOL BIOL CELL, V19, P1670, DOI 10.1091/mbc.E07-07-0639; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Mutavchiev DR, 2016, CURR BIOL, V26, P2921, DOI 10.1016/j.cub.2016.08.048; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Pan KZ, 2014, ELIFE, V3, DOI 10.7554/eLife.02040; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; Wu L, 1997, EMBO J, V16, P1342, DOI 10.1093/emboj/16.6.1342; YOUNG PG, 1987, J CELL SCI, V88, P295; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	41	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18457	18468		10.1074/jbc.M117.793034	http://dx.doi.org/10.1074/jbc.M117.793034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28924043	hybrid, Green Published			2022-12-26	WOS:000414958100007
J	Nakhleh, J; Christophides, GK; Osta, MA				Nakhleh, Johnny; Christophides, George K.; Osta, Mike A.			The serine protease homolog CLIPA14 modulates the intensity of the immune response in the mosquito Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host defense; host-pathogen interaction; immunology; malaria; plasmodium; clip domain serine protease; melanization; mosquito immunity	PROPHENOLOXIDASE PROPO ACTIVATION; PATTERN-RECOGNITION PROTEIN; TENEBRIO-MOLITOR LARVAE; MASQUERADE-LIKE PROTEIN; COMPLEMENT-LIKE PROTEIN; MANDUCA-SEXTA; PACIFASTACUS-LENIUSCULUS; DROSOPHILA-MELANOGASTER; SYSTEMIC INFECTIONS; PLASMODIUM	Clip domain serine protease homologs (SPHs) are positive and negative regulators of Anopheles gambiae immune responses mediated by the complement-like protein TEP1 against Plasmodium malaria parasites and other microbial infections. We have previously reported that the SPH CLIPA2 is a negative regulator of the TEP1-mediated response by showing that CLIPA2 knockdown (kd) enhances mosquito resistance to infections with fungi, bacteria, and Plasmodium parasites. Here, we identify another SPH, CLIPA14, as a novel regulator of mosquito immunity. We found that CLIPA14 is a hemolymph protein that is rapidly cleaved following a systemic infection. CLIPA14 kd mosquitoes elicited a potent melanization response against Plasmodium berghei ookinetes and exhibited significantly increased resistance to Plasmodium infections as well as to systemic and oral bacterial infections. The activity of the enzyme phenoloxidase, which initiates melanin biosynthesis, dramatically increased in the hemolymph of CLIPA14 kd mosquitoes in response to systemic bacterial infections. Ookinete melanization and hemolymph phenoloxidase activity were further increased after cosilencing CLIPA14 and CLIPA2, suggesting that these two SPHs act in concert to control the melanization response. Interestingly, CLIPA14 RNAi phenotypes and its infection-induced cleavage were abolished in a TEP1 loss-of-function background. Our results suggest that a complex network of SPHs functions downstream of TEP1 to regulate the melanization reaction.	[Nakhleh, Johnny; Osta, Mike A.] Amer Univ Beirut, Dept Biol, Bliss St, Beirut 11072020, Lebanon; [Christophides, George K.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	American University of Beirut; Imperial College London	Osta, MA (corresponding author), Amer Univ Beirut, Dept Biol, Bliss St, Beirut 11072020, Lebanon.	mo07@aub.edu.lb		Christophides, George/0000-0002-3323-1687	American University of Beirut University Research Board; K. A. Shair Award; Lebanese National Council for Scientific Research; Wellcome Trust [093587/Z/10/Z, 107983/Z/15/Z]	American University of Beirut University Research Board; K. A. Shair Award; Lebanese National Council for Scientific Research; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the American University of Beirut University Research Board, K. A. Shair Award, and Lebanese National Council for Scientific Research (to M. A. O. and J. N.). The work at Imperial College London was supported by Wellcome Trust Project Grant 093587/Z/10/Z and Senior Investigator Award 107983/Z/15/Z (to G. K. C.). The authors declare that they have no conflicts of interest with the contents of this article.	An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Jearaphunt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121073; Kamareddine L, 2016, J INNATE IMMUN, V8, P314, DOI 10.1159/000443883; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Sutthangkul J, 2015, J BIOL CHEM, V290, P6470, DOI 10.1074/jbc.M114.605568; Takahashi D, 2015, P NATL ACAD SCI USA, V112, P13856, DOI 10.1073/pnas.1517236112; Veillard F, 2016, BIOCHIMIE, V122, P255, DOI 10.1016/j.biochi.2015.10.007; Volohonsky G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006113; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Y, 2014, INSECT BIOCHEM MOLEC, V50, P82, DOI 10.1016/j.ibmb.2014.04.005; Yassine H, 2014, J INNATE IMMUN, V6, P806, DOI 10.1159/000363296; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	53	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18217	18226		10.1074/jbc.M117.797787	http://dx.doi.org/10.1074/jbc.M117.797787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28928218	Green Published, hybrid			2022-12-26	WOS:000414458200019
J	Li, ZG; Liu, JH; Li, J; Kong, YF; Sandusky, G; Rao, X; Liu, YL; Wan, J; Liu, XQ				Li, Zhiguo; Liu, Jinghui; Li, Jie; Kong, Yifan; Sandusky, George; Rao, Xi; Liu, Yunlong; Wan, Jun; Liu, Xiaoqi			Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; PHOSPHORYLATION; INHIBITION; APOPTOSIS; P53; GEMCITABINE; EFFICACY; PROTEIN; ARREST; G2	Polo-like kinase 1 (Plk1), a serine/threonine protein kinase normally expressed in mitosis, is frequently up-regulated in multiple types of human tumors regardless of the cell cycle stage. However, the causal relationship between Plk1 up-regulation and tumorigenesis is incompletely investigated. To this end, using a conditional expression system, here we generated Plk1 transgenic mouse lines to examine the role of Plk1 in tumorigenesis. Plk1 overexpression in mouse embryonic fibroblasts prepared from the transgenic mice led to aberrant mitosis followed by aneuploidy and apoptosis. Surprisingly, Plk1 overexpression had no apparent phenotypes in the mice. Given that no malignant tumor formation was observed even after a long period of Plk1 overexpression, we reasoned that additional factors are required for tumorigenesis in Plk1-overexpressing mice. Because Plk1 can directly participate in the regulation of theDNAdamage response (DDR) pathway, we challenged Plk1-overexpressing mice with ionizing radiation (IR) and found that Plk1-overexpressing mice are much more sensitive to IR than their wild-type littermates. Analysis of tumor development in the Plk1-overexpressing mice indicated a marked decrease in the time required for tumor emergence after IR. At the molecular level, Plk1 overexpression led to reduced phosphorylation of the serine/threonine kinases ATM and Chk2 and of histone H2AX after IR treatment both in vivo and in vitro. Furthermore, RNA-Seq analysis suggested that Plk1 elevation decreases the expression of several DDR genes. We conclude that Plk1 overexpression may contribute to tumor formation by both inducing chromosomal instability and suppressing the DDR pathway.	[Li, Zhiguo; Liu, Jinghui; Li, Jie; Kong, Yifan; Liu, Xiaoqi] Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA; [Sandusky, George] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Rao, Xi; Liu, Yunlong; Wan, Jun] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562	Walther Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA196634, R01CA196835, P30CA023168, R01CA157429] Funding Source: NIH RePORTER	Walther Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The RNA-Seq analysis was performed by the Collaborative Core for Cancer Bioinformatics shared by Indiana University Simon Cancer Center and Purdue University Center for Cancer Research with the support from the Walther Cancer Foundation.	Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Cholewa BD, 2013, CANCER RES, V73, P6848, DOI 10.1158/0008-5472.CAN-13-2197; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hou XZ, 2013, PROSTATE, V73, P1352, DOI 10.1002/pros.22683; Hyun SY, 2014, BMB REP, V47, P249, DOI 10.5483/BMBRep.2014.47.5.061; Johnson LN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002234; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lee K., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.4046/TRD.2015.78.4.360; Li J, 2016, CELL CYCLE, V15, P711, DOI 10.1080/15384101.2016.1148838; Li ZN, 2015, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-015-0415-1; Li ZG, 2017, CANCER RES, V77, P3169, DOI 10.1158/0008-5472.CAN-16-2787; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodel F, 2010, AM J PATHOL, V177, P918, DOI 10.2353/ajpath.2010.100040; Scharow A, 2016, CHEMBIOCHEM, V17, P759, DOI 10.1002/cbic.201500535; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shao C, 2015, J BIOL CHEM, V290, P2024, DOI 10.1074/jbc.M114.596817; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Strebhardt K, 2015, EXPERT OPIN DRUG DIS, V10, P1, DOI 10.1517/17460441.2015.962510; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; SUNKEL CE, 1988, J CELL SCI, V89, P25; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhang Z, 2014, CANCER RES, V74, P6635, DOI 10.1158/0008-5472.CAN-14-1916	40	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17461	17472		10.1074/jbc.M117.810960	http://dx.doi.org/10.1074/jbc.M117.810960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28900036	hybrid, Green Published			2022-12-26	WOS:000414009300026
J	Mills, CA; Suzuki, A; Arceci, A; Mo, JY; Duncan, A; Salmon, ED; Emanuele, MJ				Mills, Christine A.; Suzuki, Aussie; Arceci, Anthony; Mo, Jin Yao; Duncan, Alex; Salmon, Edward D.; Emanuele, Michael J.			Nucleolar and spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3 ligase complex during chromosome segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDZONE FORMATION; TOPOISOMERASE-II; RANGAP1; SUMOYLATION; RANBP2; MICROTUBULES; KINETOCHORES; CONJUGATION; TARGETS; PRC1	The mitotic spindle is composed of dynamic microtubules and associated proteins that together direct chromosome movement during mitosis. The spindle plays a vital role in accurate chromosome segregation fidelity and is a therapeutic target in cancer. Nevertheless, the molecular mechanisms by which many spindle-associated proteins function remains unknown. The nucleolar and spindle-associated protein NUSAP1 is a microtubule-binding protein implicated in spindle stability and chromosome segregation. We show here that NUSAP1 localizes to dynamic spindle microtubules in a unique chromosome-centric pattern, in the vicinity of overlapping microtubules, during metaphase and anaphase of mitosis. Mass spectrometry-based analysis of endogenous NUSAP1 interacting proteins uncovered a cell cycle-regulated interaction between the RanBP2-RanGAP1-UBC9 SUMO E3 ligase complex and NUSAP1. Like NUSAP1 depletion, RanBP2 depletion impaired the response of cells to the microtubule poison Taxol. NUSAP1 contains a conserved SAP domain (SAF-A/B, Acinus, and PIAS). SAP domains are common among many other SUMO E3s, and are implicated in substrate recognition and ligase activity. We speculate that NUSAP1 contributes to accurate chromosome segregation by acting as a co-factor for RanBP2-RanGAP1-UBC9 during cell division.	[Mills, Christine A.; Arceci, Anthony; Duncan, Alex; Emanuele, Michael J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mills, Christine A.; Emanuele, Michael J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Suzuki, Aussie; Salmon, Edward D.] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA; [Arceci, Anthony; Emanuele, Michael J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Mo, Jin Yao; Duncan, Alex] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Mo, Jin Yao; Duncan, Alex] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Emanuele, MJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Emanuele, MJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Emanuele, MJ (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	emanuele@email.unc.edu	Suzuki, Aussie/ABF-4170-2021; , Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Suzuki, Aussie/0000-0001-7390-5116	Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120309, T32GM007040] Funding Source: NIH RePORTER	Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks to the Emanuele laboratory for critical feedback throughout this study. This work was done in part at the University of North Carolina Flow Cytometry and Proteomics Core Facilities, supported in part by Cancer Center Core Support Grant P30 CA016086 to the Lineberger Cancer Center.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Chou HY, 2011, CELL CYCLE, V10, P4083, DOI 10.4161/cc.10.23.18200; Choudhury R, 2016, CELL REP, V16, P3359, DOI 10.1016/j.celrep.2016.08.058; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Harlow E., 1999, USING ANTIBODIES LAB; Hu CK, 2012, MOL BIOL CELL, V23, P2702, DOI 10.1091/mbc.E12-01-0058; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kellogg EH, 2016, P NATL ACAD SCI USA, V113, P9430, DOI 10.1073/pnas.1609903113; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Li L, 2007, CELL SIGNAL, V19, P2046, DOI 10.1016/j.cellsig.2007.05.017; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Okamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142252; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Ribbeck K, 2007, CURR BIOL, V17, P230, DOI 10.1016/j.cub.2006.11.050; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Schou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100692; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Suzuki A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9161; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Vanden Bosch A, 2010, J CELL SCI, V123, P3244, DOI 10.1242/jcs.063875; Verbakel W, 2011, BIOCHEM BIOPH RES CO, V411, P732, DOI 10.1016/j.bbrc.2011.07.015; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Westman BJ, 2010, MOL CELL, V39, P618, DOI 10.1016/j.molcel.2010.07.025; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	48	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17178	17189		10.1074/jbc.M117.796045	http://dx.doi.org/10.1074/jbc.M117.796045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28900032	hybrid, Green Published			2022-12-26	WOS:000414009300003
J	He, L; Liu, Y; Yin, H; Zhang, JP; Zhang, J; Zhang, J				He, Ling; Liu, Yin; Yin, Heng; Zhang, Junpeng; Zhang, Jing; Zhang, Jiang			Automatic initial and final segmentation in cleft palate speech of Mandarin speakers	PLOS ONE			English	Article								The speech unit segmentation is an important pre-processing step in the analysis of cleft palate speech. In Mandarin, one syllable is composed of two parts: initial and final. In cleft palate speech, the resonance disorders occur at the finals and the voiced initials, while the articulation disorders occur at the unvoiced initials. Thus, the initials and finals are the minimum speech units, which could reflect the characteristics of cleft palate speech disorders. In this work, an automatic initial/final segmentation method is proposed. It is an important preprocessing step in cleft palate speech signal processing. The tested cleft palate speech utterances are collected from the Cleft Palate Speech Treatment Center in the Hospital of Stomatology, Sichuan University, which has the largest cleft palate patients in China. The cleft palate speech data includes 824 speech segments, and the control samples contain 228 speech segments. The syllables are extracted from the speech utterances firstly. The proposed syllable extraction method avoids the training stage, and achieves a good performance for both voiced and unvoiced speech. Then, the syllables are classified into with "quasi-unvoiced" or with "quasi-voiced" initials. Respective initial/final segmentation methods are proposed to these two types of syllables. Moreover, a two-step segmentation method is proposed. The rough locations of syllable and initial/final boundaries are refined in the second segmentation step, in order to improve the robustness of segmentation accuracy. The experiments show that the initial/final segmentation accuracies for syllables with quasi-unvoiced initials are higher than quasi-voiced initials. For the cleft palate speech, the mean time error is 4.4ms for syllables with quasi-unvoiced initials, and 25.7ms for syllables with quasi-voiced initials, and the correct segmentation accuracy P-30 for all the syllables is 91.69%. For the control samples, P-30 for all the syllables is 91.24%.	[He, Ling; Liu, Yin; Zhang, Junpeng; Zhang, Jing; Zhang, Jiang] Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China; [Yin, Heng] Sichuan Univ, Hosp Stomatol, Dept Cleft Lip & Palate, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhang, J; Zhang, J (corresponding author), Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China.	zhangjing@scu.edu.cn; zhangjiang_@hotmail.com		zhang, jin/0000-0003-2663-053X	National Natural Science Foundation of China [61503264]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China 61503264. LH receives this funding. http://www.nsfc.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China 61503264.	BRUGNARA F, 1993, SPEECH COMMUN, V12, P357, DOI 10.1016/0167-6393(93)90083-W; Cairns DA, 1996, IEEE T BIO-MED ENG, V43, P35, DOI 10.1109/10.477699; Chen Bin, 2012, Acta Acustica, V37, P104; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Cho JW, 2016, SIGNAL PROCESS, V120, P200, DOI 10.1016/j.sigpro.2015.09.002; Dai YH, 2009, COMMUNICATIONS TECHN, V42, P181; [丁慧 Ding Hui], 2004, [应用声学, Applied Acoustics], V23, P20; Dowling E., 1992, 1992 C 26 AS C, V2, P1105; El Ayadi M, 2017, SPEECH COMMUN, V92, P52, DOI 10.1016/j.specom.2017.05.005; Golding-Kushner K. J., 2001, THERAPY TECHNIQUES C, P19; Guo QY, 2010, INT CONF COMPUT AUTO, P123, DOI 10.1109/ICCAE.2010.5451414; Harding A, 1996, EUR J DISORDER COMM, V31, P331; Hsieh CT, 1999, J INF SCI ENG, V15, P615; Jia Z. B., 2006, THESIS; [李皓 Li Hao], 2012, [声学学报, Acta Acustica], V37, P339; Li J, 2016, INT C AS LANG PROC, P57; Li Jin, 2010, Proceedings of the 2010 International Conference on Intelligent Computation Technology and Automation (ICICTA 2010), P591, DOI 10.1109/ICICTA.2010.309; Li X, 2005, ACTA ACUSTICA; Li Y., 2015, ASSESSMENT TREATMENT; Lin X., 2013, LINGUISTICS PHONETIC, P35; Liu YJ, 2005, J GANSU SCI, V17, P90; Lu D, 2011, J GUILIN U ELECT TEC; Mporas I, 2011, SIGNAL PROCESS, V91, P2101, DOI 10.1016/j.sigpro.2011.03.020; Nakagawa S., 1988, 9th International Conference on Pattern Recognition (IEEE Cat. No.88CH2614-6), P960, DOI 10.1109/ICPR.1988.28414; Nieto R. G., 2014, 2014 19 S IM SIGN PR, P1; Noetzel A., 1991, Electro International. Conference Record, P580, DOI 10.1109/ELECTR.1991.718279; Rah DK, 2001, ANN BIOMED ENG, V29, P587, DOI 10.1114/1.1380422; Reichl W, 1993, EUROPEAN C SPEECH CO, V279-280, P277; SETHY A, 2002, INT C SPOK LANG PROC; Shastri L, 1999, P 14 INT C PHON SCI, V910, P1721; Sheng H., 1999, 9 NAT C SIGN PROC; Su Min, 2008, Audio Engineering, V32, P49; Takahashi N, 2002, INT C SPOK LANG PROC, V101, P13; Toledano DT, 2000, INT CONF ACOUST SPEE, P3438, DOI 10.1109/ICASSP.2000.860140; Triskova H, 2011, ARCH ORIENT, V79, P99; Vijayalakshmi P., 2009, TENCON 2009 2009 IEE, P1; Vijayalakshmi R, 2007, IEEE T BIO-MED ENG, V54, P621, DOI 10.1109/TBME.2006.889191; Wang Yan, 2011, Computer Engineering and Applications, V47, P134, DOI 10.3778/j.issn.1002-8331.2011.14.038; XIAO SC, 2004, AUDIO ENG, V6, P37, DOI DOI 10.1016/J.SIGPRO.2011.03.020; Zao L, 2014, IEEE SIGNAL PROC LET, V21, P620, DOI 10.1109/LSP.2014.2311435; Zhang Baoqi, 2010, Acta Acustica, V35, P701; Zhang T, 2013, 2013 3RD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND NETWORK TECHNOLOGY (ICCSNT), P1050, DOI 10.1109/ICCSNT.2013.6967284; ZHANG X, 2007, NONINVASIVE ESTIMATI, P506; Zhao XF, 2008, CAN CON EL COMP EN, P139	44	1	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184267	10.1371/journal.pone.0184267	http://dx.doi.org/10.1371/journal.pone.0184267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926572	Green Submitted, gold, Green Published			2022-12-26	WOS:000411166600013
J	Duc, C; Pradal, M; Sanchez, I; Noble, J; Tesniere, C; Blondin, B				Duc, Camille; Pradal, Martine; Sanchez, Isabelle; Noble, Jessica; Tesniere, Catherine; Blondin, Bruno			A set of nutrient limitations trigger yeast cell death in a nitrogen-dependent manner during wine alcoholic fermentation	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; ASSIMILABLE NITROGEN; PANTOTHENIC-ACID; MICROARRAY DATA; METABOLISM; EXPRESSION; KINETICS; GLYCOGEN; GROWTH	Yeast cell death can occur during wine alcoholic fermentation. It is generally considered to result from ethanol stress that impacts membrane integrity. This cell death mainly occurs when grape musts processing reduces lipid availability, resulting in weaker membrane resistance to ethanol. However the mechanisms underlying cell death in these conditions remain unclear. We examined cell death occurrence considering yeast cells ability to elicit an appropriate response to a given nutrient limitation and thus survive starvation. We show here that a set of micronutrients (oleic acid, ergosterol, pantothenic acid and nicotinic acid) in low, growth-restricting concentrations trigger cell death in alcoholic fermentation when nitrogen level is high. We provide evidence that nitrogen signaling is involved in cell death and that either SCH9 deletion or Tor inhibition prevent cell death in several types of micronutrient limitation. Under such limitations, yeast cells fail to acquire any stress resistance and are unable to store glycogen. Unexpectedly, transcriptome analyses did not reveal any major changes in stress genes expression, suggesting that post-transcriptional events critical for stress response were not triggered by micronutrient starvation. Our data point to the fact that yeast cell death results from yeast inability to trigger an appropriate stress response under some conditions of nutrient limitations most likely not encountered by yeast in the wild. Our conclusions provide a novel frame for considering both cell death and the management of nutrients during alcoholic fermentation.	[Duc, Camille; Pradal, Martine; Sanchez, Isabelle; Tesniere, Catherine; Blondin, Bruno] Univ Montpellier, Montpellier SupAgro, INRA, UMR SPO, Montpellier, France; [Duc, Camille; Noble, Jessica] Lallemand SAS, Blagnac, France	INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Lallemand - France	Blondin, B (corresponding author), Univ Montpellier, Montpellier SupAgro, INRA, UMR SPO, Montpellier, France.	bruno.blondin@supagro.fr	Tesnière, Catherine/L-8771-2018	Tesnière, Catherine/0000-0003-4865-9229				Alexandre H, 1994, UNION OENOLOGUES FRA, V34, P11; Ambroset C, 2011, GENET, V1; [Anonymous], 2014, PLOS ONE, V9; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bisson LF, 1999, AM J ENOL VITIC, V50; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Carmona-Gutierrez D, 2012, CELL DEATH DIFFER, V19, P913, DOI 10.1038/cdd.2012.31; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delobel P, 2012, LETT APPL MICROBIOL, V55, P338, DOI 10.1111/j.1472-765X.2012.03301.x; Enjalbert B, 2000, MICROBIOL-SGM, V146, P2685, DOI 10.1099/00221287-146-10-2685; Fabrizio P, 2003, GENETICS, V163, P35; Guaragnella N, 2011, BIOCH SOC T, V39; Hagen KM, 2008, AM J ENOL VITICULT, V59, P432; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kitagaki H, 2007, ETHANOL INDUCED DEAT; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Landolfo S, 2008, BBA-GEN SUBJECTS, V1780, P892, DOI 10.1016/j.bbagen.2008.03.008; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Li LH, 2013, MOL BIOL CELL, V24, P3697, DOI 10.1091/mbc.E13-05-0241; Lis P, 2016, ONCOTARGET, V7, P10153, DOI 10.18632/oncotarget.7174; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; NI HT, 1995, MOL MICROBIOL, V16, P1197, DOI 10.1111/j.1365-2958.1995.tb02342.x; Orozco H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-104; Orozco H, 2012, MECH AGEING DEV, V133, P348, DOI 10.1016/j.mad.2012.03.013; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Quan ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005282; R Core Team, 2014, NO TITLE R A LANGUAG; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; SABLAYROLLES JM, 1989, BIOPROCESS ENG, V4, P139, DOI 10.1007/BF00369763; Sablayrolles JM, 1987, BIOTECHNOL TECH, V1; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tesniere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061645; Tsang F, 2015, J BIOL CHEM, V290, P12753, DOI 10.1074/jbc.M115.644534; Wang XD, 2003, J APPL MICROBIOL, V94, P349, DOI 10.1046/j.1365-2672.2003.01827.x; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Zhang R, 2012, J CHROMATOGR SCI, V50, P598, DOI 10.1093/chromsci/bms035	44	29	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184838	10.1371/journal.pone.0184838	http://dx.doi.org/10.1371/journal.pone.0184838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922393	Green Submitted, gold, Green Published			2022-12-26	WOS:000411059300032
J	Okubo, T; Osaki, T; Nozaki, E; Uemura, A; Sakai, K; Matushita, M; Matsuo, J; Nakamura, S; Kamiya, S; Yamaguchi, H				Okubo, Torahiko; Osaki, Takako; Nozaki, Eriko; Uemura, Akira; Sakai, Kouhei; Matushita, Mizue; Matsuo, Junji; Nakamura, Shinji; Kamiya, Shigeru; Yamaguchi, Hiroyuki			Walker occupancy has an impact on changing airborne bacterial communities in an underground pedestrian space, as small-dust particles increased with raising both temperature and humidity	PLOS ONE			English	Article							INDOOR AIR; OUTDOOR AIR; RESPIRATORY HEALTH; EXPOSURE; RESUSPENSION; POLLUTANTS; DEPOSITION; DIVERSITY; POLLUTION; SYSTEM	Although human occupancy is a source of airborne bacteria, the role of walkers on bacterial communities in built environments is poorly understood. Therefore, we visualized the impact of walker occupancy combined with other factors (temperature, humidity, atmospheric pressure, dust particles) on airborne bacterial features in the Sapporo underground pedestrian space in Sapporo, Japan. Air samples (n = 18; 4,800L/each sample) were collected at 8: 00 h to 20: 00 h on 3 days (regular sampling) and at early morning/late night (5: 50 h to 7: 50 h/22: 15 h to 24: 45 h) on a day (baseline sampling), and the number of CFUs (colony forming units) OTUs (operational taxonomic units) and other factors were determined. The results revealed that temperature, humidity, and atmospheric pressure changed with weather. The number of walkers increased greatly in the morning and evening on each regular sampling day, although total walker numbers did not differ significantly among regular sampling days. A slight increase in small dust particles (0.3-0.5 mu m) was observed on the days with higher temperature regardless of regular or baseline sampling. At the period on regular sampling, CFU levels varied irregularly among days, and the OTUs of 22-phylum types were observed, with the majority being from Firmicutes or Proteobacteria (gamma-), including Staphylococcus sp. derived from human individuals. The data obtained from regular samplings reveled that although no direct interaction of walker occupancy and airborne CFU and OTU features was observed upon Pearson's correlation analysis, cluster analysis indicated an obvious lineage consisting of walker occupancy, CFU numbers, OTU types, small dust particles, and seasonal factors (including temperature and humidity). Meanwhile, at the period on baseline sampling both walker and CFU numbers were similarly minimal. Taken together, the results revealed a positive correlation of walker occupancy with airborne bacteria that increased with increases in temperature and humidity in the presence of airborne small particles. Moreover, the results indicated that small dust particles at high temperature and humidity may be a crucial factor responsible for stabilizing the bacteria released from walkers in built environments. The findings presented herein advance our knowledge and understanding of the relationship between humans and bacterial communities in built environments, and will help improve public health in urban communities.	[Okubo, Torahiko; Uemura, Akira; Sakai, Kouhei; Matushita, Mizue; Matsuo, Junji; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Osaki, Takako; Nozaki, Eriko; Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Mitaka, Tokyo, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Bunkyo Ku, Tokyo, Japan	Hokkaido University; Kyorin University; Juntendo University	Yamaguchi, H (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	Okubo, Torahiko/Q-1707-2019	Okubo, Torahiko/0000-0002-3194-5862	Management Expenses Grant for National University; Japan Society for the Promotion of Science in Japan [15K08471]; Grants-in-Aid for Scientific Research [15K08471] Funding Source: KAKEN	Management Expenses Grant for National University; Japan Society for the Promotion of Science in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Although this study was supported by the Management Expenses Grant for National University and the Japan Society for the Promotion of Science in Japan (15K08471), we declare that the funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript and except these, there was no additional external funding received for this study.	Adams RI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128022; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Bhangar S, 2014, INDOOR AIR, V24, P604, DOI 10.1111/ina.12111; Bouillard L, 2005, ANN AGR ENV MED, V12, P187; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Dybwad M, 2014, APPL ENVIRON MICROB, V80, P257, DOI 10.1128/AEM.02849-13; Ferro AR, 2004, ENVIRON SCI TECHNOL, V38, P1759, DOI 10.1021/es0263893; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Ghosh B, 2015, ENVIRON INT, V85, P254, DOI 10.1016/j.envint.2015.09.018; Guo H, 2010, ENVIRON SCI POLLUT R, V17, P1268, DOI 10.1007/s11356-010-0306-2; Johnson L, 2010, J OCCUP ENVIRON HYG, V7, P585, DOI 10.1080/15459624.2010.508951; Karottki DG, 2015, INT J ENV RES PUB HE, V12, P1667, DOI 10.3390/ijerph120201667; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; LUCKEY TD, 1972, AM J CLIN NUTR, V25, P1292; Menetrez MY, 2001, J AIR WASTE MANAGE, V51, P1436, DOI 10.1080/10473289.2001.10464365; Nicolas M, 2009, ENVIRON SCI TECHNOL, V43, P7437, DOI 10.1021/es901569d; Ouidir M, 2015, ENVIRON INT, V84, P161, DOI 10.1016/j.envint.2015.07.021; Pantelic J, 2015, INDOOR AIR, V25, P683, DOI 10.1111/ina.12187; Pope CA, 1999, ENVIRON HEALTH PERSP, V107, P567, DOI 10.2307/3434399; Prussin AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0144-z; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Qian J, 2008, AEROSOL SCI TECH, V42, P566, DOI 10.1080/02786820802220274; Rivas I, 2014, ENVIRON INT, V69, P200, DOI 10.1016/j.envint.2014.04.009; Rosenfelder M, 2016, INT J BIOMETEOROL, V60, P277, DOI 10.1007/s00484-015-1024-8; Sanchez-Soberon F, 2015, ENVIRON RES, V143, P10, DOI 10.1016/j.envres.2015.09.008; THATCHER TL, 1995, ATMOS ENVIRON, V29, P1487, DOI 10.1016/1352-2310(95)00016-R; Tischer C, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0042-y; Tschernig T, EXPT TOXICOLOGIC PAT, V65, P883; van Kampen V, 2014, ANN OCCUP HYG, V58, P693, DOI 10.1093/annhyg/meu026; Verschaeve L, 2009, MED HYPOTHESES, V73, P802, DOI 10.1016/j.mehy.2009.01.058; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang J, 2015, INDOOR AIR, V25, P176, DOI 10.1111/ina.12127; Yang W, 2011, J EXPO SCI ENV EPID, V21, P310, DOI 10.1038/jes.2010.23	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184980	10.1371/journal.pone.0184980	http://dx.doi.org/10.1371/journal.pone.0184980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922412	Green Submitted, Green Published, gold			2022-12-26	WOS:000411059300051
J	Ostermann, JK; Witt, CM; Reinhold, T				Ostermann, Julia K.; Witt, Claudia M.; Reinhold, Thomas			A retrospective cost-analysis of additional homeopathic treatment in Germany: Long-term economic outcomes	PLOS ONE			English	Article							DISORDERS; TRIAL; CARE	Objectives This study aimed to provide a long-term cost comparison of patients using additional homeopathic treatment (homeopathy group) with patients using usual care (control group) over an observation period of 33 months. Methods Health claims data from a large statutory health insurance company were analysed from both the societal perspective (primary outcome) and from the statutory health insurance perspective (secondary outcome). To compare costs between patient groups, homeopathy and control patients were matched in a 1: 1 ratio using propensity scores. Predictor variables for the propensity scores included health care costs and both medical and demographic variables. Health care costs were analysed using an analysis of covariance, adjusted for baseline costs, between groups both across diagnoses and for specific diagnoses over a period of 33 months. Specific diagnoses included depression, migraine, allergic rhinitis, asthma, atopic dermatitis, and headache. Results Data from 21,939 patients in the homeopathy group (67.4% females) and 21,861 patients in the control group (67.2% females) were analysed. Health care costs over the 33 months were 12,414 EUR [95% CI 12,022-12,805] in the homeopathy group and 10,428 EUR [95% CI 10,036-10,820] in the control group (p< 0.0001). The largest cost differences were attributed to productivity losses (homeopathy: EUR 6,289 [6,118-6,460]; control: EUR 5,498 [5,326-5,670], p< 0.0001) and outpatient costs (homeopathy: EUR 1,794 [1,770-1,818]; control: EUR 1,438 [1,414-1,462], p< 0.0001). Although the costs of the two groups converged over time, cost differences remained over the full 33 months. For all diagnoses, homeopathy patients generated higher costs than control patients. Conclusion The analysis showed that even when following-up over 33 months, there were still cost differences between groups, with higher costs in the homeopathy group.	[Ostermann, Julia K.; Witt, Claudia M.; Reinhold, Thomas] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Maryland; University of Maryland Baltimore	Ostermann, JK (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	julia.ostermann@charite.de	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Reinhold, Thomas/0000-0001-5169-7029; Ostermann, Julia/0000-0002-0180-8752	statutory health insurance company Techniker Krankenkasse	statutory health insurance company Techniker Krankenkasse	This is an investigator initiated study that is co-sponsored by the statutory health insurance company Techniker Krankenkasse. The co-sponsor provided data, but was not involved in the main data analysis, data interpretation, writing, or decision to submit the manuscript. All authors had full access to the data and are responsible for the veracity and completeness of the data reported. All authors had full access to the data in the study and take final responsibility to submit for publication.	Anlauf M, 2015, GMS, P13; [Anonymous], 2014, R LANG ENV STAT COMP; Baars EW, 2014, BMJ OPEN, V4, DOI DOI 10.1136/BMJ0PEN-2014-005332; Brien S, 2011, RHEUMATOLOGY, V50, P1070, DOI 10.1093/rheumatology/keq234; DZVh&Auml;, 2012, SEL KLASS HOM BET KR; Friemel S, 2005, PSYCHIAT PRAX, V32, P113, DOI 10.1055/s-2004-834611; House of Commons Science and Technology Committee, 2010, EV CHECK 2 HOM; Insel TR, 2008, AM J PSYCHIAT, V165, P663, DOI 10.1176/appi.ajp.2008.08030366; Jain Asha, 2003, Homeopathy, V92, P71, DOI 10.1016/S1475-4916(03)00004-3; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kliems H, 2011, J ALTERN COMPLEM MED, V17, P265, DOI 10.1089/acm.2010.0158; MADDOX J, 1988, NATURE, V334, P287, DOI 10.1038/334287a0; Marian F, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-52; Mathie RT, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-142; OPATHIE Keine Abrechnung zulasten der gesetzlichen Krankenversicherung, 2017, DTSCH ARZTEBL, V114; Ostermann JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134657; Roll S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054973; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SIMON G, 1995, AM J PSYCHIAT, V152, P352; Smith K, 2012, BIOETHICS, V26, P398, DOI 10.1111/j.1467-8519.2010.01876.x; Statistisches Bundesamt, 2014, JAHR ARB; Studer HP, 2011, FORSCH KOMPLEMENTMED, V18, P315, DOI 10.1159/000334797; Thompson EA, 2011, HOMEOPATHY, V100, P122, DOI 10.1016/j.homp.2011.05.001; Viksveen P, 2014, EUR J HEALTH ECON, V15, P157, DOI 10.1007/s10198-013-0462-7; Witt C, 2005, COMPLEMENT THER MED, V13, P79, DOI 10.1016/j.ctim.2005.03.005; Witt CM, 2009, DERMATOLOGY, V219, P329, DOI 10.1159/000248854	27	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0182897	10.1371/journal.pone.0182897	http://dx.doi.org/10.1371/journal.pone.0182897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915242	Green Submitted, Green Published, gold			2022-12-26	WOS:000410861600003
J	Horemheb-Rubio, G; Ramos-Cervantes, P; Arroyo-Figueroa, H; Avila-Rios, S; Garcia-Morales, C; Reyes-Teran, G; Escobedo, G; Estrada, G; Garcia-Iglesias, T; Munoz-Saucedo, N; Kershenobich, D; Ostrosky-Wegman, P; Ruiz-Palacios, GM				Horemheb-Rubio, Gibran; Ramos-Cervantes, Pilar; Arroyo-Figueroa, Hugo; Avila-Rios, Santiago; Garcia-Morales, Claudia; Reyes-Teran, Gustavo; Escobedo, Galileo; Estrada, Gloria; Garcia-Iglesias, Trinidad; Munoz-Saucedo, Nayeli; Kershenobich, David; Ostrosky-Wegman, Patricia; Ruiz-Palacios, Guillermo M.			High HPgV replication is associated with improved surrogate markers of HIV progression	PLOS ONE			English	Article							GB-VIRUS-C; C/HEPATITIS-G-VIRUS; BLOOD-DONORS; PHYLOGENETIC ANALYSIS; DOWN-REGULATION; HIGH PREVALENCE; INFECTION; TRANSMISSION; RNA; RECOMBINATION	Background Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPgV infection and HPgV/HIV co-infection. Methods We analyzed and quantified 7,890 serum samples for HPgV viremia by One-Step RT-Real-Time PCR, 6,484 from healthy blood donors and 1,406 from HIV-infected patients. Data on HIV progression were obtained from patients' records. HPgV genotyping was performed in 445 samples by nested PCR of the 5'URT region. Finite Mixture Models were used to identify clustering patterns of HPgV viremia in blood donors and co-infected antiretroviral (ART)naive patients. Results HPgV was detected in 2.98% of blood donors and 33% of HIV patients, with a wide range of viral loads. The most prevalent genotypes were 3 (58.6%) and 2 (33.7%). HPgV viral loads from healthy blood donors and HPgV/HIV+ ART-naive co-infected patients were clustered into two component distributions, low and high, with a cut-off point of 5.07log(10) and 5.06log(10), respectively. High HPgV viremia was associated with improved surrogate markers of HIV infection, independent of the estimated duration of HIV infection or HIV treatment. Conclusions HPgV prevalence in Mexico was similar to that reported for other countries. The prevalent genotypes could be related to Mexico's geographic location and ethnicity, since genotype 2 is frequent in the United States and Europe and genotype 3 in Asia and Amerindian populations. HPgV viral load demonstrated two patterns of replication, low and high. The more pronounced beneficial response observed in co-infected patients with high HPgV viremia may explain discrepancies found between other studies. Mechanisms explaining high and low HPgV replication should be explored to determine whether the persistently elevated replication depends on host or viral factors.	[Horemheb-Rubio, Gibran; Ramos-Cervantes, Pilar; Arroyo-Figueroa, Hugo; Ruiz-Palacios, Guillermo M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Avila-Rios, Santiago; Garcia-Morales, Claudia; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Infect Dis Res Ctr, Mexico City, DF, Mexico; [Escobedo, Galileo] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Liver Pancreas & Intestinal Motil Lab, Mexico City, DF, Mexico; [Estrada, Gloria] Hosp Gen Mexico City, Blood Bank, Mexico City, DF, Mexico; [Garcia-Iglesias, Trinidad; Munoz-Saucedo, Nayeli] Univ Guadalajara, Ctr Univ Ciencias Salud, Immnuol Lab, Guadalajara, Jalisco, Mexico; [Kershenobich, David] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Biomed Res Inst, Mexico City, DF, Mexico; [Estrada, Gloria] Inst Nacl Transfus Sanguinea, Res & Normat, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad de Guadalajara; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Ruiz-Palacios, GM (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico.	gmrps@unam.mx	Ruiz-Palacios, Guillermo/GYQ-5462-2022; Avila-Rios, Santiago/AAB-4383-2020	Reyes-Teran, Gustavo/0000-0002-4115-4888	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [323782]; CONACyT [323782]	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We did not receive any specific funding for this research work, except for a PhD scholarship from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico), fellowship no. 323782, for the first author, Gibran Horemheb-Rubio, MD.; We thank Beatriz Remus, MD, for reviewing the manuscript and Gioconda Vallarta, MA, for design of the manuscript's diagrams. Gibran Horemheb Rubio Quintanares, MD, is a doctoral student from Programa de Doctorado de Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship No. 323782 from CONACyT.	AbuOdeh RO, 2015, J MED VIROL, V87, P2074, DOI 10.1002/jmv.24289; Alvarado-Mora MV, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-345; Anggorowati N, 2013, MICROBIOL IMMUNOL, V57, P298, DOI 10.1111/1348-0421.12033; [Anonymous], 2000, AIDS Res Hum Retroviruses, V16, P1123; Avila-Rios S, 2011, PLOS ONE, P6; Avila-Rios S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142604; Berzsenyi MD, 2011, J HEPATOL, V55, P536, DOI 10.1016/j.jhep.2010.12.021; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Biernacki C, 2003, COMPUT STAT DATA AN, V41, P561, DOI 10.1016/S0167-9473(02)00163-9; Bishop C.M., 2006, PATTERN RECOGN, P423; Bjorkman P, 2001, VOX SANG, V81, P148, DOI 10.1046/j.1423-0410.2001.00098.x; Bjorkman P, 2007, AIDS, V21, P1641, DOI 10.1097/QAD.0b013e32823bc9b7; Blackard JT, 2016, J GEN VIROL, V97, P1537, DOI 10.1099/jgv.0.000477; Blackard JT, 2017, J MED VIROL; Chang CM, 2014, CANCER RES, V74, P5553, DOI 10.1158/0008-5472.CAN-14-0209; Chivero ET, 2014, J GEN VIROL, V95, P1307, DOI 10.1099/vir.0.063016-0; Dmitriev P. N., 2010, Voprosy Virusologii, V55, P23; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Feng Y, 2011, CHINA PLOS ONE, P6; Feng Y, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.14169; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Handelsman E, 2007, HIV MED, V8, P561, DOI 10.1111/j.1468-1293.2007.00510.x; Kaye S, 2005, CLIN INFECT DIS, V40, P876, DOI 10.1086/428123; Keys JR, 2014, J MED VIROL, V86, P473, DOI 10.1002/jmv.23829; Keyvani H, 2012, HEPAT MON, V12, P38, DOI 10.5812/kowsar.1735143X.817; Krajden M, 2010, INT J CANCER, V126, P2885, DOI 10.1002/ijc.25035; Lanteri MC, 2015, J INFECT DIS, V211, P1585, DOI 10.1093/infdis/jiu660; Lauck M, 2015, J VIROL, V89, P2425, DOI 10.1128/JVI.02752-14; Liu P, 1997, TRANSFUSION, V37, P732, DOI 10.1046/j.1537-2995.1997.37797369450.x; Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Muerhoff AS, 2005, J GEN VIROL, V86, P1729, DOI 10.1099/vir.0.80854-0; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Naito H, 2001, J VIROL METHODS, V91, P3, DOI 10.1016/S0166-0934(00)00207-X; Neibecker M, 2011, J MED VIROL, V83, P685, DOI 10.1002/jmv.22029; Nerurkar VR, 1998, J MED VIROL, V56, P123, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;123::AID-JMV4&gt;3.0.CO;2-A; Oubina JR, 1999, VIRUS RES, V65, P121, DOI 10.1016/S0168-1702(99)00109-4; Patrikar Seema, 2014, Med J Armed Forces India, V70, P134, DOI 10.1016/j.mjafi.2013.08.005; Quiros E, 1998, EUR J EPIDEMIOL, V14, P617, DOI 10.1023/A:1007448501661; Re V, 2001, VOX SANG, V81, P54, DOI 10.1046/j.1423-0410.2001.00076.x; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Schleicher SB, 2003, J MED VIROL, V71, P226, DOI 10.1002/jmv.10474; Sentjens R, 2003, TRANSFUSION, V43, P1558, DOI 10.1046/j.1537-2995.2003.00561.x; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2009, AIDS, V23, P605, DOI 10.1097/QAD.0b013e32831f1b00; Tamura K, MEGA6 MOL EVOLUTIONA; Tanaka Y, 1998, AM J TROP MED HYG, V59, P462, DOI 10.4269/ajtmh.1998.59.462; Vahidnia F, 2012, CLIN INFECT DIS, V55, P1012, DOI 10.1093/cid/cis589; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Young D, 2017, PACKAGE MIXTOOLS; Zanetti AR, 1998, J MED VIROL, V54, P107, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;107::AID-JMV7&gt;3.0.CO;2-A; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	53	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184494	10.1371/journal.pone.0184494	http://dx.doi.org/10.1371/journal.pone.0184494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910347	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200052
J	Mindu, C; Lopez-Varela, E; Alonso-Menendez, Y; Mausse, Y; Augusto, OJ; Gondo, K; Munoz, J; Sacarlal, J; Garcia-Basteiro, AL; Alonso, PL; Munguambe, K				Mindu, Carolina; Lopez-Varela, Elisa; Alonso-Menendez, Yara; Mausse, Yolanda; Augusto, Orvalho Joaquim; Gondo, Kizito; Munoz, Jose; Sacarlal, Jahit; Garcia-Basteiro, Alberto L.; Alonso, Pedro L.; Munguambe, Khatia			Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; TRADITIONAL HEALERS; PULMONARY TUBERCULOSIS; EXPERIENCES; ADHERENCE; CHILDREN; MANHICA	Background Tuberculosis (TB) remains an important public health concern, especially in poorly resourced settings. TB diagnosis is challenging, particularly for children, who are the most vulnerable to its' impacts. Lack of knowledge and awareness of the disease compromises prompt diagnosis and treatment compliance. Objective To gain insights regarding caretakers' knowledge of the aetiology and prevention of paediatric TB in southern Mozambique, to describe their care-seeking behaviours and to assess the acceptability of diagnostic procedures. Methods A total of 35 caretakers were interviewed, all of which had children with TB compatible symptoms. Eleven were caretakers of children diagnosed with TB at the health facility, 11 of children for whom TB was excluded as a diagnosis at the health facility and 13 of children with TB compatible symptoms identified in the community. The first two groups took part in a TB incidence study, while the third group did not. All underwent the same semi-structured interviews, the results of which were analysed and compared using content analysis. Results Even when confronted with signs suggestive of TB, most caretakers never suspected it or misinterpreted the signs, even among caretakers with TB and TB contacts. There was limited knowledge of TB, except among those undergoing treatment. The transgression of social norms was often presented as an explanation for TB in parallel to medically sound causes. The use of traditional care for prevention is widespread, but it varied for treatment purposes. TB diagnostic procedures were considered painful but were unanimously tolerated. Conclusions and significance Misconceptions of paediatric TB, associated complex care-seeking itineraries and negative feelings of the diagnostic procedures may result in delays, low adherence and lost to follow-up, which needs to be addressed by adequately framed health promotion approaches.	[Mindu, Carolina; Lopez-Varela, Elisa; Alonso-Menendez, Yara; Mausse, Yolanda; Augusto, Orvalho Joaquim; Gondo, Kizito; Munoz, Jose; Sacarlal, Jahit; Garcia-Basteiro, Alberto L.; Alonso, Pedro L.; Munguambe, Khatia] CISM, Cambeve, Maputo, Mozambique; [Lopez-Varela, Elisa; Munoz, Jose; Garcia-Basteiro, Alberto L.; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Global Hlth Inst, Barcelona, Spain; [Sacarlal, Jahit; Munguambe, Khatia] UEM, Fac Med, Maputo, Mozambique; [Garcia-Basteiro, Alberto L.] Acad Med Ctr, AIGHD, Amsterdam, Netherlands	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam; Academic Medical Center Amsterdam	Lopez-Varela, E; Munguambe, K (corresponding author), CISM, Cambeve, Maputo, Mozambique.; Lopez-Varela, E (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Global Hlth Inst, Barcelona, Spain.; Munguambe, K (corresponding author), UEM, Fac Med, Maputo, Mozambique.	elisa.lopez@manhica.net; khatia.munguambe@manhica.net	varela, elisa lopez/ABE-4092-2020; Alonso, Pedro L/AAZ-3645-2020; Gutiérrez, José/GSJ-1846-2022; Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, Jose Muñoz/X-5917-2018; Sacarlal, Jahit/R-3172-2016; Augusto, Orvalho/J-8767-2019	varela, elisa lopez/0000-0002-6725-5687; Alonso, Pedro L/0000-0003-3292-3443; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Sacarlal, Jahit/0000-0003-1059-217X; Augusto, Orvalho/0000-0002-0005-3968; Fernandez, Ivette/0000-0001-5179-0477; Alonso Menendez, Yara/0000-0003-0183-5061	Fundo Nacional de Investigacao, Ministry of Science and Technology, Mozambique [0073-INV/FNI]; Spanish Agency for International Cooperation and Development (AECID)	Fundo Nacional de Investigacao, Ministry of Science and Technology, Mozambique; Spanish Agency for International Cooperation and Development (AECID)	This work was supported by the Fundo Nacional de Investigacao, Ministry of Science and Technology, Mozambique (grant: 0073-INV/FNI). The CISM receives core funding from the Spanish Agency for International Cooperation and Development (AECID).	Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Barker RD, 2006, INT J TUBERC LUNG D, V10, P670; Bjerrum S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-6; Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038; Brouwer JA, 1998, INT J TUBERC LUNG D, V2, P231; Chow F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-67; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Franck C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-426; Garcia-Basteiro AL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1534-y; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7; Green EC, 2010, PURITY POLLUTION INV; Instituto Nacional de Estat A o stica (INE), 2010, 3 REC GER POP CAD SO; Jani Yagnavalkya B G D T N, 2015, INT J RES MED SCI, V3, P3572; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Loapez-Varela E, 2015, EUR RESPIR J; Looez-Varela E, 2015, PEDIATR INFECT DIS J, V34, P686, DOI 10.1097/INF.0000000000000710; Makanjuola T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087166; Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8; Melaku S, 2013, TUBERC RES TREAT, V2013, DOI DOI 10.1155/2013/475605; Montgomery CM, 2010, SOC SCI MED, V70, P1648, DOI 10.1016/j.socscimed.2010.01.020; Munguambe K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-344; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Oeser CC, 2005, AM J TROP MED HYG, V73, P571, DOI 10.4269/ajtmh.2005.73.571; PAZSOLDAN VA, 2014, FRONT PUBLIC HEALTH, V2, P1; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Stop TB Partnership, 2015, STOP TB PARTNERSHIP; da Silva TDV, 2014, REV ESC ENFERM USP, V48, P39, DOI 10.1590/S0080-623420140000800007; WHO, 2016, GLOB TUB REP; WHO/UNICEF, 2015, MOZ WHO UNICEF EST I; Wilkinson D, 1999, INT J TUBERC LUNG D, V3, P838; World Health Organization, 2014, WHOHTMTB2014082014; World Health Organization (WHO), 2014, WHO VACC PREV DIS MO; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454; Zhang SR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-132	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0182213	10.1371/journal.pone.0182213	http://dx.doi.org/10.1371/journal.pone.0182213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910284	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200003
J	Woo, YC; Lee, CH; Fong, CHY; Tso, AWK; Cheung, BMY; Lam, KSL				Woo, Yu Cho; Lee, Chi Ho; Fong, Carol H. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Lam, Karen S. L.			Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population	PLOS ONE			English	Article							FOLLOW-UP; RISK; PREVALENCE; SCORE; CRITERIA	Aim Diabetes is a serious global health problem. A simple and effective screening tool should have substantial public health benefit. We investigated the performance of the latest American Diabetes Association diabetes screening methods in our aging Chinese population. Methods Subjects without diabetes who returned for the 4th Hong Kong Cardiovascular Risk Factors Prevalence Study in 2010-2012 were evaluated for the probability of having diabetes with reference to the age-and body mass index-based screening criteria (screening criteria) and the diabetes risk test (risk test), and the conclusion drawn was compared to their measured glycaemic status. Diabetes was defined by fasting glucose >= 7 mmol/L or 2-hour post oral glucose tolerance test glucose >= 11.1 mmol/L. Results 1415 subjects, aged 58.1 +/- 10.2, were evaluated. 95 (6.7%) had diabetes. The risk test showed good accuracy (area under the receiver operating curve 0.725) in screening for diabetes with an optimal cut-off score of five. Compared to the screening criteria, the risk test had significantly better specificity (0.57 vs. 0.41, p < 0.001), positive predictive value (0.12 vs. 0.09, p < 0.001) and positive diagnostic likelihood ratio (1.85 vs. 1.37, p < 0.001). To diagnose one case of diabetes, fewer subjects (11 vs. 18) needed to be tested for blood glucose if the risk test was adopted. Conclusion The risk test appears to be a more effective screening tool in our population. It is simple to use and can be adopted as a public health strategy for identifying people with undiagnosed diabetes for early intervention.	[Woo, Yu Cho; Lee, Chi Ho; Fong, Carol H. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Chi Ho; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Cheung, BMY; Lam, KSL (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.; Cheung, BMY; Lam, KSL (corresponding author), Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	mycheung@hku.hk; ksllam@hku.hk	Lee, Chi HO/AAS-7948-2021; Lee, Paul Chi-Ho/GZG-6173-2022; /E-9829-2010	Lee, Chi-Ho/0000-0002-7569-409X; /0000-0001-9106-7363	Hong Kong Research Grants Council [GRF HKU/763312]; Ng Teng Fong Charitable Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ng Teng Fong Charitable Foundation	This work was supported from the Hong Kong Research Grants Council (GRF HKU/763312) and Ng Teng Fong Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS75; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Census and Statistics Department HKSAR, 2016, WOM MEN HONG KONG KE; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Christian Stock TH, 2014, DTCOMPAIR COMP BINAR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gu W, 2009, BIOSTATISTICS, V10, P172, DOI 10.1093/biostatistics/kxn025; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mason C, 2009, OBESITY, V17, P1789, DOI 10.1038/oby.2009.87; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Moskowitz CS, 2006, CLIN TRIALS, V3, P272, DOI 10.1191/1740774506cn147oa; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang WQ, 1998, DIABETES RES CLIN PR, V39, P185, DOI 10.1016/S0168-8227(98)00002-3; Waugh NR, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17350; Woo YC, 2015, DIABETIC MED, V32, P1207, DOI 10.1111/dme.12691; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184840	10.1371/journal.pone.0184840	http://dx.doi.org/10.1371/journal.pone.0184840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910380	gold, Green Published, Green Submitted			2022-12-26	WOS:000410859200104
J	Ganczer, A; Balogh, M; Albert, L; Debertin, G; Kovacs-Oller, T; Volgyi, B				Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela			Transiency of retinal ganglion cell action potential responses determined by PSTH time constant	PLOS ONE			English	Article							MOUSE RETINA; BIPOLAR CELLS; PRIMATE RETINA; KAINATE; RECEPTORS; CHANNELS; PATHWAYS	Retinal ganglion cells (RGC) have been described to react to light stimuli either by producing short bursts of spikes or by maintaining a longer, continuous train of action potentials. Fast, quickly decaying responses are considered to be transient in nature and encode information about movement and direction, while cell responses that show a slow, drawn-out response fall into the sustained category and are thought to be responsible for carrying information related to color and contrast. Multiple approaches have been introduced thus far to measure and determine response transiency. In this study, we adopted and slightly modified a method described by Zeck and Masland to characterize RGC response transiency values and compare them to those obtained by alternative methods. As the first step, RGC spike responses were elicited by light stimulation and peristimulus time histograms (PSTHs) were generated. PSTHs then were used to calculate the time constant (PSTH tau approach). We show that this method is comparable to or more reliable than alternative approaches to describe the temporal characteristics of RGC light responses. In addition, we also show that PSTH tau-s are compatible with time constants measured on RGC and/or bipolar cell graded potentials; thus they are suitable for studying signaling through parallel retinal pathways.	[Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela] MTA PTE NAP B Retinal Elect Synapses Res Grp, Pecs, Hungary; [Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela] Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary; [Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs	Volgyi, B (corresponding author), MTA PTE NAP B Retinal Elect Synapses Res Grp, Pecs, Hungary.; Volgyi, B (corresponding author), Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary.; Volgyi, B (corresponding author), Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary.	volgyi01@gamma.ttk.pte.hu	Volgyi, Bela/A-9079-2013; Kovács-Öller, Tamás/B-5530-2012; Volgyi, Bela/B-1016-2011	Volgyi, Bela/0000-0001-7481-390X; Kovács-Öller, Tamás/0000-0002-3353-4485; 	OTKA [K105247]; Hungarian Brain Research Program [KTIA_NAP_13-2- 2015-0008]; European Union; State of Hungary - European Social Fund [TAMOP-4.2.4.A/211/1-2012-0001]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program; European Union(European Commission); State of Hungary - European Social Fund	Supported by OTKA K105247 to B.V. and by the Hungarian Brain Research Program (KTIA_NAP_13-2- 2015-0008) to B.V. This research was also supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/211/1-2012-0001 National Excellence Program to B.V.	Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DeVries SH, 2006, NEURON, V50, P735, DOI 10.1016/j.neuron.2006.04.034; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Ichinose T, 2014, J NEUROSCI, V34, P8761, DOI 10.1523/JNEUROSCI.3965-13.2014; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Lindstrom SH, 2014, J PHYSIOL-LONDON, V592, P1457, DOI 10.1113/jphysiol.2013.265033; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Puthussery T, 2014, J NEUROSCI, V34, P7611, DOI 10.1523/JNEUROSCI.4855-13.2014; Volgyi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069426; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183436	10.1371/journal.pone.0183436	http://dx.doi.org/10.1371/journal.pone.0183436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898257	gold, Green Submitted, Green Published			2022-12-26	WOS:000410449500005
J	Chiang, WF; Cheng, TM; Chang, CC; Pan, SH; Changou, CA; Chang, TH; Lee, KH; Wu, SY; Chen, YF; Chuang, KH; Shieh, DB; Chen, YL; Tu, CC; Tsui, WL; Wu, MH				Chiang, W-F; Cheng, T-M; Chang, C-C; Pan, S-H; Changou, C. A.; Chang, T-H; Lee, K-H; Wu, S-Y; Chen, Y-F; Chuang, K-H; Shieh, D-B; Chen, Y-L; Tu, C-C; Tsui, W-L; Wu, M-H			Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation	ONCOGENE			English	Article							SINGLE-DOMAIN ANTIBODY; CANCER PROGRESSION; PROTEIN; ADENOCARCINOMA; INVASIVENESS; DIMERIZATION; ACTIVATION; FRAGMENTS; INVASION; THERAPY	Aberrant protein glycosylation could be a distinct surface-marker of cancer cells that influences cancer progression and metastasis because glycosylation can regulate membrane protein folding which alters receptor activation and changes epitope exposure for antibody (Ab) recognition. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), a glycophosphoinositol-anchored protein, is a heavily glycosylated tumor antigen. However, the clinical significance and biological effect of CEACAM6 glycosylation has not been addressed in cancers. We recently developed an anti-CEACAM6 Ab (TMU) from an immune llama library which can be engineered to a single-domain (sd)Ab or a heavy-chain (HC)Ab. The TMU HCAb specifically recognized glycosylated CEACAM6 compared to the conventional antibodies. Using the TMU HCAb, we found that glycosylated CEACAM6 was a tumor marker associated with recurrence in early-stage OSCC (oral squamous cell carcinoma) patients. CEACAM6 promoted OSCC cell invasion, migration, cytoskeletal rearrangement, and metastasis via interaction with epidermal growth factor (EGF) receptor (EGFR) and enhancing EGFR activation, clustering and intracellular signaling cascades. These functions were modulated by N-acetylglucosaminyltransferase 5 (MGAT5) which mediated N-glycosylation at Asn(256) (N256) of CEACAM6. Finally, the TMU sdAb and HCAb treatment inhibited the migration, invasion and EGF-induced signaling in CEACAM6-overexpressing cells. In conclusion, the complex N-glycosylation of CEACAM6 is critical for EGFR signaling of OSCC invasion and metastasis. Targeting glycosylated CEACAM6 with the TMU sdAb or TMU HCAb could be a feasible therapy for OSCC.	[Chiang, W-F; Cheng, T-M; Chang, C-C; Changou, C. A.; Tsui, W-L; Wu, M-H] Taipei Med Univ, Grad Inst Translat Med, Coll Med Sci & Technol, 250 Wuxing St, Taipei 11031, Taiwan; [Chiang, W-F] Chi Mei Med Ctr, Oral & Maxillofacial Sect, Tainan, Taiwan; [Chiang, W-F] Natl Yang Ming Univ, Sch Dent, Taipei, Taiwan; [Chang, C-C] Taipei Med Univ, Coll Pharm, PhD Program Biotechnol Res & Dev, Taipei, Taiwan; [Pan, S-H] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Coll Med, Taipei, Taiwan; [Pan, S-H] Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan; [Pan, S-H] Acad Sinica, Taipei, Taiwan; [Pan, S-H] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei, Taiwan; [Changou, C. A.; Lee, K-H] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Chang, T-H; Wu, M-H] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Wu, S-Y] Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Wu, S-Y] Taipei Med Univ, Sch Med, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chen, Y-F] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Chuang, K-H] Taipei Med Univ, Grad Inst Pharmacognosy, Coll Pharm, Taipei, Taiwan; [Shieh, D-B; Chen, Y-L] Natl Cheng Kung Univ & Hosp, Inst Basic Med Sci, Inst Oral Med, Tainan, Taiwan; [Shieh, D-B; Chen, Y-L] Natl Cheng Kung Univ & Hosp, Dept Stomatol, Coll Med, Tainan, Taiwan; [Shieh, D-B] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan, Taiwan; [Shieh, D-B] Natl Cheng Kung Univ, Ctr Micro Nano Sci & Technol, Tainan, Taiwan; [Tu, C-C] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Wu, M-H] Taipei Med Univ, Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan	Taipei Medical University; Chi Mei Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; Taipei Medical University	Wu, MH (corresponding author), Taipei Med Univ, Grad Inst Translat Med, Coll Med Sci & Technol, 250 Wuxing St, Taipei 11031, Taiwan.	mhwu1015@tmu.edu.tw	Chiang, Wei-Fan/L-6537-2019; CHEN, YIH-FUNG/CAH-9367-2022; Chen, Yuh-Ling/AAS-7957-2021	Chiang, Wei-Fan/0000-0002-9240-1404; CHEN, YIH-FUNG/0000-0002-5595-1319; Wu, Szu-Yuan/0000-0001-5637-558X; Pan, Szu-Hua/0000-0002-0138-0434	National Core Facility Program for Biotechnology Grants of the Ministry of Science and Technology [MOST 104-2319-B-001-001]; Ministry of Science and Technology, Taiwan [MOST 103-2320-B-038-013-MY3, MOST 104-2321-B-038-007]; Taipei Medical University [TMU101-AE3-Y20, 103CM-TMU-01, CLFHR10222, TMU-T104-06]; Chi-Mei Medical Center, Taiwan; National Health Research Institutes, Taiwan [NHRI-EX105-10409BC]	National Core Facility Program for Biotechnology Grants of the Ministry of Science and Technology; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University; Chi-Mei Medical Center, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	RNAi reagents were obtained from the National Core Facility for Manipulation of Gene Function by RNAi, miRNA, miRNA sponges, and the CRISPR/Genomic Research Center, Academia Sinica, supported by the National Core Facility Program for Biotechnology Grants of the Ministry of Science and Technology (MOST 104-2319-B-001-001). The human samples were from the Human Tumor Tissue Bank, Chi-Mei Medical Center (Liouying, Tainan, Taiwan). We thank the Image and Bioinformatics Core Facility of Taipei Medical University which provided assistance with deconvolution microscopy and the microarray analysis. This work was supported by grants MOST 103-2320-B-038-013-MY3 and MOST 104-2321-B-038-007 from the Ministry of Science and Technology, Taiwan; grants TMU101-AE3-Y20, 103CM-TMU-01, CLFHR10222 and TMU-T104-06 from Taipei Medical University and Chi-Mei Medical Center, Taiwan; and grant NHRI-EX105-10409BC from the National Health Research Institutes, Taiwan.	Balk-Moller E, 2014, AM J PATHOL, V184, P1198, DOI 10.1016/j.ajpath.2013.12.013; Baral TN, 2011, J IMMUNOL METHODS, V371, P70, DOI 10.1016/j.jim.2011.06.017; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Bonsor DA, 2015, P NATL ACAD SCI USA, V112, P13561, DOI 10.1073/pnas.1509511112; Camacho-Leal P, 2007, J CELL PHYSIOL, V211, P791, DOI 10.1002/jcp.20989; Cameron S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-74; Chan CHF, 2004, MOL THER, V9, P775, DOI 10.1016/j.ymthe.2004.03.009; Chen YF, 2009, CANCER RES, V69, P8585, DOI 10.1158/0008-5472.CAN-09-2284; Cheng TM, 2012, EUR J CANCER, V50, P713; Cooper JB, 2009, HEAD NECK-J SCI SPEC, V31, P1086, DOI 10.1002/hed.21109; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, ONCOGENE, V23, P5834, DOI 10.1038/sj.onc.1207775; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Gemei M, 2013, CANCER-AM CANCER SOC, V119, P729, DOI 10.1002/cncr.27794; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Khosroshahi SA, 2016, PROTEIN EXPRES PURIF, V120, P59, DOI 10.1016/j.pep.2015.12.005; Kobayashi M, 2012, BRIT J CANCER, V107, P1745, DOI 10.1038/bjc.2012.422; Kolla V, 2009, AM J PHYSIOL-LUNG C, V296, pL1019, DOI 10.1152/ajplung.90596.2008; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Monteiro LS, 2014, ORAL DIS, V20, P178, DOI 10.1111/odi.12087; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Riley CJ, 2009, CANCER RES, V69, P1933, DOI 10.1158/0008-5472.CAN-08-2707; Sato Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24823; Sharafinski ME, 2010, HEAD NECK-J SCI SPEC, V32, P1412, DOI 10.1002/hed.21365; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; WONG DYK, 1990, J ORAL MAXIL SURG, V48, P385, DOI 10.1016/0278-2391(90)90436-6; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yang SC, 2003, J ORAL PATHOL MED, V32, P600, DOI 10.1034/j.1600-0714.2003.00199.x; Zang MD, 2015, BBA-MOL BASIS DIS, V1852, P1020, DOI 10.1016/j.bbadis.2015.02.005; Zang MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112908; Zhuo Y, 2016, J BIOL CHEM, V291, P20085, DOI 10.1074/jbc.M116.740050	40	22	23	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					116	127		10.1038/onc.2017.303	http://dx.doi.org/10.1038/onc.2017.303			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28892050				2022-12-26	WOS:000422625000012
J	Marqueti, RC; Durigan, JLQ; Oliveira, AJS; Mekaro, MS; Guzzoni, V; Aro, AA; Pimentel, ER; Selistre-de-Araujo, HS				Marqueti, Rita C.; Durigan, Joao L. Q.; Oliveira, Anderson Jose S.; Mekaro, Marcelo Shinyu; Guzzoni, Vinicius; Aro, Andrea A.; Pimentel, Edson Rosa; Selistre-de-Araujo, Heloisa S.			Effects of aging and resistance training in rat tendon remodeling	FASEB JOURNAL			English	Article						calcaneal tendon; proteoglycans; turnover; glycosaminoglycans; strength training	ANABOLIC-ANDROGENIC STEROIDS; LEUCINE-RICH PROTEOGLYCANS; GROWTH-FACTOR-I; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; STRUCTURAL-PROPERTIES; COLLAGEN-SYNTHESIS; CONNECTIVE-TISSUE; ACHILLES-TENDON; SKELETAL-MUSCLE	In elderly persons, weak tendons contribute to functional limitations, injuries, and disability, but resistance training can attenuate this age-related decline. We evaluated the effects of resistance training on the extracellular matrix (ECM) of the calcaneal tendon (CT) in young and old rats and its effect on tendon remodeling. Wistar rats aged 3 mo (young, n = 30) and 20 mo (old, n = 30) were divided into 4 groups: young sedentary, young trained, old sedentary (OS), and old trained (OT). The training sessions were conducted over a 12-wk period. Aging in sedentary rats showed down-regulation in key genes that regulated ECMremodeling. Moreover, the OS group showed a calcification focus in the distal region of the CT, with reduced blood vessel volume density. In contrast, resistance training was effective in up-regulating connective tissue growth factor, VEGF, and decorin gene expression in old rats. Resistance training also increased proteoglycan content in young and old rats in special small leucine-rich proteoglycans and blood vessels and prevented calcification in OT rats. These findings confirm that resistance training is a potentialmechanismin the prevention of aging-related loss in ECMand that it attenuates the detrimental effects of aging in tendons, such as ruptures and tendinopathies.	[Marqueti, Rita C.; Durigan, Joao L. Q.; Oliveira, Anderson Jose S.] Univ Brasilia UnB, Campus Univ,Ctr Metropolitano 1,Conjunto A, BR-72220900 Brasilia, DF, Brazil; [Mekaro, Marcelo Shinyu; Guzzoni, Vinicius; Selistre-de-Araujo, Heloisa S.] Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil; [Aro, Andrea A.; Pimentel, Edson Rosa] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Pimentel, Edson Rosa] Heminio Ometto Univ Ctr UNIARARAS, Sao Paulo, Brazil	Universidade de Brasilia; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Estadual de Campinas	Marqueti, RC (corresponding author), Univ Brasilia UnB, Campus Univ,Ctr Metropolitano 1,Conjunto A, BR-72220900 Brasilia, DF, Brazil.	marqueti@gmail.com	Marqueti, Rita de Cassia/D-1622-2012; Durigan, João Luiz Quagliotti/D-1110-2012; Mekaro, Marcelo S/M-8639-2017; de Aro, Andrea Aparecida/E-3753-2012; Guzzoni, Vinicius/E-6860-2013	Marqueti, Rita de Cassia/0000-0001-9126-3882; Durigan, João Luiz Quagliotti/0000-0002-7511-5289; Mekaro, Marcelo S/0000-0002-1267-6759; de Aro, Andrea Aparecida/0000-0003-2895-0000; Guzzoni, Vinicius/0000-0003-1024-5952	Sao Paulo Research Foundation (FAPESP) [2010/19390-5, 2011/11229-3, 2013/00798-2]; Federal District Research Support Foundation (FAPDF) [193.000.653/2015]; Brazilian National Council for Scientific and Technological Development (CNPq) [445069/2014-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Federal District Research Support Foundation (FAPDF); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank Prof. Dr. Larry W. Fischer (U.S. National Institutes of Health and Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan) for providing the antibodies and Jose Campanholi Neto and Patty Karina dos Santos (both from Federal University of Sao Carlos) for technical assistance. This work was supported by Sao Paulo Research Foundation (FAPESP) Grants 2010/19390-5, 2011/11229-3, and 2013/00798-2; by Federal District Research Support Foundation (FAPDF) Grant 193.000.653/2015; and by the Brazilian National Council for Scientific and Technological Development (CNPq) Grant 445069/2014-7. The authors declare no conflicts of interest.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Aro AA, 2013, LIFE SCI, V92, P799, DOI 10.1016/j.lfs.2013.02.011; Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Borst SE, 2001, MED SCI SPORT EXER, V33, P648; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Dourte LM, 2013, J ORTHOP RES, V31, P1430, DOI 10.1002/jor.22372; Dunkman AA, 2014, MATRIX BIOL, V35, P232, DOI 10.1016/j.matbio.2013.10.008; Dyment Nathaniel A, 2015, Curr Mol Biol Rep, V1, P124; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Freedman BR, 2015, BBA-MOL CELL RES, V1853, P3153, DOI 10.1016/j.bbamcr.2015.04.015; Goh KL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898732; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gordon JA, 2015, J BIOMECH, V48, P2110, DOI 10.1016/j.jbiomech.2015.02.058; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2012, J APPL PHYSIOL, V113, P827, DOI 10.1152/japplphysiol.00401.2012; Herchenhan A, 2015, GROWTH HORM IGF RES, V25, P13, DOI 10.1016/j.ghir.2014.09.001; Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kilts T, 2009, SCAND J MED SCI SPOR, V19, P536, DOI 10.1111/j.1600-0838.2009.00909.x; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kjaer M., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P41; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Koskinen SOA, 2004, J APPL PHYSIOL, V96, P861, DOI 10.1152/japplphysiol.00489.2003; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Magnusson SP, 2003, SCAND J MED SCI SPOR, V13, P211, DOI 10.1034/j.1600-0838.2003.00308.x; Marqueti RC, 2014, SCAND J MED SCI SPOR, V24, pe39, DOI 10.1111/sms.12135; Marqueti RC, 2008, EUR J APPL PHYSIOL, V104, P1087, DOI 10.1007/s00421-008-0867-7; Marqueti RC, 2006, AM J SPORT MED, V34, P1274, DOI 10.1177/0363546506286867; Marqueti RD, 2017, J BIOMECH, V53, P29, DOI 10.1016/j.jbiomech.2016.12.029; Marqueti RD, 2012, EUR J APPL PHYSIOL, V112, P1505, DOI 10.1007/s00421-011-2114-x; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Oliva F, 2012, MED SPORT SCI, V57, P53, DOI 10.1159/000328878; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Samiric T, 2004, MATRIX BIOL, V23, P127, DOI 10.1016/j.matbio.2004.03.004; Sarasa-Renedo A, 2005, SCAND J MED SCI SPOR, V15, P223, DOI 10.1111/j.1600-0838.2005.00461.x; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Smith RKW, 2002, COMP BIOCHEM PHYS A, V133, P1039, DOI 10.1016/S1095-6433(02)00148-4; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wood LK, 2016, J ORTHOP RES, V34, P346, DOI 10.1002/jor.22824; Yu TY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-2; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang JY, 2016, ONCOTARGET, V7, P8498, DOI 10.18632/oncotarget.7381; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130454	56	31	31	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					353	368		10.1096/fj.201700543R	http://dx.doi.org/10.1096/fj.201700543R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899880				2022-12-26	WOS:000419172700032
J	Rumora, AE; Lentz, SI; Hinder, LM; Jackson, SW; Valesano, A; Levinson, GE; Feldman, EL				Rumora, Amy E.; Lentz, Stephen I.; Hinder, Lucy M.; Jackson, Samuel W.; Valesano, Andrew; Levinson, Gideon E.; Feldman, Eva L.			Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons	FASEB JOURNAL			English	Article						diabetic neuropathy; DRG; hyperglycemia; palmitate; mitochondrial transport	INDUCED OXIDATIVE STRESS; AXONAL-TRANSPORT; FATTY-ACID; DAMAGED MITOCHONDRIA; ANIMAL-MODELS; SCHWANN-CELLS; CALCIUM; DYSFUNCTION; NEUROPATHY; PROTEINS	Mitochondrial trafficking plays a central role in dorsal root ganglion (DRG) neuronal cell survival and neurotransmission by transporting mitochondria from the neuronal cell body throughout the bundles of DRG axons. In type 2 diabetes (T2DM), dyslipidemia and hyperglycemia damage DRG neurons and induce mitochondrial dysfunction; however, the impact of free fatty acids and glucose on mitochondrial trafficking in DRG neurons remains unknown. To evaluate the impact of free fatty acids compared to hyperglycemia on mitochondrial transport, primary adult mouse DRG neuron cultures were treated with physiologic concentrations of palmitate and glucose and assessed for alterations in mitochondrial trafficking, mitochondrial membrane potential, and mitochondrial bioenergetics. Palmitate treatment significantly reduced the number of motile mitochondria in DRG axons, but physiologic concentrations of glucose did not impair mitochondrial trafficking dynamics. Palmitate-treated DRG neurons also exhibited a reduction in mitochondrial velocity, and impaired mitochondrial trafficking correlated with mitochondrial depolarization in palmitate-treated DRG neurons. Finally, we found differential bioenergetic effects of palmitate and glucose on resting and energetically challenged mitochondria in DRG neurons. Together, these results suggest that palmitate induces DRG neuron mitochondrial depolarization, inhibiting axonal mitochondrial trafficking and altering mitochondrial bioenergetic capacity.	[Rumora, Amy E.; Hinder, Lucy M.; Jackson, Samuel W.; Valesano, Andrew; Levinson, Gideon E.; Feldman, Eva L.] Univ Michigan, Dept Neurol, 5017 AAT BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Lentz, Stephen I.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, 5017 AAT BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	efeldman@umich.edu		Feldman, Eva/0000-0002-9162-2694; Valesano, Andrew/0000-0002-3649-8352; Lentz, Stephen/0000-0003-1686-7998; Hinder, Lucy/0000-0002-5206-8010	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R24 DK082841, R01 DK107956, T32 1T32DK101357-01]; Novo Nordisk Foundation [NNF14SA0006]; Juvenile Diabetes Research Foundation's Angelika Bierhaus Postdoctoral Fellowship in Diabetic Complications; American Diabetes Association, Program for Neurology Research and Discovery; A. Alfred Taubman Medical Research Institute; NIH, NIDDK [P60DK020572]; University of Michigan Core Services - NIH NIDDK [DK089503]; Novo Nordisk Fonden [NNF14OC0011633] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082841, P30DK089503, R01DK107956, P30DK020572, P60DK020572, T32DK101357] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Juvenile Diabetes Research Foundation's Angelika Bierhaus Postdoctoral Fellowship in Diabetic Complications; American Diabetes Association, Program for Neurology Research and Discovery; A. Alfred Taubman Medical Research Institute; NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan Core Services - NIH NIDDK; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Stacey Sakowski Jacoby for expert editorial advice; Carey Backus for lending expertise in mitoDNA quantitative PCR analyses; and John M. Hayes, Colin M. Mervak, and Nandini S. Abburi (all from the University of Michigan) for contributions to pilot trafficking and mitochondrial depolarization experiments. Funding was provided by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants R24 DK082841 and R01 DK107956 (to E.L.F.) and T32 1T32DK101357-01 (to A.E.R.); Novo Nordisk Foundation Grant NNF14SA0006 (to E.L.F.); Juvenile Diabetes Research Foundation's Angelika Bierhaus Postdoctoral Fellowship in Diabetic Complications (to L.M.H.); American Diabetes Association, Program for Neurology Research and Discovery; and the A. Alfred Taubman Medical Research Institute. Confocal microscopy and image analysis were performed with equipment at the Michigan Diabetes Research Center's Microscopy and Image Analysis Core, supported by NIH, NIDDK Grant P60DK020572; and University of Michigan Core Services, supported by NIH NIDDK Grant DK089503 (Seahorse XF Analyzer). A.E.R. and S.I.L. share senior authorship. The authors declare no conflicts of interest.	Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070; Belosludtsev K N, 2012, Patol Fiziol Eksp Ter, P20; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Breton MC, 2013, DIABETES CARE, V36, P740, DOI 10.2337/dc12-0354; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Cai Q, 2011, NEUROSCI RES, V70, P9, DOI 10.1016/j.neures.2011.02.005; Cai Q, 2009, NEURON, V61, P493, DOI 10.1016/j.neuron.2009.02.003; Callaghan BC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007543.pub2; Callaghan BC, 2012, CURR OPIN NEUROL, V25, P536, DOI 10.1097/WCO.0b013e328357a797; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fu MM, 2014, DEV CELL, V29, P577, DOI 10.1016/j.devcel.2014.04.015; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; Hinder LM, 2014, ANTIOXID REDOX SIGN, V21, P588, DOI 10.1089/ars.2013.5248; Hinder LM, 2013, J ENDOCRINOL, V216, P1, DOI 10.1530/JOE-12-0356; Ho PWL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-3; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; International Diabetes Federation (IDF), 2015, IDF DIAB ATL; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Karki P, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0003-8; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Lee JM, 2006, DIABETES CARE, V29, P1192; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Lovas JR, 2013, BBA-MOL CELL RES, V1833, P184, DOI 10.1016/j.bbamcr.2012.04.007; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Merrill GF, 1998, J APPL PHYSIOL, V85, P1909, DOI 10.1152/jappl.1998.85.5.1909; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Peeraer Eve, 2011, J Pain Res, V4, P55, DOI 10.2147/JPR.S15452; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Remizov O, 2003, MOL CELL ENDOCRINOL, V212, P1, DOI 10.1016/j.mce.2003.09.026; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Russell JW, 2001, NEUROLOGY, V56, pA394; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Sas KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86976; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; STEWART MA, 1966, BIOCHEM BIOPH RES CO, V22, P488, DOI 10.1016/0006-291X(66)90300-7; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Takihara Y, 2015, P NATL ACAD SCI USA, V112, P10515, DOI 10.1073/pnas.1509879112; Tao K, 2014, DEV NEUROBIOL, V74, P557, DOI 10.1002/dneu.22149; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2004, DIABETES, V53, P726, DOI 10.2337/diabetes.53.3.726; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Vincent AM, 2010, ACTA NEUROPATHOL, V120, P477, DOI 10.1007/s00401-010-0697-7; Vincent AM, 2009, J PERIPHER NERV SYST, V14, P257, DOI 10.1111/j.1529-8027.2009.00237.x; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Vincent AM, 2009, ANTIOXID REDOX SIGN, V11, P425, DOI 10.1089/ars.2008.2235; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang ZX, 2015, MOL NEUROBIOL, V51, P1309, DOI 10.1007/s12035-014-8810-x; Webster WA, 2013, CAN J PHYSIOL PHARM, V91, P375, DOI 10.1139/cjpp-2012-0138; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Yamamoto H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1735841; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zherebitskaya E, 2009, DIABETES, V58, P1356, DOI 10.2337/db09-0034	84	43	43	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					195	207		10.1096/fj.201700206R	http://dx.doi.org/10.1096/fj.201700206R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904018	Green Published, Green Submitted			2022-12-26	WOS:000419172700019
J	Heier, C; Kien, B; Huang, FF; Eichmann, TO; Xie, H; Zechner, R; Chang, PA				Heier, Christoph; Kien, Benedikt; Huang, Feifei; Eichmann, Thomas O.; Xie, Hao; Zechner, Rudolf; Chang, Ping-An			The phospholipase PNPLA7 functions as a lysophosphatidylcholine hydrolase and interacts with lipid droplets through its catalytic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); lipid droplet; lysophospholipid; phospholipase; phospholipid metabolism; protein domain	NEUROPATHY TARGET ESTERASE; PROTEIN; MUTATIONS; MEMBRANE; PHOSPHATIDYLCHOLINE; IDENTIFICATION; LIPASE; PURIFICATION; EXPRESSION; DISEASE	Mammalian patatin-like phospholipase domain-containing proteins (PNPLAs) are lipid-metabolizing enzymes with essential roles in energy metabolism, skin barrier development, and brain function. A detailed annotation of enzymatic activities and structure-function relationships remains an important prerequisite to understand PNPLA functions in (patho-)physiology, for example, in disorders such as neutral lipid storage disease, non-alcoholic fatty liver disease, and neurodegenerative syndromes. In this study, we characterized the structural features controlling the subcellular localization and enzymatic activity of PNPLA7, a poorly annotated phospholipase linked to insulin signaling and energy metabolism. We show that PNPLA7 is an endoplasmic reticulum (ER) transmembrane protein that specifically promotes hydrolysis of lysophosphatidylcholine in mammalian cells. We found that transmembrane and regulatory domains in the PNPLA7 N-terminal region cooperate to regulate ER targeting but are dispensable for substrate hydrolysis. Enzymatic activity is instead mediated by the C-terminal domain, which maintains full catalytic competence even in the absence of N-terminal regions. Upon elevated fatty acid flux, the catalytic domain targets cellular lipid droplets and promotes interactions of PNPLA7 with these organelles in response to increased cAMP levels. We conclude that PNPLA7 acts as an ER-anchored lysophosphatidylcholine hydrolase that is composed of specific functional domains mediating catalytic activity, subcellular positioning, and interactions with cellular organelles. Our study provides critical structural insights into an evolutionarily conserved class of phospholipid-metabolizing enzymes.	[Heier, Christoph; Kien, Benedikt; Eichmann, Thomas O.; Xie, Hao; Zechner, Rudolf; Chang, Ping-An] Karl Franzens Univ Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Zechner, Rudolf] BioTechMed Graz, A-8010 Graz, Austria; [Huang, Feifei; Chang, Ping-An] Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing 400065, Peoples R China	University of Graz; Chongqing University of Posts & Telecommunications	Chang, PA (corresponding author), Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing 400065, Peoples R China.	changpingan@aliyun.com		Eichmann, Thomas O./0000-0002-8521-2795; Kien, Benedikt/0000-0002-3083-2479; Heier, Christoph/0000-0001-6858-408X	Austrian Science Fund (FWF) [SFB LIPOTOX F30]; Wittgenstein Award [Z136]; Foundation Leducq Transatlantic Network on Triglycerides [12CVD04]; European Union [340896]; European Research Council LipoCheX; National Natural Science Foundation in China [31271523]; Natural Science Foundation Project of Chongqing Science and Technology Commission [2014jcyjA10033, cstc2016jcyjA0572]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Wittgenstein Award(Austrian Science Fund (FWF)); Foundation Leducq Transatlantic Network on Triglycerides; European Union(European Commission); European Research Council LipoCheX; National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science and Technology Commission(Natural Science Foundation of Chongqing)	This work was supported by Austrian Science Fund (FWF) Grant SFB LIPOTOX F30 and Wittgenstein Award Z136, Foundation Leducq Transatlantic Network on Triglycerides Grant 12CVD04, European Union's Seventh Framework Program Grant FP/2007-2013/ERC under Grant Agreement 340896, European Research Council LipoCheX, National Natural Science Foundation in China Grant 31271523, and Natural Science Foundation Project of Chongqing Science and Technology Commission Grants 2014jcyjA10033 and cstc2016jcyjA0572. The authors declare that they have no conflicts of interest with the contents of this article.	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Brasaemle Dawn L, 2016, Curr Protoc Cell Biol, V72, DOI 10.1002/cpcb.10; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furse S, 2015, MOL MEMBR BIOL, V32, P117, DOI 10.3109/09687688.2015.1066894; Glynn P, 2005, BBA-MOL CELL BIOL L, V1736, P87, DOI 10.1016/j.bbalip.2005.08.002; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Heier C, 2015, J BIOL CHEM, V290, P26141, DOI 10.1074/jbc.M115.671842; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Hufnagel RB, 2015, J MED GENET, V52, P85, DOI 10.1136/jmedgenet-2014-102856; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JOHNSON MK, 1969, BIOCHEM J, V114, P711, DOI 10.1042/bj1140711; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kmoch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6614; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Li Y, 2003, J BIOL CHEM, V278, P8820, DOI 10.1074/jbc.M210743200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lush MJ, 1998, BIOCHEM J, V332, P1; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Papadopoulos C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005149; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Read DJ, 2009, J NEUROSCI, V29, P11594, DOI 10.1523/JNEUROSCI.3007-09.2009; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato S, 2010, FEBS LETT, V584, P4389, DOI 10.1016/j.febslet.2010.09.047; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Song Y, 2013, DIS MODEL MECH, V6, P404, DOI 10.1242/dmm.009688; Synofzik M, 2014, BRAIN, V137, P69, DOI 10.1093/brain/awt326; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Xie MX, 2003, ARCH BIOCHEM BIOPHYS, V416, P137, DOI 10.1016/S0003-9861(03)00264-9; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	43	11	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19087	19098		10.1074/jbc.M117.792978	http://dx.doi.org/10.1074/jbc.M117.792978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28887301	Green Published, hybrid			2022-12-26	WOS:000415848000031
J	Zhang, G; Vilim, FS; Liu, DD; Romanova, EV; Yu, K; Yuan, WD; Xiao, H; Hummon, AB; Chen, TT; Alexeeva, V; Yin, SY; Chen, SA; Cropper, EC; Sweedler, JV; Weiss, KR; Jing, J				Zhang, Guo; Vilim, Ferdinand S.; Liu, Dan-Dan; Romanova, Elena V.; Yu, Ke; Yuan, Wang-Ding; Xiao, Hui; Hummon, Amanda B.; Chen, Ting-Ting; Alexeeva, Vera; Yin, Si-Yuan; Chen, Song-An; Cropper, Elizabeth C.; Sweedler, Jonathan V.; Weiss, Klaudiusz R.; Jing, Jian			Discovery of leucokinin-like neuropeptides that modulate a specific parameter of feeding motor programs in the molluscan model, Aplysia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); neurobiology; neuropeptide; neuroscience; neurotransmitter; Aplysia; Leucokinin; arthropods; feeding; neuromodulation	PROTEIN-COUPLED RECEPTOR; REPRESENTATIONAL DIFFERENCE ANALYSIS; ACID-CONTAINING NEUROPEPTIDE; LEUCOPHAEA-MADERAE; FUNCTIONAL-CHARACTERIZATION; DISTINGUISHES INGESTION; DROSOPHILA-MELANOGASTER; SYNAPTIC CONNECTIONS; MALPIGHIAN TUBULES; MYOTROPIC PEPTIDE	A better understanding of neuromodulation in a behavioral system requires identification of active modulatory transmitters. Here, we used identifiable neurons in a neurobiological model system, the mollusc Aplysia, to study neuropeptides, a diverse class of neuromodulators. We took advantage of two types of feeding neurons, B48 and B1/B2, in the Aplysia buccal ganglion that might contain different neuropeptides. We performed a representational difference analysis (RDA) by subtraction of mRNAs in B48 versus mRNAs in B1/B2. The RDA identified an unusually long (2025 amino acids) peptide precursor encoding Aplysia leucokinin-like peptides (ALKs; e.g. ALK-1 and ALK-2). Northern blot analysis revealed that, compared with other ganglia (e.g. the pedal-pleural ganglion), ALK mRNA is predominantly present in the buccal ganglion, which controls feeding behavior. We then used in situ hybridization and immunohistochemistry to localize ALKs to specific neurons, including B48. MALDI-TOF MS on single buccal neurons revealed expression of 40 ALK precursor-derived peptides. Among these, ALK-1 and ALK-2 are active in the feeding network; they shortened the radula protraction phase of feeding motor programs triggered by a command-like neuron. We also found that this effect may be mediated by the ALK-stimulated enhancement of activity of an interneuron, which has previously been shown to terminate protraction. We conclude that our multipronged approach is effective for determining the structure and defining the diverse functions of leucokinin-like peptides. Notably, the ALK precursor is the first verified nonarthropod precursor for leucokinin-like peptides with a novel, marked modulatory effect on a specific parameter (protraction duration) of feeding motor programs.	[Zhang, Guo; Liu, Dan-Dan; Yu, Ke; Yuan, Wang-Ding; Xiao, Hui; Chen, Ting-Ting; Yin, Si-Yuan; Chen, Song-An; Jing, Jian] Nanjing Univ, State Key Lab Pharmaceut Biotechnol,Sch Life Sci, Collaborat Innovat Ctr Chem Life Sci,Adv Inst Lif, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Vilim, Ferdinand S.; Alexeeva, Vera; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Vilim, Ferdinand S.; Alexeeva, Vera; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Romanova, Elena V.; Hummon, Amanda B.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Romanova, Elena V.; Hummon, Amanda B.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Hummon, Amanda B.] Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA	Nanjing University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame	Jing, J (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing 210023, Jiangsu, Peoples R China.	jingj01@live.com	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Romanova, Elena/0000-0002-2040-3312; Jing, Jian/0000-0003-1422-143X	National Natural Science Foundation of China [31671097, 31371104, J1103512, J1210026]; NINDS, National Institutes of Health [RO1 NS066587, RO1 NS070583, RO1 NS031609]; NIDA, National Institutes of Health [P30 DA018310]; National Science Foundation [CHE 16-067915]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066587, R01NS070583, R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; Division Of Chemistry [1606791] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Natural Science Foundation of China Grants 31671097, 31371104, J1103512, and J1210026; NINDS, National Institutes of Health, Grants RO1 NS066587, RO1 NS070583, and RO1 NS031609; NIDA, National Institutes of Health, Grant P30 DA018310; and National Science Foundation Grant CHE 16-067915. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and other funding agencies.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Bai L, 2013, J BIOL CHEM, V288, P32837, DOI 10.1074/jbc.M113.486670; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; BLACKBURN MB, 1995, J INSECT PHYSIOL, V41, P723, DOI 10.1016/0022-1910(95)00005-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHURCH PJ, 1991, J NEUROSCI, V11, P618; CHURCH PJ, 1994, J NEUROPHYSIOL, V72, P1794, DOI 10.1152/jn.1994.72.4.1794; CLOTTENS FL, 1993, REGUL PEPTIDES, V49, P145, DOI 10.1016/0167-0115(93)90436-C; COAST GM, 1990, J INSECT PHYSIOL, V36, P481, DOI 10.1016/0022-1910(90)90098-Z; Comi TJ, 2017, J AM CHEM SOC, V139, P3920, DOI 10.1021/jacs.6b12822; Cox KJA, 1997, J NEUROSCI, V17, P1197; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; CROPPER EC, 1987, P NATL ACAD SCI USA, V84, P3486, DOI 10.1073/pnas.84.10.3486; CROPPER EC, 1990, P NATL ACAD SCI USA, V87, P933, DOI 10.1073/pnas.87.3.933; Cropper EC, 2014, CURR OPIN NEUROBIOL, V29, P33, DOI 10.1016/j.conb.2014.04.011; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Evans CG, 2003, J NEUROSCI, V23, P2920; Evans CG, 1996, J NEUROPHYSIOL, V76, P1267, DOI 10.1152/jn.1996.76.2.1267; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; HAYES TK, 1989, LIFE SCI, V44, P1259, DOI 10.1016/0024-3205(89)90362-7; Holman G.M., 1990, P195; HOLMAN GM, 1983, COMP BIOCHEM PHYS C, V76, P39, DOI 10.1016/0742-8413(83)90041-5; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V84, P271, DOI 10.1016/0742-8413(86)90093-9; HOLMAN GM, 1987, COMP BIOCHEM PHYS C, V88, P31, DOI 10.1016/0742-8413(87)90043-0; HOLMAN GM, 1987, COMP BIOCHEM PHYS C, V88, P27, DOI 10.1016/0742-8413(87)90042-9; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Hurwitz I, 2003, J NEUROPHYSIOL, V89, P2120, DOI 10.1152/jn.00497.2002; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309, DOI 10.1152/jn.1996.75.4.1309; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1327, DOI 10.1152/jn.1996.75.4.1327; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2017, NETWORK FUNCTIONS AND PLASTICITY: PERSPECTIVES FROM STUDYING NEURONAL ELECTRICAL COUPLING IN MICROCIRCUITS, P79, DOI 10.1016/B978-0-12-803471-2.00005-9; Jing J, 2004, J NEUROSCI, V24, P6315, DOI 10.1523/JNEUROSCI.0965-04.2004; Jing J, 2003, J NEUROSCI, V23, P5283; Jing J, 2002, J NEUROSCI, V22, P6228; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2009, ENCY NEUROSCIENCE, P1149; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing J, 2015, J NEUROSCI, V35, P9137, DOI 10.1523/JNEUROSCI.0180-15.2015; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; Li LJ, 1998, PEPTIDES, V19, P1425, DOI 10.1016/S0196-9781(98)00094-1; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Livnat I, 2016, ANAL CHEM, V88, P11868, DOI 10.1021/acs.analchem.6b03658; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; MORTON DW, 1993, J COMP PHYSIOL A, V173, P519; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nielsen H, 1996, PROTEINS, V24, P165, DOI 10.1002/(SICI)1097-0134(199602)24:2<165::AID-PROT4>3.0.CO;2-I; Nusbaum MP, 2012, CURR OPIN NEUROBIOL, V22, P592, DOI 10.1016/j.conb.2012.01.003; Perrins R, 1998, J NEUROSCI, V18, P3977; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Proekt A, 2005, J NEUROSCI, V25, P9637, DOI 10.1523/JNEUROSCI.2932-05.2005; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; Radford JHC, 2004, J EXP BIOL, V207, P4573, DOI 10.1242/jeb.01317; Romanova EV, 2014, NEUROPSYCHOPHARMACOL, V39, P50, DOI 10.1038/npp.2013.145; Romanova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048764; ROSEN SC, 1991, J NEUROSCI, V11, P3630; Sasaki K, 2013, J NEUROSCI, V33, P93, DOI 10.1523/JNEUROSCI.3841-12.2013; Sasaki K, 2007, J NEUROPHYSIOL, V98, P3796, DOI 10.1152/jn.00965.2007; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; SCHOOFS L, 1992, REGUL PEPTIDES, V37, P49, DOI 10.1016/0167-0115(92)90063-Z; Schoofs L, 2017, ANNU REV ENTOMOL, V62, P35, DOI 10.1146/annurev-ento-031616-035500; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Southey Bruce R, 2008, Front Neuroinform, V2, P7, DOI 10.3389/neuro.11.007.2008; Strand FL, 1999, NEUROPEPTIDES REGULA; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Sweedler JV, 2002, J NEUROSCI, V22, P7797; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Terhzaz S, 1999, J EXP BIOL, V202, P3667; VEENSTRA JA, 1994, BIOCHEM BIOPH RES CO, V202, P715, DOI 10.1006/bbrc.1994.1989; Vilim FS, 2010, J NEUROSCI, V30, P131, DOI 10.1523/JNEUROSCI.3282-09.2010; Vilim FS, 2001, PEPTIDES, V22, P2027, DOI 10.1016/S0196-9781(01)00561-7; Wu JS, 2007, J NEUROSCI, V27, P10818, DOI 10.1523/JNEUROSCI.1806-07.2007; Wu JS, 2014, J NEUROSCI, V34, P6510, DOI 10.1523/JNEUROSCI.5094-13.2014; Yang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147335; YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514	89	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18775	18789		10.1074/jbc.M117.795450	http://dx.doi.org/10.1074/jbc.M117.795450			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28924050	Green Published, hybrid			2022-12-26	WOS:000415848000004
J	Chen, FY; Lee, A; Ge, SK; Nathan, S; Knox, SM; McNamara, NA				Chen, Feeling Y.; Lee, Albert; Ge, Shaokui; Nathan, Sara; Knox, Sarah M.; McNamara, Nancy A.			Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren's syndrome	PLOS ONE			English	Article							KERATINIZING SQUAMOUS METAPLASIA; PERIPHERAL NERVOUS-SYSTEM; DRY EYE; LYMPHOCYTIC INFILTRATION; OCULAR SURFACE; CELLS; INTERLEUKIN-1; NERVES; MANIFESTATIONS; INFLAMMATION	Sjogren's syndrome (SS) is a chronic, autoimmune exocrinopathy that leads to severe dryness of the mouth and eyes. Exocrine function is highly regulated by neuronal mechanisms but little is known about the link between chronic inflammation, innervation and altered exocrine function in the diseased eyes and exocrine glands of SS patients. To gain a better understanding of neuronal regulation in the immunopathogenesis of autoimmune exocrinopathy, we profiled a mouse model of spontaneous, autoimmune exocrinopathy that possess key characteristics of peripheral neuropathy experienced by SS patients. Mice deficient in the autoimmune regulator (Aire) gene developed spontaneous, CD4+ T cell-mediated exocrinopathy and aqueous-deficient dry eye that were associated with loss of nerves innervating the cornea and lacrimal gland. Changes in innervation and tear secretion were accompanied by increased proliferation of corneal epithelial basal cells, limbal expansion of KRT19-positive progenitor cells, increased vascularization of the peripheral cornea and reduced nerve function in the lacrimal gland. In addition, we found extensive loss of MIST1+ secretory acinar cells in the Aire -/- lacrimal gland suggesting that acinar cells are a primary target of the disease, Finally, topical application of ophthalmic steroid effectively restored corneal innervation in Aire -/- mice thereby functionally linking nerve loss with local inflammation in the aqueous-deficient dry eye. These data provide important insight regarding the relationship between chronic inflammation and neuropathic changes in autoimmune-mediated dry eye. Peripheral neuropathies characteristic of SS appear to be tightly linked with the underlying immunopathological mechanism and Aire -/- mice provide an excellent tool to explore the interplay between SS-associated immunopathology and peripheral neuropathy.	[Chen, Feeling Y.; Lee, Albert; Nathan, Sara; Knox, Sarah M.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Ge, Shaokui; McNamara, Nancy A.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Ge, Shaokui; McNamara, Nancy A.] Univ Calif Berkeley, Vis Sci Grad Program, Berkeley, CA 94720 USA; [McNamara, Nancy A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Knox, SM (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; McNamara, NA (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.; McNamara, NA (corresponding author), Univ Calif Berkeley, Vis Sci Grad Program, Berkeley, CA 94720 USA.; McNamara, NA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	sarah.knox@ucst.edu; nency.mcnamara@ucsf.edu	Knox, Sarah Monica/GNW-5445-2022		Allergan Foundation - American Optometric Foundation; National Eye Institute [R01-EY026492]; NATIONAL EYE INSTITUTE [R01EY026492, R01EY025980, P30EY002162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R35DE028255] Funding Source: NIH RePORTER	Allergan Foundation - American Optometric Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funding by an Allergan Foundation Research Grant awarded by the American Optometric Foundation and National Eye Institute grant R01-EY026492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funding by an Allergan Foundation Research Grant awarded by the American Optometric Foundation and National Eye Institute grant R01-EY026492.	Alegria GC, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000179; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Birnbaum J, 2010, NEUROLOGIST, V16, P287, DOI 10.1097/NRL.0b013e3181ebe59f; Bougea A, 2015, INT J CHRONIC DIS, V2015; Bougea Anastasia, 2016, Int J Chronic Dis, V2016, P9854813, DOI 10.1155/2016/9854813; Chen YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077286; Chen YT, 2012, LAB INVEST, V92, P556, DOI 10.1038/labinvest.2011.189; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Chen YT, 2009, MOL VIS, V15, P563; Chen YF, 2014, AM J PATHOL, V184, P1695, DOI 10.1016/j.ajpath.2014.02.024; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Deshmukh US, 2008, ARTHRITIS RHEUM-US, V58, P1318, DOI 10.1002/art.23368; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Eskandari F, 2003, ARTHRITIS RES THER, V5, P251, DOI 10.1186/ar1002; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P813, DOI 10.1167/iovs.11-8379; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Ghanem RC, 2011, CURR EYE RES, V36, P989, DOI 10.3109/02713683.2011.593730; Goules AV, 2016, AUTOIMMUN REV, V15, P695, DOI 10.1016/j.autrev.2016.03.004; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Lafitte C, 2001, J NEUROL, V248, P577, DOI 10.1007/s004150170135; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; MELLGREN SI, 1989, NEUROLOGY, V39, P390, DOI 10.1212/WNL.39.3.390; Mori K, 2005, BRAIN, V128, P2518, DOI 10.1093/brain/awh605; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P4575, DOI 10.1167/iovs.12-9760; Paranyuk Y, 2001, CURR EYE RES, V23, P199, DOI 10.1076/ceyr.23.3.199.5468; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Pavlakis PP, 2012, J AUTOIMMUN, V39, P27, DOI 10.1016/j.jaut.2012.01.003; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Robinson CP, 1996, CLIN IMMUNOL IMMUNOP, V79, P50, DOI 10.1006/clin.1996.0050; Stepp M.A., 2016, GLIA; Tsai W-H., 1995, MOMENT PRESERVING TH, P44; Tuisku IS, 2008, EXP EYE RES, V86, P879, DOI 10.1016/j.exer.2008.03.002; Vijmasi T, 2014, INVEST OPHTH VIS SCI, V55, P5401, DOI 10.1167/iovs.14-13924; Vijmasi T, 2013, MOL VIS, V19, P1957; WILLIAMS RM, 1994, J AUTONOM NERV SYST, V47, P95, DOI 10.1016/0165-1838(94)90070-1; Yamaguchi T, 2016, CORNEA, V35, pS65, DOI 10.1097/ICO.0000000000000989; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Zeng XPL, 2013, J IMMUNOL, V190, P3895, DOI 10.4049/jimmunol.1203001; Zhou DL, 2014, EXPERT REV CLIN IMMU, V10, P513, DOI 10.1586/1744666X.2014.900441	48	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184916	10.1371/journal.pone.0184916	http://dx.doi.org/10.1371/journal.pone.0184916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926640	Green Published, gold			2022-12-26	WOS:000411166600053
J	Cirkovic, I; Trajkovic, J; Hauschild, T; Andersen, PS; Shittu, A; Larsen, AR				Cirkovic, Ivana; Trajkovic, Jasmina; Hauschild, Tomasz; Andersen, Paal Skytt; Shittu, Adebayo; Larsen, Anders Rhod			Nasal and pharyngeal carriage of methicillinresistant Staphylococcus sciuri among hospitalised patients and healthcare workers in a Serbian university hospital	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; MOLECULAR CHARACTERIZATION; RESISTANCE; STRAINS; MEMBERS; AUREUS; MEC; GENES; IDENTIFICATION; EPIDEMIOLOGY	There has been a paucity of data on methicillin-resistant Staphylococcus sciuri (MRSS) epidemiology in European healthcare settings. The aim of the study was to determine the prevalence of nasal and pharyngeal carriage and diversity of MRSS among inpatients and healthcare workers (HCWs) in the largest healthcare centre in Serbia, and to assess performance of different methods for MRSS screening. Nasal and pharyngeal swabs were obtained from 195 patients and 105 HCWs in different departments. Each swab was inoculated directly onto MRSA-ID, oxacillin-resistance screening agar and mannitol salt agar (MSA) with 2 mg/L of oxacillin. After inoculation, each swab was dipped in Mueller-Hinton broth with 6.5% NaCl and after overnight incubation, subcultured onto oxacillin-MSA. Characterisation of isolated MRSS strains was determined by antimicrobial susceptibility testing, PFGE, SCCmec typing and antimicrobial resistance genes detection. MRSS nasal and pharyngeal carriage rate was high (5%) in our hospital and department-variable. PFGE revealed a possible cross-transmission of MRSS between a patient and an HCW, and dissemination across hospital wards. All analysed isolates were multidrug resistant. Fusidic acid resistance was discovered in 93.7% of isolates, but fusA mutations in EF-G and fusB/C genes were not detected. SCCmec regions of MRSS contained elements of classic methicillinresistant S. aureus type III. Broth enrichment prior to isolation on oxacillin-MSA was superior to direct cultivation on different media with a sensitivity/specificity of 100% and 88.5%, respectively. MRSS is a significant coloniser of patients and HCWs in the hospital. Further research is needed to investigate the clinical significance of the bacterium in our settings.	[Cirkovic, Ivana; Trajkovic, Jasmina] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Hauschild, Tomasz] Univ Bialystok, Inst Biol, Dept Microbiol, Bialystok, Poland; [Andersen, Paal Skytt; Larsen, Anders Rhod] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark; [Shittu, Adebayo] Obafemi Awolowo Univ, Dept Microbiol, Ife, Nigeria	University of Belgrade; University of Bialystok; Statens Serum Institut; Obafemi Awolowo University	Cirkovic, I (corresponding author), Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia.	cirkoviciv@yahoo.com	Shittu, Adebayo Osagie/AGX-7853-2022; Andersen, Paal S/H-2087-2015	Shittu, Adebayo Osagie/0000-0003-3992-4123; Andersen, Paal S/0000-0001-5656-0427; Hauschild, Tomasz/0000-0002-1262-5548; Larsen, Anders Rhod/0000-0002-1713-8765; Cirkovic, Ivana/0000-0003-1515-1824	Ministry of Education, Science and Technological Development of Serbia [175039]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grants No. 175039, http://www.mpn.gov.rs/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim ML, 2009, MICROB DRUG RESIST, V15, P19, DOI 10.1089/mdr.2009.0881; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Bignardi GE, 1996, J ANTIMICROB CHEMOTH, V37, P53, DOI 10.1093/jac/37.1.53; Busscher JF, 2006, VET MICROBIOL, V113, P131, DOI 10.1016/j.vetmic.2005.10.028; Cirkovic I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127347; Couto I, 2000, J CLIN MICROBIOL, V38, P1136, DOI 10.1128/JCM.38.3.1136-1143.2000; Couto I, 2003, J BACTERIOL, V185, P645, DOI 10.1128/JB.185.2.645-653.2003; Dakic I, 2005, J CLIN MICROBIOL, V43, P2782, DOI 10.1128/JCM.43.6.2782-2785.2005; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Garcia MC, 2002, FOOD MICROBIOL, V19, P23, DOI 10.1006/fmic.2001.0457; Harrison EM, 2014, J ANTIMICROB CHEMOTH, V69, P911, DOI 10.1093/jac/dkt452; Hauschild T, 2003, J VET MED B, V50, P241, DOI 10.1046/j.1439-0450.2003.00662.x; Hauschild T, 2007, MICROB DRUG RESIST, V13, P77, DOI 10.1089/mdr.2007.713; Hauschild T, 2007, INT J ANTIMICROB AG, V29, P356, DOI 10.1016/j.ijantimicag.2006.10.002; Hauschild T, 2009, INT J ANTIMICROB AG, V33, P383, DOI 10.1016/j.ijantimicag.2008.09.020; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; McLaws FB, 2011, ANTIMICROB AGENTS CH, V55, P1173, DOI 10.1128/AAC.00817-10; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Nemeghaire S, 2014, VET MICROBIOL, V171, P342, DOI 10.1016/j.vetmic.2014.02.005; Nemeghaire S, 2014, VET MICROBIOL, V171, P357, DOI 10.1016/j.vetmic.2014.01.041; Pan A, 2013, J HOSP INFECT, V83, P107, DOI 10.1016/j.jhin.2012.09.020; Schoenfelder SMK, 2017, VET MICROBIOL, V200, P79, DOI 10.1016/j.vetmic.2016.04.019; Severin JA, 2010, ANTIMICROB AGENTS CH, V54, P5413, DOI 10.1128/AAC.00426-10; Stepanovic S, 2006, J CLIN MICROBIOL, V44, P934, DOI 10.1128/JCM.44.3.934-937.2006; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2005, J CLIN MICROBIOL, V43, P956, DOI 10.1128/JCM.43.2.956-958.2005; Stepanovic S, 2006, MICROB DRUG RESIST, V12, P115, DOI 10.1089/mdr.2006.12.115; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tulinski P, 2012, APPL ENVIRON MICROB, V78, P299, DOI 10.1128/AEM.05594-11; Urushibara N, 2011, MICROB DRUG RESIST, V17, P291, DOI 10.1089/mdr.2010.0144; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zhou YJ, 2008, J BACTERIOL, V190, P508, DOI 10.1128/JB.01549-07	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185181	10.1371/journal.pone.0185181	http://dx.doi.org/10.1371/journal.pone.0185181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926634	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600075
J	Herbert, RJH; Collins, K; Mallinson, J; Hall, AE; Pegg, J; Rosso, K; Clarke, L; Clements, T				Herbert, Roger J. H.; Collins, Ken; Mallinson, Jenny; Hall, Alice E.; Pegg, Josephine; Rosso, Kathryn; Clarke, Leo; Clements, Tom			Epibenthic and mobile species colonisation of a geotextile artificial surf reef on the south coast of England	PLOS ONE			English	Article							ROCKY INTERTIDAL COMMUNITY; UNDERWATER VIDEO STATIONS; STABLE-ISOTOPE ANALYSES; HABITAT COMPLEXITY; NATURAL REEFS; MARINE-INVERTEBRATES; BENTHIC ASSEMBLAGES; SUBTIDAL EPIBIOTA; ALGAL SUCCESSION; FISH ASSEMBLAGES	With increasing coastal infrastructure and use of novel materials there is a need to investigate the colonisation of assemblages associated with new structures, how these differ to natural and other artificial habitats and their potential impact on regional biodiversity. The colonisation of Europe's first artificial surf reef (ASR) was investigated at Boscombe on the south coast of England (2009-2014) and compared with assemblages on existing natural and artificial habitats. The ASR consists of geotextile bags filled with sand located 220m offshore on a sandy sea bed at a depth of 0-5m. Successional changes in epibiota were recorded annually on differently orientated surfaces and depths using SCUBA diving and photography. Mobile faunal assemblages were sampled using Baited Remote Underwater Video (BRUV). Distinct stages in colonisation were observed, commencing with bryozoans and green algae which were replaced by red algae, hydroids and ascidians, however there were significant differences in assemblage structure with depth and orientation. The reef is being utilised by migratory, spawning and juvenile life-history stages of fish and invertebrates. The number of non-native species was larger than on natural reefs and other artificial habitats and some occupied a significant proportion of the structure. The accumulation of 180 benthic and mobile taxa, recorded to date, appears to have arisen from a locally rich and mixed pool of native and non-native species. Provided no negative invasive impacts are detected on nearby protected reefs the creation of novel yet diverse habitats may be considered a beneficial outcome.	[Herbert, Roger J. H.; Hall, Alice E.; Clarke, Leo] Bournemouth Univ, Dept Life & Environm Sci, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England; [Collins, Ken; Mallinson, Jenny; Clements, Tom] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton, Hants, England; [Pegg, Josephine] Univ Ctr Sparsholt, Winchester, Hants, England; [Rosso, Kathryn] British Trust Ornithol, Thetford, Norfolk, England	Bournemouth University; NERC National Oceanography Centre; University of Southampton; British Trust for Ornithology	Herbert, RJH (corresponding author), Bournemouth Univ, Dept Life & Environm Sci, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England.	rherbert@bournemouth.ac.uk	Clarke, Leo/P-7750-2019	Herbert, Roger/0000-0002-9854-3112; Pegg, Josephine/0000-0001-6364-4741	Esmee Fairbairn Foundation; Bournemouth Borough Council	Esmee Fairbairn Foundation; Bournemouth Borough Council	This work received support from the Esmee Fairbairn Foundation and Bournemouth Borough Council The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful for financial support from the Esmee Fairbairn Foundation and Bournemouth Borough Council. We thank Mike Markey, skipper of Peveril Myth, John Humphreys, skipper of Sea Rush and divers Nick Owen, Lin Baldock, Jane Maddocks, Lucy Martin, Matt Doggett, Kathryn Dawson, Steve Trewhella, Ralf Hubner, Sally Keith and others from SeaSearch. We also thank Ruth Throssel, Eleanor Stacy, Ross Wheeler and Wayne O'Brien who assisted with the fieldwork. We are grateful to Harry Manley for production of the map (Fig 1).	Adams TP, 2014, J APPL ECOL, V51, P330, DOI 10.1111/1365-2664.12207; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2015, DIVERS DISTRIB, V21, P755, DOI 10.1111/ddi.12301; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ANDERSON MJ, 1994, J EXP MAR BIOL ECOL, V184, P217, DOI 10.1016/0022-0981(94)90006-X; Antoniadou C, 2010, J EXP MAR BIOL ECOL, V382, P145, DOI 10.1016/j.jembe.2009.11.004; ARDIZZONE GD, 1989, B MAR SCI, V44, P592; Arenas F, 2006, J MAR BIOL ASSOC UK, V86, P1329, DOI 10.1017/S0025315406014354; Bacchiocchi F, 2003, ESTUAR COAST SHELF S, V56, P1157, DOI 10.1016/S0272-7714(02)00322-0; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; BOHNSACK JA, 1985, B MAR SCI, V37, P11; Borrero JC, 2003, P 3 INT SURF REEF S, P83; Bouchoucha M, 2016, MAR ECOL PROG SER, V547, P193, DOI 10.3354/meps11641; BREITBURG DL, 1985, OECOLOGIA, V65, P173, DOI 10.1007/BF00379215; Brown CJ, 2005, BIOFOULING, V21, P73, DOI 10.1080/08927010512331344197; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2006, OECOLOGIA, V149, P482, DOI 10.1007/s00442-006-0459-3; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Caddy J. F., 2007, MARINE HABITAT COVER; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; CARTER JW, 1985, B MAR SCI, V37, P86; Carvalho S, 2013, MAR ENVIRON RES, V92, P170, DOI 10.1016/j.marenvres.2013.09.013; Chapman MG, 2002, J EXP MAR BIOL ECOL, V275, P95, DOI 10.1016/S0022-0981(02)00134-X; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clynick BG, 2008, MAR ENVIRON RES, V65, P18, DOI 10.1016/j.marenvres.2007.07.005; Collins KJ, 2012, UNDERWATER TECHNOL, V30, P183, DOI 10.3723/ut.30.183; Collins KJ, 1990, P ISLE WIGHT NATURAL, V9, P41; Connell J.H., 1985, P125; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; Cresson P, 2014, J EXP MAR BIOL ECOL, V452, P54, DOI 10.1016/j.jembe.2013.11.014; Dafforn KA, 2015, FRONT ECOL ENVIRON, V13, P82, DOI 10.1890/140050; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P249, DOI 10.1016/0022-0981(87)90057-8; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P195, DOI 10.1016/0022-0981(87)90055-4; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P217, DOI 10.1016/0022-0981(87)90056-6; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Edwards RA, 2005, MAR FRESHWATER RES, V56, P133, DOI 10.1071/MF04202; FAGER EW, 1971, LIMNOL OCEANOGR, V16, P241; Falace A, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P435; FARRELL TM, 1991, ECOL MONOGR, V61, P95, DOI 10.2307/1943001; Fletcher S, 2011, LAND USE POLICY, V28, P395, DOI 10.1016/j.landusepol.2010.08.002; Folpp H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063505; Froese R., 2015, FISHBASE; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; Glasby TM, 2001, MAR ECOL PROG SER, V214, P127, DOI 10.3354/meps214127; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Gonzalez-Gurriaran E, 2002, J CRUSTACEAN BIOL, V22, P91, DOI 10.1651/0278-0372(2002)022[0091:MPOFSC]2.0.CO;2; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Guidetti P, 2004, MAR ECOL PROG SER, V274, P57, DOI 10.3354/meps274057; Haggit T, 2014, BAITED REMOTE UNDERW; Harvey E. S., 2013, 2010002 FRDC; Hatcher AM, 1998, HYDROBIOLOGIA, V367, P153, DOI 10.1023/A:1003228100220; Hayward PJ, 1995, HDB MARINE FAUNA N W, pxi; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Herbert RJH, 2012, J BIOGEOGR, V39, P585, DOI 10.1111/j.1365-2699.2011.02626.x; Hunter WR, 2009, ICES J MAR SCI, V66, P691, DOI 10.1093/icesjms/fsp058; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Jacobi CM, 1996, J EXP MAR BIOL ECOL, V206, P39, DOI 10.1016/S0022-0981(96)02605-6; Jenkins S.R., 2010, BIOFOULING, V456, P60, DOI [10.1002/9781444315462.ch4, DOI 10.1002/9781444315462.CH4]; Jensen AC, 2000, ARTIFICIAL REEFS EUR; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Mallinson J.J., 2000, Proceedings of the Dorset Natural History & Archaeological Society, V121, P113; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; Mead S, 2010, P 32 C COAST ENG SHA; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; Mineur F, 2012, OCEANOGR MAR BIOL, V50, P189; Moura A, 2008, BIOFOULING, V24, P381, DOI 10.1080/08927010802256414; Noel LMLJ, 2009, ECOL STUD-ANAL SYNTH, V206, P213, DOI 10.1007/978-3-540-92704-4_15; Parsons DF, 2016, MAR ECOL PROG SER, V561, P155, DOI 10.3354/meps11927; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Platt WJ, 2003, ECOL MONOGR, V73, P507, DOI 10.1890/01-0552; Ponti M, 2015, MAR ENVIRON RES, V104, P10, DOI 10.1016/j.marenvres.2014.12.004; Relini G, 2002, ICES J MAR SCI, V59, pS132, DOI 10.1006/jmsc.2002.1272; Rendle EJ, 2014, MAR POLICY, V45, P349, DOI 10.1016/j.marpol.2013.09.004; Rule MJ, 2005, MAR ECOL PROG SER, V290, P67, DOI 10.3354/meps290067; Russell B, 2014, IUCN RED LIST THREAT; Sampedro MP, 2004, J CRUSTACEAN BIOL, V24, P168, DOI 10.1651/C-2404; Schmid K, 2016, HYDROBIOLOGIA, V112, P75; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, BIOL BULL-US, V216, P373; Sherman RL, 2002, ICES J MAR SCI, V59, pS196, DOI 10.1006/jmsc.2001.1163; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; SOUSA WP, 1992, SYST ASSOC SPEC VOL, V46, P425; Stobart B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127559; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; THOMAS CJ, 1993, MAR ECOL PROG SER, V95, P19, DOI 10.3354/meps095019; TODD CD, 1988, J EXP MAR BIOL ECOL, V115, P113, DOI 10.1016/0022-0981(88)90097-4; Ushiama S, 2016, BIOFOULING, V32, P1049, DOI 10.1080/08927014.2016.1224860; Utne-Palm AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143487; VADAS RL, 1988, J PHYCOL, V24, P338; Vaz-Pinto F, 2014, MAR ENVIRON RES, V94, P72, DOI 10.1016/j.marenvres.2013.12.007; Vega Fernandez T, 2008, AQUAT BIOL, V1, P239, DOI 10.3354/ab00027; Walker SJ, 2014, BIODIVERS CONSERV, V23, P433, DOI 10.1007/s10531-013-0611-4; Wetzel MA, 2011, GEOTEXT GEOMEMBRANES, V29, P440, DOI 10.1016/j.geotexmem.2010.12.004; Wilding TA, 2007, J EXP MAR BIOL ECOL, V353, P279, DOI 10.1016/j.jembe.2007.10.001; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Wootton JT, 2002, ECOL RES, V17, P249, DOI 10.1046/j.1440-1703.2002.00484.x; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	110	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184100	10.1371/journal.pone.0184100	http://dx.doi.org/10.1371/journal.pone.0184100			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926608	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600009
J	Andruszkiewicz, EA; Sassoubre, LM; Boehm, AB				Andruszkiewicz, Elizabeth A.; Sassoubre, Lauren M.; Boehm, Alexandria B.			Persistence of marine fish environmental DNA and the influence of sunlight	PLOS ONE			English	Article							EDNA; BIODIVERSITY; CONSERVATION; DEGRADATION; ABUNDANCE; IMPACTS; QUANTIFICATION; TEMPERATURE; DIVERSITY; GENOMICS	Harnessing information encoded in environmental DNA (eDNA) in marine waters has the potential to revolutionize marine biomonitoring. Whether using organism-specific quantitative PCR assays or metabarcoding in conjunction with amplicon sequencing, scientists have illustrated that realistic organism censuses can be inferred from eDNA. The next step is establishing ways to link information obtained from eDNA analyses to actual organism abundance. This is only possible by understanding the processes that control eDNA concentrations. The present study uses mesocosm experiments to study the persistence of eDNA in marine waters and explore the role of sunlight in modulating eDNA persistence. We seeded solute-permeable dialysis bags with water containing indigenous eDNA and suspended them in a large tank containing seawater. Bags were subjected to two treatments: half the bags were suspended near the water surface where they received high doses of sunlight, and half at depth where they received lower doses of sunlight. Bags were destructively sampled over the course of 87 hours. eDNA was extracted from water samples and used as template for a Scomber japonicus qPCR assay and a marine fish-specific 12S rRNA PCR assay. The latter was subsequently sequenced using a metabarcoding approach. S. japonicus eDNA, as measured by qPCR, exhibited first order decay with a rate constant similar to 0.01 hr(-1) with no difference in decay rate constants between the two experimental treatments. eDNA metabarcoding identified 190 organizational taxonomic units (OTUs) assigned to varying taxonomic ranks. There was no difference in marine fish communities as measured by eDNA metabarcoding between the two experimental treatments, but there was an effect of time. Given the differences in UVA and UVB fluence received by the two experimental treatments, we conclude that sunlight is not the main driver of fish eDNA decay in the experiments. However, there are clearly temporal effects that need to be considered when interpreting information obtained using eDNA approaches.	[Andruszkiewicz, Elizabeth A.; Sassoubre, Lauren M.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Sassoubre, Lauren M.] Univ Buffalo State Univ New York, Dept Civil Struct & Environm Engn, Buffalo, NY USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	aboehm@stanford.edu	Allan, Elizabeth Andruszkiewicz/AAD-2255-2021	Boehm, Alexandria/0000-0002-8162-5090; Allan, Elizabeth Andruszkiewicz/0000-0002-9675-0003	U.S. Environmental Protection Agency (EPA) [F15E211913419]	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This work was supported by a gift from the Seaver Institute to Woods Institute for the Environment at Stanford University. This publication was developed under STAR Fellowship Assistance Agreement no. F15E211913419 awarded by the U.S. Environmental Protection Agency (EPA). It has not been formally reviewed by EPA. The views expressed in this publication are solely those of Elizabeth Andruszkiewicz and coauthors, and EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; Allard L, 2014, FISHERIES MANAG ECOL, V21, P234, DOI 10.1111/fme.12071; Andruszkiewicz EA, 2017, PLOS ONE, V12; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cammen KM, 2016, J HERED, V107, P481, DOI 10.1093/jhered/esw044; Cao Y, 2012, J APPL MICROBIOL, V113, P66, DOI 10.1111/j.1365-2672.2012.05305.x; Carey VJ, 2015, GEE GEN ESTIMATION E; Chamberlain SA, 2013, TAXIZE TAXONOMIC SEA, P1; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Corlett RT, 2017, TRENDS BIOTECHNOL, V35, P55, DOI 10.1016/j.tibtech.2016.06.009; Creer S, 2017, MARINE ECOLOGY GENET, V1, P1; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Forsstrom T, 2016, MAR POLLUT BULL, V109, P350, DOI 10.1016/j.marpolbul.2016.05.054; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Guo ZW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013113; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hinlo R, 2017, MANAG BIOL INVASION, V8, P89, DOI 10.3391/mbi.2017.8.1.09; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2015, MOL ECOL RESOUR, V15, P461, DOI 10.1111/1755-0998.12377; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Kelley JL, 2016, NAT REV GENET, V17, P523, DOI 10.1038/nrg.2016.66; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Maraccini PA, 2016, ENVIRON SCI TECHNOL, V50, P5068, DOI 10.1021/acs.est.6b00505; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Mattioli MC, 2017, WATER RES, V108, P106, DOI 10.1016/j.watres.2016.10.066; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Merkes CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113346; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Oksanen J., 2020, COMMUNITY ECOL PACKA; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Radulovici Adriana E., 2010, Diversity, V2, P450; Ribeiro AM, 2017, MAR GENOM, V31, P1, DOI 10.1016/j.margen.2016.09.002; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Schratzberger M, 2002, MAR BIOL, V140, P83, DOI 10.1007/s002270100688; Shelton AO, 2016, FRAMEWORK INFERRING, P1; Shogren AJ, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0290; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Stoeckle MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175186; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Team R.C, R LANG ENV STAT COMP; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Turner CR, 2012, EVALUATING ENV DNA D, P1; Wang M., 2014, ADV STAT, V2014; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yang W, 2013, PLOS ONE, V8; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	81	41	43	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0185043	10.1371/journal.pone.0185043	http://dx.doi.org/10.1371/journal.pone.0185043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915253	Green Published, Green Submitted, gold			2022-12-26	WOS:000410861600030
J	Huang, C; Yang, Y; Chen, XT; Wang, C; Li, Y; Zheng, CL; Wang, YH				Huang, Chao; Yang, Yang; Chen, Xuetong; Wang, Chao; Li, Yan; Zheng, Chunli; Wang, Yonghua			Large-scale cross-species chemogenomic platform proposes a new drug discovery strategy of veterinary drug from herbal medicines	PLOS ONE			English	Article							NATURAL-PRODUCTS; APOPTOSIS; PROTEIN; TARGET	Veterinary Herbal Medicine (VHM) is a comprehensive, current, and informative discipline on the utilization of herbs in veterinary practice. Driven by chemistry but progressively directed by pharmacology and the clinical sciences, drug research has contributed more to address the needs for innovative veterinary medicine for curing animal diseases. However, research into veterinary medicine of vegetal origin in the pharmaceutical industry has reduced, owing to questions such as the short of compatibility of traditional natural-product extract libraries with high-throughput screening. Here, we present a cross-species chemo-genomic screening platform to dissect the genetic basis of multifactorial diseases and to determine the most suitable points of attack for future veterinary medicines, thereby increasing the number of treatment options. First, based on critically examined pharmacology and text mining, we build a cross-species drug-likeness evaluation approach to screen the lead compounds in veterinary medicines. Second, a specific cross-species target prediction model is developed to infer drug-target connections, with the purpose of understanding how drugs work on the specific targets. Third, we focus on exploring the multiple targets interference effects of veterinary medicines by heterogeneous network convergence and modularization analysis. Finally, we manually integrate a disease pathway to test whether the cross-species chemo-genomic platform could uncover the active mechanism of veterinary medicine, which is exemplified by a specific network module. We believe the proposed cross-species chemo-genomic platform allows for the systematization of current and traditional knowledge of veterinary medicine and, importantly, for the application of this emerging body of knowledge to the development of new drugs for animal diseases.	[Huang, Chao; Chen, Xuetong; Wang, Yonghua] Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [Yang, Yang] Shihezi Univ, Sch Pharm, Shihezi, Peoples R China; [Wang, Chao] Dalian Ocean Univ, Coll Econ & Management, Dalian, Peoples R China; [Li, Yan] Dalian Univ Technol, Dept Mat Sci & Chem Engn, Dalian, Liaoning, Peoples R China; [Zheng, Chunli] Northwest Univ, Sch Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Shihezi University; Dalian Ocean University; Dalian University of Technology; Northwest University Xi'an	Wang, YH (corresponding author), Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.; Zheng, CL (corresponding author), Northwest Univ, Sch Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China.	chunlizheng@126.com; yh_wang@nwsuaf.edu.cn	li, yong/HDN-3885-2022; Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022		Northwest A & F University, National Natural Science Foundation of China [31170796, 81373892]; National Natural Science Foundation of China [U1603285]	Northwest A & F University, National Natural Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Northwest A & F University, National Natural Science Foundation of China (31170796 and 81373892) supported the study design. National Natural Science Foundation of China (31540008) supported the data collection and analysis. National Natural Science Foundation of China (U1603285) supported publishing and preparing the manuscript.	Adrian M, 1996, J AGR FOOD CHEM, V44, P1979, DOI 10.1021/jf950807o; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bhutani KK, 2010, INDIAN J EXP BIOL, V48, P199; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fang L, 2014, J SEP SCI, V37, P3245, DOI 10.1002/jssc.201400711; Fu Y, 2014, J TRADIT CHINESE MED, V1, P84, DOI [10.1016/j.jtcms.2014.09.006, DOI 10.1016/j.jtcms.2014.09.006]; Graziose Rocky, 2010, Curr Drug Discov Technol, V7, P2; Harvey AL, 1999, TRENDS PHARMACOL SCI, V20, P196, DOI 10.1016/S0165-6147(99)01346-2; Hecker N, 2012, NUCLEIC ACIDS RES, V40, pD1113, DOI 10.1093/nar/gkr912; Hodgins DC, 2002, POLYMICROBIAL DISEASES, P213; Hu SQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005367; Huang C, 2014, BRIEF BIOINFORM, V15, P710, DOI 10.1093/bib/bbt035; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Khandarkar K, 2013, UNIVERSAL J CHEM, V1, P38; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim HC, 2010, TUBERC RESPIR DIS, V68, P125, DOI 10.4046/trd.2010.68.3.125; Kim MJ, 2009, NUTR RES PRACT, V3, P180, DOI 10.4162/nrp.2009.3.3.180; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Laudato M., 2013, OA ALTERN MED, V1, P1; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Liu Z, 2016, SCI REP, P6; Maobe M A G, 2013, EUROP J APPL SCI, V5, P01; Marrassini C, 2011, J NAT PROD, V74, P1503, DOI 10.1021/np100937e; Mauri A, 2006, MATCH-COMMUN MATH CO, V56, P237; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Newman R, 1989, NUTR REPORTS INT US, V51, P851; Niu XF, 2015, CHEM-BIOL INTERACT, V239, P34, DOI 10.1016/j.cbi.2015.06.026; Petranovic D, 2010, FEMS YEAST RES, V10, P1046, DOI 10.1111/j.1567-1364.2010.00689.x; Qiu JZ, 2012, J INFECT DIS, V206, P292, DOI 10.1093/infdis/jis336; Qureshi MH, 2003, J IMMUNOL, V170, P1002, DOI 10.4049/jimmunol.170.2.1002; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Russo R, 2009, NAT PROD COMMUN, V4, P1777; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Sessa R, 2009, INT J IMMUNOPATH PH, V22, P659, DOI 10.1177/039463200902200311; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stogdale L., 2008, CAN VET J, V49, P802; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian P, 2011, NATURE, V480, pS84, DOI 10.1038/480S84a; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; van Laarhoven T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066952; Vandamme D, 2009, BBA-MOL CELL RES, V1793, P1259, DOI 10.1016/j.bbamcr.2009.04.004; Viegi L, 2003, J ETHNOPHARMACOL, V89, P221, DOI 10.1016/j.jep.2003.08.003; Vlasblom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-99; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; Wang W, 2013, PAC S BIOC PAC S BIO; Wang XL, 2011, BIOCHEM J, V435, P285, DOI 10.1042/BJ20101864; Wang Y, 2015, SYSTEMS PHARM DISSEC; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhang Z-B, 2007, PLANT PHYSIOL, V144, P942; Zheng C, 2015, SCI REPORTS, V5; Zheng CL, 2014, MOL DIVERS, V18, P621, DOI 10.1007/s11030-014-9521-y	58	6	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184880	10.1371/journal.pone.0184880	http://dx.doi.org/10.1371/journal.pone.0184880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915268	Green Published, gold, Green Submitted			2022-12-26	WOS:000410861600019
J	Calvo-Martin, JM; Papaceit, M; Segarra, C				Calvo-Martin, Juan M.; Papaceit, Montserrat; Segarra, Carmen			Molecular population genetics of the Polycomb genes in Drosophila subobscura	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ADAPTIVE PROTEIN EVOLUTION; POSITIVE SELECTION DRIVES; NUCLEOTIDE VARIATION; HISTONE METHYLTRANSFERASE; SU(Z) 12; MELANOGASTER; POLYMORPHISM; CHROMOSOME; SUBUNIT	Polycomb group (PcG) proteins are important regulatory factors that modulate the chromatin state. They form protein complexes that repress gene expression by the introduction of posttranslational histone modifications. The study of PcG proteins divergence in Drosophila revealed signals of coevolution among them and an acceleration of the nonsynonymous evolutionary rate in the lineage ancestral to the obscura group species, mainly in subunits of the Pcl-PRC2 complex. Herein, we have studied the nucleotide polymorphism of PcG genes in a natural population of D. subobscura to detect whether natural selection has also modulated the evolution of these important regulatory genes in a more recent time scale. Results show that most genes are under the action of purifying selection and present a level and pattern of polymorphism consistent with predictions of the neutral model, the exceptions being Su(z)12 and Pho. MK tests indicate an accumulation of adaptive changes in the SU(Z)12 protein during the divergence of D. subobscura and D. guanche. In contrast, the HKA test shows a deficit of polymorphism at Pho. The most likely explanation for this reduced variation is the location of this gene in the dot-like chromosome and would indicate that this chromosome also has null or very low recombination in D. subobscura, as reported in D. melanogaster.	[Segarra, Carmen] Univ Barcelona, Dept Genet Microbiol & Estadist, Fac Biol, Barcelona, Spain; Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Segarra, C (corresponding author), Univ Barcelona, Dept Genet Microbiol & Estadist, Fac Biol, Barcelona, Spain.	csegarra@ub.edu		Segarra, Carmen/0000-0002-3201-5405	Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya, Catalonia, Spain; Ministerio de Economia y Competitividad, Spain [BFU2012-35168, BFU2015-63732]; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Catalonia, Spain [2009SGR-1287, 2014SGR10555]	Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya, Catalonia, Spain(Generalitat de Catalunya); Ministerio de Economia y Competitividad, Spain(Spanish Government); Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Catalonia, Spain(Generalitat de Catalunya)	This work was supported by a predoctoral fellowship from Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalonia, Spain, to JMCM.; and grants BFU2012-35168 and BFU2015-63732 from Ministerio de Economia y Competitividad, Spain, and 2009SGR-1287 and 2014SGR10555 from Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Catalonia, Spain, to Montserrat Aguade.	AKASHI H, 1995, GENETICS, V139, P1067; Alvarez-Ponce D, 2012, MOL BIOL EVOL, V29, P123, DOI 10.1093/molbev/msr160; Arguello JR, 2010, MOL BIOL EVOL, V27, P848, DOI 10.1093/molbev/msp291; Beck EA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17197; Beh LY, 2012, P NATL ACAD SCI USA, V109, pE1063, DOI 10.1073/pnas.1118678109; Betancourt AJ, 2009, CURR BIOL, V19, P655, DOI 10.1016/j.cub.2009.02.039; Burland T G, 2000, Methods Mol Biol, V132, P71; Calvo-Martin JM, 2016, HEREDITY, V116, P213, DOI 10.1038/hdy.2015.91; Calvo-Martin JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40536; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; Eanes WF, 2011, J EXP BIOL, V214, P165, DOI 10.1242/jeb.046458; Findlay GD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004108; Flores HA, 2015, G3-GENES GENOM GENET, V5, P583, DOI 10.1534/g3.114.015875; FU YX, 1993, GENETICS, V133, P693; Gibert JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001280; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hochman B., 1976, GENET BIOL DROSOPHIL, V1b, P903; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Krimbas Costas B., 1992, P127; KUNZEMUHL E, 1958, CHROMOSOMA, V9, P559; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Leung W, 2010, GENETICS, V185, P1519, DOI 10.1534/genetics.110.116129; Levine MT, 2008, GENETICS, V179, P475, DOI 10.1534/genetics.107.085423; LEWONTIN RC, 1964, GENETICS, V49, P49; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOUKAS M, 1979, J HERED, V70, P17, DOI 10.1093/oxfordjournals.jhered.a109181; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Munte A, 2005, GENETICS, V169, P1573, DOI 10.1534/genetics.104.032748; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Nobrega C, 2008, MOL BIOL EVOL, V25, P1534, DOI 10.1093/molbev/msn100; Nowak AJ, 2011, J BIOL CHEM, V286, P23388, DOI 10.1074/jbc.M110.207407; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papaceit M, 2006, EVOLUTION, V60, P768, DOI 10.1111/j.0014-3820.2006.tb01155.x; Papaceit M, 2013, EVOLUTION, V67, P66, DOI 10.1111/j.1558-5646.2012.01731.x; Podemski L, 2001, CHROMOSOMA, V110, P305, DOI 10.1007/s004120100151; Pratdesaba R, 2015, MOL ECOL, V24, P1729, DOI 10.1111/mec.13155; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; PREVOSTI A, 1964, GENET RES, V5, P27, DOI 10.1017/S0016672300001002; Rai AN, 2013, MOL CELL BIOL, V33, P4844, DOI 10.1128/MCB.00307-13; Ramos-Onsins SE, 2007, EVOL BIOINFORM, V3, P41; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Riley RM, 2003, MOL ECOL, V12, P1315, DOI 10.1046/j.1365-294X.2003.01741.x; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Voigt S, 2015, GENETICS, V200, P591, DOI 10.1534/genetics.115.177030; Wang RL, 1996, GENETICS, V144, P1113; Wang W, 2004, GENETICS, V166, P1783, DOI 10.1534/genetics.166.4.1783; Wang W, 2002, SCIENCE, V295, P134, DOI 10.1126/science.1064521; Wong A, 2008, MOL BIOL EVOL, V25, P497, DOI 10.1093/molbev/msm270; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	60	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0185005	10.1371/journal.pone.0185005	http://dx.doi.org/10.1371/journal.pone.0185005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910411	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200125
J	Kang, M; Lee, KH; Lee, HS; Jeong, CW; Ku, JH; Kim, HH; Kwak, C				Kang, Minyong; Lee, Kyoung-Hwa; Lee, Hye Sun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol			Concurrent treatment with simvastatin and NF-kB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anticancer effects via control of the NF-kB/LIN28/let-7 miRNA signaling pathway	PLOS ONE			English	Article							MEVALONATE PATHWAY; LIN28; APOPTOSIS; STATINS; ACTIVATION; PRODUCTS; GROWTH; TUMORS	We examined the anti-cancer effects and molecular mechanism of simvastatin in human castration-resistant prostate cancer (CRPC) cells, particularly focused on LIN28B and its target molecule, let-7 microRNA (miRNA) among the various target genes of NF-kB. A human CRPC cell line (PC3) was used in the current study. Gene expression patterns were evaluated using real time-PCR and western blot analysis. CCK-8 assay was used for assessing cell viability and proliferation, and a clonogenic assay was adopted to evaluate clonal proliferative capabilities. Induction of apoptotic cell death was analyzed via flow cytometry. Small interfering RNA (siRNA) and short-hairpin RNA (shRNA) were used for manipulating the expression of genes of interest. PC3 showed relatively higher expression levels of LIN28B and lower expression levels of let-7 miRNAs. Simvastatin treatment significantly inhibited cell viability and clonal proliferation in a dose-dependent manner. Importantly, the downregulated let-7 miRNA family was restored after simvastatin treatment. We further observed that human CRPC cells transfected with LIN28B-siRNA or shRNA also showed upregulated let-7 miRNAs. Finally, dual treatment with simvastatin and an NF-kB inhibitor (CAPE) synergistically induced apoptotic cell death, along with reduction of LIN28B expression, and restoration of let-7 miRNAs levels. Our data illustrate that simvastatin remarkably inhibits the growth of human CRPC cells by suppressing NF-kB and LIN28B and subsequently upregulating let-7 miRNAs. Moreover, concurrent treatment with simvastatin and an NF-kB inhibitor synergistically suppressed the growth of human CRPC cells, suggesting a novel therapeutic approach for human CRPC treatment.	[Kang, Minyong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea; [Lee, Kyoung-Hwa; Lee, Hye Sun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kwak, C (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	mdrafael@snu.ac.kr	Song, Young Goo/AGV-5104-2022; Kang, Minyong/AAO-6484-2020	Song, Young Goo/0000-0002-0733-4156; 	Seoul National University Hospital [0320140010]; Astrazeneca Korea [0620132330]; National Research Foundation (NRF) of Korea - Ministry of Education [2016R1D1A1A02936950]	Seoul National University Hospital; Astrazeneca Korea(AstraZeneca); National Research Foundation (NRF) of Korea - Ministry of Education	This study was funded by a research grant from the Seoul National University Hospital Research Fund (No. 0320140010) and Astrazeneca Korea (No. 0620132330). This work was also supported by Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (No. 2016R1D1A1A02936950). The funders had no role in study design, experiments, data collection and analysis, preparation of the manuscript, or the decision to publish.	Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Cornford P, 2016, EUROPEAN UROLOGY; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ingersoll MA, 2016, CANCER LETT, V383, P94, DOI 10.1016/j.canlet.2016.09.008; Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431; Kamel W, 2016, MOL CANC THERAPEUTIC; Kim JH, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-56; Manu KA, 2014, J MOL MED, V92, P267, DOI 10.1007/s00109-013-1095-0; Matusewicz L, 2015, TUMOR BIOL, V36, P4889, DOI 10.1007/s13277-015-3551-7; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Park YH, 2013, J UROLOGY, V189, P1547, DOI 10.1016/j.juro.2012.10.030; Popiolek M, 2013, EUR UROL, V63, P428, DOI 10.1016/j.eururo.2012.10.002; Spampanato C, 2012, INT J ONCOL, V40, P935, DOI 10.3892/ijo.2011.1273; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Tummala R, 2016, PROSTATE, V76, P445, DOI 10.1002/pros.23134; Tummala R, 2013, AM J PATHOL, V183, P288, DOI 10.1016/j.ajpath.2013.03.011; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang H, 2016, TUMOR BIOL, V37, P2841, DOI 10.1007/s13277-015-4759-2; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wang TT, 2016, ONCOTARGET, V7, P2532, DOI 10.18632/oncotarget.6304; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	26	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184644	10.1371/journal.pone.0184644	http://dx.doi.org/10.1371/journal.pone.0184644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910332	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200071
J	Lee, SR; Shim, S; Yu, T; Jeong, K; Chung, HW				Lee, Sa Ra; Shim, Sunah; Yu, Taeri; Jeong, Kyungah; Chung, Hye Won			Sources of pain in laparoendoscopic gynecological surgeons: An analysis of ergonomic factors and proposal of an aid to improve comfort	PLOS ONE			English	Article							MINIMALLY INVASIVE SURGERY; LAPAROSCOPIC SURGERY; GUIDELINES; HEIGHT	Minimally invasive surgery (MIS) offers cosmetic benefits to patients; however, surgeons often experience pain during MIS. We administered an ergonomic questionnaire to 176 Korean laparoscopic gynecological surgeons to determine potential sources of pain during surgery. Logistic regression analysis was used to identify factors that had a significant impact on gynecological surgeons' pain. Operating table height at the beginning of surgery and during the operation were significantly associated with neck and shoulder discomfort (P <0.001). The ability to control the operating table height was the single factor most significantly associated with neck (P <0.001) and shoulder discomfort (P <0.001). Discomfort of the hand/digits was significantly associated with the trocar site (P = 0.035). The type of electrocautery activation switch and foot pedal were significantly related to surgeons' foot and leg discomfort (P <0.001). In evaluating the co-occurrence of pain in 4 different sites (neck, shoulder, back, hand/digits), the neck and shoulder were determined to have the highest co-occurrence of pain (Spearman's. = 0.64, P <0.001). These results provide guidance for identifying ergonomic solutions to reduce gynecological laparoscopic surgeons' pain. Based on our results, we propose the use of an ergonomic surgical step stool to reduce physical pain related to performing laparoscopic operations.	[Lee, Sa Ra; Shim, Sunah; Yu, Taeri; Jeong, Kyungah; Chung, Hye Won] Ewha Womans Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Ewha Womans University	Lee, SR (corresponding author), Ewha Womans Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	sarahmd@ewha.ac.kr			National Research Foundation of Korea [NRF-2015R1C1A1A02038010]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a research grant from the National Research Foundation of Korea (NRF-2015R1C1A1A02038010), www.nrf.re.kr/.	Berquer R, 2002, SURG ENDOSC, V16, P416, DOI 10.1007/s00464-001-8190-y; Franasiak J, 2012, GYNECOL ONCOL, V126, P437, DOI 10.1016/j.ygyno.2012.05.016; Lee Doo Haeng, 2015, Obstet Gynecol Sci, V58, P289, DOI 10.5468/ogs.2015.58.4.289; Matern U, 2005, SURG ENDOSC, V19, P436, DOI 10.1007/s00464-004-9030-7; Nguyen NT, 2001, AM J SURG, V182, P720, DOI 10.1016/S0002-9610(01)00801-7; Park A, 2010, J AM COLL SURGEONS, V210, P306, DOI 10.1016/j.jamcollsurg.2009.10.017; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramakrishnan VR, 2013, AM J RHINOL ALLERGY, V27, P245, DOI 10.2500/ajra.2013.27.3872; Sataa Sallami, 2012, Tunis Med, V90, P843; Soueid A, 2010, INT J SURG, V8, P118, DOI 10.1016/j.ijsu.2009.11.008; Szeto GPY, 2012, J SURG RES, V172, pE19, DOI 10.1016/j.jss.2011.08.004; Uhrich ML, 2002, SURG ENDOSC, V16, P635, DOI 10.1007/s00464-001-8151-5; van Det MJ, 2009, SURG ENDOSC, V23, P1279, DOI 10.1007/s00464-008-0148-x; van Veelen MA, 2003, SURG ENDOSC, V17, P1077, DOI 10.1007/s00464-002-9105-2; van Veelen MA, 2003, SURG ENDOSC, V17, P1086, DOI 10.1007/s00464-002-9185-z; van Veelen MA, 2002, SURG ENDOSC, V16, P674, DOI 10.1007/s00464-001-9116-4; van Veelen MA, 2002, J LAPAROENDOSC ADV A, V12, P47, DOI 10.1089/109264202753486920; Wauben LSGL, 2006, SURG ENDOSC, V20, P1268, DOI 10.1007/s00464-005-0647-y	18	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184400	10.1371/journal.pone.0184400	http://dx.doi.org/10.1371/journal.pone.0184400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910316	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200044
J	Lynch, CM; van Berkel, VH; Frieboes, HB				Lynch, Chip M.; van Berkel, Victor H.; Frieboes, Hermann B.			Application of unsupervised analysis techniques to lung cancer patient data	PLOS ONE			English	Article							SURVIVAL PREDICTION; WEB SERVER; EPIDEMIOLOGY; SURVEILLANCE; IDENTIFICATION; SELECTION; PROTEINS; OUTCOMES; TRENDS; RNA	This study applies unsupervised machine learning techniques for classification and clustering to a collection of descriptive variables from 10,442 lung cancer patient records in the Surveillance, Epidemiology, and End Results (SEER) program database. The goal is to automatically classify lung cancer patients into groups based on clinically measurable disease-specific variables in order to estimate survival. Variables selected as inputs for machine learning include Number of Primaries, Age, Grade, Tumor Size, Stage, and TNM, which are numeric or can readily be converted to numeric type. Minimal up-front processing of the data enables exploring the out-of-the-box capabilities of established unsupervised learning techniques, with little human intervention through the entire process. The output of the techniques is used to predict survival time, with the efficacy of the prediction representing a proxy for the usefulness of the classification. A basic single variable linear regression against each unsupervised output is applied, and the associated Root Mean Squared Error (RMSE) value is calculated as a metric to compare between the outputs. The results show that self-ordering maps exhibit the best performance, while k-Means performs the best of the simpler classification techniques. Predicting against the full data set, it is found that their respective RMSE values (15.591 for self-ordering maps and 16.193 for k-Means) are comparable to supervised regression techniques, such as Gradient Boosting Machine (RMSE of 15.048). We conclude that unsupervised data analysis techniques may be of use to classify patients by defining the classes as effective proxies for survival prediction.	[Lynch, Chip M.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [van Berkel, Victor H.] Univ Louisville, Dept Cardiovasc & Thorac Surg, Louisville, KY 40292 USA; [Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.; Frieboes, HB (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	hbfrie01@louisville.edu	van Berkel, Victor/AAC-1956-2021	Frieboes, Hermann/0000-0001-5959-4286	National Cancer Institute [R15CA203605]; NATIONAL CANCER INSTITUTE [R15CA203605] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute, R15CA203605 to HBF. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Abreu PH, 2013, 13 MED C MED BIOL EN; Abreu PH, 2014, INT C HLTH INF; ACS, 2017, NONSM CELL LUNG CANC; Agrawal Ankit, 2011, International Journal of Knowledge Discovery in Bioinformatics, V2, P34, DOI 10.4018/jkdb.2011040103; Agrawal A, 2011, 11 INT C DAT MIN WOR; Agrawal A, 2011, P 10 INT WORKSH DAT; Agrawal A, 2012, SCI PROGRAMMING-NETH, V20, P29, DOI [10.1155/2012/920245, 10.3233/SPR-2012-0335]; [Anonymous], 2015, WHAT YOU NEED KNOW L; [Anonymous], AJCC CANC STAG; [Anonymous], RES DAT 1973 2009; [Anonymous], 2015, OV SEER PROGR SURV E; Bhaskarla A, 2010, J SURG RES, V162, P1, DOI 10.1016/j.jss.2009.12.030; Chen DC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/632786; Chen W, 2017, J BIOMOL STRUCT DYN, V35, P683, DOI 10.1080/07391102.2016.1157761; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dimitoglu G, 2012, J COMPUTING, V4, P1; Fradkin D., 2006, MACHINE LEARNING MET; Fraley C, 2003, J CLASSIF, V20, P263, DOI 10.1007/s00357-003-0015-3; Franceschi P, 2014, PROTEOMICS, V14, P853, DOI 10.1002/pmic.201300308; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; Garcia-Laencina PJ, 2015, COMPUT BIOL MED, V59, P125, DOI 10.1016/j.compbiomed.2015.02.006; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; In H, 2015, J SURG ONCOL, V111, P657, DOI 10.1002/jso.23883; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kapadia NS, 2012, INT J RADIAT ONCOL, V84, pS545, DOI 10.1016/j.ijrobp.2012.07.1453; Krishnaiah V., 2013, INT J COMPUTER SCI I, V4, P39; Lally BE, 2009, LUNG CANCER, V64, P226, DOI 10.1016/j.lungcan.2008.08.010; Leslie Christina, 2002, Pac Symp Biocomput, P564; Liang ZY, 2017, BIOINFORMATICS, V33, P467, DOI 10.1093/bioinformatics/btw630; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lin H, 2019, IEEE ACM T COMPUT BI, V16, P1316, DOI 10.1109/TCBB.2017.2666141; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu ZQ, 2010, ADV EXP MED BIOL, V680, P11, DOI 10.1007/978-1-4419-5913-3_2; Moorthy K, 2011, BIOINFORMATION, V7, P142; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Ramalingam S, 1998, J CLIN ONCOL, V16, P651, DOI 10.1200/JCO.1998.16.2.651; Santos MS, 2015, J BIOMED INFORM, V58, P49, DOI 10.1016/j.jbi.2015.09.012; Skrypnyk I, 2012, MACH LEARN APPL ICML; Swan AL, 2013, OMICS, V17, P595, DOI 10.1089/omi.2013.0017; Tang H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3267325; Tang H, 2016, MOL BIOSYST, V12, P1269, DOI 10.1039/c5mb00883b; Team RC, 2015, LANG ENV STAT COMP V; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Wang Samuel J, 2007, Gastrointest Cancer Res, V1, P84; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; Wu XC, 2004, CANCER EPIDEM BIOMAR, V13, P1215; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang CJ, 2016, ONCOTARGET, V7, P69783, DOI 10.18632/oncotarget.11975; Zhang T, 2017, NUCLEIC ACIDS RES, V45, pD135, DOI 10.1093/nar/gkw728; Zhao YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34817	56	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184370	10.1371/journal.pone.0184370	http://dx.doi.org/10.1371/journal.pone.0184370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910336	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200043
J	Termini, JM; Gupta, S; Raffa, FN; Guirado, E; Fischl, MA; Niu, LG; Kanagavelu, S; Stone, GW				Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Guirado, Elizabeth; Fischl, Margaret A.; Niu, Liguo; Kanagavelu, Saravana; Stone, Geoffrey W.			Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion	PLOS ONE			English	Article							CLINICAL-TRIAL; KAPPA-B; VACCINE; IMMUNOTHERAPY; LMP1; ANTIGEN; CD40; PROSTAGLANDIN-E2; INTERLEUKIN-12; EXPRESSION	Dendritic cells (DC) are a promising cell type for cancer vaccines due to their high immunostimulatory capacity. However, improper maturation of DC prior to treatment may account for the limited efficacy of DC vaccine clinical trials. Latent Membrane Protein-1 (LMP1) of Epstein-Barr virus was examined for its ability to mature and activate DC as a gene-based molecular adjuvant for DC vaccines. DC were transduced with an adenovirus 5 vector (Ad5) expressing LMP1 under the control of a Tet-inducible promoter. Ad5-LMP1 was found to mature and activate both human and mouse DC. LMP1 enhanced in vitro migration of DC toward CCL19, as well as in vivo migration of DC to the inguinal lymph nodes of mice following intradermal injection. LMP1-transduced DC increased T cell proliferation in a Pmel-1 adoptive transfer model and enhanced survival in B16-F10 melanoma models. LMP1-DC also enhanced protection in a vaccinia-Gag viral challenge assay. LMP1 induced high levels of IL-12p70 secretion in mouse DC when compared to standard maturation protocols. Importantly, LMP1-transduced human DC retained the capacity to secrete IL-12p70 and TNF in response to DC restimulation. In contrast, DC matured with Monocyte Conditioned Media-Mimic cocktail (Mimic) were impaired in IL-12p70 secretion following restimulation. Overall, LMP1 matured and activated DC, induced migration to the lymph node, and generated high levels of IL-12p70 in a murine model. We propose LMP1 as a promising molecular adjuvant for DC vaccines.	[Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Guirado, Elizabeth; Niu, Liguo; Kanagavelu, Saravana; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Guirado, Elizabeth; Niu, Liguo; Kanagavelu, Saravana; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Fischl, Margaret A.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Fischl, Margaret A.] Univ Miami, Miller Sch Med, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Kanagavelu, Saravana] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Stone, Geoffrey W.] NGM Biopharmaceut, San Francisco, CA 94080 USA	University of Miami; University of Miami; University of Miami; University of Miami; Cedars Sinai Medical Center	Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA.; Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.; Stone, GW (corresponding author), NGM Biopharmaceut, San Francisco, CA 94080 USA.	drgeoffstone@gmail.com			National Institutes of Health, National Institute of Allergy and Infectious Diseases [R21AI093294, R21AI078834, P30AI073961]; Florida Department of Health [1BF02]	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Florida Department of Health	GWS was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases grants R21AI093294 and R21AI078834, Florida Department of Health and Bankhead-Coley Cancer Research Program TTF award 1BF02, and National Institutes of Health, National Institute of Allergy and Infectious Diseases grant P30AI073961 to the Miami Center for AIDS Research (PI Savita Pahwa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcipowski KM, 2012, J IMMUNOL, V189, P5165, DOI 10.4049/jimmunol.1201821; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Baumforth KRN, 1999, J CLIN PATHOL-MOL PA, V52, P307; Benteyn D, 2014, METHODS MOL BIOL, V1139, P3, DOI 10.1007/978-1-4939-0345-0_1; Boudreau JE, 2011, MOL THER, V19, P841, DOI 10.1038/mt.2011.57; Butterfield LH, 2008, J IMMUNOTHER, V31, P294, DOI 10.1097/CJI.0b013e31816a8910; Carreno BM, 2013, J CLIN INVEST, V123, P3383, DOI 10.1172/JCI68395; Chia WK, 2012, ANN ONCOL, V23, P997, DOI 10.1093/annonc/mdr341; Chiappori AA, 2010, EXPERT OPIN BIOL TH, V10, P983, DOI 10.1517/14712598.2010.484801; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fujiwara S, 2012, J IMMUNOTHER, V35, P513, DOI 10.1097/CJI.0b013e3182619cb4; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Gottschalk S, 2003, BLOOD, V101, P1905, DOI 10.1182/blood-2002-05-1514; Gupta S, 2011, J LEUKOCYTE BIOL, V90, P389, DOI 10.1189/jlb.0211068; Gupta S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-39; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lesterhuis WJ, 2011, CLIN CANCER RES, V17, P5725, DOI 10.1158/1078-0432.CCR-11-1261; Luftig M, 2003, P NATL ACAD SCI USA, V100, P15595, DOI 10.1073/pnas.2136756100; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Maurais E, 2009, VIROLOGY, V385, P227, DOI 10.1016/j.virol.2008.11.033; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Morelli AE, 2003, TRENDS IMMUNOL, V24, P108, DOI 10.1016/S1471-4906(03)00023-1; Murphy G, 1996, PROSTATE, V29, P371; Nair S, 2003, J IMMUNOL, V171, P6275, DOI 10.4049/jimmunol.171.11.6275; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 2003, CURRENT PROTOCOLS IM, p[20, 1]; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Van Brussel I, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/690643; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Williams BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046981; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031	45	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184915	10.1371/journal.pone.0184915	http://dx.doi.org/10.1371/journal.pone.0184915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910387	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200120
J	Vasek, J; Cepkova, PH; Viehmannova, I; Ocelak, M; Huansi, DC; Vejl, P				Vasek, Jakub; Cepkova, Petra Hlasna; Viehmannova, Iva; Ocelak, Martin; Cachique Huansi, Danter; Vejl, Pavel			Dealing with AFLP genotyping errors to reveal genetic structure in Plukenetia volubilis (Euphorbiaceae) in the Peruvian Amazon	PLOS ONE			English	Article							POPULATION-STRUCTURE; INFERENCE; HOMOPLASY; SOFTWARE; MARKERS; IMPACT; PARAMETERS; DIVERSITY; EVOLUTION; SELECTION	An analysis of the population structure and genetic diversity for any organism often depends on one or more molecular marker techniques. Nonetheless, these techniques are not absolutely reliable because of various sources of errors arising during the genotyping process. Thus, a complex analysis of genotyping error was carried out with the AFLP method in 169 samples of the oil seed plant Plukenetia volubilis L. from small isolated subpopulations in the Peruvian Amazon. Samples were collected in nine localities from the region of San Martin. Analysis was done in eight datasets with a genotyping error from 0 to 5%. Using eleven primer combinations, 102 to 275 markers were obtained according to the dataset. It was found that it is only possible to obtain the most reliable and robust results through a multiplelevel filtering process. Genotyping error and software set up influence both the estimation of population structure and genetic diversity, where in our case population number (K) varied between 2-9 depending on the dataset and statistical method used. Surprisingly, discrepancies in K number were caused more by statistical approaches than by genotyping errors themselves. However, for estimation of genetic diversity, the degree of genotyping error was critical because descriptive parameters (He, F-ST, PLP 5%) varied substantially (by at least 25%). Due to low gene flow, P. volubilis mostly consists of small isolated subpopulations (Phi(PT) = 0.252-0.323) with some degree of admixture given by socio-economic connectivity among the sites; a direct link between the genetic and geographic distances was not confirmed. The study illustrates the successful application of AFLP to infer genetic structure in non-model plants.	[Vasek, Jakub; Vejl, Pavel] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Genet & Breeding, Prague, Czech Republic; [Cepkova, Petra Hlasna] Crop Res Inst, Div Crop Genet & Breeding, Gene Bank, Prague, Czech Republic; [Viehmannova, Iva; Ocelak, Martin] Czech Univ Life Sci Prague, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Prague, Czech Republic; [Cachique Huansi, Danter] Peruvian Amazon Res Inst, Tarapoto, Peru	Czech University of Life Sciences Prague; Czech Crop Research Institute (CRI); Czech University of Life Sciences Prague	Cepkova, PH (corresponding author), Crop Res Inst, Div Crop Genet & Breeding, Gene Bank, Prague, Czech Republic.	hlasna@vurv.cz	Vasek, Jakub/ABA-2890-2021; Hlasna, Petra/GQP-8050-2022; Vejl, Pavel/ABA-2874-2021; Viehmannova, Iva/G-2633-2019	Viehmannova, Iva/0000-0002-2540-7443	Internal Grant Agency of the University of Life Science Prague CIGA Project [20144207]; Internal Grant Agency of Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague IGA Project [20165014]; Talent Foundation of Josef, Marie and Zdenka Hlavkovych; CULS Prague; UNU in Pucallpa; Ministry of Agriculture of the Czech Republic [R00415]	Internal Grant Agency of the University of Life Science Prague CIGA Project; Internal Grant Agency of Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague IGA Project; Talent Foundation of Josef, Marie and Zdenka Hlavkovych; CULS Prague; UNU in Pucallpa; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This research was supported financially by an Internal Grant Agency of the University of Life Science Prague CIGA Project No. 20144207, by the Internal Grant Agency of Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague IGA Project No. 20165014, by The Talent Foundation of Josef, Marie and Zdenka Hlavkovych and Scholarship ("Nadani Josefa, Marie a Zdenky Hlavkovych") provided on base of Bilateral Agreement between CULS Prague and UNU in Pucallpa and by the Ministry of Agriculture of the Czech Republic (no. R00415). We would like to thank Lucas Garcia Chujutalli for his cooperation in samples collection and Dr. Martina Melounova for help with scientific English terms and vocabulary.	Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Arthofer W, 2010, MOL ECOL RESOUR, V10, P385, DOI 10.1111/j.1755-0998.2009.02751.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brack A., 1999, DICCIONARIO ENCICLO; Bussmann RW, 2013, ECON BOT, V67, P387, DOI 10.1007/s12231-013-9247-2; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Caballero A, 2010, MOL BIOL EVOL, V27, P1139, DOI 10.1093/molbev/msq001; Chirinos R, 2013, FOOD CHEM, V141, P1732, DOI 10.1016/j.foodchem.2013.04.078; Chybicki IJ, 2011, HEREDITY, V107, P589, DOI 10.1038/hdy.2011.51; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fanali C, 2011, J AGR FOOD CHEM, V59, P13043, DOI 10.1021/jf203184y; GILLESPIE LJ, 1993, SYST BOT, V18, P575, DOI 10.2307/2419535; Greene SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105145; Guillen MD, 2003, J AM OIL CHEM SOC, V80, P755, DOI 10.1007/s11746-003-0768-z; Gupta S, 2013, MOL BIOTECHNOL, V53, P237, DOI 10.1007/s12033-012-9517-8; Gutierrez LF, 2011, GRASAS ACEITES, V62, P76, DOI 10.3989/gya044510; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; HAMAKER BR, 1992, CEREAL CHEM, V69, P461; Hasbun R, 2012, TREE GENET GENOMES, V8, P925, DOI 10.1007/s11295-011-0463-6; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; Herrmann M, 2013, MOL ECOL RESOUR, V13, P128, DOI 10.1111/1755-0998.12033; Holland BR, 2008, SYST BIOL, V57, P347, DOI 10.1080/10635150802044037; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Keneni G, 2012, PLANT MOL BIOL REP, V30, P654, DOI 10.1007/s11105-011-0374-6; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lambert SM, 2013, MOL ECOL, V22, P3981, DOI 10.1111/mec.12292; Ley AC, 2013, MOL ECOL, V22, P1984, DOI 10.1111/mec.12214; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maurer NE, 2012, FOOD CHEM, V134, P1173, DOI 10.1016/j.foodchem.2012.02.143; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Melito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079043; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Osorio LRM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-77; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Paris M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-287; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Porcher E, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0668-2; Price DL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-268; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2015, LANG ENV STAT COMP; Reisch C, 2014, PLANT ECOL, V215, P1493, DOI 10.1007/s11258-014-0409-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Stout AB, 1933, AGR EXPT STA B, V257; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Zhang H, 2012, HEREDITY, V108, P616, DOI 10.1038/hdy.2011.132; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	65	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184259	10.1371/journal.pone.0184259	http://dx.doi.org/10.1371/journal.pone.0184259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910307	Green Published, gold, Green Submitted			2022-12-26	WOS:000410859200035
J	Claassens, NJ; Siliakus, MF; Spaans, SK; Creutzburg, SCA; Nijsse, B; Schaap, PJ; Quax, TEF; van der Oost, J				Claassens, Nico J.; Siliakus, Melvin F.; Spaans, Sebastiaan K.; Creutzburg, Sjoerd C. A.; Nijsse, Bart; Schaap, Peter J.; Quax, Tessa E. F.; van der Oost, John			Improving heterologous membrane protein production in Escherichia coli by combining transcriptional tuning and codon usage algorithms	PLOS ONE			English	Article							GENE-EXPRESSION; GFP-FUSIONS; OVEREXPRESSION; OPTIMIZATION; GENOME; BIAS; SUBSTITUTIONS; PURIFICATION; TRANSLATION; LEMO21(DE3)	High-level, recombinant production of membrane-integrated proteins in Escherichia coli is extremely relevant for many purposes, but has also been proven challenging. Here we study a combination of transcriptional fine-tuning in E. coli LEMO21(DE3) with different codon usage algorithms for heterologous production of membrane proteins. The overexpression of 6 different membrane proteins is compared for the wild-type gene codon usage variant, a commercially codon-optimized variant, and a codon-harmonized variant. We show that transcriptional fine-tuning plays a major role in improving the production of all tested proteins. Moreover, different codon usage variants significantly improved production of some of the tested proteins. However, not a single algorithm performed consistently best for the membrane-integrated production of the 6 tested proteins. In conclusion, for improving heterologous membrane protein production in E. coli, the major effect is accomplished by transcriptional tuning. In addition, further improvements may be realized by attempting different codon usage variants, such as codon harmonized variants, which can now be easily generated through our online Codon Harmonizer tool.	[Claassens, Nico J.; Siliakus, Melvin F.; Spaans, Sebastiaan K.; Creutzburg, Sjoerd C. A.; van der Oost, John] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Nijsse, Bart; Schaap, Peter J.] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Quax, Tessa E. F.] Albert Ludwigs Univ Freiburg, Inst Biol 2, Freiburg, Germany; [Siliakus, Melvin F.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, T Horntje Texel, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Freiburg; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Claassens, NJ (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.	nicoclaassens@gmail.com	van+der+Oost, John/Y-2548-2019; Quax, Tessa E.F./AAE-9830-2019	Quax, Tessa E.F./0000-0001-5516-5871; Schaap, Peter/0000-0002-4346-6084	SIAM Gravitation Grant [KW-17-003.02-024, 024.002.002]	SIAM Gravitation Grant	This work was supported by http://www.be-basic.orgi; www.wur.nl (KW-17-003.02-024) and SIAM Gravitation Grant (Netherlands Organization for Scientific Research) to Willem M. de Vos (Project reference: 024.002.002).	Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Bratanov D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128390; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Caforio A, 2015, BIOCHEM J, V470, P343, DOI 10.1042/BJ20150626; Claassens NJ, 2013, TRENDS BIOTECHNOL, V31, P633, DOI 10.1016/j.tibtech.2013.08.006; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Gould Nathan, 2014, Front Bioeng Biotechnol, V2, P41, DOI 10.3389/fbioe.2014.00041; Gustafsson C, 2012, PROTEIN EXPRES PURIF, V83, P37, DOI 10.1016/j.pep.2012.02.013; Hjelm A, 2013, METHODS MOL BIOL, V1033, P381, DOI 10.1007/978-1-62703-487-6_24; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Jain S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00641; Keniya MV, 2014, MOL PHARMACEUT, V11, P3452, DOI 10.1021/mp500230b; Lee KA, 2011, J NANOSCI NANOTECHNO, V11, P4261, DOI 10.1166/jnn.2011.3669; Lundstrom K, 2007, J CELL MOL MED, V11, P224, DOI 10.1111/j.1582-4934.2007.00028.x; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Marino J, 2015, J MOL BIOL, V427, P943, DOI 10.1016/j.jmb.2014.11.002; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mirzadeh K, 2015, ACS SYNTH BIOL, V4, P959, DOI 10.1021/acssynbio.5b00033; Norholm MHH, 2013, FEBS LETT, V587, P2352, DOI 10.1016/j.febslet.2013.05.063; Norholm MHH, 2012, BBA-BIOMEMBRANES, V1818, P1091, DOI 10.1016/j.bbamem.2011.08.018; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Sarduy ES, 2012, PROTEIN EXPRES PURIF, V83, P59, DOI 10.1016/j.pep.2012.03.008; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Schlegel S, 2015, CELL REP, V10, P1758, DOI 10.1016/j.celrep.2015.02.029; Schlegel S, 2014, BBA-MOL CELL RES, V1843, P1739, DOI 10.1016/j.bbamcr.2013.10.023; Schlegel S, 2012, J MOL BIOL, V423, P648, DOI 10.1016/j.jmb.2012.07.019; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Van Zyl LJ, 2014, APPL MICROBIOL BIOT, V98, P1247, DOI 10.1007/s00253-013-5380-1; Vuoristo KS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00849; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	48	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184355	10.1371/journal.pone.0184355	http://dx.doi.org/10.1371/journal.pone.0184355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902855	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200032
J	Mercader, MA; He, DC; Sharma, AC; Marchitto, MC; Trachiotis, G; Bornzin, GA; Jonas, R; Moak, JP				Mercader, Marco A.; He, Dingchao; Sharma, Aditya C.; Marchitto, Mark C.; Trachiotis, Gregory; Bornzin, Gene A.; Jonas, Richard; Moak, Jeffrey P.			Selective autonomic stimulation of the AV node fat pad to control rapid post-operative atrial arrhythmias	PLOS ONE			English	Article							JUNCTIONAL ECTOPIC TACHYCARDIA; VENTRICULAR RATE CONTROL; VAGAL-STIMULATION; NERVE-STIMULATION; FIBRILLATION; HEART; MODEL; DOGS	Junctional ectopic tachycardia (JET) and atrial fibrillation (AF) occur in patients recovering from open-heart surgery (OHS). Pharmacologic treatment is used for the control of postoperative atrial arrhythmias (POAA), but is associated with side effects. There is a need for a reversible, modulated solution to rate control. We propose a non-pharmacologic technique that can modulate AV nodal conduction in a selective fashion. Ten mongrel dogs underwent OHS. Stimulation of the anterior right (AR) and inferior right (IR) fat pad (FP) was done using a 7-pole electrode. The IR was more effective in slowing the ventricular rate (VR) to AF (52 +/- 20 vs. 15 +/- 10%, p = 0.003) and JET (12 +/- 7 vs. 0 +/- 0%, p = 0.02). Selective site stimulation within a FP region could augment the effect of stimulation during AF (57 +/- 20% (maximum effect) vs. 0 +/- 0% (minimum effect), p<0.001). FP stimulation at increasing stimulation voltage (SV) demonstrated a voltage-dependent effect (8 +/- 14% (low V) vs. 63 +/- 17 (high V) %, p<0.001). In summary, AV node fat pad stimulation had a selective effect on the AV node by decreasing AV nodal conduction, with little effect on atrial activity.	[Mercader, Marco A.; Sharma, Aditya C.] George Washington Univ, Dept Med, Div Cardiol, Washington, DC 20052 USA; [He, Dingchao; Jonas, Richard] Childrens Natl Hlth Syst, Div Cardiac Surg, Dept Surg, Washington, DC USA; [Marchitto, Mark C.] George Washington Univ, Sch Med, Washington, DC USA; [Trachiotis, Gregory] George Washington Univ, Dept Surg, Div Cardiothorac Surg, Washington, DC USA; [Bornzin, Gene A.] St Jude Med, IESD, Sylmar, CA USA; [Moak, Jeffrey P.] Childrens Natl Hlth Syst, Div Cardiol, Dept Pediat, Washington, DC USA	George Washington University; Children's National Health System; George Washington University; George Washington University; Children's National Health System	Mercader, MA (corresponding author), George Washington Univ, Dept Med, Div Cardiol, Washington, DC 20052 USA.	mmercader@mfa.gwu.edu			Heart and Vascular Institute of The George Washington University; Children's Hospital Health System; St. Jude Medical	Heart and Vascular Institute of The George Washington University; Children's Hospital Health System; St. Jude Medical(St. Jude Medical)	Heart and Vascular Institute of The George Washington University provided us with a grant to pay for the cost of all ten experiments. Children's Hospital Health System also provided us with a grant to purchase equipment used in this experiments. St. Jude Medical (Gene Bornzin) provided us with the fat pad stimulation electrode prototype. St. Jude Medical did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials (fat pad stimulation electrode prototype).	Chinda K, 2016, HEART RHYTHM, V13, P771, DOI 10.1016/j.hrthm.2015.11.031; Dodge-Khatami A, 2002, EUR J CARDIO-THORAC, V21, P255, DOI 10.1016/S1010-7940(01)01089-2; FATKIN D, 1994, J AM COLL CARDIOL, V23, P307, DOI 10.1016/0735-1097(94)90412-X; Gillinov AM, 2016, NEW ENGL J MED, V374, P1911, DOI 10.1056/NEJMoa1602002; Grosse-Wortmann L, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-85; He DC, 2015, PEDIATR CARDIOL, V36, P1179, DOI 10.1007/s00246-015-1141-5; Lewis ME, 2001, J PHYSIOL-LONDON, V534, P547, DOI 10.1111/j.1469-7793.2001.00547.x; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Moak JP, 2013, PACE, V36, P1156, DOI 10.1111/pace.12163; Moak JP, 2013, CIRC-ARRHYTHMIA ELEC, V6, P641, DOI 10.1161/CIRCEP.113.000090; Moak JP, 2013, J THORAC CARDIOV SUR, V146, P212, DOI 10.1016/j.jtcvs.2012.08.068; Rossi P, 2009, J INTERV CARD ELECTR, V24, P37, DOI 10.1007/s10840-008-9286-2; Saul JP, 2005, CIRCULATION, V112, P3470, DOI 10.1161/CIRCULATIONAHA.105.534149; Schauerte P, 2000, J CARDIOVASC ELECTR, V11, P64, DOI 10.1111/j.1540-8167.2000.tb00738.x; Wallick DW, 2001, AM J PHYSIOL-HEART C, V281, pH1490, DOI 10.1152/ajpheart.2001.281.4.H1490; Zhang YH, 2005, CIRCULATION, V112, P2904, DOI 10.1161/CIRCULATIONAHA.105.568832; Zhang YH, 2004, HEART RHYTHM, V1, P469, DOI 10.1016/j.hrthm.2004.06.011; Zhuang SW, 2002, CIRCULATION, V106, P1853, DOI 10.1161/01.CIR.0000031802.58532.04	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183804	10.1371/journal.pone.0183804	http://dx.doi.org/10.1371/journal.pone.0183804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902899	Green Published, gold, Green Submitted			2022-12-26	WOS:000410669200018
J	Yoo, JY; Yang, WS; Lee, JH; Kim, BG; Broaddus, RR; Lim, JM; Kim, TH; Jeong, JW				Yoo, J-Y; Yang, W. S.; Lee, J. H.; Kim, B. G.; Broaddus, R. R.; Lim, J. M.; Kim, T. H.; Jeong, J-W			MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells	ONCOGENE			English	Article							PROGESTERONE-RECEPTOR; ENDOMETRIAL CANCER; CONSERVATIVE TREATMENT; SIGNAL TRANSDUCER; ACTIVATION; EXPRESSION; PROLIFERATION; HYPERPLASIA; LACTOFERRIN; INHIBITOR	Endometrial cancer is the most common malignancy of the female genital tract. Progesterone (P4) has been used for several decades in endometrial cancer treatment, especially in women who wish to retain fertility. However, it is unpredictable which patients will respond to P4 treatment and which may have a P4-resistant cancer. Therefore, identifying the mechanism of P4 resistance is essential to improve the therapies for endometrial cancer. Mitogen-inducible gene 6 (Mig-6) is a critical mediator of progesterone receptor (PGR) action in the uterus. In order to study the function of Mig-6 in P4 resistance, we generated a mouse model in which we specifically ablated Mig-6 in uterine epithelial cells using Sprr2f-cre mice (Sprr2f(cre+) Mig-6(f/f)). Female mutant mice develop endometrial hyperplasia due to aberrant phosphorylation of signal transducers and activators of transcription 3 (STAT3) and proliferation of the endometrial epithelial cells. The results from our immunoprecipitation and cell culture experiments showed that MIG-6 inhibited phosphorylation of STAT3 via protein interactions. Our previous study showed P4 resistance in mice with Mig-6 ablation in Pgr-positive cells (Pgr(cre/+) Mig-6(f/f)). However, Sprr2f(cre+) Mig-6(f/f) mice were P4-responsive. P4 treatment significantly decreased STAT3 phosphorylation and epithelial proliferation in the uterus of mutant mice. We showed that Mig-6 has an important function of tumor suppressor via inhibition of STAT3 phosphorylation in uterine epithelial cells, and the antitumor effects of P4 are mediated by the endometrial stroma. These data help to develop a new signaling pathway in the regulation of steroid hormones in the uterus, and to overcome P4 resistance in human reproductive diseases, such as endometrial cancer.	[Yoo, J-Y; Yang, W. S.; Lee, J. H.; Kim, B. G.; Kim, T. H.; Jeong, J-W] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA; [Yoo, J-Y] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Yang, W. S.; Lim, J. M.] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Broaddus, R. R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lim, J. M.] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Jeong, J-W] Spectrum Hlth Syst, Dept Womens Hlth, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine; Yonsei University; Yonsei University Health System; Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center; Seoul National University (SNU)	Kim, TH; Jeong, JW (corresponding author), Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	TaeHoon.Kim@hc.msu.edu; JaeWook.Jeong@hc.msu.edu		Yoo, Jung-Yoon/0000-0001-9366-3863	America Cancer Society [RSG-12-084-01-TBG]; National Institutes of Health (NIH) [HD084478]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016R1D1A1B03934346]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084478] Funding Source: NIH RePORTER	America Cancer Society; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank Dr Diego H Castrillon (University of Texas Southwestern Medical Center, Dallas, TX, USA) for Sprr2f-cre mice. We would also like to thank Hanna E Teasley and Paige Wells for manuscript preparation. This work was supported by America Cancer Society, RSG-12-084-01-TBG and National Institutes of Health (NIH, HD084478) to JWJ and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2016R1D1A1B03934346) to JYY.	Ambros RA, 2000, INT J GYNECOL PATHOL, V19, P206, DOI 10.1097/00004347-200007000-00002; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Bovicelli A, 2013, J CELL PHYSIOL, V228, P1154, DOI 10.1002/jcp.24292; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; Daikoku T, 2014, ENDOCRINOLOGY, V155, P2718, DOI 10.1210/en.2014-1265; Decruze SB, 2007, INT J GYNECOL CANCER, V17, P964, DOI 10.1111/j.1525-1438.2007.00897.x; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Furtek SL, 2016, ACS CHEM BIOL, V11, P308, DOI 10.1021/acschembio.5b00945; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Hahn HS, 2009, INT J GYNECOL CANCER, V19, P1068, DOI 10.1111/IGC.0b013e3181aae1fb; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Kaunitz AM, 1998, INT J FERTIL WOMEN M, V43, P73; Kim BG, 2015, HUM REPROD, V30, P1069, DOI 10.1093/humrep/dev050; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Kim TH, 2013, CANCER RES, V73, P5090, DOI 10.1158/0008-5472.CAN-13-0241; Kurita T, 2000, BIOL REPROD, V62, P831, DOI 10.1095/biolreprod62.4.831; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Li L, 2002, J BIOL CHEM, V277, P17397, DOI 10.1074/jbc.M109962200; Lin CI, 2011, J CLIN ENDOCR METAB, V96, pE554, DOI 10.1210/jc.2010-1800; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; van Laar T, 2001, MOL CARCINOGEN, V31, P63, DOI 10.1002/mc.1040; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928	48	6	7	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 11	2018	37	2					255	262		10.1038/onc.2017.335	http://dx.doi.org/10.1038/onc.2017.335			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS8AN	28925396	Green Submitted, Green Accepted			2022-12-26	WOS:000422631700011
J	Sieber, J; Wieder, N; Ostrosky-Frid, M; Dvela-Levitt, M; Aygun, O; Udeshi, ND; Carr, SA; Greka, A				Sieber, Jonas; Wieder, Nicolas; Ostrosky-Frid, Mauricio; Dvela-Levitt, Moran; Aygun, Ozan; Udeshi, Namrata D.; Carr, Steven A.; Greka, Anna			Lysine trimethylation regulates 78-kDa glucose-regulated protein proteostasis during endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; endoplasmic reticulum stress (ER stress); GRP78; protein degradation; proteomics; unfolded protein response (UPR); BIP; HSPA5; METTL21A; lysine trimethylation	PODOCYTES; PHOSPHORYLATION; METHYLATION; ENRICHMENT; CHAPERONE; BIP	The up-regulation of chaperones such as the 78-kDa glucose-regulated protein (GRP78, also referred to as BiP or HSPA5) is part of the adaptive cellular response to endoplasmic reticulum (ER) stress. GRP78 is widely used as a marker of the unfolded protein response, associated with sustained ER stress. Here we report the discovery of a proteostatic mechanism involving GRP78 trimethylation in the context of ER stress. Using mass spectrometry-based proteomics, we identified two GRP78 fractions, one homeostatic and one induced by ER stress. ER stress leads to de novo biosynthesis of non-trimethylated GRP78, whereas homeostatic, METTL21A-dependent lysine 585-trimethylated GRP78 is reduced. This proteostatic mechanism, dependent on the posttranslational modification of GRP78, allows cells to differentially regulate specific protein abundance during cellular stress.	[Sieber, Jonas; Wieder, Nicolas; Dvela-Levitt, Moran; Greka, Anna] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sieber, Jonas; Wieder, Nicolas; Dvela-Levitt, Moran; Aygun, Ozan; Udeshi, Namrata D.; Carr, Steven A.; Greka, Anna] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ostrosky-Frid, Mauricio] Univ Nacl Autonoma Mexico, Plan Combined Studies Med PECEM, Fac Med, Mexico City 04510, DF, Mexico	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidad Nacional Autonoma de Mexico	Greka, A (corresponding author), Harvard Med Sch, Harvard Inst Med, Brigham & Womens Hosp, 4 Blackfan Circle, Boston, MA USA.	agreka@bwh.harvard.edu	Carr, Steven A./AAH-8366-2019; Ostrosky-Frid, Mauricio/U-5227-2017	Sieber, Jonas/0000-0002-4325-4444; Ostrosky-Frid, Mauricio/0000-0002-0672-1074; Wieder, Nicolas/0000-0001-5683-2891	Swiss National Science Foundation [PBBSP3-144160, P300P3-151739]; Deutsche Forschungsgesellschaft [WI 4612/1-1]; Broad-ISF postdoctoral fellowship; National Institutes of Health [DK099465, DK095045]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Broad-ISF postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by Swiss National Science Foundation Fellowships PBBSP3-144160 and P300P3-151739.; Supported by Deutsche Forschungsgesellschaft Fellowship WI 4612/1-1.; Supported by a Broad-ISF postdoctoral fellowship.; Supported by National Institutes of Health Grants DK099465 and DK095045. To whom correspondence should be addressed: Brigham and Women's Hospital, Harvard Medical School, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA02115. Tel.:617-525-5939; Fax:617-525-5965; E-mail: agreka@bwh.harvard.edu or agreka@broadinstitute.org.	Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Buvall L, 2017, J AM SOC NEPHROL, V28, P837, DOI 10.1681/ASN.2016040414; Buvall L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3863; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sieber J, 2013, AM J PATHOL, V183, P735, DOI 10.1016/j.ajpath.2013.05.023; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1	26	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18878	18885		10.1074/jbc.M117.797084	http://dx.doi.org/10.1074/jbc.M117.797084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28912266	hybrid, Green Published			2022-12-26	WOS:000415848000013
J	Boopathy, GTK; Kulkarni, M; Ho, SY; Boey, A; Chua, EWM; Barathi, VA; Carney, TJ; Wang, XM; Hong, WJ				Boopathy, Gandhi T. K.; Kulkarni, Madhura; Ho, Sze Yuan; Boey, Adrian; Chua, Edmond Wei Min; Barathi, Veluchamy A.; Carney, Tom J.; Wang, Xiaomeng; Hong, Wanjin			Cavin-2 regulates the activity and stability of endothelial nitric-oxide synthase (eNOS) in angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-INDUCED RETINOPATHY; PATHOLOGICAL ANGIOGENESIS; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; IN-VIVO; CAVEOLAE; MICROPARTICLES; MEMBRANE; CELLS; ACTIVATION	Angiogenesis is a highly regulated process for formation of new blood vessels from pre-existing ones. Angiogenesis is dysregulated in various pathologies, including age-related macular degeneration, arthritis, and cancer. Inhibiting pathological angiogenesis therefore represents a promising therapeutic strategy for treating these disorders, highlighting the need to study angiogenesis in more detail. To this end, identifying the genes essential for blood vessel formation and elucidating their function are crucial for a complete understanding of angiogenesis. Here, focusing on potential candidate genes for angiogenesis, we performed a morpholino-based genetic screen in zebrafish and identified Cavin-2, a membrane-bound phosphatidylserine-binding protein and critical organizer of caveolae (small microdomains in the plasma membrane), as a regulator of angiogenesis. Using endothelial cells, we show that Cavin-2 is required for in vitro angiogenesis and also for endothelial cell proliferation, migration, and invasion. We noted a high level of Cavin-2 expression in the neovascular tufts in the mouse model of oxygen-induced retinopathy, suggesting a role for Cavin-2 in pathogenic angiogenesis. Interestingly, we also found that Cavin-2 regulates the production of nitric oxide (NO) in endothelial cells by controlling the stability and activity of the endothelial nitric-oxide synthase (eNOS) and that Cavin-2 knockdown cells produce much less NO than WT cells. Also, mass spectrometry, flow cytometry, and electron microscopy analyses indicated that Cavin-2 is secreted in endothelial microparticles (EMPs) and is required for EMP biogenesis. Taken together, our results indicate that in addition to its function in caveolae biogenesis, Cavin-2 plays a critical role in endothelial cell maintenance and function by regulating eNOS activity.	[Boopathy, Gandhi T. K.; Boey, Adrian; Chua, Edmond Wei Min; Carney, Tom J.; Wang, Xiaomeng; Hong, Wanjin] ASTAR, IMCB, 61 Biopolis Dr, Singapore 138673, Singapore; [Kulkarni, Madhura; Ho, Sze Yuan; Carney, Tom J.; Wang, Xiaomeng] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Barathi, Veluchamy A.; Wang, Xiaomeng] SERI, 20 Coll Rd, Singapore 169856, Singapore; [Barathi, Veluchamy A.] Duke NUS Grad Med Sch, Ophthalmol & Visual Sci Acad Clin Program, 8 Coll Rd, Singapore 169857, Singapore; [Barathi, Veluchamy A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Boopathy, Gandhi T. K.; Barathi, Veluchamy A.; Carney, Tom J.; Wang, Xiaomeng; Hong, Wanjin] SERI IMCB, SERI IMCB Programme Retinal Angiogen Dis SIPRAD, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Boopathy, GTK; Hong, WJ (corresponding author), ASTAR, IMCB, 61 Biopolis Dr, Singapore 138673, Singapore.	gandhibtk@imcb.a-star.edu.sg; mcbhwj@imcb.a-star.edu.sg	Wang, Xiaomeng/F-9504-2015; Carney, Tom J/H-4389-2011; Boey, Adrian/AAC-4239-2022; Carney, Tom James/ACF-9214-2022	Carney, Tom J/0000-0003-2371-1924; Carney, Tom James/0000-0003-2371-1924; T. K. Boopathy, Gandhi/0000-0002-1821-9540; Wang, Xiaomeng/0000-0002-1036-2764; Boey, Adrian/0000-0003-2835-6159	Agency for Science, Technology and Research (A*STAR); SERI-IMCB Programme in Retinal Angiogenic Diseases (SIPRAD)	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); SERI-IMCB Programme in Retinal Angiogenic Diseases (SIPRAD)	This work was supported by Agency for Science, Technology and Research (A*STAR) funds (to W. H.) and the SERI-IMCB Programme in Retinal Angiogenic Diseases (SIPRAD). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baguley B., 2001, ANTICANCER DRUG DEV; Banz Y, 2008, BRIT J HAEMATOL, V142, P627, DOI 10.1111/j.1365-2141.2008.07230.x; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Brown LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013905; BURGENER R, 1990, BIOCHEM J, V269, P729, DOI 10.1042/bj2690729; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; COHEN RA, 1995, PROG CARDIOVASC DIS, V38, P105, DOI 10.1016/S0033-0620(05)80002-7; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Curtis AM, 2013, VASC MED, V18, P204, DOI 10.1177/1358863X13499773; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; FLAVAHAN NA, 1992, CIRCULATION, V85, P1927, DOI 10.1161/01.CIR.85.5.1927; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mineo C, 2012, ADV EXP MED BIOL, V729, P51, DOI 10.1007/978-1-4614-1222-9_4; Miyoshi H, 1996, GASTROENTEROLOGY, V110, P1897, DOI 10.1053/gast.1996.v110.pm8964416; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Razani B, 2001, J BIOL CHEM, V276, P38121; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	64	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17760	17776		10.1074/jbc.M117.794743	http://dx.doi.org/10.1074/jbc.M117.794743			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28912276	hybrid, Green Published			2022-12-26	WOS:000414013000015
J	Sathiyamoorthy, K; Vijayalakshmi, J; Tirupati, B; Fan, LX; Saper, MA				Sathiyamoorthy, Karthik; Vijayalakshmi, J.; Tirupati, Bhramara; Fan, Lixin; Saper, Mark A.			Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL-MODE ANALYSIS; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; WALL SYNTHESIS; PROTEINS; DYNAMICS; SCATTERING; STIMULATE; MOTIONS; FITNESS	In many Gram-negative bacteria, the peptidoglycan synthase PBP1A requires the outer membrane lipoprotein LpoA for constructing a functional peptidoglycan required for bacterial viability. Previously, we have shown that the C-terminal domain of Haemophilus influenzae LpoA (HiLpoA) has a highly conserved, putative substrate-binding cleft between two alpha/beta lobes. Here, we report a 2.0 angstrom resolution crystal structure of the HiLpoA N-terminal domain. Two subdomains contain tetratricopeptide-like motifs that form a concave groove, but their relative orientation differs by similar to 45 degrees from that observed in an NMR structure of the Escherichia coli LpoA N domain. We also determined three 2.0-2.8 angstrom resolution crystal structures containing four independent full-length HiLpoA molecules. In contrast to an elongated model previously suggested for E. coli LpoA, each HiLpoA formed a U-shaped structure with a different C-domain orientation. This resulted from both N-domain twisting and rotation of the C domain (up to 30 degrees) at the end of the relatively immobile interdomain linker. Moreover, a previously predicted hinge between the lobes of the LpoA C domain exhibited variations of up to 12 degrees. Small-angle X-ray scattering data revealed excellent agreement with a model calculated by normal mode analysis from one of the full-length HiLpoA molecules but even better agreement with an ensemble of this molecule and two of the partially extended normal mode analysis-predicted models. The different LpoA structures helped explain how an outer membrane-anchored LpoA can either withdraw from or extend toward the inner membrane-bound PBP1A through peptidoglycan gaps and hence regulate the synthesis of peptidoglycan necessary for bacterial viability.	[Sathiyamoorthy, Karthik; Vijayalakshmi, J.; Tirupati, Bhramara; Saper, Mark A.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Saper, Mark A.] Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA; [Fan, Lixin] Leidos Biomed Res Inc, Small Angle Xray Scattering Core Facil, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Sathiyamoorthy, Karthik] Stanford Univ, Dept Struct Biol, Palo Alto, CA 94305 USA; [Tirupati, Bhramara] Adv Bion, Valencia, CA 91355 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Saper, MA (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	saper@umich.edu	Sathiyamoorthy, Karthik/K-6190-2015	Sathiyamoorthy, Karthik/0000-0002-5736-8709	DOE Office of Science [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; E. I. DuPont de Nemours Co.; Dow Chemical Company; State of Illinois; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099984] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; E. I. DuPont de Nemours Co.; Dow Chemical Company; State of Illinois; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Brian Akerley for support from the beginning of this project and for reading the manuscript. We thank Mykola Murskyj for help with cloning and members of the Saper laboratory for advice. For the SAXS experiments, we acknowledge use of the SAXS Core facility of the Center for Cancer Research, NCI/National Institutes of Health, and thank Dr. Xiaobing Zuo for expert support. We thank the outstanding synchrotron support staff at LSCAT and DND-CAT. We also benefitted from discussions with Tobias Dorr, Matthew Larson, Kathleen Wisser, Erik R. P. Zuiderweg, and Charles Brooks III. We also thank Ilan Rosenshine and Susan Buchanan for hosting M. A. S. in their laboratories. We thank the software authors for writing and sharing the software necessary for this project. Jerry Brown provided expert editing. This research used resources of the Advanced Photon Source (APS), a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (ANL) under Contract DE-AC02-06CH11357. The SAXS beamline 12-ID-B at APS was allocated under the PUP-24152 agreement between NCI/National Institutes of Health and ANL. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The LpoA-N data were measured at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of APS. DND-CAT was supported by E. I. DuPont de Nemours & Co., The Dow Chemical Company, and the State of Illinois.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Azari F, 2013, J BACTERIOL, V195, P1680, DOI 10.1128/JB.02149-12; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Dorr T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004433; Dorr T, 2014, INFECT IMMUN, V82, P2115, DOI 10.1128/IAI.00012-14; Doruker P, 2002, J COMPUT CHEM, V23, P119, DOI 10.1002/jcc.1160; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Gray AN, 2015, ELIFE, V4, DOI 10.7554/eLife.07118; Han S, 2011, J AM CHEM SOC, V133, P20536, DOI 10.1021/ja208835z; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jean NL, 2014, STRUCTURE, V22, P1047, DOI 10.1016/j.str.2014.04.017; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King DT, 2014, J BIOL CHEM, V289, P19245, DOI 10.1074/jbc.M114.565879; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; Lee TK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13170; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Lupoli TJ, 2014, J AM CHEM SOC, V136, P52, DOI 10.1021/ja410813j; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Parashar V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001512; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tama F, 2003, PROTEIN PEPTIDE LETT, V10, P119, DOI 10.2174/0929866033479077; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Troshin PV, 2011, BIOINFORMATICS, V27, P2001, DOI 10.1093/bioinformatics/btr304; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Turner RD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2503; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vijayalakshmi J, 2008, PROTEINS, V73, P204, DOI 10.1002/prot.22033; Wong SM, 2013, P NATL ACAD SCI USA, V110, P15413, DOI 10.1073/pnas.1311217110; Wong SM, 2003, GENE, V316, P177, DOI 10.1016/S0378-1119(03)00762-5; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839; Zouhir S, 2013, NUCLEIC ACIDS RES, V41, P7920, DOI 10.1093/nar/gkt546	64	10	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17626	17642		10.1074/jbc.M117.804997	http://dx.doi.org/10.1074/jbc.M117.804997			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28887305	Green Published, hybrid			2022-12-26	WOS:000414013000006
J	Tsuboi, M; Taniuchi, K; Shimizu, T; Saito, M; Saibara, T				Tsuboi, Makiko; Taniuchi, Keisuke; Shimizu, Takahiro; Saito, Motoaki; Saibara, Toshiji			The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; ACTIN REORGANIZATION; DNA-BINDING; HOMEODOMAIN PROTEIN; EPITHELIAL-CELLS; BREAST-CANCER; GROWTH-FACTOR; K-RAS; METASTASIS; MIGRATION	HOX genes encode transcription factors that function as sequence-specific transcription factors that are involved in cellular proliferation, differentiation, and death. The aim of this study was to investigate the role of a HOX family protein, HOXB7, in the motility and invasiveness of pancreatic cancer cells. We previously identified a HOXB7 transcript that is one of a number of transcripts that are preferentially translated in membrane protrusions in pancreatic cancer cells. Immunocytochemistry showed that HOXB7 was localized to the cell protrusions of migrating pancreatic cancer cells. Knockdown of HOXB7 by transfection with HOXB7-specific siRNA decreased these protrusions and inhibited the motility and invasiveness of the cells. Transfection of a HOXB7-rescue construct into the HOXB7-knockdown cells restored peripheral actin structures in cell protrusions and abrogated the HOXB7 knockdown-induced decrease in cell protrusions. It is generally accepted that the Rho family of GTPases regulate the organization of actin filaments and contribute to the formation of cell protrusions. The levels of the active Rho GTPases were not influenced by HOXB7 in the cells; however, HOXB7 knockdown decreased the level of phosphorylated ERK1/2. This inactivation of ERK1/2 decreased cell protrusions, thereby inhibiting the invasiveness of pancreatic cancer cells. Further investigation showed that HOXB7/ERK1/2 signaling selectively stimulated JNK and HSP27 phosphorylation and thereby increased the motility and invasiveness of pancreatic cancer cells. These results suggested that HOXB7 stimulates ERK1/2 phosphorylation and provided evidence that HOXB7, besides its role in transcriptional regulation, also promotes cell motility and invasiveness.	[Tsuboi, Makiko; Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi 7838505, Japan; [Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Oko Cho, Nankoku, Kochi 7838505, Japan; [Shimizu, Takahiro; Saito, Motoaki] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi 7838505, Japan	Kochi University; Kochi University; Kochi University	Taniuchi, K (corresponding author), Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Oko Cho, Nankoku, Kochi 7838505, Japan.	ktaniuchi@kochi-u.ac.jp			 [24591013];  [15K14396]	; 	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) 24591013 and 15K14396. The authors declare that they have no conflicts of interest with the contents of this article.	Ahrendt SA, 2002, ONCOLOGY-NY, V16, P725; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Baumgart M, 2005, CELL ONCOL, V27, P3; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 2001, CANCER RES, V61, P6532; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chen HX, 2008, CANCER RES, V68, P3637, DOI 10.1158/0008-5472.CAN-07-2926; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; How C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067846; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Kaltschmidt JA, 2002, NAT CELL BIOL, V4, P937, DOI 10.1038/ncb882; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ridley AJ, 2001, J CELL SCI, V114, P2713; Robitaille H, 2010, J INVEST DERMATOL, V130, P74, DOI 10.1038/jid.2009.185; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Taniuchi K, 2014, NEOPLASIA, V16, P1082, DOI 10.1016/j.neo.2014.10.007; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Taniuchi K, 2012, NEOPLASIA, V14, P440, DOI 10.1593/neo.12352; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Uekita T, 2014, MOL CANCER RES, V12, P1449, DOI 10.1158/1541-7786.MCR-13-0587; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Yip-Schneider MT, 1999, INT J ONCOL, V15, P271; Yip-Schneider MT, 2003, PANCREAS, V27, P337, DOI 10.1097/00006676-200311000-00012; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-61	49	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17681	17702		10.1074/jbc.M116.772780	http://dx.doi.org/10.1074/jbc.M116.772780			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28912272	hybrid, Green Published			2022-12-26	WOS:000414013000010
J	Zimmermann, K; Eells, R; Heinrich, F; Rintoul, S; Josey, B; Shekhar, P; Losche, M; Stern, LJ				Zimmermann, Kerstin; Eells, Rebecca; Heinrich, Frank; Rintoul, Stefanie; Josey, Brian; Shekhar, Prabhanshu; Losche, Mathias; Stern, Lawrence J.			The cytosolic domain of T-cell receptor zeta associates with membranes in a dynamic equilibrium and deeply penetrates the bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCR-CD3 COMPLEX; TRANSMEMBRANE DIMER; LIPID MEMBRANES; CYTOPLASMIC DOMAIN; CRYSTAL-STRUCTURE; SUBUNIT CONTAINS; BINDING MOTIF; IN-VITRO; CHAIN; PHOSPHORYLATION	Interactions between lipid bilayers and the membrane-proximal regions of membrane-associated proteins play important roles in regulating membrane protein structure and function. The T-cell antigen receptor is an assembly of eight single-pass membrane-spanning subunits on the surface of T lymphocytes that initiates cytosolic signaling cascades upon binding antigens presented by MHC-family proteins on antigen-presenting cells. Its zeta-subunit contains multiple cytosolic immunoreceptor tyrosine-based activation motifs involved in signal transduction, and this subunit by itself is sufficient to couple extracellular stimuli to intracellular signaling events. Interactions of the cytosolic domain of zeta (zeta(cyt)) with acidic lipids have been implicated in the initiation and regulation of transmembrane signaling. zeta(cyt) is unstructured in solution. Interaction with acidic phospholipids induces structure, but its disposition when bound to lipid bilayers is controversial. Here, using surface plasmon resonance and neutron reflection, we characterized the interaction of zeta(cyt) with planar lipid bilayers containing mixtures of acidic and neutral lipids. We observed two binding modes of zeta(cyt) to the bilayers in dynamic equilibrium: one in which zeta(cyt) is peripherally associated with lipid headgroups and one in which it penetrates deeply into the bilayer. Such an equilibrium between the peripherally bound and embedded forms of zeta(cyt) apparently controls accessibility of the immunoreceptor tyrosine-based activation signal transduction pathway. Our results reconcile conflicting findings of the zeta structure reported in previous studies and provide a framework for understanding how lipid interactions regulate motifs to tyrosine kinases and may regulate the T-cell antigen receptor biological activities for this cell-surface receptor system.	[Zimmermann, Kerstin; Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA; [Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Eells, Rebecca; Heinrich, Frank; Rintoul, Stefanie; Josey, Brian; Shekhar, Prabhanshu; Losche, Mathias] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Losche, Mathias] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Heinrich, Frank; Losche, Mathias] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Rintoul, Stefanie] Harvard Sch Business, Boston, MA 02163 USA; [Shekhar, Prabhanshu] Intel Corp, Beaverton, OR 97007 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Carnegie Mellon University; Carnegie Mellon University; National Institute of Standards & Technology (NIST) - USA; Harvard University; Intel Corporation	Stern, LJ (corresponding author), Univ Massachusetts, Med Sch, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA.	Lawrence.Stern@umassmed.edu	Heinrich, Frank/A-5339-2010; Lösche, Mathias/J-2986-2013	Heinrich, Frank/0000-0002-8579-553X; Lösche, Mathias/0000-0001-6666-916X	 [S10RR027897]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI038996, R01AI038996, R37AI038996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101647] Funding Source: NIH RePORTER	; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael J. Eck (Harvard Medical School) for recombinant baculovirus and appreciate the help from Lara Strittmatter and Gregory M. Hendricks (University of Massachusetts Medical School, Electron Microscopy Facility, Project S10RR027897).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; ANKNER JF, 1992, P SOC PHOTO-OPT INS, V1738, P260, DOI 10.1117/12.130637; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; BenTal N, 1997, BIOPHYS J, V73, P1717, DOI 10.1016/S0006-3495(97)78203-1; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Bridgeman JS, 2014, CLIN EXP IMMUNOL, V175, P258, DOI 10.1111/cei.12216; Budvytyte R, 2013, LANGMUIR, V29, P8645, DOI 10.1021/la401132c; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; DeFord-Watts LM, 2009, J IMMUNOL, V183, P1055, DOI 10.4049/jimmunol.0900404; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Duchardt E, 2007, CHEMBIOCHEM, V8, P820, DOI 10.1002/cbic.200600413; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Elisabeth Gasteiger, 2005, PROTEIN IDENTIFICATI; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; Frigault MJ, 2016, INT IMMUNOL, V28, P355, DOI 10.1093/intimm/dxw018; Furlan G, 2014, J BIOL CHEM, V289, P28514, DOI 10.1074/jbc.M114.574319; Gagnon E, 2010, CELL, V142, P669, DOI 10.1016/j.cell.2010.08.019; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; Heinrich F, 2014, BBA-BIOMEMBRANES, V1838, P2341, DOI 10.1016/j.bbamem.2014.03.007; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirby BJ, 2012, CURR OPIN COLLOID IN, V17, P44, DOI 10.1016/j.cocis.2011.11.001; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kuhns MS, 2008, CELL, V135, P594, DOI 10.1016/j.cell.2008.10.033; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laczko I, 1998, BIOCHEM BIOPH RES CO, V242, P474, DOI 10.1006/bbrc.1997.7989; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; MacCallum JL, 2011, BIOPHYS J, V101, P110, DOI 10.1016/j.bpj.2011.05.038; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Petruk AA, 2013, BBA-BIOMEMBRANES, V1828, P2637, DOI 10.1016/j.bbamem.2013.07.019; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sharma S, 2014, BBA-BIOMEMBRANES, V1838, P739, DOI 10.1016/j.bbamem.2013.12.001; Shekhar P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661986; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Sigalov AB, 2009, BIOCHEM BIOPH RES CO, V389, P388, DOI 10.1016/j.bbrc.2009.09.002; Sun GQ, 1997, BIOCHEMISTRY-US, V36, P2139, DOI 10.1021/bi962291n; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Szymczak AL, 2005, J IMMUNOL, V174, P4153, DOI 10.4049/jimmunol.174.7.4153; TRASATTI S, 1991, PURE APPL CHEM, V63, P711, DOI 10.1351/pac199163050711; Vanderah DJ, 2003, LANGMUIR, V19, P2612, DOI 10.1021/la026990e; Weissenhorn W, 1996, EUR J BIOCHEM, V238, P440, DOI 10.1111/j.1432-1033.1996.0440z.x; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	60	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17746	17759		10.1074/jbc.M117.794370	http://dx.doi.org/10.1074/jbc.M117.794370			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28893902	hybrid, Green Published			2022-12-26	WOS:000414013000014
J	Cartoni, R; Pekkurnaz, G; Wang, C; Schwarz, TL; He, ZG				Cartoni, Romain; Pekkurnaz, Gulcin; Wang, Chen; Schwarz, Thomas L.; He, Zhigang			A high mitochondrial transport rate characterizes CNS neurons with high axonal regeneration capacity	PLOS ONE			English	Article							MICROFLUIDIC CULTURE PLATFORM; GROWTH CONE; INJURY; MECHANISMS; MOTILITY; DEFICITS	Improving axonal transport in the injured and diseased central nervous system has been proposed as a promising strategy to improve neuronal repair. However, the contribution of each cargo to the repair mechanism is unknown. DRG neurons globally increase axonal transport during regeneration. Because the transport of specific cargos after axonal insult has not been examined systematically in a model of enhanced regenerative capacity, it is unknown whether the transport of all cargos would be modulated equally in injured central nervous system neurons. Here, using a microfluidic culture system we compared neurons co-deleted for PTEN and SOCS3, an established model of high axonal regeneration capacity, to control neurons. We measured the axonal transport of three cargos (mitochondria, synaptic vesicles and late endosomes) in regenerating axons and found that the transport of mitochondria, but not the other cargos, was increased in PTEN/SOCS3 co-deleted axons relative to controls. The results reported here suggest a pivotal role for this organelle during axonal regeneration.	[Cartoni, Romain; Pekkurnaz, Gulcin; Wang, Chen; Schwarz, Thomas L.; He, Zhigang] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Cartoni, Romain; Pekkurnaz, Gulcin; Wang, Chen; Schwarz, Thomas L.; He, Zhigang] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Pekkurnaz, Gulcin] Univ Calif San Diego, Div Biol Sci, Sect Neurobiol, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Schwarz, TL; He, ZG (corresponding author), Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Schwarz, TL; He, ZG (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Schwarz, TL (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu; zhigang.he@childrens.harvard.edu		Pekkurnaz, Gulcin/0000-0002-7388-6178	International Foundation for Research in Paraplegia; Wings for Life Spinal Cord Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [R01EY021242, R01GM069808]; NIH [R01GM069808, P30 HD018655, P30EY012196]; 3R Research Foundation Switzerland [129-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196, R01EY021242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	International Foundation for Research in Paraplegia; Wings for Life Spinal Cord Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 3R Research Foundation Switzerland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the International Foundation for Research in Paraplegia (http://www.irp.ch), Wings for Life Spinal Cord Research Foundation (http://www.wingsforlife. com) (R.C.); grant R01EY021242 from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (http://www.Ammadelsonfoundation.org) (Z. H.), NIH grant R01GM069808 (T.L.S.); and grant 129-11 from the 3R Research Foundation Switzerland (http://www.forschung3r.ch) (Z.H. and T.L.S.). Children's Hospital Boston Intellectual And Developmental Disabilities Research Center (IDDRC) and viral cores supported by NIH grants P30 HD018655 and P30EY012196 were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Anthony Hill from the IDDCR-Cellular imaging core of Boston Children's Hospital for technical assistance with live imaging and members of the Schwarz and He labs for technical advice and valuable input. This study was supported by the International Foundation for Research in Paraplegia, Wings for Life Spinal Cord Research Foundation (R.C.); grant R01EY021242 from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z. H.), grant R01GM069808 (T.L.S.); and grant 129-11 from the 3R Research Foundation Switzerland (Z.H. and T.L.S.). IDDRC and viral cores supported by NIH grants P30 HD018655 and P30EY012196 were used for this study.	Belin S, 2015, NEURON, V86, P1000, DOI 10.1016/j.neuron.2015.03.060; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Cartoni R, 2016, NEURON, V92, P1294, DOI 10.1016/j.neuron.2016.10.060; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Han SM, 2016, NEURON, V92, P1308, DOI 10.1016/j.neuron.2016.11.025; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Mar FM, 2014, J NEUROSCI, V34, P5965, DOI 10.1523/JNEUROSCI.4680-13.2014; Melkov A, 2017, CELL MOL LIFE SCI, V39, P1169; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Pinto MJ, 2016, J NEUROCHEM, V139, P921, DOI 10.1111/jnc.13702; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sorbara CD, 2014, NEURON, V84, P1183, DOI 10.1016/j.neuron.2014.11.006; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101	25	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184672	10.1371/journal.pone.0184672	http://dx.doi.org/10.1371/journal.pone.0184672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926622	gold, Green Submitted, Green Published			2022-12-26	WOS:000411166600032
J	Chen, TC; Yeh, CY; Lin, CW; Yang, CM; Yang, CH; Lin, IH; Chen, PY; Cheng, JY; Hu, FR				Chen, Ta-Ching; Yeh, Chao-Yuan; Lin, Chao-Wen; Yang, Chung-May; Yang, Chang-Hao; Lin, I-Hung; Chen, Pao-Yang; Cheng, Jung-Yu; Hu, Fung-Rong			Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases	PLOS ONE			English	Article							PERIPAPILLARY CHOROIDAL THICKNESS; ENDOTHELIN-1 PLASMA-LEVELS; BLOOD-FLOW-VELOCITY; NERVE-FIBER LAYER; MULTIPLE-SCLEROSIS; WHITE-MATTER; CEREBRAL HYPOPERFUSION; COHERENCE TOMOGRAPHY; AXONAL DEGENERATION; ALZHEIMERS-DISEASE	Purpose Optic neuritis is highly correlated with multiple sclerosis and is a major cause of acute visual loss and long-term neuronal degeneration. Primary cerebral hypoperfusion has been reported in brain demyelinating diseases. This study investigated whether peripapillary perfusion is changed in patients with acute optic neuritis (AON). Methods This three-year cohort study was conducted from September 1 2012, to August 31, 2015. Two hundred and forty-one patients with non-glaucomatous acute optic neuropathy were screened, and 42 non-highly myopic patients who had suffered their first episode of unilaterally idiopathic AON were studied. All cases received spectral-domain optical coherence tomography (OCT) examination, general survey, and standard corticosteroid therapy. OCT images were analyzed using a customized MATLAB program for measuring peripapillary choroidal thickness (PCT). Multivariate regression models were constructed to identify factors that are significantly related to peripapillary perfusion. Results Decreased PCT was found in eyes experiencing AON combined with disc swelling (the ratio of lesion eye PCT/fellow eye PCT was 0.87 +/- 0.08; range, from 0.75 to 1.00). In comparison to the healthy fellow eyes, approximately every 26% increase in the thickness of the retinal nerve fiber layer due to axonal swelling was associated with a 10% decreased thickness of PCT. Thinner PCT is also correlated with poorer trough vision, which may lead to poorer final vision. These findings were obvious in patients with optic papillitis but not in patients with retrobulbar neuritis. Conclusions Peripapillary vascular hypoperfusion was found in patients experiencing AON combined with disc swelling. These findings are unlike those for other ocular inflammatory diseases but are consistent with cerebral hypoperfusion, which is found in brain demyelinating diseases; thus, these findings may represent a new neurovascular model in this field.	[Chen, Ta-Ching; Lin, Chao-Wen; Yang, Chung-May; Yang, Chang-Hao; Hu, Fung-Rong] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ta-Ching] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, Chao-Yuan] Univ Southern Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Lin, I-Hung] Natl Taiwan Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chen, Pao-Yang] Acad Sinica, Inst Plant & Microbial Biol, Taipei, Taiwan; [Cheng, Jung-Yu] Ming Chuan Univ, Dept Healthcare Informat & Management, Taoyuan, Taiwan	National Taiwan University; National Taiwan University; University of Southern California; National Taiwan University; Academia Sinica - Taiwan; Ming Chuan University	Hu, FR (corresponding author), Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei, Taiwan.	fungronghu@ntuh.gov.tw	Yang, Chang-Hao/AAR-3759-2021; Chen, Pao-Yang/ABG-9939-2020; Yang, Chung-May/AAV-3737-2020	Chen, Pao-Yang/0000-0002-7402-3075; Chen, Ta-Ching/0000-0003-4358-6585; YANG, CHUNG-MAY/0000-0003-4082-420X; Lin, I-Hung/0000-0003-4268-2540; YANG, CHANG-HAO/0000-0002-4328-8716; Yeh, Chao-Yuan/0000-0002-1947-1596; HU, FUNG-RONG/0000-0002-2102-5317				Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Aktas O, 2016, CURRENT OPINION NEUR; Al-Louzi OA, 2015, MULTIPLE SCLEROSIS; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P6393, DOI 10.1167/iovs.12-10224; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cai J., 2015, CURR EYE RES, P1; Cambron M, 2012, J CEREBR BLOOD F MET, V32, P413, DOI 10.1038/jcbfm.2011.193; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Cole SR, 2000, INVEST OPHTH VIS SCI, V41, P1017; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; D'haeseleer M, 2015, J CEREBR BLOOD F MET, V35, P1406, DOI 10.1038/jcbfm.2015.131; D'haeseleer M, 2013, P NATL ACAD SCI USA, V110, P5654, DOI 10.1073/pnas.1222560110; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; Diem R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010956; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Fard MA, 2015, INVESTIGATIVE OPHTHA; Freitas-Neto CA, 2016, OPHTHALMOLOGY, V123, P222, DOI 10.1016/j.ophtha.2015.06.045; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Gabilondo I, 2015, ANN NEUROL, V77, P517, DOI 10.1002/ana.24351; Gupta P, 2015, INVEST OPHTH VIS SCI, V56, P1475, DOI 10.1167/iovs.14-15742; Harb E, 2015, AM J OPHTHALMOL, V160, P62, DOI 10.1016/j.ajo.2015.04.018; Haufschild T, 2001, J NEURO-OPHTHALMOL, V21, P37, DOI 10.1097/00041327-200103000-00011; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Henderson APD, 2011, ANN NEUROL, V70, P955, DOI 10.1002/ana.22554; Hickman SJ, 2002, LANCET, V360, P1953, DOI 10.1016/S0140-6736(02)11919-2; Hirooka K, 2015, GRAEF ARCH CLIN EXP, V253, P609, DOI 10.1007/s00417-014-2927-5; Hsiang HW, 2008, AM J OPHTHALMOL, V146, P102, DOI 10.1016/j.ajo.2008.03.010; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Ishikawa S, 2014, BRIT J OPHTHALMOL, V98, P1508, DOI 10.1136/bjophthalmol-2014-305333; Jiang R, 2015, INVEST OPHTH VIS SCI, V56, P4045, DOI 10.1167/iovs.15-16521; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Kobelt G, 2006, NEUROLOGY, V66, P1696, DOI 10.1212/01.wnl.0000218309.01322.5c; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Lee S, 2014, INVEST OPHTH VIS SCI, V55, P4378, DOI 10.1167/iovs.14-14227; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Marshall O, 2014, JAMA NEUROL, V71, P1275, DOI 10.1001/jamaneurol.2014.1668; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; Mehta H, 2015, EYE, V29, P1060, DOI 10.1038/eye.2015.65; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; Moghimi S, 2016, INVEST OPHTH VIS SCI, V57, P1293, DOI 10.1167/iovs.15-18312; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Noseworthy JH, 2001, NEUROLOGY, V56, P1514, DOI 10.1212/WNL.56.11.1514; Novais EA, 2015, OSLI RETINA, V46, P920, DOI 10.3928/23258160-20151008-04; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Okamoto M, 2015, OSLI RETINA, V46, P25, DOI 10.3928/23258160-20150101-04; Pache M, 2003, EUR NEUROL, V49, P164, DOI 10.1159/000069085; Papadaki EZ, 2012, MAGN RESON MED, V68, P1932, DOI 10.1002/mrm.24194; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Roed H, 2005, J NEUROIMMUNOL, V162, P165, DOI 10.1016/j.jneuroim.2005.02.002; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Saindane AM, 2007, AM J NEURORADIOL, V28, P767; Sanchez-Catasus CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066271; SODERSTROM M, 1993, NEUROLOGY, V43, P1215, DOI 10.1212/WNL.43.6.1215; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Tran JQ, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000018; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Tsakiri A, 2012, MULT SCLER J, V18, P72, DOI 10.1177/1352458511415452; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yun C, 2016, GRAEFEARCH CLIN EX	70	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184927	10.1371/journal.pone.0184927	http://dx.doi.org/10.1371/journal.pone.0184927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926646	Green Published, gold, Green Submitted			2022-12-26	WOS:000411166600055
J	Miyamoto, K; Ohkawara, B; Ito, M; Masuda, A; Hirakawa, A; Sakai, T; Hiraiwa, H; Hamada, T; Ishiguro, N; Ohno, K				Miyamoto, Kentaro; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Hirakawa, Akihiro; Sakai, Tadahiro; Hiraiwa, Hideki; Hamada, Takashi; Ishiguro, Naoki; Ohno, Kinji			Fluoxetine ameliorates cartilage degradation in osteoarthritis by inhibiting Wnt/beta-catenin signaling	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; ENDOCHONDRAL OSSIFICATION; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; HIP OSTEOARTHRITIS; CELL-LINE; WNT; MOUSE; MODEL	Abnormal activation of the Wnt/beta-catenin signaling is implicated in the osteoarthritis (OA) pathology. We searched for a pre-approved drug that suppresses abnormally activated Wnt/beta-catenin signaling and has a potency to reduce joint pathology in OA. We introduced the TOPFlash reporter plasmid into HCS-2/8 human chondrosarcoma cells to estimate the Wnt/beta-catenin activity in the presence of 10 mu M each compound in a panel of pre-approved drugs. We found that fluoxetine, an antidepressant in the class of selective serotonin reuptake inhibitors (SSRI), down-regulated Wnt/beta-catenin signaling in human chondrosarcoma cells. Fluoxetine inhibited both Wnt3A- and LiCl-induced loss of proteoglycans in chondrogenically differentiated ATDC5 cells. Fluoxetine increased expression of Sox9 (the chondrogenic master regulator), and decreased expressions of Axin2 (a marker for Wnt/beta-catenin signaling) and Mmp13 (matrix metalloproteinase 13). Fluoxetine suppressed a LiCl-induced increase of total beta-catenin and a LiCl-induced decrease of phosphorylated beta-catenin in a dose-dependent manner. An in vitro protein-binding assay showed that fluoxetine enhanced binding of beta-catenin with Axin1, which is a scaffold protein forming the degradation complex for beta-catenin. Fluoxetine suppressed LiCl-induced beta-catenin accumulation in human OA chondrocytes. Intraarticular injection of fluoxetine in a rat OA model ameliorated OA progression and suppressed beta-catenin accumulation.	[Miyamoto, Kentaro; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi, Japan; [Miyamoto, Kentaro; Sakai, Tadahiro; Hiraiwa, Hideki; Hamada, Takashi; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Nagoya, Aichi, Japan; [Hirakawa, Akihiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Ohkawara, B (corresponding author), Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi, Japan.	biseiohkawara@med.nagoya-u.ac.jp	Ohno, Kinji/H-4020-2012; Ito, Mikako/I-1941-2012; Hirakawa, Akihiro/AAE-5936-2019; Ohno, Kinji/ABD-5787-2020	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW); Japan Agency for Medical Research and Development (AMED); Hori Sciences & Arts foundation; 24th General Assembly of the Japanese Association of Medical Sciences; Grants-in-Aid for Scientific Research [16K15661, 15H04840] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hori Sciences & Arts foundation; 24th General Assembly of the Japanese Association of Medical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Ministry of Health, Labor and Welfare (MHLW), the Japan Agency for Medical Research and Development (AMED), the Hori Sciences & Arts foundation, and the 24th General Assembly of the Japanese Association of Medical Sciences.; We would like to thank Dr. Masaharu Takigawa at Okayama University for providing HCS-2/8 cells. This work was supported by a grants-in-aid of the 24th General Assembly of the Japanese Association of Medical Sciences.	Alvarez-Garcia O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034788; Asai N, 2014, BIOCHEM BIOPH RES CO, V451, P302, DOI 10.1016/j.bbrc.2014.07.125; Blom AB, 2010, CURR DRUG TARGETS, V11, P620; Blom AB, 2009, ARTHRITIS RHEUM, V60, P501, DOI 10.1002/art.24247; Bouaziz W, 2016, P NATL ACAD SCI USA, V113, P5453, DOI 10.1073/pnas.1514854113; Chan HN, 2009, ANN ACAD MED SINGAP, V38, P974; Citrome L, 2012, INT J CLIN PRACT, V66, P431, DOI 10.1111/j.1742-1241.2012.02899.x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299; De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Kawaguchi H, 2008, MOL CELLS, V25, P1; Kozawa E, 2012, ARTHRITIS RHEUM-US, V64, P454, DOI 10.1002/art.33398; Lane NE, 2007, ARTHRITIS RHEUM-US, V56, P3319, DOI 10.1002/art.22867; Lin YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep31986; Liu SS, 2016, MOL MED REP, V13, P1999, DOI 10.3892/mmr.2016.4798; Lodewyckx Liesbet, 2009, Curr Rheumatol Rep, V11, P23; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Ma B, 2013, CALCIFIED TISSUE INT, V92, P399, DOI 10.1007/s00223-012-9675-5; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Magni LR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004185.pub3; Manabe N, 1999, RHEUMATOLOGY, V38, P714, DOI 10.1093/rheumatology/38.8.714; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Matsushita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081569; Min JL, 2005, ARTHRITIS RHEUM-US, V52, P1077, DOI 10.1002/art.20993; Nakashima M, 2012, BIOCHEM BIOPH RES CO, V422, P508, DOI 10.1016/j.bbrc.2012.05.036; Nalesso G, 2016, ANN RHEUM DIS; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Papathanasiou I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3805; Papathanasiou I, 2010, J ORTHOP RES, V28, P348, DOI 10.1002/jor.20993; Rentsendorj O, 2005, BIOCHEM J, V389, P705, DOI 10.1042/BJ20050214; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Staines KA, 2012, CELL BIOCHEM FUNCT, V30, P633, DOI 10.1002/cbf.2852; Takamatsu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092699; Takegami Y, 2016, BIOCHEM BIOPH RES CO, V473, P255, DOI 10.1016/j.bbrc.2016.03.089; TAKIGAWA M, 1989, CANCER RES, V49, P3996; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wieland HA, 2005, NAT REV DRUG DISCOV, V4, P331, DOI 10.1038/nrd1693; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	47	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184388	10.1371/journal.pone.0184388	http://dx.doi.org/10.1371/journal.pone.0184388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926590	gold, Green Published, Green Submitted			2022-12-26	WOS:000411166600016
J	Poteat, T; Parke, C; Solares, D; Williams, JK; Wolf, RC; Metheny, N; Vazzano, A; Dent, J; Gibbs, A; Nonyane, BAS; Toiv, N				Poteat, Tonia; Parke, Chulwoo; Solares, Diego; Williams, John K.; Wolf, R. Cameron; Metheny, Noah; Vazzano, Andrea; Dent, Juan; Gibbs, Ashley; Nonyane, Bareng Aletta Sanny; Toiv, Nora			Changing hearts and minds: Results from a multi-country gender and sexual diversity training	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; HIV; MEN; ATTITUDES; EPIDEMICS; WORKERS	Engaging key populations, including gender and sexual minorities, is essential to meeting global targets for reducing new HIV infections and improving the HIV continuum of care. Negative attitudes toward gender and sexual minorities serve as a barrier to political will and effective programming for HIV health services. The President's Emergency Plan for AIDS Relief (PEPFAR), established in 2003, provided Gender and Sexual Diversity Trainings for 2,825 participants including PEPFAR staff and program implementers, U.S. government staff, and local stakeholders in 38 countries. The outcomes of these one-day trainings were evaluated among a subset of participants using a mixed methods pre- and post-training study design. Findings suggest that sustainable decreases in negative attitudes toward gender and sexual minorities are achievable with a one-day training.	[Poteat, Tonia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Parke, Chulwoo] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Solares, Diego; Vazzano, Andrea; Dent, Juan; Gibbs, Ashley] Palladium Grp, Hlth Policy Project, Washington, DC USA; [Williams, John K.] Ctr Dis Control & Prevent, Div Global HIV TB, Atlanta, GA USA; [Wolf, R. Cameron; Metheny, Noah] US Agcy Int Dev, Washington, DC 20523 USA; [Nonyane, Bareng Aletta Sanny] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Toiv, Nora] Off US Global AIDS Coordinator, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Poteat, T (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	tpoteat@jhu.edu	Nonyane, Bareng A.S./AAC-8118-2020; Park, Chulwoo/P-3710-2019	Nonyane, Bareng A.S./0000-0001-5633-7487; Park, Chulwoo/0000-0003-0667-6549; Poteat, Tonia/0000-0001-6541-3787	USAID; PEPFAR [AID-OAA-A-10-00067]; NIH [P30A1094189]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; PEPFAR; NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); PEPFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; PEPFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by support from USAID and PEPFAR to the Health Policy Project (HPP) under Agreement No. AID-OAA-A-10-00067 and with assistance from the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30A1094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; The findings and conclusions in this article are based upon the Gender & Sexual Diversity Training which was developed by the USAID- and PEPFAR-funded Health Policy Project, in coordination with a U.S. government interagency team, including members of the PEPFAR Key Populations Technical Working Group and the PEPFAR Gender Technical Working Group. We are grateful to the dedicated staff who devoted countless hours to developing and implementing the GSD Training as well as the numerous training participants for their willingness to take part in this evaluation.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Bateman C, 2011, SAMJ S AFR MED J, V101, P91, DOI 10.7196/SAMJ.4735; Beyrer C, 2008, SEX TRANSM INFECT, V84, P410, DOI 10.1136/sti.2008.033290; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chan PA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-153; Cook T.D., 1978, ADV EXP SOC PSYCHOL, V11, P1, DOI [10.1016/S0065-2601(08)60004-0, DOI 10.1016/S0065-2601(08)60004-0]; Creswell J.W., 2007, DESIGNING CONDUCTING; Ellis SJ, 2002, J HOMOSEXUAL, V44, P121, DOI 10.1300/J082v44n01_07; Grosso A, 2015, GLOB PUBLIC HEALTH, V10, P1172, DOI 10.1080/17441692.2015.1043314; HADDOCK G, 1993, J PERS SOC PSYCHOL, V65, P1105, DOI 10.1037/0022-3514.65.6.1105; Hill DB, 2005, SEX ROLES, V53, P531, DOI 10.1007/s11199-005-7140-x; Horowitz JM, 2013, GLOBAL DIVIDE HOMOSE, P1; Hurtado SL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1402-z; Huskinson TLH, 2006, SOC COGNITION, V24, P453, DOI 10.1521/soco.2006.24.4.453; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Mansh M, 2015, ACAD MED, V90, P574, DOI 10.1097/ACM.0000000000000656; O'Hanlan KA, J GAY LESBIAN MED AS, V1, P25; Poteat T, 2014, CURR OPIN HIV AIDS, V9, P168, DOI 10.1097/COH.0000000000000030; Prakashkumar M D, 2014, Indian J Lepr, V86, P99; Reynolds R, 2010, GLOBAL FORUM MSM HIV; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; Sheehan KimBartel., 2001, J COMPUT-MEDIAT COMM, V6, pJCMC621, DOI [DOI 10.1111/J.1083-6101.2001.TB00117.X, 10.1111/j.1083-6101.2001.tb00117.x]; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Stahlman Shauna, 2017, JMIR Public Health Surveill, V3, pe23, DOI 10.2196/publichealth.7334; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; U.S. Department of State, 2014, PEPFAR 3 0 CONTR EP; UNAIDS, 2014, NAT COMM POL INSTR 2; UNAIDS, 2014, 90 90 90 AMB TREATM; Varas-Diaz N, 2016, AIDS CARE, V28, P376, DOI 10.1080/09540121.2015.1090537; Vincent M L, 1985, Fam Life Educ, V3, P23; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Wirtz AL, 2012, 19 INT AIDS C WASH D; World Health Organization, 2017, VIOL WOM HIV AIDS CR; Zanna M., 2008, ATTITUDES NEW LOOK O	38	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184484	10.1371/journal.pone.0184484	http://dx.doi.org/10.1371/journal.pone.0184484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926568	Green Submitted, Green Published, gold			2022-12-26	WOS:000411166600019
J	Kawakubo, M; Demehri, S; Manstein, D				Kawakubo, Masayoshi; Demehri, Shadmehr; Manstein, Dieter			Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response	PLOS ONE			English	Article							BASAL-CELL CARCINOMAS; REGULATORY T-CELLS; PHOTODYNAMIC THERAPY; SOLID STRESS; DELIVERY; BETA; IMMUNOSUPPRESSION; PHOTOTHERMOLYSIS; ADENOCARCINOMA; HYPERTHERMIA	Background Ablative fractional photothermolysis (aFP) using a CO2 laser generates multiple small diameter tissue lesions within the irradiation field. aFP is commonly used for a wide variety of dermatological indications, including treatment of photodamaged skin and dyschromia, drug delivery and modification of scars due to acne, surgical procedures and burns. In this study we explore the utility of aFP for treating oncological indications, including induction of local tumor regression and inducing anti-tumor immunity, which is in marked contrast to current indications of aFP. Methodology/Principal findings We used a fractional CO2 laser to treat a tumor established by BALB/c colon carcinoma cell line (CT26. CL25), which expressed a tumor antigen, beta-galactosidase (beta-gal). aFP treated tumors grew significantly slower as compared to untreated controls. Complete remission after a single aFP treatment was observed in 47% of the mice. All survival mice from the tumor inoculation rejected re-inoculation of the CT26. CL25 colon carcinoma cells and moreover 80% of the survival mice rejected CT26 wild type colon carcinoma cells, which are parental cells of CT26. CL25 cells. Histologic section of the FP-treated tumors showed infiltrating neutrophil in the tumor early after aFP treatment. Flow cytometric analysis of tumor-infiltrating lymphocytes showed aFP treatment abrogated the increase in regulatory T lymphocyte (Treg), which suppresses anti-tumor immunity and elicited the expansion of epitope-specific CD8(+) T lymphocytes, which were required to mediate the tumor-suppressing effect of aFP. Conclusion We have demonstrated that aFP is able to induce a systemic anti-tumor adaptive immunity preventing tumor recurrence in a murine colon carcinoma in a mouse model. This study demonstrates a potential role of aFP treatments in oncology and further studies should be performed.	[Kawakubo, Masayoshi; Demehri, Shadmehr; Manstein, Dieter] Massachusetts Gen Hosp, Res Inst, Cutaneous Biol Res Ctr, Dept Dermatol, Charlestown, MA 02114 USA; [Kawakubo, Masayoshi; Demehri, Shadmehr; Manstein, Dieter] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kawakubo, M (corresponding author), Massachusetts Gen Hosp, Res Inst, Cutaneous Biol Res Ctr, Dept Dermatol, Charlestown, MA 02114 USA.; Kawakubo, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mkawakubo@mgh.harvard.edu	Demehri, Shadmehr/N-5732-2019		NIH HHS [DP5 OD021353] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021353] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allemann IB, 2010, LASER MED SCI, V25, P137, DOI 10.1007/s10103-009-0734-8; BARKER DE, 1951, PLAST RECONSTR SURG, V7, P115, DOI 10.1097/00006534-195102000-00004; BODMER S, 1989, J IMMUNOL, V143, P3222; Chaput N, 2007, J IMMUNOL, V179, P4969, DOI 10.4049/jimmunol.179.8.4969; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chen XY, 2014, J CONTROL RELEASE, V192, P310, DOI 10.1016/j.jconrel.2014.08.006; Chen XY, 2012, J CONTROL RELEASE, V159, P43, DOI 10.1016/j.jconrel.2012.01.002; COLOMBO MP, 1992, J IMMUNOL, V149, P113; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; GOMER CJ, 1984, PHOTOCHEM PHOTOBIOL, V40, P435, DOI 10.1111/j.1751-1097.1984.tb04614.x; Haak CS, 2015, BRIT J DERMATOL, V172, P215, DOI 10.1111/bjd.13166; Haedersdal M, 2014, LASER SURG MED, V46, P462, DOI 10.1002/lsm.22259; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Hantash BM, 2007, LASER SURG MED, V39, P87, DOI 10.1002/lsm.20405; HARRIS JW, 1976, CANCER RES, V36, P2733; Hazeldine J, 2016, BURNS TRAUMA, V4, DOI 10.1186/s41038-016-0059-3; HENDERSON BW, 1987, CANCER RES, V47, P3110; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jalian HR, 2014, LASER SURG MED, V46, P1, DOI 10.1002/lsm.22201; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kato H, 2003, LUNG CANCER, V42, P103, DOI 10.1016/S0169-5002(03)00242-3; KELLER R, 1983, INVAS METAST, V3, P183; Khan MH, 2005, LASER SURG MED, V36, P270, DOI 10.1002/lsm.20142; Kim HW, 2014, DERMATOL SURG, V40, P1361, DOI 10.1097/DSS.0000000000000185; Kirkbride KC, 2003, EXPERT OPIN BIOL TH, V3, P251; Konnikov N, 2011, LASER SURG MED, V43, P72, DOI 10.1002/lsm.21035; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Li XS, 2011, PHOTOCH PHOTOBIO SCI, V10, P817, DOI 10.1039/c0pp00306a; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Manstein D, 2004, LASER SURG MED, V34, P426, DOI 10.1002/lsm.20048; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; MOAN J, 1985, CANCER RES, V45, P1608; Mroz P, 2013, CANCER RES, V73, P6462, DOI 10.1158/0008-5472.CAN-11-2572; Mroz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015194; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nanashima A, 2012, ANTICANCER RES, V32, P4931; NEUMANN RA, 1991, J AM ACAD DERMATOL, V25, P991, DOI 10.1016/0190-9622(91)70296-E; Ortiz AE, 2015, LASER SURG MED, V47, P106, DOI 10.1002/lsm.22310; Park DH, 2014, EUR J CANCER, V50, P1259, DOI 10.1016/j.ejca.2014.01.008; Prignano F, 2009, DERMATOL THER, V22, pS8, DOI 10.1111/j.1529-8019.2009.01265.x; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Tierney EP, 2012, DERMATOL SURG, V38, P1777, DOI 10.1111/j.1524-4725.2012.02572.x; Tierney EP, 2009, DERMATOL SURG, V35, P1445, DOI 10.1111/j.1524-4725.2009.01258.x; Toraya-Brown S, 2014, INT J HYPERTHER, V30, P531, DOI 10.3109/02656736.2014.968640; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Trelles MA, 2010, J DRUGS DERMATOL, V9, P315; Usuda J, 2010, CLIN CANCER RES, V16, P2198, DOI 10.1158/1078-0432.CCR-09-2520; Weiss ET, 2013, J AM ACAD DERMATOL, V68, P98, DOI 10.1016/j.jaad.2012.05.033; Wislez M, 2003, CANCER RES, V63, P1405	53	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184852	10.1371/journal.pone.0184852	http://dx.doi.org/10.1371/journal.pone.0184852			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922374	Green Published, Green Submitted, gold			2022-12-26	WOS:000411059300036
J	Aldawsari, A; Khan, MA; Hameed, BH; Alqadami, AA; Siddiqui, MR; Alothman, ZA; Ahmed, AYBH				Aldawsari, Abdullah; Khan, Moonis Ali; Hameed, B. H.; Alqadami, Ayoub Abdullah; Siddiqui, Masoom Raza; Alothman, Zeid Abdullah; Ahmed, A. Yacine Badjah Hadj			Mercerized mesoporous date pit activated carbon - A novel adsorbent to sequester potentially toxic divalent heavy metals from water	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; ADSORPTION; REMOVAL; IONS; CADMIUM; COPPER; PALM; KINETICS; SORPTION; CD(II)	A substantive approach converting waste date pits to mercerized mesoporous date pit activated carbon (DPAC) and utilizing it in the removal of Cd(II), Cu(II), Pb(II), and Zn(II) was reported. In general, rapid heavy metals adsorption kinetics for Co range: 25-100 mg/L was observed, accomplishing 77-97% adsorption within 15 min, finally, attaining equilibrium in 360 min. Linear and non-linear isotherm studies revealed Langmuir model applicability for Cd(II) and Pb(II) adsorption, while Freundlich model was fitted to Zn(II) and Cu(II) adsorption. Maximum monolayer adsorption capacities (qm) for Cd(II), Pb(II), Cu(II), and Zn(II) obtained by non-linear isotherm model at 298 K were 212.1, 133.5, 194.4, and 111 mg/g, respectively. Kinetics modeling parameters showed the applicability of pseudo-secondorder model. The activation energy (Ea) magnitude revealed physical nature of adsorption. Maximum elution of Cu(II) (81.6%), Zn(II) (70.1%), Pb(II) (96%), and Cd(II) (78.2%) were observed with 0.1 M HCl. Thermogravimetric analysis of DPAC showed a total weight loss (in two-stages) of 28.3%. Infra-red spectral analysis showed the presence of carboxyl and hydroxyl groups over DPAC surface. The peaks at 820, 825, 845 and 885 cm(-1) attributed to Zn-O, Pb-O, Cd-O, and Cu-O appeared on heavy metals saturated DPAC, confirmed their binding on DPAC during the adsorption.	[Aldawsari, Abdullah; Khan, Moonis Ali; Alqadami, Ayoub Abdullah; Siddiqui, Masoom Raza; Alothman, Zeid Abdullah; Ahmed, A. Yacine Badjah Hadj] King Saud Univ, Coll Sci, Dept Chem, Riyadh, Saudi Arabia; [Hameed, B. H.] Univ Sains Malaysia, Sch Chem Engn, Engn Campus, Nibong Tebal, Penang, Malaysia	King Saud University; Universiti Sains Malaysia	Khan, MA (corresponding author), King Saud Univ, Coll Sci, Dept Chem, Riyadh, Saudi Arabia.	mokhan@ksu.edu.sa	Khan, Moonis Ali/C-6356-2011; Hameed, Bassim H./C-1270-2009; Siddiqui, Prof Masoom Raza/ABC-7839-2020; Aldawsari, Abdullah/GQH-3210-2022; ALOthman, Zeid A./E-7333-2014; Alqadami, Ayoub/D-9862-2017; Alqadami, Ayoub Abdullah/ABD-1898-2020	Khan, Moonis Ali/0000-0002-0548-8581; Hameed, Bassim H./0000-0001-5171-6189; ALOthman, Zeid A./0000-0001-9970-2480; Aldawsari, Abdullah/0000-0003-2709-9381; Alqadami, Ayoub/0000-0002-4527-0931	DSR at King Saud University [RG-1437-031]; Deanship of Scientific Research at King Saud University [RG-1437-031]	DSR at King Saud University(King Saud University); Deanship of Scientific Research at King Saud University(King Saud University)	This work has been funded by DSR at King Saud University through the Research group No. RG-1437-031. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the Research group No. RG-1437-031.	Ahmad T, 2012, ENVIRON SCI POLLUT R, V19, P1464, DOI 10.1007/s11356-011-0709-8; Ahmed MJ, 2016, PROCESS SAF ENVIRON, V102, P168, DOI 10.1016/j.psep.2016.03.010; Ajmal M, 2005, J HAZARD MATER, V122, P177, DOI 10.1016/j.jhazmat.2005.03.029; Ajmal M, 2006, J HAZARD MATER, V135, P242, DOI 10.1016/j.jhazmat.2005.11.054; Akasha I, 2016, FOOD CHEM, V197, P799, DOI 10.1016/j.foodchem.2015.11.046; Al-Farsi MA, 2011, NUTS AND SEEDS IN HEALTH AND DISEASE PREVENTION, P447, DOI 10.1016/B978-0-12-375688-6.10053-2; Al-Ghouti MA, 2010, J HAZARD MATER, V176, P510, DOI 10.1016/j.jhazmat.2009.11.059; Aldawsari A, 2017, DESALIN WATER TREAT, V62, P273, DOI 10.5004/dwt.2017.0529; Alqadami AA, 2017, J CLEAN PROD, V156, P426, DOI 10.1016/j.jclepro.2017.04.085; Alsohaimi IH, 2015, CHEM ENG J, V270, P9, DOI 10.1016/j.cej.2015.02.008; Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016; Ameh P.O., 2013, INT J MODERN CHEM, V5, P136; Anirudhan TS, 2011, J ENVIRON SCI, V23, P1989, DOI 10.1016/S1001-0742(10)60515-3; Barneveld WH, 1993, FAO AGR SERVICES B, V101; Bhatnagar A, 2010, CHEM ENG J, V157, P277, DOI 10.1016/j.cej.2010.01.007; Chen XC, 2011, BIORESOURCE TECHNOL, V102, P8877, DOI 10.1016/j.biortech.2011.06.078; Danish M, 2011, J CHEM ENG DATA, V56, P3607, DOI 10.1021/je200460n; Dubinin M. M, 1947, PROC ACAD SCI USSR C, V55, P327, DOI DOI 10.4236/OJS.2014.41001; El-Hendawy ANA, 2009, J HAZARD MATER, V167, P260, DOI 10.1016/j.jhazmat.2008.12.118; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Grottrup J, 2017, CERAMICS INTER; Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jain AK, 2003, J HAZARD MATER, V101, P31, DOI 10.1016/S0304-3894(03)00146-8; Khandanlou R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120264; Kula I, 2008, BIORESOURCE TECHNOL, V99, P492, DOI 10.1016/j.biortech.2007.01.015; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X; Motsi T, 2009, INT J MINER PROCESS, V92, P42, DOI 10.1016/j.minpro.2009.02.005; Mouni L, 2010, DESALIN WATER TREAT, V16, P66, DOI 10.5004/dwt.2010.1106; Murugadoss G, 2016, J LUMIN, V170, P78, DOI 10.1016/j.jlumin.2015.10.034; Oubekka LD, 2016, REV ROUM CHIM, V61, P175; Rao RAK, 2010, J HAZARD MATER, V173, P273, DOI 10.1016/j.jhazmat.2009.08.080; SASO, 2009, 10252009 GSO; Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064; Tajar AF, 2009, J HAZARD MATER, V165, P1159, DOI 10.1016/j.jhazmat.2008.10.131; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; Wang FY, 2010, J HAZARD MATER, V177, P300, DOI 10.1016/j.jhazmat.2009.12.032; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072475; WHO, 2011, GUID DRINK WAT QUAL; ZOUBOULIS AI, 1992, SEPAR SCI TECHNOL, V27, P2143, DOI 10.1080/01496399208019471	42	33	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e014493	10.1371/journal.pone.0184493	http://dx.doi.org/10.1371/journal.pone.0184493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910368	Green Submitted, Green Published, gold			2022-12-26	WOS:000410859200051
J	Kumar, NP; Moideen, K; Viswanathan, V; Sivakumar, S; Menon, PA; Kornfeld, H; Babu, S				Kumar, Nathella Pavan; Moideen, Kadar; Viswanathan, Vijay; Sivakumar, Shanmugam; Menon, Pradeep A.; Kornfeld, Hardy; Babu, Subash			Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes comorbidity and reversal upon treatment	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ACTIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; CATHELICIDIN LL-37; GRANULYSIN LEVELS; MELLITUS; CELLS; EXPRESSION; PLASMA; FLUID	Background The association of antimicrobial peptides (AMPs) with tuberculosis-diabetes comorbidity (PTB-DM) is not well understood. Methods To study the association of AMPs with PTB-DM, we examined the systemic levels of cathelicidin (LL37), human beta defensin-2 (HBD2), human neutrophil peptides 1-3, (HNP1-3) and granulysin in individuals with either PTB-DM, PTB, latent TB (LTB) or no TB infection (NTB). Results Circulating levels of cathelicidin and HBD2 were significantly higher and granulysin levels were significantly lower in PTB-DM compared to PTB, LTB or NTB, while the levels of HNP1-3 were significantly higher in PTB-DM compared to LTB or NTB individuals. Moreover, the levels of cathelicidin and/or HBD2 were significantly higher in PTB-DM or PTB individuals with bilateral and cavitary disease and also exhibited a significant positive relationship with bacterial burden. Cathelidin, HBD2 and HNP1-3 levels exhibited a positive relationship with HbA1c and/or fasting blood glucose levels. Finally, anti-tuberculosis therapy resulted in significantly diminished levels of cathelicidin, HBD2, granulysin and significantly enhanced levels of HNP1-3 and granulysin in PTB-DM and/or PTB individuals. Conclusion Therefore, our data demonstrate that PTB-DM is associated with markedly enhanced levels of AMPs and diminished levels of granulysin.	[Kumar, Nathella Pavan; Moideen, Kadar; Babu, Subash] Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India; [Viswanathan, Vijay] Prof M Viswanathan Diabet Res Ctr, Madras, Tamil Nadu, India; [Sivakumar, Shanmugam; Menon, Pradeep A.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Worcester, MA USA; [Babu, Subash] NIAID, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India.; Babu, S (corresponding author), NIAID, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sbabu@mail.nih.gov	Kornfeld, Hardy/AAS-2903-2021; Babu, Subash/GXG-4746-2022; Kumar, Nathella Pavan/AAU-2328-2021		Indian Department of Biotechnology; Indian Council of Medical Research; National Institute for Allergy and Infectious Diseases, National Institutes of Health; CRDF Global [USB1-31149-XX-13]; Division of Intramural Research, NIAID, NIH	Indian Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRDF Global; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was jointly sponsored by the Indian Department of Biotechnology; the Indian Council of Medical Research; and the National Institute for Allergy and Infectious Diseases, National Institutes of Health, and administered by CRDF Global [grant USB1-31149-XX-13]. This work was also funded in part by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashitani J, 2002, CHEST, V121, P519, DOI 10.1378/chest.121.2.519; Bates M, 2015, COLD SPRING HARB PER; Bloom BR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0006-2015; Cakir E, 2014, INT J TUBERC LUNG D, V18, P671, DOI 10.5588/ijtld.13.0831; Castaneda-Sanchez JI, 2013, PATHOGENS, V2, P13, DOI 10.3390/pathogens2010013; Di Liberto D, 2007, TUBERCULOSIS, V87, P322, DOI 10.1016/j.tube.2007.01.003; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Girardi E, 2017, INT J INFECT DIS; Gonzalez-Curiel I, 2011, HUM IMMUNOL, V72, P656, DOI 10.1016/j.humimm.2011.03.027; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rivas-Santiago B, 2009, INFECT IMMUN, V77, P4690, DOI 10.1128/IAI.01515-08; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P312, DOI 10.1016/j.tube.2007.01.002; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Silva JP, 2016, BIOTECHNOL ADV, V34, P924, DOI 10.1016/j.biotechadv.2016.05.007; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Yamshchikov AV, 2010, AM J CLIN NUTR, V92, P603, DOI 10.3945/ajcn.2010.29411; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhan YF, 2015, EXP THER MED, V9, P11, DOI 10.3892/etm.2014.2042	33	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184753	10.1371/journal.pone.0184753	http://dx.doi.org/10.1371/journal.pone.0184753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910369	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000410859200091
J	Shen, ZL; Jiang, LL; Yang, SR; Ye, J; Dai, N; Liu, XY; Li, N; Lu, J; Liu, F; Lu, Y; Sun, XJ; Cheng, YQ; Xu, XF				Shen, Zonglin; Jiang, Linling; Yang, Shuran; Ye, Jing; Dai, Nan; Liu, Xiaoyan; Li, Na; Lu, Jin; Liu, Fang; Lu, Yi; Sun, Xuejin; Cheng, Yuqi; Xu, Xiufeng			Identify changes of brain regional homogeneity in early and later adult onset patients with first-episode depression using resting-state fMRI	PLOS ONE			English	Article							DEFAULT MODE NETWORK; CEREBRAL-BLOOD-FLOW; LATE-LIFE DEPRESSION; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; RECURRENT DEPRESSION; NAIVE DEPRESSION; SYMPTOM CLUSTERS; EMOTIONAL FACES; DISORDER	Objective Previous work exhibited different brain grey matter volume (GMV) changes between patients with early adult onset depression (EOD, age 18-29) and later adult onset depression (LOD, age 30-44) by using 30-year-old as the cut-off age. To identify whether regional homogeneity (ReHo) changes are also different between EOD and LOD by using same cutoff age, we used resting-state functional magnetic resonance imaging (fMRI) to detect the abnormal ReHo between patients with EOD and LOD in the present study. Methods Resting-state fMRI scans of 58 patients with EOD, 62 patients with LOD, 60 young healthy controls (HC), and 52 old HC were obtained. The ReHo approach was used to analyze the images. Results The ANOVA analysis revealed that the ReHo values in the frontoparietal, occipital, and cerebellar regions were significantly different among the four groups. Relative to patients with LOD, patients with EOD displayed significantly increased ReHo in the left precuneus, and decreased ReHo in the right fusiform. The ReHo values in the left precuneus and the right fusiform had no significant correlation with the score of the depression rating scale or illness duration in both patient subgroups. Compared to young HC, patients with EOD showed significantly increased ReHo in the right frontoparietal regions and the right calcarine. Furthermore, the increased ReHo in the right frontoparietal regions, right insula and left hippocampus, and decreased ReHo in the left inferior occipital gyrus, right middle occipital gyrus, left calcarine, and left supplementary motor area were observed in patients with LOD when compared to old HC. Conclusions The ReHo of brain areas that were related to mood regulation was changed in the first-episode, drug-naive adult patients with MDD. Adult patients with EOD and LOD exhibited different ReHo abnormalities relative to each age-matched comparison group, suggesting that depressed adult patients with different age-onset might have different pathological mechanism.	[Shen, Zonglin; Jiang, Linling; Yang, Shuran; Ye, Jing; Dai, Nan; Liu, Xiaoyan; Li, Na; Lu, Jin; Liu, Fang; Xu, Xiufeng] Kunming Med Univ, Dept Psychiat, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Lu, Yi; Sun, Xuejin] Kunming Med Univ, Dept Med Imaging, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Cheng, Yuqi] Mental Hlth Inst Yunnan Prov, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University	Xu, XF (corresponding author), Kunming Med Univ, Dept Psychiat, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.	xfxu2004@sina.com		Shen, Zonglin/0000-0002-1015-4535	National Natural Science Foundation of China [81160171, 81660237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Agreement Number 81160171, 81660237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany S, 2013, J AFFECT DISORDERS, V149, P175, DOI 10.1016/j.jad.2013.01.019; Bellgowan JF, 2015, J AM ACAD CHILD PSY, V54, P841, DOI 10.1016/j.jaac.2015.08.001; Buchanan A, 2014, J PSYCHIATR RES, V59, P38, DOI 10.1016/j.jpsychires.2014.09.002; Bukh Jens Drachmann, 2011, Clin Pract Epidemiol Ment Health, V7, P140, DOI 10.2174/1745017901107010140; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Charlton RA, 2013, INT J GERIATR PSYCH, V28, P1166, DOI 10.1002/gps.3939; Chen JD, 2012, J AFFECT DISORDERS, V143, P56, DOI 10.1016/j.jad.2012.05.025; Cheng YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112307; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Graff-Guerrero A, 2004, J AFFECT DISORDERS, V80, P55, DOI 10.1016/S0165-0327(03)00049-1; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Grayson L, 2013, J AFFECT DISORDERS, V150, P161, DOI 10.1016/j.jad.2013.03.021; Guo WB, 2015, J AFFECT DISORDERS, V179, P31, DOI 10.1016/j.jad.2015.03.028; Guo WB, 2014, PROG NEURO-PSYCHOPH, V54, P1, DOI 10.1016/j.pnpbp.2014.05.008; Guo WB, 2013, J AFFECT DISORDERS, V151, P1097, DOI 10.1016/j.jad.2013.09.003; Harald B, 2012, J AFFECT DISORDERS, V139, P126, DOI 10.1016/j.jad.2011.07.015; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ho TC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00040; Janssen J, 2006, INT J GERIATR PSYCH, V21, P86, DOI 10.1002/gps.1428; Joormann J, 2007, J ABNORM PSYCHOL, V116, P135, DOI 10.1037/0021-843X.116.1.135; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kendall MG, 1990, RANK CORRELATION MET, Vvii; Kendler KS, 2009, BIOL PSYCHIAT, V65, P808, DOI 10.1016/j.biopsych.2008.11.015; Korten NCM, 2012, J AFFECT DISORDERS, V138, P259, DOI 10.1016/j.jad.2012.01.042; Kujawa AJ, 2011, J ABNORM CHILD PSYCH, V39, P125, DOI 10.1007/s10802-010-9438-6; Lai CH, 2016, BRAIN IMAGING BEHAV, V10, P187, DOI 10.1007/s11682-015-9381-9; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lau WKW, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.55; Lemogne C, 2010, J AFFECT DISORDERS, V124, P196, DOI 10.1016/j.jad.2009.11.003; Liang MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079999; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lyons MJ, 1998, ARCH GEN PSYCHIAT, V55, P468, DOI 10.1001/archpsyc.55.5.468; Park SC, 2014, YONSEI MED J, V55, P1712, DOI 10.3349/ymj.2014.55.6.1712; Parker G, 1999, J AFFECT DISORDERS, V52, P11, DOI 10.1016/S0165-0327(98)00084-6; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Perico CAM, 2005, NEUROSCI LETT, V384, P265, DOI 10.1016/j.neulet.2005.04.088; Qin JL, 2014, MAGN RESON MED, V72, P1397, DOI 10.1002/mrm.25036; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen ZL, 2016, NEUROIMAGE-CLIN, V12, P492, DOI 10.1016/j.nicl.2016.08.016; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Tozzi F, 2008, PSYCHOL MED, V38, P641, DOI 10.1017/S0033291707002681; Vasic N, 2015, J PSYCHIATR NEUROSCI, V40, P412, DOI 10.1503/jpn.140246; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Xue S, 2016, BEHAV BRAIN RES, V306, P13, DOI 10.1016/j.bbr.2016.03.012; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang X, 2015, NEUROPSYCH DIS TREAT, V11, P2415, DOI 10.2147/NDT.S93055; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhong X, 2016, J AFFECT DISORDERS, V206, P280, DOI 10.1016/j.jad.2016.09.005; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	58	20	21	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184712	10.1371/journal.pone.0184712	http://dx.doi.org/10.1371/journal.pone.0184712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910390	Green Published, Green Submitted, gold			2022-12-26	WOS:000410859200082
J	Chen, JF; Li, RH; Xia, YS; Bai, GH; Guo, PG; Wang, ZL; Zhang, H; Siddique, KHM				Chen, Jingfang; Li, Ronghua; Xia, Yanshi; Bai, Guihua; Guo, Peiguo; Wang, Zhiliang; Zhang, Hua; Siddique, Kadambot H. M.			Development of EST-SSR markers in flowering Chinese cabbage (Brassica campestris L. ssp chinensis var. utilis Tsen et Lee) based on de novo transcriptomic assemblies	PLOS ONE			English	Article							MICROSATELLITES; GENES; TOOL	Flowering Chinese cabbage is one of the most important vegetable crops in southern China. Genetic improvement of various agronomic traits in this crop is underway to meet high market demand in the region, but the progress is hampered by limited number of molecular markers available in this crop. This study aimed to develop EST-SSR markers from transcriptome sequences generated by next-generation sequencing. RNA-seq of eight cabbage samples identified 48,975 unigenes. Of these unigenes, 23,267 were annotated in 56 gene ontology ( GO) categories, 6,033 were mapped to 131 KEGG pathways, and 7,825 were assigned to clusters of orthologous groups (COGs). From the unigenes, 8,165 EST-SSR loci were identified and 98.57% of them were 1-3 nucleotide repeats with 14.32%, 41.08% and 43.17% of mono-, di- and tri-nucleotide repeats, respectively. Fifty-eight types of motifs were identified with A/T, AG/CT, AT/AT, AC/GT, AAG/CTT and AGG/CCT the most abundant. The lengths of repeated nucleotide sequences in all SSR loci ranged from 12 to 60 bp, with most (88.51%) under 20 bp. Among 170 primer pairs were randomly selected from a total of 4,912 SSR primers we designed, 48 yielded unambiguously polymorphic bands with high reproducibility. Cluster analysis using 48 SSRs classified 34 flowering Chinese cabbage cultivars into three groups. A large number of EST-SSR markers identified in this study will facilitate marker-assisted selection in the breeding programs of flowering Chinese cabbage.	[Chen, Jingfang; Li, Ronghua; Xia, Yanshi; Guo, Peiguo; Wang, Zhiliang] Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China; [Bai, Guihua] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA; [Zhang, Hua] Guangzhou Acad Agr Sci, Guangzhou, Guangdong, Peoples R China; [Siddique, Kadambot H. M.] Univ Western Australia, UWA Inst Agr, Perth, WA, Australia; [Siddique, Kadambot H. M.] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia	Guangzhou University; United States Department of Agriculture (USDA); University of Western Australia; University of Western Australia	Guo, PG (corresponding author), Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China.	guopg@gzhu.edu.cn	bai, guihua/L-6374-2019; Siddique, Kadambot H.M./B-3462-2011; Li, Ronghua/AAP-8236-2021	bai, guihua/0000-0002-1194-319X; Siddique, Kadambot H.M./0000-0001-6097-4235; 	Guangdong Natural Science Foundation of China [2015A030313500]; Provincial Key International Cooperative Research Platform of Guangdong Higher Education [2015KGJHZ015]; Major Scientific Research Project of Guangdong Higher Education [2015KGJHZ015]; Science and Technology Plan of Guangdong of China [2016B020201001]	Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Provincial Key International Cooperative Research Platform of Guangdong Higher Education; Major Scientific Research Project of Guangdong Higher Education; Science and Technology Plan of Guangdong of China	This work was supported by the Guangdong Natural Science Foundation of China (http://www.gdstc.gov.cn) through grant 2015A030313500 to PG, by the Provincial Key International Cooperative Research Platform and the Major Scientific Research Project of Guangdong Higher Education (http://www.gdhed.edu.cn) through grant 2015KGJHZ015 to PG, and by the Science and Technology Plan of Guangdong of China (http://www.gdstc.gov.cn) through grant 2016B020201001 to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Blavet N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-376; Chen HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151040; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen J, 2016, NO HORTICULTURE, V15, P86; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding Q, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/473028; Du F, 2015, PLANT MOL BIOL REP, V33, P281, DOI 10.1007/s11105-014-0746-9; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galvao KSC, 2015, GENET MOL RES, V14, P7344, DOI 10.4238/2015.July.3.10; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [郭培国 Guo Peiguo], 2015, [园艺学报, Acta Horticulturae Sinica], V42, P350; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Huang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00496; Krawczak M, 2006, COMMUNITY GENETICS, V9; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li Rui, 2009, ELECT APPL METALLURG, V28, P16; Liu WJ, 2017, ELECTROPHORESIS, V38, P1175, DOI 10.1002/elps.201700009; Liu Z, 2013, PLOS ONE, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0083549; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Nagy S, 2012, BIOCHEM GENET, V50, P670, DOI 10.1007/s10528-012-9509-1; Pejic I, 1998, THEOR APPL GENET, V97, P1248, DOI 10.1007/s001220051017; Qiao Y, 2012, MOL PLANT BREEDING, V10, P1369; Rohlf F, 2000, MULTIVARIATE ANAL SY; Russell J, 2014, MOL BREEDING, V33, P835, DOI 10.1007/s11032-013-9996-8; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Song XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1534-0; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tsai CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141761; Tuler AC, 2015, MOL BIOL REP, V42, P1501, DOI 10.1007/s11033-015-3927-1; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yagi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-734; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Zhai LL, 2014, MOL BREEDING, V33, P611, DOI 10.1007/s11032-013-9978-x; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang XW, 2014, GENE, V551, P206, DOI 10.1016/j.gene.2014.08.058	45	20	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184736	10.1371/journal.pone.0184736	http://dx.doi.org/10.1371/journal.pone.0184736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902884	Green Published, Green Submitted, gold			2022-12-26	WOS:000410669200057
J	Chen, YK; Zhi, JK; Zhang, H; Li, J; Zhao, QH; Xu, JC				Chen, Yongkun; Zhi, Junkai; Zhang, Hao; Li, Jian; Zhao, Qihong; Xu, Jichen			Transcriptome analysis of Phytolacca americana L. in response to cadmium stress	PLOS ONE			English	Article							ARABIDOPSIS-HALLERI; HYPERACCUMULATING PLANTS; SALT STRESS; METAL; GENE; ROOT; CD; PHYTOREMEDIATION; ACCUMULATION; METALLOTHIONEINS	Phytolacca americana L. (pokeweed) has metal phytoremediation potential, but little is known about its metal accumulation-related genes. In this study, the de novo sequencing of total RNA produced 53.15 million reads covering 10.63 gigabases of transcriptome raw data in cadmium (Cd)-treated and untreated pokeweed. Of the 97,502 assembled unigenes, 42,197 had significant matches in a public database and were annotated accordingly. An expression level comparison between the samples revealed 1515 differentially expressed genes (DEGs), 923 down-and 592 up-regulated under Cd treatment. A KEGG pathway enrichment analysis of DEGs revealed that they were involved in 72 metabolism pathways, with photosynthesis, phenylalanine metabolism, ribosome, phenylpropanoid biosynthesis, flavonoid biosynthesis and carbon fixation in photosynthetic organisms containing 24, 18, 72, 14, 7 and 15 genes, respectively. Genes related to heavy metal tolerance, absorption, transport and accumulation were also identified, including 11 expansins, 8 nicotianamine synthases, 6 aquaporins, 4 ZRT/IRT-like proteins, 3 ABC transporters and 3 metallothioneins. The gene expression results of 12 randomly selected DEGs were validated using quantitative real-time PCR, and showed different response patterns to Cd in their roots, stems and leaves. These results may be helpful in increasing our understanding of heavy metal hyperaccumulators and in future phytoremediation applications.	[Chen, Yongkun; Zhi, Junkai; Zhang, Hao; Li, Jian; Zhao, Qihong; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University	Xu, JC (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	jcxu282@sina.com			Fundamental Research Funds for the Central Universities grants [2015ZCQ-SW-01]; Beijing Natural Science Foundation [5122019]	Fundamental Research Funds for the Central Universities grants; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Fundamental Research Funds for the Central Universities grants (2015ZCQ-SW-01) and Beijing Natural Science Foundation (5122019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Callahan DL, 2006, J BIOL INORG CHEM, V11, P2, DOI 10.1007/s00775-005-0056-7; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Chen YK, 2015, PLANT CELL TISS ORG, V121, P389, DOI 10.1007/s11240-015-0710-x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Delalande O, 2010, FEBS J, V277, P5086, DOI 10.1111/j.1742-4658.2010.07913.x; Eapen S, 2005, BIOTECHNOL ADV, V23, P97, DOI 10.1016/j.biotechadv.2004.10.001; Fu XP, 2011, J HAZARD MATER, V186, P103, DOI 10.1016/j.jhazmat.2010.10.122; Gao J, 2015, BIOCHEM BIOPH RES CO, V459, P60, DOI 10.1016/j.bbrc.2015.02.066; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064643; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; He JL, 2013, PLANT PHYSIOL, V162, P424, DOI 10.1104/pp.113.215681; Kelly G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087888; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2004, PLANT MOL BIOL, V54, P805, DOI 10.1007/s11103-004-0190-6; Lin YF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00261; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu J, 2015, J HAZARD MATER, V294, P99, DOI 10.1016/j.jhazmat.2015.03.060; Liu XQ, 2010, CHEMOSPHERE, V78, P1136, DOI 10.1016/j.chemosphere.2009.12.030; Lochlainn SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017814; Maurel C, 1997, ANNU REV PLANT PHYS, V48, P399, DOI 10.1146/annurev.arplant.48.1.399; McGrath SP, 2006, ENVIRON POLLUT, V141, P115, DOI 10.1016/j.envpol.2005.08.022; Milner MJ, 2014, PLANT J, V78, P398, DOI 10.1111/tpj.12480; Peng KJ, 2008, J HAZARD MATER, V154, P674, DOI 10.1016/j.jhazmat.2007.10.080; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; SALT DE, 1995, PLANT PHYSIOL, V109, P1427, DOI 10.1104/pp.109.4.1427; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Venkatachalam P, 2009, ENVIRON SCI TECHNOL, V43, P843, DOI 10.1021/es801304n; Weber M, 2006, PLANT CELL ENVIRON, V29, P950, DOI 10.1111/j.1365-3040.2005.01479.x; Xie Y, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00202, 10.3389/fpls.2015.00202]; Xu J, 2012, NEW PHYTOL, V196, P110, DOI 10.1111/j.1469-8137.2012.04235.x; Xu L, 2015, PLANT SCI, V236, P313, DOI 10.1016/j.plantsci.2015.04.015; Xu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093275; [严海燕 Yan Haiyan], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P16; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhou ZS, 2013, J HAZARD MATER, V252, P123, DOI 10.1016/j.jhazmat.2013.02.011; Zimeri AM, 2005, PLANT MOL BIOL, V58, P839, DOI 10.1007/s11103-005-8268-3	42	24	25	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184681	10.1371/journal.pone.0184681	http://dx.doi.org/10.1371/journal.pone.0184681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898278	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500043
J	Chen, YY; Sheu, SJ; Hu, HY; Chu, DC; Chou, P				Chen, Yu-Yen; Sheu, Shwu-Jiuan; Hu, Hsiao-Yun; Chu, Dachen; Chou, Pesus			Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; MORTALITY; HOMOCYSTEINE; PREVALENCE; BRANCH; VALIDATION; MORBIDITY; STROKE	Objective To investigate a possible association between retinal vein occlusion (RVO) and an increased risk of developing acute myocardial infarction (AMI). Design A population-based retrospective cohort study using the entire population of the Taiwan National Health Insurance Research Database (NHIRD) from 1 st January, 2001 to 31 st December, 2013. Methods A total of 37921 subjects with RVO were enrolled in the RVO group, and 113763 subjects without RVO were enrolled in the comparison group. The comparison group consisted of randomly selected individuals who were propensity score (PS)-matched with the RVO group at a ratio of 1: 3, based on age, gender, obesity, stroke, hyperviscosity syndrome, glaucoma, and the use of antithrombotic drugs. A log-rank test was used to compare the cumulative hazard of AMI between the two groups. A multivariate Cox regression analysis was used to estimate the adjusted hazard ratios (HRs) of AMI, adjusted for PS, diabetes, hypertension, hyperlipidemia, congestive heart failure, and chronic renal failure. Results The mean age of the cohort was 62.4 +/- 13.2 years. RVO patients had significantly higher proportions of diabetes, hypertension, hyperlipidemia, congestive heart failure, and chronic renal failure than the comparisons. The mean follow-up period was 5.52 years in the RVO group and 5.55 years in the comparison group (p = 0.16). A log-rank test comparing the cumulative hazard curves of AMI for the two groups revealed a significant difference (p< 0.0001). In the multivariate Cox regression after adjustment for PS and confounders, the RVO group had a significantly higher risk of AMI (adjusted HR = 1.21; 95% CI: 1.13 to 1.30). When the RVO group was divided into central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) and analyzed separately, both groups had significantly higher adjusted HRs for developing AMI than the comparison group. Moreover, the CRVO group had a significantly higher risk of AMI than the BRVO group. Conclusions People with RVO are at significantly greater risk of developing AMI than individuals without RVO.	[Chen, Yu-Yen; Sheu, Shwu-Jiuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Yu-Yen] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Yilan County, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Sheu, Shwu-Jiuan; Chu, Dachen] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Hu, Hsiao-Yun; Chu, Dachen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chu, Dachen] Taipei City Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Taipei City Hospital; Taipei City Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.	pschou@ym-edu.tw						APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; Bertelsen M, 2014, OPHTHALMOLOGY, V121, P637, DOI 10.1016/j.ophtha.2013.07.025; Bertelsen M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7885; Bonow R., 2012, BRAUNWALDS HEART DIS, DOI DOI 10.1093/eurheartj/ehw249; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Di Capua M, 2012, NUTR METAB CARDIOVAS, V22, P23, DOI 10.1016/j.numecd.2010.03.008; Di Capua M, 2010, J THROMB THROMBOLYS, V30, P16, DOI 10.1007/s11239-009-0388-1; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Jones M, 2016, J CRIT CARE, V36, P195, DOI 10.1016/j.jcrc.2016.07.017; Kesler A, 2008, BLOOD COAGUL FIBRIN, V19, P259, DOI 10.1097/MBC.0b013e3282f2b60e; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Kolar P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/724780; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lim LL, 2008, BRIT J OPHTHALMOL, V92, P1316, DOI 10.1136/bjo.2008.140640; MANSOUR AM, 1992, OPHTHALMOLOGICA, V204, P199, DOI 10.1159/000310294; McGimpsey SJ, 2009, OPHTHALMOLOGY, V116, P1778, DOI 10.1016/j.ophtha.2009.02.033; Newman-Casey PA, 2014, OPHTHALMOLOGY, V121, P1939, DOI 10.1016/j.ophtha.2014.04.045; Parsons LS, PERFROMING 1 N CASE; Ponto KA, 2015, J THROMB HAEMOST, V13, P1254, DOI 10.1111/jth.12982; Rim TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22351; Shih CH, 2015, INT J CARDIOL, V178, P256, DOI 10.1016/j.ijcard.2014.10.110; Sodi A, 2011, RETINA-J RET VIT DIS, V31, P724, DOI 10.1097/IAE.0b013e3181eef419; Sofi F, 2008, ATHEROSCLEROSIS, V198, P223, DOI 10.1016/j.atherosclerosis.2007.09.009; The Taiwan National Health Research Institutes, NAT HLTH INS RES DAT; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Werther W, 2011, ARCH OPHTHALMOL-CHIC, V129, P326, DOI 10.1001/archophthalmol.2011.2; Yasuda M, 2010, INVEST OPHTH VIS SCI, V51, P3205, DOI 10.1167/iovs.09-4453; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033	31	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184016	10.1371/journal.pone.0184016	http://dx.doi.org/10.1371/journal.pone.0184016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898259	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500011
J	Kumar, B; Miller, K; Charon, NW; Legleiter, J				Kumar, Bharath; Miller, Kelly; Charon, Nyles W.; Legleiter, Justin			Periplasmic flagella in Borrelia burgdoferi function to maintain cellular integrity upon external stress	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BURGDORFERI; MOTILITY; PROTEIN; CHEMOTAXIS; DYNAMICS; SHAPE; COMPLEMENTATION; INACTIVATION; CYTOSKELETON	Tapping mode atomic force microscopy (AFM) in solution was used to analyze the role of the internally located periplasmic flagella (PFs) of the Lyme disease spirochete Borrelia burgdorferi in withstanding externally applied cellular stresses. By systematically imaging immobilized spirochetes with increasing tapping forces, we found that mutants that lack PFs are more readily compressed and damaged by the imaging process compared to wild-type cells. This finding suggest that the PFs, aside from being essential for motility and involved in cell shape, play a cytoskeletal role in dissipating energy and maintaining cellular integrity in the presence of external stress.	[Kumar, Bharath; Legleiter, Justin] West Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Miller, Kelly; Charon, Nyles W.] West Virginia Univ, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV USA; [Charon, Nyles W.; Legleiter, Justin] West Virginia Univ, WVU nanoSAFE, Morgantown, WV 26506 USA; [Legleiter, Justin] West Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Legleiter, J (corresponding author), West Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.; Legleiter, J (corresponding author), West Virginia Univ, WVU nanoSAFE, Morgantown, WV 26506 USA.; Legleiter, J (corresponding author), West Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA.	justin.legleiter@mail.wvu.edu		Legleiter, Justin/0000-0002-5262-1867	National Institutes of Health [R01-DE023431, R01-A10297]; WV Higher Education Policy Commission/Division of Science and Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WV Higher Education Policy Commission/Division of Science and Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by ther National Institutes of Health, Grant # R01-DE023431 and Grant # R01-A10297, (https://www.nih.gov/) and the WV Higher Education Policy Commission/Division of Science and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker RG, 2007, APPL ENVIRON MICROB, V73, P1180, DOI 10.1128/AEM.01913-06; Burke KA, 2013, BIOCHEMISTRY-US, V52, P808, DOI 10.1021/bi301070v; Caro-Quintero A, 2012, MBIO, V3, DOI 10.1128/mBio.00025-12; Chaibva M, 2015, SURFACE SCI TOOLS NA, P69; CHARON NW, 1992, J BACTERIOL, V174, P832, DOI 10.1128/jb.174.3.832-840.1992; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Charon NW, 2009, J BACTERIOL, V191, P600, DOI 10.1128/JB.01288-08; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Dombrowski C, 2009, BIOPHYS J, V96, P4409, DOI 10.1016/j.bpj.2009.02.066; Ebady R, 2016, CELL REP, V16, P2593, DOI 10.1016/j.celrep.2016.08.013; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Goldstein SF, 1996, J BACTERIOL, V178, P6539, DOI 10.1128/jb.178.22.6539-6545.1996; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; Guzman HV, 2013, ACS NANO, V7, P3198, DOI 10.1021/nn4012835; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143; Kumar B, 2010, J APPL PHYS, V107, DOI 10.1063/1.3309330; Legleiter J, 2006, P NATL ACAD SCI USA, V103, P4813, DOI 10.1073/pnas.0505628103; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Limberger RJ, 2004, J MOL MICROB BIOTECH, V7, P30, DOI 10.1159/000077867; Lin T, 2015, MBIO, V6, DOI 10.1128/mBio.00579-15; Marx KA, 2007, ANAL BIOCHEM, V361, P77, DOI 10.1016/j.ab.2006.09.023; Miller KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098338; Miller MR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.134, 10.1038/nmicrobiol.2016.134]; Moon KH, 2016, MOL MICROBIOL, V102, P336, DOI 10.1111/mmi.13463; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2015, CURR OPIN MICROBIOL, V28, P106, DOI 10.1016/j.mib.2015.09.006; Paster BJ, 2011, BERGEYS MANUAL SYSTE, V3, P471; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Sartakova ML, 2001, J BACTERIOL, V183, P6558, DOI 10.1128/JB.183.22.6558-6564.2001; Shaik NH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866664; Shamitko-Klingensmith N, 2015, SCANNING, V37, P23, DOI 10.1002/sca.21175; Shamitko-Klingensmith N, 2012, LANGMUIR, V28, P13411, DOI 10.1021/la302705f; Sultan SZ, 2015, INFECT IMMUN, V83, P1765, DOI 10.1128/IAI.03097-14; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; Sze CW, 2012, INFECT IMMUN, V80, P2485, DOI 10.1128/IAI.00145-12; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Vig DK, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.218104; Wolgemuth CW, 2006, J MOL MICROB BIOTECH, V11, P221, DOI 10.1159/000094056; Wolgemuth CW, 2015, SEMIN CELL DEV BIOL, V46, P104, DOI 10.1016/j.semcdb.2015.10.015; Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403; Xue RD, 2015, ADV SCI, V2, DOI 10.1002/advs.201500129; Yang J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.268101; Zhang K, 2012, MOL MICROBIOL, V85, P782, DOI 10.1111/j.1365-2958.2012.08139.x; Zhao XW, 2013, P NATL ACAD SCI USA, V110, P14390, DOI 10.1073/pnas.1308306110	49	0	0	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184648	10.1371/journal.pone.0184648	http://dx.doi.org/10.1371/journal.pone.0184648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898274	Green Published, gold, Green Submitted			2022-12-26	WOS:000410449500039
J	Leijs, MM; Koppe, JG; Vulsma, T; Olie, K; van Aalderen, WMC; de Voogt, P; Legler, J; ten Tusscher, GW				Leijs, Marike M.; Koppe, Janna G.; Vulsma, Thomas; Olie, Kees; van Aalderen, Wim M. C.; de Voogt, Pim; Legler, Juliette; ten Tusscher, Gavin W.			Alterations in the programming of energy metabolism in adolescents with background exposure to dioxins, dl-PCBs and PBDEs	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POLYCHLORINATED-BIPHENYLS; INSULIN-SECRETION; DIABETES-MELLITUS; AH RECEPTOR; HEALTH; ASSOCIATIONS; VETERANS; PATHWAY	Objectives Dioxins and PCBs are highly toxic and persistent environmental pollutants that are measurable in humans worldwide. These persistent organic pollutants are associated with a higher incidence of diabetes mellitus. We hypothesise that perinatal (background) exposure to industrial pollutants like dioxins also influences body mass development and energy metabolism in later life. Study design In The Netherlands, the perinatal exposure (prenatal exposure and postnatal lactational intake) to dioxins has been studied prospectively since 1987. Fasting glucose, insulin, HbA1c and leptin were analysed in 33 children of the original cohort of 60. BMI, glucose: insulin and BMI: leptin ratios were calculated. Prenatal exposure, lactational intake and current serum levels of dioxins (PCDD/F), dl-PCBs and PBDE concentrations were determined using (HR)GC-MS. Results Prenatal dioxin (PCDD/F) exposure was positively correlated to the glucose: insulin ratio (p = 0.024) and negatively correlated to the fasting insulin concentration (p = 0.017) in adolescence. Postnatal lactational PCDD/F intake was also negatively correlated to fasting insulin concentration (p = 0.028). Current serum levels of PCDD/Fs and total TEQ (dl-PCBs +PCDD/Fs) were positively correlated to the fasting serum glucose concentration (p = 0.015 and p = 0.037, respectively). No metabolic effects were seen in association with current serum levels of PBDEs. A positive correlation between the insulin and leptin concentrations (p = 0.034) was observed. No effects were found on leptin levels, BMI: leptin ratio, HbA1c levels or BMI. Discussion/Conclusion This study indicates that prenatal and lactational exposure influences glucose metabolism in adolescents, presumably through a negative effect on insulin secretion by pancreatic beta cells. Additionally, the very low recent background exposure to dioxins in puberty possibly has an effect on the glucose level.	[Leijs, Marike M.; Koppe, Janna G.; Vulsma, Thomas; van Aalderen, Wim M. C.] Acad Med Ctr, Emma Childrens Hosp, Dept Paediat & Neonatol, Amsterdam, Netherlands; [Leijs, Marike M.; Olie, Kees; de Voogt, Pim] Univ Amsterdam, IBED AEE, Amsterdam, Netherlands; [Koppe, Janna G.] Ecobaby Fdn, Loenersloot, Netherlands; [de Voogt, Pim] KWR Watercycle Res Inst, Nieuwegein, Netherlands; [Legler, Juliette] Vrije Univ Amsterdam, Inst Environm Studies IVM, Amsterdam, Netherlands; [ten Tusscher, Gavin W.] Westfriesgasthuis, Dept Paediat & Neonatol, Hoorn, Netherlands; [Leijs, Marike M.] RTWH Univ Aachen, Dept Dermatol & Allergol, Aachen, Germany; [Legler, Juliette] Brunel Univ, Coll Hlth & Life Sci, London, England	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; KWR Watercycle Research Institute; Vrije Universiteit Amsterdam; Brunel University	Leijs, MM (corresponding author), Acad Med Ctr, Emma Childrens Hosp, Dept Paediat & Neonatol, Amsterdam, Netherlands.; Leijs, MM (corresponding author), Univ Amsterdam, IBED AEE, Amsterdam, Netherlands.; ten Tusscher, GW (corresponding author), Westfriesgasthuis, Dept Paediat & Neonatol, Hoorn, Netherlands.; Leijs, MM (corresponding author), RTWH Univ Aachen, Dept Dermatol & Allergol, Aachen, Germany.	mleijs@ukaachen.de; g.tentusscher@westfriesgasthuis.nl	de Voogt, Pim/C-5683-2017; ten Tusscher, Gavin/ABG-5282-2021	de Voogt, Pim/0000-0001-9065-9797; ten Tusscher, Gavin/0000-0001-6448-5631; Leijs, Marike/0000-0002-2911-1025	Netherlands Ministry of Housing, Spatial Planning and the Environment; E.C. grant [227391]	Netherlands Ministry of Housing, Spatial Planning and the Environment; E.C. grant	The study was financially supported by the Netherlands Ministry of Housing, Spatial Planning and the Environment. The paper was supported by E.C. grant: OBELIX nr: 227391.	Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; de Voogt P., 1989, HALOGENATED BIPHENYL, V3 -45; Esser A, 2016, INT J HYG ENVIR HEAL, V219, P557, DOI 10.1016/j.ijheh.2016.06.001; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Grandjean P, 2011, EPIDEMIOLOGY, V22, P410, DOI 10.1097/EDE.0b013e318212fab9; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Ilsen A, 1996, CHEMOSPHERE, V33, P1317, DOI 10.1016/0045-6535(96)00269-X; Jensen TK, 2014, J CLIN ENDOCR METAB, V99, pE2643, DOI 10.1210/jc.2014-1683; Jones OAH, 2008, LANCET, V371, P287, DOI 10.1016/S0140-6736(08)60147-6; Kim YH, 2009, INT J TOXICOL, V28, P151, DOI 10.1177/1091581809336885; Koizumi A, 2005, ENVIRON RES, V99, P31, DOI 10.1016/j.envres.2004.12.002; Kurita H, 2009, J APPL TOXICOL, V29, P689, DOI 10.1002/jat.1459; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee YH, 2003, INT J DEV BIOL, V47, P459; Leijs M., 2014, BIOMONITORING, V1, P1; Leijs MM, 2008, CHEMOSPHERE, V73, P176, DOI 10.1016/j.chemosphere.2008.05.056; Leijs MM, 2008, CHEMOSPHERE, V73, P999, DOI 10.1016/j.chemosphere.2008.05.053; Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324; Linden J, 2005, J BIOCHEM MOL TOXIC, V19, P139, DOI 10.1002/jbt.20065; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; McDonald E, 2012, INT J BIOCHEM CELL B, V44, P72, DOI 10.1016/j.biocel.2011.09.008; Michalek J, 2000, VETERANS AGENT ORANG; Michalek JE, 2003, J TOXICOL ENV HEAL A, V66, P211, DOI 10.1080/15287390306373; Michalek JE, 2008, J OCCUP ENVIRON MED, V50, P330, DOI 10.1097/JOM.0b013e31815f889b; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Nash JT, 2013, J TOXICOL ENV HEAL A, V76, P142, DOI 10.1080/15287394.2012.738457; Novelli M, 2005, TOXICOL LETT, V156, P307, DOI 10.1016/j.toxlet.2004.12.004; OLIE K, 1977, Chemosphere, V6, P455, DOI 10.1016/0045-6535(77)90035-2; Pilsner JR, 2017, REPROD TOXICOL, V69, P221, DOI 10.1016/j.reprotox.2017.03.002; PLUIM HJ, 1994, ACTA PAEDIATR, V83, P583; PLUIM HJ, 1994, ENVIRON HEALTH PERSP, V102, P968, DOI 10.2307/3431920; Pluim HJ, 2003, PRE POSTNATAL EXPOSU; Ravelli A. C. J., 1998, International Journal of Obesity, V22, pS18; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; Stapleton HM, 2012, ENVIRON HEALTH PERSP, V120, P1049, DOI 10.1289/ehp.1104802; ten Tusscher GW, 2004, CHEMOSPHERE, V54, P1329, DOI 10.1016/S0045-6535(03)00254-6; ten Tusscher GW, 1999, ORGANOHALOGEN COMPOU, V42, P213; ten Tusscher GW, 2002, THESIS; Uchi Hiroshi, 2013, Fukuoka Acta Medica, V104, P85; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Villano CM, 2006, TOXICOL SCI, V92, P1, DOI 10.1093/toxsci/kfj215; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Yoshioka W, 2011, TOXICOL SCI, V122, P457, DOI 10.1093/toxsci/kfr130; Zhang SQ, 2015, ENVIRON SCI TECHNOL, V49, P10084, DOI 10.1021/acs.est.5b01597	52	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184006	10.1371/journal.pone.0184006	http://dx.doi.org/10.1371/journal.pone.0184006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898241	Green Published, Green Submitted, gold			2022-12-26	WOS:000410449500010
J	Lopez-Diez, E; Perez, S; Carballo, M; Inarrea, A; de la Orden, A; Castro, M; Rodriguez, M; Almuster, S; Montero, R; Perez, M; Sanchez, J; Ojea, A				Lopez-Diez, Elena; Perez, Sonia; Carballo, Manuel; Inarrea, Amparo; de la Orden, Angel; Castro, Maximo; Rodriguez, Moises; Almuster, Sheila; Montero, Ruben; Perez, Miguel; Sanchez, Jorge; Ojea, Antonio			Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population	PLOS ONE			English	Article							MALE SEXUAL PARTNERS; GENITAL HUMAN-PAPILLOMAVIRUS; FEMALE PARTNERS; HPV INFECTION; MALE CIRCUMCISION; CERVICAL-CANCER; PENILE CANCER; CONDOM USE; MEN; WOMEN	Background High risk human papillomavirus (HR-HPV) infection in males is a health issue with implications for HPV-related lesions in their partners. The identification of risk factors for male infection may improve our understanding of HR-HPV transmission and prevention. The aim of this study was to evaluate the relationships between lifestyle, genital warts and HR-HPV infection. The study was focused on men with an increased risk of HR-HPV infection: male sexual partners of women diagnosed with high-grade squamous intraepithelial cervical lesions. Methods Men were enrolled and prospectively recruited within the first six months after diagnosis of cervical lesions in their female partners (n = 175, 2013-2016). Epidemiological and sexual behaviour data were obtained. The presence of genital warts was established by visual inspection. Detection and genotyping of HR-HPV infection in genital samples were performed with a Linear Array HPV Genotyping Test. All HR-HPV positive men were offered a follow-up exam at 12 months. SPSS version 19 was used for statistical analysis. Results and discussion The prevalence of HR-HPV infection in men was 45.1% (79/175). Genital warts were observed in 10.3% (18/175) of the subjects. Detection of genital warts (OR 3.5, p = 0.015), smoking habits (OR 2.3, p = 0.006) and sexual debut before 16 years old (OR 2, p = 0.035) were associated with an increased risk for HR-HPV infection (univariate analysis). This association was also observed for genital warts and smoking status in a multivariate analysis. The same genotype was found after one year in 71.4% (20/28) of subjects. Conclusions The presence of genital warts and smoking habits seem to be associated with a higher risk of HR-HPV infection in males. Earlier sexual debut may increase this risk. Extensive knowledge of the natural history of HR-HPV infection in males is an absolute requirement for the design and implementation of prevention strategies for the general population as well as for specific populations such as couples after treatment for high-grade cervical lesions.	[Lopez-Diez, Elena; Carballo, Manuel; Castro, Maximo; Rodriguez, Moises; Almuster, Sheila; Montero, Ruben; Perez, Miguel; Sanchez, Jorge; Ojea, Antonio] Univ Hosp Vigo, Dept Urol, Vigo, Spain; [Perez, Sonia] Univ Hosp Vigo, Dept Microbiol, Vigo, Spain; [Inarrea, Amparo; de la Orden, Angel] Univ Hosp Vigo, Dept Obstet & Gynecol, Vigo, Spain	Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Vigo	Lopez-Diez, E (corresponding author), Univ Hosp Vigo, Dept Urol, Vigo, Spain.	elena.lopez.diez@sergas.es	Almuster, Sheila/AFV-2386-2022; Carballo Quinta, Manuel/ABF-5188-2021	Lopez Diez, Elena/0000-0002-8411-6945; PEREZ CASTRO, SONIA/0000-0003-1734-1904				Afonso LA, 2013, BRAZ J MED BIOL RES, V46, P533, DOI 10.1590/1414-431X20132519; Albero G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-18; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Andrews JC, 2016, J LOW GENIT TRACT DI, V20, P195, DOI 10.1097/LGT.0000000000000226; [Anonymous], 2003, J NATL CANC I MONOGR, P20; Arbyn M, 2014, J PATHOL; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; Bar-Am A, 2007, EUR J GYNAECOL ONCOL, V28, P207; Bleeker MCG, 2003, INT J CANCER, V107, P804, DOI 10.1002/ijc.11473; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Bosch FX, 1996, JNCI-J NATL CANCER I, V88, P1060, DOI 10.1093/jnci/88.15.1060; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Burchell AN, 2014, J INFECT DIS, V210, P846, DOI 10.1093/infdis/jiu200; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; de Bruijn RE, 2013, BJU INT, V112, P905, DOI 10.1111/bju.12237; de Irala J, 2011, ARCH SEX BEHAV, V40, P853, DOI 10.1007/s10508-011-9779-4; Dunne EF, 2013, INFECT DIS CLIN N AM, V27, P765, DOI 10.1016/j.idc.2013.09.001; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Giraldo PC, 2008, EUR J OBSTET GYN R B, V137, P88, DOI 10.1016/j.ejogrb.2006.12.026; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Hebnes JB, 2014, J SEX MED, V11, P2630, DOI 10.1111/jsm.12652; Kalra R, 2000, J PHARMACOL EXP THER, V293, P166; Lopez Diez E, 2016, ENFERM INFEC MICR CL; Lopez-Diez E, 2016, INTECH; Lopez-Romero R, 2013, INT J CLIN EXP PATHO, V6, P1409; Lu BB, 2012, CANCER EPIDEM BIOMAR, V21, P1542, DOI 10.1158/1055-9965.EPI-12-0483; Lu BB, 2009, J INFECT DIS, V199, P362, DOI 10.1086/596050; Martin-Ezquerra G, 2012, EUR J DERMATOL, V22, P200, DOI 10.1684/ejd.2011.1622; McGinley KF, 2011, J AM OSTEOPATH ASSOC, V111, pS26; Morales R, 2012, CANCER EPIDEM BIOMAR, V21, P1956, DOI 10.1158/1055-9965.EPI-12-0470; Munk AC, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-30; Munk AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045114; Nicolau SM, 2005, UROLOGY, V65, P251, DOI 10.1016/j.urology.2004.09.031; Nielson CM, 2007, J INFECT DIS, V196, P1137, DOI 10.1086/521632; Nyitray AG, 2014, CURR PROBL DERMATOL, V45, P75, DOI 10.1159/000358370; Parada R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-223; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Perez-Castro S, 2013, ENFERM INFEC MICR CL; Reiter PL, 2010, CANCER EPIDEM BIOMAR, V19, P2916, DOI 10.1158/1055-9965.EPI-10-0576; Repp KK, 2012, J INFECT DIS, V205, P1287, DOI 10.1093/infdis/jis181; Arroyo LS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2713-x; Schabath MB, 2012, CANCER EPIDEM BIOMAR, V21, P102, DOI 10.1158/1055-9965.EPI-11-0591; Schillaci R, 2013, FERTIL STERIL, V100, P1236, DOI 10.1016/j.fertnstert.2013.06.042; Smith MA, 2015, J INFECT DIS, V211, P91, DOI 10.1093/infdis/jiu370; Tornu Bladu A., 2012, PROG OBSTET GINECOL, V55, P10, DOI DOI 10.1016/S0304-5013(12)73065-0; Vandepapeliere P, 2005, J INFECT DIS, V192, P2099, DOI 10.1086/498164; Zhu YP, 2017, ASIAN J ANDROL, V19, P125, DOI 10.4103/1008-682X.175092	48	7	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184492	10.1371/journal.pone.0184492	http://dx.doi.org/10.1371/journal.pone.0184492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898279	gold, Green Submitted, Green Published			2022-12-26	WOS:000410449500030
J	Blagodatskikh, KA; Kramarov, VM; Barsova, EV; Garkovenko, AV; Shcherbo, DS; Shelenkov, AA; Ustinova, VV; Tokarenko, MR; Baker, SC; Kramarova, TV; Ignatov, KB				Blagodatskikh, Konstantin A.; Kramarov, Vladimir M.; Barsova, Ekaterina V.; Garkovenko, Alexey V.; Shcherbo, Dmitriy S.; Shelenkov, Andrew A.; Ustinova, Vera V.; Tokarenko, Maria R.; Baker, Simon C.; Kramarova, Tatiana V.; Ignatov, Konstantin B.			Improved DOP-PCR (iDOP-PCR): A robust and simple WGA method for efficient amplification of low copy number genomic DNA	PLOS ONE			English	Article							CELL	Whole-genome amplification (WGA) techniques are used for non-specific amplification of low-copy number DNA, and especially for single-cell genome and transcriptome amplification. There are a number of WGA methods that have been developed over the years. One example is degenerate oligonucleotide-primed PCR (DOP-PCR), which is a very simple, fast and inexpensive WGA technique. Although DOP-PCR has been regarded as one of the pioneering methods for WGA, it only provides low genome coverage and a high allele dropout rate when compared to more modern techniques. Here we describe an improved DOP-PCR (iDOP-PCR). We have modified the classic DOP-PCR by using a new thermostable DNA polymerase (SD polymerase) with a strong strand-displacement activity and by adjustments in primers design. We compared iDOP-PCR, classic DOP-PCR and the well-established PicoPlex technique for whole genome amplification of both high-and low-copy number human genomic DNA. The amplified DNA libraries were evaluated by analysis of short tandem repeat genotypes and NGS data. In summary, iDOP-PCR provided a better quality of the amplified DNA libraries compared to the other WGA methods tested, especially when low amounts of genomic DNA were used as an input material.	[Blagodatskikh, Konstantin A.; Kramarov, Vladimir M.; Ignatov, Konstantin B.] Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia; [Kramarov, Vladimir M.; Shelenkov, Andrew A.; Ignatov, Konstantin B.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Barsova, Ekaterina V.; Garkovenko, Alexey V.; Shcherbo, Dmitriy S.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Garkovenko, Alexey V.] Genet Expertise LLC, Moscow, Russia; [Shcherbo, Dmitriy S.; Shelenkov, Andrew A.; Tokarenko, Maria R.] Evrogen JSC, Moscow, Russia; [Shcherbo, Dmitriy S.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Ustinova, Vera V.] Syntol JSC, Moscow, Russia; [Baker, Simon C.] Bioline Ltd, London, England; [Baker, Simon C.] Birkbeck Univ London, London, England; [Kramarova, Tatiana V.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden	All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University; University of London; Birkbeck University London; Stockholm University	Ignatov, KB (corresponding author), Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia.; Ignatov, KB (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	ignatovkb@bk.ru	Shelenkov, Andrey/G-2916-2011; Ignatov, Konstantin/D-9593-2018; Tokarenko, Maria/AAB-6537-2020; Ustinova, Vera V/I-9476-2014; Blagodatskikh, Konstantin A/A-4521-2011	Shelenkov, Andrey/0000-0002-7409-077X; Ignatov, Konstantin/0000-0001-8900-5278; Garkovenko, Alexey/0000-0001-6809-5999; Blagodatskikh, Konstantin/0000-0002-8732-0300	Ministry of Education and Science of Russian Federation [14.579.21.0012, RFMEFI57914X0012]; Russian State Budget [0112-2016-0006]	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian State Budget	The work was supported by the Ministry of Education and Science of Russian Federation, grant 14.579.21.0012 (ID # RFMEFI57914X0012) and by the grant 0112-2016-0006 from the Russian State Budget. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genetic Expertise LLC provided support in the form of salaries for A.V.G. and provided equipment for STR-analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syntol JSC provided support in the form of salaries for V.V.U. and reagents for NGS-analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioline Ltd provided support in the form of salaries for S.C.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.Evrogen JSC provided equipment for NGS-analysis and provided support in the form of salaries for authors E.V.B., D.S.S., A.A.S. and M.R.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bergen AW, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-24; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Deleye L, 2015, FERTIL STERIL, V104, P1276, DOI 10.1016/j.fertnstert.2015.07.1144; Deleye L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11711; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16; Huang L, 2015, ANNU REV GENOM HUM G, V16, P79, DOI 10.1146/annurev-genom-090413-025352; Ignatov KB, 2014, BIOTECHNIQUES, V57, P81, DOI 10.2144/000114198; Kamberov E, 2012, US Patent, Patent No. [8,206,913, 8]; Korfhage Christian, 2013, Curr Protoc Mol Biol, V104, DOI 10.1002/0471142727.mb0714s104; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Shojaei S. H., 2014, BMC GENOMICS, V15, P1; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Van der Aa N, 2013, GENOME MED, V5, DOI 10.1186/gm475; Zheng YM, 2011, J ZHEJIANG UNIV-SC B, V12, P1, DOI 10.1631/jzus.B1000196; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	19	19	22	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184507	10.1371/journal.pone.0184507	http://dx.doi.org/10.1371/journal.pone.0184507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892497	Green Published, Green Submitted, gold			2022-12-26	WOS:000410243200015
J	Wen, YH; Chen, Z; Lu, JF; Ables, E; Scemama, JL; Yang, LV; Lu, JQ; Hu, XH				Wen, Yuhua; Chen, Zhan; Lu, Jianfen; Ables, Elizabeth; Scemama, Jean-Luc; Yang, Li V.; Lu, Jun Q.; Hu, Xin-Hua			Quantitative analysis and comparison of 3D morphology between viable and apoptotic MCF-7 breast cancer cells and characterization of nuclear fragmentation	PLOS ONE			English	Article							MELANOMA-CELLS; FLOW CYTOMETER; DOXORUBICIN; CLASSIFICATION; MICROSCOPE	Morphological changes in apoptotic cells provide essential markers for defining and detection of apoptosis as a fundamental mechanism of cell death. Among these changes, the nuclear fragmentation and condensation have been regarded as the important markers but quantitative characterization of these changes is yet to be achieved. We have acquired confocal image stacks of 206 viable and apoptotic MCF-7 cells stained by three fluorescent dyes. Three-dimensional (3D) parameters were extracted to quantify and compare their differences in morphology. To analyze nuclear fragmentation, a new method has been developed to determine clustering of nuclear voxels in the reconstructed cells due to fluorescence intensity changes in nuclei of apoptotic cells. The results of these studies reveal that the 3D morphological changes in cytoplasm and nuclear membranes in apoptotic cells provide sensitive targets for label-free detection and staging of apoptosis. Furthermore, the clustering analysis and morphological data on nuclear fragmentation are highly useful for derivation of optical cell models and simulation of diffraction images to investigate light scattering by early apoptotic cells, which can lead to future development of label-free and rapid methods of apoptosis assay based on cell morphology.	[Wen, Yuhua; Hu, Xin-Hua] Hunan Inst Sci & Technol, Inst Adv Opt, Yueyang, Hunan, Peoples R China; [Wen, Yuhua] Hunan Inst Sci & Technol, Sch Phys, Yueyang, Hunan, Peoples R China; [Chen, Zhan; Lu, Jun Q.; Hu, Xin-Hua] East Carolina Univ, Dept Phys, Greenville, NC 27858 USA; [Lu, Jianfen; Ables, Elizabeth; Scemama, Jean-Luc] East Carolina Univ, Dept Biol, Greenville, NC USA; [Yang, Li V.] East Carolina Univ, Dept Internal Med, Brody Sch Med, Greenville, NC USA	Hunan Institute of Science & Technology; Hunan Institute of Science & Technology; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Hu, XH (corresponding author), Hunan Inst Sci & Technol, Inst Adv Opt, Yueyang, Hunan, Peoples R China.; Hu, XH (corresponding author), East Carolina Univ, Dept Phys, Greenville, NC 27858 USA.	hux@ecu.edu	wen, yu/AAJ-7482-2021	Yang, Li/0000-0002-8654-4927; Ables, Elizabeth/0000-0002-6934-9302; Hu, Xin/0000-0002-4353-9028	National Natural Science Foundation of China [51407066]; Natural Science Foundation of Hunan Province of China [13JJ6066]; China Scholarship Council [201508430226]; XHH; JLS; East Carolina University [IRA-2016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province of China(Natural Science Foundation of Hunan Province); China Scholarship Council(China Scholarship Council); XHH; JLS; East Carolina University	YW acknowledges grant support from National Natural Science Foundation of China (#51407066), Natural Science Foundation of Hunan Province of China (#13JJ6066) and China Scholarship Council (#201508430226); XHH, JLS and JQL acknowledge an internal research grant support from East Carolina University (IRA-2016).; Financial Disclosure: YW acknowledges grant support from National Natural Science Foundation of China (#51407066), Natural Science Foundation of Hunan Province of China (#13JJ6066) and China Scholarship Council (#201508430226); XHH, JLS and JQL acknowledge an internal research grant support from East Carolina University (IRA-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brock RS, 2006, J QUANT SPECTROSC RA, V102, P25, DOI 10.1016/j.jqsrt.2006.02.075; Chorna I, 2004, EXP ONCOL, V26, P111; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czeczuga-Semeniuk E, 2004, FOLIA HISTOCHEM CYTO, V42, P221; Darzynkiewicz Z, METHODS CELL BIOL, P527; Dong K, 2011, BIOMED OPT EXPRESS, V2, P1717, DOI 10.1364/BOE.2.001717; Fauver M, 2005, OPT EXPRESS, V13, P4210, DOI 10.1364/OPEX.13.004210; Feng YM, 2014, CYTOM PART A, V85A, P817, DOI 10.1002/cyto.a.22504; Hamerly G, 2003, NIPS; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Isikman SO, 2011, P NATL ACAD SCI USA, V108, P7296, DOI 10.1073/pnas.1015638108; Jacobs KM, 2009, J BIOPHOTONICS, V2, P521, DOI 10.1002/jbio.200910044; Jacobs KM, 2009, OPT LETT, V34, P2985, DOI 10.1364/OL.34.002985; Jiang WH, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.7.071102; Kosar PA, 2016, J MEMBRANE BIOL, V249, P129, DOI 10.1007/s00232-015-9855-0; Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018; Mangan AP, 1999, IEEE T VIS COMPUT GR, V5, P308, DOI 10.1109/2945.817348; Rastegar Hussein, 2013, Acta Med Iran, V51, P591; Shi HB, 2012, J AM CHEM SOC, V134, P17972, DOI 10.1021/ja3064588; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang H, 2016, PATTERN REC IN PRESS, V61, P234; Wlodkowic D, 2007, CYTOM PART A, V71A, P61, DOI 10.1002/cyto.a.20366; Yang X, 2014, BIOMED OPT EXPRESS, V5, P2172, DOI 10.1364/BOE.5.002172; Yoon J, 2015, BIOMED OPT EXPRESS, V6, P3865, DOI 10.1364/BOE.6.003865; Zhang J, 2016, OPT EXPRESS, V24, P366, DOI 10.1364/OE.24.000366; Zhang Y, 2012, INTEGR BIOL-UK, V4, P1428, DOI 10.1039/c2ib20153d	27	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184726	10.1371/journal.pone.0184726	http://dx.doi.org/10.1371/journal.pone.0184726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886199	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100181
